PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Suzuki, D; Shibata, K; Tsuchida, A; Okubo, T				Suzuki, Daisuke; Shibata, Kiyoshi; Tsuchida, Akira; Okubo, Tsuneo			Thermo-sensitive colloidal crystals composed of monodisperse colloidal silica- and poly(N-isopropyl acrylamide) gel spheres	COLLOID AND POLYMER SCIENCE			English	Article						Thermo-sensitive colloidal crystal; Thermo-sensitive hydrogel spheres; Colloidal silica spheres; Poly (N-isopropyl acrylamide); Adsorption; Segregation	TRANSMISSION ELECTRON-MICROSCOPY; PHOTONIC CRYSTALS; CRYSTALLIZATION; SUSPENSIONS; SEGREGATION; SIZE; MICROGRAVITY; TRANSITION; NUCLEATION; PARTICLES	Thermo-sensitive colloidal crystals were prepared simply and conveniently by mixing of colloidal silica spheres with a series of thermo-sensitive gel spheres, poly (N-isopropyl acrylamide) (pNIPAm, 225 similar to 1500 nm in hydrodynamic diameter, 0.5 similar to 5 mol% in degree of cross-linking and at 20 similar to 45 A degrees C) in the deionized aqueous suspension. The thermo-reversible change in the lattice spacing of colloidal crystals of monodispersed silica spheres (CS83, 103 nm in diameter) depends on the size of the admixed pNIPAm. For gel spheres with similar or less than that of the silica spheres, the lattice spacing decreased with rising temperature. On the other hand, the spacing increased with temperature for the mixtures with pNIPAm spheres of larger than the size of the silica spheres. A mechanism, which is able to explain properly the several experiments including the present work, is proposed, i.e., balancing between the weak adsorption and segregation effects of silica with gel spheres.	[Suzuki, Daisuke] Grad Sch Text Sci & Technol, Div Smart Text, Ueda, Nagano 3868567, Japan; [Suzuki, Daisuke] Shinshu Univ, Inst Fiber Engn, Interdisciplinary Cluster Cutting Edge Res, Ueda, Nagano 3868567, Japan; [Shibata, Kiyoshi; Tsuchida, Akira] Gifu Univ, Dept Appl Chem, Gifu, Gifu 5011193, Japan; [Okubo, Tsuneo] Inst Colloidal Org, Uji, Kyoto 6110012, Japan	Okubo, T (reprint author), Inst Colloidal Org, Hatoyama 3-1-112, Uji, Kyoto 6110012, Japan.	okubotsu@ybb.ne.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [22685024]	D.S. and A.T. from Japan Society for the promotion of Science for Scientific Research (B) are highly appreciated. D.S. also acknowledges Grant-in-Aid for Young Scientists (A) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (22685024).	HACHISU S, 1976, J COLLOID INTERF SCI, V55, P499, DOI 10.1016/0021-9797(76)90060-6; Suzuki D, 2012, COLLOID POLYM SCI, V290, P107, DOI 10.1007/s00396-011-2534-5; PIERANSKI P, 1983, CONTEMP PHYS, V24, P25, DOI 10.1080/00107518308227471; SOOD AK, 1991, SOLID STATE PHYS, V45, P1; LOWEN H, 1993, PHYS REV LETT, V70, P1557, DOI 10.1103/PhysRevLett.70.1557; LINDSAY HM, 1982, J CHEM PHYS, V76, P3774, DOI 10.1063/1.443417; Xia YN, 2000, ADV MATER, V12, P693, DOI 10.1002/(SICI)1521-4095(200005)12:10<693::AID-ADMA693>3.0.CO;2-J; ROSATO A, 1987, PHYS REV LETT, V58, P1038, DOI 10.1103/PhysRevLett.58.1038; WILLIAMS R, 1976, PHYS REV LETT, V37, P348, DOI 10.1103/PhysRevLett.37.348; Pelton R, 2000, ADV COLLOID INTERFAC, V85, P1, DOI 10.1016/S0001-8686(99)00023-8; Holtz JH, 1997, NATURE, V389, P829; Suzuki D, 2011, COLLOID POLYM SCI, V289, P1799, DOI 10.1007/s00396-011-2499-4; SHIBAYAMA M, 1993, ADV POLYM SCI, V109, P1; Okubo T, 1999, COLLOID SURFACE A, V153, P515, DOI 10.1016/S0927-7757(98)00474-9; DHONT JKG, 1992, J COLLOID INTERF SCI, V152, P386, DOI 10.1016/0021-9797(92)90041-J; Debord JD, 2000, J PHYS CHEM B, V104, P6327, DOI 10.1021/jp001238c; BUTLER S, 1995, PHYS REV E, V52, P6424, DOI 10.1103/PhysRevE.52.6424; OKUBO T, 1993, PROG POLYM SCI, V18, P481, DOI 10.1016/0079-6700(93)90015-5; AASTUEN DJW, 1986, PHYS REV LETT, V57, P1733, DOI 10.1103/PhysRevLett.57.1733; WILLIAMS JC, 1976, POWDER TECHNOL, V15, P245, DOI 10.1016/0032-5910(76)80053-8; Okubo T, 2002, LANGMUIR, V18, P6783, DOI 10.1021/la020315n; HILTNER PA, 1971, J PHYS CHEM-US, V75, P1881, DOI 10.1021/j100681a020; VERHAEGH NAM, 1994, LANGMUIR, V10, P1427, DOI 10.1021/la00017a019; MITAKU S, 1978, JPN J APPL PHYS, V17, P305, DOI 10.1143/JJAP.17.305; OKUBO T, 1994, ACS SYM SER, V548, P364; Gao J, 2002, LANGMUIR, V18, P1360, DOI 10.1021/la011405f; Okubo T, 2008, POLYM J, V40, P882, DOI 10.1295/polymj.PJ2007182; KOSE A, 1973, J COLLOID INTERF SCI, V44, P330, DOI 10.1016/0021-9797(73)90224-5; Shibayama M, 1998, MACROMOL CHEM PHYSIC, V199, P1; Okubo T, 2012, COLLOID POLYM SCI, V290, P1901, DOI 10.1007/s00396-012-2727-6; Crassous JJ, 2006, LANGMUIR, V22, P2403, DOI 10.1021/la053198f; OKUBO T, 1988, J CHEM SOC FARAD T 1, V84, P1163, DOI 10.1039/f19888401163; Okubo T, 2006, COLLOID POLYM SCI, V285, P351, DOI 10.1007/s00396-006-1578-4; Hellweg T, 2000, COLLOID POLYM SCI, V278, P972, DOI 10.1007/s003960000350; Xia YN, 2001, ADV MATER, V13, P369, DOI 10.1002/1521-4095(200103)13:6<369::AID-ADMA369>3.0.CO;2-T; PUSEY PN, 1986, NATURE, V320, P340, DOI 10.1038/320340a0; OKUBO T, 1986, J CHEM SOC FARAD T 1, V82, P3163, DOI 10.1039/f19868203163; Okubo T, 2011, COLLOID POLYM SCI, V289, P1273, DOI 10.1007/s00396-011-2459-z; Crassous JJ, 2008, COLLOID POLYM SCI, V286, P805, DOI 10.1007/s00396-008-1873-3; Okubo T, 2000, COLLOID POLYM SCI, V278, P202, DOI 10.1007/s003960050033; Crassous JJ, 2008, LANGMUIR, V25, P7862; Okubo T, 2002, ENCY SURFACE COLLOID, P1300; Okubo T, 2005, STRUCTURAL COLORS BI, P267; Okubo T, 2002, FORMA, V17, P141; OKUBO T, 1988, ACCOUNTS CHEM RES, V21, P281, DOI 10.1021/ar00151a005; OTTEWILL RH, 1985, BER BUNSEN PHYS CHEM, V89, P517; RUSSEL WB, 1990, PHASE TRANSIT, V21, P127, DOI 10.1080/01411599008206886; Vanderhoff W, 1970, CLEAN SURFACES THEIR, P15; Vanel L, 1997, PHYS REV LETT, V78, P1255, DOI 10.1103/PhysRevLett.78.1255	49	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	OCT	2015	293	10					2763	2769		10.1007/s00396-015-3661-1		7	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CR7YP	WOS:000361568400004		
J	Otsuka, Y; Takeuchi, M; Otsuka, M; Ben-Nissan, B; Grossin, D; Tanaka, H				Otsuka, Yuta; Takeuchi, Masaki; Otsuka, Makoto; Ben-Nissan, Besim; Grossin, David; Tanaka, Hideji			Effect of carbon dioxide on self-setting apatite cement formation from tetracalcium phosphate and dicalcium phosphate dihydrate; ATR-IR and chemoinformatics analysis	COLLOID AND POLYMER SCIENCE			English	Article						Self-setting apatite cement; Hydroxyapatite; Attenuated total reflection Fourier transform infrared spectroscopy; Principal component analysis; Crystalline transformation; Differentiated scores	CALCIUM; HYDROXYAPATITE; BEHAVIOR; RELEASE; SUBSTITUTION; SPECTROSCOPY; PHASE; SERUM	Rapid self-setting apatite cement (SSAC) formation from tetracalcium phosphate (TeCP) and dicalcium phosphate dihydrate (DCPD) has been investigated by an attenuated total reflection Fourier transform infrared (ATR-IR) spectroscopy coupled with a principal component analysis (PCA). After TeCP and DCPD were kneaded with phosphoric acid, the peaks of ATR-IR spectra for the kneaded sample shift significantly in the ranges of 2250-2400 and 850-1150 cm(-1) due to the crystalline transformation into hydroxyapatite (HAp). The PCA results indicate that the loadings of principal components 1 and 2 (PC1 and PC2, respectively) are ascribed to CO2 and phosphate group, respectively, in the transforming cement. The PC1 score initially increases to reach a maximum at around 1000 s and then decreases. In contrast, the PC2 score increases continuously, but its increment became lesser with time. Although the profiles of PC2 score against PC1 score are similar in shape, there are deviations among the profiles obtained through quadruplicate experiments. The scores are, therefore, time differentiated, and the relationship between the differentiated scores is analyzed. The time differentiation approach is found to be useful for understanding complicated chemical reactions. The PCA results suggest that SSAC formation can be divided into three major stages. In the first stage, CO2 concentration in the transforming cement rapidly increases, which triggers HAp crystallization. In the second stage, CO2 concentration still increases, but its increasing rate drastically decreases; HAp crystallization continues with increasing rate. In the last stage, CO2 concentration decreases, and HAp crystallization significantly slows down.	[Otsuka, Yuta] Univ Tokushima, Grad Sch Pharmaceut Sci, Tokushima 7708505, Japan; [Takeuchi, Masaki; Tanaka, Hideji] Univ Tokushima, Inst Hlth Biosci, Tokushima 7708505, Japan; [Otsuka, Makoto] Musashino Univ, Fac Pharm, Pharmaceut Sci Res Inst, Nishi Ku, Tokyo 2028585, Japan; [Ben-Nissan, Besim] Univ Technol Sydney, Fac Sci, Sch Chem & Forens Sci, Sydney, NSW 2007, Australia; [Grossin, David] Univ Toulouse, CIRIMAT Carnot Inst, INPT UPS CNRS UMR 5085, Toulouse, France	Otsuka, Y (reprint author), Univ Tokushima, Grad Sch Pharmaceut Sci, 1-78-1 Shomachi, Tokushima 7708505, Japan.	y.otsuka36156803@gmail.com			Aspire Travel Grant from Tokushima University Foundation	This research was partly supported by an Aspire Travel Grant from Tokushima University Foundation.	Shinzawa H, 2009, J RAMAN SPECTROSC, V40, P1720, DOI 10.1002/jrs.2525; EIDELMAN N, 1987, CALCIFIED TISSUE INT, V41, P18, DOI 10.1007/BF02555126; HONG YC, 1991, J BIOMED MATER RES, V25, P485, DOI 10.1002/jbm.820250406; Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6; Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546; Hamanishi C, 1996, J BIOMED MATER RES, V33, P139, DOI 10.1002/(SICI)1097-4636(199623)33:3<139::AID-JBM3>3.0.CO;2-R; CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603; LEGEROS RZ, 1967, SCIENCE, V155, P1409, DOI 10.1126/science.155.3768.1409; Ulian G, 2013, AM MINERAL, V98, P752, DOI 10.2138/am.2013.4315; Otsuka Y, 2013, COLLOID SURFACE B, V102, P931, DOI 10.1016/j.colsurfb.2012.07.049; Hayakawa S, 2013, ACTA BIOMATER, V9, P4856, DOI 10.1016/j.actbio.2012.08.024; DENISSEN HW, 1980, J BIOMED MATER RES, V14, P713, DOI 10.1002/jbm.820140603; WELCH MJ, 1969, J PHYS CHEM-US, V73, P3351, DOI 10.1021/j100844a033; ELLIOTT JC, 1985, CALCIFIED TISSUE INT, V37, P372, DOI 10.1007/BF02553704; Otsuka M, 1997, PHARMACEUT RES, V14, P444, DOI 10.1023/A:1012039214184; Muller L, 2007, BIOMOL ENG, V24, P462, DOI 10.1016/j.bioeng.2007.07.011; OTSUKA M, 1995, J BIOMED MATER RES, V29, P25, DOI 10.1002/jbm.820290105; Hamada H, 2012, J APPL BIOMATER FUNC, V10, P22, DOI 10.5301/JABFM.2012.9272; FUKASE Y, 1990, J DENT RES, V69, P1852, DOI 10.1177/00220345900690121201; MIYAMOTO Y, 1995, BIOMATERIALS, V16, P855, DOI 10.1016/0142-9612(95)94147-D; OTSUKA M, 1991, CHEM PHARM BULL, V39, P2753; EIDELMAN N, 1987, CALCIFIED TISSUE INT, V40, P71, DOI 10.1007/BF02555708; Ronson TK, 2002, LANGMUIR, V18, P5019, DOI 10.1021/la011676q; Otsuka M, 2012, J BIOMED MATER RES A, V100A, P2186, DOI 10.1002/jbm.a.33243; HSU J, 1994, J COLLOID INTERF SCI, V167, P414, DOI 10.1006/jcis.1994.1376; Brown W. E., 1985, US Patent, Patent No. [4518430, 4,518,430]; CAMO Software Research & Development Team, WELC UNSCR X; Doi Y, 1988, J JPN SOC DENT MAT D, V7, P176; Halaka FG, 1985, BIOPHYS J, V8, P209; LeGeros R.Z., 1991, MONOGRAPHS ORAL SCI; Martens H., 1989, MULTIVARIATE CALIBRA; Naes T., 2002, USER FRIENDLY GUIDE; Otsuka Y, BIO MED MAT IN PRESS; Petrov I, 1967, SPECTROCHIM ACTA A, V23, P2636, DOI 10.1016/0584-8539(67)80155-7	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	OCT	2015	293	10					2781	2788		10.1007/s00396-015-3616-6		8	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CR7YP	WOS:000361568400006		
J	Kitano, H; Tokuwa, K; Ueno, H; Li, L; Saruwatari, Y				Kitano, Hiromi; Tokuwa, Ken-ichi; Ueno, Haruka; Li, Lifu; Saruwatari, Yoshiyuki			Zwitterionic polymer-grafted microspheres prepared by RAFT polymerization	COLLOID AND POLYMER SCIENCE			English	Article						Anti-biofouling; Critical flocculation concentration; Iridescence; RAFT polymerization; Zwitterionic polymer-grafted microsphere	CHAIN-TRANSFER POLYMERIZATION; COLLOIDAL CRYSTALS; SILICA PARTICLES; BLOCK-COPOLYMERS; INTERFACE; EMULSION; AGENTS; CHARGE	Using a macro-RAFT agent composed of zwitterionic poly(carboxymethyl betaine) (PCMB), butyl acrylate was polymerized in emulsion polymerization system to give microspheres (PCMB-MS). Microspheres having cationic or anionic graft chains were also prepared using the similar procedures. The dispersion of PCMB-MS was very stable, and the addition of neither sodium chloride nor proteins affected colloidal properties of the MS at all. In contrast, significant salt- and protein-induced aggregations of the lopsidedly charged microspheres were observed. Upon deionization, furthermore, the dispersion of anionic poly(methacrylic acid)-grafted-MS (PMA-MS) showed clear iridescence, and its peak reflectivity was more than 90 % due to the formation of colloid crystal driven by both the electrostatic and steric repulsions between the MSs. The dispersion of PCMB-MS also showed iridescence, though its reflectivity (< 60 %) was smaller than that of PMA-MS probably because of the smaller electrostatic repulsion between PCMB-MSs than that between PMA-MSs.	[Kitano, Hiromi; Tokuwa, Ken-ichi; Ueno, Haruka; Li, Lifu] Toyama Univ, Grad Sch Sci & Engn, Dept Appl Chem, Toyama 9308555, Japan; [Saruwatari, Yoshiyuki] Osaka Organ Chem Ind Ltd, R&D Lab, Kashiwara 5820020, Japan	Kitano, H (reprint author), Toyama Univ, Grad Sch Sci & Engn, Dept Appl Chem, Toyama 9308555, Japan.	kitano@eng.u-toyama.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [20106007]; Japan Society for Promotion of Sciences (JSPS) [22350101, 26188100]	This work was supported by a Grant-in-Aid (20106007) for Scientific Research on Innovate Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan and a Grant-in-Aid (22350101 and 26188100) for Scientific Research from the Japan Society for Promotion of Sciences (JSPS). The authors are grateful to Osaka Organic Chemical Industry Ltd. for the continuous support to pursue this work.	Tandon V, 2008, ELECTROPHORESIS, V29, P1092, DOI 10.1002/elps.200700734; Tuzar Z, 1997, MACROMOLECULES, V30, P2509, DOI 10.1021/ma9615617; Barner-Kowollik C, 2008, J POLYM SCI POL CHEM, V46, P5715, DOI 10.1002/pola.22866; Makino K, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/2/023001; Patton DL, 2005, MACROMOLECULES, V38, P8597, DOI 10.1021/ma051035s; Ohno K, 2006, MACROMOLECULES, V39, P1245, DOI 10.1021/ma0521708; Fujita M, 2012, J COLLOID INTERF SCI, V368, P629, DOI 10.1016/j.jcis.2011.11.021; Yoshinaga K, 2005, LANGMUIR, V21, P4471, DOI 10.1021/la0467786; Stachurski J, 1996, J COLLOID INTERF SCI, V184, P433, DOI 10.1006/jcis.1996.0637; Mitsukami Y, 2001, MACROMOLECULES, V34, P2248, DOI 10.1021/ma0018087; Lee W, 2004, LANGMUIR, V20, P5262, DOI 10.1021/la035694e; Fujita M, 2008, MACROMOLECULES, V41, P2852, DOI 10.1021/ma7024489; Makino K, 1999, J COLLOID INTERF SCI, V218, P275, DOI 10.1006/jcis.1999.6404; Zhou NC, 2006, POLYM BULL, V57, P491, DOI 10.1007/s00289-006-0601-8; Tada S, 2009, MACROMOL BIOSCI, V9, P63, DOI 10.1002/mabi.200800150; Ohshima H, 2009, SCI TECHNOL ADV MAT, V10, DOI 10.1088/1468-6996/10/6/063001; Franks GV, 2005, LANGMUIR, V21, P8670, DOI 10.1021/la051379b; Suzuki H, 2011, COLLOID SURFACE B, V84, P111, DOI 10.1016/j.colsurfb.2010.12.023; Marinova KG, 1996, LANGMUIR, V12, P2045, DOI 10.1021/la950928i; Ferguson CJ, 2005, MACROMOLECULES, V38, P2191, DOI 10.1021/ma048787r; Lai JT, 2002, MACROMOLECULES, V35, P6754, DOI 10.1021/ma020362m; BUSSCHER HJ, 1995, COLLOID SURFACE B, V5, P111, DOI 10.1016/0927-7765(95)01224-7; Matsuoka H, 2001, MACROMOL RAPID COMM, V22, P51, DOI 10.1002/1521-3927(20010201)22:2<51::AID-MARC51>3.0.CO;2-5; Barner-Kowollik C., 2008, HDB RAFT POLYM; Fitch R. M, 1997, POLYM COLLOIDS COMPR; Hiemenz P., 1997, PRINCIPLES COLLOID S; Higgins J. S., 1994, POLYM NEUTRON SCATTE; McCormack CL, 2004, ACCOUNTS CHEM RES, V37, P312, DOI 10.1021/ar0302484; Ohshima H, 2010, BIOPHYSICAL CHEM BIO; Okuda Y, Japan Patent, Patent No. 3032155; Skey J, 2008, CHEM COMMUN, P4183, DOI 10.1039/b804260h; Perrin J., 1990, ATOMS; Uchiyama Y, Japan Patent, Patent No. 3878315; Yamakawa T, 1979, BIOCH DATA BOOK	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	OCT	2015	293	10					2931	2939		10.1007/s00396-015-3695-4		9	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CR7YP	WOS:000361568400022		
J	Morisada, S; Kojima, S; Sumi, T; Kawakita, H; Ohto, K				Morisada, Shintaro; Kojima, Shoko; Sumi, Takahiro; Kawakita, Hidetaka; Ohto, Keisuke			Fabrication of non-close-packed colloidal monolayers by convective self-assembly using cationic polyelectrolyte-grafted silica particles	COLLOID AND POLYMER SCIENCE			English	Article						Colloidal monolayer; Non-close-packed structure; Polyelectrolyte-grafted silica particle; Convective self-assembly	PATTERN-FORMATION; VINYL-ACETATE; CRYSTALS; SPHERES; SURFACES; ARRAYS; POLYMERIZATION; NANOPARTICLES; LITHOGRAPHY	Two cationic polyelectrolytes, poly((3-acrylamidopropyl)trimethylammonium chloride) (PAPTAC) and poly(vinylbenzyl trimethylammonium chloride) (PVBTA), have been grafted on the surface of the silica particles, and then these polyelectrolyte-grafted silica particles have been applied to the convective self-assembly (CSA) process using mica substrate to prepare colloidal layers. When the PAPTAC-grafted silica particles (PAPTAC-Si) were used, we obtained the colloidal monolayers with a curious pattern composed of many wiggle beads. By the CSA process using the PVBATA-grafted silica particles (PVBTA-Si), on the other hand, we succeeded in fabricating the colloidal monolayers having a somewhat constant interparticle distance, that is, a non-close-packed (NCP) structure without using any templates. Although both particles have cationic polyelectrolytes on their surfaces, the structures of the resultant colloidal monolayers are quite different from each other, indicating that the molecular structure of the grafted polymer is crucially important for the patterning of the colloidal layers through the CSA process.	[Morisada, Shintaro; Sumi, Takahiro; Kawakita, Hidetaka; Ohto, Keisuke] Saga Univ, Dept Chem & Appl Chem, Saga 8408502, Japan; [Kojima, Shoko] Tokyo Inst Technol, Dept Environm Chem & Engn, Midori Ku, Yokohama, Kanagawa 2268502, Japan	Morisada, S (reprint author), Saga Univ, Dept Chem & Appl Chem, 1 Honjyo, Saga 8408502, Japan.	morisada@cc.saga-u.ac.jp			JSPS KAKENHI [26420767]; Saga University	This work was partly supported by JSPS KAKENHI Grant Number 26420767 and Saga University Dean's Grant 2013 for promising young researchers.	Velev OD, 1999, LANGMUIR, V15, P3693, DOI 10.1021/la981729c; STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; Watanabe S, 2013, ADV POWDER TECHNOL, V24, P897, DOI 10.1016/j.apt.2013.06.001; Higashitani K, 2011, LANGMUIR, V27, P2080, DOI 10.1021/la103902z; Zhang JH, 2010, ADV MATER, V22, P4249, DOI 10.1002/adma.201000755; Xia YN, 2000, ADV MATER, V12, P693, DOI 10.1002/(SICI)1521-4095(200005)12:10<693::AID-ADMA693>3.0.CO;2-J; FEDER J, 1980, J THEOR BIOL, V87, P237, DOI 10.1016/0022-5193(80)90358-6; PHILIPSE AP, 1989, J COLLOID INTERF SCI, V128, P121, DOI 10.1016/0021-9797(89)90391-3; Wong S, 2003, J AM CHEM SOC, V125, P15589, DOI 10.1021/ja0379969; Dimitrov AS, 1996, LANGMUIR, V12, P1303, DOI 10.1021/la9502251; Cai ZY, 2014, ACS APPL MATER INTER, V6, P10265, DOI 10.1021/am501672e; Jiang P, 2005, J AM CHEM SOC, V127, P3710, DOI 10.1021/ja042789+; Li F, 2011, ANGEW CHEM INT EDIT, V50, P360, DOI 10.1002/anie.201001451; Bansmann J, 2007, LANGMUIR, V23, P10150, DOI 10.1021/la7012304; Nguyen V, 2003, J APPL POLYM SCI, V87, P300, DOI 10.1002/app.11376; Morisada S, 2011, IND ENG CHEM RES, V50, P12358, DOI 10.1021/ie200779w; BROWNE T, 1992, J APPL POLYM SCI, V44, P671, DOI 10.1002/app.1992.070440414; Kralchevsky PA, 2001, CURR OPIN COLLOID IN, V6, P383, DOI 10.1016/S1359-0294(01)00105-4; Meijer JM, 2012, LANGMUIR, V28, P7631, DOI 10.1021/la3007052; Joannopoulos JD, 1997, NATURE, V386, P143, DOI 10.1038/386143a0; Yin YD, 2001, J AM CHEM SOC, V123, P8718, DOI 10.1021/ja011048v; Baksh MM, 2004, NATURE, V427, P139, DOI 10.1038/nature02209; Lin SY, 1998, SCIENCE, V282, P274, DOI 10.1126/science.282.5387.274; Tan BJY, 2004, J PHYS CHEM B, V108, P18575, DOI 10.1021/jp0475741; Zhang H, 2006, PHYS CHEM CHEM PHYS, V8, P3288, DOI 10.1039/b604745a; Yan X, 2005, J AM CHEM SOC, V127, P7688, DOI 10.1021/ja0428208; Schaak RE, 2004, LANGMUIR, V20, P7293, DOI 10.1021/la049466b; Watanabe S, 2009, LANGMUIR, V25, P7287, DOI 10.1021/la900315h; Jiang P, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2218832; Joannopoulos JD, 2001, NATURE, V414, P257, DOI 10.1038/35104718; Jiang P, 1999, CHEM MATER, V11, P2132, DOI 10.1021/cm990080+; Brewer DD, 2011, LANGMUIR, V27, P11660, DOI 10.1021/la202040x; Plettl A, 2009, ADV FUNCT MATER, V19, P3279, DOI 10.1002/adfm.200900907; Sun SH, 2000, SCIENCE, V287, P1989, DOI 10.1126/science.287.5460.1989	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	OCT	2015	293	10					2985	2993		10.1007/s00396-015-3706-5		9	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CR7YP	WOS:000361568400028		
J	Nakayama, N; Kawashima, M; Kaido, M; Arita, R; Tsubota, K				Nakayama, Naohiko; Kawashima, Motoko; Kaido, Minako; Arita, Reiko; Tsubota, Kazuo			Analysis of Meibum Before and After Intraductal Meibomian Gland Probing in Eyes With Obstructive Meibomian Gland Dysfunction	CORNEA			English	Article						meibomian gland dysfunction; meibum; intraductal probing	INTERNATIONAL WORKSHOP; DRY EYE; SUBCOMMITTEE; MANAGEMENT; LIPIDS	Purpose:To evaluate whether the amount of meibum and its viscosity change after intraductal meibomian gland probing in patients with refractory obstructive meibomian gland dysfunction (o-MGD).Methods:Six lid margins of 3 patients with refractory o-MGD underwent intraductal meibomian gland probing. Meibum and the clinical outcome were evaluated before the procedure and at a 1-month postoperative visit. Meibum was quantified with a Meibometer, and its viscosity (Shimazaki grade) was assessed simultaneously. The tear film condition was evaluated by lipid layer interferometry (DR1, Kowa, Nagoya, Japan), and meibomian gland loss was analyzed by noncontact infrared meibography. Lid margin findings, tear break-up time, fluorescein score, and ocular symptoms were also assessed.Results:At the postoperative visits, all cases showed improvements in meibum lipid levels (446-1376, 757-802, and 396-571 meibometer units) and meibum viscosity (grade 3-0, 3-1, and 3-2). Two cases showed an improvement in tear break-up time (2-5 and 0-6 seconds). No morphological changes in the meibomian gland were observed in any cases.Conclusions:Intraductal meibomian gland probing seems to improve meibomian gland lipid levels, and it may be a good treatment option for cases of o-MGD that are resistant to conventional treatment.	[Nakayama, Naohiko; Kawashima, Motoko; Kaido, Minako; Arita, Reiko; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo 1608582, Japan	Kawashima, M (reprint author), Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	motoko-k@a3.keio.jp					Butovich IA, 2013, EXP EYE RES, V117, P4, DOI 10.1016/j.exer.2013.05.010; Goto E, 2003, ARCH OPHTHALMOL-CHIC, V121, P173; Maskin SL, 2010, CORNEA, V29, P1145, DOI 10.1097/ICO.0b013e3181d836f3; Wladis EJ, 2012, OPHTHAL PLAST RECONS, V28, P416, DOI 10.1097/IOP.0b013e3182627ebc; Sakane Y, 2013, JAMA OPHTHALMOL, V131, P1331, DOI 10.1001/jamaophthalmol.2013.4503; Shimazaki J, 1998, OPHTHALMOLOGY, V105, P1485, DOI 10.1016/S0161-6420(98)98033-2; Arita R, 2013, JAMA OPHTHALMOL, V131, P818, DOI 10.1001/jamaophthalmol.2013.1895; Pucker AD, 2012, OCUL SURF, V10, P230, DOI 10.1016/j.jtos.2012.07.004; Knop E, 2011, INVEST OPHTH VIS SCI, V52, P1938, DOI 10.1167/iovs.10-6997c; Eom Y, 2014, CORNEA, V33, P448, DOI 10.1097/ICO.0000000000000092; Guillon M, 2012, EYE CONTACT LENS, V38, P319, DOI 10.1097/ICL.0b013e318268305a; Geerling G, 2011, INVEST OPHTH VIS SCI, V52, P2050, DOI 10.1167/iovs.10-6997g; Arita R, 2008, OPHTHALMOLOGY, V115, P911, DOI [10.1016/j.ophtha.2007.06.031, 10.1016/j.ophtha.2007.06.03]; CHEW CKS, 1992, INVEST OPHTH VIS SCI, V33, P950; Fermon S, 2015, Arch Soc Esp Oftalmol, V90, P76, DOI 10.1016/j.oftal.2014.04.014; Oleñik Andrea, 2014, Clin Ophthalmol, V8, P831, DOI 10.2147/OPTH.S62470	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0277-3740	1536-4798		CORNEA	Cornea	OCT	2015	34	10					1206	1208		10.1097/ICO.0000000000000558		3	Ophthalmology	Ophthalmology	CR7MF	WOS:000361533500004		
J	Liu, Y; Hirayama, M; Cui, X; Connell, S; Kawakita, T; Tsubota, K				Liu, Ying; Hirayama, Masatoshi; Cui, Xin; Connell, Samuel; Kawakita, Tetsuya; Tsubota, Kazuo			Effectiveness of Autologous Serum Eye Drops Combined With Punctal Plugs for the Treatment of Sjogren Syndrome-Related Dry Eye	CORNEA			English	Article						dry eye; Sjogren syndrome-related dry eye; autologous serum eye drops; long-term treatment; punctal plugs	OCULAR SURFACE; KERATOCONJUNCTIVITIS SICCA; TEAR FLUID; DISEASE; EFFICACY; OCCLUSION	Purpose:To evaluate the efficacy and safety of autologous serum (AS) eye drops combined with punctal plugs (PPs) in patients with Sjogren syndrome (SS)-related dry eye.Methods:A retrospective clinical study was performed in patients with dry eye caused by SS. We evaluated the Schirmer test value, tear breakup time (tBUT), and fluorescein and Rose Bengal (RB) staining scores at baseline, 3 months, 6 months, 1 year, and >1 year after treatment. The dry eye indexes were also evaluated in 2 subgroups, which determined by the using of PPs, including the AS + PP group and AS only group.Results:A total of 56 eyes of 28 patients were investigated with a mean follow-up of 42.3 26.1 months. After the application of AS eye drops, the Schirmer test showed no significant changes. The tBUT (2.7 +/- 1.9 seconds) was significantly improved at each time point (3.9 +/- 3.1, 4.5 +/- 3.1, 3.7 +/- 2.5, and 5.1 +/- 4.0; P < 0.01), fluorescein staining (4.3 +/- 2.8) was significantly improved at each time point (2.2 +/- 2.2, 1.9 +/- 1.9, 1.8 +/- 1.6, and 1.8 +/- 1.8; P < 0.01), and RB (2.6 +/- 3.0) staining was significantly improved from 6-month treatment (1.5 +/- 1.9, 1.9 +/- 1.9, and 1.4 +/- 1.8; P < 0.05, 0.01, and 0.01, respectively). When combined with PPs, the tBUT and RB staining scores were found to be significantly improved in the AS + PP group compared with those of the AS only group.Conclusions:Long-term application of AS eye drops was found to be an effective and apparently safe treatment for SS dry eye. Furthermore, PPs in combination with AS eye drops were considered to have an additive effect on SS dry eye.	[Liu, Ying; Hirayama, Masatoshi; Connell, Samuel; Kawakita, Tetsuya; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo 1608582, Japan; [Cui, Xin] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA	Kawakita, T (reprint author), Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	kawakita@a2.keio.jp			Ishidsu Shun Memorial Scholarship, Japan	Supported by Ishidsu Shun Memorial Scholarship, Japan. Statistical analysis was supported by the Center for Clinical Research, Department of Preventive Medicine and Public Health, Keio University School.	Tsubota K, 1999, BRIT J OPHTHALMOL, V83, P390, DOI 10.1136/bjo.83.4.390; Dogru M, 2011, EXPERT OPIN PHARMACO, V12, P325, DOI 10.1517/14656566.2010.518612; Danjo Y, 1997, GRAEF ARCH CLIN EXP, V235, P761, DOI 10.1007/BF02332860; Stern ME, 1998, CORNEA, V17, P584, DOI 10.1097/00003226-199811000-00002; TSUBOTA K, 1991, AM J OPHTHALMOL, V111, P106; [Anonymous], 2013, PAN DRY EYE SYNDR PR; Leite SC, 2006, BONE MARROW TRANSPL, V38, P223, DOI 10.1038/sj.bmt.1705426; Gupta A, 1996, CURR EYE RES, V15, P605, DOI 10.3109/02713689609008900; Jirsova K, 2014, CURR EYE RES, V39, P21, DOI 10.3109/02713683.2013.824987; Mansour K, 2007, CORNEA, V26, P147, DOI 10.1097/01.ico.0000244877.30997.6a; Higuchi A, 2007, CURR EYE RES, V32, P83, DOI 10.1080/02713680601147690; Akpek EK, 2011, OPHTHALMOLOGY, V118, P1242, DOI 10.1016/j.ophtha.2010.12.016; Takamura E, 2002, ADV EXP MED BIOL, V506, P1247; Ziakas NG, 2010, CLIN EXP OPHTHALMOL, V38, P683, DOI 10.1111/j.1442-9071.2010.02304.x; Ogawa Y, 2003, BONE MARROW TRANSPL, V31, P579, DOI 10.1038/sj.bmt.1703862; Lee GA, 2008, CLIN EXP OPHTHALMOL, V36, P119, DOI 10.1111/j.1442-9071.2008.01680.x; Salman IA, 2010, CUTAN OCUL TOXICOL, V29, P116, DOI 10.3109/15569521003709558; Kojima T, 2005, AM J OPHTHALMOL, V139, P242, DOI 10.1016/j.ajo.2004.08.040; Tananuvat N, 2001, CORNEA, V20, P802, DOI 10.1097/00003226-200111000-00005; Solomon A, 2001, INVEST OPHTH VIS SCI, V42, P2283; Borchers AT, 2003, CLIN REV ALLERG IMMU, V25, P89, DOI 10.1385/CRIAI:25:1:89; Kojima T, 2014, AM J OPHTHALMOL, V157, P311, DOI 10.1016/j.ajo.2013.10.019; Gaynes BI, 2002, DRUG SAFETY, V25, P233, DOI 10.2165/00002018-200225040-00002; FOX RI, 1984, ARTHRITIS RHEUM, V27, P459, DOI 10.1002/art.1780270415; Roberts CW, 2007, CORNEA, V26, P805, DOI 10.1097/ICO.0b013e318074e460; Roescher N, 2009, ORAL DIS, V15, P519, DOI 10.1111/j.1601-0825.2009.01582.x; Tsubota K, 1999, OPHTHALMOLOGY, V106, P1984, DOI 10.1016/S0161-6420(99)90412-8; Celebi ARC, 2014, GRAEF ARCH CLIN EXP, V252, P619, DOI 10.1007/s00417-014-2599-1; Ervin AM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006775.pub2; Geerling G, 2004, BRIT J OPHTHALMOL, V88, P1467, DOI 10.1136/bjo.2004.044347; Pflugfelder Stephen C, 2003, Ocul Surf, V1, P31; Quinto GG, 2008, ARQ BRAS OFTALMOL, V71, P47, DOI 10.1590/S0004-27492008000700010	32	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0277-3740	1536-4798		CORNEA	Cornea	OCT	2015	34	10					1214	1220		10.1097/ICO.0000000000000542		7	Ophthalmology	Ophthalmology	CR7MF	WOS:000361533500006		
J	Nakagawa, H; Hattori, T; Koike, N; Ehara, T; Fujita, K; Takahashi, H; Kumakura, S; Kuroda, M; Matsumoto, T; Goto, H				Nakagawa, Hayate; Hattori, Takaaki; Koike, Naohito; Ehara, Tomoko; Fujita, Koji; Takahashi, Hiroki; Kumakura, Shigeto; Kuroda, Masahiko; Matsumoto, Tetsuya; Goto, Hiroshi			Investigation of the Role of Bacteria in the Development of Acanthamoeba Keratitis	CORNEA			English	Article						Acanthamoeba keratitis; bacteria; Fungiflora Y; animal model; contact lens	FREE-LIVING AMEBAS; QUANTITATIVE PCR; RAPID DETECTION; FUNGIFLORA Y; ENDOSYMBIONTS; WATER; INFECTIONS; DIAGNOSIS; MEMBERS	Purpose:Recently, much interest has been shown in bacteria extracted from Acanthamoeba strains isolated from patients with Acanthamoeba keratitis (AK). We hypothesized that the bacteria in Acanthamoeba strains may be a contributing factor in the development of AK. To prove this hypothesis, we investigated the involvement of bacteria harbored by Acanthamoeba in causing progressive ocular infection in rabbit corneas.Methods:One Acanthamoeba strain (T4 genotype) that harbored bacteria was isolated from a patient with AK. The Acanthamoeba strain pretreated or not pretreated with levofloxacin (LVFX) was inoculated into rabbit corneas. We also tested the effect of LVFX eye drops on keratitis induced by the Acanthamoeba strain. The infected rabbit eyes were evaluated for clinical scores, Acanthamoeba 18S rDNA and bacterial 16S rDNA numbers were analyzed by the real-time polymerase chain reaction, and the presence of Acanthamoeba was analyzed by histological examination.Results:Inoculation of nonpretreated Acanthamoeba resulted in severe keratitis. In contrast, inoculation of LVFX-pretreated Acanthamoeba did not induce keratitis (mean clinical score, 17.3 vs. 2.3; P < 0.05). Rabbit corneas inoculated with nonpretreated Acanthamoeba followed by topical LVFX therapy developed severe keratitis. In corneas inoculated with nonpretreated Acanthamoeba followed by LVFX therapy, the number of Acanthamoeba 18S rDNA copies was significantly higher than in other groups (P < 0.05), whereas the bacterial 16S rDNA gene was undetectable. Acanthamoeba cysts were detected by Fungiflora Y staining only in corneas inoculated with nonpretreated Acanthamoeba followed by LVFX therapy.Conclusions:These results suggest that the presence of bacteria in Acanthamoeba may be required for the development of AK.	[Nakagawa, Hayate; Hattori, Takaaki; Takahashi, Hiroki; Kumakura, Shigeto; Goto, Hiroshi] Tokyo Med Univ, Dept Ophthalmol, Shinjuku Ku, Tokyo 1608402, Japan; [Koike, Naohito; Ehara, Tomoko; Matsumoto, Tetsuya] Tokyo Med Univ, Dept Microbiol, Shinjuku Ku, Tokyo 1608402, Japan; [Fujita, Koji; Kuroda, Masahiko] Tokyo Med Univ, Dept Mol Pathol, Shinjuku Ku, Tokyo 1608402, Japan	Nakagawa, H (reprint author), Tokyo Med Univ Hosp, Dept Ophthalmol, Shinjuku Ku, 6-7-1 Nishi Shinjuku, Tokyo 1600023, Japan.	rocklife1031@yahoo.co.jp					Ren MY, 2010, YONSEI MED J, V51, P121, DOI 10.3349/ymj.2010.51.1.121; Chong Eva-Marie, 2007, International Ophthalmology Clinics, V47, P33, DOI 10.1097/IIO.0b013e318036bcf4; Vural A, 2007, CLIN EXP OPHTHALMOL, V35, P749, DOI 10.1111/j.1442-9071.2007.01620.x; Molmeret M, 2005, APPL ENVIRON MICROB, V71, P20, DOI 10.1128/AEM.71.1.20-28.2005; La Scola B, 1999, LANCET, V353, P1330, DOI 10.1016/S0140-6736(99)00906-X; JOHNSON MK, 1990, CURR EYE RES, V9, P1107, DOI 10.3109/02713689008997584; Sugita S, 2011, BRIT J OPHTHALMOL, V95, P345, DOI 10.1136/bjo.2009.171504; Inoue T, 1999, BRIT J OPHTHALMOL, V83, P632; Takai K, 2000, APPL ENVIRON MICROB, V66, P5066, DOI 10.1128/AEM.66.11.5066-5072.2000; Scheid P, 2008, PARASITOL RES, V102, P945, DOI 10.1007/s00436-007-0858-3; Said NA, 2004, CURR EYE RES, V29, P429, DOI 10.1080/02713680490522470; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; ALIZADEH H, 1995, CORNEA, V14, P180; Tu EY, 2009, AM J OPHTHALMOL, V148, P13, DOI 10.1016/j.ajo.2009.01.020; Barker J, 1999, FEMS MICROBIOL LETT, V173, P291, DOI 10.1016/S0378-1097(99)00076-2; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; Fritsche TR, 1999, APPL ENVIRON MICROB, V65, P206; Steinert M, 1998, APPL ENVIRON MICROB, V64, P2256; Schroeder JM, 2001, J CLIN MICROBIOL, V39, P1903, DOI 10.1128/JCM.39.5.1903-1911.2001; Okude M, 2012, MICROBES ENVIRON, V27, P423, DOI 10.1264/jsme2.ME11353; Polat ZA, 2007, PARASITOL RES, V101, P1621, DOI 10.1007/s00436-007-0704-7; Shiraishi A, 2009, BRIT J OPHTHALMOL, V93, P1563, DOI 10.1136/bjo.2009.158113; LARKIN DFP, 1990, BRIT J OPHTHALMOL, V74, P551, DOI 10.1136/bjo.74.9.551; Sharma R, 2013, OPTOMETRY VISION SCI, V90, pE53, DOI 10.1097/OPX.0b013e31827f15b4; Alsam S, 2006, J MED MICROBIOL, V55, P689, DOI 10.1099/jmm.0.46497-0; Schmitz-Esser S, 2008, APPL ENVIRON MICROB, V74, P5822, DOI 10.1128/AEM.01093-08; Ikeda Y, 2012, OPHTHALMOLOGY, V119, P1111, DOI 10.1016/j.ophtha.2011.12.023; Khan NA, 2006, FEMS MICROBIOL REV, V30, P564, DOI 10.1111/j.1574-6976.2006.00023.x; Booton GC, 2002, J CLIN MICROBIOL, V40, P1621, DOI 10.1128/JCM.40.5.1621-1625.2002; Iovieno A, 2010, OPHTHALMOLOGY, V117, P445, DOI 10.1016/j.ophtha.2009.08.033; Awwad Shady T, 2007, Eye Contact Lens, V33, P1, DOI 10.1097/ICL.0b013e31802b64c1; Buchner P, 1953, ANN APP BIOL, V41, P223; Clinical and Laboratory Standards Institute, 2012, M100S22 CLSI, P32; Foulks Gary N, 2007, Eye Contact Lens, V33, P412, DOI 10.1097/ICL.0b013e318157e8be; Foulks GN, 2007, EYE CONTACT LENS, V33, P24; Horn M, 2004, J EUKARYOT MICROBIOL, V51, P509, DOI 10.1111/j.1550-7408.2004.tb00278.x; Lee B, 2009, CORNEA, V29, P210; Martinez AJ, 1997, BRAIN PATHOL, V7, P583, DOI 10.1111/j.1750-3639.1997.tb01076.x; Olofsson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078873; Winiecka-Krusnell J, 2001, RES MICROBIOL, V152, P613, DOI 10.1016/S0923-2508(01)01240-2	40	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0277-3740	1536-4798		CORNEA	Cornea	OCT	2015	34	10					1308	1315		10.1097/ICO.0000000000000541		8	Ophthalmology	Ophthalmology	CR7MF	WOS:000361533500021		
J	Garrote, M; Kimura, C; Matsui, K; Sandoval, AM; Takamori, E				Garrote, Marta; Kimura, Chieko; Matsui, Kengo; Sandoval, Antonio Moreno; Takamori, Emi			C-ORAL-JAPON: Corpus of Spontaneous Spoken Japanese	CORPUS LINGUISTICS AND LINGUISTIC THEORY			English	Article						corpus linguistics; Japanese; spontaneous spoken corpus; linguistic resources	OF-THE-ART	Research on Language Technologies demands a wide range of linguistic resources. C-ORAL-JAPON is a corpus of spontaneous spoken Japanese. It has more than 12 recording hours and 149,380 words, divided into three types of texts: monologues, dialogues and conversations. The corpus is made up of 39 text files (transcription) aligned with the corresponding audio files. In total, 59 Japanese native speakers of different ages have participated in the corpus recordings. Thanks to its characteristics, this corpus is an ideal resource for linguistic or sociolinguistic studies, or to be used as working material in teaching Japanese as a foreign language.	[Garrote, Marta] Univ Autonoma Madrid, Philol & Didact Dept, EFL, E-28049 Madrid, Spain; [Kimura, Chieko] Univ Autonoma Madrid, Japanese, E-28049 Madrid, Spain; [Matsui, Kengo] Tokyo Univ Foreign Studies, Fuchu, Tokyo, Japan; [Sandoval, Antonio Moreno] Univ Autonoma Madrid, Lab Linguist Informat, E-28049 Madrid, Spain; [Sandoval, Antonio Moreno] UAM Spanish Treebank & Spanish, Madrid, Spain	Garrote, M (reprint author), Univ Autonoma Madrid, E-28049 Madrid, Spain.	marta.garrote@uam.es			Spanish Government [TIN2010-20644-C03-03]; Madrid Regional Government [S2009/TIC-1542]; UAM-Santander grant	This research has been supported by the Spanish Government (TIN2010-20644-C03-03), the Madrid Regional Government (S2009/TIC-1542) and a UAM-Santander grant. The project has been directed by Dr. Antonio Moreno Sandoval and developed by the Computational Linguistics Lab at University Autonoma of Madrid (LLI-UAM). We are grateful for the collaboration of the Tokyo University of Foreign Studies for providing the natural recording environment. We want to thank Prof. T. Takagaki for his support. All authors except Kengo Matsui are from UAM.	Huang CR, 2006, LANG RESOUR EVAL, V40, P203, DOI 10.1007/s10579-007-9041-9; Tokunaga T, 2008, LANG RESOUR EVAL, V42, P109, DOI 10.1007/s10579-008-9071-y; Baker Paul, 2010, SOCIOLINGUISTICS COR; Campillos Leonardo, 2010, ESPANOL ORAL CONTEXT, V1; Cresti Emanuela, 2005, C ORAL ROM INTEGRATE; Garrote Marta, 2010, CORPUS HABLA INFANTI; Garrote Marta, DISFLUENCIAS D UNPUB; Gonzalez Ledesma Ana, 2009, MARCADORES DISCURSO; Maekawa K., 2003, P ISCA IEEE WORKSH S, P7; Marcos Marin Francisco, 1993, LIT LINGUISTIC COMPU, V8, P283; Matsumoto Y., 2007, CHASEN MORPHOLOGICAL; McEnery T., 2006, CORPUS BASED LANGUAG; Milroy L., 2003, SOCIOLINGUISTICS MET; Moreno Antonio, 2005, C ORAL ROM INTEGRATE, P135; Spanger P, 2012, LANG RESOUR EVAL, V46, P461, DOI 10.1007/s10579-010-9134-8; Takamori Emi, 2012, WORKING PAPERS CORPU, V8, P263; Takamori Emi, 2012, JAPANESE LANGUAGE ED, V16	17	0	0	DE GRUYTER MOUTON	BERLIN	GENTHINER STRASSE 13, 10785 BERLIN, GERMANY	1613-7027	1613-7035		CORPUS LINGUIST LING	Corpus Linguist. Linguist. Theo.	OCT	2015	11	2					373	392		10.1515/cllt-2013-0004		20	Linguistics; Language & Linguistics	Linguistics	CS0IF	WOS:000361741500008		
J	Araki, E; Inagaki, N; Tanizawa, Y; Oura, T; Takeuchi, M; Imaoka, T				Araki, E.; Inagaki, N.; Tanizawa, Y.; Oura, T.; Takeuchi, M.; Imaoka, T.			Efficacy and safety of once-weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once-daily insulin glargine in Japanese patients with type 2 diabetes: a randomized, open-label, phase III, non-inferiority study	DIABETES OBESITY & METABOLISM			English	Article						dulaglutide; GLP-1 receptor agonist; insulin glargine; type 2 diabetes	PEPTIDE-1 ANALOG LIRAGLUTIDE; CONTROLLED-TRIAL; RECEPTOR AGONISTS; WEEKLY ALBIGLUTIDE; GLYCEMIC CONTROL; ASIAN PATIENTS; BASAL INSULIN; DOUBLE-BLIND; METFORMIN; GLP-1	Aims: To evaluate 0.75 mg of dulaglutide, a once-weekly glucagon-like peptide-1 receptor agonist, compared with once-daily insulin glargine for glycaemic control in Japanese patients with type 2 diabetes (T2D). Methods: In this phase III, randomized, open-label, parallel-group, 26-week study, 361 patients with inadequately controlled T2D receiving sulphonyl-ureas and/or biguanides, aged >= 20 years, with glycated haemoglobin (HbA1c) levels 7.0-10.0% (53-86 mmol/mol), inclusive, were randomized (1 : 1) to receive dulaglutide or glargine. Participants and investigators were not masked to treatment allocation. The primary measure was change from baseline in HbA1c at 26 weeks, analysed using a mixed-effects model for repeated measures, with a predefined non-inferiority margin of 0.4%. Results: At week 26, least-squares (LS) mean (standard error) reductions in HbA1c were -1.44 (0.05)% [-15.74 (0.55) mmol/mol] in the dulaglutide group and -0.90 (0.05)% [-9.84 (0.55) mmol/mol] in the glargine group. The mean between-group treatment difference in HbA1c was -0.54% (95% CI -0.67, -0.41) [-5.90 mmol/mol (95% CI -7.32, -4.48)]; p<0.001. Dulaglutide significantly reduced body weight compared with glargine at week 26 (LS mean difference -1.42 kg, 95% CI -1.89, -0.94; p<0.001). The most frequent adverse events with dulaglutide treatment were nasopharyngitis and gastrointestinal symptoms. The incidence of hypoglycaemia was significantly lower with dulaglutide [47/181 (26%)] compared with glargine [86/180 (48%)], p<0.001. Conclusion: In Japanese patients with T2D uncontrolled on sulphonylureas and/or biguanides, once-weekly dulaglutide was superior to once-daily glargine for reduction in HbA1c at 26 weeks. Although dulaglutide increased gastrointestinal symptoms, it was well tolerated, with an acceptable safety profile.	[Araki, E.] Kumamoto Univ, Fac Life Sci, Dept Metab Med, Kumamoto, Japan; [Inagaki, N.] Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto, Japan; [Tanizawa, Y.] Yamaguchi Univ, Grad Sch Med, Div Endocrinol Metab Hematol Sci & Therapeut, Yamaguchi, Japan; [Oura, T.; Takeuchi, M.; Imaoka, T.] Eli Lilly Japan KK, Chuo Ku, Kobe, Hyogo 6510086, Japan	Takeuchi, M (reprint author), Eli Lilly Japan KK, Chuo Ku, 7-1-5 Isogamidori, Kobe, Hyogo 6510086, Japan.	takeuchi_masakazu@yahoo.co.jp			Eli Lilly K.K. (Kobe, Japan)	This trial was sponsored by Eli Lilly K.K. (Kobe, Japan). We thank the trial investigators, trial staff and trial participants for their contributions. We would also like to thank Miwa Sakaridani for clinical trial management of the study and Mary K. Re of inVentiv Health Clinical (Ann Arbor, MI, USA) for assisting with medical writing and the preparation of tables and figures.	Childs BP, 2005, DIABETES CARE, V28, P1245; Glaesner W, 2010, DIABETES-METAB RES, V26, P287, DOI 10.1002/dmrr.1080; Mudaliar S, 2009, AM J MED, V122, P25, DOI 10.1016/j.amjmed.2009.03.014; Kadowaki T, 2011, J DIABETES INVEST, V2, P210, DOI 10.1111/j.2040-1124.2010.00084.x; Diamant M, 2010, LANCET, V375, P2234, DOI 10.1016/S0140-6736(10)60406-0; Giorgino F, 2014, DIABETES, V63, pA87; Inagaki N, 2012, CLIN THER, V34, P1892, DOI 10.1016/j.clinthera.2012.07.007; Seino Y, 2012, DIABETES OBES METAB, V14, P910, DOI 10.1111/j.1463-1326.2012.01618.x; Umpierrez G, 2014, DIABETES CARE, V37, P2168, DOI 10.2337/dc13-2759; Heine RJ, 2005, ANN INTERN MED, V143, P559; Nauck M, 2014, DIABETES CARE, V37, P2149, DOI 10.2337/dc13-2761; Kaku K, 2011, J DIABETES INVEST, V2, P441, DOI 10.1111/j.2040-1124.2011.00128.x; Bloomgarden Z, 2014, J DIABETES, V6, P271, DOI 10.1111/1753-0407.12152; Rosenstock J, 2005, DIABETES CARE, V28, P950, DOI 10.2337/diacare.28.4.950; Lorenz M, 2013, BIOORG MED CHEM LETT, V23, P4011, DOI 10.1016/j.bmcl.2013.05.022; Wysham C, 2014, DIABETES CARE, V37, P2159, DOI 10.2337/dc13-2760; Russell-Jones D, 2009, DIABETOLOGIA, V52, P2046, DOI 10.1007/s00125-009-1472-y; Nauck M, 2013, DIABETIC MED, V30, P109, DOI 10.1111/dme.12003; Kaku K, 2010, DIABETES OBES METAB, V12, P341, DOI 10.1111/j.1463-1326.2009.01194.x; Weissman P, 2014, DIABETOLOGIA, V57, P2475, DOI 10.1007/s00125-014-3360-3; [Anonymous], 2012, DIABETES CARE, DOI [DOI 10.2337/DC12-041.3, 10.2337/dc12-0413]; Seino Y, 2010, CURR MED RES OPIN, V26, P1013, DOI 10.1185/03007991003672551; Dungan KM, 2014, LANCET, V384, P1349, DOI 10.1016/S0140-6736(14)60976-4; Ji LN, 2013, J DIABETES INVEST, V4, P53, DOI 10.1111/j.2040-1124.2012.00238.x; Madsbad S, 2011, DIABETES OBES METAB, V13, P394, DOI 10.1111/j.1463-1326.2011.01357.x; Gutzwiller JP, 2004, PHYSIOL BEHAV, V82, P17, DOI 10.1016/j.physbeh.2004.04.019; Pratley RE, 2014, LANCET DIABETES ENDO, V2, P289, DOI 10.1016/S2213-8587(13)70214-6; Odawara M, 2012, DIABETES TECHNOL THE, V14, P635, DOI 10.1089/dia.2011.0220; Lund A, 2014, EUR J INTERN MED, V25, P407, DOI 10.1016/j.ejim.2014.03.005; Odawara M, 2011, DIABETES TECHNOL THE, V13, P67, DOI 10.1089/dia.2010.0170; Terauchi Y, 2014, ENDOCR J, V61, P949; AstraZeneca K.K., 2015, BYDUREON; AstraZeneca K.K., 2015, BYETTA; Eli Lilly and Company Houten, 2014, TRULICITY; Kawamori R, 2003, J CLIN THER MED, V19, P445; Lilly USA LLC Indianapolis, 2014, TRULICITY; MacDonald PE, 2002, DIABETES, V51, pS434, DOI 10.2337/diabetes.51.2007.S434; Novo Nordisk Pharma Ltd Tokyo, 2014, VICTOZA; Onishi Y, 2015, J DIABETES INVEST, V6, P201, DOI 10.1111/jdi.12275; Sanofi K.K., 2014, LYXUMIA; The Japan Diabetes Society, 2013, TREATM GUID DIAB 201; World Medical Association Declaration of Helsinki, 1997, JAMA-J AM MED ASSOC, V277, P925	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-8902	1463-1326		DIABETES OBES METAB	Diabetes Obes. Metab.	OCT	2015	17	10								10.1111/dom.12540		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CR9TV	WOS:000361700800010		
J	Ikeda, S; Takano, Y; Cynshi, O; Tanaka, R; Christ, AD; Boerlin, V; Beyer, U; Beck, A; Ciorciaro, C; Meyer, M; Kadowaki, T				Ikeda, S.; Takano, Y.; Cynshi, O.; Tanaka, R.; Christ, A. D.; Boerlin, V.; Beyer, U.; Beck, A.; Ciorciaro, C.; Meyer, M.; Kadowaki, T.			A novel and selective sodium-glucose cotransporter-2 inhibitor, tofogliflozin, improves glycaemic control and lowers body weight in patients with type 2 diabetes mellitus	DIABETES OBESITY & METABOLISM			English	Article						drug development; phase I-II study; SGLT2 inhibitor; type 2 diabetes	CANAGLIFLOZIN MONOTHERAPY; SGLT2 INHIBITION; DOUBLE-BLIND; DAPAGLIFLOZIN; SAFETY; EFFICACY; METFORMIN; EXERCISE; PLACEBO; TRIAL	Aim: To assess the efficacy, safety and tolerability of different doses of tofogliflozin, a novel, highly selective sodium-glucose cotransporter 2 (SGLT2) inhibitor, in patients with type 2 diabetes mellitus (T2DM). Methods: In a 12-week, multicentre, multinational, randomized, double-blind, parallel-group, placebo-controlled, dose-finding study, patients with inadequate glycaemic control from diet and exercise alone, or from diet and exercise plus a stable dose of metformin, were randomized to one of five doses of tofogliflozin (2.5, 5, 10, 20, or 40 mg) or placebo. The primary efficacy endpoint was absolute change at week 12 from baseline in glycated haemoglobin (HbA1c), minus the change in the placebo group. Results: Statistically significant dose-dependent reductions in HbA1c were shown in all treated groups except the 2.5-mg dose group, with a maximum reduction of 0.56% (placebo-subtracted) at the 40-mg dose, along with increased urinary glucose excretion. Metformin treatment had no substantial influence on tofogliflozin efficacy. Dose-dependent reductions in fasting plasma glucose and body weight were observed, and glucose intolerance was improved, with a trend towards blood pressure reduction. Slight increases were observed for mean ketone bodies with no abnormal change in ketone body ratio. No deaths or treatment-related serious adverse events were reported. The incidence of adverse events was similar in the placebo (37.9%) to that in the tofogliflozin group (35.9-46.3%). Withdrawal because of adverse events was rare (<= 2 patients per treatment group), with similar rates of withdrawal in the placebo and tofogliflozin groups. Conclusions: A once-daily dose of tofogliflozin for 12 weeks was an effective, safe and well-tolerated treatment for T2DM.	[Ikeda, S.; Takano, Y.; Cynshi, O.; Tanaka, R.] Chugai Pharmaceut Co Ltd, Tokyo, Japan; [Christ, A. D.; Boerlin, V.; Beyer, U.; Beck, A.; Ciorciaro, C.; Meyer, M.] F Hoffman La Roche AG, Basel, Switzerland; [Kadowaki, T.] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan	Ikeda, S (reprint author), Chugai Pharmaceut Co Ltd, Clin Sci & Strategy Dept, Chuo Ku, 2-1-1 Nihonbashi Muromachi, Tokyo 1038324, Japan.	ikedascy@chugai-pharm.co.jp			F. Hoffman-La Roche AG; Chugai Pharmaceutical Co., Ltd	The authors wish to thank all investigators, study teams and patients for participating in this study. This study was funded by F. Hoffman-La Roche AG and Chugai Pharmaceutical Co., Ltd, and was previously presented, in part, at the 72nd Scientific Sessions of the American Diabetes Association, Philadelphia, PA, 8-12 June 2012 and at the 48th European Association for the Study of Diabetes Annual Meeting, Berlin, 1-5 October 2012.	Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Mitrakou A, 2011, DIABETES RES CLIN PR, V93, pS66, DOI 10.1016/S0168-8227(11)70016-X; Stenlof K, 2013, DIABETES OBES METAB, V15, P372, DOI 10.1111/dom.12054; Bailey CJ, 2010, LANCET, V375, P2223, DOI 10.1016/S0140-6736(10)60407-2; Komoroski B, 2009, CLIN PHARMACOL THER, V85, P513, DOI 10.1038/clpt.2008.250; Ferrannini E, 2014, J CLIN INVEST, V124, P499, DOI 10.1172/JCI72227; Wilding JPH, 2014, DIABETES OBES METAB, V16, P124, DOI 10.1111/dom.12187; Ferrannini E, 2013, DIABETES CARE, V36, P4015, DOI 10.2337/dc13-0663; Chao EC, 2010, NAT REV DRUG DISCOV, V9, P551, DOI 10.1038/nrd3180; DeFronzo RA, 2012, DIABETES OBES METAB, V14, P5, DOI 10.1111/j.1463-1326.2011.01511.x; Heise T, 2013, DIABETES OBES METAB, V15, P613, DOI 10.1111/dom.12073; Freitas HS, 2008, ENDOCRINOLOGY, V149, P717, DOI 10.1210/en.2007-1088; Merovci A, 2014, J CLIN INVEST, V124, P509, DOI 10.1172/JCI70704; Ferrannini E, 2010, DIABETES CARE, V33, P2217, DOI 10.2337/dc10-0612; Rahmoune H, 2005, DIABETES, V54, P3427, DOI 10.2337/diabetes.54.12.3427; Suzuki M, 2012, J PHARMACOL EXP THER, V341, P692, DOI 10.1124/jpet.112.191593; Yu AS, 2010, AM J PHYSIOL-CELL PH, V299, pC1277, DOI 10.1152/ajpcell.00296.2010; Sha S, 2011, DIABETES OBES METAB, V13, P669, DOI 10.1111/j.1463-1326.2011.01406.x; Ohtake Y, 2012, J MED CHEM, V55, P7828, DOI 10.1021/jm300884k; Stenlof K, 2014, CURR MED RES OPIN, V30, P163, DOI 10.1185/03007995.2013.850066; Nagata T, 2013, AM J PHYSIOL-ENDOC M, V304, pE414, DOI 10.1152/ajpendo.00545.2012; Bolinder J, 2012, J CLIN ENDOCR METAB, V97, P1020, DOI 10.1210/jc.2011-2260; Banerjee SK, 2009, CARDIOVASC RES, V84, P111, DOI 10.1093/cvr/cvp190; Lavalle-Gonzalez FJ, 2013, DIABETOLOGIA, V56, P2582, DOI 10.1007/s00125-013-3039-1; Rieg T, 2014, AM J PHYSIOL-RENAL, V306, pF188, DOI 10.1152/ajprenal.00518.2013; Smulders RA, 2013, 49 ANN M EUR ASS STU	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-8902	1463-1326		DIABETES OBES METAB	Diabetes Obes. Metab.	OCT	2015	17	10								10.1111/dom.12538		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CR9TV	WOS:000361700800009		
J	Miyagawa, J; Odawara, M; Takamura, T; Iwamoto, N; Takita, Y; Imaoka, T				Miyagawa, J.; Odawara, M.; Takamura, T.; Iwamoto, N.; Takita, Y.; Imaoka, T.			Once-weekly glucagon-like peptide-1 receptor agonist dulaglutide is non-inferior to once-daily liraglutide and superior to placebo in Japanese patients with type 2 diabetes: a 26-week randomized phase III study	DIABETES OBESITY & METABOLISM			English	Article						dulaglutide; GLP-1 receptor agonist; liraglutide; placebo; type 2 diabetes	CONTROLLED-TRIAL; OPEN-LABEL; ANALOG LIRAGLUTIDE; GLYCEMIC CONTROL; DOUBLE-BLIND; EFFICACY; EXENATIDE; SAFETY; GLP-1; METFORMIN	Aims: To examine the efficacy and safety of once-weekly dulaglutide monotherapy (0.75 mg) compared with placebo and once-daily liraglutide (0.9 mg) in Japanese patients with type 2 diabetes. Methods: This was a phase III, 52-week (26-week primary endpoint), randomized, double-blind, placebo-controlled, open-label comparator (liraglutide) trial comparing 492 Japanese patients with type 2 diabetes (dulaglutide, n=281; liraglutide, n=141; and placebo, n=70) who were aged >= 20 years. Patients and investigators were blinded to treatment assignment for dulaglutide and placebo but not for liraglutide. The primary objective evaluated the superiority of dulaglutide versus placebo on change from baseline in glycated haemoglobin (HbA1c) at 26 weeks. Analyses were performed on the full analysis set. Results: At 26 weeks, once-weekly dulaglutide was superior to placebo and non-inferior to once-daily liraglutide for HbA1c change from baseline [least squares mean difference: dulaglutide vs placebo -1.57% (95% confidence interval -1.79 to -1.35); dulaglutide vs liraglutide -0.10% (95% confidence interval -0.27 to 0.07)]. The most frequently reported adverse events were nasopharyngitis, constipation, diarrhoea, nausea, abdominal distension and decreased appetite; only decreased appetite was different between the dulaglutide and liraglutide groups [dulaglutide, n=2 (0.7%); liraglutide, n=8 (5.8%); p=0.003]. Nine (1.8%) patients experienced hypoglycaemia [dulaglutide, n=6 (2.1%); liraglutide, n=2 (1.5%); placebo, n=1 (1.4%)], with no event being severe. Conclusions: In Japanese patients with type 2 diabetes, once-weekly dulaglutide (0.75 mg) was superior to placebo and non-inferior to once-daily liraglutide (0.9 mg) for reduction in HbA1c at 26 weeks. Dulaglutide was safe and well tolerated.	[Miyagawa, J.] Hyogo Coll Med, Dept Internal Med, Div Diabet Endocrinol & Metab, Nishinomiya, Hyogo 6638501, Japan; [Odawara, M.] Tokyo Med Univ, Dept Diabet Endocrinol Metab & Rheumatol, Divis Diabet Endocrinol & Metab, Tokyo 1608402, Japan; [Takamura, T.] Kanazawa Univ, Grad Sch Med Sci, Dept Comprehens Metabol, Kanazawa, Ishikawa, Japan; [Iwamoto, N.; Takita, Y.; Imaoka, T.] Eli Lilly Japan KK, Chuo Ku, Kobe, Hyogo 6510086, Japan	Iwamoto, N (reprint author), Eli Lilly Japan KK, Chuo Ku, 7-1-5 Isogamidori, Kobe, Hyogo 6510086, Japan.	Iwamoto_noriyuki@lilly.com			Eli Lilly and Company	The trial was sponsored by Eli Lilly and Company. We would like to thank the study investigators, staff, and participants for their needed contributions. We would also like to thank Miwa Sakaridani for clinical trial management of the study. The authors would like to thank David Meats (in Ventiv Health Clinical) for hismedical writing contributions for the submission of this manuscript.	Glaesner W, 2010, DIABETES-METAB RES, V26, P287, DOI 10.1002/dmrr.1080; Kadowaki T, 2011, J DIABETES INVEST, V2, P210, DOI 10.1111/j.2040-1124.2010.00084.x; Ussher JR, 2014, CIRC RES, V114, P1788, DOI 10.1161/CIRCRESAHA.114.301958; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Inagaki N, 2012, CLIN THER, V34, P1892, DOI 10.1016/j.clinthera.2012.07.007; Buse JB, 2013, LANCET, V381, P117, DOI 10.1016/S0140-6736(12)61267-7; Creutzfeldt WOC, 1996, DIABETES CARE, V19, P580, DOI 10.2337/diacare.19.6.580; Umpierrez G, 2014, DIABETES CARE, V37, P2168, DOI 10.2337/dc13-2759; Anini Y, 2003, ENDOCRINOLOGY, V144, P3244, DOI 10.1210/en.2003-0143; Seino Y, 2013, J DIABETES INVEST, V4, P108, DOI 10.1111/jdi.12065; Nauck M, 2014, DIABETES CARE, V37, P2149, DOI 10.2337/dc13-2761; Dmitrienko A, 2008, BIOMETRICAL J, V50, P667, DOI 10.1002/bimj.200710464; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Wysham C, 2014, DIABETES CARE, V37, P2159, DOI 10.2337/dc13-2760; Monami M, 2014, DIABETES RES CLIN PR, V103, P269, DOI 10.1016/j.diabres.2014.01.010; Xiao CT, 2012, ARTERIOSCL THROM VAS, V32, P1513, DOI 10.1161/ATVBAHA.112.246207; Seino Y, 2008, DIABETES RES CLIN PR, V81, P161, DOI 10.1016/j.diabres.2008.03.018; Riddle MC, 2013, DIABETES CARE, V36, P2489, DOI 10.2337/dc12-2454; Kaku K, 2010, DIABETES OBES METAB, V12, P341, DOI 10.1111/j.1463-1326.2009.01194.x; Dungan KM, 2014, LANCET, V384, P1349, DOI 10.1016/S0140-6736(14)60976-4; Ji LN, 2013, J DIABETES INVEST, V4, P53, DOI 10.1111/j.2040-1124.2012.00238.x; Pratley RE, 2014, LANCET DIABETES ENDO, V2, P289, DOI 10.1016/S2213-8587(13)70214-6; Gutzwiller JP, 1999, AM J PHYSIOL-REG I, V276, pR1541; Parkes DG, 2001, METABOLISM, V50, P583, DOI 10.1053/meta.2001.22519; Seino Y, 2012, J DIABETES INVEST, V3, P388, DOI 10.1111/j.2040-1124.2012.00193.x; Hendarto H, 2012, METABOLISM, V61, P1422, DOI 10.1016/j.metabol.2012.03.002; Meier JJ, 2006, DIABETOLOGIA, V49, P452, DOI 10.1007/s00125-005-0126-y; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Terauchi Y, 2014, ENDOCR J, V61, P949; Tong J, 2014, DIABETES, V63, P407, DOI 10.2337/db13-1764; Eli Lilly and Company, 2014, TRUL SUMM PROD CHAR; Eli Lilly and Company, 2014, TRUL PRESCR INF; Hirose Takahisa, 2005, Curr Diab Rep, V5, P226, DOI 10.1007/s11892-005-0013-4; Kim YG, 2014, DIABETES OBES METAB, V16, P900, DOI 10.1111/dom.12293; Robinson LE, 2013, BMJ OPEN, V24, P3, DOI DOI 10.1136/BMIOPEN-2012-001986; World Medical Association Declaration of Helsinki, 1997, JAMA-J AM MED ASSOC, V277, P925	36	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-8902	1463-1326		DIABETES OBES METAB	Diabetes Obes. Metab.	OCT	2015	17	10								10.1111/dom.12534		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CR9TV	WOS:000361700800008		
J	Wang, LX; Ishihara, T; Ibayashi, Y; Tatsushima, K; Setoyama, D; Hanada, Y; Takeichi, Y; Sakamoto, S; Yokota, S; Mihara, K; Kang, DC; Ishihara, N; Takayanagi, R; Nomura, M				Wang, Lixiang; Ishihara, Takaya; Ibayashi, Yuta; Tatsushima, Keita; Setoyama, Daiki; Hanada, Yuki; Takeichi, Yukina; Sakamoto, Shohei; Yokota, Sadaki; Mihara, Katsuyoshi; Kang, Dongchon; Ishihara, Naotada; Takayanagi, Ryoichi; Nomura, Masatoshi			Disruption of mitochondrial fission in the liver protects mice from diet-induced obesity and metabolic deterioration	DIABETOLOGIA			English	Article						DRP1; ER stress; FGF 21; Mitochondria-ER juxtaposition structure; Mitochondrial dynamics	GROWTH-FACTOR 21; ENDOPLASMIC-RETICULUM STRESS; INSULIN-RESISTANCE; ISLET HYPERPLASIA; CELLS; FGF21; ACTIVATION; INDUCTION; APOPTOSIS; DYNAMICS	Aim/hypothesis Mitochondria and the endoplasmic reticulum (ER) physically interact by close structural juxtaposition, via the mitochondria-associated ER membrane. Inter-organelle communication between the ER and mitochondria has been shown to regulate energy metabolism and to be central to the modulation of various key processes such as ER stress. We aimed to clarify the role of mitochondrial fission in this communication. Methods We generated mice lacking the mitochondrial fission protein dynamin-related protein 1 (DRP1) in the liver (Drp1LiKO mice). Results Drp1LiKO mice showed decreased fat mass and were protected from high-fat diet (HFD)-induced obesity. Analysis of liver gene expression profiles demonstrated marked elevation of ER stress markers. In addition, we observed increased expression of the fibroblast growth factor 21 (FGF21) gene through induction of activating transcription factor 4, master regulator of the integrated stress response. Conclusions/interpretation Disruption of mitochondrial fission in the liver provoked ER stress, while inducing the expression of FGF21 to increase energy expenditure and protect against HFD-induced obesity.	[Wang, Lixiang; Ibayashi, Yuta; Tatsushima, Keita; Hanada, Yuki; Takeichi, Yukina; Sakamoto, Shohei; Takayanagi, Ryoichi; Nomura, Masatoshi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Higashi Ku, Fukuoka 8128582, Japan; [Ishihara, Takaya; Ishihara, Naotada] Kurume Univ, Dept Prot Biochem, Inst Life Sci, Kurume, Fukuoka 830, Japan; [Setoyama, Daiki; Kang, Dongchon] Kyushu Univ, Dept Clin Chem & Lab Med, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Yokota, Sadaki] Nagasaki Int Univ, Fac Pharmaceut Sci, Div Funct Morphol, Sasebo, Nagasaki, Japan; [Mihara, Katsuyoshi] Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka 8128582, Japan	Nomura, M (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	nomura@med.kyushu-u.ac.jp			Japanese Society for the Promotion of Science (JSPS) KAKENHI [26461383, 12F02426, 23390247]; Japan Medical Association	This work was supported in part by the Japanese Society for the Promotion of Science (JSPS) KAKENHI (MN, Grant no. 26461383, 12F02426; RT, Grant no. 23390247) and Grants-in-Aid for Research Fellowship for Young Science Foundation and Banyu Science Foundation (LW). The work of MN was supported by a grant from the Medical Research Encouragement Prize of The Japan Medical Association.	Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049977; Schaap FG, 2013, BIOCHIMIE, V95, P692, DOI 10.1016/j.biochi.2012.10.019; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Marchand A, 2006, J BIOL CHEM, V281, P19124, DOI 10.1074/jbc.M602157200; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Huang JS, 2011, AM J PATHOL, V179, P703, DOI 10.1016/j.ajpath.2011.04.030; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Nomura M, 2014, DIABETOLOGIA, V57, P157, DOI 10.1007/s00125-013-3062-2; Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Carracedo A, 2006, CANCER CELL, V9, P301, DOI 10.1016/j.ccr.2006.03.005; Keipert S, 2014, AM J PHYSIOL-ENDOC M, V306, pE469, DOI 10.1152/ajpendo.00330.2013; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Cao SS, 2012, CURR BIOL, V22, pR622, DOI 10.1016/j.cub.2012.07.004; Otera H, 2011, J BIOCHEM, V149, P241, DOI 10.1093/jb/mvr002; Kim KH, 2013, BIOCHEM BIOPH RES CO, V440, P76, DOI 10.1016/j.bbrc.2013.09.026; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Katagiri H, 2007, CIRC RES, V101, P27, DOI 10.1161/CIRCRESAHA.106.151621; Ishihara N, 2013, ANTIOXID REDOX SIGN, V19, P389, DOI 10.1089/ars.2012.4830; Chan D, 2006, Cell Death Differ, V13, P680, DOI 10.1038/sj.cdd.4401857; FOLCH J, 1957, J BIOL CHEM, V226, P497; Kim SH, 2015, DIABETOLOGIA, V58, P809, DOI 10.1007/s00125-014-3475-6; Marchi S, 2014, BBA-BIOENERGETICS, V1837, P461, DOI 10.1016/j.bbabio.2013.10.015; Muise ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073011; Sanchez-Lopez E, 2013, CELL DEATH DIS, V28, pe933; Shen QF, 2014, MOL BIOL CELL, V25, P145, DOI 10.1091/mbc.E13-09-0525; So WY, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.80; Tubbs E, 2014, DIABETES, V63, P3279, DOI 10.2337/db13-1751	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	OCT	2015	58	10					2371	2380		10.1007/s00125-015-3704-7		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CR7NY	WOS:000361538600021		
J	Endo, N; Rahayu, LP; Ito, Y; Tanaka, T				Endo, N.; Rahayu, L. P.; Ito, Y.; Tanaka, T.			Ovarian and hormonal responses to single or continuous peripheral administration of senktide, a neurokinin 3 receptor agonist, during the follicular phase in goats	DOMESTIC ANIMAL ENDOCRINOLOGY			English	Article						Estrus; Goat; Luteinizing hormone; Neurokinin 3; Ovulation; Senktide	GONADOTROPIN-RELEASING-HORMONE; PULSE-GENERATOR ACTIVITY; ARCUATE NUCLEUS; ESTROUS-CYCLE; HYPOGONADOTROPIC HYPOGONADISM; KISSPEPTIN NEURONS; SELECTIVE AGONISTS; SEXUAL-BEHAVIOR; LUTEAL-PHASE; DYNORPHIN-A	The present study aimed to investigate the effects of single or continuous administration of a neurokinin 3 receptor agonist, senktide, on hormonal and follicular dynamics in follicular phase goats. Goats were injected with PGF(2 alpha) in the luteal phase and treated with an intravaginal progesterone device for 10 d. At 12 h after the cessation of progesterone treatment, the goats received a single intravenous injection of senktide (200 nmol, n = 4) or vehicle (n = 4), or continuous intravenous infusion of senktide (20 nmol/min, n = 6) or vehicle (n = 6) for 6 h. Blood sampling and ovarian ultrasonography were performed during the experiment A single injection of senktide did not influence the number of luteinizing hormone (LH) pulses and mean LH concentration. On the other hand, continuous injection of senktide caused a sustained increase in LH secretion, and mean LH concentration in samples collected at 10-min intervals for 6 h after the start of infusion was higher than that of vehicle-treated goats (2.8 +/- 1.3 vs 1.0 +/- 0.6 ng/mL, P < 0.01). In 4 of 6 goats, LH concentrations reached their peaks during the 6-h senktide infusion, and ovulation was observed at 48 h after the start of infusion without estrous behavior. The remaining 2 senktide-treated goats and all vehicle-treated goats showed estrus and ovulated at 72 or 96 h after treatment These results suggest that continuous infusion of senktide in follicular phase goats can cause a sustained increase in LH and advance the time of ovulation. (C) 2015 Elsevier Inc. All rights reserved.	[Endo, N.; Rahayu, L. P.; Ito, Y.; Tanaka, T.] Tokyo Univ Agr & Technol, Lab Vet Reprod, Fuchu, Tokyo 1838509, Japan; [Endo, N.; Rahayu, L. P.; Tanaka, T.] Gifu Univ, United Grad Sch Vet Sci, Gifu 5011193, Japan	Tanaka, T (reprint author), Tokyo Univ Agr & Technol, Lab Vet Reprod, Fuchu, Tokyo 1838509, Japan.	tomomit@cc.tuat.ac.jp			Ministry of Agriculture, Forestry and Fisheries of Japan (Research Program on Development of Innovative Technology for Animal Reproduction, REP); Japan Society for the Promotion of Science [26850195]	The authors thank Dr Y. Mori, The University of Tokyo, for providing anti-ovine LH serum (YM #18), Dr A.F. Parlow and the National Hormone & Peptide Program for providing reagents used in the LH radioimmunoassay, Dr S. Oishi, Kyoto University, for providing senktide, and Zoetis Japan Inc for providing CIDR-G. The authors also thank Dr H. Okamura (National Institute of Agrobiological Sciences) and Dr S. Ohkura (Nagoya University) for productive discussions and their technical advice. This study was supported in part by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Research Program on Development of Innovative Technology for Animal Reproduction, REP2004) and a Grant-in-Aid for Young Scientists B from the Japan Society for the Promotion of Science (no. 26850195).	KIMURA S, 1983, P JPN ACAD B-PHYS, V59, P101, DOI 10.2183/pjab.59.101; RILEY GM, 1981, J REPROD FERTIL, V63, P559; MORI Y, 1984, J REPROD FERTIL, V72, P223; Navarro VM, 2011, AM J PHYSIOL-ENDOC M, V300, pE202, DOI 10.1152/ajpendo.00517.2010; ISHIKAWA J, 1992, BIOL REPROD, V46, P1144, DOI 10.1095/biolreprod46.6.1144; Rance NE, 2010, BRAIN RES, V1364, P116, DOI 10.1016/j.brainres.2010.08.059; LAMMING GE, 1988, J REPROD FERTIL, V82, P237; Ramaswamy S, 2010, ENDOCRINOLOGY, V151, P4494, DOI 10.1210/en.2010-0223; Goodman RL, 2013, ENDOCRINOLOGY, V154, P4259, DOI 10.1210/en.2013-1331; Navarro VM, 2009, J NEUROSCI, V29, P11859, DOI 10.1523/JNEUROSCI.1569-09.2009; Caraty A, 2007, ENDOCRINOLOGY, V148, P5258, DOI 10.1210/en.2007-0554; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; Nestor CC, 2012, ENDOCRINOLOGY, V153, P2756, DOI 10.1210/en.2011-2009; WALLACE JM, 1988, J ENDOCRINOL, V116, P123, DOI 10.1677/joe.0.1160123; Billings HJ, 2010, ENDOCRINOLOGY, V151, P3836, DOI 10.1210/en.2010-0174; Severini C, 2002, PHARMACOL REV, V54, P285, DOI 10.1124/pr.54.2.285; Guran T, 2009, J CLIN ENDOCR METAB, V94, P3633, DOI 10.1210/jc.2009-0551; Young J, 2010, J CLIN ENDOCR METAB, V95, P2287, DOI 10.1210/jc.2009-2600; Suganuma C, 2007, ANIM REPROD SCI, V101, P285, DOI 10.1016/j.anireprosci.2006.09.015; Wakabayashi Y, 2010, J NEUROSCI, V30, P3124, DOI 10.1523/JNEUROSCI.5848-09.2010; Sakamoto K, 2012, J REPROD DEVELOP, V58, P700, DOI 10.1262/jrd.2011-038; Fabre-Nys C, 2007, HORM BEHAV, V52, P18, DOI 10.1016/j.yhbeh.2007.04.001; PETERS AR, 1985, J REPROD FERTIL, V75, P557; FABRENYS C, 1993, HORM BEHAV, V27, P108, DOI 10.1006/hbeh.1993.1008; Oakley AE, 2009, ENDOCR REV, V30, P713, DOI 10.1210/er.2009-0005; VELDHUIS JD, 1986, AM J PHYSIOL, V250, pE486; Peters AR, 2005, ANIM REPROD SCI, V88, P155, DOI 10.1016/j.anireprosci.2005.05.008; MEE MO, 1990, J DAIRY SCI, V73, P1500; Tanaka T, 1995, NEUROENDOCRINOLOGY, V62, P553, DOI 10.1159/000127051; FOSTER JP, 1980, J REPROD FERTIL, V59, P321; Mussard ML, 2007, J ANIM SCI, V85, P937, DOI 10.2527/jas.2006-592; WORMSER U, 1986, EMBO J, V5, P2805; Goodman RL, 2007, ENDOCRINOLOGY, V148, P5752, DOI 10.1210/en.2007-0961; Komar CM, 2001, BIOL REPROD, V64, P1797, DOI 10.1095/biolreprod64.6.1797; JAGGER JP, 1987, J REPROD FERTIL, V80, P263; Baird D T, 1981, J Reprod Fertil Suppl, V30, P119; Endo Natsumi, 2014, BMC Res Notes, V7, P773, DOI 10.1186/1756-0500-7-773; Grachev P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044344; KANAZAWA I, 1984, Neuroscience Research, V2, P111, DOI 10.1016/0168-0102(84)90009-9; LAUFER R, 1986, J BIOL CHEM, V261, P257; Okada Miwako, 1998, Journal of Reproduction and Development, V44, P53, DOI 10.1262/jrd.44.53; Orita Jun, 2000, Journal of Reproduction and Development, V46, P31, DOI 10.1262/jrd.46.31; Wakabayashi Y, 2010, 40 SOC NEUR ANN M; Yamamura T, 2015, J REPROD DEVELOP, V61, P20, DOI 10.1262/jrd.2014-109	44	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0739-7240	1879-0054		DOMEST ANIM ENDOCRIN	Domest. Anim. Endocrinol.	OCT	2015	53						136	143		10.1016/j.domaniend.2015.07.003		8	Agriculture, Dairy & Animal Science; Endocrinology & Metabolism	Agriculture; Endocrinology & Metabolism	CR7BI	WOS:000361502500016		
J	Han, X; Inoue, A				Han, Xu; Inoue, Atsushi			TESTS FOR PARAMETER INSTABILITY IN DYNAMIC FACTOR MODELS	ECONOMETRIC THEORY			English	Article							COVARIANCE-MATRIX ESTIMATION; NUMBER; TIME	In this paper, we develop tests for structural breaks of factor loadings in dynamic factor models. We focus on the joint null hypothesis that all factor loadings are constant over time. Because the number of factor loading parameters goes to infinity as the sample size grows, conventional tests cannot be used. Based on the fact that the presence of a structural change in factor loadings yields a structural change in second moments of factors obtained from the full sample principal component estimation, we reduce the infinite-dimensional problem into a finite-dimensional one and our statistic compares the pre- and postbreak subsample second moments of estimated factors. Our test is consistent under the alternative hypothesis in which a fraction of or all factor loadings have structural changes. The Monte Carlo results show that our test has good finite-sample size and power.	[Han, Xu] City Univ Hong Kong, Kowloon, Hong Kong, Peoples R China; [Inoue, Atsushi] Vanderbilt Univ, Nashville, TN 37235 USA; [Inoue, Atsushi] Tohoku Univ, Sendai, Miyagi 980, Japan	Han, X (reprint author), City Univ Hong Kong, Dept Econ & Finance, Kowloon, Hong Kong, Peoples R China.	xuhan25@cityu.edu.hk; atsushi.inoue@vanderbilt.edu					ANDREWS DWK, 1993, ECONOMETRICA, V61, P821, DOI 10.2307/2951764; ANDREWS DWK, 1994, ECONOMETRICA, V62, P1383, DOI 10.2307/2951753; Bai JS, 1997, ECONOMET THEOR, V13, P315; Breitung J, 2011, J ECONOMETRICS, V163, P71, DOI 10.1016/j.jeconom.2010.11.008; Stock JH, 2002, J AM STAT ASSOC, V97, P1167, DOI 10.1198/016214502388618960; Stock JH, 1996, J BUS ECON STAT, V14, P11, DOI 10.2307/1392096; Ledoit O, 2004, J MULTIVARIATE ANAL, V88, P365, DOI 10.1016/S0047-259X(03)00096-4; Choi I, 2012, ECONOMET THEOR, V28, P274, DOI 10.1017/S0266466611000338; NEWEY WK, 1994, REV ECON STUD, V61, P631, DOI 10.2307/2297912; Bai JS, 2002, ECONOMETRICA, V70, P191, DOI 10.1111/1468-0262.00273; Stock JH, 2002, J BUS ECON STAT, V20, P147, DOI 10.1198/073500102317351921; Hall AR, 2000, ECONOMETRICA, V68, P1517, DOI 10.1111/1468-0262.00171; Bai JS, 2010, ECONOMET THEOR, V26, P1577, DOI 10.1017/S0266466609990727; Bai J, 2003, ECONOMETRICA, V71, P135, DOI 10.1111/1468-0262.00392; Banerjee A., 2008, 6706 CEPR; Bates B., 2012, J ECONOMETR IN PRESS; Bernanke BS, 2005, Q J ECON, V120, P387, DOI 10.1162/0033553053327452; Boivin J., 2006, 12772 NBER; Chen L., 2012, DETECTING BIG STRUCT; Cheng X., 2013, SHRINKAGE ESTI UNPUB; Eickmeier S., 2011, DP8321 CEPR; Han X., 2014, TESTS PARAMETER INST; Onatski A, 2010, REV ECON STAT, V92, P1004, DOI 10.1162/REST_a_00043; Sargent TJ, 1977, NEW METHODS BUSINESS; Stock J. H., 2005, 11467 NBER	25	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0266-4666	1469-4360		ECONOMET THEOR	Economet. Theory	OCT	2015	31	5					1117	1152		10.1017/S0266466614000486		36	Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods; Statistics & Probability	Business & Economics; Mathematics; Mathematical Methods In Social Sciences	CR8AY	WOS:000361574700008		
J	Sun, YY; Zhang, WH; Li, DS; Gao, L; Hou, CL; Zhang, YH; Liu, YQ				Sun, Youyi; Zhang, Wenhui; Li, Diansen; Gao, Li; Hou, Chunlin; Zhang, Yinghe; Liu, Yaqing			Direct formation of porous MnO2/Ni composite foam applied for high-performance supercapacitors at mild conditions	ELECTROCHIMICA ACTA			English	Article						porous MnO2; Ni foam; hydrothermal method; low temperature; supercapacitor	NICKEL FOAM; ELECTROCHEMICAL PROPERTIES; NANOSHEET ARRAYS; FACILE SYNTHESIS; TEMPERATURE; NANOWIRES; ELECTRODE; DELTA-MNO2; DEPOSITION; GROWTH	Here, a novel three dimensional Ni foam-supported porous MnO2 film (porous MnO2/Ni composite foam) was successfully synthesized by the simple hydrothermal method using Ni foam as substrate. The porous MnO2 film had closely coated on the backbones of the Ni foam without assistant of surfactant at mild conditions. At the same time, the pore size of porous MnO2/Ni composite foam was easily controlled by the reaction temperature. Furthermore, it was found that the capacitive properties of porous MnO2/Ni composite foam were related to the pore size of MnO2 film. It showed smaller pore size, and it exhibited better capacitive behavior for the electrode, in which the porous MnO2/Ni composite foam with pore size of ca.50.0 similar to 150.0 nm showed high rate capability of 1086.0 F/g at 10.0 A/g and good cycle stability with capacitance retention of 98.0% after 500 cycles. The high capacitive properties was due to the active materials MnO2 grown on the the backbone of the Ni foam and porous structure of MnO2 materials, resulting in the reduce of resistance and enhancement of active surface area. Our work not only demonstrates the controlled synthesis of high-quality porous MnO2/Ni composite foam at mild conditions on a large scale, but also provides a universal route for the rational design of supercapacitors with high performance. (C) 2015 Elsevier Ltd. All rights reserved.	[Sun, Youyi; Zhang, Wenhui; Gao, Li; Hou, Chunlin; Liu, Yaqing] North Univ China, Res Ctr Engn Technol Polymer Composites Shanxi Pr, Taiyuan 030051, Peoples R China; [Li, Diansen] Beijing Univ Aeronaut & Astronaut, Sch Chem & Environm, Key Lab Bioinspired Energy Mat & Devices, Beijing 100191, Peoples R China; [Zhang, Yinghe] Waseda Univ, Int Ctr Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan	Liu, YQ (reprint author), North Univ China, Res Ctr Engn Technol Polymer Composites Shanxi Pr, Taiyuan 030051, Peoples R China.	lyq@nuc.edu.cn			National Natural Science Foundation of China [11202006, 11202007]; Shanxi provincial natural science foundation of China [2014021018-6]	The authors are grateful for the support by National Natural Science Foundation of China under grants (11202006 and 11202007), and the Shanxi provincial natural science foundation of China (2014021018-6).	Li YJ, 2015, J POWER SOURCES, V279, P138, DOI 10.1016/j.jpowsour.2014.12.153; Yang J, 2014, ELECTROCHIM ACTA, V136, P189, DOI 10.1016/j.electacta.2014.05.074; Lang XY, 2011, NAT NANOTECHNOL, V6, P232, DOI 10.1038/nnano.2011.13; Kundu M, 2013, J POWER SOURCES, V243, P676, DOI 10.1016/j.jpowsour.2013.06.059; Kuo SL, 2006, J ELECTROCHEM SOC, V153, pA1317, DOI 10.1149/1.2197667; Yan DL, 2012, MATER LETT, V82, P156, DOI 10.1016/j.matlet.2012.05.084; Sun XX, 2014, RSC ADV, V4, P30233, DOI 10.1039/c4ra03983a; Wei WF, 2011, CHEM SOC REV, V40, P1697, DOI 10.1039/c0cs00127a; Athouel L, 2008, J PHYS CHEM C, V112, P7270, DOI 10.1021/jp0773029; Brousse T, 2015, J ELECTROCHEM SOC, V162, pA5185, DOI 10.1149/2.0201505jes; Xie YJ, 2015, CRYSTENGCOMM, V17, P3005, DOI 10.1039/c5ce00058k; Bao LH, 2011, NANO LETT, V11, P1215, DOI 10.1021/nl104205s; Li WY, 2014, J MATER CHEM A, V2, P1443, DOI 10.1039/c3ta14182a; Pang MJ, 2015, ELECTROCHIM ACTA, V161, P297, DOI 10.1016/j.electacta.2015.02.089; Zhang LL, 2009, CHEM SOC REV, V38, P2520, DOI 10.1039/b813846j; Zhu T, 2014, J MATER SCI, V49, P6118, DOI 10.1007/s10853-014-8343-8; Yuan YF, 2012, MATER LETT, V73, P194, DOI 10.1016/j.matlet.2012.01.046; Huang HF, 2014, NANOSCALE, V6, P2426, DOI 10.1039/c3nr05952a; Naikoo GA, 2015, J MATER SCI-MATER EL, V26, P2403, DOI 10.1007/s10854-015-2698-8; Wang GP, 2012, CHEM SOC REV, V41, P797, DOI 10.1039/c1cs15060j; Li YF, 2014, J SOLID STATE ELECTR, V18, P2521, DOI 10.1007/s10008-014-2498-8; Zhang YF, 2014, RSC ADV, V4, P8466, DOI 10.1039/c3ra46195e; Sun ZP, 2013, NANOSCALE, V5, P4379, DOI 10.1039/c3nr00209h; Wang JW, 2014, MET MATER INT, V20, P989, DOI 10.1007/s12540-014-6001-y; Miller JR, 2008, SCIENCE, V321, P651, DOI 10.1126/science.1158736; Sumboja A, 2013, ADV MATER, V25, P2809, DOI 10.1002/adma.201205064; Bao FX, 2015, ELECTROCHIM ACTA, V157, P31, DOI 10.1016/j.electacta.2015.01.060; Chen W., 2011, NANO LETT, V11, P51652	28	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-4686	1873-3859		ELECTROCHIM ACTA	Electrochim. Acta	OCT 1	2015	178						823	828		10.1016/j.electacta.2015.08.092		6	Electrochemistry	Electrochemistry	CR7VQ	WOS:000361560300098		
J	Suematsu, M; Yoshizawa-Fujita, M; Zhu, H; Forsyth, M; Takeoka, Y; Rikukawa, M				Suematsu, Mitsutake; Yoshizawa-Fujita, Masahiro; Zhu, Haijin; Forsyth, Maria; Takeoka, Yuko; Rikukawa, Masahiro			Effect of zwitterions on electrochemical properties of oligoether-based electrolytes (vol 175, pg 209, 2015)	ELECTROCHIMICA ACTA			English	Correction									[Suematsu, Mitsutake; Yoshizawa-Fujita, Masahiro; Takeoka, Yuko; Rikukawa, Masahiro] Sophia Univ, Dept Mat & Life Sci, Chiyoda Ku, Tokyo 1028554, Japan; [Zhu, Haijin; Forsyth, Maria] Deakin Univ, Inst Frontier Mat, Geelong, Vic 3216, Australia; [Zhu, Haijin; Forsyth, Maria] Deakin Univ, ARC Ctr Excellence Electromat Sci, Geelong, Vic 3216, Australia	Yoshizawa-Fujita, M (reprint author), Sophia Univ, Dept Mat & Life Sci, Chiyoda Ku, 7-1 Kioi Cho, Tokyo 1028554, Japan.	masahi-f@sophia.ac.jp					Suematsu M, 2015, ELECTROCHIM ACTA, V175, P209, DOI 10.1016/j.electacta.2014.12.067	1	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-4686	1873-3859		ELECTROCHIM ACTA	Electrochim. Acta	OCT 1	2015	178						900	900		10.1016/j.electacta.2015.09.003		1	Electrochemistry	Electrochemistry	CR7VQ	WOS:000361560300106		
J	Goto, T; Watase, H; Morita, H; Nagai, H; Brown, CA; Brown, DFM; Hasegawa, K				Goto, Tadahiro; Watase, Hiroko; Morita, Hiroshi; Nagai, Hideya; Brown, Calvin A., III; Brown, David F. M.; Hasegawa, Kohei		Japanese Emergency Med Network Inv	Repeated attempts at tracheal intubation by a single intubator associated with decreased success rates in emergency departments: an analysis of a multicentre prospective observational study	EMERGENCY MEDICINE JOURNAL			English	Article							AIRWAY MANAGEMENT; ENDOTRACHEAL INTUBATION; LARYNGOSCOPY	Objective To determine whether the success rate of repeated attempts at tracheal intubation by a single intubator was lower than those by alternate intubators in the emergency department (ED). Methods An analysis of data from a multicentre prospective registry (Japanese Emergency Airway Network Registry) of 13 academic and community EDs in Japan between April 2010 and August 2012. We included all adult and paediatric patients who underwent repeated attempts at tracheal intubation in the ED. We compared the intubation success rates at the second and third attempts between attempts at intubation by a single intubator who performed the previous attempts, and the attempts by alternate intubators. Results We recorded 4094 patients (capture rate, 96%); 1289 patients with repeated attempts at tracheal intubation were eligible for this study. Among these, 871 patients (68%) had a second attempt at intubation by single intubators. At the second attempt, tracheal intubation by a single intubator was associated with a decreased success rate (adjusted odds ratio or AOR, 0.50; 95% CI 0.36 to 0.71), compared with alternate intubators. At the third attempt, intubation by a single intubator was also associated with a decreased success rate (58% vs 70%; unadjusted OR, 0.58; 95% CI 0.38 to 0.89). However, after adjustment for potential confounders, the association lost statistical significance (AOR, 0.89; 95% CI 0.52 to 1.56). Conclusions In this large multicentre study of ED patients undergoing tracheal intubation, second attempts at intubation by a single intubator, compared with those by alternate intubators, were independently associated with a decreased success rate.	[Goto, Tadahiro; Morita, Hiroshi] Univ Fukui Hosp, Dept Emergency Med, Fukui 9101193, Japan; [Goto, Tadahiro] Osaka Saiseikai Senri Hosp, Senri Crit Care Med Ctr, Suita, Osaka, Japan; [Watase, Hiroko] Japanese Emergency Med Network, Seattle, WA USA; [Nagai, Hideya] Fukui Prefectural Hosp, Dept Emergency Med, Fukui, Japan; [Brown, Calvin A., III] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Brown, David F. M.; Hasegawa, Kohei] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA	Goto, T (reprint author), Univ Fukui Hosp, Dept Emergency Med, 23-3 Shimoaiduki, Fukui 9101193, Japan.	qq_gto@yahoo.co.jp			St Luke's Life Science Institute; Massachusetts General Hospital; Brigham and Women's Hospital	This study was supported by a grant from St Luke's Life Science Institute, and a grant from Massachusetts General Hospital and Brigham and Women's Hospital. The study sponsors have no involvement in the study design, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.	Hasegawa K, 2012, RESUSCITATION, V83, P428, DOI 10.1016/j.resuscitation.2011.11.027; Hasegawa K, 2012, ANN EMERG MED, V60, P749, DOI 10.1016/j.annemergmed.2012.04.005; Imamura T, 2013, AM J EMERG MED, V31, P190, DOI 10.1016/j.ajem.2012.07.008; Hwang J, 2013, AM J EMERG MED, V31, P32, DOI 10.1016/j.ajem.2012.05.016; Mort TC, 2004, ANESTH ANALG, V99, P607, DOI 10.1213/01.ANE.0000122825.04923.15; Walls RM, 2011, J EMERG MED, V41, P347, DOI 10.1016/j.jemermed.2010.02.024; Wongyingsinn M, 2009, EMERG MED J, V26, P604, DOI 10.1136/emj.2008.061192; Schmitt HJ, 2002, J CLIN ANESTH, V14, P335, DOI 10.1016/S0952-8180(02)00368-9; Sagarin MJ, 2005, ANN EMERG MED, V46, P328, DOI 10.1016/j.annemergmed.2005.01.009; Adnet F, 1997, ANESTHESIOLOGY, V87, P1290, DOI 10.1097/00000542-199712000-00005; Sakles JC, 2013, ACAD EMERG MED, V20, P71, DOI 10.1111/acem.12055; Bair AE, 2002, J EMERG MED, V23, P131, DOI 10.1016/S0736-4679(02)00501-2; Apfelbaum Jeffrey L, 2013, Anesthesiology, V118, P251, DOI 10.1097/ALN.0b013e31827773b2; Hasegawa Kohei, 2013, Int J Emerg Med, V6, P12, DOI 10.1186/1865-1380-6-12; Prakash S, 2011, ANESTHESIOL RES PRAC, V2011	15	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	OCT	2015	32	10					781	786		10.1136/emermed-2013-203473		6	Emergency Medicine	Emergency Medicine	CS0IQ	WOS:000361743100007		
J	Hong, GW; Abe, N; Baclay, M; Arciaga, L				Hong, George William; Abe, Naoya; Baclay, Magdaleno, Jr.; Arciaga, Lourdes			Assessing users' performance to sustain off-grid renewable energy systems: The capacity and willingness approach	ENERGY FOR SUSTAINABLE DEVELOPMENT			English	Article						Off-grid rural electrification; Sustainability assessment; Renewable energy systems; User capacity; Willingness to sustain; Ordered logit analysis		This paper investigates the sustainability of off-grid renewable energy systems (RES) installed in rural communities. Through a solar home system (SHS) case project in Alumar Island, Philippines, the performance of users to sustain their systems was assessed using a novel approach proposed by the authors: the capacity and willingness approach. This approach was an adaptation to advancements in human development theory the paradigm shift from the traditional resources approach to the capabilities approach, as proposed by A. Sen. The actual financial and technical performances of users were predicted using ordered logit regression analysis. It was found that financial capacity attributes, e.g., income and expenses, were prominent in explaining financial performance; know-how-related attributes, e.g., education, were prominent in explaining technical performance; and willingness-related attributes, i.e., willingness to pay, explained both financial and technical performance. The findings aim to provide developers and communities with better strategies for beneficiary scoping, technology selection, and capacity development. (C) 2015 International Energy Initiative. Published by Elsevier Inc. All rights reserved.	[Hong, George William; Abe, Naoya] Tokyo Inst Technol, Int Dev Engn Dept IDE, Meguro Ku, Tokyo 1528550, Japan; [Baclay, Magdaleno, Jr.] Ruralenergy Org, Solar Energy Res, Cebu, Philippines; [Arciaga, Lourdes] Philippine Dept Energy, Energy Resource Dev & Utilizat Div, Taguig, Metro Manila, Philippines	Hong, GW (reprint author), Tokyo Inst Technol, Int Dev Engn Dept IDE, Meguro Ku, 2-12-1-14-4 Ookayama, Tokyo 1528550, Japan.	william.hong@ruralenergy.org; nabe@ide.titech.ac.jp; jun.baclay@ruralenergy.org; louarciaga@yahoo.com					Alkire S., 2008, CAPABILITY APPROACH; Hong GW, 2012, RENEW SUST ENERG REV, V16, P4616, DOI 10.1016/j.rser.2012.04.009; Hu B, 2006, STAT SINICA, V16, P847; Ayuso M, 2007, INSUR MATH ECON, V41, P71, DOI 10.1016/j.insmatheco.2006.09.008; Armstrong D, 2009, ORDERED LOGIT PROBIT; Browne L, 2001, MEASURING CAPACITY B; Chambers R, 2009, WHOSE REALITY COUNTS; Hong GW, 2011, RENEW SUST ENERG REV, V16, P54; Hong GW, 2011, EU PVSEC P, P4052, DOI DOI 10.4229/26THEUPVSEC2011-5DO.11.3; Long J. S., 1997, REGRESSION MODELS CA; Lynam J. K., 1989, Agricultural Economics, V3, P381, DOI 10.1016/0169-5150(89)90010-8; Morgan P, 1997, DESIGN USE CAPACITY; NREL National Renewable Energy Laboratory, 1999, WILL PAY EL REN SOUR; Sambamoorthi N, 1999, HIERARCHICAL CLUSTER; Sen A., 1992, INEQUALITY REEXAMINE; Sen AK, 2008, EC HAPPINESS CAPABIL; StataCorp, 2007, STAT STAT SOFTW REL; Tae YJ, 1993, ENERGY EC; Todaro Michael P., 2009, EC DEV; UNDP, 2007, OUR COMMON FUTURE; UNWCED (United Nations World Commission on Environment and Development), 1987, OUR COMMON FUTURE; USAID, 1998, STRAT PRES REP NGO C; World Bank, 2008, DES SUST OFF GRID RU; Yonehara A, 2009, HUMAN DEV POLICY GLO	24	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0973-0826			ENERGY SUSTAIN DEV	Energy Sustain Dev.	OCT	2015	28						102	114		10.1016/j.esd.2015.07.004		13	Energy & Fuels	Energy & Fuels	CS0VP	WOS:000361780600012		
J	Cai, GC; Sun, YP; Takeuchi, T; Zhang, JW				Cai, Gaochuang; Sun, Yuping; Takeuchi, Takashi; Zhang, Jianwei			Proposal of a complete seismic shear strength model for circular concrete columns	ENGINEERING STRUCTURES			English	Article						Circular concrete column; Seismic shear strength; Drift ratio; Shear strength degradation	STRESS-STRAIN MODEL; BEHAVIOR	A complete shear strength model is proposed to define the relationship between seismic shear strength and lateral drift ratio of circular concrete columns. The proposed bi-linear model comprises the initial shear strength branch and the shear strength degradation branch, and it can trace the degradation of shear strength along with lateral deformation. The formula to assess the initial shear strength is derived from the equilibrium of the forces acting on the primary shear failure plane and Mohr-Coulomb failure criteria for concrete, while the degradation slope of shear strength is associated with a factor indirectly representing the contribution by the so-called dowel action of longitudinal reinforcements. Another feature of the proposed model is that it can be used to directly calculate the seismic shear strength of circular columns without transforming circular section into an equivalent rectangular or square section. In order to calibrate the proposed model and verify its reliability and accuracy, eighty-eight relatively large scale circular concrete columns that many researchers have reported failing in shear are collected. These previous tests cover a wide range of structural factors such as concrete strength, axial load ratio, yield strength and amount of transverse as well as longitudinal reinforcements, and shear span ratio. Comparisons between the experimental results and the calculated ones indicate that the proposed model can predict the seismic shear strength and trace the shear strength degradation till large deformation more accurately than previous models. (C) 2015 Elsevier Ltd. All rights reserved.	[Cai, Gaochuang; Sun, Yuping; Takeuchi, Takashi] Kobe Univ, Grad Sch Engn, Dept Architecture, Kobe, Hyogo 6578501, Japan; [Zhang, Jianwei] Beijing Univ Technol, Coll Architecture & Civil Engn, Beijing 100124, Peoples R China	Sun, YP (reprint author), Kobe Univ, Grad Sch Engn, Dept Architecture, Nada Ku, 1E-206,1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	sun@person.kobe-u.ac.jp					Ang B.G., 1989, ACI STRUCT J, V86, P45; Ang BG, 1985, 855 U CANT DEP CIV E; WONG YL, 1993, ACI STRUCT J, V90, P180; Belleri A, 2014, ACI STRUCT J, V111, P661; Bahn BY, 1998, ACI MATER J, V95, P178; MANDER JB, 1988, J STRUCT ENG-ASCE, V114, P1804; Sun YP, 2013, APPL MECH MATER, V438-439, P1453, DOI 10.4028/www.scientific.net/AMM.438-439.1453; Kim JH, 2005, J STRUCT ENG-ASCE, V131, P197, DOI 10.1016/(ASCE)0733-9445(2005)131:1(197); Dancygier AN, 2001, J STRUCT ENG-ASCE, V127, P81, DOI 10.1061/(ASCE)0733-9445(2001)127:1(81); [Anonymous], 2011, BUILD COD REQ STRUCT; Kowalsky MJ, 2000, ACI STRUCT J, V97, P388; Applied Technology Council, 1996, ATC32; Architecture Institute of Japan, 2010, AIJ STAND STRUCT CAL; Architecture Institute of Japan, 1999, DES GUID EARTHQ RES; Bertero VV, 1991, UBCEERC9115; Cai GC, 2014, THESIS KOBE U KOBE; Caltrans, 1996, EARTHQ RETR AN SINGL; CUSSON D, 1995, J STRUCT ENG-ASCE, V121, P468, DOI 10.1061/(ASCE)0733-9445(1995)121:3(468); Kent DC, 1971, J STRUCTURAL DIVISIO, V97, P1969; Kim J, 2011, P JCI, V33, P193; Lim KY, 1991, MOMENT REDUCING HING; Miyake Y, 2005, P JCI, V27, P229; Moehle JP, 1992, UCBEERC9204; Panian L, 2012, CONCR INT MAG AM CON, V34, P23; Park R., 1975, REINFORCED CONCRETE; Priestley KN, 2000, 12WCEE, P1; PRIESTLEY MJN, 1994, J STRUCT ENG-ASCE, V120, P2310, DOI 10.1061/(ASCE)0733-9445(1994)120:8(2310); Sakino X, 1993, T JCI, V15, P455; Sako Y, 2000, P JCI, V22, P673; Sfandards New Zealand (NZS 3101), 2006, 3101 NZS; Sheikh S.A., 1982, ACI J, V79, P296; Sun YP, 1996, J STRUCT CONSTR ENG, V486, P95; Vallenas J, 1977, UCBEERC7713; Yamada K, 2002, P JCI, V24, P217; Yamamoto T, 2002, P JCI, V24, P181; Yamamoto T, 2001, P JCI, V23, P187	36	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0141-0296	1873-7323		ENG STRUCT	Eng. Struct.	OCT 1	2015	100						399	409		10.1016/j.engstruct.2015.06.032		11	Engineering, Civil	Engineering	CS0TE	WOS:000361774300033		
J	Chen, B; Yamada, M; Iwasaka, Y; Zhang, DZ; Wang, H; Wang, ZZ; Lei, HC; Shi, GY				Chen, Bin; Yamada, Maromu; Iwasaka, Yasunobu; Zhang, Daizhou; Wang, Hong; Wang, Zhenzhu; Lei, Hengchi; Shi, Guangyu			Origin of non-spherical particles in the boundary layer over Beijing, China: based on balloon-borne observations	ENVIRONMENTAL GEOCHEMISTRY AND HEALTH			English	Article						Vertical mixing; Boundary layer; Tethered balloon; Aerosol; Beijing	DEPOLARIZATION RATIO; POLLUTION AEROSOLS; RAMAN LIDAR; DUST; TROPOSPHERE; NAGOYA; WINTER; SIZE; PM10	Vertical structures of aerosols from the ground to about 1,000 m altitude in Beijing were measured with a balloon-borne optical particle counter. The results showed that, in hazy days, there were inversions at approximately 500-600 m, below which the particulate matters were well mixed vertically, while the concentration of particles decreased sharply above the mixing layer. Electron microscopic observation of the particles collected with the balloon-borne impactor indicates that the composition of particles is different according to weather conditions in the boundary mixing layer of Beijing city and suggests that dust particles are always dominant in coarse-mode particles. Interestingly, sea-salt particles are frequently identified, suggesting the importance of marine air inflow to the Beijing area even in summer. The Ca-rich spherical particles are also frequently identified, suggesting chemical modification of dust particle by NOx or emission of CaO and others from local emission. Additionally, those types of particles showed higher concentration above the mixing layer under the relatively calm weather condition of summer, suggesting the importance of local-scale convection found in summer which rapidly transported anthropogenic particles above the mixing layer. Lidar extinction profiles qualitatively have good consistency with the balloon-borne measurements. Attenuation effects of laser pulse intensity are frequently observed due to high concentration of particulate matter in the Beijing atmosphere, and therefore quantitative agreement of lidar return and aerosol concentration can be hardly observed during dusty condition. Comparing the depolarization ratio obtained from the lidar measurements with the balloon-borne measurements, the contribution of the dry sea-salt particles, in addition to the dust particles, is suggested as an important factor causing depolarization ratio in the Beijing atmosphere.	[Chen, Bin; Wang, Zhenzhu] Chinese Acad Sci, Key Lab Atmospher Composit & Opt Radiat, Beijing, Peoples R China; [Chen, Bin; Lei, Hengchi; Shi, Guangyu] Chinese Acad Sci, Inst Atmospher Phys, Beijing 100029, Peoples R China; [Yamada, Maromu; Iwasaka, Yasunobu] Kanazawa Univ, Ctr Innovat, Kanazawa, Ishikawa 9201192, Japan; [Zhang, Daizhou] Prefectural Univ Kumamoto, Fac Environm & Symbiot Sci, Kumamoto 8628502, Japan; [Wang, Hong] Chinese Acad Meteorol Sci, Beijing 100081, Peoples R China	Chen, B (reprint author), Chinese Acad Sci, Key Lab Atmospher Composit & Opt Radiat, Beijing, Peoples R China.	chen_bin@mail.iap.ac.cn; zzwang@aiofm.ac.cn			National Natural Science Foundation of China [41475136, 41130104]; International Science & Technology Cooperation Program of China [2013DFG22820]; Open Research Fund of Key Laboratory of Atmospheric Composition and Optical Radiation; Chinese Academy of Sciences	This work was supported by the National Natural Science Foundation of China (Grant No. 41475136), supported by International Science & Technology Cooperation Program of China (Grant No. 2013DFG22820), supported by the National Natural Science Foundation of China (Grant No. 41130104) and supported by Open Research Fund of Key Laboratory of Atmospheric Composition and Optical Radiation, Chinese Academy of Sciences. The authors are also thankful to the staff of Beijing Meteorological Observatory for the kind support on the meteorological data and for the help in launching the balloon.	[Anonymous], 2004, J GEOPHYS RES, DOI [10.1029/2002JD003253, DOI 10.1029/2002JD003253]; Kwon SA, 1997, ATMOS ENVIRON, V31, P1459, DOI 10.1016/S1352-2310(96)00310-X; Yuan H, 2008, ATMOS ENVIRON, V42, P2141, DOI 10.1016/j.atmosenv.2007.11.048; Chen WN, 2007, ATMOS ENVIRON, V41, P7698, DOI 10.1016/j.atmosenv.2007.06.001; Chan CY, 2005, ATMOS ENVIRON, V39, P5113, DOI 10.1016/j.atmosenv.2005.05.009; Chen WN, 2007, ATMOS ENVIRON, V41, P1440, DOI 10.1016/j.atmosenv.2006.10.012; Wang Y, 2006, ATMOS ENVIRON, V40, P6579, DOI 10.1016/j.atmosenv.2006.05.066; Zhang RJ, 2007, J ENVIRON SCI-CHINA, V19, P564, DOI 10.1016/S1001-0742(07)60094-1; Zhang DZ, 1999, ATMOS ENVIRON, V33, P3213, DOI 10.1016/S1352-2310(99)00116-8; Sakai T, 2000, ATMOS ENVIRON, V34, P431, DOI 10.1016/S1352-2310(99)00328-3; Murayama T, 1999, J GEOPHYS RES-ATMOS, V104, P31781, DOI 10.1029/1999JD900503; Zhang Q, 2009, ATMOS ENVIRON, V43, P5526, DOI 10.1016/j.atmosenv.2009.05.037; Pilinis C, 1998, J GEOPHYS RES-ATMOS, V103, P3789, DOI 10.1029/97JD02792; Zhang WJ, 2010, ATMOS RES, V95, P197, DOI 10.1016/j.atmosres.2009.09.017; Xu L, 2001, ATMOS ENVIRON, V35, P3145, DOI 10.1016/S1352-2310(00)00532-X; Han LH, 2007, ATMOS ENVIRON, V41, P7533, DOI 10.1016/j.atmosenv.2007.05.046; SU WH, 1991, J AEROSOL SCI, V22, pS601, DOI 10.1016/S0021-8502(05)80173-9; Benjamin G., 2006, ATMOS ENVIRON, V40, P5167; Bian LG, 2002, J APPL METEOROLOGICA, V13, P13; Hayashi M, 1998, J METEOROL SOC JPN, V76, P549; IWASAKA Y, 1988, Tellus Series B Chemical and Physical Meteorology, V40, P494; Kim YS, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2002JD003269; MADNAWAT PVS, 1993, ATMOS ENVIRON A-GEN, V27, P1985, DOI 10.1016/0960-1686(93)90272-Z; Matsuki A., 2005, WATER AIR SOIL POLL, V5, P101, DOI 10.1007/s11267-005-0730-3; Murayama T, 2001, J GEOPHYS RES-ATMOS, V106, P18345, DOI 10.1029/2000JD900554; See S W, 2006, J GEOPHYS RES, V111, pD10, DOI DOI 10.1029/2005JD006180; Sumedha M., 2011, PROCEDIA ENV SCI, V8, P421; Wang S. -Y., 2002, J APPL METEOROLOGY, V13, P177; Yu SQ, 2002, J APPL METEOROLOGICA, V13, P92; Zhang D., 2005, WATER AIR SOIL POLL, P261, DOI DOI 10.1007/S11267-005-0743-Y; Zhang R. - J., 2000, CLIMATIC ENV RES, V5, P6	31	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0269-4042	1573-2983		ENVIRON GEOCHEM HLTH	Environ. Geochem. Health	OCT	2015	37	5			SI		791	800		10.1007/s10653-014-9668-6		10	Engineering, Environmental; Environmental Sciences; Public, Environmental & Occupational Health; Water Resources	Engineering; Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Water Resources	CS1CS	WOS:000361800800001		
J	Bakir-Gungor, B; Remmers, EF; Meguro, A; Mizuki, N; Kastner, DL; Gul, A; Sezerman, OU				Bakir-Gungor, Burcu; Remmers, Elaine F.; Meguro, Akira; Mizuki, Nobuhisa; Kastner, Daniel L.; Gul, Ahmet; Sezerman, Osman Ugur			'Epistatic interactions between autoimmunity and genetic thrombophilia' Reply	EUROPEAN JOURNAL OF HUMAN GENETICS			English	Letter							BEHCETS-DISEASE		[Bakir-Gungor, Burcu] Abdullah Gul Univ, Fac Engn & Nat Sci, Dept Comp Engn, Kayseri, Turkey; [Remmers, Elaine F.; Kastner, Daniel L.] NHGRI, Inflammatory Dis Sect, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Meguro, Akira; Mizuki, Nobuhisa] Yokohama City Univ, Sch Med, Dept Ophthalmol, Yokohama, Kanagawa 232, Japan; [Gul, Ahmet] Istanbul Univ, Dept Internal Med, Div Rheumatol, Istanbul, Turkey; [Sezerman, Osman Ugur] Sabanci Univ, Fac Engn & Nat Sci, Dept Biol Sci & Bioengn, Istanbul, Turkey	Bakir-Gungor, B (reprint author), Abdullah Gul Univ, Fac Engn & Nat Sci, Dept Comp Engn, Kayseri, Turkey.	burcu.gungor@agu.edu.tr					Gul A, 1996, BRIT J RHEUMATOL, V35, P1178; Leiba M, 2001, ANN RHEUM DIS, V60, P1081, DOI 10.1136/ard.60.12.1081; Aleman MM, 2014, J CLIN INVEST, V124, P3590, DOI 10.1172/JCI75386; Bakir-Gungor B, 2015, EUR J HUM GENET, V23, P678, DOI 10.1038/ejhg.2014.158; Stoimenis D, 2015, EUR J HUM GENET, V23, P1279, DOI 10.1038/ejhg.2014.287	5	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1018-4813	1476-5438		EUR J HUM GENET	Eur. J. Hum. Genet.	OCT	2015	23	10					1279	1280		10.1038/ejhg.2014.288		3	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CS0KK	WOS:000361747700003		
J	Kyo, S; Mizumoto, Y; Takakura, M; Nakamura, M; Sato, E; Katagiri, H; Ishikawa, M; Nakayama, K; Fujiwara, H				Kyo, Satoru; Mizumoto, Yasunari; Takakura, Masahiro; Nakamura, Mitsuhiro; Sato, Emi; Katagiri, Hiroshi; Ishikawa, Masako; Nakayama, Kentaro; Fujiwara, Hiroshi			Nerve-sparing abdominal radical trachelectomy: a novel concept to preserve uterine branches of pelvic nerves	EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY			English	Article						Trachelectomy; Cervical cancer; Nerve-sparing; Autonomic nerve; Uterine branch	STAGE CERVICAL-CANCER; MAST-CELLS; HYSTERECTOMY; FEASIBILITY; PREGNANCY; OUTCOMES; DISSECTION; CARCINOMA	Objectives: Nerve-sparing techniques to avoid bladder dysfunction in abdominal radical hysterectomy have been established during the past two decades, and they have been applied to radical trachelectomy. Although trachelectomy retains the uterine corpus, no report mentions the preservation of uterine branches of pelvic nerves. The aim of the present study was to introduce and discuss our unique concept for preserving them. Study design and results: Four cases with FIGO stage Ia2-Ib1 cervical cancer, in which preservation of uterine branches of the pelvic nerves was attempted, are presented. Operative procedures basically followed the previously reported standard approaches for nerve-sparing radical hysterectomy or trachelectomy, except for some points. Before resection of the sacrouterine ligament, the hypogastric nerve was first identified and translocated laterally. Subsequently, the uterine branches of the pelvic nerve were identified as a continuation of the hypogastric nerve and could be scooped with forceps by detachment of the surrounding connective tissues. Further detachment toward the uterine corpus enabled them to be completely separated from the cervix. This separation was extended up to the level of the junction of the upper and lower branches of the uterine artery. Thereafter, standard resection of the parametrium and paracolpium was performed, followed by cervical resection when it was confirmed that the isolated uterine branches of the pelvic nerves were safely translocated and preserved. There were no recurrences of cancer in these patients. Conclusions: Uterine branches of autonomic nerves can be safely preserved, and the procedure may be considered one of the nerve-sparing techniques for radical abdominal trachelectomy, which may hopefully improve the reproductive outcomes of this operation, although it needs to be evaluated with more patients. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Kyo, Satoru; Sato, Emi; Katagiri, Hiroshi; Ishikawa, Masako; Nakayama, Kentaro] Shimane Univ, Fac Med, Dept Obstet & Gynecol, Izumo, Shimane 6938501, Japan; [Mizumoto, Yasunari; Takakura, Masahiro; Nakamura, Mitsuhiro; Fujiwara, Hiroshi] Kanazawa Univ, Sch Med Sci, Dept Obstet & Gynecol, Kanazawa, Ishikawa 9208641, Japan	Kyo, S (reprint author), Shimane Univ, Fac Med, Dept Obstet & Gynecol, 89-1 Enyacho, Izumo, Shimane 6938501, Japan.	satoruky@med.shimane-u.ac.jp					Amussen M, 1983, CLIN GYNECOLOGICAL U; Rudolph MI, 2004, BIOCELL, V28, P1; Beiner ME, 2008, GYNECOL ONCOL, V110, P168, DOI 10.1016/j.ygyno.2008.04.027; Hockel M, 1998, AM J OBSTET GYNECOL, V178, P971, DOI 10.1016/S0002-9378(98)70533-2; Trimbos JB, 2001, INT J GYNECOL CANCER, V11, P180, DOI 10.1046/j.1525-1438.2001.01023.x; Diaz JP, 2008, GYNECOL ONCOL, V111, P255, DOI 10.1016/j.ygyno.2008.07.014; Li J, 2013, GYNECOL ONCOL, V131, P87, DOI 10.1016/j.ygyno.2013.07.079; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Marchiole P, 2007, GYNECOL ONCOL, V106, P132, DOI 10.1016/j.ygyno.2007.03.009; Fujii S, 2007, GYNECOL ONCOL, V107, P4, DOI 10.1016/j.ygyno.2007.08.076; Rob L, 2011, LANCET ONCOL, V12, P192, DOI 10.1016/S1470-2045(10)70084-X; Cao DY, 2013, BRIT J CANCER, V109, P2778, DOI 10.1038/bjc.2013.656; Kelemen K, 1998, AM J REPROD IMMUNOL, V39, P351; Nishio H, 2013, HUM REPROD, V28, P1793, DOI 10.1093/humrep/det118; PADILLA L, 1990, CELL MOL BIOL, V36, P93; van Gent MDJM, 2014, INT J GYNECOL CANCER, V24, P735, DOI 10.1097/IGC.0000000000000114; Speiser D, 2011, INT J GYNECOL CANCER, V21, P1635, DOI 10.1097/IGC.0b013e3182230294; Yabuki Y, 1996, GYNECOL ONCOL, V62, P370, DOI 10.1006/gyno.1996.0251; Smith JR, 1997, BRIT J OBSTET GYNAEC, V104, P1196, DOI 10.1111/j.1471-0528.1997.tb10946.x; Yuan XJ, 2009, PROSTAG OTH LIPID M, V90, P94, DOI 10.1016/j.prostaglandins.2009.09.004; Kunzmann S, 2003, FASEB J, V17, P1089, DOI 10.1096/fj.02-1008com; Wethington SL, 2013, INT J GYNECOL CANCER, V23, P1092, DOI 10.1097/IGC.0b013e318296034e; Yabuki Y, 2000, GYNECOL ONCOL, V77, P155, DOI 10.1006/gyno.1999.5723; SHELESNYAK MC, 1952, AM J PHYSIOL, V170, P522; Pareja R, 2013, GYNECOL ONCOL, V131, P77, DOI 10.1016/j.ygyno.2013.06.010; YABUKI Y, 1991, AM J OBSTET GYNECOL, V164, P7; Miyazaki S, 2003, J LEUKOCYTE BIOL, V74, P514, DOI 10.1189/jlb.1102566; Piccinni MP, 2000, J NEUROIMMUNOL, V109, P30, DOI 10.1016/S0165-5728(00)00299-X; GORDON JR, 1990, NATURE, V346, P274, DOI 10.1038/346274a0; Cibula D, 2008, GYNECOL ONCOL, V111, pS111, DOI 10.1016/j.ygyno.2008.07.028; DUCLOS AJ, 1995, AM J REPROD IMMUNOL, V33, P354; Kato Tomoyasu, 2002, Anatomical Science International, V77, P161, DOI 10.1046/j.0022-7722.2002.00023.x; Kuwabara Y, 2000, J Obstet Gynaecol Res, V26, P1; SAKAMOTO S, 1988, BAILLIERE CLIN OB GY, V2, P953, DOI 10.1016/S0950-3552(98)80022-9	34	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0301-2115	1872-7654		EUR J OBSTET GYN R B	Eur. J. Obstet. Gynecol. Reprod. Biol.	OCT	2015	193						5	9		10.1016/j.ejogrb.2015.06.029		5	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CS0UJ	WOS:000361777400002		
J	Akahira-Azuma, M; Yonemoto, N; Mori, R; Hosokawa, S; Matsushita, T; Sukhbat, K; Nansal, G; Bavuusuren, B; Shonkhuuz, E				Akahira-Azuma, Moe; Yonemoto, Naohiro; Mori, Rintaro; Hosokawa, Shinichi; Matsushita, Takeji; Sukhbat, Khulan; Nansal, Gerelmaa; Bavuusuren, Bayasgalantai; Shonkhuuz, Enkhtur			An hour-specific transcutaneous bilirubin nomogram for Mongolian neonates	EUROPEAN JOURNAL OF PEDIATRICS			English	Article						Neonatal hyperbilirubinemia; Transcutaneous bilirubin; Hour-specific nomogram; Mongolian	NEWBORN POPULATION; HYPERBILIRUBINEMIA; TERM; JAUNDICE	Transcutaneous bilirubin (TcB) nomograms have been developed for different populations. However, the TcB level, rate of rise and peak varies among countries and ethnicities. The aim of this study was to establish an hour-specific TcB nomogram for healthy term and late preterm Mongolian neonates during the first 144 h after birth. A total of 5084 TcB measurements from 1297 healthy neonates (gestational age a parts per thousand yen35 weeks, birth weight a parts per thousand yen2000 g) were obtained from October 2012 to October 2013. All measurements were performed using the Jaundice Meter, the JM-103 at 6 to 144 postnatal hours. Mongolian infants had the following characteristics: 27.1 % were delivered by cesarean section, 17.8 % had a birth weight > 4000 g, and > 90 % were being breastfed. TcB percentiles for each designated time point were calculated for the development of an hour-specific nomogram. TcB levels increased most rapidly in the first 24 h and less rapidly from 24 to 78 h, reaching a plateau after 78 h for the 50th percentile. TcB levels of Mongolian neonates for each time point were higher than those of previous studies. Conclusion: The higher values of the TcB nomogram for Mongolian neonates may be due to their Asian ethnicity and exclusive breastfeeding.	[Akahira-Azuma, Moe; Hosokawa, Shinichi; Matsushita, Takeji] Natl Ctr Global Hlth & Med, Dept Pediat, Shinjuku Ku, Tokyo 1628655, Japan; [Yonemoto, Naohiro] Natl Inst Mental Hlth, Natl Ctr Neurol & Psychiat, Dept Neuropsychopharmacol, Kodaira, Tokyo 1878553, Japan; [Mori, Rintaro] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Setagaya Ku, Tokyo 1578535, Japan; [Sukhbat, Khulan; Nansal, Gerelmaa; Bavuusuren, Bayasgalantai; Shonkhuuz, Enkhtur] Natl Ctr Maternal & Child Hlth Mongolia, Ulaanbaatar 16060, Mongol Peo Rep	Akahira-Azuma, M (reprint author), Natl Ctr Global Hlth & Med, Dept Pediat, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	nth3son@yahoo.co.jp; nyonemoto@gmail.com; rintaromori@gmail.com; shosokaw@hosp.ncgm.go.jp; tmatsush@hosp.ncgm.go.jp; hulan_1213@yahoo.com; ngerelmaa@yahoo.com; bayasgalantai.b@gmail.com; enkhtur_mgl@yahoo.com			National Center for Global Health and Medicine [24A-1, 26A-201, 27A-1404]	This work was supported in part by Grants-in-Aid for Research from the National Center for Global Health and Medicine (24A-1, 26A-201 and 27A-1404).	Akahira-Azuma M, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-151; American Academy of Pediatrics Subcommittee on Hyperbilirrubinemia, 2004, PEDIATRICS, V114, P297; Slusher TM, 2011, SEMIN PERINATOL, V35, P185, DOI 10.1053/j.semperi.2011.02.014; Maisels MJ, 2006, PEDIATRICS, V117, P1169, DOI 10.1542/peds.2005-0744; Chen YJ, 2012, EUR J PEDIATR, V171, P167, DOI 10.1007/s00431-011-1512-8; Kuzniewicz MW, 2014, PEDIATRICS, V134, P504, DOI 10.1542/peds.2014-0987; Kaplan M, 2011, NEONATOLOGY, V100, P354, DOI 10.1159/000330055; Yu ZB, 2011, EUR J PEDIATR, V170, P185, DOI 10.1007/s00431-010-1281-9; Dijk PH, 2012, ACTA PAEDIATR, V101, P3, DOI 10.1111/j.1651-2227.2011.02544.x; Fouzas S, 2010, PEDIATRICS, V125, pE52, DOI 10.1542/peds.2009-0403; De Luca D, 2008, ACTA PAEDIATR, V97, P146, DOI 10.1111/j.1651-2227.2007.00622.x; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Varvarigou A, 2009, PEDIATRICS, V124, P1052, DOI 10.1542/peds.2008-2322; Bental YA, 2009, ACTA PAEDIATR, V98, P1902, DOI 10.1111/j.1651-2227.2009.01385.x; Dennery PA, 2001, NEW ENGL J MED, V344, P581; Engle WD, 2009, AM J PERINAT, V26, P425, DOI 10.1055/s-0029-1214238; Mishra S, 2010, INDIAN J PEDIATR, V77, P45, DOI 10.1007/s12098-010-0007-3; De Luca D, 2009, ARCH PEDIAT ADOL MED, V163, P1054, DOI 10.1001/archpediatrics.2009.187; Yamamoto LG, 2012, PEDIATR EMERG CARE, V28, P380, DOI [10.1097/PEC.0b013e31824dcb43, 10.1097/01.PEC.0000414154.07261.8e]; Yang WC, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-145; Kuboi T, 2013, PEDIATR INT, V55, P608, DOI 10.1111/ped.12149; Setia S, 2002, ARCH PEDIAT ADOL MED, V156, P276; Engle WD, 2014, SEMIN PERINATOL, V38, P438, DOI 10.1053/j.semperi.2014.08.007; De Luca D, 2013, TRANSCUTANEOUS BILIR, P67; Maisels M Jeffrey, 2009, Pediatrics, V124, P1193, DOI 10.1542/peds.2009-0329; Ota E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105155; Sanpavat Suwimol, 2005, Journal of the Medical Association of Thailand, V88, P1187; Strickland SS, 1993, NOMADIC PEOPLES, V33, P231	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6199	1432-1076		EUR J PEDIATR	Eur. J. Pediatr.	OCT	2015	174	10					1299	1304		10.1007/s00431-015-2536-2		6	Pediatrics	Pediatrics	CR9BY	WOS:000361649400004		
J	Tanaka, K; Watanabe, K				Tanaka, Kanji; Watanabe, Katsumi			Effects of learning duration on implicit transfer	EXPERIMENTAL BRAIN RESEARCH			English	Article						Implicit learning; Sequence learning; Transfer	SEQUENTIAL-PROCEDURES; MOTOR SEQUENCES; MEMORY; REPRESENTATIONS; ACTIVATION; KNOWLEDGE; MOVEMENTS; NETWORKS; CHUNKING; MODES	Implicit learning and transfer in sequence acquisition play important roles in daily life. Several previous studies have found that even when participants are not aware that a transfer sequence has been transformed from the learning sequence, they are able to perform the transfer sequence faster and more accurately; this suggests implicit transfer of visuomotor sequences. Here, we investigated whether implicit transfer could be modulated by the number of trials completed in a learning session. Participants learned a sequence through trial and error, known as the m x n task (Hikosaka et al. in J Neurophysiol 74:1652-1661, 1995). In the learning session, participants were required to successfully perform the same sequence 4, 12, 16, or 20 times. In the transfer session, participants then learned one of two other sequences: one where the button configuration Vertically Mirrored the learning sequence, or a randomly generated sequence. Our results show that even when participants did not notice the alternation rule (i.e., vertical mirroring), their total working time was less and their total number of errors was lower in the transfer session compared with those who performed a Random sequence, irrespective of the number of trials completed in the learning session. This result suggests that implicit transfer likely occurs even over a shorter learning duration.	[Tanaka, Kanji; Watanabe, Katsumi] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan; [Tanaka, Kanji; Watanabe, Katsumi] Waseda Univ, Fac Sci & Engn, Tokyo, Japan	Tanaka, K (reprint author), Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	kanji.t9@gmail.com			JSPS [20727086, 20320624]; CREST	This work was supported by a Grant-in-Aid for Young Scientists (20727086) to KT and Grant-in-Aid for Scientific Research (20320624) from the JSPS and CREST to KW.	Abrahamse EL, 2013, FRONT HUM NEUROSCI, V7, P1; Verwey WB, 1999, J EXP PSYCHOL HUMAN, V25, P1693, DOI 10.1037/0096-1523.25.6.1693; Watanabe K, 2010, EXP BRAIN RES, V203, P233, DOI 10.1007/s00221-010-2217-3; Bapi RS, 2006, NEUROIMAGE, V32, P714, DOI 10.1016/j.neuroimage.2006.04.205; Sakai K, 2004, TRENDS COGN SCI, V8, P547, DOI 10.1016/j.tics.2004.10.005; Verwey WB, 2010, ACTA PSYCHOL, V134, P206, DOI 10.1016/j.actpsy.2010.02.001; Tanaka K, 2013, EXP BRAIN RES, V228, P411, DOI 10.1007/s00221-013-3573-6; Perruchet P, 2006, TRENDS COGN SCI, V10, P233, DOI 10.1016/j.tics.2006.03.006; Verwey WB, 2012, ACTA PSYCHOL, V140, P274, DOI 10.1016/j.actpsy.2012.05.007; Watanabe K, 2006, EXP BRAIN RES, V174, P673, DOI 10.1007/s00221-006-0512-9; Sakai K, 2003, EXP BRAIN RES, V152, P229, DOI 10.1007/s00221-003-1548-8; Hikosaka O, 1996, J NEUROPHYSIOL, V76, P617; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Bapi RS, 2000, EXP BRAIN RES, V132, P149, DOI 10.1007/s002219900332; Rand MK, 2000, EXP BRAIN RES, V131, P293, DOI 10.1007/s002219900283; Li FF, 2013, CONSCIOUS COGN, V22, P920, DOI 10.1016/j.concog.2013.06.004; Tanaka K, 2014, COGNITIVE SCI, V38, P565, DOI 10.1111/cogs.12098; Bo J, 2009, J NEUROPHYSIOL, V101, P3116, DOI 10.1152/jn.00006.2009; Ziori E, 2008, Q J EXP PSYCHOL, V61, P601, DOI 10.1080/17470210701255374; Sakai K, 1998, J NEUROSCI, V18, P1827; Dienes Z, 2004, COGNITIVE SCI, V28, P531, DOI 10.1016/j.cogsci.2004.03.003; Verwey WB, 2003, PSYCHOL RES-PSYCH FO, V67, P106, DOI 10.1007/s00426-002-0120-7; Abrahamse EL, 2010, PSYCHON B REV, V17, P603, DOI 10.3758/PBR.17.5.603; Pothos EM, 2007, PSYCHOL BULL, V133, P227, DOI 10.1037/0033-2909.133.2.227; Kuhn G, 2005, J EXP PSYCHOL LEARN, V31, P1417, DOI 10.1037/0278-7393.31.6.1417; HIKOSAKA O, 1995, J NEUROPHYSIOL, V74, P1652; Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; Dienes Z., 2006, MIND SOC, V5, P105, DOI DOI 10.1007/S11299-006-0012-4; Dienes Z, 2012, LANGUAGE MUSIC COGNI, P156; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Reber A. S., 1967, J VERB LEARN VERB BE, V6, P317; Tanaka K, 2014, ACTA PSYCHOL, V153, P1, DOI 10.1016/j.actpsy.2014.09.003; Verwey W. B., 2010, FRONTIERS PSYCHOL, V1, P1, DOI DOI 10.3389/FPSYG.2010.00032	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	OCT	2015	233	10					2767	2776		10.1007/s00221-015-4348-z		10	Neurosciences	Neurosciences & Neurology	CR8WU	WOS:000361635800002		
J	Shibagaki, K; Okamoto, K; Katsuta, O; Nakamura, M				Shibagaki, Keiichi; Okamoto, Kazuyoshi; Katsuta, Osamu; Nakamura, Masatsugu			Beneficial protective effect of pramipexole on light-induced retinal damage in mice	EXPERIMENTAL EYE RESEARCH			English	Article						Age-related macular degeneration; Light-induced retinal damage; Apoptosis; Pramipexole; Antioxidant	FREE-RADICAL SCAVENGER; N-TERT-BUTYLNITRONE; MACULAR DEGENERATION; IN-VIVO; OXIDATIVE STRESS; RAT RETINA; ANTIPARKINSONIAN DRUGS; PARKINSONS-DISEASE; LIPID-PEROXIDATION; PIGMENT EPITHELIUM	We investigated the effects of pramipexole, a potent dopamine receptor D2/D3 agonist, on light-induced retinal damage in mice, H2O2-induced retinal pigment epithelium ARPE-19 cell injury in humans, and hydroxyl radical scavenging activity in a cell-free system. Pramipexole (0.1 and 1 mg/ kg body weight) was orally administered to mice 1 h before light exposure (5000 lux, 2 h). Electrophysiological and morphologic studies were performed to evaluate the effects of the pramipexole on light-induced retinal damage in mice. Pramipexole significantly prevented the reduction of the a- and b-wave electroretinogram (ERG) amplitudes caused by light exposure in a dose-dependent manner. In parallel, damage to the inner and outer segments (IS/OS) of the photoreceptors, loss of photoreceptor nuclei, and the number of Tdt-mediated dUTP nick-end labeling (TUNEL)-positive cells in the outer nuclear layer (ONL) caused by light exposure were notably ameliorated by pramipexole. Additionally, pramipexole suppressed H(2)O(2-)induced ARPE-19 cell death in vitro in a concentration-dependent manner. The effect of pramipexole was significant at concentrations of 10(-6) M or higher. Pramipexole also significantly prevented H2O2-induced activation of caspases-3/7 and the intracellular accumulation of reactive oxygen species (ROS) in a concentration-dependent manner ranging from 10(-5) to 10(-3) M. Furthermore, pramipexole increased the scavenging activity toward a hydroxyl radical generated from H2O2 in a Fenton reaction. Our results suggest that pramipexole protects against light-induced retinal damage as an antioxidant and that it may be a novel and effective therapy for retinal degenerative disorders, such as dry age-related macular degeneration. (C) 2015 Elsevier Ltd. All rights reserved.	[Shibagaki, Keiichi; Katsuta, Osamu; Nakamura, Masatsugu] Santen Pharmaceut Co Ltd, Div Res & Dev, Kita Ku, Osaka 5308552, Japan; [Shibagaki, Keiichi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara 6300192, Japan; [Okamoto, Kazuyoshi] Santen Pharmaceut Co Ltd, Corp Dev Div, Kita Ku, Osaka 5308552, Japan	Shibagaki, K (reprint author), Santen Pharmaceut Co Ltd, Div Res & Dev, Kita Ku, 4-20 Ofuka Cho, Osaka 5308552, Japan.	keiichi.shibagaki@santen.co.jp					Age-Related Eye Disease Study Research Group, 2001, Archives of Ophthalmology, V119, P1417; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Jiang CP, 2012, WORLD J GASTROENTERO, V18, P1753, DOI 10.3748/wjg.v18.i15.1753; Delcourt C, 1998, ARCH OPHTHALMOL-CHIC, V116, P1031; Yoneda S, 2003, BRAIN RES, V967, P257, DOI 10.1016/S006-8993(03)02270-4; Fujita Y, 2006, N-S ARCH PHARMACOL, V372, P257, DOI 10.1007/s00210-005-0025-2; DOREY CK, 1989, INVEST OPHTH VIS SCI, V30, P1691; Tanito M, 2006, NEUROSCI LETT, V398, P63, DOI 10.1016/j.neulet.2005.12.070; Imai S, 2010, EUR J PHARMACOL, V642, P77, DOI 10.1016/j.ejphar.2010.05.057; Kitamura Y, 1998, MOL PHARMACOL, V54, P1046; Masutomi K, 2012, PHOTOCHEM PHOTOBIOL, V88, P1356, DOI 10.1111/j.1751-1097.2012.01129.x; Tsuruma K, 2011, MOL VIS, V17, P3556; Seddon JM, 2011, OPHTHALMOLOGY, V118, P2203, DOI 10.1016/j.ophtha.2011.04.029; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435; Cassarino DS, 1998, J NEUROCHEM, V71, P295; Ueki Y, 2008, J NEUROCHEM, V105, P784, DOI 10.1111/j.1471-4159.2007.05180.x; Hall ED, 1996, BRAIN RES, V742, P80, DOI 10.1016/S0006-8993(96)00968-7; Hartnett ME, 1996, OPHTHALMOLOGY, V103, P58; ELDRED GE, 1993, NATURE, V361, P724, DOI 10.1038/361724a0; Shimazaki H, 2011, INVEST OPHTH VIS SCI, V52, P7289, DOI 10.1167/iovs.11-7983; Tanito M, 2005, INVEST OPHTH VIS SCI, V46, P3859, DOI 10.1167/iovs.05-0672; YAMASHITA H, 1992, RETINA-J RET VIT DIS, V12, P59, DOI 10.1097/00006982-199212010-00012; Ranchon I, 2001, INVEST OPHTH VIS SCI, V42, P1375; CRUICKSHANKS KJ, 1993, ARCH OPHTHALMOL-CHIC, V111, P514; ROZANOWSKA M, 1995, J BIOL CHEM, V270, P18825; Kovach JL, 2012, J OPHTHALMOL, DOI 10.1155/2012/786870; Hahn P, 2003, ARCH OPHTHALMOL-CHIC, V121, P1099, DOI 10.1001/archopht.121.8.1099; Clarke CE, 2002, LANCET, V360, P1767, DOI 10.1016/S0140-6736(02)11668-0; Zhang J, 1999, AM J PATHOL, V154, P1423, DOI 10.1016/S0002-9440(10)65396-5; Kaarniranta K, 2009, J MOL MED-JMM, V87, P117, DOI 10.1007/s00109-008-0418-z; Zou LL, 2000, NEUROSCI LETT, V281, P167, DOI 10.1016/S0304-3940(00)00853-3; Kakimura J, 2001, EUR J PHARMACOL, V417, P59, DOI 10.1016/S0014-2999(01)00902-5; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Inden M, 2009, NEUROCHEM INT, V55, P760, DOI 10.1016/j.neuint.2009.07.009; Tanito M, 2002, INVEST OPHTH VIS SCI, V43, P2392; O'Driscoll C, 2011, EXP EYE RES, V93, P65, DOI 10.1016/j.exer.2011.04.007; Tomita H, 2005, INVEST OPHTH VIS SCI, V46, P427, DOI 10.1167/iovs.04-0946; Jeong MH, 2014, J RADIAT RES, V55, P464, DOI 10.1093/jrr/rrt140; Shen JK, 2007, HISTOL HISTOPATHOL, V22, P1301; Ramirez AD, 2003, EUR J PHARMACOL, V475, P29, DOI 10.1016/s0014-2999(03)02087-9; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Holz FG, 1999, GRAEF ARCH CLIN EXP, V237, P145, DOI 10.1007/s004170050209; Spencer ML, 2002, J BIOL CHEM, V277, P20160, DOI 10.1074/jbc.M201092200; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Imai S, 2010, J PHARMACOL EXP THER, V335, P645, DOI 10.1124/jpet.110.171298; Derouiche A, 1999, EUR J NEUROSCI, V11, P1391, DOI 10.1046/j.1460-9568.1999.00557.x; Yu Y, 2012, INVEST OPHTH VIS SCI, V53, P1548, DOI 10.1167/iovs.11-8657; Li C, 2010, NEUROCHEM RES, V35, P1546, DOI 10.1007/s11064-010-0214-3; Song HW, 2014, J BIOL CHEM, V289, P14194, DOI 10.1074/jbc.M114.561910; Pattee GL, 2003, AMYOTROPH LATERAL SC, V4, P90, DOI 10.1080/14660820310012736; Inokuchi Y, 2009, J PHARMACOL EXP THER, V329, P687, DOI 10.1124/jpet.108.148676; Bird AC, 2014, JAMA OPHTHALMOL, V132, P338, DOI 10.1001/jamaophthalmol.2013.5799; Rickman CB, 2013, INVEST OPHTH VIS SCI, V54, pORSF68, DOI 10.1167/iovs.13-12757; Roth C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-4; Shibagaki K., EXPERIMENTAL; Yokoyama K., 1999, XENOBIO METABOL DISP, V14, P300	56	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0014-4835	1096-0007		EXP EYE RES	Exp. Eye Res.	OCT	2015	139						64	72		10.1016/j.exer.2015.07.007		9	Ophthalmology	Ophthalmology	CS0VW	WOS:000361781300006		
J	Tsukahara, R; Umazume, K; Yamakawa, N; McDonald, K; Kaplan, HJ; Tamiya, S				Tsukahara, Rintaro; Umazume, Kazuhiko; Yamakawa, Naoyuki; McDonald, Kevin; Kaplan, Henry J.; Tamiya, Shigeo			Dasatinib affects focal adhesion and myosin regulation to inhibit matrix contraction by Muller cells	EXPERIMENTAL EYE RESEARCH			English	Article						Muller cells; Epiretinal membrane; Contraction; Dasatinib; Focal adhesion; Stress fibers	IDIOPATHIC EPIRETINAL MEMBRANE; TRACTIONAL FORCE GENERATION; COLLAGEN GEL CONTRACTION; PIGMENT EPITHELIAL-CELLS; PROLIFERATIVE VITREORETINOPATHY; STRESS FIBERS; PAXILLIN PHOSPHORYLATION; KINASE INHIBITOR; GROWTH-FACTORS; MACULAR HOLES	Epiretinal membrane (ERM) contraction is associated with a variety of ocular diseases that cause macular dysfunction. Trans-differentiated Muller cells have been identified in ERMs, and have been implicated to be involved in the contractile process. In this study, we tested the effect of dasatinib, an FDA-approved tyrosine kinase inhibitor, on matrix contraction caused by Muller cells, and examined molecular mechanism of action. Type I collagen matrix contraction assays were used to examine the effect of drugs on matrix contraction by trans-differentiated Muller cells. Fluophore-conjugated phalloidin was used for the detection of actin cytoskeleton, and Western-blot analyses were carried out to examine protein expression and phosphorylation status. Dasatinib inhibited collagen matrix contraction by transdifferentiated Muller cells that was associated with decreased cell spreading and reduction of actomyosin stress fibers. Concomitantly, dasatinib-treated Muller cells had reduced phosphorylation of Src family kinase, paxillin, as well as myosin II light chain. Specific inhibitors of Rho/ROCK and myosin II confirmed the critical role played by this pathway in Muller cell contraction. Our data demonstrate that dasatinib significantly reduced matrix contraction by Muller cells via inhibition of focal adhesion, as well as actomyosin contraction. (C) 2015 Elsevier Ltd. All rights reserved.	[Tsukahara, Rintaro; McDonald, Kevin; Kaplan, Henry J.; Tamiya, Shigeo] Univ Louisville, Dept Ophthalmol & Visual Sci, Louisville, KY 40202 USA; [Tamiya, Shigeo] Univ Louisville, Dept Biochem & Mol Genet, Louisville, KY 40202 USA; [Tsukahara, Rintaro; Umazume, Kazuhiko; Yamakawa, Naoyuki] Tokyo Med Univ, Dept Ophthalmol, Shinjuku Ku, Tokyo 1600023, Japan	Tamiya, S (reprint author), Univ Louisville, Sch Med, Dept Ophthalmol & Visual Sci, 301 E Muhammad Ali Blvd, Louisville, KY 40202 USA.	shigeo.tamiya@louisville.edu			DoD [DM090475]; Kentucky Science and Engineering Foundation R&D Excellence grant [KSEF-148- 502-10-271]; Research to Prevent Blindness, New York, NY; KY Lions Eye Foundation; KY Research Challenge Trust Fund; JSPS KAKENHI [26861470]	Grant information: Grant DM090475 from the DoD (S Tamiya); Kentucky Science and Engineering Foundation R&D Excellence grant #KSEF-148- 502-10-271 (S Tamiya); Unrestricted Grant from Research to Prevent Blindness, New York, NY; KY Lions Eye Foundation; KY Research Challenge Trust Fund (HJ Kaplan); JSPS KAKENHI Grant Number 26861470 (K Umazume).	Umazume K, 2014, AM J PATHOL, V184, P1419, DOI 10.1016/j.ajpath.2014.01.022; Pennock S, 2014, PROG RETIN EYE RES, V40, P16, DOI 10.1016/j.preteyeres.2013.12.006; Morales SA, 2007, EXP EYE RES, V85, P790, DOI 10.1016/j.exer.2007.08.014; Hauck SM, 2003, GLIA, V44, P251, DOI 10.1002/glia.10292; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Snead DRJ, 2008, EYE, V22, P1310, DOI 10.1038/eye.2008.36; Hinz B, 2001, MOL BIOL CELL, V12, P2730; Guidry C, 2003, INVEST OPHTH VIS SCI, V44, P1355, DOI 10.1167/iovs.02-0046; Guidry C, 1996, INVEST OPHTH VIS SCI, V37, P740; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Christopher LJ, 2008, DRUG METAB DISPOS, V36, P1357, DOI 10.1124/dmd.107.018267; Umazume K, 2013, INVEST OPHTH VIS SCI, V54, P1150, DOI 10.1167/iovs.12-10418; Pichot CS, 2009, BRIT J CANCER, V101, P38, DOI 10.1038/sj.bjc.6605101; KAMPIK A, 1980, AM J OPHTHALMOL, V90, P797; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Bu SC, 2014, RETINA-J RET VIT DIS, V34, P2317, DOI 10.1097/IAE.0000000000000349; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Guidry C, 2009, INVEST OPHTH VIS SCI, V50, P1929, DOI 10.1167/iovs.08-2475; Kinose F, 2005, MOL VIS, V11, P366; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Zhao F, 2013, RETINA-J RET VIT DIS, V33, P77, DOI 10.1097/IAE.0b013e3182602087; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; RYAN SJ, 1985, AM J OPHTHALMOL, V100, P188; Schneider IC, 2009, MOL BIOL CELL, V20, P3155, DOI 10.1091/mbc.E09-03-0219; Messmer EM, 1998, GRAEF ARCH CLIN EXP, V236, P248, DOI 10.1007/s004170050072; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Burridge K, 2013, J CELL BIOL, V200, P9, DOI 10.1083/jcb.201210090; Feist RM, 2014, GRAEF ARCH CLIN EXP, V252, P347, DOI 10.1007/s00417-013-2531-0; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; GUIDRY C, 1992, INVEST OPHTH VIS SCI, V33, P2429; Bringmann A, 2009, GRAEF ARCH CLIN EXP, V247, P865, DOI 10.1007/s00417-009-1082-x; Grinnell F, 2010, ANNU REV CELL DEV BI, V26, P335, DOI [10.1146/annurev.cellbio.042308.113318, 10.1146/annurev.cellbio.012308.113318]; Guidry C, 1997, INVEST OPHTH VIS SCI, V38, P456; Tamiya S, 2010, INVEST OPHTH VIS SCI, V51, P2755, DOI 10.1167/iovs.09-4725; Dumbauld DW, 2010, J CELL PHYSIOL, V223, P746, DOI 10.1002/jcp.22084; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Bu SC, 2014, RETINA-J RET VIT DIS, V34, P897, DOI 10.1097/IAE.0000000000000013; Meitinger D, 2001, EXP EYE RES, V73, P681, DOI 10.1006/exer.2001.1079; Caccia D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-278; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; FOOS RY, 1974, A GRAEF ARCH KLIN EX, V189, P231, DOI 10.1007/BF02384852; Pournaras C J, 2000, Semin Ophthalmol, V15, P100; Yang MT, 2011, INTEGR BIOL-UK, V3, P663, DOI 10.1039/c0ib00156b	45	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0014-4835	1096-0007		EXP EYE RES	Exp. Eye Res.	OCT	2015	139						90	96		10.1016/j.exer.2015.07.019		7	Ophthalmology	Ophthalmology	CS0VW	WOS:000361781300009		
J	Nakabayashi, S; Kawai, M; Yoshioka, T; Song, YS; Tani, T; Yoshida, A; Nagaoka, T				Nakabayashi, Seigo; Kawai, Motofumi; Yoshioka, Takafumi; Song, Yong-Seok; Tani, Tomofumi; Yoshida, Akitoshi; Nagaoka, Taiji			Effect of intravitreal Rho kinase inhibitor ripasudil (K-115) on feline retinal microcirculation	EXPERIMENTAL EYE RESEARCH			English	Article						Rho kinase inhibitor; K-115; Laser Doppler velocimetry; Retinal blood flow; Ripasudil; Microcirculation	OPEN-ANGLE GLAUCOMA; OPTIC-NERVE HEAD; OCULAR BLOOD-FLOW; INTRAOCULAR-PRESSURE; MYOSIN PHOSPHATASE; CLINICAL-TRIALS; SMOOTH-MUSCLE; HYPERTENSION; ARTERIOLES; RABBITS	Ripasudil (K-115) is a novel Rho kinase inhibitor with a potent intraocular pressure-lowering effect. However, it is unclear whether ripasudil affects the retinal blood flow (RBF). We investigated the effect of ripasudil on feline retinal microcirculation. Ripasudil (5 mu M, 50 mu M or 5 mM; n = 5 each concentration) or vehicle (PBS; n = 5) was injected intravitreally. The vessel diameter (D) and blood velocity (V) were measured by laser Doppler velocimetry simultaneously in the first-order retinal arterioles and the RBF was calculated. The measurements started 5 min before the injection and were performed every 10 min for 120 min. After the intravitreal injection, the retinal circulatory parameters did not change significantly in PBS or 5 mu M of ripasudil. The blood V and RBF increased significantly compared to baseline, whereas the vessel D did not change significantly in 50 mu M and 5 mM of ripasudil. The V in 50 mu M, and the V and RBF in 5 mM of ripasudil significantly increased compared to those in PBS. Intravitreal administration of ripasudil increased the blood V and RBF in cats, suggesting that ripasudil has the potential to improve the retinal blood flow. (C) 2015 Elsevier Ltd. All rights reserved.	[Nakabayashi, Seigo; Kawai, Motofumi; Yoshioka, Takafumi; Song, Yong-Seok; Tani, Tomofumi; Yoshida, Akitoshi; Nagaoka, Taiji] Asahikawa Med Univ, Dept Ophthalmol, Asahikawa, Hokkaido 0788510, Japan	Nakabayashi, S (reprint author), Asahikawa Med Univ, Dept Ophthalmol, Midorigaoka Higashi 2-1-1-1, Asahikawa, Hokkaido 0788510, Japan.	nby@asahikawa-med.ac.jp; m-kawai@asahikawa-med.ac.jp; takafumiyoshioka@hotmail.com; ysong@asahikawa-med.ac.jp; asa555@asahikawa-med.ac.jp; ayoshida@asahikawa-med.ac.jp; nagaoka@asahikawa-med.ac.jp			Ministry of Education, Science, and Culture, Tokyo, Japan [25293352, 18591904]; Kowa Company, Ltd.	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture, Tokyo, Japan (B) 25293352 and (C) 18591904 (to T. Nagaoka) and in part by grants from Kowa Company, Ltd.	Okamura N, 2007, J OCUL PHARMACOL TH, V23, P207, DOI 10.1089/jop.2006.128; Izumi N, 2008, J OCUL PHARMACOL TH, V24, P521, DOI 10.1089/jop.2007.0065; Mizuno K, 2002, INVEST OPHTH VIS SCI, V43, P3243; Kawai M, 2012, JPN J OPHTHALMOL, V56, P458, DOI 10.1007/s10384-012-0156-1; Ishizaki T, 1996, EMBO J, V15, P1885; Tanihara H, 2015, JAMA OPHTHALMOL, V133, P755, DOI 10.1001/jamaophthalmol.2015.0525; Tanihara H, 2013, JAMA OPHTHALMOL, V131, P1288, DOI 10.1001/jamaophthalmol.2013.323; Potts LB, 2012, INVEST OPHTH VIS SCI, V53, P2904, DOI 10.1167/iovs.12-9542; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Nagaoka T, 2002, INVEST OPHTH VIS SCI, V43, P3037; Potts LB, 2013, INVEST OPHTH VIS SCI, V54, P7587, DOI [10.1167/iovs13-13178, 10.1167/iovs.13-13178]; Jarajapu YPR, 2005, AM J PHYSIOL-HEART C, V289, pH1917, DOI 10.1152/ajpheart.01012.2004; Isobe T, 2014, CURR EYE RES, V39, P813, DOI 10.3109/02713683.2013.874444; Tani T, 2014, INVEST OPHTH VIS SCI, V55, P360, DOI 10.1167/iovs.13-12591; Tanihara H, 2013, AM J OPHTHALMOL, V156, P731, DOI 10.1016/j.ajo.2013.05.016; Arita R, 2009, DIABETES, V58, P215, DOI 10.2337/db08-0762; Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Su WW, 2006, INVEST OPHTH VIS SCI, V47, P3390, DOI 10.1167/iovs.06-0024; Sugiyama T, 2011, INVEST OPHTH VIS SCI, V52, P64, DOI 10.1167/iovs.10-5265; FEKE GT, 1987, IEEE T BIO-MED ENG, V34, P673, DOI 10.1109/TBME.1987.325992; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Harris A, 1999, PROG RETIN EYE RES, V18, P669; Wang YP, 2009, CIRC RES, V104, P531, DOI 10.1161/CIRCRESAHA.108.188524; Tanihara H, 2015, ACTA OPHTHALMOL, V93, pE254, DOI 10.1111/aos.12599; Nagaoka T, 2010, INVEST OPHTH VIS SCI, V51, P6729, DOI 10.1167/iovs.10-5364; Takagi C, 1996, INVEST OPHTH VIS SCI, V37, P2504; Costa VP, 2003, PROG RETIN EYE RES, V22, P769, DOI 10.1016/S1350-9462(03)00064-8; Tokushige H, 2011, CURR EYE RES, V36, P964, DOI 10.3109/02713683.2011.599106; KUO L, 1992, NEWS PHYSIOL SCI, V7, P5; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429	30	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0014-4835	1096-0007		EXP EYE RES	Exp. Eye Res.	OCT	2015	139						132	135		10.1016/j.exer.2015.07.008		4	Ophthalmology	Ophthalmology	CS0VW	WOS:000361781300014		
J	Xu, YC; Maeno, K; Nagahara, H; Taniguchi, R				Xu, Yichao; Maeno, Kazuki; Nagahara, Hajime; Taniguchi, Rin-ichiro			Camera array calibration for light field acquisition	FRONTIERS OF COMPUTER SCIENCE			English	Article						light field; camera array; calibration; rectification; digital refocusing	RECTIFICATION	Light field cameras are becoming popular in computer vision and graphics, with many research and commercial applications already having been proposed. Various types of cameras have been developed with the camera array being one of the ways of acquiring a 4D light field image using multiple cameras. Camera calibration is essential, since each application requires the correct projection and ray geometry of the light field. The calibrated parameters are used in the light field image rectified from the images captured by multiple cameras. Various camera calibration approaches have been proposed for a single camera, multiple cameras, and a moving camera. However, although these approaches can be applied to calibrating camera arrays, they are not effective in terms of accuracy and computational cost. Moreover, less attention has been paid to camera calibration of a light field camera. In this paper, we propose a calibration method for a camera array and a rectification method for generating a light field image from the captured images. We propose a two-step algorithm consisting of closed form initialization and nonlinear refinement, which extends Zhang's well-known method to the camera array. More importantly, we introduce a rigid camera constraint whereby the array of cameras is rigidly aligned in the camera array and utilize this constraint in our calibration. Using this constraint, we obtained much faster and more accurate calibration results in the experiments.	[Xu, Yichao; Maeno, Kazuki; Nagahara, Hajime; Taniguchi, Rin-ichiro] Kyushu Univ, Grad Sch Informat Sci & Elect Engn, Fukuoka 8190395, Japan	Xu, YC (reprint author), Kyushu Univ, Fukuoka 8190395, Japan.	xu@limu.ait.kyushu-u.ac.jp					[Anonymous], 1987, IEEE J ROBOTIC AUTOM, DOI DOI 10.1109/JRA.1987.1087109; [Anonymous], 1997, P 5 PAC C COMP GRAPH; Fusiello A, 2000, MACH VISION APPL, V12, P16, DOI 10.1007/s001380050120; Zhang ZY, 2000, IEEE T PATTERN ANAL, V22, P1330, DOI 10.1109/34.888718; Maeno K, 2013, PROC CVPR IEEE, P2786, DOI 10.1109/CVPR.2013.359; Dansereau DG, 2013, PROC CVPR IEEE, P1027, DOI 10.1109/CVPR.2013.137; Wilburn B, 2005, ACM T GRAPHIC, V24, P765, DOI 10.1145/1073204.1073259; Snavely N, 2008, INT J COMPUT VISION, V80, P189, DOI 10.1007/s11263-007-0107-3; Svoboda T, 2005, PRESENCE-TELEOP VIRT, V14, P407, DOI 10.1162/105474605774785325; Wetzstein G, 2011, 2011 IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION (ICCV), P1180, DOI 10.1109/ICCV.2011.6126367; Bok Y, 2014, P EUR C COMP VIS, V8694, P47; Cho D, 2013, P IEEE INT C COMP VI; Deng K, 2003, COMPUT GRAPH-UK, V27, P169, DOI 10.1016/S0097-8493(02)00274-1; Fukushima N, 2008, P IWAIT 2008, pB5; Georgiev T, 2010, J ELECT IMAGING, V19; Heikkila J, 1997, PROC CVPR IEEE, P1106, DOI 10.1109/CVPR.1997.609468; Levenberg K., 1944, Quarterly of Applied Mathematics, V2; Levoy M., 1996, Computer Graphics Proceedings. SIGGRAPH '96, DOI 10.1145/237170.237199; Loop C., 1999, P IEEE C COMP VIS PA, V1, P125; Marquart D., 1963, SIAM J APPL MATH, V11, P431, DOI DOI 10.1137/0111030; Ng R, 2005, COMPUTER SCI TECHNIC; Seitz S., 2006, 2006 IEEE COMP SOC C, V1, P519, DOI 10.1109/CVPR.2006.19; Ueshiba T., 2003, Proceedings Ninth IEEE International Conference on Computer Vision; Vaish V, 2004, PROC CVPR IEEE, P2; Vaish V., 2006, P 2006 IEEE COMP SOC, V2, P2331; WEI GQ, 1994, IEEE T PATTERN ANAL, V16, P469	26	0	0	HIGHER EDUCATION PRESS	BEIJING	SHATANHOU ST 55, BEIJING 100009, PEOPLES R CHINA	2095-2228	2095-2236		FRONT COMPUT SCI-CHI	Front.. Comput. Sci.	OCT	2015	9	5					691	702		10.1007/s11704-015-4237-4		12	Computer Science, Information Systems; Computer Science, Software Engineering; Computer Science, Theory & Methods	Computer Science	CR8NP	WOS:000361611300003		
J	Horiuchi, A; Hosoi, K; Kajiyama, M; Tanaka, N; Sano, K; Graham, DY				Horiuchi, Akira; Hosoi, Kenji; Kajiyama, Masashi; Tanaka, Naoki; Sano, Kenji; Graham, David Y.			Prospective, randomized comparison of 2 methods of cold snare polypectomy for small colorectal polyps	GASTROINTESTINAL ENDOSCOPY			English	Article							COLONOSCOPIC POLYPECTOMY; CONVENTIONAL POLYPECTOMY; CANCER; REMOVAL	Background: Both cold-only snare and hot polypectomy snare are used for the removal of small colorectal polyps. Objective: To compare the outcome of cold snare polypectomy of small colorectal polyps with a snare exclusively designed as a cold snare versus cold snare polypectomy by using a traditional polypectomy snare. Design: Prospective, randomized, controlled study. Setting: Municipal hospital in Japan. Interventions: Patients with colorectal polyps 10 mm or smaller in diameter were randomized to dedicated cold snare (dedicated cold snare group) or traditional cold snare (traditional cold snare group). The primary outcome measure was complete resection rates by cold snaring based on pathological examination. Secondary outcomes included bleeding within 2 weeks after polypectomy and identification of submucosal arteries and injured arteries in the resected specimens. Results: Seventy-six patients having 210 eligible polyps were randomized: dedicated cold snare group, N = 37 (98 polyps) and traditional cold snare group, N = 39 (112 polyps). Patient demographic characteristics including the number, size, and shape of the polyps removed were similar in the 2 groups. The complete resection rate was significantly greater with the dedicated cold than with the traditional cold snare (91% [89/98] vs 79% [88/112], P = .015), with a marked difference with 8- to 10-mm polyps, both flat and pedunculated. Immediate bleeding and hematochezia rates were similar (19% vs 21%, P = .86; 5.4% vs 7.7%, P =.69). No delayed bleeding occurred. Histology demonstrated a similar prevalence of arteries and injured arteries in the submucosa (33% [32/96] vs 30% [31/104], P =.59; 3.1% [3/96] vs 6.7% [7/104], P =.24). Limitations: Small sample size, single-center study. Conclusion: Polypectomy by using a dedicated cold snare resulted in complete polyp removal more often than did cold snaring with a traditional snare, especially polyps 8 to 10 mm in diameter, whether flat or pedunculated.	[Horiuchi, Akira; Kajiyama, Masashi; Tanaka, Naoki] Showa Inan Gen Hosp, Ctr Digest Dis, Komagane 3994117, Japan; [Hosoi, Kenji] Juntendo Univ, Fac Med, Dept Pediat, Tokyo, Japan; [Sano, Kenji] Shinshu Univ Hosp, Dept Lab Med, Matsumoto, Nagano, Japan; [Graham, David Y.] Baylor Coll Med, Dept Internal Med, Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA	Horiuchi, A (reprint author), Showa Inan Gen Hosp, Ctr Digest Dis, 3230 Akaho, Komagane 3994117, Japan.						Rex DK, 2002, AM J GASTROENTEROL, V97, P1296, DOI 10.1016/S0002-9270(02)04168-0; Pohl H, 2013, GASTROENTEROLOGY, V144, P74, DOI 10.1053/j.gastro.2012.09.043; Horiuchi A, 2013, DIGEST DIS SCI, V58, P534, DOI 10.1007/s10620-012-2403-1; Ichise Y, 2011, DIGESTION, V84, P78, DOI 10.1159/000323959; Fyock CJ, 2010, WORLD J GASTROENTERO, V16, P3630, DOI 10.3748/wjg.v16.i29.3630; Deenadayalu VP, 2005, GASTROINTEST ENDOSC, V62, P253, DOI 10.1016/S0016-5107(05)00376-7; Citarda F, 2001, GUT, V48, P812, DOI 10.1136/gut.48.6.812; Repici A, 2012, ENDOSCOPY, V44, P27, DOI 10.1055/s-0031-1291387; Horiuchi A, 2014, GASTROINTEST ENDOSC, V79, P417, DOI 10.1016/j.gie.2013.08.040; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Lee CK, 2013, AM J GASTROENTEROL, V108, P1593, DOI 10.1038/ajg.2013.302; Liu SL, 2012, DIGEST DIS SCI, V57, P1786, DOI 10.1007/s10620-012-2115-6; Horiuchi A, 2012, GASTROINTEST ENDOSC, V75, P506, DOI 10.1016/j.gie.2011.08.020; Hewett DG, 2013, GASTROENTEROL CLIN N, V42, P443, DOI 10.1016/j.gtc.2013.05.015	14	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	OCT	2015	82	4					686	692		10.1016/j.gie.2015.02.012		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CR8BB	WOS:000361575000016		
J	Matsuzawa, T; Ishida, H; Yoshida, S; Isayama, H; Kuwai, T; Maetani, I; Shimada, M; Yamada, T; Saito, S; Tomita, M; Koizumi, K; Hirata, N; Sasaki, T; Enomoto, T; Saida, Y				Matsuzawa, Takeaki; Ishida, Hideyuki; Yoshida, Shuntaro; Isayama, Hiroyuki; Kuwai, Toshio; Maetani, Iruru; Shimada, Mamoru; Yamada, Tomonori; Saito, Shuji; Tomita, Masafumi; Koizumi, Koichi; Hirata, Nobuto; Sasaki, Takashi; Enomoto, Toshiyuki; Saida, Yoshihisa			A Japanese prospective multicenter study of self-expandable metal stent placement for malignant colorectal obstruction: short-term safety and efficacy within 7 days of stent procedure in 513 cases	GASTROINTESTINAL ENDOSCOPY			English	Article							COLONIC OBSTRUCTION; EMERGENCY-SURGERY; RISK-FACTORS; CANCER; MANAGEMENT; METAANALYSIS; BRIDGE; EXPERIENCE; ENDOSCOPY; CARCINOMA	Background: Endoscopic self-expandable metal stent placement has been used as an alternative to surgery for malignant colorectal obstruction; however, factors affecting its clinical outcome are unclear. Objective: To clarify the short-term safety and efficacy of endoscopic self-expandable metal stent placement for malignant colorectal obstruction and to identify factors associated with its clinical and technical failure. Design: Prospective clinical cohort study. Setting: Fourteen academic centers and 32 community hospitals. Patients: A total of 513 consecutive patients with malignant colorectal obstruction. Intervention: Endoscopic self-expandable metal stent placement, sharing of stent placement methods among participating facilities. Main Outcome Measurements: The primary endpoint was clinical success, defined as symptom and radiological finding resolution within 24 hours. Secondary endpoints were technical success and adverse events. The follow-up period was 7 days. Results: The clinical and technical success rates were 95.5% and 97.9%, respectively. Major adverse events included perforation (2.1%), stent migration (1.0%), and stent occlusion (0.8%). The main causes of perforation were the procedure itself (0.8%) and comorbidities (obstructive colitis and impending perforation) not apparent before stent placement (0.6%). Extrinsic tumor origin was independently associated with the clinical failure after stent placement (odds ratio 4.23; 95% confidence interval, 1.21-14.79; P = . 02). Stricture marking trended toward a negative association with technical failure (P =.09). Limitations: Noncomparative study. Conclusion: Strict inclusion criteria and stricture marking may improve the technical and clinical success of stent placement.	[Matsuzawa, Takeaki; Ishida, Hideyuki] Saitama Med Univ, Saitama Med Ctr, Dept Digest Tract & Gen Surg, Saitama, Japan; [Yoshida, Shuntaro] Univ Tokyo, Grad Sch Med, Dept Endoscopy & Endoscop Surg, Tokyo, Japan; [Isayama, Hiroyuki] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Kuwai, Toshio] Natl Hosp Org, Kure Med Ctr, Dept Gastroenterol, Kure, Japan; [Kuwai, Toshio] Chugoku Canc Ctr, Kure, Japan; [Maetani, Iruru] Toho Univ, Ohashi Med Ctr, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo 1538515, Japan; [Shimada, Mamoru] Moriguchi Keijinkai Hosp, Dept Surg, Osaka, Japan; [Yamada, Tomonori] Japanese Red Cross Nagoya Daini Hosp, Dept Gastroenterol, Nagoya, Aichi, Japan; [Saito, Shuji] Natl Hosp Org, Yokohama Med Ctr, Dept Surg, Yokohama, Kanagawa, Japan; [Tomita, Masafumi] Kishiwada Tokushukai Hosp, Dept Surg, Osaka, Japan; [Koizumi, Koichi] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Gastroenterol, Tokyo, Japan; [Hirata, Nobuto] Kameda Med Ctr, Dept Gastroenterol, Kamogawa, Japan; [Sasaki, Takashi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan; [Enomoto, Toshiyuki; Saida, Yoshihisa] Toho Univ, Ohashi Med Ctr, Dept Surg, Tokyo 1538515, Japan	Saida, Y (reprint author), Toho Univ, Ohashi Med Ctr, Dept Surg, Meguro Ku, 2-17-6 Ohashi, Tokyo 1538515, Japan.				Boston Scientific Japan; Century Medical Inc; ZEON; Taewong Medical; Piolax Medical Devices; Olympus Medical Systems; MC Medica	Dr Matsu has received personal fees from Boston Scientific Japan. Dr Yoshida has received personal fees from Boston Scientific Japan, Century Medical Inc, and ZEON. Dr Isayama has received donations and fees from Boston Scientific Japan, Century Medical Inc, and Taewong Medical. Dr Kuwai has received personal fees from Boston Scientific Japan, Dr Maetani has received personal frees from Boston Scientific Japan, Century Medical Inc, Piolax Medical Devices, and MC Medica. Dr Shimada has received personal fees from Boston Scientific Japan. Dr Saito has received personal fees from Boston Scientific Japan and Century Medical Inc. Dr Koizuma has received personal fees from Century Medical Inc and Olympus Medical Systems. Dr Sasaki has received personal fees from Boston Scientific Japan and Piolax Medical Devices. Dr Saida has received grants and personal fees from Boston Scientific Japan, Century Medical Inc, and Olympus Medical Systems. All other authors disclosed no financial relationships relevant to this publication.	Sebastian S, 2004, AM J GASTROENTEROL, V99, P2051, DOI 10.1111/j.1572-0241.2004.40017.x; Adler DG, 2002, AM J GASTROENTEROL, V97, P72; Saida Y, 1996, DIS COLON RECTUM, V39, P552, DOI 10.1007/BF02058710; van Hooft JE, 2014, ENDOSCOPY, V46, P990, DOI 10.1055/s-0034-1390700; Repici A, 2008, GASTROINTEST ENDOSC, V67, P77, DOI 10.1016/j.gie.2007.08.019; Saida Y, 2011, SURG ENDOSC, V25, P1748, DOI 10.1007/s00464-010-1310-9; Keranen I, 2012, SURG ENDOSC, V26, P423, DOI 10.1007/s00464-011-1890-z; Smothers L, 2003, DIS COLON RECTUM, V46, P24, DOI 10.1097/01.DCR.0000044719.17980.4C; Cirocchi R, 2013, SURG ONCOL, V22, P14, DOI 10.1016/j.suronc.2012.10.003; Cennamo V, 2013, INT J COLORECTAL DIS, V28, P855, DOI 10.1007/s00384-012-1599-z; Khot UP, 2002, BRIT J SURG, V89, P1096, DOI 10.1046/j.1365-2168.2002.02148.x; Watt AM, 2007, ANN SURG, V246, P24, DOI 10.1097/01.sla.0000261124.72687.72; REEDERS JWAJ, 1982, EUR J RADIOL, V2, P41; Tan KK, 2009, J GASTROINTEST SURG, V13, P2252, DOI 10.1007/s11605-009-0986-4; Small AJ, 2010, GASTROINTEST ENDOSC, V71, P560, DOI 10.1016/j.gie.2009.10.012; Meisner S, 2012, GASTROENT RES PRACT, DOI 10.1155/2012/296347; van Hooft JE, 2011, LANCET ONCOL, V12, P344, DOI 10.1016/S1470-2045(11)70035-3; Yoon JY, 2011, GASTROINTEST ENDOSC, V74, P858, DOI 10.1016/j.gie.2011.05.044; Sasaki K, 2012, DIS COLON RECTUM, V55, P72, DOI 10.1097/DCR.0b013e318239be5e; Keswani RN, 2009, GASTROINTEST ENDOSC, V69, P675, DOI 10.1016/j.gie.2008.09.009; Yoshida S, 2013, DIGEST ENDOSC, V25, P160, DOI 10.1111/j.1443-1661.2012.01353.x; Baron TH, 2012, GASTROINTEST ENDOSC, V75, P653, DOI 10.1016/j.gie.2011.12.020; van Halsema EE, 2014, GASTROINTEST ENDOSC, V79, P970, DOI 10.1016/j.gie.2013.11.038; Anwar MA, 2006, SURG ONCOL, V15, P91, DOI 10.1016/j.suronc.2006.09.001; Meisner S, 2011, GASTROINTEST ENDOSC, V74, P876, DOI 10.1016/j.gie.2011.06.019; Tan CJ, 2012, BRIT J SURG, V99, P469, DOI 10.1002/bjs.8689; Ansaloni L, 2010, WORLD J EMERG SURG, V5, DOI 10.1186/1749-7922-5-29; Harrison ME, 2010, GASTROINTEST ENDOSC, V71, P669, DOI 10.1016/j.gie.2009.11.027; DEANS GT, 1994, BRIT J SURG, V81, P1270, DOI 10.1002/bjs.1800810905; Foundation for Promotion of Cancer Research, CANC STAT JAP 2013; Sabbagh C, 2013, ANN SURG, V258, P107, DOI 10.1097/SLA.0b013e31827e30ce; van Hooft JE, 2006, LANCET, V368, P1573	32	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	OCT	2015	82	4					697	+		10.1016/j.gie.2015.03.1978		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CR8BB	WOS:000361575000018		
J	Iacopini, F; Saito, Y; Yamada, M; Grossi, C; Rigato, P; Costamagna, G; Gotoda, T; Matsuda, T; Scozzarro, A				Iacopini, Federico; Saito, Yutaka; Yamada, Masayoshi; Grossi, Cristina; Rigato, Patrizia; Costamagna, Guido; Gotoda, Takuji; Matsuda, Takahisa; Scozzarro, Agostino			Curative endoscopic submucosal dissection of large nonpolypoid superficial neoplasms in ulcerative colitis (with videos)	GASTROINTESTINAL ENDOSCOPY			English	Article							COLORECTAL NEOPLASIA; DYSPLASTIC LESIONS; MUCOSAL RESECTION; POLYPECTOMY; MANAGEMENT; CHROMOENDOSCOPY; COLONOSCOPY; JAPAN	Background: Endoscopic resection of superficial neoplasms in inflammatory bowel disease (IBD) is appropriate if a complete resection can be achieved. However, EMR is ineffective for large, nonpolypoid neoplasms in IBD due to submucosal fibrosis, and no data are available on the efficacy of endoscopic submucosal dissection (ESD). Objective: To assess ESD feasibility and efficacy for large, nonpolypoid neoplasms in patients with IBD. Design: Prospective case series. Setting: Multicenter: Italian and Japanese centers. Patients: Consecutive patients with long-standing ulcerative colitis and a superficial nonpolypoid neoplasm, >20 mm within the colitic mucosa. Intervention: Neoplasm characterization and delineation by chromoscopy and narrow-band imaging. ESD performed according to the standard technique. Main Outcome Measurements: Feasibility, safety, curative resection rates. Results: Nine patients with 10 neoplasms were included (7 and 3 in the Italian and Japanese centers, respectively). Neoplasms were laterally spreading tumors-non-granular in 5 cases, in the left side of the colon in 7, had median size of 33 mm, and were associated with scar in 5 cases. Margin delineation was difficult in 5 cases. Submucosal fibrosis was present in 9 cases. ESD was en bloc with negative margins (R0) in 8 cases, and curative in 7. No endoscopic invisible dysplasia or cancer was found during the follow-up (median 24 months, range 6-72 months) at the resection site and elsewhere within the colitic mucosa. Limitations: Small series. Conclusion: ESD achieves curative resections in patients with IBD, but the procedure is difficult because of the high prevalence of submucosal fibrosis. Patients need to be accurately evaluated before resection and adhere to strict long-term follow-ups.	[Iacopini, Federico; Grossi, Cristina; Scozzarro, Agostino] Osped S Giuseppe ASL Roma H, Gastroenterol & Endoscopy Unit, Albano L, Italy; [Saito, Yutaka; Yamada, Masayoshi; Matsuda, Takahisa] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan; [Rigato, Patrizia] Osped S Giuseppe ASL Roma H, Pathol Unit, Marino, Italy; [Costamagna, Guido] Univ Cattolica Sacro Cuore, Digest Surg Endoscopy, I-00168 Rome, Italy; [Gotoda, Takuji] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1608402, Japan	Iacopini, F (reprint author), Via T Mertel 16A, Rome, Italy.	federico.iacopini@gmail.com					Kisiel JB, 2012, INFLAMM BOWEL DIS, V18, P226, DOI 10.1002/ibd.21687; Engelsgjerd M, 1999, GASTROENTEROLOGY, V117, P1288, DOI 10.1016/S0016-5085(99)70278-7; Hurlstone DP, 2007, GUT, V56, P838, DOI 10.1136/gut.2006.106294; Smith LA, 2008, INFLAMM BOWEL DIS, V14, P1380, DOI 10.1002/ibd.20497; Rutter MD, 2014, CLIN GASTROENTEROL H, V12, P359, DOI 10.1016/j.cgh.2013.05.033; van den Broek FJC, 2011, ENDOSCOPY, V43, P108, DOI 10.1055/s-0030-1255956; Matsumoto T, 2008, INFLAMM BOWEL DIS, V14, P259, DOI 10.1002/ibd.20267; Kiesslich R, 2003, GASTROENTEROLOGY, V124, P880, DOI 10.1053/gast.2003.50146; Schlemper RJ, 2000, J GASTROEN HEPATOL, V15, pG49, DOI 10.1046/j.1440-1746.2000.02266.x; Matsumoto A, 2010, SCAND J GASTROENTERO, V45, P1329, DOI 10.3109/00365521.2010.495416; Iacopini F, 2012, GASTROINTEST ENDOSC, V76, P1188, DOI 10.1016/j.gie.2012.08.024; Nakajima T, 2013, SURG ENDOSC, V27, P3262, DOI 10.1007/s00464-013-2903-x; Rutter MD, 2004, GASTROINTEST ENDOSC, V60, P334, DOI 10.1016/S0016-5107(04)01710-9; Biancone L, 2008, J CROHNS COLITIS, V2, P63, DOI 10.1016/j.crohns.2007.12.001; Matsuda T, 2008, AM J GASTROENTEROL, V103, P2700, DOI 10.1111/j.1572-0241.2008.02190.x; Rubin PH, 1999, GASTROENTEROLOGY, V117, P1295, DOI 10.1016/S0016-5085(99)70279-9; Kim YJ, 2013, DIGEST DIS SCI, V58, P1727, DOI 10.1007/s10620-013-2560-x; Suzuki H, 2008, Endoscopy, V40 Suppl 2, pE130, DOI 10.1055/s-2006-944868	18	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	OCT	2015	82	4					734	738		10.1016/j.gie.2015.02.052		5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CR8BB	WOS:000361575000024		
J	Mori, H; Kobara, H; Nishiyama, N; Fujihara, S; Ayaki, M; Ikeda, Y; Masaki, T				Mori, Hirohito; Kobara, Hideki; Nishiyama, Noriko; Fujihara, Shintaro; Ayaki, Maki; Ikeda, Yoshitaka; Masaki, Tsutomu			Safer endoscopic submucosal dissection for duodenal cancer with sufficient bulging by preclipping method	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Mori, Hirohito; Kobara, Hideki; Nishiyama, Noriko; Fujihara, Shintaro; Ayaki, Maki; Ikeda, Yoshitaka; Masaki, Tsutomu] Kagawa Univ, Fac Med, Dept Gastroenterol & Neurol, Takamatsu, Kagawa 760, Japan; [Mori, Hirohito] Ehime Rosai Hosp, Dept Surg Gastroenterol, Niihama, Japan	Mori, H (reprint author), Kagawa Univ, Fac Med, Dept Gastroenterol & Neurol, Takamatsu, Kagawa 760, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	OCT	2015	82	4					749	750		10.1016/j.gie.2015.05.006		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CR8BB	WOS:000361575000033		
J	Imai, K; Hotta, K; Kakushima, N; Ono, H				Imai, Kenichiro; Hotta, Kinichi; Kakushima, Naomi; Ono, Hiroyuki			Precutting EMR for cecal tumors extending to the appendiceal orifice	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Imai, Kenichiro; Hotta, Kinichi; Kakushima, Naomi; Ono, Hiroyuki] Shizuoka Canc Ctr, Div Endoscopy, Shizuoka, Japan	Imai, K (reprint author), Shizuoka Canc Ctr, Div Endoscopy, Shizuoka, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	OCT	2015	82	4					750	750		10.1016/j.gie.2015.05.007		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CR8BB	WOS:000361575000034		
J	Ritsuno, H; Sakamoto, N; Osada, T; Goto, SP; Watanabe, S				Ritsuno, Hideaki; Sakamoto, Naoto; Osada, Taro; Goto, Shingo P.; Watanabe, Sumio			Large superficial tumor of the colon involving a diverticulum removed by endoscopic submucosal dissection	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Ritsuno, Hideaki; Sakamoto, Naoto; Osada, Taro; Goto, Shingo P.; Watanabe, Sumio] Juntendo Univ, Sch Med, Dept Gastroenterol, Tokyo 113, Japan	Ritsuno, H (reprint author), Juntendo Univ, Sch Med, Dept Gastroenterol, Tokyo 113, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	OCT	2015	82	4					751	751		10.1016/j.gie.2015.05.002		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CR8BB	WOS:000361575000035		
J	Seishima, R; Uraoka, T; Hasegawa, H; Okabayashi, K; Tsuruta, M; Hayashi, Y; Kitagawa, Y				Seishima, Ryo; Uraoka, Toshio; Hasegawa, Hirotoshi; Okabayashi, Koji; Tsuruta, Masashi; Hayashi, Yuichiro; Kitagawa, Yuko			Colon cancer arising from a sessile serrated adenoma/polyp detected on positron emission tomography/computed tomography	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Seishima, Ryo; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan; [Uraoka, Toshio] Natl Hosp Org Tokyo, Med Ctr, Dept Gastroenterol, Tokyo, Japan; [Hasegawa, Hirotoshi; Okabayashi, Koji; Tsuruta, Masashi] Dept Surg, Tokyo, Japan; [Hayashi, Yuichiro] Div Diagnost Pathol, Tokyo, Japan	Seishima, R (reprint author), Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	OCT	2015	82	4					760	761		10.1016/j.gie.2015.03.1981		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CR8BB	WOS:000361575000045		
J	Marc, O; Hovius, N; Meunier, P; Uchida, T; Hayashi, S				Marc, O.; Hovius, N.; Meunier, P.; Uchida, T.; Hayashi, S.			Transient changes of landslide rates after earthquakes	GEOLOGY			English	Article							2005 KASHMIR EARTHQUAKE; MOUNTAIN CATCHMENT; SEDIMENT; IMPACTS; RELEASE; EROSION; JAPAN	Earthquakes impart an impressive force on epicentral landscapes, with immediate catastrophic hillslope response. However, their legacy on geomorphic process rates remains poorly constrained. We have determined the evolution of landslide rates in the epicentral areas of four intermediate to large earthquakes (M-w, 6.6-7.6). In each area, landsliding correlates with the cumulative precipitation during a given interval. Normalizing for this meteorological forcing, landslide rates have been found to peak after an earthquake and decay to background values in 1-4 yr, with the decay time scale probably proportional to the earthquake magnitude. The transient pulse of landsliding is not related to external forcing such as rainfall or aftershocks, and we tentatively attribute it to the reduction and subsequent recovery of ground strength. Observed geomorphic trends are not linked with groundwater level changes or root system damage, both of which could affect substrate strength. We propose that they are caused by reversible damage of rock mass and/or loosening of regolith. Qualitative accounts of ground cracking due to strong ground motion abound, and our observations are circumstantial evidence of its potential importance in setting landscape sensitivity to meteorological forcing after large earthquakes.	[Marc, O.; Hovius, N.] German Res Ctr Geosci GFZ, Helmholtz Ctr Potsdam, D-14473 Potsdam, Germany; [Marc, O.; Hovius, N.] Univ Potsdam, Inst Earth & Environm Sci, D-14476 Potsdam, Germany; [Meunier, P.] Ecole Normale Super, Lab Geol, F-75231 Paris 5, France; [Uchida, T.; Hayashi, S.] Natl Inst Land & Infrastructure Management, Res Ctr Disaster Risk Management, Tsukuba, Ibaraki 3050804, Japan	Marc, O (reprint author), German Res Ctr Geosci GFZ, Helmholtz Ctr Potsdam, D-14473 Potsdam, Germany.				European Union [264517]	Marc was funded by a fellowship in the European Union Marie Curie International Training Network TOPOMOD (project reference 264517). We are grateful for Landsat imagery made freely available by NASA. Comments by Sean Gallen and two anonymous reviewers helped improve the clarity of the manuscript.	Hovius N, 2011, EARTH PLANET SC LETT, V304, P347, DOI 10.1016/j.epsl.2011.02.005; Burtin A, 2014, EARTH SURF DYNAM, V2, P21, DOI 10.5194/esurf-2-21-2014; Iverson RM, 2000, WATER RESOUR RES, V36, P1897, DOI 10.1029/2000WR900090; Larsen IJ, 2010, NAT GEOSCI, V3, P247, DOI 10.1038/NGEO776; Saba SB, 2010, GEOMORPHOLOGY, V124, P17, DOI 10.1016/j.geomorph.2010.07.026; Stevens C, 1998, GEOLOGY, V26, P847, DOI 10.1130/0091-7613(1998)026<0847:MCDARF>2.3.CO;2; Meunier P, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031337; Owen LA, 2008, GEOMORPHOLOGY, V94, P1, DOI 10.1016/j.geomorph.2007.04.007; Allen RB, 1999, ECOLOGY, V80, P708; Marc O, 2015, NAT HAZARD EARTH SYS, V15, P723, DOI 10.5194/nhess-15-723-2015; Vittoz P, 2001, J VEG SCI, V12, P417, DOI 10.2307/3236856; Wang CY, 2004, GEOLOGY, V32, P769, DOI 10.1130/G20753.1; KEEFER DK, 1994, GEOMORPHOLOGY, V10, P265, DOI 10.1016/0169-555X(94)90021-3; Chien FC, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015092; Malamud BD, 2004, EARTH SURF PROC LAND, V29, P687, DOI [10.1002/esp.1064, 10.1002/esq.1064]; Lawrence Z, 2009, B SEISMOL SOC AM, V99, P1650, DOI 10.1785/0120080177; Hikima K, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023588; Suzuki W, 2010, B SEISMOL SOC AM, V100, P256, DOI 10.1785/0120090043; Lin GW, 2008, EARTH SURF PROC LAND, V33, P1354, DOI 10.1002/esp.1716; Eckhardt K, 2005, HYDROL PROCESS, V19, P507, DOI 10.1002/hyp.5675; Huang RQ, 2014, ENG GEOL, V182, P111, DOI 10.1016/j.enggeo.2014.07.008; Muir-Wood R., 1993, J GEOPHYS RES, V98, p22 035; Shin T.-C., 2004, SEISMOLOGICAL SOC AM, V91, P895, DOI [10.1785/0120000738, DOI 10.1785/0120000738]; Storchak DA, 2013, SEISMOL RES LETT, V84, P810, DOI 10.1785/0220130034; TUTTON MA, 1994, AUSTRALAS I MIN MET, V94, P33	25	0	0	GEOLOGICAL SOC AMER, INC	BOULDER	PO BOX 9140, BOULDER, CO 80301-9140 USA	0091-7613	1943-2682		GEOLOGY	Geology	OCT	2015	43	10					883	886		10.1130/G36961.1		4	Geology	Geology	CS1MQ	WOS:000361830400009		
J	Trevisonno, M; Kaneva, P; Watanabe, Y; Fried, GM; Feldman, LS; Lebedeva, E; Vassiliou, MC				Trevisonno, M.; Kaneva, P.; Watanabe, Y.; Fried, G. M.; Feldman, L. S.; Lebedeva, E.; Vassiliou, M. C.			A survey of general surgeons regarding laparoscopic inguinal hernia repair: practice patterns, barriers, and educational needs	HERNIA			English	Article						Inguinal hernia surgery; General surgery/education; Laparoscopy/methods/utilization; Questionnaires	GUIDELINES	Practice patterns for inguinal hernia repair vary significantly among surgeons. The purpose of this study was to identify perceived indications for laparoscopic inguinal hernia repair (LIHR), and to identify barriers to its adoption and educational needs for surgeons. A web-based survey was sent to general surgery members of several North American surgical societies, and to surgical residents through program directors. The 33-item survey was divided in 4 sections: demographics, utilization of techniques, management based on 11 clinical scenarios, reasons for not performing LIHR and educational needs for those who want to learn. Six hundred and ninety-seven general surgeons and 206 general surgery residents responded to the survey. Surgeons with MIS fellowships, and surgeons at the beginning of their careers are more likely to perform LIHR. Out of the 11 clinical scenarios, surgeons preferred a laparoscopic approach (totally extraperitoneal or transabdominal preperitoneal) for bilateral (48 %) and recurrent (44 %) hernias. However, 46 % of respondents never perform LIHR. Of these, 70 % consider the benefits of laparoscopy to be minimal, 59 % said they lack the requisite training, and 26 % are interested in learning. Surgeons (70 %) and residents (73 %) agreed that the best educational method would be a course followed by expert proctoring. Surgeons remain divided on the utility of laparoscopic surgery for inguinal hernia repair. Nearly half of responding surgeons never perform LIHR, and the other half offer it selectively. One quarter of surgeons who do not perform LIHR are interested in learning. This reveals a knowledge gap that could be addressed with educational programs.	[Trevisonno, M.; Kaneva, P.; Watanabe, Y.; Fried, G. M.; Feldman, L. S.; Lebedeva, E.; Vassiliou, M. C.] McGill Univ, McGill Univ Hlth Ctr, Steinberg Bernstein Ctr Minimally Invas Surg & In, Montreal, PQ H3G 1A4, Canada; [Watanabe, Y.] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 2, Sapporo, Hokkaido, Japan	Vassiliou, MC (reprint author), McGill Univ, McGill Univ Hlth Ctr, Steinberg Bernstein Ctr Minimally Invas Surg & In, 1650 Cedar Ave,L9-313, Montreal, PQ H3G 1A4, Canada.	melina.vassiliou@mcgill.ca			Covidien Canada; Mitacs-Accelerate program	The Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation is supported by an unrestricted educational grant from Covidien Canada. Salary support was also provided by the Mitacs-Accelerate program for the first author.	Bosker R, 2011, INT J COLORECTAL DIS, V26, P941, DOI 10.1007/s00384-011-1161-4; Araujo SEA, 2009, HEPATO-GASTROENTEROL, V56, P1651; Simons MP, 2009, HERNIA, V13, P343, DOI 10.1007/s10029-009-0529-7; Rosenberg J, 2008, HERNIA, V12, P583, DOI 10.1007/s10029-008-0399-4; Zendejas B, 2012, AM J SURG, V203, P313, DOI 10.1016/j.amjsurg.2011.10.005; Rutkow IM, 2003, SURG CLIN N AM, V83, P1045, DOI 10.1016/S0039-6109(03)00132-4; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Morales-Conde S, 2012, SURG ENDOSC, V26, P2639, DOI 10.1007/s00464-012-2247-y; McCormack K, 2005, HEALTH TECHNOL ASSES, V9, P1; Neumayer L, 2004, NEW ENGL J MED, V350, P1819, DOI 10.1056/NEJMoa040093; Alkhoury F, 2010, J SURG EDUC, V67, P316, DOI 10.1016/j.jsurg.2010.08.001; Smink DS, 2009, J LAPAROENDOSC ADV S, V19, P745, DOI 10.1089/lap.2009.0183; Qureshi A, 2011, SURG ENDOSC, V25, P3057, DOI 10.1007/s00464-011-1670-9; Onitsuka A, 2003, SURG TODAY, V33, P155; Fox RD, 1998, BRIT MED J, V316, P466; Hedrick T, 2009, AM J SURG, V197, P73, DOI 10.1016/j.amjsurg.2008.08.013; LOMAS J, 1989, NEW ENGL J MED, V321, P1306, DOI 10.1056/NEJM198911093211906; Sanjay P, 2007, Hernia, V11, P403, DOI 10.1007/s10029-007-0241-4; Society of American Gastrointestinal Endoscopic Surgeons (SAGES), 1998, SURG ENDOSC, V12, P374; Yang J, 2013, ANZ J SURG, V83, P312, DOI 10.1111/ans.12010	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1265-4906	1248-9204		HERNIA	Hernia	OCT	2015	19	5					719	724		10.1007/s10029-014-1287-8		6	Surgery	Surgery	CS1MH	WOS:000361829400005		
J	Trevisonno, M; Kaneva, P; Watanabe, Y; Fried, GM; Feldman, LS; Andalib, A; Vassiliou, MC				Trevisonno, M.; Kaneva, P.; Watanabe, Y.; Fried, G. M.; Feldman, L. S.; Andalib, A.; Vassiliou, M. C.			Current practices of laparoscopic inguinal hernia repair: a population-based analysis	HERNIA			English	Article						Inguinal hernia surgery; Laparoscopy; Database; Utilization	MESH REPAIR; VALIDATION; ICD-9-CM; SURGERY	The selection of a laparoscopic approach for inguinal hernias varies among surgeons. It is unclear what is being done in actual practice. The purpose of this study was to report practice patterns for treatment of inguinal hernias among Quebec surgeons, and to identify factors that may be associated with the choice of operative approach. We studied a population-based cohort of patients who underwent an inguinal hernia repair between 2007 and 2011 in Quebec, Canada. A generalized linear model was used to identify predictors associated with the selection of a laparoscopic approach. 49,657 inguinal hernias were repaired by 478 surgeons. Laparoscopic inguinal hernia repair (LIHR) was used in 8 % of all cases. LIHR was used to repair 28 % of bilateral hernias, 10 % of recurrent hernias, 6 % of unilateral hernias, and 4 % of incarcerated hernias. 268 (56 %) surgeons did not perform any laparoscopic repairs, and 11 (2 %) surgeons performed more than 100 repairs. These 11 surgeons performed 61 % of all laparoscopic cases. Patient factors significantly associated with having LIHR included younger age, fewer comorbidities, bilateral hernias, and recurrent hernias. An open approach is favored for all clinical scenarios, even for situations where published guidelines recommend a laparoscopic approach. Surgeons remain divided on the best technique for inguinal hernia repair: while more than half never perform LIHR, the small proportion who perform many use the technique for a large proportion of their cases. There appears to be a gap between the best practices put forth in guidelines and what surgeons are doing in actual practice. Identification of barriers to the broader uptake of LIHR may help inform the design of educational programs to train those who have the desire to offer this technique for certain cases, and have the volume to overcome the learning curve.	[Trevisonno, M.; Kaneva, P.; Watanabe, Y.; Fried, G. M.; Feldman, L. S.; Andalib, A.; Vassiliou, M. C.] McGill Univ, McGill Univ Hlth Ctr, Steinberg Bernstein Ctr Minimally Invas Surg & In, Montreal, PQ H3G 1A4, Canada; [Watanabe, Y.] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 2, Sapporo, Hokkaido, Japan	Vassiliou, MC (reprint author), McGill Univ, McGill Univ Hlth Ctr, Steinberg Bernstein Ctr Minimally Invas Surg & In, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	melina.vassiliou@mcgill.ca			Covidien Canada; Mitacs-Accelerate program	The Steinberg-Bernstein Centre for Minimally Invasive Surgery at McGill University is supported by an unrestricted educational grant from Covidien Canada. Salary support was also provided by the Mitacs-Accelerate program for the first author.	Simons MP, 2009, HERNIA, V13, P343, DOI 10.1007/s10029-009-0529-7; Kingsnorth A, 2003, LANCET, V362, P1561, DOI 10.1016/S0140-6736(03)14746-0; Rosenberg J, 2008, HERNIA, V12, P583, DOI 10.1007/s10029-008-0399-4; Zendejas B, 2012, AM J SURG, V203, P313, DOI 10.1016/j.amjsurg.2011.10.005; Wara P, 2005, BRIT J SURG, V92, P1277, DOI 10.1002/bjs.5076; Mahon D, 2003, SURG ENDOSC, V17, P1386, DOI 10.1007/s00464-002-9223-x; Morales-Conde S, 2012, SURG ENDOSC, V26, P2639, DOI 10.1007/s00464-012-2247-y; McCormack K, 2005, HEALTH TECHNOL ASSES, V9, P1; Edwards CC, 2000, SURG LAPARO ENDO PER, V10, P149, DOI 10.1097/00019509-200006000-00010; Neumayer L, 2004, NEW ENGL J MED, V350, P1819, DOI 10.1056/NEJMoa040093; Wilchesky M, 2004, J CLIN EPIDEMIOL, V57, P131, DOI 10.1016/S0895-4356(03)00246-4; Alkhoury F, 2010, J SURG EDUC, V67, P316, DOI 10.1016/j.jsurg.2010.08.001; Smink DS, 2009, J LAPAROENDOSC ADV S, V19, P745, DOI 10.1089/lap.2009.0183; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Qureshi A, 2011, SURG ENDOSC, V25, P3057, DOI 10.1007/s00464-011-1670-9; BLAIS R, 1993, CAN MED ASSOC J, V148, P1729; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Kanonidou Z, 2007, Hippokratia, V11, P175; McCormack K, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858, DOI 10.1002/14651858.CD001785]; National Institute for Health and Care Excellence, 2004, TECHN APPR GUID 83 G; Regie de l'assurance-maladie du Quebec, 2004, STAT ANN; Rosenberg Jacob, 2011, Dan Med Bull, V58, pC4243; Statistics Canada, 2011, POP DWELL COUNTS CAN; Trevisonno M, 2014, HERNIA, DOI [10.1007/s10029-014-1287-8, DOI 10.1007/S10029-014-1287-8]	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1265-4906	1248-9204		HERNIA	Hernia	OCT	2015	19	5					725	733		10.1007/s10029-015-1358-5		9	Surgery	Surgery	CS1MH	WOS:000361829400006		
J	Matsunaga, R; Negishi, M; Higashi, H; Shida, H; Akakura, K				Matsunaga, R.; Negishi, M.; Higashi, H.; Shida, H.; Akakura, K.			Prophylactic procedure for inguinal hernia after radical retropubic prostatectomy	HERNIA			English	Article						Inguinal hernia; Prophylaxis; Prostatectomy; Hernia-free rate	RISK-FACTORS; CANCER; PREVENTION; SURGERY	The incidence of inguinal hernias (IH) after radical retropubic prostatectomy (RRP) has been reported to range from 10 to 50 %, but no prophylaxis for IH has yet been established. We proposed a prophylaxis for IH after RRP. A total of 180 patients underwent RRP at our hospital between 2000 and 2011. In January 2008, we started to perform a prophylaxis involving the dissection of the processus vaginalis. This procedure was performed in 73 patients. We then compared the incidence of IH between the patients that did (prophylaxis group) and did not (no prophylaxis group) undergo the prophylaxis. We also studied the risk factors for IH after RRP. In the no prophylaxis group, 25 (23 %) of the 107 patients developed IH, and the IH-free rate at one postoperative year was 86 %. In contrast, only 3 (4.1 %) of the 73 patients in the prophylaxis group developed IH, resulting in IH-free rate of 96 % at one postoperative year (P = 0.0235). Among the patients in the no prophylaxis group, the mean body mass index of the hernia group was significantly lower than that of the no hernia group (P = 0.006). Our results suggest that our prophylaxis is useful for preventing IH after RRP.	[Matsunaga, R.; Negishi, M.; Higashi, H.; Shida, H.] Tokyo Koseinenkin Hosp, Dept Surg, Tokyo, Japan; [Akakura, K.] Tokyo Koseinenkin Hosp, Dept Urol, Tokyo, Japan	Matsunaga, R (reprint author), Tokyo Koseinenkin Hosp, Dept Surg, Tokyo, Japan.	rimatsun@east.ncc.go.jp					Fujii Y, 2010, UROLOGY, V75, P713, DOI 10.1016/j.urology.2009.05.051; Abe T, 2007, UROLOGY, V69, P326, DOI 10.1016/j.urology.2006.09.043; Sekita N, 2009, INT J UROL, V16, P110, DOI 10.1111/j.1442-2042.2008.02190.x; Rutkow IM, 1998, SURG CLIN N AM, V78, P941, DOI 10.1016/S0039-6109(05)70363-7; Sakai Y, 2009, INT J UROL, V16, P848, DOI 10.1111/j.1442-2042.2009.02370.x; Regan TC, 1996, UROLOGY, V47, P536, DOI 10.1016/S0090-4295(99)80491-9; Nielsen ME, 2005, UROLOGY, V66, P1034, DOI 10.1016/j.urology.2005.05.028; Zhu SM, 2013, J UROLOGY, V189, P884, DOI 10.1016/j.juro.2012.08.241; Stranne J, 2006, J UROLOGY, V176, P2072, DOI 10.1016/j.juro.2006.07.007; Kawakami S, 2009, INT J UROL, V16, P257, DOI 10.1111/j.1442-2042.2008.02212.x; Lodding P, 2001, J UROLOGY, V166, P964, DOI 10.1016/S0022-5347(05)65874-0; Walsh PC, 2000, J UROLOGY, V163, P1802, DOI 10.1016/S0022-5347(05)67547-7; Twu CM, 2005, UROLOGY, V66, P814, DOI 10.1016/j.urology.2005.04.034; Ichioka K, 2004, UROLOGY, V63, P278, DOI 10.1016/j.urology.2003.09.038; Stranne J, 2010, J UROLOGY, V184, P984, DOI 10.1016/j.juro.2010.04.067; Nilsson H, 2013, ANN SURG, P1; Stranne J, 2011, NAT REV UROL, V8, P266, DOI 10.1038/nrurol.2011.40	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1265-4906	1248-9204		HERNIA	Hernia	OCT	2015	19	5					785	788		10.1007/s10029-014-1323-8		4	Surgery	Surgery	CS1MH	WOS:000361829400014		
J	Hayama, S; Ohtaka, K; Takahashi, Y; Ichimura, T; Senmaru, N; Hirano, S				Hayama, S.; Ohtaka, K.; Takahashi, Y.; Ichimura, T.; Senmaru, N.; Hirano, S.			Laparoscopic reduction and repair for incarcerated obturator hernia: comparison with open surgery	HERNIA			English	Article						Transabdominal preperitoneal repair; Obturator hernia; Protective reduction	COMPUTED-TOMOGRAPHY; DIAGNOSIS; OUTCOMES	Transabdominal preperitoneal (TAPP) repair for obturator hernia (OH) is not well established. Therefore, we evaluated the efficacy of TAPP for OH repair compared with open surgery. We retrospectively analyzed patients who underwent surgery for OH at our hospital between 2006 and 2011. Since 2009, we have used TAPP repair for OH instead of open surgery. The clinical results of TAPP repair were compared with those of open surgery performed before 2008. Six patients with OH were treated by TAPP repair; occult contralateral OH was found by laparoscopic exploration in three (50 %) patients and was simultaneously repaired. Bowel incarceration was reduced by water pressure through Nelaton catheter in all but one patient. Bowel resection was performed in two patients after the laparoscopic assessment. For incarcerated OH, five of six cases were repaired using synthetic mesh, and the remaining case was addressed with simple peritoneal closure. Before 2008, six patients with OH underwent open surgery. The background of patients was comparable in the TAPP group and the open surgery group. There were no deaths in either group, but one metachronous contralateral OH occurred in the open surgery group within a short time frame, whereas none occurred in the TAPP group. TAPP repair, including the inspection of the viability of the incarcerated intestine and protective reduction and assessment of the entire groin area is an effective and minimally invasive strategy for OH patients.	[Hayama, S.; Ohtaka, K.; Takahashi, Y.; Ichimura, T.; Senmaru, N.] Steel Mem Muroran Hosp, Dept Surg, Muroran, Hokkaido 0500076, Japan; [Hayama, S.; Ichimura, T.; Senmaru, N.; Hirano, S.] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 2, Kita Ku, Sapporo, Hokkaido, Japan	Hayama, S (reprint author), Steel Mem Muroran Hosp, Dept Surg, 1-45 Chiribetucyo, Muroran, Hokkaido 0500076, Japan.	s-hayama@par.odn.ne.jp					Abrahamson J, 1997, MAINGOTS ABDOMINAL O, P479; Chan KV, 2014, HERNIA, V18, P387, DOI 10.1007/s10029-013-1169-5; TUCKER JG, 1995, AM SURGEON, V61, P36; Deeba S, 2011, J MINIM ACCESS SURG, V7, P201, DOI 10.4103/0972-9941.85642; Miki Y, 1998, SURG TODAY, V28, P652; Mantoo SK, 2009, SINGAP MED J, V50, P866; BJORK KJ, 1988, SURG GYNECOL OBSTET, V167, P217; GRAY SW, 1974, SURGERY, V75, P20; Shapiro K, 2004, SURG ENDOSC, V18, P954, DOI 10.1007/s00464-003-8212-z; SINHA SN, 1983, AUST NZ J SURG, V53, P349, DOI 10.1111/j.1445-2197.1983.tb02461.x; Yokoyama T, 2011, WORLD J SURG, V35, P2323, DOI 10.1007/s00268-011-1211-7; Ng DCK, 2014, HERNIA, V18, P381, DOI 10.1007/s10029-013-1080-0; FELIX EL, 1995, SURG ENDOSC-ULTRAS, V9, P984; Humes DJ, 2013, BRIT J SURG, V100, P1827, DOI 10.1002/bjs.9336; LO CY, 1994, AM J SURG, V167, P396, DOI 10.1016/0002-9610(94)90123-6; Neumayer L, 2004, NEW ENGL J MED, V350, P1819, DOI 10.1056/NEJMoa040093; Togawa Y, 2014, HERNIA, V18, P407, DOI 10.1007/s10029-013-1095-6; Karasaki T, 2014, HERNIA, V18, P393, DOI 10.1007/s10029-013-1159-7; Yau KK, 2005, CAN J SURG, V48, P76; Ijiri R, 1996, SURGERY, V119, P137, DOI 10.1016/S0039-6060(96)80160-7; Karasaki T, 2014, HERNIA, V18, P413, DOI 10.1007/s10029-013-1068-9; TCHUPETLOWSKY S, 1995, SURGERY, V117, P109, DOI 10.1016/S0039-6060(05)80237-5; CUBILLO E, 1983, AM J ROENTGENOL, V140, P735; Bergstein Jack M., 1996, Surgery (St Louis), V119, P133, DOI 10.1016/S0039-6060(96)80159-0; Fujita J, 2000, DIGEST ENDOSC, V12, P338, DOI 10.1046/j.1443-1661.2000.00067.x; Haith L R Jr, 1998, JSLS, V2, P191; Maharaj D, 2002, Hernia, V6, P45; Martinez Insua C, 2001, HERNIA, V5, P161, DOI 10.1007/s100290100018; Sawayama H, 2014, HERNIA, V18, P399, DOI 10.1007/s10029-013-1058-y; Sze Li S, 2012, MALAYS J MED SCI, V19, P69; Wauschkuhn CA, 2013, SURG CLIN N AM, V93, P1269	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1265-4906	1248-9204		HERNIA	Hernia	OCT	2015	19	5					809	814		10.1007/s10029-014-1328-3		6	Surgery	Surgery	CS1MH	WOS:000361829400019		
J	Yokoyama, T; Kobayashi, A; Shimizu, A; Motoyama, H; Miyagawa, S				Yokoyama, T.; Kobayashi, A.; Shimizu, A.; Motoyama, H.; Miyagawa, S.			Laparoscopic repair for a previously unreported form of ventral hernia on the right iliac fossa in an elderly emaciated woman	HERNIA			English	Article						Ventral hernia; Right iliac fossa; Transabdominal preperitoneal laparoscopic herniorrhaphy	ABDOMINAL-WALL HERNIAS; OBTURATOR HERNIA	An 81-year-old emaciated woman was admitted to our hospital with a one-year history of recurrent bilateral inguinal swellings. Palpable lumps were observed not only in bilateral groin areas, but also on the right iliac fossa (RIF) of her abdomen. During a planned transabdominal preperitoneal laparoscopic herniorrhaphy, a previously unreported form of ventral hernia was observed at a position lateral and cranial to the right internal inguinal ring, which probably corresponded to the palpable lump on the RIF. The hernia orifice was 2 cm in diameter, and a vascular structure ran through the orifice. The contents of the hernia consisted of fatty tissue arising from the retroperitoneal tissue. Routine exploration revealed orifices of the following hernias: left indirect, right direct, bilateral femoral, bilateral obturator, and right Spigelian hernia. Her postoperative course was uneventful and a mass on the right lower quadrant disappeared after operation.	[Yokoyama, T.; Kobayashi, A.; Shimizu, A.; Motoyama, H.; Miyagawa, S.] Shinshu Univ, Sch Med, Dept Surg 1, Matsumoto, Nagano 3908621, Japan	Kobayashi, A (reprint author), Shinshu Univ, Sch Med, Dept Surg 1, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	kbys@shinshu-u.ac.jp					Salameh JR, 2008, SURG CLIN N AM, V88, P45, DOI 10.1016/j.suc.2007.10.004; PANTON ONM, 1994, AM J SURG, V167, P535, DOI 10.1016/0002-9610(94)90252-6; Jansen PL, 2004, SURGERY, V136, P1, DOI 10.1016/j.surg.2004.01.004; BJORK KJ, 1988, SURG GYNECOL OBSTET, V167, P217; Thumbe VK, 2001, SURG ENDOSC-ULTRAS, V15, P47, DOI 10.1007/s004640000254; GRAY SW, 1974, SURGERY, V75, P20; Muysoms FE, 2009, HERNIA, V13, P407, DOI 10.1007/s10029-009-0518-x; Yokoyama T, 2011, WORLD J SURG, V35, P2323, DOI 10.1007/s00268-011-1211-7; KOZLOWSKI JM, 1977, ARCH SURG-CHICAGO, V112, P1001; Crawford DL, 1998, AM SURGEON, V64, P976; Evans DS, 1996, BRIT J SURG, V83, P1361, DOI 10.1002/bjs.1800831010; Kakarla Venkata R, 2010, Am Surg, V76, pE239; Moreno-Egea A, 2007, ARCH SURG-CHICAGO, V142, P82, DOI 10.1001/archsurg.142.1.82	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1265-4906	1248-9204		HERNIA	Hernia	OCT	2015	19	5					841	843		10.1007/s10029-013-1180-x		3	Surgery	Surgery	CS1MH	WOS:000361829400024		
J	Neupane, S; Sohn, WJ; Gwon, GJ; Kim, KR; Lee, S; An, CH; Suh, JY; Shin, HI; Yamamoto, H; Cho, SW; Lee, Y; Kim, JY				Neupane, Sanjiv; Sohn, Wern-Joo; Gwon, Gi-Jeong; Kim, Ki-Rim; Lee, Sanggyu; An, Chang-Hyeon; Suh, Jo-Young; Shin, Hong-In; Yamamoto, Hitoshi; Cho, Sung-Won; Lee, Youngkyun; Kim, Jae-Young			The role of APCDD1 in epithelial rearrangement in tooth morphogenesis	HISTOCHEMISTRY AND CELL BIOLOGY			English	Article						APCDD1; Epithelial rearrangement; Inner enamel epithelium; Enamel knot; Cusp patterning	ENAMEL KNOT; CELL-PROLIFERATION; CUSP FORMATION; MOUSE MOLAR; GROWTH; WNT; EXPRESSION; GENE	Adenomatosis polyposis coli downregulated 1 (APCDD1), a negative regulator of Wnt signaling, was examined to understand detailed mechanisms underlying Wnt signaling tooth development. In situ hybridization showed that Apcdd1 was expressed in the condensed mesenchyme at the bud stage, and in the inner enamel epithelium (IEE), including enamel knot (EK) at the cap stage. In vitro organ cultivation by using Apcdd1 antisense oligodeoxynucleotides was performed at E13.5 for 2 days to define the developmental functions of APCDD1 during tooth development. Analysis of histogenesis and cellular events such as cell adhesion, proliferation, apoptosis and epithelial rearrangement after Apcdd1 knockdown showed altered morphogenesis of the tooth germ with decreased cell proliferation and altered localization of cell adhesion molecules. Actin filament staining and 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (DiI) labeling of IEE cells showed that Apcdd1 knockdown enhanced epithelial rearrangement in the IEE and EK. To understand the precise signaling regulations of Apcdd1, we evaluated the altered expression patterns of signaling molecules, related with Wnt and enamel knot signalings using RT-qPCR. Tooth germs at cap stage were transplanted into the kidney capsules and were allowed to develop into calcified teeth for 3 weeks. Apcdd1 knockdown increased the number of ectopic cusps on the mesial side of the tooth. Our results suggested that APCDD1 modulates the gene expression of Wnt- and EK-related signaling molecules at the cap stage of tooth development, and is involved in tooth cusp patterning by modulating the epithelial rearrangement in the IEE.	[Neupane, Sanjiv; Sohn, Wern-Joo; Gwon, Gi-Jeong; Lee, Youngkyun; Kim, Jae-Young] Kyungpook Natl Univ, IHBR, Sch Dent, Dept Biochem, Taegu 700412, South Korea; [Kim, Ki-Rim] Kyungpook Natl Univ, IHBR, Dept Dent Hyg, Taegu 700412, South Korea; [Lee, Sanggyu] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu 700412, South Korea; [An, Chang-Hyeon] Kyungpook Natl Univ, IHBR, Sch Dent, Dept Oral & Maxillofacial Radiol, Taegu 700412, South Korea; [Suh, Jo-Young] Kyungpook Natl Univ, IHBR, Sch Dent, Dept Periodontol, Taegu 700412, South Korea; [Shin, Hong-In] Kyungpook Natl Univ, IHBR, Sch Dent, Dept Oral & Maxillofacial Pathol, Taegu 700412, South Korea; [Yamamoto, Hitoshi] Tokyo Dent Coll, Dept Histol & Dev Biol, Tokyo, Japan; [Cho, Sung-Won] Yonsei Univ, Coll Dent, Dept Oral Biol, Div Anat & Dev Biol, Seoul 120749, South Korea	Kim, JY (reprint author), Kyungpook Natl Univ, IHBR, Sch Dent, Dept Biochem, 2177 Dalgubeol Daero, Taegu 700412, South Korea.	jykim91@knu.ac.kr			National Research Foundation of Korea (NRF) - Korean Government (MSIP) [2008-0062282]	This study was supported by a National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MSIP; No. 2008-0062282).	Shimomura Y, 2010, NATURE, V464, P1043, DOI 10.1038/nature08875; Coin R, 1999, INT J DEV BIOL, V43, P261; JERNVALL J, 1994, INT J DEV BIOL, V38, P463; Cobourne MT, 2005, CURR TOP DEV BIOL, V65, P255; Wang XP, 2009, DEVELOPMENT, V136, P1939, DOI 10.1242/dev.033803; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Jernvall J, 2012, DEVELOPMENT, V139, P3487, DOI 10.1242/dev.085084; Stewart GA, 2002, J IMMUNOL, V169, P5451; Loes S, 2001, MECH DEVELOP, V107, P155, DOI 10.1016/S0925-4773(01)00454-3; Sohn WJ, 2014, J DENT RES, V93, P78, DOI 10.1177/0022034513511247; Otsu K, 2011, J CELL PHYSIOL, V226, P2527, DOI 10.1002/jcp.22597; Biggs LC, 2014, SEMIN CELL DEV BIOL, V25, P11, DOI 10.1016/j.semcdb.2014.01.007; Williams-Masson EM, 1998, DEV BIOL, V204, P263, DOI 10.1006/dbio.1998.9048; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Jukkola T, 2004, GENE EXPR PATTERNS, V4, P755, DOI 10.1016/j.modgep.2004.03.006; Liu F, 2008, DEV BIOL, V313, P210, DOI 10.1016/j.ydbio.2007.10.016; Vaahtokari A, 1996, MECH DEVELOP, V54, P39, DOI 10.1016/0925-4773(95)00459-9; Obara N, 2007, CELL TISSUE RES, V330, P461, DOI 10.1007/s00441-007-0502-7; Kassai Y, 2005, SCIENCE, V309, P2067, DOI 10.1126/science.1116848; Sohn WJ, 2011, CELL TISSUE RES, V344, P271, DOI 10.1007/s00441-011-1148-z; Takahashi M, 2002, CANCER RES, V62, P5651; Rallis C, 2010, DEVELOPMENT, V137, P3591, DOI 10.1242/dev.050070; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Cho SW, 2007, DIFFERENTIATION, V75, P441, DOI 10.1111/j.1432-0436.2006.00153.x; Pispa J, 2003, DEV BIOL, V262, P195, DOI 10.1016/S0012-1606(03)00325-7; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Thesleff I, 2002, INT REV CYTOL, V217, P93; Pispa J, 2004, DEV DYNAM, V231, P432, DOI 10.1002/dvdy.20138; Salmivirta K, 1996, DEV DYNAM, V205, P104, DOI 10.1002/(SICI)1097-0177(199602)205:2<104::AID-AJA2>3.0.CO;2-M; Martinez-Rico C, 2009, J CELL SCI, V123, P712; Neupane S, 2014, CELL TISSUE RES, V358, P109, DOI 10.1007/s00441-014-1908-7; Obara N, 2004, HISTOCHEM CELL BIOL, V121, P352; Palacios J, 1995, INT J DEV BIOL, V39, P363; Tsai SY, 2014, DEV BIOL, V385, P179, DOI 10.1016/j.ydbio.2013.11.023; Tummers M, 2009, J EXP ZOOL PART B, V312B, P309, DOI 10.1002/jez.b.21280	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0948-6143	1432-119X		HISTOCHEM CELL BIOL	Histochem. Cell Biol.	OCT	2015	144	4					377	387		10.1007/s00418-015-1345-z		11	Cell Biology; Microscopy	Cell Biology; Microscopy	CR9CB	WOS:000361649700007		
J	Tannai, A; Goto, H; Akiyama, T; Matsumoto, Y				Tannai, Akari; Goto, Haruka; Akiyama, Takuya; Matsumoto, Yuji			Revisiting alkaline nitrobenzene oxidation: quantitative evaluation of biphenyl structures in cedar wood lignin (Cryptomeria japonica) by a modified nitrobenzene oxidation method	HOLZFORSCHUNG			English	Article						alkaline nitrobenzene oxidation; biphenyl-type structures; guaiacyl lignin; gymnosperm lignin; lignin model compounds; 5-5 linkage; softwood	MODEL COMPOUNDS; NMR-SPECTROSCOPY; COMPOUND; STANDARD	A modified alkaline nitrobenzene oxidation (NBO) method was developed to enable the analysis of the biphenyl structures of cedar wood lignin. The most essential point of the process is a modified work-up process in pyridine and a prolonged gas chromatography analysis of the silylated products. By applying this mean to cedar wood meal, a novel biphenyl product, dehydrovanillin-vanillic acid (1-carboxy-1'-formyl-4,4'-dihydroxy-3,3'-dimethoxy5,5'-biphenyl), was detected together with known products, dehydrodivanillin and dehydrodivanillic acid. The highest total yield of biphenyl products was detected when NBO was carried out for 2-4 h at 170 degrees C. The workup procedure was slightly modified so that the biphenyl products can be quantified. The NBO conversion rates of biphenyl linkages of lignin were also examined with a biphenyl-type lignin model compound, and this gave rise to 75% biphenyl-type NBO degradation products. Under the same condition, the total yield of vanillin and vanillic acid (VA) from a non-condensed-type beta-O-4 model compound was 89%. Because the latter did not exhibit any peak of the biphenyl products, it can be concluded that all the biphenyl products obtained by NBO (0.17 mmol g(-1)) were from the lignin of the native wood. It was calculated that at least 6.7 of 100 phenylpropanoid units of cedar lignin were involved in biphenyl structures even if the NBO conversion rate was not taken into consideration. The synthesis and analytical data of 11 lignin model compounds is described.	[Tannai, Akari; Goto, Haruka; Akiyama, Takuya; Matsumoto, Yuji] Univ Tokyo, Wood Chem Lab, Grad Sch Agr & Life Sci, Dept Biomat Sci,Bunkyo Ku, Tokyo 1138657, Japan; [Akiyama, Takuya] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Akiyama, T (reprint author), Univ Tokyo, Wood Chem Lab, Grad Sch Agr & Life Sci, Dept Biomat Sci,Bunkyo Ku, Tokyo 1138657, Japan.	akiyama@woodchem.fp.a.u-tokyo.ac.jp			Japan Science and Technology Agency, PRESTO; Japan Science and Technology Agency ['PRESTO']	The authors gratefully acknowledge the funding from the Japan Science and Technology Agency, PRESTO. Funding: Japan Science and Technology Agency (Grant/Award Number: 'PRESTO').	Billa E, 1996, J SCI FOOD AGR, V72, P250, DOI 10.1002/(SICI)1097-0010(199610)72:2<250::AID-JSFA651>3.0.CO;2-D; Yamamura M, 2010, PLANT BIOTECHNOL-NAR, V27, P305, DOI 10.5511/plantbiotechnology.27.305; SCHULTZ TP, 1987, J ORG CHEM, V52, P279, DOI 10.1021/jo00378a023; SCHULTZ TP, 1986, HOLZFORSCHUNG, V40, P93, DOI 10.1515/hfsg.1986.40.2.93; Peng X, 1998, APPL ENVIRON MICROB, V64, P2520; DRUMOND M, 1989, J WOOD CHEM TECHNOL, V9, P421, DOI 10.1080/02773818908050309; Fukushima RS, 2001, J AGR FOOD CHEM, V49, P3133, DOI 10.1021/jf010449r; Katahira R, 2001, J WOOD SCI, V47, P378, DOI 10.1007/BF00766789; PEW JC, 1955, J AM CHEM SOC, V77, P2831, DOI 10.1021/ja01615a048; MESHITSUKA G, 1985, J WOOD CHEM TECHNOL, V5, P391, DOI 10.1080/02773818508085201; LEE DY, 1988, MOKUZAI GAKKAISHI, V34, P34; RALPH J, 1986, HOLZFORSCHUNG, V40, P23, DOI 10.1515/hfsg.1986.40.1.23; LEOPOLD B, 1952, ACTA CHEM SCAND, V6, P38, DOI 10.3891/acta.chem.scand.06-0038; BRUNOW G, 1995, J CHEM CRYSTALLOGR, V25, P1, DOI 10.1007/BF01666186; PEW JC, 1963, J ORG CHEM, V28, P1048, DOI 10.1021/jo01039a044; IIYAMA K, 1990, J SCI FOOD AGR, V51, P481, DOI 10.1002/jsfa.2740510405; Akiyama T, 2005, HOLZFORSCHUNG, V59, P276, DOI 10.1515/HF.2005.045; Quideau S, 1997, J CHEM SOC PERK T 1, P2351, DOI 10.1039/a701808h; Capanema EA, 2004, J AGR FOOD CHEM, V52, P1850, DOI 10.1021/jf035282b; KAVANAGH KR, 1955, CAN J CHEM, V33, P24, DOI 10.1139/v55-005; Chen C.L., 1992, METHODS LIGNIN CHEM, P301; Chen F.D., 1995, J WOOD CHEM TECHNOL, V15, P329; Karhunen P, 1996, J CHEM SOC PERK T 1, P2303, DOI 10.1039/p19960002303; LANDUCCI LL, 1981, HOLZFORSCHUNG, V35, P67, DOI 10.1515/hfsg.1981.35.2.67; Sarkanen K.V., 1971, LIGNINS OCCURRENCE F, P1	25	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0018-3830	1437-434X		HOLZFORSCHUNG	Holzforschung	OCT	2015	69	8					951	958		10.1515/hf-2014-0153		8	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CS1MW	WOS:000361831200004		
J	Endo, H; Han, TS; Aoki, T; Sasaki, M				Endo, H.; Han, T. S.; Aoki, T.; Sasaki, M.			Numerical Study on Secrecy Capacity and Code Length Dependence of the Performances in Optical Wiretap Channels	IEEE PHOTONICS JOURNAL			English	Article						Physical layer security; free space optical communication; secrecy capacity; finite-length analysis	QUANTUM CRYPTOGRAPHY; AMPLIFICATION; INFORMATION; SECURITY	Secrecy issues of free-space optical links realizing information theoretically secure communications and high transmission rates are discussed. We numerically study secrecy communication rates of optical wiretap channel based on on-off keying (OOK) modulation under typical conditions met in satellite-ground links. It is shown that, under reasonable degraded conditions on a wiretapper, information theoretically secure communications should be possible in a much wider distance range than a range limit of quantum key distribution, enabling secure optical links between geostationary Earth orbit satellites and ground stations with currently available technologies. We also provide the upper bounds on the decoding error probability and the leaked information to estimate a necessary code length for given required levels of performances. This result ensures that a reasonable length of wiretap channel code for our proposed scheme must exist.	[Endo, H.; Han, T. S.; Sasaki, M.] Natl Inst Informat & Commun Technol, Quantum ICT Lab, Koganei, Tokyo 1848795, Japan; [Endo, H.; Aoki, T.] Waseda Univ, Dept Appl Phys, Shinjuku Ku, Tokyo 1698050, Japan	Sasaki, M (reprint author), Natl Inst Informat & Commun Technol, Quantum ICT Lab, 4-2-1 Nukuikitamachi, Koganei, Tokyo 1848795, Japan.	psasaki@nict.go.jp			Council for Science, Technology, and Innovation (Cabinet Office, Government of Japan) through the ImPACT Program	This work was supported by the Council for Science, Technology, and Innovation (Cabinet Office, Government of Japan) through the ImPACT Program.	Agaskar M., 2013, P IEEE ICC, P2520; Negi R, 2005, IEEE VTS VEH TECHNOL, P1906; Laourine A, 2012, IEEE T INFORM THEORY, V58, P7073, DOI 10.1109/TIT.2012.2217191; Juarez JC, 2006, IEEE COMMUN MAG, V44, P46, DOI 10.1109/MCOM.2006.248164; EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; Bloch M, 2008, IEEE T INFORM THEORY, V54, P2515, DOI 10.1109/TIT.2008.921908; Swindlehurst AL, 2009, INT CONF ACOUST SPEE, P2437, DOI 10.1109/ICASSP.2009.4960114; CSISZAR I, 1978, IEEE T INFORM THEORY, V24, P339, DOI 10.1109/TIT.1978.1055892; Peev M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/7/075001; Sun XL, 2013, OPT EXPRESS, V21, P1865, DOI 10.1364/OE.21.001865; Chou TH, 2012, IEEE T INFORM THEORY, V58, P2455, DOI 10.1109/TIT.2011.2176311; Kedar D., 2004, IEEE Communications Magazine, V42, DOI 10.1109/MCOM.2004.1299334; Wang N, 2014, J OPT COMMUN NETW, V6, P1072, DOI 10.1364/JOCN.6.001072; Hayashi M, 2011, IEEE T INFORM THEORY, V57, P3989, DOI 10.1109/TIT.2011.2110950; Toyoshima M, 2005, J OPT NETW, V4, P300, DOI 10.1364/JON.4.000300; KABANOV YM, 1978, THEOR PROBAB APPL+, V23, P143, DOI 10.1137/1123013; Sasaki M, 2011, OPT EXPRESS, V19, P10387, DOI 10.1364/OE.19.010387; WYNER AD, 1975, AT&T TECH J, V54, P1355; Gisin N, 2002, REV MOD PHYS, V74, P145, DOI 10.1103/RevModPhys.74.145; Bennett C. H., 1984, P IEEE INT C COMP SY, P175; Bloch M., 2011, PHYS LAYER SECURITY; Boroson DM, 2014, P ICSOS MAY 7 9, V89710, P1; Csiszar I., 1996, PROBLEMS INFORMATION, V32, P48; Gallager R.G., 1968, INFORM THEORY RELIAB; Han TS, 2014, IEEE T INFORM THEORY, V60, P6819, DOI 10.1109/TIT.2014.2355811; Hwang W.-Y., 2003, PHYS REV LETT, V91, P1; Korner J., 1981, INFORM THEORY CODING; Lopez-Martinez F. J., 2015, IEEE PHOTONICS J, V7, P1; Mostafa A., 2014, P IEEE ICC, P3342; Neergaard-Nielsen JS, 2013, NAT PHOTONICS, V7, P440, DOI [10.1038/nphoton.2013.101, 10.1038/NPHOTON.2013.101]; Puryear A., 2011, P IEEE GLOBECOM, P1; Sasaki M., 2014, IEEE J SEL TOP QUANT, V21, P1; Toyoshima M., 2012, J NAT I INF COMMUN T, V59, P125; Wyner A. D., 1988, IEEE T INFORM THEORY, V36, P1449	34	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1943-0655	1943-0647		IEEE PHOTONICS J	IEEE Photonics J.	OCT	2015	7	5							7903418	10.1109/JPHOT.2015.2472281		18	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CR8OL	WOS:000361613500026		
J	Akopyan, F; Sawada, J; Cassidy, A; Alvarez-Icaza, R; Arthur, J; Merolla, P; Imam, N; Nakamura, Y; Datta, P; Nam, GJ; Taba, B; Beakes, M; Brezzo, B; Kuang, JB; Manohar, R; Risk, WP; Jackson, B; Modha, DS				Akopyan, Filipp; Sawada, Jun; Cassidy, Andrew; Alvarez-Icaza, Rodrigo; Arthur, John; Merolla, Paul; Imam, Nabil; Nakamura, Yutaka; Datta, Pallab; Nam, Gi-Joon; Taba, Brian; Beakes, Michael; Brezzo, Bernard; Kuang, Jente B.; Manohar, Rajit; Risk, William P.; Jackson, Bryan; Modha, Dharmendra S.			True North: Design and Tool Flow of a 65 mW 1 Million Neuron Programmable Neurosynaptic Chip	IEEE TRANSACTIONS ON COMPUTER-AIDED DESIGN OF INTEGRATED CIRCUITS AND SYSTEMS			English	Article						Asynchronous circuits; asynchronous communication; design automation; design methodology; image recognition; logic design; low-power electronics; neural networks; neural network hardware; neuromorphics; parallel architectures; real-time systems; synchronous circuits; very large-scale integration	SPIKING NEURONS; PLACEMENT; NETWORK; SCALE; ARCHITECTURE; SYSTEMS; BRAIN	The new era of cognitive computing brings forth the grand challenge of developing systems capable of processing massive amounts of noisy multisensory data. This type of intelligent computing poses a set of constraints, including real-time operation, low-power consumption and scalability, which require a radical departure from conventional system design. Brain-inspired architectures offer tremendous promise in this area. To this end, we developed TrueNorth, a 65 mW real-time neurosynaptic processor that implements a non-von Neumann, low-power, highly-parallel, scalable, and defect-tolerant architecture. With 4096 neurosynaptic cores, the TrueNorth chip contains 1 million digital neurons and 256 million synapses tightly interconnected by an event-driven routing infrastructure. The fully digital 5.4 billion transistor implementation leverages existing CMOS scaling trends, while ensuring one-to-one correspondence between hardware and software. With such aggressive design metrics and the TrueNorth architecture breaking path with prevailing architectures, it is clear that conventional computer-aided design (CAD) tools could not be used for the design. As a result, we developed a novel design methodology that includes mixed asynchronous-synchronous circuits and a complete tool flow for building an event-driven, low-power neurosynaptic chip. The TrueNorth chip is fully configurable in terms of connectivity and neural parameters to allow custom configurations for a wide range of cognitive and sensory perception applications. To reduce the system's communication energy, we have adapted existing application-agnostic very large-scale integration CAD placement tools for mapping logical neural networks to the physical neurosynaptic core locations on the TrueNorth chips. With that, we have successfully demonstrated the use of TrueNorth-based systems in multiple applications, including visual object recognition, with higher performance and orders of magnitude lower power consumption than the same algorithms run on von Neumann architectures. The TrueNorth chip and its tool flow serve as building blocks for future cognitive systems, and give designers an opportunity to develop novel brain-inspired architectures and systems based on the knowledge obtained from this paper.	[Akopyan, Filipp; Sawada, Jun; Cassidy, Andrew; Alvarez-Icaza, Rodrigo; Merolla, Paul; Imam, Nabil; Datta, Pallab; Taba, Brian; Risk, William P.; Modha, Dharmendra S.] IBM Res Almaden, San Jose, CA 95120 USA; [Arthur, John] IBM Res Almaden, Brain Inspired Comp Grp, San Jose, CA 95120 USA; [Jackson, Bryan] IBM Res Almaden, Hardware Design, Cognit Comp SyNAPSE Grp, San Jose, CA 95120 USA; [Nakamura, Yutaka] IBM Res Tokyo, Tokyo 6008028, Japan; [Nam, Gi-Joon; Kuang, Jente B.] IBM Res Austin, Austin, TX USA; [Beakes, Michael; Brezzo, Bernard] IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA; [Manohar, Rajit] Cornell Univ, Ithaca, NY 14850 USA	Akopyan, F (reprint author), IBM Res Almaden, San Jose, CA 95120 USA.	akopyan@us.ibm.com; sawada@us.ibm.com; andrewca@us.ibm.com; arodrigo@us.ibm.com; arthurjo@us.ibm.com; pameroll@us.ibm.com; ni49@us.ibm.com; xyutaka@jp.ibm.com; pdatta@us.ibm.com; gnam@us.ibm.com; btaba@us.ibm.com; beakes@us.ibm.com; brezzo@us.ibm.com; kuang@us.ibm.com; rajit@csl.cornell.edu; risk@us.ibm.com; bryanlj@us.ibm.com; dmodha@us.ibm.com			Defense Advanced Research Projects Agency [HR0011-09-C-0002]	This work was supported by Defense Advanced Research Projects Agency under Contract HR0011-09-C-0002. This paper was recommended by Associate Editor C. J. Alpert.	Amir A., 2013, P IEEE INT JOINT C N, P1; Ananthanarayanan R, 2007, P 2007 ACM IEEE INT, P1, DOI DOI 10.1145/1362622.1362627; Ananthanarayanan R., 2009, P IEEE C HIGH PERF C, V2009, P1; Andreopoulos A., 2015, IBM J RES DEV, V59, p[1, 16, 9]; Painkras E, 2013, IEEE J SOLID-ST CIRC, V48, P1943, DOI 10.1109/JSSC.2013.2259038; Shepard KL, 1996, IEEE IC CAD, P524, DOI 10.1109/ICCAD.1996.569906; Benjamin B, 2014, P IEEE, V102, P699, DOI 10.1109/JPROC.2014.2313565; Viola P, 2001, PROC CVPR IEEE, P511; Nam GJ, 2006, IEEE T COMPUT AID D, V25, P678, DOI 10.1109/TCAD.2006.870079; Andreopoulos A, 2013, COMPUT VIS IMAGE UND, V117, P827, DOI 10.1016/j.cviu.2013.04.005; Wong CG, 2003, DES AUT CON, P508; [Anonymous], 2006, 13642005 IEEE; Vygen J, 1997, DES AUT CON, P746; Kasturi R, 2014, INT C PATT RECOG, P2401, DOI 10.1109/ICPR.2014.416; Viswanathan N, 2007, DES AUT CON, P453, DOI 10.1109/DAC.2007.375208; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Merolla P, 2014, IEEE T CIRCUITS-I, V61, P820, DOI 10.1109/TCSI.2013.2284184; Modha DS, 2010, P NATL ACAD SCI USA, V107, P13485, DOI 10.1073/pnas.1008054107; MARTIN AJ, 1986, DISTRIB COMPUT, V1, P226, DOI 10.1007/BF01660034; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Cassidy AS, 2013, NEURAL NETWORKS, V45, P4, DOI 10.1016/j.neunet.2013.05.011; Merolla PA, 2014, SCIENCE, V345, P668, DOI 10.1126/science.1254642; Alpert CJ, 2003, IEEE T COMPUT AID D, V22, P1343, DOI 10.1109/TCAD.2003.818126; Manohar R, 2001, PR INT SYMP ADV RES, P96, DOI 10.1109/ASYNC.2001.914073; Arthur JV, 2012, P INT JOINT C NEUR N, P1; Bengio Yoshua, 2009, Foundations and Trends in Machine Learning, V2, DOI 10.1561/2200000006; Caldwell AE, 2000, DES AUT CON, P693, DOI 10.1145/337292.337617; Cassidy A. S., 2014, P INT C HIGH PERF CO, P27; Cassidy A. S., 2013, P IEEE INT JOINT C N, P1; Coates A., 2011, P 28 INT C MACH LEAR, P921; Esser S. K., 2013, P IEEE INT JOINT C N, P1; Fang D., 2006, PALEOMAGNETISM TARIM, P1; Hsu J, 2014, IEEE SPECTRUM, V51, P17; Lines A. M., 1998, CALTECHCSTR1998CSTR9; Manohar R., 1999, 574 ECE CORN U; Martin A. J., 2004, P 4 AS CIRC DES WORK; Martin A. J., 1990, P 6 MIT C ADV RES VL, P263; Martin A. J., 1988, CALTECHCSTR1988CSTR8; Moradi S., 2013, TBIOCAS, V8, P1, DOI [10.1109/TBCAS.2013.2255873, DOI 10.1109/TBCAS.2013.2255873]; Muller D. E., 1959, P INT S THEOR SWITCH, P204; NAM GJ, 2005, P ISPD, P216, DOI 10.1145/1055137.1055182; Nam GJ, 2007, INTEGR CIRCUIT SYST, P1, DOI 10.1007/978-0-387-68739-1; Nystrom M., 2001, THESIS CALTECH PASAD; Park J., 2014, P IEEE BIOM CIRC SYS, P675; Preissl R., 2012, P 2012 INT C HIGH PE, P1; Schemmel J., 2012, PROCEEDINGS OF THE 2, P702; Shin Y., 2013, P IEEE INT SOL STAT, P154; Stromatias E., 2013, P IEEE INT JOINT C N, P1; Wong T. M., 2012, RJ10502 IBM RES DIV	49	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0070	1937-4151		IEEE T COMPUT AID D	IEEE Trans. Comput-Aided Des. Integr. Circuits Syst.	OCT	2015	34	10					1537	1557		10.1109/TCAD.2015.2474396		21	Computer Science, Hardware & Architecture; Computer Science, Interdisciplinary Applications; Engineering, Electrical & Electronic	Computer Science; Engineering	CR9NJ	WOS:000361683200001		
J	Niwa, H; Suda, J; Kimoto, T				Niwa, Hiroki; Suda, Jun; Kimoto, Tsunenobu			Impact Ionization Coefficients in 4H-SiC Toward Ultrahigh-Voltage Power Devices	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Avalanche breakdown; device simulation; impact ionization coefficient; photodiode (PD); silicon carbide (SiC)	4H SILICON-CARBIDE; TEMPERATURE-DEPENDENCE; AVALANCHE PHOTODIODES; RATES; HOLES; SEMICONDUCTORS; TERMINATION; ELECTRONS; FIELDS	A temperature dependence of impact ionization coefficients in 4H-SiC was studied in a wide range of electric field toward the accurate designing of ultrahigh-voltage devices. The photomultiplication measurement was conducted for various photodiodes with different multiplication layer structures to obtain multiplication factors and ionization coefficients in a wide range of electric field strength. Especially, using multiplication layer structure with low doping concentration, the hole impact ionization coefficient was extracted at low electric field of 1 MV/cm. In high-temperature measurement, the hole ionization coefficient decreased with the increase of temperature, as observed in other semiconductor materials. For the electron ionization coefficient, however, its temperature dependence was very small and values obtained at room temperature could be used, at least up to 150 degrees C.	[Niwa, Hiroki; Suda, Jun; Kimoto, Tsunenobu] Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6158510, Japan	Niwa, H (reprint author), Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6158510, Japan.	niwa@semicon.kuee.kyoto-u.ac.jp; suda@kuee.kyoto-u.ac.jp; kimoto@kuee.kyoto-u.ac.jp			Funding Program for World-Leading Innovative Research and Development on Science and Technology; Cross-Ministerial Strategic Innovation Promotion Program through Council for Science, Technology and Innovation	This work was supported in part by the Funding Program for World-Leading Innovative Research and Development on Science and Technology and in part by the Cross-Ministerial Strategic Innovation Promotion Program through the Council for Science, Technology and Innovation. The review of this paper was arranged by Editor S. N. E. Madathil.	Niwa H, 2014, MATER SCI FORUM, V778-780, P461, DOI 10.4028/www.scientific.net/MSF.778-780.461; Yan F, 2002, MATER SCI FORUM, V389-3, P1305; Miyake H, 2012, IEEE ELECTR DEVICE L, V33, P1598, DOI 10.1109/LED.2012.2215004; Cheng L, 2014, MATER SCI FORUM, V778-780, P1089, DOI 10.4028/www.scientific.net/MSF.778-780.1089; Loh WS, 2008, IEEE T ELECTRON DEV, V55, P1984, DOI 10.1109/TED.2008.926679; Hatakeyama T, 2009, PHYS STATUS SOLIDI A, V206, P2284, DOI 10.1002/pssa.200925213; LEE CA, 1964, PHYS REV, V134, pA761, DOI 10.1103/PhysRev.134.A761; Hatakeyama T, 2004, APPL PHYS LETT, V85, P1380, DOI 10.1063/1.1784520; Ng BK, 2003, IEEE T ELECTRON DEV, V50, P1724, DOI 10.1109/TED.2003.815144; CHYNOWETH AG, 1958, PHYS REV, V109, P1537, DOI 10.1103/PhysRev.109.1537; Kimoto T, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.040103; Konstantinov AO, 1997, APPL PHYS LETT, V71, P90, DOI 10.1063/1.119478; Raghunathan R, 1999, SOLID STATE ELECTRON, V43, P199, DOI 10.1016/S0038-1101(98)00248-2; WOODS MH, 1973, SOLID STATE ELECTRON, V16, P381, DOI 10.1016/0038-1101(73)90013-0; Kaji N, 2015, IEEE T ELECTRON DEV, V62, P374, DOI 10.1109/TED.2014.2352279; Cha HY, 2008, JPN J APPL PHYS, V47, P5423, DOI 10.1143/JJAP.47.5423; BHATNAGAR M, 1993, IEEE T ELECTRON DEV, V40, P645, DOI 10.1109/16.199372; CROWELL CR, 1966, APPL PHYS LETT, V9, P242, DOI 10.1063/1.1754731; Raghunathan R, 1997, ISPSD '97: 1997 IEEE INTERNATIONAL SYMPOSIUM ON POWER SEMICONDUCTOR DEVICES AND ICS, P173, DOI 10.1109/ISPSD.1997.601463; Agarwal A, 2004, MATER RES SOC SYMP P, V815, P243; BULMAN GE, 1982, SOLID STATE ELECTRON, V25, P1189, DOI 10.1016/0038-1101(82)90079-X; Loh WS, 2009, MATER SCI FORUM, V615-617, P311; Green JE, 2012, IEEE T ELECTRON DEV, V59, P1030, DOI 10.1109/TED.2012.2185499; Raynaud C, 2009, PHYS STATUS SOLIDI A, V206, P2273, DOI 10.1002/pssa.200825183; Brunt EV, 2014, PROC INT SYMP POWER, P358, DOI 10.1109/ISPSD.2014.6856050; GRANT WN, 1973, SOLID STATE ELECTRON, V16, P1189, DOI 10.1016/0038-1101(73)90147-0; OKUTO Y, 1975, SOLID STATE ELECTRON, V18, P161, DOI 10.1016/0038-1101(75)90099-4; Stillman G. E., 1977, SEMICONDUCTORS SEMIM, V12; Watanabe N., 2014, JPN J APPL PHYS, V53	29	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	OCT	2015	62	10					3326	3333		10.1109/TED.2015.2466445		8	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CR9NP	WOS:000361684000032		
J	Tao, S; Kudo, M; Pei, BN; Nonaka, H; Toyama, J				Tao, Shuai; Kudo, Mineichi; Pei, Bing-Nan; Nonaka, Hidetoshi; Toyama, Jun			Multiperson Locating and Their Soft Tracking in a Binary Infrared Sensor Network	IEEE TRANSACTIONS ON HUMAN-MACHINE SYSTEMS			English	Article						Infrared sensors; localization; sensor network; soft tracking	TARGET TRACKING; KALMAN FILTER	Low-cost sensor networks for multitarget tracking are increasingly becoming important equipment in many applications. A major problem is that these sensors usually provide only a binary response in each epoch, if a target is present or absent. Efficient approaches for realizing the location and tracking of multiple targets are needed. In this paper, we develop a soft tracking system using an infrared ceiling sensor network and propose a novel algorithm for tracking multiple people. In this system, 43 infrared sensors were attached to the ceiling of an office room (15.0 m x 8.5 m). Some pieces of weak evidence such as locations of personal desks, and the moving directions of people, were used for soft tracking. Through experiments, the ability of tracking in different situations was evaluated. The tracking accuracy during a 3 h period was investigated. The results showed that this system was able to track up to eight people simultaneously for hours in an office room. The tracking accuracy was above 90% most of the time, although some identity ambiguities occurred.	[Tao, Shuai; Pei, Bing-Nan] Dalian Univ, Dept Informat & Engn, Dalian 116622, Liaoning, Peoples R China; [Kudo, Mineichi; Nonaka, Hidetoshi] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido 0600814, Japan; [Toyama, Jun] Inst Pract Applicat Math, Sapporo, Hokkaido 0630001, Japan	Tao, S (reprint author), Dalian Univ, Dept Informat & Engn, Dalian 116622, Liaoning, Peoples R China.	taoshuai@dlu.edu.cn; mine@main.ist.hokudai.ac.jp; peibingnan@dlu.edu.cn; nonaka@main.ist.hokudai.ac.jp; mandheling@nifty.com			National Natural Science Foundation of China [61201420]	This work is supported by the National Natural Science Foundation of China under Grant 61201420. This paper was recommended by Associate Editor D. Monekosso.	Fang JS, 2006, OPT EXPRESS, V14, P609, DOI 10.1364/OPEX.14.000609; Schulz D, 2001, IEEE INT CONF ROBOT, P1665; [Anonymous], 2011, ADV MULTIMEDIA MODEL, DOI 10.1007/978-3-642-17832-0_15; Bshara M, 2011, IEEE T VEH TECHNOL, V60, P1016, DOI 10.1109/TVT.2011.2107926; Tao S, 2011, LECT NOTES COMPUT SC, V6855, P122; Yam CY, 2004, PATTERN RECOGN, V37, P1057, DOI 10.1016/j.patcog.2003.09.012; Gu DB, 2007, IEEE INT CONF ROBOT, P3856, DOI 10.1109/ROBOT.2007.364070; Hightower J, 2001, COMPUTER, V34, P57, DOI 10.1109/2.940014; Hosokawa T, 2009, PATTERN ANAL APPL, V12, P237, DOI 10.1007/s10044-008-0119-9; Zhao T, 2004, IEEE T PATTERN ANAL, V26, P1208; Cevher V, 2001, P SOC PHOTO-OPT INS, V4385, P187, DOI 10.1117/12.421122; Hosokawa T, 2005, LECT NOTES ARTIF INT, V3684, P682; Mori T, 2004, IEEE SYS MAN CYBERN, P5271; Hao Q, 2006, IEEE SENS J, V6, P1683, DOI 10.1109/JSEN.2006.884562; Arthi R., 2010, P 2 ICOAC DEC, P14; BAHETI RS, 1986, IEEE T AERO ELEC SYS, V22, P8, DOI 10.1109/TAES.1986.310687; Bar-Shalom Y., 1987, TRACKING DATA ASS; Hightower J., 2003, P IJCAI, V18, P921; Ikeda T., 2006, P IEEE INT C MULT FU, P530; Ing G., 2005, P IEEE 6 WORKSH SIGN, P935; Khan S., 2001, P 8 IEEE INT C COMP, V1, P331, DOI 10.1109/ICCV.2001.937537; Liu J. J., 2010, P IEEE COMP SOC C CO, P23; Mechitov K., 2003, P 1 INT C EMB NETW S, P332; Nonaka Hidetoshi, 2011, Proceedings of the 1st International Conference on Pervasiveand Embedded Computing and Communication Systems. PECCS 2011; Sawai K., 2004, I ELECT INF COMMUN E, VJ87D-II11, P2054; Shankar M., 2006, OPT ENG, V45; Sogo T., 2004, Systems and Computers in Japan, V35, DOI 10.1002/scj.1228; Wang ZJ, 2010, ACM T SENSOR NETWORK, V6, DOI 10.1145/1777406.1777411	28	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2291	2168-2305		IEEE T HUM-MACH SYST	IEEE T. Hum.-Mach. Syst.	OCT	2015	45	5			SI		550	561		10.1109/THMS.2014.2365466		12	Computer Science, Artificial Intelligence; Computer Science, Cybernetics	Computer Science	CR9NE	WOS:000361682500002		
J	Abe, M; Shibata, K				Abe, Mitsushi; Shibata, Keiichiro			Coil Block Designs With Good Homogeneity for MRI Magnets Based on SVD Eigenmode Strengths	IEEE TRANSACTIONS ON MAGNETICS			English	Article						Coil block (CB); magnetic resonance imaging (MRI) magnet; optimization; singular value decomposition	RESONANCE-IMAGING MAGNETS; INVERSE APPROACH; MAIN MAGNETS; FIELD; OPTIMIZATION; HYBRID	This paper describes an improved method to determine coil block (CB) placements with good homogeneities for magnetic resonance imaging magnets. Each magnet has a main coil (MC) for strong magnetic fields in a volume of interest and a shield coil (SC) to make the magnetic fields weak outside the magnet. The CB placements are done in three steps and at every step, the SC magnetic moments are tuned. In step 1, approximate placements are done with axially distributed circular filament loop currents. According to the distribution, rough placements of CBs are done for the MC. In step 2, the CB cross-sectional shapes and positions are optimized to get good homogeneity with real numbers of winding turns. In step 3, the CB shapes are approximated with integer numbers of winding turns and conductor sizes, and the CB positions are tuned to get as good homogeneities as the step 1 result. In all steps, optimizations are done through truncated singular value decompositions. In steps 2 and 3, the placements are done with respect to eigenmode strengths, which are obtained in step 1. For a magnet with six MC-CBs, seven symmetric eigenmode strengths are tuned. The CB placements for magnets can be obtained with good homogeneities and integerized CB winding turns using the method.	[Abe, Mitsushi; Shibata, Keiichiro] Hitachi Ltd, Ctr Technol Innovat Energy, Hitachi, Ibaraki 3191221, Japan	Abe, M (reprint author), Hitachi Ltd, Ctr Technol Innovat Energy, Hitachi, Ibaraki 3191221, Japan.	mitsushi.abe.pg@hitachi.com					Abe M., 2014, JPN J MAGN RESON MED, V34, P372; Abe M., 2009, THESIS GRADUATE U AD; Abe M, 1996, FUSION TECHNOL, V29, P277; Morrow G, 2000, IEEE T APPL SUPERCON, V10, P744, DOI 10.1109/77.828339; Abe M, 2003, PHYS PLASMAS, V10, P1022, DOI 10.1063/1.1557073; Zhao HW, 2000, MED PHYS, V27, P599, DOI 10.1118/1.598899; Boozer AH, 2000, PHYS PLASMAS, V7, P629, DOI 10.1063/1.873849; Cheng YCN, 2004, IEEE T APPL SUPERCON, V14, P2008, DOI 10.1109/TASC.2004.831507; THOMPSON MR, 1994, IEEE T MAGN, V30, P108, DOI 10.1109/20.272522; Abe M, 2013, IEEE T MAGN, V49, P5645, DOI 10.1109/TMAG.2013.2275411; Pomphrey N, 2001, NUCL FUSION, V41, P339, DOI 10.1088/0029-5515/41/3/312; Cioffi M, 2006, IEEE T MAGN, V42, P1099, DOI 10.1109/TMAG.2006.871983; Shaw NR, 2002, IEEE T APPL SUPERCON, V12, P733, DOI 10.1109/TASC.2002.1018506; Tieng QM, 2009, IEEE T APPL SUPERCON, V19, P3645, DOI 10.1109/TASC.2009.2015954; Abe M, 2013, IEEE T MAGN, V49, P2873, DOI 10.1109/TMAG.2012.2236564; KALAFALA AK, 1990, IEEE T MAGN, V26, P1181, DOI 10.1109/20.53996; Wang QL, 2009, IEEE T APPL SUPERCON, V19, P2289, DOI 10.1109/TASC.2009.2017894; Cheng YCN, 2003, MAGN RESON MATER PHY, V16, P57, DOI 10.1007/s10334-003-0012-x; Cosmus TC, 2011, IEEE T APPL SUPERCON, V21, P2104, DOI 10.1109/TASC.2010.2084981; Sinha G, 2008, IEEE T MAGN, V44, P2351, DOI 10.1109/TMAG.2008.2001843; Zhao HW, 1999, J MAGN RESON, V141, P340, DOI 10.1006/jmre.1999.1924; Wang CZ, 2011, IEEE T APPL SUPERCON, V21, P2245, DOI 10.1109/TASC.2010.2090324; DeMeester G, 2002, MAGN RESON MATER PHY, V13, P193, DOI 10.1016/S1352-8661(01)00149-1; Guamieri M., 1990, IEEE Transactions on Magnetics, V26, DOI 10.1109/20.106394; Iinuma H., 2013, P 10 ANN M PART ACC	25	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9464	1941-0069		IEEE T MAGN	IEEE Trans. Magn.	OCT	2015	51	10							7002713	10.1109/TMAG.2015.2412515		13	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CR9NW	WOS:000361684700016		
J	Hirohata, A; Sukegawa, H; Yanagihara, H; Zutic, I; Seki, T; Mizukami, S; Swaminathan, R				Hirohata, Atsufumi; Sukegawa, Hiroaki; Yanagihara, Hideto; Zutic, Igor; Seki, Takeshi; Mizukami, Shigemi; Swaminathan, Raja			Roadmap for Emerging Materials for Spintronic Device Applications	IEEE TRANSACTIONS ON MAGNETICS			English	Article						Half-metallic ferromagnets; magnetic anisotropy; magnetic materials; spintronics	DILUTED MAGNETIC SEMICONDUCTOR; SPIN-POLARIZATION; PERPENDICULAR-ANISOTROPY; HEUSLER-ALLOY; SINGLE-CRYSTALS; BAND-STRUCTURE; POINT-CONTACT; MAGNETORESISTANCE; FIELD; FERROMAGNETISM	The Technical Committee of the IEEE Magnetics Society has selected seven research topics to develop their roadmaps, where major developments should be listed alongside expected timelines: 1) hard disk drives; 2) magnetic random access memories; 3) domain-wall devices; 4) permanent magnets; 5) sensors and actuators; 6) magnetic materials; and 7) organic devices. Among them, magnetic materials for spintronic devices have been surveyed as the first exercise. In this roadmap exercise, we have targeted magnetic tunnel and spin-valve junctions as spintronic devices. These can be used, for example, as a cell for a magnetic random access memory and a spin-torque oscillator in their vertical form as well as a spin transistor and a spin Hall device in their lateral form. In these devices, the critical role of magnetic materials is to inject spin-polarized electrons efficiently into a nonmagnet. We have accordingly identified two key properties to be achieved by developing new magnetic materials for future spintronic devices: 1) half-metallicity at room temperature (RT) and 2) perpendicular anisotropy in nanoscale devices at RT. For the first property, five major magnetic materials are selected for their evaluation for future magnetic/spintronic device applications: 1) Heusler alloys; 2) ferrites; 3) rutiles; 4) perovskites; and 5) dilute magnetic semiconductors. These alloys have been reported or predicted to be half-metallic ferromagnets at RT. They possess a bandgap at the Fermi level E-F only for its minority spins, achieving 100% spin polarization at EF. We have also evaluated L1(0) alloys and D0(22)-Mn alloys for the development of a perpendicularly anisotropic ferromagnet with large spin polarization. We have listed several key milestones for each material on their functionality improvements, property achievements, device implementations, and interdisciplinary applications within 35 years time scale. The individual analyses and the projections are discussed in the following sections.	[Hirohata, Atsufumi] Univ York, Dept Elect, York YO10 5DD, N Yorkshire, England; [Sukegawa, Hiroaki] Natl Inst Mat Sci, Magnet Mat Unit, Tsukuba, Ibaraki 3050047, Japan; [Yanagihara, Hideto] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058577, Japan; [Zutic, Igor] SUNY Buffalo, Dept Phys, Buffalo, NY 14260 USA; [Seki, Takeshi] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Mizukami, Shigemi] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Swaminathan, Raja] Intel Corp, Chandler, AZ 85226 USA	Hirohata, A (reprint author), Univ York, Dept Elect, York YO10 5DD, N Yorkshire, England.	atsufumi.hirohata@york.ac.uk	Mizukami, Shigemi/C-1671-2010; Seki, Takeshi/A-9957-2011	Mizukami, Shigemi/0000-0001-9913-1833; 	Engineering and Physical Sciences Research Council [EP/K03278X/1, EP/M02458X/1]; EU-FP7 Program [NMP3-SL-2013-604398]; Precursory Research for Embryonic Science and Technology-Japan Science and Technology (JST) Agency; Division of Electrical, Communications and Cyber Systems through National Science Foundation (NSF) [ECCS-1102092, ECCS-1508873]; Division of Materials Research through NSF Grant [DMR-1124601]; U.S. Office of Naval Research [N000141310754]; ASPIMATT JST; New Energy and Industrial Technology Development Organization through Development of an Infrastructure for Normally-Off Computing Technology Project.	The work of A. Hirohata was supported in part by the Engineering and Physical Sciences Research Council under Grant EP/K03278X/1 and Grant EP/M02458X/1 and in part by EU-FP7 Program under Grant NMP3-SL-2013-604398. The work of A. Hirohata and T. Seki was supported by the Precursory Research for Embryonic Science and Technology-Japan Science and Technology (JST) Agency. The work of Igor Zutic was supported in part by the Division of Electrical, Communications and Cyber Systems through the National Science Foundation (NSF) under Grant ECCS-1102092 and Grant ECCS-1508873, in part by the Division of Materials Research through NSF Grant DMR-1124601, and in part by the U.S. Office of Naval Research under Grant N000141310754. The work of S. Mizukami was supported in part by ASPIMATT JST and in part by the New Energy and Industrial Technology Development Organization through the Development of an Infrastructure for Normally-Off Computing Technology Project. The authors would like to thank the Technical Committee of the IEEE Magnetics Society, who initiated this roadmap as the first exercise of this kind.	MUNEKATA H, 1989, PHYS REV LETT, V63, P1849, DOI 10.1103/PhysRevLett.63.1849; Zayets V, 2004, APPL PHYS LETT, V84, P565, DOI 10.1063/1.1644339; Iihama S, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4897547; VONHELMOLT R, 1993, PHYS REV LETT, V71, P2331, DOI 10.1103/PhysRevLett.71.2331; Ramos AV, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2787880; Yakushiji K, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3524230; YANASE A, 1984, J PHYS SOC JPN, V53, P312, DOI 10.1143/JPSJ.53.312; Lee J, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.045314; Rangaraju N, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.117202; Nayak AK, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.127204; Sato J, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.113005; Miura Y, 2014, IEEE T MAGN, V50, DOI 10.1109/TMAG.2013.2276625; Dietl T, 2000, SCIENCE, V287, P1019, DOI 10.1126/science.287.5455.1019; DEGROOT RA, 1983, PHYS REV LETT, V50, P2024, DOI 10.1103/PhysRevLett.50.2024; Hirohata A, 2013, APPL PHYS A-MATER, V111, P423, DOI 10.1007/s00339-013-7679-2; Lewis SP, 1997, PHYS REV B, V55, P10253, DOI 10.1103/PhysRevB.55.10253; Ikeda S, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2976435; Bibes M, 2007, IEEE T ELECTRON DEV, V54, P1003, DOI 10.1109/TED.2007.894366; Saha D, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.205309; Block T, 2003, J SOLID STATE CHEM, V176, P646, DOI 10.1016/j.jssc.2003.07.002; Soulen RJ, 1998, SCIENCE, V282, P85, DOI 10.1126/science.282.5386.85; Zutic I, 2006, IBM J RES DEV, V50, P121; Sawicki M, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.205204; Erwin SC, 2004, NAT MATER, V3, P410, DOI 10.1038/nmat1127; ONODERA K, 1994, ELECTRON LETT, V30, P1954, DOI 10.1049/el:19941327; Rudolph J, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2146064; Inomata K, 2003, JPN J APPL PHYS 2, V42, pL419, DOI 10.1143/JJAP.42.L419; Mizukami S, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.123002; Ohno H, 2010, NAT MATER, V9, P952, DOI 10.1038/nmat2913; Tezuka N, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3116717; Ikeda S, 2010, NAT MATER, V9, P721, DOI [10.1038/nmat2804, 10.1038/NMAT2804]; Niizeki T, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824761; Mitani S, 2005, IEEE T MAGN, V41, P2606, DOI 10.1109/TMAG.2005.854718; SWARTZENDRUBER LJ, 1991, J MAGN MAGN MATER, V100, P573, DOI 10.1016/0304-8853(91)90841-W; Matzen S, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4738790; Sakuraba Y, 2005, JPN J APPL PHYS 2, V44, pL1100, DOI 10.1143/JJAP.44.L1100; Serrate D, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/2/023201; Dietl T, 2010, NAT MATER, V9, P965, DOI [10.1038/nmat2898, 10.1038/NMAT2898]; SIRATORI K, 1960, J PHYS SOC JPN, V15, P210, DOI 10.1143/JPSJ.15.210; Moussy JB, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/14/143001; Meng H, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2198797; Kubota T, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3659484; FLIPPEN RB, 1963, J APPL PHYS, V34, P2026, DOI 10.1063/1.1729730; Mizukami S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.117201; Mangin S, 2006, NAT MATER, V5, P210, DOI 10.1038/nmat1595; PAULEVE J, 1968, J APPL PHYS, V39, P989; Holub M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.146603; Ohno H, 1996, APPL PHYS LETT, V69, P363, DOI 10.1063/1.118061; Tokura Y, 1999, J MAGN MAGN MATER, V200, P1, DOI 10.1016/S0304-8853(99)00352-2; Bowen M, 2003, APPL PHYS LETT, V82, P233, DOI 10.1063/1.1534619; Zutic I, 2004, REV MOD PHYS, V76, P323, DOI 10.1103/RevModPhys.76.323; Ji Y, 2001, PHYS REV LETT, V86, P5585, DOI 10.1103/PhysRevLett.86.5585; Kurt H, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4754123; Sukegawa H, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.184401; Ogiwara M, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4845035; Wu F, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3108085; [Anonymous], 1999, ADV PHYS; Kojima T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.010204; Coey JMD, 1998, PHYS REV LETT, V80, P3815, DOI 10.1103/PhysRevLett.80.3815; Hirohata A, 2006, CURR OPIN SOLID ST M, V10, P93, DOI 10.1016/j.cossms.2006.11.006; Takahashi YK, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3318297; Galanakis I, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.174429; ESAKI L, 1967, PHYS REV LETT, V19, P852, DOI 10.1103/PhysRevLett.19.852; Balke B, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2722206; FURDYNA JK, 1988, J APPL PHYS, V64, pR29, DOI 10.1063/1.341700; Galanakis I., 2005, HALF METALLIC ALLOYS; Glasbrenner JK, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.140403; Heusler F., 1903, Verhandlungen der Deutschen Physikalischen Gesellschaft, V5; Hopfner H, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4862330; Ivanov O. A., 1973, PHYS MET METALLOGR, V35, P81; Nagaev E. L., 1983, PHYS MAGNETIC SEMICO; Seki T., 2009, EPITAXIAL FERROMAGNE, P145; Siroki K., 1998, U.S. Patent, Patent No. [5 757 538, 5757538]; Sugihara A, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4870625; Wen ZC, 2014, ADV MATER, V26, P6483, DOI 10.1002/adma.201401959; Zhao K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2447; Zhao K, 2014, CHINESE SCI BULL, V59, P2524, DOI 10.1007/s11434-014-0398-z	77	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9464	1941-0069		IEEE T MAGN	IEEE Trans. Magn.	OCT	2015	51	10								10.1109/TMAG.2015.2457393		11	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CR9NW	WOS:000361684700001		
J	Kishimoto, M; Miyamoto, R; Oda, T; Yanagihara, H; Ohkohchi, N; Kita, E				Kishimoto, Mikio; Miyamoto, Ryoichi; Oda, Tatsuya; Yanagihara, Hideto; Ohkohchi, Nobuhiro; Kita, Eiji			Quantity Determination of Magnetic Particles Intravenously Administered to Mice Tissues Using Magnetization Measurements	IEEE TRANSACTIONS ON MAGNETICS			English	Article						Accumulation; administration; Fe3O4 particles; magnetization	SUPERPARAMAGNETIC NANOPARTICLES; HYPERTHERMIA; SURFACE; MAGNETOMETER; CELLS; FLUID; FIELD	This paper presents a method that has been developed to determine the quantity of accumulated magnetic particles in mice tissues using magnetization measurements. Dispersions of platelet Fe3O4 particles with the size of 30-50 nm and a saturation magnetization of similar to 80 Am-2/kg were intravenously administered to mice. Primary tissues were dried to measure the magnetization. The amounts of Fe3O4 particles accumulated in the tissues were obtained by dividing the magnetization of tissues by the magnetization of Fe3O4 particles under a magnetic field of 39.8 kA/m. A remarkable accumulation of particles was observed in the liver and the spleen, being supported by the observation of tissues using Prussian blue staining. Total Fe3O4 particles accumulated in primary tissues were similar to 38-40 and 40-44 wt% against the particles in administered dispersions with 3 and 0.4 wt% contents, respectively. The method developed in this paper is considered to be effective for verifying magnetic hyperthermia and thermoablation therapies, in which the quantity of accumulated particles directly reflects the heating power required for those therapies.	[Kishimoto, Mikio; Yanagihara, Hideto; Kita, Eiji] Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 3058573, Japan; [Miyamoto, Ryoichi; Oda, Tatsuya; Ohkohchi, Nobuhiro] Univ Tsukuba, Div Med, Dept Surg, Tsukuba, Ibaraki 3058573, Japan	Kishimoto, M (reprint author), Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 3058573, Japan.	kishimoto.mikio.gb@u.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23300185, 23300362]; Innovative Research Support Program (Pilot Models) at University of Tsukuba, Tsukuba, Japan	This work was supported by a Grant-in-Aid Scientific Research through the Ministry of Education, Culture, Sports, Science and Technology of Japan under Grant 23300185 and Grant 23300362 and the Innovative Research Support Program (Pilot Models) at the University of Tsukuba, Tsukuba, Japan.	Kishimoto M, 2014, J MAGN MAGN MATER, V352, P13, DOI 10.1016/j.jmmm.2013.10.003; Zoulalian V, 2006, J PHYS CHEM B, V110, P25603, DOI 10.1021/jp066811s; Kita E, 2008, IEEE T MAGN, V44, P4452, DOI 10.1109/TMAG.2008.2002005; Hilger I, 2013, INT J HYPERTHER, V29, P828, DOI 10.3109/02656736.2013.832815; Babes L, 1999, J COLLOID INTERF SCI, V212, P474, DOI 10.1006/jcis.1998.6053; JOHNSON GA, 1993, MAGN RESON QUART, V9, P1; Jordan A, 1999, J MAGN MAGN MATER, V201, P413, DOI 10.1016/S0304-8853(99)00088-8; Hashimoto S, 2009, PHYS MED BIOL, V54, P2571, DOI 10.1088/0031-9155/54/8/021; Strom V, 2004, NANOTECHNOLOGY, V15, P457, DOI 10.1088/0957-4484/15/5/009; Hergt R, 2005, J MAGN MAGN MATER, V293, P80, DOI 10.1016/j.jmmm.2005.01.047; Fortin JP, 2007, J AM CHEM SOC, V129, P2628, DOI 10.1021/ja067457e; Rosensweig RE, 2002, J MAGN MAGN MATER, V252, P370, DOI 10.1016/S0304-8853(02)00706-0; Gupta AK, 2004, IEEE T NANOBIOSCI, V3, P66, DOI 10.1109/TNB.2003.820277; Yamada K, 2010, INT J HYPERTHER, V26, P465, DOI 10.3109/02656731003681028; Ujiie K, 2011, COLLOID SURFACE B, V88, P771, DOI 10.1016/j.colsurfb.2011.08.013; Cheraghipour E, 2013, J MAGN MAGN MATER, V328, P91, DOI 10.1016/j.jmmm.2012.09.042; Traina CA, 2007, LANGMUIR, V23, P9158, DOI 10.1021/la701653v; Flynn ER, 2007, J MAGN MAGN MATER, V311, P429, DOI 10.1016/j.jmmm.2006.10.1148; Enpuku K., 2006, J APPL PHYS, V100; Hergt R., 2007, MAGNETISM MED, P550; Horng H. E., 2006, APPL PHYS LETT, V88; Kishimoto M, 2014, IEEE T NANOBIOSCI, V13, P425, DOI 10.1109/TNB.2014.2337659; Kita E., 2010, J PHYS D, V43	23	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9464	1941-0069		IEEE T MAGN	IEEE Trans. Magn.	OCT	2015	51	10							5300706	10.1109/TMAG.2015.2443732		6	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CR9NW	WOS:000361684700010		
J	Yin, YF; Yu, Y; Zimmermann, R				Yin, Yifang; Yu, Yi; Zimmermann, Roger			On Generating Content-Oriented Geo Features for Sensor-Rich Outdoor Video Search	IEEE TRANSACTIONS ON MULTIMEDIA			English	Article						Feature fusion; geographic coverage; map segmentation; semantic annotation; video search	SIMILARITY MEASUREMENT; REPRESENTATION; RELEVANCE	Advanced technologies in consumer electronics products have enabled individual users to record, share, and view videos on mobile devices. With the volume of videos increasing tremendously on the Internet, fast and accurate video search has attracted much research attention. A good similarity measure is a key component in a video retrieval system. Most of the existing solutions only rely on either the low-level visual features or the surrounding textual annotations. Those approaches often suffer from low recall as they are highly susceptible to changes in viewpoint, illumination, and noisy tags. By leveraging geo-metadata, more reliable and precise search results can be obtained. However, two issues remain challenging: (1) how to quantify the spatial relevance of videos with the visual similarity to generate a pertinent ranking of results according to users' needs, and (2) how to design a compact video representation that supports efficient indexing for fast video retrieval. In this study, we propose a novel video description which consists of (a) determining the geographic coverage of a video based on the camera's field-of-view and a pre-constructed geo-codebook, and (b) fusing video spatial relevance and region-aware visual similarities to achieve a robust video similarity measure. Toward a better encoding of a video's geo-coverage, we construct a geo-codebook by semantically segmenting a map into a collection of coherent regions. To evaluate the proposed technique we developed a video retrieval prototype. Experiments show that our proposed method improves the mean average precision by 4.6% similar to 10.5%, compared with existing approaches.	[Yin, Yifang; Zimmermann, Roger] Natl Univ Singapore, Sch Comp, Singapore 117417, Singapore; [Yu, Yi] Natl Inst Informat, Digital Content & Media Sci Res Div, Tokyo 1018430, Japan	Yin, YF (reprint author), Natl Univ Singapore, Sch Comp, Singapore 117417, Singapore.	yifang@comp.nus.edu.sg; yiyu@nii.ac.jp; rogerz@comp.nus.edu.sg			National Natural Science Foundation of China [61472266]; National University of Singapore (Suzhou) Research Institute	This work was supported in part by the National Natural Science Foundation of China under Grant 61472266, and by the National University of Singapore (Suzhou) Research Institute. The associate editor coordinating the review of this manuscript and approving it for publication was Prof. Chia-Wen Lin.	Ballan L, 2013, INT WORK CONTENT MUL, P229, DOI 10.1109/CBMI.2013.6576588; Newman MEJ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.056131; Manjunath BS, 1996, IEEE T PATTERN ANAL, V18, P837, DOI 10.1109/34.531803; Cheng MM, 2015, IEEE T PATTERN ANAL, V37, P569, DOI 10.1109/TPAMI.2014.2345401; Ay SA, 2010, MULTIMEDIA SYST, V16, P105, DOI 10.1007/s00530-009-0177-x; Li LJ, 2014, INT J COMPUT VISION, V107, P20, DOI 10.1007/s11263-013-0660-x; Cheung SCS, 2000, IEEE IMAGE PROC, P85; Cheung SCS, 2003, IEEE T CIRC SYST VID, V13, P59, DOI 10.1109/TCSVT.2002.808080; Wang M, 2009, IEEE T MULTIMEDIA, V11, P465, DOI 10.1109/TMM.2009.2012919; Ballatore A, 2013, KNOWL INF SYST, V37, P61, DOI 10.1007/s10115-012-0571-0; Judd T, 2009, IEEE I CONF COMP VIS, P2106, DOI 10.1109/ICCV.2009.5459462; Zhou DY, 2004, ADV NEUR IN, V16, P321; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Arslan Ay S., 2008, P 16 ACM INT C MULT, P309, DOI 10.1145/1459359.1459401; Ballesteros Luis Guillermo Martinez, 2010, Proceedings of the 2010 IEEE ANDESCON, DOI 10.1109/ANDESCON.2010.5632320; Campbell M., 2006, P TRECVID 2006; Cao L., 2012, P 20 ACM INT C MULT, P299; Crandall D. J., 2009, P 18 INT C WORLD WID, P761, DOI DOI 10.1145/1526709.1526812; De Choudhury M., 2010, P 21 ACM C HYP HYP H, P35, DOI 10.1145/1810617.1810626; Hauff C., 2013, PROCEEDINGS OF THE A, P1037; Hauptmann A. G., 2004, P ACM MULT NEW YORK, P668, DOI 10.1145/1027527.1027681; Hsu W., 2007, P ACM INT C MULT, P971, DOI DOI 10.1145/1291233.1291446.ISBN; Intagorn S., 2011, PROCEEDINGS OF THE 1, P425; Jain R., 2010, P INT C MULT MM 10, P1259, DOI 10.1145/1873951.1874199; Kamahara J., 2012, P ACM MULT 2012 WORK, P9; Kennedy L. S., 2008, P 17 INT C WORLD WID, P297, DOI 10.1145/1367497.1367539; Kim Y., 2012, P ACM INT C KNOWL DI, P1540; Kleban J., 2009, P CIVR, P1, DOI 10.1145/1646396.1646413; Kumar C., 2011, P 4 BCS IRSG C FUT D, P2; Li XR, 2009, IEEE T MULTIMEDIA, V11, P1310, DOI 10.1109/TMM.2009.2030598; Li X., 2012, P INT C MULT INF RET, P4; Liao S., 2014, PHYS OCCUPATIONAL TH, P1; Liu J, 2007, P ACM MULT, P208, DOI DOI 10.1145/1291233.1291279; OHare N., 2005, P 2 IEE EUR WORKSH I, P323; Penatti O. A. B., 2012, P ACM ICMR, P53; Seo H.J., 2009, J VIS, V8, P1; Shen H. T., 2005, P SIGMOD, P730, DOI 10.1145/1066157.1066240; Shen Z., 2011, P ACM INT C MULT, P93; Silva T. H., 2013, P ACM SIGKDD URBCOMP, P1; Stricker M., 1995, Proceedings of the SPIE - The International Society for Optical Engineering, V2420, DOI 10.1117/12.205308; Thomee B., 2013, PROCEEDINGS OF THE A, P1285; Tian X., 2008, P ACM INT C MULT, P131, DOI DOI 10.1145/1459359.1459378.ISBN; van Leuken R. H., 2009, P 18 INT C WORLD WID, P341, DOI DOI 10.1145/1526709.1526756; Wei X.-Y., 2007, P ACM INT C MULT AUG, P981, DOI 10.1145/1291233.1291447; Yin Y., 2015, ACM T MULTIM COMPUT, V11, P29; Yin Y., 2015, ACM T MULTIM COMPUT, V11, P39; Yuan J., 2011, P ACM MULT, P453; Zhang B., 2010, P 18 SIGSPATIAL INT, P260, DOI 10.1145/1869790.1869828	48	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1520-9210	1941-0077		IEEE T MULTIMEDIA	IEEE Trans. Multimedia	OCT	2015	17	10					1760	1772		10.1109/TMM.2015.2458042		13	Computer Science, Information Systems; Computer Science, Software Engineering; Telecommunications	Computer Science; Telecommunications	CR9OD	WOS:000361685400007		
J	Qian, YA; Zheng, QH; Sakai, T; Ye, JT; Liu, J				Qian, Yanan; Zheng, Qinghua; Sakai, Tetsuya; Ye, Junting; Liu, Jun			Dynamic author name disambiguation for growing digital libraries	INFORMATION RETRIEVAL			English	Article						Digital library; Author disambiguation; Data stream; Clustering; Multi-classification		When a digital library user searches for publications by an author name, she often sees a mixture of publications by different authors who have the same name. With the growth of digital libraries and involvement of more authors, this author ambiguity problem is becoming critical. Author disambiguation (AD) often tries to solve this problem by leveraging metadata such as coauthors, research topics, publication venues and citation information, since more personal information such as the contact details is often restricted or missing. In this paper, we study the problem of how to efficiently disambiguate author names given an incessant stream of published papers. To this end, we propose a "BatchAD+IncAD" framework for dynamic author disambiguation. First, we perform batch author disambiguation (BatchAD) to disambiguate all author names at a given time by grouping all records (each record refers to a paper with one of its author names) into disjoint clusters. This establishes a one-to-one mapping between the clusters and real-world authors. Then, for newly added papers, we periodically perform incremental author disambiguation (IncAD), which determines whether each new record can be assigned to an existing cluster, or to a new cluster not yet included in the previous data. Based on the new data, IncAD also tries to correct previous AD results. Our main contributions are: (1) We demonstrate with real data that a small number of new papers often have overlapping author names with a large portion of existing papers, so it is challenging for IncAD to effectively leverage previous AD results. (2) We propose a novel IncAD model which aggregates metadata from a cluster of records to estimate the author's profile such as her coauthor distributions and keyword distributions, in order to predict how likely it is that a new record is "produced" by the author. (3) Using two labeled datasets and one large-scale raw dataset, we show that the proposed method is much more efficient than state-of-the-art methods while ensuring high accuracy.	[Qian, Yanan; Zheng, Qinghua; Ye, Junting; Liu, Jun] Xi An Jiao Tong Univ, Dept Comp Sci & Technol, Xian 710049, Peoples R China; [Sakai, Tetsuya] Waseda Univ, Dept Comp Sci & Engn, Tokyo, Japan	Qian, YA (reprint author), Xi An Jiao Tong Univ, Dept Comp Sci & Technol, Xian 710049, Peoples R China.	yaya213@gmail.com			National Science Foundation of China [61173112, 60921003, 91118005, 91218301, 61221063]; National High Technology Research and Development Program of China [2012AA011003]; National Science and Technology Pillar Program [2011BAK08B02, 2011BAK08B05, 2012BAH16F02]; National Key Technologies R&D Program of China [2013BAK09B01]	The authors are grateful to the reviewers for reviewing this paper. The authors thank Professor Jim Kirk from the computer science department of Union University for revising the English expressions of the paper. The authors also thank the Microsoft Academic Search team for providing the API for data accessing. This research is supported by the National Science Foundation of China under Grant Nos. 61173112, 60921003, 91118005, 91218301, 61221063; National High Technology Research and Development Program of China under Grant No. 2012AA011003; Key Projects in the National Science and Technology Pillar Program under Grant Nos. 2011BAK08B02, 2011BAK08B05, 2012BAH16F02; National Key Technologies R&D Program of China under Grant No. 2013BAK09B01.	Amigo E, 2009, INFORM RETRIEVAL, V12, P461, DOI 10.1007/s10791-008-9066-8; Song Y, 2007, PROCEEDINGS OF THE 7TH ACM/IEE JOINT CONFERENCE ON DIGITAL LIBRARIES, P342, DOI 10.1145/1255175.1255243; Zhang R, 2010, LECT NOTES COMPUT SC, V6185, P198; Gong J, 2009, PROCEEDINGS 32ND ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P778, DOI 10.1145/1571941.1572124; Jinha AE, 2010, LEARN PUBL, V23, P258, DOI 10.1087/20100308; Tang J, 2012, IEEE T KNOWL DATA EN, V24, P975, DOI 10.1109/TKDE.2011.13; Pereira DA, 2009, JCDL 09: PROCEEDINGS OF THE 2009 ACM/IEEE JOINT CONFERENCE ON DIGITAL LIBRARIES, P49; Monz C, 2009, PROCEEDINGS 32ND ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P650, DOI 10.1145/1571941.1572060; Huang J, 2006, LECT NOTES ARTIF INT, V4213, P536; Rahm E, 2001, VLDB J, V10, P334, DOI 10.1007/s007780100057; Balog K, 2009, WEAVING SERVICES AND PEOPLE ON THE WORLD WIDE WEB, P301, DOI 10.1007/978-3-642-00570-1_15; [Anonymous], 2009, ACM IEEE JOINT C DIG; Bhattacharya I., 2007, ACM T KNOWL DISCOV D, V1, P1, DOI 10.1145/1217299.1217304; Bollen J., 2007, P WORLD WID WEB C, P1247, DOI DOI 10.1145/1242572.1242789; Byung-won O., 2007, SIAM INT C DAT MIN; Byung-won O., 2005, ACM IEEE JOINT C DIG, P344; Byung-won O., 2006, P JCDL 06, P51; Cao T., 2008, SEMANTIC WEB, V5367, P420, DOI 10.1007/978-3-540-89704-0_29; Cheng Y., 2013, P 22 ACM INT C INF K, P1213; Culotta A., 2007, WORKSH INF INT WEB W; de Carvalho A. P., 2011, JIDM, V2, P289; Esperidiao L. V. B., 2014, J INFORM DATA MANAGE, V5, P293; Fan X., 2008, P CIKM 08, P1449, DOI 10.1145/1458082.1458327; Godoi T.A., 2013, P 13 ACM IEEE CS JOI, P209; Han H., 2005, ACM IEEE JOINT C DIG, P334; Han H., 2004, P 2004 JOINT ACM IEE, P296; Han H., 2003, INT SEM WEB C; Jiang L., 2009, P WWW 09, P1201, DOI 10.1145/1526709.1526928; Joachims T., 1999, ADV KERNEL METHODS S, V1999, P169; McRae-Spencer D. M., 2006, P ACM IEEE JOINT C D, P53, DOI 10.1145/1141753.1141762; Na S., 2009, INFORM PROCESSING MA, V45, P84; Qian Y., 2011, P 20 ACM INT C INF K, P1241; Smalheiser N. R., 2008, ACM T KNOWL DISCOV D, V3, P11; Tan Y. F., 2006, ACM IEEE JOINT C DIG, P314; Treeratpituk P., 2012, PERSON NAME DISAMBIG; Wang F., 2008, P 9 INT C WEB AG INF, P357; Wang X., 2011, P 2011 IEEE INT C DA; Yang K. H., 2006, TRIIS06017; Yin X., 2007, DATA ENG, P1242	39	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1386-4564	1573-7659		INFORM RETRIEVAL	Inf. Retr.	OCT	2015	18	5					379	412		10.1007/s10791-015-9261-3		34	Computer Science, Information Systems	Computer Science	CS2FA	WOS:000361882000001		
J	Naiki, Y; Komatsu, T; Koide, N; Dagvadorj, J; Yoshida, T; Arditi, M; Yokochi, T				Naiki, Yoshikazu; Komatsu, Takayuki; Koide, Naoki; Dagvadorj, Jargalsaikhan; Yoshida, Tomoaki; Arditi, Moshe; Yokochi, Takashi			TGF-beta 1 inhibits the production of IFN in response to CpG DNA via ubiquitination of TNF receptor-associated factor (TRAF) 6	INNATE IMMUNITY			English	Article						Transforming growth factor-1; type I interferon; ubiquitination; CpG DNA; tumor necrosis factor receptor-associated factor 6	TRANSFORMING-GROWTH-FACTOR; INTERFERON-ALPHA INDUCTION; TOLL-LIKE RECEPTOR-9; FACTOR-BETA; DENDRITIC CELLS; T-CELLS; ACTIVATION; RECOGNITION; FAMILY; MECHANISMS	The effect of TGF-1 on CpG DNA-induced type I IFN production was examined by reconstituting a series of signaling molecules in TLR 3 signaling. TGF-1 inhibited CpG DNA-induced IFN-4 productivity in HeLa cells. Transfection of IFN regulatory factor (IRF)7 but not TNF receptor-associated factor (TRAF)6 and TRAF3 into cells triggered IFN-4 productivity, and TGF-1 inhibited IRF7-mediated type I IFN production in the presence of TRAF6. TGF-1 induced ubiquitination of TRAF6, although CpG DNA did not induce it. Moreover, TGF-1 accelerated the ubiquitination of TRAF6 in the presence of CpG DNA. TGF-1 ubiquitinated TRAF6 at K63 but not K48. TGF-1 also induced ubiquitination of IRF7. Further, TGF-1 did not impair the interaction of IRF7 and TRAF6. CpG DNA induced the phosphorylation of IRF7 in the presence of TRAF6, whereas TGF-1 inhibited the IRF7 phosphorylation. Blocking of TRAF6 ubiquitination abolished the inhibition of CpG DNA-induced type I IFN production by TGF-. Taken together, TGF- was suggested to inhibit CpG DNA-induced type I IFN production transcriptionally via ubiquitination of TRAF6.	[Naiki, Yoshikazu; Komatsu, Takayuki; Koide, Naoki; Dagvadorj, Jargalsaikhan; Yoshida, Tomoaki; Yokochi, Takashi] Aichi Med Univ, Dept Microbiol & Immunol, Sch Med, Nagakute, Aichi 48011, Japan; [Dagvadorj, Jargalsaikhan; Arditi, Moshe] Cedars Sinai Med Ctr, Div Pediat Infect Dis & Immunol, Los Angeles, CA 90048 USA	Naiki, Y (reprint author), Aichi Med Univ, Dept Microbiol & Immunol, Nagakute, Aichi 48011, Japan.	naikiy@aichi-med-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan; MEXT [S1101027]	This work was supported, in part, by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan and a grant of MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2011-2015(S1101027).	KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Sugiyama T, 2012, MOL IMMUNOL, V52, P299, DOI 10.1016/j.molimm.2012.06.008; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Chen L, 2008, FEBS LETT, V582, P2843, DOI 10.1016/j.febslet.2008.07.014; Takeshita F, 2001, J IMMUNOL, V167, P3555; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Endo M, 2007, SKELETAL RADIOL, V36, P523, DOI 10.1007/s00256-006-0234-x; Xu HM, 2003, J BIOL CHEM, V278, P36334, DOI 10.1074/jbc.M305698200; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Bekeredjian-Ding I, 2009, IMMUNOLOGY, V128, P439, DOI 10.1111/j.1365-2567.2009.03134.x; Gorelik L, 2001, NAT MED, V7, P1118, DOI 10.1038/nm1001-1118; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1079/pnas.1016933101; Ning SB, 2008, MOL CELL BIOL, V28, P6536, DOI 10.1128/MCB.00785-08; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kadowaki N, 2001, J IMMUNOL, V166, P2291; Naiki Y, 2005, J BIOL CHEM, V280, P5491; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Maruyama T, 2011, NAT IMMUNOL, V12, P86, DOI 10.1038/ni.1965; Sisirak V, 2013, INT J CANCER, V133, P771, DOI 10.1002/ijc.28072; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Takaoka A, 2008, CANCER SCI, V99, P467, DOI 10.1111/j.1349-7006.2007.00720.x; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Qing J, 2004, MOL CELL BIOL, V24, P1411, DOI 10.1128/MCB.24.3.1411-1425.2004; Wertz IE, 2010, CELL DEATH DIFFER, V17, P14, DOI 10.1038/cdd.2009.168; Ashkar Ali A., 2002, Current Molecular Medicine (Hilversum), V2, P545, DOI 10.2174/1566524023362159	31	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1753-4259	1753-4267		INNATE IMMUN-LONDON	Innate Immun.	OCT	2015	21	7					770	777		10.1177/1753425915596844		8	Biochemistry & Molecular Biology; Immunology; Medicine, Research & Experimental; Microbiology	Biochemistry & Molecular Biology; Immunology; Research & Experimental Medicine; Microbiology	CR7JU	WOS:000361526600010		
J	Massoud, SS; Junk, T; Herchel, R; Travnicek, Z; Mikuriya, M; Fischer, RC; Mautner, FA				Massoud, Salah S.; Junk, Thomas; Herchel, Radovan; Travnicek, Zdenek; Mikuriya, Masahiro; Fischer, Roland C.; Mautner, Franz A.			Structural characterization of ferromagnetic bridged-acetato and -dichlorido copper(II) complexes based on bicompartmental 4-t-butylphenol	INORGANIC CHEMISTRY COMMUNICATIONS			English	Article						Copper; Polynuclear complexes; Bridged phenolate; Bridged chloro; Crystal structure; Magnetic properties	PURPLE ACID-PHOSPHATASES; MAGNETIC-PROPERTIES; DINUCLEAR; MODELS; LIGAND	The reaction of Cu(II) salts with 2,6-bis[bis(2-pyridylmethyl)aminomethyl]-4-t-butylphenol (Lt-Bu-OH) afforded two bridged-phenoxido/hydroxido complexes. The dinuclear bridged acetate species [Cu-2(mu-Lt-Bu-O) (mu-CH3COO)](PF6)(2) (1) and the 1D polymeric doubly-bridged-chlorido {[Cu-2(mu-Lt-Bu-OH)(mu-Cl)(2)](ClO4)(2)center dot 4H(2)O}(n) (2). The two complexes were structurally characterized. Both complexes revealed ferromagnetic interactions; moderate in complex 1 (J = +30.8 cm(-1)) and very weak (J = +2.25 cm(-1)) in 2. (C) 2015 Elsevier B.V. All rights reserved.	[Massoud, Salah S.; Junk, Thomas] Univ Louisiana Lafayette, Dept Chem, Lafayette, LA 70504 USA; [Herchel, Radovan; Travnicek, Zdenek] Palacky Univ, Fac Sci, Dept Inorgan Chem, CZ-77146 Olomouc, Czech Republic; [Herchel, Radovan; Travnicek, Zdenek] Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, CZ-77146 Olomouc, Czech Republic; [Mikuriya, Masahiro] Kwansei Gakuin Univ, Sch Sci & Technol, Dept Appl Chem Environm, Sanda 6691337, Japan; [Fischer, Roland C.] Graz Univ Technol, Inst Anorgan Chem, A-8010 Graz, Austria; [Mautner, Franz A.] Graz Univ Technol, Inst Physikal & Theoret Chem, A-8010 Graz, Austria	Massoud, SS (reprint author), Univ Louisiana Lafayette, Dept Chem, Lafayette, LA 70504 USA.	ssmassoud@louisiana.edu; zdenek.travnicek@upol.cz; mautner@ptc.tu-graz.ac.at	Herchel, Radovan/B-4339-2008	Herchel, Radovan/0000-0001-8262-4666	Department of Chemistry-University of Louisiana at Lafayette; National Program of Sustainability I of the Ministry of Education, Youth and Sports of the Czech Republic [LO1305]	This research was financially supported by the Department of Chemistry-University of Louisiana at Lafayette. RH and ZT thank the National Program of Sustainability I (LO1305) of the Ministry of Education, Youth and Sports of the Czech Republic.	Bosch S, 2014, INORG CHEM, V53, P9036, DOI 10.1021/ic5009945; Ambrosi G, 2008, COORDIN CHEM REV, V252, P1121, DOI 10.1016/j.ccr.2007.09.027; Das B, 2014, J INORG BIOCHEM, V132, P6, DOI 10.1016/j.jinorgbio.2013.08.001; Nie HL, 1996, INORG CHEM, V35, P3325, DOI 10.1021/ic9511985; Neves A, 2007, J AM CHEM SOC, V129, P7486, DOI 10.1021/ja0711841; BORRASALMENAR JJ, 1994, INORG CHEM, V33, P5171, DOI 10.1021/ic00101a006; HOLZ RC, 1994, INORG CHEM, V33, P4609, DOI 10.1021/ic00099a002; Michel F, 2005, ANGEW CHEM INT EDIT, V44, P438, DOI 10.1002/anie.200461462; Camargo TP, 2015, J INORG BIOCHEM, V146, P77, DOI 10.1016/j.jinorgbio.2015.02.017; Daumann LJ, 2013, INORG CHEM, V52, P2029, DOI 10.1021/ic302418x; Berreau LM, 2006, DALTON T, P183, DOI 10.1039/b512515d; Boca R., 1999, THEORETICAL FDN MOL; Das B., 2014, EUR J INORG CHEM, P2204; Ghiladi M, 1997, J CHEM SOC DALTON, P4011, DOI 10.1039/a704388k; Massoud SS, 2014, INORG CHEM COMMUN, V50, P48, DOI 10.1016/j.inoche.2014.10.027; Massoud SS, 2015, DALTON T, V44, P2110, DOI 10.1039/c4dt03508a; Seidler-Egdal R.K., 2001, DALTON T, V40, P3336; Smith S.J., 2008, J BIOL INORG CHEM, P13	18	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1387-7003	1879-0259		INORG CHEM COMMUN	Inorg. Chem. Commun.	OCT	2015	60						1	3		10.1016/j.inoche.2015.07.010		3	Chemistry, Inorganic & Nuclear	Chemistry	CS0TJ	WOS:000361774800001		
J	Jiao, AY; Quan, HJ; Li, ZZ; Zou, YH				Jiao, A. Y.; Quan, H. J.; Li, Z. Z.; Zou, Y. H.			Study on improving the trajectory to elevate the surface quality of plane magnetic abrasive finishing	INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY			English	Article						Surface quality; Magnetic abrasive finishing (MAF); Homogeneity; Trajectory	MAGNESIUM ALLOY; IMPROVEMENT; SIMULATION	This paper aims to improve the surface integrity and surface homogeneity with various trajectories by a newly self-designed experiment device. In the experiments, three kinds of polishing trajectories were studied with attached revolution motion to magnetic abrasive brush (MAB) based on conventional magnetic abrasive finishing (MAF) process. The surface roughness, the cross-sectional shape, and the 3D micro-morphology were chosen as the response variables to explore the feasibility and benefits of the proposed improving polishing method. The results show that the plane homogeneity and surface quality improved in varying degrees after improving the polishing trajectory. In addition, combining MAF theory to analyze related reasons, the trajectory expression of the magnetic abrasive particles (MAPs) was established and was simulated by Graph software. The theoretical analysis is consistent with the experimental results which indicated that analysis of polishing trajectory can be used to predict polishing results. Thus, it is feasible to plan polishing trajectory reasonable according to workpiece profile and surface quality requirements.	[Jiao, A. Y.] Univ Sci & Technol LiaoNing, Sch Appl Technol, Anshan 114051, Peoples R China; [Quan, H. J.; Li, Z. Z.] Univ Sci & Technol LiaoNing, Sch Mech Engn & Automat, Anshan 114051, Peoples R China; [Zou, Y. H.] Utsunomiya Univ, Fac Engn, Grad Sch Engn, Utsunomiya, Tochigi 3218585, Japan	Jiao, AY (reprint author), Univ Sci & Technol LiaoNing, Sch Appl Technol, Anshan 114051, Peoples R China.	jay@ustl.edu.cn					Smaoui M, 2011, INT J ADV MANUF TECH, V56, P463, DOI 10.1007/s00170-011-3213-x; Mirian SS, 2011, INT J ADV MANUF TECH, V55, P601, DOI 10.1007/s00170-010-3109-1; Kim SO, 2008, T NONFERR METAL SOC, V18, pS369; Pan JS, 2012, PHYSCS PROC, V25, P176, DOI 10.1016/j.phpro.2012.03.067; Givi M, 2012, INT J ADV MANUF TECH, V61, P989, DOI 10.1007/s00170-011-3753-0; Liu ZQ, 2013, INT J ADV MANUF TECH, V68, P631, DOI 10.1007/s00170-013-4783-6; Singh DK, 2005, WEAR, V259, P1254, DOI 10.1016/j.wear.2005.02.030; Kim TW, 2010, INT J PRECIS ENG MAN, V11, P189, DOI 10.1007/s12541-010-0021-4; Mulik RS, 2011, INT J ADV MANUF TECH, V55, P501, DOI 10.1007/s00170-010-3102-8; Yamaguchi H, 2011, CIRP ANN-MANUF TECHN, V60, P339, DOI 10.1016/j.cirp.2011.03.119; Wang DB, 2004, INT J MACH TOOL MANU, V44, P1547, DOI 10.1016/j.ijmachtools.2004.04.024; Yin SH, 2004, INT J MACH TOOL MANU, V44, P383, DOI 10.1016/j.ijmachtools.2003.10.002; Jain VK, 2001, WEAR, V250, P384, DOI 10.1016/S0043-1648(01)00642-1; Wang AC, 2009, INT J MACH TOOL MANU, V49, P1063, DOI 10.1016/j.ijmachtools.2009.07.009; Lambropoulos JC, 2010, OPT EXPRESS, V18, P19713, DOI 10.1364/OE.18.019713; Kwak JS, 2012, T NONFERR METAL SOC, V22, pS845, DOI 10.1016/S1003-6326(12)61814-7; Lin CT, 2007, INT J ADV MANUF TECH, V34, P122, DOI 10.1007/s00170-006-0573-8; Jayswal SC, 2005, INT J ADV MANUF TECH, V26, P477, DOI 10.1007/s00170-004-2180-x; Kumar G, 2009, INT J ADV MANUF TECH, V41, P1051, DOI 10.1007/s00170-008-1557-7; Yamaguchi H, 1999, WEAR, V225, P246, DOI 10.1016/S0043-1648(99)00013-7; Zou YH, 2010, ADV MATER RES-SWITZ, V126-128, P1023, DOI 10.4028/www.scientific.net/AMR.126-128.1023; Grzesik W, 2007, INT J MACH TOOL MANU, V47, P255, DOI 10.1016/j.ijmachtools.2006.03.018; Jain VK, 2009, ADV MACHINING PROCES; Jayakumar P, 1997, J SPACECRAFT TECHNOL, V7, P58; Shen XA, 2009, MACHINERY, V5, P16; Shinmura T., 1990, ANN CIRP, V39, P325; Sigh P, 2011, INT J ENG SCI, V3, P5747; Singh Lakhvir, 2010, International Journal of Abrasive Technology, V3; Tsuchiya K, 1933, J JPN I MET, V57, P1333	29	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0268-3768	1433-3015		INT J ADV MANUF TECH	Int. J. Adv. Manuf. Technol.	OCT	2015	80	9-12					1613	1623		10.1007/s00170-015-7136-9		11	Automation & Control Systems; Engineering, Manufacturing	Automation & Control Systems; Engineering	CR8UF	WOS:000361628900012		
J	Asano, Y				Asano, Yoshihide			Epigenetic suppression of Fli1, a potential predisposing factor in the pathogenesis of systemic sclerosis	INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY			English	Review						Systemic sclerosis; Fli1; Fibroblasts; Endothelial cells; Macrophages	TRANSCRIPTION FACTOR FLI1; PROTEIN-ASSOCIATED FACTOR; DNA-BINDING ABILITY; GROWTH-FACTOR-BETA; DERMAL FIBROBLASTS; DOWN-REGULATION; SCLERODERMA FIBROBLASTS; COLLAGEN EXPRESSION; LEUKEMIA-VIRUS; T-CELLS	Systemic sclerosis (SSc) is a multisystem connective tissue disease featured by immune abnormalities, vasculopathy and tissue fibrosis with unknown etiology. A series of studies on disease-susceptibility genes and twins have demonstrated the association of genetic factors with autoimmunity and disease severity and the contribution of environmental factors to the induction of clinical features in this disease. Friend leukemia virus integration 1 (Fill), a member of Ets transcription factor family, is epigenetically suppressed in the lesional skin of SSc patients, suggesting that Fli1 is a potential predisposing factor of SSc reflecting the influence of environmental factors. Consistent with this idea, Fli1 deficiency induces SSc-like phenotypes in dermal fibroblasts and dermal microvascular endothelial cells in vivo and in vitro at molecular levels. Furthermore, Fli1 haploinsufficiency recapitulates tissue fibrosis, vascular activation and inflammation characteristic of SSc to a greater extent in bleomycin-treated mice. Importantly, bosentan, a dual endothelin receptor antagonist with a potential disease-modifying effect on SSc vasculopathy, reverses the expression of Flil protein by increasing its protein stability. Therefore, Flil may serve as a predisposing factor of SSc and can be a promising therapeutic target of this incurable and devastating disease. This article is part of a Directed Issue entitled: Epigenetics dynamics in development and disease. (C) 2015 Elsevier Ltd. All rights reserved.	[Asano, Yoshihide] Univ Tokyo, Dept Dermatol, Grad Sch Med, Tokyo 1138655, Japan	Asano, Y (reprint author), Univ Tokyo, Dept Dermatol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yasano-tky@umin.ac.jp			Actelion Pharmaceuticals	Y Asano has received honoraria and research funding from Actelion Pharmaceuticals.	Akamata K, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4529; Chrobak I, 2013, J CELL PHYSIOL, V228, P1774, DOI 10.1002/jcp.24337; Hu B, 2011, AM J PATHOL, V178, P1500, DOI 10.1016/j.ajpath.2011.01.002; Arnett FC, 2001, ARTHRITIS RHEUM, V44, P1359, DOI 10.1002/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S; Bujor AM, 2011, ARTHRITIS RHEUM-US, V63, P1729, DOI 10.1002/art.30284; Querfeld C, 1999, J DERMATOL SCI, V21, P13, DOI 10.1016/S0923-1811(99)00008-0; BENDAVID Y, 1991, GENE DEV, V5, P908, DOI 10.1101/gad.5.6.908; Akamata K, 2015, ARTHRITIS RHEUMATOL, V67, P1335, DOI 10.1002/art.39062; Sfikakis PP, 2008, RHEUMATOLOGY, V47, P735, DOI 10.1093/rheumatology/ken104; ten Freyhaus H, 2009, CLIN RES CARDIOL, V98, P265, DOI 10.1007/s00392-009-0752-3; Zhang XK, 2005, J BIOCHEM, V137, P297, DOI 10.1093/jb/mvi032; Huber LC, 2007, ARTHRITIS RHEUM, V56, P2755, DOI 10.1002/art.22759; Lian XR, 2012, ARTHRITIS RHEUM-US, V64, P2338, DOI 10.1002/art.34376; Matsushita T, 2006, J RHEUMATOL, V33, P275; Nakashima T, 2012, J IMMUNOL, V188, P3573, DOI 10.4049/jimmunol.1100591; Shirasaki F, 1999, ONCOGENE, V18, P7755; Yoshizaki A, 2010, J IMMUNOL, V185, P2502, DOI 10.4049/jimmunol.0901778; Asano Y, 2007, J BIOL CHEM, V282, P34672, DOI 10.1074/jbc.M703907200; Dong CM, 2002, P NATL ACAD SCI USA, V99, P3908, DOI 10.1073/pnas.062010399; Jiang HY, 2012, CLIN IMMUNOL, V143, P39, DOI 10.1016/j.clim.2012.01.005; Kubo M, 2003, AM J PATHOL, V163, P571, DOI 10.1016/S0002-9440(10)63685-1; Wang YQ, 2013, J CELL MOL MED, V17, P1291, DOI 10.1111/jcmm.12105; Ho HH, 2010, J INTERF CYTOK RES, V30, P893, DOI 10.1089/jir.2010.0046; Hemmatazad H, 2009, ARTHRITIS RHEUM, V60, P1519, DOI 10.1002/art.24494; Forte A, 2012, CARDIOVASC DRUG THER, V26, P9, DOI 10.1007/s10557-011-6359-8; Guiducci S, 2012, CLIN RHEUMATOL, V31, P1723, DOI 10.1007/s10067-012-2074-5; Asano Y, 2009, MOL CELL BIOL, V29, P1882, DOI 10.1128/MCB.01320-08; Cutolo M, 2013, J RHEUMATOL, V40, P40, DOI 10.3899/jrheum.120416; Feghali-Bostwick C, 2003, ARTHRITIS RHEUM, V48, P1956, DOI 10.1002/art.11173; Wang YQ, 2006, ARTHRITIS RHEUM, V54, P2271, DOI 10.1002/art.21948; Asano Y, 2010, AM J PATHOL, V176, P1983, DOI 10.2353/ajpath.2010.090593; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; Broen JCA, 2014, NAT REV RHEUMATOL, V10, P671, DOI 10.1038/nrrheum.2014.128; Czuwara-Ladykowska J, 2001, J BIOL CHEM, V276, P20839, DOI 10.1074/jbc.M010133200; Higashi-Kuwata N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3066; Jimenez SA, 2013, ISRN RHEUMATOL, V2013, DOI DOI 10.1155/2013/835948; Noda S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6797; Taniguchi T, 2015, ARTHRITIS RHEUMATOL, V67, P517, DOI 10.1002/art.38948	38	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1357-2725	1878-5875		INT J BIOCHEM CELL B	Int. J. Biochem. Cell Biol.	OCT	2015	67						86	91		10.1016/j.biocel.2015.06.004		6	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CS0TI	WOS:000361774700012		
J	Lim, YH; Bell, ML; Kan, HD; Honda, Y; Guo, YLL; Kim, H				Lim, Youn-Hee; Bell, Michelle L.; Kan, Haidong; Honda, Yasushi; Guo, Yue-Liang Leon; Kim, Ho			Economic status and temperature-related mortality in Asia	INTERNATIONAL JOURNAL OF BIOMETEOROLOGY			English	Article						Asia; Climate; Economic status; Heat waves; Income; Mortality	HEAT-RELATED MORTALITY; PUBLIC-HEALTH ADAPTATION; NATURAL DISASTERS; CLIMATE-CHANGE; CASE-CROSSOVER; IMPACT; VULNERABILITY; SHANGHAI; INCOME; JAPAN	In developed countries, low latitude and high temperature are positively associated with the population's ability to adapt to heat. However, few studies have examined the effect of economic status on the relationship between long-term exposure to high temperature and health. We compared heterogeneous temperature-related mortality effects relative to the average summer temperature in high-socioeconomic-status (SES) cities to temperature-related effects in low-SES cities. In the first stage of the research, we conducted a linear regression analysis to quantify the mortality effects of high temperature (at or above the 95th percentile) in 32 cities in Taiwan, China, Japan, and Korea. In the second stage, we used a meta-regression to examine the association between mortality risk with average summer temperature and gross domestic product (GDP) per capita. In cities with a low GDP per capita (less than 20,000 USD), the effects of temperature were detrimental to the population if the long-term average summer temperature was high. In contrast, in cities with a high GDP per capita, temperature-related mortality risk was not significantly related to average summer temperature. The relationship between long-term average summer temperature and the short-term effects of high temperatures differed based on the city-level economic status.	[Lim, Youn-Hee] Seoul Natl Univ, Med Res Ctr, Inst Environm Med, Seoul, South Korea; [Lim, Youn-Hee] Seoul Natl Univ, Coll Med, Ctr Environm Hlth, Seoul, South Korea; [Bell, Michelle L.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Kan, Haidong] Fudan Univ, Dept Environm Hlth, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Honda, Yasushi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Guo, Yue-Liang Leon] Natl Taiwan Univ, Environm & Occupat Med, Taipei 10764, Taiwan; [Kim, Ho] Seoul Natl Univ, Grad Sch Publ Hlth, Dept Epidemiol & Biostat, Seoul, South Korea; [Kim, Ho] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea	Kim, H (reprint author), Seoul Natl Univ, Grad Sch Publ Hlth, Dept Epidemiol & Biostat, Seoul, South Korea.	hokim@snu.ac.kr		GUO, Yue Leon/0000-0002-8530-4809	Women Scientist Research Program [2012R1A1A3005549]; Global Research Lab through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [K21004000001-10A0500-00710]; Ministry of the Environment, Japan [S-8, S-10]	This work was supported by the Women Scientist Research Program (#2012R1A1A3005549) and the Global Research Lab (#K21004000001-10A0500-00710) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology and Environment Research and Technology Development Fund S-8 and S-10 from the Ministry of the Environment, Japan.	Anderson GB, 2013, AM J RESP CRIT CARE; Stafoggia M, 2006, EPIDEMIOLOGY, V17, P315, DOI 10.1097/01.ede.0000208477.36665.34; Yu WW, 2012, INT J BIOMETEOROL, V56, P569, DOI 10.1007/s00484-011-0497-3; Rocklov J, 2008, SCAND J PUBLIC HEALT, V36, P516, DOI 10.1177/1403494807088458; Chung JY, 2009, SCI TOTAL ENVIRON, V408, P390, DOI 10.1016/j.scitotenv.2009.09.009; Hajat S, 2010, J EPIDEMIOL COMMUN H, V64, P753, DOI 10.1136/jech.2009.087999; Toya H, 2007, ECON LETT, V94, P20, DOI 10.1016/j.econlet.2006.06.020; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Kahn ME, 2005, REV ECON STAT, V87, P271, DOI 10.1162/0034653053970339; Honda Y, 2011, ADV GLOB CHANGE RES, V42, P189, DOI 10.1007/978-94-007-0567-8_13; Tan JG, 2007, INT J BIOMETEOROL, V51, P193, DOI 10.1007/s00484-006-0058-3; Healy JD, 2003, J EPIDEMIOL COMMUN H, V57, P784, DOI 10.1136/jech.57.10.784; Viechtbauer W, 2010, J STAT SOFTW, V36, P1; Huang CR, 2011, AM J PREV MED, V40, P183, DOI 10.1016/j.amepre.2010.10.025; Medina-Ramon M, 2006, ENVIRON HEALTH PERSP, V114, P1331, DOI 10.1289/ehp.9074; Martinez GS, 2011, INT J ENV RES PUB HE, V8, P4563, DOI 10.3390/ijerph8124563; Guo YM, 2011, ENVIRON HEALTH PERSP, V119, P1719, DOI 10.1289/ehp.1103598; O'Neill MS, 2003, AM J EPIDEMIOL, V157, P1074, DOI 10.1093/aje/kwg096; Bell ML, 2008, INT J EPIDEMIOL, V37, P796, DOI 10.1093/ije/dyn094; McMichael AJ, 2008, INT J EPIDEMIOL, V37, P1121, DOI 10.1093/ije/dyn086; Chau PH, 2009, INT J BIOMETEOROL, V53, P461, DOI 10.1007/s00484-009-0232-5; Kellenberg DK, 2008, J URBAN ECON, V63, P788, DOI 10.1016/j.jue.2007.05.003; Toloo G, 2013, INT J PUBLIC HEALTH, V58, P667, DOI 10.1007/s00038-013-0465-2; Tan JG, 2004, INT J BIOMETEOROL, V48, P157, DOI 10.1007/s00484-003-0193-z; Michelozzi P, 2010, INT J ENV RES PUB HE, V7, P2256, DOI 10.3390/ijerph7052256; Arnedo-Pena A, 2012, INT J BIOMETEOROL, P1; Blankespoor B, 2010, EC ADAPTATION EXTREM; DOH, DEP HLTH TAIW; Dominici F, 2004, J AM STAT ASSOC, V99, P938, DOI 10.1198/016214504000000656; ICLEI, 2009, CLIM AIR POLL PLANN; Intergovernmental Panel on Climate Change, 2007, CLIMATE CHANGE 2007; Kim K-H, 2014, ADAPTATION CLIMATE C, V46; Kim M, 2013, METEOROL APPL; KMA, 2014, HEAT WAV; KOSIS, 2011, REG INC 2010; NBSC, 2007, 2007 CHIN GDP CAP; Parry M.L, 2007, CLIMATE CHANGE 2007, V4; Statistics B, 2002, POP LAND AR GDP CAP	38	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0020-7128	1432-1254		INT J BIOMETEOROL	Int. J. Biometeorol.	OCT	2015	59	10					1405	1412		10.1007/s00484-014-0950-1		8	Biophysics; Environmental Sciences; Meteorology & Atmospheric Sciences; Physiology	Biophysics; Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences; Physiology	CS0DP	WOS:000361728000006		
J	Takakura, J; Nishimura, T; Choi, D; Egashira, Y; Watanuki, S				Takakura, Jun'ya; Nishimura, Takayuki; Choi, Damee; Egashira, Yuka; Watanuki, Shigeki			Nonthermal sensory input and altered human thermoregulation: effects of visual information depicting hot or cold environments	INTERNATIONAL JOURNAL OF BIOMETEOROLOGY			English	Article						Visual information; Visual-thermal interaction; Thermoregulation; Artificial media environment	THERMAL COMFORT; TEMPERATURE; LIGHT; SYSTEM; SENSITIVITY; MECHANISMS; MELATONIN; RESPONSES; EMOTIONS; EXPOSURE	A recent study showed that thermoregulatory-like cardiovascular responses can be invoked simply by exposure to visual information, even though the thermal environments are neutral and unchanged. However, it was not clear how such responses affect actual human body temperature regulation. We investigated whether such visually invoked physiological responses can substantively affect human core body temperature in a thermally challenging cold environment. Participants comprised 13 graduate or undergraduate students viewing different video images containing hot, cold, or no scenery, while room temperature was gradually lowered from 28 to 16 A degrees C over 80 min. Rectal temperature, mean skin temperature, core to skin temperature gradient, and oxygen consumption were measured during the experiment. Rectal temperature was significantly lower when hot video images were presented compared to when control video images were presented. Oxygen consumption was comparable among all video images, but core to skin temperature gradient was significantly lower when hot video images were presented. This result suggests that visual information, even in the absence of thermal energy, can affect human thermodynamics and core body temperature.	[Takakura, Jun'ya; Choi, Damee; Egashira, Yuka] Kyushu Univ, Grad Sch Integrated Frontier Sci, Minami Ku, Fukuoka 812, Japan; [Nishimura, Takayuki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Publ Hlth, Nagasaki 852, Japan; [Watanuki, Shigeki] Kyushu Univ, Fac Design, Minami Ku, Fukuoka 812, Japan	Takakura, J (reprint author), Kyushu Univ, Grad Sch Integrated Frontier Sci, Minami Ku, 4-9-1 Shiobaru, Fukuoka 812, Japan.	fridge_lab@kyudai.jp		Choi, Damee/0000-0002-0283-3044	Japan Society for the Promotion of Science [24657175]	We would like to thank Ms. Satoko Kamiya for assisting the conduction of the experiment. This study was partly funded by the Japan Society for the Promotion of Science (grant no. 24657175).	Nakamura K, 2008, NAT NEUROSCI, V11, P62, DOI 10.1038/nn2027; BERRY PC, 1961, J APPL PSYCHOL, V45, P248, DOI 10.1037/h0040221; Grassi G, 2003, CIRCULATION, V108, P729, DOI 10.1161/01.CIR.0000081769.02847.A1; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; WAGNER JA, 1974, J APPL PHYSIOL, V37, P562; EKMAN P, 1983, SCIENCE, V221, P1208, DOI 10.1126/science.6612338; Huang HW, 2010, J CLIN NEUROSCI, V17, P722, DOI 10.1016/j.jocn.2009.10.003; WALTHER OE, 1970, PFLUG ARCH EUR J PHY, V319, P162, DOI 10.1007/BF00592494; Tattersall GJ, 2012, COMPR PHYSIOL, V2, P2151, DOI 10.1002/cphy.c110055; Imholz BPM, 1998, CARDIOVASC RES, V38, P605, DOI 10.1016/S0008-6363(98)00067-4; Lemaire JJ, 2011, BRAIN RES, V1371, P43, DOI 10.1016/j.brainres.2010.11.072; Hardy JD, 1938, J NUTR, V15, P461; Marshall SJ, 2006, J ADOLESCENCE, V29, P333, DOI 10.1016/j.adolescence.2005.08.016; Collet C, 1997, J AUTONOM NERV SYST, V62, P45, DOI 10.1016/S0165-1838(96)00108-7; Aoki H, 1998, NEUROSCI LETT, V252, P91, DOI 10.1016/S0304-3940(98)00548-5; Cajochen C, 2005, J CLIN ENDOCR METAB, V90, P1311, DOI 10.1210/jc.2004-0957; Kanosue K, 2010, EUR J APPL PHYSIOL, V109, P5, DOI 10.1007/s00421-009-1256-6; FANGER PO, 1977, ERGONOMICS, V20, P11, DOI 10.1080/00140137708931596; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; Dadds MR, 1997, PSYCHOL BULL, V122, P89; Boulant JA, 1998, ANN NY ACAD SCI, V856, P108, DOI 10.1111/j.1749-6632.1998.tb08319.x; BENNETT CA, 1972, HUM FACTORS, V14, P149; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Fairhall SL, 2013, J NEUROSCI, V33, P10552, DOI 10.1523/JNEUROSCI.0051-13.2013; Wakabayashi H, 2011, INT J BIOMETEOROL, V55, P509, DOI 10.1007/s00484-010-0374-5; Romanovsky AA, 2007, AM J PHYSIOL-REG I, V292, pR37, DOI 10.1152/ajpregu.00668.2006; Nishimura T, 2011, ANTHROPOL SCI, V119, P265, DOI 10.1537/ase.101009; Winzen J, 2014, LIGHTING RES TECHNOL, V46, P465, DOI 10.1177/1477153513484028; Candas Victor, 2005, Journal of Physiological Anthropology and Applied Human Science, V24, P33, DOI 10.2114/jpa.24.33; Fraden J, 2010, HANDBOOK OF MODERN SENSORS: PHYSICS, DESIGNS, AND APPLICATIONS, FOURTH EDITION, P1, DOI 10.1007/978-1-4419-6466-3; Kakitsuba N, 2013, J PHYSIOL ANTHROPOL, V32, DOI 10.1186/1880-6805-32-6; Kanaya S, 2012, PLOS ONE, V7; Lang P. J., 2008, A8 U FLOR; Nolen-Hoeksema S, 2009, ATKINSON HILGARDS IN, P236; Parsons KC, 2002, HUMAN THERMAL ENV EF; Sechrist S, 2014, INFORM DISPLAY, V31, P40; Takakura J, 2013, J PHYSIOL ANTHROPOL, V32, DOI 10.1186/1880-6805-32-26	37	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0020-7128	1432-1254		INT J BIOMETEOROL	Int. J. Biometeorol.	OCT	2015	59	10					1453	1460		10.1007/s00484-015-0956-3		8	Biophysics; Environmental Sciences; Meteorology & Atmospheric Sciences; Physiology	Biophysics; Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences; Physiology	CS0DP	WOS:000361728000010		
J	Miyamoto, M; Matsuzaki, K; Katakura, M; Hara, T; Tanabe, Y; Shido, O				Miyamoto, Mayumi; Matsuzaki, Kentaro; Katakura, Masanori; Hara, Toshiko; Tanabe, Yoko; Shido, Osamu			Oral intake of encapsulated dried ginger root powder hardly affects human thermoregulatory function, but appears to facilitate fat utilization	INTERNATIONAL JOURNAL OF BIOMETEOROLOGY			English	Article						Gingerol; Shogaol; Thermoregulation; Heat balance; Free fatty acid; Fat oxidation	FIXED DAILY TIME; PUNGENT CONSTITUENTS; RATS; ACTIVATION; NAUSEA; FEVER; PHARMACOKINETICS; DYSRHYTHMIAS; (6)-SHOGAOL; HYPOTHERMIA	The present study investigated the impact of a single oral ingestion of ginger on thermoregulatory function and fat oxidation in humans. Morning and afternoon oral intake of 1.0 g dried ginger root powder did not alter rectal temperature, skin blood flow, O-2 consumption, CO2 production, and thermal sensation and comfort, or induce sweating at an ambient temperature of 28 A degrees C. Ginger ingestion had no effect on threshold temperatures for skin blood flow or thermal sweating. Serum levels of free fatty acids were significantly elevated at 120 min after ginger ingestion in both the morning and afternoon. Morning ginger intake significantly reduced respiratory exchange ratios and elevated fat oxidation by 13.5 % at 120 min after ingestion. This was not the case in the afternoon. These results suggest that the effect of a single oral ginger administration on the peripheral and central thermoregulatory function is miniscule, but does facilitate fat utilization although the timing of the administration may be relevant.	[Miyamoto, Mayumi] Shimane Univ, Sch Nursing, Fundamental Nursing, Izumo, Shimane 6938501, Japan; [Miyamoto, Mayumi; Matsuzaki, Kentaro; Katakura, Masanori; Hara, Toshiko; Tanabe, Yoko; Shido, Osamu] Shimane Univ, Dept Environm Physiol, Sch Med, Izumo, Shimane 6938501, Japan; [Tanabe, Yoko] Shimane Univ, Dept Biosignaling & Radioisotope Expt, Ctr Integrated Res Sci, Izumo, Shimane 6938501, Japan	Miyamoto, M (reprint author), Shimane Univ, Dept Environm Physiol, Sch Med, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	mmiyamot@med.shimane-u.ac.jp			Ministry of Education, Culture, Sports, Sciences and Technology of Japan [20590231]	The study was partly supported by Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Sciences and Technology of Japan (20590231). The authors cordially thank Sunsho Pharmaceutical Co., Ltd. for manufacturing and providing ginger and placebo capsules used in this study.	GRIVEL F, 1991, ERGONOMICS, V34, P365, DOI 10.1080/00140139108967320; Shen J, 2005, NEUROSCI LETT, V380, P289, DOI 10.1016/j.neulet.2005.01.058; Chaiyakunapruk N, 2006, AM J OBSTET GYNECOL, V194, P95, DOI 10.1016/j.ajog.2005.06.046; OGAWA T, 1967, JPN J PHYSIOL, V17, P135; Gonlachanvit S, 2003, J PHARMACOL EXP THER, V307, P1098, DOI 10.1124/jpet.103.053421; Yu YK, 2011, AAPS J, V13, P417, DOI 10.1208/s12248-011-9286-5; Alizadeh-Navaei R, 2008, SAUDI MED J, V29, P1280; Kim SO, 2005, ONCOGENE, V24, P2558, DOI 10.1038/sj.onc.1208446; Zick SM, 2008, CANCER EPIDEM BIOMAR, V17, P1930, DOI 10.1158/1055-9965.EPI-07-2934; HIRATA K, 1986, EUR J APPL PHYSIOL O, V54, P559, DOI 10.1007/BF00943341; CABANAC M, 1987, EXPERIENTIA, V43, P19, DOI 10.1007/BF01940348; Hashimoto M, 1999, J NUTR, V129, P70; Brown AC, 2009, PHYTOTHER RES, V23, P640, DOI 10.1002/ptr.2677; OGAWA T, 1993, JPN J PHYSIOL, V43, P275, DOI 10.2170/jjphysiol.43.275; Shao X, 2010, J AGR FOOD CHEM, V58, P12608, DOI 10.1021/jf1029256; Ohta H, 2008, INT J BIOMETEOROL, V52, P331, DOI 10.1007/s00484-007-0125-4; Tao Y, 2009, J AGR FOOD CHEM, V57, P10014, DOI 10.1021/jf9020224; Romanovsky AA, 2004, AM J PHYSIOL-REG I, V287, pR992, DOI 10.1152/ajpregu.00068.2004; Chittumma Porndee, 2007, Journal of the Medical Association of Thailand, V90, P15; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628; Tsukita S, 2012, CELL METAB, V16, P825, DOI 10.1016/j.cmet.2012.11.006; SUEKAWA M, 1986, J PHARMACOBIO-DYNAM, V9, P853; Ueki S, 2008, EUR J PHARMACOL, V584, P87, DOI 10.1016/j.ejphar.2008.01.031; Shido O, 2001, PHYSIOL BEHAV, V72, P387, DOI 10.1016/S0031-9384(00)00428-5; Beattie JH, 2011, MOL NUTR FOOD RES, V55, pS203, DOI 10.1002/mnfr.201100193; Ernst E, 2000, BRIT J ANAESTH, V84, P367; Quinlan JD, 2003, AM FAM PHYSICIAN, V68, P121; Shido O, 2011, CURR PROTEIN PEPT SC, V12, P288; Shido O, 1999, AM J PHYSIOL-REG I, V276, pR1095; Liu CT, 2013, J AGR FOOD CHEM, V61, P11231, DOI 10.1021/jf403523g; Lien HC, 2003, AM J PHYSIOL-GASTR L, V284, pG481, DOI 10.1152/ajpgi.00164.2002; Someya A, 2003, J PHARMACOL SCI, V92, P359; Bode AM, 2001, CANCER RES, V61, P850; Iwasaki Y, 2006, NUTR NEUROSCI, V9, P169, DOI 10.1080/10284150600955164; Romanovsky AA, 1998, ANN NY ACAD SCI, V856, P298, DOI 10.1111/j.1749-6632.1998.tb08343.x; Roth J, 2001, BRAZ J MED BIOL RES, V34, P301; Prakash UNS, 2012, J SCI FOOD AGR, V92, P503, DOI 10.1002/jsfa.4597; Grzanna R, 2005, J MED FOOD, V8, P125, DOI 10.1089/jmf.2005.8.125; Pertz HH, 2011, PLANTA MED, V77, P973, DOI 10.1055/s-0030-1270747; Bailley SM, 2014, J ENDOCRINOL, pR75; CHATONNET J., 1965, INT J BIO METEROROL, V9, P183, DOI 10.1007/BF02188475; Hara T, 2007, SHIMANE J MED SCI, V24, P37; Izumida Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3316; Nagai K, 2014, AUTON NEUROSCI-BASIC, V185, P29, DOI 10.1016/j.autneu.2014.06.005; Nwozo Sarah Onyenibe, 2014, J Integr Med, V12, P59, DOI 10.1016/S2095-4964(14)60006-6; Ohta H., 2008, Japanese Journal of Biometeorology, V45, P73; Peek C. B., 2013, SCIENCE, V342, DOI DOI 10.1126/SCIENCE.1243417; Rabellato P, 2014, JOP, V15, P33; Romanovsky AA, 2005, FRONT BIOSCI-LANDMRK, V10, P2193, DOI 10.2741/1690; SUEKAWA M, 1984, J PHARMACOBIO-DYNAM, V7, P836; SUEKAWA M, 1986, J PHARMACOBIO-DYNAM, V9, P842; Tornio A, 2014, CLIN PHARMACOL THER, V96, P498, DOI 10.1038/clpt.2014.141; Walstab J, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12107	53	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0020-7128	1432-1254		INT J BIOMETEOROL	Int. J. Biometeorol.	OCT	2015	59	10					1461	1474		10.1007/s00484-015-0957-2		14	Biophysics; Environmental Sciences; Meteorology & Atmospheric Sciences; Physiology	Biophysics; Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences; Physiology	CS0DP	WOS:000361728000011		
J	Beppu, N; Kobayashi, M; Matsubara, N; Noda, M; Yamano, T; Doi, H; Kamikonya, N; Kakuno, A; Kimura, F; Yamanaka, N; Yanagi, H; Tomita, N				Beppu, Naohito; Kobayashi, Masayoshi; Matsubara, Nagahide; Noda, Masashi; Yamano, Tomoki; Doi, Hiroshi; Kamikonya, Norihiko; Kakuno, Ayako; Kimura, Fumihiko; Yamanaka, Naoki; Yanagi, Hidenori; Tomita, Naohiro			Comparison of the pathological response of the mesorectal positive nodes between short-course chemoradiotherapy with delayed surgery and long-course chemoradiotherapy in patients with rectal cancer	INTERNATIONAL JOURNAL OF COLORECTAL DISEASE			English	Article						Rectal cancer; Preoperative chemoradiotherapy; Pathological evaluation; Positive lymph node	PREOPERATIVE CHEMORADIOTHERAPY; NEOADJUVANT CHEMORADIATION; LOCAL RECURRENCE; METASTASIS; WAIT; MANAGEMENT; RESECTION; EXCISION; THERAPY; EXTENT	The aim of this study was to compare the pathological response of mesorectal positive nodes between short-course chemoradiotherapy with delayed surgery (SCRT-delay) and long-course chemoradiotherapy (LC-CRT) in patients with rectal cancer. The resected primary tumor specimens following the two different approaches were assessed utilizing the tumor regression grade (TRG 0-4), and each positive lymph node was assessed according to the lymph node regression grade (LRG 1-3), with TRG 4 and LRG 3 indicating total regression. The lymph node sizes were measured to elucidate any correlation with LRG scores. Seventy-four patients with ypN-positive rectal cancer had 220 positive lymph nodes following the SCRT-delay, and 48 patients had 141 positive lymph nodes following the LC-CRT. The distribution of LRG 1/2/3 in the two groups was 123/72/25 and 60/31/50 (p < 0.001), respectively, and the distribution of TRG 0/1/2/3/4 in the two groups was 36/19/19/0 and 12/15/20/1 (p = 0.005), respectively. The requirements of total regression of positive lymph nodes were a primary tumor degenerated to TRG 3 with a size less than 6 mm in SCRT-delay (sensitivity, 60.9 %) or a primary tumor degenerated to TRG 2-4 with a size less than 5 mm at TRG 2 (sensitivity, 57.6 %) or 6 mm at TRG 3 and 4 (sensitivity, 84.2 %) in LC-CRT as indicated by the receiver operating characteristic curve analysis. The tumor regression effect of LC-CRT on the primary tumor and positive nodes was more favorable than SCRT-delay, and LC-CRT is able to predict the LRG 3 response with a high sensitivity.	[Beppu, Naohito; Kobayashi, Masayoshi; Matsubara, Nagahide; Noda, Masashi; Yamano, Tomoki; Tomita, Naohiro] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo 6638501, Japan; [Doi, Hiroshi; Kamikonya, Norihiko] Hyogo Coll Med, Dept Radiol, Nishinomiya, Hyogo 6638501, Japan; [Kakuno, Ayako] Meiwa Hosp, Dept Pathol, Nishinomiya, Hyogo 6638186, Japan; [Kimura, Fumihiko; Yamanaka, Naoki; Yanagi, Hidenori] Meiwa Hosp, Dept Surg, Nishinomiya, Hyogo 6638186, Japan	Beppu, N (reprint author), Hyogo Coll Med, Dept Surg, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	n_beppu@yahoo.co.jp					Kim TH, 2008, ANN SURG ONCOL, V15, P729, DOI 10.1245/s10434-007-9696-x; [Anonymous], 2006, JAP SOC CANC COL REC; Brown G, 2003, RADIOLOGY, V227, P371, DOI 10.1148/radiol.2272011747; Ueno M, 2005, BRIT J SURG, V92, P756, DOI 10.1002/bjs.4975; Willett CG, 1999, INT J RADIAT ONCOL, V45, P1107, DOI 10.1016/S0360-3016(99)00329-6; Hughes R, 2006, INT J COLORECTAL DIS, V21, P11, DOI 10.1007/s00384-005-0749-y; Graf W, 1997, RADIOTHER ONCOL, V43, P133, DOI 10.1016/S0167-8140(96)01867-1; Habr-Gama A, 2013, DIS COLON RECTUM, V56, P1109, DOI 10.1097/DCR.0b013e3182a25c4e; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; Pucciarelli S, 2005, ANN SURG ONCOL, V12, P111, DOI 10.1245/ASO.2005.03.044; Akasu T, 2005, AM J ROENTGENOL, V184, P531; Bujko K, 2005, RADIOTHER ONCOL, V76, P234, DOI 10.1016/j.radonc.2005.04.004; Sato T, 2007, INT J RADIAT ONCOL, V69, P1442, DOI 10.1016/j.ijrobp.2007.05.081; Read TE, 2004, DIS COLON RECTUM, V47, P825, DOI 10.1007/s20350-004-0535-x; CAWTHORN SJ, 1990, LANCET, V335, P1055, DOI 10.1016/0140-6736(90)92631-Q; Sato T, 2011, INT J RADIAT ONCOL, V79, P677, DOI 10.1016/j.ijrobp.2009.11.007; Hughes R, 2010, ACTA ONCOL, V49, P378, DOI 10.3109/02841860903483692; Blomqvist L, 2008, ACTA ONCOL, V47, P5, DOI 10.1080/02841860701802585; Beddy D, 2008, ANN SURG ONCOL, V15, P3471, DOI 10.1245/s10434-008-0149-y; Beppu N, 2015, SURGERY; Beppu N, 2014, INT J COLORECTAL DIS, V29, P1459, DOI 10.1007/s00384-014-1997-5; Beppu N, 2015, DIS COLON RECTUM; Chau Ian, 2006, J Clin Oncol, V24, P668, DOI 10.1200/JCO.2005.04.4875; Dworak O, 1997, INT J COLORECTAL DIS, V12, P19, DOI 10.1007/s003840050072; Habr-Gama A, 2014, INT J RADIAT ONCOL, V88, P822, DOI 10.1016/j.ijrobp.2013.12.012; Hildebrandt U, 1995, Gastrointest Endosc Clin N Am, V5, P843	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-1958	1432-1262		INT J COLORECTAL DIS	Int. J. Colorectal Dis.	OCT	2015	30	10					1339	1347		10.1007/s00384-015-2321-8		9	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CR8XD	WOS:000361636700007		
J	Nagata, N; Sakamoto, K; Arai, T; Niikura, R; Shimbo, T; Shinozaki, M; Aoki, T; Sekine, K; Okubo, H; Watanabe, K; Sakurai, T; Yokoi, C; Yanase, M; Akiyama, J; Noda, M; Uemura, N				Nagata, Naoyoshi; Sakamoto, Kayo; Arai, Tomohiro; Niikura, Ryota; Shimbo, Takuro; Shinozaki, Masafumi; Aoki, Tomonori; Sekine, Katsunori; Okubo, Hidetaka; Watanabe, Kazuhiro; Sakurai, Toshiyuki; Yokoi, Chizu; Yanase, Mikio; Akiyama, Junichi; Noda, Mitsuhiko; Uemura, Naomi			Visceral fat accumulation affects risk of colonic diverticular hemorrhage	INTERNATIONAL JOURNAL OF COLORECTAL DISEASE			English	Article						Intra-abdominal visceral fat; Obesity; Metabolic syndrome; Lower gastrointestinal bleeding; Bleeding diverticula	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ADIPOSE-TISSUE; COLONOSCOPY; DISEASE; PATHOGENESIS; RECURRENCE	Factors other than antithrombotic drugs associated with diverticular bleeding remain unknown. Visceral adiposity contributes to atherosclerosis and may affect arteriolar change at the diverticulum. We investigated whether visceral adipose tissue (VAT) measured by computed tomography (CT) is a risk factor for diverticular bleeding. A cohort of 283 patients (184 with asymptomatic diverticulosis and 99 with diverticular bleeding) undergoing colonoscopy and CT was analyzed. Associations between body mass index (BMI), VAT, subcutaneous adipose tissue (SAT), and diverticular bleeding were assessed by logistic regression models adjusted for age, gender, alcohol, smoking, diabetes mellitus, hypertension, dyslipidemia, chronic kidney disease, and antithrombotic drugs (nonsteroidal anti-inflammatory drugs (NSAIDs), low-dose aspirin, and other antiplatelet drugs). In univariate analysis, hypertension, dyslipidemia, chronic kidney disease, and NSAIDs use, low-dose aspirin, non-aspirin antiplatelets, increasing BMI, and increasing VAT area were associated with diverticular bleeding. In multivariate analysis adjusted for confounding factors, VAT area (p = 0.021), but not BMI (p = 0.551) or SAT area (p = 0.635), was positively associated with diverticular bleeding. When BMI was considered simultaneously, VAT area remained positively associated with diverticular bleeding (p = 0.018). However, none of obesity indices including VAT area were associated with recurrence of diverticular bleeding or prolonged hospitalization. This study presents new information on risk factors for diverticular bleeding. A large volume of visceral adipose tissue, but not BMI or SAT, appears to entail a risk for diverticular bleeding, after age, gender, metabolic factors, and antithrombotic drugs use adjustments.	[Nagata, Naoyoshi; Niikura, Ryota; Aoki, Tomonori; Sekine, Katsunori; Okubo, Hidetaka; Watanabe, Kazuhiro; Sakurai, Toshiyuki; Yokoi, Chizu; Yanase, Mikio; Akiyama, Junichi] Natl Ctr Global Hlth & Med, Dept Gastroenterol, Shinjuku Ku, Tokyo 1628655, Japan; [Nagata, Naoyoshi; Niikura, Ryota; Aoki, Tomonori; Sekine, Katsunori; Okubo, Hidetaka; Watanabe, Kazuhiro; Sakurai, Toshiyuki; Yokoi, Chizu; Yanase, Mikio; Akiyama, Junichi] Natl Ctr Global Hlth & Med, Dept Hepatol, Shinjuku Ku, Tokyo 1628655, Japan; [Sakamoto, Kayo; Arai, Tomohiro; Shinozaki, Masafumi] Natl Ctr Global Hlth & Med, Diagnost Radiol, Tokyo, Japan; [Shimbo, Takuro] Ohta Nishinouchi Hosp, Dept Internal Med, Fukushima, Japan; [Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Diabet Res Ctr, Tokyo, Japan; [Uemura, Naomi] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Chiba, Japan	Nagata, N (reprint author), Natl Ctr Global Hlth & Med, Dept Gastroenterol, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	nnagata_ncgm@yahoo.co.jp			Ministry of Health Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan [271000]	This study was supported in part by a Grant-in-Aid from the Ministry of Health Labor and Welfare of Japan and a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (271000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Niikura R, 2012, COLORECTAL DIS, V14, P302, DOI 10.1111/j.1463-1318.2011.02611.x; Zuckerman GR, 1999, GASTROINTEST ENDOSC, V49, P228, DOI 10.1016/S0016-5107(99)70491-8; Niikura R, 2013, WORLD J GASTROENTERO, V19, P2362, DOI 10.3748/wjg.v19.i15.2362; Jansen A, 2009, WORLD J GASTROENTERO, V15, P457, DOI 10.3748/wjg.15.457; Suzuki K, 2012, DIGESTION, V85, P261, DOI 10.1159/000336351; Fantuzzi G, 2007, ARTERIOSCL THROM VAS, V27, P996, DOI 10.1161/ATVBAHA.106.131755; Okamoto T, 2012, INT J COLORECTAL DIS, V27, P1161, DOI 10.1007/s00384-012-1491-x; Strate LL, 2011, GASTROENTEROLOGY, V140, P1427, DOI 10.1053/j.gastro.2011.02.004; Nishikawa H, 2013, ACTA GASTRO-ENT BELG, V76, P20; Strate LL, 2009, GASTROENTEROLOGY, V136, P115, DOI 10.1053/j.gastro.2008.09.025; Lee RJ, 2000, CIRCULATION, V102, P898; Strate LL, 2012, DIGEST DIS, V30, P35, DOI 10.1159/000335707; Goodpaster BH, 2002, CURR OPIN CLIN NUTR, V5, P481, DOI 10.1097/00075197-200209000-00005; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; Niikura R, 2012, INT J COLORECTAL DIS, V27, P1137, DOI 10.1007/s00384-012-1422-x; Longstreth GF, 1997, AM J GASTROENTEROL, V92, P419; Lee HY, 2013, ATHEROSCLEROSIS, V230, P177, DOI 10.1016/j.atherosclerosis.2013.07.037; Yamada A, 2008, DIS COLON RECTUM, V51, P116, DOI 10.1007/s10350-007-9137-8; CAMPBELL K, 1991, BRIT J SURG, V78, P190, DOI 10.1002/bjs.1800780218; MEYERS MA, 1976, GASTROENTEROLOGY, V71, P577; Matsushita Y, 2008, INT J OBESITY, V32, P1861, DOI 10.1038/ijo.2008.188; Tsuruoka N, 2011, J GASTROEN HEPATOL, V26, P1047, DOI 10.1111/j.1440-1746.2010.06610.x; Jensen DM, 2000, NEW ENGL J MED, V342, P78, DOI 10.1056/NEJM200001133420202; THAETE FL, 1995, INT J OBESITY, V19, P464; FOUTCH PG, 1995, AM J GASTROENTEROL, V90, P1779; MCGUIRE HH, 1994, ANN SURG, V220, P653, DOI 10.1097/00000658-199411000-00008; Miyazawa-Hoshimoto S, 2003, DIABETOLOGIA, V46, P1483, DOI 10.1007/s00125-003-1221-6; Nagata N, 2013, INT J COLORECTAL DIS; Nagata N, 2015, WORLD J GASTROENTERO, V21, P1292, DOI 10.3748/wjg.v21.i4.1292; Nagata N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081137; Nagata N, 2014, J CLIN GASTROENTEROL; Nagata N, 2014, INT J CANC; Nagata N, 2014, J GASTROENTEROL HEPA; Nagata N, 2014, GASTROINTEST ENDOSC	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-1958	1432-1262		INT J COLORECTAL DIS	Int. J. Colorectal Dis.	OCT	2015	30	10					1399	1406		10.1007/s00384-015-2295-6		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CR8XD	WOS:000361636700014		
J	Kimoto, S; Khan, BS; Mirjalili, M; Oka, F				Kimoto, Sayuri; Khan, Babak Shahbodagh; Mirjalili, Mojtaba; Oka, Fusao			Cyclic Elastoviscoplastic Constitutive Model for Clay Considering Nonlinear Kinematic Hardening Rules and Structural Degradation	INTERNATIONAL JOURNAL OF GEOMECHANICS			English	Article						Cyclic constitutive model; Clayey soils; Viscoplasticity; Nonlinear kinematical hardening rule	SHEAR MODULUS; EQUATIONS	A cyclic elastoviscoplastic constitutive model for clayey soils is proposed based on the nonlinear kinematic hardening rules and considering the structural degradation. The performance of the model is verified through the undrained triaxial test simulation of soft clay samples under cyclic and monotonic loading conditions and the cyclic compression test. The simulated results are compared with the experimental data through stress-strain relations and stress paths. The simulated results have shown a good agreement with the experimental data, which indicates the capability of the proposedmodel to reproduce the cyclic behavior of soft clayey soils. (C) 2014 American Society of Civil Engineers.	[Kimoto, Sayuri; Khan, Babak Shahbodagh; Mirjalili, Mojtaba; Oka, Fusao] Kyoto Univ, Dept Civil & Earth Resources Engn, Nishikyo Ku, Kyoto 6158540, Japan; [Khan, Babak Shahbodagh] Univ New S Wales, Sch Civil & Environm Engn, Sydney, NSW 2052, Australia; [Mirjalili, Mojtaba] ABRAND Civil Design Inc, Tehran 1651894675, Iran	Oka, F (reprint author), Kyoto Univ, Dept Civil & Earth Resources Engn, Nishikyo Ku, Kyoto 6158540, Japan.	kimoto.sayuri.6u@kyoto-u.ac.jp; babak.shahbodaghkhan@fs4.ecs.kyoto-u.ac.jp; mojtaba.mirjalili@gmail.com; oka.fusao.38x@st.kyoto-u.ac.jp					Abe N., 1985, P 5 INT C NUM METH G, V1, P407; Adachi T., 1982, SOILS FOUND, V22, P57; Adachi T., 1995, SOILS FOUND, V35, P1; Oka F, 1999, GEOTECHNIQUE, V49, P661; Kimoto S, 2005, SOILS FOUND, V45, P29; KATONA MG, 1984, J GEOTECH ENG-ASCE, V110, P1106; FAHEY M, 1992, CAN GEOTECH J, V29, P157, DOI 10.1139/t92-017; Oka F, 2004, INT J NUMER ANAL MET, V28, P131, DOI 10.1002/nag.329; Modaressi H, 1997, INT J NUMER ANAL MET, V21, P313, DOI 10.1002/(SICI)1096-9853(199705)21:5<313::AID-NAG872>3.3.CO;2-X; NAGHDI PM, 1975, Q J MECH APPL MATH, V28, P25, DOI 10.1093/qjmam/28.1.25; OKA F, 1992, NUMERICAL MODELS IN GEOMECHANICS, VOL 1 AND 2, P105; Armstrong PJ, 1966, 731 RDBN CEGB; Cambou B., 2009, GEOMECH GEOENG INT J, V4, P209; CHABOCHE JL, 1983, J PRESS VESS-T ASME, V105, P153; Dafalias Y., 1982, P IUTAM S DEF FAIL G, P97; Hardin B. O., 1972, J SOIL MECHANICS F D, V98, P667; Kaliakin V, 1990, SOILS FOUND, V30, P11; Mirjalili M., 2010, THESIS KYOTO U KYOTO; Perzyna P., 1963, P VIBRATION PROBLEMS, V4, P281; Shahbodagh Khan B., 2011, THESIS KYOTO U KYOTO; Sugiyama H., 1989, THESIS GIFU U GIFU	21	1	1	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	1532-3641	1943-5622		INT J GEOMECH	Int. J. Geomech.	OCT	2015	15	5							A4014005	10.1061/(ASCE)GM.1943-5622.0000327		14	Engineering, Geological	Engineering	CR7TX	WOS:000361555300008		
J	Watabe, Y; Leroueil, S				Watabe, Yoichi; Leroueil, Serge			Modeling and Implementation of the Isotache Concept for Long-Term Consolidation Behavior	INTERNATIONAL JOURNAL OF GEOMECHANICS			English	Article						Long-term consolidation; Secondary consolidation; Viscosity; Isotache; Strain rate	SENSITIVE NATURAL CLAYS; STRAIN RATE RELATION; OSAKA BAY; COMPRESSIBILITY; SOILS	A practical use of the isotache concept in creep settlement prediction is newly introduced in this study. The isotache concept introduces a unique relationship between the strain and the consolidation pressure corresponding to the strain rate in association with viscosity. The authors have proposed a method to simply introduce the isotache concept, which uses a compression curve normalized by preconsolidation pressure [epsilon-log(sigma'/sigma(p)')] and a strain rate dependency relationship between the preconsolidation pressure (sigma(p)') and strain rate ((epsilon) over dot = d epsilon/dt). The strain rate dependency relationship is modeled as an equation based on power law. According to the authors' method, the slope of the strain rate dependency relationship (log sigma(p)'-log epsilon(over dot)), which coincides with C-alpha e/C-c, can be calculated as a function of strain rate, showing that C-alpha e/C-c is not constant but decreases with decreasing strain rate. In engineering practice, consolidation settlement is generally estimated based on the compression curve obtained from the 24-h incremental loading oedometer test, which corresponds to a strain rate of about 1x10(-7) s(-1). Using the compression index C-c at the consolidation pressure and initial void ratio e(0), creep settlement can be easily calculated as a function of C-c = (1+e(0)) and in situ strain rate (several orders of magnitude smaller than 1x10(-7) s(-1)). This work is made available under the terms of the Creative Commons Attribution 4.0 International license, http://creativecommons.org/licenses/by/4.0/.	[Watabe, Yoichi] Port & Airport Res Inst, Soil Mech & Geoenvironm Grp, Yokosuka, Kanagawa 2390826, Japan; [Leroueil, Serge] Univ Laval, Dept Civil Engn, Quebec City, PQ G1V 0A6, Canada	Watabe, Y (reprint author), Port & Airport Res Inst, Soil Mech & Geoenvironm Grp, 3-1-1 Nagase, Yokosuka, Kanagawa 2390826, Japan.	watabe@ipc.pari.go.jp					Adachi T., 1996, GEOTECHNICAL SPECIAL, V61, P61; LEROUEIL S, 1985, GEOTECHNIQUE, V35, P159; BJERRUM L, 1967, GEOTECHNIQUE, V17, P83; Watabe Y, 2008, SOILS FOUND, V48, P495, DOI 10.3208/sandf.48.495; Tanaka H, 2006, SOILS FOUND, V46, P315, DOI 10.3208/sandf.46.315; KABBAJ M, 1988, GEOTECHNIQUE, V38, P83; Kim YT, 2001, CAN GEOTECH J, V38, P484; Cao LF, 2001, CAN GEOTECH J, V38, P755, DOI 10.1139/cgj-38-4-755; LAROCHELLE P, 1981, CAN GEOTECH J, V18, P52; YIN JH, 1994, CAN GEOTECH J, V31, P773, DOI 10.1139/t94-088; Qu G, 2010, GEOTECHNIQUE, V60, P777, DOI 10.1680/geot.8.P.031; Watabe Y, 2012, SOILS FOUND, V52, P449, DOI 10.1016/j.sandf.2012.05.005; Degago SA, 2011, GEOTECHNIQUE, V61, P897, DOI 10.1680/geot.9.P.112; Diaz-Rodriguez J. A., 2003, CHARACT ENG PROPERTI, V1, P725; Hawlader B. C., 2003, INT J GEOMECH, V1, P99, DOI [10.1061/(ASCE)1532-3641(2003)3, DOI 10.1061/(ASCE)1532-3641(2003)3:1(99)]; Imai G., 2005, P S GEOT ASP KANS IN, P49; Jamiolkowski M., 1985, P 11 INT C SOIL MECH, V1, P57; Kabbaj M., 1987, J GEOTECH ENG, V111, P1067, DOI [10.1061/(ASCE)0733-9410(1987)113:9(1067), DOI 10.1061/(ASCE)0733-9410]; Ladd C. C., 1977, P 9 INT C SOIL MECH, V2, P421; Leroueil S., 2006, P 13 DAN EUR C GEOT, P55; Leroueil S., 1988, SOILS FOUND, V28, P13, DOI DOI 10.3208/SANDF1972.28.3_13; MESRI G, 1986, GEOTECHNIQUE, V36, P283; MESRI G, 1987, J GEOTECH ENG-ASCE, V113, P230; Mesri G., 1995, P INT S COMPR CONS C, V2, P1021; Mesri G., 1985, P 11 INT C SOIL MECH, V2, P587; Norton F. H., 1929, CREEP STEEL HIGH TEM; Perzyna P., 1963, Quarterly of Applied Mathematics, V20; Suklje L., 1957, P 4 INT C SOIL MECH, V1, P200; Watabe Y, 2002, J GEOTECH GEOENVIRON, V128, P216, DOI 10.1061/(ASCE)1090-0241(2002)128:3(216)	29	2	2	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	1532-3641	1943-5622		INT J GEOMECH	Int. J. Geomech.	OCT	2015	15	5							A4014006	10.1061/(ASCE)GM.1943-5622.0000270		8	Engineering, Geological	Engineering	CR7TX	WOS:000361555300003		
J	Murase, R; Tanaka, H; Hamakawa, T; Goda, H; Tano, T; Ishikawa, A; Hino, S; Sumida, T; Nakashiro, K; Hamakawa, H				Murase, R.; Tanaka, H.; Hamakawa, T.; Goda, H.; Tano, T.; Ishikawa, A.; Hino, S.; Sumida, T.; Nakashiro, K.; Hamakawa, H.			Double sentinel lymph node mapping with indocyanine green and 99m-technetium-tin colloid in oral squamous cell carcinoma	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						sentinel lymph node biopsy; oral squamous cell carcinoma; indocyanine green	NECK-CANCER PATIENTS; BREAST-CANCER; PATENT BLUE; BIOPSY; HEAD; SURGERY; MELANOMA; EXPERIENCE; CAVITY	Oral squamous cell carcinoma (OSCC) frequently metastasizes to cervical lymph nodes, which is the most known prognostic factor. Screening methods to identify sentinel lymph nodes (SLNs) are therefore of great interest for the management of potential neck metastasis. The purpose of this study was to evaluate the clinical benefit of double SLN mapping with indocyanine green (ICG) and 99m-technetium-tin colloid (Tc-99m-tin colloid) for sentinel node navigation surgery (SNNS). Between 2007 and 2010, 16 patients diagnosed with OSCC were investigated by SLN biopsy using the double mapping method. Tc-99m-tin colloid was injected into the peri-tumoural region on the preoperative day, and ICG was administered intraoperatively in the same position to assist in detecting nodes during surgery. Based on the gamma-ray signal and near-infrared (NIR) fluorescence of ICG, SLNs were identified and thereafter assessed pathologically and genetically for cancer involvement. Radio-guided detection was successful for all patients. ICU mapping identified a relatively larger number of nodes, suggesting that several non-SLNs were potentially involved. The double mapping method assisted surgeons to explore SLNs. Since the ICG fluorescence was shielded by the subcutaneous fatty tissue and the muscle layer including platysma and sternocleidomastoid, it was necessary to retract the tissue away from nodes.	[Murase, R.; Tanaka, H.; Hamakawa, T.; Goda, H.; Ishikawa, A.; Hino, S.; Nakashiro, K.; Hamakawa, H.] Ehime Grad Univ, Sch Med, Dept Oral & Maxillofacial Surg, Toon, Ehime, Japan; [Tano, T.] Chugoku Cent Hosp, Dept Oral Surg, Hiroshima, Japan; [Sumida, T.] Kyushu Grad Univ, Sch Med, Dept Oral & Maxillofacial Surg, Fukuoka, Japan	Murase, R (reprint author), Ehime Grad Univ, Sch Med, Dept Oral & Maxillofacial Surg, Shitsukawa, Toon 7910204, Japan.	quichi@nz.ehime-u.ac.jp					Polom K, 2011, CANCER-AM CANCER SOC, V117, P4812, DOI 10.1002/cncr.26087; Broglie MA, 2011, Q J NUCL MED MOL IM, V55, P509; Hamakawa H, 2004, INT J ORAL MAX SURG, V33, P670, DOI 10.1016/j.ijom.2004.01.009; van der Vorst JR, 2013, ORAL ONCOL, V49, P15, DOI 10.1016/j.oraloncology.2012.07.017; Tanis PJ, 2008, HEAD NECK-J SCI SPEC, V30, P380, DOI 10.1002/hed.20749; Hutteman M, 2011, BREAST CANCER RES TR, V127, P163, DOI 10.1007/s10549-011-1419-0; van der Vorst JR, 2012, ANN SURG ONCOL, V19, P4104, DOI 10.1245/s10434-012-2466-4; Chao C, 2003, ANN SURG ONCOL, V10, P21, DOI 10.1245/ASO.2003.06.007; van der Poel HG, 2011, EUR UROL, V60, P826, DOI 10.1016/j.eururo.2011.03.024; Kuriakose MA, 2009, CURR OPIN OTOLARYNGO, V17, P100, DOI 10.1097/MOO.0b013e3283293631; Heuveling DA, 2012, EUR J NUCL MED MOL I, V39, P1161, DOI 10.1007/s00259-012-2080-5; Schaafsma BE, 2011, J SURG ONCOL, V104, P323, DOI 10.1002/jso.21943; Melkane AE, 2012, LARYNGOSCOPE, V122, P1782, DOI 10.1002/lary.23383; Atula T, 2008, EUR ARCH OTO-RHINO-L, V265, pS19, DOI 10.1007/s00405-007-0548-x; Brouwer OR, 2012, ANN SURG ONCOL, V19, P1988, DOI 10.1245/s10434-011-2180-7; van den Berg NS, 2012, EUR J NUCL MED MOL I, V39, P1128, DOI 10.1007/s00259-012-2129-5; Tralhao JG, 2012, HEPATO-GASTROENTEROL, V59, P1179, DOI 10.5754/hge09726; Vahrmeijer AL, 2011, BRIT J SURG, V98, P749, DOI 10.1002/bjs.7538; Coughlin A, 2010, CURR ONCOL REP, V12, P129, DOI 10.1007/s11912-010-0090-7; Eicher SA, 2002, ARCH OTOLARYNGOL, V128, P241; Nieweg OE, 2001, ANN SURG ONCOL, V8, P538, DOI 10.1245/aso.2001.8.6.538; Olmos RAV, 2014, Q J NUCL MED MOL IM, V58, P127; Omagari K, 2006, HEPATOL RES, V34, P266, DOI 10.1016/j,hepres.2005.05.010; Bredell MG, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-31; Daisne JF, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-121; Lee ES, 2015, KOREAN J RADIOL, V16, P21, DOI 10.3348/kjr.2015.16.1.21; Shima H, 2014, EXP THER MED, V8, P1447, DOI 10.3892/etm.2014.1968; Tausch C, 2014, ONCOTARGETS THER, V7, P1151, DOI 10.2147/OTT.S50394; Tong M, 2014, J BREAST CANCER, V17, P250, DOI 10.4048/jbc.2014.17.3.250	29	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	OCT	2015	44	10					1212	1217		10.1016/j.ijom.2015.05.008		6	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CR8DP	WOS:000361581600002		
J	Makiguchi, T; Yokoo, S; Ogawa, M; Miyazaki, H				Makiguchi, T.; Yokoo, S.; Ogawa, M.; Miyazaki, H.			Factors influencing internal jugular vein patency after neck dissection in oral cancer	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						neck dissection; reconstruction; internal jugular vein; thrombosis; stenosis and obstruction	FREE-TISSUE TRANSFER; VENOUS THROMBOSIS; RECONSTRUCTION; HEAD	The objective was to investigate factors influencing internal jugular vein stenosis or occlusion after neck dissection, including the reconstructive procedure. The subjects were 73 patients (81 veins) who underwent a modified radical neck dissection, in which the internal jugular vein was preserved, or an extended supraomohyoid neck dissection (E-SOHND). All procedures were performed by the same surgeon. Internal jugular vein patency was evaluated by contrast-enhanced computed tomography. Patency was evaluated in relation to gender, side of dissection, number of pathological lymph node metastases, extracapsular spread of lymph node metastases, radiotherapy, and the reconstruction method (no reconstruction, free flap, or pedicle flap). All internal jugular vein occlusions were on the left side and all except one of these patients underwent radiotherapy. Thus, radiotherapy and left side dissection were significant risk factors for occlusion. Free flap reconstruction was not a risk factor for vein stenosis or occlusion. Patients undergoing reconstruction with pedicled musculocutaneous flaps or E-SOHND were less likely to have vein occlusion. Particular care is required for left neck dissection in patients who have undergone radical neck dissection on the right side. This study suggests that covering the internal jugular vein with the muscle might prevent vein occlusion.	[Makiguchi, T.; Yokoo, S.; Ogawa, M.; Miyazaki, H.] Gunma Univ, Grad Sch Med, Dept Stomatol & Maxillofacial Surg, Maebashi, Gunma 3718511, Japan	Makiguchi, T (reprint author), Gunma Univ, Grad Sch Med, Dept Stomatol & Maxillofacial Surg, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	takayainakiguchi@gmail.com					AHMED N, 1976, MED J AUSTRALIA, V1, P217; MCQUARRIE DG, 1977, AM J SURG, V134, P455, DOI 10.1016/0002-9610(77)90377-4; Fukuiwa T, 2008, AURIS NASUS LARYNX, V35, P390, DOI 10.1016/j.anl.2007.10.005; FISHER CB, 1988, LARYNGOSCOPE, V98, P923; BALLANTYNE AJ, 1982, AM J SURG, V144, P452, DOI 10.1016/0002-9610(82)90421-4; MARKS SC, 1990, HEAD NECK-J SCI SPEC, V12, P342, DOI 10.1002/hed.2880120412; Harada H, 2003, AURIS NASUS LARYNX, V30, P269, DOI 10.1016/S0385-8146(03)00053-1; AHN C, 1989, J SURG ONCOL, V40, P252, DOI 10.1002/jso.2930400410; Kubo T, 2002, ANN PLAS SURG, V49, P490, DOI 10.1097/01.SAP.0000020055.91079.64; ZOHAR Y, 1995, ANN OTO RHINOL LARYN, V104, P532; Nagata T, 2006, INT J ORAL MAX SURG, V35, P416, DOI 10.1016/j.ijom.2005.09.004; COTTER CS, 1994, LARYNGOSCOPE, V104, P841; Miyasaka M, 2005, MICROSURG, V25, P191, DOI 10.1002/micr.20104; Brown DH, 1998, HEAD NECK-J SCI SPEC, V20, P169, DOI 10.1002/(SICI)1097-0347(199803)20:2<169::AID-HED11>3.0.CO;2-H; DOCHERTY JG, 1993, HEAD NECK-J SCI SPEC, V15, P553, DOI 10.1002/hed.2880150613; LEONTSINIS TG, 1995, LARYNGOSCOPE, V105, P169, DOI 10.1288/00005537-199502000-00011; Shigeta T, 2010, JPN J ORAL MAXILLOFA, V56, P422; Yucel EA, 2003, EUR ARCH OTO-RHINO-L, V260, P35, DOI 10.1007/s00405-002-0517-3	18	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	OCT	2015	44	10					1218	1224		10.1016/j.ijom.2015.06.009		7	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CR8DP	WOS:000361581600003		
J	Funahara, M; Hayashida, S; Sakamoto, Y; Yanamoto, S; Kosai, K; Yanagihara, K; Umeda, M				Funahara, M.; Hayashida, S.; Sakamoto, Y.; Yanamoto, S.; Kosai, K.; Yanagihara, K.; Umeda, M.			Efficacy of topical antibiotic administration on the inhibition of perioperative oral bacterial growth in oral cancer patients: a preliminary study	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						surgical site infection; topical administration of antibiotics; oral cancer surgery; oral care; oral bacteria	SURGICAL-SITE INFECTIONS; NECK-SURGERY; RISK-FACTORS; CONTAMINATED HEAD; WOUND-INFECTION; IMPEDANCE MEASUREMENT; PROPHYLAXIS	Parenteral antibiotic prophylaxis is the current standard of therapy in clean-contaminated oral cancer surgery. Nevertheless, the incidence of surgical site infection (SSI) in oral oncological surgery is relatively high, especially in major surgery with reconstruction and tracheotomy. The aims of this study were to investigate the perioperative condition related to microorganisms in the oral cavity and to examine the efficacy of the topical administration of tetracycline in reducing the number of bacteria in the oropharyngeal fluid during intubation. The number of oral bacteria was measured during intubation in patients undergoing major oral cancer surgery. The efficacy of the topical administration of tetracycline or povidone iodine gel in reducing the bacteria was then investigated. Bacteria in the oropharyngeal fluid grew from 10(6) CFU/ml to 10(8) CFU/ml during the 3 h after intubation (CFU, colony-forming units). When tetracycline was applied to the dorsum of the tongue, oral bacteria decreased immediately to 105 CFU/ml, and the number of bacteria in the oropharyngeal fluid was maintained below 107 CFU/ml for 7 h. The concentration of tetracycline in the oropharyngeal fluid was extremely high for several hours after topical administration. The topical administration of tetracycline could reduce oral bacteria in patients undergoing clean-contaminated oral cancer surgery. This method is expected to be effective in the prevention of SSI.	[Funahara, M.; Hayashida, S.; Sakamoto, Y.; Yanamoto, S.; Umeda, M.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Oral Oncol, Nagasaki 8528588, Japan; [Kosai, K.; Yanagihara, K.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Lab Med, Nagasaki 8528588, Japan	Funahara, M (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Oral Oncol, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.	bb55312902@cc.nagasaki-u.ac.jp					Lotfi CJ, 2008, OTOLARYNG HEAD NECK, V138, P74, DOI 10.1016/j.otohns.2007.09.018; JOHNSON JT, 1984, LARYNGOSCOPE, V94, P46; Lee DH, 2011, ORAL ONCOL, V47, P528, DOI 10.1016/j.oraloncology.2011.04.002; TABET JC, 1990, J OTOLARYNGOL, V19, P197; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; Simons JP, 2001, LARYNGOSCOPE, V111, P329, DOI 10.1097/00005537-200102000-00026; TESTA RT, 1993, ANTIMICROB AGENTS CH, V37, P2270; Karakida K, 2010, J INFECT CHEMOTHER, V16, P334, DOI 10.1007/s10156-010-0108-y; ELLEDGE ES, 1991, OTOLARYNG HEAD NECK, V105, P836; Cunha TFS, 2012, J CRANIO MAXILL SURG, V40, P443, DOI 10.1016/j.jcms.2011.07.019; GRANDIS JR, 1994, LARYNGOSCOPE, V104, P719; JOHNSON JT, 1984, ARCH OTOLARYNGOL, V110, P224; Penel N, 2005, ORAL ONCOL, V41, P294, DOI 10.1016/j.oraloncology.2004.08.011; Coskun H, 2000, OTOLARYNG HEAD NECK, V123, P328, DOI 10.1067/mhn.2000.105253; Ogihara H, 2009, AURIS NASUS LARYNX, V36, P457, DOI 10.1016/j.anl.2008.10.005; Li J, 2013, J HOSP INFECT, V84, P283, DOI 10.1016/j.jhin.2013.04.012; KIRCHNER JC, 1988, LARYNGOSCOPE, V98, P26; Suehiro J, 1999, J PHYS D APPL PHYS, V32, P2814, DOI 10.1088/0022-3727/32/21/316; Cloke DJ, 2004, BRIT J PLAST SURG, V57, P556, DOI 10.1016/j.bjps.2004.04.006; Hirota K, 2014, BIOCONTROL SCI, V19, P45	20	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	OCT	2015	44	10					1225	1230		10.1016/j.ijom.2015.06.002		6	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CR8DP	WOS:000361581600004		
J	Pham, HV; Ishizaki, A; Nguyen, LV; Phan, CTT; Phung, TTB; Takemoto, K; Pham, AN; Bi, X; Khu, DTK; Ichimura, H				Pham, H. V.; Ishizaki, A.; Nguyen, L. V.; Phan, C. T. T.; Phung, T. T. B.; Takemoto, K.; Pham, A. N.; Bi, X.; Khu, D. T. K.; Ichimura, H.			Two-year outcome of first-line antiretroviral therapy among HIV-1 vertically-infected children in Hanoi, Vietnam	INTERNATIONAL JOURNAL OF STD & AIDS			English	Article						Asia; ART (antiretroviral therapy); AIDS; HIV (human immunodeficiency virus); children; treatment; virological failure	RESOURCE-LIMITED SETTINGS; DRUG-RESISTANCE MUTATIONS; CD4 CELL COUNT; GENOTYPIC RESISTANCE; VIROLOGICAL FAILURE; VIRAL LOAD; TYPE-1; NEVIRAPINE; SUBTYPE; KENYA	A retrospective analysis of 86 HIV-1 vertically-infected Vietnamese children with a follow-up period > 24 months after initiating antiretroviral therapy (ART) was performed from 2008 to 2012, to assess the outcome of first-line ART in resource-limited settings. Of the 86 children, 68 (79.1%) were treated successfully (plasma HIV-1 viral load [VL] < 1000 copies/ml), and 63 (73.3%) had full viral suppression (VL < 400 copies/ml) after 24 months of ART. No significant difference between successfully treated patients and failure groups was observed in VL, CD4(+) T-cell count or clinical stage at baseline; age at ART start; or ART regimen. All 14 children with VL > 5000 copies/ml, one of four children with VL 1000-5000 copies/ml and none with VL < 1000 copies/ml developed reverse transcriptase inhibitor (RTI)-resistance mutations by 24 months of ART. Y181C and M184V/I were the most dominant non-nucleoside and nucleoside RTI-resistance mutations, respectively (13/15, 86.7%). These findings suggest that VL testing after 24 months of ART can be used to efficiently differentiate ART failures among HIV-1 vertically-infected children in resource-limited settings.	[Pham, H. V.; Ishizaki, A.; Phan, C. T. T.; Bi, X.; Ichimura, H.] Kanazawa Univ, Grad Sch Med Sci, Dept Viral Infect & Int Hlth, Kanazawa, Ishikawa 9208640, Japan; [Pham, H. V.; Nguyen, L. V.; Phan, C. T. T.; Phung, T. T. B.; Pham, A. N.; Khu, D. T. K.] Natl Hosp Pediat, Hanoi, Vietnam; [Takemoto, K.] Kanazawa Univ Hosp, Dept Clin Lab, Kanazawa, Ishikawa, Japan; [Ichimura, H.] Kanazawa Univ, Kanazawa Univ Innovat Prevent Med Joint Educ & Re, Kanazawa, Ishikawa 9208640, Japan	Ichimura, H (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Viral Infect & Int Hlth, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	ichimura@med.kanazawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan (Program of Founding Research Centers for Emerging and Reemerging Infectious Disease); National Center for Global Health and Medicine in Japan [22-S-2]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan (the Program of Founding Research Centers for Emerging and Reemerging Infectious Disease) and the Grant of National Center for Global Health and Medicine (22-S-2) in Japan.	Brady MT, 2010, JAIDS-J ACQ IMM DEF, V53, P86, DOI 10.1097/QAI.0b013e3181b9869f; Jittamala P, 2009, PEDIATR INFECT DIS J, V28, P826, DOI 10.1097/INF.0b013e3181a458f9; Hansudewechakul R, 2010, JAIDS-J ACQ IMM DEF, V55, P503, DOI 10.1097/QAI.0b013e3181f5379a; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Gupta RK, 2010, PEDIATR INFECT DIS J, V29, pE57, DOI 10.1097/INF.0b013e3181e47609; Collins IJ, 2010, CLIN INFECT DIS, V51, P1449, DOI 10.1086/657401; Lwembe R, 2007, J MED VIROL, V79, P865, DOI 10.1002/jmv.20912; Judd A, 2011, AIDS, V25, P2279, DOI 10.1097/QAD.0b013e32834d614c; Moore DM, 2006, JAIDS-J ACQ IMM DEF, V43, P436, DOI 10.1097/01.qai.0000243105.80393.42; Fitzgerald F, 2013, J INFECT DIS, V207, pS85, DOI 10.1093/infdis/jit115; Songok EM, 2004, AIDS RES HUM RETROV, V20, P255, DOI 10.1089/088922204773004996; Lwembe R, 2009, AIDS RES HUM RETROV, V25, P141, DOI 10.1089/aid.2008.0144; Ndembi N, 2004, JAIDS-J ACQ IMM DEF, V37, P1641, DOI 10.1097/00126334-200412150-00019; Brindeiro PA, 2002, J CLIN MICROBIOL, V40, P4512, DOI 10.1128/JCM.40.12.4512.4519.2002; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; Barth RE, 2011, PEDIATR INFECT DIS J, V30, P52, DOI 10.1097/INF.0b013e3181ed2af3; Arrive E, 2007, INT J EPIDEMIOL, V36, P1009, DOI 10.1093/ije/dym104; Lihana RW, 2011, J CLIN VIROL, V52, P123, DOI 10.1016/j.jcv.2011.06.014; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Johnson VA, 2001, J INFECT DIS, V183, P1688, DOI 10.1086/320697; Bisson GP, 2006, AIDS, V20, P1613, DOI 10.1097/01.aids.0000238407.00874.dc; O'Brien DP, 2006, AIDS, V20, P1955, DOI 10.1097/01.aids.0000247117.66585.ce; Dean J, 2011, AIDS RES HUM RETROV, V27, P797, DOI [10.1089/AID.2011.0013, 10.1089/aid.2011.0013]; Palumbo P, 2010, NEW ENGL J MED, V363, P1510, DOI 10.1056/NEJMoa1000931; Duncombe C, 2005, AIDS, V19, P169, DOI 10.1097/00002030-200501280-00009; Machado ES, 2004, J CLIN VIROL, V30, P24, DOI 10.1016/j.jcv.2003.08.001; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; Ishizaki A, 2009, AIDS RES HUM RETROV, V25, P175, DOI 10.1089/aid.2008.0193; Kamya MR, 2007, JAIDS-J ACQ IMM DEF, V46, P187, DOI 10.1097/QAI.0b013e31814278c0; Bannister Wendy P, 2008, AIDS, V22, P367, DOI 10.1097/QAD.0b013e3282f3cc35; Bunupuradah T, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-40; Ciaranello AL, 2009, CLIN INFECT DIS, V49, P1915, DOI 10.1086/648079; Ngo-Giang-Huong N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027427; Nhung VTT, 2010, J INT AIDS SOC S4, V13, P140; Trinh QD, 2012, AIDS RES HUM RETROV, V28, P1305, DOI 10.1089/aid.2011.0280; Trinh TT, 2011, AIDS RES TREAT, V2011; Viet Nam National Committee for AIDS Drugs and Prostitution Prevention and Control, VIET NAM AIDS RESP P; Vietnam Ministry of Health, 2009, GUID HIV AIDS DIAGN; WHO, 2013, CONS GUID US ANT DRU; WHO, 2011, CHILDR 15 YEARS EST; WHO, 2010, ANT THER HIV INF INF; World Health Organization, 2013, GLOB UPD HIV TREATM	42	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0956-4624	1758-1052		INT J STD AIDS	Int. J. STD AIDS	OCT	2015	26	11					821	830		10.1177/0956462414556328		10	Immunology; Infectious Diseases	Immunology; Infectious Diseases	CS0MM	WOS:000361754500008		
J	Kojima, A				Kojima, Atsuhiro			Vertebral artery dissecting aneurysm treated by internal trapping via the contralateral vertebral artery: A case report	INTERVENTIONAL NEURORADIOLOGY			English	Article						Internal trapping; subarachnoid hemorrhage; vertebral artery dissecting aneurysm	ENDOVASCULAR MANAGEMENT; COIL EMBOLIZATION; RECANALIZATION; OCCLUSIONS	A 42-year-old man with a history of sudden onset of severe headache followed by consciousness disturbance was brought to our hospital. Radiological examinations revealed subarachnoid hemorrhage, associated with rupture of a left vertebral artery dissecting aneurysm. Initially, internal trapping was attempted via the ipsilateral vertebral artery. However, the microcatheter could not be navigated through the true lumen to the distal side of the vertebral artery. Subsequently, therefore, the guiding catheter was placed in the right vertebral artery, and the microcatheter was retrogradely navigated successfully through the lesion to the proximal side of the left vertebral artery. Finally, the lesion was completely embolized with electrodetachable coils without complications. However, the patient died after the operation because of deterioration of the general condition. The postmortem examination revealed how an intimal flap had interfered with the antegrade navigation of the microcatheter in the lesion. The present case showed that endovascular treatment for a vertebral artery dissecting aneurysm via the contralateral vertebral artery may be a useful option in cases where antegrade navigation of the microcatheter via the ipsilateral vertebral artery is found to be difficult.	[Kojima, Atsuhiro] Saitama City Hosp, Dept Neurosurg, Saitama, Japan	Kojima, A (reprint author), 2460 Mimuro,Midori Ku, Saitama, Saitama 3368522, Japan.	akojima-nsu@umin.ac.jp					Schmidt A, 2012, J ENDOVASC THER, V19, P23, DOI 10.1583/11-3645.1; Rathore S, 2009, CIRC-CARDIOVASC INTE, V2, P124, DOI 10.1161/CIRCINTERVENTIONS.108.838862; Ye M, 2013, J VASC SURG, V58, P84, DOI 10.1016/j.jvs.2013.03.038; Sugiu K, 2005, NEURORADIOLOGY, V47, P158, DOI 10.1007/s00234-005-1341-4; Iihara K, 2002, J NEUROSURG, V97, P259, DOI 10.3171/jns.2002.97.2.0259; Rabinov JD, 2003, AM J NEURORADIOL, V24, P1421; Yuki I, 2005, J NEUROSURG, V103, P649, DOI 10.3171/jns.2005.103.4.0649; Kurata A, 2001, AM J NEURORADIOL, V22, P11; Kurata A, 2001, INTERV NEURORADIOL, V7, P73	9	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1591-0199	2385-2011		INTERV NEURORADIOL	Interv. Neuroradiol.	OCT	2015	21	5					576	579		10.1177/1591019915590358		4	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CS0QB	WOS:000361766000002		
J	Okamura, A; Nakaoka, M; Ohbayashi, N; Yahara, K; Nabika, S				Okamura, Akitake; Nakaoka, Mitsuo; Ohbayashi, Naohiko; Yahara, Kaita; Nabika, Shinya			Intraoperative idiopathic subarachnoid hemorrhage during carotid artery stenting: A case report and literature review	INTERVENTIONAL NEURORADIOLOGY			English	Article						Carotid artery stenting; subarachnoid hemorrhage; complication	CEREBRAL HYPERPERFUSION SYNDROME; INTRACRANIAL HEMORRHAGE; ENDARTERECTOMY; ANGIOPLASTY	Carotid artery stenting (CAS) has a fatal complication of intracranial hemorrhage (ICH) associated with cerebral hyperperfusion syndrome (CHS), i.e. brain hemorrhage and subarachnoid hemorrhage (SAH). Although SAH accounts for a small percentage of these patients, it is difficult to make a differential diagnosis of this syndrome from CHS without ICH because the clinical presentations resemble each other. Furthermore, not only does the cause of SAH following CAS remain unclear but also the role of controlling postoperative blood pressure is not detected in preventing ICH after CAS. Herein, we report a case of SAH following CAS and review previous literature to discuss the mechanism and the management of this fatal complication. A 78-year-old woman with a history of arteriosclerotic obliteration and myocardial infarction was referred to our department for intervention to asymptomatic severe stenosis of the right internal carotid artery. We performed CAS under local anesthesia. Although her blood pressure was controlled to normotension during the procedure, the patient complained of headache following predilation. Postoperative emergent non-contrast computed tomography revealed SAH with leakage of contrast medium occupying the right sylvian fissure. We continued strict blood pressure control, and the patient was discharged without any neurological deficit. A well-opened lumen of the stent was recognized three months later at the outpatient visit. Strict control of intraoperative and postoperative blood pressure may improve the outcome of SAH following CAS though the role in preventing ICH after CAS is unclear.	[Okamura, Akitake; Nakaoka, Mitsuo; Ohbayashi, Naohiko; Yahara, Kaita; Nabika, Shinya] Matsue Red Cross Hosp, Dept Neurosurg, Matsue, Shimane 6908506, Japan	Okamura, A (reprint author), Matsue Red Cross Hosp, Dept Neurosurg, 200 Horomachi, Matsue, Shimane 6908506, Japan.	akitake-okamura@hotmail.co.jp					Kaku Y, 2004, AM J NEURORADIOL, V25, P1403; Meyers PM, 2000, NEUROSURGERY, V47, P335, DOI 10.1097/00006123-200008000-00013; Xu Y, 2009, INTERV NEURORADIOL, V15, P316; Przewlocki T, 2007, J VASC SURG, V45, P1072, DOI 10.1016/j.jvs.2007.01.041; Ogasawara K, 2007, J NEUROSURG, V107, P1130, DOI 10.3171/JNS-07/12/1130; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Hartmann M, 2004, J NEURORADIOLOGY, V31, P63, DOI 10.1016/S0150-9861(04)96880-0; Al-Mubarak N, 2001, CATHETER CARDIO INTE, V54, P521, DOI 10.1002/ccd.1324; Kang HS, 2007, J ENDOVASC THER, V14, P77, DOI 10.1583/06-1991.1; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127; Schoser BGH, 1997, J NEUROL, V244, P101, DOI 10.1007/s004150050057; SUNDT TM, 1981, MAYO CLIN PROC, V56, P533; Sato K, 2013, JNET, V7, P259; Yoshimura S, 2009, NEUROSURGERY S, V64, P122	14	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1591-0199	2385-2011		INTERV NEURORADIOL	Interv. Neuroradiol.	OCT	2015	21	5					592	597		10.1177/1591019915594332		6	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CS0QB	WOS:000361766000005		
J	Ishihara, H; Ishihara, S; Niimi, J; Neki, H; Kakehi, Y; Uemiya, N; Kohyama, S; Yamane, F; Kato, H; Suzuki, T; Adachi, J; Mishima, K; Nishikawa, R				Ishihara, Hideaki; Ishihara, Shoichiro; Niimi, Jun; Neki, Hiroaki; Kakehi, Yoshiaki; Uemiya, Nahoko; Kohyama, Shinya; Yamane, Fumitaka; Kato, Hiroshi; Suzuki, Tomonari; Adachi, Jun-ichi; Mishima, Kazuhiko; Nishikawa, Ryo			The safety and efficacy of preoperative embolization of meningioma with N-butyl cyanoacrylate	INTERVENTIONAL NEURORADIOLOGY			English	Article						Meningioma embolization; N-butyl cyanoacrylate (NBCA); Endovascular treatment	TUMOR	Objective: Preoperative embolization of meningioma is commonly performed; however, there is no consensus on the best embolic material to reduce intraoperative blood loss and surgery time. Method: We retrospectively assessed the safety and efficacy of 56 cases of preoperative embolization of the middle meningeal artery with N-butyl cyanoacrylate (NBCA) in 105 cases of surgery for meningioma. We also defined a blood loss to tumor volume ratio to compensate for bias caused by tumor volume, and analyzed limited cases (the embolized group n = 52, the non-embolized group n = 21) of the convexity, the parasagittal region, the falx, and the sphenoidal ridge. Result: The blood loss to tumor volume ratio was significantly less in the embolized group (p < 0.007). Preoperative embolization could be useful for cases with the external carotid artery as the dominant feeder vessel (p < 0.02); however, the efficacy decreased for cases with an internal carotid artery feeder. Transient complications occurred in four cases (hemiparesis secondary to edema: two cases; intratumoral bleeding: one case; trigeminal nerve disorder: one case). The cases that showed a postoperative increase in edema or intratumoral bleeding were large tumors with the early filling of veins. For such cases, surgeons should pay close attention to slow injection speed and higher NBCA viscosity, not to cause the occlusion of draining vessels. Conclusion: Tumor embolization with NBCA can be safely performed, and the procedure significantly reduces intraoperative blood loss.	[Ishihara, Hideaki; Ishihara, Shoichiro; Niimi, Jun; Neki, Hiroaki; Kakehi, Yoshiaki; Uemiya, Nahoko; Kohyama, Shinya; Yamane, Fumitaka] Saitama Med Univ, Int Med Ctr, Dept Endovasc Neurosurg, Hidaka, Saitama 3501298, Japan; [Kato, Hiroshi] Ken O Tokorozawa Hosp, Dept Neurosurg, Tokorozawa, Saitama, Japan; [Suzuki, Tomonari; Adachi, Jun-ichi; Mishima, Kazuhiko; Nishikawa, Ryo] Saitama Med Univ, Int Med Ctr, Dept Neurooncol Neurosurg, Hidaka, Saitama 3501298, Japan	Ishihara, H (reprint author), Saitama Med Univ, Int Med Ctr, Dept Endovasc Neurosurg, 1397-1 Yamane, Hidaka, Saitama 3501298, Japan.	hideaki@saitama-med.ac.jp					Duffis EJ, 2012, J NEUROINTERV SURG, V4, P251, DOI 10.1136/neurintsurg-2012-010350; Sluzewski M, 2013, AM J NEURORADIOL, V34, P727, DOI 10.3174/ajnr.A3311; Law-ye B, 2013, ACTA NEUROCHIR, V155, P707, DOI 10.1007/s00701-013-1632-1; Yu SCH, 2004, AM J NEURORADIOL, V25, P506; Carli DFM, 2010, AM J NEURORADIOL, V31, P152, DOI 10.3174/ajnr.A1754; Tanaka M, 2006, J NEUROSURG, V104, P382, DOI 10.3171/jns.2006.104.3.382; Shah AH, 2013, J NEUROSURG, V119, P364, DOI 10.3171/2013.3.JNS121328; Kai Y, 2006, AM J NEURORADIOL, V27, P1146; Borg A, 2013, NEUROSURGERY, V73, P244, DOI 10.1227/NEU.0000000000000187; Kominami S, 2012, INTERV NEURORADIOL, V18, P133; Ishihara H, 2014, J NEUROENDOVASC THER, V8, P224; Lazzaro MA, 2011, FRONT NEUROL, V64, P1; Singla A, 2013, NEUROSURG FOCUS, V35, P1	13	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1591-0199	2385-2011		INTERV NEURORADIOL	Interv. Neuroradiol.	OCT	2015	21	5					624	630		10.1177/1591019915590537		7	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CS0QB	WOS:000361766000011		
J	Michihata, N; Matsui, H; Fushimi, K; Yasunaga, H				Michihata, Nobuaki; Matsui, Hiroki; Fushimi, Kiyohide; Yasunaga, Hideo			Clinical Features of Adult Patients Admitted to Pediatric Wards in Japan	JOURNAL OF ADOLESCENT HEALTH			English	Article						Children with special health care needs; Congenital diseases; Chronic conditions	CONGENITAL HEART-DISEASE; BIRTH-WEIGHT INFANTS; HEALTH-CARE; YOUNG-ADULTS; TRANSITION CARE; CHILDHOOD; ADOLESCENTS; CARDIOLOGY; DISORDERS; SERVICES	Purpose: Pediatricians generally need to treat adult patients who require long-term care for pediatric diseases. However, little is known about the characteristics of adult patients in pediatric wards. Using a national inpatient database, the aim of this study was to determine the clinical details of adult patients admitted to pediatric wards in Japanese acute-care hospitals. Methods: We extracted all inpatients aged >= 19 years who were admitted to pediatric departments in Japan from April 2012 to March 2013. We examined the patients' main diagnoses and the use of life-supporting home medical devices. Results: Of 417,352 patients admitted to pediatric wards during the study period, we identified 4,729 (1.1%) adult patients. The major diagnoses of the adult patients were malignancy, congenital heart disease, epilepsy, and cerebral palsy. More than 35% of the patients with cerebral palsy had a tracheostomy tube, gastrostomy tube, home central venous alimentation, or home respirator. More than 20% of patients aged >= 40 years in pediatric wards had adult diseases, including ischemic heart diseases, cerebrovascular diseases, and adult malignancy. Conclusions: Many adult patients in pediatric wards had adult diseases. It is essential to establish a disease-oriented support system for adults with chronic conditions that originated in their childhood. (C) 2015 Society for Adolescent Health and Medicine. All rights reserved.	[Michihata, Nobuaki; Matsui, Hiroki; Yasunaga, Hideo] Univ Tokyo, Dept Clin Epidemiol & Hlth Econ, Sch Publ Hlth, Tokyo 1130033, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Policy & Informat, Tokyo, Japan	Michihata, N (reprint author), Univ Tokyo, Dept Clin Epidemiol & Hlth Econ, Sch Publ Hlth, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	michihata-tky@umin.org			Ministry of Health, Labour and Welfare, Japan [H26-Policy-011, H26-Special-047]	This study was funded by a grant from the Ministry of Health, Labour and Welfare, Japan (research on policy planning and evaluation grant number: H26-Policy-011 and H26-Special-047).	Martin GR, 2012, J AM COLL CARDIOL, V59, P84, DOI 10.1016/j.jacc.2011.08.060; Kono Y, 2011, PEDIATR INT, V53, P1051, DOI 10.1111/j.1442-200X.2011.03480.x; Nathan PC, 2011, CANCER-AM CANCER SOC, V117, P2335, DOI 10.1002/cncr.26042; Reiss J, 2002, PEDIATRICS, V110, P1307; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Hudsmith LE, 2007, ARCH DIS CHILD, V92, P927, DOI 10.1136/adc.2006.103812; Binks JA, 2007, ARCH PHYS MED REHAB, V88, P1064, DOI 10.1016/j.apmr.2007.04.018; Gan HW, 2014, ARCH DIS CHILDHOOD-E, V99, P138, DOI 10.1136/archdischild-2013-305452; Okumura MJ, 2008, J GEN INTERN MED, V23, P1621, DOI 10.1007/s11606-008-0716-8; Annunziato RA, 2013, J PEDIATR-US, V163, P1628, DOI 10.1016/j.jpeds.2013.07.031; Cadario F, 2009, CLIN ENDOCRINOL, V71, P346, DOI 10.1111/j.1365-2265.2008.03467.x; Ishida Y, 2011, PEDIATR INT, V53, P291, DOI 10.1111/j.1442-200X.2010.03293.x; McDonnell WM, 2010, ARCH PEDIAT ADOL MED, V164, P572, DOI 10.1001/archpediatrics.2010.60; Khan A, 2013, ACTA PAEDIATR, V102, P216, DOI 10.1111/apa.12097; Geerlings RPJ, 2015, EPILEPSY BEHAV, V44, P127, DOI 10.1016/j.yebeh.2014.12.041; Goodman DM, 2011, PEDIATRICS, V128, P5, DOI 10.1542/peds.2010-2037; Shiina Y, 2011, INT J CARDIOL, V146, P13, DOI 10.1016/j.ijcard.2009.05.032; Holmes-Walker DJ, 2007, DIABETIC MED, V24, P764, DOI 10.1111/j.1464-5491.2007.02152.x; Fernandes SM, 2012, J AM COLL CARDIOL, V60, P2411, DOI 10.1016/j.jacc.2012.09.015; Wilson-Costello D, 2007, PEDIATRICS, V119, P37, DOI 10.1542/peds.2006-1416; Maslow G, 2013, J ADOLESCENT HEALTH, V52, P179, DOI 10.1016/j.jadohealth.2012.06.020; Davis AM, 2014, PEDIATRICS, V134, P900, DOI 10.1542/peds.2014-1909; Edwards JD, 2015, J CRIT CARE, V30, P201, DOI 10.1016/j.jcrc.2014.10.016; Heaton Paul A J, 2013, Br J Nurs, V22, P1129; Michihata N, 2014, EAT WEIGHT DISORD-ST, V19, P473, DOI 10.1007/s40519-014-0147-y	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1054-139X	1879-1972		J ADOLESCENT HEALTH	J. Adolesc. Health	OCT	2015	57	4					421	424		10.1016/j.jadohealth.2015.07.005		4	Psychology, Developmental; Public, Environmental & Occupational Health; Pediatrics	Psychology; Public, Environmental & Occupational Health; Pediatrics	CS0NX	WOS:000361759300012		
J	Hiraki, T; Liu, M; Wang, X				Hiraki, Takato; Liu, Ming; Wang, Xue			Country and industry concentration and the performance of international mutual funds	JOURNAL OF BANKING & FINANCE			English	Article						International mutual funds; Asset allocation; Portfolio concentration	PORTFOLIO CONCENTRATION; DIVERSIFICATION; MARKETS; FAMILIARITY; EFFICIENCY; FLOWS	We examine the relation between country and industry portfolio concentration and performance using a data set of international equity mutual funds. When sorted by concentration measures, funds in the most concentrated quintile outperform those in the most diversified quintile by 0.16% and 0.30% monthly in country and industry dimensions, respectively. Further analysis shows that the superior performance of concentrated funds is largely driven by industry rather than country concentration, suggesting the existence of global industry private information. Finally, we show that industry-concentrated funds rotate top-holding industries less frequently than their diversified counterparts, and that the industries these funds purchase subsequently outperform the industries they sell. (C) 2015 Elsevier B.V. All rights reserved.	[Hiraki, Takato] Tokyo Univ Sci, Sch Management, Kuki, Saitama 3468512, Japan; [Liu, Ming] Int Univ Japan, Grad Sch Int Management, Minami Uonuma, Niigata 9497277, Japan; [Wang, Xue] Renmin Univ China, Sch Business, Beijing 100872, Peoples R China	Wang, X (reprint author), Renmin Univ China, Sch Business, 59 Zhong Gunn Cun St, Beijing 100872, Peoples R China.	hiraki@rs.tus.ac.jp; mliu@iuj.ac.jp; xuewang@ruc.edu.cn			Japan Society for Promotion of Science (JSPS); National Natural Science Foundation of China (NSFC) [71302157, 71073132, 71432008]; Fundamental Research Funds for the Central Universities in China [2011221018]; Scientific Research Foundation for the Returned Overseas Chinese Scholars; State Education Ministry	We are grateful to Andres Almazan, Stephen Brown, Akitoshi Ito, Tony Ruan, Qian Sun, Kian Ming (Eric) Tan, Sheridan Titman, Kelsey Wei, Sterling Yan, and to the seminar participants at East China University of Science and Technology, Hitotsubashi University, Xiamen University, Renmin University of China, Zhongnan University of Economics and Law, the 2013 Financial Management Association Asia annual meeting, and the 2013 Nippon Finance Association annual meeting. We appreciate Y.C. Loon for his research fund to purchase the mutual fund holdings data. Takato Hiraki acknowledges the 2012-2014 type (C) grant provided by Japan Society for Promotion of Science (JSPS). Xue Wang and Ming Liu acknowledge the financial support of the National Natural Science Foundation of China (NSFC projects no. 71302157, 71073132 and 71432008), the Fundamental Research Funds for the Central Universities in China (project no. 2011221018), the Scientific Research Foundation for the Returned Overseas Chinese Scholars, and State Education Ministry. All remaining errors are our own.	Griffin JM, 1998, J FINANC ECON, V50, P351, DOI 10.1016/S0304-405X(98)00041-5; Sirri ER, 1998, J FINANC, V53, P1589, DOI 10.1111/0022-1082.00066; Albuquerque R, 2009, J FINANC ECON, V94, P18, DOI 10.1016/j.jfineco.2008.06.008; Kacperczyk M, 2014, J FINANC, V69, P1455, DOI 10.1111/jofi.12084; Petersen MA, 2009, REV FINANC STUD, V22, P435, DOI 10.1093/rfs/hhn053; Berk JB, 2004, J POLIT ECON, V112, P1269, DOI 10.1086/424739; Ivkovic Z, 2008, J FINANC QUANT ANAL, V43, P613; Griffin JM, 2010, REV FINANC STUD, V23, P3225, DOI 10.1093/rfs/hhq044; Bekaert G, 2009, J FINANC, V64, P2591, DOI 10.1111/j.1540-6261.2009.01512.x; Pool VK, 2012, REV FINANC STUD, V25, P2563, DOI 10.1093/rfs/hhs075; Huang J, 2011, REV FINANC STUD, V24, P2575, DOI 10.1093/rfs/hhr001; Brown SJ, 2009, PAC-BASIN FINANC J, V17, P295, DOI 10.1016/j.pacfin.2008.08.002; Goetzmann WN, 2008, REV FINANC, V12, P433, DOI 10.1093/rof/rfn005; Huberman G, 2001, REV FINANC STUD, V14, P659, DOI 10.1093/rfs/14.3.659; Kacperczyk M, 2005, J FINANC, V60, P1983, DOI 10.1111/j.1540-6261.2005.00785.x; Sonney F, 2009, REV FINANC STUD, V22, P2087, DOI 10.1093/rfs/hhm024; GIBBONS MR, 1989, ECONOMETRICA, V57, P1121, DOI 10.2307/1913625; Brands S., 2005, INT REV FINANC, V5, P149, DOI 10.1111/j.1468-2443.2006.00054.x; Carhart MM, 1997, J FINANC, V52, P57, DOI 10.2307/2329556; Elton E. J., 2013, HDB EC FINANCE B, V2, P1012; Fedenia M., 2011, J BANK FINANC, V37, P155; HESTON SL, 1994, J FINANC ECON, V36, P3, DOI 10.1016/0304-405X(94)90028-0; Huij J, 2011, J BANK FINANC, V35, P155, DOI 10.1016/j.jbankfin.2010.07.032; Ince O. S., 2006, J FINANC RES, V29, P463, DOI DOI 10.1111/J.1475-6803.2006.00189.X; IPPOLITO RA, 1992, J LAW ECON, V35, P45, DOI 10.1086/467244; Kacperczyk M., 2014, WORKING PAPER; Karolyi G. A., 2012, WORKING PAPER; LESSARD DR, 1974, J FINANC, V29, P379, DOI 10.2307/2978807; ROLL R, 1992, J FINANC, V47, P3, DOI 10.2307/2329089; Sapp T., 2008, FINANCIAL REV, V43, P27, DOI 10.1111/j.1540-6288.2007.00185.x; Van Nieuwerburgh S., 2009, REV ECON STUD, V77, P779; Weiss A. A., 1998, FINANCIAL ANAL J, V54, P6, DOI 10.2469/faj.v54.n3.2175	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-4266	1872-6372		J BANK FINANC	J. Bank Financ.	OCT	2015	59						297	310		10.1016/j.jbankfin.2015.04.023		14	Business, Finance; Economics	Business & Economics	CR8EA	WOS:000361582700020		
J	Takahashi, H; Yamada, K				Takahashi, Hidenori; Yamada, Kazuo			IPOs, growth, and the impact of relaxing listing requirements	JOURNAL OF BANKING & FINANCE			English	Article						IPOs; Deregulation; Firm growth	STOCK-MARKET; FINANCIAL DEVELOPMENT; COMPANIES; PRIVATE; FIRMS	We investigate the impact of relaxing listing requirements on firms' growth around initial public offerings (IPOs). Japan experienced several deregulations of listing requirements in the late 1990s. We use a dataset that covers both public and private firms for more than 30 years, which enables us to compare the firms' operating growth around IPOs as well as to compare the growth under both strict and relaxed listing requirements. When comparing the matched firms, we find that IPO firms' excess growth in profitability and productivity diminished after their IPOs, while their excess growth in terms of size (measured by sales and number of employees) still increased in the post-IPO period. This finding indicates that relaxing listing requirements enables high-growth firms to go public but does not lead to subsequent growth in productivity and profitability, although it does enable firms to be larger more after going public. (C) 2015 Elsevier B.V. All rights reserved.	[Takahashi, Hidenori] Kobe Univ, Kobe, Hyogo, Japan; [Yamada, Kazuo] Nagasaki Univ, Nagasaki 8508506, Japan	Yamada, K (reprint author), Nagasaki Univ, Fac Econ, 4-2-1 Katafuchi, Nagasaki 8508506, Japan.	k-yamada@nagasaki-u.ac.jp			Japan Society for the Promotion of Science [25780256]	This research is supported by Japan Society for the Promotion of Science Grant-in-Aid for Young Scientists (B) Grant Number 25780256.	Bharath ST, 2010, REV FINANC STUD, V23, P1771, DOI 10.1093/rfs/hhq016; Gao HS, 2013, J FINANC ECON, V109, P623, DOI 10.1016/j.jfineco.2013.04.008; Vismara S, 2012, EUR FINANC MANAG, V18, P352, DOI 10.1111/j.1468-036X.2012.00641.x; Akyol AC, 2014, J BANK FINANC, V45, P43, DOI 10.1016/j.jbankfin.2014.04.020; Brav O, 2009, J FINANC, V64, P263, DOI 10.1111/j.1540-6261.2008.01434.x; Johan SA, 2010, INT REV LAW ECON, V30, P128, DOI 10.1016/j.irle.2009.12.001; Hauner D, 2013, J BANK FINANC, V37, P895, DOI 10.1016/j.jbankfin.2012.10.008; [Anonymous], 1995, BESS ZOUSH HAK; Pagano M, 1998, J FINANC, V53, P27, DOI 10.1111/0022-1082.25448; Espenlaub S, 2012, J BUS FINAN ACCOUNT, V39, P427, DOI 10.1111/j.1468-5957.2012.02280.x; Shi C, 2013, CONTEMP ACCOUNT RES, V30, P356, DOI 10.1111/j.1911-3846.2012.01158.x; Asker J, 2015, REV FINANC STUD, V28, P342, DOI 10.1093/rfs/hhu077; Boot AWA, 2006, J FINANC, V61, P803, DOI 10.1111/j.1540-6261.2006.00855.x; Aslan H, 2011, J FINANC QUANT ANAL, V46, P489, DOI 10.1017/S0022109010000761; Cattaneo M, 2015, J CORP FINANC, V31, P116, DOI 10.1016/j.jcorpfin.2015.02.001; Rajan RG, 2003, J FINANC ECON, V69, P5, DOI 10.1016/S0304-405X(03)00125-9; JAIN BA, 1994, J FINANC, V49, P1699, DOI 10.2307/2329268; Chemmanur TJ, 1999, REV FINANC STUD, V12, P249, DOI 10.1093/rfs/12.2.249; Pour EK, 2013, J BANK FINANC, V37, P4850, DOI 10.1016/j.jbankfin.2013.08.022; Bernstein S., 2015, J FINANCE IN PRESS; Borisov A., 2012, SSRN WORKING PAPER S; Chemmanur T.J., 2009, REV FINANC STUD, V23, P1855; Clementi G.L., 2002, SSRN WORKING PAPER S; Farre-Mensa J., 2014, SSRN WORKING PAPER S; HALL BH, 1987, J IND ECON, V35, P583, DOI 10.2307/2098589; Haltiwanger J., 2013, REV ECON STAT, V92, P1035; Hsieh CT, 2014, Q J ECON, V129, P1035, DOI 10.1093/qje/qju014; Kenney M., 2012, POSTIPO EMPLOYMENT R; Krishnan K., 2014, NBER WORKING PAPER S; Kueng L., 2014, NBER WORKING PAPER S; Olley B.G.S., 1996, ECONOMETRICA, V64, P1263; Pastor L., 2008, REV FINANC STUD, V22, P3005; Ritter J.R., 2013, RESTRUCTURING SPEED; Roberts M. R., 2013, HDB EC FINANCE A; Semenenko I., 2012, J APPL FINANCE BANKI, V2, P209; Spiegel M., 2008, SSRN WORKING PAPER S; STIGLER GJ, 1971, BELL J ECON, V2, P3, DOI 10.2307/3003160; Zoushi Hakusho Bessatu, 1993, BESS ZOUSH HAK	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-4266	1872-6372		J BANK FINANC	J. Bank Financ.	OCT	2015	59						505	519		10.1016/j.jbankfin.2015.04.029		15	Business, Finance; Economics	Business & Economics	CR8EA	WOS:000361582700033		
J	Xu, C; Sugiura, K; Masuya, H; Hashimoto, K; Fukada, S				Xu, Chen; Sugiura, Kunitomo; Masuya, Hiroshi; Hashimoto, Kunitaro; Fukada, Saiji			Experimental Study on the Biaxial Loading Effect on Group Stud Shear Connectors of Steel-Concrete Composite Bridges	JOURNAL OF BRIDGE ENGINEERING			English	Article							BEHAVIOR	Clustering stud shear connectors with minimized spacing based on specifications to form group studs are useful for concrete slab prefabrication and prestress installation efficiency in steel-concrete composite bridges. To date, many long-span composite bridge girders have been designed with wide transverse cantilevers and web spacing, and most of these girders use group studs. The concrete's self-weight and the weight of moving loads result in a significant transverse bending-induced effect generally consisting of bending stresses and tensile concrete cracks. In this sense, the studs are actually under longitudinal interlayer shear force that is influenced by the transverse bending-induced effect. This biaxial loading effect has not been investigated experimentally. Thus, standard and newly designed push-out tests and corresponding analyses were carried out. In addition, the stud arrangement effect also was of concern. In this study, the ratio of stud height to shank diameter was approximately 6.2. This study found that steel-concrete interlayer friction and biaxial concrete compression around the stud roots contribute to a favorable effect of biaxial loading on stud performance. However, the residual tensile concrete cracks are unfavorable. Engineers should note the tendency toward mechanical degradation of studs when such a situation occurs. Moreover, arranging studs in clusters to form group studs may lead to comparatively more severe concrete damage at the ultimate stage. The specification-based evaluations of stud strength were found to be more or less conservative based on related test results. (C) 2014 American Society of Civil Engineers.	[Xu, Chen; Masuya, Hiroshi; Fukada, Saiji] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Sugiura, Kunitomo] Kyoto Univ, Dept Civil & Earth Resources Engn, Kyoto 6158540, Japan; [Hashimoto, Kunitaro] Kobe Univ, Dept Civil Engn, Kobe, Hyogo 6578501, Japan	Xu, C (reprint author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan.	xuchenprc@hotmail.com					AASHTO, 2007, LRFD BRIDG DES SPEC; Shim CS, 2001, J CONSTR STEEL RES, V57, P203, DOI 10.1016/S0143-974X(00)00018-3; Lee PG, 2005, J CONSTR STEEL RES, V61, P1270, DOI 10.1016/j.jcsr.2005.01.007; Badie SS, 2011, J BRIDGE ENG, V16, P653, DOI 10.1061/(ASCE)BE.1943-5592.0000215; ELIGEHAUSEN R, 1995, ACI STRUCT J, V92, P365; [Anonymous], ABAQUS 6 13 COMP SOF; Xu C, 2013, J CONSTR STEEL RES, V89, P86, DOI 10.1016/j.jcsr.2013.06.011; Mirza O, 2010, ENG STRUCT, V32, P93, DOI 10.1016/j.engstruct.2009.08.019; Pallares L, 2010, J CONSTR STEEL RES, V66, P213, DOI 10.1016/j.jcsr.2009.08.008; Xu C, 2012, J CONSTR STEEL RES, V72, P84, DOI 10.1016/j.jcsr.2011.10.029; Badie S.S., 2002, J BRIDGE ENG, V7, P195, DOI DOI 10.1061/(ASCE)1084-0702(2002)7:3(195); Chinese Standards, 2003, 500172003 GB CHIN ST; Dassault Systemes Americas, 2014, ABAQUS 6 13 DOC; European Committee for Standardization (CEN), 2005, DES COMP STEEL CON 2; Japan Society of Civil Engineers (JSCE), 2007, STAND SPEC STEEL COM; Japanese Society of Steel Construction (JSSC), 1996, 35 JSSC; Japanese Standards Association, 1999, A11131999 JIS; Japanese Standards Association, 1998, Z22411998 JIS; Japanese Standards Association, 1999, A11081999 JIS; OEHLERS DJ, 1992, J STRUCT ENG-ASCE, V118, P2004, DOI 10.1061/(ASCE)0733-9445(1992)118:8(2004); Okada J., 2006, STRUCT ENG EARTHQUAK, V23, P75, DOI DOI 10.2208/JSCESEEE.23.75S; Shim C.-S., 2008, P 6 INT C COMP CONST, V6, P92; Yamada M., 2013, P 13 E AS PAC C STRU	23	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	1084-0702	1943-5592		J BRIDGE ENG	J. Bridge Eng.	OCT	2015	20	10							04014110	10.1061/(ASCE)BE.1943-5592.0000718		14	Engineering, Civil	Engineering	CR7UU	WOS:000361557800006		
J	Zhou, W; Benharash, P; Chua, JH; Nakahara, S; Ho, JK; Mahajan, A				Zhou, Wei; Benharash, Peyman; Chua, Jason Han; Nakahara, Shiro; Ho, Jonathan K.; Mahajan, Aman			Acute Effects of Pacing at Different Ventricular Sites on Left Ventricular Rotational Mechanics in a Porcine Model	JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA			English	Article						ventricular tachycardia; pacing site; LV twist; synchrony	SPECKLE TRACKING ECHOCARDIOGRAPHY; CARDIAC RESYNCHRONIZATION THERAPY; DIASTOLIC FUNCTION; VOLUME; DYSSYNCHRONY; SYNCHRONY; ALTERNATE; STRAIN; TWIST; APEX	Objective: The purpose of this study was to examine the acute effects of pacing at different ventricular sites on hemodynamics and left ventricular (LV) rotational mechanics using speckle-tracking echocardiography (STE) in a porcine model. Design: A prospective laboratory investigation. Setting: University research laboratory. Participants: Yorkshire pigs. Interventions: In 9 pigs, after midline sternotomy, epicardial pacing was performed from the right ventricular outflow tract (RVOT), right ventricular apex (RVA), and LV free wall. Measurements and Main Results: Two-dimensional STE and conductance catheter-derived LV pressure-volume measurements were made to determine the impact of pacing from various sites on LV rotational parameters (twist/untwist) and hemodynamics. RVOT pacing caused the least decrease in end-systolic pressure from baseline (-9.5%), when compared with RVA (-19.1%) and LV (-23.4%). Systolic and diastolic parameters (Emax, Tau) also were different among RVOT (4.7 +/- 0.8 mmHg/mL, 32 +/- 4 ms), RVA (3.9 +/- 0.7 mmHg/mL, 37 +/- 6 ms), and LV sites (3.6 +/- 0.8 mmHg/mL, 42 +/- 7 ms). Similar to the effects of pacing on hemodynamics, RVOT pacing better preserved LV twist (11.1 +/- 1.8 v8.6 +/- 1.7, 5.9 +/- 0.7 degrees) and untwisting rate (64.6 +/- 8.5 v 56.2 +/- 5.3, 48.2 +/- 8.5 degrees/s) when compared with RV apical pacing and LV pacing. Furthermore, prolongation of conduction from LV lateral to anteroseptal at LV base (26.5 +/- 3.8 v 13.8 +/- 3.3 ms, p < 0.05) and LV midpapillary muscle level (35.6 +/- 5.6 v 14.1 +/- 2.4 ms, p < 0.05) was observed with LV pacing compared with RVOT pacing. Conclusions: The present data showed that the LV twist/untwist and cardiac systolic and diastolic function were least affected by RVOT pacing. This finding may be explained by the proximity of this location to the native ventricular conduction system. (C) 2015 Elsevier Inc. All rights reserved.	[Zhou, Wei; Chua, Jason Han; Ho, Jonathan K.; Mahajan, Aman] Univ Calif Los Angeles, Dept Anesthesiol, Los Angeles, CA 90095 USA; [Benharash, Peyman] Univ Calif Los Angeles, Dept Cardiovasc Surg, Los Angeles, CA 90095 USA; [Nakahara, Shiro] Dokkyo Med Univ, Mibu, Tochigi, Japan	Mahajan, A (reprint author), Univ Calif Los Angeles, David Geffen Sch Med, 650 Charles E Young Dr South,CHS Bldg 56-131, Los Angeles, CA 90095 USA.	amahajan@mednet.ucla.edu					Syuu Y, 2003, AM J PHYSIOL-REG I, V285, pR1446, DOI 10.1152/ajpregu.00243.2003; Yu CM, 2005, CIRCULATION, V112, P1580, DOI 10.1161/CIRCULATIONAHA.105.538272; Park DS, 2011, CIRCULATION, V123, P904, DOI 10.1161/CIRCULATIONAHA.110.942284; Burns AT, 2008, HEART, V94, P978, DOI 10.1136/hrt.2007.120410; Dekker ALAJ, 2004, J THORAC CARDIOV SUR, V127, P1641, DOI 10.1016/j.jtcvs.2003.10.052; Chua J, 2012, J CARDIOTHOR VASC AN, V26, P291, DOI 10.1053/j.jvca.2011.07.005; Buckingham TA, 1999, PACE, V22, P887, DOI 10.1111/j.1540-8159.1999.tb06812.x; Helle-Valle T, 2005, CIRCULATION, V112, P3149, DOI 10.1161/CIRCULATIONAHA.104.531558; Matsuoka K, 2009, J AM SOC ECHOCARDIOG, V22, P914, DOI 10.1016/j.echo.2009.05.001; Delgado V, 2009, CIRC-ARRHYTHMIA ELEC, V2, P135, DOI 10.1161/CIRCEP.108.814608; de Cock CC, 2003, EUROPACE, V5, P275, DOI 10.1016/S1099-5129(03)00031-X; Burns AT, 2009, JACC-CARDIOVASC IMAG, V2, P709, DOI 10.1016/j.jcmg.2009.01.015; Inoue K, 2010, J AM SOC ECHOCARDIOG, V23, P195, DOI 10.1016/j.echo.2009.10.015; Ho JK, 2013, J AM SOC ECHOCARDIOG, V26, P674, DOI 10.1016/j.echo.2013.03.010; Buckingham TA, 1998, PACE, V21, P1077, DOI 10.1111/j.1540-8159.1998.tb00153.x; Tse HF, 2002, J AM COLL CARDIOL, V40, P1451, DOI 10.1016/S0735-1097(02)02169-1; Da Costa A, 2013, ARCH CARDIOVASC DIS, V106, P394, DOI 10.1016/j.acvd.2012.08.005; Tops LF, 2007, J AM COLL CARDIOL, V50, P1180, DOI 10.1016/j.jacc.2007.06.011; Sorger JM, 2003, J CARDIOV MAGN RESON, V5, P521, DOI 10.1081/JCMR-120025227; Wang JW, 2007, CIRCULATION, V116, P2580, DOI 10.1161/CIRCULATIONAHA.107.706770; BAAN J, 1984, CIRCULATION, V70, P812; BAAN J, 1992, EUR HEART J, V13, P2; Takeuchi M, 2007, EUR HEART J, V28, P2756, DOI 10.1093/eurheartj/ehm440; Notomi Y, 2008, AM J PHYSIOL-HEART C, V294, pH505, DOI 10.1152/ajpheart.00975.2007; Buckberg G D, 2001, Semin Thorac Cardiovasc Surg, V13, P320; DeAnda Jr A, 1995, CIRCULATION, V92, P11458; Josephson MK., 2008, CLIN CARDIAC ELECTRO; Sengupta Partho P, 2008, Heart Fail Clin, V4, P315, DOI 10.1016/j.hfc.2008.03.001; Suga H, 1973, CIRC RES, V32; Takeuchi Masaaki, 2009, Curr Cardiol Rep, V11, P225; Zhou W., 2013, PHYSL REP, V1, P1, DOI DOI 10.1002/PHY2.110	31	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1053-0770	1532-8422		J CARDIOTHOR VASC AN	J. Cardiothorac. Vasc. Anesth.	OCT	2015	29	5					1148	1154		10.1053/j.jvca.2014.12.008		7	Anesthesiology; Cardiac & Cardiovascular Systems; Respiratory System; Peripheral Vascular Disease	Anesthesiology; Cardiovascular System & Cardiology; Respiratory System	CS0WM	WOS:000361782900006		
J	Kato, S; Chikuda, H; Ohya, J; Hayakawa, K; Takeshita, K; Tanaka, S; Ogata, T				Kato, So; Chikuda, Hirotaka; Ohya, Junichi; Hayakawa, Kentaro; Takeshita, Katsushi; Tanaka, Sakae; Ogata, Tom			Phosphorylated neurofilament subunit levels in the serum of cervical compressive myelopathy patients	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Biomarker; Cervical myelopathy; Complication; Neurofilament; Surgery	SPINAL-CORD-INJURY; NF-H; CEREBROSPINAL-FLUID; SPONDYLOTIC MYELOPATHY; PNF-H; BIOMARKER; BLOOD; HEMORRHAGE; SEVERITY; SYMPTOMS	We investigated the serum levels of the phosphorylated form of the high molecular weight neurofilament subunit (pNF-H) in patients with cervical compressive myelopathy. pNF-H is becoming increasingly recognized as a biomarker for axonal injury, however, it remains unclear whether serum pNF-H is elevated in chronic spinal cord compression. We examined 26 patients who underwent surgery for cervical compressive myelopathy. Peripheral blood samples were obtained both preoperatively and I week after surgery to evaluate the serum pNF-H levels using an enzyme-linked immunosorbent assay. A history of recent aggravation of myelopathy was also investigated. Of the 26 myelopathy patients, the preoperative serum pNF-H level was negative in 20 patients and moderately elevated in six. Patients who were positive for pNF-H were more likely to have had a recent aggravation of myelopathy compared with the pNF-H negative patients (83 versus 25%; p = 0.02). All patients who were positive for pNF-H before surgery remained positive after surgery. Two patients who became positive after surgery demonstrated a neurologic deterioration associated with the surgery. In conclusion, the serum pNF-H level was negative in the majority of patients with cervical compressive myelopathy. Our results suggest that an elevated serum level of pNF-H is associated with an acute worsening of myelopathy and that a positive conversion of pNF-H after surgery is a marker of perioperative neural damage. (C) 2015 Elsevier Ltd. All rights reserved.	[Kato, So; Chikuda, Hirotaka; Ohya, Junichi; Hayakawa, Kentaro; Takeshita, Katsushi; Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1138655, Japan; [Ogata, Tom] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, Saitama, Japan	Chikuda, H (reprint author), Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	chikuda-tky@umin.ac.jp			Ministry of Health, Labour and Welfare, Japan	This study was funded by grants from the Ministry of Health, Labour and Welfare, Japan.	CLARKE E, 1956, BRAIN, V79, P483, DOI 10.1093/brain/79.3.483; Boylan K, 2009, J NEUROCHEM, V111, P1182, DOI 10.1111/j.1471-4159.2009.06386.x; Matsushige T, 2012, J NEUROL SCI, V321, P39, DOI 10.1016/j.jns.2012.07.043; EBARA S, 1989, SPINE, V14, P1154, DOI 10.1097/00007632-198911000-00005; Pouw MH, 2009, SPINAL CORD, V47, P519, DOI 10.1038/sc.2008.176; Ueno T, 2011, SPINAL CORD, V49, P333, DOI 10.1038/sc.2010.116; Chikuda H, 2011, SPINE, V36, P1453, DOI 10.1097/BRS.0b013e3181f49718; Marquardt G, 2009, ACTA NEUROCHIR, V151, P1439, DOI 10.1007/s00701-009-0408-0; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Oshima Y, 2012, SPINE, V37, P1909, DOI 10.1097/BRS.0b013e318259a65b; BENZEL EC, 1991, J SPINAL DISORD, V4, P286; Yokobori S, 2015, WORLD NEUROSURG, V83, P867, DOI 10.1016/j.wneu.2013.03.012; Cai JY, 2013, CLIN CHIM ACTA, V424, P182, DOI 10.1016/j.cca.2013.06.019; HIRABAYASHI K, 1981, SPINE, V6, P354, DOI 10.1097/00007632-198107000-00005; Lewis SB, 2008, J CEREBR BLOOD F MET, V28, P1261, DOI 10.1038/jcbfm.2008.12; Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; Hayakawa K, 2012, SPINAL CORD, V50, P493, DOI 10.1038/sc.2011.184; Borenstein DG, 2011, ROTHMAN SIMEONE SPIN, V1, P632; Chikuda H, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-245; Jurek S., 2011, ROTHMAN SIMEONE SPIN, V1, P684; Takahashi H, 2014, J CLIN NEUROSCI, V21, P2175, DOI 10.1016/j.jocn.2014.04.021; Yoshor D, 2005, NEUROSURGERY, V57, P984, DOI 10.1227/01.NEU.0000180028.64385.d3	23	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	OCT	2015	22	10					1638	1642		10.1016/j.jocn.2015.03.047		5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CS0SS	WOS:000361773100018		
J	Sato, Y; Inokuchi, M; Takagi, Y; Otsuki, S; Fujimori, Y; Yanaka, Y; Kobayashi, K; Higuchi, K; Kojima, K; Kawano, T				Sato, Yuya; Inokuchi, Mikito; Takagi, Yoko; Otsuki, Sho; Fujimori, Yoshitaka; Yanaka, Yoshimitsu; Kobayashi, Kenta; Higuchi, Kyoko; Kojima, Kazuyuki; Kawano, Tatsuyuki			Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer	JOURNAL OF CLINICAL PATHOLOGY			English	Article							FACTOR-BINDING-PROTEINS; POOR-PROGNOSIS; PHASE-III; COLORECTAL-CANCER; 1ST-LINE THERAPY; BREAST-CANCER; GROWTH; INSULIN; RECEPTOR; HER2	Aims Insulin-like growth factor binding protein 7 (IGFBP7) is reported to have tumour suppressor function through an IGF-dependent pathway in various malignant tumours. However, the expression of IGFBP7 in adenocarcinoma and its relationship with tumour progression and survival differs among studies. Our aims were to investigate the relationship between the expression of IGFBP7 and clinicopathological variables and outcomes of patients with gastric cancer. Methods Tumour samples were obtained from 219 patients with gastric cancer who underwent gastrectomy. The expression of IGFBP7 protein was examined by immunohistochemical staining. IGFBP7 mRNA levels were analysed using real-time quantitative reverse-transcriptase PCR in 24 of the gastric cancer tumours and in adjacent non-tumour tissues. Correlation of IGFBP7 expression with clinicopathological features was analysed. Results The protein expression of IGFBP7 was positively correlated with depth of invasion, lymph node metastasis, distant metastasis or recurrence and pathological stage. High expression of IGFBP7 protein was associated with a significantly worse disease-specific survival (p<0.001) and was an independent prognostic factor in multivariable analysis (HR, 4.8; 95% CI 2.1 to 10.6; p<0.001). The IGFBP7 mRNA level was significantly higher in advanced gastric cancer than in early gastric cancer, in tumours with lymph node metastasis than in tumours without lymph node metastasis, and in tumours with distant metastasis or recurrence than in tumours without distant metastasis or recurrence. Conclusions Overexpression of IGFBP7 was associated with tumour progression and poor survival in gastric cancer. IGFBP7 may play a role in tumour progression in gastric cancer.	[Sato, Yuya; Inokuchi, Mikito; Otsuki, Sho; Fujimori, Yoshitaka; Yanaka, Yoshimitsu; Kobayashi, Kenta; Higuchi, Kyoko] Tokyo Med & Dent Univ, Dept Gastr Surg, Tokyo 1138519, Japan; [Takagi, Yoko] Tokyo Med & Dent Univ, Dept Translat Oncol, Tokyo 1138519, Japan; [Kojima, Kazuyuki] Tokyo Med & Dent Univ, Ctr Minimally Invas Surg, Tokyo 1138519, Japan; [Kawano, Tatsuyuki] Tokyo Med & Dent Univ, Dept Esophageal Surg, Tokyo 1138519, Japan	Inokuchi, M (reprint author), Tokyo Med & Dent Univ, Dept Gastr Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	m-inokuchi.srg2@tmd.ac.jp					Liu L, 2014, TUMOR BIOL, V35, P8875, DOI 10.1007/s13277-014-2160-1; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; An W, 2012, ANN SURG ONCOL, V19, P3971, DOI 10.1245/s10434-012-2407-2; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Bang YJ, 2010, LANCET, V376, P1302; Adachi Y, 2001, INT J CANCER, V95, P216, DOI 10.1002/1097-0215(20010720)95:4<216::AID-IJC1037>3.0.CO;2-O; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Mutaguchi K, 2003, CANCER RES, V63, P7717; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Rajaram S, 1997, ENDOCR REV, V18, P801, DOI 10.1210/er.18.6.801; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Shah MA, 2010, J NATL COMPR CANC NE, V8, P437; Ruan WJ, 2007, CANCER BIOL THER, V6, P354; Matsubara J, 2008, CLIN CANCER RES, V14, P3022, DOI 10.1158/1078-0432.CCR-07-1898; Grabsch H, 2010, CELL ONCOL, V32, P57, DOI 10.3233/CLO-2009-0497; Mohan S, 2002, J ENDOCRINOL, V175, P19, DOI 10.1677/joe.0.1750019; Yamashita K, 2011, WORLD J GASTROENTERO, V17, P3390, DOI 10.3748/wjg.v17.i29.3390; Ferlay J, 2010, Eur J Cancer, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Georges RB, 2011, CANCER BIOL THER, V12, P69, DOI 10.4161/cbt.12.1.15719; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Tomimaru Y, 2012, INT J CANCER, V130, P319, DOI 10.1002/ijc.25994; Burger AM, 2005, EUR J CANCER, V41, P1515, DOI 10.1016/j.ejca.2005.04.023; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/S0092-8674(00)00114-8; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; Shah MA, 2010, JAMA-J AM MED ASSOC, V303, P1753, DOI 10.1001/jama.2010.553; Kim MA, 2007, HUM PATHOL, V38, P1386, DOI 10.1016/j.humpath.2007.02.005; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Oh Y, 1998, BREAST CANCER RES TR, V47, P283, DOI 10.1023/A:1005911319432; Smith E, 2014, BRIT J CANCER, V110, P775, DOI 10.1038/bjc.2013.783; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Evdokimova V, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003184; Nagatsuma AK, 2015, GASTRIC CANCER, V18, P227, DOI 10.1007/s10120-014-0360-4	32	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0021-9746	1472-4146		J CLIN PATHOL	J. Clin. Pathol.	OCT	2015	68	10					795	801		10.1136/jclinpath-2015-202987		7	Pathology	Pathology	CS0PJ	WOS:000361763900005		
J	Horimoto, Y; Arakawa, A; Tanabe, M; Kuroda, K; Matsuoka, J; Igari, F; Himuro, T; Yoshida, Y; Tokuda, E; Shimizu, H; Hino, O; Saito, M				Horimoto, Yoshiya; Arakawa, Atsushi; Tanabe, Masahiko; Kuroda, Keiji; Matsuoka, Joe; Igari, Fumie; Himuro, Takanori; Yoshida, Yuko; Tokuda, Emi; Shimizu, Hideo; Hino, Okio; Saito, Mitsue			Menstrual cycle could affect Ki67 expression in estrogen receptor-positive breast cancer patients	JOURNAL OF CLINICAL PATHOLOGY			English	Article							LABELING INDEX; PROGESTERONE; TISSUE; METAANALYSIS; SUBTYPES; HORMONE; MARKER; WOMEN; KI-67	Background Ki67 is a potent prognostic marker for determining systemic treatment of patients with hormone receptor-positive breast cancer. However, evaluation of Ki67 expression can be difficult, due mostly to its heterogeneity. The Ki67 expression level, which indicates that a cell is undergoing division (cell cycle), rises when proliferation activity increases. Thus, Ki67 expression might be affected by hormonal stimuli. We hypothesised that Ki67 expression level might change during the menstrual cycle. We examined pairs of biopsy and surgical specimens from individual patients to evaluate this hypothesis. Methods First, the effects of estradiol on Ki67 expression in breast cancer cell lines were examined employing immunocytochemistry and Western blotting. Next, differences in Ki67 expression between biopsy and surgical specimens from 131 patients with estrogen receptor-positive tumours were retrospectively examined. Results In vitro experiments showed Ki67 expression in estrogen receptor-positive cancer cells to be dependent on estradiol stimulation. Ki67 expression was higher in biopsy samples collected in the luteal phase than in those from other phases. When biopsy and surgical samples were obtained at different times during the menstrual cycle in the same individual, there were differences in Ki67 expression between these samples. Those collected in the luteal phase showed higher Ki67 expression than samples obtained during other phases (p<0.01). Conclusions Ki67 expression varied in the same patients according to menstrual cycle phase. Our results suggest that Ki67 expression in estrogen receptor-positive breast cancer should be carefully assessed bearing in mind the patient's menstrual cycle, since the interpretation of expression could affect treatment decisions.	[Horimoto, Yoshiya; Tanabe, Masahiko; Igari, Fumie; Himuro, Takanori; Yoshida, Yuko; Tokuda, Emi; Shimizu, Hideo; Saito, Mitsue] Juntendo Univ, Dept Breast Oncol, Sch Med, Tokyo 1130033, Japan; [Horimoto, Yoshiya; Hino, Okio] Juntendo Univ, Dept Pathol & Oncol, Sch Med, Tokyo 1130033, Japan; [Arakawa, Atsushi] Juntendo Univ, Sch Med, Dept Human Pathol, Tokyo 1130033, Japan; [Kuroda, Keiji] Juntendo Univ, Dept Obstet & Gynecol, Sch Med, Tokyo 1130033, Japan; [Matsuoka, Joe] Juntendo Univ, Clin Res Support Ctr, Sch Med, Tokyo 1130033, Japan	Horimoto, Y (reprint author), Juntendo Univ, Dept Breast Oncol, Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1130033, Japan.	yoshiyahorimoto@hotmail.com					Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Cheang MCU, 2009, J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Haynes BP, 2013, BREAST CANCER RES TR, V138, P157, DOI 10.1007/s10549-013-2426-0; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; POTTEN CS, 1988, BRIT J CANCER, V58, P163, DOI 10.1038/bjc.1988.185; Brisken C, 2013, NAT REV CANCER, V13, P385, DOI 10.1038/nrc3518; Mann RM, 2008, EUR RADIOL, V18, P1307, DOI 10.1007/s00330-008-0863-7; Ramakrishnan R, 2002, MODERN PATHOL, V15, P1348, DOI 10.1097/01.MP.0000039566.20817.46; Urruticoechea A, 2005, J CLIN ONCOL, V23, P7212, DOI 10.1200/JCO.2005.07.501; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Cserni G, 2014, BREAST, V23, P259, DOI 10.1016/j.breast.2014.02.003; Dowsett M, 2011, J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Ismail PM, 2003, STEROIDS, V68, P779, DOI 10.1016/S0039-128X(03)00133-8; Simpson HW, 2000, BREAST CANCER RES TR, V63, P171, DOI 10.1023/A:1006434318939; Speroff L, 1999, J REPROD MED, V44, P172; White E, 1998, J NATL CANCER I, V90, P906, DOI 10.1093/jnci/90.12.906; Ho KK, 2009, FEBS J, V276, P4037, DOI 10.1111/j.1742-4658.2009.07112.x; Hernandez L, 2005, ANTICANCER RES, V25, P451; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; Horimoto Y, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-550; Laurinavicius A, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3639	21	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0021-9746	1472-4146		J CLIN PATHOL	J. Clin. Pathol.	OCT	2015	68	10					825	829		10.1136/jclinpath-2015-203085		5	Pathology	Pathology	CS0PJ	WOS:000361763900010		
J	Lee, J; Takeuchi, H; Fervaha, G; Powell, V; Bhaloo, A; Bies, R; Remington, G				Lee, Jimmy; Takeuchi, Hiroyoshi; Fervaha, Gagan; Powell, Valerie; Bhaloo, Amaal; Bies, Robert; Remington, Gary			The Effect of Clozapine on Hematological Indices A 1-Year Follow-Up Study	JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY			English	Article						schizophrenia; leukocytosis; eosinophilia; thrombocytosis; agranulocytosis; clozapine	HEMATOPOIETIC GROWTH-FACTOR; COLONY-STIMULATING FACTOR; TUMOR-NECROSIS-FACTOR; INDUCED THROMBOCYTOPENIA; INDUCED AGRANULOCYTOSIS; NATIONAL REGISTRY; PLASMA-LEVELS; DRUG-THERAPY; SCHIZOPHRENIA; NEUTROPENIA	Clozapine is the antipsychotic of choice for treatment-resistant schizophrenia and is linked to a need for mandatory hematological monitoring. Besides agranulocytosis, other hematological aberrations have resulted in premature termination in some cases. Considering clozapine's role in immunomodulation, we proceeded to investigate the impact of clozapine on the following 3 main hematological cell lines: red blood cells, platelets, white blood cells (WBCs), and its differential counts. Data were extracted from patients initiated on clozapine between January 2009 and December 2010 at a single hospital. Patients with a preclozapine complete blood count, who were receiving clozapine during the 1-year follow-up period, were included in the present investigation. Counts of red blood cells, platelets, WBC, and its differential including neutrophils, lymphocytes, monocytes, eosinophils, and basophils were extracted and trajectories plotted. One hundred one patients were included in this study and 66 remained on clozapine at the end of 1 year. There was a synchronized but transient increase in WBC, neutrophils, monocytes, eosinophils, basophils, and platelets beginning as early as the first week of clozapine treatment. There were no cases of agranulocytosis reported in this sample, and five developed neutropenia. A spike in neutrophils immediately preceded the onset of neutropenia in three of the five. The cumulative incidence rates were 48.9% for neutrophilia, 5.9% for eosinophilia, and 3% each for thrombocytosis and thrombocytopenia. Early hematological aberrations are visible across a range of cell lines, primarily of the myeloid lineage. These disturbances are transient and are probably related to clozapine's immunomodulatory properties. We do not suggest discontinuing clozapine as a consequence of the observed aberrations.	[Lee, Jimmy] Inst Mental Hlth, Dept Gen Psychiat 1, Singapore, Singapore; [Lee, Jimmy] Duke NUS Grad Med Sch, Off Clin Sci, Singapore, Singapore; [Lee, Jimmy; Takeuchi, Hiroyoshi; Fervaha, Gagan; Powell, Valerie; Bhaloo, Amaal; Remington, Gary] Ctr Addict & Mental Hlth, Schizophrenia Div, Toronto, ON M5T 1R8, Canada; [Takeuchi, Hiroyoshi] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Fervaha, Gagan; Remington, Gary] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Bies, Robert] Ctr Addict & Mental Hlth, Geriatr Mental Hlth Program, Toronto, ON M5T 1R8, Canada; [Bies, Robert] Indiana Univ Sch Med, Div Clin Pharmacol, Indianapolis, IN 46202 USA; [Bies, Robert] Indiana Clin & Translat Sci Inst, Indianapolis, IN USA; [Bies, Robert; Remington, Gary] Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada; [Remington, Gary] Univ Toronto, Dept Psychiat, Toronto, ON, Canada	Lee, J (reprint author), Ctr Addict & Mental Hlth, Schizophrenia Div, 250 Coll St, Toronto, ON M5T 1R8, Canada.	jimmy_lee@imh.com.sg			Academic Health Science Center Alternate Funding Plan Innovation Fund Award; Singapore Ministry of Health's National Medical Research Council [NMRC/TA/002/2012]; Canadian Institutes of Health Research; Roche; Indiana Clinical and Translational Sciences Institute; Campbell Family Foundation; Centre for Addiction and Mental Health Foundation; Japanese Society of Clinical Neuropsychopharmacology; Astellas Foundation for Research on Metabolic Disorders; Dainippon Sumitomo Pharma; Canadian Diabetes Association; Hoffman-La Roche; Laboratorios Farmaceuticos Rovi; Medicure; Neurocrine Biosciences; Novartis Canada; Research Hospital Fund-Canada Foundation for Innovation; Schizophrenia Society of Ontario	Dr Remington is supported in part by Academic Health Science Center Alternate Funding Plan Innovation Fund Award. Dr Lee is supported by the Singapore Ministry of Health's National Medical Research Council (Grant NMRC/TA/002/2012). Dr Takeuchi is supported by a fellowship grant from the Canadian Institutes of Health Research. Both funding sources had no role in study design, in the collection, analysis, and interpretation of data, in the writing of the report, as well as in the decision to submit the paper for publication.; Dr Lee has received a consulting fee from Roche. Dr Bies is a consultant for INC research and has received funds through the Indiana Clinical and Translational Sciences Institute as a result of a gift from Eli Lilly and company to Indiana University. Dr Bies is supported by the Campbell Family Foundation as well as the Indiana Clinical and Translational Sciences Institute and has received travel support from Roche and Sanofi Aventis. He serves on the Clinical Pharmacology Advisory Board for Biogen Idec. Dr Takeuchi has received fellowship grants from the Centre for Addiction and Mental Health Foundation, the Japanese Society of Clinical Neuropsychopharmacology, and Astellas Foundation for Research on Metabolic Disorders and manuscript fees from Dainippon Sumitomo Pharma within the past 5 years. Ms Powell has received an honorarium from Novartis Canada. Dr Remington has received research support, consulting fees, or speaker's fees from the Canadian Diabetes Association, the Canadian Institutes of Health Research, Hoffman-La Roche, Laboratorios Farmaceuticos Rovi, Medicure, Neurocrine Biosciences, Novartis Canada, Research Hospital Fund-Canada Foundation for Innovation, and the Schizophrenia Society of Ontario. The other authors declare no conflicts of interest.	KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789; Nasreddine W, 2008, EPILEPSIA, V49, P438, DOI 10.1111/j.1528-1167.2007.01429.x; Pollmacher T, 2000, J PSYCHIAT RES, V34, P369, DOI 10.1016/S0022-3956(00)00032-7; Zhang ML, 1996, ARCH GEN PSYCHIAT, V53, P954; Alphs LD, 1999, J CLIN PSYCHIAT, V60, P39; Hampson ME, 2000, BRIT J PSYCHIAT, V176, P400; KERWIN RW, 1995, LANCET, V345, P1063, DOI 10.1016/S0140-6736(95)90811-0; ALVIR JMJ, 1995, PSYCHOPHARMACOL BULL, V31, P311; Pons A, 2012, REV PSIQUIATR SALUD, V5, P37, DOI 10.1016/j.rpsm.2011.11.003; Roge R, 2012, SCHIZOPHR RES, V140, P204, DOI 10.1016/j.schres.2012.06.020; Williams DP, 2000, MOL PHARMACOL, V58, P207; Hippius H, 1999, J CLIN PSYCHIAT, V60, P22; Honigfeld G, 1998, J CLIN PSYCHIAT, V59, P3; BALDESSARINI RJ, 1991, NEW ENGL J MED, V324, P746; Chung JPY, 2008, CAN J PSYCHIAT, V53, P857; Cohen D, 2012, J CLIN PSYCHIAT, V73, P1307, DOI 10.4088/JCP.11r06977; Deliliers GL, 2000, HAEMATOLOGICA, V85, P233; Nielsen J, 2010, J PSYCHOPHARMACOL, V24, P965, DOI 10.1177/0269881108100320; WEINBERGER I, 1987, ARCH INTERN MED, V147, P735, DOI 10.1001/archinte.147.4.735; Oyesanmi O, 1999, PSYCHOSOMATICS, V40, P414; HUMMER M, 1994, J CLIN PSYCHIAT, V55, P429; Ames D, 1996, J CLIN PSYCHIAT, V57, P579, DOI 10.4088/JCP.v57n1205; Hayes RD, 2015, SCHIZOPHRENIA BULL, V41, P644, DOI 10.1093/schbul/sbu120; POLLMACHER T, 1995, ARCH GEN PSYCHIAT, V52, P877; Zhan YF, 2012, MOL IMMUNOL, V52, P30, DOI 10.1016/j.molimm.2012.04.009; Cohen D, 2013, AM J PSYCHIAT, V170, P366, DOI 10.1176/appi.ajp.2012.12081036; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; SAFFERMAN A, 1991, SCHIZOPHRENIA BULL, V17, P247; Maes M, 1997, SCHIZOPHR RES, V26, P221, DOI 10.1016/S0920-9964(97)00057-1; Hinze-Selch D, 1998, NEUROPSYCHOPHARMACOL, V19, P114, DOI 10.1016/S0893-133X(98)00006-2; LIESCHKE GJ, 1992, NEW ENGL J MED, V327, P28; Honigfeld G, 1996, PSYCHIATR SERV, V47, P52; Davis MC, 2014, ACTA PSYCHIAT SCAND, V130, P30, DOI 10.1111/acps.12233; Deliliers GL, 1998, HAEMATOLOGICA, V83, P882; Pollmacher T, 1997, PHARMACOPSYCHIATRY, V30, P118, DOI 10.1055/s-2007-979495; Rettenbacher MA, 2010, PHARMACOPSYCHIATRY, V43, P41, DOI 10.1055/s-0030-1249071; Hummer M, 1997, J CLIN PSYCHOPHARM, V17, P314, DOI 10.1097/00004714-199708000-00012; Nielsen J, 2013, J CLIN PSYCHIAT, V74, P603, DOI 10.4088/JCP.12r08064; VANDERPOLL T, 1992, BLOOD, V79, P693; Hummer M, 1996, PSYCHOPHARMACOLOGY, V124, P201, DOI 10.1007/BF02245622; Schulte PFJ, 2006, ANN PHARMACOTHER, V40, P683, DOI 10.1345/aph.1G396; Andersohn F, 2007, ANN INTERN MED, V146, P657; Black LL, 1996, PSYCHIATR SERV, V47, P81; MONTERO D, 1995, LANCET, V346, P56, DOI 10.1016/S0140-6736(95)92690-9; Monteleone P, 1997, PSYCHIAT RES, V71, P11, DOI 10.1016/S0165-1781(97)00036-X; Lahdelma L, 2012, J CLIN PSYCHIAT, V73, P837, DOI 10.4088/JCP.11m07244; ALVIR JMJ, 1993, NEW ENGL J MED, V329, P162, DOI 10.1056/NEJM199307153290303; Buchanan Robert W, 2010, Schizophr Bull, V36, P71, DOI 10.1093/schbul/sbp116; Francisco-Cruz A, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0774-6; IDANPAANHEIKKILA J, 1975, LANCET, V2, P611; Kate Natasha, 2013, J Pharmacol Pharmacother, V4, P149, DOI 10.4103/0976-500X.110913; KRUPP P, 1992, BRIT J PSYCHIAT, V160, P38; Pollmacher T, 1996, J CLIN PSYCHOPHARM, V16, P403, DOI 10.1097/00004714-199610000-00011; Schafer AI, 2004, NEW ENGL J MED, V350, P1211, DOI 10.1056/NEJMra035363; SPERNERUNTERWEGER B, 1993, BIOL PSYCHIAT, V34, P536, DOI 10.1016/0006-3223(93)90196-K; Tang C, 2011, ASEAN J PSYCHIAT, V12, P122	56	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-0749	1533-712X		J CLIN PSYCHOPHARM	J. Clin. Psychopharmacol.	OCT	2015	35	5					510	516		10.1097/JCP.0000000000000387		7	Pharmacology & Pharmacy; Psychiatry	Pharmacology & Pharmacy; Psychiatry	CR0TM	WOS:000361036100004		
J	Miura, S; Furuya, M; Yasuda, H; Miyaoka, T; Horiguchi, J				Miura, Shoko; Furuya, Motohide; Yasuda, Hideaki; Miyaoka, Tsuyoshi; Horiguchi, Jun			Novel Therapy With Ramelteon for Hypoactive Delirium A Case Report	JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY			English	Letter									[Miura, Shoko; Furuya, Motohide; Yasuda, Hideaki; Miyaoka, Tsuyoshi; Horiguchi, Jun] Shimane Univ, Fac Med, Dept Psychiat, Izumo, Shimane, Japan; [Furuya, Motohide] Shimane Univ, Fac Med, Dept Dev Biol, Izumo, Shimane, Japan; [Yasuda, Hideaki] Sekitou Hosp, Dept Psychiat, Oda, Japan	Miura, S (reprint author), Shimane Univ, Fac Med, Dept Psychiat, Izumo, Shimane, Japan.	mo114928@med.shimane-u.ac.jp					Al-Aama T, 2011, INT J GERIATR PSYCH, V26, P687, DOI 10.1002/gps.2582; Simpson D, 2008, DRUGS, V68, P1901, DOI 10.2165/00003495-200868130-00011; Balan S, 2003, J NEUROPSYCH CLIN N, V15, P363, DOI 10.1176/appi.neuropsych.15.3.363; Lewis MC, 2004, MED HYPOTHESES, V63, P402, DOI 10.1016/j.mehy.2004.01.033; Furuya M, 2012, PSYCHOGERIATRICS, V12, P259, DOI 10.1111/j.1479-8301.2012.00422.x; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-0749	1533-712X		J CLIN PSYCHOPHARM	J. Clin. Psychopharmacol.	OCT	2015	35	5					616	618		10.1097/JCP.0000000000000370		3	Pharmacology & Pharmacy; Psychiatry	Pharmacology & Pharmacy; Psychiatry	CR0TM	WOS:000361036100025		
J	Kojima, S; Sunada, H; Mita, K; Sakakibara, M; Lukowiak, K; Ito, E				Kojima, S.; Sunada, H.; Mita, K.; Sakakibara, M.; Lukowiak, K.; Ito, E.			Function of insulin in snail brain in associative learning	JOURNAL OF COMPARATIVE PHYSIOLOGY A-NEUROETHOLOGY SENSORY NEURAL AND BEHAVIORAL PHYSIOLOGY			English	Review						Conditioned taste aversion; Insulin; Long-term memory; Lymnaea; Synaptic enhancement	CONDITIONED TASTE-AVERSION; LONG-TERM-MEMORY; CENTRAL PATTERN GENERATOR; CENTRAL-NERVOUS-SYSTEM; CEREBRAL GIANT-CELLS; LYMNAEA-STAGNALIS; POND SNAIL; SYNAPTIC PLASTICITY; GENE-EXPRESSION; CAENORHABDITIS-ELEGANS	Insulin is well known as a hormone regulating glucose homeostasis across phyla. Although there are insulin-independent mechanisms for glucose uptake in the mammalian brain, which had contributed to a perception of the brain as an insulin-insensitive organ for decades, the finding of insulin and its receptors in the brain revolutionized the concept of insulin signaling in the brain. However, insulin's role in brain functions, such as cognition, attention, and memory, remains unknown. Studies using invertebrates with their open blood-vascular system have the promise of promoting a better understanding of the role played by insulin in mediating/modulating cognitive functions. In this review, the relationship between insulin and its impact on long-term memory (LTM) is discussed particularly in snails. The pond snail Lymnaea stagnalis has the ability to undergo conditioned taste aversion (CTA), that is, it associatively learns and forms LTM not to respond with a feeding response to a food that normally elicits a robust feeding response. We show that molluscan insulin-related peptides are up-regulated in snails exhibiting CTA-LTM and play a key role in the causal neural basis of CTA-LTM. We also survey the relevant literature of the roles played by insulin in learning and memory in other phyla.	[Kojima, S.] KBRI, Dept Struct & Funct Neural Network, Taegu 701300, South Korea; [Sunada, H.; Ito, E.] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Sanuki 7692193, Japan; [Mita, K.] Tokushima Bunri Univ, Fac Sci & Engn, Sanuki 7692193, Japan; [Sakakibara, M.] Tokai Univ, Sch High Technol Human Welf, Numazu 4100321, Japan; [Lukowiak, K.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada	Ito, E (reprint author), Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, 1314-1 Shido, Sanuki 7692193, Japan.	satoshikojima.sk@gmail.com; hsunada@kph.bunri-u.ac.jp; kmita@kagawa.bunri-u.ac.jp; manabu@tokai.ac.jp; lukowiak@ucalgary.ca; eito@kph.bunri-u.ac.jp			KAKENHI from Japan Society for the Promotion of Science [24657055, 25291074]; Canadian Institutes of Health Research [MOP 64339]	This work was supported by KAKENHI from Japan Society for the Promotion of Science [Nos. 24657055, 25291074 to E.I.] and a grant from Canadian Institutes of Health Research [No. MOP 64339 to K.L.].	Wu SP, 1999, J BIOMED SCI, V6, P409, DOI 10.1007/BF02253672; SYED NI, 1992, NEURON, V8, P767, DOI 10.1016/0896-6273(92)90097-W; TAYLOR R, 1987, BIOCHEM J, V242, P123; Azami S, 2006, J NEUROSCI RES, V84, P1610, DOI 10.1002/jnr.21045; Ito E, 2015, J EXP BIOL, V218, P1699, DOI 10.1242/jeb.120329; Takigami S, 2014, NEUROBIOL LEARN MEM, V107, P79, DOI 10.1016/j.nlm.2013.10.022; [Anonymous], 1989, LYMNAEA J NEUROCYTOL; Pirger Z, 2010, J NEUROSCI, V30, P13766, DOI 10.1523/JNEUROSCI.2577-10.2010; MCCROHAN CR, 1980, J EXP BIOL, V85, P169; Hermann PM, 1998, BEHAV NEUROSCI, V112, P656, DOI 10.1037/0735-7044.112.3.656; [Anonymous], 2015, BIOPHYSICS-USSR; Kawai R, 2004, NEUROBIOL LEARN MEM, V82, P164, DOI 10.1016/j.nlm.2004.06.003; SCHWARZBERG H, 1989, NEUROPEPTIDES, V13, P79, DOI 10.1016/0143-4179(89)90002-4; Wagatsuma A, 2006, J NEUROSCI RES, V84, P954, DOI 10.1002/jnr.21012; Murakami H, 2005, J NEUROSCI, V25, P10894, DOI 10.1523/JNEUROSCI.3600-04.2005; Kobayashi S, 1998, ZOOL SCI, V15, P683, DOI 10.2108/zsj.15.683; Kojima S, 1996, ZOOL SCI, V13, P803, DOI 10.2108/zsj.13.803; KEMENES G, 1989, BRAIN RES, V489, P163, DOI 10.1016/0006-8993(89)90019-X; Hirano Y, 2013, SCIENCE, V339, P443, DOI 10.1126/science.1227170; Takigami S, 2014, NEUROBIOL LEARN MEM, V111, P9, DOI 10.1016/j.nlm.2014.02.011; Kopf SR, 1996, NEUROBIOL LEARN MEM, V65, P189, DOI 10.1006/nlme.1996.0020; Nakamura H, 1999, NEUROSCI RES, V33, P291, DOI 10.1016/S0168-0102(99)00020-6; de la Monte SM, 2009, BMB REP, V42, P475; Izquierdo LA, 2000, BEHAV BRAIN RES, V111, P93, DOI 10.1016/S0166-4328(00)00137-6; Lukowiak K, 1996, J EXP BIOL, V199, P683; Mita K, 2014, NEUROBIOL LEARN MEM, V107, P1, DOI 10.1016/j.nlm.2013.10.013; Ramsey MM, 2005, J NEUROPHYSIOL, V94, P247, DOI 10.1152/jn.00768.2004; Sanna PP, 2002, J NEUROSCI, V22, P3359; KEMENES G, 1994, BEHAV NEURAL BIOL, V61, P139, DOI 10.1016/S0163-1047(05)80067-6; Sugai R, 2007, J EXP BIOL, V210, P1225, DOI 10.1242/jeb.02735; Alarcon-Matus P, 2015, J MOLLUS STUD, V81, P37, DOI 10.1093/mollus/eyu050; EBBERINK RHM, 1987, PEPTIDES, V8, P515, DOI 10.1016/0196-9781(87)90018-0; Arundell M, 2006, NEUROBIOL AGING, V27, P1880, DOI 10.1016/j.neurobiolaging.2005.09.040; MCCROHAN CR, 1980, J EXP BIOL, V85, P149; Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893; Yeoman MS, 2008, J NEUROCHEM, V106, P1699, DOI 10.1111/j.1471-4159.2008.05528.x; SCHECHTER R, 1994, BRAIN RES, V636, P9, DOI 10.1016/0006-8993(94)90170-8; BRUNER J, 1966, NATURE, V210, P37, DOI 10.1038/210037a0; Dyakonova VE, 2015, J EXP BIOL, V218, P1151, DOI 10.1242/jeb.111930; Dou JT, 2005, LEARN MEMORY, V12, P646, DOI 10.1101/lm.88005; Fioravante D, 2006, NEUROSCI LETT, V396, P235, DOI 10.1016/j.neulet.2005.11.036; [Anonymous], 2015, BIOPHYSICS-USSR; Ito E, 2013, CAN J ZOOL, V91, P405, DOI 10.1139/cjz-2012-0292; Sadamoto H, 2004, J NEUROBIOL, V58, P455, DOI 10.1002/neu.10296; Kojima S, 1998, BRAIN RES, V808, P113, DOI 10.1016/S0006-8993(98)00823-3; Benjamin PR, 2000, LEARN MEMORY, V7, P124, DOI 10.1101/lm.7.3.124; Begg DP, 2013, ADV PHYSIOL EDUC, V37, P53, DOI 10.1152/advan.00167.2012; Takigami S, 2013, NEUROSCI LETT, V555, P149, DOI 10.1016/j.neulet.2013.09.042; Nakamura H, 1999, NEUROSCI RES, V33, P127, DOI 10.1016/S0168-0102(98)00121-7; Kojima S, 2001, J NEUROBIOL, V49, P118, DOI 10.1002/neu.1069; Luo JN, 2012, CELL MOL LIFE SCI, V69, P471, DOI 10.1007/s00018-011-0789-0; GELPERIN A, 1975, SCIENCE, V189, P567, DOI 10.1126/science.1145215; Sugai R, 2006, J EXP BIOL, V209, P826, DOI 10.1242/jeb.02069; McNay EC, 2010, NEUROBIOL LEARN MEM, V93, P546, DOI 10.1016/j.nlm.2010.02.002; Wagatsuma A, 2005, J EXP BIOL, V208, P2389, DOI 10.1242/jeb.01625; Biessels GJ, 1998, BRAIN RES, V800, P125, DOI 10.1016/S0006-8993(98)00510-1; Hatakeyama D, 2004, CELL TISSUE RES, V318, P631, DOI 10.1007/s00441-004-0965-8; Haj-ali V, 2009, BEHAV NEUROSCI, V123, P1309, DOI 10.1037/a0017722; Chen ZC, 2013, PROG NEUROBIOL, V108, P21, DOI 10.1016/j.pneurobio.2013.06.004; Kim JI, 2011, NAT NEUROSCI, V14, P1447, DOI 10.1038/nn.2937; Staras K, 1998, J NEUROPHYSIOL, V79, P3030; ALKON DL, 1974, J GEN PHYSIOL, V64, P70, DOI 10.1085/jgp.64.1.70; ITO E, 1994, J NEUROCHEM, V62, P1337; SCHULZ PE, 1994, J NEUROSCI, V14, P5325; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; SMIT AB, 1988, NATURE, V331, P535, DOI 10.1038/331535a0; Yamanaka M, 1999, ZOOL SCI, V16, P9, DOI 10.2108/zsj.16.9; Placais PY, 2013, SCIENCE, V339, P440, DOI 10.1126/science.1226018; Kawai R, 2011, ZOOL SCI, V28, P517, DOI 10.2108/zsj.28.517; Roszer T, 2014, CELL TISSUE RES, V358, P371, DOI 10.1007/s00441-014-1966-x; Ito E, 1999, ZOOL SCI, V16, P711, DOI 10.2108/zsj.16.711; Whelan HA, 1996, J MOLLUS STUD, V62, P483, DOI 10.1093/mollus/62.4.483; Lukowiak K, 1999, COMP BIOCHEM PHYS A, V124, P265, DOI 10.1016/S1095-6433(99)00114-2; SYED NI, 1990, SCIENCE, V250, P282, DOI 10.1126/science.2218532; Kodama E, 2006, GENE DEV, V20, P2955, DOI 10.1101/gad.1479906; Smith MA, 2011, NEUROSCI BIOBEHAV R, V35, P770, DOI 10.1016/j.neubiorev.2010.09.008; Gerozissis K, 2008, EUR J PHARMACOL, V585, P38, DOI 10.1016/j.ejphar.2008.01.050; Kopf SR, 1999, NEUROBIOL LEARN MEM, V71, P50, DOI 10.1006/nlme.1998.3831; Pirger Z, 2010, J MOL NEUROSCI, V42, P464, DOI 10.1007/s12031-010-9361-x; WOZNIAK M, 1993, NEUROCHEM INT, V22, P1, DOI 10.1016/0197-0186(93)90062-A; Sasakura H, 2013, CURR OPIN NEUROBIOL, V23, P92, DOI 10.1016/j.conb.2012.09.005; Wagatsuma A, 2004, ACTA BIOL HUNG, V55, P149, DOI 10.1556/ABiol.55.2004.1-4.18; Kojima S, 1997, NEUROSCI LETT, V230, P179, DOI 10.1016/S0304-3940(97)00507-7; Oda S, 2011, J NEUROPHYSIOL, V106, P301, DOI 10.1152/jn.01029.2010; Reger MA, 2006, NEUROBIOL AGING, V27, P451, DOI 10.1016/j.neurobiolaging.2005.03.016; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Irvine EE, 2011, LEARN MEMORY, V18, P375, DOI 10.1101/lm.2111311; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; Elliott CJH, 2000, ACTA BIOL HUNG, V51, P153; Murakami J, 2013, J EXP BIOL, V216, P1771, DOI 10.1242/jeb.083469; Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014; Taylor BE, 2000, RESP PHYSIOL, V122, P197, DOI 10.1016/S0034-5687(00)00159-6; THORPE A, 1988, NATURE, V331, P483, DOI 10.1038/331483a0; Ribeiro MJ, 2003, EUR J NEUROSCI, V18, P1223, DOI 10.1046/j.1460-9568.2003.02856.x; Murakami J, 2013, J NEUROSCI, V33, P371, DOI 10.1523/JNEUROSCI.0679-12.2013; Kemenes I, 2011, EUR J NEUROSCI, V33, P143, DOI 10.1111/j.1460-9568.2010.07479.x; Schioth HB, 2012, MOL NEUROBIOL, V46, P4, DOI 10.1007/s12035-011-8229-6; Ito E, 2015, J EXP BIOL, V218, P336, DOI 10.1242/jeb.113266; Kita S, 2011, BIOL BULL-US, V220, P71; Chambers DB, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00008; Dhamoon, 2009, NEUROLOGY, V72, P293; Dhamoon, 2009, NEUROLOGY, V72, P292; Dudai Y, 1989, NEUROBIOLOGY MEMORY, P47; Hatakeyama D, 1999, BIOIMAGES, V7, P1; Hatakeyama Dai, 2013, Communicative & Integrative Biology, V6, pe23955, DOI 10.4161/cib.23955; Hirano Yukinori, 2013, Commun Integr Biol, V6, pe25152, DOI 10.4161/cib.25152; Ito E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043151; Jonas EA, 1996, J NEUROSCI, V16, P1645; Kandel ER, 1967, NEUROSCIENCES STUDY, P666; Kauffman AL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000372; Liu Y, 2015, J COMP NEUR IN PRESS; Luo JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099732; Marra V, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00161; Mita K, 2014, NEUROBIOL LEARN MEM, V116, P132, DOI 10.1016/j.nlm.2014.10.006; Nassel DR, 2015, GEN COMP EN IN PRESS; Otsuka E., 2013, BIOPHYSICS-USSR, V9, P161; Pirger Z, 2014, J GERONTOL A-BIOL, V69, P1331, DOI 10.1093/gerona/glu068; Sadamoto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020285; Sadamoto H, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00025; SOOS MA, 1986, BIOCHEM J, V235, P199; Sunada H., 2014, BIOPHYSICS-USSR, V10, P121; Takahashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075276; Teleman A. A., 2009, BIOCHEM J, V425, P13, DOI DOI 10.1042/BJ20091181; Watabe S., 2014, BIOPHYSICS-USSR, V10, P49; Zupanc GKH, 2004, BEHAV NEUROBIOLOGY, P277	126	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-7594	1432-1351		J COMP PHYSIOL A	J. Comp. Physiol. A -Neuroethol. Sens. Neural Behav. Physiol.	OCT	2015	201	10					969	981		10.1007/s00359-015-1032-5		13	Behavioral Sciences; Neurosciences; Physiology; Zoology	Behavioral Sciences; Neurosciences & Neurology; Physiology; Zoology	CR7TP	WOS:000361554300003		
J	Higurashi, S; Haruta-Ono, Y; Urazono, H; Kobayashi, T; Kadooka, Y				Higurashi, S.; Haruta-Ono, Y.; Urazono, H.; Kobayashi, T.; Kadooka, Y.			Improvement of skin condition by oral supplementation with sphingomyelin-containing milk phospholipids in a double-blind, placebo-controlled, randomized trial	JOURNAL OF DAIRY SCIENCE			English	Article						sphingomyelin; phospholipid; milk fat globule membrane; skin	FAT GLOBULE-MEMBRANE; BOVINE-MILK; HAIRLESS MICE; EPIDERMAL FUNCTION; SPHINGOLIPIDS; WOMEN; CONCENTRATE; ELASTICITY; MEALS	Sphingomyelin (SM), an essential phospholipid for the skin, is contained largely in the milk fat globule membrane surrounding milk fat, concentrated fractions of which are also generated concurrently during the manufacture of dairy products. Such an SM-containing milk phospholipid concentrate (SM-MPC) is useful for investigating the benefits of dietary SM. Here, we examined the effect of consuming SM-MPC on the condition of skin in a double-blind, placebo-controlled, randomized trial. Ninety-six healthy subjects aged 20 to 39 yr with low skin hydration were randomly assigned to 3 groups: a high-SM group supplemented with SM-MPG at a dose equivalent to 10 mg/d of SM, a low-SM group supplemented with SM-MPG equivalent to 5 mg/d of SM, and a placebo group fed a vehicle composed of olive oil and beeswax. During daily supplementation for 12 wk, parameters related to the condition of skin were evaluated at baseline and every 3 wk. Skin hydration at the heel was significantly increased at wk 9 and 12 in the low-SM group compared with the placebo group. Skin elasticity in the region below the eye was significantly increased at wk 9 in the high-SM group versus placebo. Questionnaire-based subjective perceptions of skin conditions were significantly improved for facial skin moisture at wk 3 and 12, and in the wrinkle around the eyes at wk 9 and 12 in the high-SM group versus placebo. Our results indicate that constant and long-term supplementation with SM-MPG is capable of improving the general condition of skin.	[Higurashi, S.; Haruta-Ono, Y.; Urazono, H.; Kobayashi, T.; Kadooka, Y.] Megmilk Snow Brand Co Ltd, Milk Sci Res Inst, Kawagoe, Saitama, Japan	Higurashi, S (reprint author), Megmilk Snow Brand Co Ltd, Milk Sci Res Inst, 1-1-2 Minamidai, Kawagoe, Saitama, Japan.	s-higurashi@meg-snow.com					IMOKAWA G, 1994, J CLIN INVEST, V94, P89, DOI 10.1172/JCI117352; Haruta-Ono Y, 2012, J DERMATOL SCI, V68, P56, DOI 10.1016/j.jdermsci.2012.07.006; Graves ELF, 2007, J DAIRY SCI, V90, P706; Spitsberg VL, 2005, J DAIRY SCI, V88, P2289; Boelsma E, 2003, AM J CLIN NUTR, V77, P348; Yunoki K, 2008, BIOSCI BIOTECH BIOCH, V72, P222, DOI 10.1271/bbb.70463; Izumi T, 2007, J NUTR SCI VITAMINOL, V53, P57, DOI 10.3177/jnsv.53.57; FELDMANN RJ, 1967, J INVEST DERMATOL, V48, P181; Dewettinck K, 2008, INT DAIRY J, V18, P436, DOI 10.1016/j.idairyj.2007.10.014; Ohlsson L, 2010, AM J CLIN NUTR, V91, P672, DOI 10.3945/ajcn.2009.28311; BROD J, 1991, INT J DERMATOL, V30, P84, DOI 10.1111/j.1365-4362.1991.tb04216.x; Parodi PW, 1997, J NUTR, V127, P1055; Contarini G, 2013, INT J MOL SCI, V14, P2808, DOI 10.3390/ijms14022808; Duan JJ, 2012, EXP DERMATOL, V21, P448, DOI 10.1111/j.1600-0625.2012.01501.x; SCHMELZ EM, 1994, J NUTR, V124, P702; Marini A, 2012, SKIN PHARMACOL PHYS, V25, P86, DOI 10.1159/000335261; Haruta Y, 2008, BIOSCI BIOTECH BIOCH, V72, P2151, DOI 10.1271/bbb.80212; Haruta-Ono Y, 2012, ANIM SCI J, V83, P178, DOI 10.1111/j.1740-0929.2011.00940.x; Segger D, 2008, J DERMATOL TREAT, V19, P279, DOI 10.1080/09546630801958238; Haruta Y., 2009, Milk Science, V58, P135; Hori M., 2010, ANTI AGING MED, V7, P129; Imokawa G., 2014, J CLIN EXP DERMATOL, V5, P1; JENSEN RG, 1991, J DAIRY SCI, V74, P3228; Kiillenberg D., 2012, LIPIDS HLTH DIS, V11, P3; Schmelz E. M., 2000, Nutrition Bulletin, V25, P135, DOI 10.1046/j.1467-3010.2000.00031.x; Ya-Xian Zhen, 1999, Archives of Dermatological Research, V291, P555, DOI 10.1007/s004030050453	26	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-0302	1525-3198		J DAIRY SCI	J. Dairy Sci.	OCT	2015	98	10					6706	6712		10.3168/jds.2015-9529		7	Agriculture, Dairy & Animal Science; Food Science & Technology	Agriculture; Food Science & Technology	CS1YS	WOS:000361865400007		
J	Awata, T; Yamada, S; Tsushima, K; Sakashita, H; Yamaba, S; Kajikawa, T; Yamashita, M; Takedachi, M; Yanagita, M; Kitamura, M; Murakami, S				Awata, T.; Yamada, S.; Tsushima, K.; Sakashita, H.; Yamaba, S.; Kajikawa, T.; Yamashita, M.; Takedachi, M.; Yanagita, M.; Kitamura, M.; Murakami, S.			PLAP-1/Asporin Positively Regulates FGF-2 Activity	JOURNAL OF DENTAL RESEARCH			English	Article						periodontal ligament; extracellular matrix; growth factors; cell differentiation; cell proliferation; BMP-2	FIBROBLAST-GROWTH-FACTOR; HUMAN PERIODONTAL-LIGAMENT; EXTRACELLULAR-MATRIX; NEGATIVE REGULATOR; DECORIN INTERACTS; EXPRESSION; RECEPTOR; CELLS; FAMILY; DIFFERENTIATION	PLAP-1 is an extracellular matrix protein that is predominantly expressed in the periodontal ligament within periodontal tissue. It was previously revealed that PLAP-1 negatively regulates bone morphogenetic protein 2 and transforming growth factor activity through direct interactions. However, the interaction between PLAP-1 and other growth factors has not been defined. Here, we revealed that PLAP-1 positively regulates the activity of fibroblast growth factor 2 (FGF-2), a critical growth factor in tissue homeostasis and repair. In this study, we isolated mouse embryonic fibroblasts (MEFs) from Plap-1(-/-) mice generated in our laboratory. Interestingly, Plap-1(-/-) MEFs exhibited enhanced responses to bone morphogenetic protein 2 but defective responses to FGF-2, and Plap-1 transfection into Plap-1(-/-) MEFs rescued these defective responses. In addition, binding assays revealed that PLAP-1 promotes FGF-2-FGF receptor 1 (FGFR1) complex formation by direct binding to FGF-2. Immunocytochemistry analyses revealed colocalization of PLAP-1 and FGF-2 in wild-type MEFs and reduced colocalization of FGF-2 and FGFR1 in Plap-1(-/-) MEFs compared with wild-type MEFs. Taken together, PLAP-1 positively regulates FGF-2 activity through a direct interaction. Extracellular matrix-growth factor interactions have considerable effects; thus, this approach may be useful in several regenerative medicine applications.	[Awata, T.; Yamada, S.; Tsushima, K.; Sakashita, H.; Yamaba, S.; Kajikawa, T.; Yamashita, M.; Takedachi, M.; Yanagita, M.; Kitamura, M.; Murakami, S.] Osaka Univ, Grad Sch Dent, Dept Periodontol, Suita, Osaka 5650871, Japan	Yamada, S (reprint author), Osaka Univ, Grad Sch Dent, Dept Periodontol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	satoru@dent.osaka-u.ac.jp			Japan Society for the Promotion of Science [23249086, 26293437, 26893146]	This work was supported by Grants-in-Aid from the Japan Society for the Promotion of Science (Nos. 23249086, 26293437, and 26893146). The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Yamada S, 2007, J BIOL CHEM, V282, P23070, DOI 10.1074/jbc.M611181200; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Tomoeda M, 2008, BIOCHEM BIOPH RES CO, V371, P191, DOI 10.1016/j.bbrc.2008.03.158; Xu L, 2015, OSTEOARTHR CARTILAGE, V23, P933, DOI 10.1016/j.joca.2015.02.011; Cabello-Verrugio C, 2012, J BIOL CHEM, V287, P6773, DOI 10.1074/jbc.M111.312488; Murakami S, 1999, J PERIODONTAL RES, V34, P425, DOI 10.1111/j.1600-0765.1999.tb02277.x; Vial C, 2011, J BIOL CHEM, V286, P24242, DOI 10.1074/jbc.M110.189365; Dangaria SJ, 2009, DIFFERENTIATION, V78, P79, DOI 10.1016/j.diff.2009.03.005; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; DAHL LK, 1952, P SOC EXP BIOL MED, V80, P474; Endo Y, 2012, DEV CELL, V23, P305, DOI 10.1016/j.devcel.2012.07.006; SVENSSON L, 1995, J BIOL CHEM, V270, P20712; Saeed H, 2012, STEM CELL REV REP, V8, P318, DOI 10.1007/s12015-011-9315-x; Takayama S, 1998, J PERIODONTAL RES, V33, P315, DOI 10.1111/j.1600-0765.1998.tb02205.x; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Henry SP, 2001, J BIOL CHEM, V276, P12212, DOI 10.1074/jbc.M011290200; Kishimoto K, 2010, BIOCHEM BIOPH RES CO, V397, P187, DOI 10.1016/j.bbrc.2010.05.077; Shimazu A, 1999, J DENT RES, V78, P1791; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Murakami S, 2011, PERIODONTOL 2000, V56, P188, DOI 10.1111/j.1600-0757.2010.00365.x; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lallier TE, 2001, J DENT RES, V80, P1748; Shimabukuro Y, 2005, J CELL PHYSIOL, V203, P557, DOI 10.1002/jcp.20256; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Sulochana KN, 2005, J BIOL CHEM, V280, P27935, DOI 10.1074/jbc.M414320200; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663; Okamoto T, 1997, IN VITRO CELL DEV-AN, V33, P302; Kitamura M, 2011, J DENT RES, V90, P35, DOI 10.1177/0022034510384616; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Yamada S, 2001, GENE, V275, P279, DOI 10.1016/S0378-1119(01)00683-7; Grzibovskis Maris, 2011, Stomatologija, V13, P117; Hogan B, 1994, MANIPULATING MOUSE E; Kajikawa T, 2014, J DENT RES, V93, P400, DOI 10.1177/0022034513520549; Kitamura M, 2008, PLOS ONE, V2, pe2611, DOI DOI 10.1371/J0URNAL.P0NE.0002611; SalomAo MF, 2013, DENT PRESS J ORTHOD, V19, P67; Winge SB, 2015, MOL CELL ENDOCRINOL, V399, P235, DOI 10.1016/j.mce.2014.09.018; Yamada S, 2008, JAPANESE DENT SCI RE, V44, P137, DOI 10.1016/j.jdsr.2008.07.002	40	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	OCT	2015	94	10					1417	1424		10.1177/0022034515598507		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CS1JD	WOS:000361819400013		
J	Arino, M; Ito, A; Fujiki, S; Sugiyama, S; Hayashi, M				Arino, Masumi; Ito, Ataru; Fujiki, Shozo; Sugiyama, Seiichi; Hayashi, Mikako			Multicenter study on caries risk assessment in Japanese adult patients	JOURNAL OF DENTISTRY			English	Article						Primary caries; Secondary caries; Risk assessment; CART; Cariogenic bacteria; Compliance with a preventive program; DMFT	DENTAL-CARIES; CHILDREN; PREDICTION; EXPERIENCE; INCREMENT	Objectives: This study was conducted to identify significant risk factors for the onset and the accumulation of new caries in adult patients undergoing regular preventive therapy. Methods: The data of 732 patients from nine Japanese general dental practices were retrospectively analyzed. Classification and regression tree (CART) analysis was applied to develop a caries prediction model using the following patient parameters: age, number of teeth with caries experience (DMFT), levels of mutans streptococci (SM) and lactobacilli (LB), saliva flow rate and buffer capacity, and compliance with a preventive program. Poisson regression analysis was conducted to identify factors affecting caries accumulation within three years. Results: CART analysis identified patients at high risk for primary caries with an odds ratio of 3.08 (95% CI, 1.55-5.79; p = 0.0018) according to SM levels and compliance; and those for secondary caries with an odds ratio of 3.69 (95% CI, 2.29-5.91; p < 0.0001) according to LB and SM levels. Poisson regression analyses showed that accumulation of primary caries was affected by compliance (p < 0.001), SM (p < 0.001) and LB (p = 0.013). Accumulation of secondary caries was affected by DMFT (p < 0.001), SM (p < 0.001) and LB (p < 0.001). Conclusions: CART is an important tool in identifying the risk of caries development in individual adult patients. Cariogenic bacteria are important factors for both the onset and accumulation of primary and secondary caries. Clinical significance: Participation in a regular preventive program limits the onset and the accumulation of primary caries in adult patients. (C) 2015 Elsevier Ltd. All rights reserved.	[Arino, Masumi; Ito, Ataru; Hayashi, Mikako] Osaka Univ, Grad Sch Dent, Dept Restorat Dent & Endodontol, Suita, Osaka 5650871, Japan; [Fujiki, Shozo; Sugiyama, Seiichi] Japan Hlth Care Dent Assoc, Bunkyo Ku, Tokyo 1120014, Japan	Hayashi, M (reprint author), Osaka Univ, Grad Sch Dent, Dept Restorat Dent & Endodontol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	mikarin@dent.osaka-u.ac.jp			Japan Society for the Promotion of Science [25293387]	This study was supported by Grants-in-Aid for Scientific Research (25293387) from the Japan Society for the Promotion of Science. We would like to offer our special thanks to Dr Natsuki Fujiwara (Fujiwara Dental Clinic), Dr Atsushi Okubo (Okubo Dental Office), Dr Takatomo Oi (Oi Dental Clinic), Dr Katsuyoshi Shimizu (Shimizu Dental Clinic), Dr Masaomi Suzuki (Suzuki Dental Clinic), Dr Keiko Takagi (Takagi Dental Clinic), Dr KohtaroTakisawa (Takisawa Dental Clinic), and Dr Wataru Yamanaka (YA Dental Clinic) for their contributions in providing the clinical data.	Evans RW, 2008, AUST DENT J, V53, P83, DOI 10.1111/j.1834-7819.2007.00004.x; Reich E, 1999, INT DENT J, V49, P15; RUGGGUNN AJ, 1984, ARCH ORAL BIOL, V29, P983, DOI 10.1016/0003-9969(84)90145-6; STAMM JW, 1988, J PUBLIC HEALTH DENT, V48, P225, DOI 10.1111/j.1752-7325.1988.tb03203.x; STEWART PW, 1991, J DENT RES, V70, P1239, DOI 10.1177/00220345910700090301; Bader JD, 2005, J PUBLIC HEALTH DENT, V65, P76, DOI 10.1111/j.1752-7325.2005.tb02790.x; Roberts-Thomson K, 2008, AUST DENT J, V53, P122, DOI 10.1111/j.1834-7819.2008.00020.x; MACPHERSON LMD, 1990, J DENT RES, V69, P1712, DOI 10.1177/00220345900690110201; Nishi M, 2002, COMMUNITY DENT ORAL, V30, P296, DOI 10.1034/j.1600-0528.2002.00054.x; Burt BA, 1998, ACTA ODONTOL SCAND, V56, P179, DOI 10.1080/000163598422956; AKAIKE H, 1978, ANN I STAT MATH, V30, P9, DOI 10.1007/BF02480194; Gao XL, 2010, J DENT RES, V89, P637, DOI 10.1177/0022034510364489; Rindal DB, 2006, COMMUNITY DENT ORAL, V34, P381; LEVERETT DH, 1993, J DENT RES, V72, P538, DOI 10.1177/00220345930720021101; Powell LV, 1998, J AM DENT ASSOC, V129, P349; BJERTNESS E, 1991, ACTA ODONTOL SCAND, V49, P97, DOI 10.3109/00016359109005893; STEINER M, 1992, J DENT RES, V71, P1926, DOI 10.1177/00220345920710121401; Sonbul H, 2008, ACTA ODONTOL SCAND, V66, P351, DOI 10.1080/00016350802325853; GRINDEFJORD M, 1995, CARIES RES, V29, P343; Ito A, 2011, J DENT, V39, P457, DOI 10.1016/j.jdent.2011.04.002; Messer LB, 2000, AUST DENT J, V45, P10, DOI 10.1111/j.1834-7819.2000.tb00235.x; Krasse B, 2001, J DENT RES, V80, P1785; DISNEY JA, 1992, COMMUNITY DENT ORAL, V20, P64, DOI 10.1111/j.1600-0528.1992.tb00679.x; BURT BA, 1988, J DENT RES, V67, P1422, DOI 10.1177/00220345880670111201; MILNES AR, 1985, CARIES RES, V19, P289; Patel S, 2010, J AM DENT ASSOC, V141, P527; MCGRADY JA, 1995, J DENT RES, V74, P649; FIRESTONE A R, 1985, Clinical Preventive Dentistry, V7, P24; Freitas A.A., 2002, DATA MIN KNOWL DISC, P13; Hänsel Petersson Gunnel, 2003, Acta Odontol Scand, V61, P164, DOI 10.1080/00016350310002261; Ito A, 2012, J DENT RES, V91, pS52, DOI 10.1177/0022034511435701; Pitts NB, 2006, BRIT DENT J, V200, P313, DOI 10.1038/sj.bdj.4813377; Ruiz MA, 2007, MED ORAL PATOL ORAL, V12, pE412	33	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0300-5712	1879-176X		J DENT	J. Dent.	OCT	2015	43	10					1223	1228		10.1016/j.jdent.2015.07.010		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CR7IH	WOS:000361522100006		
J	Kakuda, S; Sidhu, SK; Sano, H				Kakuda, Shinichi; Sidhu, Sharanbir K.; Sano, Hidehiko			Buffering or non-buffering; an action of pit-and-fissure sealants	JOURNAL OF DENTISTRY			English	Article						Neutralization; Buffering; Pit and fissure sealing system; Acidity; pH; Decalcification	GLASS-IONOMER; HUMAN-ENAMEL; ION-RELEASE; FLUORIDE; CEMENTS; CARIES	Objectives: The aim of this study was to evaluate the buffering capacity of glass-ionomer material in vitro. The null hypothesis tested was that there is no effect of cured glass-ionomer pit-and-fissure sealant (PFS) pastes on the environmental acidity as well as the tooth substrate. Method: For each material, a cured PFS disk and a section of human enamel were simultaneously soaked in lactic acid solution in a conical tube, and the pH of the solution was measured daily for one week. Subsequently, the total amount of calcium leached out in solution was also measured with ICP-AES. Results: The results showed that the acidity of the solutions changed over time. Significant differences of calcium ion concentration in solution were observed as a result of decalcification. As the PFS products tested did not include calcium, the concentration of calcium ion released indicated acidic erosion of the tooth enamel. Conclusions: The glass-ionomer countered the acid of the solution rapidly and preserved the structure of human tooth enamel. (C) 2015 Elsevier Ltd. All rights reserved.	[Kakuda, Shinichi; Sano, Hidehiko] Hokkaido Univ, Grad Sch Dent Med, Dept Restorat Dent, Div Oral Hlth Sci, Sapporo, Hokkaido 0608586, Japan; [Sidhu, Sharanbir K.] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, London, England	Kakuda, S (reprint author), Hokkaido Univ, Grad Sch Dent Med, Dept Restorat Dent, Div Oral Hlth Sci, Sapporo, Hokkaido 0608586, Japan.	s.kakuda@den.hokudai.ac.jp	Sano, Hidehiko/A-4802-2012; 	Kakuda, Shinichi/0000-0003-0810-0236	JSPS KAKENHI [26861587]	This work was supported by JSPS KAKENHI (Grant Number 26861587).	Czarnecka B, 2002, BIOMATERIALS, V23, P2783, DOI 10.1016/S0142-9612(02)00014-5; Antonson SA, 2012, J AM DENT ASSOC, V143, P115; Frencken JE, 2010, J DENT, V38, P59, DOI 10.1016/j.jdent.2009.09.004; TANAKA M, 1987, J DENT RES, V66, P1591, DOI 10.1177/00220345870660101601; Trairatvorakul C, 2008, J DENT RES, V87, P228; Czarnecka B, 2006, J DENT, V34, P539, DOI 10.1016/j.jdent.2005.08.007; Beauchamp J, 2008, J AM DENT ASSOC, V139, P257; Imazato S, 2009, DENT MATER J, V28, P11; Takahashi N, 2011, J DENT RES, V90, P1463, DOI 10.1177/0022034511423395; Nakajo K, 2009, DENT MATER, V25, P703, DOI [10.1016/j.dental.2008.10.014, 10.1016/j.denta1.2008.10.014]; Fujimoto Y, 2010, DENT MATER J, V29, P392, DOI 10.4012/dmj.2010-015; MILLER BH, 1995, AM J DENT, V8, P182; Ito S, 2011, J DENT, V39, P72, DOI 10.1016/j.jdent.2010.10.011; Nicholson JW, 2000, BIOMATERIALS, V21, P1989, DOI 10.1016/S0142-9612(00)00085-5; KADOMA Y, 1983, BIOMATERIALS, V4, P89, DOI 10.1016/0142-9612(83)90046-7; Clarke N G, 1971, Aust Dent J, V16, P13; Hevinga M.A., 2008, J DENT RES, P495; Martins C., 2012, CARIES RES, V47, P56; SCHERP HW, 1971, SCIENCE, V173, P1199, DOI 10.1126/science.173.4003.1199; Stephan Robert M., 1944, JOUR DENTAL RES, V23, P257, DOI 10.1177/00220345440230040401; Ten Cate J.M., 2012, J DENT RES, V91, P813	21	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0300-5712	1879-176X		J DENT	J. Dent.	OCT	2015	43	10					1285	1289		10.1016/j.jdent.2015.06.013		5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CR7IH	WOS:000361522100015		
J	Tiefenbach, T; Kohlbacher, F				Tiefenbach, Tim; Kohlbacher, Florian			Disasters, donations, and tax law changes: Disentangling effects on subjective well-being by exploiting a natural experiment	JOURNAL OF ECONOMIC PSYCHOLOGY			English	Article						Natural disaster; Donation behavior; Life satisfaction; Happiness; Taxation	PANEL-DATA; CHARITABLE DONATIONS; FUKUSHIMA; HAPPINESS; MODELS; INCOME; DETERMINANTS; JAPAN; MONEY	This study investigates (i) whether an increase in donations in the aftermath of disasters can mitigate the negative effects on subjective well-being (SWB), and if so, (ii) whether policy measures, such as tax law changes, can amplify this mitigating effect by providing further incentives for donations. To analyze these questions, we use data on the recent, impactful triple disaster on March 11,2011 in Japan (3-11). Coincidentally, only three months after the disaster, a long-planned change in tax law was put into effect that allows higher tax deductions for charitable donations. Applying a moderated mediation analysis to a unique dataset, we are able to disentangle the total rise of donations into positive effects that are caused by the disaster itself and positive effects that are caused by the recent change in the Japanese tax law. The results of our study are as follows: First, we show that about 30% of the direct negative effect of 3-11 on SWB is mediated and mitigated by donations. Second, we show that the change in taxation law could have further mitigated the negative SWB effects of 3-11, if more people had been aware of it. However, since a large majority of the Japanese public had not even been aware of the tax law change, potential mitigating effects by increased donations have not been realized. As for policy implications, our results show that governments can create incentives for donations that not only support disaster reconstruction, but also mitigate the negative SWB effects of disasters. (C) 2015 Elsevier B.V. All rights reserved.	[Tiefenbach, Tim] German Inst Japanese Studies DIJ, Chiyoda Ku, Tokyo 1020094, Japan; [Kohlbacher, Florian] Xian Jiaotong Liverpool Univ XJTLU, IBSS, Suzhou, Peoples R China	Tiefenbach, T (reprint author), German Inst Japanese Studies DIJ, Chiyoda Ku, Jochi Kioizaka Bldg 2F,7-1 Kioicho, Tokyo 1020094, Japan.	tiefenbach@dijtokyo.org; florian.kohlbacher@xjtlu.edu.cn					Adena M, 2014, SP22014302 WZB; Alois Stutzer, 2002, HAPPINESS EC EC I AF; Huck S, 2011, J PUBLIC ECON, V95, P351, DOI 10.1016/j.jpubeco.2010.10.005; Aknin LB, 2013, J ECON BEHAV ORGAN, V88, P90, DOI 10.1016/j.jebo.2013.01.008; Matsubayashi T, 2013, SOC SCI MED, V82, P126, DOI 10.1016/j.socscimed.2012.12.021; Dunn EW, 2014, CURR DIR PSYCHOL SCI, V23, P41, DOI 10.1177/0963721413512503; Dolan P, 2008, J ECON PSYCHOL, V29, P94, DOI 10.1016/j.joep.2007.09.001; Dunn EW, 2008, SCIENCE, V319, P1687, DOI 10.1126/science.1150952; Antonakis J, 2010, LEADERSHIP QUART, V21, P1086, DOI 10.1016/j.leaqua.2010.10.010; Karlan D, 2011, J PUBLIC ECON, V95, P344, DOI 10.1016/j.jpubeco.2010.11.024; Luechinger S, 2009, J PUBLIC ECON, V93, P620, DOI 10.1016/j.jpubeco.2008.10.003; Uchida Y, 2014, J HAPPINESS STUD, V15, P207, DOI 10.1007/s10902-013-9463-6; Goebel J, 2015, J POPUL ECON, V28, P1137, DOI 10.1007/s00148-015-0558-8; RANDOLPH WC, 1995, J POLIT ECON, V103, P709, DOI 10.1086/262000; Martin JA, 2013, INT J PUBLIC OPIN R, V25, P547, DOI 10.1093/ijpor/eds044; Preacher KJ, 2015, ANNU REV PSYCHOL, V66, P825, DOI 10.1146/annurev-psych-010814-015258; Rehdanz K, 2015, J ECON BEHAV ORGAN, V116, P500, DOI 10.1016/j.jebo.2015.05.014; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; BARRETT KS, 1991, NATL TAX J, V44, P365; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185; Auten GE, 2002, AM ECON REV, V92, P371, DOI 10.1257/000282802760015793; Carroll N, 2009, J POPUL ECON, V22, P445, DOI 10.1007/s00148-007-0174-3; Brown S, 2012, J ECON BEHAV ORGAN, V84, P97, DOI 10.1016/j.jebo.2012.08.005; Imbens GW, 2009, J ECON LIT, V47, P5, DOI 10.1257/jel.47.1.5; Lewbel A, 2012, J BUS ECON STAT, V30, P67, DOI 10.1080/07350015.2012.643126; Aknin LB, 2013, J PERS SOC PSYCHOL, V104, P635, DOI 10.1037/a0031578; KITCHEN H, 1992, APPL ECON, V24, P709, DOI 10.1080/00036849200000039; Kountouris Y, 2011, KYKLOS, V64, P556, DOI 10.1111/j.1467-6435.2011.00520.x; Baum C. F., 2012, INSTRUMENTAL VARIABL; Brown H. P., 2008, SO EC J, V75, P9; CLOGG CC, 1995, AM J SOCIOL, V100, P1261, DOI 10.1086/230638; Clotfelter C. T., 1985, NATL BUREAU EC RES M; Ferrer-i-Carbonell A, 2004, ECON J, V114, P641, DOI 10.1111/j.1468-0297.2004.00235.x; Greene W.H., 2012, ECONOMETRIC ANAL; Ishino T., 2012, NIHON NO KAKEIKOUDOU, V8, P255; KHANNA J, 1995, J PUBLIC ECON, V56, P257, DOI 10.1016/0047-2727(94)01421-J; Kimball M., 2006, 12062 NBER; Lobb Ano, 2012, Prehosp Disaster Med, V27, P319, DOI 10.1017/S1049023X12000908; Lyubomirsky S., 2004, PURSUING SUSTA UNPUB; Metcalfe R, 2011, ECON J, V121, pF81, DOI 10.1111/j.1468-0297.2010.02416.x; Ohtake F., 2013, 876 OS U I SOC EC RE; Okada N., 2011, INT J DISASTER RISK, V2, P34; Remler D. K., 2011, RES METHODS PRACTICE; Steinberg R., 1990, VOLUNTAS, V1, P61, DOI 10.1007/BF01397438; Sugano S, 2015, RIETI DISCUSSION PAP, V15-E-069; Tiefenbach T, 2015, J HAPPINESS STUD, V16, P333, DOI 10.1007/s10902-014-9512-9; Welsch H, 2014, ECOL ECON, V108, P171, DOI 10.1016/j.ecolecon.2014.10.022; Wooldridge J, 2011, INTRO ECONOMETRICS; Yoruk BK, 2014, J ECON PSYCHOL, V45, P71, DOI 10.1016/j.joep.2014.08.002	49	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4870	1872-7719		J ECON PSYCHOL	J. Econ. Psychol.	OCT	2015	50						94	112		10.1016/j.joep.2015.07.005		19	Economics; Psychology, Multidisciplinary	Business & Economics; Psychology	CR8CQ	WOS:000361579100008		
J	Shiraki, T; Iida, O; Takahara, M; Soga, Y; Mii, S; Okazaki, J; Kuma, S; Yamaoka, T; Kamoi, D; Shintani, Y; Ishikawa, T; Kitano, I; Uematsu, M				Shiraki, Tatsuya; Iida, Osamu; Takahara, Mitsuyoshi; Soga, Yoshimitsu; Mii, Shinsuke; Okazaki, Jin; Kuma, Sosei; Yamaoka, Terutoshi; Kamoi, Daisuke; Shintani, Yoshiaki; Ishikawa, Toshinobu; Kitano, Ikuro; Uematsu, Masaaki			Predictors of 2-Year Mortality and Risk Stratification After Surgical or Endovascular Revascularization of Infrainguinal Artery Disease in Hemodialysis Patients With Critical Limb Ischemia	JOURNAL OF ENDOVASCULAR THERAPY			English	Article						critical limb ischemia; hemodialysis; infrainguinal disease; stenosis; occlusion; endovascular therapy; bypass surgery; bypass graft; mortality	STAGE RENAL-DISEASE; BALLOON ANGIOPLASTY; AMPUTATION-FREE; SERUM-ALBUMIN; LEG BASIL; SURVIVAL; ASSOCIATION; MULTICENTER; TRIAL; VALIDATION	Purpose: To examine the 2-year mortality in hemodialysis (HD) patients with critical limb ischemia (CLI) and determine predictors that may aid in the selection of a revascularization strategy [bypass surgery or endovascular therapy (EVT)] according to current guidelines. Methods: From 2007 to 2009, 246 consecutive CLI patients (mean age 69 +/- 10 years; 170 men) on HD underwent revascularization for de novo infrainguinal lesions (178 EVT and 68 bypass grafting). The majority of the patients had diabetes (170, 69%) and tissue loss (194, 79%); nearly half (111, 45%) were nonambulatory. Overall survival after revascularization was estimated by Kaplan-Meier analysis. Predictors for 2-year mortality after revascularization were determined using a Cox proportional hazards model; results are given as the hazard ratio (HR) and 95% confidence interval (CI). Results: Overall survival rate was 77% at 1 year and 66% at 2 years. Predictors of 2-year mortality after revascularization were age >75 years (HR 1.82, 95% CI 1.14 to 2.91, p=0.012), albumin <3 g/dL (HR 2.31, 95% CI 1.39 to 3.84, p=0.001), and ejection fraction <50% (HR 1.73, 95% CI 1.06 to 2.83, p=0.027). Patients with more predictors had a higher incidence of death within 2 years after revascularization. Conclusion: Advanced age, low albumin level, and low ejection fraction were independently associated with 2-year mortality after revascularization in HD patients with CLI. Risk stratification by these factors would be useful for deciding on a revascularization strategy.	[Shiraki, Tatsuya; Iida, Osamu; Uematsu, Masaaki] Kansai Rosai Hosp, Ctr Cardiovasc, Amagasaki, Hyogo 6608511, Japan; [Takahara, Mitsuyoshi] Osaka Univ, Grad Sch Med, Dept Metab Med, Osaka, Japan; [Soga, Yoshimitsu] Kokura Mem Hosp, Dept Cardiol, Kitakyushu, Fukuoka, Japan; [Mii, Shinsuke] Steel Mem Yawata Hosp, Dept Vasc Surg, Kitakyushu, Fukuoka, Japan; [Okazaki, Jin; Kuma, Sosei] Kokura Mem Hosp, Dept Vasc Surg, Kitakyushu, Fukuoka, Japan; [Yamaoka, Terutoshi] Matsuyama Red Cross Hosp, Dept Vasc Surg, Matsuyama, Ehime, Japan; [Kamoi, Daisuke] Nagoya Kyoritsu Hosp, Dept Cardiol, Nagoya, Aichi, Japan; [Shintani, Yoshiaki] Shin Koga Hosp, Dept Cardiol, Kurume, Fukuoka, Japan; [Ishikawa, Toshinobu] Oita Oka Hosp, Dept Cardiol, Oita, Japan; [Kitano, Ikuro] Shinsuma Gen Hosp, Dept Surg, Kobe, Hyogo, Japan	Iida, O (reprint author), Kansai Rosai Hosp, Ctr Cardiovasc, 3-1-69 Inabasou, Amagasaki, Hyogo 6608511, Japan.	iida.osa@gmail.com		Kuma, Sosei/0000-0001-7291-2912; Shiraki, Tatsuya/0000-0003-1901-1642			Bradbury AW, 2005, LANCET, V366, P1925, DOI 10.1016/S0140-6736(05)67707-5; Nakano M, 2013, J ENDOVASC THER, V20, P113, DOI 10.1583/11-3782.1; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Farooq V, 2013, CIRCULATION, V128, P141, DOI 10.1161/CIRCULATIONAHA.113.001803; Albers M, 2001, EUR J VASC ENDOVASC, V22, P294, DOI 10.1053/ejvs.2001.1469; ISEKI K, 1993, KIDNEY INT, V44, P115, DOI 10.1038/ki.1993.220; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Yamamoto S, 2014, EUR J VASC ENDOVASC, V48, P316, DOI 10.1016/j.ejvs.2014.05.019; Min JK, 2011, J AM COLL CARDIOL, V58, P849, DOI 10.1016/j.jacc.2011.02.074; Schanzer A, 2008, J VASC SURG, V48, P1464, DOI 10.1016/j.jvs.2008.07.062; LOWRIE EG, 1990, AM J KIDNEY DIS, V15, P458; Pifer TB, 2002, KIDNEY INT, V62, P2238, DOI 10.1046/j.1523-1755.2002.00658.x; Iseki K, 2003, NEPHROL DIAL TRANSPL, V18, P782, DOI 10.1093/ndt/gfg145; OWEN WF, 1993, NEW ENGL J MED, V329, P1001, DOI 10.1056/NEJM199309303291404; Yamada T, 2008, J VASC SURG, V47, P318, DOI 10.1016/j.jvs.2007.10.045; Anderson JL, 2013, CIRCULATION, V127, P1425, DOI 10.1161/CIR.0b013e31828b82aa; Zorger N, 2002, J VASC INTERV RADIOL, V13, P355, DOI 10.1016/S1051-0443(07)61736-9; Shiraki T, 2014, J VASC SURG, V60, P383, DOI 10.1016/j.jvs.2014.02.059; Jaar BG, 2004, KIDNEY INT, V65, P613, DOI 10.1111/j.1523-1755.2004.00420.x; Bradbury AW, 2010, J VASC SURG, V51, p18S, DOI 10.1016/j.jvs.2010.01.074; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Rooke TW, 2011, J VASC SURG, V54, P32	22	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1526-6028	1545-1550		J ENDOVASC THER	J. Endovascular Ther.	OCT	2015	22	5					719	724		10.1177/1526602815599413		6	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CS1LQ	WOS:000361827200009		
J	Hung, PV; Maeda, T; Morita, N				Pham Van Hung; Maeda, Tomoko; Morita, Naofumi			Improvement of nutritional composition and antioxidant capacity of high-amylose wheat during germination	JOURNAL OF FOOD SCIENCE AND TECHNOLOGY-MYSORE			English	Article						High-amylose wheat; Germination; Nutrition; Antioxidant	FREE AMINO-ACIDS; DIETARY FIBER; SPROUTED WHEAT; WAXY WHEAT; METAANALYSIS; FRACTIONS; DISEASE; GRAINS; FOOD	High-amylose wheat was subjected to various germination conditions and changes in its nutritional values and antioxidant capacity were investigated. Amounts of soluble dietary fiber, total protein and free lipid of germinated high-amylose wheat increased with increased germination times, whereas no significant changes were observed for insoluble dietary fiber and free fatty acids. Total free amino acid contents of high-amylose wheat gradually increased from 129.7 to 314.4 mg/100 g of grain (db) during 48 h of germination. As compared to ungerminated wheat, essential and functional amino acids including isoleucine, leucine, phenylanaline, valine and gamma-amino butyric acid in the 48 h-germinated wheat increased by 3-10 times. Total phenolic contents of both free and bound phenolics and their antioxidant capacities significantly increased after 24 h of germination and were further improved with prolonged germination times. It appears that nutritional values and bioactive compounds of high amylose wheat significantly improved for enhanced food applications.	[Pham Van Hung] Vietnam Natl Univ, Int Univ, Sch Biotechnol, Hochiminh City, Vietnam; [Maeda, Tomoko] Hyogo Univ Teachers Educ, Dept Life & Hlth Sci, Yashiro, Hyogo 6731494, Japan; [Morita, Naofumi] Toyo Coll Food Technol, Dept Food Packaging Technol, Kawanishi, Hyogo 6660026, Japan	Hung, PV (reprint author), Vietnam Natl Univ, Int Univ, Sch Biotechnol, Quarter 6, Hochiminh City, Vietnam.	pvhung74@gmail.com; moritana2007@yahoo.co.jp					AACC International, 2000, APPR METH AM ASS CER; Nelson K, 2013, CAN J PHYSIOL PHARM, V91, P429, DOI 10.1139/cjpp-2012-0351; Bingham SA, 2003, LANCET, V361, P1496, DOI 10.1016/S0140-6736(03)13174-1; Morita N, 2002, CEREAL CHEM, V79, P491, DOI 10.1094/CCHEM.2002.79.4.491; Adom KK, 2002, J AGR FOOD CHEM, V50, P6182, DOI 10.1021/jf0205099; Liyana-Pathirana CM, 2006, J AGR FOOD CHEM, V54, P1256, DOI 10.1021/jf052556h; [Anonymous], 1997, OFFICIAL METHODS ANA; TKACHUK R, 1979, J SCI FOOD AGR, V30, P53, DOI 10.1002/jsfa.2740300110; Hung PV, 2012, J SCI FOOD AGR, V92, P667, DOI 10.1002/jsfa.4628; SAIKUSA T, 1994, J AGR FOOD CHEM, V42, P1122, DOI 10.1021/jf00041a015; Ruibal-Mendieta NL, 2002, J CEREAL SCI, V35, P337, DOI 10.1006/jcrs.2001.0434; Liyana-Pathirana CM, 2007, J CEREAL SCI, V45, P238, DOI 10.1016/j.jcs.2006.08.007; Brown L, 1999, AM J CLIN NUTR, V69, P30; Yamamori M, 2000, THEOR APPL GENET, V101, P21, DOI 10.1007/s001220051444; Yang F, 2001, INT J FOOD SCI NUTR, V52, P319, DOI 10.1080/09637480120057567; Koehler P, 2007, J AGR FOOD CHEM, V55, P4678, DOI 10.1021/jf0633037; Anderson JW, 2004, J AM COLL NUTR, V23, P5; ANDERSON JW, 1990, CRIT REV FOOD SCI, V29, P95; Bazzano LA, 2002, AM J CLIN NUTR, V76, P93; LEMAR LE, 1976, J FOOD SCI, V41, P719, DOI 10.1111/j.1365-2621.1976.tb00709.x; RANHOTRA GS, 1977, J FOOD SCI, V42, P1373, DOI 10.1111/j.1365-2621.1977.tb14501.x; HARMUTHHOENE AE, 1987, Z LEBENSM UNTERS FOR, V185, P386, DOI 10.1007/BF01042260; Christie WW, 1982, LIPID ANAL; Hung P. V., 2005, CEREAL CHEM, V82, P690; Van Hung P, 2007, STARCH-STARKE, V59, P125, DOI 10.1002/star.200600577; Hung Pham Van, 2011, Food Chem, V126, P1896, DOI 10.1016/j.foodchem.2010.12.015; Morita N, 2003, P 53 AUSTR CER CHEM, P153	27	0	0	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	0022-1155	0975-8402		J FOOD SCI TECH MYS	J. Food Sci. Technol.-Mysore	OCT	2015	52	10					6756	6762		10.1007/s13197-015-1730-6		7	Food Science & Technology	Food Science & Technology	CR7TT	WOS:000361554900069		
J	Shinke, G; Noda, T; Hatano, H; Shimizu, J; Hirota, M; Takata, A; Oshima, K; Tanida, T; Komori, T; Morita, S; Imamura, H; Iwazawa, T; Akagi, K; Dono, K				Shinke, Go; Noda, Takehiro; Hatano, Hisanori; Shimizu, Junzo; Hirota, Masashi; Takata, Akihiro; Oshima, Kazuteru; Tanida, Tsukasa; Komori, Takamichi; Morita, Shunji; Imamura, Hiroshi; Iwazawa, Takashi; Akagi, Kenzo; Dono, Keizo			Feasibility and Safety of Urgent Laparoscopic Cholecystectomy for Acute Cholecystitis After 4 Days from Symptom Onset	JOURNAL OF GASTROINTESTINAL SURGERY			English	Article						Laparoscopic cholecystectomy; Acute cholecystitis; Emergency operation; Blood loss; Late phase	RANDOMIZED CONTROLLED-TRIALS; DELAYED-CHOLECYSTECTOMY; CLINICAL-TRIAL; GANGRENOUS CHOLECYSTITIS; DAYTIME CHOLECYSTECTOMY; MANAGEMENT; METAANALYSIS; NIGHTTIME; SURGERY	It is preferable to perform laparoscopic cholecystectomy for acute cholecystitis in the acute phase, within 72 h of symptom onset. The feasibility and safety of performing urgent laparoscopic cholecystectomy in the late phase (4-7 days after symptom onset) are unclear. The aim of this study was to clarify the feasibility and safety of late phase urgent laparoscopic cholecystectomy. Between 2005 and 2014, 233 patients underwent urgent laparoscopic cholecystectomy for acute cholecystitis within 7 days. We compared clinical features and perioperative outcomes between patients who underwent laparoscopic cholecystectomy within 3 days (early phase group) and 4-7 days after symptom onset (late phase group). There were 193 patients in the early phase group and 40 patients in the late-phase group. Performing laparoscopic cholecystectomy in the late phase did not influence operation time, postoperative complications, or postoperative hospital stay. The rate of conversion to open surgery and blood loss were slightly higher in the late-phase group (8 % and 140 ml) compared with the early phase group (3 % and 69 ml) but were still acceptable. Late phase urgent laparoscopic cholecystectomy for acute cholecystitis was feasible and safe.	[Shinke, Go; Noda, Takehiro; Hatano, Hisanori; Hirota, Masashi; Takata, Akihiro; Oshima, Kazuteru; Tanida, Tsukasa; Komori, Takamichi; Morita, Shunji; Imamura, Hiroshi; Iwazawa, Takashi; Akagi, Kenzo; Dono, Keizo] Toyonaka City Hosp, Dept Surg, Toyonaka, Osaka 5608565, Japan; [Shimizu, Junzo] Osaka Rosai Hosp, Dept Surg, Sakai, Osaka, Japan	Noda, T (reprint author), Toyonaka City Hosp, Dept Surg, 4-14-1 Shibaharacho, Toyonaka, Osaka 5608565, Japan.	t-noda2000@umin.ac.jp					Lo CM, 1996, ANN SURG, V223, P37, DOI 10.1097/00000658-199601000-00006; Lo CM, 1998, ANN SURG, V227, P461, DOI 10.1097/00000658-199804000-00001; JARVINEN HJ, 1980, ANN SURG, V191, P501; Yokoe M, 2013, J HEPATO-BIL-PAN SCI, V20, P35, DOI 10.1007/s00534-012-0568-9; Ohta M, 2012, JSLS-J SOC LAPAROEND, V16, P65, DOI 10.4293/108680812X13291597716023; VANDERLINDEN W, 1981, BRIT J SURG, V68, P753; Yamashita Y, 2006, J HEPATO-BILIARY-PAN, V13, P409, DOI 10.1007/s00534-005-1088-7; SINGER JA, 1994, AM SURGEON, V60, P326; Shikata S, 2005, SURG TODAY, V35, P553, DOI 10.1007/s00595-005-2998-3; Yamashita Y, 2013, J HEPATO-BIL-PAN SCI, V20, P89, DOI 10.1007/s00534-012-0567-x; Low JK, 2007, AM SURGEON, V73, P1188; STRASBERG SM, 1995, J AM COLL SURGEONS, V180, P101; Gurusamy K, 2010, BRIT J SURG, V97, P141, DOI 10.1002/bjs.6870; Johansson M, 2003, J GASTROINTEST SURG, V7, P642, DOI 10.1016/S1091-255X(03)00065-9; Eldar S, 1998, SURG LAPAROSC ENDOSC, V8, P200, DOI 10.1097/00019509-199806000-00008; Lai PBS, 1998, BRIT J SURG, V85, P764; NORRBY S, 1983, BRIT J SURG, V70, P163, DOI 10.1002/bjs.1800700309; Gutt CN, 2013, ANN SURG, V258, P385, DOI 10.1097/SLA.0b013e3182a1599b; LAHTINEN J, 1978, SCAND J GASTROENTERO, V13, P673; Noda T, 2014, HEPATO-GASTROENTEROL, V61, P1501, DOI 10.5754/hge13830; Lau H, 2006, SURG ENDOSC, V20, P82, DOI 10.1007/s00464-005-0100-2; Siddiqui T, 2008, AM J SURG, V195, P40, DOI 10.1016/j.amjsurg.2007.03.004; Madan AK, 2002, AM J SURG, V183, P232, DOI 10.1016/S0002-9610(02)00789-4; Yamashita Y, 2007, J HEPATO-BILIARY-PAN, V14, P91, DOI 10.1007/s00534-006-1161-x; Chandler CF, 2000, AM SURGEON, V66, P896; Popkharitov AI, 2008, LANGENBECK ARCH SURG, V393, P935, DOI 10.1007/s00423-008-0313-7; Choi SB, 2011, AM SURGEON, V77, P401; Peng WK, 2005, BRIT J SURG, V92, P586, DOI 10.1002/bjs.4831; Wu JX, 2014, AM J SURG, V208, P911, DOI 10.1016/j.amjsurg.2014.09.004; Torgenson MJ, 2014, AM J SURG, V208, P917	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1091-255X	1873-4626		J GASTROINTEST SURG	J. Gastrointest. Surg.	OCT	2015	19	10					1787	1793		10.1007/s11605-015-2878-0		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CS0MP	WOS:000361754800008		
J	Kimura, J; Sasaki, K; Okabayashi, T; Shima, Y; Iwata, J; Morita, S				Kimura, Jiro; Sasaki, Kiyoshi; Okabayashi, Takehiro; Shima, Yasuo; Iwata, Jun; Morita, Sojiro			Duodeno-jejunal Intussusception with Acute Pancreatitis in Peutz-Jeghers Syndrome: The First Case Presentation in Childhood	JOURNAL OF GASTROINTESTINAL SURGERY			English	Editorial Material						Peutz-Jeghers syndrome; Duodeno-jejunal intussusception; Acute pancreatitis			[Kimura, Jiro; Sasaki, Kiyoshi] Kochi Hlth Sci Ctr, Dept Pediat Surg, Kochi, Kochi 7818555, Japan; [Kimura, Jiro; Okabayashi, Takehiro; Shima, Yasuo] Kochi Hlth Sci Ctr, Dept Surg Gastroenterol, Kochi, Kochi 7818555, Japan; [Iwata, Jun] Kochi Hlth Sci Ctr, Dept Diagnost Pathol, Kochi, Kochi 7818555, Japan; [Morita, Sojiro] Kochi Hlth Sci Ctr, Dept Radiol, Kochi, Kochi 7818555, Japan	Okabayashi, T (reprint author), Kochi Hlth Sci Ctr, Dept Surg Gastroenterol, 2125-1 Ike, Kochi, Kochi 7818555, Japan.	tokabaya@gmail.com					GIARDIELLO FM, 1987, NEW ENGL J MED, V316, P1511, DOI 10.1056/NEJM198706113162404; Zbuk KM, 2007, NAT CLIN PRACT GASTR, V4, P492, DOI 10.1038/ncpgasthep0902; McGarrity TJ, 2000, AM J GASTROENTEROL, V95, P596; Endo Kosuke, 2012, PEDIAT SURG, V44, P578	4	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1091-255X	1873-4626		J GASTROINTEST SURG	J. Gastrointest. Surg.	OCT	2015	19	10					1922	1924		10.1007/s11605-015-2827-y		3	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CS0MP	WOS:000361754800023		
J	Wada, Y; Ohtsuka, H; Adachi, K				Wada, Yohnosuke; Ohtsuka, Hideo; Adachi, Kensuke			Laparoscopic Views of Obturator Hernia	JOURNAL OF GASTROINTESTINAL SURGERY			English	Editorial Material						Obturator hernia; Laparoscopy; CT	PAIN	In this report, we highlighted the clinical manifestations of obturator hernia and focused on laparoscopic views. Given its rarity and vague symptoms, the early diagnosis of obturator hernia presents a challenge. Although delays in diagnosis cause high rates of morbidity and mortality, CT with multi-planar reformations provides an excellent means of preoperative diagnosis. Despite current progress of laparoscopic surgery, its indication is believed to be limited only in elective obturator hernia repairs because of technical difficulties associated with bowel strangulation followed by a resection anastomosis. However, in selected cases, laparoscopic techniques can provide a minimally invasive option for obturator hernia repairs. These laparoscopic views, together with CT imaging, allow a better understanding of spatial anatomy and abnormality surrounding an obturator hernia.	[Wada, Yohnosuke; Ohtsuka, Hideo; Adachi, Kensuke] Tokyo Metropolitan Tama Med Ctr, Dept Surg, Fuchu, Tokyo 1838524, Japan	Adachi, K (reprint author), Tokyo Metropolitan Tama Med Ctr, Dept Surg, 2-8-29 Musashidai, Fuchu, Tokyo 1838524, Japan.	kensuke_adachi@tmhp.jp					Nasir BS, 2012, HERNIA, V16, P315, DOI 10.1007/s10029-011-0895-9; Yokoyama Y, 1999, WORLD J SURG, V23, P214; Takada T, 2011, LANCET, V377, P1464, DOI 10.1016/S0140-6736(10)62298-2; Tateno Y, 2014, LANCET, V384, P206, DOI 10.1016/S0140-6736(14)60883-7; Losanoff JE, 2002, J AM COLL SURGEONS, V194, P657, DOI 10.1016/S1072-7515(02)01137-7; Burt Bryan M, 2010, Am J Surg, V199, pe75, DOI 10.1016/j.amjsurg.2009.06.027; Yip AW, 1993, SURGERY, V119, P266	7	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1091-255X	1873-4626		J GASTROINTEST SURG	J. Gastrointest. Surg.	OCT	2015	19	10					1925	1926		10.1007/s11605-015-2881-5		2	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CS0MP	WOS:000361754800024		
J	Hiet, MS; Bauhofer, O; Zayas, M; Roth, H; Tanaka, Y; Schirmacher, P; Willemsen, J; Grunvogel, O; Bender, S; Binder, M; Lohmann, V; Lotteau, V; Ruggieri, A; Bartenschlager, R				Hiet, Marie-Sophie; Bauhofer, Oliver; Zayas, Margarita; Roth, Hanna; Tanaka, Yasuhito; Schirmacher, Peter; Willemsen, Joschka; Gruenvogel, Oliver; Bender, Silke; Binder, Marco; Lohmann, Volker; Lotteau, Vincent; Ruggieri, Alessia; Bartenschlager, Ralf			Control of temporal activation of hepatitis C virus-induced interferon response by domain 2 of nonstructural protein 5A	JOURNAL OF HEPATOLOGY			English	Article						NS5A; HCV; Subversion of interferon response; HCV-mediated MDA5 activation	WEST NILE VIRUS; RIG-I; REGULATORY FACTOR-3; ANTIVIRAL RESPONSE; RNA REPLICATION; HEPATOMA-CELLS; NS5A PROTEIN; INFECTION; MDA5; GENE	Background & Aims: Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) is a multifunctional protein playing a crucial role in diverse steps of the viral replication cycle and perturbing multiple host cell pathways. We showed previously that removal of a region in domain 2 (D2) of NS5A (mutant NS5A(D2 Delta)) is dispensable for viral replication in hepatoma cell lines. By using a mouse model and immune-competent cell systems, we studied the role of D2 in controlling the innate immune response. Methods: In vivo replication competence of NS5A(D2 Delta) was studied in transgenic mice with human liver xenografts. Results were validated using primary human hepatocytes (PHHs) and mechanistic analyses were conducted in engineered Huh7 hepatoma cells with reconstituted innate signaling pathways. Results: Although the deletion in NS5A removed most of the interferon (IFN) sensitivity determining-region, mutant NS5A(D2 Delta) was as sensitive as the wild type to IFN-alpha and IFN-lambda in vitro, but severely attenuated in vivo. This attenuation could be recapitulated in PHHs and was linked to higher activation of the IFN response, concomitant with reduced viral replication and virus production. Importantly, immune-reconstituted Huh7-derived cell lines revealed a sequential activation of the IFN-response via RIG-I (retinoic acid-inducible gene I) and MDA5 (Myeloma differentiation associated factor 5), respectively, that was significantly higher in the case of the mutant lacking most of NS5A D2. Conclusions: Our study reveals an important role of NS5A D2 for suppression of the IFN response that is activated by HCV via RIG-I and MDA5 in a sequential manner. (C) 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.	[Hiet, Marie-Sophie; Bauhofer, Oliver; Zayas, Margarita; Roth, Hanna; Willemsen, Joschka; Gruenvogel, Oliver; Bender, Silke; Binder, Marco; Lohmann, Volker; Ruggieri, Alessia; Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, Mol Virol, D-69120 Heidelberg, Germany; [Tanaka, Yasuhito] Nagoya City Univ, Dept Virol, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Tanaka, Yasuhito] Nagoya City Univ, Liver Unit, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Schirmacher, Peter] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Willemsen, Joschka; Binder, Marco] German Canc Res Ctr, Div Virus Associated Carcinogenesis, Heidelberg, Germany; [Lotteau, Vincent] Tour Inserm CERVI, CIRI U1111, UMR5308, Lyon, France	Ruggieri, A (reprint author), Heidelberg Univ, Dept Infect Dis, Mol Virol, Neuenheimer Feld 345, D-69120 Heidelberg, Germany.	Alessia_Ruggieri@med.uni-heidelberg.de; Ralf_Bartenschlager@med.uni-heidelberg.de			Deutsche Forschungsgemeinschaft [FOR1202]	Deutsche Forschungsgemeinschaft, FOR1202 (TP1 to R.B. and TP4 to V.L.).	Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07; Kaul A, 2007, J VIROL, V81, P13168, DOI 10.1128/JVI.01362-07; Binder M, 2007, HEPATOLOGY, V46, P1365, DOI 10.1002/hep.21829; Childs K, 2007, VIROLOGY, V359, P190, DOI 10.1016/j.virol.2006.09.023; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Keskinen P, 1999, VIROLOGY, V263, P364, DOI 10.1006/viro.1999.9983; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Scheel TKH, 2011, GASTROENTEROLOGY, V140, P1032, DOI 10.1053/j.gastro.2010.11.036; Ruggieri A, 2012, CELL HOST MICROBE, V12, P71, DOI 10.1016/j.chom.2012.05.013; Li K, 2012, HEPATOLOGY, V55, P666, DOI 10.1002/hep.24763; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Scheel TKH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002696; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Frese M, 2003, J GEN VIROL, V84, P1253, DOI 10.1099/vir.0.18997-0; Cao XZ, 2015, J HEPATOL, V62, P771, DOI 10.1016/j.jhep.2014.11.007; Hato SV, 2007, CELL MICROBIOL, V9, P2921, DOI 10.1111/j.1462-5822.2007.01006.x; Foster TL, 2010, J VIROL, V84, P9267, DOI 10.1128/JVI.00616-10; Bartenschlager R, 2013, NAT REV MICROBIOL, V11, P482, DOI 10.1038/nrmicro3046; Murakami T, 1999, HEPATOLOGY, V30, P1045, DOI 10.1002/hep.510300405; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; El-Shamy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030513; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sumpter Rhea Jr, 2005, Journal of Virology, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Tan S.-L., 2006, HEPATITIS C VIRUSES, P267	32	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-8278	1600-0641		J HEPATOL	J. Hepatol.	OCT	2015	63	4					829	837				9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CS0EG	WOS:000361729900011		
J	Kokudo, T; Hasegawa, K; Uldry, E; Matsuyama, Y; Kaneko, J; Akamatsu, N; Aoki, T; Sakamoto, Y; Demartines, N; Sugawara, Y; Kokudo, N; Halkic, N				Kokudo, Takashi; Hasegawa, Kiyoshi; Uldry, Emilie; Matsuyama, Yutaka; Kaneko, Junichi; Akamatsu, Nobuhisa; Aoki, Taku; Sakamoto, Yoshihiro; Demartines, Nicolas; Sugawara, Yasuhiko; Kokudo, Norihiro; Halkic, Nermin			A new formula for calculating standard liver volume for living donor liver transplantation without using body weight	JOURNAL OF HEPATOLOGY			English	Article						Standard liver volume; Body surface area; Thoracic width; Living donor liver transplantation	SURFACE-AREA; HEPATOCELLULAR-CARCINOMA; ELDERLY-PATIENTS; ADULTS; SIZE; HEPATECTOMY; POPULATION; STEATOSIS; MORTALITY; GENDER	Background & Aims: The standard liver volume (SLV) is widely used in liver surgery, especially for living donor liver transplantation (LDLT). All the reported formulas for SLV use body surface area or body weight, which can be influenced strongly by the general condition of the patient. Methods: We analyzed the liver volumes of 180 Japanese donor candidates and 160 Swiss patients with normal livers to develop a new formula. The dataset was randomly divided into two subsets, the test and validation sample, stratified by race. The new formula was validated using 50 LDLT recipients. Results: Without using body weight-related variables, age, thoracic width measured using computed tomography, and race independently predicted the total liver volume (TLV). A new formula: 203.3 - (3.61 x age) + (58.7 x thoracic width) - (463.7 +/- race [1 = Asian, 0 = Caucasian]), most accurately predicted the TLV in the validation dataset as compared with any other formulas. The graft volume for LDLT was correlated with the postoperative prothrombin time, and the graft volume/SLV ratio calculated using the new formula was significantly better correlated with the postoperative prothrombin time than the graft volume/SLV ratio calculated using the other formulas or the graft volume/body weight ratio. Conclusions: The new formula derived using the age, thoracic width and race predicted both the TLV in the healthy patient group and the SLV in LDLT recipients more accurately than any other previously reported formulas. (C) 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.	[Kokudo, Takashi; Hasegawa, Kiyoshi; Kaneko, Junichi; Akamatsu, Nobuhisa; Aoki, Taku; Sakamoto, Yoshihiro; Sugawara, Yasuhiko; Kokudo, Norihiro] Univ Tokyo, Grad Sch Sci, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo 113, Japan; [Kokudo, Takashi; Hasegawa, Kiyoshi; Kaneko, Junichi; Akamatsu, Nobuhisa; Aoki, Taku; Sakamoto, Yoshihiro; Sugawara, Yasuhiko; Kokudo, Norihiro] Univ Tokyo, Grad Sch Sci, Artificial Organ & Transplantat Div, Dept Surg, Tokyo 113, Japan; [Uldry, Emilie; Demartines, Nicolas; Halkic, Nermin] CHU Vaudois, Univ Hosp, Dept Visceral Surg, CH-1011 Lausanne, Switzerland; [Matsuyama, Yutaka] Univ Tokyo, Sch Publ Hlth, Dept Biostat, Tokyo, Japan	Kokudo, N (reprint author), 7-3-1 Hongo,Bunkyo Ku, Tokyo, Japan.	KOKUDO-2SU@h.u-tokyo.ac.jp					Hashimoto T, 2011, NAT REV GASTRO HEPAT, V8, P667, DOI 10.1038/nrgastro.2011.216; Kokudo T, 2014, J HEPATOL, V61, P583, DOI 10.1016/j.jhep.2014.04.032; Johnson TN, 2005, LIVER TRANSPLANT, V11, P1481, DOI 10.1002/lt.20519; Lin XZ, 1998, HEPATO-GASTROENTEROL, V45, P1069; Hashimoto T, 2006, J GASTROEN HEPATOL, V21, P1710, DOI 10.1111/j.1440-1746.2006.04433.x; Yu HC, 2004, LIVER TRANSPLANT, V10, P779, DOI 10.1002/lt.20188; Suzuki H, 2013, J GASTROENTEROL, V48, P574, DOI 10.1007/s00535-013-0787-0; Chouker A, 2004, LIVER TRANSPLANT, V10, P678, DOI 10.1002/lt.20113; Pomposelli JJ, 2012, LIVER TRANSPLANT, V18, P1083, DOI 10.1002/lt.23461; Yoshizumi T, 2003, TRANSPLANT P, V35, P1415, DOI 10.1016/S0041-1345(03)00482-2; Sugawara Y, 2002, SURGERY, V132, P348, DOI 10.1067/msy.2002.126870; Chan SC, 2012, LIVER TRANSPLANT, V18, P1078, DOI 10.1002/lt.23433; SREEKUMAR KP, 1990, VET RES COMMUN, V14, P5, DOI 10.1007/BF00346377; Chan SC, 2006, WORLD J GASTROENTERO, V12, P2217; Wang WL, 2014, EUR J GASTROEN HEPAT, V26, P444, DOI 10.1097/MEG.0000000000000046; Yuan D, 2008, TRANSPL P, V40, P3536, DOI 10.1016/j.transproceed.2008.07.135; Fu-Gui L, 2009, TRANSPL P, V41, P4052, DOI 10.1016/j.transproceed.2009.08.079; Aoki T, 2011, J GASTROINTEST SURG, V15, P1594, DOI 10.1007/s11605-011-1590-y; MCMAHON T, 1973, SCIENCE, V179, P1201, DOI 10.1126/science.179.4079.1201; Fan ST, 1999, ANN SURG, V229, P322, DOI 10.1097/00000658-199903000-00004; URATA K, 1995, HEPATOLOGY, V21, P1317, DOI 10.1016/0270-9139(95)90053-5; Tzeng CWD, 2014, HPB, V16, P459, DOI 10.1111/hpb.12155; Vauthey JN, 2002, LIVER TRANSPLANT, V8, P233, DOI 10.1053/jlts.2002.31654; Dy GK, 2013, CA-CANCER J CLIN, V63, P249, DOI 10.3322/caac.21184; Soejima Y, 2012, AM J TRANSPLANT, V12, P1877, DOI 10.1111/j.1600-6143.2012.04022.x; Imamura H, 2003, ARCH SURG-CHICAGO, V138, P1198, DOI 10.1001/archsurg.138.11.1198; Dahm F, 2005, AM J TRANSPLANT, V5, P2605, DOI 10.1111/j.1600-6143.2005.01081.x; Sugawara Y, 2002, LIVER TRANSPLANT, V8, P58, DOI 10.1053/jlts.2002.29761; Tongyoo A, 2012, AM J TRANSPLANT, V12, P1229, DOI 10.1111/j.1600-6143.2011.03909.x; Kokudo N, 2005, AM J TRANSPLANT, V5, P1694, DOI 10.1111/j.1600-6143.2005.00917.x; Heinemann A, 1999, LIVER TRANSPLANT SUR, V5, P366, DOI 10.1002/lt.500050516; Siriwardana RC, 2011, LIVER TRANSPLANT, V17, P1437, DOI 10.1002/lt.22430; DELAND FH, 1968, RADIOLOGY, V91, P1195; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; DUBOIS D, 1989, NUTRITION, V5, P303; Makuuchi M, 2006, BR MED B, V75-76, P15, DOI 10.1093/bmb/ldh058; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098; Poovathumkadavil A, 2010, TRANSPL P, V42, P3600, DOI 10.1016/j.transproceed.2010.07.098; Ribero D, 2013, ANN SURG, V258, P801, DOI 10.1097/SLA.0000000000000213	39	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-8278	1600-0641		J HEPATOL	J. Hepatol.	OCT	2015	63	4					848	854				7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CS0EG	WOS:000361729900013		
J	Cheng, AL; Kang, YK; He, AR; Lim, HY; Ryoo, BY; Hung, CH; Sheen, IS; Izumi, N; Austin, T; Wang, Q; Greenberg, J; Shiratori, S; Beckman, RA; Kudo, M				Cheng, Ann-Lii; Kang, Yoon-Koo; He, Aiwu Ruth; Lim, Ho Yeong; Ryoo, Baek-Yeol; Hung, Chao-Hung; Sheen, I-Shyan; Izumi, Namiki; Austin, TaShara; Wang, Qiang; Greenberg, Jonathan; Shiratori, Shinichi; Beckman, Robert A.; Kudo, Masatoshi		Investigators Study Grp	Safety and efficacy of tigatuzumab plus sorafenib as first-line therapy in subjects with advanced hepatocellular carcinoma: A phase 2 randomized study	JOURNAL OF HEPATOLOGY			English	Article						Advanced hepatocellular carcinoma; Combination therapy; CS-1008; Monoclonal antibody; Sorafenib; Tigatuzumab	MULTIKINASE INHIBITOR; TRAIL SENSITIZATION; CLINICAL-TRIALS; SOLID TUMORS; ANTIBODY; CELLS; CS-1008; CANCER; MCL-1; CHEMOTHERAPY	Background & Aims: Tigatuzumab is a humanized monoclonal antibody that acts as a death receptor-5 agonist and exerts tumour necrosis factor-related apoptosis-inducing ligand-like activity. In this phase II study, safety and tolerability of the combination of tigatuzumab and sorafenib was evaluated in patients with advanced hepatocellular carcinoma. Methods: Adults with advanced hepatocellular carcinoma, measurable disease, and an Eastern Cooperative Oncology Group performance score <= 1 were enrolled. Eligible subjects were randomly assigned 1: 1: 1 to tigatuzumab (6 mg/kg loading, 2 mg/kg/week maintenance) plus sorafenib 400 mg twice daily; tigatuzumab (6 mg/kg loading, 6 mg/kg/week maintenance) plus sorafenib 400 mg twice daily; or sorafenib 400 mg twice daily. The primary end point was time to progression. Secondary end points included overall survival and safety. Results: 163 subjects were randomized to treatment. Median time to progression was 3.0 months in the tigatuzumab 6/2 mg/kg combination group (p = 0.988 vs. sorafenib), 3.9 months in the tigatuzumab 6/6 mg/kg combination group (p = 0.586 vs. sorafenib), and 2.8 months in the sorafenib alone group. Median overall survival was 12.2 months in the tigatuzumab 6/6 mg/kg combination group (p = 0.659 vs. sorafenib), vs. 8.2 months in both other treatment groups (p = 0.303, tigatuzumab 6/2 mg/kg combination vs. sorafenib). The most common treatment-emergent adverse events were palmar-plantar erythrodysesthesia syndrome, diarrhea, and decreased appetite. Conclusions: Tigatuzumab combined with sorafenib vs. sorafenib alone in adults with advanced hepatocellular carcinoma did not meet its primary efficacy end point, although tigatuzumab plus sorafenib is well tolerated in hepatocellular carcinoma. (C) 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.	[Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Kang, Yoon-Koo; Ryoo, Baek-Yeol] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea; [He, Aiwu Ruth] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Lim, Ho Yeong] Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea; [Hung, Chao-Hung] Chang Gung Med Fdn Kaohsiung, Kaohsiung, Taiwan; [Sheen, I-Shyan] Chang Gung Med Fdn Linkuo, Taoyaun, Taiwan; [Izumi, Namiki] Japan Red Cross Musashino Hosp, Tokyo, Japan; [Austin, TaShara] Novartis Pharmaceut, E Hanover, NJ USA; [Wang, Qiang; Greenberg, Jonathan; Shiratori, Shinichi] Daiichi Sankyo Pharma Dev, Edison, NJ USA; [Beckman, Robert A.] Georgetown Univ, Med Ctr, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Beckman, Robert A.] Georgetown Univ, Med Ctr, Innovat Ctr Biomed Informat, Washington, DC 20007 USA; [Beckman, Robert A.] Georgetown Univ, Med Ctr, Dept Biostat Bioinformat & Biomath, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Beckman, Robert A.] Georgetown Univ, Med Ctr, Innovat Ctr Biomed Informat, Washington, DC 20007 USA; [Kudo, Masatoshi] Kinki Univ Hosp, Osaka, Japan	Cheng, AL (reprint author), Natl Taiwan Univ Hosp, 7 Chung Shan South Rd, Taipei 10002, Taiwan.	alcheng@ntu.edu.tw			Daiichi Sankyo Pharma Development, a division of Daiichi Sankyo, Inc.; Daiichi Sankyo Pharma Development	This work was supported with funding from Daiichi Sankyo Pharma Development, a division of Daiichi Sankyo, Inc. Editorial assistance was provided by Sola Neunie,; MSc, of PAREXEL, and was funded by Daiichi Sankyo Pharma Development.	Reck M, 2013, LUNG CANCER, V82, P441, DOI 10.1016/j.lungcan.2013.09.014; Ricci MS, 2007, CANCER CELL, V12, P66, DOI 10.1016/j.ccr.2007.05.006; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Forero-Torres A, 2010, CANCER BIOTHER RADIO, V25, P13, DOI 10.1089/cbr.2009.0673; NERENSTONE SR, 1988, CANCER TREAT REV, V15, P1, DOI 10.1016/0305-7372(88)90007-2; Kim SH, 2008, CANCER RES, V68, P2062, DOI 10.1158/0008-5472.CAN-07-6278; Chen KF, 2013, BRIT J PHARMACOL, V168, P658, DOI 10.1111/j.1476-5381.2012.02212.x; Descotes J, 2008, EXPERT OPIN DRUG MET, V4, P1537, DOI 10.1517/17425250802525496 ; Herr I, 2007, HEPATOLOGY, V46, P266, DOI 10.1002/hep.21740; Meng XW, 2007, J BIOL CHEM, V282, P29831, DOI 10.1074/jbc.M706110200; Kao JH, 2005, LIVER INT, V25, P696, DOI 10.1111/j.1478-3231.2005.01139.x; Yada A, 2008, ANN ONCOL, V19, P1060, DOI 10.1093/annonc/mdn015; Lencioni R, 2010, HEPATOLOGY, V52, P762, DOI 10.1002/hep.23725; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; OKADA S, 1992, HEPATOLOGY, V16, P112, DOI 10.1002/hep.1840160119; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Chang SKY, 2012, SINGAP MED J, V53, P32; Beckman RA, 2007, CANCER, V109, P170, DOI 10.1002/cncr.22402; Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Rosato RR, 2007, CANCER RES, V67, P9490, DOI 10.1158/0008-5472.CAN-07-0598; Llovet JM, 2008, J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Llovet JM, 2013, J CLIN ONCOL, V31, P3509, DOI 10.1200/JCO.2012.47.3009; Bayer Pharma AG, NEX SOR SUMM PROD CH; Beckman Robert A, 2011, Ther Deliv, V2, P333, DOI 10.4155/tde.10.91; Davis Gary L, 2008, Proc (Bayl Univ Med Cent), V21, P266; Dhanasekaran Renumathy, 2012, Hepat Med, V4, P19, DOI 10.2147/HMER.S16316; NHS Choices, ALC REL LIV DIS SYMP	29	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-8278	1600-0641		J HEPATOL	J. Hepatol.	OCT	2015	63	4					896	904				9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CS0EG	WOS:000361729900018		
J	Yada, A; Iimuro, Y; Uyama, N; Uda, Y; Okada, T; Fujimoto, J				Yada, Akito; Iimuro, Yuji; Uyama, Naoki; Uda, Yugo; Okada, Toshihiro; Fujimoto, Jiro			Splenectomy attenuates murine liver fibrosis with hypersplenism stimulating hepatic accumulation of Ly-6C(lo) macrophages	JOURNAL OF HEPATOLOGY			English	Article						Splenectomy; Liver fibrosis; Monocyte/macrophage; Progenitor cell	PERIPHERAL-BLOOD; CELLS; MICE; RECRUITMENT; EXPRESSION; CIRRHOSIS; SUBSETS; DISEASE	Background & Aims: Splenectomy in cirrhotic patients has been reported to improve liver function; however the underlying mechanism remains obscure. In the present study, we investigated the mechanism using a murine model, which represents well the compensated liver cirrhosis. Methods: C57BL/6 male mice were allowed to drink water including thioacetamide (TAA: 300 mg/L) ad libitum for 32 weeks. After splenectomy at 32 weeks, mice were sacrificed on days one, seven, and 28, respectively, while TAA-administration was continued. Perioperative changes in peripheral blood and liver tissues were analyzed. Results: TAA treatment of mice for 32 weeks reproducibly achieved advanced liver fibrosis with splenomegaly, thrombocytopenia, and leukocytopenia. After splenectomy, liver fibrosis was attenuated, and macrophages/monocytes were significantly increased in peripheral blood, as well as in the liver. Progenitor-like cells expressing CK-19, EpCAM, or CD-133 appeared in the liver after TAA treatment, and gradually disappeared after splenectomy. Macrophages/monocytes accumulated in the liver, most of which were negative for Ly-6C, were adjacent to the hepatic progenitor-like cells, and quantitative RT-PCR indicated increased canonical Wnt and decreased Notch signals. As a result, a significant amount of beta-catenin accumulated in the progenitor-like cells. Moreover, relatively small Ki67-positive hepatic cells were significantly increased. Protein expression of MMP-9, to which Ly-6G-positive neutrophils contributed, was also increased in the liver after splenectomy. Conclusions: The hepatic accumulation of macrophages/monocytes, most of which are Ly-6C(lo), the reduction of fibrosis, and the gradual disappearance of hepatic progenitor-like cells possibly play significant roles in the tissue remodeling process in cirrhotic livers after splenectomy. (C) 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.	[Yada, Akito; Iimuro, Yuji; Uyama, Naoki; Uda, Yugo; Okada, Toshihiro; Fujimoto, Jiro] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo 6638501, Japan	Iimuro, Y (reprint author), Hyogo Coll Med, Dept Surg, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	siimuro@hyo-med.ac.jp			Japan Society for the Promotion of Science (JSPS) [25461966, 22591510]	This study was supported in part by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (JSPS), 25461966 and 22591510.	Elsebae Magdy M A, 2008, Int J Surg, V6, P362, DOI 10.1016/j.ijsu.2008.06.001; Lalor PF, 2002, IMMUNOL CELL BIOL, V80, P52, DOI 10.1046/j.1440-1711.2002.01062.x; Asano Y, 2007, HEPATOL RES, V37, P1080, DOI 10.1111/j.1872-034X.2007.00206.x; Greenbaum LE, 2011, INT J BIOCHEM CELL B, V43, P222, DOI 10.1016/j.biocel.2009.11.006; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; Ushitora Y, 2011, DIGEST SURG, V28, P9, DOI 10.1159/000321886; Thomas JA, 2011, HEPATOLOGY, V53, P2003, DOI 10.1002/hep.24315; Palacios RS, 2008, LAB INVEST, V88, P1192, DOI 10.1038/labinvest.2008.91; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Watanabe M, 2009, J GASTROEN HEPATOL, V24, P78, DOI 10.1111/j.1440-1746.2008.05497.x; FERRANTE A, 1987, CLIN EXP IMMUNOL, V70, P158; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; MCBRIDE JA, 1968, BRIT J HAEMATOL, V14, P225, DOI 10.1111/j.1365-2141.1968.tb01489.x; Tomikawa M, 2002, J GASTROEN HEPATOL, V17, P77, DOI 10.1046/j.1440-1746.2002.02656.x; Imura S, 2010, HEPATOL RES, V40, P894, DOI 10.1111/j.1872-034X.2010.00688.x; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Roderfeld M, 2006, FASEB J, V20, P444, DOI 10.1096/fj.05-4828com; Sugawara Y, 2000, J AM COLL SURGEONS, V190, P446, DOI 10.1016/S1072-7515(99)00294-X; Takahashi K, 2013, WORLD J GASTROENTERO, V19, P5250, DOI 10.3748/wjg.v19.i32.5250; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; GOOSSENS PL, 1990, J IMMUNOL METHODS, V132, P137, DOI 10.1016/0022-1759(90)90407-M; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; DURIG M, 1984, J LAB CLIN MED, V104, P110; Kodama Takahiro, 2010, Gastroenterology, V138, P2487, DOI 10.1053/j.gastro.2010.02.054; Kodama T, 2010, GASTROENTEROLOGY, V138, P2498; Kodama T, 2010, GASTROENTEROLOGY, V138, pe2481; Nomura Y, 2013, HEPATOL RES; Williams MJ, 2014, GASTROENTEROLOGY, V146, P349, DOI 10.1053/j.gastro.2013.11.034; Yang L, 2014, GASTROENTEROLOGY, V146, pe1331	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-8278	1600-0641		J HEPATOL	J. Hepatol.	OCT	2015	63	4					905	916				12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CS0EG	WOS:000361729900019		
J	Arai, Y; Yamashita, K; Kuriyama, K; Shiokawa, M; Kodama, Y; Sakurai, T; Mizugishi, K; Uchida, K; Kadowaki, N; Takaori-Kondo, A; Kudo, M; Okazaki, K; Strober, W; Chiba, T; Watanabe, T				Arai, Yasuyuki; Yamashita, Kouhei; Kuriyama, Katsutoshi; Shiokawa, Masahiro; Kodama, Yuzo; Sakurai, Toshiharu; Mizugishi, Kiyomi; Uchida, Kazushige; Kadowaki, Norimitsu; Takaori-Kondo, Akifumi; Kudo, Masatoshi; Okazaki, Kazuichi; Strober, Warren; Chiba, Tsutomu; Watanabe, Tomohiro			Plasmacytoid Dendritic Cell Activation and IFN-alpha Production Are Prominent Features of Murine Autoimmune Pancreatitis and Human IgG4-Related Autoimmune Pancreatitis	JOURNAL OF IMMUNOLOGY			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; REGULATORY T-CELLS; CLINICAL-SIGNIFICANCE; SCLEROSING DISEASE; IMMUNE-RESPONSE; INNATE IMMUNITY; IGG4; MICE; INVOLVEMENT	The abnormal immune response accompanying IgG4-related autoimmune pancreatitis (AIP) is presently unclear. In this study, we examined the role of plasmacytoid dendritic cell (pDC) activation and IFN-alpha production in this disease as well as in a murine model of AIP (MRL/Mp mice treated with polyinosinic-polycytidylic acid). We found that the development of AIP in treated MRL/Mp mice occurred in parallel with pancreatic accumulation of pDCs producing IFN-alpha, and with pDC depletion and IFN-alpha-blocking studies, we showed that such accumulation was necessary for AIP induction. In addition, we found that the pancreas of treated MRL/Mp mice contained neutrophil extracellular traps (NETs) shown previously to stimulate pDCs to produce IFN-alpha. Consistent with these findings, we found that patients with IgG4-related AIP also exhibited pancreatic tissue localization of IFN-alpha-expressing pDCs and had significantly higher serum IFN-alpha levels than healthy controls. In addition, the inflamed pancreas of these patients but not controls also contained NETs that were shown to be capable of pDC activation. More importantly, patient pDCs cultured in the presence of NETs produced greatly increased levels of IFN-alpha and induced control B cells to produce IgG4 (but not IgG1) as compared with control pDCs. These data suggest that pDC activation and production of IFN-alpha is a major cause of murine AIP; in addition, the increased pDC production of IFN-alpha and its relation to IgG4 production observed in IgG4-related AIP suggest that this mechanism also plays a role in the human disease.	[Arai, Yasuyuki; Yamashita, Kouhei; Mizugishi, Kiyomi; Kadowaki, Norimitsu; Takaori-Kondo, Akifumi] Kyoto Univ, Dept Hematol & Oncol, Grad Sch Med, Kyoto 6068507, Japan; [Kuriyama, Katsutoshi; Shiokawa, Masahiro; Kodama, Yuzo; Chiba, Tsutomu; Watanabe, Tomohiro] Kyoto Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Kyoto 6068507, Japan; [Sakurai, Toshiharu; Kudo, Masatoshi] Kinki Univ, Dept Gastroenterol & Hepatol, Sch Med, Osaka 5898511, Japan; [Uchida, Kazushige; Okazaki, Kazuichi] Kansai Med Univ, Dept Gastroenterol & Hepatol, Osaka 5731191, Japan; [Strober, Warren; Watanabe, Tomohiro] NIAID, Mucosal Immun Sect, Lab Host Def, NIH, Bethesda, MD 20892 USA; [Watanabe, Tomohiro] Kyoto Univ, Ctr Innovat Immunoregulat Technol & Therapeut, Grad Sch Med, Kyoto 6068507, Japan	Watanabe, T (reprint author), Kyoto Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	kouhei@k-uhp.kyoto-u.ac.jp; tnahrwtnb@k-uhp.kyoto-u.ac.jp			Japan Society for the Promotion of Science [25293172, 15K15370, 15K09499]; Japanese Society of Gastroenterology; Kato Memorial Trust for Nambyo Research; Special Coordination Funds from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Astellas Pharma Inc.; Health and Labor Sciences Research Grants for Research on Intractable Diseases from the Ministry of Health, Labor and Welfare, Japan	This work was supported by Grants-in-Aid for Scientific Research 25293172 and 15K15370 from the Japan Society for the Promotion of Science, the Japanese Society of Gastroenterology, the Kato Memorial Trust for Nambyo Research, Special Coordination Funds from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Astellas Pharma Inc. in Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program. This work was also supported by Health and Labor Sciences Research Grants for Research on Intractable Diseases from the Ministry of Health, Labor and Welfare, Japan (to T.W.) and by Grant-in-Aid for Scientific Research 15K09499 from the Japan Society for the Promotion of Science (to K.Y.).	Valencia X, 2007, J IMMUNOL, V178, P2579; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Miyoshi H, 2008, PANCREAS, V36, P133, DOI 10.1097/MPA.0b013e3181577553; Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023; Doring Y, 2012, CIRCULATION, V125, P1673, DOI 10.1161/CIRCULATIONAHA.111.046755; Watanabe T, 2013, J GASTROENTEROL, V48, P247, DOI 10.1007/s00535-012-0626-8; Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466; Arai Y, 2014, BIOCHEM BIOPH RES CO, V443, P556, DOI 10.1016/j.bbrc.2013.12.007; Watanabe T, 2012, ARTHRITIS RHEUM-US, V64, P914, DOI 10.1002/art.33386; Kamisawa T, 2013, GUT, V62, P1373, DOI 10.1136/gutjnl-2012-304224; Yamanishi H, 2011, PANCREAS, V40, P840, DOI 10.1097/MPA.0b013e3182143b10; Nishio A, 2011, PANCREAS, V40, P95, DOI 10.1097/MPA.0b013e3181f3a5d4; KANNO H, 1992, CLIN EXP IMMUNOL, V89, P68; Fitzner B, 2009, PANCREATOLOGY, V9, P233, DOI 10.1159/000199434; Tezuka H, 2011, IMMUNITY, V34, P247, DOI 10.1016/j.immuni.2011.02.002; Akitake R, 2010, GUT, V59, P542, DOI 10.1136/gut.2009.200972; Hussain A, 2009, IMMUNOLOGY, V128, P236, DOI 10.1111/j.1365-2567.2009.03108.x; Yamamoto M, 2014, NAT REV RHEUMATOL, V10, P148, DOI 10.1038/nrrheum.2013.183; Gregorio J, 2010, J EXP MED, V207, P2921, DOI 10.1084/jem.20101102; Tsuji Y, 2012, IMMUNITY, V37, P326, DOI 10.1016/j.immuni.2012.05.024; Arai Y, 2013, BIOL BLOOD MARROW TR, V19, P1683, DOI 10.1016/j.bbmt.2013.09.005; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; Yang J, 2011, RHEUMATOLOGY, V50, P1366, DOI 10.1093/rheumatology/ker116; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; Reizis B, 2011, NAT REV IMMUNOL, V11, P558, DOI 10.1038/nri3027; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Jeannin P, 1998, J IMMUNOL, V160, P3555; Schwaiger T, 2014, GUT, V63, P494, DOI 10.1136/gutjnl-2012-303635; Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; Liu Z, 2012, NAT MED, V18, P871, DOI 10.1038/nm.2752; Loschko J, 2011, J IMMUNOL, V187, P6346, DOI 10.4049/jimmunol.1102307; Shi GP, 2013, J IMMUNOL, V191, P415, DOI 10.4049/jimmunol.1201732; Boiocchi L, 2013, BLOOD, V122, P296, DOI 10.1182/blood-2013-05-500413; Kamisawa T, 2006, J GASTROENTEROL, V41, P613, DOI 10.1007/s00535-006-1862-6; Asada M, 2010, PANCREAS, V39, P224, DOI 10.1097/MPA.0b013e3181bab5e2; Okazaki K, 2011, J GASTROENTEROL, V46, P277, DOI 10.1007/s00535-011-0386-x; Kaplan MJ, 2012, J IMMUNOL, V189, P2689, DOI 10.4049/jimmunol.1201719; Okazaki K, 2000, GASTROENTEROLOGY, V118, P573, DOI 10.1016/S0016-5085(00)70264-2; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Watanabe T, 2010, J CLIN INVEST, V120, P1645, DOI 10.1172/JCI39481; Behnen M, 2014, J IMMUNOL, V193, P1954, DOI 10.4049/jimmunol.1400478; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Pelayo R, 2005, BLOOD, V105, P4407, DOI 10.1182/blood-2004-07-2529; Zen Y, 2007, HEPATOLOGY, V45, P1538, DOI 10.1002/hep.21697; Cerutti A, 2011, TRENDS IMMUNOL, V32, P202, DOI 10.1016/j.it.2011.02.004; Price JV, 2013, J CLIN INVEST, V123, P5135, DOI 10.1172/JCI70231; Barrientos L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00166; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, P20, DOI DOI 10.1126/SCITRANSLMED.3001201; Kawa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001637; Kiyama K, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3810; Knight JS, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00380; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Mitroulis I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029318; Schauer C, 2014, NAT MED, V20, P515, DOI 10.1038/nm.3547; Tomas NM, 2014, NEW ENGL J MED, V371, P2277, DOI 10.1056/NEJMoa1409354; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603	57	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	OCT 1	2015	195	7					3033	3044		10.4049/jimmunol.1500971		12	Immunology	Immunology	CS0ID	WOS:000361741200011		
J	Abe, A; Tani-ichi, S; Shitara, S; Cui, G; Yamada, H; Miyachi, H; Kitano, S; Hara, T; Abe, R; Yoshikai, Y; Ikuta, K				Abe, Akifumi; Tani-ichi, Shizue; Shitara, Soichiro; Cui, Guangwei; Yamada, Hisataka; Miyachi, Hitoshi; Kitano, Satsuki; Hara, Takahiro; Abe, Ryo; Yoshikai, Yasunobu; Ikuta, Koichi			An Enhancer of the IL-7 Receptor alpha-Chain Locus Controls IL-7 Receptor Expression and Maintenance of Peripheral T Cells	JOURNAL OF IMMUNOLOGY			English	Article							INTERLEUKIN-7 RECEPTOR; GLUCOCORTICOID-RECEPTOR; LYMPHOID PROGENITORS; POSITIVE SELECTION; UP-REGULATION; IN-VIVO; MEMORY; TRANSCRIPTION; ACTIVATION; SURVIVAL	The IL-7R plays critical roles in lymphocyte development and homeostasis. Although IL-7R expression is strictly regulated during lymphocyte differentiation and the immune response, little is known regarding its in vivo regulation. To address this issue, we established a mouse line with targeted deletion of the conserved non-coding sequence 1 (CNS1) element found 3.6 kb upstream of the IL-7R alpha promoter. We report that IL-7R alpha is expressed normally on T and B cells in thymus and bone marrow of CNS1(-/-) mice except for in regulatory T cells. In contrast, these mice show reduced IL-7R alpha expression in conventional CD4 and CD8 T cells as well as regulatory T, NKT, and gamma delta T cells in the periphery. CD4 T cells of CNS1(-/-) mice showed IL-7R alpha upregulation in the absence of growth factors and IL-7R alpha downregulation by IL-7 or TCR stimulation, although the expression levels were lower than those in control mice. Naive CD4 and CD8 T cells of CNS1(-/-) mice show attenuated survival by culture with IL-7 and reduced homeostatic proliferation after transfer into lymphopenic hosts. CNS1(-/-) mice exhibit impaired maintenance of Ag-stimulated T cells. Furthermore, IL-7R alpha upregulation by glucocorticoids and TNF-alpha was abrogated in CNS1(-/-) mice. This work demonstrates that the CNS1 element controls IL-7R alpha expression and maintenance of peripheral T cells, suggesting differential regulation of IL-7R alpha expression between central and peripheral lymphoid organs.	[Abe, Akifumi; Tani-ichi, Shizue; Shitara, Soichiro; Cui, Guangwei; Hara, Takahiro; Ikuta, Koichi] Kyoto Univ, Lab Biol Protect, Dept Biol Responses, Inst Virus Res, Kyoto 6068507, Japan; [Abe, Akifumi; Shitara, Soichiro] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068501, Japan; [Cui, Guangwei] Kyoto Univ, Grad Sch Med, Kyoto 6068501, Japan; [Yamada, Hisataka; Yoshikai, Yasunobu] Kyushu Univ, Div Host Def, Network Ctr Infect Dis, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Miyachi, Hitoshi; Kitano, Satsuki] Kyoto Univ, Inst Virus Res, Reprod Engn Team, Kyoto 6068507, Japan; [Abe, Ryo] Tokyo Univ Sci, Res Inst Biomed Sci, Div Immunobiol, Chiba 2780022, Japan	Ikuta, K (reprint author), Kyoto Univ, Lab Biol Protect, Dept Biol Responses, Inst Virus Res,Sakyo Ku, 53 Shogoin Kawaharacho, Kyoto 6068507, Japan.	ikuta@virus.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25460589, 26460572, 25111504, 15H01153, 24790469, 24790468]; Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Fujiwara Memorial Foundation; Shimizu Foundation for Immunology and Neuroscience; BioLegend/TOMY Digital Biology Young Scientist Research Award	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Scientific Research [C] Grants 25460589 [to K.I.] and 26460572 [to S.T.], Scientific Research on Innovative Areas Grants 25111504 and 15H01153 [to K.I.], and Young Scientists [B] Grants 24790469 [to S.T.] and 24790468 [to T.H.]). This work was also supported by the Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a grant from the Fujiwara Memorial Foundation, a grant from the Shimizu Foundation for Immunology and Neuroscience, and by the BioLegend/TOMY Digital Biology Young Scientist Research Award for 2011.	Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Corcoran AE, 1998, NATURE, V391, P904; Castro I, 2011, J IMMUNOL, V187, P5170, DOI 10.4049/jimmunol.1003961; Ye SK, 2001, IMMUNITY, V15, P813, DOI 10.1016/S1074-7613(01)00230-8; Pope C, 2001, J IMMUNOL, V166, P3402; Cullen R, 2009, J IMMUNOL, V183, P5807, DOI 10.4049/jimmunol.0803520; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; Chen X, 2009, J IMMUNOL, V183, P6135, DOI 10.4049/jimmunol.0901576; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Brewer JA, 2002, J IMMUNOL, V169, P1837; Mittelstadt PR, 2012, J CLIN INVEST, V122, P2384, DOI 10.1172/JCI63067; Xue HH, 2007, IMMUNITY, V26, P421, DOI 10.1016/j.immuni.2007.03.010; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Matsuda JL, 2002, NAT IMMUNOL, V3, P966, DOI 10.1038/ni837; ISHIKAWA H, 1993, P NATL ACAD SCI USA, V90, P8204, DOI 10.1073/pnas.90.17.8204; Van de Wiele CJV, 2004, J IMMUNOL, V172, P4235; Alves NL, 2008, J IMMUNOL, V180, P5201; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; WALUNAS TL, 1995, J IMMUNOL, V155, P1873; Vogt TK, 2009, BLOOD, V113, P3961, DOI 10.1182/blood-2008-08-176321; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Min B, 2005, J IMMUNOL, V174, P6039; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Tani-ichi S, 2013, P NATL ACAD SCI USA, V110, P612, DOI 10.1073/pnas.1219242110; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; DeKoter RP, 2007, J BIOL CHEM, V282, P14194, DOI 10.1074/jbc.M700377200; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; Mazzucchelli R, 2008, BLOOD, V112, P3283, DOI 10.1182/blood-2008-02-137414; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; Franchimont D, 2002, J IMMUNOL, V168, P2212; McCaughtry TM, 2012, J EXP MED, V209, P2263, DOI 10.1084/jem.20121505; Yajima T, 2005, J IMMUNOL, V174, P3590; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Lee HC, 2005, J IMMUNOL, V174, P7800; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Moore TA, 1996, J IMMUNOL, V157, P2366; Baccala R, 2005, J IMMUNOL, V174, P4606; Feng XM, 2011, NAT IMMUNOL, V12, P544, DOI 10.1038/ni.2034; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Kikuchi K, 2005, J EXP MED, V201, P1197, DOI 10.1084/jem.20050158; Singh A, 2007, J LEUKOCYTE BIOL, V82, P1201, DOI 10.1189/jib.0407240; Tripathi P, 2010, J IMMUNOL, V185, P2116, DOI 10.4049/jimmunol.1000842	46	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	OCT 1	2015	195	7					3129	3138		10.4049/jimmunol.1302447		10	Immunology	Immunology	CS0ID	WOS:000361741200019		
J	Iwayanagi, Y; Igawa, T; Maeda, A; Haraya, K; Wada, NA; Shibahara, N; Ohmine, K; Nambu, T; Nakamura, G; Mimoto, F; Katada, H; Ito, S; Tachibana, T; Jishage, K; Hattori, K				Iwayanagi, Yuki; Igawa, Tomoyuki; Maeda, Atsuhiko; Haraya, Kenta; Wada, Naoko A.; Shibahara, Norihito; Ohmine, Ken; Nambu, Takeru; Nakamura, Genki; Mimoto, Futa; Katada, Hitoshi; Ito, Shunsuke; Tachibana, Tatsuhiko; Jishage, Kou-ichi; Hattori, Kunihiro			Inhibitory Fc gamma RIIb-Mediated Soluble Antigen Clearance from Plasma by a pH-Dependent Antigen-Binding Antibody and Its Enhancement by Fc Engineering	JOURNAL OF IMMUNOLOGY			English	Article							IGG IMMUNE-COMPLEXES; MONOCLONAL-ANTIBODY; THERAPEUTIC ANTIBODIES; IN-VIVO; RECEPTOR; CELLS; VARIANT; AFFINITY; TARGETS; MICE	Fc engineering can modulate the Fc-Fc gamma R interaction and thus enhance the potency of Abs that target membrane-bound Ags, but it has not been applied to Abs that target soluble Ags. In this study, we revealed a previously unknown function of inhibitory Fc gamma RII in vivo and, using an Ab that binds to Ag pH dependently, demonstrated that the function can be exploited to target soluble Ag. Because pH-dependent Ab dissociates Ag in acidic endosome, its Ag clearance from circulation reflects the cellular uptake rate of Ag/Ab complexes. In vivo studies showed that Fc gamma R but not neonatal FcR contributes to Ag clearance by the pHdependent Ab, and when Fc binding to mouse Fc gamma RII and III was increased, Ag clearance was markedly accelerated in wild-type mice and FcR g-chain knockout mice, but the effect was diminished in Fc gamma RII knockout mice. This demonstrates that mouse Fc gamma RII efficiently promotes Ab uptake into the cell and its subsequent recycling back to the cell surface. Furthermore, when a human IgG1 Fc variant with selectively increased binding to human Fc gamma RIIb was tested in human Fc gamma RIIb transgenic mice, Ag clearance was accelerated without compromising the Ab half-life. Taken together, inhibitory Fc gamma RIIb was found to play a prominent role in the cellular uptake of monomeric Ag/Ab immune complexes in vivo, and when the Fc of a pH-dependent Ab was engineered to selectively enhance human Fc gamma RIIb binding, the Ab could accelerate soluble Ag clearance from circulation. We assume such a function would enhance the therapeutic potency of Abs that target soluble Ags.	[Iwayanagi, Yuki; Igawa, Tomoyuki; Maeda, Atsuhiko; Haraya, Kenta; Wada, Naoko A.; Shibahara, Norihito; Ohmine, Ken; Nambu, Takeru; Nakamura, Genki; Mimoto, Futa; Katada, Hitoshi; Ito, Shunsuke; Tachibana, Tatsuhiko; Jishage, Kou-ichi; Hattori, Kunihiro] Chugai Pharmaceut Co Ltd, Div Res, Tokyo 1038324, Japan	Igawa, T (reprint author), Chugai Pharmaceut Co Ltd, Chuo Ku, 1-1 Nihonbashi Muromachi 2 Chome, Tokyo 1038324, Japan.	igawatmy@chugai-pharm.co.jp			Chugai Pharmaceutical Co., Ltd.	This work was supported by Chugai Pharmaceutical Co., Ltd.	Jayson GC, 2005, EUR J CANCER, V41, P555, DOI 10.1016/j.ejca.2004.11.021; Byrd JC, 2007, CLIN CANCER RES, V13, P4448, DOI 10.1158/1078-0432.CCR-06-1463; KURLANDER RJ, 1984, J IMMUNOL, V133, P855; Li FB, 2012, P NATL ACAD SCI USA, V109, P10966, DOI 10.1073/pnas.1208698109; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Clynes RA, 2000, NAT MED, V6, P443; RASHID A, 1992, J IMMUNOL, V148, P1382; Igawa T, 2010, NAT BIOTECHNOL, V28, P1203, DOI 10.1038/nbt.1691; Haringman JJ, 2006, ARTHRITIS RHEUM, V54, P2387, DOI 10.1002/art.21975; Xiao JJ, 2010, AAPS J, V12, P646, DOI 10.1208/s12248-010-9222-0; Overdijk MB, 2012, J IMMUNOL, V189, P3430, DOI 10.4049/jimmunol.1200356; Dall'Acqua WF, 2002, J IMMUNOL, V169, P5171; Zhang CY, 2010, J BIOL CHEM, V285, P34250, DOI 10.1074/jbc.M110.143834; LUKEHART SA, 1985, J IMMUNOL, V134, P585; Baker K, 2011, P NATL ACAD SCI USA, V108, P9927, DOI 10.1073/pnas.1019037108; BENACERRAF B, 1959, J IMMUNOL, V82, P131; TOMIYAMA Y, 1992, BLOOD, V80, P2261; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; HAND PH, 1992, CANCER IMMUNOL IMMUN, V35, P165, DOI 10.1007/BF01756183; Mimoto F, 2013, PROTEIN ENG DES SEL, V26, P589, DOI 10.1093/protein/gzt022; Richards JO, 2008, MOL CANCER THER, V7, P2517, DOI 10.1158/1535-7163.MCT-08-0201; Mimoto F, 2014, MOL IMMUNOL, V58, P132, DOI 10.1016/j.molimm.2013.11.017; Davda JP, 2010, MABS-AUSTIN, V2, P576, DOI 10.4161/mabs.2.5.12833; Igawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063236; Roopenian DC, 2010, METHODS MOL BIOL, V602, P93, DOI 10.1007/978-1-60761-058-8_6; Weflen AW, 2013, MOL BIOL CELL, V24, P2398, DOI 10.1091/mbc.E13-04-0174; Ganesan LP, 2012, J IMMUNOL, V189, P4981, DOI 10.4049/jimmunol.1202017; Jefferis R, 2002, IMMUNOL LETT, V82, P57, DOI 10.1016/S0165-2478(02)00019-6; AREND WP, 1979, J IMMUNOL, V123, P447; Pollreisz A, 2008, BRIT J DERMATOL, V159, P578, DOI 10.1111/j.1365-2133.2008.08700.x; Lux A, 2013, J CLIN IMMUNOL, V33, pS4, DOI 10.1007/s10875-012-9782-0; Clynes R, 1998, P NATL ACAD SCI USA, V95, P652, DOI 10.1073/pnas.95.2.652; Leabman MK, 2013, MABS-AUSTIN, V5, P896, DOI 10.4161/mabs.26436; Martin Pauline L, 2005, J Immunotoxicol, V1, P131, DOI 10.1080/15476910490894904	34	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	OCT 1	2015	195	7					3198	3205		10.4049/jimmunol.1401470		8	Immunology	Immunology	CS0ID	WOS:000361741200026		
J	Yamazaki, S; Nakano, N; Honjo, A; Hara, M; Maeda, K; Nishiyama, C; Kitaura, J; Ohtsuka, Y; Okumura, K; Ogawa, H; Shimizu, T				Yamazaki, Susumu; Nakano, Nobuhiro; Honjo, Asuka; Hara, Mutsuko; Maeda, Keiko; Nishiyama, Chiharu; Kitaura, Jiro; Ohtsuka, Yoshikazu; Okumura, Ko; Ogawa, Hideoki; Shimizu, Toshiaki			The Transcription Factor Ehf Is Involved in TGF-beta-Induced Suppression of Fc epsilon RI and c-Kit Expression and Fc epsilon RI-Mediated Activation in Mast Cells	JOURNAL OF IMMUNOLOGY			English	Article							CHAIN GENE-EXPRESSION; TRANSFORMING GROWTH FACTOR-BETA(1); DENDRITIC CELLS; UP-REGULATION; FACTOR ESE-3; BONE-MARROW; MECHANISM; PROMOTER; DIFFERENTIATION; TGF-BETA-1	Fc epsilon RI, which is composed of alpha, beta, and gamma subunits, plays an important role in IgE-mediated allergic responses. TGF-beta 1 has been reported to suppress Fc epsilon RI and stem cell factor receptor c-Kit expression on mast cell surfaces and to suppress mast cell activation induced by cross-linking of Fc epsilon RI. However, the molecular mechanism by which these expressions and activation are suppressed by TGF-beta 1 remains unclear. In this study, we found that the expression of Ets homologous factor (Ehf), a member of the Ets family transcriptional factors, is upregulated by TGF-beta/Smad signaling in mouse bone marrow-derived mast cells (BMMCs). Forced expression of Ehf in BMMCs repressed the transcription of genes encoding Fc epsilon RI alpha, Fc epsilon RI beta, and c-Kit, resulting in a reduction in cell surface Fc epsilon RI and c-Kit expression. Additionally, forced expression of Ehf suppressed Fc epsilon RI-mediated degranulation and cytokine production. Ehf inhibited the promoter activity of genes encoding Fc epsilon RI alpha, Fc epsilon RI beta, and c-Kit by binding to these gene promoters. Furthermore, the mRNA levels of Gata1, Gata2, and Stat5b were lower in BMMCs stably expressing Ehf compared with control cells. Because GATA-1 and GATA-2 are positive regulators of Fc epsilon RI and c-Kit expression, decreased expression of GATAs may be also involved in the reduction of Fc epsilon RI and c-Kit expression. Decreased expression of Stat5 may contribute to the suppression of cytokine production by BMMCs. In part, mast cell response to TGF-beta 1 was mimicked by forced expression of Ehf, suggesting that TGF-beta 1 suppresses Fc epsilon RI and c-Kit expression and suppresses Fc epsilon RI-mediated activation through upregulation of Ehf.	[Yamazaki, Susumu; Nakano, Nobuhiro; Honjo, Asuka; Hara, Mutsuko; Maeda, Keiko; Nishiyama, Chiharu; Kitaura, Jiro; Okumura, Ko; Ogawa, Hideoki] Juntendo Univ, Grad Sch Med, Atopy Allergy Res Ctr, Tokyo 1138421, Japan; [Yamazaki, Susumu; Honjo, Asuka; Ohtsuka, Yoshikazu; Shimizu, Toshiaki] Juntendo Univ, Grad Sch Med, Dept Pediat & Adolescent Med, Tokyo 1138421, Japan; [Nishiyama, Chiharu] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Tokyo 1258585, Japan	Nakano, N (reprint author), Juntendo Univ, Grad Sch Med, Atopy Allergy Res Ctr, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	nbnakano@juntendo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; program for the Strategic Research Foundation at Private Universities	This work was supported in part by grants-in-aid for scientific research (to N.N.) and a Ministry of Education, Culture, Sports, Science and Technology, Japan-supported program for the Strategic Research Foundation at Private Universities, 2011-2015.	Kanada S, 2008, J IMMUNOL, V180, P8204; Pullen NA, 2012, J BIOL CHEM, V287, P2045, DOI 10.1074/jbc.M111.311142; Nishiyama C, 2005, INT IMMUNOL, V17, P847, DOI 10.1093/intimm/dxh278; Wright SH, 2002, CLIN EXP ALLERGY, V32, P315, DOI 10.1046/j.1365-2222.2002.01233.x; Hasegawa M, 2003, J IMMUNOL, V171, P1927; Sprater F, 2014, SCAND J IMMUNOL, V79, P20, DOI 10.1111/sji.12126; COPELAND NG, 1990, CELL, V63, P175, DOI 10.1016/0092-8674(90)90298-S; Maeda K, 2010, J IMMUNOL, V185, P4252, DOI 10.4049/jimmunol.1001228; Brown JK, 2003, CLIN EXP ALLERGY, V33, P132, DOI 10.1046/j.1365-2222.2003.01571.x; Kashyap M, 2005, EXP HEMATOL, V33, P1281, DOI 10.1016/j.exphem.2005.07.001; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Taniue K, 2011, EMBO REP, V12, P682, DOI 10.1038/embor.2011.81; Maeda K, 2003, J IMMUNOL, V170, P334; Nishiyama C, 1999, J IMMUNOL, V163, P623; Appel S, 2006, BLOOD, V107, P3265, DOI 10.1182/blood-2005-06-2480; Takahashi K, 2003, J IMMUNOL, V171, P2478; RAZIN E, 1984, J IMMUNOL, V132, P1479; Kas K, 2000, J BIOL CHEM, V275, P2986, DOI 10.1074/jbc.275.4.2986; Nishiyama C, 2006, BIOSCI BIOTECH BIOCH, V70, P1, DOI 10.1271/bbb.70.1; Fernando J, 2013, J IMMUNOL, V191, P4505, DOI 10.4049/jimmunol.1202723; DUTTLINGER R, 1993, DEVELOPMENT, V118, P705; Mokrani M, 2014, J IMMUNOL, V192, P2471, DOI 10.4049/jimmunol.1302192; Fang Y, 2013, MUCOSAL IMMUNOL, V6, P1168, DOI 10.1038/mi.2013.16; Kitamura N, 2012, J ALLERGY CLIN IMMUN, V129, P814, DOI 10.1016/j.jaci.2011.10.019; DUBOIS CM, 1994, BLOOD, V83, P3138; Stephens DN, 2013, J BIOL CHEM, V288, P34304, DOI 10.1074/jbc.M113.504399; Brenne K, 2012, HUM PATHOL, V43, P496, DOI 10.1016/j.humpath.2011.05.023; Ito T, 2005, J IMMUNOL, V174, P376; Nishiyama C, 2004, J IMMUNOL, V173, P6458; Nakano N, 2009, J ALLERGY CLIN IMMUN, V123, P74, DOI 10.1016/j.jaci.2008.10.040; Miller HRP, 1999, BLOOD, V93, P3473; Albino D, 2012, CANCER RES, V72, P2889, DOI 10.1158/0008-5472.CAN-12-0212; Silverman ES, 2002, AM J RESP CELL MOL, V27, P697, DOI 10.1165/rcmb.2002-0011OC; Maeda K, 2006, BLOOD, V108, P262, DOI 10.1182/blood-2005-07-2878; Brown JK, 2004, AM J PATHOL, V165, P95, DOI 10.1016/S0002-9440(10)63278-6; Gomez G, 2005, J IMMUNOL, V174, P5987; Nishiyama C, 2002, J IMMUNOL, V168, P4546; Tugores A, 2001, J BIOL CHEM, V276, P20397, DOI 10.1074/jbc.M010930200; Rosbottom A, 2002, J IMMUNOL, V169, P5689; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Wang QH, 2008, IMMUNOGENETICS, V60, P557, DOI 10.1007/s00251-008-0318-y; Inage E, 2014, J IMMUNOL, V192, P3936, DOI 10.4049/jimmunol.1302366; Sprater F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049577	44	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	OCT 1	2015	195	7					3427	3435		10.4049/jimmunol.1402856		9	Immunology	Immunology	CS0ID	WOS:000361741200048		
J	Castaneda, MT; Adachi, O; Hours, RA				Teresita Castaneda, Maria; Adachi, Osao; Alberto Hours, Roque			Reduction of L-phenylalanine in protein hydrolysates using L-phenylalanine ammonia-lyase from Rhodosporidium toruloides	JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY			English	Article						Phenylketonuria; Phenylalanine ammonialyase; Rhodosporidium toruloides; Casein acid hydrolysate; L-Phe removal	CINNAMIC ACID; HYDROXYLASE DEFICIENCY; ENZYME-REACTORS; AMINO-ACID; PHENYLKETONURIA; PURIFICATION; PKU; MANAGEMENT; METABOLISM; YEAST	l-Phenylalanine ammonia-lyase (PAL, EC 4.3.1.25) from Rhodosporidium toruloides was utilized to remove l-phenylalanine (l-Phe) from different commercial protein hydrolysates. A casein acid hydrolysate (CAH, l-Phe similar to 2.28 %) was employed as a model substrate. t-Cinnamic acid resulting from deamination of l-Phe was extracted, analyzed at lambda = 290 nm, and used for PAL activity determination. Optimum reaction conditions, optimized using successive Doehlert design, were 35 mg mL(-1) of CAH and 800 mU mL(-1) of PAL, while temperature and pH were 42 A degrees C and 8.7, respectively. Reaction kinetics of PAL with CAH was determined under optimized conditions. Then, removal of l-Phe from CAH was tested. Results showed that more than 92 % of initial l-Phe was eliminated. Similar results were obtained with other protein hydrolysates. These findings demonstrate that PAL is a useful biocatalyst for l-Phe removal from protein hydrolysates, which can be evaluated as potential ingredients in foodstuffs for PKU patients.	[Teresita Castaneda, Maria; Alberto Hours, Roque] Natl Univ La Plata, Res & Dev Ctr Ind Fermentat, Sch Sci, CINDEFI,UNLP CONICET La Plata, La Plata, Buenos Aires, Argentina; [Adachi, Osao] Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi 7538515, Japan; [Alberto Hours, Roque] Natl Technol Univ La Plata, Reg Fac UTN FRLP, Dept Chem Engn, La Plata, Buenos Aires, Argentina	Hours, RA (reprint author), Natl Univ La Plata, Res & Dev Ctr Ind Fermentat, Sch Sci, CINDEFI,UNLP CONICET La Plata, 47 & 115,B1900ASH, La Plata, Buenos Aires, Argentina.	hours@biotec.org.ar		Castaneda, Maria Teresita/0000-0001-5346-7817	Argentina National Research Council (CONICET) [PIP 0662]; National University of La Plata (UNLP) [11/X650]; National Technological University (UTN) [25/I060]; Japan Society for the Promotion of Science KAKENHI [23580135]	This research was supported by grants from the Argentina National Research Council (CONICET, PIP 0662), the National University of La Plata (UNLP, 11/X650), and the National Technological University (UTN, 25/I060). In addition, a part of this work was supported by FY 2011-2013 Grant-in-Aid for Scientific Research (C), Japan Society for the Promotion of Science KAKENHI 23580135 to O. Adachi. Authors extend their appreciation to Ms. Alicia Maria Noceti and Dr. Gustavo J. C. Borrajo for their assistance.	Soltanizadeh N, 2014, COMPR REV FOOD SCI F, V13, P287, DOI 10.1111/1541-4337.12057; HAVIR EA, 1968, BIOCHEMISTRY-US, V7, P1896, DOI 10.1021/bi00845a038; Sarkissian CN, 2008, P NATL ACAD SCI USA, V105, P20894, DOI 10.1073/pnas.0808421105; FRITZ RR, 1976, J BIOL CHEM, V251, P4646; WHETTEN RW, 1992, PLANT PHYSIOL, V98, P380, DOI 10.1104/pp.98.1.380; AMBRUS CM, 1987, ANN INTERN MED, V106, P531; Feillet F, 2010, PEDIATRICS, V126, P333, DOI 10.1542/peds.2009-3584; OGATA K, 1967, AGR BIOL CHEM TOKYO, V31, P200; Kim W, 2004, MOL THER, V10, P220, DOI 10.1016/j.ymthe.2004.05.001; ADACHI O, 1990, AGR BIOL CHEM TOKYO, V54, P2839; Courtney-Martin G, 2002, AM J PHYSIOL-ENDOC M, V283, pE1249, DOI 10.1152/ajpendo.00319.2001; Kure S, 1999, J PEDIATR-US, V135, P375, DOI 10.1016/S0022-3476(99)70138-1; Vockley J, 2014, GENET MED, V16, P188, DOI 10.1038/gim.2013.157; KOUKOL J, 1961, J BIOL CHEM, V236, P2692; Ates S, 2010, TURK J BIOCHEM, V35, P58; Aguiar A, 2015, MOL GENET METAB, V115, P17, DOI 10.1016/j.ymgme.2015.03.006; YAMADA S, 1981, APPL ENVIRON MICROB, V42, P773; HODGINS DS, 1971, J BIOL CHEM, V246, P2977; Longo N, 2014, LANCET, V384, P37, DOI 10.1016/S0140-6736(13)61841-3; Ney DM, 2009, J INHERIT METAB DIS, V32, P32, DOI 10.1007/s10545-008-0952-4; van Spronsen FJ, 2010, J INHERIT METAB DIS, V33, P671, DOI 10.1007/s10545-010-9216-1; AMBRUS CM, 1983, J PHARMACOL EXP THER, V224, P598; OGATA K, 1966, AGR BIOL CHEM TOKYO, V30, P311; Campistol J, 2011, DEV MED CHILD NEUROL, V53, P405, DOI 10.1111/j.1469-8749.2010.03869.x; ATHERTON ND, 1988, CLIN CHEM, V34, P2241; Borrajo G, 2012, ACTA PED MEX, V33, P279; Cleary MA, 2015, PAEDIAT CHILD HLTH, V25, P108; D'Cunha GB, 1996, PHYTOCHEMISTRY, V42, P17; Doehlert D. H, 1970, APPL STATISTICS, V19, P231, DOI 10.2307/2346327; Williams Robin A, 2008, Clin Biochem Rev, V29, P31	30	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1367-5435	1476-5535		J IND MICROBIOL BIOT	J. Ind. Microbiol. Biotechnol.	OCT	2015	42	10					1299	1307		10.1007/s10295-015-1664-z		9	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CR9CE	WOS:000361650000001		
J	Tajima, T; Hamada, M; Nakashimada, Y; Kato, J				Tajima, Takahisa; Hamada, Mai; Nakashimada, Yutaka; Kato, Junichi			Efficient aspartic acid production by a psychrophile-based simple biocatalyst	JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY			English	Article						Alginate; Biomass; Aspartic acid; Psychrophilic bacteria; Immobilization	ESCHERICHIA-COLI-CELLS; BACILLUS SP YM55-1; THERMOSTABLE ASPARTASE; MICROBIAL-CELLS; CONSTRUCTION; IMMOBILIZATION; PURIFICATION; ENZYMES	We previously constructed a Psychrophile-based Simple bioCatalyst (PSCat) reaction system, in which psychrophilic metabolic enzymes are inactivated by heat treatment, and used it here to study the conversion of aspartic acid from fumaric acid mediated by the activity of aspartate ammonia-lyase (aspartase). In Escherichia coli, the biosynthesis of aspartic acid competes with that of L-malic acid produced from fumaric acid by fumarase. In this study, E. coli aspartase was expressed in psychrophilic Shewanella livingstonensis Ac10 heat treated at 50 A degrees C for 15 min. The resultant PSCat could convert fumaric acid to aspartic acid without the formation of L-malic acid because of heat inactivation of psychrophilic fumarase activity. Furthermore, alginate-immobilized PSCat produced high yields of aspartic acid and could be re-used nine times. The results of our study suggest that PSCat can be applied in biotechnological production as a new approach to increase the yield of target compounds.	[Tajima, Takahisa; Hamada, Mai; Nakashimada, Yutaka; Kato, Junichi] Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Higashihiroshima 7398530, Japan; [Tajima, Takahisa; Nakashimada, Yutaka] Japan Sci & Technol Agcy JST, CREST, Tokyo, Japan	Tajima, T (reprint author), Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, 1-3-1 Kagamiyama, Higashihiroshima 7398530, Japan.	ttajima@hiroshima-u.ac.jp			Core Research for Evolutional Science and Technology (CREST) Program through Japan Science and Technology Agency	We thank Professor Tatsuo Kurihara in Kyoto University for providing S. livingstonensis Ac10-Rif<SUP>r</SUP>. This study was partially supported by the Core Research for Evolutional Science and Technology (CREST) Program through the Japan Science and Technology Agency.	Feller G, 2003, NAT REV MICROBIOL, V1, P200, DOI 10.1038/nrmicro773; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; UEDA Y, 1991, J BIOCHEM-TOKYO, V109, P728; Kawata Y, 1999, ARCH BIOCHEM BIOPHYS, V366, P40, DOI 10.1006/abbi.1999.1186; Chao YP, 2000, ENZYME MICROB TECH, V27, P19, DOI 10.1016/S0141-0229(00)00149-6; TOSA T, 1979, BIOTECHNOL BIOENG, V21, P1697, DOI 10.1002/bit.260211002; SATO T, 1975, BIOTECHNOL BIOENG, V17, P1797, DOI 10.1002/bit.260171209; CHIBATA I, 1974, APPL MICROBIOL, V27, P878; Singh RS, 2013, BIORESOURCE TECHNOL, V145, P217, DOI 10.1016/j.biortech.2012.11.041; Kawamoto J, 2009, J BACTERIOL, V191, P632, DOI 10.1128/JB.00881-08; ARAI H, 1991, AGR BIOL CHEM TOKYO, V55, P2431; FUSEE MC, 1981, APPL ENVIRON MICROB, V42, P672; Miyake R, 2007, APPL ENVIRON MICROB, V73, P4849, DOI 10.1128/AEM.00824-07; Kazuoka T, 2003, J BIOCHEM, V133, P51, DOI 10.1093/jb/mvg012; Cardenas-Fernandez M, 2012, BIOPROC BIOSYST ENG, V35, P1437, DOI 10.1007/s00449-012-0732-2; Sambrook J., 1989, MOL CLONING LAB MANU; Tajima T, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-69; Takano J, 1997, US Patent, Patent No. [US 5916782 A, 5916782]; Werpy T, 2004, TOP VALUE ADDED CHEM	19	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1367-5435	1476-5535		J IND MICROBIOL BIOT	J. Ind. Microbiol. Biotechnol.	OCT	2015	42	10					1319	1324		10.1007/s10295-015-1669-7		6	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CR9CE	WOS:000361650000003		
J	Zabelina, V; Uchino, K; Mochida, Y; Yonemura, N; Klymenko, V; Sezutsu, H; Tamura, T; Sehnal, F				Zabelina, Valeriya; Uchino, Keiro; Mochida, Yuji; Yonemura, Naoyuki; Klymenko, Vyacheslav; Sezutsu, Hideki; Tamura, Toshiki; Sehnal, Frantisek			Construction and long term preservation of clonal transgenic silkworms using a parthenogenetic strain	JOURNAL OF INSECT PHYSIOLOGY			English	Article						Silkworm; Transgenesis; Parthenogenesis; Cryopreservation; Biotechnology	BOMBYX-MORI L; ARTIFICIAL PARTHENOGENESIS; LIQUID-NITROGEN; FROZEN OVARIES; EGGS; GENE; TRANSFORMATION; INJECTION; INSEMINATION; MUTAGENESIS	For the functional analysis of insect genes as well as for the production of recombinant proteins for biomedical use, clonal transgenic silkworms are very useful. We examined if they could be produced in the parthenogenetic strain that had been maintained for more than 40 years as a female line in which embryogenesis is induced with nearly 100% efficiency by a heat shock treatment of unfertilized eggs. All individuals have identical female genotype. Silkworm transgenesis requires injection of the DNA constructs into the non-diapausing eggs at the preblastodermal stage of embryogenesis. Since our parthenogenetic silkworms produce diapausing eggs, diapause programing was eliminated by incubating ovaries of the parthenogenetic strain in standard male larvae. Chorionated eggs were dissected from the implants, activated by the heat shock treatment and injected with the transgene construct. Several transgenic individuals occurred in the daughter generation. Southern blotting analysis of two randomly chosen transgenic lines VTG1 and VTG14 revealed multiple transgene insertions. Insertions found in the parental females were transferred to the next generation without any changes in their sites and copy numbers, suggesting that transgenic silkworms can be maintained as clonal strains with homozygous transgenes. Cryopreservation was developed for the storage of precious genotypes. As shown for the VTG1 and VTG14 lines, larval ovaries can be stored in DMSO at the temperature of liquid nitrogen, transferred to Grace's medium during defrosting, and then implanted into larvae of either sex of the standard silkworm strains C146 and w1-pnd. Chorionated eggs, which developed in the implants, were dissected and activated by the heat shock to obtain females (nearly 100% efficiency) or by a cold shock to induce development to both sexes in 4% of the eggs. It was then possible to establish bisexual lines homozygous for the transgene. (C) 2015 Elsevier Ltd. All rights reserved.	[Zabelina, Valeriya; Sehnal, Frantisek] Biol Ctr CAS, Ceske Budejovice 37005, Czech Republic; [Uchino, Keiro; Yonemura, Naoyuki; Sezutsu, Hideki; Tamura, Toshiki] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan; [Mochida, Yuji] Inst Sericulture, Ami, Ibaraki 3000324, Japan; [Klymenko, Vyacheslav] Kharkov Natl Univ, UA-61077 Kharkov, Ukraine	Sehnal, F (reprint author), Biol Ctr CAS, Ceske Budejovice 37005, Czech Republic.	vzabelina@entu.cas.cz; uchinoK@affrc.go.jp; mochida@ss.silk.or.jp; yonemura@affrc.go.jp; stemway@gmail.com; ttamura@affrc.go.jp; sehnal@bc.cas.cz			project Postdok_BIOGLOBE [CZ.1.07/2.3.00/30.0032]; European Social Fund; state budget of the Czech Republic [RVO 60077344]; Czech Science Foundation [P502/10/2382]	We thank Mr. Kaoru Nakamura and Mr. Toshiharu Misawa for rearing the silkworms. The working stay of V. Zabelina in the Biology Centre, Czech Academy of Sciences, and in the National Institute of Agrobiological Sciences, Japan, was supported by project CZ.1.07/2.3.00/30.0032 Postdok_BIOGLOBE co-financed by the European Social Fund and the state budget of the Czech Republic (RVO 60077344). Part of the expenditures was covered by Grant P502/10/2382 from the Czech Science Foundation.	Takasu Y, 2014, METHODS, V69, P46, DOI 10.1016/j.ymeth.2014.02.014; Iizuka T, 2013, ADV FUNCT MATER, V23, P5232, DOI 10.1002/adfm.201300365; Grenier AM, 2004, J INSECT PHYSIOL, V50, P751, DOI 10.1016/j.jinsphys.2004.06.002; Sakudoh T, 2007, P NATL ACAD SCI USA, V104, P8941, DOI 10.1073/pnas.0702860104; SHIOMI K, 1994, J INSECT PHYSIOL, V40, P693, DOI 10.1016/0022-1910(94)90096-5; Kiuchi T, 2014, NATURE, V509, P633, DOI 10.1038/nature13315; Ito K, 2008, P NATL ACAD SCI USA, V105, P7523, DOI 10.1073/pnas.0711841105; Mochida Yuji, 2007, Journal of Insect Biotechnology and Sericology, V76, P97; Uchino K, 2008, INSECT BIOCHEM MOLEC, V38, P1165, DOI 10.1016/j.ibmb.2008.09.009; SHINBO H, 1989, CRYOBIOLOGY, V26, P389, DOI 10.1016/0011-2240(89)90063-1; Uchino K, 2007, MOL GENET GENOMICS, V277, P213, DOI 10.1007/s00438-006-0176-y; Tomita M, 2011, BIOTECHNOL LETT, V33, P645, DOI 10.1007/s10529-010-0498-z; KUSUDA J, 1985, J INSECT PHYSIOL, V31, P963, DOI 10.1016/0022-1910(85)90031-9; Tatematsu K, 2010, TRANSGENIC RES, V19, P473, DOI 10.1007/s11248-009-9328-2; Sezutsu Hideki, 2009, Journal of Insect Biotechnology and Sericology, V78, P1; ASTAUROV BL, 1973, GENETIKA+, V9, P93; TERSKAYA ER, 1975, GENETIKA+, V11, P54; Inoue S, 2005, INSECT BIOCHEM MOLEC, V35, P51, DOI 10.1016/j.jibm.2004.10.002; Tamura Toshiki, 2007, Journal of Insect Biotechnology and Sericology, V76, P155; Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P759, DOI 10.1016/j.ibmb.2010.07.012; Sturtevant AH, 1915, AM NAT, V49, P42, DOI 10.1086/279453; Tan A, 2005, P NATL ACAD SCI USA, V102, P11751, DOI 10.1073/pnas.0500954102; Mochida YJ, 2003, CRYOBIOLOGY, V46, P153, DOI 10.1016/S0011-2240(03)00021-X; Quan GX, 2007, INSECT SCI, V14, P85, DOI 10.1111/j.1744-7917.2007.00129.x; Tamura T, 2000, NAT BIOTECHNOL, V18, P81; Horn C, 2002, INSECT BIOCHEM MOLEC, V32, P1221, DOI 10.1016/S0965-1748(02)00085-1; Banno Y, 2013, CRYOBIOLOGY, V66, P283, DOI 10.1016/j.cryobiol.2013.03.004; Sajwan S, 2013, INSECT BIOCHEM MOLEC, V43, P17, DOI 10.1016/j.ibmb.2012.10.011; Astaurov B.L., 1940, ARTIFICIAL PARTHENOG; HASIMOTO HARUO, 1933, JAP JOUR GENETICS, V8, P245; Kawai S., 2012, P NATL ACAD SCI USA, V109, pf591; Klymenko Vyacheslav V., 2001, Journal of Insect Biotechnology and Sericology, V70, P155; Klymenko VV, 2013, ANIM BREED GENET UKR, V47, P40; Mochida Y., 2014, Sanshi Konchu Biotec (Journal of Insect Biotechnology and Sericology), V83, P163; Spiridonova T.L., 1987, IZV AKAD NAUK MOLDAV, V2, P69; Strunnikov V.A., 1987, GENETIC METHODS SELE; Strunnikov V. A., 1969, Genetika, V5, P52; Takami T, 1969, GEN TXB SILKWORM EGG; Takasu Y, 2013, PLOS ONE, V8, P73458; Tatematsu K, 2012, J BIOTECHNOL BIOMA S, V9, P1; Zabelina VY, 2008, SERICOLOGIA, V48, P123; Zabelina V.Y., J BIOSCI UNPUB	42	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-1910	1879-1611		J INSECT PHYSIOL	J. Insect Physiol.	OCT	2015	81						28	35		10.1016/j.jinsphys.2015.06.011		8	Entomology; Physiology; Zoology	Entomology; Physiology; Zoology	CS1WT	WOS:000361860300004		
J	Sugimoto, TN; Kayukawa, T; Matsuo, T; Tsuchida, T; Ishikawa, Y				Sugimoto, Takafumi N.; Kayukawa, Takumi; Matsuo, Takashi; Tsuchida, Tsutomu; Ishikawa, Yukio			A short, high-temperature treatment of host larvae to analyze Wolbachia-host interactions in the moth Ostrinia scapulalis	JOURNAL OF INSECT PHYSIOLOGY			English	Article						Wolbachia; Heat treatment; Male killing; Endosymbiont; Sex-ratio distortion	MALE-KILLING WOLBACHIA; CYTOPLASMIC INCOMPATIBILITY; SEXUAL MOSAICS; FURNACALIS; DROSOPHILA; EXPRESSION; DENSITY; INSECT; BORER; RATIO	Maternally inherited endosymbiotic bacteria of the genus Wolbachia cause various reproductive alterations in their hosts. Wolbachia induces male-specific death during embryonic and larval stages in the moth Ostrinia scapulalis. To investigate how the density of Wolbachia affects their performance in the host, we attempted to reduce its density using a short, high-temperature treatment of the host at the larval stage. Individuals cured of infection as well as sexual mosaics, which harbor Wolbachia, were obtained by this method in the next generation. The sex of uninfected offspring was exclusively male, similar to that of the offspring of larvae treated with antibiotics. A strong correlation was found between Wolbachia density in female moths and the sex ratio of their progeny. These results suggest that a short, high-temperature treatment at the larval stage reduced the density of Wolbachia in the adult stage, and, hence, inhibited interference with the host's development in the next generation. Since the direct effects of the heat treatment on Wolbachia were transient, this method may be useful for specifying the critical time for interference by Wolbachia in host development. (C) 2015 Elsevier Ltd. All rights reserved.	[Sugimoto, Takafumi N.; Matsuo, Takashi; Ishikawa, Yukio] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; [Sugimoto, Takafumi N.; Tsuchida, Tsutomu] Toyama Univ, Grad Sch Sci & Engn, Toyama 9308555, Japan; [Kayukawa, Takumi] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan	Sugimoto, TN (reprint author), Toyama Univ, Grad Sch Sci & Engn, Toyama 9308555, Japan.	sugimoto.tn@gmail.com					Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509; Mouton L, 2006, PARASITOLOGY, V132, P49, DOI 10.1017/S0031182005008723; Dyer KA, 2005, EVOLUTION, V59, P838; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Kageyama D, 2003, GENOME, V46, P983, DOI 10.1139/G03-082; Sugimoto TN, 2010, INSECT BIOCHEM MOLEC, V40, P847, DOI 10.1016/j.ibmb.2010.08.004; Kageyama D, 2003, GENOME, V46, P974, DOI 10.1139/G03-083; Sugimoto TN, 2012, BIOL LETTERS, V8, P412, DOI 10.1098/rsbl.2011.1114; Kageyama D, 2004, P ROY SOC B-BIOL SCI, V271, P251, DOI 10.1098/rspb.2003.2604; Jaenike J, 2009, OIKOS, V118, P353, DOI 10.1111/j.1600-0706.2008.17110.x; Hurst GDD, 2000, GENETICS, V156, P699; Kageyama D, 1998, HEREDITY, V81, P311, DOI 10.1038/sj.hdy.6883910; Sugimoto TN, 2015, APPL ENTOMOL ZOOL, V50, P271, DOI 10.1007/s13355-014-0315-6; Kageyama D, 2002, HEREDITY, V88, P444, DOI 10.1038/sj/hdy/6800077; Pascal C., 2004, Agrociencia (Montevideo), V8, P11; R Development Core Team, 2014, R LANG ENV STAT COMP; Sakamoto Hironori, 2008, Journal of Insect Science (Tucson), V8, P1, DOI 10.1673/031.008.6701; Van Opijnen T, 1999, EXP APPL ACAROL, V23, P871, DOI 10.1023/A:1006363604916; Wiwatanaratanabutr I, 2009, J INVERTEBR PATHOL, V102, P220, DOI 10.1016/j.jip.2009.08.009	19	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-1910	1879-1611		J INSECT PHYSIOL	J. Insect Physiol.	OCT	2015	81						48	51		10.1016/j.jinsphys.2015.06.016		4	Entomology; Physiology; Zoology	Entomology; Physiology; Zoology	CS1WT	WOS:000361860300007		
J	Kobelkova, A; Goto, SG; Peyton, JT; Ikeno, T; Lee, RE; Denlinger, DL				Kobelkova, Alena; Goto, Shin G.; Peyton, Justin T.; Ikeno, Tomoko; Lee, Richard E., Jr.; Denlinger, David L.			Continuous activity and no cycling of clock genes in the Antarctic midge during the polar summer	JOURNAL OF INSECT PHYSIOLOGY			English	Article						Polar biology; Circadian rhythms; Clock genes; Natural conditions; Continuous light	CIRCADIAN BEHAVIORAL RHYTHMS; CONTINUOUS DAYLIGHT; NATURAL CONDITIONS; PLASMA MELATONIN; NERVOUS-SYSTEM; TIMELESS GENES; ARCTIC SUMMER; DROSOPHILA; PERIOD; EXPRESSION	The extreme seasonal shifts of day length in polar regions, ranging from constant light in the summer to constant darkness in the winter, pose an intriguing environment for probing activity rhythms and the functioning of circadian clocks. Here, we monitor locomotor activity during the summer on the Antarctic Peninsula and under laboratory conditions, as well as the accompanying patterns of clock gene expression in the Antarctic midge, the only insect endemic to Antarctica. Larvae and adults are most active during the warmest portion of the day, but at a constant temperature they remain continuously active regardless of the photoregime, and activity also persists in constant darkness. The canonical clock genes period, timeless, Clock, and vrille are expressed in the head but we detected no cycling of expression in either the field or under diverse photoregimes in the laboratory. The timekeeping function of the clock has possibly been lost, enabling the midge to opportunistically exploit the unpredictable availability of permissive thermal conditions for growth, development, and reproduction during the short summer in Antarctica. (C) 2015 Elsevier Ltd. All rights reserved.	[Kobelkova, Alena; Peyton, Justin T.; Denlinger, David L.] Ohio State Univ, Dept Entomol, Columbus, OH 43210 USA; [Kobelkova, Alena; Peyton, Justin T.; Denlinger, David L.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA; [Goto, Shin G.; Ikeno, Tomoko] Osaka City Univ, Grad Sch Sci, Osaka 5588585, Japan; [Lee, Richard E., Jr.] Miami Univ, Dept Zool, Oxford, OH 45056 USA	Denlinger, DL (reprint author), Ohio State Univ, Dept Entomol, Columbus, OH 43210 USA.	denlinger.1@osu.edu			National Science Foundation [OPP-ANT-0837613, OPP-ANT-0837559]	We thank Palmer Station staff for support provided during our field seasons and Martina Hajduskova for assistance in preparing figures of the activity patterns. This work was supported by National Science Foundation OPP-ANT-0837613 and OPP-ANT-0837559.	Sakai T, 2004, P NATL ACAD SCI USA, V101, P16058, DOI 10.1073/pnas.0401472101; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; Kaneko M, 1997, J NEUROSCI, V17, P6745; Sandrelli F, 2008, INSECT MOL BIOL, V17, P447, DOI 10.1111/j.1365-2583.2008.00832.x; Bajgar A, 2013, P NATL ACAD SCI USA, V110, P4416, DOI 10.1073/pnas.1217060110; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Codd V, 2007, GENETICS, V177, P1539, DOI 10.1534/genetics.107.079160; Reierth E, 1998, CAN J ZOOL, V76, P2031, DOI 10.1139/cjz-76-11-2031; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Beaver LM, 2003, J BIOL RHYTHM, V18, P463, DOI 10.1177/0748730403259108; Schmid B, 2011, J BIOL RHYTHM, V26, P464, DOI 10.1177/0748730411414264; Menegazzi P, 2012, J BIOL RHYTHM, V27, P433, DOI 10.1177/0748730412463181; COCKREM JF, 1991, J PINEAL RES, V10, P2, DOI 10.1111/j.1600-079X.1991.tb00002.x; MICHE F, 1991, GEN COMP ENDOCR, V84, P249, DOI 10.1016/0016-6480(91)90048-B; Williams CT, 2012, PHYSIOL BIOCHEM ZOOL, V85, P397, DOI 10.1086/666509; Vleck CM, 2002, CONDOR, V104, P667, DOI 10.1650/0010-5422(2002)104[0667:AODROP]2.0.CO;2; Silverin B, 2009, HORM BEHAV, V56, P163, DOI 10.1016/j.yhbeh.2009.04.002; Qiu J, 1996, MOL CELL BIOL, V16, P4182; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Menegazzi P, 2013, J BIOL RHYTHM, V28, P3, DOI 10.1177/0748730412471303; Convey P, 1996, EUR J ENTOMOL, V93, P1; Ashley NT, 2013, J EXP ZOOL PART A, V319A, P10, DOI 10.1002/jez.1768; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Harada E, 2014, POLAR BIOL, V37, P1213, DOI 10.1007/s00300-014-1511-0; George H, 1997, GENETICS, V146, P1345; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; EWER J, 1992, J NEUROSCI, V12, P3321; Lu WQ, 2010, CURR BIOL, V20, P533, DOI 10.1016/j.cub.2010.01.042; Gentile C, 2009, J BIOL RHYTHM, V24, P444, DOI 10.1177/0748730409349169; Kobelkova A, 2010, J BIOL RHYTHM, V25, P399, DOI 10.1177/0748730410385283; van Oort BEH, 2005, NATURE, V438, P1095, DOI 10.1038/4381095a; Vanin S, 2012, NATURE, V484, P371, DOI 10.1038/nature10991; Beck S.D., 1980, INSECT PHOTOPERIODIS; Bloch G, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0019; Kobelkova A, 2015, J BIOL RHYTHM, V30, P104, DOI 10.1177/0748730414568430; Steiger SS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1016; Stelzer RJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-93; Teschke M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026090	38	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-1910	1879-1611		J INSECT PHYSIOL	J. Insect Physiol.	OCT	2015	81						90	96		10.1016/j.jinsphys.2015.07.008		7	Entomology; Physiology; Zoology	Entomology; Physiology; Zoology	CS1WT	WOS:000361860300012		
J	Nakato, M; Matsuo, M; Kono, N; Arita, M; Arai, H; Ogawa, J; Kioka, N; Ueda, K				Nakato, Mitsuhiro; Matsuo, Michinori; Kono, Nozomu; Arita, Makoto; Arai, Hiroyuki; Ogawa, Jun; Kioka, Noriyuki; Ueda, Kazumitsu			Neurite outgrowth stimulation by n-3 and n-6 PUFAs of phospholipids in apoE-containing lipoproteins secreted from glial cells	JOURNAL OF LIPID RESEARCH			English	Article						polyunsaturated fatty acid; apolipoprotein E-containing lipoprotein; neuron; apolipoprotein E; low density lipoprotein receptor-related protein 1	RECEPTOR-RELATED PROTEIN; POLYUNSATURATED FATTY-ACIDS; DOCOSAHEXAENOIC ACID; APOLIPOPROTEIN-E; NERVOUS-SYSTEM; HIPPOCAMPAL-NEURONS; LDL RECEPTOR; BRAIN; GROWTH; LRP	PUFAs, which account for 25-30% of the total fatty acids in the human brain, are important for normal brain development and cognitive function. However, it remains unclear how PUFAs are delivered to neurons and exert their effects. In this study, we demonstrated that n-3 and n-6 PUFAs added to the medium are incorporated into membrane phospholipids of primary glial cells from rat cortices, and then secreted as the fatty acid moiety of phospholipids in apoE-containing lipoproteins (LpEs). Tandem mass spectrometry analysis further showed that LpEs secreted from glial cells contain a variety of metabolites of PUFAs produced in glial cells by elongation and unsaturation. LpEs are absorbed by endocytosis into neurons via LDL receptor-related protein 1. LpE-containing n-3 and n-6 PUFAs exhibit a strong effect on neurite outgrowth of hippocampal neurons by increasing the number of branches. This study sheds light on the novel role of LpEs in the central nervous system and also a novel pathway in which PUFAs act on neurons.	[Nakato, Mitsuhiro; Ogawa, Jun; Kioka, Noriyuki; Ueda, Kazumitsu] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto 6068502, Japan; [Matsuo, Michinori] Kyoto Womens Univ, Fac Home Econ, Dept Food & Nutr, Kyoto 6058501, Japan; [Kono, Nozomu; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Arita, Makoto] RIKEN, Ctr Integrat Med Sci, Lab Metabol, Yokohama, Kanagawa 2300045, Japan; [Ueda, Kazumitsu] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto 6068502, Japan	Matsuo, M (reprint author), Kyoto Womens Univ, Fac Home Econ, Dept Food & Nutr, Kyoto 6058501, Japan.	matsuomi@kyoto-wu.ac.jp; uedak@kais.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [25221203, 24580139, 26660071]; Bio-Oriented Technology Research Advancement Institution of Japan; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from the Ministry of Agriculture, Forestry and Fisheries of Japan; World Premier International Research Center Initiative, MEXT	This work was supported by Grant-in-Aid for Scientific Research 25221203 (K.U.) and 24580139 and 26660071 (M.M.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); by the Bio-Oriented Technology Research Advancement Institution of Japan; and by Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from the Ministry of Agriculture, Forestry and Fisheries of Japan. This work was also supported by the World Premier International Research Center Initiative, MEXT.	LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Bacskai BJ, 2000, P NATL ACAD SCI USA, V97, P11551, DOI 10.1073/pnas.200238297; MONARD D, 1973, P NATL ACAD SCI USA, V70, P1894, DOI 10.1073/pnas.70.6.1894; TOOYAMA I, 1995, BRAIN RES, V691, P235, DOI 10.1016/0006-8993(95)00735-9; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; Horrocks LA, 2004, PROSTAG LEUKOTR ESS, V70, P361, DOI 10.1016/j.plefa.2003.12.011; Wu HT, 2009, BBA-MOL CELL BIOL L, V1791, P8, DOI 10.1016/j.bbalip.2008.10.004; Zhang WT, 2011, FRONT BIOSCI-LANDMRK, V16, P2653, DOI 10.2741/3878; Matsuo M, 2011, BBA-MOL CELL BIOL L, V1811, P31, DOI 10.1016/j.bbalip.2010.10.004; HOULGATTE R, 1989, J NEUROSCI RES, V24, P143, DOI 10.1002/jnr.490240204; Fagan AM, 1996, J BIOL CHEM, V271, P30121; Martin DD, 1996, LIPIDS, V31, P1283, DOI 10.1007/BF02587914; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Chen CT, 2015, PROSTAG LEUKOTR ESS, V92, P33, DOI 10.1016/j.plefa.2014.05.007; HOLTZMAN DM, 1995, P NATL ACAD SCI USA, V92, P9480, DOI 10.1073/pnas.92.21.9480; INNERARITY TL, 1979, J BIOL CHEM, V254, P4186; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Cao DH, 2005, J NUTR BIOCHEM, V16, P538, DOI 10.1016/j.jnutbio.2005.02.002; Hayashi H, 2007, J NEUROSCI, V27, P1933, DOI 10.1523/JNEUROSCI.5471-06.2007; Calderon F, 2004, J NEUROCHEM, V90, P979, DOI 10.1111/j.1471-4159.2004.02520.x; Gong JS, 2002, J BIOL CHEM, V277, P29919, DOI 10.1074/jbc.M203934200; Koch S, 2001, J LIPID RES, V42, P1143; Hayashi H, 2009, J BIOL CHEM, V284, P29605, DOI 10.1074/jbc.M109.039560; AVELDANO MI, 1973, BIOCHIM BIOPHYS ACTA, V296, P1, DOI 10.1016/0005-2760(73)90038-6; Morita S, 2007, HEPATOLOGY, V46, P188, DOI 10.1002/hep.21591; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; TREEN M, 1992, ARCH BIOCHEM BIOPHYS, V294, P564, DOI 10.1016/0003-9861(92)90726-D; AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; PITAS RE, 1987, BIOCHIM BIOPHYS ACTA, V917, P148, DOI 10.1016/0005-2760(87)90295-5; Hayashi H, 2004, J BIOL CHEM, V279, P14009, DOI 10.1074/jbc.M313828200; BU GJ, 1994, J BIOL CHEM, V269, P18521; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI13992; Robson LG, 2010, NEUROBIOL AGING, V31, P678, DOI 10.1016/j.neurobiolaging.2008.05.027; Hayashi H, 2012, J BIOL CHEM, V287, P25395, DOI 10.1074/jbc.M112.370130; Chen CT, 2013, J LIPID RES, V54, P2410, DOI 10.1194/jlr.M038505; Vance JE, 2010, BBA-MOL CELL BIOL L, V1801, P806, DOI 10.1016/j.bbalip.2010.02.007; MOORE SA, 1991, J NEUROCHEM, V56, P518, DOI 10.1111/j.1471-4159.1991.tb08180.x; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Moore SA, 2001, J MOL NEUROSCI, V16, P195, DOI 10.1385/JMN:16:2-3:195; Ruiz J, 2005, J LIPID RES, V46, P1721, DOI 10.1194/jlr.M5000114-JLR200; Teo JL, 2005, P NATL ACAD SCI USA, V102, P12171, DOI 10.1073/pnas.0504600102; Amundson DM, 1999, J BIOCHEM BIOPH METH, V38, P43, DOI 10.1016/S0165-022X(98)00036-0; Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0022-2275	1539-7262		J LIPID RES	J. Lipid Res.	OCT	2015	56	10					1880	1890		10.1194/jlr.M058164		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CS1RV	WOS:000361846300003		
J	Nakamura, Y				Nakamura, Yutaka			Differentiability of von Neumann-Morgenstern utility functions	JOURNAL OF MATHEMATICAL ECONOMICS			English	Article						Differentiability; Expected utility; Risk aversion; Downside risk; Prudence; Temperance		This paper studies necessary and sufficient preference-based conditions for differentiability of risk averse (prudent, or temperate) von Neumann-Morgenstern utility functions. The very idea to devise those conditions is based on the reverse claim of an old observation by Arrow that a risk-averse expected-utility maximizer will always accept a sufficiently small stake in any positive expected-value bet if her von Neumann-Morgenstern utility function is differentiable. (C) 2015 Elsevier B.V. All rights reserved.	Univ Tsukuba, Grad Sch Syst & Informat Engn, Div Social Syst & Management, Tsukuba, Ibaraki 3058573, Japan	Nakamura, Y (reprint author), Univ Tsukuba, Grad Sch Syst & Informat Engn, Div Social Syst & Management, 1-1-1 Tennnoudai, Tsukuba, Ibaraki 3058573, Japan.	nakamura@sk.tsukuba.ac.jp					Nielsen LT, 1999, ECON THEOR, V14, P285, DOI 10.1007/s001990050294; Eeckhoudt L, 2006, AM ECON REV, V96, P280, DOI 10.1257/000282806776157777; Arrow K., 1971, ESSAYS THEORY RISK B; Eeckhoudt L., 1995, ECON LETT, V48, P311; Eeckhoudt L., 2005, EC FINANCIAL DECISIO; Fishburn P. C., 1970, UTILITY THEORY DECIS; Fishburn P.C., 1982, FDN EXPECTED UTILITY; Hammond P.J., 1999, HDB UTILITY THEORY, V1; von Neumann J., 1953, THEORY GAMES EC BEHA	9	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0304-4068			J MATH ECON	J. Math. Econ.	OCT	2015	60						74	80		10.1016/j.jmateco.2015.06.008		7	Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods	Business & Economics; Mathematics; Mathematical Methods In Social Sciences	CS0VS	WOS:000361780900009		
J	Yamada, K; Aiba, K; Kitaura, Y; Kondo, Y; Nomura, N; Nakamura, Y; Fukushi, D; Murayama, K; Shimomura, Y; Pitt, J; Yamaguchi, S; Yokochi, K; Wakamatsu, N				Yamada, Kenichiro; Aiba, Kaori; Kitaura, Yasuyuki; Kondo, Yusuke; Nomura, Noriko; Nakamura, Yuji; Fukushi, Daisuke; Murayama, Kei; Shimomura, Yoshiharu; Pitt, James; Yamaguchi, Seiji; Yokochi, Kenji; Wakamatsu, Nobuaki			Clinical, biochemical and metabolic characterisation of a mild form of human short-chain enoyl-CoA hydratase deficiency: significance of increased N-acetyl-S-(2-carboxypropyl) cysteine excretion	JOURNAL OF MEDICAL GENETICS			English	Article							ACID BETA-OXIDATION; VALINE METABOLISM; ECHS1 MUTATIONS; LEIGH-SYNDROME; RAT-LIVER; PURIFICATION; DEHYDROGENASE; DISORDERS; CROTONASE; HYDROLASE	Background Short-chain enoyl-CoA hydratase-ECHS1 -catalyses many metabolic pathways, including mitochondrial short-chain fatty acid a-oxidation and branched-chain amino acid catabolic pathways; however, the metabolic products essential for the diagnosis of ECHS1 deficiency have not yet been determined. The objective of this report is to characterise ECHS1 and a mild form of its deficiency biochemically, and to determine the candidate metabolic product that can be efficiently used for neonatal diagnosis. Methods We conducted a detailed clinical, molecular genetics, biochemical and metabolic analysis of sibling patients with ECHS1 deficiency. Moreover, we purified human ECHS1, and determined the substrate specificity of ECHS1 for five substrates via different metabolic pathways. Results Human ECHS1 catalyses the hydration of five substrates via different metabolic pathways, with the highest specificity for crotonyl-CoA and the lowest specificity for tiglyl-CoA. The patients had relatively high (similar to 7%) residual ECHS1 enzyme activity for crotonyl-CoA and methacrylyl-CoA caused by the compound heterozygous mutations (c. 176A> G, (p. N59S) and c. 413C> T, (p. A138V)) with normal mitochondrial complex I-IV activities. Affected patients excrete large amounts of N-acetyl-S-(2-carboxypropyl) cysteine, a metabolite of methacrylyl-CoA. Conclusions Laboratory data and clinical features demonstrated that the patients have a mild form of ECHS1 deficiency harbouring defective valine catabolic and a-oxidation pathways. N-Acetyl-S-(2-carboxypropyl) cysteine level was markedly high in the urine of the patients, and therefore, N-acetyl-S-(2-carboxypropyl) cysteine was regarded as a candidate metabolite for the diagnosis of ECHS1 deficiency. This metabolite is not part of current routine metabolic screening protocols, and its inclusion, therefore, holds immense potential in accurate diagnosis.	[Yamada, Kenichiro; Nomura, Noriko; Fukushi, Daisuke; Wakamatsu, Nobuaki] Aichi Human Serv Ctr, Dept Genet, Inst Dev Res, Kasugai, Aichi 4800392, Japan; [Aiba, Kaori; Nakamura, Yuji] Toyohashi Municipal Hosp, Dept Pediat, Toyohashi, Aichi, Japan; [Kitaura, Yasuyuki; Kondo, Yusuke; Shimomura, Yoshiharu] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Nagoya, Aichi 4648601, Japan; [Murayama, Kei] Chiba Childrens Hosp, Dept Metab, Chiba, Japan; [Pitt, James] Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Parkville, Vic, Australia; [Yamaguchi, Seiji] Shimane Univ, Fac Med, Dept Pediat, Izumo, Shimane, Japan; [Yokochi, Kenji] Seirei Mikatahara Gen Hosp, Dept Pediat Neurol, Hamamatsu, Shizuoka, Japan	Wakamatsu, N (reprint author), Aichi Human Serv Ctr, Dept Genet, Inst Dev Res, 713-8 Kamiya Cho, Kasugai, Aichi 4800392, Japan.	nwaka@inst-hsc.jp			Takeda Science Foundation [10]; Ministry of Education, Culture, Sports, Science and Technology of Japan [26462225]	This work was supported by Takeda Science Foundation a grant for specific research No. 10 in 2009 and grants (26462225) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to NW).	KANAZAWA M, 1993, ENZYME PROTEIN, V47, P9; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; FONG JC, 1977, J BIOL CHEM, V252, P542; Reuter MS, 2014, AM J MED GENET A, V164, P3162, DOI 10.1002/ajmg.a.36766; STERN JR, 1953, J AM CHEM SOC, V75, P2277, DOI 10.1021/ja01105a533; BROWN GK, 1982, PEDIATRICS, V70, P532; Wanders RJA, 2012, J INHERIT METAB DIS, V35, P5, DOI 10.1007/s10545-010-9236-x; HASS GM, 1969, J BIOL CHEM, V244, P6080; Jiang LL, 1996, J BIOCHEM-TOKYO, V120, P633; Yamaguchi S, 2001, J CHROMATOGR B, V758, P81, DOI 10.1016/S0378-4347(01)00102-5; Zhang WM, 2013, CLIN BIOCHEM, V46, P694, DOI 10.1016/j.clinbiochem.2012.11.008; UCHIDA Y, 1992, J BIOL CHEM, V267, P1034; Loupatty FJ, 2007, AM J HUM GENET, V80, P195, DOI 10.1086/510725; Wanders RJA, 2010, J INHERIT METAB DIS, V33, P479, DOI 10.1007/s10545-010-9104-8; SHIMOMURA Y, 1994, J BIOL CHEM, V269, P14248; Gotoda Y, 1998, AM J HUM GENET, V63, P1015, DOI 10.1086/302048; Cooper AJL, 1997, MOL GENETIC BASIS NE, P1195; Ferdinandusse S, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-188; Fong J C, 1981, Methods Enzymol, V71 Pt C, P390; Haack TB, 2015, Ann Clin Transl Neur, V2, P492, DOI 10.1002/acn3.189; Peters H, 2014, BRAIN, V137, P2903, DOI 10.1093/brain/awu216; Sakai C, 2015, HUM MUTAT, V36, P232, DOI 10.1002/humu.22730; Soler-Alfonso C, 2015, PEDIATR NEUROL, V52, P361, DOI 10.1016/j.pediatrneurol.2014.10.023; Yamada K, 2014, MOL GENET METAB REP, V1, P455	24	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-2593	1468-6244		J MED GENET	J. Med. Genet.	OCT	2015	52	10					691	698		10.1136/jmedgenet-2015-103231		8	Genetics & Heredity	Genetics & Heredity	CS0PC	WOS:000361763100006		
J	Imamura, K; Takayama, S; Saito, A; Inoue, E; Nakayama, Y; Ogata, Y; Shirakawa, S; Nagano, T; Gomi, K; Morozumi, T; Akiishi, K; Watanabe, K; Yoshie, H				Imamura, K.; Takayama, S.; Saito, A.; Inoue, E.; Nakayama, Y.; Ogata, Y.; Shirakawa, S.; Nagano, T.; Gomi, K.; Morozumi, T.; Akiishi, K.; Watanabe, K.; Yoshie, H.			Evaluation of a novel immunochromatographic device for rapid and accurate clinical detection of Porphyromonas gingivalis in subgingival plaque	JOURNAL OF MICROBIOLOGICAL METHODS			English	Article						lmmunochromatography; Periodontopathic bacteria; Porphyromonas gingivalis; Periodontitis	OUTER-MEMBRANE PROTEIN; INHIBITS COAGGREGATION ACTIVITY; ENZYMATIC METHOD SK-013; TANNERELLA-FORSYTHIA; TREPONEMA-DENTICOLA; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; BACTEROIDES-GINGIVALIS; PERIODONTAL-DISEASE; DNA-PROBE; SAMPLES	An important goal for the improved diagnosis and management of infectious and inflammatory diseases, such as periodontitis, is the development of rapid and accurate technologies for the decentralized detection of bacterial pathogens. The aim of this prospective multicenter study was to evaluate the clinical use of a novel immunochromatographic device with monoclonal antibodies for the rapid point-of-care detection and semi-quantification of Porphyromonas gingivalis in subgingival plaque. Sixty-three patients with chronic periodontitis and 28 periodontally healthy volunteers were subjected to clinical and microbiological examinations. Subgingival plaque samples were analyzed for the presence of P. gingivalis using a novel immunochromatography based device DK13-PG-001, designed to detect the 40 k-outer membrane protein of P. gingivalis, and compared with a PCR-Invader method. In the periodontitis group, a significant strong positive correlation in detection results was found between the test device score and the PCR-Invader method (Spearman rank correlation, r = 0.737, p < 0.0001). The sensitivity, specificity, and positive and negative predictive values of the test device were 96.2%, 91.8%, 90.4% and 96.7%, respectively. The detection threshold of the test device was determined to be approximately 10(4) (per two paper points). There were significant differences in the bacterial counts by the PCR-Invader method among groups with different ranges of device scores. With a cut-off value of 1:1.25 in device score, none of periodontally healthy volunteers were tested positive for the subgingival presence of P. gingivalis, whereas 76% (n = 48) of periodontitis subjects were tested positive. There was a significant positive correlation between device scores for P. gingivalis and periodontal parameters including probing pocket depth and clinical attachment level (r = 0.317 and 0.281, respectively, p < 0.01). The results suggested that the DK13-PG-001 device kit can be effectively used for rapid, chair-side detection and semi-quantification of P. gingivalis in subgingival plaque. (C) 2015 Elsevier B.V. All rights reserved.	[Imamura, K.; Takayama, S.; Saito, A.] Tokyo Dent Coll, Dept Periodontol, Chiyoda Ku, Tokyo 1010061, Japan; [Inoue, E.; Nakayama, Y.; Ogata, Y.] Nihon Univ, Dept Periodontol, Sch Dent Matsudo, Matsudo, Chiba 2718587, Japan; [Shirakawa, S.; Nagano, T.; Gomi, K.] Tsurumi Univ, Sch Dent Med, Dept Periodontol, Tsurumi Ku, Yokohama, Kanagawa 2308501, Japan; [Morozumi, T.; Yoshie, H.] Niigata Univ, Div Periodontol, Dept Oral Biol Sci, Grad Sch Med & Dent Sci,Chuo Ku, Niigata 9518514, Japan; [Akiishi, K.] Denka Seiken Co Ltd, Reagent R&D Dept, Gosen, Niigata 9591695, Japan; [Watanabe, K.] Showa Yakuhin Kako Co Ltd, Chuo Ku, Tokyo 1040061, Japan	Saito, A (reprint author), Tokyo Dent Coll, Dept Periodontol, Chiyoda Ku, 2-9-18 Misaki Cho, Tokyo 1010061, Japan.	atsaito@tdc.ac.jp			Denka Seiken Co., Ltd.; Showa Yakuhin Kako Co., Ltd, Tokyo, Japan	The authors report no competing interests. This study was funded by authors' own institutions and supported in part by research funds from Denka Seiken Co., Ltd., and Showa Yakuhin Kako Co., Ltd, Tokyo, Japan. The authors had full control of the data, of the analyses and received no commercial input in the preparation of the manuscript.	Shibata Y, 2003, BIOCHEM BIOPH RES CO, V300, P351, DOI 10.1016/S0006-291X(02)02826-7; Eick S, 2002, J CLIN PERIODONTOL, V29, P638, DOI 10.1034/j.1600-051X.2002.290708.x; Kaman WE, 2012, J CLIN MICROBIOL, V50, P104, DOI 10.1128/JCM.05313-11; LOESCHE WJ, 1992, J CLIN MICROBIOL, V30, P427; Cai Y, 2013, J ORAL SCI, V55, P107; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Hamajima S, 2007, ARCH ORAL BIOL, V52, P697, DOI 10.1016/j.archoralbio.2006.12.013; Helbig JH, 2001, J MED MICROBIOL, V50, P509; Namikoshi J, 2003, VACCINE, V22, P250, DOI 10.1016/S0264-410X(03)00576-0; Eick S, 2011, DIAGN MICR INFEC DIS, V69, P12, DOI 10.1016/j.diagmicrobio.2010.08.017; LOESCHE WJ, 1992, J PERIODONTOL, V63, P1102; Tomita S, 2013, MICROB PATHOGENESIS, V61-62, P11, DOI 10.1016/j.micpath.2013.04.006; ISHIHARA K, 1992, J PERIODONTAL RES, V27, P81, DOI 10.1111/j.1600-0765.1992.tb01807.x; HIRATSUKA K, 1992, ARCH ORAL BIOL, V37, P717, DOI 10.1016/0003-9969(92)90078-M; Ngom B, 2010, ANAL BIOANAL CHEM, V397, P1113, DOI 10.1007/s00216-010-3661-4; TAKAZOE I, 1984, J DENT RES, V63, P422, DOI 10.1177/00220345840630031201; Mein CA, 2000, GENOME RES, V10, P330, DOI 10.1101/gr.10.3.330; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Boyer BP, 1996, J CLIN PERIODONTOL, V23, P477, DOI 10.1111/j.1600-051X.1996.tb00578.x; Komiya A, 2000, J PERIODONTOL, V71, P760, DOI 10.1902/jop.2000.71.5.760; Park MY, 2009, J CLIN MICROBIOL, V47, P481, DOI 10.1128/JCM.01253-08; Teles RP, 2006, PERIODONTOL 2000, V42, P180, DOI 10.1111/j.1600-0757.2006.00192.x; Socransky SS, 2002, PERIODONTOL 2000, V28, P12, DOI 10.1034/j.1600-0757.2002.280102.x; LOE H, 1967, J PERIODONTOL, V38, P610, DOI 10.1902/jop.1967.38.6.610; SEIDA K, 1992, J PERIODONTAL RES, V27, P86, DOI 10.1111/j.1600-0765.1992.tb01808.x; Amano A, 2010, PERIODONTOL 2000, V54, P9, DOI 10.1111/j.1600-0757.2010.00376.x; Ishii Y, 2015, MICROB PATHOGENESIS, V82, P37, DOI 10.1016/j.micpath.2015.03.017; Hajishengallis G, 2014, EUR J IMMUNOL, V44, P328, DOI 10.1002/eji.201344202; ABIKO Y, 1990, ARCH ORAL BIOL, V35, P689, DOI 10.1016/0003-9969(90)90091-N; Mineoka T, 2008, J PERIODONTOL, V79, P670, DOI 10.1902/jop.2008.070398 ; Tada A, 2012, JPN J INFECT DIS, V65, P415; Fujise O, 2002, J PERIODONTOL, V73, P1253, DOI 10.1902/jop.2002.73.11.1253; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Xiang XM, 2010, J PERIODONTOL, V81, P186, DOI 10.1902/jop.2009.090419; Dunn JJ, 2003, J CLIN MICROBIOL, V41, P2180, DOI 10.1128/JCM.41.5.2180-2183.2003; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Nakagawa T., 1995, J JPN SOC PERIODONTO, V37, P312; Preshaw Philip M, 2004, Dent Update, V31, P448; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322	42	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7012	1872-8359		J MICROBIOL METH	J. Microbiol. Methods	OCT	2015	117						4	10		10.1016/j.mimet.2015.07.002		7	Biochemical Research Methods; Microbiology	Biochemistry & Molecular Biology; Microbiology	CS1XA	WOS:000361861000002		
J	Shiraiwa, K; Ogawa, Y; Eguchi, M; Hikono, H; Kusumoto, M; Shimoji, Y				Shiraiwa, Kazumasa; Ogawa, Yohsuke; Eguchi, Masahiro; Hikono, Hirokazu; Kusumoto, Masahiro; Shimoji, Yoshihiro			Development of an SNP-based PCR assay for rapid differentiation of a Japanese live vaccine strain from field isolates of Erysipelothrix rhusiopathiae	JOURNAL OF MICROBIOLOGICAL METHODS			English	Article						Erysipelothrix rhusiopathiae; Genome sequencing; SNP-based PCR; Vaccine strain; Strain-specific detection	SWINE ERYSIPELAS; PIGS; DISCRIMINATION; GENOME	The differentiation of vaccine from non-vaccine isolates is important for disease control. Based on single nucleotide polymorphisms identified by comparison of the genomes of the Koganei 65-0.15 vaccine strain and a reference strain of Erysipelothrix rhusiopathiae, we developed a PCR assay that can differentiate the vaccine strain from field isolates. (C) 2015 Elsevier B.V. All rights reserved.	[Shiraiwa, Kazumasa; Ogawa, Yohsuke; Eguchi, Masahiro; Hikono, Hirokazu; Kusumoto, Masahiro; Shimoji, Yoshihiro] Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Tsukuba, Ibaraki 3050856, Japan; [Shimoji, Yoshihiro] Tokyo Univ Sci, Res Inst Biol Sci, Noda, Chiba 2788510, Japan	Shimoji, Y (reprint author), NARO, Natl Inst Anim Hlth, 3-1-5 Kannondai, Tsukuba, Ibaraki 3050856, Japan.	shimoji@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries of Japan [VAC2012]	This study was supported by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (VAC2012) (to Y. S.).	To H, 2012, J VET MED SCI, V74, P949, DOI 10.1292/jvms.11-0533; Van Ert MN, 2007, J CLIN MICROBIOL, V45, P47, DOI 10.1128/JCM.01233-06; Shimoji Y, 1998, J CLIN MICROBIOL, V36, P86; SETO K, 1971, JPN J VET SCI, V33, P161; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Huijsmans CJJ, 2011, APPL ENVIRON MICROB, V77, P2051, DOI 10.1128/AEM.02293-10; Ogawa Y, 2011, J BACTERIOL, V193, P2959, DOI 10.1128/JB.01500-10; Imada Y, 2004, J CLIN MICROBIOL, V42, P2121, DOI 10.1128/JCM.42.5.2121-2126.2004; Ozawa M, 2009, J VET MED SCI, V71, P697, DOI 10.1292/jvms.71.697; Nagai S, 2008, J VET DIAGN INVEST, V20, P336; Kuroda M, 2010, J CLIN MICROBIOL, V48, P2821, DOI 10.1128/JCM.00137-10; Uchiyama M, 2014, BIOLOGICALS, V42, P109, DOI 10.1016/j.biologicals.2013.12.002; Gopaul KK, 2010, J CLIN MICROBIOL, V48, P1461, DOI 10.1128/JCM.02193-09; Bakker Henk C den, 2011, Appl Environ Microbiol, V77, P8648, DOI 10.1128/AEM.06538-11; Making S, 1998, J VET MED SCI, V60, P1017, DOI 10.1292/jvms.60.1017; Sawada T., 2006, J VET EPIDEMIOL, V10, P21, DOI 10.2743/jve.10.21; Wood RL, 2006, DIS SWINE, P629	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7012	1872-8359		J MICROBIOL METH	J. Microbiol. Methods	OCT	2015	117						11	13		10.1016/j.mimet.2015.07.001		3	Biochemical Research Methods; Microbiology	Biochemistry & Molecular Biology; Microbiology	CS1XA	WOS:000361861000003		
J	Ogata, K; Matsuda, K; Tsuji, H; Nomoto, K				Ogata, Kiyohito; Matsuda, Kazunori; Tsuji, Hirokazu; Nomoto, Koji			Sensitive and rapid RT-qPCR quantification of pathogenic Candida species in human blood	JOURNAL OF MICROBIOLOGICAL METHODS			English	Article						Blood; Candida; Quantitative RT-PCR	TRANSCRIPTION-QUANTITATIVE PCR; RIBOSOMAL-RNA MOLECULES; INVASIVE CANDIDIASIS; SURVEILLANCE PROGRAM; CHROMAGAR CANDIDA; STREAM INFECTIONS; IDENTIFICATION; TIME; DIAGNOSIS; CULTURES	For accurate diagnosis and appropriate treatment of candidiasis, we developed a highly sensitive quantitative RTPCR (RT-qPCR) system for five Candida species that have been reported to be the major causes of bloodstream fungal infection (Candida albicans, Candida glabrata, Candida tropicalis, Candida parapsilosis, and Candida krusei), together with a system for all pathogenic Candida species. Cells of each fungal species spiked into human peripheral blood (PB) were specifically detected at a lower detection limit of 10(0) cell/1 mL PB by this system using the newly developed specific primer sets targeting 18S or 26S rRNA of the five Candida species, together with the existing group primer set. The total count of the five Candida spp. as the sum of those obtained by using the five species primer sets was equivalent to the count obtained by using the group primer set, indicating that the group set covered the major five Candida spp. in human blood with the same degree of accuracy as the species primer sets. The RT-qPCR counts of the Candida species were in good agreement with CPU counts obtained by their culture on CHROMagarTm, with a lower detection limit of 10 cell/mL of PB. Candida rRNA molecules were stably stored for at least 7 days at 4 degrees C by keeping the blood specimens in an RNA stabilizing reagent. These results strongly suggest that this sensitive system is useful for accurate and rapid diagnosis of Candida bloodstream infections. (C) 2015 Elsevier B.V. All rights reserved.	[Ogata, Kiyohito; Matsuda, Kazunori; Tsuji, Hirokazu; Nomoto, Koji] Yakult Cent Inst, Tokyo 1868650, Japan; [Matsuda, Kazunori] ESV, Yakult Honsha European Res Ctr Microbiol, B-9052 Zwijnaarde, Belgium	Tsuji, H (reprint author), Yakult Cent Inst, 5-11 Izumi, Tokyo 1868650, Japan.	hirokazu-tsuji@yakult.co.jp					Tsuji H, 2012, BENEF MICROBES, V3, P113, DOI 10.3920/BM2011.0038; Nguyen MH, 2012, CLIN INFECT DIS, V54, P1240, DOI 10.1093/cid/cis200; Chang HC, 2001, J CLIN MICROBIOL, V39, P3466, DOI 10.1128/JCM.39.10.3466-3471.2001; White PL, 2003, J MED MICROBIOL, V52, P229, DOI 10.1099/jmm.0.05049-0; Diekema DJ, 2002, J CLIN MICROBIOL, V40, P1298, DOI 10.1128/JCM.40.4.1298-1302.2002; Matsuda K, 2012, APPL ENVIRON MICROB, V78, P5111, DOI 10.1128/AEM.07990-11; Sato J, 2014, DIABETES CARE, V37, P2343, DOI 10.2337/dc13-2817; Almirante B, 2005, J CLIN MICROBIOL, V43, P1829, DOI 10.1128/JCM.43.4.1829-1835.2005; Held J, 2013, J CLIN MICROBIOL, V51, P1158, DOI 10.1128/JCM.02473-12; Khlif M, 2009, CLIN MICROBIOL INFEC, V15, P656, DOI 10.1111/j.1469-0691.2009.02762.x; Flevari A, 2013, CLIN INTERV AGING, V8, P1199, DOI 10.2147/CIA.S39120; Leaw SN, 2006, J CLIN MICROBIOL, V44, P693, DOI 10.1128/JCM.44+3.693-699.2006; Aittakorpi A, 2012, J CLIN MICROBIOL, V50, P3635, DOI 10.1128/JCM.01461-12; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Takakura S, 2004, J ANTIMICROB CHEMOTH, V53, P283, DOI 10.1093/jac/dkh053; Nagata S, 2011, BRIT J NUTR, V106, P549, DOI 10.1017/S000711451100064X; Ahmad S, 2002, J CLIN MICROBIOL, V40, P2483, DOI 10.1128/JCM.40.7.2483-2489.2002; Slavin MA, 2010, J ANTIMICROB CHEMOTH, V65, P1042, DOI 10.1093/jac/dkq053; Kurakawa T, 2013, J MICROBIOL METH, V92, P213, DOI 10.1016/j.mimet.2012.12.008; Chang A, 2008, FUTURE MICROBIOL, V3, P463, DOI 10.2217/17460913.3.4.463; Garey KW, 2006, CLIN INFECT DIS, V43, P25, DOI 10.1086/504810; Borman AM, 2009, J CLIN MICROBIOL, V47, P2307, DOI 10.1128/JCM.00240-09; Arendrup MC, 2011, J CLIN MICROBIOL, V49, P3300, DOI 10.1128/JCM.00179-11; Nishigaki E, 2014, ANN SURG, V259, P477, DOI 10.1097/SLA.0b013e31828e39e8; Matsuda K, 2009, APPL ENVIRON MICROB, V75, P1961, DOI 10.1128/AEM.01843-08; Kubota H, 2010, APPL ENVIRON MICROB, V76, P5440, DOI 10.1128/AEM.03132-09; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2002, J CLIN MICROBIOL, V40, P852, DOI 10.1128/JCM.40.3.852-856.2002; Bu R, 2005, J MED MICROBIOL, V54, P243, DOI 10.1099/jmm.0.45856-0; Ahmad S, 2012, INDIAN J MED MICROBI, V30, P264, DOI 10.4103/0255-0857.99482; Hajjeh RA, 2004, J CLIN MICROBIOL, V42, P1519, DOI 10.1128/JCM.42.4.1519-1527.2004; Pfaller MA, 2010, J CLIN MICROBIOL, V48, P1366, DOI 10.1128/JCM.02117-09; Malani A, 2005, CLIN INFECT DIS, V41, P975, DOI 10.1086/432939; Harbarth S, 1999, SCHWEIZ MED WSCHR, V129, P1521; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P167, DOI 10.1128/AEM.70.1.167-173.2004; Lamoth F, 2010, J CLIN MICROBIOL, V48, P3510, DOI 10.1128/JCM.00147-10; Skovbjerg S, 2009, CLIN MICROBIOL INFEC, V15, P680, DOI 10.1111/j.1469-0691.2009.02796.x; Pfaller MA, 1996, J CLIN MICROBIOL, V34, P58; Pfaller MA, 2011, ANTIMICROB AGENTS CH, V55, P561, DOI 10.1128/AAC.01079-10; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; ODDS FC, 1994, J CLIN MICROBIOL, V32, P1923; Morrell M, 2005, ANTIMICROB AGENTS CH, V49, P3640, DOI 10.1128/AAC.49.9.3640-3645.2005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Pfeiffer CD, 2011, J CLIN MICROBIOL, V49, P2879, DOI 10.1128/JCM.00609-11; Sakaguchi S, 2010, J CLIN MICROBIOL, V48, P1624, DOI 10.1128/JCM.01724-09; Bougnoux ME, 1999, J CLIN MICROBIOL, V37, P925; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Wallet F, 2010, CLIN MICROBIOL INFEC, V16, P774, DOI 10.1111/j.1469-0691.2009.02940.x; Bosshard P.P., 2011, MYCOSES, V54; Juyal Deepak, 2013, N Am J Med Sci, V5, P541, DOI 10.4103/1947-2714.118919; Li F, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-353; Loonen AJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072349; Rodloff C., 2011, J MED RES, V16, P187, DOI DOI 10.1186/2047-783X-16-4-187	53	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7012	1872-8359		J MICROBIOL METH	J. Microbiol. Methods	OCT	2015	117						128	135		10.1016/j.mimet.2015.07.021		8	Biochemical Research Methods; Microbiology	Biochemistry & Molecular Biology; Microbiology	CS1XA	WOS:000361861000022		
J	Nakano, Y; Yamamoto, J; Takahashi, M; Soejima, Y; Akiba, D; Kitagawa, T; Ueta, K; Miyaoka, R; Umemura, T; Nishizawa, S				Nakano, Yoshiteru; Yamamoto, Junkoh; Takahashi, Mayu; Soejima, Yoshiteru; Akiba, Daisuke; Kitagawa, Takehiro; Ueta, Kunihiro; Miyaoka, Ryo; Umemura, Takeru; Nishizawa, Shigeru			Pilocytic astrocytoma presenting with atypical features on magnetic resonance imaging	JOURNAL OF NEURORADIOLOGY			English	Article						Glioma; Pilocytic astrocytoma; Magnetic resonance imaging	DISSEMINATION; CHILDHOOD	Pilocytic astrocytoma, which is classified as a grade I astrocytic tumor by the World Health Organization, is the most common type of glioma in children and young adults. Pilocytic astrocytoma generally appears as a well-circumscribed, contrast-enhancing lesion, frequently with cystic components on magnetic resonance imaging (MRI). However, it has been reported that the MRI appearance of pilocytic astrocytoma may be similar to that of high-grade gliomas in some cases. We here report on 6 cases of pilocytic astrocytoma with atypical MRI findings, including small cyst formation, heterogeneously enhancing tumor nodules, irregularly enhancing tumor nodules, and enhancing tumor nodules with internal hemorrhage. All tumors were successfully resected, and the histological diagnoses were pilocytic astrocytoma. When the tumor is located near a cerebral cistern or ventricle, the risk of leptomeningeal dissemination is increased. Furthermore, partial resection has also been associated with a higher risk of recurrence and leptomeningeal dissemination. To date, all but one patient are alive and recurrence-free. Because the preoperative diagnosis influences the decision on the extent of resection and because of the high risk of leptomeningeal dissemination associated with these tumors, careful and correct diagnosis by MRI is important. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Nakano, Yoshiteru; Yamamoto, Junkoh; Takahashi, Mayu; Soejima, Yoshiteru; Akiba, Daisuke; Kitagawa, Takehiro; Ueta, Kunihiro; Miyaoka, Ryo; Umemura, Takeru; Nishizawa, Shigeru] Univ Occupat & Environm Hlth, Dept Neurosurg, Sch Med, Kitakyushu, Fukuoka 8078555, Japan	Nakano, Y (reprint author), Univ Occupat & Environm Hlth, Dept Neurosurg, Sch Med, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	yo-naka@med.uoeh-u.ac.jp					HAYOSTEK CJ, 1993, CANCER, V72, P856, DOI 10.1002/1097-0142(19930801)72:3<856::AID-CNCR2820720335>3.0.CO;2-K; Kato K, 2011, NEUROL MED-CHIR, V51, P82, DOI 10.2176/nmc.51.82; Kumar AJ, 2010, J COMPUT ASSIST TOMO, V34, P601, DOI 10.1097/RCT.0b013e3181d77d52; Kageji T, 2003, J NEURO-ONCOL, V62, P281, DOI 10.1023/A:1023363122666; FORSYTH PA, 1993, CANCER, V72, P1335, DOI 10.1002/1097-0142(19930815)72:4<1335::AID-CNCR2820720431>3.0.CO;2-E; Shingu T, 2007, NEUROL MED-CHIR, V47, P222, DOI 10.2176/nmc.47.222; Figueiredo EG, 2003, ARQ NEURO-PSIQUIAT, V61, P842, DOI 10.1590/S0004-282X2003000500025; Knorr Z, 2013, J NEURORADIOLOGY, V40, P68, DOI 10.1016/j.neurad.2011.12.002; McCowage G, 1996, MED PEDIATR ONCOL, V27, P32, DOI 10.1002/(SICI)1096-911X(199607)27:1<32::AID-MPO7>3.0.CO;2-V; COAKLEY KJ, 1995, MAYO CLIN PROC, V70, P747; Vandesteen L, 2013, J NEURORADIOLOGY, V40, P229, DOI 10.1016/j.neurad.2013.06.004; Louis DN, 2007, WHO CLASSIFICATION T, P14	12	0	0	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0150-9861	1773-0406		J NEURORADIOLOGY	J. Neuroradiol.	OCT	2015	42	5					278	282		10.1016/j.neurad.2014.09.001		5	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CS1VB	WOS:000361855500005		
J	Fukuoka, K; Yanagisawa, T; Watanabe, Y; Suzuki, T; Matsutani, M; Kuji, I; Nishikawa, R				Fukuoka, Kohei; Yanagisawa, Takaaki; Watanabe, Yuko; Suzuki, Tomonari; Matsutani, Masao; Kuji, Ichiei; Nishikawa, Ryo			Clinical interpretation of residual uptake in C-11-methionine positron emission tomography after treatment of basal ganglia germ cell tumors: report of 3 cases	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						intracranial germ cell tumors; methionine PET; basal ganglia; residual accumulation; oncology	CEREBRAL HEMIATROPHY; GERMINOMA	Although C-11-methionine (MET) PET has been used to diagnose intracranial germ cell tumors (GCTs) arising in the basal ganglia, whether this imaging technique is useful in assessing treatment response and residual tumor is still, unclear. The authors report 3 cases of basal ganglia GCTs in which the residual MET uptake at the end of treatment did not develop into a relapse, even without additional treatment. Case 1 is a 22-year-old man who had a second relapse of a left basal ganglia germinoma with diffuse dissemination on the walls of both of his lateral ventricles. MET-PET revealed high MET accumulation around tumors and their surroundings (maximum standardized uptake value [SUVmax] 3.3). After all treatments, MET-PET demonstrated mild tracer accumulation in both basal ganglia (SUVmax 2.2). Progression-free survival was 56 months from the second relapse without any further treatment. Case 2 is a 17-year-old boy with a left basal ganglia germinoma that showed increased MET uptake (SUVmax 4.2). After treatment, MET-PET revealed residual MET uptake (SUVmax 2.4) along the left posterior limb of the internal capsule. Progression-free survival was 52 months from the start of treatment. Case 3 is a 7-year-old boy with a left basal ganglia choriocarcinoma with increased tumor MET uptake (SUVmax 2.5). A minor enhanced mass remained on MRI after treatment with residual MET accumulation (SUVmax 1.4). Progression-free survival was 44 months. Treatment strategies based on MET uptake on PET should be carefully designed in patients with basal ganglia GCTs to avoid overtreatment and complications.	[Fukuoka, Kohei; Yanagisawa, Takaaki; Watanabe, Yuko; Suzuki, Tomonari] Saitama Med Univ, Int Med Ctr, Div Pediat Neurooncol, Dept Neurooncol Neurosurg, Hidaka, Japan; [Kuji, Ichiei] Saitama Med Univ, Int Med Ctr, Dept Nucl Med, Hidaka, Japan; [Matsutani, Masao; Nishikawa, Ryo] Saitama Med Univ, Int Med Ctr, Dept Neurooncol Neurosurg, Hidaka, Japan	Fukuoka, K (reprint author), Natl Canc Ctr, Div Brain Tumor Translat Res, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	kohfukuoka@gmail.com					Nariai T, 2005, J NEUROSURG, V103, P498, DOI 10.3171/jns.2005.103.3.0498; Sudo A, 2003, AM J NEURORADIOL, V24, P1909; Nagano-Saito A, 2001, ANN NUCL MED, V15, P387, DOI 10.1007/BF02988250; Lee J, 2009, CHILD NERV SYST, V25, P29, DOI 10.1007/s00381-008-0674-9; Kawai N, 2008, SURG NEUROL, V70, P408, DOI 10.1016/j.surneu.2007.04.010; Okamoto S, 2011, ANN NUCL MED, V25, P213, DOI 10.1007/s12149-010-0450-2; Kawai N, 2009, CHILD NERV SYST, V25, P845, DOI 10.1007/s00381-009-0841-7; Fujii Y, 2008, J NEUROL SCI, V270, P189, DOI 10.1016/j.jns.2008.02.006; Rosenblum MK, 2007, WHO CLASSIFICATION T, P198	9	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	OCT	2015	16	4					367	371		10.3171/2015.3.PEDS14458		5	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	CS1XS	WOS:000361862800002		
J	Hikata, T; Watanabe, K; Fujita, N; Iwanami, A; Hosogane, N; Ishii, K; Nakamura, M; Toyama, Y; Matsumoto, M				Hikata, Tomohiro; Watanabe, Kota; Fujita, Nobuyuki; Iwanami, Akio; Hosogane, Naobumi; Ishii, Ken; Nakamura, Masaya; Toyama, Yoshiaki; Matsumoto, Morio			Impact of sagittal spinopelvic alignment on clinical outcomes after decompression surgery for lumbar spinal canal stenosis without coronal imbalance	JOURNAL OF NEUROSURGERY-SPINE			English	Article						lumbar spinal canal stenosis; spinopelvic alignment; decompression surgery; sagittal vertical axis	LOW-BACK-PAIN; QUALITY-OF-LIFE; IMPORTANT DIFFERENCE; RADIOGRAPHIC PARAMETERS; FOLLOW-UP; DISABILITY; QUESTIONNAIRE; SCOLIOSIS; DEFORMITY; FUSION	OBJECT The object of this study was to investigate correlations between sagittal spinopelvic alignment and improvements in clinical and quality-of-life (QOL) outcomes after lumbar decompression surgery for lumbar spinal canal stenosis (LCS) without coronal imbalance. METHODS The authors retrospectively reviewed data from consecutive patients treated for LCS with decompression surgery in the period from 2009 through 2011. They examined correlations between preoperative or postoperative sagittal vertical axis (SVA) and radiological parameters, clinical outcomes, and health-related (HR)QOL scores in patients divided according to SVA. Clinical outcomes were assessed according to Japanese Orthopaedic Association (JOA) and visual analog scale (VAS) scores. Health-related QOL was evaluated using. the Roland-Morris Disability Questionnaire (RMDQ) and the JOA Back Pain Evaluation Questionnaire (JOABPEQ). RESULTS One hundred nine patients were eligible for inclusion in the study. Compared to patients with normal sagittal alignment prior to surgery (Group A: SVA <50 mm), those with preoperative sagittal imbalance (Group B: SVA >= 50 mm) had significantly smaller lumbar lordosis and thoracic kyphosis angles and larger pelvic tilt. In Group B, there was a significant decrease in postoperative SVA compared with the preoperative SVA (76.3 +/- 29.7 mm vs 54.3 +/- 39.8 mm, p = 0.004). The patients in Group B with severe preoperative sagittal imbalance (SVA > 80 mm) had residual sagittal imbalance after surgery (82.8 +/- 41.6 mm). There were no significant differences in clinical and HRQOL outcomes between Groups A and B. Compared to patients with normal postoperative SVA (Group C: SVA < 50 mm), patients with a postoperative SVA >= 50 mm (Group D) had significantly lower JOABPEQ scores, both preoperative and postoperative, for walking ability (preop: 36.6 +/- 26.3 vs 22.7 +/- 26.0, p = 0.038, respectively; postop: 71.1 +/- 30.4 vs 42.5 +/- 29.6, p < 0.001) and social functioning (preop: 38.7 +/- 18.5 vs 30.2 +/- 16.7, p = 0.045; postop: 67.0 +/- 25.8 vs 49.6 +/- 20.0, p = 0.001), as well as significantly higher postoperative RMDQ (4.9 +/- 5.2 vs 7.9 +/- 5.7, p = 0.015) and VAS scores for low-back pain (2.68 +/- 2.69 vs 3.94 +/- 2.59, p = 0.039). CONCLUSIONS Preoperative sagittal balance was not significantly correlated with clinical or HRQOL outcomes after decompression surgery in LCS patients without coronal imbalance. Decompression surgery improved the SVA value in patients with preoperative sagittal imbalance; however, the patients with severe preoperative sagittal imbalance (SVA > 80 mm) had residual imbalance after decompression surgery. Both clinical and HRQOL outcomes were negatively affected by postoperative residual sagittal imbalance.	[Hikata, Tomohiro; Watanabe, Kota; Fujita, Nobuyuki; Iwanami, Akio; Hosogane, Naobumi; Ishii, Ken; Nakamura, Masaya; Toyama, Yoshiaki; Matsumoto, Morio] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan	Matsumoto, M (reprint author), Keio Univ, Sch Med, Dept Orthopaed Surg, Shinjyuku Ku, 35 Shinanomachi, Tokyo, Japan.	morio@a5.keio.jp					KELLGREN JH, 1958, ANN RHEUM DIS, V17, P388, DOI 10.1136/ard.17.4.388; Chiba K, 2001, SPINE, V26, P2112, DOI 10.1097/00007632-200110010-00014; Smith A, 2008, SPINE, V33, P2101, DOI 10.1097/BRS.0b013e31817ec3b0; Baldus C, 2008, SPINE, V33, P2214, DOI 10.1097/BRS.0b013e31817c0466; Glassman SD, 2005, SPINE, V30, P2024, DOI 10.1097/01.brs.0000179086.30449.96; Parker SL, 2011, J NEUROSURG-SPINE, V14, P598, DOI 10.3171/2010.12.SPINE10472; Watanabe K, 2005, J NEUROSURG-SPINE, V3, P405, DOI 10.3171/spi.2005.3.5.0405; Jang JS, 2009, NEUROSURGERY, V64, P115, DOI 10.1227/01.NEU.0000335642.14527.26; Jackson RP, 2000, SPINE, V25, P2808, DOI 10.1097/00007632-200011010-00014; Copay AG, 2008, SPINE J, V8, P968, DOI 10.1016/j.spinee.2007.11.006; Lundin O, 2001, SCAND J MED SCI SPOR, V11, P103, DOI 10.1034/j.1600-0838.2001.011002103.x; LAGRONE MO, 1988, J BONE JOINT SURG AM, V70A, P569; Rose PS, 2009, SPINE, V34, P785, DOI 10.1097/BRS.0b013e31819d0c86; Livshits G, 2011, ANN RHEUM DIS, V70, P1740, DOI 10.1136/ard.2010.137836; Parker SL, 2012, J NEUROSURG-SPINE, V16, P61, DOI 10.3171/2011.8.SPINE1194; Parker SL, 2012, J NEUROSURG-SPINE, V16, P471, DOI 10.3171/2012.1.SPINE11842; Lafage V, 2009, SPINE, V34, pE599, DOI 10.1097/BRS.0b013e3181aad219; JACKSON RP, 1994, SPINE, V19, P1611, DOI 10.1097/00007632-199407001-00010; FRYMOYER JW, 1984, J BONE JOINT SURG AM, V66A, P1048; Kulkarni AV, 2006, J CLIN EPIDEMIOL, V59, P176, DOI 10.1016/j.jclinepi.2005.07.011; Fukui M, 2009, J ORTHOP SCI, V14, P348, DOI 10.1007/s00776-009-1337-8; Roland M, 2000, SPINE, V25, P3115, DOI 10.1097/00007632-200012150-00006; Schwab FJ, 2013, SPINE, V38, pE803, DOI 10.1097/BRS.0b013e318292b7b9; Barrey C, 2007, EUR SPINE J, V16, P1459, DOI 10.1007/s00586-006-0294-6; Smith JS, 2009, SPINE, V34, P1693, DOI 10.1097/BRS.0b013e3181ac5fcd; Bridwell KH, 2009, SPINE, V34, P2171, DOI 10.1097/BRS.0b013e3181a8fdc8; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f	27	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	OCT	2015	23	4					451	458		10.3171/2015.1.SPINE14642		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CS1YF	WOS:000361864100009		
J	Matsukawa, K; Yato, Y; Imabayashi, H; Hosogane, N; Asazuma, T; Nemoto, K				Matsukawa, Keitaro; Yato, Yoshiyuki; Imabayashi, Hideaki; Hosogane, Naobumi; Asazuma, Takashi; Nemoto, Koichi			Biomechanical evaluation of the fixation strength of lumbar pedicle screws using cortical bone trajectory: a finite element study	JOURNAL OF NEUROSURGERY-SPINE			English	Article						cortical bone trajectory; finite element analysis; lumbar pedicle screw; fixation strength; pullout strength; bone mineral density	TRANSPEDICULAR SCREWS; MINERAL DENSITY; IN-VITRO; STABILITY; INSERTION; INSTRUMENTATION; MODEL	OBJECT Cortical bone trajectory (CBT) maximizes thread contact with the cortical bone surface and provides increased fixation strength. Even though the superior stability of axial screw fixation has been demonstrated, little is known about the biomechanical stiffness against multidirectional loading or its characteristics within a unit construct. The purpose of the present study was to quantitatively evaluate the anchorage performance of CBT by the finite element (FE) method. METHODS Thirty FE models of L-4 vertebrae from human spines (mean age [+/- SD] 60.9 +/- 18.7 years, 14 men and 16 women) were computationally created and pedicle screws were placed using the traditional trajectory (TT) and CBT. The TT screw was 6.5 mm in diameter and 40 mm in length, and the CBT screw was 5.5 mm in diameter and 35 mm in length. To make a valid comparison, the same shape of screw was inserted into the same pedicle in each subject. First, the fixation strength of a single pedicle screw was compared by axial pullout and multidirectional loading tests. Next, vertebral fixation strength within a construct was examined by simulating the motions of flexion, extension, lateral bending, and axial rotation. RESULTS CBT demonstrated a 26.4% greater mean pullout strength (POS; p = 0.003) than TT, and also showed a mean 27.8% stronger stiffness (p < 0.05) during cephalocaudal loading and 140.2% stronger stiffness (p < 0.001) during mediolateral loading. The CBT construct had superior resistance to flexion and extension loading and inferior resistance to lateral bending and axial rotation. The vertebral fixation strength of the construct was significantly correlated with bone mineral density of the femoral neck and the POS of a single screw. CONCLUSIONS CBT demonstrated superior fixation strength for each individual screw and sufficient stiffness in flexion and extension within a construct. The IT construct was superior to the CBT construct during lateral bending and axial rotation.	[Matsukawa, Keitaro; Imabayashi, Hideaki; Hosogane, Naobumi; Nemoto, Koichi] Natl Def Med Ctr, Dept Orthopaed Surg, Tokorozawa, Saitama 3598513, Japan; [Yato, Yoshiyuki; Asazuma, Takashi] Murayama Med Ctr, Natl Hosp Org, Dept Orthopaed Surg, Tokyo, Japan	Matsukawa, K (reprint author), Natl Def Med Ctr, Dept Orthopaed Surg, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	keitaro197897@hotmail.com					Wahba GM, 2010, SPINE, V35, P278, DOI 10.1097/BRS.0b013e3181bda4e6; Buhler DW, 1998, SPINE, V23, P1220, DOI 10.1097/00007632-199806010-00009; ABUMI K, 1990, SPINE, V15, P1142, DOI 10.1097/00007632-199011010-00011; WEINSTEIN JN, 1988, SPINE, V13, P1012, DOI 10.1097/00007632-198809000-00008; Labrom RD, 2005, SPINE, V30, pE556, DOI 10.1097/01.brs.0000181053.38677.c2; Imai K, 2006, SPINE, V31, P1789, DOI 10.1097/01.brs.0000225993.57349.df; Tsitsopoulos PP, 2012, J SPINAL DISORD TECH, V25, pE240, DOI 10.1097/BSD.0b013e31824c820c; COE JD, 1990, SPINE, V15, P902, DOI 10.1097/00007632-199009000-00012; Matsukawa K, 2014, SPINE, V39, pE240, DOI 10.1097/BRS.0000000000000116; HALVORSON TL, 1994, SPINE, V19, P2415, DOI 10.1097/00007632-199411000-00008; Wu SS, 1998, CLIN BIOMECH, V13, pS1, DOI 10.1016/S0268-0033(97)00069-7; Faizan A, 2014, J SPINAL DISORD TECH, V27, pE118, DOI 10.1097/BSD.0b013e3182a11478; Sterba W, 2007, CLIN BIOMECH, V22, P385, DOI 10.1016/j.clinbiomech.2006.11.007; Matsukawa K, 2013, J SPINAL DISORD TECH, V26, pE248, DOI 10.1097/BSD.0b013e318288ac39; Chatzistergos PE, 2010, SPINE, V35, pE332, DOI 10.1097/BRS.0b013e3181ba0b0c; Hirano T, 1997, SPINE, V22, P2504, DOI 10.1097/00007632-199711010-00007; Chao CK, 2008, J SPINAL DISORD TECH, V21, P130, DOI 10.1097/BSD.0b013e318073cc4b; Santoni BG, 2009, SPINE J, V9, P366, DOI 10.1016/j.spinee.2008.07.008; Krenn MH, 2008, J NEUROSURG-SPINE, V9, P90, DOI 10.3171/SPI/2008/9/7/090; Inceoglu S, 2011, J NEUROSURG-SPINE, V14, P670, DOI 10.3171/2010.11.SPINE09886; Silva P, 2013, EUR SPINE J, V22, P1829, DOI 10.1007/s00586-013-2810-9; Perez-Orribo L, 2013, SPINE, V38, P635, DOI 10.1097/BRS.0b013e318279a95e; Liebschner MAK, 2004, BIOMATERIALS, V25, P1697, DOI 10.1016/S0142-9612(03)00515-5; Zander T, 2003, EUR SPINE J, V12, P427, DOI 10.1007/s00586-003-0540-0; Mahmoud A, 2005, J PROSTHET DENT, V93, P183, DOI 10.1016/j.prosdent.2004.11.011; LAW M, 1993, SPINE, V18, P2438; Lim TH, 2001, SPINE, V26, P2498, DOI 10.1097/00007632-200111150-00020; Brodke D S, 2001, Spine J, V1, P373, DOI 10.1016/S1529-9430(01)00116-4; Keyak JH, 1998, J BIOMECH, V31, P125; ZINDRICK MR, 1986, CLIN ORTHOP RELAT R, P99	30	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	OCT	2015	23	4					471	478		10.3171/2015.1.SPINE141103		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CS1YF	WOS:000361864100012		
J	Kato, S; Murakami, H; Demura, S; Yoshioka, K; Hayashi, H; Yokogawa, N; Fang, X; Tsuchiya, H				Kato, Satoshi; Murakami, Hideki; Demura, Satoru; Yoshioka, Katsuhito; Hayashi, Hiroyuki; Yokogawa, Noriaki; Fang, Xiang; Tsuchiya, Hiroyuki			Gradual spinal cord decompression through migration of floated plaques after anterior decompression via a posterolateral approach for OPLL in the thoracic spine	JOURNAL OF NEUROSURGERY-SPINE			English	Article						ossification of the posterior longitudinal ligament; thoracic spine; anterior decompression; posterolateral approach; gradual spinal cord decompression; migrating floated plaques	POSTERIOR LONGITUDINAL LIGAMENT; OSSIFICATION; MYELOPATHY; FUSION	OBJECT Several surgical procedures have been developed to treat thoracic OPLL (ossification of the posterior longitudinal ligament). However, favorable surgical results are not always achieved, and consistent protocols and procedures for surgical treatment of OPLL in this region have not been established. Beak-type OPLL in the thoracic spine is known to be the most complicated form of OPLL to treat surgically. In this study, the authors examine the clinical outcomes after anterior decompression via a posterolateral approach for beak-type OPLL in the thoracic spine and address the gradual spinal cord decompression caused by migration of the floated plaques after surgery. METHODS Between 2011 and 2013, a total of 12 patients with thoracic myelopathy due to OPLL were surgically treated at the authors' institute. The study group for this paper comprises 6 of those 12 patients. These 6 patients, who had beak-type OPLL, underwent with anterior decompression and instrumented fusion via the authors' posterolateral approach based surgical technique. The other 6 patients, who exhibited other types of OPLL, underwent posterior decompression and instrumented fusion. In the study group (the 6 patients with beak-type OPLL), half of the patients (the 3 patients who were treated first) were treated with removal of the ossified ligament. These patients are referred to as the removal group. The other 3 patients were treated by means of "floating" the OPLL plaques and are referred to as the floating group. Clinical and radiographic outcomes were evaluated in these 6 cases. RESULTS The recovery rates were 52.4% in the removal group and 60.0% in the floating group. Two patients in the removal group had operative complications, including a dural tear and temporary neurological deterioration. No operative complications were encountered in the floating group. In all 3 cases in the floating group, floating of the ossified ligament was completely achieved, and the floated plaque gradually migrated into the ventral bone resection areas. The mean migration distances of the floated plaque were 2.4 mm, 4.3 mm, 4.7 mm, and 4.8 mm at 1, 3, 6, and 12 months after surgery. CONCLUSIONS Treatment of beak-type OPLL in the thoracic spine via the posterolateral approach based floating plaque technique was safe and effective in this small case series. Gradual migration of the floated plaques provided additional spinal cord decompression during the postoperative course.	[Kato, Satoshi; Murakami, Hideki; Demura, Satoru; Yoshioka, Katsuhito; Hayashi, Hiroyuki; Yokogawa, Noriaki; Fang, Xiang; Tsuchiya, Hiroyuki] Kanazawa Univ, Sch Med, Dept Orthopaed Surg, Kanazawa, Ishikawa 9208641, Japan	Kato, S (reprint author), Kanazawa Univ, Sch Med, Dept Orthopaed Surg, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	skato323@gmail.com			Health Labour Sciences Research Grant	This work was supported by a Health Labour Sciences Research Grant. No benefits in any form have been or will be received from any commercial party related directly or indirectly to the subject of this article.	Matsumoto M, 2008, SPINE, V33, P1034, DOI 10.1097/BRS.0b013e31816c913b; Matsuyama Y, 2005, J SPINAL DISORD TECH, V18, P492, DOI 10.1097/01.bsd.0000155033.63557.9c; Takahata M, 2008, SPINE, V33, P1199, DOI 10.1097/BRS.0b013e3181714515; TOMITA K, 1990, SPINE, V15, P1114, DOI 10.1097/00007632-199011010-00006; YONENOBU K, 1990, SPINE, V15, P1121, DOI 10.1097/00007632-199011010-00007; Kato S, 2012, J NEUROSURG-SPINE, V17, P525, DOI 10.3171/2012.9.SPINE12617; Fujimura Y, 1997, SPINE, V22, P305, DOI 10.1097/00007632-199702010-00015; HIRABAYASHI K, 1981, SPINE, V6, P354, DOI 10.1097/00007632-198107000-00005; Min JH, 2008, J SPINAL DISORD TECH, V21, P116, DOI 10.1097/BSD.0b013e318060091a; Kurosa Y, 1996, SPINE, V21, P1458, DOI 10.1097/00007632-199606150-00012; Tokuhashi Y, 2006, SPINE, V31, pE26, DOI 10.1097/01.brs.0000193940.75354.e5; IDO K, 1995, J SPINAL DISORD, V8, P317; Tsuzuki N, 2001, SPINE, V26, P1623, DOI 10.1097/00007632-200107150-00025	13	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	OCT	2015	23	4					479	483		10.3171/2015.1.SPINE14960		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CS1YF	WOS:000361864100013		
J	Takai, K; Komori, T; Taniguchi, M				Takai, Keisuke; Komori, Takashi; Taniguchi, Makoto			Microvascular anatomy of spinal dural arteriovenous fistulas: arteriovenous connections and their relationships with the dura mater	JOURNAL OF NEUROSURGERY-SPINE			English	Article						arteriovenous malformation; dural arteriovenous fistula; arteriovenous shunt; angioarchitecture; pathology; endovascular treatment; surgical treatment; vascular disorders	SURGICAL-TREATMENT; VASCULAR MALFORMATIONS; DRAINING VEIN; EMBOLIZATION; FEATURES; INTERRUPTION; MANAGEMENT; CORD; ONYX	OBJECT The microvascular anatomy of spinal dural arteriovenous fistulas (AVFs), especially the relationships of the vessels with the dura mater, has yet to be angiographically demonstrated in detail and proven histologically. METHODS From January 2012 through April 2014, a total of 7 patients with spinal dural AVFs in the thoracic region underwent open microsurgical obliteration at Tokyo Metropolitan Neurological Hospital. The microvascular anatomy of spinal dural AVFs was comprehensively assessed by using advanced microangiography, including 3D computer graphics and intraoperative indocyanine green video angiography, and by histological findings. RESULTS The 2 microangiography techniques revealed the spatial course and in vivo blood flow of the meningeal vessels and their relationships with the dura mater in sufficient detail. The meningeal branch of the intercostal artery split into multiple meningeal vessels on the outer dural surface adjacent to the root sleeve. After crossing the dura mater to the inner dural surface, these vessels gathered and joined a single intradural draining vessel. On the inner dural surface, the single draining vessel was fed by the surrounding multiple meningeal vessels, which appeared to be caput medusae. Histological findings revealed that the structure of the meningeal branch of the intercostal artery corresponded to that of a normal artery. The structure of intradural draining vessels corresponded to that of a vein modified by retrograde arterial inflow. On the inner dural surface, more than 1 meningeal artery gathered and joined with the proximal radiculomedullary vein. CONCLUSIONS Spinal dural AVFs are located on the inner dural surface, where multiple direct AV connections between more than 1 meningeal feeding artery and a single proximal radiculomedullary vein occur at the site where the vein connects to the dura mater.	[Takai, Keisuke; Taniguchi, Makoto] Tokyo Metropolitan Neurol Hosp, Dept Neurosurg, Fuchu, Tokyo 1830042, Japan; [Komori, Takashi] Tokyo Metropolitan Neurol Hosp, Dept Lab Med & Pathol, Fuchu, Tokyo 1830042, Japan	Takai, K (reprint author), Tokyo Metropolitan Neurol Hosp, Dept Neurosurg, 2-6-1 Musashidai, Fuchu, Tokyo 1830042, Japan.	takai-nsu@umin.ac.jp					Adamczyk P, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.2.FOCUS1224; Colby GP, 2009, J NEUROSURG-SPINE, V11, P705, DOI 10.3171/2009.6.SPINE09315; Atkinson JLD, 2001, MAYO CLIN PROC, V76, P1120; Blackburn SL, 2014, J NEUROINTERV SURG, V6, P536, DOI 10.1136/neurintsurg-2013-010779; Jellema K, 2005, J NEUROSURG-SPINE, V2, P580, DOI 10.3171/spi.2005.2.5.0580; Morris JM, 2012, RADIOL CLIN N AM, V50, P823, DOI 10.1016/j.rcl.2012.04.011; BENHAIEM N, 1983, ACTA NEUROPATHOL, V62, P103; Guillevin R, 2005, AM J NEURORADIOL, V26, P929; KNEISLEY LW, 1980, PARAPLEGIA, V18, P33; Takai K, 2011, J NEUROSURG-SPINE, V15, P654, DOI 10.3171/2011.8.SPINE11155; Takai K, 2013, J NEUROSURG-SPINE, V18, P398, DOI 10.3171/2013.1.SPINE12305; McCutcheon IE, 1996, J NEUROSURG, V84, P215, DOI 10.3171/jns.1996.84.2.0215; Sherif C, 2008, NEURORADIOLOGY, V50, P67, DOI 10.1007/s00234-007-0303-4; Andres RH, 2008, NEURORADIOLOGY, V50, P869, DOI 10.1007/s00234-008-0425-3; OLDFIELD EH, 1983, J NEUROSURG, V59, P1019, DOI 10.3171/jns.1983.59.6.1019; van Dijk JMC, 2002, STROKE, V33, P1578, DOI 10.1161/01.STR.0000018009.83713.06; AFSHAR JKB, 1995, J NEUROSURG, V82, P196, DOI 10.3171/jns.1995.82.2.0196; Cecchi PC, 2008, ACTA NEUROCHIR, V150, P563, DOI 10.1007/s00701-008-1560-7; Krings T, 2009, AM J NEURORADIOL, V30, P639, DOI 10.3174/ajnr.A1485; SYMON L, 1984, J NEUROSURG, V60, P238, DOI 10.3171/jns.1984.60.2.0238; Steinmetz MP, 2004, NEUROSURGERY, V55, P77, DOI 10.1227/01.NEU.0000126878.95006.0F; Gokhale Sankalp, 2014, Surg Neurol Int, V5, P7, DOI 10.4103/2152-7806.125628; Lad Shivanand P, 2009, Neurosurg Focus, V26, P1, DOI 10.3171/FOC.2009.26.1.E10; Medel R, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.1.E7; Hanel RA, 2010, NEUROSURGERY, V66, P978, DOI 10.1227/01.NEU.0000368108.94233.22	25	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	OCT	2015	23	4					526	533		10.3171/2014.11.SPINE14786		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CS1YF	WOS:000361864100020		
J	Tomiyama, T; Ishihara, K; Suda, M; Kanaya, K; Sakurai, M; Takahashi, N; Takano, H; Nitta, K; Hakozaki, K; Kumita, S				Tomiyama, Takeshi; Ishihara, Keiichi; Suda, Masaya; Kanaya, Koji; Sakurai, Minoru; Takahashi, Naoto; Takano, Hitoshi; Nitta, Koichi; Hakozaki, Kenta; Kumita, Shin-ichiro			Impact of time-of-flight on qualitative and quantitative analyses of myocardial perfusion PET studies using N-13-ammonia	JOURNAL OF NUCLEAR CARDIOLOGY			English	Article						N-13-ammonia; Time-of-flight (TOF); Myocardial blood flow (MBF); Myocardial flow reserve (MFR); Positron emission tomography (PET)	POSITRON-EMISSION-TOMOGRAPHY; CORONARY-ARTERY STENOSIS; POINT-SPREAD-FUNCTION; BLOOD-FLOW; QUANTIFICATION; RESERVE; RECONSTRUCTION; SEVERITY; SCANNER	The impact of time-of-flight (TOF) in myocardial perfusion N-13-ammonia positron emission tomography (PET) is unclear. Twenty consecutive subjects underwent rest and adenosine stress N-13-ammonia myocardial perfusion PET. Two sets of images were reconstructed using TOF-ordered subset expectation maximization (TOF-OSEM) and 3-dimensional row-action maximum likelihood algorithm (3D-RAMLA). Qualitative and quantitative analyses from the TOF-OSEM and 3D-RAMLA reconstructions were compared. Count profile curves revealed that TOF relatively increased the uptake of N-13-ammonia at the lateral walls, and apical thinning was emphasized on the TOF images. Both segmental rest and stress myocardial blood flow (MBF) values were higher with TOF-OSEM use than with 3D-RAMLA use (rest MBF: 0.955 +/- A 0.201 vs 0.836 +/- A 0.185, P < .001; stress MBF: 2.149 +/- A 0.697 vs 2.058 +/- A 0.721, P < .001). The differentiation of MBF between reconstructions was more enhanced under rest conditions. Thus, segmental myocardial flow reserve (MFR) observed using TOF-OSEM reconstruction was lower than that observed using 3D-RAMLA (2.25 +/- A 0.57 vs 2.46 +/- A 0.75, P < .001). No remarkable differences were observed between segmental and territorial results. TOF increased lateral wall counts and emphasized apical thinning. Quantitatively, TOF reconstruction showed increased MBF, especially under relatively low perfusion conditions.	[Tomiyama, Takeshi; Kumita, Shin-ichiro] Nippon Med Sch, Dept Radiol, Tokyo 1138603, Japan; [Ishihara, Keiichi; Suda, Masaya; Kanaya, Koji; Sakurai, Minoru; Hakozaki, Kenta] Nippon Med Sch, Clin Imaging Ctr Hlth Care, Tokyo 1138603, Japan; [Takahashi, Naoto; Takano, Hitoshi] Nippon Med Sch, Dept Cardiovasc Med, Tokyo 1138603, Japan; [Nitta, Koichi] Hitachi Med Corp, NM & RT Syst Sales Div, Tokyo, Japan	Tomiyama, T (reprint author), Nippon Med Sch, Dept Radiol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	tk2@nms.ac.jp					Akamatsu G, 2014, EUR J RADIOL, V83, P226, DOI 10.1016/j.ejrad.2013.09.030; Fiechter M, 2013, INT J CARDIOL, V167, P1023, DOI 10.1016/j.ijcard.2012.03.076; Surti S, 2007, J NUCL MED, V48, P471; Campisi R, 1998, CIRCULATION, V98, P119; DeGrado TR, 1996, J NUCL CARDIOL, V3, P494, DOI 10.1016/S1071-3581(96)90059-8; Schepis T, 2007, J NUCL MED, V48, P1783, DOI 10.2967/jnumed.107.044099; Yokoyama I, 1996, CIRCULATION, V94, P3232; Koepfli P, 2004, J NUCL MED, V45, P537; Tarantola G, 2003, J NUCL MED, V44, P756; Hajjiri MM, 2009, JACC-CARDIOVASC IMAG, V2, P751, DOI 10.1016/j.jcmg.2009.04.004; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Rahmim A, 2004, PHYS MED BIOL, V49, P4239, DOI 10.1088/0031-9155/49/18/004; Di Carli MF, 2007, J NUCL MED, V48, P783, DOI 10.2967/jnumed.106.032789; Alexanderson E, 2012, J NUCL CARDIOL, V19, P979, DOI 10.1007/s12350-012-9584-z; Prieto E, 2013, CLIN NUCL MED, V38, P103, DOI 10.1097/RLU.0b013e318279b9df; Slart RHJA, 2011, J NUCL MED, V52, P873, DOI 10.2967/jnumed.110.084954; Prior JO, 2005, CIRCULATION, V111, P2291, DOI 10.1161/01.CIR.0000164232.62768.51; Herzog BA, 2009, J AM COLL CARDIOL, V54, P150, DOI 10.1016/j.jacc.2009.02.069; Klingensmith William C 3rd, 2009, J Nucl Med Technol, V37, P215, DOI 10.2967/jnmt.109.062059; Sciagra R., 2012, SCI CAIRO, V2012; UREN NG, 1994, NEW ENGL J MED, V330, P1782, DOI 10.1056/NEJM199406233302503	21	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1071-3581	1532-6551		J NUCL CARDIOL	J. Nucl. Cardiol.	OCT	2015	22	5					998	1007		10.1007/s12350-014-0037-8		10	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CR8RU	WOS:000361622400026		
J	Nakamura, H; Isobe, A; Minobe, S; Mitsudera, H; Nonaka, M; Suga, T				Nakamura, Hisashi; Isobe, Atsuhiko; Minobe, Shoshiro; Mitsudera, Humio; Nonaka, Masami; Suga, Toshio			"Hot Spots" in the climate system-new developments in the extratropical ocean-atmosphere interaction research: a short review and an introduction	JOURNAL OF OCEANOGRAPHY			English	Editorial Material							KUROSHIO EXTENSION JET; SST ANOMALIES; SATELLITE-OBSERVATIONS; BOUNDARY-LAYER; GULF-STREAM; FRONTS; EDDIES; SEA; VARIABILITY; SHIFTS		[Nakamura, Hisashi] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo 1538904, Japan; [Isobe, Atsuhiko] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan; [Minobe, Shoshiro] Hokkaido Univ, Grad Sch Sci, Sapporo, Hokkaido 0600810, Japan; [Mitsudera, Humio] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan; [Nonaka, Masami] Japan Agcy Marine Earth Sci & Technol, Yokohama, Kanagawa 2360001, Japan; [Suga, Toshio] Tohoku Univ, Grad Sch Sci, Sendai, Miyagi 9808578, Japan	Nakamura, H (reprint author), Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo 1538904, Japan.	hisashi@atmos.rcast.u-tokyo.ac.jp	Kyushu, RIAM/F-4018-2015				Nonaka M, 2003, J CLIMATE, V16, P1404, DOI 10.1175/1520-0442(2003)16<1404:COSSTA>2.0.CO;2; Kushnir Y, 2002, J CLIMATE, V15, P2233, DOI 10.1175/1520-0442(2002)015<2233:AGRTES>2.0.CO;2; Frankignoul C, 2011, J CLIMATE, V24, P762, DOI 10.1175/2010JCLI3731.1; Small RJ, 2008, DYNAM ATMOS OCEANS, V45, P274, DOI 10.1016/j.dynatmoce.2008.01.001; Sugimoto S, 2011, J CLIMATE, V24, P6551, DOI 10.1175/2011JCLI4023.1; Qiu B, 2005, J PHYS OCEANOGR, V35, P2090, DOI 10.1175/JPO2807.1; Nakamura H, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034010; Minobe S, 2008, NATURE, V452, P206, DOI 10.1038/nature06690; Sasaki YN, 2011, J PHYS OCEANOGR, V41, P979, DOI 10.1175/2010JPO4550.1; Chelton DB, 2010, OCEANOGRAPHY, V23, P52; Masunaga R, 2015, J CLIMATE, V28, P1764, DOI 10.1175/JCLI-D-14-00314.1; Hotta D, 2011, J CLIMATE, V24, P3377, DOI 10.1175/2010JCLI3910.1; Xie SP, 2004, B AM METEOROL SOC, V85, P195, DOI 10.1175/BAMS-85-2-195; Taguchi B, 2007, J CLIMATE, V20, P2357, DOI 10.1175/JCLI4142.1; Chelton DB, 2004, SCIENCE, V303, P978, DOI 10.1126/science.1091901; O'Neill LW, 2010, J CLIMATE, V23, P559, DOI 10.1175/2009JCLI2662.1; Kelly KA, 2010, J CLIMATE, V23, P5644, DOI 10.1175/2010JCLI3346.1; Oka E, 2012, J OCEANOGR, V68, P5, DOI 10.1007/s10872-011-0032-5; Wu LX, 2012, NAT CLIM CHANGE, V2, P161, DOI 10.1038/NCLIMATE1353; Taguchi B, 2012, J CLIMATE, V25, P111, DOI 10.1175/JCLI-D-11-00046.1; Sasaki YN, 2012, J CLIMATE, V25, P6627, DOI 10.1175/JCLI-D-11-00727.1; Nakamura H, 2004, GEOPHYS MONOGR SER, V147, P329; Tokinaga H, 2009, J CLIMATE, V22, P4241, DOI 10.1175/2009JCLI2763.1; Oka E, 2012, J OCEANOGR, V68, P355, DOI 10.1007/s10872-011-0098-0; Kwon YO, 2010, J CLIMATE, V23, P3249, DOI 10.1175/2010JCLI3343.1; Tanimoto Y, 2011, J CLIMATE, V24, P4419, DOI 10.1175/2011JCLI4062.1; Aoki S, 2015, J OCEANOGR, V71, P623, DOI 10.1007/s10872-015-0284-6; Faure V, 2015, J OCEANOGR, V71; Hosoda S, 2015, J OCEANOGR, V71; Kawai Y, 2015, J OCEANOGR, V71; Kida S, 2015, J OCEANOGR, V71; Kubota M., 2007, FLUX NEWS, V4, P13; Miyama M, 2012, TELLUS A, V64, P18962; Nakamura H, 2015, J OCEANOGR, V71; Sasaki H, 2014, NATURE COMM, V5; Sasaki YN, 2015, J OCEANOGR, V71; Schneider N, 2015, J ATMOS SCI IN PRESS, V72; Shimada T, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046625; Wada A, 2015, J OCEANOGR, V71	39	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	OCT	2015	71	5					463	467		10.1007/s10872-015-0321-5		5	Oceanography	Oceanography	CS2FL	WOS:000361883200001		
J	Kida, S; Mitsudera, H; Aoki, S; Guo, XY; Ito, S; Kobashi, F; Komori, N; Kubokawa, A; Miyama, T; Morie, R; Nakamura, H; Nakamura, T; Nakano, H; Nishigaki, H; Nonaka, M; Sasaki, H; Sasaki, YN; Suga, T; Sugimoto, S; Taguchi, B; Takaya, K; Tozuka, T; Tsujino, H; Usui, N				Kida, Shinichiro; Mitsudera, Humio; Aoki, Shigeru; Guo, Xinyu; Ito, Shin-ichi; Kobashi, Fumiaki; Komori, Nobumasa; Kubokawa, Atsushi; Miyama, Toru; Morie, Ryosuke; Nakamura, Hisashi; Nakamura, Tomohiro; Nakano, Hideyuki; Nishigaki, Hajime; Nonaka, Masami; Sasaki, Hideharu; Sasaki, Yoshi N.; Suga, Toshio; Sugimoto, Shusaku; Taguchi, Bunmei; Takaya, Koutarou; Tozuka, Tomoki; Tsujino, Hiroyuki; Usui, Norihisa			Oceanic fronts and jets around Japan: a review	JOURNAL OF OCEANOGRAPHY			English	Review						Oceanic fronts; Western North Pacific; Air-sea interaction; Kuroshio Extension; Kuroshio-Oyashio confluence region; Subtropical fronts	SEA-SURFACE TEMPERATURE; ANTARCTIC CIRCUMPOLAR CURRENT; PACIFIC SUBTROPICAL COUNTERCURRENT; HAWAIIAN LEE COUNTERCURRENT; SETO INLAND SEA; EAST-CHINA-SEA; NORTH PACIFIC; KUROSHIO EXTENSION; GULF-STREAM; ATMOSPHERIC RESPONSE	This article reviews progress in our understanding of oceanic fronts around Japan and their roles in air-sea interaction. Fronts associated with the Kuroshio and its extension, fronts within the area of the Kuroshio-Oyashio confluence, and the subtropical fronts are described with particular emphasis on their structure, variability, and role in air-sea interaction. The discussion also extends to the fronts in the coastal and marginal seas, the Seto Inland Sea and Japan Sea. Studies on oceanic fronts have progressed significantly during the past decade, but many of these studies focus on processes at individual fronts and do not provide a comprehensive view. Hence, one of the goals of this article is to review the oceanic fronts around Japan by describing the processes based on common metrics. These metrics focus primarily on surface properties to obtain insights into air-sea interactions that occur along oceanic fronts. The basic characteristics derived for each front (i.e., metrics) are then presented as a table. We envision that many of the coupled ocean-atmosphere global circulation models in the coming decade will represent oceanic fronts reasonably well, and it is hoped that this review along with the table of metrics will provide a useful benchmark for evaluating these models.	[Kida, Shinichiro; Komori, Nobumasa; Miyama, Toru; Nakamura, Hisashi; Nonaka, Masami; Sasaki, Hideharu; Taguchi, Bunmei] Japan Agcy Marine Earth Sci & Technol, Applicat Lab, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Mitsudera, Humio; Aoki, Shigeru; Nakamura, Tomohiro] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 060, Japan; [Guo, Xinyu] Ehime Univ, Ctr Marine Environm Studies, Matsuyama, Ehime, Japan; [Ito, Shin-ichi] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan; [Kobashi, Fumiaki] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Tokyo, Japan; [Kubokawa, Atsushi] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido, Japan; [Morie, Ryosuke] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan; [Nakamura, Hisashi] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Nakano, Hideyuki; Tsujino, Hiroyuki; Usui, Norihisa] Meteorol Res Inst, Tsukuba, Ibaraki 305, Japan; [Nishigaki, Hajime] Oita Univ, Fac Educ & Welf Sci, Oita 87011, Japan; [Sasaki, Yoshi N.] Hokkaido Univ, Grad Sch Sci, Sapporo, Hokkaido, Japan; [Suga, Toshio; Sugimoto, Shusaku] Tohoku Univ, Grad Sch Sci, Dept Geophys, Sendai, Miyagi 980, Japan; [Takaya, Koutarou] Kyoto Sangyo Univ, Fac Sci, Kyoto 603, Japan; [Tozuka, Tomoki] Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Tokyo 113, Japan	Kida, S (reprint author), Japan Agcy Marine Earth Sci & Technol, Applicat Lab, Kanazawa Ku, 3173-25 Showa Machi, Yokohama, Kanagawa 2360001, Japan.	kidas@jamstec.go.jp	Tozuka, Tomoki/A-1805-2009; Sasaki, Yoshi/A-3263-2015; Ito, Shin-ichi/E-2981-2012; Miyama, Toru/A-3824-2009	Ito, Shin-ichi/0000-0002-3635-2580; Miyama, Toru/0000-0002-6400-0312	Japan Society for Promotion of Science [2205]	We thank the editor, Dr. Shoshiro Minobe, and three anonymous reviewers for their constructive comments on the manuscript. The altimeter products are produced by Ssalto/Duacs and distributed by AVISO with support from CNES (http://www.aviso.oceanobs.com/duacs/). APDRC at the University of Hawaii at Manoa (http://apdrc.soest.hawaii.edu/) was also used to obtain some of the data sets. This work is supported by the Japan Society for Promotion of Science through a Grant-in-Aid for Scientific Research on Innovative Areas 2205.	Howe PJ, 2009, DEEP-SEA RES PT I, V56, P1093, DOI 10.1016/j.dsr.2009.03.007; Seo H, 2014, J GEOPHYS RES-ATMOS, V119, P418, DOI 10.1002/2013JD020523; Qiu B, 1999, J PHYS OCEANOGR, V29, P2471, DOI 10.1175/1520-0485(1999)029<2471:SEFMOT>2.0.CO;2; Nakamura H, 2004, J CLIMATE, V17, P1828, DOI 10.1175/1520-0442(2004)017<1828:SVITSH>2.0.CO;2; Ogawa F, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049922; Tomita H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049902; Minobe S, 2010, J CLIMATE, V23, P3699, DOI 10.1175/2010JCLI3359.1; Tsujino H, 2013, CLIM DYNAM, V41, P2287, DOI 10.1007/s00382-012-1641-4; Frankignoul C, 2011, J CLIMATE, V24, P762, DOI 10.1175/2010JCLI3731.1; Niiler PP, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001461; Sun YJ, 2006, J OCEANOGR, V62, P801, DOI 10.1007/s10872-006-0099-6; Okajima S, 2014, J CLIMATE, V27, P3889, DOI 10.1175/JCLI-D-13-00140.1; Sasaki H, 2012, J OCEANOGR, V68, P93, DOI 10.1007/s10872-011-0074-8; Yasuda I, 1996, J PHYS OCEANOGR, V26, P448, DOI 10.1175/1520-0485(1996)026<0448:DAMONP>2.0.CO;2; IMASATO N, 1987, J PHYS OCEANOGR, V17, P953, DOI 10.1175/1520-0485(1987)017<0953:AEIWEB>2.0.CO;2; Kubota M, 2002, J OCEANOGR, V58, P213, DOI 10.1023/A:1015845321836; Small RJ, 2008, DYNAM ATMOS OCEANS, V45, P274, DOI 10.1016/j.dynatmoce.2008.01.001; Imawaki S, 2001, GEOPHYS RES LETT, V28, P17, DOI 10.1029/2000GL011796; Shimada T, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035810; Qiu B, 1997, J PHYS OCEANOGR, V27, P431, DOI 10.1175/1520-0485(1997)027<0431:EAFMOT>2.0.CO;2; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; ICHIKAWA H, 1993, DEEP-SEA RES PT I, V40, P583, DOI 10.1016/0967-0637(93)90147-U; Sugimoto S, 2011, J CLIMATE, V24, P6551, DOI 10.1175/2011JCLI4023.1; Rintoul SR, 2001, J GEOPHYS RES-OCEANS, V106, P2815, DOI 10.1029/2000JC900107; Yasuda I, 2003, J OCEANOGR, V59, P389, DOI 10.1023/A:1025580313836; Dinniman MS, 1999, J PHYS OCEANOGR, V29, P537, DOI 10.1175/1520-0485(1999)029<0537:FITNPO>2.0.CO;2; SIMPSON JH, 1974, NATURE, V250, P404, DOI 10.1038/250404a0; Yamamoto M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046214; Kobashi F, 2012, J OCEANOGR, V68, P21, DOI 10.1007/s10872-011-0083-7; LINDZEN RS, 1987, J ATMOS SCI, V44, P2418, DOI 10.1175/1520-0469(1987)044<2418:OTROSS>2.0.CO;2; WALLACE JM, 1989, J CLIMATE, V2, P1492, DOI 10.1175/1520-0442(1989)002<1492:TIOSST>2.0.CO;2; GORDON AL, 1985, SCIENCE, V227, P1030, DOI 10.1126/science.227.4690.1030; Suga T, 2008, PROG OCEANOGR, V77, P285, DOI 10.1016/j.pocean.2006.12.005; Shi R, 2011, BOUND-LAY METEOROL, V138, P299, DOI 10.1007/s10546-010-9555-3; [Anonymous], 1987, J OCEANOGR SOC JAPAN, DOI DOI 10.1007/BF02109215; JOYCE TM, 1993, J GEOPHYS RES-OCEANS, V98, P10111, DOI 10.1029/93JC00572; Nakamura H, 2010, GEOPHYS MONOGR SER, V189, P149, DOI 10.1029/2008GM000789; Nonaka M, 2006, J CLIMATE, V19, P1970, DOI 10.1175/JCLI3793.1; ZHANG RC, 1993, J GEOPHYS RES-OCEANS, V98, P967, DOI 10.1029/92JC01854; Chen CTA, 2009, J MARINE SYST, V78, P394, DOI 10.1016/j.jmarsys.2008.11.016; Park KA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019424; Isoguchi O, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003080; Qiu B, 2005, J PHYS OCEANOGR, V35, P2090, DOI 10.1175/JPO2807.1; Nakamura H, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034010; Qiu B, 2013, J PHYS OCEANOGR, V43, P344, DOI 10.1175/JPO-D-12-0133.1; Aoki Y, 2002, J PHYS OCEANOGR, V32, P2299, DOI 10.1175/1520-0485(2002)032<2299:SSFOTN>2.0.CO;2; POLLARD RT, 1992, J PHYS OCEANOGR, V22, P609, DOI 10.1175/1520-0485(1992)022<0609:VAVCAA>2.0.CO;2; NAKANO T, 1994, J PHYS OCEANOGR, V24, P609, DOI 10.1175/1520-0485(1994)024<0609:TKSATE>2.0.CO;2; Beal LM, 2011, NATURE, V472, P429, DOI 10.1038/nature09983; Abe H, 2013, J OCEANOGR, V69, P191, DOI 10.1007/s10872-012-0166-0; Xie SP, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015884; Minobe S, 2008, NATURE, V452, P206, DOI 10.1038/nature06690; Kobashi F, 2008, J CLIMATE, V21, P5960, DOI 10.1175/2008JCLI2311.1; CROMWELL T, 1956, TELLUS, V8, P94; RODEN GI, 1982, J GEOPHYS RES-OC ATM, V87, P9537, DOI 10.1029/JC087iC12p09537; Sasaki YN, 2011, OCEAN MODEL, V39, P209, DOI 10.1016/j.ocemod.2011.04.004; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; TALLEY LD, 1995, J PHYS OCEANOGR, V25, P475, DOI 10.1175/1520-0485(1995)025<0475:NPIWIT>2.0.CO;2; Hickox R, 2000, GEOPHYS RES LETT, V27, P2945, DOI 10.1029/1999GL011223; Niiler PP, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018628; Waterman S, 2011, J PHYS OCEANOGR, V41, P1182, DOI 10.1175/2010JPO4564.1; Hurlburt HE, 1998, J GEOPHYS RES-OCEANS, V103, P7549, DOI 10.1029/97JC02723; Schneider N, 2002, J CLIMATE, V15, P586, DOI 10.1175/1520-0442(2002)015<0586:AONPDV>2.0.CO;2; QIU B, 1991, J GEOPHYS RES-OCEANS, V96, P18491, DOI 10.1029/91JC01834; Usui N, 2013, J OCEANOGR, V69, P647, DOI 10.1007/s10872-013-0197-1; Kazmin AS, 1996, J GEOPHYS RES-OCEANS, V101, P907, DOI 10.1029/95JC02992; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Sugimoto S, 2012, J OCEANOGR, V68, P219, DOI 10.1007/s10872-011-0089-1; BERNSTEIN RL, 1981, J PHYS OCEANOGR, V11, P692, DOI 10.1175/1520-0485(1981)011<0692:SATMPI>2.0.CO;2; Ambe D, 2004, J OCEANOGR, V60, P375, DOI 10.1023/B:JOCE.0000038343.31468.fe; Miyazawa Y, 2004, J PHYS OCEANOGR, V34, P2203, DOI 10.1175/1520-0485(2004)034<2203:ROMEIT>2.0.CO;2; YANAGI T, 1987, CONT SHELF RES, V7, P149, DOI 10.1016/0278-4343(87)90076-8; Kagimoto T, 1997, J PHYS OCEANOGR, V27, P403, DOI 10.1175/1520-0485(1997)027<0403:STVOTK>2.0.CO;2; Kubokawa A, 1999, J PHYS OCEANOGR, V29, P1314, DOI 10.1175/1520-0485(1999)029<1314:VTSABA>2.0.CO;2; Masunaga R, 2015, J CLIMATE, V28, P1764, DOI 10.1175/JCLI-D-14-00314.1; Joyce TM, 2009, J CLIMATE, V22, P3177, DOI 10.1175/2008JCLI2690.1; Kobashi F, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2006JC003479; Gentemann CL, 2010, IEEE T GEOSCI REMOTE, V48, P1009, DOI 10.1109/TGRS.2009.2030322; Cunningham SA, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001147; Thomas LN, 2005, J PHYS OCEANOGR, V35, P1086, DOI 10.1175/JPO2737.1; Andres M, 2008, J OCEANOGR, V64, P937, DOI 10.1007/s10872-008-0077-2; Hotta D, 2011, J CLIMATE, V24, P3377, DOI 10.1175/2010JCLI3910.1; Tomita H, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005545; Tanimoto Y, 2009, J CLIMATE, V22, P1360, DOI 10.1175/2008JCLI2420.1; Minobe S, 2004, J PHYS OCEANOGR, V34, P2382, DOI 10.1175/JPO2627.1; Seo Y, 2014, J CLIMATE, V27, P5929, DOI 10.1175/JCLI-D-13-00641.1; Nakano H, 2008, DYNAM ATMOS OCEANS, V45, P135, DOI 10.1016/j.dynatmoce.2007.09.002; Sampe T, 2010, J CLIMATE, V23, P1793, DOI 10.1175/2009JCLI3163.1; Xie SP, 2004, B AM METEOROL SOC, V85, P195, DOI 10.1175/BAMS-85-2-195; Takeoka H, 2002, J OCEANOGR, V58, P93, DOI 10.1023/A:1015828818202; Suga T, 2004, J PHYS OCEANOGR, V34, P3, DOI 10.1175/1520-0485(2004)034<0003:TNPCOW>2.0.CO;2; Qiu CH, 2012, J OCEANOGR, V68, P417, DOI 10.1007/s10872-012-0106-z; Lumpkin R, 2013, OCEANOGRAPHY, V26, P58; Miyazawa Y, 2009, J OCEANOGR, V65, P737; Shimada T, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003345; Chelton DB, 2004, SCIENCE, V303, P978, DOI 10.1126/science.1091901; Shimada T, 2005, REMOTE SENS ENVIRON, V98, P21, DOI 10.1016/j.rse.2005.05.018; Nonaka M, 2009, J CLIMATE, V22, P6515, DOI 10.1175/2009JCLI2960.1; Xie SP, 2001, SCIENCE, V292, P2057, DOI 10.1126/science.1059781; Kelly KA, 2010, J CLIMATE, V23, P5644, DOI 10.1175/2010JCLI3346.1; Sallee JB, 2008, J CLIMATE, V21, P3020, DOI 10.1175/2007JCLI1702.1; Tozuka T, 2014, GEOPHYS RES LETT, V41, P2447, DOI 10.1002/2014GL059624; [Anonymous], 1969, DEEP SEA RES S; PATTERSON SL, 1985, J PHYS OCEANOGR, V15, P865, DOI 10.1175/1520-0485(1985)015<0865:SCAKED>2.0.CO;2; Miyasaka T, 2010, J CLIMATE, V23, P2115, DOI 10.1175/2009JCLI3008.1; Itoh S, 2010, J PHYS OCEANOGR, V40, P1018, DOI 10.1175/2009JPO4265.1; Yu LS, 2007, B AM METEOROL SOC, V88, P527, DOI 10.1175/BAMS-88-4-527; Yu ZJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016710; Oka E, 2012, J OCEANOGR, V68, P5, DOI 10.1007/s10872-011-0032-5; Rio MH, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006505; Xie SP, 2011, J CLIMATE, V24, P1212, DOI 10.1175/2010JCLI3896.1; Belkin I, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013806; Yoshida S, 2011, J GEOPHYS RES-OCEANS, V116, DOI [10.1029/2011J0007286, 10.1029/2011JC007286]; Hoskins B, 2013, Q J ROY METEOR SOC, V139, P573, DOI 10.1002/qj.1991; Smirnov D, 2015, J CLIMATE, V28, P1126, DOI 10.1175/JCLI-D-14-00285.1; Lutjeharms JRE, 2001, J MARINE SYST, V30, P115, DOI 10.1016/S0924-7963(01)00041-0; Qiu B, 2008, J PHYS OCEANOGR, V38, P1764, DOI 10.1175/2008JPO3921.1; Yuan XJ, 1996, J GEOPHYS RES-OCEANS, V101, P16491, DOI 10.1029/96JC01249; Oka E, 2011, J PHYS OCEANOGR, V41, P113, DOI 10.1175/2010JPO4419.1; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Iizuka S, 2013, SOLA, V9, P1, DOI 10.2151/sola.2013-001; Isobe A, 2002, J PHYS OCEANOGR, V32, P994, DOI 10.1175/1520-0485(2002)032<0994:AVOTKT>2.0.CO;2; Wagawa T, 2014, J PHYS OCEANOGR, V44, P1636, DOI 10.1175/JPO-D-12-0192.1; Suga T, 1997, J PHYS OCEANOGR, V27, P140, DOI 10.1175/1520-0485(1997)027<0140:TDITNP>2.0.CO;2; Taguchi B, 2012, J CLIMATE, V25, P111, DOI 10.1175/JCLI-D-11-00046.1; Sasaki YN, 2012, J CLIMATE, V25, P6627, DOI 10.1175/JCLI-D-11-00727.1; Sokolov S, 2007, J PHYS OCEANOGR, V37, P1394, DOI 10.1175/JPO3111.1; Liu WT, 2007, J CLIMATE, V20, P5784, DOI 10.1175/2007JCLI1732.1; Qiu B, 2010, J PHYS OCEANOGR, V40, P213, DOI 10.1175/2009JPO4285.1; QIU B, 1990, J GEOPHYS RES-OCEANS, V95, P18191; Nakamura H, 2004, GEOPHYS MONOGR SER, V147, P329; Tokinaga H, 2009, J CLIMATE, V22, P4241, DOI 10.1175/2009JCLI2763.1; Kobashi F, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001225; Taguchi B, 2009, J CLIMATE, V22, P6536, DOI 10.1175/2009JCLI2910.1; Kuwano-Yoshida A, 2010, Q J ROY METEOR SOC, V136, P1583, DOI 10.1002/qj.660; Yoshikawa Y, 2001, J GEOPHYS RES-OCEANS, V106, P1033, DOI 10.1029/2000JC000226; Nakamura H, 1997, B AM METEOROL SOC, V78, P2215, DOI 10.1175/1520-0477(1997)078<2215:DCVITN>2.0.CO;2; Nakamura H, 2012, J CLIMATE, V25, P7772, DOI 10.1175/JCLI-D-12-00326.1; Sasaki H, 2013, J CLIMATE, V26, P7267, DOI 10.1175/JCLI-D-12-00586.1; Kwon YO, 2010, J CLIMATE, V23, P3249, DOI 10.1175/2010JCLI3343.1; JOHNS WE, 1995, J GEOPHYS RES-OCEANS, V100, P817, DOI 10.1029/94JC02497; Tatebe H, 2001, J GEOPHYS RES-OCEANS, V106, P16685, DOI 10.1029/2000JC000467; Chang PH, 2009, J OCEANOGR, V65, P721; Sasaki H, 2010, OCEAN DYNAM, V60, P705, DOI 10.1007/s10236-009-0258-6; Tanimoto Y, 2011, J CLIMATE, V24, P4419, DOI 10.1175/2011JCLI4062.1; HAYES SP, 1989, J CLIMATE, V2, P1500, DOI 10.1175/1520-0442(1989)002<1500:TIOSST>2.0.CO;2; Kawabe M, 1995, J PHYS OCEANOGR, V25, P3103, DOI 10.1175/1520-0485(1995)025<3103:VOCPVA>2.0.CO;2; Chang YL, 2014, J PHYS OCEANOGR, V44, P818, DOI 10.1175/JPO-D-13-0162.1; Antonov JI, 2006, NOAA ATLAS NESDIS, V2; Antonov JI, 2010, NOAA ATLAS NESDIS, V2; BINGHAM FM, 1992, J GEOPHYS RES-OCEANS, V97, P11177, DOI 10.1029/92JC01001; Book JW, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000795; Bryden HL, 2005, J OCEANOGR, V61, P479, DOI 10.1007/s10872-005-0057-8; Conkright ME, 2002, NOAA ATLAS NESDIS, V1; Favorite F, 1976, INT N PACIFIC FISHER, V33; Flament P, 1998, ATLAS HAWAII, P82; Fujiwara I, 1981, MARINE SCI MONTHLY, V13, P264; Gouretski V. V., 2004, BER BUNDESAMTES SEES, V35, P1; Hinata T., 1996, OCEANOGR MAG, V45, P9; HOFMANN EE, 1985, J GEOPHYS RES-OCEANS, V90, P7087, DOI 10.1029/JC090iC04p07087; Hogg N.G., 1992, J MAR RES, V78, P1231; Hurlburt HE, 1996, J GEOPHYS RES, V101, P951; Iizuka S, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012576; Imawaki S, 2013, OCEAN CIRCULATION CL, pChapter 13; Isobe A, 1997, J OCEANOGR, V53, P373; ISODA Y, 1991, ELSEV OCEANOGR SERIE, V54, P103; Isoda Y, 1994, LA MER, V32, P285; Jacobs GA, 1999, J OCEANOGR, V55, P247, DOI 10.1023/A:1007898131004; Kagimoto T, 2008, HIGH RESOLUTION NUMERICAL MODELLING OF THE ATMOSPHERE AND OCEAN, P209, DOI 10.1007/978-0-387-49791-4_13; Kawabe M, 1988, J OCEANOGR SOC JPN, V44, P293, DOI 10.1007/BF02302572; Kawabe M, 1987, J OCEANOGR SOC JAPAN, V43, P111, DOI 10.1007/BF02111887; Kawai H, 1972, KUROSHIO ITS PHYSICA, P235; Kawai Y, 2015, J OCEANOGR, V71, P511, DOI 10.1007/s10872-014-0266-0; Kimura K, 1949, MAPS FISHING GROUNDS; Kitahara T, 1921, OCEAN STUDY NIGHT FA, P303; Kurihara Y., 2000, WEATHER B, V73, pS1; Lee CM, 2006, OCEANOGRAPHY, V19, P110; Masumoto Y., 2004, J EARTH SIMULATOR, V1, P35; Mellor G, 2002, OCEAN FORECASTING CO, P55; Miyama T, 2012, TELLUS A, V64, DOI 10.3402/tellusa.v64i0.18962; Mizuno K, 1983, J PHYS OCEANOGR, V13, P1848; Murakami M, 1993, UMI NO KENKYU, V2, P343; Nakamura H, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/1999JC000085; Nakamura H, 2012, JAPAN GEOSCI LETT, V8, P1; Nakamura H, 1999, EL NINO DECADAL INTE, P49; O'Reilly CH, 2015, Q J ROY METEOR SOC, V141, P52, DOI 10.1002/qj.2334; OHTANI K, 1970, Journal of the Oceanographical Society of Japan, V26, P271, DOI 10.1007/BF02769468; Oka E., 1998, J OCEANOGR, V54, P605, DOI DOI 10.1007/BF02823281; Qiu B, 2010, DEEP-SEA RES PT II, V57, P1098, DOI 10.1016/j.dsr2.2008.11.036; Rintoul S.R., 2013, INT GEOPHYS SER, P471; RODEN GI, 1980, J GEOPHYS RES-OC ATM, V85, P2704, DOI 10.1029/JC085iC05p02704; Sasaki H, 2008, HIGH RESOLUTION NUMERICAL MODELLING OF THE ATMOSPHERE AND OCEAN, P157, DOI 10.1007/978-0-387-49791-4_10; Shimada T, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046625; SPALL MA, 1995, J GEOPHYS RES-OCEANS, V100, P2543, DOI 10.1029/94JC02860; Talley L. D., 2006, OCEANOGRAPHY, V19, P32, DOI DOI 10.5670/0CEAN0G.2006.42; Talley L.D., 2011, DESCRIPTIVE PHYS OCE; Tanimoto Y, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001750; Tomczak M., 2003, REGIONAL OCEANOGRAPH; Uda M, 1969, J OCEANOGR SOC JAPAN, V25, P201; Uda M, 1938, GEOPHYS MAG, V11, P307; Ueno H, 2000, J GEOPHYS RES-OCEANS, V105, P16885, DOI 10.1029/2000JC900020; Zweng M. M., 2013, NOAA ATLAS NESDIS, V2	202	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	OCT	2015	71	5					469	497		10.1007/s10872-015-0283-7		29	Oceanography	Oceanography	CS2FL	WOS:000361883200002		
J	Sasaki, YN; Minobe, S				Sasaki, Yoshi N.; Minobe, Shoshiro			Climatological mean features and interannual to decadal variability of ring formations in the Kuroshio Extension region	JOURNAL OF OCEANOGRAPHY			English	Article						Kuroshio Extension; Pinch-off ring; Jet; Heat transport; Interannual to decadal variability	GENERAL-CIRCULATION MODEL; GULF-STREAM MEANDERS; THIN-JET THEORY; WARM-CORE RING; NORTH PACIFIC; MESOSCALE EDDIES; EDDY TRANSPORTS; HEAT-TRANSPORT; SHATSKY RISE; OCEAN	This study examines the climatological mean features of oceanic rings shed from the Kuroshio Extension (KE) jet and their interannual to decadal variability using satellite altimeter observations from October 1992 to December 2010. To objectively capture ring shedding from the KE jet, a new method that consists of the detection of the jet length changes and the tracking of a ring is proposed. Spatial distribution of the ring formations in the KE region indicates that cyclonic (cold-core) rings were most frequently formed in the upstream region between 143A degrees and 147A degrees E around the steady meander of the KE jet. In contrast, most of anticyclonic (warm-core) rings were formed in the downstream region west of the Shatsky Rise. These pinched-off rings in both the upstream and downstream regions generally propagated westward, but about two-thirds of the rings were reabsorbed by the jet. Nevertheless, about one-fourth of the meridional eddy heat transport at the latitude of the KE resulted from the rings that are not reabsorbed by the jet. The number of ring formations showed substantial interannual to decadal variability. In the upstream and downstream KE region, decadal and interannual variability was dominant, respectively. These ring formation fluctuations were negatively correlated with the strength of the KE jet. It is also revealed that the ring formation variations play an important role in sea surface temperature changes north of the KE jet.	[Sasaki, Yoshi N.; Minobe, Shoshiro] Hokkaido Univ, Grad Sch Sci, Sapporo, Hokkaido 0600810, Japan	Sasaki, YN (reprint author), Hokkaido Univ, Grad Sch Sci, Sci 8th Bldg 8-3-20,N10 W8, Sapporo, Hokkaido 0600810, Japan.	sasakiyo@mail.sci.hokudai.ac.jp	Sasaki, Yoshi/A-3263-2015		Ministry of Education, Culture, Sports, Science, and Technology of Japan [22106008, 25800258]	We thank two anonymous reviewers for comments that helped improve the manuscript. This research was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (Grant Number 22106008) and a Grant-in-Aid for Young Scientists (Grant Number 25800258), wholly funded by the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Kouketsu S, 2012, J OCEANOGR, V68, P63, DOI 10.1007/s10872-011-0049-9; Chelton DB, 2011, PROG OCEANOGR, V91, P167, DOI 10.1016/j.pocean.2011.01.002; Inatsu M, 2013, J CLIMATE, V26, P8641, DOI 10.1175/JCLI-D-12-00379.1; AUER SJ, 1987, J GEOPHYS RES-OCEANS, V92, P11709, DOI 10.1029/JC092iC11p11709; Qiu B, 2007, J PHYS OCEANOGR, V37, P982, DOI 10.1175/JPO3097.1; Aoki K, 2013, J PHYS OCEANOGR, V43, P1899, DOI 10.1175/JPO-D-12-0223.1; OLSON DB, 1991, ANNU REV EARTH PL SC, V19, P283, DOI 10.1146/annurev.earth.19.1.283; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Rio MH, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002226; Sasai Y, 2010, OCEAN DYNAM, V60, P693, DOI 10.1007/s10236-010-0264-8; Sugimoto S, 2011, J CLIMATE, V24, P6551, DOI 10.1175/2011JCLI4023.1; Chelton DB, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030812; BUSH ABG, 1995, J PHYS OCEANOGR, V25, P1959, DOI 10.1175/1520-0485(1995)025<1959:TFOOEI>2.0.CO;2; MCWILLIAMS JC, 1979, J PHYS OCEANOGR, V9, P1155, DOI 10.1175/1520-0485(1979)009<1155:OTEOIN>2.0.CO;2; Inatsu M, 2009, ATMOS SCI LETT, V10, P267, DOI 10.1002/asl.238; Qiu B, 2005, J PHYS OCEANOGR, V35, P2090, DOI 10.1175/JPO2807.1; Yim BY, 2010, J PHYS OCEANOGR, V40, P340, DOI 10.1175/2009JPO4243.1; Stammer D, 1998, J PHYS OCEANOGR, V28, P727, DOI 10.1175/1520-0485(1998)028<0727:OECETA>2.0.CO;2; Jochumsen K, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC006042; Bond NA, 2008, J CLIMATE, V21, P1680, DOI [10.1175/2007JCLI1797.1, 10.1175/2007JCLIJ797.1]; Sasaki YN, 2011, J PHYS OCEANOGR, V41, P979, DOI 10.1175/2010JPO4550.1; Lee T, 1996, J PHYS OCEANOGR, V26, P225, DOI 10.1175/1520-0485(1996)026<0225:PAGOGS>2.0.CO;2; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; Hurlburt HE, 1998, J GEOPHYS RES-OCEANS, V103, P7549, DOI 10.1029/97JC02723; Schneider N, 2002, J CLIMATE, V15, P586, DOI 10.1175/1520-0442(2002)015<0586:AONPDV>2.0.CO;2; Chambers DP, 1997, J GEOPHYS RES-OCEANS, V102, P10525, DOI 10.1029/96JC03644; Nishihama Y, 2013, J OCEANOGR, V69, P135, DOI 10.1007/s10872-012-0161-5; Deser C, 1999, J CLIMATE, V12, P1697, DOI 10.1175/1520-0442(1999)012<1697:EFAWDI>2.0.CO;2; Martin AP, 2001, DEEP-SEA RES PT II, V48, P757, DOI 10.1016/S0967-0645(00)00096-5; WHITE WB, 1985, J PHYS OCEANOGR, V15, P917, DOI 10.1175/1520-0485(1985)015<0917:STCVIT>2.0.CO;2; WYRTKI K, 1976, J GEOPHYS RES-OC ATM, V81, P2641, DOI 10.1029/JC081i015p02641; KAWAMURA H, 1986, DEEP-SEA RES, V33, P1617, DOI 10.1016/0198-0149(86)90070-1; Qiu B, 2005, J PHYS OCEANOGR, V35, P458, DOI 10.1175/JPO2696.1; LUTJEHARMS JRE, 1988, NATURE, V331, P251, DOI 10.1038/331251a0; Sasaki YN, 2013, J PHYS OCEANOGR, V43, P442, DOI 10.1175/JPO-D-12-096.1; Taguchi B, 2007, J CLIMATE, V20, P2357, DOI 10.1175/JCLI4142.1; CUSHMANROISIN B, 1990, J PHYS OCEANOGR, V20, P758, DOI 10.1175/1520-0485(1990)020<0758:WMOME>2.0.CO;2; Itoh S, 2010, J PHYS OCEANOGR, V40, P1018, DOI 10.1175/2009JPO4265.1; Waterman S, 2013, J PHYS OCEANOGR, V43, P1666, DOI 10.1175/JPO-D-12-0152.1; GILL AE, 1973, DEEP-SEA RES, V20, P141, DOI 10.1016/0011-7471(73)90049-1; Oka E, 2011, J PHYS OCEANOGR, V41, P666, DOI 10.1175/2011JPO4501.1; CUSHMANROISIN B, 1993, J PHYS OCEANOGR, V23, P91, DOI 10.1175/1520-0485(1993)023<0091:AGTFEB>2.0.CO;2; CHAO SY, 1994, J PHYS OCEANOGR, V24, P1512, DOI 10.1175/1520-0485(1994)024<1512:ZJOTOA>2.0.CO;2; MIZUNO K, 1983, J PHYS OCEANOGR, V13, P1847, DOI 10.1175/1520-0485(1983)013<1847:AAIVIT>2.0.CO;2; Rainville L, 2007, OCEAN MODEL, V17, P338, DOI 10.1016/j.ocemod.2007.03.002; Tokinaga H, 2009, J CLIMATE, V22, P4241, DOI 10.1175/2009JCLI2763.1; JOYCE T, 1984, NATURE, V308, P837, DOI 10.1038/308837a0; Fujii Y, 2013, J GEOPHYS RES-OCEANS, V118, P2035, DOI 10.1002/jgrc.20094; SHUM CK, 1990, J GEOPHYS RES-OCEANS, V95, P17865, DOI 10.1029/JC095iC10p17865; Ducet N, 2000, J GEOPHYS RES-OCEANS, V105, P19477, DOI 10.1029/2000JC900063; Nakano H, 2013, J GEOPHYS RES-OCEANS, V118, P5461, DOI 10.1002/jgrc.20375; Souza JMAC, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049359; Mariano AJ, 1996, DEEP-SEA RES PT I, V43, P1531, DOI 10.1016/S0967-0637(96)00021-0; Chelton DB, 1998, J PHYS OCEANOGR, V28, P433, DOI 10.1175/1520-0485(1998)028<0433:GVOTFB>2.0.CO;2; CUSHMANROISIN B, 1993, J GEOPHYS RES-OCEANS, V98, P2543, DOI 10.1029/92JC02059; Ducet N, 2001, J GEOPHYS RES-OCEANS, V106, P16603, DOI 10.1029/2000JC000205; Ebuchi N., 2001, J OCEANOGR, V57, P471, DOI 10.1023/A:1021293822277; Emery WJ, 2004, DATA ANAL METHODS PH; Kaplan D, 1995, UNDERSTANDING NONLIN, P420; O'Reilly CH, 2015, Q J ROY METEOR SOC, V141, P52, DOI 10.1002/qj.2334; Qiu B, 2010, DEEP-SEA RES PT II, V57, P1098, DOI 10.1016/j.dsr2.2008.11.036; Yasuda I, 1992, DEEP-SEA RES, V39, P131	62	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	OCT	2015	71	5					499	509		10.1007/s10872-014-0270-4		11	Oceanography	Oceanography	CS2FL	WOS:000361883200003		
J	Kawai, Y; Miyama, T; Iizuka, S; Manda, A; Yoshioka, MK; Katagiri, S; Tachibana, Y; Nakamura, H				Kawai, Yoshimi; Miyama, Toru; Iizuka, Satoshi; Manda, Atsuyoshi; Yoshioka, Mayumi K.; Katagiri, Shuichiro; Tachibana, Yoshihiro; Nakamura, Hisashi			Marine atmospheric boundary layer and low-level cloud responses to the Kuroshio Extension front in the early summer of 2012: three-vessel simultaneous observations and numerical simulations	JOURNAL OF OCEANOGRAPHY			English	Article						Kuroshio extension; Intensive observation; Early summer; SST front; Mid-latitude air-sea interaction; Longwave radiation; Low-level cloud; Water vapor; Ceilometer; Model experiment	SEA-SURFACE TEMPERATURE; GULF-STREAM; IN-SITU; REANALYSIS; VARIABILITY; RESOLUTION; SATELLITE; MODEL	Intensive atmospheric observations were carried out with five research vessels in total across the sea surface temperature (SST) front along the Kuroshio Extension in the early summer of 2012, to identify the effects of the front on the thermal structure and cloud formation in the marine atmospheric boundary layer (MABL). Three of the vessels were aligned together along the 143A degrees E meridian with latitudinal separation of as small as 30' or 45', going back and forth across the SST front for in situ observations during 2-6 July. The SST front was quite sharp and moved northward by about 50 km in 3 days, which was not well represented in objectively analyzed SST data sets. The observations captured rapid changes of the mesoscale MABL structure across the SST front, which were particularly evident in cloud base height and downward longwave radiation (DLR) at the surface. The higher base of low-level clouds observed over the warmer water resulted from stronger turbulent mixing in the MABL, which became prominent under the northerlies. The most frequently measured DLR value was greater by 20 W m(-2) to the south of the SST front than to the north. High-resolution atmospheric model experiments conducted with and without the frontal SST gradient have confirmed its critical importance for the MABL structure and low-level clouds. These imprints of the SST front simulated in the models are sensitive to SST data assigned at the lower boundary of the model.	[Kawai, Yoshimi] Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Global Change, Yokosuka, Kanagawa 2370061, Japan; [Miyama, Toru; Nakamura, Hisashi] Japan Agcy Marine Earth Sci & Technol, Applicat Lab, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Iizuka, Satoshi] Natl Res Inst Earth Sci & Disaster Prevent, Monitoring & Forecast Res Dept, Tsukuba, Ibaraki 3050006, Japan; [Manda, Atsuyoshi] Nagasaki Univ, Grad Sch Fisheries Sci & Environm Studies, Nagasaki 8528521, Japan; [Yoshioka, Mayumi K.; Katagiri, Shuichiro] Tohoku Univ, Grad Sch Sci, Ctr Atmospher & Ocean Studies, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Tachibana, Yoshihiro] Mie Univ, Grad Sch Bioresources, Tsu, Mie 5148507, Japan; [Nakamura, Hisashi] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan	Kawai, Y (reprint author), Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Global Change, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan.	ykawai@jamstec.go.jp	Miyama, Toru/A-3824-2009	Miyama, Toru/0000-0002-6400-0312	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [22106007, 22106003, 22106004, 22106005, 22106006, 22106009]	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, Grants-in-Aid for Scientific Research on Innovative Areas (22106007, 22106003, 22106004, 22106005, 22106006 and 22106009). The authors would like to sincerely thank the captains, crews, and cruise leaders of R/V Seisui-maru, R/V Wakataka-maru, and R/V Tansei-maru. Weather charts, MGDSST and MSM data were provided by the Japan Meteorological Agency. Dr. Miyazawa of JAMSTEC and his colleagues kindly provided their JCOPE2 product. The authors thank Dr. Y. Wang of IPRC, University of Hawaii, for providing the IPRC-RAM. The authors are also extremely grateful to Prof. T. Murayama of Tokyo University of Marine Science and Technology, Dr. H. Tomita of Nagoya University, and all the colleagues who got involved in the intensive observation campaign. The editor and anonymous reviewers provided us with valuable comments and helped us to improve the paper.	Stevens DE, 2002, J ATMOS SCI, V59, P3285, DOI 10.1175/1520-0469(2002)059<3285:EODSAN>2.0.CO;2; Randall DA, 2007, CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P589; Liu JW, 2014, J CLIMATE, V27, P4421, DOI 10.1175/JCLI-D-13-00469.1; Small RJ, 2008, DYNAM ATMOS OCEANS, V45, P274, DOI 10.1016/j.dynatmoce.2008.01.001; Bony S, 2004, CLIM DYNAM, V22, P71, DOI 10.1007/s00382-003-0369-6; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Yasuda I, 2003, J OCEANOGR, V59, P389, DOI 10.1023/A:1025580313836; Kawai Y, 2014, J GEOPHYS RES-ATMOS, V119, DOI 10.1002/2013JD021126; Sakurai T, 2005, INT GEOSCI REMOTE SE, P2606; Hotta D, 2011, J CLIMATE, V24, P3377, DOI 10.1175/2010JCLI3910.1; Tanimoto Y, 2009, J CLIMATE, V22, P1360, DOI 10.1175/2008JCLI2420.1; Miyazawa Y, 2009, J OCEANOGR, V65, P737; Vellore R, 2007, WEATHER FORECAST, V22, P1101, DOI 10.1175/WAF1029.1; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Kelly KA, 2010, J CLIMATE, V23, P5644, DOI 10.1175/2010JCLI3346.1; Nakamura H, 2004, GEOPHYS MONOGR SER, V147, P329; Tokinaga H, 2009, J CLIMATE, V22, P4241, DOI 10.1175/2009JCLI2763.1; Taguchi B, 2009, J CLIMATE, V22, P6536, DOI 10.1175/2009JCLI2910.1; Kwon YO, 2010, J CLIMATE, V23, P3249, DOI 10.1175/2010JCLI3343.1; Wang YQ, 2005, J CLIMATE, V18, P934, DOI 10.1175/JCLI3302.1; Tanimoto Y, 2011, J CLIMATE, V24, P4419, DOI 10.1175/2011JCLI4062.1; Katsaros KB, 2004, BOUND-LAY METEOROL, V112, P381, DOI 10.1023/B:BOUN.0000027905.90989.b2; Boucher O, 2013, CLIMATE CHANGE 2013, P571, DOI DOI 10.1017/CBO9781107415324.016; Masunaga R, 2015, J CLIM IN PRESS; National Centers for Environmental Prediction/National Weather Service/NOM/U. S. Department of Commerce, 2000, NCEP FNL OP MOD GLOB; Shimada T, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046625; Skamarock W. C., 2008, 475 NCAR, V475, P113, DOI DOI 10.5065/D68S4MVH; Tochimoto E, 2012, SOLA, V8, DOI 10.2151/sola.2012-003	29	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	OCT	2015	71	5					511	526		10.1007/s10872-014-0266-0		16	Oceanography	Oceanography	CS2FL	WOS:000361883200004		
J	Faure, V; Kawai, Y				Faure, Vincent; Kawai, Yoshimi			Heat and salt budgets of the mixed layer around the Subarctic Front of the North Pacific Ocean	JOURNAL OF OCEANOGRAPHY			English	Article						Ocean mixed layer; Heat budget; Salt budget; Subarctic Front; Kuroshio-Oyashio extension; Mode water; Ekman advection; Geostrophic advection; Air-sea flux; Mixed layer base entrainment	REGION; VARIABILITY; TRANSPORT	The Subarctic Front (SAF) of the North Pacific Ocean is important because it considerably affects the storm track in the troposphere, and mode water ocean mixed layer (OML) forms south of the front. However, processes controlling the sea surface temperature and salinity in the area of the SAF are not fully understood. Using Argo, satellite, and atmospheric reanalysis data, we investigate the OML heat budget seasonal cycle around the SAF in a domain defined by 150A degrees-168A degrees E and 40A degrees-46A degrees N. In summer, a large imbalance suggests a non-negligible cooling effect due to vertical mixing. In winter, we find that in the area of mode water OML, air-sea fluxes contribute to 60 % of heat dissipation. The remaining cooling is due to lateral advection and mixed layer base entrainment, while eddies warm the OML. North of the SAF, the geostrophic and Ekman flows have comparable cooling effects. Entrainment also cools the OML in fall, but vanishes in winter. In March, entrainment warming due to a temperature inversion below the OML is found to be negligible. We also estimate the salinity budget of the OML. In winter, entrainment contributes to a salinity increase north of the SAF, but it is negligible in the mode water OML area. The contribution of salinity to buoyancy loss during fall and winter OML deepening is relatively small, especially south of the front where it accounts for only 6 % of total buoyancy loss.	[Faure, Vincent; Kawai, Yoshimi] Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Global Change, Yokosuka, Kanagawa 2370061, Japan	Faure, V (reprint author), Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Global Change, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan.	vincent-faure@laposte.net		Faure, Vincent/0000-0003-2347-069X	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [22106007]; NASA Earth Science MEaSUREs DISCOVER Project; AMSR-E Science Team; NASA Earth Science Physical Oceanography Program; NASA Ocean Vector Winds Science Team; OAA Climate Observations and Monitoring (COM) program	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, Grant-in-Aid for Scientific Research on Innovative Areas (22106007). AMSR-E data are produced by Remote Sensing Systems (RSS; www.remss.com) and sponsored by the NASA Earth Science MEaSUREs DISCOVER Project and the AMSR-E Science Team. WindSat is sponsored by the NASA Earth Science Physical Oceanography Program. The QuikSCAT data are provided by RSS, sponsored by the NASA Ocean Vector Winds Science Team. The Ssalto/Duacs data is distributed by Aviso with support from CNES. The WHOI OAFlux project is funded by the NOAA Climate Observations and Monitoring (COM) program. We thank three anonymous reviewers for their helpful comments.	Kouketsu S, 2012, J OCEANOGR, V68, P63, DOI 10.1007/s10872-011-0049-9; Tomita H, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022075; Tomita H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049902; Faure V, 2011, OCEAN DYNAM, V61, P1441, DOI 10.1007/s10236-011-0444-1; Kelly KA, 2004, J CLIMATE, V17, P573, DOI 10.1175/1520-0442(2004)017<0573:TRBOHT>2.0.CO;2; Nonaka M, 2006, J CLIMATE, V19, P1970, DOI 10.1175/JCLI3793.1; Kawai Y, 2014, J GEOPHYS RES-ATMOS, V119, DOI 10.1002/2013JD021126; Isoguchi O, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003080; Yim BY, 2010, J PHYS OCEANOGR, V40, P340, DOI 10.1175/2009JPO4243.1; Cerovecki I, 2011, J CLIMATE, V24, P6283, DOI 10.1175/2011JCLI3858.1; Kara AB, 2000, J GEOPHYS RES-OCEANS, V105, P16783, DOI 10.1029/2000JC900071; Masunaga R, 2015, J CLIMATE, V28, P1764, DOI 10.1175/JCLI-D-14-00314.1; Qiu B, 2005, J PHYS OCEANOGR, V35, P458, DOI 10.1175/JPO2696.1; Suga T, 2004, J PHYS OCEANOGR, V34, P3, DOI 10.1175/1520-0485(2004)034<0003:TNPCOW>2.0.CO;2; Helber RW, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007382; Itoh S, 2010, J PHYS OCEANOGR, V40, P1018, DOI 10.1175/2009JPO4265.1; Oka E, 2012, J OCEANOGR, V68, P5, DOI 10.1007/s10872-011-0032-5; de Boisseson E, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006283; Sloyan BM, 2010, J PHYS OCEANOGR, V40, P1558, DOI 10.1175/2010JPO4114.1; Tokinaga H, 2009, J CLIMATE, V22, P4241, DOI 10.1175/2009JCLI2763.1; Tanimoto Y, 2011, J CLIMATE, V24, P4419, DOI 10.1175/2011JCLI4062.1; QIU B, 1993, J PHYS OCEANOGR, V23, P2027, DOI 10.1175/1520-0485(1993)023<2027:UOHBIT>2.0.CO;2; Argo, 2014, ARG FLOATS DAT MET G; de Boyer Montegut C, 2007, J GEOPHYS RES, V112; Dong S, 2009, J GEOPHYS RES, V114; Emery WJ, 2001, DATA ANAL METHODS PH; Favorite F., 1976, B INT N PAC COMM, V33, P1; Kantha L, 2010, MODELING TURBULENT M, P1; Nakamura H, 2008, GEOPHYS RES LETT, V35; Ohno Y, 2004, GEOPHYS RES LETT, V31; Saitoi H, 2007, J OCEANOGR, V63, P589, DOI 10.1007/s10872-007-0052-3; Tomita H, 2010, J GEOPHYS RES, V115; Ueno H, 2000, J GEOPHYS RES-OCEANS, V105, P16885, DOI 10.1029/2000JC900020; Wunsch C., 1996, OCEAN CIRCULATION IN	34	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	OCT	2015	71	5					527	539		10.1007/s10872-015-0318-0		13	Oceanography	Oceanography	CS2FL	WOS:000361883200005		
J	Hosoda, S; Nonaka, M; Tomita, T; Taguchi, B; Tomita, H; Iwasaka, N				Hosoda, Shigeki; Nonaka, Masami; Tomita, Tomohiko; Taguchi, Bunmei; Tomita, Hiroyuki; Iwasaka, Naoto			Impact of downward heat penetration below the shallow seasonal thermocline on the sea surface temperature	JOURNAL OF OCEANOGRAPHY			English	Article						Heat capacity; Seasonal variability; North Pacific; Argo; J-OFURO2; Air-sea interaction	KUROSHIO EXTENSION SYSTEM; NORTH PACIFIC; UPPER-OCEAN; MIXED-LAYER; INTERANNUAL VARIABILITY; TEMPORAL COHERENCE; SST ANOMALIES; RECURRENCE; FLUX	Observational data are used to investigate summer heat penetration into the subsurface ocean in order to quantify the heat capacity of the upper ocean with respect to surface heat exchange. Sea surface temperature is strongly modulated by the change in heat capacity, which could influence the overlying atmosphere and hence trigger climate variations, even during the warming season, when the ocean has been regarded as being rather passive. Few studies have focused on the heat exchange process in surface and subsurface layers because of the existence of a strong seasonal thermocline at the bottom of thin summer mixed layers (ML). By introducing the concept of the heat penetration depth (HPD), defined as the depth to which the downward net heat flux (Q (net)) distinctly penetrates, we here characterize the heat capacity in terms of the heat content above the HPD using a simple, one-dimensional vertical model during the warming season. Seasonal changes in the HPD indicate that the thermal effects of Q (net) gradually penetrate below the shallow seasonal thermocline due to vertical eddy diffusivity. Downward heat penetration into the layer below the shallow seasonal thermocline occurs widely throughout the North Pacific, and two-thirds of Q (net) penetrates below the ML. In a hypothetical analysis of the case where the observed Q (net) accumulates only within the ML, the change in SST is unrealistically larger than that of the observed SST. These results indicate that heat penetration plays a crucial role in climate variations during the warming season.	[Hosoda, Shigeki] Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Global Change, Yokosuka, Kanagawa 2370061, Japan; [Nonaka, Masami; Taguchi, Bunmei] Japan Agcy Marine Earth Sci & Technol, Applicat Lab, Yokohama, Kanagawa, Japan; [Tomita, Tomohiko] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto, Japan; [Tomita, Hiroyuki] Nagoya Univ, Hydrospher Atmospher Res Ctr, Nagoya, Aichi 4648601, Japan; [Iwasaka, Naoto] Tokyo Univ Marine Sci & Technol, Fac Marine Technol, Tokyo, Japan	Hosoda, S (reprint author), Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Global Change, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan.	hosodas@jamstec.go.jp	Tomita, Tomohiko/O-5733-2015	Tomita, Tomohiko/0000-0003-4612-4503	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [22106006, 22510023, 21540458, 24540476, 23340139]	We thank the participants in the regular meetings of the Mid-and High-Latitude Climate Predictability Research Team for their useful discussions. Members of the data management team of the Strategic Ocean Monitoring Research Team of the Japan Agency for Marine-Earth Science and Technology (JAMSTEC) helped with the use of Argo float data and the refinement of the dataset. Argo float data were obtained from the GDAC websites at http://www.coriolis.eu.org/ and http://www.usgodae.org/argo/argo.html. We obtained heat flux data from the J-OFURO2 website at http://dtsv.scc.u-tokai.ac.jp/. This work was supported by Grants-in-Aid for Scientific Research (22106006, 22510023, 21540458, 24540476, and 23340139) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan.	ROSSOW WB, 1991, B AM METEOROL SOC, V72, P2, DOI 10.1175/1520-0477(1991)072<0002:ICDP>2.0.CO;2; Liu QY, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024493; Tomita T, 2002, J METEOROL SOC JPN, V80, P1289, DOI 10.2151/jmsj.80.1289; Kubota M, 2002, J OCEANOGR, V58, P213, DOI 10.1023/A:1015845321836; Alexander MA, 1999, J CLIMATE, V12, P2419, DOI 10.1175/1520-0442(1999)012<2419:TROSAI>2.0.CO;2; Moisan JR, 1998, J PHYS OCEANOGR, V28, P401, DOI 10.1175/1520-0485(1998)028<0401:TSHBOT>2.0.CO;2; ALEXANDER MA, 1995, J PHYS OCEANOGR, V25, P122, DOI 10.1175/1520-0485(1995)025<0122:AMFTRO>2.0.CO;2; FRANKIGNOUL C, 1977, TELLUS, V29, P289; NAMIAS J, 1974, J GEOPHYS RES, V79, P797, DOI 10.1029/JC079i006p00797; Deser C, 1996, J CLIMATE, V9, P1840, DOI 10.1175/1520-0442(1996)009<1840:UOTVIT>2.0.CO;2; Ueda H, 2009, J CLIMATE, V22, P649, DOI 10.1175/2008JCLI2341.1; Sugimoto S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021410; Hosoda S, 2010, J OCEANOGR, V66, P773, DOI 10.1007/s10872-010-0063-3; Tomita H, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005545; Kosaka Y, 2006, Q J ROY METEOR SOC, V132, P2009, DOI 10.1256/qj.05.204; Qiu B, 2006, J PHYS OCEANOGR, V36, P457, DOI 10.1175/JPO2849.1; Deser C, 2003, J CLIMATE, V16, P57, DOI 10.1175/1520-0442(2003)016<0057:UTPOSS>2.0.CO;2; HALL MM, 1982, DEEP-SEA RES, V29, P339, DOI 10.1016/0198-0149(82)90099-1; Tomita T, 2010, INT J CLIMATOL, V30, P2205, DOI 10.1002/joc.2040; NAMIAS J, 1970, J GEOPHYS RES, V75, P5952, DOI 10.1029/JC075i030p05952; Qiu B, 2000, J PHYS OCEANOGR, V30, P1486, DOI 10.1175/1520-0485(2000)030<1486:IVOTKE>2.0.CO;2; Hack JJ, 2006, J CLIMATE, V19, P2267, DOI 10.1175/JCLI3764.1; PAULSON CA, 1977, J PHYS OCEANOGR, V7, P952, DOI 10.1175/1520-0485(1977)007<0952:IMITUO>2.0.CO;2; NITTA T, 1987, J METEOROL SOC JPN, V65, P373; Gent Peter R., 2010, Climate Dynamics, V34, DOI 10.1007/s00382-009-0614-8; AKIMA H, 1970, J ACM, V17, P589, DOI 10.1145/321607.321609; Tomita T, 2006, J CLIMATE, V19, P300, DOI 10.1175/JCLI3616.1; Alexander MA, 2001, PROG OCEANOGR, V49, P41, DOI 10.1016/S0079-6611(01)00015-5; Antonov JA, 2006, NOAA ATLAS NESDIS, V2; Argo Data Management Team, 2012, ARG US MAN VER 2 4, P85; Argo Data Management Team, 2002, 3 ARG DAT MAN M MAR, P42; DASARO EA, 1995, J PHYS OCEANOGR, V25, P2909, DOI 10.1175/1520-0485(1995)025<2909:UOICFB>2.0.CO;2; de Boyer Montegut C, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002378; Farewell CW, 2003, J CLIMATOL, V16, P571; FRANKIGNOUL C, 1985, REV GEOPHYS, V23, P357, DOI 10.1029/RG023i004p00357; Hanawa K., 1981, Tohoku Geophysical Journal, Science Reports of the Tohoku University, Fifth Series, V28; Hosoda S., 2008, JAMSTEC REP RES DEV, V8, P47, DOI DOI 10.5918/JAMSTECR.8.47; Koblinsky CJ, 2001, OBS OC 21 CENT, P248; Locarnini R.A., 2006, WORLD OCEAN ATLAS 20, V1; UNESCO, 1981, UNESCO TECHN PAP MAR, V37, P1; Wahl S, 2009, CLIM DYNAM, V36, P891; Yu L, 2008, OA200801 WOODS HOL O; Zhang HM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027086; Zhang H-M, 2006, AM MET SOC 2006 ANN	44	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	OCT	2015	71	5					541	556		10.1007/s10872-015-0275-7		16	Oceanography	Oceanography	CS2FL	WOS:000361883200006		
J	Hosoda, S; Nonaka, M; Sasai, Y; Sasaki, H				Hosoda, Shigeki; Nonaka, Masami; Sasai, Yoshikazu; Sasaki, Hideharu			Early summertime interannual variability in surface and subsurface temperature in the North Pacific	JOURNAL OF OCEANOGRAPHY			English	Article						Summertime temperature variability; North Pacific; Argo; OFES; Air-sea interaction; Interannual variability	OYASHIO CONFLUENCE REGION; TURBULENT HEAT FLUXES; ARCTIC FRONTAL ZONE; EDDY-RESOLVING OGCM; KUROSHIO EXTENSION; SST ANOMALIES; DECADAL VARIABILITY; STORM-TRACK; OCEAN; SEA	Vertical structures of early summer ocean temperature variability on interannual and longer time scales in the North Pacific (NP) are investigated based on observational data obtained by the Argo. In the central and especially eastern NP regions, temperature variance is large but limited to the shallower layer. Given shallow mixed layer isolated by strong stratification from the subsurface layer due to strong short wave radiation in summer, the limitation to the shallower layer is expected. On the contrary, temperature variability in the western NP region frequently extends several hundred meters in depth. In the western NP, longer time scale variability of temperature is also apparent as temperature difference before and after 2008. Solutions of an eddy-resolving ocean general circulation model strongly suggest that the temperature variability is associated with changes in the oceanic frontal structures that extend to subsurface layer: enhancement of the northern branch of Kuroshio Extension and associated weakened meridional temperature gradients to the south and north of the current after 2008. The deep structure of temperature variability apparently indicates that it is caused not by atmospheric thermal forcing, but by oceanic structure changes, and it is corroborated by the similar variability in the subsurface salinity field. Also, it is shown that atmospheric thermal forcing strongly affects early summer sea surface temperature variability in the eastern NP, but not in the western NP.	[Hosoda, Shigeki; Sasai, Yoshikazu] Japan Agcy Marine Earth Sci & Technol, Res & Develop Ctr Global Change, Yokosuka, Kanagawa 2370061, Japan; [Nonaka, Masami; Sasaki, Hideharu] Japan Agcy Marine Earth Sci & Technol, Applicat Lab, Yokohama, Kanagawa, Japan	Hosoda, S (reprint author), Japan Agcy Marine Earth Sci & Technol, Res & Develop Ctr Global Change, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan.	hosodas@jamstec.go.jp			Japan Society of Promotion of Science (JSPS) [2205]	This study is supported in part by the Japan Society of Promotion of Science (JSPS) through Grants-in-Aid for Scientific Research in Innovative Areas 2205. The Earth Simulator was utilized in support of JAMSTEC. Members of the Argo Data Management Team of the Japan Agency for Marine-Earth Science and Technology (JAMSTEC) helped with the use of Argo float data and refinement of the data set. Also, the authors thank two reviewers for their constructive comments that helped improve this study. Argo float data were obtained from the GDAC web sites at http://www.cori-olis.eu.org/ and http://www.usgodae.org/argo/argo.html.	Nonaka M, 2003, J CLIMATE, V16, P1404, DOI 10.1175/1520-0442(2003)16<1404:COSSTA>2.0.CO;2; Ogawa F, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049922; Hosoda S, 2015, J OCEANOGR, V71, P541, DOI 10.1007/s10872-015-0275-7; Frankignoul C, 2011, J CLIMATE, V24, P762, DOI 10.1175/2010JCLI3731.1; [Anonymous], 2011, SSALTO DUACS US HDB; Okajima S, 2014, J CLIMATE, V27, P3889, DOI 10.1175/JCLI-D-13-00140.1; Small RJ, 2008, DYNAM ATMOS OCEANS, V45, P274, DOI 10.1016/j.dynatmoce.2008.01.001; Sugimoto S, 2011, J CLIMATE, V24, P6551, DOI 10.1175/2011JCLI4023.1; ALEXANDER MA, 1995, J PHYS OCEANOGR, V25, P122, DOI 10.1175/1520-0485(1995)025<0122:AMFTRO>2.0.CO;2; Nonaka M, 2006, J CLIMATE, V19, P1970, DOI 10.1175/JCLI3793.1; Nakamura H, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034010; Picaut J, 1996, SCIENCE, V274, P1486, DOI 10.1126/science.274.5292.1486; Sasaki H, 2012, J PHYS OCEANOGR, V42, P1233, DOI 10.1175/JPO-D-11-0180.1; Minobe S, 2008, NATURE, V452, P206, DOI 10.1038/nature06690; Sugimoto S, 2014, J CLIMATE, V27, P9349, DOI 10.1175/JCLI-D-14-00195.1; Tanimoto Y, 2009, J CLIMATE, V22, P1360, DOI 10.1175/2008JCLI2420.1; Sampe T, 2010, J CLIMATE, V23, P1793, DOI 10.1175/2009JCLI3163.1; Qiu B, 2006, J PHYS OCEANOGR, V36, P457, DOI 10.1175/JPO2849.1; Xie SP, 2004, B AM METEOROL SOC, V85, P195, DOI 10.1175/BAMS-85-2-195; Sasaki YN, 2013, J PHYS OCEANOGR, V43, P442, DOI 10.1175/JPO-D-12-096.1; Chelton DB, 2004, SCIENCE, V303, P978, DOI 10.1126/science.1091901; Nonaka M, 2009, J CLIMATE, V22, P6515, DOI 10.1175/2009JCLI2960.1; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; NAMIAS J, 1970, J GEOPHYS RES, V75, P5952, DOI 10.1029/JC075i030p05952; Nonaka M, 2008, J CLIMATE, V21, P6283, DOI 10.1175/2008JCLI2294.1; Ashok K, 2009, NATURE, V461, P481, DOI 10.1038/461481a; Norris JR, 2000, J CLIMATE, V13, P422, DOI 10.1175/1520-0442(2000)013<0422:IAIVIT>2.0.CO;2; Tomita T, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029676; Taguchi B, 2012, J CLIMATE, V25, P111, DOI 10.1175/JCLI-D-11-00046.1; MIZUNO K, 1983, J PHYS OCEANOGR, V13, P1847, DOI 10.1175/1520-0485(1983)013<1847:AAIVIT>2.0.CO;2; Sasaki YN, 2012, J CLIMATE, V25, P6627, DOI 10.1175/JCLI-D-11-00727.1; Nakamura H, 2004, GEOPHYS MONOGR SER, V147, P329; O'Neill LW, 2003, J CLIMATE, V16, P2340, DOI 10.1175/2780.1; Taguchi B, 2009, J CLIMATE, V22, P6536, DOI 10.1175/2009JCLI2910.1; Ducet N, 2000, J GEOPHYS RES-OCEANS, V105, P19477, DOI 10.1029/2000JC900063; Hasegawa T, 2013, J CLIMATE, V26, P8126, DOI 10.1175/JCLI-D-12-00187.1; Taguchi B, 2005, J CLIMATE, V18, P2979, DOI 10.1175/JCLI3449.1; Argo Data Management Team, 2002, P ARG DAT MAN 3 M MA, P42; Hosoda S., 2008, JAMSTEC REP RES DEV, V8, P47, DOI DOI 10.5918/JAMSTECR.8.47; Kida S, 2015, J OCEANOGR, V71, P469, DOI 10.1007/s10872-015-0283-7; Koblinsky C. J., 2001, OBSERVING OCEANS 21, P248; Komori N., 2005, J EARTH SIMULATOR, V4, P31; Masumoto Y., 2004, J EARTH SIMULATOR, V1, P35; Miyama T, 2012, TELLUS A, V64, DOI 10.3402/tellusa.v64i0.18962; Nakamura M, 2014, J CLIMATE, V27, P7861, DOI 10.1175/JCLI-D-13-00609.1; O'Reilly CH, 2015, Q J ROY METEOR SOC, V141, P52, DOI 10.1002/qj.2334; Pacanowski RC, 2000, MOM 3 0 MANUAL, P680; Sasaki H, 2008, HIGH RESOLUTION NUMERICAL MODELLING OF THE ATMOSPHERE AND OCEAN, P157, DOI 10.1007/978-0-387-49791-4_10; Yu L, 2008, OA200801 WOODS HOL O, P64	49	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	OCT	2015	71	5					557	573		10.1007/s10872-015-0307-3		17	Oceanography	Oceanography	CS2FL	WOS:000361883200007		
J	Nakamura, H; Hiranaka, R; Ambe, D; Saito, T				Nakamura, Hirohiko; Hiranaka, Riku; Ambe, Daisuke; Saito, Tsutomu			Local wind effect on the Kuroshio path state off the southeastern coast of Kyushu	JOURNAL OF OCEANOGRAPHY			English	Article						Small meander formation mechanism; Seasonality; Local wind forcing; Observational data analyses; Theoretical considerations; Numerical experiments	SEA-SURFACE TEMPERATURE; MESOSCALE EDDIES; OKINAWA TROUGH; OCEANIC JET; JAPAN; VARIABILITY; EXTENSION; MEANDERS; VELOCITY; SOUTH	Small meanders of the Kuroshio southeast of Kyushu, Japan, are conventionally known to form in winter or early spring, but rarely in other seasons. This study examines the seasonal nature of the small meander formation as it relates to the seasonal monsoon winds over the East China Sea, based on observational data analyses, theoretical considerations and numerical experiments. Positional data of the Kuroshio path indicate that the small meander experiences phase locking with the seasonal cycle, as is conventionally thought, although its intensity is modulated on decadal time scales. Monthly mean data of the surface geostrophic current and wind stress fields indicate that the southwestward wind blowing against the Kuroshio in the autumn and early winter causes an inshore-ward shift of the Kuroshio in the northern Okinawa Trough. This effect acts to strengthen the convoluted pattern of the Kuroshio path around Kyushu, and to develop the small meander southeast of the same island. Assuming that the Kuroshio is a surface geostrophic jet with a double-exponential velocity profile, the observed evidence is well explained by a combination of Ekman layer dynamics and quasi-geostrophic dynamics. More specifically, Ekman pumping due to nonlinear Ekman divergence over the jet decreases (increases) the surface velocity of the offshore (inshore) side of the jet, resulting in the inshore-ward shift of the jet. A two-layer shallow water model with idealized topography shows that the response of the modeled Kuroshio to the local wind stress is consistent with observational and theoretical results.	[Nakamura, Hirohiko; Hiranaka, Riku] Kagoshima Univ, Fac Fisheries, Kagoshima 8900056, Japan; [Ambe, Daisuke; Saito, Tsutomu] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Kanazawa Ku, Yokohama, Kanagawa 2368648, Japan	Nakamura, H (reprint author), Kagoshima Univ, Fac Fisheries, 4-50-20 Shimoarata, Kagoshima 8900056, Japan.	nakamura@fish.kagoshima-u.ac.jp			Japan Society for the Promotion of Science [22106002, 22244057, 15H03725]	We wish to thank two anonymous reviewers for their critical reading of the manuscript and important comments. A dataset of the surface geostrophic current fields in 1992-2011 was produced as part of the Study on Prediction and Application of Fish Species Alternation (SUPRFISH) promoted by the Agriculture, Forestry and Fisheries Research Council (AFFRC), Japan. The overall work of this study was supported by the Japan Society for the Promotion of Science [Grant-in-Aid for Scientific Research 22106002, 22244057, 15H03725].	Ambe D, 2008, REP RIAM KYUSHU U, V135, P83; Nonaka M, 2003, J CLIMATE, V16, P1404, DOI 10.1175/1520-0442(2003)16<1404:COSSTA>2.0.CO;2; Nakamura H, 2012, J OCEANOGR, V68, P321, DOI 10.1007/s10872-012-0101-4; Ebuchi N, 2003, J OCEANOGR, V59, P25, DOI 10.1023/A:1022856122033; Tsujino H, 2013, CLIM DYNAM, V41, P2287, DOI 10.1007/s00382-012-1641-4; Niiler PP, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001461; IKEDA M, 1981, J PHYS OCEANOGR, V11, P1638, DOI 10.1175/1520-0485(1981)011<1638:MEDFSG>2.0.CO;2; Nagano A, 2004, J OCEANOGR, V60, P879, DOI 10.1007/s10872-004-5780-z; Uchida H, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016445; Xie SP, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015884; NIILER PP, 1969, J GEOPHYS RES, V74, P7048, DOI 10.1029/JC074i028p07048; Usui N, 2013, J OCEANOGR, V69, P647, DOI 10.1007/s10872-013-0197-1; Kashima M, 2009, J OCEANOGR, V65, P73, DOI 10.1007/s10872-009-0007-y; Feng M, 2000, J PHYS OCEANOGR, V30, P2257, DOI 10.1175/1520-0485(2000)030<2257:SAVOTK>2.0.CO;2; Nakamura H, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002656; Chelton DB, 2004, SCIENCE, V303, P978, DOI 10.1126/science.1091901; Zhai XM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028907; Nakamura H, 2010, J PHYS OCEANOGR, V40, P530, DOI 10.1175/2009JPO4156.1; Nakamura H, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004574; Kawabe M, 1995, J PHYS OCEANOGR, V25, P3103, DOI 10.1175/1520-0485(1995)025<3103:VOCPVA>2.0.CO;2; BLUMBERG A F, 1987, 3 DIMENSIONAL COASTA, V4, P208; Ichikawa K, 2001, J OCEANOGR, V57, P55, DOI 10.1023/A:1011174720390; IFREMER (French Research Institute for Exploitation of the Sea), 2002, C2MUTW05IF IFREMER; IFREMER (French Research Institute for Exploitation of the Sea), 2002, C2MUTW04IF IFREMER; Kampf J, 2009, OCEAN MODELING BEGIN; Lin XP, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034312; Moriyasu S, 1961, J OCEANOGR SOC JAPAN, V17, P14; Nakamura H, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027516; Pond GL, 1983, INTRO DYNAMIC OCEANO; ROBINSON AR, 1967, TELLUS, V19, P269; Sekine Y, 1981, J OCEANOGR SOC JAPAN, V37, P87, DOI 10.1007/BF02072561; Solomon H, 1978, J OCEANOGR SOC JPN, V34, P81, DOI 10.1007/BF02109256; Usui N, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004266	33	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	OCT	2015	71	5					575	596		10.1007/s10872-015-0309-1		22	Oceanography	Oceanography	CS2FL	WOS:000361883200008		
J	Wada, A				Wada, Akiyoshi			Unusually rapid intensification of Typhoon Man-yi in 2013 under preexisting warm-water conditions near the Kuroshio front south of Japan	JOURNAL OF OCEANOGRAPHY			English	Article						Rapid intensification; Kuroshio; Mesovortex; Atmosphere-wave-ocean-coupled model	TROPICAL-CYCLONE INTENSIFICATION; SURFACE DRAG COEFFICIENT; WESTERN NORTH PACIFIC; AIR-SEA INTERACTION; NUMERICAL SIMULATIONS; OCEAN INTERACTION; BOUNDARY-LAYER; VERTICAL SHEAR; FUTURE CHANGES; COUPLED MODEL	In 2013, sea-level pressure within Typhoon Man-yi dropped by more than 15 hPa in 6 h. The storm underwent extremely rapid intensification just north of 30A degrees N near the coast of Japan. This study evaluated the importance of preexisting oceanic conditions around the Kuroshio Current for the rapid intensification, by performing a set of sensitivity experiments using an atmosphere-wave-ocean-coupled model. The results of both the sensitivity experiments and various observations suggest that warm water conditions in the ocean played a decisive role in the intensification and steepening of the sea-level pressure gradient within the storm area, whereas storm-induced sea surface cooling was important in suppressing excessive intensification during the early intensification phase of Man-yi. The rapid intensification was caused by excitement of a mesovortex inside the radius of the maximum surface wind. This unusual excitement was related to barotropic-convective instability induced by relatively high sea surface temperature and steep horizontal gradients in both sea-level pressure and tangential wind on the downshear side of the environmental vertical windshear vector. The local Rossby penetration depth around the mesovortex increased because of reduced static stability, increased relative vorticity, and an increase of the Coriolis parameter on the downshear side of the environmental vertical windshear vector where warm water in the ocean was transported along the Kuroshio Current. Preexisting high sea surface temperature conditions and storm-induced sea surface cooling also affected the extraordinarily heavy rainfall, particularly in the northern Kinki districts, which was simulated reasonably well in the numerical experiments.	Japan Meteorol Agcy, Meteorol Res Inst, Tsukuba, Ibaraki 3050052, Japan	Wada, A (reprint author), Japan Meteorol Agcy, Meteorol Res Inst, Tsukuba, Ibaraki 3050052, Japan.	awada@mri-jma.go.jp			KAKENHI from MEXT [25106708]	The author is grateful to Mr. S. Ishizaki for providing operational oceanic data. The author wishes to thank Mr. R. Oyama, Dr. S. Kanada, Mr. U. Shimada and Dr. N. Usui for fruitful discussions and two reviewers for providing useful comments to improve the manuscript. This work was funded by KAKENHI Grant Number 25106708 from MEXT.	Montgomery MT, 1997, Q J ROY METEOR SOC, V123, P435, DOI 10.1002/qj.49712353810; Taylor PK, 2001, J PHYS OCEANOGR, V31, P572, DOI 10.1175/1520-0485(2001)031<0572:TDOSSR>2.0.CO;2; Cecil DJ, 1999, MON WEATHER REV, V127, P103, DOI 10.1175/1520-0493(1999)127<0103:RBTCIA>2.0.CO;2; Kossin JP, 2001, J ATMOS SCI, V58, P1079, DOI 10.1175/1520-0469(2001)058<1079:TDRITK>2.0.CO;2; Kaplan J, 2010, WEATHER FORECAST, V25, P220, DOI 10.1175/2009WAF2222280.1; Nguyen MC, 2011, Q J ROY METEOR SOC, V137, P829, DOI 10.1002/qj.823; Small RJ, 2008, DYNAM ATMOS OCEANS, V45, P274, DOI 10.1016/j.dynatmoce.2008.01.001; DEARDORFF JW, 1980, BOUND-LAY METEOROL, V18, P495, DOI 10.1007/BF00119502; Montgomery MT, 2010, Q J ROY METEOR SOC, V136, P1945, DOI 10.1002/qj.702; Black ML, 2002, MON WEATHER REV, V130, P2291, DOI 10.1175/1520-0493(2002)130<2291:EPHJOA>2.0.CO;2; Bao JW, 2000, MON WEATHER REV, V128, P2190, DOI 10.1175/1520-0493(2000)128<2190:NSOASI>2.0.CO;2; Wang B, 2008, METEOROL ATMOS PHYS, V99, P1, DOI 10.1007/s00703-006-0238-z; Cazenave A, 2011, WIRES CLIM CHANGE, V2, P647, DOI 10.1002/wcc.139; Reasor PD, 2013, MON WEATHER REV, V141, P2949, DOI 10.1175/MWR-D-12-00334.1; Murakami H, 2012, J CLIMATE, V25, P3237, DOI 10.1175/JCLI-D-11-00415.1; Pun IF, 2013, GEOPHYS RES LETT, V40, P4680, DOI 10.1002/grl.50548; Schubert WH, 1999, J ATMOS SCI, V56, P1197, DOI 10.1175/1520-0469(1999)056<1197:PEAECA>2.0.CO;2; Reasor PD, 2012, MON WEATHER REV, V140, P425, DOI 10.1175/MWR-D-11-00080.1; Nolan DS, 2009, MON WEATHER REV, V137, P3651, DOI 10.1175/2009MWR2785.1; Kossin JP, 2014, NATURE, V509, P349, DOI 10.1038/nature13278; Wada A, 2013, J GEOPHYS RES-OCEANS, V118, P2667, DOI 10.1002/jgrc.20203; Usui N, 2006, ADV SPACE RES, V37, P806, DOI 10.1016/j.asr.2005.09.022; Wada A, 2010, SOLA, V6A, P13, DOI 10.2151/sola.6A-004; Lloyd ID, 2011, J CLIMATE, V24, P1138, DOI 10.1175/2010JCLI3763.1; Qiu B, 2012, J PHYS OCEANOGR, V42, P193, DOI 10.1175/JPO-D-11-061.1; Lin II, 2008, MON WEATHER REV, V136, P3288, DOI 10.1175/2008MWR2277.1; Hawkins JD, 2008, IEEE T GEOSCI REMOTE, V46, P901, DOI 10.1109/TGRS.2008.915753; Yablonsky RM, 2009, MON WEATHER REV, V137, P4410, DOI 10.1175/2009MWR2863.1; Arakane S, 2014, J METEOROL SOC JPN, V92, P141, DOI 10.2151/jmsj.2014-201; DEARDORFF JW, 1983, J PHYS OCEANOGR, V13, P988, DOI 10.1175/1520-0485(1983)013<0988:AMLMLE>2.0.CO;2; Rogers R, 2013, MON WEATHER REV, V141, P2970, DOI 10.1175/MWR-D-12-00357.1; Kelly KA, 2010, J CLIMATE, V23, P5644, DOI 10.1175/2010JCLI3346.1; Kawai Y, 2007, J OCEANOGR, V63, P721, DOI 10.1007/s10872-007-0063-0; Wada A, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011993; KLEMP JB, 1978, J ATMOS SCI, V35, P1070, DOI 10.1175/1520-0469(1978)035<1070:TSOTDC>2.0.CO;2; Wada A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035129; Shay LK, 2000, MON WEATHER REV, V128, P1366, DOI 10.1175/1520-0493(2000)128<1366:EOAWOF>2.0.CO;2; Wada A, 2009, J OCEANOGR, V65, P373, DOI 10.1007/s10872-009-0034-8; Zhang JA, 2008, BOUND-LAY METEOROL, V128, P173, DOI 10.1007/s10546-008-9281-2; Lin II, 2013, GEOPHYS RES LETT, V40, P1878, DOI 10.1002/grl.50091; Smith RK, 2010, Q J ROY METEOR SOC, V136, P1671, DOI 10.1002/qj.687; AKIMA H, 1970, J ACM, V17, P589, DOI 10.1145/321607.321609; Mei W, 2013, P NATL ACAD SCI USA, V110, P15207, DOI 10.1073/pnas.1306753110; Thomsen GL, 2014, Q J ROY METEOR SOC, V140, P407, DOI 10.1002/qj.2048; Ito K, 2011, J ATMOS SCI, V68, P2250, DOI 10.1175/JAS-D-10-05022.1; Hence DA, 2011, J ATMOS SCI, V68, P1637, DOI 10.1175/2011JAS3578.1; Kwon YO, 2010, J CLIMATE, V23, P3249, DOI 10.1175/2010JCLI3343.1; Kanada S, 2013, J CLIMATE, V26, P9986, DOI 10.1175/JCLI-D-12-00477.1; Zhu P, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009643; BENDER MA, 1993, J GEOPHYS RES-ATMOS, V98, P23245, DOI 10.1029/93JD02370; DVORAK VF, 1975, MON WEATHER REV, V103, P420, DOI 10.1175/1520-0493(1975)103<0420:TCIAAF>2.0.CO;2; JONES SC, 1995, Q J ROY METEOR SOC, V121, P821, DOI 10.1002/qj.49712152406; Kawai Y, 2015, J OCEANOGR, V71, P511, DOI 10.1007/s10872-014-0266-0; Koba H., 1990, J METEOR RES, V42, P59; Kondo J., 1975, Boundary-Layer Meteorology, V9; Leipper D. F., 1972, Journal of Physical Oceanography, V2, DOI 10.1175/1520-0485(1972)002<0218:HHPOTG>2.0.CO;2; Lin II, 2005, MON WEATHER REV, V133, P2635, DOI 10.1175/MWR3005.1; LIN YL, 1983, J CLIM APPL METEOROL, V22, P1065, DOI 10.1175/1520-0450(1983)022<1065:BPOTSF>2.0.CO;2; Makihara Y, 1996, J METEOR SOC JAPAN, V74; Palmen E. H., 1948, GEOPHYSICA, V3, P26; Saito K., 2012, ATMOSPHERIC MODEL AP, P85, DOI [DOI 10.5772/35368, dx.doi.org/10.5772/35368]; Shay L. K., 2010, GLOBAL PERSPECTIVES, V4, P93, DOI DOI 10.1142/9789814293488_0003; Spencer R. W., 1989, Journal of Atmospheric and Oceanic Technology, V6, DOI 10.1175/1520-0426(1989)006<0254:PROLAO>2.0.CO;2; Sugi M., 1990, Geophysical Magazine, V43; Wada A, 2013, CAS JSC WGNE RES ACT, V43, P7; Wada A, 2002, PAP METEOROL GEOPHYS, V52, P31, DOI [10.2467/mripapers.52.31, DOI 10.2467/MRIPAPERS.52.31]; Wada A, 2012, CAS JSC WGNE RES ACT, V42	67	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	OCT	2015	71	5					597	622		10.1007/s10872-015-0273-9		26	Oceanography	Oceanography	CS2FL	WOS:000361883200009		
J	Aoki, S; Mizuta, G; Sasaki, H; Sasai, Y; Rintoul, SR; Bindoff, NL				Aoki, Shigeru; Mizuta, Genta; Sasaki, Hideharu; Sasai, Yoshikazu; Rintoul, Stephen R.; Bindoff, Nathaniel L.			Atlantic-Pacific asymmetry of subsurface temperature change and frontal response of the Antarctic Circumpolar Current for the recent three decades	JOURNAL OF OCEANOGRAPHY			English	Article						Antarctic Circumpolar Current; Atlantic; Pacific; Warming; Frontal shift; Multi-decadal variability	HEMISPHERE CLIMATE-CHANGE; SOUTHERN-OCEAN; VARIABILITY; WINDS; GYRE	For the 32-year period from 1979 to 2010, trends of surface and subsurface temperature and meridional motion of the current system in the Antarctic Circumpolar Current (ACC) region are studied with in situ observations and an eddy-resolving general circulation model. The observed and simulated surface temperature shows a similar pattern between the Atlantic and Pacific: warming to the north of the Subantarctic/Subtropical Fronts in the Atlantic and of the Subtropical Front in the Pacific and cooling to the south of those fronts. The subsurface temperature trend, again from both observation and model, reveals an asymmetric pattern between the Atlantic and Pacific: subsurface warming is dominant over the whole ACC region in the Atlantic, while both warming and cooling are significant in the Pacific, the former located to the north of the Subantarctic Front and the latter to the south. The model reveals that the ACC has generally shifted poleward in the Atlantic, while it has shifted equatorward around Subantarctic Front and Polar Front in the Pacific. The ACC shift is consistent with the overall subsurface temperature trend. The basin-scale difference of the ACC response can be related to the different regime of the trend in meridional gradient of the zonal wind stress to the north and south of 50-55A degrees S and suggests a coupling of the ACC and overlying westerly on the multi-decadal time scale.	[Aoki, Shigeru] Hokkaido Univ, Inst Low Temp Sci, Kita Ku, Sapporo, Hokkaido 0600819, Japan; [Mizuta, Genta] Hokkaido Univ, Grad Sch Environm Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Sasaki, Hideharu] JAMSTEC, Applicat Lab, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Sasai, Yoshikazu] JAMSTEC, Res & Dev Ctr Global Change, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Rintoul, Stephen R.; Bindoff, Nathaniel L.] Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia; [Rintoul, Stephen R.; Bindoff, Nathaniel L.] CSIRO, Hobart, Tas, Australia; [Rintoul, Stephen R.] Ctr Australian Weather & Climate Res, Hobart, Tas, Australia; [Rintoul, Stephen R.] Wealth Oceans Natl Res Flagship, Hobart, Tas, Australia; [Bindoff, Nathaniel L.] Univ Tasmania, Hobart, Tas, Australia; [Bindoff, Nathaniel L.] ARC Ctr Excellence Climate Syst Sci, Hobart, Tas, Australia	Aoki, S (reprint author), Hokkaido Univ, Inst Low Temp Sci, Kita Ku, N19W8, Sapporo, Hokkaido 0600819, Japan.	shigeru@lowtem.hokudai.ac.jp			MEXT of the Japanese Government [22106009]; Australian Government, through the Antarctic Climate and Ecosystems Cooperative Research Centre; Australian Government Department of the Environment; Bureau of Meteorology; CSIRO through the Australian Climate Change Science Program	We thank Akira Taniguchi for his data handling of OFES. Discussion with Drs. Andy Hogg and Katsuro Katsumata are very helpful in interpreting the results. Comments and suggestions from two anonymous reviewers helped substantially improve this manuscript. This work was supported by Grant-in-Aid for Scientific Research (22106009) of the MEXT of the Japanese Government, by the Cooperative Research Centre program of the Australian Government, through the Antarctic Climate and Ecosystems Cooperative Research Centre and by the Australian Government Department of the Environment, the Bureau of Meteorology and CSIRO through the Australian Climate Change Science Program.	Ogawa F, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049922; Aoki S, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000307; Meredith MP, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026499; Yuan XJ, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015673; Morrow R, 2008, PROG OCEANOGR, V77, P351, DOI 10.1016/j.pocean.2007.03.002; Wang Z, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006757; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Gille ST, 2002, SCIENCE, V295, P1275, DOI 10.1126/science.1065863; Gille ST, 2008, J CLIMATE, V21, P4749, DOI 10.1175/2008JCLI2131.1; Fyfe JC, 2007, J CLIMATE, V20, P5391, DOI 10.1175/2007JCLI1764.1; Gillett NP, 2003, SCIENCE, V302, P273, DOI 10.1126/science.1087440; Cai W, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024911; Wang ZM, 2013, J GEOPHYS RES-OCEANS, V118, P1070, DOI 10.1002/jgrc.20111; Boning CW, 2008, NAT GEOSCI, V1, P864, DOI 10.1038/ngeo362; Sokolov S, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005108; Cai WJ, 2010, J CLIMATE, V23, P197, DOI 10.1175/2009JCLI3081.1; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; Sallee JB, 2008, J CLIMATE, V21, P3020, DOI 10.1175/2007JCLI1702.1; Hogg AM, 2008, J CLIMATE, V21, P608, DOI 10.1175/2007JCLI1925.1; Roemmich D, 2007, J PHYS OCEANOGR, V37, P162, DOI 10.1175/JPO3004.1; Fyfe JC, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027247; Bajish CC, 2013, SOLA, V9, P32, DOI 10.2151/sola.2013-008; Marshall GJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026627; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Wu LX, 2012, NAT CLIM CHANGE, V2, P161, DOI 10.1038/NCLIMATE1353; Levitus S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021592; Nakamura H, 2004, GEOPHYS MONOGR SER, V147, P329; Screen JA, 2009, J CLIMATE, V22, P806, DOI 10.1175/2008JCLI2416.1; Boyer TP, 1998, NOAA ATLAS NESDIS; Fyfe JC, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025332; Godfrey J. S., 1989, DEEP-SEA RES, V45, P89, DOI [10.1080/03091928908208894, DOI 10.1080/03091928908208894]; Levitus S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051106; Locarnini R.A., 2010, NOAA ATLAS NESDIS, V68, P184; Masumoto Y., 2004, J EARTH SIMULATOR, V1, P35; Meijers AJS, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006832; Rintoul S.R., 2013, INT GEOPHYS SER, P471; Sasaki H, 2008, HIGH RESOLUTION NUMERICAL MODELLING OF THE ATMOSPHERE AND OCEAN, P157, DOI 10.1007/978-0-387-49791-4_10	38	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	OCT	2015	71	5					623	636		10.1007/s10872-015-0284-6		14	Oceanography	Oceanography	CS2FL	WOS:000361883200010		
J	Tamai, M; Nagasao, T; Miki, T; Hamamoto, Y; Kogure, T; Tanaka, Y				Tamai, Motoki; Nagasao, Tomohisa; Miki, Takanori; Hamamoto, Yusuke; Kogure, Testukuni; Tanaka, Yoshio			Rotation arc of pedicled anterolateral thigh flap for abdominal wall reconstruction: How far can it reach?	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Article						Anterolateral thigh flap; Flap; Abdominal reconstruction; Pedicle; Abdominal wall; Rotation arc	TENSOR FASCIAE LATAE; PERFORATOR FLAPS; DEFECTS; VERSATILITY; GROIN; ANGIOGRAPHY; MORBIDITY; RESECTION	Purpose: The aim of this study was to elucidate the extent to which pedicled anterolateral thigh (ALT) flaps can reach in reconstruction of abdominal wall defects. Methods: A total of 60 pedicled ALT flaps were raised from cadavers and were experimentally transferred to the abdominal region. The distance between the umbilicus and the most cranial point of the flap after transfer was defined as cranially reachable distance (CRD). Three issues were evaluated: (1) the difference in the CRD when the flap pedicle was positioned superficial or deep into the rectus femoris (RF) and sartorius (SA) muscles; (2) the difference in the CRD in those cases where the main artery of RF arises from the descending branch of the lateral femoral circumflex artery, and is preserved or severed; and (3) maximum values of CRD. Results: (1) CRD was significantly greater when the pedicle was passed deep into the muscles (-2.5 +/- 3.8 SD cm) compared with superficial (-5.8 +/- 3.3 SD cm), indicating placement of pedicles beneath the two muscles enables additional extension. (2) CRD was significantly greater for the severed condition (-0.3 +/- 4.0 SD cm) than for the preserved condition (-3.3 +/- 4.1 SD cm), indicating severing the main artery of RF allows additional extension. (3) Out of the 60 specimens, the CRD was cranial to the umbilicus in 17 flaps, indicating pedicled ALT flaps can reach the umbilicus in less than one-third (17/60) of cases. Conclusion: Pedicled ALT flaps can reliably reach regions inferior to the umbilicus. However, for defects superior to the umbilicus, other reconstructive options should be considered. (C) 2015 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.	[Tamai, Motoki; Nagasao, Tomohisa; Hamamoto, Yusuke; Kogure, Testukuni; Tanaka, Yoshio] Kagawa Univ, Grad Sch Med, Fac Med, Dept Plast & Reconstruct Surg, Takamatsu, Kagawa 760, Japan; [Miki, Takanori] Kagawa Univ, Grad Sch Med, Fac Med, Dept Anat & Neurobiol, Takamatsu, Kagawa 760, Japan	Nagasao, T (reprint author), Kagawa Univ, Grad Sch Med, Fac Med, Dept Plast & Reconstruct Surg, Miki, Ikenobe 17501, Japan.	nagasao@med.kagawa-u.ac.jp					Kimata Y, 1999, PLAST RECONSTR SURG, V103, P1191, DOI 10.1097/00006534-199904040-00014; Nojima K, 2005, PLAST RECONSTR SURG, V116, P182, DOI 10.1097/01.PRS.0000170801.78135.00; Neligan PC, 2010, CLIN PLAST SURG, V37, P677, DOI 10.1016/j.cps.2010.07.001; Ting J, 2010, J PLAST RECONSTR AES, V63, pE65, DOI 10.1016/j.bjps.2009.05.025; Kayano S, 2012, J PLAST RECONSTR AES, V65, P1525, DOI 10.1016/j.bjps.2012.05.003; MATHES SJ, 1981, PLAST RECONSTR SURG, V67, P177, DOI 10.1097/00006534-198167020-00007; Williams JK, 1998, PLAST RECONSTR SURG, V101, P713, DOI 10.1097/00006534-199803000-00020; NAHAI F, 1979, PLAST RECONSTR SURG, V63, P788, DOI 10.1097/00006534-197963060-00004; MATHES SJ, 1977, BRIT J PLAST SURG, V30, P282, DOI 10.1016/0007-1226(77)90118-7; Gravvanis AI, 2006, MICROSURG, V26, P432, DOI 10.1002/micr.20267; Valdatta L, 2002, ANN PLAS SURG, V49, P145, DOI 10.1097/00000637-200208000-00006; Kimura N, 2003, PLAST RECONSTR SURG, V112, P1875, DOI 10.1097/01.PRS.0000091248.41007.2D; Kimata Y, 1997, ARCH OTOLARYNGOL, V123, P1325; Kimata Y, 2000, PLAST RECONSTR SURG, V106, P584, DOI 10.1097/00006534-200009030-00009; BOGART JN, 1976, PLAST RECONSTR SURG, V58, P716, DOI 10.1097/00006534-197612000-00014; Friji MT, 2010, ANN PLAS SURG, V64, P458, DOI 10.1097/SAP.0b013e3181b4bc70; CAFFEE HH, 1983, PLAST RECONSTR SURG, V71, P348, DOI 10.1097/00006534-198303000-00010; Wang XC, 2006, ANN PLAS SURG, V56, P151, DOI 10.1097/01.sap.0000189685.82616.59; Kimata Y, 1998, PLAST RECONSTR SURG, V102, P1517, DOI 10.1097/00006534-199810000-00026; Guneren E, 2005, BRIT J PLAST SURG, V58, P845, DOI 10.1016/j.bjps.2005.01.011; Mathes SJ, 2000, ANN SURG, V232, P586, DOI 10.1097/00000658-200010000-00014; Lannon DA, 2011, PLAST RECONSTR SURG, V127, P677, DOI 10.1097/PRS.0b013e3181fed714; Wei FC, 2002, PLAST RECONSTR SURG, V109, P2219, DOI 10.1097/00006534-200206000-00007; Collins J, 2012, CAN J PLAST SURG, V20, P17; HERSHEY FB, 1964, AM J SURG, V107, P586, DOI 10.1016/0002-9610(64)90325-3; LoGiudice JA, 2014, PLAST RECONSTR SURG, V133, P162, DOI 10.1097/01.prs.0000436838.41936.af; Maruyama Y, 1996, EUR J PLAST SURG, V19, P136; Monahan J, 2014, ANN PLAS SURG, V73, P602, DOI 10.1097/SAP.0b013e318276da2d; Valerio I, 2015, J RECONSTR MICROSURG, V31, P45, DOI 10.1055/s-0034-1383821	29	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	OCT	2015	68	10					1417	1424		10.1016/j.bjps.2015.06.010		8	Surgery	Surgery	CS2EF	WOS:000361879900015		
J	Miyamoto, S; Fujiki, M; Sakuraba, M				Miyamoto, Shimpei; Fujiki, Masahide; Sakuraba, Minoru			Clinical analysis of 33 flow-through latissimus dorsi flaps	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Article						Latissimus dorsi; Flow-through; Thoracodorsal artery perforator; Circumflex scapular; Serratus anterior branch	END-TO-SIDE; THORACODORSAL ARTERY; RECONSTRUCTION; ANASTOMOSIS; EXTREMITY; DEFECTS; ANATOMY; SYSTEM; BRANCH; CADAVER	Introduction: Indications for flow-through latissimus dorsi (LD) flaps have been limited for reconstructing distal extremities. In addition, there has been little discussion in regard to the question of which branch is most suitable as a distal runoff of the flow-through anastomosis. The aims of this study were to investigate the feasibility of flow-through LD flaps in various areas in the body and the rationale for branch selection for the distal runoff vessel. Methods: This retrospective study included 33 patients who underwent reconstruction of an oncology-related defect with a free flow-through LD flap. Defect locations, branches used for the distal runoff, and postoperative complications were investigated. Results: The defect location was in the lower extremity in 13 patients, the scalp in seven, the upper extremity in six, the pelvis in six, and the chest in one. In 19 of the 33 patients, the defects were located in areas other than the distal extremities. The circumflex scapular artery (CSA) was most frequently used as the distal runoff vessel (24 patients) followed by the serratus anterior branch (SAB) (five patients). All flaps were transferred successfully without anastomotic failure.' Conclusions: The flow-through LD flap is a reliable option for reconstruction in many areas of the body. It can provide high success rates not only for extremity reconstruction but also for scalp and pelvic reconstruction. The CSA matches well with the workhorse recipient vessels. The SAB is suitable when there is a vascular defect of the recipient artery. (C) 2015 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.	[Miyamoto, Shimpei; Fujiki, Masahide] Natl Canc Ctr, Div Plast & Reconstruct Surg, Chuo Ku, Tokyo 1040045, Japan; [Sakuraba, Minoru] Natl Canc Ctr Hosp East, Div Plast & Reconstruct Surg, Kawahiwa, Chiba 2778577, Japan	Miyamoto, S (reprint author), Natl Canc Ctr, Div Plast & Reconstruct Surg, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	shimiyam@ncc.go.jp					Koshima I, 1999, PLAST RECONSTR SURG, V103, P1483, DOI 10.1097/00006534-199904050-00021; Garvey PB, 2011, PLAST RECONSTR SURG, V127, P190, DOI 10.1097/PRS.0b013e3181f95a19; Miyamoto S, 2015, MICROSURG, V35, P284, DOI 10.1002/micr.22324; Seitz A, 1999, CELLS TISSUES ORGANS, V164, P227, DOI 10.1159/000016663; Hung SJ, 2000, MICROSURG, V20, P72, DOI 10.1002/(SICI)1098-2752(2000)20:2<72::AID-MICR5>3.0.CO;2-1; GODINA M, 1979, PLAST RECONSTR SURG, V64, P673, DOI 10.1097/00006534-197964050-00013; van Driel AA, 2010, PLAST RECONSTR SURG, V126, P460, DOI 10.1097/PRS.0b013e3181de2260; Miyamoto S, 2008, PLAST RECONSTR SURG, V122, P449, DOI 10.1097/PRS.0b013e31817d62c5; Nasir S, 2010, ANN PLAS SURG, V65, P164, DOI 10.1097/SAP.0b013e3181e57cb3; Miyamoto S, 2013, MICROSURG, V33, P60, DOI 10.1002/micr.22043; Kim JT, 2008, J PLAST RECONSTR AES, V61, P1157, DOI 10.1016/j.bjps.2008.03.048; Valnicek SM, 2004, PLAST RECONSTR SURG, V113, P2001, DOI 10.1097/01.prs.0000122235.09892.da; Yokota K, 2011, J RECONSTR MICROSURG, V27, P109, DOI 10.1055/s-0030-1268209; Malikov S, 2005, SURG RADIOL ANAT, V27, P86, DOI 10.1007/s00276-004-0299-y; BARTLETT SP, 1981, PLAST RECONSTR SURG, V67, P631, DOI 10.1097/00006534-198105000-00010; Yang LC, 2013, J PLAST RECONSTR AES, V66, P193, DOI 10.1016/j.bjps.2012.09.005; Kawamura K, 2005, PLAST RECONSTR SURG, V116, P1082, DOI 10.1097/01.prs.0000178791.85118.ca; Jesus R. C., 2008, Folia Morphologica, V67, P58; Rausky J, 2013, J PLAST RECONSTR AES, V66, P1798, DOI 10.1016/j.bjps.2013.04.064; COLEMAN JJ, 1991, PLAST RECONSTR SURG, V87, P682, DOI 10.1097/00006534-199104000-00013; Katsuta T, 2001, NEUROSURGERY, V49, P879, DOI 10.1097/00006123-200110000-00019; Miyamoto S, 2015, ANN PLAS SURG, V74, P199, DOI 10.1097/SAP.0b013e3182996eaa; Miyamoto S, 2015, MICROSURG, DOI [http://dx.doi.org/10.1002/micr.22374, DOI 10.1002/MICR.22374]; Miyamoto Shimpei, 2014, Plast Reconstr Surg Glob Open, V2, pe127, DOI 10.1097/GOX.0000000000000080; ROWSELL AR, 1984, BRIT J PLAST SURG, V37, P574, DOI 10.1016/0007-1226(84)90152-8; Satomi Yoshiaki, 2007, Hand Surg, V12, P19, DOI 10.1142/S0218810407003407; Yano T, 2014, PLAST RECONSTR SURG, V134, p92E, DOI 10.1097/PRS.0000000000000283	27	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	OCT	2015	68	10					1425	1431		10.1016/j.bjps.2015.05.038		7	Surgery	Surgery	CS2EF	WOS:000361879900016		
J	Yamamoto, T; Yoshimatsu, H; Hayashi, A; Koshima, I				Yamamoto, Takumi; Yoshimatsu, Hidehiko; Hayashi, Akitatsu; Koshima, Isao			Parallel pocket incision: Less invasive surgical intervention for the treatment of intractable pressure ulcer with wound edge undermining	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Article						Pressure ulcer; Incision; Surgery; Decubitus; Flap; Minimally invasive	SORE RECONSTRUCTION; PROPELLER FLAP; MANAGEMENT	Background: The treatment of deep pressure ulcer with a wide wound edge undermining ( pocket) is challenging, especially when conservative treatments are ineffective. As most patients with a pressure ulcer suffer from systemic comorbidities, invasive surgery cannot be performed on all patients, and less invasive treatment is required. Methods: Less invasive surgical intervention to a deep pressure ulcer, parallel pocket incision (PPI), was performed on 10 patients with intractable pressure ulcers with a pocket formation. In PPI procedures, two parallel skin incisions were made to open up the deepest fold of the pocket and to preserve the skin overlying the pocket lesion; through the created incisions, the necrotic tissues around the deepest fold of the undermining could be easily removed, which facilitated spontaneous wound healing. Postoperative results and complications were evaluated. Results: All PPI procedures were safely performed under local infiltration anesthesia without major postoperative complication; minor bleeding was seen intraoperatively in three patients, which could be easily controlled with electric cautery coagulation. Nine of 10 ulcers were cured after PPI, and one could not be followed up due to the patient's death non-related to the pressure ulcer. For the nine cured patients, the average time for cure was 14.9 weeks, and no recurrence was observed at postoperative 6 months. Conclusions: PPI is a simple, technically easy, and less invasive surgical intervention to an intractable pressure ulcer with a pocket, which can be safely performed under local infiltration anesthesia even on a patient with severe systemic comorbidities. (C) 2015 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.	[Yamamoto, Takumi; Yoshimatsu, Hidehiko; Hayashi, Akitatsu; Koshima, Isao] Univ Tokyo, Dept Plast & Reconstruct Surg, Tokyo 1138655, Japan; [Yamamoto, Takumi] Noda Hosp, Dept Plast Surg, Chiba, Japan	Yamamoto, T (reprint author), Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tyamamoto-tky@umin.ac.jp					GRANICK MS, 1994, CLIN DERMATOL, V12, P71, DOI 10.1016/0738-081X(94)90258-5; Moon SH, 2015, ANN PLAS SURG, V74, P589, DOI 10.1097/SAP.0b013e3182a1e6c4; Jakubietz RG, 2009, MICROSURG, V29, P672, DOI 10.1002/micr.20678; Schiffman J, 2009, WORLD J SURG, V33, P1396, DOI 10.1007/s00268-009-0024-4; Lin CT, 2014, J PLAST RECONSTR AES, V67, P526, DOI 10.1016/j.bjps.2013.12.031; Ueta M, 2011, J WOUND CARE, V20, P503; Lin PY, 2012, MICROSURG, V32, P189, DOI 10.1002/micr.20982; Chen YC, 2014, J PLAST RECONSTR AES, V67, P377, DOI 10.1016/j.bjps.2013.12.029; Yang CH, 2011, ANN PLAS SURG, V66, P179, DOI 10.1097/SAP.0b013e3181db7562; Nagase T, 2013, WOUND REPAIR REGEN, V21, P512, DOI 10.1111/wrr.12057; Urushidate S, 2011, J PLAST SURG HAND SU, V45, P66, DOI 10.3109/2000656X.2011.569193; NPUAP EPUAP, 2009, PREV TREATM PRESS UL; Sameem M, 2012, PLAST RECONSTR SURG, V130, p67e; SHEA JD, 1975, CLIN ORTHOP RELAT R, P89; Sørensen Jens Lykke, 2004, Am J Surg, V188, P42, DOI 10.1016/S0002-9610(03)00290-3	15	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	OCT	2015	68	10					1432	1437		10.1016/j.bjps.2015.06.004		6	Surgery	Surgery	CS2EF	WOS:000361879900017		
J	Saito, T; Yoshimatsu, H; Yamamoto, T; Narushima, M				Saito, Takafumi; Yoshimatsu, Hidehiko; Yamamoto, Takumi; Narushima, Mitsunaga			Precise measurement using a new background sheet with crack scales for super microsurgical anastomosis	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Letter							LYMPHATICOVENULAR ANASTOMOSIS		[Saito, Takafumi; Yoshimatsu, Hidehiko; Yamamoto, Takumi; Narushima, Mitsunaga] Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, Tokyo 1138655, Japan	Saito, T (reprint author), Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	saitotkfm@yahoo.co.jp					Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1987, DOI 10.1097/PRS.0b013e31820cf5c6; Nguyen TH, 2008, CLIN ORTHOP RELAT R, V466, P3123, DOI 10.1007/s11999-008-0388-z; Yamamoto T, 2013, MICROSURG, V33, P130, DOI 10.1002/micr.22040; Koshima Isao, 2012, Ann Vasc Dis, V5, P409, DOI 10.3400/avd.ra.12.00080; Yamamoto T, 2014, MICROSURG, V34, P23, DOI 10.1002/micr.22115	5	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	OCT	2015	68	10					1476	1477		10.1016/j.bjps.2015.05.030		3	Surgery	Surgery	CS2EF	WOS:000361879900027		
J	Yoshimatsu, H; Yamamoto, T; Iida, T				Yoshimatsu, Hidehiko; Yamamoto, Takumi; Iida, Takuya			Deep branch of the superficial circumflex iliac artery for backup	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Letter							PERFORATOR FLAP; RECONSTRUCTION; DEFECTS		[Yoshimatsu, Hidehiko; Yamamoto, Takumi; Iida, Takuya] Univ Tokyo, Dept Plast & Reconstruct Surg, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan	Yoshimatsu, H (reprint author), Univ Tokyo, Dept Plast & Reconstruct Surg, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	hidehiko.yoshimatsu@gmail.com					Koshima I, 2004, PLAST RECONSTR SURG, V113, P233, DOI 10.1097/01.PRS.0000095948.03605.20; Hong JP, 2013, ANN PLAS SURG, V71, P380, DOI 10.1097/SAP.0b013e3182503ac5; Groin Flaps, 1993, ATLAS MICROVASCULAR, P120; Yoshimatsu H, 2015, J PLAST RECONSTR AES, V68, pE61, DOI 10.1016/j.bjps.2014.11.018	4	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	OCT	2015	68	10					1478	1479		10.1016/j.bjps.2015.05.041		3	Surgery	Surgery	CS2EF	WOS:000361879900029		
J	Yoshino, Y; Yamamoto, T; Fujisawa, K; Saito, T; Ishiura, R; Iida, T				Yoshino, Yukiko; Yamamoto, Takumi; Fujisawa, Ko; Saito, Takafumi; Ishiura, Ryohei; Iida, Takuya			Inguinal seroma prevention after superficial circumflex iliac artery perforator flap harvest using non-microsurgical lympho-venous shunt	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Letter							INDOCYANINE GREEN LYMPHOGRAPHY; LOWER-EXTREMITY LYMPHEDEMA; DERMAL BACKFLOW PATTERNS		[Yoshino, Yukiko; Yamamoto, Takumi; Fujisawa, Ko; Saito, Takafumi; Ishiura, Ryohei; Iida, Takuya] Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, Tokyo 1138655, Japan	Yoshino, Y (reprint author), Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tyamamoto-tky@umin.ac.jp					Yamamoto T, 2011, PLAST RECONSTR SURG, V128, P941, DOI 10.1097/PRS.0b013e3182268cd9; Iida T, 2013, J PLAST RECONSTR AES, V66, P1596, DOI 10.1016/j.bjps.2013.03.031; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1979, DOI 10.1097/PRS.0b013e31820cf5df; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, p314E, DOI 10.1097/PRS.0b013e3182268da8; Yamamoto T, 2014, J PLAST RECONSTR AES, V67, P1573, DOI 10.1016/j.bjps.2014.06.007	5	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	OCT	2015	68	10					1479	1481		10.1016/j.bjps.2015.06.007		4	Surgery	Surgery	CS2EF	WOS:000361879900030		
J	Weidman, AC; Augustine, AA; Murayama, K; Elliot, AJ				Weidman, Aaron C.; Augustine, Adam A.; Murayama, Kou; Elliot, Andrew J.			Internalizing symptomatology and academic achievement: Bi-directional prospective relations in adolescence	JOURNAL OF RESEARCH IN PERSONALITY			English	Article						Academic achievement; Depression; Anxiety; Adolescence; Longitudinal	CHILDRENS MANIFEST ANXIETY; LIFE EVENTS; HIGH-SCHOOL; DEPRESSIVE SYMPTOMS; STRESS GENERATION; MAJOR DEPRESSION; MIDDLE SCHOOL; SELF-ESTEEM; DEVELOPMENTAL CASCADES; ATTENTIONAL CONTROL	Prior research has documented negative, concurrent relations between internalizing symptomatology and academic achievement among adolescents. The present study provided the first rigorous, longitudinal examination of the bi-directional, prospective relations between adolescent internalizing symptomatology and academic achievement. One hundred and thirty adolescents reported depression and anxiety annually from 6th through 10th grades, and GPA records were obtained annually from schools. Results showed that (a) high depression and anxiety at the beginning of a school year predicted lower GPA during that school year, and (b) low GPA in any school year predicted higher depression and anxiety at the beginning of the following school year. These findings underscore the tight link between adolescent (C) 2015 Elsevier Inc. All rights reserved.	[Weidman, Aaron C.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Murayama, Kou] Univ Reading, Reading RG6 2AH, Berks, England; [Murayama, Kou] Kochi Univ Technol, Kochi, Japan; [Elliot, Andrew J.] Univ Rochester, Rochester, NY 14627 USA	Weidman, AC (reprint author), Univ British Columbia, Dept Psychol, 2136 W Mall, Vancouver, BC V6T 1Z4, Canada.	acweidman@psych.ubc.ca			William T. Grant Foundation [2585]; Marie Curie Career Integration Grant [CIG630680]; JSPS KAKENHI [15H05401]	This research was supported in part by a William T. Grant Foundation grant (2585) to Andrew J. Elliot. Thanks are extended to the administrators at the Rush-Henrietta Central School District for their assistance, and gratitude is expressed to the parent and student participants in the project. This research was also partly supported by the Marie Curie Career Integration Grant (CIG630680; to Kou Murayama) and JSPS KAKENHI (Grant Number 15H05401; to Kou Murayama).	American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Hankin BL, 2007, CHILD DEV, V78, P279, DOI 10.1111/j.1467-8624.2007.00997.x; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037//0033-295X.96.2.234; Cole DA, 2006, J ABNORM PSYCHOL, V115, P40, DOI 10.1037/0021-843X.115.1.40; Derryberry D, 2002, J ABNORM PSYCHOL, V111, P225, DOI 10.1037//0021-843X.111.2.225; Gramzow RH, 2003, J RES PERS, V37, P41, DOI 10.1016/S0092-6566(02)00535-4; Garber J, 2010, CLIN PSYCHOL-SCI PR, V17, P293, DOI 10.1111/j.1468-2850.2010.01221.x; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P929, DOI 10.1001/archpsyc.60.9.929; Oertig D, 2013, J PERS, V81, P365, DOI 10.1111/jopy.12019; Alspaugh JW, 1998, J EDUC RES, V92, P20; Roeser RW, 1998, DEV PSYCHOPATHOL, V10, P321, DOI 10.1017/S0954579498001631; Baumeister RF, 2003, PSYCHOL SCI, P1; WIGFIELD A, 1991, DEV PSYCHOL, V27, P552, DOI 10.1037/0012-1649.27.4.552; Harkness KL, 2010, J ABNORM PSYCHOL, V119, P791, DOI 10.1037/a0020629; Kouros CD, 2014, DEV PSYCHOL, V50, P2633, DOI 10.1037/a0038190; Isakson K, 1999, J YOUTH ADOLESCENCE, V28, P1, DOI 10.1023/A:1021616407189; Higgins ET, 1997, J PERS SOC PSYCHOL, V72, P515, DOI 10.1037/0022-3514.72.3.515; Harkness KL, 2009, J ABNORM PSYCHOL, V118, P278, DOI 10.1037/a0015749; REYNOLDS CR, 1978, J ABNORM CHILD PSYCH, V6, P271, DOI 10.1007/BF00919131; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037//0003-066X.55.1.68; HARTER S, 1992, AM EDUC RES J, V29, P777, DOI 10.3102/00028312029004777; Grimm KJ, 2007, INT J BEHAV DEV, V31, P328, DOI 10.1177/0165025407077754; Benner AD, 2011, EDUC PSYCHOL REV, V23, P299, DOI 10.1007/s10648-011-9152-0; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; Krueger RF, 1999, ARCH GEN PSYCHIAT, V56, P921, DOI 10.1001/archpsyc.56.10.921; Hishinuma ES, 2012, DEV PSYCHOL, V48, P1327, DOI 10.1037/a0026978; Saluja G, 2004, ARCH PEDIAT ADOL MED, V158, P760, DOI 10.1001/archpedi.158.8.760; Bandura A, 1999, J PERS SOC PSYCHOL, V76, P258, DOI 10.1037/0022-3514.76.2.258; Hankin BL, 2001, COGNITIVE THER RES, V25, P607, DOI 10.1023/A:1005561616506; Elliot AJ, 1997, J PERS SOC PSYCHOL, V72, P218, DOI 10.1037/0022-3514.72.1.218; Masten AS, 2005, DEV PSYCHOL, V41, P733, DOI 10.1037/0012-1649.41.5.733; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P276, DOI 10.1111/j.1469-7610.2006.01614.x; Uliaszek AA, 2012, J ABNORM PSYCHOL, V121, P4, DOI 10.1037/a0025835; GREENE RW, 1993, J COMMUNITY PSYCHOL, V21, P162, DOI 10.1002/1520-6629(199304)21:2<162::AID-JCOP2290210208>3.0.CO;2-D; Monroe SM, 2009, CURR DIR PSYCHOL SCI, V18, P68, DOI 10.1111/j.1467-8721.2009.01611.x; Hammen C, 2005, ANNU REV CLIN PSYCHO, V1, P293, DOI 10.1146/annurev.clinpsy.1.102803.143938; Zimmerman MA, 2002, J APPL SOC PSYCHOL, V32, P86, DOI 10.1111/j.1559-1816.2002.tb01421.x; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002; Bollen KA, 2004, SOCIOL METHOD RES, V32, P336, DOI 10.1177/0049124103260222; Verboom CE, 2014, DEV PSYCHOL, V50, P247, DOI 10.1037/a0032547; Seligman LD, 2004, J CLIN CHILD ADOLESC, V33, P557, DOI 10.1207/s15374424jccp3303_13; Moilanen KL, 2010, DEV PSYCHOPATHOL, V22, P635, DOI 10.1017/S0954579410000337; Watson D, 2005, J ABNORM PSYCHOL, V114, P522, DOI 10.1037/0021-843X.114.4.522; Shankman SA, 2007, J ABNORM PSYCHOL, V116, P95, DOI 10.1037/0021-843X.116.1.95; Elliot AJ, 2003, J PERS, V71, P369; Rudolph KD, 2009, J CLIN CHILD ADOLESC, V38, P473, DOI 10.1080/15374410902976296; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; Osborne JW, 1997, J EDUC PSYCHOL, V89, P728, DOI 10.1037//0022-0663.89.4.728; Allen JL, 2008, J ABNORM CHILD PSYCH, V36, P1047, DOI 10.1007/s10802-008-9240-x; Dickson J, 2004, COGNITION EMOTION, V18, P423, DOI 10.1080/02699930341000013; Curran PJ, 2001, DECADE BEHAV, P107, DOI 10.1037/10409-004; Owens TJ, 2008, J YOUTH ADOLESCENCE, V37, P1242, DOI 10.1007/s10964-008-9319-2; Kendler KS, 1999, AM J PSYCHIAT, V156, P837; Cummings CM, 2014, PSYCHOL BULL, V140, P816, DOI 10.1037/a0034733; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9101.88.5.879; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Chen FF, 2008, J PERS SOC PSYCHOL, V95, P1005, DOI 10.1037/a0013193; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P789, DOI 10.1001/archpsyc.60.8.789; Sowislo JF, 2013, PSYCHOL BULL, V139, P213, DOI 10.1037/a0028931; Laurent J, 1999, PSYCHOL ASSESSMENT, V11, P326, DOI 10.1037/1040-3590.11.3.326; BROWN GW, 1986, J AFFECT DISORDERS, V11, P1, DOI 10.1016/0165-0327(86)90054-6; Aud S., 2012, COND ED; Bandura A., 1986, SOCIAL FDN THOUGHT A; BLUMBERG SH, 1985, J PERS SOC PSYCHOL, V49, P194, DOI 10.1037/0022-3514.49.1.194; Blyth D. A., 1983, J EARLY ADOLESC, V3, P105, DOI DOI 10.1177/027243168331008; BROWN GW, 1987, BRIT J PSYCHIAT, V150, P30, DOI 10.1192/bjp.150.1.30; Brown GW, 1978, SOCIAL ORIGINS DEPRE; Cicchetti D., 1986, DEPRESSION YOUNG PEO, P71; Dahl RE, 2002, J ADOLESCENT HEALTH, V31, P175, DOI 10.1016/S1054-139X(02)00506-2; Enders C. K., 2006, STRUCTURAL EQUATION, P313; Finkel S. E, 1995, CAUSAL ANAL PANEL DA; Higgins E. T., 2013, PLEASURE PAIN MOTIVA; Hudson J. L, 2004, ETIOLOGY DEV GEN ANX, P51; Kline R. B., 2010, PRINCIPLES PRACTICES; KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995; McArdle J. J., 1988, HDB MULTIVARIATE EXP, P561, DOI DOI 10.1007/978-1-4613-0893-5_17; McArdle JJ, 1990, HDB PSYCHOL AGING, P21; Obradovic J., 2010, J CLIN CHILD ADOLESC, V39, P109; Rudolph K. D., 2004, ED ADOLESCENTS CHALL, P33; Seipp B., 1991, ANXIETY RES, V4, P27, DOI DOI 10.1080/08917779108248762; Seligman L D, 1998, Clin Child Fam Psychol Rev, V1, P125, DOI 10.1023/A:1021887712873; Strauman TJ, 2002, SELF IDENTITY, V1, P151, DOI 10.1080/152988602317319339	83	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0092-6566	1095-7251		J RES PERS	J. Res. Pers.	OCT	2015	58						106	114		10.1016/j.jrp.2015.07.005		9	Psychology, Social	Psychology	CS0UD	WOS:000361776800012		
J	Ide, J; Karasugi, T; Okamoto, N; Taniwaki, T; Oka, K; Mizuta, H				Ide, Junji; Karasugi, Tatsuki; Okamoto, Nobukazu; Taniwaki, Takuya; Oka, Kiyoshi; Mizuta, Hiroshi			Functional and structural comparisons of the arthroscopic knotless double-row suture bridge and single-row repair for anterosuperior rotator cuff tears	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Knotless double-row suture bridge repair; single-row repair; anterosuperior rotator cuff tear	SUBSCAPULARIS TENDON; SUPRASPINATUS TEAR; RETEAR PATTERNS; BEAR-HUG; FOOTPRINT; SHOULDER; RUPTURE	Background: We compared the outcomes of knotless double-row suture bridge and single-row repairs in patients undergoing arthroscopic repair for anterosuperior rotator cuff tears. Methods: We included 61 full-thickness anterosuperior rotator cuff tears treated by arthroscopic repair, namely, single-row repair (group 1: 25 shoulders; mean patient age, 64 years) and the knotless double-row suture bridge repair (group 2: 36 shoulders; mean patient age, 62 years). Preoperative and postoperative magnetic resonance imaging was performed for all shoulders. Clinical outcomes were evaluated for mean follow-up periods of 81 months (range, 72-96 months) in group 1 and 34 months (range, 24-42 months) in group 2, using the University of California, Los Angeles and Japanese Orthopaedic Association assessments. Results: At the final follow-up, both groups showed improvement in the average University of California, Los Angeles and Japanese Orthopaedic Association scores and range of motion, although no intergroup differences were observed. Both groups showed improved abduction strength, and the average score was higher in group 2 (P = .0112). The lift-off and belly-press test results were improved in both groups. Postoperatively, the incidence of positive lift-off tests tended to be lower (P = .075) and that of positive belly-press tests was lower in group 2, P = .049). The repair failure rate tended to be lower in group 2 (14% [5 of 36]) than in group 1 (32% [8 of 25]; P - .0839). Conclusions: Arthroscopic knotless double-row suture bridge repair of anterosuperior rotator cuff tears yielded functional outcomes equivalent to those of single-row repair and may be useful for improving subscapularis function, abduction strength, and tendon healing. (C) 2015 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Ide, Junji] Kumamoto Univ, Kumamoto Univ Hosp, Dept Adv Joint Reconstruct Surg, Kumamoto 8608556, Japan; [Karasugi, Tatsuki; Okamoto, Nobukazu; Taniwaki, Takuya; Oka, Kiyoshi; Mizuta, Hiroshi] Kumamoto Univ, Fac Life Sci, Dept Orthopaed Surg, Kumamoto 8608556, Japan	Ide, J (reprint author), Kumamoto Univ, Kumamoto Univ Hosp, Dept Adv Joint Reconstruct Surg, Cent Ward, 1-1-1 Honjo, Kumamoto 8608556, Japan.	ide@kumamoto-u.ac.jp					Hirano M, 2002, J SHOULDER ELB SURG, V11, P576, DOI 10.1067/mse.2002.127097; Ide J, 2008, ARTHROSCOPY, V24, P749, DOI 10.1016/j.arthro.2008.02.009; Bartl C, 2012, ARCH ORTHOP TRAUM SU, V132, P41, DOI 10.1007/s00402-011-1400-8; Cho NS, 2010, AM J SPORT MED, V38, P664, DOI 10.1177/0363546509350081; Ide J, 2007, J BONE JOINT SURG AM, V89A, P2378, DOI 10.2106/JBJS.G.00082; Namdari S, 2008, J BONE JOINT SURG AM, V90A, P1906, DOI 10.2106/JBJS.F.01446; Park MC, 2007, J SHOULDER ELB SURG, V16, P461, DOI 10.1016/j.jse.2006.09.010; Gerber C, 2000, J BONE JOINT SURG AM, V82A, P505; Nho SJ, 2010, ARTHROSCOPY, V26, P1667, DOI 10.1016/j.arthro.2010.04.008; Quigley RJ, 2013, J ORTHOP RES, V31, P1254, DOI 10.1002/jor.22363; Bennett WF, 2003, ARTHROSCOPY, V19, P21, DOI 10.1053/jars.2003.50023; Neyton L, 2013, ARTHROSCOPY, V29, P10, DOI 10.1016/j.arthro.2012.06.020; Park MC, 2007, J SHOULDER ELB SURG, V16, P469, DOI 10.1016/j.jse.2006.09.011; Warner JJP, 2001, J SHOULDER ELB SURG, V10, P37, DOI 10.1067/mse.2001.112022; Kim KC, 2014, AM J SPORT MED, V42, P558, DOI 10.1177/0363546514521577; Wellmann M, 2009, KNEE SURG SPORT TR A, V17, P1477, DOI 10.1007/s00167-009-0890-1; Gerber C, 1996, J BONE JOINT SURG AM, V78A, P1015; Ide J, 2005, AM J SPORT MED, V33, P1672, DOI 10.1177/0363546505277141; Kreuz PC, 2005, AM J SPORT MED, V33, P1831, DOI 10.1177/0363546505277118; Ide J, 2005, ARTHROSCOPY, V21, P1090, DOI 10.1016/j.arthro.2005.05.010; Burkhart SS, 2002, ARTHROSCOPY, V18, P454, DOI 10.1053/jars.2002.30648; NEER CS, 1983, J BONE JOINT SURG AM, V65, P1232; Pennock AT, 2011, AM J SPORT MED, V39, P2338, DOI 10.1177/0363546510392710; Werner CML, 2008, J SHOULDER ELB SURG, V17, P237, DOI 10.1016/j.jse.2007.06.002; Adams CR, 2008, ARTHROSCOPY, V24, P1381, DOI 10.1016/j.arthro.2008.08.004; Gerhardt C, 2012, AM J SPORT MED, V40, P2777, DOI 10.1177/0363546512462123; Barth JRH, 2006, ARTHROSCOPY, V22, P1076, DOI 10.1016/j.arthro.2006.05.005; Ide J, 2004, J SHOULDER ELB SURG, V13, P174, DOI 10.1016/j.jse.2003.11.001; Gartsman GM, 2013, J SHOULDER ELB SURG, V22, P1480, DOI 10.1016/j.jse.2013.06.020; Flury MP, 2006, J SHOULDER ELB SURG, V15, P659, DOI 10.1016/j.jse.2005.07.013; Hama H, 1992, J Shoulder Elbow Surg, V1, P253, DOI 10.1016/S1058-2746(09)80067-0; HARRYMAN DT, 1991, J BONE JOINT SURG AM, V73A, P982; JOBE FW, 1983, CLIN ORTHOP RELAT R, P117; Lanz U, 2013, ARTHROSCOPY, V29, P1471, DOI 10.1016/j.arthro.2013.06.004; Nové-Josserand Laurent, 2012, J Bone Joint Surg Am, V94, pe125; Walch G, 1994, J Shoulder Elbow Surg, V3, P353, DOI 10.1016/S1058-2746(09)80020-7; Warner JJ, 1994, CLIN ORTHOP RELAT R, V304, P78	37	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	OCT	2015	24	10					1544	1554		10.1016/j.jse.2015.03.015		11	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CR7ZT	WOS:000361571600011		
J	Yamanaka, K; Mori, M; Chiba, A				Yamanaka, Kenta; Mori, Manami; Chiba, Akihiko			Assessment of precipitation behavior in dental castings of a Co-Cr-Mo alloy	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Co-Cr-Mo alloys; Dental casting; Microstructure; Precipitate; Solidification segregation; Mechanical properties	MECHANICAL-PROPERTIES; IMPLANT ALLOYS; SIGMA-PHASE; MICROSTRUCTURES; NI; COMBINATION; DISSOLUTION; EVOLUTION; CHROMIUM	This study investigated solute portioning and precipitation in dental castings of a Co-Cr-Mo alloy and discussed their effects on alloy performance, in particular, the mechanical properties. Samples of a commercial Co-29Cr-6Mo (mass%) alloy were prepared using a dental-casting machine. The precipitates formed owing to the partitioning behaviors of the alloying elements were investigated using scanning electron microscopy, electron backscatter diffraction analysis, electron probe microanalysis, and transmission electron microscopy. The prepared samples exhibited a very coarse face-centered-cubic gamma-phase dendritic structure with an average grain size of a few millimeters. A large number of precipitates, which decomposed further into complex interdendritic constituents (sigma- and M23C6 carbide phases) were observed in the interdendritic regions rich in Cr, Mo, Si, and C. A reaction between the CT-phase and carbon is probably responsible for the carbide M23C6; however, this reaction did not occur to completion in the current case in spite of slow cooling (i.e., long exposure to elevated temperatures) in dental casting. While these precipitates result in high strength (hardness) and/or brittleness, the properties can be improved further by optimizing the alloy composition and the manufacturing process. The results of this study shed light on the significance of precipitation control in dental castings of Co-Cr-Mo alloys and should aid in the design of novel biomedical Co-Cr-based dental alloys that exhibit better performances. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamanaka, Kenta; Mori, Manami; Chiba, Akihiko] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Mori, Manami] Sendai Natl Coll Technol, Dept Mat & Environm Engn, Natori, Miyagi 9811239, Japan	Yamanaka, K (reprint author), Tohoku Univ, Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	k..yamanaka@imr.tohoku.ac.jp			"Nanotechnology Platform" of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, at the Center for Integrated Nanotechnology Support, Tohoku University [26870050]; Inter-University Cooperative Research Program; Innovative Research for Biosis-Abiosis Intelligent Interface program of MEXT, Japan; Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP), Japan Science and Technology Agency (JST), Japan	We thank Mr. Yasuhiro Torita, Shofu Inc., for providing the cast samples and for assistance with determining the tensile properties of the investigated alloy. We also thank Mr. Shun Ito, Dr. Makoto Nagasako, Dr. Yumiko Kodama, and Ms. Kumiko Suzuki for their technical assistance. This research was supported by a Grant-in-Aid for Young Scientists (B) (No. 26870050) from the "Nanotechnology Platform" of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, at the Center for Integrated Nanotechnology Support, Tohoku University; the Inter-University Cooperative Research Program; the Innovative Research for Biosis-Abiosis Intelligent Interface program of MEXT, Japan; and the Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP), Japan Science and Technology Agency (JST), Japan.D	Okamoto H, 2003, J PHASE EQUILIB, V24, P377, DOI 10.1361/105497103770330460; Yamanaka K, 2014, J MECH BEHAV BIOMED, V29, P417, DOI 10.1016/j.jmbbm.2013.10.006; Yamanaka K, 2014, J MECH BEHAV BIOMED, V37, P274, DOI 10.1016/j.jmbbm.2014.05.025; Bettini E, 2011, ELECTROCHIM ACTA, V56, P9413, DOI 10.1016/j.electacta.2011.08.028; Matkovic T, 2004, J ALLOY COMPD, V366, P293, DOI 10.1016/j.jallcom.2003.07.004; Yamanaka K, 2014, MATER DESIGN, V55, P987, DOI 10.1016/j.matdes.2013.10.052; Ramirez LE, 2002, SCRIPTA MATER, V47, P811, DOI 10.1016/S1359-6462(02)00305-6; Kurosu S, 2007, MATER TRANS, V48, P1517, DOI 10.2320/matertrans.MRA2007606; Lee SH, 2008, MATER TRANS, V49, P260, DOI 10.2320/matertrans.MRA2007220; Calcagnotto M, 2010, MAT SCI ENG A-STRUCT, V527, P2738, DOI 10.1016/j.msea.2010.01.004; Yamanaka K, 2013, ACTA BIOMATER, V9, P6259, DOI 10.1016/j.actbio.2012.12.013; Denkhaus E, 2002, CRIT REV ONCOL HEMAT, V42, P35, DOI 10.1016/S1040-8428(01)00214-1; Yamanaka K, 2014, MAT SCI ENG C-MATER, V40, P127, DOI 10.1016/j.msec.2014.03.053; Mori M, 2010, MAT SCI ENG A-STRUCT, V528, P614, DOI 10.1016/j.msea.2010.09.002; Tsai MH, 2013, INTERMETALLICS, V33, P81, DOI 10.1016/j.intermet.2012.09.022; DICKINS GJ, 1956, ACTA CRYSTALLOGR, V9, P297, DOI 10.1107/S0365110X56000826; Kurosu S, 2010, METALL MATER TRANS A, V41A, P2613, DOI 10.1007/s11661-010-0273-8; Kurosu S, 2006, MATER TRANS, V47, P1961, DOI 10.2320/matertrans.47.1961; Liao Y, 2012, J MECH BEHAV BIOMED, V12, P39, DOI 10.1016/j.jmbbm.2012.03.013; Caudillo M, 2002, J BIOMED MATER RES, V59, P378, DOI 10.1002/jbm.10001; Viennot S, 2006, J PROSTHET DENT, V96, P100, DOI 10.1016/j.prosdent.2006.04.013; Giacchi JV, 2011, MATER CHARACT, V62, P53, DOI 10.1016/j.matchar.2010.10.011; Wataha JC, 2002, J PROSTHET DENT, V87, P351, DOI 10.1067/mpr.2002.123817; Yoda K, 2012, ACTA BIOMATER, V8, P2856, DOI 10.1016/j.actbio.2012.03.024; Chiba A, 1999, PHILOS MAG A, V79, P1533; Chen Y., 2013, WEAR, V310, P51; Craig R., 2000, DENT MAT PROPERTIES; Mineta S., 2011, METALL MATER TRANS A, V42, P1941; Mori M., 2014, J ALLOY COMPD, V520, P411; Powers JM, 2006, CRAIGS RESTORATIVE D; Saldivar-Garcia AJ, 2005, J BIOMED MATER RES A, V74A, P269, DOI 10.1002/jbm.a.30392; Yamanaka K., 2013, J MECH BEHAV BIOMED, V32, P52	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	OCT	2015	50						268	276		10.1016/j.jmbbm.2015.06.020		9	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CS0TL	WOS:000361775000024		
J	Cui, HW; Jiu, JT; Sugahara, T; Nagao, S; Suganuma, K; Uchida, H; Kihara, K				Cui, Hui-Wang; Jiu, Jin-Ting; Sugahara, Tohru; Nagao, Shijo; Suganuma, Katsuaki; Uchida, Hiroshi; Kihara, Katsunori			Solidification and thermal degradation of printable, stretchable electrical conductor from waterborne polyurethane and silver flakes	JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY			English	Article						Electrical conductor; Solidification; Thermal degradation; Kinetics	POLYHEDRAL OLIGOMERIC SILSESQUIOXANE; AGRAWAL INTEGRAL-EQUATION; EXFOLIATED MONTMORILLONITE; PYROLYSIS KINETICS; CLICK CHEMISTRY; ELECTRONICS; ADHESIVES; NETWORK; FILMS	In this study, we prepared high-performance printable, stretchable electrical conductor from waterborne polyurethane and micro-silver flakes. The solidification and thermal degradation were investigated using differential scanning calorimetry and thermogravimetric analysis methods. The electrical conductor achieved solidification by volatilizing and removing the free water. The thermal degradation mainly happened in the range of 250-450 A degrees C caused by the pyrolysis of the polymeric matrix of polyurethane. The pyrolysis kinetic equations were obtained using the kinetic methods, e.g., d alpha/dt = e(22.16)(1 - alpha)(0.78) alpha (0.13)e((-149.14/RT)) for the polyurethane, d alpha/dt = e(22.76)(1 - alpha)(0.84) alpha (0.11)e((-150.69/RT)), d alpha/dt = e(21.43)(1 - alpha)(0.77) alpha (0.06)e((-143.77/RT)), and d alpha/dt = e(19.06)(1 - alpha)(0.75) alpha (0.12)e((-130.53/RT)) for the electrical conductor containing 80, 85, and 90 % mass percentage of micro-silver flakes, where alpha was the fractional extent conversion at a given time t (or a given temperature T). Their overall order of reaction was 0.91, 0.95, 0.83, and 0.87, respectively, less than 1, demonstrating the thermal degradation was a single, simple reaction.	[Cui, Hui-Wang; Jiu, Jin-Ting; Sugahara, Tohru; Nagao, Shijo; Suganuma, Katsuaki] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 567, Japan; [Uchida, Hiroshi] Business Dev Ctr, Inst Polymers & Chem, Ichihara, Chiba 2900067, Japan; [Kihara, Katsunori] Sumika Bayer Urethane Co Ltd, Innovat Ctr Japan, Amagasaki, Hyogo 6610977, Japan	Cui, HW (reprint author), Osaka Univ, Inst Sci & Ind Res, Mihogaoka 8-1, Ibaraki, Osaka 567, Japan.	cuihuiwang@hotmail.com					Cao Q, 2013, NAT NANOTECHNOL, V8, P180, DOI [10.1038/nnano.2012.257, 10.1038/NNANO.2012.257]; KAMAL MR, 1973, POLYM ENG SCI, V13, P59, DOI 10.1002/pen.760130110; Kranzlin N, 2012, ANGEW CHEM INT EDIT, V51, P4743, DOI 10.1002/anie.201200428; Yoshida Y, 2013, J AM CHEM SOC, V135, P4110, DOI 10.1021/ja4004987; Kumar KM, 2013, RSC ADV, V3, P4033, DOI 10.1039/c3ra22959a; Kaltenbrunner M, 2013, NATURE, V499, P458, DOI 10.1038/nature12314; DONNELLAN T, 1982, POLYM ENG SCI, V22, P821, DOI 10.1002/pen.760221306; Lee P, 2012, ADV MATER, V24, P3326, DOI 10.1002/adma.201200359; Kim DH, 2012, ANNU REV BIOMED ENG, V14, P113, DOI 10.1146/annurev-bioeng-071811-150018; Stoyanov H, 2013, ADV MATER, V25, P578, DOI 10.1002/adma.201202728; Chen D, 2013, ACS APPL MATER INTER, V5, P1206, DOI 10.1021/am303292y; Cui HW, 2013, POLYM BULL, V70, P3143, DOI 10.1007/s00289-013-1013-1; Cui HW, 2015, J THERM ANAL CALORIM, V119, P425, DOI 10.1007/s10973-014-4195-3; Cui HW, 2015, RSC ADV, V5, P2677, DOI 10.1039/c4ra11735b; Friebe C, 2013, RSC ADV, V3, P11686, DOI 10.1039/c3ra41356j; Cui HW, 2014, J THERM ANAL CALORIM, V117, P1365, DOI 10.1007/s10973-014-3902-4; Mehra S, 2013, NANOSCALE, V5, P4400, DOI 10.1039/c3nr00863k; Galwey AK, 2012, J THERM ANAL CALORIM, V109, P1625, DOI 10.1007/s10973-011-1851-8; Cui HW, 2014, APPL CLAY SCI, V91-92, P1, DOI 10.1016/j.clay.2014.01.016; Cui HW, 2014, APPL CLAY SCI, V101, P604, DOI 10.1016/j.clay.2014.09.026; FLYNN JH, 1991, J THERM ANAL, V37, P293, DOI 10.1007/BF02055932; Friedman H. L., 1964, J POLYM SCI C, V6, P183, DOI DOI 10.1002/P0LC.5070060121; Lim KH, 2013, ADV MATER, V25, P2994, DOI 10.1002/adma.201204236; OZAWA T, 1965, B CHEM SOC JPN, V38, P1881, DOI 10.1246/bcsj.38.1881; Wm Wendlandt W., 1986, THERMAL ANAL	25	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1388-6150	1572-8943		J THERM ANAL CALORIM	J. Therm. Anal. Calorim.	OCT	2015	122	1					295	305		10.1007/s10973-015-4689-7		11	Thermodynamics; Chemistry, Analytical; Chemistry, Physical	Thermodynamics; Chemistry	CR6CP	WOS:000361431200032		
J	Marx, A; Chan, JKC; Coindre, JM; Detterbeck, F; Girard, N; Harris, NL; Jaffe, ES; Kurrer, MO; Marom, EM; Moreira, AL; Mukai, K; Orazi, A; Strobel, P				Marx, Alexander; Chan, John K. C.; Coindre, Jean-Michel; Detterbeck, Frank; Girard, Nicolas; Harris, Nancy L.; Jaffe, Elaine S.; Kurrer, Michael O.; Marom, Edith M.; Moreira, Andre L.; Mukai, Kiyoshi; Orazi, Attilio; Stroebel, Philipp			The 2015 World Health Organization Classification of Tumors of the Thymus Continuity and Changes	JOURNAL OF THORACIC ONCOLOGY			English	Review						Classification; Thymus; Thymoma; Atypical type A thymoma; Thymic carcinoma; Adenocarcinoma; NUT carcinoma; Carcinoid; Neuroendocrine; Combined large-cell neuroendocrine carcinoma; Combined thymic carcinoma; Mediastinal; Mediastinum; Germ cell tumor; Lymphoma; Primary mediastinal large B-cell lymphoma; Grey zone lymphoma; Hodgkin lymphoma; Dendritic cell tumor; Sarcoma; Neuroblastoma; Metastasis; Ectopic tumor; Positron emission tomography; Computed tomography; Cytology; Histology; Pathology; Immunohistochemistry; Immunohistology; Staging; Genetic; GTF2I; International Thymic Malignancy Interest Group; World Health Organization	B-CELL LYMPHOMA; FORTHCOMING 8TH EDITION; NUT MIDLINE CARCINOMA; CLASSICAL HODGKINS LYMPHOMA; STAGING PROJECT PROPOSALS; MALIGNANCY INTEREST GROUP; GRAY ZONE LYMPHOMA; EPITHELIAL TUMORS; MUCOEPIDERMOID CARCINOMA; TNM CLASSIFICATION	This overview of the 4th edition of the World Health Organization (WHO) Classification of thymic tumors has two aims. First, to comprehensively list the established and new tumor entities and variants that are described in the new WHO Classification of thymic epithelial tumors, germ cell tumors, lymphomas, dendritic cell and myeloid neoplasms, and soft-tissue tumors of the thymus and mediastinum; second, to highlight major differences in the new WHO Classification that result from the progress that has been made since the 3rd edition in 2004 at immunohistochemical, genetic and conceptual levels. Refined diagnostic criteria for type A, AB, B1-B3 thymomas and thymic squamous cell carcinoma are given, and it is hoped that these criteria will improve the reproducibility of the classification and its clinical relevance. The clinical perspective of the classification has been strengthened by involving experts from radiology, thoracic surgery, and oncology; by incorporating state-of-the-art positron emission tomography/computed tomography images; and by depicting prototypic cytological specimens. This makes the thymus section of the new WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart a valuable tool for pathologists, cytologists, and clinicians alike. The impact of the new WHO Classification on therapeutic decisions is exemplified in this overview for thymic epithelial tumors and mediastinal lymphomas, and future perspectives and challenges are discussed.	[Marx, Alexander] Heidelberg Univ, Univ Med Ctr Mannheim, Inst Pathol, D-68167 Mannheim, Germany; [Chan, John K. C.] Queen Elizabeth Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Coindre, Jean-Michel] Inst Bergonie, Dept Pathol, Bordeaux, France; [Detterbeck, Frank] Yale Univ, Sch Med, Dept Thorac Surg, New Haven, CT USA; [Girard, Nicolas] Hosp Civils Lyon, Louis Pradel Hosp, Dept Resp Med, Lyon, France; [Harris, Nancy L.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Jaffe, Elaine S.] NCI, Hematopathol Sect, Pathol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Kurrer, Michael O.] Gemeinschaftspraxis Pathol, Zurich, Switzerland; [Marom, Edith M.] Chaim Sheba Med Ctr, Dept Diagnost Imaging, IL-52621 Tel Hashomer, Israel; [Moreira, Andre L.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Mukai, Kiyoshi] Saiseikai Cent Hosp, Dept Diagnost Pathol, Tokyo, Japan; [Orazi, Attilio] New York Presbyterian Hosp, Weill Cornell Med Ctr, Dept Pathol & Lab Med, New York, NY USA; [Stroebel, Philipp] Univ Gottingen, Dept Pathol, Univ Med Ctr Gottingen, Inst Pathol, Gottingen, Germany	Marx, A (reprint author), Heidelberg Univ, Univ Med Ctr Mannheim, Inst Pathol, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.	alexander.marx@umm.de					Manner J, 2010, AM J PATHOL, V176, P34, DOI 10.2353/ajpath.2010.090637; Filosso PL, 2015, J THORAC CARDIOV SUR, V149, P103, DOI 10.1016/j.jtcvs.2014.08.061; Bonn BR, 2013, BLOOD, V121, P3153, DOI 10.1182/blood-2012-12-474148; Loehrer PJ, 2004, J CLIN ONCOL, V22, P293, DOI 10.1200/JCO.2004.02.047; Vanhentenrijk V, 2006, J PATHOL, V210, P155, DOI 10.1002/path.2043; Suster S, 2008, HEMATOL ONCOL CLIN N, V22, P381, DOI 10.1016/j.hoc.2008.03.001; Robinson DR, 2013, NAT GENET, V45, P180, DOI 10.1038/ng.2509; Kondo K, 2014, J THORAC ONCOL, V9, pS81, DOI 10.1097/JTO.0000000000000291; Steidl C, 2012, BLOOD, V120, P3530, DOI 10.1182/blood-2012-06-439570; Behringer K, 2015, LANCET, V385, P1418, DOI 10.1016/S0140-6736(14)61469-0; Girard N, 2009, CLIN CANCER RES, V15, P6790, DOI 10.1158/1078-0432.CCR-09-0644; Zynger DL, 2008, AM J CLIN PATHOL, V130, P224, DOI 10.1309/8DN7DQRDFB4QNH3N; Shi M, 2014, AM J SURG PATHOL, V38, P1715, DOI 10.1097/PAS.0000000000000297; Detterbeck FC, 2006, ANN THORAC SURG, V81, P2328, DOI 10.1016/j.athoracsur.2005.11.067; LeMieux MH, 2015, CANCER MED-US, V4, P513, DOI 10.1002/cam4.405; Ahmad U, 2015, J THORAC CARDIOV SUR, V149, P95, DOI 10.1016/j.jtcvs.2014.09.124; Brown JG, 2009, AM J SURG PATHOL, V33, P1113, DOI 10.1097/PAS.0b013e3181a2443b; Marx A, 2014, J THORAC ONCOL, V9, P596, DOI 10.1097/JTO.0000000000000154; Strobel P, 2014, GENE CHROMOSOME CANC, V53, P738, DOI 10.1002/gcc.22183; Zhou Y, 2013, MODERN PATHOL, V26, P1338, DOI 10.1038/modpathol.2013.78; Lopez-Chavez A, 2015, J CLIN ONCOL, V33, P1000, DOI 10.1200/JCO.2014.58.2007; Dunleavy K, 2013, NEW ENGL J MED, V368, P1408, DOI 10.1056/NEJMoa1214561; Strobel P, 2004, J CLIN ONCOL, V22, P1501, DOI 10.1200/JCO.2004.10.113; Weissferdt A, 2013, MODERN PATHOL, V26, P1554, DOI 10.1038/modpathol.2013.111; Greaves P, 2013, BLOOD, V122, P2856, DOI 10.1182/blood-2013-06-508044; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Haroche J, 2013, BLOOD, V121, P1495, DOI 10.1182/blood-2012-07-446286; Detterbeck FC, 2014, J THORAC ONCOL, V9, pS65, DOI 10.1097/JTO.0000000000000290; Ehemann V, 2008, INT J CANCER, V122, P2719, DOI 10.1002/ijc.23335; Kuppers R, 2012, HEMATOL-AM SOC HEMAT, P328, DOI 10.1182/asheducation-2012.1.328; Moran CA, 2000, AM J CLIN PATHOL, V113, P345; Tonon G, 2003, NAT GENET, V33, P208, DOI 10.1038/ng1083; Detterbeck FC, 2011, J THORAC ONCOL, V6, pS1710, DOI 10.1097/JTO.0b013e31821e8cff; Thomas A, 2015, LANCET ONCOL, V16, P177, DOI 10.1016/S1470-2045(14)71181-7; de Jong J, 2008, J PATHOL, V215, P21, DOI 10.1002/path.2332; Eberle FC, 2011, MODERN PATHOL, V24, P1586, DOI 10.1038/modpathol.2011.116; Steidl C, 2011, NATURE, V471, P377, DOI 10.1038/nature09754; Bauer DE, 2012, CLIN CANCER RES, V18, P5773, DOI 10.1158/1078-0432.CCR-12-1153; Chen C, 2009, CANCER INVEST, V27, P582, DOI 10.1080/07357900802620869; Roden AC, 2013, HUM PATHOL, V44, P2799, DOI 10.1016/j.humpath.2013.07.031; Vladislav IT, 2013, MODERN PATHOL, V26, P1059, DOI 10.1038/modpathol.2013.49; Zhou R, 2001, AM J PATHOL, V159, P1853, DOI 10.1016/S0002-9440(10)63031-3; French C, 2014, NAT REV CANCER, V14, P149, DOI 10.1038/nrc3659; Eberle FC, 2011, HAEMATOL-HEMATOL J, V96, P558, DOI 10.3324/haematol.2010.033167; Moran CA, 2012, AM J CLIN PATHOL, V137, P444, DOI 10.1309/AJCP76KEGWQKWOKA; Looijenga LHJ, 2003, CANCER RES, V63, P2244; Achcar RDD, 2009, HUM PATHOL, V40, P854, DOI 10.1016/j.humpath.2008.11.007; Nicholson AG, 2014, J THORAC ONCOL, V9, pS73, DOI 10.1097/JTO.0000000000000303; Di Tommaso L, 2007, AM J SURG PATHOL, V31, P1161, DOI 10.1097/PAS.0b013e3180555ba8; Chilosi M, 2003, VIRCHOWS ARCH, V443, P175, DOI 10.1007/s00428-003-0857-4; Zamo A, 2005, MODERN PATHOL, V18, P1448, DOI 10.1038/modpathol.3800440; Adam P, 2014, VIRCHOWS ARCH, V465, P313, DOI 10.1007/s00428-014-1606-6; Rajan A, 2014, J THORAC ONCOL, V9, pS131, DOI 10.1097/JTO.0000000000000298; Dotto J, 2007, AM J CLIN PATHOL, V127, P415, DOI 10.1309/2GAYKPDDM85P2VEW; Burkhardt B, 2006, LEUKEMIA, V20, P1422, DOI 10.1038/sj.leu.2404275; Petrini I, 2014, NAT GENET, V46, P844, DOI 10.1038/ng.3016; Kominato S, 2012, PATHOL INT, V62, P93, DOI 10.1111/j.1440-1827.2011.02764.x; Kacker C, 2013, GENE CHROMOSOME CANC, V52, P93, DOI 10.1002/gcc.22009; Strobel P, 2014, HISTOPATHOLOGY, V64, P557, DOI 10.1111/his.12279; Callens C, 2012, J CLIN ONCOL, V30, P1966, DOI 10.1200/JCO.2011.39.7661; Gokmen-Polar Y, 2012, LAB INVEST, V92, P1564, DOI 10.1038/labinvest.2012.115; Nonaka D, 2007, AM J SURG PATHOL, V31, P1038, DOI 10.1097/PAS.0b013e31802b4917; Marx A, 2015, EXP NEUROL, V270, P55, DOI 10.1016/j.expneurol.2015.02.010; Coustan-Smith E, 2009, LANCET ONCOL, V10, P147, DOI 10.1016/S1470-2045(08)70314-0; Marx A, 2015, LANCET ONCOL, V16, P124, DOI 10.1016/S1470-2045(15)70010-0; Petrini I, 2013, CLIN CANCER RES, V19, P1960, DOI 10.1158/1078-0432.CCR-12-3260; Brambilla C, 2014, CLIN CANCER RES, V20, P5777, DOI 10.1158/1078-0432.CCR-14-0459; den Bakker MA, 2014, J THORAC ONCOL, V9, pS125, DOI 10.1097/JTO.0000000000000297; Fletcher CDM, 2014, WHO CLASSIFICATION T; French CA, 2014, CANCER DISCOV, V4, P928, DOI 10.1158/2159-8290.CD-14-0014; Girard Nicolas, 2013, Eur Respir Rev, V22, P75, DOI 10.1183/09059180.00007312; Go H, 2011, LEUKEMIA LYMPHOMA, V52, P2276, DOI 10.3109/10428194.2011.596968; Green AC, 2015, HISTOPATHOLOGY, V66, P884, DOI 10.1111/his.12512; Huang Bei, 2013, Front Oncol, V3, P316, DOI 10.3389/fonc.2013.00316; Huang J, 2014, J THORAC ONCOL, V9, P1573, DOI 10.1097/JTO.0000000000000269; Moser B, 2015, AM J SURG PATHOL, V39, P541, DOI 10.1097/PAS.0000000000000359; Pellegrino M, 2012, CASE REP MED, V2012; Pelosi G, 2015, MOD PATHOL S2, V28, p487A; Rajan A, 2014, LANCET ONCOL, V15, P191, DOI 10.1016/S1470-2045(13)70596-5; Rennspiess D, 2015, J THORAC ONCOL, V10, P360, DOI 10.1097/JTO.0000000000000390; Roden AC, 2015, J THORAC ONCOL, V10, P691, DOI 10.1097/JTO.0000000000000482; Rosai J, 1999, HISTOLOGICAL TYPING; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Swerdlow S, 2008, WHO CLASSIFICATION T; Thomas A, 2014, CLIN CANCER RES, V20, P5392, DOI 10.1158/1078-0432.CCR-14-0968; Travis W, 2004, PATHOLOGY GENETICS T; Travis WD, 2015, WHO CLASSIFICATION T; Twa DDW, 2014, BLOOD, V123, P2062, DOI 10.1182/blood-2013-10-535443; Ueda Yuichiro, 2012, Case Rep Oncol, V5, P459, DOI 10.1159/000342357; Wang YS, 2014, SCI REP-UK, V4, DOI 10.1038/srep07336; Weis CA, 2015, J THORAC ONCOL, V10, P367, DOI 10.1097/JTO.0000000000000393	91	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	OCT	2015	10	10					1383	1395		10.1097/JTO.0000000000000654		13	Oncology; Respiratory System	Oncology; Respiratory System	CS0AP	WOS:000361719200001		
J	Fukuizumi, A; Akagi, K; Sakai, H				Fukuizumi, Aya; Akagi, Kiwamu; Sakai, Hiroshi			A Case of Atypical Carcinoid Harboring Variant 3a/b EML4-ALK Rearrangement	JOURNAL OF THORACIC ONCOLOGY			English	Letter							CELL LUNG-CANCER; EML4-ALK FUSION		[Fukuizumi, Aya; Sakai, Hiroshi] Saitama Canc Ctr, Dept Thorac Oncol, Ina, Saitama 3620806, Japan; [Akagi, Kiwamu] Saitama Canc Ctr, Dept Mol Diag & Canc Prevent, Ina, Saitama 3620806, Japan	Fukuizumi, A (reprint author), Saitama Canc Ctr, Dept Thorac Oncol, 780 Komuro, Ina, Saitama 3620806, Japan.	ayafukuizumi@cancer-c.pref.saitama.jp					Toyokawa G, 2012, J THORAC ONCOL, V7, pE39, DOI 10.1097/JTO.0b013e3182762bcb; Toyokawa G, 2013, LUNG CANCER, V81, P487, DOI 10.1016/j.lungcan.2013.05.022; Omachi N, 2014, J THORAC ONCOL, V9, pE40, DOI 10.1097/JTO.0000000000000103	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	OCT	2015	10	10					E104	E106		10.1097/JTO.0000000000000635		3	Oncology; Respiratory System	Oncology; Respiratory System	CS0AO	WOS:000361719100006		
J	Nagai, K; Hoshino, Y; Nishizawa, Y; Araki, D; Matsushita, T; Matsumoto, T; Takayama, K; Nagamune, K; Kurosaka, M; Kuroda, R				Nagai, Kanto; Hoshino, Yuichi; Nishizawa, Yuichiro; Araki, Daisuke; Matsushita, Takehiko; Matsumoto, Tomoyuki; Takayama, Koji; Nagamune, Kouki; Kurosaka, Masahiro; Kuroda, Ryosuke			Quantitative comparison of the pivot shift test results before and after anterior cruciate ligament reconstruction by using the three-dimensional electromagnetic measurement system	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Rotational instability; Pivot shift test; Electromagnetic measurement system; Acceleration; Anterior cruciate ligament injury; ACL reconstruction	IN-VIVO MEASUREMENT; DEFICIENT KNEE; ACL RECONSTRUCTION; KINEMATICS; BUNDLE; INSUFFICIENCY; AUGMENTATION; STABILITY; ACCURACY; DEVICE	Tibial acceleration during the pivot shift test is a potential quantitative parameter to evaluate rotational laxity of anterior cruciate ligament (ACL) insufficiency. However, clinical application of this measurement has not been fully examined. This study aimed to measure and compare tibial acceleration before and after ACL reconstruction (ACLR) in ACL-injured patients. We hypothesized tibial acceleration would be reduced by ACLR and tibial acceleration would be consistent in the same knee at different time points. Seventy ACL-injured patients who underwent ACLR were enrolled. Tibial acceleration during the pivot shift test was measured using an electromagnetic measurement system before ALCR and at the second-look arthroscopy 1 year post-operatively. Tibial acceleration was compared to clinical grading and between ACL-injured/ACL-reconstructed and contralateral knees. Pre-operative tibial acceleration was increased stepwise with the increase in clinical grading (P < 0.01). Tibial acceleration in ACL-injured knee (1.9 +/- A 1.2 m/s(2)) was larger than that in the contralateral knee (0.8 +/- A 0.3 m/s(2), P < 0.01), and reduced to 0.9 +/- A 0.3 m/s(2) post-operatively (P < 0.01). There was no difference between ACL-reconstructed and contralateral knee (n.s.). Tibial acceleration in contralateral knees was consistent pre- and post-operatively (n.s.). Tibial acceleration measurement demonstrated increased rotational laxity in ACL-injured knees and its reduction by ALCR. Additionally, consistent measurements were obtained in ACL-intact knees at different time points. Therefore, tibial acceleration during the pivot shift test could provide quantitative evaluation of rotational stability before and after ACL reconstruction. III.	[Nagai, Kanto; Nishizawa, Yuichiro; Araki, Daisuke; Matsushita, Takehiko; Matsumoto, Tomoyuki; Takayama, Koji; Kurosaka, Masahiro; Kuroda, Ryosuke] Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Hoshino, Yuichi] Kobe Kaisei Hosp, Dept Orthopaed Surg, Kobe, Hyogo, Japan; [Nagamune, Kouki] Univ Fukui, Grad Sch Engn, Dept Human & Artificial Intelligent Syst, Fukui 910, Japan	Kuroda, R (reprint author), Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kurodar@med.kobe-u.ac.jp					Kopf S, 2012, KNEE SURG SPORT TR A, V20, P718, DOI 10.1007/s00167-012-1903-z; Labbe DR, 2011, J BIOMECH, V44, P1, DOI 10.1016/j.jbiomech.2010.08.012; Lopomo N, 2012, COMPUT METHOD BIOMEC, V15, P1323, DOI 10.1080/10255842.2011.591788; Hoshino Y, 2013, KNEE SURG SPORT TR A, V21, P975, DOI 10.1007/s00167-013-2396-0; Adachi N, 2000, ARCH ORTHOP TRAUM SU, V120, P128, DOI 10.1007/s004020050028; Ishibashi Y, 2009, ARTHROSCOPY, V25, P488, DOI 10.1016/j.arthro.2008.10.008; Lopomo N, 2010, J ORTHOP RES, V28, P164, DOI 10.1002/jor.20966; Kocher MS, 2004, AM J SPORT MED, V32, P629, DOI 10.1177/0363546503261722; Engebretsen L, 2012, KNEE SURG SPORT TR A, V20, P698, DOI 10.1007/s00167-011-1744-1; Citak M, 2011, KNEE SURG SPORT TR A, V19, P707, DOI 10.1007/s00167-010-1289-8; Kitamura N, 2013, AM J SPORT MED, V41, P2500, DOI 10.1177/0363546513499529; Labbe DR, 2010, J BIOMECH, V43, P3080, DOI 10.1016/j.jbiomech.2010.08.011; Lane CG, 2008, KNEE SURG SPORT TR A, V16, P487, DOI 10.1007/s00167-008-0504-3; Leitze Z, 2005, CLIN ORTHOP RELAT R, P229, DOI 10.1097/01.blo.0000160026.14363.22; Yamamoto Y, 2004, AM J SPORT MED, V32, P1825, DOI 10.1177/0363546504263947; Kuroda R, 2012, AM J SPORT MED, V40, P91, DOI 10.1177/0363546511423634; Hoshino Y, 2012, KNEE SURG SPORT TR A, V20, P732, DOI 10.1007/s00167-011-1850-0; Araki D, 2013, ARTHROSCOPY, V29, P1053, DOI 10.1016/j.arthro.2013.02.012; Musahl V, 2012, KNEE SURG SPORT TR A, V20, P793, DOI 10.1007/s00167-011-1857-6; Kubo S, 2007, CLIN ORTHOP RELAT R, P54, DOI 10.1097/BLO.0b013e31802b4a38; Siebold R, 2008, ARTHROSCOPY, V24, P1289, DOI 10.1016/j.arthro.2008.06.016; Zaffagnini S, 2012, KNEE SURG SPORT TR A, V20, P153, DOI 10.1007/s00167-011-1589-7; Zaffagnini S, 2012, KNEE SURG SPORT TR A, V20, P743, DOI 10.1007/s00167-012-1897-6; Bull AMJ, 2002, J BONE JOINT SURG BR, V84B, P1075, DOI 10.1302/0301-620X.84B7.13094; Milne AD, 1996, J BIOMECH, V29, P791, DOI 10.1016/0021-9290(96)83335-5; Lopomo N, 2012, KNEE SURG SPORT TR A, V20, P713, DOI 10.1007/s00167-011-1865-6; Pearle AD, 2009, J BONE JOINT SURG AM, V91A, P115, DOI 10.2106/JBJS.H.01553; Berruto M, 2013, KNEE SURG SPORT TR A, V21, P981, DOI 10.1007/s00167-013-2436-9; Hoshino Y, 2007, AM J SPORT MED, V35, P1098, DOI 10.1177/0363546507299447; Asai S, 2014, KNEE SURG SPORT TR A, V22, P972, DOI 10.1007/s00167-013-2499-7; Jonsson H, 2004, ACTA ORTHOP SCAND, V75, P594, DOI 10.1080/00016470410001484; Maeyama A, 2011, KNEE SURG SPORT TR A, V19, P1233, DOI 10.1007/s00167-010-1382-z; Lopomo N, 2013, KNEE SURG SPORT TR A, V21, P767, DOI 10.1007/s00167-013-2435-x; Bignozzi S, 2010, KNEE SURG SPORT TR A, V18, P37, DOI 10.1007/s00167-009-0853-6; Fujita Norifumi, 2011, Arthroscopy, V27, P906, DOI 10.1016/j.arthro.2011.02.015; GALWAY HR, 1980, CLIN ORTHOP RELAT R, P45; Galway HR, 1972, J BONE JOINT SURG BR, V54, P763; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136; Hefti F, 1993, Knee Surg Sports Traumatol Arthrosc, V1, P226; Tashman S, 2004, AM J SPORT MED, V32, P975, DOI 10.1177/0363546503261709	40	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	OCT	2015	23	10					2876	2881		10.1007/s00167-015-3776-4		6	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CS0EB	WOS:000361729400015		
J	Takeda, S; Tajima, G; Fujino, K; Yan, J; Kamei, Y; Maruyama, M; Kikuchi, S; Doita, M				Takeda, Sanjuro; Tajima, Goro; Fujino, Kotaro; Yan, Jun; Kamei, Youichi; Maruyama, Moritaka; Kikuchi, Shuhei; Doita, Minoru			Morphology of the femoral insertion of the lateral collateral ligament and popliteus tendon	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Postero-lateral corner; Lateral collateral ligament; Popliteus tendon; Femoral insertion	POSTERIOR CRUCIATE LIGAMENT; POSTEROLATERAL CORNER; SURGICAL TECHNIQUE; POPLITEOFIBULAR LIGAMENT; KNEE-JOINT; RECONSTRUCTION; INSTABILITY; STABILITY; ANATOMY; RUPTURE	To clarify the femoral insertion of the lateral collateral ligament (LCL) and popliteus tendon (PT) and related osseous landmarks on three-dimensional images. Twenty-six non-paired, formalin-fixed human cadaveric knees were evaluated in this study. Femoral insertion of the LCL and PT was identified and marked. Three-dimensional images were created, and the surface area, location, positional relationships, and morphology of the femoral insertion of the LCL, PT, and related osseous structures were analysed. The mean surface areas of the LCL and PT femoral insertions were 55.8 +/- A 25.0 and 52.5 +/- A 24.2 mm(2), respectively. Variations in the positional relationships between the LCL and PT insertions (PT inserted parallel and posterior to the LCL insertion to the long axis of the femur) were observed. The lateral epicondyle and popliteal sulcus could be clearly identified as osseous landmarks on three-dimensional images in all knees. Most of the LCL was inserted postero-distal to the apex of the lateral epicondyle, and the PT was inserted at the anterior end of the popliteal sulcus in all knees. We observed variation in the positional relationship between the femoral insertion of the LCL and PT. However, the relationships between their insertions and osseous landmarks were consistent. The findings of this study contribute to the understanding of the PLC osseous anatomy and should assist surgeons in performing PLC surgery with a more anatomic perspective.	[Takeda, Sanjuro; Tajima, Goro; Fujino, Kotaro; Kamei, Youichi; Maruyama, Moritaka; Kikuchi, Shuhei; Doita, Minoru] Iwate Med Univ, Dept Orthopaed Surg, Morioka, Iwate 0208505, Japan; [Yan, Jun] Iwate Med Univ, Dept Anat, Morioka, Iwate 0208505, Japan	Tajima, G (reprint author), Iwate Med Univ, Dept Orthopaed Surg, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	gorot56jp@mac.com					Kim JG, 2009, ARCH ORTHOP TRAUM SU, V129, P381, DOI 10.1007/s00402-008-0722-7; Jakobsen BW, 2010, ARTHROSCOPY, V26, P918, DOI 10.1016/j.arthro.2009.11.019; Levy BA, 2010, AM J SPORT MED, V38, P804, DOI 10.1177/0363546509352459; GOLLEHON DL, 1987, J BONE JOINT SURG AM, V69A, P233; LaPrade RF, 2004, AM J SPORT MED, V32, P1405, DOI 10.1177/0363546503262687; Fanelli GC, 1996, ARTHROSCOPY, V12, P521, DOI 10.1016/S0749-8063(96)90189-9; Maynard MJ, 1996, AM J SPORT MED, V24, P311, DOI 10.1177/036354659602400311; Jung GH, 2010, ARCH ORTHOP TRAUM SU, V130, P1027, DOI [10.1007/s00402-010-1123-2, 10.1007/s00402-010-1077-4]; Zeng SX, 2011, ANAT SCI INT, V86, P213, DOI [10.1007/s12565-011-0112-z, 10.1007/s12565-011-0114-x]; LaPrade RF, 2003, AM J SPORT MED, V31, P854; Gelaude F, 2008, COMPUT AIDED SURG, V13, P188, DOI [10.3109/10929080802195783, 10.1080/10929080802195783]; Sekiya JK, 2005, ARTHROSCOPY, V21, P1400, DOI 10.1016/j.arthro.2005.08.024; LaPrade RF, 2005, AM J SPORT MED, V33, P1386, DOI 10.1177/036354650427143; WASCHER DC, 1993, AM J SPORT MED, V21, P400, DOI 10.1177/036354659302100313; CLANCY WG, 1983, J BONE JOINT SURG AM, V65, P310; Pietrini SD, 2009, AM J SPORT MED, V37, P542, DOI 10.1177/0363546508328117; HUGHSTON JC, 1985, J BONE JOINT SURG AM, V67A, P351; Stannard JP, 2005, AM J SPORT MED, V33, P881, DOI 10.1177/0363546504271208; Covey DC, 2001, J BONE JOINT SURG AM, V83A, P106; Brinkman JM, 2005, J BONE JOINT SURG BR, V87B, P1364, DOI 10.1302/0301-620X.87B10.16536; Miyatake S, 2011, AM J SPORT MED, V39, P1462, DOI 10.1177/0363546511404135; Victor J, 2009, AM J SPORT MED, V37, P2028, DOI 10.1177/0363546509337407; Kamath GV, 2010, AM J SPORT MED, V38, P570, DOI 10.1177/0363546509350066; Camarda Lawrence, 2010, J Orthop Traumatol, V11, P73, DOI 10.1007/s10195-010-0088-9; Clancy William G Jr, 2003, Am J Orthop (Belle Mead NJ), V32, P171; Fujino K, 2013, KNEE SURG SPORTS TRA; Niki Yasuo, 2012, Sports Med Arthrosc Rehabil Ther Technol, V4, P21, DOI 10.1186/1758-2555-4-21; Noyes FR, 1996, AM J SPORT MED, V24, P415, DOI 10.1177/036354659602400404; STAUBLI H-U, 1990, Arthroscopy, V6, P209, DOI 10.1016/0749-8063(90)90077-Q; Terry GC, 1996, AM J SPORT MED, V24, P732, DOI 10.1177/036354659602400606; Yan J, 2012, SURG SCI, V3, P484	31	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	OCT	2015	23	10					3049	3054		10.1007/s00167-014-3059-5		6	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CS0EB	WOS:000361729400038		
J	Kimura, Y; Tsuda, E; Hiraga, Y; Yamamoto, Y; Maeda, S; Ishibashi, Y				Kimura, Yuka; Tsuda, Eiichi; Hiraga, Yasuharu; Yamamoto, Yuji; Maeda, Shugo; Ishibashi, Yasuyuki			Intraoperative laxity measurements using a navigation system in anatomical double-bundle posterior cruciate ligament reconstruction	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Posterior cruciate ligament (PCL); Double-bundle reconstruction; Navigation system; Anterolateral bundle; Posteromedial bundle	ACL RECONSTRUCTION; BIOMECHANICAL EVALUATION; KNEE-JOINT; SINGLE; GRAFT; PLACEMENT; INJURIES; OUTCOMES; TENDON	The objective of this study was to evaluate knee kinematics during double-bundle posterior cruciate ligament reconstruction (DB-PCLR) intraoperatively using a navigation system, and especially assess biomechanical behaviour of the anterolateral bundle (ALB) and posteromedial bundle (PMB) graft in DB-PCLR. Also, clinical results of minimum 2-year follow-up were investigated. Nine patients received DB-PCLR with hamstring graft. Before reconstruction, knee laxities, including posterior tibial translation (PTT) in neutral rotation at 15A degrees, 30A degrees, 45A degrees, 60A degrees, 75A degrees and 90A degrees of knee flexion, were measured using a kinematic-based navigation system. After the PMB or ALB was temporally fixed, the knee laxities were measured in the same manner. Each patient was evaluated pre- and post-operatively with side-to-side difference of tibial position in gravity sag view and Lysholm score. Both ALB and PMB fixation restrained the PTT compared to PCL deficiency throughout all knee flexion angles. At 90A degrees of knee flexion, ALB fixation significantly decreased PTT compare to PMB fixation (p = 0.014) and DB-PCLR significantly decreased PTT compare to ALB fixation (p = 0.045). The mean side-to-side difference of tibial position in gravity sag view was 12.0 +/- A 1.7 mm preoperatively and 2.3 +/- A 1.8 mm at final follow-up, and the mean Lysholm scores were 68.9 +/- A 20.9 and 96.3 +/- A 2.9, respectively. There were no significant differences in the PTT between ALB and PMB fixations at 0A degrees to 75A degrees of knee flexion, and both ALB and PMB reconstructions are important for restraining PTT. At 90A degrees of knee flexion, the ALB grafts may be more important to control PTT compared to PMB grafts; however, neither single-bundle reconstruction with ALB nor PMB could function as DB-PCLR did. In addition, PTT after DB-PCLR was strongly correlated side-to-side difference in posterior sag view at the final follow-up. The results from this study indicated that both ALB and PMB are important to stabilize PCL-deficient knees. Therapeutic study, Level III.	[Kimura, Yuka; Tsuda, Eiichi; Hiraga, Yasuharu; Yamamoto, Yuji; Maeda, Shugo; Ishibashi, Yasuyuki] Hirosaki Univ, Dept Orthopaed Surg, Grad Sch Med, Hirosaki, Aomori 0368562, Japan	Kimura, Y (reprint author), Hirosaki Univ, Dept Orthopaed Surg, Grad Sch Med, Zaifu Cho 5, Hirosaki, Aomori 0368562, Japan.	yukax10@cc.hirosaki-u.ac.jp					Mannor DA, 2000, AM J SPORT MED, V28, P833; Harner CD, 1999, ARTHROSCOPY, V15, P741, DOI 10.1016/S0749-8063(99)70006-X; Koh J, 2006, ORTHOPEDICS, V29, pS122; Fox RJ, 1998, AM J SPORT MED, V26, P395; GOLLEHON DL, 1987, J BONE JOINT SURG AM, V69A, P233; Desai N, 2014, KNEE SURG SPORT TR A, V22, P1009, DOI 10.1007/s00167-013-2811-6; Shino K, 2000, ARTHROSCOPY, V16, P670, DOI 10.1053/jars.2000.7688; Ishibashi Y, 2009, ARTHROSCOPY, V25, P488, DOI 10.1016/j.arthro.2008.10.008; GROOD ES, 1988, J BONE JOINT SURG AM, V70A, P88; Sekiya JK, 2005, ARTHROSCOPY, V21, P1042, DOI 10.1016/j.arthro.2005.05.023; Tajima G, 2009, J BONE JOINT SURG AM, V91A, P859, DOI 10.2106/JBJS.H.00991; Race A, 1998, J BONE JOINT SURG BR, V80B, P173, DOI 10.1302/0301-620X.80B1.7453; Markolf KL, 2006, ARTHROSCOPY, V22, P1100, DOI 10.1016/j.arthro.2006.05.018; Ahmad CS, 2003, AM J SPORT MED, V31, P221; Tsukada H, 2012, ARTHROSCOPY, V28, P264, DOI 10.1016/j.arthro.2011.07.020; Nakamura N, 2011, J ORTHOP SCI, V16, P516, DOI 10.1007/s00776-011-0112-9; Ishibashi Y, 2008, AM J SPORT MED, V36, P1903, DOI 10.1177/0363546508323245; Markolf KL, 2006, J BONE JOINT SURG AM, V88A, P1788, DOI 10.2106/JBJS.E.00427; Hiraga Y, 2006, KNEE SURG SPORT TR A, V14, P13, DOI 10.1007/s00167-005-0633-x; CLANCY WG, 1983, J BONE JOINT SURG AM, V65, P310; Harner CD, 2000, AM J SPORT MED, V28, P144; Yang JH, 2012, AM J SPORT MED, V40, P2052, DOI 10.1177/0363546512454532; Harner CD, 1998, AM J SPORT MED, V26, P471; Papannagari R, 2007, AM J SPORT MED, V35, P1507, DOI 10.1177/0363546507300061; Koh J, 2005, ORTHOPEDICS, V28, pS1283; Ettinger M, 2013, KNEE SURG SPORT TR A, V21, P2057, DOI 10.1007/s00167-012-2190-4; Colombet P, 2007, CLIN ORTHOP RELAT R, P59, DOI 10.1097/blo.0b013e31802baf56; GIRGIS FG, 1975, CLIN ORTHOP RELAT R, P216; Hanner CD, 1995, AM J SPORTS MED, V23, P736; LYSHOLM J, 1982, AM J SPORT MED, V10, P150, DOI 10.1177/036354658201000306; TEGNER Y, 1985, CLIN ORTHOP RELAT R, P43	31	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	OCT	2015	23	10					3085	3093		10.1007/s00167-014-3418-2		9	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CS0EB	WOS:000361729400043		
J	Okazaki, K; Takayama, Y; Osaki, K; Matsuo, Y; Mizu-uchi, H; Hamai, S; Honda, H; Iwamoto, Y				Okazaki, Ken; Takayama, Yukihisa; Osaki, Kanji; Matsuo, Yoshio; Mizu-uchi, Hideki; Hamai, Satoshi; Honda, Hiroshi; Iwamoto, Yukihide			Subclinical cartilage degeneration in young athletes with posterior cruciate ligament injuries detected with T1 rho magnetic resonance imaging mapping	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Posterior cruciate ligament (PCL); Conservative treatment; Osteoarthritis; Cartilage; Magnetic resonance imaging (MRI)	ARTICULAR-CARTILAGE; FOLLOW-UP; 3 T; KNEE; RECONSTRUCTION; OSTEOARTHRITIS; HISTORY	Prediction of the risk of osteoarthritis in asymptomatic active patients with an isolated injury of the posterior cruciate ligament (PCL) is difficult. T1 rho magnetic resonance imaging (MRI) enables the quantification of the proteoglycan content in the articular cartilage. The purpose of this study was to evaluate subclinical cartilage degeneration in asymptomatic young athletes with chronic PCL deficiency using T1 rho MRI. Six athletes with chronic PCL deficiency (median age 17, range 14-36 years) and six subjects without any history of knee injury (median age 31.5, range 24-33 years) were recruited. Regions of interest were placed on the articular cartilage of the tibia and the distal and posterior areas of the femoral condyle, and T1 rho values were calculated. On stress radiographs, the mean side-to-side difference in posterior laxity was 9.8 mm. The T1 rho values at the posterior area of the lateral femoral condyle and the superficial layer of the distal area of the medial and lateral femoral condyle of the patients were significantly increased compared with those of the normal controls (p < 0.05). At the tibial plateau, the T1 rho values in both the medial and lateral compartments were significantly higher in patients compared with those in the normal controls (p < 0.05). T1 rho MRI detected unexpected cartilage degeneration in the well-functioning PCL-deficient knees of young athletes. One should be alert to the possibility of subclinical cartilage degeneration even in asymptomatic patients who show no degenerative changes on plain radiographs or conventional MRI. IV.	[Okazaki, Ken; Osaki, Kanji; Mizu-uchi, Hideki; Hamai, Satoshi; Iwamoto, Yukihide] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, Fukuoka 8120054, Japan; [Takayama, Yukihisa; Matsuo, Yoshio; Honda, Hiroshi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Fukuoka 8120054, Japan	Okazaki, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8120054, Japan.	okazaki@med.kyushu-u.ac.jp					Jazrawi LM, 2011, J AM ACAD ORTHOP SUR, V19, P420; Boynton MD, 1996, AM J SPORT MED, V24, P306, DOI 10.1177/036354659602400310; DIJKGRAAF LC, 1995, J ORAL MAXIL SURG, V53, P1182, DOI 10.1016/0278-2391(95)90632-0; Wu CH, 2007, ARTHROSCOPY, V23, P420, DOI 10.1016/j.arthro.2006.12.011; Sekiya JK, 2005, ARTHROSCOPY, V21, P1042, DOI 10.1016/j.arthro.2005.05.023; Li X, 2007, OSTEOARTHR CARTILAGE, V15, P789, DOI 10.1016/j.joca.2007.01.011; Kim YM, 2011, AM J SPORT MED, V39, P425, DOI 10.1177/0363546510374452; Bolbos RI, 2009, OSTEOARTHR CARTILAGE, V17, P12, DOI 10.1016/j.joca.2008.05.016; Hirose J, 2013, AM J SPORT MED, V41, P2353, DOI 10.1177/0363546513496048; Lopez-Vidriero E, 2010, SPORTS MED ARTHROSC, V18, P230, DOI 10.1097/JSA.0b013e3181fbaf38; Kraus VB, 2009, ANN RHEUM DIS, V68, P1673, DOI 10.1136/ard.2008.094722; Tsushima H, 2012, RHEUMATOL INT, V32, P2867, DOI 10.1007/s00296-011-2140-3; Young AA, 2005, J BONE JOINT SURG AM, V87A, P2763, DOI 10.2106/JBJS.D.02923; Crema MD, 2011, RADIOGRAPHICS, V31, P37, DOI 10.1148/rg.311105084; Shelbourne KD, 2005, ARTHROSCOPY, V21, P457, DOI 10.1016/j.arthro.2004.11.013; Theologis AA, 2014, KNEE SURG SPORT TR A, V22, P298, DOI 10.1007/s00167-013-2397-z; Shelbourne KD, 1999, AM J SPORT MED, V27, P276; Li XJ, 2011, MAGN RESON IMAGING, V29, P324, DOI 10.1016/j.mri.2010.09.004; Takayama Y, 2013, EUR J RADIOL, V82, pE192, DOI 10.1016/j.ejrad.2012.11.031; Colvin Alexis Chiang, 2009, Bull NYU Hosp Jt Dis, V67, P45; Fanelli Gregory C, 2010, J Knee Surg, V23, P61; FOWLER PJ, 1987, AM J SPORT MED, V15, P553, DOI 10.1177/036354658701500606; KELLER PM, 1993, AM J SPORT MED, V21, P132, DOI 10.1177/036354659302100122; Mariani P P, 1997, Knee Surg Sports Traumatol Arthrosc, V5, P239, DOI 10.1007/s001670050057; Patel Dipak V, 2007, HSS J, V3, P137, DOI 10.1007/s11420-007-9058-z	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	OCT	2015	23	10					3094	3100		10.1007/s00167-014-3469-4		7	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CS0EB	WOS:000361729400044		
J	Miyao, M; Kotani, H; Ishida, T; Kawai, C; Manabe, S; Abiru, H; Tamaki, K				Miyao, Masashi; Kotani, Hirokazu; Ishida, Tokiko; Kawai, Chihiro; Manabe, Sho; Abiru, Hitoshi; Tamaki, Keiji			Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression	LABORATORY INVESTIGATION			English	Article							INDUCED MOUSE MODEL; NONALCOHOLIC STEATOHEPATITIS; INSULIN-RESISTANCE; RAT-LIVER; DISEASE; MICE; DIET; CAPILLARIZATION; ATHEROSCLEROSIS; REGENERATION	Liver sinusoidal endothelial cells (LSECs) are involved in the transport of nutrients, lipids, and lipoproteins, and LSEC injury occurs in various liver diseases including nonalcoholic fatty liver disease (NAFLD). However, the association between LSEC injury and NAFLD progression remains elusive. Accordingly, in this study, we aimed to elucidate the precise role of LSEC in the pathophysiology of NAFLD using two different mouse models, namely the choline-deficient, L-amino acid-defined and high-fat diet models. Administration of these diets resulted in liver metabolic dysregulation mimicking human NAFLD, such as steatosis, ballooning, lobular inflammation, and fibrosis, as well as central obesity, insulin resistance, and hyperlipidemia. LSEC injury appeared during the simple steatosis phase, and preceded the appearance of activated Kupffer cells and hepatic stellate cells (HSCs). These results indicate that LSEC injury may have a 'gatekeeper' role in the progression from simple steatosis to the early nonalcoholic steatohepatitis (NASH) stage, and LSEC injury may be necessary for the activation of Kupffer cells and HSCs, which in turn results in the development and perpetuation of chronic liver injuries. Taken together, our data provide new insights into the role of LSEC injury in NAFLD/NASH pathogenesis.	[Miyao, Masashi; Kotani, Hirokazu; Ishida, Tokiko; Kawai, Chihiro; Manabe, Sho; Abiru, Hitoshi; Tamaki, Keiji] Kyoto Univ, Grad Sch Med, Dept Forens Med, Kyoto 6068501, Japan	Kotani, H (reprint author), Kyoto Univ, Grad Sch Med, Dept Forens Med, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	kotani@fp.med.kyoto-u.ac.jp			JSPS KAKENHI Grant [26860465]; Kyoto University Young Scientists Start-up Grant	We gratefully acknowledge Haruyasu Kohda and Keiko Furuta for their skillful technical assistance with the electron microscopy. Further, we thank Dr Leila Jemail and Editage for their careful reading of the manuscript and their thoughtful comments. We also acknowledge Hirozo Minami for his technical assistance with the histopathological analyses. This work was supported by a Grant-in-Aid for Young Scientists (B) (JSPS KAKENHI Grant Number 26860465) and a Kyoto University Young Scientists Start-up Grant (MM).	Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; SCHAFFNER F, 1963, GASTROENTEROLOGY, V44, P239; DeLeve LD, 2008, HEPATOLOGY, V48, P920, DOI 10.1002/hep.22351; Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754; Leclercq IA, 2007, J HEPATOL, V47, P142, DOI 10.1016/j.jhep.2007.04.002; Miller AM, 2010, ALCOHOL CLIN EXP RES, V34, P719, DOI 10.1111/j.1530-0277.2009.01141.x; Caballero F, 2010, J BIOL CHEM, V285, P18528, DOI 10.1074/jbc.M109.099333; DeLeve LD, 2013, J CLIN INVEST, V123, P1861, DOI 10.1172/JCI66025; Miyao M, 2013, DIGEST LIVER DIS, V45, P216, DOI 10.1016/j.dld.2012.09.007; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Tosello-Trampont AC, 2012, J BIOL CHEM, V287, P40161, DOI 10.1074/jbc.M112.417014; Xie GH, 2012, GASTROENTEROLOGY, V142, P918, DOI 10.1053/j.gastro.2011.12.017; Lee YA, 2015, GUT, V64, P830, DOI 10.1136/gutjnl-2014-306842; Brock RW, 2007, MICROCIRCULATION, V14, P339, DOI 10.1080/10739680701282986; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Le Couteur DG, 2002, LANCET, V359, P1612, DOI 10.1016/S0140-6736(02)08524-0; WISSE E, 1985, HEPATOLOGY, V5, P683, DOI 10.1002/hep.1840050427; Denda A, 2002, JPN J CANCER RES, V93, P125; Furrer K, 2011, P NATL ACAD SCI USA, V108, P2945, DOI 10.1073/pnas.1012531108; FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1; Dill MT, 2012, GASTROENTEROLOGY, V142, P967, DOI 10.1053/j.gastro.2011.12.052; Clapper JR, 2013, AM J PHYSIOL-GASTR L, V305, pG483, DOI 10.1152/ajpgi.00079.2013; DeLeve LD, 2004, AM J PHYSIOL-GASTR L, V287, pG757, DOI 10.1152/ajpgi.00017.2004; Ioannou GN, 2013, J LIPID RES, V54, P1326, DOI 10.1194/jlr.M034876; Gaidos JKJ, 2008, LIVER INT, V28, P650, DOI 10.1111/j.1478-3231.2008.01693.x; Xie GH, 2013, GUT, V62, P299, DOI 10.1136/gutjnl-2011-301494; Braet F, 2002, COMP HEPATOL, V1, P1, DOI DOI 10.1186/1476-5926-1-1.PUBMED:12437787; NIH, 1996, GUIDE CARE USE LAB A; Pasarin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032785; Stankovic MN, 2014, ARCH MED RES, V45, P116, DOI 10.1016/j.arcmed.2013.12.010	30	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	OCT	2015	95	10					1130	1144		10.1038/labinvest.2015.95		15	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CS2NY	WOS:000361909200004		
J	Hirozane, T; Suzuki, T; Yoshida, H				Hirozane, Toru; Suzuki, Taku; Yoshida, Hirobumi			Pycnodysostosis with a patella fracture	LANCET DIABETES & ENDOCRINOLOGY			English	Editorial Material									[Hirozane, Toru; Suzuki, Taku; Yoshida, Hirobumi] Nasu Red Cross Hosp, Dept Orthopaed Surg, Ohtawara, Tochigi 3240062, Japan	Suzuki, T (reprint author), Nasu Red Cross Hosp, Dept Orthopaed Surg, 1081-4 Nakadawara, Ohtawara, Tochigi 3240062, Japan.	taku19781109@gmail.com						0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2213-8587			LANCET DIABETES ENDO	Lancet Diabetes Endocrinol.	OCT	2015	3	10					826	826		10.1016/S2213-8587(15)00087-X		1	Endocrinology & Metabolism	Endocrinology & Metabolism	CR9DK	WOS:000361653200024		
J	Morifuji, M; Higashi, S; Oba, C; Ichikawa, S; Kawahata, K; Yamaji, T; Itoh, H; Manabe, Y; Sugawara, T				Morifuji, Masashi; Higashi, Seiichiro; Oba, Chisato; Ichikawa, Satomi; Kawahata, Keiko; Yamaji, Taketo; Itoh, Hiroyuki; Manabe, Yuki; Sugawara, Tatsuya			Milk Phospholipids Enhance Lymphatic Absorption of Dietary Sphingomyelin in Lymph-Cannulated Rats	LIPIDS			English	Article						Bioavailability; Sphingomyelin; Ceramides; Lymph; Rats; Mass spectrometry	COLONIC CRYPT FOCI; BOVINE-MILK; HAIRLESS MICE; MASS-SPECTROMETRY; P-GLYCOPROTEIN; SPHINGOLIPIDS; IDENTIFICATION; METABOLISM; PHOSPHATIDYLCHOLINE; CHOLESTEROL	Supplementation with sphingomyelin has been reported to have beneficial effects on disease prevention and health maintenance. However, compared with glycerolipids, intact sphingomyelin and ceramides are poorly absorbed. Therefore, if the bioavailability of dietary sphingomyelin is increased, then the dose administered can be reduced. This study was designed to identify molecular species of ceramide in rat lymph after the ingestion of milk sphingomyelin, and to compare the effect of purified sphingomyelin with milk phospholipids concentrate (MPL, 185 mg sphingomyelin/g) on lymphatic absorption of milk sphingomyelin. Lymph was collected hourly for 6 h from lymph-cannulated rats (n = 8/group) after the administration of a control emulsion (triolein, bovine serum albumin, and sodium taurocholate), a sphingomyelin emulsion (control + purified sphingomyelin), or a MPL emulsion (control + MPL). Molecular species of ceramide in lymph were analyzed using high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). Molecular species of ceramide, containing not only d18:1, but also d17:1 and d16:1 sphingosine with 16:0, 22:0, 23:0, and 24:0 fatty acids (specific to milk sphingomyelin), were increased in rat lymph after the administration of milk sphingomyelin. Their molecular species were similar to those of dietary milk sphingomyelin. Recovery of ceramide moieties from dietary sphingomyelin was 1.28- to 1.80-fold significantly higher in the MPL group than in the sphingomyelin group. Our results demonstrated that dietary sphingomyelin from milk was transported to lymph as molecular species of ceramide hydrolyzed from milk sphingomyelin and co-ingestion of sphingomyelin with glycerophospholipids enhanced the bioavailability of dietary sphingomyelin.	[Morifuji, Masashi; Higashi, Seiichiro; Oba, Chisato; Ichikawa, Satomi; Kawahata, Keiko; Yamaji, Taketo; Itoh, Hiroyuki] Meiji Co Ltd, Food Sci Res Labs, Odawara, Kanagawa 2500862, Japan; [Manabe, Yuki; Sugawara, Tatsuya] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Sakyo Ku, Kyoto, Kyoto 6068502, Japan	Morifuji, M (reprint author), Meiji Co Ltd, Food Sci Res Labs, 540 Naruda, Odawara, Kanagawa 2500862, Japan.	masashi.morifuji@meiji.com					Cuomo J, 2011, J NAT PROD, V74, P664, DOI 10.1021/np1007262; Sugawara T, 2010, J LIPID RES, V51, P1761, DOI 10.1194/jlr.M002204; Byrdwell WC, 2007, J CHROMATOGR A, V1146, P164, DOI 10.1016/j.chroma.2007.01.108; Sperling P, 2001, ARCH BIOCHEM BIOPHYS, V388, P293, DOI 10.1006/abbi.2001.2308; Haruta-Ono Y, 2012, J DERMATOL SCI, V68, P56, DOI 10.1016/j.jdermsci.2012.07.006; Sperling P, 1998, J BIOL CHEM, V273, P28590, DOI 10.1074/jbc.273.44.28590; GREEN PHR, 1981, J LIPID RES, V22, P1153; Blaas N, 2011, J AGR FOOD CHEM, V59, P6018, DOI 10.1021/jf200943n; ZEISEL SH, 1986, J NUTR, V116, P50; Sugawara T, 2010, LIPIDS, V45, P451, DOI 10.1007/s11745-010-3417-0; Vesper H, 1999, J NUTR, V129, P1239; Watanabe S, 2011, J FUNCT FOODS, V3, P313, DOI 10.1016/j.jff.2011.06.002; Schmelz EM, 1997, NUTR CANCER, V28, P81; Morifuji M, 2015, J DERMATOL SCI, V78, P224, DOI 10.1016/j.jdermsci.2015.02.017; GREEN PHR, 1981, AUST NZ J MED, V11, P84, DOI 10.1111/j.1445-5994.1981.tb03746.x; SCHMELZ EM, 1994, J NUTR, V124, P702; Schmelz EM, 1996, CANCER RES, V56, P4936; Nishimukai M, 2004, J NUTR, V134, P1862; NILSSON A, 1968, BIOCHIM BIOPHYS ACTA, V164, P575, DOI 10.1016/0005-2760(68)90187-2; HEGARDT FG, 1971, Z ERNAHRUNGSWISS, V10, P223; Haruta Y, 2008, BIOSCI BIOTECH BIOCH, V72, P2151, DOI 10.1271/bbb.80212; Sugawara T, 2004, BIOSCI BIOTECH BIOCH, V68, P2541, DOI 10.1271/bbb.68.2541; Ueda K, 1999, ANTI-CANCER DRUG DES, V14, P115; CAREY MC, 1978, J CLIN INVEST, V61, P998, DOI 10.1172/JCI109025; Jager R, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-11; Zeisel SH, 2003, J NUTR, V133, P1302	26	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0024-4201	1558-9307		LIPIDS	Lipids	OCT	2015	50	10					987	996		10.1007/s11745-015-4054-4		10	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	CR7VW	WOS:000361560900007		
J	Liu, YH; Yang, HJ; Takazawa, E; Satish-Kumar, M; You, CF				Liu, Yung-Hsin; Yang, Huai-Jen; Takazawa, Eiichi; Satish-Kumar, Madhusoodhan; You, Chen-Feng			Decoupling of the Lu-Hf, Sm-Nd, and Rb-Sr isotope systems in eclogites and a garnetite from the Sulu ultra-high pressure metamorphic terrane: Causes and implications	LITHOS			English	Article						Hf isotope; Nd isotope; UHP metamorphism; Sulu; Eclogite; Protolith	ZIRCON U-PB; COESITE-BEARING ECLOGITES; SUBDUCTED CONTINENTAL-CRUST; CENTRAL CHINA; EASTERN CHINA; DABIE OROGEN; TRACE-ELEMENT; SOUTH CHINA; TECTONIC IMPLICATIONS; LITHOSPHERIC MANTLE	The whole-rock Hf, Sr and Nd isotope data of five high-Fe-Ti eclogites, nine high-Al edogites, and a garnetite from the Sulu ultrahigh pressure (UHF) metamorphic terrane at eastern China were analyzed to resolve the causes for the decoupling of the Lu-Hf, Sm-Nd, and Rb-Sr isotope systems in these UHP rocks and to infer their protolith characteristics. Seven of the nine high-Al eclogites define an Rb-87/Sr-86-Sr-87/Sr-86 errorchron age of 192 +/- 43 Ma (MSWD = 2.8), which is within the time span of retrograde metamorphism despite the large uncertainty. The high-Fe-Ti eclogites and garnetite, however, have low Rb-87/Sr-86 ratios of <0.031 with scattered Sr-87/Sr-86 ratios of 0.7042-0.7058. Accordingly, it is inferred that the Rb-Sr isotope system in the samples reflects the effects of processes postdating the UHP metamorphism. Despite having different constituent mineral assemblages and whole rock geochemistry, the samples, however, define a Sm-147/Nd-144-Nd-143/Nd-144 errorchron age of 232 +/- 36 Ma (MSWD = 4.6). Although the uncertainty of +/-36 Ma implies incomplete Nd isotope equilibrium among the samples, the large overlap between this errorchron age span and the mineral isochron ages of 245-210 Ma for the UHP metamorphism indicates the control of peak metamorphism on the Sm-Nd isotope system. The incomplete Nd isotope re-equilibration was accompanied by metamorphic modification on the Sm/Nd ratios as indicated by the U-shaped LREE patterns. The initial epsilon(Nd)(780) values of the protolith rocks calculated from the Sm/Nd ratios of the samples deviate from the igneous initial epsilon(Nd)(t)-epsilon(Hf)(t) trend to significantly lower values, consistent with the metamorphic increase in the Sm/Nd ratios. In contrast, the Lu/Hf ratios are generally within the range for basalts and do not vary systematically with the Hf-176/Hf-177 ratios. The protolith epsilon(Hf)(780) values calculated from the Lu/Hf ratios of the samples are nearly identical to the initial epsilon(Hf)(t) values of the -780 Ma magmatic zircon cores from the Yangtze craton, suggesting the dominance of protolith characteristics on the Lu-Hf isotope system, Being controlled by different processes, the Rb-Sr, Sm-Nd, and Lu-Hf isotope systems of the investigated samples are therefore decoupled. The epsilon(Nd)(220)-epsilon(Hf)(220) compositions of the samples deviate from the epsilon(Nd)(t)-epsilon(Hf)(t) trend of intraplate lavas to high epsilon(Hf)(220) at a given epsilon(Nd)(220) and are within the arc lava field. The protolith epsilon(Nd)(780)-epsilon(Hf)(780) compositions calculated from metamorphic initials using igneous Sm/Nd and Lu/Hf ratios show a similar distribution pattern, strengthening the arc affinity of the eclogites. These arc signatures together with the felsic-mafic bimodal geochemical features of the UHF rocks from the Sulu terrane are explained as the characteristics of protoliths generated by backarc rifting. (C) 2015 Elsevier B.V. All rights reserved.	[Liu, Yung-Hsin] Acad Sinica, Inst Earth Sci, Taipei 11529, Taiwan; [Yang, Huai-Jen; You, Chen-Feng] Natl Cheng Kung Univ, Dept Earth Sci, Tainan 70101, Taiwan; [Takazawa, Eiichi; Satish-Kumar, Madhusoodhan] Niigata Univ, Dept Geol, Nishi Ku, Niigata 9502181, Japan	Yang, HJ (reprint author), Natl Cheng Kung Univ, Dept Earth Sci, 1 Univ Rd, Tainan 70101, Taiwan.	hjyang@mail.ncku.edu.tw			NSC [NSC97-2116-M-006-005, NSC98-2116-M-006-0013]	We acknowledge Kuo-Fang Huang and Der-Chuen Lee for Hf isotope analyses and Ying-Jui Hsu for trace element analysis. Discussion with Tzen-Fu Yui, Chuanheng Zhang, and Der-Chuen Lee stimulated our thinking. Two anonymous reviews and editorial efforts of Marco Scambelluri are highly appreciated. This research is supported by the NSC grants NSC97-2116-M-006-005 and NSC98-2116-M-006-0013 to H.-J. Yang.	AMES L, 1993, GEOLOGY, V21, P339, DOI 10.1130/0091-7613(1993)021<0339:TOCOTS>2.3.CO;2; Chen RX, 2007, J METAMORPH GEOL, V25, P873, DOI 10.1111/j.1525-1314.2007.00735.x; Martin C, 2010, CONTRIB MINERAL PETR, V159, P437, DOI 10.1007/s00410-009-0434-1; Petrinovic IA, 2006, J VOLCANOL GEOTH RES, V152, P240, DOI 10.1016/j.jvolgeores.2005.10.008; Xie Z, 2006, CHEM GEOL, V231, P214, DOI 10.1016/j.chemgeo.2006.01.028; Xiao L, 2007, PRECAMBRIAN RES, V154, P221, DOI 10.1016/j.precamres.2006.12.013; Eggins SM, 1997, CHEM GEOL, V134, P311, DOI 10.1016/S0009-2541(96)00100-3; Hoffmann JE, 2011, GEOCHIM COSMOCHIM AC, V75, P6610, DOI 10.1016/j.gca.2011.08.018; Wang YJ, 2005, CHEM GEOL, V220, P165, DOI 10.1016/j.chemgeo.2005.02.020; Banno S, 2000, LITHOS, V52, P97, DOI 10.1016/S0024-4937(99)00086-9; Cheng H, 2008, J METAMORPH GEOL, V26, P741, DOI 10.1111/j.1525-1314.2008.00785.x; Gao J, 2007, GEOCHIM COSMOCHIM AC, V71, P4974, DOI 10.1016/j.gca.2007.07.027; Choi SH, 2006, CHEM GEOL, V232, P134, DOI 10.1016/j.chemgeo.2006.02.014; Kato T, 1997, J METAMORPH GEOL, V15, P169, DOI 10.1111/j.1525-1314.1997.00013.x; Jahn BM, 2003, LITHOS, V70, P243, DOI 10.1016/S0024-4937(03)00101-4; Yang JJ, 2003, LITHOS, V70, P359, DOI 10.1016/S0024-4937(03)00106-3; Barry TL, 2006, EARTH PLANET SC LETT, V252, P223, DOI 10.1016/j.epsl.2006.09.034; Dong YP, 2012, PRECAMBRIAN RES, V196, P247, DOI 10.1016/j.precamres.2011.12.007; Jahn BM, 1999, INT GEOL REV, V41, P859; Jicha BR, 2004, J PETROL, V45, P1845, DOI 10.1093/petrology/egh036; Salters VJM, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000597; Hacker BR, 1998, EARTH PLANET SC LETT, V161, P215, DOI 10.1016/S0012-821X(98)00152-6; Nebel O, 2007, EARTH PLANET SC LETT, V254, P377, DOI 10.1016/j.epsl.2006.11.046; Murphy JB, 2006, GEOLOGY, V34, P325, DOI 10.1130/G22068.1; SALTERS VJM, 1991, EARTH PLANET SC LETT, V104, P364, DOI 10.1016/0012-821X(91)90216-5; ZHANG RY, 1995, J METAMORPH GEOL, V13, P659, DOI 10.1111/j.1525-1314.1995.tb00250.x; Brewer TS, 2004, PRECAMBRIAN RES, V134, P249, DOI 10.1016/j.precamres.2004.06.003; Wang W, 2010, INT J EARTH SCI, V99, P727, DOI 10.1007/s00531-009-0424-6; Zhang RY, 2002, AM MINERAL, V87, P445; Chen RX, 2010, LITHOS, V114, P132, DOI 10.1016/j.lithos.2009.08.006; Zheng YF, 2007, LITHOS, V96, P127, DOI 10.1016/j.lithos.2006.10.003; Zhang JJ, 2009, LITHOS, V110, P305, DOI 10.1016/j.lithos.2009.01.006; Zheng YF, 2002, GEOCHIM COSMOCHIM AC, V66, P625, DOI 10.1016/S0016-7037(01)00801-8; Fan WM, 2004, CHEM GEOL, V209, P27, DOI 10.1016/j.chemgeo.2004.04.020; Pearce JA, 1999, J PETROL, V40, P1579, DOI 10.1093/petrology/40.11.1579; Rowley DB, 1997, EARTH PLANET SC LETT, V151, P191, DOI 10.1016/S0012-821X(97)81848-1; Chen JF, 2007, CONTRIB MINERAL PETR, V153, P251, DOI 10.1007/s00410-006-0145-9; Handley HK, 2007, J PETROL, V48, P1155, DOI 10.1093/petrology/egm013; Carswell DA, 2000, LITHOS, V52, P121, DOI 10.1016/S0024-4937(99)00088-2; Scherer EE, 2000, GEOCHIM COSMOCHIM AC, V64, P3413, DOI 10.1016/S0016-7037(00)00440-3; Weis D, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001473; Ker CM, 2015, GONDWANA RES, V28, P721, DOI 10.1016/j.gr.2014.06.006; Chen RX, 2007, CHEM GEOL, V242, P51, DOI 10.1016/j.chemgeo.2007.03.008; Kessel R, 2005, NATURE, V437, P724, DOI 10.1038/nature03971; Wu RX, 2006, PRECAMBRIAN RES, V146, P179, DOI 10.1016/j.precamres.2006.01.012; John T, 2004, EARTH PLANET SC LETT, V227, P441, DOI 10.1016/j.epsl.2004.09.009; Thompson PME, 2004, LITHOS, V74, P91, DOI 10.1016/j.lithos.2004.01.004; Jourdan F, 2007, J PETROL, V48, P1043, DOI 10.1093/petrology/egm010; BROOKS C, 1972, REV GEOPHYS SPACE GE, V10, P551, DOI 10.1029/RG010i002p00551; Upton BGJ, 2005, CONTRIB MINERAL PETR, V149, P40, DOI 10.1007/s00410-004-0634-7; Griffin WL, 2000, GEOCHIM COSMOCHIM AC, V64, P133, DOI 10.1016/S0016-7037(99)00343-9; Zhou MF, 2002, J GEOL, V110, P611, DOI 10.1086/341762; Becker H, 1999, CHEM GEOL, V160, P291, DOI 10.1016/S0009-2541(99)00104-7; Hergt JM, 2007, CHEM GEOL, V245, P9, DOI 10.1016/j.cheingeo.2007.07.022; Tommasi A, 2001, EARTH PLANET SC LETT, V185, P199, DOI 10.1016/S0012-821X(00)00350-2; Ames L, 1996, TECTONICS, V15, P472, DOI 10.1029/95TC02552; Raith MM, 1999, PRECAMBRIAN RES, V98, P129, DOI 10.1016/S0301-9268(99)00045-5; Xie Z, 2004, CHEM GEOL, V206, P137, DOI 10.1016/j.chemgeo.2004.01.013; WHITE WM, 1984, EARTH PLANET SC LETT, V67, P167, DOI 10.1016/0012-821X(84)90112-2; Zhang ZM, 2006, J METAMORPH GEOL, V24, P727, DOI 10.1111/j.1525-1314.2006.00665.x; SCHERTL HP, 1994, EUR J MINERAL, V6, P995; Zhou MF, 2006, PRECAMBRIAN RES, V144, P19, DOI 10.1016/j.precamres.2005.11.002; MATTAUER M, 1985, NATURE, V317, P496, DOI 10.1038/317496a0; Patchett PJ, 2004, EARTH PLANET SC LETT, V222, P29, DOI 10.1016/j.epsl.2004.02.030; BlichertToft J, 1997, EARTH PLANET SC LETT, V148, P243, DOI 10.1016/S0012-821X(97)00040-X; Liu FL, 2004, INT GEOL REV, V46, P409, DOI 10.2747/0020-6814.46.5.409; Blichert-Toft J, 1999, GEOCHIM COSMOCHIM AC, V63, P3901, DOI 10.1016/S0016-7037(99)00183-0; Thompson RN, 2007, J PETROL, V48, P1119, DOI 10.1093/petrology/egm012; Peate DW, 2003, J PETROL, V44, P279, DOI 10.1093/petrology/44.2.279; VIDAL P, 1991, B SOC GEOL FR, V162, P993; ZINDLER A, 1986, ANNU REV EARTH PL SC, V14, P493, DOI 10.1146/annurev.earth.14.1.493; Schmitz MD, 2004, GEOLOGY, V32, P405, DOI 10.1130/G20241.1; Chavagnac V, 1996, CHEM GEOL, V133, P29, DOI 10.1016/S0009-2541(96)00068-X; Scambelluri M, 2001, LITHOS, V55, P213, DOI 10.1016/S0024-4937(00)00046-3; Hacker BR, 2009, J METAMORPH GEOL, V27, P827, DOI 10.1111/j.1525-1314.2009.00840.x; Xia QX, 2008, CHEM GEOL, V247, P36, DOI 10.1016/j.chemgeo.2007.09.013; Li SG, 2000, GEOCHIM COSMOCHIM AC, V64, P1077, DOI 10.1016/S0016-7037(99)00319-1; Reagan MK, 2008, J PETROL, V49, P441, DOI 10.1093/petrology/egm087; Vervoort JD, 1999, EARTH PLANET SC LETT, V168, P79, DOI 10.1016/S0012-821X(99)00047-3; Schmidt A, 2008, EARTH PLANET SC LETT, V273, P203, DOI 10.1016/j.epsl.2008.06.036; Ernst WG, 1997, P NATL ACAD SCI USA, V94, P9532, DOI 10.1073/pnas.94.18.9532; Zheng YF, 2006, CHEM GEOL, V231, P135, DOI 10.1016/j.chemgeo.2006.01.005; Zhao ZF, 2006, J METAMORPH GEOL, V24, P687, DOI 10.1111/j.1525-1314.2006.00662.x; PATCHETT PJ, 1984, EARTH PLANET SC LETT, V69, P365, DOI 10.1016/0012-821X(84)90195-X; Druschke P, 2006, J GEOL, V114, P627, DOI 10.1086/506162; Woodhead JD, 2001, EARTH PLANET SC LETT, V192, P331, DOI 10.1016/S0012-821X(01)00453-8; Liu YH, 2007, CHEM GEOL, V239, P64, DOI 10.1016/j.chemgeo.2006.12.005; Li SG, 1999, INT GEOL REV, V41, P1114; Zhang RY, 1996, AM MINERAL, V81, P181; Hacker BR, 2006, TECTONICS, V25, DOI 10.1029/2005TC001937; Jahn BM, 2003, EMU NOTES MINERALOGY, V5, P365; Kay S.M., 1994, J GEOPHYS RES, V99, P323; Konig S, 2007, CONTRIB MINERAL PETR, V153, P85, DOI 10.1007/s00410-006-0136-x; LI SG, 1993, CHEM GEOL, V109, P89, DOI 10.1016/0009-2541(93)90063-O; Liu YH, 2010, TERR ATMOS OCEAN SCI, V21, P277, DOI 10.3319/TAO.2009.06.12.01(TT); Ludwig K. R, 2003, SPECIAL PUBLICATION, V4, P74; Munker C., 2001, GEOCHEMISTRY GEOPHYS, V2; OKAY AI, 1993, TECTONICS, V12, P1320, DOI 10.1029/93TC01544; Pamic J, 2000, MINER PETROL, V68, P271, DOI 10.1007/s007100050013; Polat A, 2003, GEOCHIM COSMOCHIM AC, V67, P441, DOI 10.1016/S0016-7037(02)01094-3; Shu Q, 2014, EARTH PLANET SC LETT, V389, P143, DOI 10.1016/j.epsl.2013.12.028; Smith D.C., 1988, ECLOGITES ECLOGITE F, V12, P1; Sun S. S., 1989, GEOL SOC SPEC PUBL, V42, P313, DOI DOI 10.1144/GSL.SP.1989.042.01.19; Zheng YF, 2004, GEOCHIM COSMOCHIM AC, V68, P4145, DOI 10.1016/j.gca.2004.01.007	104	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0024-4937	1872-6143		LITHOS	Lithos	OCT	2015	234						1	14		10.1016/j.ijsolstr.2015.07.013		14	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	CS1WM	WOS:000361859600001		
J	Katoh, S; Ikeda, M; Shimizu, H; Abe, M; Ohue, Y; Mouri, K; Kobashi, Y; Oka, M				Katoh, Shigeki; Ikeda, Masaki; Shimizu, Hiroki; Abe, Masaaki; Ohue, Yoshihiro; Mouri, Keiji; Kobashi, Yoshihiro; Oka, Mikio			Increased Galectin-9 Concentration and Number of CD4+Foxp3high+Cells in Bronchoalveolar Lavage Fluid of Patients with Cryptogenic Organizing Pneumonia	LUNG			English	Article						Galectin-9; Regulatory T cells; Cryptogenic organizing pneumonia; Lung fibrosis; Bronchoalveolar lavage fluid	REGULATORY T-CELLS; IDIOPATHIC PULMONARY-FIBROSIS; LUNG INFLAMMATION; INVOLVEMENT; SUPPRESSES; CD44	Purpose Galectin-9 (Gal-9) is a beta-galactoside-binding protein that exhibits various biological reactions, such as chemoattraction, cell aggregation, and apoptosis. Recent studies demonstrated that Gal-9 has a role as an immunomodulator in excessive immunological reactions by expanded regulatory T cells (Tregs). We examined the role of Gal-9 in the pathogenesis of one of the major idiopathic interstitial pneumonias, cryptogenic organizing pneumonia (COP) as compared with idiopathic pulmonary fibrosis (IPF). Methods Gal-9, transforming growth factor-beta 1, and interleukin (IL)-10 levels in the bronchoalveolar lavage fluid (BALF) of patients with COP and IPF were estimated by enzyme-linked immunosorbent assay. Forkhead box protein 3 (Foxp3) expressing Tregs were evaluated by flow cytometry. The effect of Gal-9 on interactions between human lung fibroblast cells and hyarulonan was assessed in vitro. Results Gal-9 and IL-10 levels in the BALF were significantly higher in patients with COP than in patients with IPF. The number of CD4+Foxp3high+cells was significantly higher in the BALF of patients with COP than in those with IPF. Gal-9 levels significantly correlated with the absolute number of CD4+CD25+Foxp3+cells or CD4+Foxp3high+cells, but not with the absolute number of CD4+CD25+Foxp3-cells, in the BALF of patients with COP. Gal-9 suppressed the CD44-dependent interaction of human lung fibroblast cells with hyarulonan in a dose-dependent manner. Conclusions Our findings suggest that increased Gal-9 levels in the lung have a protective role against lung inflammation and fibrosis in patients with COP through the induction of Tregs in the lung and CD44-dependent inhibitory effects on lung fibroblast cells.	[Katoh, Shigeki; Ikeda, Masaki; Shimizu, Hiroki; Abe, Masaaki; Ohue, Yoshihiro; Mouri, Keiji; Kobashi, Yoshihiro; Oka, Mikio] Kawasaki Med Univ, Dept Resp Med, Kurashiki, Okayama 7010192, Japan	Katoh, S (reprint author), Kawasaki Med Univ, Dept Resp Med, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	kshigeki@med.kawasaki-m.ac.jp					American Thoracic Society/European Respiratory Society, 2002, AM J RESP CRIT CARE, V165, P277; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Arikawa T, 2010, EUR J IMMUNOL, V40, P548, DOI 10.1002/eji.200939886; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Wada J, 1997, J BIOL CHEM, V272, P6078; Idali F, 2008, CLIN EXP IMMUNOL, V152, P127, DOI 10.1111/j.1365-2249.2008.03609.x; Takahashi K, 1999, INT J CANCER, V80, P387, DOI 10.1002/(SICI)1097-0215(19990129)80:3<387::AID-IJC9>3.0.CO;2-T; Katoh S, 2007, AM J RESP CRIT CARE, V176, P27, DOI 10.1164/rccm.200608-1243OC; Wu C, 2014, IMMUNITY, V41, P270, DOI 10.1016/j.immuni.2014.06.011; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Katoh S, 2010, INT ARCH ALLERGY IMM, V153, P294, DOI 10.1159/000314371; Hou J, 2013, THORAX, V68, P1131, DOI 10.1136/thoraxjnl-2012-201956; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Katoh S, 2012, INT ARCH ALLERGY IMM, V158, P58, DOI 10.1159/000337769; Katoh S, 2014, TOHOKU J EXP MED, V232, P263, DOI 10.1620/tjem.232.263; Kotsianidis I, 2009, AM J RESP CRIT CARE, V179, P1121, DOI 10.1164/rccm.200812-1936OC; Matsumoto N, 2013, LUNG, V191, P191, DOI 10.1007/s00408-012-9446-0; Paust S, 2005, IMMUNOL REV, V204, P195, DOI 10.1111/j.0105-2896.2005.00247.x; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Hirashima Mitsuomi, 2004, Glycoconjugate Journal, V19, P593; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2040	1432-1750		LUNG	Lung	OCT	2015	193	5					683	689		10.1007/s00408-015-9775-x		7	Respiratory System	Respiratory System	CS1JR	WOS:000361820800008		
J	Noguchi, S; Eitoku, M; Moriya, S; Kondo, S; Kiyosawa, H; Watanabe, T; Suganuma, N				Noguchi, Shuhei; Eitoku, Masamitsu; Moriya, Shigeharu; Kondo, Shinji; Kiyosawa, Hidenori; Watanabe, Takashi; Suganuma, Narufumi			Regulation of Gene Expression by Sodium Valproate in Epithelial-to-Mesenchymal Transition	LUNG			English	Article						Pulmonary fibrosis; Non-small cell lung cancer; Histone modification; Epithelial-to-mesenchymal transition; Sodium valproate; RNA-Seq	CELL LUNG-CANCER; IDIOPATHIC PULMONARY-FIBROSIS; HISTONE DEACETYLASE INHIBITION; A549 CELLS; FIBROBLASTS; TGF-BETA-1; DIFFERENTIATION; MIGRATION; MICE; EMT	Purpose Epithelial-to-mesenchymal transition (EMT) is an important mechanism in cancer metastasis and pulmonary fibrosis. Previous studies demonstrated effect of histone H3 and H4 acetylation in cancer and pulmonary fibrosis, so we hypothesized that histone modification might play a crucial role in gene regulation during EMT. In this study, we investigated the mechanism behind EMT by analyzing comprehensive gene expression and the effect of sodium valproate (VPA), a class I histone deacetylase inhibitory drug, on histone modification. Methods EMT was induced in human alveolar epithelial cells (A549) using 5 ng/mL of transforming growth factor (TGF)-beta 1. Various concentrations of VPA were then administered, and Western blotting was used to analyze histone acetylation or methylation. Comprehensive gene expression analysis was carried out by RNA sequencing, and chromatin immunoprecipitation was performed with an anti-acetyl histone H3 lysine 27 antibody. Results TGF-beta 1 stimulation led to a decrease in histone acetylation, especially that of histone H3K27, and H3K27ac localization was decreased at particular gene loci. This decrease was recovered by VPA treatment, which also up-regulated the mRNA expression of genes down-regulated by TGF-beta 1, and correlated with the localization of H3K27ac. However, genes up-regulated by TGF-beta 1 stimulation were not suppressed by VPA, with the exception of COL1A1. Conclusions Histone acetylation was down-regulated by TGF-beta 1 stimulation in A549 cells. VPA partially inhibited EMT and the decrease of histone acetylation, which plays an important role in the progression of EMT.	[Noguchi, Shuhei; Eitoku, Masamitsu; Kiyosawa, Hidenori; Suganuma, Narufumi] Kochi Univ, Kochi Med Sch, Dept Environm Med, Nankoku, Kochi 7838505, Japan; [Moriya, Shigeharu] RIKEN, Ctr Sustainable Resource Sci, Biomass Engn Program Cooperat Div, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Kondo, Shinji] Natl Inst Polar Res, Res Integrat Ctr, Res Org Informat & Syst, Tachikawa, Tokyo 1908518, Japan; [Watanabe, Takashi] Kochi Univ Technol, Org Reg Alliances, Kochi 7828502, Japan; [Watanabe, Takashi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Sch Pharm, Chuo Ku, Kumamoto 8620973, Japan	Suganuma, N (reprint author), Kochi Univ, Kochi Med Sch, Dept Environm Med, Oko Cho Kohasu, Nankoku, Kochi 7838505, Japan.	nsuganuma@kochi-u.ac.jp			Head of the Medical Sciences Cluster; JSPS KAKENHI [25242013]	This work was supported by a discretionary Grant from the Head of the Medical Sciences Cluster and the Dean of the Medical School at Kochi Medical School, and JSPS KAKENHI Grant Number 25242013. The authors thank Dr. Masahide Seki and Dr. Yutaka Suzuki for technical advice on ChIP assay.	Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot2006.98; Katayama M, 2010, INTENS CARE MED, V36, P479, DOI 10.1007/s00134-009-1719-6; Kolosionek E, 2009, MOL BIOL CELL, V20, P4751, DOI 10.1091/mbc.E09-01-0019; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; KOTANI I, 1995, THROMB RES, V77, P493, DOI 10.1016/0049-3848(95)00025-9; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Lappi-Blanco E, 2004, AM J RESP CRIT CARE, V169, P27, DOI 10.1164/rccm.200210-1234OC; Ho CS, 2014, LUNG CANCER, V83, P154, DOI 10.1016/j.lungcan.2013.11.024; Guo WC, 2009, AM J PHYSIOL-LUNG C, V297, pL864, DOI 10.1152/ajplung.00128.2009; Abulaiti A, 2013, LUNG CANCER, V82, P204, DOI 10.1016/j.lungcan.2013.08.008; Sanders YY, 2011, AM J RESP CELL MOL, V45, P16, DOI 10.1165/rcmb.2010-0154OC; Barbetti V, 2013, EPIGENETICS-US, V8, P210, DOI 10.4161/epi.23538; Rho JK, 2009, LUNG CANCER, V63, P219, DOI 10.1016/j.lungcan.2008.05.017; Sides MD, 2011, AM J RESP CELL MOL, V44, P852, DOI 10.1165/rcmb.2009-0232OC; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; MacKinnon AC, 2012, AM J RESP CRIT CARE, V185, P537, DOI 10.1164/rccm.201106-0965OC; Chilosi M, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-95; Warburton D, 2013, AM J PHYSIOL-LUNG C, V304, pL83, DOI 10.1152/ajplung.00258.2012; Zhang XY, 2013, INT J MOL SCI, V14, P19605, DOI 10.3390/ijms141019605; Marudamuthu AS, 2015, J BIOL CHEM, V290, P9428, DOI 10.1074/jbc.M114.601815; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Obacz J, 2015, EUR J CELL BIOL, V94, P139, DOI 10.1016/j.ejcb.2015.01.002; Saika S, 2006, AM J PHYSIOL-CELL PH, V290, pC282, DOI 10.1152/ajpcell.00306.2005; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Yoshikawa M, 2007, J AM SOC NEPHROL, V18, P58, DOI 10.1681/ASN.2005111187; Hisatomi K, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-24; Huang SK, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.146; Kallsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050000; Keating DT, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-114; Liu FT, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-66; Liu J, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.37; Maitah MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016068; Mizuuchi Y., 2014, LAB INVEST, V95, P193, DOI [10.1038/labinvest.2014.138, DOI 10.1038/LABINVEST.2014.138]; Peng RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059348; Saito A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056587; Suzuki A, 2014, NUCLEIC ACIDS RES, V42, P13557, DOI 10.1093/nar/gku885; Tischler V, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-127; Wu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046393; Xi Y, 2014, AM J RESP CELL MOL, V50, P51, DOI 10.1165/rcmb.2013-0099OC; Yang HP, 2015, LUNG CANCER, V87, P249, DOI 10.1016/j.lungcan.2014.12.015; Yang JB, 2015, AM J PATHOL, V185, P1001, DOI 10.1016/j.ajpath.2014.12.008; Ye Q, 2014, SARCOIDOSIS VASC DIF, V31, P219; Zhang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064954; Zhang Y., 2011, P INT EL MACH SYST I, P1, DOI DOI 10.1109/NAPS.2011.6025169	45	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2040	1432-1750		LUNG	Lung	OCT	2015	193	5					691	700		10.1007/s00408-015-9776-9		10	Respiratory System	Respiratory System	CS1JR	WOS:000361820800009		
J	Kawada, T				Kawada, Tomoyuki			Sleep Apnea, Depression, and Sleep Problems: Inter-relationship in Patients with Severe Obstructive Sleep Apnea	LUNG			English	Letter									Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, Tokyo 1138602, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	kawada@nms.ac.jp					Yalamanchali S, 2013, JAMA OTOLARYNGOL, V139, P1343, DOI 10.1001/jamaoto.2013.5338; Heinzer R, 2015, LANCET RESP MED, V3, P310, DOI 10.1016/S2213-2600(15)00043-0; Lee W, 2015, LUNG, V193, P261, DOI 10.1007/s00408-015-9687-9	3	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2040	1432-1750		LUNG	Lung	OCT	2015	193	5					865	865		10.1007/s00408-015-9771-1		1	Respiratory System	Respiratory System	CS1JR	WOS:000361820800035		
J	Kudo, Y; Matsubayashi, J; Saji, H; Akata, S; Shimada, Y; Kato, Y; Kakihana, M; Kajiwara, N; Ohira, T; Nagao, T; Ikeda, N				Kudo, Yujin; Matsubayashi, Jun; Saji, Hisashi; Akata, Soichi; Shimada, Yoshihisa; Kato, Yasufumi; Kakihana, Masatoshi; Kajiwara, Naohiro; Ohira, Tatsuo; Nagao, Toshitaka; Ikeda, Norihiko			Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients	LUNG CANCER			English	Article						IASLC/ATS/ERS classification; Adenocarcinoma; GGO; Noninvasive adenocarcinoma; Minimally invasive adenocarcinoma; Invasive adenocarcinoma	GROUND-GLASS OPACITY; VISCERAL PLEURAL INVASION; THIN-SECTION CT; INTERNATIONAL-ASSOCIATION; PROGNOSTIC-SIGNIFICANCE; SUBLOBAR RESECTION; DISEASE RECURRENCE; FLEISCHNER-SOCIETY; PULMONARY NODULES; VESSEL INVASION	Objectives: The detection rate of small pulmonary nodules has recently increased and new techniques have been developed to improve diagnostic yield. The IASLC/ATS/ERS classification demonstrated a difference in prognosis depending on the histological subtypes of lung adenocarcinoma. We evaluated the association between high-resolution computed tomography (HRCT) findings and the classification of these tumors. Methods: We reviewed the data of 220 lung adenocarcinoma (<= 3 cm) patients who received complete resection with lymph node dissection in our hospital. From the HRCT findings, the tumors were classified into the following 3 categories: pure-solid nodules, part-solid nodules, or pure ground-glass opacity (GGO) nodules. Pathological invasion factor (PIF) was evaluated by the degree of blood vessel invasion, lymphatic permeation, and visceral pleural invasion. Results: The tumors were classified as pure GGO nodules in 16 patients, part-solid nodules in 91, and pure-solid nodules in 113 from the HRCT findings. Tumors were diagnosed as noninvasive or minimally invasive adenocarcinomas (NMIADs) in 44 patients, and invasive adenocarcinomas (IADs) in 176. Lymph node metastasis was present in 31 patients (14.1%) and PIF in 101 (45.9%). All pure-solid nodules were IADs with a high PIF frequency (75.2%) or with lymph node metastasis (26.5%). All pure GGO nodules were NMIADs or lepidic-predominant adenocarcinomas. Among the part-solid nodules, IAD was detected in 67.0% of the patients and PIF in 16.5%. The consolidation/tumor (C/T) ratio and consolidation size were associated with IAD (optimal cut-off values: 0.4 and 8 mm, respectively) and PIF (0.8 and 15 mm, respectively). Conclusions: The HRCT findings correlated with the IASLC/ATS/ERS classification and were useful for evaluating the histological nature of the tumors. Most pure-solid tumors had the potential for high-grade malignancy, including PIF and lymph node metastasis. For part-solid tumors, the C/T ratio and consolidation size were important for predicting PIF and for diagnosing LAD according to this classification. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Kudo, Yujin; Saji, Hisashi; Shimada, Yoshihisa; Kato, Yasufumi; Kakihana, Masatoshi; Kajiwara, Naohiro; Ohira, Tatsuo; Ikeda, Norihiko] Tokyo Med Univ, Dept Thorac Surg, Tokyo 1600023, Japan; [Matsubayashi, Jun; Nagao, Toshitaka] Tokyo Med Univ, Dept Anat Pathol, Tokyo 1600023, Japan; [Saji, Hisashi] St Marianna Univ, Sch Med, Dept Chest Surg, Tokyo, Japan; [Akata, Soichi] Tokyo Med Univ, Dept Radiol, Tokyo 1600023, Japan	Kudo, Y (reprint author), Tokyo Med Univ, Dept Thorac Surg, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	yjnkudo@gmail.com			Japan Society for the Promotion of Science (JSPS KAKENHI) [26861129]	This study was supported by a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (JSPS KAKENHI Grant Number 26861129) to Y.K.	Kurimoto N, 2004, CHEST, V126, P959, DOI 10.1378/chest.126.3.959; Ohde Y, 2003, LUNG CANCER-J IASLC, V42, P303, DOI 10.1016/j.tungcan.2003.07.001; Suzuki K, 2011, J THORAC ONCOL, V6, P751, DOI 10.1097/JTO.0b013e31821038ab; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Kudo Y, 2013, LUNG CANCER, V81, P187, DOI 10.1016/j.lungcan.2013.04.016; Matsumura Y, 2014, J THORAC ONCOL, V9, P337, DOI 10.1097/JTO.0000000000000073; Naito Y, 2010, CHEST, V138, P1411, DOI 10.1378/chest.10-0185; Sica G, 2010, AM J SURG PATHOL, V34, P1155, DOI 10.1097/PAS.0b013e3181e4ee32; Aoki T, 2001, RADIOLOGY, V220, P803, DOI 10.1148/radiol.2203001701; Ikeda N, 2004, ANN THORAC SURG, V78, P1011, DOI 10.1016/j.athorascur.2004.03.048; Tsutani Y, 2012, J THORAC CARDIOV SUR, V143, P607, DOI 10.1016/j.jtcvs.2011.10.037; Harada M, 2011, J THORAC ONCOL, V6, P48, DOI 10.1097/JTO.0b013e3181f8a1f1; Travis WD, 2013, J CLIN ONCOL, V31, P992, DOI 10.1200/JCO.2012.46.9270; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Godoy MCB, 2009, RADIOLOGY, V253, P606, DOI 10.1148/radiol.2533090179; Neri S, 2014, ANN SURG, V260, P383, DOI 10.1097/SLA.0000000000000617; Russell PA, 2011, J THORAC ONCOL, V6, P1496, DOI 10.1097/JTO.0b013e318221f701; Suzuki K, 2002, ANN THORAC SURG, V74, P1635, DOI 10.1016/S0003-4975(02)03895-X; Lederlin M, 2013, EUR RESPIR J, V41, P943, DOI 10.1183/09031936.00056612; Kudo Y, 2012, LUNG CANCER, V78, P153, DOI 10.1016/j.lungcan.2012.08.004; NOGUCHI M, 1995, CANCER, V75, P2844, DOI 10.1002/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#; Tsutani Y, 2013, J THORAC CARDIOV SUR, V146, P17, DOI 10.1016/j.jtcvs.2012.11.019; Shimizu K, 2005, J THORAC CARDIOV SUR, V130, P160, DOI 10.1016/j.jtcvs.2004.11.021; Hishida T, 2013, EUR J CARDIO-THORAC, V43, P772, DOI 10.1093/ejcts/ezs396; Yoshizawa A, 2013, J THORAC ONCOL, V8, P52, DOI 10.1097/JTO.0b013e3182769aa8; Goldstraw P, 2009, J THORAC ONCOL, V4, P671, DOI 10.1097/JTO.0b013e31819e7814; Yoshizawa A, 2011, MODERN PATHOL, V24, P653, DOI 10.1038/modpathol.2010.232; Okada M, 2006, J THORAC CARDIOV SUR, V132, P769, DOI 10.1016/j.jtcvs.2006.02.063; Shimada Y, 2012, CHEST, V141, P1003, DOI 10.1378/chest.11-0017; Yanagawa N, 2013, J THORAC ONCOL, V8, P612, DOI 10.1097/JTO.0b013e318287c3eb; Jang HJ, 1996, RADIOLOGY, V199, P485; Warth A, 2012, J CLIN ONCOL, V30, P1438, DOI 10.1200/JCO.2011.37.2185; Hashizume T, 2008, CHEST, V133, P441, DOI 10.1378/chest.07-1533; Asano F, 2006, CHEST, V130, P559, DOI 10.1378/chest.130.2.559; Hattori A, 2012, ANN THORAC SURG, V94, P212, DOI 10.1016/j.athoracsur.2012.03.033; Austin J.H., 2011, RADIOLOGY, V266, P62; Eguchi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097867; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Masuda M., 2012, GEN THORAC CARDIOVAS, V62, P734; Saji H., 2014, ACTA RADIOL; Travis W, 2004, PATHOLOGY GENETICS T; Tsutani Y, 2014, CHEST, V145, P66, DOI 10.1378/chest.13-1094	43	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	OCT	2015	90	1					47	54		10.1016/j.lungcan.2015.07.007		8	Oncology; Respiratory System	Oncology; Respiratory System	CR8BI	WOS:000361575700007		
J	Yoshimura, N; Kudoh, S; Mitsuoka, S; Yoshimoto, N; Oka, T; Nakai, T; Suzumira, T; Matusura, K; Tochino, Y; Asai, K; Kimura, T; Kawaguchi, T; Hirata, K				Yoshimura, Naruo; Kudoh, Shinzoh; Mitsuoka, Shigeki; Yoshimoto, Naoki; Oka, Takako; Nakai, Toshiyuki; Suzumira, Tomohiro; Matusura, Kuniomi; Tochino, Yoshihiro; Asai, Kazuhisa; Kimura, Tatsuo; Kawaguchi, Tomoya; Hirata, Kazuto			Phase II study of a combination regimen of gefitinib and pemetrexed as first-line treatment in patients with advanced non-small cell lung cancer harboring a sensitive EGFR mutation	LUNG CANCER			English	Article						Non-small cell lung cancer; Epidermal growth factor receptor; Gefitinib; Pemetrexed; Phase II study; First-line treatment	OPEN-LABEL; ERLOTINIB; CHEMOTHERAPY; TRIAL; CISPLATIN; GEMCITABINE; MULTICENTER; GUIDELINE; AFATINIB	Purpose: Patients with advanced non-small cell lung cancer (NSCLC) harboring a sensitive epidermal growth factor receptor (EGFR) mutation have been shown to exhibit a marked response to EGFR-tyrosine kinase inhibitor (TKI) treatment. Pemetrexed and gefitinib were reported to have a schedule-dependent cytotoxic synergism. We evaluated the efficacy and safety of a combination regimen of gefitinib and pemetrexed as first-line chemotherapy in EGFR-mutated NSCLC patients. Patients and methods: Systemic therapy-naive patients with advanced non-squamous NSCLC harboring a sensitive EGFR mutation were included in this study. Pemetrexed was administered on day 1 at a dose of 500 mg/m(2), and gefitinib was sequentially administered on days 2-16. This treatment regimen was repeated every 3 weeks until disease progression. Results: Twenty-six patients were enrolled in this study. The median number of treatment cycles was 16 (range, 1-35). The overall response rate (ORR) was 84.6% (95% confidence interval [CI], 70.7-98.5%), and the disease control rate (DCR) was 96.2% (95% CI, 88.9-100%). Grade 3/4 hematological toxicities included neutropenia (15.4%), leukopenia (7.7%), and anemia (3.8%). No grade 4 non-hematological toxicities were observed. The main grade 3 non-hematological toxicities were infection (11.5%), increased alanine aminotransferase (11.5%) and aspartate aminotransferase (7.7%) levels, fatigue (3.8%), diarrhea (3.8%), and pneumonitis (3.8%). We observed a median progression-free survival (PFS) of 18.0 months (95% CI, 15.0-21.0 months) and a median survival time (MST) of 32.0 months (95% CI, 28.5-35.5 months). There were no treatment-related deaths. Conclusions: The combination regimen used in this study showed a high ORR, long median PFS, and acceptable toxicity. A future randomized trial on pemetrexed plus gefitinib compared with gefitinib alone is warranted. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Yoshimura, Naruo; Kudoh, Shinzoh; Mitsuoka, Shigeki; Suzumira, Tomohiro; Kawaguchi, Tomoya] Osaka City Univ, Grad Sch Med, Dept Clin Oncol, Abeno Ku, Osaka 5458585, Japan; [Yoshimura, Naruo; Mitsuoka, Shigeki; Yoshimoto, Naoki; Oka, Takako; Nakai, Toshiyuki; Suzumira, Tomohiro; Matusura, Kuniomi; Tochino, Yoshihiro; Asai, Kazuhisa; Kimura, Tatsuo; Kawaguchi, Tomoya; Hirata, Kazuto] Osaka City Univ, Grad Sch Med, Dept Resp Med, Abeno Ku, Osaka 5458585, Japan; [Tochino, Yoshihiro] Osaka City Univ, Grad Sch Med, Dept Med Educ & Gen Practice, Abeno Ku, Osaka 5458585, Japan; [Kimura, Tatsuo] Osaka City Univ, Grad Sch Med, Dept Premier Prevent Med, Abeno Ku, Osaka 5458585, Japan	Yoshimura, N (reprint author), Osaka City Univ, Grad Sch Med, Dept Clin Oncol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	y-naruo@sc4.so-net.ne.jp					Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Sugawara S, 2015, ANN ONCOL, V26, P888, DOI 10.1093/annonc/mdv063; Chen CY, 2011, LUNG CANCER, V74, P132, DOI 10.1016/j.lungcan.2011.01.024; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Gatzemeier U, 2007, J CLIN ONCOL, V25, P1545, DOI 10.1200/JCO.2005.05.1474; Okabe T, 2008, MOL CANCER THER, V7, P599, DOI 10.1158/1535-7163.MCT-07-0567; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Wu YL, 2013, LANCET ONCOL, V14, P777, DOI 10.1016/S1470-2045(13)70254-7; Paz-Ares L, 2010, J CELL MOL MED, V14, P51, DOI 10.1111/j.1582-4934.2009.00991.x; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Li TH, 2007, CLIN CANCER RES, V13, P3413, DOI 10.1158/1078-0432.CCR-06-2923; Davies AM, 2009, J THORAC ONCOL, V4, P862, DOI 10.1097/JTO.0b013e3181a94b08; Inoue A, 2014, J CLIN ONCOL S, V32, p5s; Kanda S, 2013, J CLIN ONCOL S, V31; Lee CK, 2015, J CLIN ONCOL; Mok TS, 2014, ANN ONCOL, V25, pv1; Puri T, 2013, J THORAC ONCOL S2, V8; SIMON R, 1989, CONTROL CLIN TRIALS, V10, P1, DOI 10.1016/0197-2456(89)90015-9; Takeda M, 2015, LUNG CANCER, V88, P74, DOI 10.1016/j.lungcan.2015.01.026; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1	26	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	OCT	2015	90	1					65	70		10.1016/j.lungcan.2015.06.002		6	Oncology; Respiratory System	Oncology; Respiratory System	CR8BI	WOS:000361575700010		
J	Narita, Y; Matsushima, Y; Shiroiwa, T; Chiba, K; Nakanishi, Y; Kurokawa, T; Urushihara, H				Narita, Yusuke; Matsushima, Yukiko; Shiroiwa, Takeru; Chiba, Koji; Nakanishi, Yoichi; Kurokawa, Tatsuo; Urushihara, Hisashi			Cost-effectiveness analysis of EGFR mutation testing and gefitinib as first-line therapy for non-small cell lung cancer	LUNG CANCER			English	Article						Pharmacoeconomics; Cost-effectiveness analysis; Non-small cell lung cancer; Gefitinib; Individualized medicine	PHASE-III; OPEN-LABEL; CHEMOTHERAPY; ADENOCARCINOMA; GEMCITABINE	Objectives: The combination use of gefitinib and epidermal growth factor receptor (EGFR) testing is a standard first-line therapy for patients with non-small cell lung cancer (NSCLC). Here, we examined the cost-effectiveness of this approach in Japan. Materials and methods: Our analysis compared the 'EGFR testing strategy', in which EGFR mutation testing was performed before treatment and patients with EGFR mutations received gefitinib while those without mutations received standard chemotherapy, to the 'no-testing strategy,' in which genetic testing was not conducted and all patients were treated with standard chemotherapy. A three-state Markov model was constructed to predict expected costs and outcomes for each strategy. We included only direct medical costs from the healthcare payer's perspective. Outcomes in the model were based on those reported in the Iressa Pan-Asia Study (IPASS). The incremental cost-effectiveness ratio (ICER) was calculated using quality-adjusted life-years (QALYs) gained. Sensitivity and scenario analyses were conducted. Results: The incremental cost and effectiveness per patient of the 'EGFR testing strategy' compared to the 'no-testing strategy' was estimated to be approximately JPY122,000 (US$1180; US$1 = JPY104 as of February 2014) and 0.036 QALYs. The ICER was then calculated to be around JPY3.38 million (US$32,500) per QALY gained. These results suggest that the 'EGFR testing strategy' is cost-effective compared with the 'no-testing strategy' when JPY5.0 million to 6.0 million per QALY gained is considered an acceptable threshold. These results were supported by the sensitivity and scenario analyses. Conclusion: The combination use of gefitinib and EGFR testing can be considered a cost-effective first-line therapy compared to chemotherapy such as carboplatin paclitaxel for the treatment for NSCLC in Japan. (C) 2015 The Authors. Published by Elsevier Ireland Ltd.	[Narita, Yusuke; Matsushima, Yukiko; Kurokawa, Tatsuo; Urushihara, Hisashi] Keio Univ, Fac Pharm, Dept Drug Dev & Regulatory Sci, Tokyo 1058512, Japan; [Shiroiwa, Takeru] Natl Inst Publ Hlth, Dept Hlth & Welf Serv, Saitama, Japan; [Chiba, Koji] Yokohama Univ Pharm, Lab Clin Pharmacol, Yokohama, Kanagawa, Japan; [Nakanishi, Yoichi] Kyushu Univ, Fac Med Sci, Dept Clin Med, Chest Dis Res Inst, Fukuoka 812, Japan	Urushihara, H (reprint author), Keio Univ, Fac Pharm, Dept Drug Dev & Regulatory Sci, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.	urushihara-hs@pha.keio.ac.jp			Eli Lilly Japan K.K.; Eisai Co., Ltd.	Hisashi Urushihara is a paid consultant of Eli Lilly Japan K.K. and Eisai Co., Ltd.: this does not affect the study planning, data analysis, interpretation of data and decision to publish. Other authors have no conflicts of interest to declare.	Goffin J, 2010, J THORAC ONCOL, V5, P260, DOI 10.1097/JTO.0b013e3181c6f035; Ku GY, 2011, LUNG CANCER, V74, P469, DOI 10.1016/j.lungcan.2011.04.008; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Brown T, 2010, HEALTH TECHNOL ASSES, V14, P71, DOI 10.3310/hta14suppl2/10; Han JY, 2012, J CLIN ONCOL, V30, P1122, DOI 10.1200/JCO.2011.36.8456; Douillard JY, 2014, BRIT J CANCER, V110, P55, DOI 10.1038/bjc.2013.721; [Anonymous], 2012, NAT HLTH INS DRUG PR; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Shiroiwa T, 2010, HEALTH ECON, V19, P422, DOI 10.1002/hec.1481; D'Addario G, 2010, ANN ONCOL, V21, pv116, DOI 10.1093/annonc/mdq189; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Fallowfield LJ, 2005, LUNG CANCER-J IASLC, V48, P365, DOI 10.1016/j.lungcan.2004.11.018; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Briggs A, 2006, DECISION MODELLING H; Lopes GD, 2012, CANCER-AM CANCER SOC, V118, P1032, DOI 10.1002/cncr.26372; Fathi Amir T, 2008, Semin Thorac Cardiovasc Surg, V20, P210, DOI 10.1053/j.semtcvs.2008.09.002; Ferlay J., 2012, INT J CANCER, V136, pE359, DOI DOI 10.1002/IJC.29210; Horai T., 2013, REGIMENS CHEMOTHERAP; Kamae I., 2014, PORTRAIT HLTH EC, P73; Ministry of Health Labor and Welfare, 2013, REC SPEND PRESCR DRU; Ministry of Health Labour and Welfare, 2014, SUMM MED CAR EXP 201; Mitsudomi Tetsuya, 2006, Int J Clin Oncol, V11, P190, DOI 10.1007/s10147-006-0583-4; Nafees B, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-84; Research group on economic evaluation for Japanese public medical benefits, 2013, GUID EC EV HEALTHC T; Social Insurance Research Laboratory, 2012, REIMB SCHED SOC INS; The Center for Cancer Control and Information Services, 2014, CANC STAT JAP; The Center for Cancer Control and Information Services, 2014, CANC MORT 1958 2013; The Center for Cancer Control and Information Services, 2014, PROJ CANC INC 2014; The Japan Lung Cancer Society, 2014, GUID TREATM LUNG CAN; Urushihara H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053224	34	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	OCT	2015	90	1					71	77		10.1016/j.lungcan.2015.07.006		7	Oncology; Respiratory System	Oncology; Respiratory System	CR8BI	WOS:000361575700011		
J	Yamagishi, T; Fujimoto, N; Nishi, H; Miyamoto, Y; Hara, N; Asano, M; Fuchimoto, Y; Wada, S; Kitamura, K; Ozaki, S; Kishimoto, T				Yamagishi, Tomoko; Fujimoto, Nobukazu; Nishi, Hideyuki; Miyamoto, Yosuke; Hara, Naofumi; Asano, Michiko; Fuchimoto, Yasuko; Wada, Sae; Kitamura, Kenichi; Ozaki, Shinji; Kishimoto, Takumi			Prognostic significance of the lymphocyte-to-monocyte ratio in patients with malignant pleural mesothelioma	LUNG CANCER			English	Article						Asbestos; Lymphocyte-to-monocyte ratio; Malignant pleural mesothelioma; Prognostic score	CANCER; INFLAMMATION; SURVIVAL; MACROPHAGES; CELLS; VALIDATION; CARCINOMA; DIAGNOSIS; SYSTEM	Objectives: Chronic inflammation plays a key role in the pathogenesis of malignant pleural mesothelioma (MPM) as a result of asbestos exposure. Several inflammation-based prognostic scores including the lymphocyte-to-monocyte ratio (LMR), Glasgow Prognostic Score (GPS), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) reportedly predict survival in many malignancies, while the role of LMR in MPM remains unclear. The aim of this study was to evaluate the clinical value of LMR and to compare the prognostic value of these inflammation-based scores in predicting overall survival (OS) in MPM. Materials and methods: One hundred and fifty patients with histologically proven MPM were included in this retrospective study. Kaplan-Meier curves and multivariate Cox-regression analyses were calculated for OS. The area under the receiver operating characteristics curve (AUC) was calculated to compare the discriminatory ability of each scoring system. Results: An elevated LMR was significantly associated with prolonged OS. Patients with LMR <2.74 had significantly poor survival compared with LMR >= 2.74 (median, 5.0 versus 14.0 months; p = 0.000). The LMR consistently had a higher AUC value at 6 months (0.722), 12 months (0.712), and 24 months (0.670), compared with other scores. Multivariate analysis showed that the LMR was independently associated with OS. Conclusions: The LMR is an independent prognostic marker for OS in patients with MPM and is superior to other inflammation-based prognostic scores with respect to prognostic ability. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Yamagishi, Tomoko; Miyamoto, Yosuke; Hara, Naofumi; Asano, Michiko; Fuchimoto, Yasuko; Wada, Sae; Kitamura, Kenichi; Ozaki, Shinji] Okayama Rosai Hosp, Dept Resp Med, Okayama 7028055, Japan; [Fujimoto, Nobukazu] Okayama Rosai Hosp, Dept Med Oncol, Okayama 7028055, Japan; [Nishi, Hideyuki] Okayama Rosai Hosp, Dept Surg, Okayama 7028055, Japan; [Kishimoto, Takumi] Okayama Rosai Hosp, Dept Internal Med, Okayama 7028055, Japan	Fujimoto, N (reprint author), Okayama Rosai Hosp, Dept Med Oncol, 1-10-25 Chikkomidorimachi, Okayama 7028055, Japan.	nobufujimot@gmail.com			Japan Labour Health and Welfare Organization	This study is supported by "the research and development and the dissemination projects related to the 9 fields of occupational injuries and illnesses" of the Japan Labour Health and Welfare Organization.	Stotz M, 2014, BRIT J CANCER, V110, P435, DOI 10.1038/bjc.2013.785; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; RABINOWICH H, 1987, CANCER RES, V47, P173; McMillan DC, 2013, CANCER TREAT REV, V39, P534, DOI 10.1016/j.ctrv.2012.08.003; Burt BM, 2011, CANCER-AM CANCER SOC, V117, P5234, DOI 10.1002/cncr.26143; Fogar P, 2006, PANCREAS, V32, P22, DOI 10.1097/01.mpa.0000188305.90290.50; Kinoshita A, 2012, BRIT J CANCER, V107, P988, DOI 10.1038/bjc.2012.354; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Mossman BT, 1998, AM J RESP CRIT CARE, V157, P1666; Kao SCH, 2010, CLIN CANCER RES, V16, P5805, DOI 10.1158/1078-0432.CCR-10-2245; Lameijer MA, 2013, EXPERT REV MOL DIAGN, V13, P567, DOI 10.1586/14737159.2013.819216; Bugada D, 2014, BIOMED RES INT, DOI 10.1155/2014/142425; Edwards JG, 2000, THORAX, V55, P731, DOI 10.1136/thorax.55.9.731; Pinato DJ, 2012, J THORAC ONCOL, V7, P587, DOI 10.1097/JTO.0b013e31823f45c1; Lievense LA, 2013, LUNG CANCER, V80, P256, DOI 10.1016/j.lungcan.2013.02.017; Porrata LF, 2012, HAEMATOL-HEMATOL J, V97, P262, DOI 10.3324/haematol.2011.050138; Cao C, 2014, LUNG CANCER, V83, P240, DOI 10.1016/j.lungcan.2013.11.026; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Fennell DA, 2005, J CLIN ONCOL, V23, P184, DOI 10.1200/JCO.2005.07.050; Herndon JE, 1998, CHEST, V113, P723, DOI 10.1378/chest.113.3.723; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Bograd AJ, 2011, CANCER IMMUNOL IMMUN, V60, P1509, DOI 10.1007/s00262-011-1103-6; Proctor MJ, 2011, BRIT J CANCER, V104, P726, DOI 10.1038/sj.bjc.6606087; Gemba K, 2012, CANCER SCI, V103, P483, DOI 10.1111/j.1349-7006.2011.02165.x; Cao Christopher, 2012, Ann Cardiothorac Surg, V1, P428, DOI 10.3978/j.issn.2225-319X.2012.11.07; Coussens L.M., 2002, NATURE, V420, P806; Feng JF, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-58; Fujiwara Y., 2014, ANTICANCER RES, V34, P5133; Hu PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108062; Li JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054839; Li ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041658; Lin GN, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0070-0; Linton Anthony, 2012, Ann Cardiothorac Surg, V1, P516, DOI 10.3978/j.issn.2225-319X.2012.10.02; Ni XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111886; Porrata L. F., 2013, BONE MARROW RES; AISNER J, 1995, CHEST, V108, P1122; Temraz S, 2014, BMC UROL, V4, P76, DOI DOI 10.1186/1471-2490-14-76]	37	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	OCT	2015	90	1					111	117		10.1016/j.lungcan.2015.07.014		7	Oncology; Respiratory System	Oncology; Respiratory System	CR8BI	WOS:000361575700017		
J	Akomo-Okoue, EF; Inoue, E; Atteke, C; Nakashima, Y; Hongo, S; Inoue-Murayama, M; Yamagiwa, J				Akomo-Okoue, Etienne Francois; Inoue, Eiji; Atteke, Christiane; Nakashima, Yoshihiro; Hongo, Shun; Inoue-Murayama, Miho; Yamagiwa, Juichi			Noninvasive genetic analysis for assessing the abundance of duiker species among habitats in the tropical forest of Moukalaba, Gabon	MAMMAL RESEARCH			English	Article						Duiker; Dung count method; Genetic species identification; Distribution pattern; Tropical forest; Human impact	NATIONAL-PARK; UDZUNGWA MOUNTAINS; RAIN-FOREST; LONG-TERM; LOGGING CONCESSIONS; NORTHERN CONGO; DUNG DECAY; BUSHMEAT; WILDLIFE; MAMMALS	We investigated the relative abundance of four duiker species and the environmental effect including human impacts on their abundance in the forest of Moukalaba, Gabon. We counted and collected fresh faeces from duikers in thirteen 2-km line transects established in different types of vegetation. Genetic species identification showed that blue duiker (Philantomba monticola), Ogilby's duiker (Cephalophus ogilbyi, which might include the sister species Peter's duiker Cephalophus callipygus), bay duiker (Cephalophus dorsalis), and yellow-backed duiker (Cephalophus silvicultor) coexisted. Genetic analyses successfully identified Ogilby's and bay duiker, which are difficult to discriminate using other methods. The blue, Ogilby's, and yellow-backed duikers were found in all transects. The dung abundance of bay duiker was quite low compared to other duiker species. This result suggests the importance of accumulating information regarding the abundance of each duiker species for updating their conservation status. The dung count method with genetic species identification may be useful for this purpose. The dung abundance of Ogilby's duikers and blue duikers was affected by human impacts, while that of yellow-backed duikers was not affected by human impacts. The dung abundance of Ogilby's duikers was lower in young secondary forests, which are regenerating after significant human disturbance. In contrast, generalized liner mixed model showed that the dung abundance of blue duikers was not affected by vegetation type and was lower in transects nearer to the villages, which might be due to past hunting activity. The difference in human impacts among duiker species should be considered for their conservation management.	[Akomo-Okoue, Etienne Francois; Inoue, Eiji; Hongo, Shun; Yamagiwa, Juichi] Kyoto Univ, Grad Sch Sci, Kyoto 6068502, Japan; [Akomo-Okoue, Etienne Francois] Inst Rech Ecol Trop IRET CENAREST, Libreville, BP, Gabon; [Atteke, Christiane] Univ Sci & Tech Masuku, Dept Biol, Franceville 498, BP, Gabon; [Nakashima, Yoshihiro] Nihon Univ, Coll Bioresource Sci, Fujisawa, Kanagawa 2520880, Japan; [Inoue-Murayama, Miho] Kyoto Univ, Wildlife Res Ctr, Kyoto 6068203, Japan	Inoue, E (reprint author), Kyoto Univ, Grad Sch Sci, Kyoto 6068502, Japan.	inoue@jinrui.zool.kyoto-u.ac.jp		Hongo, Shun/0000-0001-8167-1348	Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA); Science and Technology Research Partnership for Sustainable Development (SATREPS)	We are indebted to the Ministere des Eaux et Forets and Agence National des Parcs Nationaux (ANPN) of the Gabonese government for their cooperation and permission to conduct this research. We are grateful to Dr. Ngomanda, Dr. Takenoshita, Dr. Ngok Banak, the deceased Dr. Mougougou, Ms. Ando, Mr. Mbehang Nguema, Ms. Nze Nkogue, other PROCOBHA researchers, Ms. Hiramatsu, Ms. Yagi, Mr. Ichiyama, all of the field assistants at Moukalaba-Doudou National Park, and the villagers of Doussala, Konzi, and Mboungou for support in conducting this research. We also thank Dr. Nakagawa and other members of Human Evolution Studies at Kyoto University, for advice on this research. This study was financially supported by the Japan Science and Technology Agency (JST) and Japan International Cooperation Agency (JICA), and Science and Technology Research Partnership for Sustainable Development (SATREPS).	Akomo-Okoue E.F., 2015, TROPICS, V23, P137; DUBOST G, 1978, MAMMALIA, V42, P1, DOI 10.1515/mamm.1978.42.1.1; Clark CJ, 2009, CONSERV BIOL, V23, P1281, DOI 10.1111/j.1523-1739.2009.01243.x; Terada C, 2012, OECOLOGIA, V169, P981, DOI 10.1007/s00442-012-2270-7; Hassanin A, 2012, CR BIOL, V335, P32, DOI 10.1016/j.crvi.2011.11.002; van Vliet N, 2009, AFR J ECOL, V47, P40, DOI 10.1111/j.1365-2028.2007.00913.x; Kumpel NF, 2010, CONSERV BIOL, V24, P861, DOI 10.1111/j.1523-1739.2010.01505.x; Nielsen MR, 2012, WORLD DEV, V40, P1224, DOI 10.1016/j.worlddev.2011.11.009; Alves J, 2014, MAMM BIOL, V79, P338, DOI 10.1016/j.mambio.2014.05.007; Hayaishi S, 2006, PRIMATES, V47, P158, DOI 10.1007/s10329-005-0169-1; Remis MJ, 2011, AFR J ECOL, V49, P70, DOI 10.1111/j.1365-2028.2010.01229.x; Poulsen JR, 2009, CONSERV BIOL, V23, P1597, DOI 10.1111/j.1523-1739.2009.01251.x; Johnston AR, 2011, CONSERV GENET, V12, P1173, DOI 10.1007/s10592-011-0220-2; Ahumada JA, 2011, PHILOS T R SOC B, V366, P2703, DOI 10.1098/rstb.2011.0115; Msuha MJ, 2012, BIODIVERS CONSERV, V21, P2747, DOI 10.1007/s10531-012-0331-1; Breuer T, 2012, AFR J ECOL, V50, P335, DOI 10.1111/j.1365-2028.2012.01331.x; Rist J, 2009, BIOTROPICA, V41, P700, DOI 10.1111/j.1744-7429.2009.00527.x; Smith PA, 2002, J BIOGEOGR, V29, P1089, DOI 10.1046/j.1365-2699.2002.00751.x; Melletti M, 2009, AFR J ECOL, V47, P797, DOI 10.1111/j.1365-2028.2008.01010.x; Bowkett AE, 2013, CONSERV GENET RESOUR, V5, P1095, DOI 10.1007/s12686-013-9935-3; Breuer T, 2010, AFR J ECOL, V48, P551, DOI 10.1111/j.1365-2028.2009.01121.x; Ntie S, 2010, ANIM CONSERV, V13, P80, DOI 10.1111/j.1469-1795.2009.00303.x; JOHNS AD, 1988, BIOTROPICA, V20, P31, DOI 10.2307/2388423; Treves A, 2010, BIOL CONSERV, V143, P521, DOI 10.1016/j.biocon.2009.11.025; Macdonald DW, 2011, CONSERV BIOL, V25, P1220, DOI 10.1111/j.1523-1739.2011.01741.x; Jimoh SO, 2013, AFR J ECOL, V51, P228, DOI 10.1111/aje.12027; Fa JE, 2009, MAMMAL REV, V39, P231, DOI 10.1111/j.1365-2907.2009.00149.x; Vanthomme H, 2013, CONSERV BIOL, V27, P281, DOI 10.1111/cobi.12017; Topp-Jorgensen E, 2009, TROP CONSERV SCI, V2, P70; FEER F, 1989, REV ECOL-TERRE VIE, V44, P225; Vermeulen C, 2009, BIODIVERS CONSERV, V18, P2705, DOI 10.1007/s10531-009-9614-6; Bowkett AE, 2009, CONSERV GENET, V10, P251, DOI 10.1007/s10592-008-9564-7; Mansson J, 2011, EUR J WILDLIFE RES, V57, P1017, DOI 10.1007/s10344-011-0512-3; Poulsen JR, 2011, ECOL APPL, V21, P1819, DOI 10.1890/10-1083.1; Rovero F, 2009, J APPL ECOL, V46, P1011, DOI 10.1111/j.1365-2664.2009.01705.x; Muchaal PK, 1999, CONSERV BIOL, V13, P385, DOI 10.1046/j.1523-1739.1999.013002385.x; Mockrin MH, 2011, CONSERV BIOL, V25, P514, DOI 10.1111/j.1523-1739.2011.01660.x; Burton AC, 2012, BIODIVERS CONSERV, V21, P3079, DOI 10.1007/s10531-012-0355-6; Viquerat SMA, 2012, S AFR J WILDL RES, V42, P1, DOI 10.3957/056.042.0110; Forsyth DM, 2011, NEW ZEAL J ZOOL, V38, P237, DOI 10.1080/03014223.2011.592200; van Vliet N, 2012, ORYX, V46, P196, DOI 10.1017/S0030605311000202; van Vliet N, 2008, AFR J ECOL, V46, P411, DOI 10.1111/j.1365-2028.2007.00879.x; Robinson CAJ, 2011, ENVIRON CONSERV, V38, P247, DOI 10.1017/S0376892910000949; Nakashima Y, 2013, AFR ZOOL, V48, P395; Hoppe-Dominik B, 2011, AFR J ECOL, V49, P450, DOI 10.1111/j.1365-2028.2011.01277.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Barton K, 2011, MUMIN MULTIMODEL INF; Blaney S, 2001, UTILISATION RESSOURC; Brostrom G, 2009, PACKAGE GLMMML; Burnham K. P., 2002, MODEL SELECTION MULT; Christy P, 2008, CHECKLIST AMPHIBIANS; DUBOST G, 1984, J MAMMAL, V65, P298, DOI 10.2307/1381169; Foerster S., 2011, CONSERVATION BIOLOGY, V26, P335; Jennings AP, 2015, MAMMAL RES, V60, P107, DOI 10.1007/s13364-014-0204-y; Johnston AR, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-120; Kingdon J., 1997, KINGDON FIELD GUIDE; Kingdon JS, 2013, MAMMALS AFRICA; Mugerwa B, 2012, AFR J ECOL, V51, P21; Newing H, 2001, BIODIVERS CONSERV, V10, P99, DOI 10.1023/A:1016671524034; R Development Core Team, 2011, R LANG ENV STAT COMP; Takenoshita Yuji, 2008, African Study Monographs Supplementary Issue, V39, P23; White LJT, 1994, J ANIM ECOL, V63, P449	62	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	2199-2401	2199-241X		MAMMAL RES	Mammal Res.	OCT	2015	60	4					375	384		10.1007/s13364-015-0233-1		10	Zoology	Zoology	CR9UI	WOS:000361702400011		
J	Uesugi, T; Kawasaki, M; Ninomiya, M; Kamiya, Y; Takigawa, Y; Higashi, K				Uesugi, Tokuteru; Kawasaki, Megumi; Ninomiya, Masaki; Kamiya, Yuhei; Takigawa, Yorinobu; Higashi, Kenji			Significance of Si impurities on exceptional room-temperature superplasticity in a high-purity Zn-22%Al alloy	MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES MICROSTRUCTURE AND PROCESSING			English	Article						Fracture; Impurity; Superplasticity; Ultrafine grains; Zn-AI alloy	ZN-22 PCT AL; SEVERE PLASTIC-DEFORMATION; HIGH-PRESSURE TORSION; CHANNEL-ANGULAR EXTRUSION; BOUNDARY SLIDING BEHAVIOR; ATOMIC-FORCE MICROSCOPY; GRAIN-BOUNDARY; ALUMINUM-ALLOY; EUTECTOID ALLOY; STRAIN-RATE	Recent numerous studies demonstrated the advantages of producing bulk metals with submicrometer grain sizes which provide the opportunity to demonstrate improved mechanical characteristics including superplastic properties. Besides the effort, although the impurity may cause low ductility due to grain boundary segregation, there are limited studies to date on the influence of general impurities upon flow behavior of conventional superplastic materials. Accordingly, the present report demonstrates the significance of Si impurity on superplastic properties in an ultrafine-grained high-purity Zn-22%Al eutectoid alloy at room temperature. The alloy was prepared to include different levels of Si contents up to 1500 ppm in the high-purity alloy and the consistent fine grain sizes of similar to 0.60 mu m were introduced through a series of solutionizing followed by cold rolling. Tensile testing showed an occurrence of excellent room-temperature superplasticity and the maximum elongation of 500% was recorded at an optimal superplastic strain rate of 1.0 x 10(-3) s(-1) in the alloy with less Si. Increasing Si contents reduced ductility without changing the strain rate sensitivity, thereby implying the consistency in the deformation mechanism for superplastic flow but the difference in the fracture mode. The present analysis estimates a threshold stress and demonstrate the validity of applying the conventional superplastic relationship for depicting the room-temperature superplastic flow in the high-purity Zn-22%Al alloy. Moreover, the separate fracture modes are proposed for the alloy with increasing Si impurity contents by taking fractographs after superplastic elongations. (C) 2015 Elsevier B.V. All rights reserved.	[Uesugi, Tokuteru; Kawasaki, Megumi; Ninomiya, Masaki; Kamiya, Yuhei; Takigawa, Yorinobu; Higashi, Kenji] Osaka Prefecture Univ, Dept Mat Sci, Grad Sch Engn, Naka Ku, Sakai, Osaka 5998531, Japan; [Kawasaki, Megumi] Hanyang Univ, Div Mat Sci & Engn, Seoul 133791, South Korea; [Kawasaki, Megumi] Univ So Calif, Dept Aerosp & Mech Engn, Los Angeles, CA 90089 USA; [Kawasaki, Megumi] Univ So Calif, Dept Mat Sci, Los Angeles, CA 90089 USA	Kawasaki, M (reprint author), Div Mat Sci & Engn, 222 Wangsimni Ro, Seoul 133791, South Korea.	megumi@hanyang.ac.kr	Kawasaki, Megumi/A-1872-2010; Takigawa, Yorinobu/A-6555-2010		Takenaka Corp.; NRF Korea - MoE [NRF-2014R1A1A2057697]	This work was supported in part by Takenaka Corp. and in part by the NRF Korea funded by MoE under Grant no. NRF-2014R1A1A2057697 (MK).	Kawasaki M, 2008, MATER TRANS, V49, P84, DOI 10.2320/matertrans.ME200720; Ha TK, 1997, METALL MATER TRANS A, V28, P1711, DOI 10.1007/s11661-997-0263-7; Valiev RZ, 2010, J MATER SCI, V45, P4718, DOI 10.1007/s10853-010-4588-z; Kushibe A, 2007, MATER SCI FORUM, V551-552, P583; Tanaka T, 2004, MATER TRANS, V45, P2547, DOI 10.2320/matertrans.45.2547; ISHIKAWA H, 1977, METALL TRANS A, V8, P523, DOI 10.1007/BF02661769; Demirtas M, 2015, J ALLOY COMPD, V623, P213, DOI 10.1016/j.jallcom.2014.10.111; Xia SH, 2008, MAT SCI ENG A-STRUCT, V493, P111, DOI 10.1016/j.msea.2007.07.100; Chou CY, 2007, SCRIPTA MATER, V57, P972, DOI 10.1016/j.scriptamat.2007.04.029; Hirata T, 2007, SCRIPTA MATER, V56, P477, DOI 10.1016/j.scriptamat.2006.11.022; Tanaka T, 2008, SCRIPTA MATER, V58, P643, DOI 10.1016/j.scriptamat.2007.11.028; Tanaka T, 2008, SCRIPTA MATER, V59, P215, DOI 10.1016/j.scriptamat.2008.03.005; Tanaka T, 2004, MATER TRANS, V45, P1261, DOI 10.2320/matertrans.45.1261; Kawasaki M, 2014, IOP CONF SER-MAT SCI, V63, DOI 10.1088/1757-899X/63/1/012101; Kumar P, 2006, MAT SCI ENG A-STRUCT, V429, P324, DOI 10.1016/j.msea.2006.05.044; CHAUDHURY PK, 1994, METALL MATER TRANS A, V25, P2391, DOI 10.1007/BF02648859; McFadden SX, 1999, NATURE, V398, P684; Cho TS, 2014, ACTA MATER, V72, P67, DOI 10.1016/j.actamat.2014.03.026; Kawasaki M, 2010, MAT SCI ENG A-STRUCT, V527, P7008, DOI 10.1016/j.msea.2010.07.090; AHMED MMI, 1979, J MATER SCI, V14, P2913, DOI 10.1007/BF00611474; KAIBYSHEV OA, 1978, ACTA METALL MATER, V26, P1877, DOI 10.1016/0001-6160(78)90100-1; Furukawa M, 1998, MAT SCI ENG A-STRUCT, V241, P122, DOI 10.1016/S0921-5093(97)00481-4; PARK KT, 1990, METALL TRANS A, V21, P2605, DOI 10.1007/BF02647008; Langdon TG, 2009, J MATER SCI, V44, P5998, DOI 10.1007/s10853-009-3780-5; Huang Y, 2002, J MATER SCI, V37, P4993, DOI 10.1023/A:1021071228521; Kumar P, 2005, MAT SCI ENG A-STRUCT, V410, P447, DOI 10.1016/j.msea.2005.08.092; Tanaka T, 2005, SCRIPTA MATER, V52, P231, DOI [10.1016/j.scriptamat.2004.09.023, 10.1016/j.sciptamat.2004.09.023]; Kawasaki M, 2012, MATER TRANS, V53, P87, DOI 10.2320/matertrans.MD201106; Tanaka T, 2003, SCRIPTA MATER, V49, P361, DOI 10.1016/S1359-6462(03)00328-2; Huang Y, 2003, MAT SCI ENG A-STRUCT, V358, P114, DOI 10.1016/S0921-5093(03)00268-5; LANGDON TG, 1994, ACTA METALL MATER, V42, P2437, DOI 10.1016/0956-7151(94)90322-0; MOHAMED FA, 1983, J MATER SCI, V18, P582, DOI 10.1007/BF00560647; Duong K, 2001, METALL MATER TRANS A, V32, P103, DOI 10.1007/s11661-001-0106-x; Tanaka T, 2002, MATER TRANS, V43, P2449, DOI 10.2320/matertrans.43.2449; ISHIKAWA H, 1975, PHILOS MAG, V32, P1269, DOI 10.1080/14786437508228105; JIANG XG, 1994, J MATER SCI, V29, P5499, DOI 10.1007/BF00349941; NAZIRI H, 1975, ACTA METALL MATER, V23, P489, DOI 10.1016/0001-6160(75)90088-7; Razumovskiy VI, 2011, SCRIPTA MATER, V65, P926, DOI 10.1016/j.scriptamat.2011.08.014; Choi IC, 2014, SCRIPTA MATER, V75, P102, DOI 10.1016/j.scriptamat.2013.12.003; Ha TK, 2001, MAT SCI ENG A-STRUCT, V307, P98, DOI 10.1016/S0921-5093(00)01952-3; PARK KT, 1994, MAT SCI ENG A-STRUCT, V188, P59, DOI 10.1016/0921-5093(94)90356-5; CHOKSHI AH, 1993, MAT SCI ENG R, V10, P237, DOI 10.1016/0927-796X(93)90009-R; Kawasaki M, 2010, ACTA MATER, V58, P919, DOI 10.1016/j.actamat.2009.10.007; Kawasaki M, 2008, J MATER SCI, V43, P7360, DOI 10.1007/s10853-008-2771-2; Uesugi T, 2012, MATER TRANS, V53, P1699, DOI 10.2320/matertrans.M2012108; Duong K, 1998, ACTA MATER, V46, P4571, DOI 10.1016/S1359-6454(98)00128-1; Chinh N.Q., 2013, MAT SCI ENG A-STRUCT, V543, P117; Demirtas M., 2014, MAT SCI ENG A-STRUCT, V620, P233; Demirtas M, 2015, MAT SCI ENG A-STRUCT, V644, P17, DOI 10.1016/j.msea.2015.07.041; Farghalli A., 1976, SCRIPTA METALL, V10, P759; Higashi K., 2010, J JPN I LIGHT MET, V60, P411, DOI 10.2464/jilm.60.411; Kaibyshev OA, 2005, SUPERPLASTICITY MICR; Kamiya Yuhei, 2014, Advanced Materials Research, V922, DOI 10.4028/www.scientific.net/AMR.922.328; LANGDON TG, 1994, MAT SCI ENG A-STRUCT, V174, P225, DOI 10.1016/0921-5093(94)91092-8; Kawasaki M, 2011, MAT SCI ENG A-STRUCT, V528, P6140, DOI 10.1016/j.msea.2011.04.053; LANGDON TG, 1982, METALL TRANS A, V13, P689, DOI 10.1007/BF02642383; Kawasaki M, 2009, MAT SCI ENG A-STRUCT, V503, P48, DOI 10.1016/j.msea.2008.04.081; Makii K., 2004, Materials Science Forum, V447-448; MOHAMED FA, 1975, ACTA METALL MATER, V23, P1443, DOI 10.1016/0001-6160(75)90153-4; MOHAMED FA, 1977, METALL TRANS A, V8, P933, DOI 10.1007/BF02661575; Naziri, 1974, ACTA METALL, V22, P1321; Nieh T. G., 1997, SUPERPLASTICITY META; TorresVillasenor G, 1997, MATER SCI FORUM, V243-2, P553; Uesugi Tokuteru, 2015, [Письма о материалах, Letters on Materials, Pis'ma o materialakh], V5, P269; Zhao YH, 2008, SCRIPTA MATER, V59, P627, DOI 10.1016/j.scriptamat.2008.05.031	65	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0921-5093	1873-4936		MAT SCI ENG A-STRUCT	Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.	OCT 1	2015	645						47	56		10.1016/j.msea.2015.07.087		10	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Science & Technology - Other Topics; Materials Science; Metallurgy & Metallurgical Engineering	CR8DS	WOS:000361581900006		
J	Ding, HL; Shi, XB; Wang, YQ; Cheng, GP; Kamado, S				Ding, Hanlin; Shi, Xiaobin; Wang, Yongqiang; Cheng, Guangping; Kamado, Shigeharu			Texture weakening and ductility variation of Mg-2Zn alloy with CA or RE addition	MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES MICROSTRUCTURE AND PROCESSING			English	Article						Magnesium; Ca addition; Texture weakening; Ductility	STRETCH FORMABILITY; MG-ZN; MECHANICAL-PROPERTIES; PLASTIC-DEFORMATION; PARTICLE ADDITION; ROOM-TEMPERATURE; GRAIN-GROWTH; MAGNESIUM; ANISOTROPY; EVOLUTION	Five Mg alloys, Mg-2Zn, Mg-0.5RE, Mg-0.5Ca, Mg-2Zn-0.5Ca and Mg-2Zn-0.5RE (wt%), were subjected to hot extrusion for the purpose of evaluating the effect of Ca addition on the mechanical properties and texture characteristics of Mg sheets. Ca addition to pure Mg and Mg-Zn alloys contributes to the texture weakening of extruded sheets. The ductility increase through the addition of Ca to Mg is related to the texture weakening of extruded Ca-containing alloys. The enhancement of extrusion temperature leads to a broader spread of basal poles toward TD, but a strengthened texture intensity. The reduction of c/a ratio and the decrease of SFE may be responsible for the texture weakening of Ca-containing alloys. (C) 2015 Elsevier B.V. All rights reserved.	[Ding, Hanlin; Shi, Xiaobin; Wang, Yongqiang; Cheng, Guangping] Anhui Univ Technol, Sch Mat Sci & Engn, Maanshan 243002, Peoples R China; [Kamado, Shigeharu] Nagaoka Univ Technol, Dept Mech Engn, Niigata 9402188, Japan	Ding, HL (reprint author), Anhui Univ Technol, Sch Mat Sci & Engn, Maanshan 243002, Peoples R China.	hanlinding@yahoo.com			National Natural Science Foundation of China [51204003]; Recruitment Program of High-end Foreign Experts of the State Administration of Foreign Experts Affairs, China [GDW20153400193]	The financial support of National Natural Science Foundation of China, Grant no. 51204003 is gratefully acknowledged. This research was supported in part by Recruitment Program of High-end Foreign Experts of the State Administration of Foreign Experts Affairs, China under Grant no. GDW20153400193.	Sandlobes S, 2012, ACTA MATER, V60, P3011, DOI 10.1016/j.actamat.2012.02.006; Bohlen J, 2007, ACTA MATER, V55, P2101, DOI 10.1016/j.actamat.2006.11.013; Chino Y, 2010, MAT SCI ENG A-STRUCT, V528, P566, DOI 10.1016/j.msea.2010.09.081; Kim WJ, 2011, MAT SCI ENG A-STRUCT, V528, P874, DOI 10.1016/j.msea.2010.09.007; Al-Samman T, 2011, MAT SCI ENG A-STRUCT, V528, P3809, DOI 10.1016/j.msea.2011.01.080; Ganeshan S, 2009, ACTA MATER, V57, P3876, DOI 10.1016/j.actamat.2009.04.038; Agnew SR, 2005, INT J PLASTICITY, V21, P1161, DOI 10.1016/j.ijplas.2004.05.018; Lu LW, 2015, J ALLOY COMPD, V628, P130, DOI 10.1016/j.jallcom.2014.12.196; Oh-ishi K, 2009, MAT SCI ENG A-STRUCT, V526, P177, DOI 10.1016/j.msea.2009.07.027; Wang Y, 2003, MATER CHEM PHYS, V81, P11, DOI 10.1016/S0254-0584(03)00168-8; Chino Y, 2011, MATER TRANS, V52, P1477, DOI 10.2320/matertrans.M2011048; Chino Y, 2008, ACTA MATER, V56, P387, DOI 10.1016/j.actamat.2007.09.036; Jung IH, 2015, SCRIPTA MATER, V102, P1, DOI 10.1016/j.scriptamat.2014.12.010; Basu I, 2014, ACTA MATER, V67, P116, DOI 10.1016/j.actamat.2013.12.015; Illkova K, 2014, J ALLOY COMPD, V617, P253, DOI 10.1016/j.jallcom.2014.08.022; Bohlen J, 2015, MATER CHARACT, V101, P144, DOI 10.1016/j.matchar.2015.02.002; Sandlobes S, 2011, ACTA MATER, V59, P429, DOI 10.1016/j.actamat.2010.08.031; Robson JD, 2014, METALL MATER TRANS A, V45A, P3205, DOI 10.1007/s11661-013-1950-1; Bhattacharyya JJ, 2015, ACTA MATER, V86, P80, DOI 10.1016/j.actamat.2014.12.009; Wu WX, 2014, J ALLOY COMPD, V585, P111, DOI 10.1016/j.jallcom.2013.09.028; Borkar H, 2013, J ALLOY COMPD, V555, P219, DOI 10.1016/j.jallcom.2012.12.078; Ding H.L., 2015, T NONFERROU IN PRESS, V25; Sankaranarayanan S, 2014, MATER DESIGN, V56, P428, DOI 10.1016/j.matdes.2013.11.031; Sankaranarayanan S, 2014, J ALLOY COMPD, V615, P211, DOI 10.1016/j.jallcom.2014.06.163; Stanford N, 2010, MAT SCI ENG A-STRUCT, V528, P314, DOI 10.1016/j.msea.2010.08.097; Yuasa M, 2014, ACTA MATER, V65, P207, DOI 10.1016/j.actamat.2013.10.063	26	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0921-5093	1873-4936		MAT SCI ENG A-STRUCT	Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.	OCT 1	2015	645						196	204		10.1016/j.msea.2015.08.025		9	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Science & Technology - Other Topics; Materials Science; Metallurgy & Metallurgical Engineering	CR8DS	WOS:000361581900024		
J	Kim, MS; Nishikawa, H				Kim, Min-Su; Nishikawa, Hiroshi			Effects of bonding temperature on microstructure, fracture behavior and joint strength of Ag nanoporous bonding for high temperature die attach	MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES MICROSTRUCTURE AND PROCESSING			English	Article						Mechanical characterization; Nanostructured materials; bonding; interface; Lead-free; Die attach	METALLOORGANIC NANOPARTICLES; FREE SOLDERS; SILVER; GOLD; FABRICATION; NANOSILVER; SPECTRA; PASTE	Ag nanoparticle sintering has received much attention as an alternative joining method to lead-based soldering for high temperature electronic applications. However, there are still certain issues with this method, such as difficulties of in controlling the joining layer thickness and the occurrence of unexpected voids resulting from solvent evaporations In this study, the effect of bonding temperature (200-400 degrees C) and environment (air and N-2) on the joint strength of Ag nanoporous bonding (NPB) on electroless nickel/immersion gold finished Cu disks was investigated. A nanoporous Ag sheet fabricated using dealloying method from an Al-Ag precursor was adopted as the insert material. The NPB was conducted at various temperatures (200-400 degrees C) for 30 min at a pressure of 20 MPa in both air and N2 environments. The joint strength of NPB was closely related with the microstructure of the Ag layer and the fracture mode of the joint, and increased with increasing bonding temperature through the formation of strong interface and a coarsened Ag layer. The effect of the bonding environment was not significant, except in the case of bonding temperature of 400 degrees C. (C) 2015 Elsevier B.V. All rights reserved.	[Kim, Min-Su; Nishikawa, Hiroshi] Osaka Univ, Joining & Welding Res Inst, Osaka 5670047, Japan; [Kim, Min-Su] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan	Kim, MS (reprint author), Osaka Univ, Joining & Welding Res Inst, 11-1 Mihogaoka, Osaka 5670047, Japan.	mskim927@gmail.com			Japan Society for the Promotion of Science (JSPS) [25289241]	This research was supported by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (Grant no. 25289241). The authors would also like to thank the contributors on the NIST X-ray Photoelectron Spectroscopy Database [34] for the great helpful information of reference data for the XPS peak identification utilized in this research.	KIM KS, 1974, SURF SCI, V43, P625, DOI 10.1016/0039-6028(74)90281-7; Bosco NS, 2005, ACTA MATER, V53, P2019, DOI 10.1016/j.actamat.2005.01.013; Suganuma K, 2009, JOM-US, V61, P64, DOI 10.1007/s11837-009-0013-y; Ide E, 2006, MATER TRANS, V47, P211, DOI 10.2320/matertrans.47.211; KAUSHIK VK, 1991, J ELECTRON SPECTROSC, V56, P273, DOI 10.1016/0368-2048(91)85008-H; Yan JF, 2012, SCRIPTA MATER, V66, P582, DOI 10.1016/j.scriptamat.2012.01.007; Seker E, 2007, ACTA MATER, V55, P4593, DOI 10.1016/j.actamat.2007.03.018; Yamakawa T, 2013, J ELECTRON MATER, V42, P1260, DOI 10.1007/s11664-013-2583-2; Coutts MJ, 2009, J PHYS CHEM C, V113, P1325, DOI 10.1021/jp808927t; Kroupa A, 2012, J MATER ENG PERFORM, V21, P629, DOI 10.1007/s11665-012-0125-3; TURNER NH, 1990, SURF INTERFACE ANAL, V15, P215, DOI 10.1002/sia.740150305; Shi YW, 2010, J MATER SCI-MATER EL, V21, P875, DOI 10.1007/s10854-009-0010-5; Payne BP, 2009, J ELECTRON SPECTROSC, V175, P55, DOI 10.1016/j.elspec.2009.07.006; Chidambaram V, 2010, J ALLOY COMPD, V490, P170, DOI 10.1016/j.jallcom.2009.10.108; Akada Y, 2008, MATER TRANS, V49, P1537, DOI 10.2320/matertrans.MF200805; Kim MS, 2013, J MATER SCI, V48, P5645, DOI 10.1007/s10853-013-7360-3; Ogura H, 2010, J ELECTRON MATER, V39, P1233, DOI 10.1007/s11664-010-1236-y; Hakamada M, 2009, J MATER RES, V24, P301, DOI 10.1557/JMR.2009.0037; Xiao K, 2014, J MATER RES, V29, P1006, DOI 10.1557/jmr.2014.42; Mei YH, 2013, J ELECTRON MATER, V42, P1209, DOI 10.1007/s11664-013-2561-8; Zeng G, 2012, MICROELECTRON RELIAB, V52, P1306, DOI 10.1016/j.microrel.2012.02.018; Bai JG, 2007, IEEE T ELECTRON PACK, V30, P241, DOI 10.1109/TEPM.2007.906508; Biesinger MC, 2011, APPL SURF SCI, V257, P2717, DOI 10.1016/j.apsusc.2010.10.051; Takaku Y, 2006, J ELECTRON MATER, V35, P1926, DOI 10.1007/s11664-006-0295-6; Biener J, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2051791; Erdman N., 2006, MICROSC TODAY, V14, P22; Hague A., 2012, J MATER SCI-MATER EL, V23, P115; Kim MS, 2014, SCRIPTA MATER, V92, P43, DOI 10.1016/j.scriptamat.2014.08.010; Liu Y, 2012, POWER ELECTRONIC PACKAGING: DESIGN, ASSEMBLY PROCESS, RELIABILITY AND MODELING, P1, DOI 10.1007/978-1-4614-1053-9; Lochel B. P., 1984, J ELECTROCHEM SOC, V131, P709; Nishikawa H, 2010, OPEN SURF SCI J, V3, P60; NIST, 2012, NIST XRAY PHOT SPECT; SHIRLEY DA, 1972, PHYS REV B, V5, P4709, DOI 10.1103/PhysRevB.5.4709; Siow K.S., 2014, J ELECT MAT, V43, P947	34	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0921-5093	1873-4936		MAT SCI ENG A-STRUCT	Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.	OCT 1	2015	645						264	272		10.1016/j.msea.2015.08.015		9	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Science & Technology - Other Topics; Materials Science; Metallurgy & Metallurgical Engineering	CR8DS	WOS:000361581900032		
J	Hamidie, RDR; Yamada, T; Ishizawa, R; Saito, Y; Masuda, K				Hamidie, Ronald D. Ray; Yamada, Tatsuya; Ishizawa, Rie; Saito, Yoko; Masuda, Kazumi			Curcumin treatment enhances the effect of exercise on mitochondrial biogenesis in skeletal muscle by increasing cAMP levels	METABOLISM-CLINICAL AND EXPERIMENTAL			English	Article						Endurance training; Mitochondria; Polyphenol; Skeletal muscle; cAMP	ACTIVATED PROTEIN-KINASE; ISCHEMIA REPERFUSION INJURY; TRANSCRIPTIONAL CONTROL; CONTRACTILE ACTIVITY; INSULIN-RESISTANCE; COACTIVATOR PGC-1; AMPK ACTIVATION; STRESS-RESPONSE; SIRT1 ACTIVITY; RESVERATROL	Background. In response to physiologic stressors, skeletal muscle has the potential to elicit wide variety of adaptive responses, such as biogenesis of mitochondria and clearance of damaged mitochondria to promote healthy muscle. The polyphenol curcumin, derived from the rhizome Curcuma longa L., is a natural antioxidant that exhibits various pharmacological activities and therapeutic properties. However, the effect of curcumin on the regulation of mitochondrial biogenesis in skeletal muscle remains unknown. The present study aimed to examine the effects of combination of endurance training (eTR) and curcumin treatment on the expression of AMPK, SIRT1, PGC-1 alpha, and OXPHOS subunits, mitochondrial DNA copy number, and CS activity in rat skeletal muscle. Furthermore, the present study also examined the effect of exercise and curcumin treatment on the levels of cAMP and downstream targets of PKA including phosphorylated CREB and LKB-1. Methods. Ten-week-old male Wistar rats were randomly divided into non-eTR and eTR groups. Low doses (50 mg/kg-BW/day) or high doses (100 mg/kg-BW/day) of curcumin dissolved in dimethyl sulfoxide (DMSO) were injected intraperitoneally in all animals for 28 days to investigate the effect of curcumin alone and the combined effect of curcumin with eTR. Western blotting (WB) and immunoprecipitation (IP) were performed to detect the presence of proteins. Results. Our results demonstrated that combination of curcumin treatment and eTR increased the expression of COX-IV, OXPHOS subunits, mitochondrial DNA copy number and CS activity in the gastrocnemius (Gas) and soleus (Sol) muscles. In addition, this combination increased AMPK phosphorylation, NAD(+)/NADH ratio, SIRT1 expression, and PGC-1 alpha deacetylation. Furthermore, curcumin treatment as well as exercise also increased levels of cAMP and downstream target of PICA including phosphorylation CREB and LKB-1 which are involved in the regulation of mitochondrial biogenesis. Conclusion. Taken together, these results suggest that the combination of curcumin treatment and eTR has the potential to accelerate mitochondrial biogenesis in skeletal muscle by increasing cAMP levels. (C) 2015 Elsevier Inc. All rights reserved.	[Hamidie, Ronald D. Ray; Yamada, Tatsuya; Ishizawa, Rie; Masuda, Kazumi] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Hamidie, Ronald D. Ray] Indonesia Univ Educ, Fac Sport & Hlth Educ, Java 40154, Indonesia; [Saito, Yoko] Kanazawa Seiryo Univ, Fac Human Sci, Kanazawa, Ishikawa 9208620, Japan; [Masuda, Kazumi] Kanazawa Univ, Fac Human Sci, Kanazawa, Ishikawa 9201192, Japan	Masuda, K (reprint author), Kanazawa Univ, Fac Human Sci, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	masudak@staff.kanazawa-u.ac.jp			Japanese Ministry of Education, Science, Sports and Culture [26282183, 15K12665]; Shibuya Science, Culture and Sport Foundation, Japan; Directorate General of High Education, Indonesia	This research was supported by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Science, Sports and Culture (26282183, 15K12665, KM), and also by funding from Shibuya Science, Culture and Sport Foundation, Japan (KM). RH was supported by a scholarship from Directorate General of High Education, Indonesia, for the international collaboration.	Abdel Aziz Mohamed Talaat, 2012, J Sex Med, V9, P1815, DOI 10.1111/j.1743-6109.2012.02741.x; Abusnina A, 2009, ARCH CARDIOVASC D S1, V102, pS43; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Chung SW, 2010, ARCH BIOCHEM BIOPHYS, V501, P79, DOI 10.1016/j.abb.2010.05.003; Kuo JJ, 2012, INT J MOL MED, V30, P643, DOI 10.3892/ijmm.2012.1020; Veeranki S, 2011, DEV BIOL, V360, P351, DOI 10.1016/j.ydbio.2011.10.006; Na LX, 2011, NUTR METAB CARDIOVAS, V21, P526, DOI 10.1016/j.numecd.2009.11.009; Blough E, 1999, BIOTECHNIQUES, V26, P202; Ferrara N, 2008, REJUV RES, V11, P139, DOI 10.1089/rej.2007.0576; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Yang Y, 2013, FREE RADICAL BIO MED, V65, P667, DOI 10.1016/j.freeradbiomed.2013.07.007; Boily G, 2009, ONCOGENE, V28, P2882, DOI 10.1038/onc.2009.147; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Suwa M, 2008, METABOLISM, V57, P986, DOI 10.1016/j.metabol.2008.02.017; Than TA, 2011, J BIOL CHEM, V286, P22047, DOI 10.1074/jbc.M111.240481; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Aftab N, 2010, PHYTOTHER RES, V24, P500, DOI 10.1002/ptr.2960; Vina J, 2009, ADV DRUG DELIVER REV, V61, P1369, DOI 10.1016/j.addr.2009.06.006; Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Chowanadisai W, 2010, J BIOL CHEM, V285, P142, DOI 10.1074/jbc.M109.030130; Koh HJ, 2008, CURR OPIN CLIN NUTR, V11, P227, DOI 10.1097/MCO.0b013e3282fb7b76; Hood DA, 2001, J APPL PHYSIOL, V90, P1137; Menzies KJ, 2013, J BIOL CHEM, V288, P6968, DOI 10.1074/jbc.M112.431155; Joseph AM, 2012, EXP DIABETES RES, DOI 10.1155/2012/642038; Holloszy JO, 2008, J PHYSIOL PHARMACOL, V59, P5; Eckert GP, 2013, NEUROCHEM INT, V62, P595, DOI 10.1016/j.neuint.2013.02.014; Gurd BJ, 2011, APPL PHYSIOL NUTR ME, V36, P589, DOI [10.1139/h11-070, 10.1139/H11-070]; Nam SM, 2014, J MED FOOD, V17, P641, DOI 10.1089/jmf.2013.2965; PALMER WK, 1988, MED SCI SPORT EXER, V20, P525; Liu L, 2014, NEUROCHEM RES, V39, P1322, DOI 10.1007/s11064-014-1315-1; Bogacka I, 2005, J CLIN ENDOCR METAB, V90, P6650, DOI 10.1210/jc.2005-1024; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Benton CR, 2008, J BIOL CHEM, V283, P4228, DOI 10.1074/jbc.M704332200; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Chen ZP, 2003, DIABETES, V52, P2205, DOI 10.2337/diabetes.52.9.2205; Terada S, 2002, BIOCHEM BIOPH RES CO, V296, P350, DOI 10.1016/S0006-291X(02)00881-1; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Furuichi Y, 2010, ACTA PHYSIOL, V200, P57, DOI 10.1111/j.1748-1716.2010.02101.x; Kuo JJ, 2012, INT J MOL MED, V30, P673, DOI 10.3892/ijmm.2012.1049; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; ROY RR, 1991, J APPL PHYSIOL, V70, P2522; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Stapleton D, 1997, FEBS LETT, V409, P452, DOI 10.1016/S0014-5793(97)00569-3; WILLIAMS RS, 1986, J BIOL CHEM, V261, P376; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Baur JA, 2010, SCIENCE, V329, P3; Boily G, 2008, PLOS ONE, V3, pe1759; Fernandez-Marcos P. J., 2011, AM J CLIN NUTR, V276, P35826, DOI DOI 10.3945/AJCN.110.001917; Baur JA, 2010, SCIENCE, V329, P1012, DOI 10.1126/science.329.5995.1012; Kawanaka K, 1997, J APPL PHYSIOL, V83, P43; Ohyama K, 2015, AM J PHYSIOL-ENDOC M, V308, P315; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Queen Brannon L, 2010, Curr Aging Sci, V3, P34; Rouse M, 2014, J ENDOCRINOL, V223, P107, DOI 10.1530/JOE-14-0335; Srere PA, 1969, METHOD ENZYMOL, P3; Taylor EB, 2005, AM J PHYSIOL-ENDOC M, V289, P960; Terada S, 2004, AM J PHYSIOL-ENDOC M, V286, P208; Uguccioni G, 2011, AM J PHYSIOL-ENDOC M, V300, P361; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	71	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0026-0495	1532-8600		METABOLISM	Metab.-Clin. Exp.	OCT	2015	64	10					1334	1347		10.1016/j.metabol.2015.07.010		14	Endocrinology & Metabolism	Endocrinology & Metabolism	CR8ZG	WOS:000361642400017		
J	Fan, Y; Shibata, E; Iizuka, A; Nakamura, T				Fan, Yong; Shibata, Etsuro; Iizuka, Atsushi; Nakamura, Takashi			Crystallization Behavior of Copper Smelter Slag During Molten Oxidation	METALLURGICAL AND MATERIALS TRANSACTIONS B-PROCESS METALLURGY AND MATERIALS PROCESSING SCIENCE			English	Article							IRON-OXIDE; OXYGEN	Copper slag is composed of iron silicate obtained by smelting copper concentrate and silica flux. One of the most important criteria for the utilization of this secondary resource is the recovery of iron from the slag matrix to decrease the volume of dumped slag. The molten oxidation process with crushing magnetic separation appears to be a more sustainable approach and is based on directly blowing oxidizing gas onto molten slag after the copper smelting process. In the current study, using an infrared furnace, the crystallization behavior of the slag during molten oxidation was studied to better understand the trade-off between magnetite and hematite precipitations, as assessed by X-ray diffraction (using an internal standard). Furthermore, the crystal morphology was examined using a laser microscope and Raman imaging system to understand the iron oxide transformation, and the distribution of impurities such as Cu, Zn, As, Cr, and Pb were complemented with scanning electron microscopy and energy dispersive spectroscopy. In addition, the reaction mechanism was investigated with a focus on the oxidation processes.	[Fan, Yong] Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Shibata, Etsuro; Iizuka, Atsushi; Nakamura, Takashi] Tohoku Univ, IMRAM, Aoba Ku, Sendai, Miyagi 9808577, Japan	Fan, Y (reprint author), Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, 6-6-20 Aramaki Aza Aoba, Sendai, Miyagi 9808579, Japan.	etsuro@tagen.tohoku.ac.jp					SAYADYAGHOUBI Y, 1995, METALL MATER TRANS B, V26, P795, DOI 10.1007/BF02651726; [Anonymous], 2004, PHAS EQ DIAGR DAT 31; SASABE M, 1983, CAN METALL QUART, V22, P29; Fan Y, 2014, MATER TRANS, V55, P958, DOI 10.2320/matertrans.M-M2014819; Fan Y., 2013, J MMIJ, V5, P177; Alexander L., 1948, Analytical Chemistry, V20, DOI 10.1021/ac60022a002; Samsonov G. V., 1982, OXIDE HDB, P53; Sasabe M., 1982, IRON STEEL I, V7, P767; Sasabe M., 1979, IRON STEEL I, V12, P1727; Stumm W., 2013, WORLD MINERAL PRODUC	10	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5615	1543-1916		METALL MATER TRANS B	Metall. Mater. Trans. B-Proc. Metall. Mater. Proc. Sci.	OCT	2015	46	5					2158	2164		10.1007/s11663-015-0365-3		7	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CR7VD	WOS:000361558700016		
J	Iwata, Y; Nakajima, S; Suzuki, T; Keefe, RSE; Plitman, E; Chung, JK; Caravaggio, F; Mimura, M; Graff-Guerrero, A; Uchida, H				Iwata, Y.; Nakajima, S.; Suzuki, T.; Keefe, R. S. E.; Plitman, E.; Chung, J. K.; Caravaggio, F.; Mimura, M.; Graff-Guerrero, A.; Uchida, H.			Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials	MOLECULAR PSYCHIATRY			English	Review							PLACEBO-CONTROLLED TRIAL; MAGNETIC-RESONANCE SPECTROSCOPY; PERSISTENT NEGATIVE SYMPTOMS; EARLY-PHASE SCHIZOPHRENIA; ADD-ON TREATMENT; D-SERINE; PREFRONTAL CORTEX; D-CYCLOSERINE; 1ST-EPISODE SCHIZOPHRENIA; CLINICAL-TRIALS	Hypofunction of N-methyl-D-aspartate (NMDA) receptors has been proposed to have an important role in the cognitive impairments observed in schizophrenia. Although glutamate modulators may be effective in reversing such difficult-to-treat conditions, the results of individual studies thus far have been inconsistent. We conducted a systematic review and meta-analysis to examine whether glutamate positive modulators have beneficial effects on cognitive functions in patients with schizophrenia. A literature search was conducted to identify double-blind randomized placebo-controlled trials in schizophrenia or related disorders, using Embase, Medline, and PsycINFO (last search: February 2015). The effects of glutamate positive modulators on cognitive deficits were evaluated for overall cognitive function and eight cognitive domains by calculating standardized mean differences (SMDs) between active drugs and placebo added to antipsychotics. Seventeen studies (N = 1391) were included. Glutamate positive modulators were not superior to placebo in terms of overall cognitive function (SMD = 0.08, 95% confidence interval = -0.06 to 0.23) (11 studies, n = 858) nor each of eight cognitive domains (SMDs = -0.03 to 0.11) (n = 367-940) in this population. Subgroup analyses by diagnosis (schizophrenia only studies), concomitant antipsychotics, or pathway of drugs to enhance the glutamatergic neurotransmission (glycine allosteric site of NMDA receptors or alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors) suggested no procognitive effect of glutamate positive modulators. Further, no effect was found in individual compounds on cognition. In conclusion, glutamate positive modulators may not be effective in reversing overall cognitive impairments in patients with schizophrenia as adjunctive therapies.	[Iwata, Y.; Nakajima, S.; Plitman, E.; Chung, J. K.; Caravaggio, F.; Graff-Guerrero, A.] Ctr Addict & Mental Hlth, Multimodal Imaging Grp, Res Imaging Ctr, Toronto, ON M5T 1R8, Canada; [Iwata, Y.; Nakajima, S.; Graff-Guerrero, A.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Iwata, Y.; Nakajima, S.; Suzuki, T.; Mimura, M.; Uchida, H.] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Nakajima, S.; Graff-Guerrero, A.; Uchida, H.] Ctr Addict & Mental Hlth, Geriatr Mental Hlth Div, Toronto, ON M5T 1R8, Canada; [Keefe, R. S. E.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Plitman, E.; Chung, J. K.; Caravaggio, F.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Graff-Guerrero, A.] Ctr Addict & Mental Hlth, Campbell Res Inst, Toronto, ON M5T 1R8, Canada	Nakajima, S (reprint author), Ctr Addict & Mental Hlth, Multimodal Imaging Grp, 250 Coll St, Toronto, ON M5T 1R8, Canada.	shinichiro_nakajima@hotmail.com	Uchida, Hiroyuki/I-4867-2015	Uchida, Hiroyuki/0000-0002-0628-7036	Wiley Japan; CIHR; Japan Society for the Promotion of Science; Dainippon Sumitomo Pharma; Kyowa Hakko Kirin; Astellas; Dainippon Sumitomo; Eli Lilly; Elsevier Japan; Janssen; Meiji Seika; Novartis; Otsuka; Department of Veteran's Affair; Feinstein Institute for Medical Research; GlaxoSmithKline; National Institute of Mental Health; Psychogenics; Research Foundation for Mental Hygiene; Singapore National Medical Research Council; Asahi Kasei Pharma; Astellas Pharmaceutical; Daiichi Sankyo; Dainippon-Sumitomo Pharma; Eisai; Janssen Pharmaceutical; Meiji-Seika Pharma; Mochida Pharmaceutical; MSD; Novartis Pharma; Otsuka Pharmaceutical; Pfizer; Shionogi; Takeda; Tanabe Mitsubishi Pharma; Yoshitomi Yakuhin; Canadian Institutes of Health Research (CIHR); US National Institute of Health; Ontario Mental Health Foundation; Brain and Behavior Research Foundation; Mexico ICyTDF; CONACyT; Ministry of Economic Development and Innovation of Ontario; Ontario AHSC AFP Innovation Fund; W Garfield Weston Foundation	YI has received manuscript fees from Wiley Japan within the past 3 years. SN has received fellowship grants from the CIHR and Japan Society for the Promotion of Science, and manuscript fees from Dainippon Sumitomo Pharma and Kyowa Hakko Kirin. TS has received manuscript or speaker's fees from Astellas, Dainippon Sumitomo, Eli Lilly, Elsevier Japan, Janssen, Meiji Seika, Novartis, Otsuka and Wiley Japan within the past 3 years. RSEK currently or in the past 3 years has received investigator-initiated research funding support from the Department of Veteran's Affair, Feinstein Institute for Medical Research, GlaxoSmithKline, National Institute of Mental Health, Novartis, Psychogenics, Research Foundation for Mental Hygiene and the Singapore National Medical Research Council. He currently or in the past 3 years has received honoraria, served as a consultant, or advisory board member for Abbvie, Akebia, Amgen, Astellas, Asubio, AviNeuro/ChemRar, BiolineRx, Biogen Idec, Biomarin, Boehringer-Ingelheim, Eli Lilly, FORUM, GW Pharmaceuticals, Helicon, Lundbeck, Merck, Minerva Neurosciences, Mitsubishi, Novartis, Otsuka, Pfizer, Roche, Shire, Sunovion, Takeda, Targacept and WWCT. RSEK receives royalties from the BACS testing battery, the MATRICS Battery (BACS Symbol Coding) and the Virtual Reality Functional Capacity Assessment Tool (VRFCAT). He is also a shareholder in NeuroCog Trials and Sengenix. EP has received the Ontario Graduate Scholarship and the Canada Graduate Scholarship. FC has received the Ontario Graduate Scholarship and the Canada Graduate Scholarship. MM has received grants and/or speaker's honoraria from Asahi Kasei Pharma, Astellas Pharmaceutical, Daiichi Sankyo, Dainippon-Sumitomo Pharma, Eisai, Eli Lilly, GlaxoSmithKline, Janssen Pharmaceutical, Meiji-Seika Pharma, Mochida Pharmaceutical, MSD, Novartis Pharma, Otsuka Pharmaceutical, Pfizer, Shionogi, Takeda, Tanabe Mitsubishi Pharma and Yoshitomi Yakuhin within the past 3 years. AG has received research support from the following external funding agencies: the Canadian Institutes of Health Research (CIHR), US National Institute of Health, Ontario Mental Health Foundation, Brain and Behavior Research Foundation, Mexico ICyTDF, CONACyT, Ministry of Economic Development and Innovation of Ontario, Ontario AHSC AFP Innovation Fund and W Garfield Weston Foundation. HU has received grants from Astellas Pharmaceutical, Eisai, Otsuka Pharmaceutical, GlaxoSmithKline, Shionogi, Dainippon-Sumitomo Pharma, Eli Lilly, Mochida Pharmaceutical, Meiji-Seika Pharma and Yoshitomi Yakuhin and speaker's honoraria from Otsuka Pharmaceutical, Eli Lilly, Shionogi, GlaxoSmithKline, Yoshitomi Yakuhin, Dainippon-Sumitomo Pharma, Meiji-Seika Pharma, Abbvie, MSD and Janssen Pharmaceutical within the past 2 years. Other authors have no financial or other relationship relevant to the subject of this manuscript.	Ahmed AO, 2014, CNS DRUGS, V28, P301, DOI 10.1007/s40263-014-0146-6; SASSOEPOGNETTO M, 1993, NEUROREPORT, V5, P7, DOI 10.1097/00001756-199310000-00001; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Tamba M, 1999, INT J RADIAT BIOL, V75, P1177; Rusch N, 2008, SCHIZOPHR RES, V99, P155, DOI 10.1016/j.schres.2007.05.024; Panzanelli P, 1997, BRAIN RES, V758, P143, DOI 10.1016/S0006-8993(97)00211-4; Meador-Woodruff JH, 2000, BRAIN RES REV, V31, P288, DOI 10.1016/S0165-0173(99)00044-2; Poels EMP, 2014, SCHIZOPHR RES, V152, P325, DOI 10.1016/j.schres.2013.12.013; Gardner DM, 2010, AM J PSYCHIAT, V167, P686, DOI 10.1176/appi.ajp.2009.09060802; Torgalsboen AK, 2014, PSYCHIAT RES, V216, P1, DOI 10.1016/j.psychres.2014.01.031; Lane HY, 2010, INT J NEUROPSYCHOPH, V13, P451, DOI 10.1017/S1461145709990939; Tanahashi S, 2012, BRIT J PHARMACOL, V165, P1543, DOI 10.1111/j.1476-5381.2011.01638.x; Chengappa KNR, 2012, SCHIZOPHR RES, V142, P145, DOI 10.1016/j.schres.2012.10.001; Ohrmann P, 2007, J PSYCHIATR RES, V41, P625, DOI 10.1016/j.jpsychires.2006.07.002; Imbesi M, 2008, NEUROSCI LETT, V447, P134, DOI 10.1016/j.neulet.2008.10.006; Malhotra AK, 1997, NEUROPSYCHOPHARMACOL, V17, P141; Marx CE, 2009, NEUROPSYCHOPHARMACOL, V34, P1885, DOI 10.1038/npp.2009.26; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Green MF, 2004, BIOL PSYCHIAT, V56, P301, DOI 10.1016/j.biopsych.2004.06.023; Javitt DC, 1999, SCHIZOPHRENIA BULL, V25, P763; D'Souza DC, 2013, NEUROPSYCHOPHARMACOL, V38, P492, DOI 10.1038/npp.2012.208; Smith CC, 2014, MOL PHARMACOL, V86, P390, DOI 10.1124/mol.114.094128; Malhotra AK, 1996, NEUROPSYCHOPHARMACOL, V14, P301, DOI 10.1016/0893-133X(95)00137-3; Wu Y, 2007, P NATL ACAD SCI USA, V104, P18163, DOI 10.1073/pnas.0708699104; Ohnuma T, 2012, INT J PSYCHIAT MED, V44, P17, DOI 10.2190/PM.44.1.b; Kantrowitz JT, 2010, SCHIZOPHR RES, V121, P125, DOI 10.1016/j.schres.2010.05.012; Schoemaker JH, 2014, J CLIN PSYCHOPHARM, V34, P190, DOI 10.1097/JCP.0000000000000073; Bakardjiev A, 1998, GLIA, V24, P346, DOI 10.1002/(SICI)1098-1136(199811)24:3<346::AID-GLIA9>3.0.CO;2-#; Takahata R, 2003, NEUROPSYCHOPHARMACOL, V28, P1117, DOI 10.1038/sj.npp.1300127; Choi KH, 2013, BRIT J PSYCHIAT, V203, P172, DOI 10.1192/bjp.bp.111.107359; Ibrahim HM, 2000, AM J PSYCHIAT, V157, P1811, DOI 10.1176/appi.ajp.157.11.1811; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Hashimoto K, 2013, EUR ARCH PSY CLIN N, V263, P367, DOI 10.1007/s00406-013-0399-y; Green MF, 1999, SCHIZOPHRENIA BULL, V25, P309; Levkovitz Y, 2010, J CLIN PSYCHIAT, V71, P138, DOI 10.4088/JCP.08m04666yel; CARONE FA, 1975, ARCH PATHOL, V99, P658; Reid MA, 2013, SCHIZOPHR RES, V147, P348, DOI 10.1016/j.schres.2013.04.036; Liu F, 2014, SCHIZOPHR RES, V153, P169, DOI 10.1016/j.schres.2014.01.011; Lieberman JA, 2008, PHARMACOL REV, V60, P358, DOI 10.1124/pr.107.00107; Hashimoto K, 2014, EXPERT OPIN THER TAR, V18, P1049, DOI 10.1517/14728222.2014.934225; Kegeles LS, 2012, ARCH GEN PSYCHIAT, V69, P449, DOI 10.1001/archgenpsychiatry.2011.1519; Egger M, 1997, BRIT MED J, V315, P629; Jackson ME, 2004, P NATL ACAD SCI USA, V101, P8467, DOI 10.1073/pnas.0308455101; LINDENMAYER JP, 1994, J NERV MENT DIS, V182, P631, DOI 10.1097/00005053-199411000-00006; Diaz P, 2005, J CLIN PSYCHOPHARM, V25, P277, DOI 10.1097/01.jcp.0000165740.22377.6d; Goldberg TE, 2007, ARCH GEN PSYCHIAT, V64, P1115, DOI 10.1001/archpsyc.64.10.1115; Lane HY, 2013, JAMA PSYCHIAT, V70, P1267, DOI 10.1001/jamapsychiatry.2013.2159; Shirayama Y, 2010, NEUROIMAGE, V49, P2783, DOI 10.1016/j.neuroimage.2009.10.031; Duncan EJ, 2004, SCHIZOPHR RES, V71, P239, DOI 10.1016/j.schres.2004.03.013; Goff DC, 2008, NEUROPSYCHOPHARMACOL, V33, P465, DOI 10.1038/sj.npp.1301444; Goff DC, 1999, ARCH GEN PSYCHIAT, V56, P21, DOI 10.1001/archpsyc.56.1.21; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Berk M, 2008, BIOL PSYCHIAT, V64, P361, DOI [10.1016/j.biopsych.2008.03.004, 10.1016/j.biopsych.2008.03-004]; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199; Kraguljac NV, 2013, JAMA PSYCHIAT, V70, P1294, DOI 10.1001/jamapsychiatry.2013.2437; Buchanan RW, 2007, AM J PSYCHIAT, V164, P1593, DOI 10.1176/appi.ajp.2007.06081358; Goff DC, 2001, J CLIN PSYCHOPHARM, V21, P484, DOI 10.1097/00004714-200110000-00005; Ventura J, 2009, SCHIZOPHR RES, V113, P189, DOI 10.1016/j.schres.2009.03.035; Tsai GC, 1998, BIOL PSYCHIAT, V44, P1081, DOI 10.1016/S0006-3223(98)00279-0; MacDonald ML, 2015, BIOL PSYCHIAT, V77, P959, DOI 10.1016/j.biopsych.2014.09.006; Hafner H, 2003, SCHIZOPHRENIA BULL, V29, P325; Corigliano V, 2014, PSYCHIAT RES, V220, P129, DOI 10.1016/j.psychres.2014.07.067; OLNEY JW, 1995, NEUROPSYCHOPHARMACOL, V13, P335, DOI 10.1016/0893-133X(95)00079-S; Sanacora G, 2008, NAT REV DRUG DISCOV, V7, P426, DOI 10.1038/nrd2462; Cain CK, 2014, SCHIZOPHR RES, V153, P177, DOI 10.1016/j.schres.2014.01.016; Heresco-Levy U, 2004, SCHIZOPHR RES, V66, P89, DOI 10.1016/S0920-9964(03)00129-4; Smythies J, 1999, EUR J PHARMACOL, V370, P1, DOI 10.1016/S0014-2999(99)00048-5; Ayesa-Arriola R, 2013, PSYCHIAT RES, V209, P302, DOI 10.1016/j.psychres.2013.01.024; Tsai GE, 2010, CURR PHARM DESIGN, V16, P522; HIRSCHBERG R, 1988, AM J NEPHROL, V8, P50, DOI 10.1159/000167553; Bustillo JR, 2011, BIOL PSYCHIAT, V69, P19, DOI 10.1016/j.biopsych.2010.08.024; Tsai GCE, 1999, AM J PSYCHIAT, V156, P1822; Higgins BM, 2011, AM J VET RES, V72, P905, DOI 10.2460/ajvr.72.7.905; Cascade Elisa F, 2007, Psychiatry (Edgmont), V4, P21; Coyle JT, 1996, HARVARD REV PSYCHIAT, V3, P241, DOI 10.3109/10673229609017192; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Guy W, 1976, ECDEU ASSESSMENT MAN, P218; Javitt D C, 1999, Curr Psychiatry Rep, V1, P25, DOI 10.1007/s11920-999-0007-z; Javitt DC, 2004, MOL PSYCHIATR, V9, P979, DOI 10.1038/sj.mp.4001602; Krysta Krzysztof, 2013, Psychiatr Danub, V25 Suppl 2, pS244; Milev P, 2005, AM J PSYCHIAT, V162, P495, DOI 10.1176/appi.ajp.162.3.495; OLNEY JW, 1995, ARCH GEN PSYCHIAT, V52, P998; Weiser Mark, 2012, J Clin Psychiatry, V73, pe728, DOI 10.4088/JCP.11m07031	83	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1359-4184	1476-5578		MOL PSYCHIATR	Mol. Psychiatr.	OCT	2015	20	10					1151	1160		10.1038/mp.2015.68		10	Biochemistry & Molecular Biology; Neurosciences; Psychiatry	Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry	CS2OE	WOS:000361909800002		
J	Tanaka, S; Takahashi, T; Koide, A; Ishihara, S; Koikeda, S; Koide, S				Tanaka, Shun-ichi; Takahashi, Tetsuya; Koide, Akiko; Ishihara, Satoru; Koikeda, Satoshi; Koide, Shohei			Monobody-mediated alteration of enzyme specificity	NATURE CHEMICAL BIOLOGY			English	Article							ACTIVE-SITE RESIDUES; BACILLUS-CIRCULANS; BINDING-PROTEINS; CYCLODEXTRIN GLYCOSYLTRANSFERASE; WHITE LYSOZYME; III DOMAIN; GALACTOSIDASE; MUTANTS; DESIGN; OLIGOSACCHARIDES	Current methods for engineering enzymes modify enzymes themselves and require a detailed mechanistic understanding or a high-throughput assay. Here, we describe a new approach where catalytic properties are modulated with synthetic binding proteins, termed monobodies, directed to an unmodified enzyme. Using the example of a beta-galactosidase from Bacillus circulans, we efficiently identified monobodies that restricted its substrates for its transgalactosylation reaction and selectively enhanced the production of small oligosaccharide prebiotics.	[Tanaka, Shun-ichi; Koide, Akiko; Koide, Shohei] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Tanaka, Shun-ichi; Takahashi, Tetsuya; Ishihara, Satoru; Koikeda, Satoshi] Amano Enzyme Inc, Gifu R&D Ctr, Frontier Res Dept, Gifu, Japan	Tanaka, S (reprint author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.	skoide@uchicago.edu			US National Institutes of Health grant [P30CA014599]	We acknowledge the use of the University of Chicago Genomics Core, which is supported by US National Institutes of Health grant P30CA014599 to the University of Chicago Comprehensive Cancer Center.	Ishikawa K, 2015, FEBS J, V282, P2540, DOI 10.1111/febs.13298; Wojcik J, 2010, NAT STRUCT MOL BIOL, V17, P519, DOI 10.1038/nsmb.1793; Davids T, 2013, CURR OPIN CHEM BIOL, V17, P215, DOI 10.1016/j.cbpa.2013.02.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Schmitt J, 2002, PROTEIN ENG, V15, P595, DOI 10.1093/protein/15.7.595; van der Veen BA, 2000, J MOL BIOL, V296, P1027, DOI 10.1006/jmbi.2000.3528; BLAKE CCF, 1967, PROC R SOC SER B-BIO, V167, P378, DOI 10.1098/rspb.1967.0035; WILKS HM, 1988, SCIENCE, V242, P1541, DOI 10.1126/science.3201242; Barile D, 2013, CURR OPIN BIOTECH, V24, P214, DOI 10.1016/j.copbio.2013.01.008; Song JY, 2011, BIOSCI BIOTECH BIOCH, V75, P268, DOI 10.1271/bbb.100574; Goldsmith M, 2012, CURR OPIN STRUC BIOL, V22, P406, DOI 10.1016/j.sbi.2012.03.010; Song JY, 2011, BIOSCI BIOTECH BIOCH, V75, P1194, DOI 10.1271/bbb.110014; Koide S, 2012, METHOD ENZYMOL, V503, P135, DOI 10.1016/B978-0-12-396962-0.00006-9; Koide A, 2012, J MOL BIOL, V415, P393, DOI 10.1016/j.jmb.2011.12.019; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Koide A, 2007, P NATL ACAD SCI USA, V104, P6632, DOI 10.1073/pnas.0700149104; Davies GJ, 1997, BIOCHEM J, V321, P557; Gilbreth RN, 2011, P NATL ACAD SCI USA, V108, P7751, DOI 10.1073/pnas.1102294108; Albayrak N, 2002, BIOTECHNOL BIOENG, V77, P8, DOI [10.1002/bit.1195, 10.1002/bit.1195.abs]; Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; Chen-Goodspeed M, 2001, BIOCHEMISTRY-US, V40, P1332, DOI 10.1021/bi001549d; STROKOPYTOV B, 1995, BIOCHEMISTRY-US, V34, P2234, DOI 10.1021/bi00007a018; Sha F, 2013, P NATL ACAD SCI USA, V110, P14924, DOI 10.1073/pnas.1303640110; Nishikori S, 2012, J MOL BIOL, V424, P391, DOI 10.1016/j.jmb.2012.09.022; Bultema JB, 2014, FEBS OPEN BIO, V4, P1015, DOI 10.1016/j.fob.2014.11.002; CHEN KQ, 1991, BIO-TECHNOL, V9, P1073, DOI 10.1038/nbt1191-1073; Li S, 2012, COMPUT STRUCT BIOTEC, V2, DOI [DOI 10.5936/CSBJ.201209017, 10.5936/csbj.201209017]; Mak WS, 2014, CURR OPIN STRUC BIOL, V27, P87, DOI 10.1016/j.sbi.2014.05.010	30	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2015	11	10					762	+		10.1038/NCHEMBIO.1896		5	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CR7NG	WOS:000361536500007		
J	Shibutani, ST; Saitoh, T; Nowag, H; Munz, C; Yoshimori, T				Shibutani, Shusaku T.; Saitoh, Tatsuya; Nowag, Heike; Muenz, Christian; Yoshimori, Tamotsu			Autophagy and autophagy-related proteins in the immune system	NATURE IMMUNOLOGY			English	Review							MHC CLASS-II; GENOME-WIDE ASSOCIATION; TOLL-LIKE RECEPTORS; T-CELL HOMEOSTASIS; CHAIN 3 PROTEIN; DENDRITIC CELLS; CROSS-PRESENTATION; INNATE IMMUNITY; MYCOBACTERIUM-TUBERCULOSIS; GENE ATG16L1	Autophagy is an intracellular bulk degradation system that is highly conserved in eukaryotes. The discovery of autophagy-related ('ATG') proteins in the 1990s greatly advanced the mechanistic understanding of autophagy and clarified the fact that autophagy serves important roles in various biological processes. In addition, studies have revealed other roles for the autophagic machinery beyond autophagy. In this Review, we introduce advances in the knowledge of the roles of autophagy and its components in immunity, including innate immunity, inflammatory responses and adaptive immunity.	[Shibutani, Shusaku T.; Yoshimori, Tamotsu] Osaka Univ, Grad Sch Frontier Biosci, Lab Intracellular Membrane Dynam, Osaka, Japan; [Shibutani, Shusaku T.; Yoshimori, Tamotsu] Osaka Univ, Grad Sch Med, Dept Genet, Osaka, Japan; [Saitoh, Tatsuya] Univ Tokushima, Inst Enzyme Res, Div Mol Genet, Tokushima, Tokushima, Japan; [Nowag, Heike; Muenz, Christian] Univ Zurich, Inst Expt Immunol, Viral Immunobiol, CH-8091 Zurich, Switzerland	Yoshimori, T (reprint author), Osaka Univ, Grad Sch Frontier Biosci, Lab Intracellular Membrane Dynam, Osaka, Japan.	tamyoshi@fbs.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Agency for Medical Research and Development CREST; Cancer Research Switzerland [KFS-3234-08-2013]; Worldwide Cancer Research [14-1033]; University of Zurich; Baugarten Foundation; Sobek Foundation; Fondation Acteria; Swiss Vaccine Research Institute; Swiss National Science Foundation [310030_143979, CRSII3_136241]	Supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (S.T.S., T.S. and Y.T.), the Japan Agency for Medical Research and Development CREST (S.T.S., T.S. and Y.T.), Cancer Research Switzerland (KFS-3234-08-2013 for H.N. and C.M.), Worldwide Cancer Research (14-1033 for H.N. and C.M.), the clinical research programs KFSP<SUP>MS</SUP> and KFSP<SUP>HHLD</SUP> of the University of Zurich (H.N. and C.M.), the Baugarten Foundation (H.N. and C.M.), the Sobek Foundation (H.N. and C.M.), Fondation Acteria (H.N. and C.M.), the Swiss Vaccine Research Institute (H.N. and C.M.) and the Swiss National Science Foundation (310030_143979 and CRSII3_136241 for H.N. and C.M.).	Abderrazak A, 2015, CIRCULATION, V131, P1061, DOI 10.1161/CIRCULATIONAHA.114.013730; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Lassen KG, 2014, P NATL ACAD SCI USA, V111, P7741, DOI 10.1073/pnas.1407001111; Collins AC, 2015, CELL HOST MICROBE, V17, P820, DOI 10.1016/j.chom.2015.05.005; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; Yanai H, 2013, P NATL ACAD SCI USA, V110, P20699, DOI 10.1073/pnas.1320808110; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Maejima I, 2013, EMBO J, V32, P2336, DOI 10.1038/emboj.2013.171; Arsov I, 2011, J IMMUNOL, V186, P2201, DOI 10.4049/jimmunol.1002223; Huang J, 2014, NAT REV MICROBIOL, V12, P101, DOI 10.1038/nrmicro3160; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Willinger T, 2012, P NATL ACAD SCI USA, V109, P8670, DOI 10.1073/pnas.1205305109; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; CLARK SL, 1957, J BIOPHYS BIOCHEM CY, V3, P349, DOI 10.1083/jcb.3.3.349; Kasai M, 2009, J IMMUNOL, V183, P7278, DOI 10.4049/jimmunol.0804087; Conway KL, 2013, GASTROENTEROLOGY, V145, P1347, DOI 10.1053/j.gastro.2013.08.035; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Dooley HC, 2014, MOL CELL, V55, P238, DOI 10.1016/j.molcel.2014.05.021; Liang XH, 1998, J VIROL, V72, P8586; Conway KL, 2013, AUTOPHAGY, V9, P528, DOI 10.4161/auto.23484; Farfariello V, 2012, J LEUKOCYTE BIOL, V92, P421, DOI 10.1189/jlb.0312123; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; Henault J, 2012, IMMUNITY, V37, P986, DOI 10.1016/j.immuni.2012.09.014; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Kovacs JR, 2012, CELL DEATH DIFFER, V19, P144, DOI 10.1038/cdd.2011.78; Shen SS, 2012, MOL CELL, V48, P667, DOI 10.1016/j.molcel.2012.09.013; Castillo EF, 2012, P NATL ACAD SCI USA, V109, pE3168, DOI 10.1073/pnas.1210500109; Blanchet FP, 2010, IMMUNITY, V32, P654, DOI 10.1016/j.immuni.2010.04.011; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Martins I, 2014, CELL DEATH DIFFER, V21, P79, DOI 10.1038/cdd.2013.75; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Lupfer C, 2013, NAT IMMUNOL, V14, P480, DOI 10.1038/ni.2563; Fujita N, 2009, J BIOL CHEM, V284, P32602, DOI 10.1074/jbc.M109.037671; Itakura E, 2010, AUTOPHAGY, V6, P764; Pua HH, 2009, J IMMUNOL, V182, P4046, DOI 10.4049/jimmunol.0801143; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; NOVIKOFF AB, 1959, J BIOPHYS BIOCHEM CY, V6, P136, DOI 10.1083/jcb.6.1.136; Johnstone C, 2012, IMMUNOL CELL BIOL, V90, P978, DOI 10.1038/icb.2012.43; Martinez J, 2015, NAT CELL BIOL, V17, P893, DOI 10.1038/ncb3192; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Pengo N, 2013, NAT IMMUNOL, V14, P298, DOI 10.1038/ni.2524; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Kristensen AR, 2008, MOL CELL PROTEOMICS, V7, P2419, DOI 10.1074/mcp.M800184-MCP200; Fiegl D, 2013, J IMMUNOL, V190, P2791, DOI 10.4049/jimmunol.1202741; Wenger T, 2012, AUTOPHAGY, V8, P350, DOI [10.4161/auto.18806, 10.4161/auto.8.3.18806]; Mostowy S, 2011, J BIOL CHEM, V286, P26987, DOI 10.1074/jbc.M111.223610; Jia KL, 2009, P NATL ACAD SCI USA, V106, P14564, DOI 10.1073/pnas.0813319106; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Fujita N, 2013, J CELL BIOL, V203, P115, DOI 10.1083/jcb.201304188; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Hwang S, 2012, CELL HOST MICROBE, V11, P397, DOI 10.1016/j.chom.2012.03.002; Ma J, 2012, J BIOL CHEM, V287, P34149, DOI 10.1074/jbc.M112.382812; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Dreux M, 2010, CELL CYCLE, V9, P1295; Dey B, 2015, NAT MED, V21, P401, DOI 10.1038/nm.3813; Shaw SY, 2013, ACS CHEM BIOL, V8, P2724, DOI 10.1021/cb400352d; Thorburn J, 2009, CELL DEATH DIFFER, V16, P175, DOI 10.1038/cdd.2008.143; Plantinga TS, 2011, GUT, V60, P1229, DOI 10.1136/gut.2010.228908; Yordy B, 2013, INT IMMUNOL, V25, P1, DOI 10.1093/intimm/dxs101; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; Kageyama S, 2011, MOL BIOL CELL, V22, P2290, DOI 10.1091/mbc.E10-11-0893; Romao S, 2013, J CELL BIOL, V203, P757, DOI 10.1083/jcb.201308173; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Parekh VV, 2013, J IMMUNOL, V190, P5086, DOI 10.4049/jimmunol.1202071; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tey SK, 2012, BLOOD, V120, P994, DOI 10.1182/blood-2012-01-402404; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; DeSelm CJ, 2011, DEV CELL, V21, P966, DOI [10.1016/j.devcel.2011.08.016, 10.1016/j.devce1.2011.08.016]; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Manzanillo PS, 2013, NATURE, V501, P512, DOI 10.1038/nature12566; Starr T, 2012, CELL HOST MICROBE, V11, P33, DOI 10.1016/j.chom.2011.12.002; Uhl M, 2009, CELL DEATH DIFFER, V16, P991, DOI 10.1038/cdd.2009.8; Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Ng ACY, 2011, P NATL ACAD SCI USA, V108, P4631, DOI 10.1073/pnas.1000093107; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Chaturvedi A, 2008, IMMUNITY, V28, P799, DOI 10.1016/j.immuni.2008.03.019; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; De Luca A, 2012, J CLIN INVEST, V122, P1816, DOI 10.1172/JCI60862; Orvedahl A, 2011, NATURE, V480, P113, DOI 10.1038/nature10546; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Taylor MP, 2009, J VIROL, V83, P6599, DOI 10.1128/JVI.01819-08; Huett A, 2012, CELL HOST MICROBE, V12, P778, DOI 10.1016/j.chom.2012.10.019; Fujita N, 2011, CURR OPIN CELL BIOL, V23, P492, DOI 10.1016/j.ceb.2011.03.003; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Leung CS, 2010, P NATL ACAD SCI USA, V107, P2165, DOI 10.1073/pnas.0909448107; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Miao YX, 2015, CELL, V161, P1306, DOI 10.1016/j.cell.2015.05.009; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; Romao S, 2013, SEMIN CANCER BIOL, V23, P391, DOI 10.1016/j.semcancer.2013.03.001; Guo WJ, 2014, AUTOPHAGY, V10, P972, DOI 10.4161/auto.28374; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Marshall RS, 2015, MOL CELL, V58, P1053, DOI 10.1016/j.molcel.2015.04.023; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Jia W, 2011, J IMMUNOL, V186, P1564, DOI 10.4049/jimmunol.1001822; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; Marchiando AM, 2013, CELL HOST MICROBE, V14, P216, DOI 10.1016/j.chom.2013.07.013; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Keller CW, 2011, J BIOL CHEM, V286, P3970, DOI 10.1074/jbc.M110.159392; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Pilli M, 2012, IMMUNITY, V37, P223, DOI 10.1016/j.immuni.2012.04.015; Yoneyama M, 2015, CURR OPIN IMMUNOL, V32, P48, DOI 10.1016/j.coi.2014.12.012; Liang QM, 2014, CELL HOST MICROBE, V15, P228, DOI 10.1016/j.chom.2014.01.009; Aichinger M, 2013, J EXP MED, V210, P287, DOI 10.1084/jem.20122149; Razani B, 2012, CELL METAB, V15, P534, DOI 10.1016/j.cmet.2012.02.011; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Manjithaya R, 2010, J CELL BIOL, V188, P537, DOI 10.1083/jcb.200911149; Benjamin JL, 2013, CELL HOST MICROBE, V13, P723, DOI 10.1016/j.chom.2013.05.004; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Wang CH, 2012, P NATL ACAD SCI USA, V109, P11008, DOI 10.1073/pnas.1203952109; Murthy A, 2014, NATURE, V506, P456, DOI 10.1038/nature13044; Henson SM, 2014, J CLIN INVEST, V124, P4004, DOI 10.1172/JCI75051; Li B, 2010, CANCER IMMUNOL IMMUN, V59, P313, DOI 10.1007/s00262-009-0752-1; Ireland JM, 2011, J EXP MED, V208, P2625, DOI 10.1084/jem.20110640; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Lei Y, 2012, IMMUNITY, V36, P933, DOI 10.1016/j.immuni.2012.03.025; Jounai N, 2011, J IMMUNOL, V186, P1646, DOI 10.4049/jimmunol.1001654; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; CUERVO AM, 1995, EUR J BIOCHEM, V227, P792, DOI 10.1111/j.1432-1033.1995.tb20203.x; Py BF, 2007, AUTOPHAGY, V3, P117; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Miller BC, 2008, AUTOPHAGY, V4, P309; Kobayashi S, 2010, AUTOPHAGY, V6, P36; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003; Ma J, 2014, J IMMUNOL, V192, P1356, DOI 10.4049/jimmunol.1302835; Li YH, 2008, CANCER RES, V68, P6889, DOI 10.1158/0008-5472.CAN-08-0161; Milan E, 2015, AUTOPHAGY, V11, P1161, DOI 10.1080/15548627.2015.1052928; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Dupont N, 2009, CELL HOST MICROBE, V6, P137, DOI 10.1016/j.chom.2009.07.005; Chen M, 2014, NAT MED, V20, P507, DOI 10.1038/nm.3521; Hung YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3111; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Jin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093143; Netea M.G., 2014, ANNU REV IMMUNOL, V33, P49; Nowag Heike, 2014, EBioMedicine, V1, P116, DOI 10.1016/j.ebiom.2014.11.007; Puleston D.J., 2014, ELIFE, V3, P3, DOI DOI 10.7554/ELIFE.03706; Robinson SM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004045; Xu XJ, 2014, NAT IMMUNOL, V15, P1152, DOI 10.1038/ni.3025; Ye W, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-100	169	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2015	16	10					1014	1024		10.1038/ni.3273		11	Immunology	Immunology	CR9OO	WOS:000361686500006		
J	Yoshida, K; Maekawa, T; Zhu, Y; Renard-Guillet, C; Chatton, B; Inoue, K; Uchiyama, T; Ishibashi, KI; Yamada, T; Ohno, N; Shirahige, K; Okada-Hatakeyama, M; Ishii, S				Yoshida, Keisuke; Maekawa, Toshio; Zhu, Yujuan; Renard-Guillet, Claire; Chatton, Bruno; Inoue, Kentaro; Uchiyama, Takeru; Ishibashi, Ken-ichi; Yamada, Takuji; Ohno, Naohito; Shirahige, Katsuhiko; Okada-Hatakeyama, Mariko; Ishii, Shunsuke			The transcription factor ATF7 mediates lipopolysaccharide-induced epigenetic changes in macrophages involved in innate immunological memory	NATURE IMMUNOLOGY			English	Article							TISSUE-RESIDENT MACROPHAGES; NF-KAPPA-B; ANALYSIS REVEALS; CDNA CLONES; CHIP-CHIP; BINDING; GENE; ACTIVATION; MONOCYTES; FAMILY	Immunological memory is thought to be mediated exclusively by lymphocytes. However, enhanced innate immune responses caused by a previous infection increase protection against reinfection, which suggests the presence of innate immunological memory. Here we identified an important role for the stress-response transcription factor ATF7 in innate immunological memory. ATF7 suppressed a group of genes encoding factors involved in innate immunity in macrophages by recruiting the histone H3K9 dimethyltransferase G9a. Treatment with lipopolysaccharide, which mimics bacterial infection, induced phosphorylation of ATF7 via the kinase p38, which led to the release of ATF7 from chromatin and a decrease in repressive histone H3K9me2 marks. A partially disrupted chromatin structure and increased basal expression of target genes were maintained for long periods, which enhanced resistance to pathogens. ATF7 might therefore be important in controlling memory in cells of the innate immune system.	[Yoshida, Keisuke; Maekawa, Toshio; Zhu, Yujuan; Ishii, Shunsuke] Japan Sci & Technol Agcy, RIKEN Tsukuba Inst, CREST Res Project, Lab Mol Genet, Tsukuba, Ibaraki, Japan; [Zhu, Yujuan; Ishii, Shunsuke] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Funct Genom, Tsukuba, Ibaraki, Japan; [Renard-Guillet, Claire; Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Lab Genome Struct & Funct, Tokyo, Japan; [Chatton, Bruno] Univ Strasbourg, Biotechnol & Signalisat Cellulaire UMR7242, Illkirch Graffenstaden, France; [Inoue, Kentaro; Okada-Hatakeyama, Mariko] RIKEN Ctr Integrat Med Sci, Lab Integrated Cellular Syst, Yokohama, Kanagawa, Japan; [Uchiyama, Takeru; Yamada, Takuji] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Yokohama, Kanagawa 227, Japan; [Ishibashi, Ken-ichi; Ohno, Naohito] Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Immunopharmacol Microbial Prod, Tokyo, Japan	Ishii, S (reprint author), Japan Sci & Technol Agcy, RIKEN Tsukuba Inst, CREST Res Project, Lab Mol Genet, Tsukuba, Ibaraki, Japan.	sishii@rtc.riken.jp		Yoshida, Keisuke/0000-0002-5579-9716	Ministry of Education, Culture, Sports, Science, and Technology	We thank K. Morikawa (University of Tsukuba) for S. aureus; the staff of the Research Resources Center of the RIKEN Brain Science Institute for microarray analysis; and Y. Shinkai (RIKEN) for discussions. Supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology.	Ichimura T, 2005, J BIOL CHEM, V280, P13928, DOI 10.1074/jbc.M413654200; Seong KH, 2012, GENES CELLS, V17, P249, DOI 10.1111/j.1365-2443.2012.01587.x; Hirose N, 2009, BIOCHEM BIOPH RES CO, V385, P72, DOI 10.1016/j.bbrc.2009.05.001; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Smyth GK, 2005, STAT BIOL HEALTH, P397; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; van Essen D, 2010, MOL CELL, V39, P750, DOI 10.1016/j.molcel.2010.08.010; Liu CL, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-19; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Hiroi M, 2003, J BIOL CHEM, V278, P651, DOI 10.1074/jbc.M204544200; Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Kurtz J, 2005, TRENDS IMMUNOL, V26, P186, DOI 10.1016/j.it.2005.02.001; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Sano Y, 1999, J BIOL CHEM, V274, P8949, DOI 10.1074/jbc.274.13.8949; GORHE DS, 1967, NATURE, V216, P1242, DOI 10.1038/2161242a0; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Droit A, 2010, BIOINFORMATICS, V26, P678, DOI 10.1093/bioinformatics/btq023; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; MAEKAWA T, 1989, EMBO J, V8, P2023; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Seong KH, 2011, CELL, V145, P1049, DOI 10.1016/j.cell.2011.05.029; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Benn CS, 2013, TRENDS IMMUNOL, V34, P431, DOI 10.1016/j.it.2013.04.004; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; FARBER JM, 1990, P NATL ACAD SCI USA, V87, P5238, DOI 10.1073/pnas.87.14.5238; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; GAIRE M, 1990, NUCLEIC ACIDS RES, V18, P3467, DOI 10.1093/nar/18.12.3467; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Ishibashia K, 2002, INT IMMUNOPHARMACOL, V2, P1109, DOI 10.1016/S1567-5769(02)00062-0; Maekawa T, 2010, EMBO J, V29, P184, DOI 10.1038/emboj.2009.318; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Shivers RP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000892; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490	59	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2015	16	10					1034	+		10.1038/ni.3257		12	Immunology	Immunology	CR9OO	WOS:000361686500008		
J	Takada, K; Van Laethem, F; Xing, Y; Akane, K; Suzuki, H; Murata, S; Tanaka, K; Jameson, SC; Singer, A; Takahama, Y				Takada, Kensuke; Van Laethem, Francois; Xing, Yan; Akane, Kazuyuki; Suzuki, Haruhiko; Murata, Shigeo; Tanaka, Keiji; Jameson, Stephen C.; Singer, Alfred; Takahama, Yousuke			TCR affinity for thymoproteasome-dependent positively selecting peptides conditions antigen responsiveness in CD8(+) T cells	NATURE IMMUNOLOGY			English	Article							CORTICAL EPITHELIAL-CELLS; CLASS-I MOLECULES; MHC CLASS-I; NEGATIVE SELECTION; DEVELOPING THYMOCYTES; MEMORY PHENOTYPE; SELF-PEPTIDES; MICE; REPERTOIRE; RECOGNITION	In the thymus, low-affinity T cell antigen receptor (TCR) engagement facilitates positive selection of a useful T cell repertoire. Here we report that TCR responsiveness of mature CD8(+) T cells is fine tuned by their affinity for positively selecting peptides in the thymus and that optimal TCR responsiveness requires positive selection on major histocompatibility complex class I-associated peptides produced by the thymoproteasome, which is specifically expressed in the thymic cortical epithelium. Thymoproteasome-independent positive selection of monoclonal CD8(+) T cells results in aberrant TCR responsiveness, homeostatic maintenance and immune responses to infection. These results demonstrate a novel aspect of positive selection, in which TCR affinity for positively selecting peptides produced by thymic epithelium determines the subsequent antigen responsiveness of mature CD8(+) T cells in the periphery.	[Takada, Kensuke; Takahama, Yousuke] Univ Tokushima, Inst Genome Res, Div Expt Immunol, Tokushima, Tokushima, Japan; [Van Laethem, Francois; Singer, Alfred] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Xing, Yan; Jameson, Stephen C.] Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55455 USA; [Akane, Kazuyuki; Suzuki, Haruhiko] Nagoya Univ, Dept Immunol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Murata, Shigeo] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Tokyo 113, Japan	Takahama, Y (reprint author), Univ Tokushima, Inst Genome Res, Div Expt Immunol, Tokushima, Tokushima, Japan.	takahama@genome.tokushima-u.ac.jp			MEXT-JSPS [24111004, 23249025, 24790475, 26460576]; Naito Foundation; Takeda Science Foundation; Uehara Memorial Foundation	We thank H. Kosako, I. Ohigashi, M. Kozai and B. Kim for helpful discussion and reading the manuscript. This work was supported by grants from MEXT-JSPS (24111004 and 23249025 to Y.T. and 24790475 and 26460576 to K. Takada), Naito Foundation (to Y.T. and K. Takada), Takeda Science Foundation (to K. Takada), and Uehara Memorial Foundation (to K. Takada).	BEVAN MJ, 1981, IMMUNOL TODAY, V2, P216, DOI 10.1016/0167-5699(81)90050-5; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Persaud SP, 2014, NAT IMMUNOL, V15, P266, DOI 10.1038/ni.2822; Sosinowski T, 2013, J IMMUNOL, V190, P1936, DOI 10.4049/jimmunol.1203149; Joncker NT, 2009, J IMMUNOL, V182, P4572, DOI 10.4049/jimmunol.0803900; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Haluszczak C, 2009, J EXP MED, V206, P435, DOI 10.1084/jem.20081829; Brodin P, 2009, TRENDS IMMUNOL, V30, P143, DOI 10.1016/j.it.2009.01.006; Santori FR, 2002, IMMUNITY, V17, P131, DOI 10.1016/S1074-7613(02)00361-8; ALLEN PM, 1994, CELL, V76, P593, DOI 10.1016/0092-8674(94)90497-9; Xing Y, 2013, P NATL ACAD SCI USA, V110, P6979, DOI 10.1073/pnas.1222244110; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Obar JJ, 2011, J IMMUNOL, V187, P4967, DOI 10.4049/jimmunol.1102335; Van Laethem F, 2013, CELL, V154, P1326, DOI 10.1016/j.cell.2013.08.009; Haring JS, 2005, J IMMUNOL, V174, P6791; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; VANKAER L, 1992, CELL, V71, P1205; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; ANDERSON G, 1994, J EXP MED, V179, P2027, DOI 10.1084/jem.179.6.2027; Nitta T, 2010, IMMUNITY, V32, P29, DOI 10.1016/j.immuni.2009.10.009; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; VONBOEHMER H, 1988, ANNU REV IMMUNOL, V6, P309, DOI 10.1146/annurev.immunol.6.1.309; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Brodin P, 2009, BLOOD, V113, P2434, DOI 10.1182/blood-2008-05-156836; Juang J, 2010, J EXP MED, V207, P1223, DOI 10.1084/jem.20092170; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; Fu G, 2014, TRENDS IMMUNOL, V35, P311, DOI 10.1016/j.it.2014.05.003; BRANDLE D, 1991, EUR J IMMUNOL, V21, P2195, DOI 10.1002/eji.1830210930; Love PE, 2000, J IMMUNOL, V165, P3080; Hogquist KA, 2014, NAT IMMUNOL, V15, P815, DOI 10.1038/ni.2938; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Capone M, 2001, BLOOD, V97, P1336, DOI 10.1182/blood.V97.5.1336; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; MAMALAKI C, 1993, DEV IMMUNOL, V3, P159, DOI 10.1155/1993/98015; Takahama Y, 2012, CURR OPIN IMMUNOL, V24, P92, DOI 10.1016/j.coi.2012.01.006; Hogquist KA, 1997, IMMUNITY, V6, P389, DOI 10.1016/S1074-7613(00)80282-4; MORSE HC, 1987, IMMUNOGENETICS, V25, P71, DOI 10.1007/BF00364270; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; Fulton RB, 2015, NAT IMMUNOL, V16, P107, DOI 10.1038/ni.3043; Lee JY, 2013, P NATL ACAD SCI USA, V110, P13498, DOI 10.1073/pnas.1307572110; Mandl JN, 2013, IMMUNITY, V38, P263, DOI 10.1016/j.immuni.2012.09.011; Sasaki K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8484; Takada Kensuke, 2015, Adv Immunol, V125, P87, DOI 10.1016/bs.ai.2014.09.003	46	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2015	16	10					1069	+		10.1038/ni.3237		9	Immunology	Immunology	CR9OO	WOS:000361686500012		
J	Kim, YS; Liu, MJ; Ishida, Y; Ebina, Y; Osada, M; Sasaki, T; Hikima, T; Takata, M; Aida, T				Kim, Youn Soo; Liu, Mingjie; Ishida, Yasuhiro; Ebina, Yasuo; Osada, Minoru; Sasaki, Takayoshi; Hikima, Takaaki; Takata, Masaki; Aida, Takuzo			Thermoresponsive actuation enabled by permittivity switching in an electrostatically anisotropic hydrogel	NATURE MATERIALS			English	Article							LONG-RANGE; NANOSHEETS; POLY(N-ISOPROPYLACRYLAMIDE); SPECTROSCOPY; TRANSITION; REPULSION; WATER	Electrostatic repulsion, long used for attenuating surface friction(1,2), is not typically employed for the design of bulk structural materials. We recently developed a hydrogel(3) with a layered structure consisting of cofacially oriented electrolyte nanosheets(4). Because this unusual geometry imparts a large anisotropic electrostatic repulsion(5) to the hydrogel interior, the hydrogel resisted compression orthogonal to the sheets but readily deformed along parallel shear. Building on this concept, here we show a hydrogel actuator(6-11) that operates by modulating its anisotropic electrostatics(12) in response to changes of electrostatic permittivity associated with a lower critical solution temperature transition(3,14). In the absence of substantial water uptake and release, the distance between the nanosheets rapidly expands and contracts on heating and cooling, respectively, so that the hydrogel lengthens and shortens significantly, even in air. An L-shaped hydrogel with an oblique nanosheet configuration can thus act as a unidirectionally proceeding actuator that operates without the need for external physical biases(15-18).	[Kim, Youn Soo; Aida, Takuzo] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; [Liu, Mingjie; Ishida, Yasuhiro; Aida, Takuzo] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan; [Ebina, Yasuo; Osada, Minoru; Sasaki, Takayoshi] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan; [Hikima, Takaaki; Takata, Masaki] RIKEN, SPring Ctr 8, Sayo, Hyogo 6795198, Japan	Ishida, Y (reprint author), RIKEN, Ctr Emergent Matter Sci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	y-ishida@riken.jp; aida@macro.t.u-tokyo.ac.jp	Ishida, Yasuhiro/I-8204-2012; Liu, Mingjie/G-1109-2010	Liu, Mingjie/0000-0003-0824-9858	JSPS;  [25000005]	This work was financially supported by a Grant-in-Aid for Specially Promoted Research (25000005) on 'Physically Perturbed Assembly for Tailoring High-Performance Soft Materials with Controlled Macroscopic Structural Anisotropy'. We also acknowledge the ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan). Y.S.K. thanks JSPS for a Young Scientist Fellowship. The small-angle X-ray scattering measurements were performed at BL45XU in SPring-8 with the approval of the RIKEN SPring-8 Center (proposal 20140073).	ANANDARAJAH A, 1991, INT J NUMER ANAL MET, V15, P683, DOI 10.1002/nag.1610151002; TORBET J, 1981, NATURE, V289, P91, DOI 10.1038/289091a0; Kohlmeyer RR, 2013, ANGEW CHEM INT EDIT, V52, P9234, DOI 10.1002/anie.201210232; Gomez-Galvan F, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/2/025602; SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R; OSADA Y, 1992, NATURE, V355, P242, DOI 10.1038/355242a0; Kim J, 2011, NAT MATER, V10, P747, DOI [10.1038/nmat3090, 10.1038/NMAT3090]; Yao ZW, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.042605; Pelton R, 2000, ADV COLLOID INTERFAC, V85, P1, DOI 10.1016/S0001-8686(99)00023-8; SHIBAYAMA M, 1993, ADV POLYM SCI, V109, P1; RHIM WK, 1993, REV SCI INSTRUM, V64, P2961, DOI 10.1063/1.1144475; Fujisawa T, 2000, J APPL CRYSTALLOGR, V33, P797, DOI 10.1107/S002188980000131X; Maeda Y, 2000, LANGMUIR, V16, P7503, DOI 10.1021/la0001575; Ida S, 2008, J AM CHEM SOC, V130, P7052, DOI 10.1021/ja7114772; Fullbrandt M, 2014, J PHYS CHEM B, V118, P3750, DOI 10.1021/jp501325x; Xia LW, 2010, J COLLOID INTERF SCI, V349, P106, DOI 10.1016/j.jcis.2010.05.070; Cui HG, 2010, SCIENCE, V327, P555, DOI 10.1126/science.1182340; Morales D, 2014, SOFT MATTER, V10, P1337, DOI 10.1039/c3sm51921j; Osada M, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.153301; Sasaki T, 1996, J AM CHEM SOC, V118, P8329, DOI 10.1021/ja960073b; YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0; Palmer LC, 2014, J AM CHEM SOC, V136, P14377, DOI [10.1021/ja5082519, 10.1021/ja50825191]; Hull JR, 2000, SUPERCOND SCI TECH, V13, pR1, DOI 10.1088/0953-2048/13/2/201; Liu MJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3029; Liu MJ, 2015, NATURE, V517, P68, DOI 10.1038/nature14060; Pagonis K, 2004, POLYMER, V45, P2149, DOI 10.1016/j.polymer.2004.01.063; Smalley M, 2006, CLAY SWELLING COLLOI; Verwey E. J. W., 1948, THEORY STABILITY LYO	28	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-1122	1476-4660		NAT MATER	Nat. Mater.	OCT	2015	14	10					1002	1007		10.1038/NMAT4363		6	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CS0SF	WOS:000361771800019		
J	Takahashi, H; Sugimoto, A; Nambu, Y; Yamauchi, T; Hirata, Y; Kawakami, T; Avdeev, M; Matsubayashi, K; Du, F; Kawashima, C; Soeda, H; Nakano, S; Uwatoko, Y; Ueda, Y; Sato, TJ; Ohgushi, K				Takahashi, Hiroki; Sugimoto, Akira; Nambu, Yusuke; Yamauchi, Touru; Hirata, Yasuyuki; Kawakami, Takateru; Avdeev, Maxim; Matsubayashi, Kazuyuki; Du, Fei; Kawashima, Chizuru; Soeda, Hideto; Nakano, Satoshi; Uwatoko, Yoshiya; Ueda, Yutaka; Sato, Taku J.; Ohgushi, Kenya			Pressure-induced superconductivity in the iron-based ladder material BaFe2S3	NATURE MATERIALS			English	Article								All the iron-based superconductors identified so far share a square lattice composed of Fe atoms as a common feature, despite having different crystal structures. In copper-based materials, the superconducting phase emerges not only in square-lattice structures but also in ladder structures. Yet iron-based superconductors without a square-lattice motif have not been found, despite being actively sought out. Here, we report the discovery of pressure-induced superconductivity in the iron-based spin-ladder material BaFe2S3, a Mott insulator with striped-type magnetic ordering below similar to 120 K. On the application of pressure this compound exhibits a metal-insulator transition at about 11 GPa, followed by the appearance of superconductivity below T-c = 14 K, right after the onset of the metallic phase. Our findings indicate that iron-based ladder compounds represent promising material platforms, in particular for studying the fundamentals of iron-based superconductivity.	[Takahashi, Hiroki; Sugimoto, Akira; Kawakami, Takateru; Kawashima, Chizuru; Soeda, Hideto] Nihon Univ, Coll Humanities & Sci, Setagaya Ku, Tokyo 1568550, Japan; [Nambu, Yusuke; Sato, Taku J.] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan; [Nambu, Yusuke] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Yamauchi, Touru; Hirata, Yasuyuki; Matsubayashi, Kazuyuki; Du, Fei; Uwatoko, Yoshiya; Ueda, Yutaka; Ohgushi, Kenya] Univ Tokyo, ISSP, Kashiwa, Chiba 2778581, Japan; [Avdeev, Maxim] Australian Nucl Sci & Technol Org, Bragg Inst, Kirrawee Dc, NSW 2232, Australia; [Avdeev, Maxim] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [Du, Fei] Jilin Univ, Coll Phys, Minist Educ, Key Lab Phys & Technol Adv Batteries, Changchun 130012, Peoples R China; [Nakano, Satoshi] Natl Inst Mat Sci, Ultra High Pressure Proc Grp, Tsukuba, Ibaraki 3050044, Japan; [Ueda, Yutaka] Toyota Phys & Chem Res Inst, Nagakute, Aichi 4801192, Japan; [Ohgushi, Kenya] Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan	Takahashi, H (reprint author), Nihon Univ, Coll Humanities & Sci, Setagaya Ku, Tokyo 1568550, Japan.	hiroki@chs.nihon-u.ac.jp; ohgushi@m.tohoku.ac.jp	Nambu, Yusuke/C-3863-2012; Du, Fei/E-1563-2012; Sato, Taku/I-7664-2015; Ohgushi, Kenya/K-5319-2012	Nambu, Yusuke/0000-0003-1167-7124; Sato, Taku/0000-0003-2511-4998; 	JSPS [23244068, 23340097, 24340088, 26287073, 26800175]; Strategic Research Base Development Program for Private Universities of MEXT [S0901022]; Grant Program of the Yamada Science Foundation	This work was partly supported by JSPS Grants-in-Aid for Scientific Research (A) (23244068), for Scientific Research (B) (23340097, 24340088 and 26287073) and for Young Scientists (B) (26800175), the Strategic Research Base Development Program for Private Universities (2009, S0901022) of MEXT and the Grant Program of the Yamada Science Foundation. The synchrotron radiation X-ray experiments were performed at BL-18C of KEK-PF under the approval of Proposal No. 2014G587.	Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Caron JM, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.180405; Takahashi H, 2008, NATURE, V453, P376, DOI 10.1038/nature06972; Luo QL, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.024404; Dagotto E, 1996, SCIENCE, V271, P618, DOI 10.1126/science.271.5249.618; Ye F, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.137003; Lv WC, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.094508; Gonen ZS, 2000, CHEM MATER, V12, P3331, DOI 10.1021/cm0000346; Saparov B, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.245132; Uehara M, 1996, J PHYS SOC JPN, V65, P2764, DOI 10.1143/JPSJ.65.2764; Dagotto E, 2013, REV MOD PHYS, V85, P849, DOI 10.1103/RevModPhys.85.849; Krzton-Maziopa A, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/40/402201; Du F, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.214436; HONG HY, 1972, J SOLID STATE CHEM, V5, P93, DOI 10.1016/0022-4596(72)90015-1; Luo QL, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.035128; Dai PC, 2012, NAT PHYS, V8, P709, DOI 10.1038/NPHYS2438; Kuroki K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.087004; Caron JM, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.180409; Guo JG, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.180520; Hisada A, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.073703; Lei HC, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.214511; Luo QL, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.045115; Mazin I.I., 2008, PHYS REV LETT, V101; Medvedev M. V., 2012, JETP LETT, V95, P37; Monney C, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.165103; Nambu Y, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.064413; Onari S, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.187001; Rotter M, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.020503; Uehara M., 2005, FRONTIERS MAGNETIC M	29	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-1122	1476-4660		NAT MATER	Nat. Mater.	OCT	2015	14	10					1008	+		10.1038/NMAT4351		6	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CS0SF	WOS:000361771800020		
J	Fujii, M; Matano, M; Nanki, K; Sato, T				Fujii, Masayuki; Matano, Mami; Nanki, Kosaku; Sato, Toshiro			Efficient genetic engineering of human intestinal organoids using electroporation	NATURE PROTOCOLS			English	Article							STEM-CELLS; MAMMALIAN-CELLS	Gene modification in untransformed human intestinal cells is an attractive approach for studying gene function in intestinal diseases. However, because of the lack of practical tools, such studies have largely depended upon surrogates, such as gene-engineered mice or immortalized human cell lines. By taking advantage of the recently developed intestinal organoid culture method, we developed a methodology for modulating genes of interest in untransformed human colonic organoids via electroporation of gene vectors. Here we describe a detailed protocol for the generation of intestinal organoids by culture with essential growth factors in a basement membrane matrix. We also describe how to stably integrate genes via the piggyBac transposon, as well as precise genome editing using the CRCRISPRSPRSPR-Cas9 system. Beginning with crypt isolation from a human colon sample, genetically modified organoids can be obtained in 3 weeks.	[Fujii, Masayuki; Matano, Mami; Nanki, Kosaku; Sato, Toshiro] Keio Univ, Sch Med, Dept Gastroenterol, Tokyo, Japan; [Fujii, Masayuki] Univ Tokyo, Dept Surg Oncol, Tokyo, Japan	Sato, T (reprint author), Keio Univ, Sch Med, Dept Gastroenterol, Tokyo, Japan.	t.sato@a7.keio.jp			Project for Development of Innovative Research on Cancer Therapeutics (P-Direct); Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by grants from a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), by a Grant-in-Aid for Scientific Research on Innovative Areas 'Stem Cell Aging and Disease' and by Grants-in-Aid for Scientific Research, Ministry of Education, Culture, Sports, Science and Technology of Japan. L-Wnt3A cells and the R-spondin1-producing cell line were kindly gifted by H. Clevers (Hubrecht Institute) and C. Kuo (Stanford University), respectively.	Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Melkonyan H, 1996, NUCLEIC ACIDS RES, V24, P4356, DOI 10.1093/nar/24.21.4356; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Wang FC, 2013, GASTROENTEROLOGY, V145, P383, DOI 10.1053/j.gastro.2013.04.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/nmeth.1802, 10.1038/NMETH.1802]; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; Schwank G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076871; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002	11	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1754-2189	1750-2799		NAT PROTOC	Nat. Protoc.	OCT	2015	10	10					1474	1485		10.1038/nprot.2015.088		12	Biochemical Research Methods	Biochemistry & Molecular Biology	CS1NE	WOS:000361832200002		
J	Shiomi, H; Kimura, T				Shiomi, Hiroki; Kimura, Takeshi			INTERVENTIONAL CARDIOLOGY Nonprimary PCI at centres without onsite surgical backup	NATURE REVIEWS CARDIOLOGY			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION; EXPERT CONSENSUS DOCUMENT; SITE CARDIAC-SURGERY; CARDIOVASCULAR ANGIOGRAPHY; TASK-FORCE; HOSPITALS		[Shiomi, Hiroki; Kimura, Takeshi] Kyoto Univ, Dept Cardiovasc Med, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan	Kimura, T (reprint author), Kyoto Univ, Dept Cardiovasc Med, Grad Sch Med, Sakyo Ku, Shogoin Kawahara Cho, Kyoto 6068501, Japan.	taketaka@kuhp.kyoto-u.ac.jp					Aversano T, 2012, NEW ENGL J MED, V366, P1792, DOI 10.1056/NEJMoa1114540; Bashore TM, 2012, J AM COLL CARDIOL, V59, P2221, DOI 10.1016/j.jacc.2012.02.010; Lee JM, 2015, CIRCULATION, V132, P388, DOI 10.1161/CIRCULATIONAHA.115.016137; Dehmer GJ, 2014, J AM COLL CARDIOL, V63, P2624, DOI 10.1016/j.jacc.2014.03.002; Jacobs AK, 2013, NEW ENGL J MED, V368, P1498, DOI 10.1056/NEJMoa1300610; Kutcher MA, 2009, J AM COLL CARDIOL, V54, P16, DOI 10.1016/j.jacc.2009.03.038; Levine GN, 2011, CIRCULATION, V124, pE574, DOI 10.1161/CIR.0b013e31823ba622; Zia M. I., 2011, CAN J CARDIOL, V27	8	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1759-5002	1759-5010		NAT REV CARDIOL	Nat. Rev. Cardiol.	OCT	2015	12	10					563	564		10.1038/nrcardio.2015.131		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CR9PR	WOS:000361689400001		
J	Sasaki, A; Kakita, A; Yoshida, K; Konno, T; Ikeuchi, T; Hayashi, S; Matsuo, H; Shioda, K				Sasaki, Atsushi; Kakita, Akiyoshi; Yoshida, Kunihiro; Konno, Takuya; Ikeuchi, Takeshi; Hayashi, Shintaro; Matsuo, Hidenori; Shioda, Kei			Variable expression of microglial DAP12 and TREM2 genes in Nasu-Hakola disease	NEUROGENETICS			English	Article						DAP12; Macrophage; Microglia; Nasu-Hakola disease; PLOSL; TREM2	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA; BONE-CYSTS; PRESENILE-DEMENTIA; SCLEROSING LEUKOENCEPHALOPATHY; MEMBRANOUS LIPODYSTROPHY; ALZHEIMERS-DISEASE; CELLS; RECEPTORS; BRAIN; CNS	Nasu-Hakola disease (NHD) is a form of presenile dementia associated with sclerosing leukoencephalopathy and polycystic lipomembranous osteodysplasia. This extremely rare inherited disease is caused by mutations in either DAP12 or TREM2. The present study was designed to assess the relationship between DAP12/TREM2 genotype, mRNA and protein expression levels by both Western blotting and immunohistochemistry, and the tissue distribution and pathomorphological phenotype of the microglia. Molecular genetic testing performed in three NHD cases confirmed that two cases had mutations in DAP12 and that one case carried a mutation in TREM2. Protein levels were analyzed in four cases. Interestingly, significant DAP12 expression was found in numerous microglia in one NHD case with a homozygous DAP12 single-base substitution, and both real-time PCR and Western blotting confirmed the finding. In contrast, levels of both DAP12 and TREM2, respectively, were much lower in the other cases. Immunohistochemistry using established microglial markers revealed consistently mild activation of microglia in the cerebral white matter although there was no or only little expression of DAP12 in three of the NHD cases. The highly different expression of DAP12 represents the first description of such variable expressivity in NHD microglia. It raises important questions regarding the mechanisms underlying dementia and white matter damage in NHD.	[Sasaki, Atsushi; Shioda, Kei] Saitama Med Univ, Dept Pathol, Iruma, Saitama 3500495, Japan; [Kakita, Akiyoshi] Niigata Univ, Brain Res Inst, Dept Pathol, Niigata, Japan; [Yoshida, Kunihiro] Shinshu Univ, Sch Med, Dept Brain Dis Res, Matsumoto, Nagano 390, Japan; [Konno, Takuya] Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan; [Ikeuchi, Takeshi] Niigata Univ, Brain Res Inst, Dept Mol Genet, Niigata, Japan; [Hayashi, Shintaro] Mishima Hosp, Dept Neurol, Niigata, Japan; [Matsuo, Hidenori] Nagasaki Kawatana Med Ctr, Dept Neurol, Nagasaki, Japan	Sasaki, A (reprint author), Saitama Med Univ, Dept Pathol, 38 Morohongo, Iruma, Saitama 3500495, Japan.	asasaki@saitama-med.ac.jp	Konno, Takuya/P-8920-2015		Ministry of Education, Culture, Supports, Science and Technology, Japan [25430051]; Research Committee for Hereditary Cerebral Small Vessel Disease and Associated Disorders from the Ministry of Health, Labour and Welfare, Japan	The authors would like to thank Drs. T Togo and N Aoki for supplying tissue samples. The expert technical assistance of Tomio Honma and Toshinori Nagai is gratefully acknowledged. This work was supported by a Grant-in-Aid for Scientific Research (C) (25430051) from the Ministry of Education, Culture, Supports, Science and Technology, Japan, and by a Grant-in-Aid from the Research Committee for Hereditary Cerebral Small Vessel Disease and Associated Disorders from the Ministry of Health, Labour and Welfare, Japan.	Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Thrash JC, 2009, NEUROCHEM RES, V34, P38, DOI 10.1007/s11064-008-9657-1; MEHDI H, 1990, GENE, V91, P173, DOI 10.1016/0378-1119(90)90085-6; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Montalbetti L, 2005, FUNCT NEUROL, V20, P71; Paloneva J, 2000, NAT GENET, V25, P357; Kiialainen A, 2005, NEUROBIOL DIS, V18, P314, DOI 10.1016/j.nbd.2004.09.007; Arai H, 1997, J BONE MINER RES, V12, P915, DOI 10.1359/jbmr.1997.12.6.915; Kielar C, 2009, HUM MOL GENET, V18, P4066, DOI 10.1093/hmg/ddp355; SASAKI A, 1992, NEUROPATH APPL NEURO, V18, P13, DOI 10.1111/j.1365-2990.1992.tb00761.x; Husemann J, 2002, GLIA, V40, P195, DOI 10.1002/glia.10148; PAULUS W, 1992, ACTA NEUROPATHOL, V84, P538; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Satoh J, 2011, NEUROPATHOLOGY, V31, P363, DOI 10.1111/j.1440-1789.2010.01174.x; Kondo T, 2002, NEUROLOGY, V59, P1105; Otero K, 2009, NAT IMMUNOL, V10, P734, DOI 10.1038/ni.1744; Paloneva J, 2001, NEUROLOGY, V56, P1552; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; Kaneko M, 2010, NEUROPATHOLOGY, V30, P463, DOI 10.1111/j.1440-1789.2010.01127.x; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; NASU T, 1973, ACTA PATHOL JAPON, V23, P539; MINAGAWA M, 1985, CLIN NEUROPATHOL, V4, P38; Aoki N, 2011, NEUROPATHOLOGY, V31, P135, DOI 10.1111/j.1440-1789.2010.01152.x; Verloes A, 1997, J MED GENET, V34, P753, DOI 10.1136/jmg.34.9.753; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Neumann H, 2013, NEW ENGL J MED, V368, P182, DOI 10.1056/NEJMe1213157; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; Pekkarinen P, 1998, AM J HUM GENET, V62, P362, DOI 10.1086/301722; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Bianchin MM, 2004, CELL MOL NEUROBIOL, V24, P1, DOI 10.1023/B:CEMN.0000012721.08168.ee; Wakselman S, 2008, J NEUROSCI, V28, P8138, DOI 10.1523/JNEUROSCI.1006-08.2008; Trapp BD, 2007, GLIA, V55, P360, DOI 10.1002/glia.20462; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Chouery Eliane, 2008, Hum Mutat, V29, pE194, DOI 10.1002/humu.20836; Giuliano S, 2014, PLOS ONE, V9; Guerreiro, 2013, NEW ENGL J MED, V368, P117; Hakola H P, 1972, Acta Psychiatr Scand Suppl, V232, P1; Kettenmann K, 2013, NEURON, V77, P10; Konno T, 2013, NEUROLOGY, V82, P139; Lue LF, 2015, BRAIN PATHOL, V25, P469, DOI 10.1111/bpa.12190; Lue LF, 2015, NEUROSCIENCE, V302, P138, DOI 10.1016/j.neuroscience.2014.09.050; Numasawa Y, 2010, EUR J NEUROL, V18, P1179, DOI [10.1111/j.1468-1331.2010.03311.x, DOI 10.1111/J.1468-1331.2010.03311.X]; Sierra A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00006	46	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1364-6745	1364-6753		NEUROGENETICS	Neurogenetics	OCT	2015	16	4					265	276		10.1007/s10048-015-0451-3		12	Genetics & Heredity; Clinical Neurology	Genetics & Heredity; Neurosciences & Neurology	CR7VG	WOS:000361559100002		
J	Kon, T; Nishijima, H; Haga, R; Funamizu, Y; Ueno, T; Arai, A; Suzuki, C; Nunomura, J; Baba, M; Tomiyama, M				Kon, Tomoya; Nishijima, Haruo; Haga, Rie; Funamizu, Yukihisa; Ueno, Tatsuya; Arai, Akira; Suzuki, Chieko; Nunomura, Jin-ichi; Baba, Masayuki; Tomiyama, Masahiko			Lateral medullary infarction masquerading as involvement of spinal cord	NEUROLOGICAL SCIENCES			English	Letter							PURE SENSORY DEFICIT; ISOLATED MANIFESTATION; LEVEL		[Kon, Tomoya; Nishijima, Haruo; Haga, Rie; Funamizu, Yukihisa; Ueno, Tatsuya; Arai, Akira; Suzuki, Chieko; Nunomura, Jin-ichi; Baba, Masayuki; Tomiyama, Masahiko] Aomori Prefectural Cent Hosp, Dept Neurol, Aomori, Aomori 0308553, Japan	Kon, T (reprint author), Aomori Prefectural Cent Hosp, Dept Neurol, 2-1-1 Higashi Tsukurimichi, Aomori, Aomori 0308553, Japan.	tk10608pc@nifty.com		Nishijima, Haruo/0000-0002-1065-664X			Xia C, 2013, NEUROL INDIA, V61, P327, DOI 10.4103/0028-3886.115096; Hongo H, 2014, J STROKE CEREBROVASC, V23, P182, DOI 10.1016/j.jstrokecerebrovasdis.2012.09.011; Song IU, 2007, J CLIN NEUROL, V3, P112, DOI 10.3988/jcn.2007.3.2.112; Phan TG, 1999, J NEUROL NEUROSUR PS, V66, P691, DOI 10.1136/jnnp.66.5.691; Chang Wei-Lun, 2010, Acta Neurol Taiwan, V19, P204; Haymaker W, 1969, BINGS LOCAL DIAGNOSI, P148; National Institute of Neurological Disorders and Stroke Committee, 1990, STROKE, V21, P637	7	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	OCT	2015	36	10					1937	1938		10.1007/s10072-015-2286-y		2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CS1JY	WOS:000361821500030		
J	Fukuda, H; Handa, A; Koyanagi, M; Yoshida, K; Lo, BWY; Yamagata, S				Fukuda, Hitoshi; Handa, Akira; Koyanagi, Masaomi; Yoshida, Kazumichi; Lo, Benjamin W. Y.; Yamagata, Sen			Endovascular Therapy for Ruptured Cerebral Aneurysms in the Elderly: Poor Accessibility of the Guiding Catheter and Use of Local Anesthesia as the Predictors of Procedure-Related Rupture	NEUROSURGERY			English	Article						Accessibility; Endovascular coiling; Guiding catheter; Intracranial aneurysm; Procedure-related rupture; Subarachnoid hemorrhage	INTRACRANIAL ANEURYSMS; COIL EMBOLIZATION; SUBARACHNOID HEMORRHAGE; INITIAL-EXPERIENCE; DETACHABLE COILS; VOLUME CENTER; SAFETY; EFFICACY; OUTCOMES; SCALE	BACKGROUND:Endovascular therapy is favored for ruptured intracranial aneurysms in the elderly. However, poor accessibility to the aneurysm through the parent artery and use of local anesthesia in this age group may predispose to intraprocedural complications.OBJECTIVE:To evaluate whether age-related poor access to the ruptured target aneurysm and use of local anesthesia are associated with increased incidence of procedure-related rupture during endovascular embolization.METHODS:A total of 117 patients with 117 ruptured aneurysms underwent endovascular embolization at a single institution. Correlation of increasing age with poor accessibility of the guiding catheter was analyzed. In addition, the distance from the aneurysm to the guiding catheter was investigated to identify an association with incidence of procedure-related rupture. Correlation of local anesthesia with procedure-related rupture was also evaluated in the multivariable analysis.RESULTS:Increasing age was significantly associated with poor accessibility of the guiding catheter (P = .001, Mann-Whitney U test). Procedure-related rupture occurred in 9 of 117 aneurysms (7.7%). Longer distance between distal aneurysms and low-positioned guiding catheters carried a higher risk of procedure-related rupture than a shorter distance between proximal aneurysms and high-positioned guiding catheters (odds ratio, 19.3; 95% confidence interval, 1.84-201; P = .01, multivariable analysis). Use of local anesthesia was also a significant risk factor of procedure-related rupture by multivariable analysis.CONCLUSION:Increasing age was correlated with poor accessibility of the guiding catheter in endovascular embolization of ruptured intracranial aneurysms. Distally located aneurysms treated through a low-positioned guiding catheter and use of local anesthesia increased the risk of procedure-related rupture.ABBREVIATIONS:CI, confidence intervalICA, internal carotid arteryOR, odds ratioVA, vertebral artery	[Fukuda, Hitoshi; Handa, Akira; Koyanagi, Masaomi; Yoshida, Kazumichi; Yamagata, Sen] Kurashiki Cent Hosp, Dept Neurosurg, Kurashiki, Okayama 7100052, Japan; [Lo, Benjamin W. Y.] McGill Univ, Ctr Hlth, Dept Neurosurg, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada	Fukuda, H (reprint author), Kurashiki Cent Hosp, Dept Neurosurg, 1-1-1 Miwa, Kurashiki, Okayama 7100052, Japan.	fukudaharpseal@gmail.com					Turk A, 2013, J NEUROINTERV SURG, V5, P247, DOI 10.1136/neurintsurg-2011-010256; Kan P, 2013, NEUROSURGERY, V72, P216, DOI 10.1227/NEU.0b013e31827b9183; Vanninen R, 1999, RADIOLOGY, V211, P325; Nguyen TN, 2008, J NEUROSURG, V108, P1088, DOI 10.3171/JNS/2008/108/6/1088; Sedat J, 2002, STROKE, V33, P2620, DOI 10.1161/01.STR.0000034788.70971.14; BYRNE JV, 1995, J NEUROL NEUROSUR PS, V59, P616, DOI 10.1136/jnnp.59.6.616; Kang DH, 2014, J NEUROSURG, V121, P605, DOI 10.3171/2014.5.JNS132107; DRAKE CG, 1988, J NEUROSURG, V68, P985; Chaudhary N, 2012, J NEUROINTERV SURG, V4, P301, DOI 10.1136/neurintsurg-2011-010041; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; McDougall CG, 1998, J NEUROSURG, V89, P87, DOI 10.3171/jns.1998.89.1.0087; Ricolfi F, 1998, AM J NEURORADIOL, V19, P1653; Khosla A, 2012, AM J NEURORADIOL, V33, P953, DOI 10.3174/ajnr.A2881; Schuette AJ, 2011, NEUROSURGERY, V68, P731, DOI 10.1227/NEU.0b013e3182077373; Tummala RP, 2001, NEUROSURGERY, V49, P1059, DOI 10.1097/00006123-200111000-00007; Spiotta AM, 2013, J NEUROINTERV SURG, V5, P582, DOI 10.1136/neurintsurg-2012-010552; Brisman JL, 2005, NEUROSURGERY, V57, P1103, DOI 10.1227/01.NEU.0000185631.20246.1A; Delenge D, 1974, RADIOLOGY SKULL BRAI, V2, P1202; Frontera JA, 2006, NEUROSURGERY, V59, P21, DOI 10.1227/01.NEU.0000218821.34014.1B; Gonzalez NR, 2010, NEUROSURGERY, V66, P714, DOI 10.1227/01.NEU.0000367451.59090.D7; Japan Cabinet Office, SIT AG ANN REP AG SO; Park Min S, 2008, Neurosurgery, V63, pE616, DOI 10.1227/01.NEU.0000324918.46479.DD; Raymond J, 1997, NEUROSURGERY, V41, P1235, DOI 10.1097/00006123-199712000-00002; Takahashi M, 1974, ATLAS VERTEBRAL ANGI; Vinuela F, 1997, J NEUROSURG, V86, P475, DOI 10.3171/jns.1997.86.3.0475	25	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0148-396X			NEUROSURGERY	Neurosurgery	OCT	2015	77	4					544	552		10.1227/NEU.0000000000000874		9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CR8KR	WOS:000361601000011		
J	Cho, W; Takeda, W; Oh, Y; Aiba, N; Lee, Y				Cho, Wookyoun; Takeda, Wakako; Oh, Yujin; Aiba, Naomi; Lee, Youngmee			Perceptions and practices of commensality and solo-eating among Korean and Japanese university students: A cross-cultural analysis	NUTRITION RESEARCH AND PRACTICE			English	Article						Commensality; solo-eating; cross-cultural study; cultural consensus analysis; university students	BIRTH COHORT; FOOD-INTAKE; TIME-USE; OBESITY; OVERWEIGHT; CONSENSUS; PATTERNS; ADULTS; AGE	BACKGROUND/OBJECTIVES: Commensality, eating together with others, is a major representation of human sociality. In recent time, environments around comnnensality have changed significantly due to rapid social changes, and the decline of commensality is perceived as a serious concern in many modern societies. This study employs a cross-cultural analysis of university students in two East Asian countries, and examines cross-cultural variations of perceptions and actual practices of comnnensality and solo-eating. SUBJECTS/METHODS: The analysis was drawn from a free-list survey and a self-administrative questionnaires of university students in urban Korea and Japan. The free-listing survey was conducted with a small cohort to explore common images and meanings of commensality and solo-eating. The self-administrative questionnaire was developed based on the result of the free-list survey, and conducted with a larger cohort to examine reasons and problems of practices and associated behaviors and food intake. RESULTS: We found that Korean subjects tended to show stronger associations between solo-eating and negative emotions while the Japanese subjects expressed mixed emotions towards the practice of solo-eating. In the questionnaire, more Korean students reported they prefer commensality and tend to eat more quantities when they eat commensally. In contrast, more Japanese reported that they do not have preference on commensality and there is no notable difference in food quantities when they eat commensally and alone. Compared to the general Korean cohort finding, more proportion of overweight and obese groups of Korean subjects reported that they tend to eat more when they are alone than normal and underweight groups. This difference was not found in the overweight Japanese subjects. CONCLUSION: Our study revealed cross-cultural variations of perceptions and practices of commensality and solo-eating in a non-western setting.	[Cho, Wookyoun; Lee, Youngmee] Gachon Univ, Dept Food & Nutr, Gyeonggi 461701, South Korea; [Takeda, Wakako] Australian Natl Univ, Res Sch Populat Hlth, Natl Ctr Epidemiol & Populat Hlth, Acton, ACT 2601, Australia; [Oh, Yujin] Korea Hlth Promot Fdn, Res Evaluat Team, Seoul 100705, South Korea; [Aiba, Naomi] Kanagawa Inst Technol, Dept Nutr & Life Sci, Yokohama, Kanagawa 2430392, Japan	Takeda, W (reprint author), Australian Natl Univ, Res Sch Populat Hlth, Natl Ctr Epidemiol & Populat Hlth, Bldg 62,Mills Rd, Acton, ACT 2601, Australia.	wakako.takeda@anu.edu.au			National Research Foundation of Korea (NRF)'s the Korea-Japan Basic Scientific Cooperation Program; Japan Society's Promoting Science (JSPS)'s Bilateral program	This research was supported by the National Research Foundation of Korea (NRF)'s the 2011 Korea-Japan Basic Scientific Cooperation Program and Japan Society's Promoting Science (JSPS)'s Bilateral program. We thank Dr. Megumi Tsubota-Utsugi for her contribution to data collection and analyses of questionnaire.	Kanazawa M, 2002, ASIA PAC J CLIN NUTR, V11, pS732, DOI 10.1046/j.1440-6047.11.s8.19.x; Brubaker R, 2004, THEOR SOC, V33, P31, DOI 10.1023/B:RYSO.0000021405.18890.63; CONGER JC, 1980, J PERS, V48, P258, DOI 10.1111/j.1467-6494.1980.tb00832.x; Funatogawa I, 2009, INT J EPIDEMIOL, V38, P83, DOI 10.1093/ije/dyn182; ROMNEY AK, 1986, AM ANTHROPOL, V88, P313, DOI 10.1525/aa.1986.88.2.02a00020; POPKIN BM, 1993, POPUL DEV REV, V19, P138, DOI 10.2307/2938388; Warde A, 2007, ACTA SOCIOL, V50, P363, DOI 10.1177/0001699307083978; Smith CS, 2004, J GEN INTERN MED, V19, P514, DOI 10.1111/j.1525-1497.2004.30061.x; Mestdag I, 2009, SOCIOL REV, V57, P703; Tourangeau R, 2000, SCIENCE OF SELF-REPORT, P29; [Anonymous], 2004, FOOD QUAL PREFER, V15, P901; MAYKOVICH MK, 1978, SOC PROBL, V25, P453, DOI 10.1525/sp.1978.25.4.03a00100; Khang YH, 2010, J KOREAN MED SCI, V25, P1582, DOI 10.3346/jkms.2010.25.11.1582; Ulijaszek SJ, 2007, ECON HUM BIOL, V5, P443, DOI 10.1016/j.ehb.2007.08.006; Ochiai E, 2014, INT SOCIOL, V29, P209, DOI 10.1177/0268580914530415; Jauho M, 2013, FOOD CULT SOC, V16, P43, DOI 10.2752/175174413X13500468045362; Fischler C, 2011, SOC SCI INFORM, V50, P528, DOI 10.1177/0539018411413963; Schrauf RW, 2008, J GERONTOL B-PSYCHOL, V63, pS385; Allman-Farinelli MA, 2008, EUR J CLIN NUTR, V62, P898, DOI 10.1038/sj.ejcn.1602769; Herman CP, 2003, PSYCHOL BULL, V129, P873, DOI 10.1037/0033-2909.129.6.873; Salvy SJ, 2007, PHYSIOL BEHAV, V92, P840, DOI 10.1016/j.physbeh.2007.06.014; Chang K-S, 1999, EC SOC, p[28, 30], DOI 10.1080/03085149900000023; Charmaz Kathy, 2006, CONSTRUCTING GROUNDE; Dales L, 2014, ASIAN STUD REV, V38, P224, DOI 10.1080/10357823.2014.902033; Danesi G., 2012, HOSP SOC, V1, P153; Danesi G, 2012, J EAT HOSP RES, V1, P77; Farmer Paul, 1999, INFECT INEQUALITIES; Furlong A, 2013, YOUTH STUDIES INTRO; HEATHERTON TF, 1991, PSYCHOL BULL, V110, P86, DOI 10.1037//0033-2909.110.1.86; [Korea Centers for Disease Control & Prevention Ministry of Health & Welfare], 2012, KOR HLTH STAT 2011 K; Lee YoungMee, 2013, Korean Journal of Community Nutrition, V18, P25; Mennell S, 1992, SOCIOLOGY FOOD EATIN; Ministry of Health Labour and Welfare (JP), 2015, NAT HLTH NUTR SURV J; Organisation for Economic Co-operation and Development, 2014, ED GLANC 2014 OECD I; Organisation for Economic Co-operation and Development (FR), 2013, TRENDS SHAP ED 2013, P40; Pliner P, 2009, WOODHEAD PUBL FOOD S, P169, DOI 10.1533/9781845695712.4.169; Quinlan M., 2005, FIELD METHOD, V1, P219, DOI 10.1177/1525822X05277460; SCHACHTE.S, 1968, J PERS SOC PSYCHOL, V10, P91, DOI 10.1037/h0026284; Weller S. C., 1988, SYSTEMATIC DATA COLL; World Health Organization, 2002, GLOB DIETS NONC DIS	40	0	0	KOREAN NUTRITION SOC	SEOUL	804 KST CTR, 635-4 YEOGSAM-SONG KANGNAM-KU, SEOUL, 135-703, SOUTH KOREA	1976-1457	2005-6168		NUTR RES PRACT	Nutr. Res. Pract.	OCT	2015	9	5					523	529		10.4162/nrp.2015.9.5.523		7	Nutrition & Dietetics	Nutrition & Dietetics	CS1UK	WOS:000361853400011		
J	Song, S; Kim, EK; Hong, S; Shin, S; Song, Y; Baik, HW; Joung, H; Paik, HY				Song, Sujin; Kim, Eun-Kyung; Hong, Soyoung; Shin, Sangah; Song, YoonJu; Baik, Hyun Wook; Joung, Hyojee; Paik, Hee Young			Low consumption of fruits and dairy foods is associated with metabolic syndrome in Korean adults from outpatient clinics in and near Seoul	NUTRITION RESEARCH AND PRACTICE			English	Article						Fruits; dairy foods; food consumption; metabolic syndrome; Korean adults	NATIONAL-HEALTH; CENTRAL OBESITY; DIETARY-INTAKE; RISK; PREVALENCE; ADHERENCE; EPIDEMIOLOGY; COMMUNITIES; PREVENTION; CALCIUM	BACKGROUND/OBJECTIVES: The aim of this study was to examine differences in nutrient intake and food consumption by the presence of metabolic syndrome-in Korean adults. SUBJECTS/METHODS: Study subjects in this cross-sectional study were recruited from four outpatient clinics in and near the Seoul metropolitan area of South Korea between 2006 and 2012. A total of 668 subjects (413 men and 255 women) aged >= 30 y were included in the final data analyses. For each subject, daily nutrient intake and food consumption were calculated using three days of dietary intake data obtained from a combination of 24-hour recalls and dietary records. To evaluate food consumption, mean number of servings consumed per day and percentages of recommended number of servings for six food groups were calculated. Metabolic syndrome was defined using the National Cholesterol Education Program Adult Treatment Panel III criteria. The general linear model was performed to examine differences in nutrient intake and food consumption by sex and the presence of metabolic syndrome after adjustment for potential confounding variables. RESULTS: Nutrient intake did not differ by the presence of metabolic syndrome in both men and women. Men with metabolic syndrome had lower consumption and percentage of the recommendation for fruits compared with those without metabolic syndrome (1.6 vs. 1.1 servings/day, P-value = 0.001; 63.5 vs. 49.5%, P-value = 0.013). Women with metabolic syndrome showed lower consumption and percentage of the recommendation for dairy foods than those without metabolic syndrome (0.8 vs. 0.5 servings/day, P-value = 0.001; 78.6 vs. 48.9%, P-value = 0.001). CONCLUSIONS: Low intakes of fruits and dairy foods might be associated with the risk of having metabolic syndrome among Korean adults. Dietary advice on increasing consumption of these foods is needed to prevent and attenuate the risk of metabolic syndrome.	[Song, Sujin; Paik, Hee Young] Seoul Natl Univ, Dept Food & Nutr, Seoul 151742, South Korea; [Kim, Eun-Kyung] Ewha Womans Univ, Dept Nutr Sci & Food Management, Seoul 120750, South Korea; [Hong, Soyoung; Joung, Hyojee] Seoul Natl Univ, Grad Sch Publ Hlth, Inst Hlth & Environm, Div Publ Hlth Nutr, Seoul 151742, South Korea; [Shin, Sangah] Univ Tokyo, Grad Sch Med, Tokyo 1130033, Japan; [Song, YoonJu] Catholic Univ Korea, Sch Human Ecol, Food & Nutr, Gyeonggi 420743, South Korea; [Baik, Hyun Wook] DMC Bundang Jesaeng Hosp, Div Gastroenterol & Clin Nutr, Dept Internal Med, Gyeonggi 463774, South Korea	Paik, HY (reprint author), Seoul Natl Univ, Dept Food & Nutr, 1 Gwanak Ro, Seoul 151742, South Korea.	hypaik@snu.ac.kr			Seoul City RBD program [10526]; Cooperative Research Program for Agriculture Science and Technology Development through Rural Development Administration in Republic of Korea [PJ007211]; Basic Science Research Program through the National Research Foundation of Korea of the Ministry of Education, Science, and Technology [2010-0004536]	This study was supported by the Seoul City R&BD program (grant number 10526); the Cooperative Research Program for Agriculture Science and Technology Development through Rural Development Administration in Republic of Korea (grant number PJ007211); and the Basic Science Research Program through the National Research Foundation of Korea of the Ministry of Education, Science, and Technology (grant number 2010-0004536).	Jung HJ, 2011, NUTR RES PRACT, V5, P560, DOI 10.4162/nrp.2011.5.6.560; Puchau B, 2010, NUTRITION, V26, P534, DOI 10.1016/j.nut.2009.06.017; Cho GJ, 2009, MENOPAUSE, V16, P992, DOI [10.1097/gme.0b013e31819e23cb, 10.1097/gme.0b013e31819c23cb]; Fumeron F, 2011, DIABETES CARE, V34, P813, DOI 10.2337/dc10-1772; Kesse-Guyot E, 2013, NUTR METAB CARDIOVAS, V23, P677, DOI 10.1016/j.numecd.2012.02.005; Shin H, 2013, J KOREAN MED SCI, V28, P1482, DOI 10.3346/jkms.2013.28.10.1482; Elwood PC, 2007, J EPIDEMIOL COMMUN H, V61, P695, DOI 10.1136/jech.2006.053157; Kim J, 2013, J HUM NUTR DIET, V26, P171, DOI 10.1111/jhn.12098; Kouki R, 2011, EUR J CLIN NUTR, V65, P368, DOI 10.1038/ejcn.2010.262; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Yoo S, 2004, AM J CLIN NUTR, V80, P841; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Azadbakht L, 2005, AM J CLIN NUTR, V82, P523; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; [Anonymous], 2005, CIRCULATION, DOI DOI 10.1161/CIRCULATIONAHA.105.169404; Aleixandre A, 2008, CRIT REV FOOD SCI, V48, P905, DOI 10.1080/10408390701761886; Babio N, 2009, NUTR METAB CARDIOVAS, V19, P563, DOI 10.1016/j.numecd.2008.10.007; Shin SK, 2015, NUTR RES PRACT, V9, P328, DOI [10.4162/nrp.2015.9.3.328, 10.4162/nrp.2015.93.328]; Liu S, 2005, DIABETES CARE, V28, P2926, DOI 10.2337/diacare.28.12.2926; Fogli-Cawley JJ, 2007, AM J CLIN NUTR, V86, P1193; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Beydoun MA, 2008, AM J CLIN NUTR, V87, P1914; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Cohen DA, 2010, J PUBLIC HEALTH-UK, V32, P379, DOI 10.1093/pubmed/fdp117; Mattei J, 2013, J NUTR, V143, P1753, DOI 10.3945/jn.113.180141; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Jung HJ, 2015, ASIA PAC J CLIN NUTR, V24, P308, DOI 10.6133/apjcn.2015.24.2.20; Shin A, 2009, J AM DIET ASSOC, V109, P633, DOI 10.1016/j.jada.2008.12.015; Esmaillzadeh A, 2006, AM J CLIN NUTR, V84, P1489; Otsuka R, 2010, HYPERTENS RES, V33, P548, DOI 10.1038/hr.2010.29; Lee SY, 2007, DIABETES RES CLIN PR, V75, P72, DOI 10.1016/j.diabres.2006.04.013; Dugan CE, 2014, METAB SYNDR RELAT D, V12, P62, DOI 10.1089/met.2013.0109; Ford ES, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-35; Hosseinpour-Niazi S, 2011, DIABETES RES CLIN PR, V94, P276, DOI 10.1016/j.diabres.2011.07.020; Jung HJ, 2013, KOREAN J HLTH PROMOT, V13, P107; Korean Nutrition Society, 2010, DIET REF INT KOR; Lee ChangJin, 2012, Korean Journal of Community Nutrition, V17, P795; Park MH, 2003, CULTURAL LIFE KOREA; Rural Resources Development Institute (KR), 2006, FODO COMP TABL; Song S, 2014, J FOOD COMPOS ANAL, V36, P72, DOI 10.1016/j.jfca.2014.04.010	40	0	0	KOREAN NUTRITION SOC	SEOUL	804 KST CTR, 635-4 YEOGSAM-SONG KANGNAM-KU, SEOUL, 135-703, SOUTH KOREA	1976-1457	2005-6168		NUTR RES PRACT	Nutr. Res. Pract.	OCT	2015	9	5					554	562		10.4162/nrp.2015.9.5.554		9	Nutrition & Dietetics	Nutrition & Dietetics	CS1UK	WOS:000361853400015		
J	Hoshino, R; Adachi, S				Hoshino, Ryosuke; Adachi, Sadao			Photo-induced degradation and thermal decomposition in ZnSnF6 center dot 6H(2)O:Mn4+ red-emitting phosphor	OPTICAL MATERIALS			English	Article						Red phosphor; ZnSnF6 center dot 6H(2)O; K2SiF6; Hexafluorometallate; White-LED	DOPED YTTRIUM ORTHOALUMINATE; PHOTOLUMINESCENT PROPERTIES; OPTICAL-PROPERTIES; HYDRATE PHOSPHOR; MANGANESE IONS; HIGH-PRESSURE; DATA-STORAGE; MN4+ IONS; LUMINESCENCE; CRYSTALS	ZnSnF6 center dot 6H(2)O:Mn4+ red-emitting hexahydrate phosphor is synthesized by the chemical reaction method, and its unique structural and optical properties are investigated using X-ray diffraction measurement, photoluminescence (PL) analysis, PL excitation spectroscopy, and electron spin resonance (ESR) spectroscopy. The Mn4+-activated phosphor exhibits remarkable degradation in the PL intensity under Xe lamp exposure and also by the coherent laser beam irradiation with the following order of degradation: Ar+ (488 nm) > He-Cd (325 nm) > He-Ne laser (632.8 nm). The mechanism of degradation is considered to be due to a change in the valence state of manganese ions from Mn4+ to Mn5+ by the photooxidation and/or disproportionation. The ESR measurement supports decreased Mn4+ spin density in the Xe-lamp exposed, degraded sample. The changes in the structural and PL properties are also observed after thermal annealing above similar to 100 degrees C and explained by the thermal-annealing-induced dehydration/decomposition of the host material. (C) 2015 Elsevier B.V. All rights reserved.	[Hoshino, Ryosuke; Adachi, Sadao] Gunma Univ, Fac Sci & Technol, Div Elect & Informat, Kiryu, Gunma 3768515, Japan	Adachi, S (reprint author), Gunma Univ, Fac Sci & Technol, Div Elect & Informat, Kiryu, Gunma 3768515, Japan.	adachi@el.gunma-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [26289085]	This work was supported by a Grant-in-Aid for Scientific Research (B) (26289085) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors would like to thank T. Miyazaki, T. Nakamura, and H. Oike for their experimental supports and useful discussion.	Adachi S, 2005, WILEY SER MATER ELEC, P1, DOI 10.1002/0470090340; Aleksandrovskii AS, 2002, INORG MATER, V38, P1225; Aleksandrovsky AS, 2007, PHYS SOLID STATE+, V49, P1695, DOI 10.1134/S1063783407090156; Sekiguchi D, 2013, J APPL PHYS, V113, DOI 10.1063/1.4803880; CHAPOULIE R, 1991, MATER CHEM PHYS, V30, P47, DOI 10.1016/0254-0584(91)90153-L; Arai Y, 2011, J LUMIN, V131, P2652, DOI 10.1016/j.jlumin.2011.06.042; Xu YK, 2011, J ELECTROCHEM SOC, V158, pJ58, DOI 10.1149/1.3530793; Rakhimov RR, 1998, SOLID STATE COMMUN, V108, P549, DOI 10.1016/S0038-1098(98)00403-7; Hoshino R, 2015, J LUMIN, V162, P63, DOI 10.1016/j.jlumin.2015.02.011; Noginov MA, 1999, J OPT SOC AM B, V16, P3, DOI 10.1364/JOSAB.16.000003; Kasa R, 2012, J ELECTROCHEM SOC, V159, pJ89, DOI 10.1149/2.005204jes; Dawson B, 2004, CHEM MATER, V16, P5311, DOI 10.1021/cm0489284; Lv LF, 2014, J LUMIN, V152, P214, DOI 10.1016/j.jlumin.2013.10.052; Okamoto S, 2010, J ELECTROCHEM SOC, V157, pJ59, DOI 10.1149/1.3276089; Zhang SX, 2004, J LUMIN, V106, P39, DOI 10.1016/S0022-2313(03)00132-7; Wei LL, 2015, ACS APPL MATER INTER, V7, P10656, DOI 10.1021/acsami.5b02212; Xu YK, 2009, J APPL PHYS, V105, DOI 10.1063/1.3056375; Zhang JC, 2012, CHINESE PHYS B, V21, DOI 10.1088/1674-1056/21/12/124102; Adachi S, 2012, J ELECTROCHEM SOC, V159, pJ34, DOI 10.1149/2.064202jes; Galanciak D, 2005, J PHYS-CONDENS MAT, V17, P7185, DOI 10.1088/0953-8984/17/46/003; Xu YK, 2012, J ELECTROCHEM SOC, V159, pE11, DOI 10.1149/2.026201jes; Arai Y, 2011, J ELECTROCHEM SOC, V158, pJ179, DOI 10.1149/1.3576124; Kasa R, 2010, J APPL PHYS, V108, DOI 10.1063/1.3516489; Arai T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.092401; Singh V, 2007, OPT MATER, V30, P468, DOI 10.1016/j.optmat.2007.01.003; RAY S, 1973, ACTA CRYSTALLOGR B, V29, P2741, DOI 10.1107/S056774087300748X; Adachi S, 2009, J APPL PHYS, V106, DOI 10.1063/1.3160303; HOPPE R, 1972, Z ANORG ALLG CHEM, V392, P1, DOI 10.1002/zaac.19723920102; Bryknar Z, 2004, FERROELECTRICS, V298, P43, DOI 10.1080/00150190490423183; Hoshino R, 2013, J APPL PHYS, V114, DOI 10.1063/1.4836896; Onuma H, 2010, J SOC INF DISPLAY, V18, P211, DOI 10.1889/JSID18.3.211; Sekiguchi D, 2015, OPT MATER, V42, P417, DOI 10.1016/j.optmat.2015.01.039; Kubus M, 2013, J LUMIN, V137, P88, DOI 10.1016/j.jlumin.2012.12.038; Takahashi T, 2008, J ELECTROCHEM SOC, V155, pE183, DOI 10.1149/1.2993159; Moine B, 2006, OPT MATER, V28, P587, DOI 10.1016/j.optmat.2005.09.067; JAYARAM G, 1994, PHYS REV B, V49, P12813, DOI 10.1103/PhysRevB.49.12813; Arai Y, 2011, J ELECTROCHEM SOC, V158, pJ81, DOI 10.1149/1.3532784; Arai Y, 2010, OPT MATER, V32, P1095, DOI 10.1016/j.optmat.2010.03.004; Brik MG, 2013, J LUMIN, V133, P69, DOI 10.1016/j.jlumin.2011.08.047; Oyama T, 2014, J APPL PHYS, V116, DOI 10.1063/1.4897363; Noginov MA, 1998, J OPT SOC AM B, V15, P1463, DOI 10.1364/JOSAB.15.001463; Noginov MA, 2000, PHYS REV B, V61, P1884, DOI 10.1103/PhysRevB.61.1884; Zhydachevskii Y, 2006, J PHYS-CONDENS MAT, V18, P5389, DOI 10.1088/0953-8984/18/23/011; Zhydachevskii Y, 2006, J PHYS-CONDENS MAT, V18, P11385, DOI 10.1088/0953-8984/18/49/028; Zimmermann J, 2005, J LUMIN, V114, P24, DOI 10.1016/j.jlumin.2004.11.011; Rao RP, 2005, J LUMIN, V113, P271, DOI 10.1016/j.jlumin.2004.10.018; Loutts GB, 1998, PHYS REV B, V57, P3706, DOI 10.1103/PhysRevB.57.3706; Xie MB, 2010, J ELECTROCHEM SOC, V157, pJ401, DOI 10.1149/1.3491358; Hoshino R, 2014, ECS J SOLID STATE SC, V3, pR144, DOI 10.1149/2.0031408jss; Kilck S., 1998, PHYS REV B, V57, P203; Kuznetsov V. G., 1968, RUSS J INORG CHEM, V13, P685; Sekiguchi D, 2014, ECS J SOLID STATE SC, V3, pR60, DOI 10.1149/2.025404jss; Seong T.-Y., 2013, 3 NITRIDE BASED LIGH	53	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-3467	1873-1252		OPT MATER	Opt. Mater.	OCT	2015	48						36	43		10.1016/j.optmat.2015.07.019		8	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	CR8CI	WOS:000361578300007		
J	Empizo, MJF; Yamanoi, K; Santos-Putungan, AB; Arita, R; Minami, Y; Luong, MV; Shimizu, T; Estacio, ES; Somintac, AS; Salvador, AA; Sarmago, RV; Sarukura, N				Empizo, Melvin John F.; Yamanoi, Kohei; Santos-Putungan, Alexandra B.; Arita, Ren; Minami, Yuki; Mui Viet Luong; Shimizu, Toshihiko; Estacio, Elmer S.; Somintac, Armando S.; Salvador, Arnel A.; Sarmago, Roland V.; Sarukura, Nobuhiko			Blue-shifted and picosecond amplified UV emission from aqueous chemical grown ZnO microrods	OPTICAL MATERIALS			English	Article						ZnO; II-VI semiconductor; Microrods; Solution growth; Photoluminescence	TIME-RESOLVED PHOTOLUMINESCENCE; ZINC-OXIDE; HYDROTHERMAL SYNTHESIS; STIMULATED-EMISSION; OPTICAL-PROPERTIES; ROOM-TEMPERATURE; WAVE-GUIDES; LASER ACTION; THIN-FILMS; NANOWIRES	Room-temperature amplified spontaneous emission (ASE) has been observed from aqueous chemical grown zinc oxide (ZnO) microrods. The well-faceted microrods have only a single narrow ultraviolet (UV) emission at 390 nm (3.2 eV) with average lifetimes as fast as 85-100 ps. The characteristic ASE also exhibits blue-shifted peaks and shortened lifetimes. At present, the peak shifting and the lifetime shortening are attributed to the band filling and photo-induced screening effects and to the nonradiative relaxation process, respectively. Results indicate that the ZnO microrods have good structural and optical quality which leads to their suitable use for optoelectronic applications. (C) 2015 Elsevier B.V. All rights reserved.	[Empizo, Melvin John F.; Yamanoi, Kohei; Arita, Ren; Minami, Yuki; Mui Viet Luong; Shimizu, Toshihiko; Sarukura, Nobuhiko] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan; [Santos-Putungan, Alexandra B.] Univ Philippines Los Banos, Inst Math Sci & Phys, College Los Banos 4031, Laguna, Philippines; [Santos-Putungan, Alexandra B.; Estacio, Elmer S.; Somintac, Armando S.; Salvador, Arnel A.; Sarmago, Roland V.] Univ Philippines Diliman, Natl Inst Phys, Quezon City 1101, Philippines	Empizo, MJF (reprint author), Osaka Univ, Inst Laser Engn, 2-6 Yamadaoka, Suita, Osaka 5650871, Japan.	mjfempizo@ile.osaka-u.ac.jp	Sarukura, Nobuhiko/F-3276-2015	Sarukura, Nobuhiko/0000-0003-2353-645X	Japan Science and Technology Agency (JST) through the Adaptable & Seamless Technology Transfer Program through Target-driven R&D (A-STEP) Grant [AS241047M]	This work was supported by the Japan Science and Technology Agency (JST) through the Adaptable & Seamless Technology Transfer Program through Target-driven R&D (A-STEP) Grant Number AS241047M.	Aneesh P.M., 2007, NANOPHOTONIC MAT, VIV, P6639; Koida T, 2003, APPL PHYS LETT, V82, P532, DOI 10.1063/1.1540220; Kwok WM, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2378560; Xu CX, 2006, J PHYS D APPL PHYS, V39, P1690, DOI 10.1088/0022-3727/39/8/032; Ozgur U, 2004, APPL PHYS LETT, V84, P3223, DOI 10.1063/1.1713034; Empizo MJF, 2014, OPT MATER, V38, P256, DOI 10.1016/j.optmat.2014.10.044; Johnson JC, 2003, J PHYS CHEM B, V107, P8816, DOI 10.1021/jp034482n; Shih YT, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/16/165201; Voss T, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2364146; Xing YJ, 2003, APPL PHYS LETT, V83, P1689, DOI 10.1063/1.1605808; Kong YC, 2001, APPL PHYS LETT, V78, P407, DOI 10.1063/1.1342050; Zhang LX, 2011, APPL SURF SCI, V258, P711, DOI 10.1016/j.apsusc.2011.07.116; Vayssieres L, 2003, ADV MATER, V15, P464, DOI 10.1002/adma.200390108; Yu SF, 2003, APPL PHYS LETT, V83, P4288, DOI 10.1063/1.1629784; Cao H, 2000, PHYS REV E, V61, P1985, DOI 10.1103/PhysRevE.61.1985; Zhu GP, 2008, OPT MATER, V31, P181, DOI 10.1016/j.optmat.2008.02.012; Kwok WM, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2137456; Chen SJ, 2005, ADV MATER, V17, P586, DOI 10.1002/adma.200401263; Wen FS, 2005, SOLID STATE COMMUN, V135, P34, DOI 10.1016/j.ssc.2005.03.066; Huang ZY, 2007, CRYST GROWTH DES, V7, P1686, DOI 10.1021/cg060557d; Zu P, 1997, SOLID STATE COMMUN, V103, P459, DOI 10.1016/S0038-1098(97)00216-0; Nagaraju G, 2010, MAT SCI SEMICON PROC, V13, P21, DOI 10.1016/j.mssp.2010.02.002; Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367; Xu CX, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1847716; Sun XW, 1999, J APPL PHYS, V86, P408, DOI 10.1063/1.370744; Zhang H, 2004, NANOTECHNOLOGY, V15, P622, DOI 10.1088/0957-4484/15/5/037; Wang DD, 2009, J LUMIN, V129, P996, DOI 10.1016/j.jlumin.2009.04.012; Bagnall DM, 1998, APPL PHYS LETT, V73, P1038, DOI 10.1063/1.122077; Yu SF, 2004, APPL PHYS LETT, V84, P3241, DOI 10.1063/1.1734681; Ibupoto ZH, 2013, MATERIALS, V6, P3584, DOI 10.3390/ma6083584; Polsongkram D, 2008, PHYSICA B, V403, P3713, DOI 10.1016/j.physb.2008.06.020; Li WF, 2012, NANO-MICRO LETT, V4, P98, DOI 10.3786/nml.v4i2.p98-102; Zhong YC, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3499274; Zimmler MA, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2965797; LAUDISE RA, 1960, J PHYS CHEM-US, V64, P688, DOI 10.1021/j100834a511; Yang PD, 2000, SCIENCE, V287, P465, DOI 10.1126/science.287.5452.465; Leung YH, 2005, NANOTECHNOLOGY, V16, P579, DOI 10.1088/0957-4484/16/4/040; Shalish I, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.245401; Ding M, 2012, OPT EXPRESS, V20, P13657, DOI 10.1364/OE.20.013657; Cao H, 2000, PHYS REV LETT, V84, P5584, DOI 10.1103/PhysRevLett.84.5584; Zou BS, 2006, J PHYS CHEM B, V110, P12865, DOI 10.1021/jp061357d; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE; Li C. P., 2006, SOLID STATE COMMUN, V139, P335; Lopez-Romero S., 2013, WJCMP, V3, P152; Ozgiir U., 2009, ZINC OXIDE FUNDAMENT; Ozgur U, 2005, J APPL PHYS, V98, DOI 10.1063/1.1992666; Santos-Putungan A. B., 2015, INT J PHILIPP SCI TE, V8, P43; Santos-Putungan A.B., 2014, HCTL OPEN INT J TECH, V11, P1; Service RE, 1997, SCIENCE, V276, P895, DOI 10.1126/science.276.5314.895	49	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-3467	1873-1252		OPT MATER	Opt. Mater.	OCT	2015	48						179	184		10.1016/j.optmat.2015.07.041		6	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	CR8CI	WOS:000361578300028		
J	Hamada, H; Nishii, T; Tamura, S; Tanaka, H; Wakayama, T; Sugano, N				Hamada, H.; Nishii, T.; Tamura, S.; Tanaka, H.; Wakayama, T.; Sugano, N.			Comparison of load responsiveness of cartilage T1rho and T2 in porcine knee joints: an experimental loading MRI study	OSTEOARTHRITIS AND CARTILAGE			English	Article						MRI; Cartilage T1rho; Cartilage T2; Staged loading	ARTICULAR-CARTILAGE; PRESSURE DISTRIBUTION; OSTEOARTHRITIS; DEFORMATION; RELAXATION; ANGLE	Objective: To compare changes in T1rho and T2 values of the femoral cartilage in porcine knee joints under staged loading and unloading conditions. Design: Sixteen porcine knee joints with intact capsules and surrounding muscle were imaged using a custom-made pressure device and 3.0 T magnetic resonance imaging. Sagittal T1rho and T2 images were obtained for the lateral and medial condyles under the following compression loads: none (Load 0), 140 N (Load 140), 300 N (Load 300), and no compression after decompression (Post-load). The percentage changes of cartilage T1rho and T2 values under each loading condition from those at Load 0 were calculated for weight-bearing overall and eight subdivided regions of interest (ROIs) in both femoral condyles. The actual contact pressure under Load 140 and Load 300 was measured using pressure-sensitive film. Results: For the overall ROI, the mean decreases of T1rho and T2 values were 4.4% and 5.1% under Load 140% and 10.9% and 10.6% under Load 300 in the medial condyle and were 5.2% and 4.0% under Load 140% and 10.6% and 6.0% under Load 300 in the lateral condyle. In the medial condyle, the actual contact pressure correlated highly with percentage changes in T1rho (r = -0.84, P < 0.01) and T2 (r = -0.79, P < 0.01), but those correlations were relatively low in the lateral condyle. Conclusion: Although there were side-dependent variations in the correlations with actual pressure, cartilage T1rho and T2 showed similarly sensitive responses to applied load. (C) 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.	[Hamada, H.] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka 5650871, Japan; [Nishii, T.; Tamura, S.; Sugano, N.] Osaka Univ, Grad Sch Med, Dept Orthopaed Med Engn, Suita, Osaka 5650871, Japan; [Tanaka, H.] Osaka Univ, Grad Sch Med, Dept Diagnost & Intervent Radiol, Suita, Osaka 5650871, Japan; [Wakayama, T.] Asia Pacific, GE Healthcare Appl Sci Lab, Tokyo, Japan	Nishii, T (reprint author), Osaka Univ, Grad Sch Med, Dept Orthopaed Med Engn, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	nishii@rf7.so-net.ne.jp			Ministry of Education, Science and Culture of Japan [5293322]	Part of this study was funded by Grant-in-Aid for Scientific Research, the Ministry of Education, Science and Culture of Japan 5293322.	Wang N, 2015, J MAGN RESON IMAGING, V41, P1281, DOI 10.1002/jmri.24658; Shiomi T, 2010, OSTEOARTHR CARTILAGE, V18, P902, DOI 10.1016/j.joca.2010.05.002; Mosher TJ, 2013, OSTEOARTHR CARTILAGE, V21, P1425, DOI 10.1016/j.joca.2013.07.010; Souza RB, 2010, OSTEOARTHR CARTILAGE, V18, P1557, DOI 10.1016/j.joca.2010.10.001; FUKUBAYASHI T, 1980, ACTA ORTHOP SCAND, V51, P871, DOI 10.3109/17453678008990887; Nishii T, 2008, J MAGN RESON IMAGING, V28, P175, DOI 10.1002/jmri.21418; Temple MM, 2007, OSTEOARTHR CARTILAGE, V15, P1042, DOI 10.1016/j.joca.2007.03.005; RUBENSTEIN JD, 1993, RADIOLOGY, V188, P219; Grunder W, 2000, MAGN RESON MED, V43, P884, DOI 10.1002/1522-2594(200006)43:6<884::AID-MRM15>3.0.CO;2-U; Liess C, 2002, OSTEOARTHR CARTILAGE, V10, P907, DOI 10.1053/joca.2002.0847; Alhadlaq HA, 2005, J MAGN RESON IMAGING, V22, P665, DOI 10.1002/jmri.20418; Subburaj K, 2012, J ORTHOP RES, V30, P919, DOI 10.1002/jor.22031; Herberhold C, 1999, J BIOMECH, V32, P1287, DOI 10.1016/S0021-9290(99)00130-X; Temple-Wong MM, 2009, OSTEOARTHR CARTILAGE, V17, P1469, DOI 10.1016/j.joca.2009.04.017; Mlynarik Y, 2004, J MAGN RESON, V169, P300	15	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1063-4584	1522-9653		OSTEOARTHR CARTILAGE	Osteoarthritis Cartilage	OCT	2015	23	10					1776	1779		10.1016/j.joca.2015.05.019		4	Orthopedics; Rheumatology	Orthopedics; Rheumatology	CR8TS	WOS:000361627500016		
J	Goetz, JE; Fredericks, D; Petersen, E; Rudert, MJ; Baer, T; Swanson, E; Roberts, N; Martin, J; Tochigi, Y				Goetz, J. E.; Fredericks, D.; Petersen, E.; Rudert, M. J.; Baer, T.; Swanson, E.; Roberts, N.; Martin, J.; Tochigi, Y.			A clinically realistic large animal model of intra-articular fracture that progresses to post-traumatic osteoarthritis	OSTEOARTHRITIS AND CARTILAGE			English	Article						Post-traumatic osteoarthritis; Closed fracture; Intra-articular fracture; Yucatan minipig	TIBIAL PLAFOND FRACTURES; INFLAMMATORY CYTOKINES; MOUSE KNEE; ARTHRITIS; CARTILAGE; SEVERITY; INJURIES; MARKERS; MICE	Objective: Translation of promising treatments for post-traumatic osteoarthritis (PTOA) to patients with intra-articular fracture (IAF) has been limited by the lack of a realistic large animal model. To address this issue we developed a large animal model of IAF in the distal tibia of Yucatan minipigs and documented the natural progression of this injury. Design: Twenty-two fractures were treated using open reduction and internal fixation with either an anatomic reduction or an intentional 2-mm step-off. Pre-operatively, and 3 days, 1, 2, 4, 8, and 12 weeks post-operatively, animals were sedated for synovial fluid draws and radiographs. Limb loading was monitored at the same time points using a Tekscan Walkway. Animals were sacrificed at 12 weeks and the limbs were harvested for histological evaluation. Results: All animals achieved bony union by 12 weeks, facilitating nearly complete recovery of the initial 60% decrease in limb loading. TNF alpha, IL1 beta, IL6, and IL8 concentrations in the fractured limbs were elevated (P < 0.05) at specific times during the 2 weeks after fracture. Histological cartilage degeneration was more severe in the step-off group (0.0001 < P < 0.27 compared to normal) than in the anatomic reconstruction group (0.27 < P < 0.99 compared to normal). Conclusions: This model replicated key features of a human IAF, including surgical stabilization, inflammatory responses, and progression to osteoarthritic cartilage degeneration, thereby providing a potentially useful model for translating promising treatment options to clinical practice. (C) 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.	[Goetz, J. E.; Fredericks, D.; Petersen, E.; Rudert, M. J.; Baer, T.; Roberts, N.; Martin, J.] Univ Iowa, Dept Orthopaed & Rehabil, Iowa City, IA USA; [Goetz, J. E.; Martin, J.] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA; [Swanson, E.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Tochigi, Y.] Dokkyo Med Univ, Koshigaya Hosp, Dept Orthopaed, Saitama, Japan	Goetz, JE (reprint author), Orthopaed Biomech Lab, 2180 Westlawn Bldg, Iowa City, IA 52242 USA.	jessica-goetz@uiowa.edu			US Department of Defense [W81XWH-10-1-0864]	This work was funded by a grant W81XWH-10-1-0864 from the US Department of Defense. The study sponsor had no influence over the methods, results, or conclusions resulting from this work. The authors wish to acknowledge the hard work of Bryce Diestelmeier, Gail Kurriger, and the staff at the Bone Healing Research Laboratory.	Fernandes JC, 2002, BIORHEOLOGY, V39, P237; Backus JD, 2011, J ORTHOP RES, V29, P501, DOI 10.1002/jor.21270; Anderson DD, 2011, J ORTHOP RES, V29, P802, DOI 10.1002/jor.21359; Li W, 2008, J ORTHOP RES, V26, P1039, DOI 10.1002/jor.20642; Furman BD, 2007, J ORTHOP RES, V25, P578, DOI 10.1002/jor.20331; Arunakul M, 2013, J ORTHOP RES, V31, P1555, DOI 10.1002/jor.22393; Sward P, 2012, OSTEOARTHR CARTILAGE, V20, P1302, DOI 10.1016/j.joca.2012.07.021; Tochigi Y, 2011, J BONE JOINT SURG AM, V93A, P533, DOI [10.2106/JBJS.I.01777, 10.2106/JBJS.J.01777]; Patzkowski JC, 2012, J AM ACAD ORTHOP SUR, V20, pS48, DOI 10.5435/JAAOS-20-08-S48; DOIGE C, 1975, CAN J COMP MED, V39, P7; Little CB, 2010, OSTEOARTHR CARTILAGE, V18, pS80, DOI 10.1016/j.joca.2010.04.016; McKinley TO, 2010, J ORTHOP TRAUMA, V24, P567, DOI 10.1097/BOT.0b013e3181ed298d; Tannast M, 2012, J BONE JOINT SURG AM, V94A, P1559, DOI 10.2106/JBJS.K.00444; Ward BD, 2008, ARTHRITIS RHEUM, V58, P744, DOI 10.1002/art.23288; Lewis JS, 2011, OSTEOARTHR CARTILAGE, V19, P864, DOI 10.1016/j.joca.2011.04.011; Moussavi-Harami SF, 2009, J ORTHOP RES, V27, P522, DOI 10.1002/jor.20779; Rivera JC, 2012, J AM ACAD ORTHOP SUR, V20, pS64, DOI 10.5435/JAAOS-20-08-S64; Anderson DD, 2011, J ORTHOP RES, V29, P33, DOI 10.1002/jor.21202; Brown TD, 2006, J ORTHOP TRAUMA, V20, P739, DOI 10.1097/01.bot.0000246468.80635.ef; Louer CR, 2012, ARTHRITIS RHEUM-US, V64, P3220, DOI 10.1002/art.34533; Furman BD, 2006, J ORTHOP TRAUMA, V20, P719, DOI 10.1097/01.bot.0000211160.05864.14; Wegener K M, 1993, Zentralbl Veterinarmed A, V40, P359; TEENY SM, 1993, CLIN ORTHOP RELAT R, P108; Lewis JS, 2013, ARTHRITIS RHEUM-US, V65, P660, DOI 10.1002/art.37796; Tochigi Y, 2013, OSTEOARTHR CARTILAGE, V21, P200, DOI 10.1016/j.joca.2012.10.004; Cross JD, 2011, J AM ACAD ORTHOP SUR, V19, pS1; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523; Cameron M L, 1994, Knee Surg Sports Traumatol Arthrosc, V2, P38, DOI 10.1007/BF01552652; Diestelmeier BW, 2014, J BIOMECH ENG, V136; Furman BD, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4591; Goldring M B, 2000, Curr Rheumatol Rep, V2, P459, DOI 10.1007/s11926-000-0021-y; Olson SA, 2014, J AM ACAD ORTHOP SUR, V22, P29, DOI 10.5435/JAAOS-22-01-29; Ovadia DN, 1986, J BONE JOINT SURG AM, V68-A, P51; Pedersen D. R., 2013, ORTHOPEDIC RES REV, V2013, P13, DOI DOI 10.2147/0RR.S38400; Schenker ML, 2014, J AM ACAD ORTHOP SUR, V22, P20, DOI 10.5435/JAAOS-22-01-20; Stolberg-Stolberg JA, 2013, J ORTHOP RES, V31, P1283, DOI 10.1002/jor.22348	36	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1063-4584	1522-9653		OSTEOARTHR CARTILAGE	Osteoarthritis Cartilage	OCT	2015	23	10					1797	1805		10.1016/j.joca.2015.05.022		9	Orthopedics; Rheumatology	Orthopedics; Rheumatology	CR8TS	WOS:000361627500019		
J	Okazaki, K; Uchida, K				Okazaki, Kazuichi; Uchida, Kazushige			Autoimmune Pancreatitis The Past, Present, and Future	PANCREAS			English	Article						IgG4-related disease; autoimmune pancreatitis; type 1 AIP; type 2 AIP; AIH - autoimmune hepatitis; AIP - autoimmune pancreatitis; BAFF - B-cell activating factor; CA - carbonic anhydrase; CT - computed tomography; ERCP - endoscopic retrograde cholangiopancreatography; IBD - inflammatory bowel disease; JPS - Japan Pancreas Society; LPSP - lymphoplasmacytic sclerosing pancreatitis; MRI - magnetic resonance imagery; PSC - primary sclerosing cholangitis; PSTI - pancreatic secretory trypsin inhibitor; TLR - toll-like receptor		Before the immunoglobulin G4 (IgG4) era, autoimmune pancreatitis was proposed as a single clinical entity of autoimmune disease. In the IgG4 era, the following 2 subtypes have been proposed: type 1 is the pancreatic manifestation of IgG4-related disease and type 2 presents with granulocytic epithelial lesions. The characteristic features of type 1 are increased serum IgG4, lymphoplasmacytic sclerosing pancreatitis (abundant infiltration of IgG4+ plasmacytes and lymphocytes, storiform fibrosis, and obliterative phlebitis), other organ involvements (eg, sclerosing cholangitis, sclerosing sialadenitis, retroperitoneal fibrosis), and responsiveness to steroid. Diagnosis of both types can be made using the International Consensus Diagnostic Criteria. Different from type 2, approximately half of type 1 shows a relapse within 1 year after remission. Despite consensus for the initial steroid treatment, steroid maintenance and treatment for relapses are controversial. In the long term, approximately 10% of type 1 may develop chronic pancreatitis or pancreatic stone formation. It is controversial whether autoimmune pancreatitis is a risk factor for malignancy. Although the pathogenic mechanism remains unclear, multiple factors such as genetic background and abnormal immunity may be involved. Future studies should be conducted to identify more specific and novel biomarkers for each subtype, alternative treatment options for relapse, and the precise pathogenic mechanism.	[Okazaki, Kazuichi; Uchida, Kazushige] Kansai Med Univ, Div Gastroenterol & Hepatol, Dept Internal Med 3, Hirakata, Osaka 5731197, Japan	Okazaki, K (reprint author), Kansai Med Univ, Div Gastroenterol & Hepatol, Dept Internal Med 3, 2-5-1 Shinmachi, Hirakata, Osaka 5731197, Japan.	okazaki@hirakata.kmu.ac.jp			Ministry of Culture and Science of Japan [23591017, 24591020, 26461038]; Ministry of Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan from CREST Japan Science and Technology Agency	This study was partially supported by (1) Grant-in-Aid for Scientific Research (C) of the Ministry of Culture and Science of Japan (23591017, 24591020, 26461038), (2) the Research Program on Intractable Diseases from the Ministry of Labor and Welfare of Japan, and (3) grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan from CREST Japan Science and Technology Agency.		0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-3177	1536-4828		PANCREAS	Pancreas	OCT	2015	44	7					1006	1016		10.1097/MPA.0000000000000382		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CR8LW	WOS:000361605100002		
J	Horibe, M; Egi, M; Sasaki, M; Sanui, M				Horibe, Masayasu; Egi, Moritoki; Sasaki, Mitsuhito; Sanui, Masamitsu			Continuous Regional Arterial Infusion of Protease Inhibitors for Treatment of Severe Acute Pancreatitis Systematic Review and Meta-Analysis	PANCREAS			English	Review						severe acute pancreatitis; acute necrotizing pancreatitis; continuous regional arterial infusion; protease inhibitor	METAANALYSIS; MANAGEMENT	Objective We performed a systematic review and meta-analysis of observational studies and randomized controlled trials (RCTs) to assess the benefit and risk of continuous regional arterial infusion (CRAI) of protease inhibitors (CRAIpis) in patients with severe acute pancreatitis (SAP) or acute necrotizing pancreatitis (ANP). Methods The search was performed using the key words pancreatitis and regional arterial infusion. All language studies involving adult cases of SAP or ANP, which assessed the impact of the CRAIpis, were included. Results Our analysis included 8 observational studies and 2 RCTs from 376 potentially relevant articles. With regard to the observational studies, the CRAIpi was significantly associated with decreased both mortality (odds ratio, 0.40; 95% confidential interval [CI], 0.25-0.64; P = 0.0001) and the need for urgent surgical intervention (odds ratio, 0.22; 95% CI, 0.12-0.3; P < 0.0001). In the RCTs, the application of CRAIpi tends to decrease the mortality but does not reach the significance (risk reduction, -0.12; 95% CI, -0.36-0.12; P = 0.33). Conclusions The CRAIpi has the potential to reduce the mortality or the need for urgent surgical intervention in cases of SAP or ANP. Further, large multicenter trials are needed to refute or confirm our findings.	[Horibe, Masayasu] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Egi, Moritoki] Kobe Univ Hosp, Dept Anesthesiol & Intens Care, Kobe, Hyogo, Japan; [Sasaki, Mitsuhito] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan; [Sanui, Masamitsu] Jichi Med Univ, Saitama Med Ctr, Dept Anesthesiol & Crit Care Med, Saitama, Japan	Egi, M (reprint author), 7-5-2 Kusunoki Cho,Chuo Ku, Kobe, Hyogo 6500017, Japan.	moriori@tg8.so-net.ne.jp					Bassi C, 1999, DIGESTION, V60, P5, DOI 10.1159/000051445; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sutton AJ, 2008, STAT MED, V27, P625, DOI 10.1002/sim.2934; Tenner S, 2013, AM J GASTROENTEROL, V108, P1400, DOI 10.1038/ajg.2013.218; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Heinrich S, 2006, ANN SURG, V243, P154, DOI 10.1097/01.sla.0000197334.58374.70; GABRYELEWICZ A, 1988, DIGESTION, V40, P19; Dervenis C, 1999, INT J PANCREATOL, V25, P195; Yasuda T, 2007, J GASTROENTEROL, V42, P681, DOI 10.1007/s00535-007-2081-5; Takeda K, 1996, AM J SURG, V171, P394, DOI 10.1016/S0002-9610(97)89617-1; Seta T, 2004, EUR J GASTROEN HEPAT, V16, P1287, DOI 10.1097/00042737-200412000-00009; Imaizumi H, 2004, PANCREAS, V28, P369, DOI 10.1097/00006676-200405000-00003; BRADLEY EL, 1993, ARCH SURG-CHICAGO, V128, P586; Furuya T, 2005, J ABDOM EMERG MED, V25, P613; Hamada T, 2013, CRIT CARE, V17, DOI 10.1186/cc13029; Kitamura K, 2005, DIGESTION ABSORPTION, V28, P23; Matsumura N, 2005, J ABDOM EMERG MED, V25, P607; Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535; Piascik M, 2010, PANCREAS, V39, P863, DOI 10.1097/MPA.0b013e3181d37239; Satoh Hirohiko, 2004, J Med Invest, V51, P186, DOI 10.2152/jmi.51.186; Takeda K, 2007, GALLBLADDER PANCREAS, V28, P967; Takuma Y, 2007, DIG MED, V44, P306; Uno K, 2008, DIG MED, V46, P567	23	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-3177	1536-4828		PANCREAS	Pancreas	OCT	2015	44	7					1017	1023		10.1097/MPA.0000000000000375		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CR8LW	WOS:000361605100003		
J	Inui, K; Igarashi, Y; Irisawa, A; Ohara, H; Tazuma, S; Hirooka, Y; Fujita, N; Miyakawa, H; Sata, N; Shimosegawa, T; Tanaka, M; Shiratori, K; Sugiyama, M; Takeyama, Y				Inui, Kazuo; Igarashi, Yoshinori; Irisawa, Atsushi; Ohara, Hirotaka; Tazuma, Susumu; Hirooka, Yoshiki; Fujita, Naotaka; Miyakawa, Hiroyuki; Sata, Naohiro; Shimosegawa, Tooru; Tanaka, Masao; Shiratori, Keiko; Sugiyama, Masanori; Takeyama, Yoshifumi			Japanese Clinical Guidelines for Endoscopic Treatment of Pancreatolithiasis	PANCREAS			English	Article						chronic pancreatitis; endoscopic pancreatic sphincterotomy; endoscopic pancreatic duct stenting; endoscopic minor papilla sphincterotomy; extracorporeal shock wave lithotripsy; pancreatectomy		Objectives In addition to surgery, procedures for patients with pancreatolithiasis are developing; therefore, establishing practical guidelines for the management of pancreatolithiasis is required. Methods Three committees (the professional committee for asking clinical questions (CQs) and statements by Japanese endoscopists, the expert panel committee for rating statements by the modified Delphi method, and the evaluating committee by moderators) were organized. Eight endoscopists and a surgeon for pancreatolithiasis made the CQs and statements from a total of 694 reports of published literature by PubMed search (from 1983 to 2012). The expert panelists individually rated these clinical statements using a modified Delphi approach, in which a clinical statement receiving a median score greater than 7 on a 9-point scale from the panel was regarded as valid. Results The professional committee made 3, 7, and 10 CQs and statements for the concept and pathogenesis, diagnosis, and treatment, respectively. The expert panelists regarded them as valid after a 2-round modified Delphi approach. Conclusions After evaluation by the moderators, the Japanese clinical guidelines for pancreatolithiasis were established. Further discussions and studies for international guidelines are needed.	[Inui, Kazuo] Fujita Hlth Univ, Teaching Hosp 2, Dept Gastroenterol, Nagoya, Aichi 4548509, Japan; [Igarashi, Yoshinori] Toho Univ, Omori Med Ctr, Div Gastroenterol & Hepatol, Tokyo, Japan; [Irisawa, Atsushi] Fukushima Med Univ, Aizu Med Ctr, Dept Internal Med, Fukushima, Japan; [Ohara, Hirotaka] Nagoya City Univ, Grad Sch Med Sci, Dept Community Based Med Educ, Nagoya, Aichi, Japan; [Tazuma, Susumu] Hiroshima Univ, Grad Sch Med Sci, Dept Gen Med, Programs Appl Med,Clin Pharmacotherapy, Hiroshima, Japan; [Hirooka, Yoshiki] Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi 4648601, Japan; [Fujita, Naotaka] Sendai City Med Ctr, Dept Gastroenterol, Sendai, Miyagi, Japan; [Inui, Kazuo] Sapporo Kosei Gen Hosp, Div Biliopancreatol, Sapporo, Hokkaido, Japan; [Sata, Naohiro] Jichi Med Univ, Dept Surg, Shimotsuke, Japan; [Shimosegawa, Tooru] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 980, Japan; [Tanaka, Masao] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 812, Japan; [Shiratori, Keiko] Tokyo Womens Med Univ, Dept Gastroenterol, Tokyo, Japan; [Sugiyama, Masanori] Kyorin Univ, Sch Med, Dept Surg, Mitaka, Tokyo 181, Japan; [Takeyama, Yoshifumi] Kinki Univ, Sch Med, Dept Surg, Osakasayama, Japan	Inui, K (reprint author), Fujita Hlth Univ, Sch Med, Teaching Hosp 2, Dept Gastroenterol,Nakagawa Ku, 3-6-10 Otobashi, Nagoya, Aichi 4548509, Japan.	kinui@fujita-hu.ac.jp			Ministry of Health, Labor, and Welfare of Japan	This study was supported by the grant-in-aid for the Intractable Pancreatic Diseases, supported by the Ministry of Health, Labor, and Welfare of Japan.		0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-3177	1536-4828		PANCREAS	Pancreas	OCT	2015	44	7					1053	1064		10.1097/MPA.0000000000000449		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CR8LW	WOS:000361605100007		
J	Notohara, K; Nishimori, I; Mizuno, N; Okazaki, K; Ito, T; Kawa, S; Egawa, S; Kihara, Y; Kanno, A; Masamune, A; Shimosegawa, T				Notohara, Kenji; Nishimori, Isao; Mizuno, Nobumasa; Okazaki, Kazuichi; Ito, Tetsuhide; Kawa, Shigeyuki; Egawa, Shinichi; Kihara, Yasuyuki; Kanno, Atsushi; Masamune, Atsushi; Shimosegawa, Tooru			Clinicopathological Features of Type 2 Autoimmune Pancreatitis in Japan Results of a Multicenter Survey	PANCREAS			English	Article						autoimmune pancreatitis; idiopathic duct-centric pancreatitis; granulocytic epithelial lesion; inflammatory bowel disease; IgG4	SCLEROSING PANCREATITIS; IGG4-RELATED DISEASE; DIAGNOSTIC-CRITERIA; INFILTRATION; SUBTYPES; PROPOSAL	Objective The aim of the study was to clarify clinicopathological features of type 2 autoimmune pancreatitis (AIP) in Japan; a multicenter survey was carried out. Methods The first screening collected patients with pancreatitis whose pancreatic tissue samples were available and who fulfilled at least 1 of the following 3 criteria as possible type 2 AIP: (1) histological presence of granulocytic epithelial lesion, (2) age of 50 years or younger, and (3) association of ulcerative colitis, Sjogren syndrome, and/or primary biliary cirrhosis. Patients with histologically confirmed type 1 AIP were also collected as a control. Clinical information was gathered by questionnaire. Results A histological re-evaluation identified 8 patients with type 2 AIP and 20 with type 1 AIP. Three of the latter had intralobular neutrophilic infiltration. Factors more frequent in type 2 included age younger than 40 years, abdominal pain, and elevation of serum amylase and lipase, whereas patients with type 1 more frequently showed jaundice, elevated serum IgG and IgG4, presence of autoantibodies, association of IgG4-related disease, sclerosing cholangitis and diabetes mellitus, and imaging findings of intrapancreatic biliary stenosis and extrapancreatic biliary dilatation. Conclusions The clinical features of type 2 AIP in Japan were similar to those of western countries. Intralobular neutrophilic infiltration in type 1 is a potential pitfall, especially in the biopsy-based diagnosis.	[Notohara, Kenji] Kurashiki Cent Hosp, Dept Anat Pathol, Kurashiki, Okayama, Japan; [Nishimori, Isao] Nishimori Clin, Kochi, Japan; [Mizuno, Nobumasa] Aichi Canc Ctr Hosp, Dept Gastroenterol, Nagoya, Aichi 464, Japan; [Okazaki, Kazuichi] Kansai Med Univ, Dept Gastroenterol & Hepatol, Hirakata, Osaka, Japan; [Ito, Tetsuhide] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 812, Japan; [Kawa, Shigeyuki] Shinshu Univ, Ctr Hlth Safety & Environm, Matsumoto, Nagano 390, Japan; [Egawa, Shinichi] Tohoku Univ, Grad Sch Med, Div Hepatobiliary Pancreat Surg, Sendai, Miyagi 980, Japan; [Kihara, Yasuyuki] Kitakyushu Gen Hosp, Dept Gastroenterol, Kitakyushu, Fukuoka, Japan; [Kanno, Atsushi; Masamune, Atsushi; Shimosegawa, Tooru] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 980, Japan	Shimosegawa, T (reprint author), Tohoku Univ, Grad Sch Med, Div Gastroenterol, Aoba Ku, 1-1 Seiryomachi, Sendai, Miyagi 9808574, Japan.	tshimosegawa@int3.med.tohoku.ac.jp			Health and Labour Sciences Research Grants (Intractable Diseases) from Japan's Ministry of Health, Labour, and Welfare	Supported by the Health and Labour Sciences Research Grants (Intractable Diseases) from Japan's Ministry of Health, Labour, and Welfare.	Okazaki K, 2006, J GASTROENTEROL, V41, P626, DOI 10.1007/s00535-006-1868-0; Kamisawa T, 2003, GUT, V52, P683, DOI 10.1136/gut.52.5.683; Zamboni G, 2004, VIRCHOWS ARCH, V445, P552, DOI 10.1007/s00428-004-1140-z; KAWAGUCHI K, 1991, HUM PATHOL, V22, P387, DOI 10.1016/0046-8177(91)90087-6; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Deshpande V, 2012, MODERN PATHOL, V25, P1181, DOI 10.1038/modpathol.2012.72; Kamisawa T, 2011, PANCREAS, V40, P809, DOI 10.1097/MPA.0b013e3182258a15; Song TJ, 2012, J GASTROEN HEPATOL, V27, P700, DOI 10.1111/j.1440-1746.2011.06934.x; Stone JH, 2012, ARTHRITIS RHEUM-US, V64, P3061, DOI 10.1002/art.34593; Chari ST, 2010, PANCREAS, V39, P549, DOI 10.1097/MPA.0b013e3181e4d9e5; Hamano H, 2006, J GASTROENTEROL, V41, P1197, DOI 10.1007/s00535-006-1908-9; Kamisawa T, 2003, J GASTROENTEROL, V38, P982, DOI 10.1007/s00535-003-1175-y; Notohara K, 2003, AM J SURG PATHOL, V27, P1119, DOI 10.1097/00000478-200308000-00009; Sah RP, 2010, GASTROENTEROLOGY, V139, P140, DOI 10.1053/j.gastro.2010.03.054; Detlefsen S, 2012, PANCREATOLOGY, V12, P276, DOI 10.1016/j.pan.2012.03.055; Deshpande V, 2011, AM J SURG PATHOL, V35, P26, DOI 10.1097/PAS.0b013e3182027717; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Zhang L, 2007, MODERN PATHOL, V20, P23, DOI 10.1038/modpathol.3800689; Hamano H, 2002, LANCET, V359, P1403, DOI 10.1016/S0140-6736(02)08359-9; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; YOSHIDA K, 1995, DIGEST DIS SCI, V40, P1561, DOI 10.1007/BF02285209	21	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-3177	1536-4828		PANCREAS	Pancreas	OCT	2015	44	7					1072	1077		10.1097/MPA.0000000000000438		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CR8LW	WOS:000361605100009		
J	Kimura, H; Ohtsuka, T; Matsunaga, T; Watanabe, Y; Tamura, K; Ideno, N; Aso, T; Miyazaki, T; Osoegawa, T; Aishima, S; Miyasaka, Y; Ueda, J; Ushijima, Y; Igarashi, H; Ito, T; Takahata, S; Oda, Y; Mizumoto, K; Tanaka, M				Kimura, Hideyo; Ohtsuka, Takao; Matsunaga, Taketo; Watanabe, Yusuke; Tamura, Koji; Ideno, Noboru; Aso, Teppei; Miyazaki, Tetsuyuki; Osoegawa, Takashi; Aishima, Shinichi; Miyasaka, Yoshihiro; Ueda, Junji; Ushijima, Yasuhiro; Igarashi, Hisato; Ito, Tetsuhide; Takahata, Shunichi; Oda, Yoshinao; Mizumoto, Kazuhiro; Tanaka, Masao			Predictors and Diagnostic Strategies for Early-Stage Pancreatic Ductal Adenocarcinoma A Retrospective Study	PANCREAS			English	Article						pancreatic ductal adenocarcinoma; early-stage pancreatic cancer; endoscopic retrograde pancreatography (ERP)	DIABETES-MELLITUS; CANCER REGISTRY; CARCINOMA; RISK; CYTOLOGY; CHOLANGIOPANCREATOGRAPHY; CYTODIAGNOSIS; METAANALYSIS; CONCOMITANT; DILATATION	Objectives As a strategy to diagnose early-stage pancreatic ductal adenocarcinoma (PDAC) is urgently needed, we aimed to clarify characteristics of early-stage PDAC. Methods We retrospectively reviewed medical records of 299 consecutive patients who underwent R0 or R1 surgical resection for PDAC between 1994 and 2013 and compared clinical characteristics between patients with early-stage (stages 0-I by Japanese General Rules for Pancreatic Cancer) and advanced-stage (stages II-IV) disease. Diagnostic processes were also analyzed. Results Twenty-four patients (8%) had early-stage PDAC (stage 0: 11; stage I: 13). Univariate and multivariate analyses showed that presence or history of intraductal papillary mucinous neoplasm (P < 0.01), history of pancreatitis (P < 0.01), and presence or history of extrapancreatic malignancies (P = 0.01) independently predicted detection of early-stage PDAC. Cytological examination during endoscopic retrograde pancreatography cytology was approximate to 65% sensitive in preoperative diagnosis of early-stage PDAC, whereas other imaging modalities were only 29% to 38% sensitive; 9 of 24 early-stage PDACs were diagnosed by endoscopic retrograde pancreatography cytology alone. Conclusions Endoscopic retrograde pancreatography cytology for patients with intraductal papillary mucinous neoplasm or pancreatitis may help diagnose early-stage PDAC. Surveillance of extrapancreatic malignancies might also provide opportunities to detect early-stage PDAC as a second malignancy.	[Kimura, Hideyo; Ohtsuka, Takao; Matsunaga, Taketo; Watanabe, Yusuke; Tamura, Koji; Ideno, Noboru; Aso, Teppei; Miyasaka, Yoshihiro; Ueda, Junji; Takahata, Shunichi; Mizumoto, Kazuhiro; Tanaka, Masao] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 8128582, Japan; [Miyazaki, Tetsuyuki; Aishima, Shinichi; Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 8128582, Japan; [Osoegawa, Takashi; Igarashi, Hisato; Ito, Tetsuhide] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 8128582, Japan; [Ushijima, Yasuhiro] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Fukuoka 8128582, Japan	Tanaka, M (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	masaotan@med.kyushu-u.ac.jp					COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Kiriyama S, 2010, J HEPATO-BIL-PAN SCI, V17, P24, DOI 10.1007/s00534-009-0214-3; NAKAIZUMI A, 1995, CANCER, V76, P750, DOI 10.1002/1097-0142(19950901)76:5<750::AID-CNCR2820760507>3.0.CO;2-#; Shimosegawa T, 2010, J GASTROENTEROL, V45, P584, DOI 10.1007/s00535-010-0242-4; Uehara H, 2009, GASTROINTEST ENDOSC, V70, P52, DOI 10.1016/j.gie.2008.09.059; Egawa S, 2004, PANCREAS, V28, P235, DOI 10.1097/00006676-200404000-00004; Yamaguchi K, 1997, INT J PANCREATOL, V22, P227; Ogawa Y, 2002, CANCER, V94, P2344, DOI 10.1002/cncr.10493; Mori Y, 2013, PANCREAS, V42, P187, DOI 10.1097/MPA.0b013e3182649979; Tummala P, 2013, PANCREAS, V42, P108, DOI 10.1097/MPA.0b013e318254f473; McGuire DE, 1996, GASTROINTEST ENDOSC, V44, P300, DOI 10.1016/S0016-5107(96)70168-2; Isaji S, 2004, PANCREAS, V28, P231, DOI 10.1097/00006676-200404000-00003; ISHIKAWA O, 1992, SURGERY, V111, P294; Ueda J, 2013, SURGERY, V153, P357, DOI [10.1016/j.surg.2012.08.005, 10.1016/j.surg,2012.08.005]; Inoue K, 2003, GASTROINTEST ENDOSC, V58, P510, DOI 10.1067/S0016-5107(03)01962-X; Ben QW, 2011, EUR J CANCER, V47, P1928, DOI 10.1016/j.ejca.2011.03.003; Rebours V, 2008, AM J GASTROENTEROL, V103, P111, DOI 10.1111/j.1572-0241.2007.01597.x; Yokohata K, 2000, SCAND J GASTROENTERO, V35, P1229, DOI 10.1080/003655200750056745; Tanaka M, 1997, GASTROINTEST ENDOSC, V46, P447, DOI 10.1016/S0016-5107(97)70039-7; Permuth-Wey J, 2009, FAM CANCER, V8, P109, DOI 10.1007/s10689-008-9214-8; SHEMESH E, 1990, CANCER, V65, P893, DOI 10.1002/1097-0142(19900215)65:4<893::AID-CNCR2820650412>3.0.CO;2-G; Hackert T, 2012, PANCREAS, V41, P212, DOI 10.1097/MPA.0b013e3182240602; Egawa S, 2012, PANCREAS, V41, P985, DOI 10.1097/MPA.0b013e318258055c; [Anonymous], 2009, JPN GUIDELINES MANAG; Yamaguchi K, 2002, PANCREATOLOGY, V2, P484, DOI 10.1159/000064716; Iiboshi T, 2012, PANCREAS, V41, P523, DOI 10.1097/MPA.0b013e31823c0b05; Matsuno S, 2004, PANCREAS, V28, P219, DOI 10.1097/00006676-200404000-00002; Ohtsuka T, 2013, J HEPATO-BIL-PAN SCI, V20, P356, DOI 10.1007/s00534-012-0541-7; Ingkakul T, 2010, ANN SURG, V251, P70, DOI 10.1097/SLA.0b013e3181c5ddc3; Japan Pancreas Society, 2011, CLASS PANCR CARC; Kamata K, 2014, ENDOSCOPY, V46, P22, DOI 10.1055/s-0033-1353603; Ohtsuka T, 2014, SURG TODAY, V44, P1887, DOI 10.1007/s00595-014-0845-0	32	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-3177	1536-4828		PANCREAS	Pancreas	OCT	2015	44	7					1148	1154		10.1097/MPA.0000000000000393		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CR8LW	WOS:000361605100020		
J	Kawaguchi, C; Sho, M; Tanaka, T; Akahori, T; Kinoshita, S; Nagai, M; Yasuda, S; Nishiwada, S; Nishiofuku, H; Kichikawa, K; Nakajima, Y				Kawaguchi, Chihiro; Sho, Masayuki; Tanaka, Toshihiro; Akahori, Takahiro; Kinoshita, Shoichi; Nagai, Minako; Yasuda, Satoshi; Nishiwada, Satoshi; Nishiofuku, Hideyuki; Kichikawa, Kimihiko; Nakajima, Yoshiyuki			Impact of Smoking on Pancreatic Cancer Patients Receiving Current Chemotherapy	PANCREAS			English	Article						chemotherapy; pancreatic cancer; prognosis; smoking; surgery	GEMCITABINE-INDUCED NEUTROPENIA; TOBACCO-SPECIFIC CARCINOGEN; RANDOMIZED PHASE-III; CIGARETTE-SMOKING; PLUS GEMCITABINE; RISK-FACTORS; SURVIVAL; OBESITY; TRIAL; ADENOCARCINOMA	Objective Smoking may affect pharmacokinetics of chemotherapeutic agents and hemodynamics of the smokers, thereby influencing adverse events and efficacy of chemotherapy in patients with pancreatic cancer (PC). The aim of this study was to clarify how smoking totally affected patients with PC receiving current chemotherapy. Methods We evaluated the impact of smoking status on the performance of chemotherapy and survival in 262 patients with PC including 158 resectable and 104 unresectable PC. Results There were more male and younger patients in current smokers than in nonsmokers. In unresectable PC, current smokers had more metastatic tumors than locally advanced tumors compared with nonsmokers. In current smokers receiving chemotherapy, the baseline white blood cell count, neutrophil count, and hemoglobin concentration were significantly higher in current smokers than in nonsmokers. Furthermore, grades 3 to 4 neutropenia was observed more often in nonsmokers than smokers. On the other hand, the performance and efficacy of the planned adjuvant chemotherapy were similar between smokers and nonsmokers. More importantly, there was no significant difference in overall prognosis between smokers and nonsmokers receiving chemotherapy. Conclusions Smoking status has no significant impact on the efficacy of current chemotherapy for both resectable and unresectable PC.	[Kawaguchi, Chihiro; Sho, Masayuki; Akahori, Takahiro; Kinoshita, Shoichi; Nagai, Minako; Yasuda, Satoshi; Nishiwada, Satoshi; Nakajima, Yoshiyuki] Nara Med Univ, Dept Surg, Kashihara, Nara 6348522, Japan; [Tanaka, Toshihiro; Nishiofuku, Hideyuki; Kichikawa, Kimihiko] Nara Med Univ, Dept Radiol, Kashihara, Nara 6348522, Japan	Sho, M (reprint author), Nara Med Univ, Dept Surg, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	m-sho@naramed-u.ac.jp			Smoking Research Foundation	This study was supported by a research grant from the Smoking Research Foundation.	Allison DC, 1998, J SURG ONCOL, V67, P151, DOI 10.1002/(SICI)1096-9098(199803)67:3<151::AID-JSO2>3.0.CO;2-8; Ueno H, 2013, J CLIN ONCOL, V31, P1640, DOI 10.1200/JCO.2012.43.3680; Van Tiel ED, 2002, ANN EPIDEMIOL, V12, P378, DOI 10.1016/S1047-2797(01)00282-4; Kanai M, 2009, ANN ONCOL, V20, P1397, DOI 10.1093/annonc/mdp008; Askari MDF, 2006, PANCREAS, V33, P53, DOI 10.1097/01.mpa.0000226883.55828.e9; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Flook R, 2009, CAN J GASTROENTEROL, V23, P546; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Ueno H, 2009, BRIT J CANCER, V101, P908, DOI 10.1038/sj.bjc.6605256; van der Bol JM, 2007, J CLIN ONCOL, V25, P2719, DOI 10.1200/JCO.2006.09.6115; HELMAN N, 1975, AM J CLIN PATHOL, V63, P35; O'Malley M, 2013, ONCOLOGY-BASEL, V85, P216, DOI 10.1159/000355107; [Anonymous], 2013, NATL COMPREHENSIVE C; Seufferlein T, 2012, ANN ONCOL, V23, P33, DOI 10.1093/annonc/mds224; Dandona M, 2011, PANCREAS, V40, P931, DOI 10.1097/MPA.0b013e318215a9b1; Lin YS, 2002, CANCER CAUSE CONTROL, V13, P249, DOI 10.1023/A:1015052710213; Iodice S, 2008, LANGENBECK ARCH SURG, V393, P535, DOI 10.1007/s00423-007-0266-2; Hamilton M, 2006, CLIN CANCER RES, V12, P2166, DOI 10.1158/1078-0432.CCR-05-2235; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Gandini S, 2008, INT J CANCER, V122, P155, DOI 10.1002/ije.23033; Schuller HM, 2010, FUTURE ONCOL, V6, P221, DOI [10.2217/fon.09.171, 10.2217/FON.09.171]; Tempero MA, 2012, J NATL COMPR CANC NE, V10, P703; Park SM, 2006, J CLIN ONCOL, V24, P5017, DOI 10.1200/JCO.2006.07.0243; Askari MDF, 2005, J CANCER RES CLIN, V131, P639, DOI 10.1007/s00432-005-0002-7; Kawada T, 2004, ARCH MED RES, V35, P246, DOI 10.1016/j.arcmed.2004.02.001; Vincenzi B, 2009, EXPERT OPIN BIOL TH, V9, P945, DOI 10.1517/14712590903081694; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Yu GP, 1997, CANCER DETECT PREV, V21, P497; Brand RE, 2009, CLIN GASTROENTEROL H, V7, P1007, DOI 10.1016/j.cgh.2009.06.008; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Pelucchi C, 2014, PANCREAS, V43, P47, DOI 10.1097/MPA.0b013e3182a7c74b; Paulson AS, 2013, GASTROENTEROLOGY, V144, P1316, DOI 10.1053/j.gastro.2013.01.078; Olson SH, 2010, INT J CANCER, V127, P2412, DOI 10.1002/ijc.25240; Mulder I, 2002, EUR J GASTROEN HEPAT, V14, P1343, DOI 10.1097/00042737-200212000-00010; Sobin LH, 2009, TNM CLASSIFICATION M	35	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-3177	1536-4828		PANCREAS	Pancreas	OCT	2015	44	7					1155	1160		10.1097/MPA.0000000000000395		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CR8LW	WOS:000361605100021		
J	Takabayashi, N; Murata, K; Tanaka, S; Kawakami, K				Takabayashi, Nobuyoshi; Murata, Kyoko; Tanaka, Shiro; Kawakami, Koji			Cost-Effectiveness of Proton Pump Inhibitor Co-Therapy in Patients Taking Aspirin for Secondary Prevention of Ischemic Stroke	PHARMACOECONOMICS			English	Article							LOW-DOSE ASPIRIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RANDOMIZED CONTROLLED-TRIALS; DOUBLE-BLIND; CARDIOVASCULAR PREVENTION; GASTRODUODENAL ULCERS; ACETYLSALICYLIC-ACID; ANTIPLATELET THERAPY; JAPANESE COMMUNITY; HEMORRHAGIC STROKE	Low-dose aspirin (ASA) is effective for secondary prevention of ischemic stroke but can increase the risks of hemorrhagic stroke, upper gastrointestinal bleeding (UGIB), and dyspepsia. Prophylactic administration of proton pump inhibitors (PPIs) reduces the risks of these digestive symptoms. We investigated the cost effectiveness of adding a PPI to ASA therapy for ischemic stroke patients in Japan. A Markov state-transition model was developed to compare the cost effectiveness of ASA monotherapy with ASA plus PPI co-therapy in patients with histories of upper gastrointestinal ulcers and ischemic stroke. The model takes into account ASA adherence rate and adverse effects due to ASA, including hemorrhagic stroke and UGIB. The analysis was performed from the perspective of healthcare payers in 2013. In the base case, total life-years by PPI co-therapy and monotherapy were 16.005 and 15.932, respectively. The difference in duration of no therapy (no ASA or PPI) between the therapies was 558.5 days, which would prevent 30.3 recurrences of ischemic stroke per 1000 person-years. The incremental cost-effectiveness ratio of PPI co-therapy relative to monotherapy was Ayen1,191,665 (US$11,458) per life-year gained. In a one-way sensitivity analysis, PPI co-therapy was consistently cost effective at a willingness to pay of Ayen5,000,000 (US$48,077) per life-year gained. In a probabilistic sensitivity analysis, the probability that PPI co-therapy was cost effective was 89.74 % at the willingness to pay. Co-therapy with ASA plus PPI appears to be cost-effective compared with ASA monotherapy. The addition of PPI also appeared to prolong the duration of ASA therapy, thereby reducing the risk of ischemic stroke.	[Takabayashi, Nobuyoshi; Murata, Kyoko; Tanaka, Shiro; Kawakami, Koji] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Sakyo Ku, Kyoto 6068501, Japan; [Takabayashi, Nobuyoshi] Takeda Pharmaceut Co Ltd, Osaka, Japan	Kawakami, K (reprint author), Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Sakyo Ku, Kyoto 6068501, Japan.	kawakami.koji.4e@kyoto-u.ac.jp			Kyowa Hakko Kirin; Bayer; Dainippon Sumitomo Pharma; Olympus; Stella Pharma; Kaken Pharmaceutical; Advanced Medicalcare; Otsuka Pharmaceuticals	NT is an employee of Takeda Pharmaceutical Co., Ltd. KM and ST have no personal interests to declare. KK has received research funding from Kyowa Hakko Kirin, Bayer, Dainippon Sumitomo Pharma, Olympus, and Stella Pharma; honorariums from Daiichi Sankyo, Eisai, Boehringer Ingelheim Japan Inc., Novartis Pharmaceutical K.K., Astra Zeneca, CSL Behring, MSD, Shionogi Pharmaceuticals, Takeda; and consultancy fees from Kyowa Hakko Kirin, Olympus, Kaken Pharmaceutical, Advanced Medicalcare, and Otsuka Pharmaceuticals.	Lai KC, 2002, NEW ENGL J MED, V346, P2033, DOI 10.1056/NEJMoa012877; Lanas A, 2007, AM J GASTROENTEROL, V102, P507, DOI 10.1111/j.1572-0241.2006.01062.x; Scheiman JM, 2011, HEART, V97, P797, DOI 10.1136/hrt.2010.217547; de Groot NL, 2013, CARDIOVASC DRUG THER, V27, P341, DOI 10.1007/s10557-013-6448-y; Shirao S, 2010, CEREBROVASC DIS, V30, P105, DOI 10.1159/000314713; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; Yoneda Y, 2005, HEALTH POLICY, V73, P202, DOI 10.1016/j.healthpol.2004.11.016; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI [10.1016/S2214-109X(13)70089-5, 10.1016/S0140-6736(13)61953-4]; Derry S, 2000, BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; Sugano K, 2011, J GASTROENTEROL, V46, P724, DOI 10.1007/s00535-011-0397-7; Shinohara Y, 2008, STROKE, V39, P1827, DOI 10.1161/STROKEAHA.107.505131; Sakamoto C, 2006, EUR J CLIN PHARMACOL, V62, P765, DOI 10.1007/s00228-006-0171-6; Saini SD, 2011, ALIMENT PHARM THER, V34, P243, DOI 10.1111/j.1365-2036.2011.04707.x; Tsugawa Y, 2013, MED CARE, V51, P782, DOI 10.1097/MLR.0b013e31829c8b70; Targownik LE, 2010, GASTROENTEROLOGY, V138, P896, DOI 10.1053/j.gastro.2009.11.014; Johnson ES, 1999, ARCH INTERN MED, V159, P1248, DOI 10.1001/archinte.159.11.1248; Merino EM, 2013, AM J CARDIOL, V112, P1075, DOI 10.1016/j.amjcard.2013.05.051; Yeomans N, 2008, AM J GASTROENTEROL, V103, P2465, DOI [10.1111/j.1572-0241.2008.01995.x, 10.1111/j.1572-2008.01995.x]; Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2; Weisman SM, 2002, ARCH INTERN MED, V162, P2197, DOI 10.1001/archinte.162.19.2197; Sugano K, 2014, GUT, V63, P1061, DOI 10.1136/gutjnl-2013-304722; Ishikawa S, 2012, HEPATO-GASTROENTEROL, V59, P147, DOI 10.5754/hge09689; KOMIYA T, 1994, STROKE, V25, P2337; Uchiyama S, 2011, CEREBROVASC DIS, V31, P601, DOI 10.1159/000327035; Laine L, 2009, AM J GASTROENTEROL, V104, pS21, DOI 10.1038/ajg.2009.48; McCarthy DM, 2010, CURR OPIN GASTROEN, V26, P624, DOI 10.1097/MOG.0b013e32833ea9d9; Yang YX, 2010, GASTROENTEROLOGY, V139, P1115, DOI 10.1053/j.gastro.2010.08.023; Herlitz J, 2010, AM J CARDIOVASC DRUG, V10, P125, DOI 10.2165/11318440-000000000-00000; McQuaid KR, 2006, AM J MED, V119, P624, DOI 10.1016/j.amjmed.2005.10.039; Shinohara Y, 2010, LANCET NEUROL, V9, P959, DOI 10.1016/S1474-4422(10)70198-8; He J, 1998, JAMA-J AM MED ASSOC, V280, P1930, DOI 10.1001/jama.280.22.1930; Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Morimoto T, 2004, AM J MED, V117, P459, DOI 10.1016/j.amjmed.2064.04.017; Abraham NS, 2010, AM J GASTROENTEROL, V105, P2533, DOI 10.1038/ajg.2010.445; Kimura K, 2005, CEREBROVASC DIS, V19, P171, DOI 10.1159/000083252; Kiyohara Y, 2003, STROKE, V34, P2343, DOI 10.1161/01.STR.0000091845.14833.43; Cabinet Office Government of Japan, ANN REP AG SOC 2013; Charlot M, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2690; Gotoh F, 2000, J Stroke Cerebrovasc Dis, V9, P147, DOI 10.1053/jscd.2000.7216; Koga M, 2008, JPN J STROKE, V30, P735; Larsen J, 2009, BMC PUBLIC HEALTH, V9; Ministry of health labour and welfare, 2012, EL POINT TABL DIAGN; Ministry of Health Labour and Welfare, EST NAT MED CAR EXP; Ministry of health labour and welfare, REV MED FEE; Ministry of Health Labour and Welfare, PAT SURV 2012; Ministry of Health Labour and Welfare, YEAR 2012 ABR LIF TA; Ministry of health labour and welfare, 2012, VAR INF MED FEE; Ministry of Health Labour and Welfare Government of Japan, HLTH JAP 21 2 TERM; OECD (Organization for Economic Co-operation and Development), PURCH POW PAR PPPS E; Research group on economic evaluation for Japanese public medical benefits, 2013, GUID EC EV HEALTHC T; Rosemary J, 2007, Curr Clin Pharmacol, V2, P93, DOI 10.2174/157488407779422302; Shiroiwa Takeru, 2013, Cost Eff Resour Alloc, V11, P22, DOI 10.1186/1478-7547-11-22; Takeda Pharmaceutical Co. Ltd, SUBM DOSS LANS; The Joint Committee on Guidelines for the Management of Stroke, 2009, JAP GUID MAN STROK; Yakugyo kenkyukai, 2012, NAT HLTH INS DRUG DI	56	0	0	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1170-7690	1179-2027		PHARMACOECONOMICS	Pharmacoeconomics	OCT	2015	33	10					1091	1100		10.1007/s40273-015-0289-4		10	Economics; Health Care Sciences & Services; Health Policy & Services; Pharmacology & Pharmacy	Business & Economics; Health Care Sciences & Services; Pharmacology & Pharmacy	CR8TE	WOS:000361626100008		
J	Fukushima, Y; Chen, WJ; Yokohira, T				Fukushima, Yukinobu; Chen, Wenjie; Yokohira, Tokumi			A trail multi-splitting method for throughput improvement in light trail networks	PHOTONIC NETWORK COMMUNICATIONS			English	Article						Light trail network; Medium access control; Token passing; Token-holding time decision problem		Light trail networks have been proposed as an extension of lightpath networks in order to enable sub-wavelength bandwidth allocation in WDM networks. The networks need a medium access control (MAC) method to avoid collisions of data transmissions. We have proposed a MAC method which adopts a token-passing mechanism. The method splits one trail into two trails: one upstream trail and one downstream trail and permits independent data transmissions on the trails. However, the method leaves bandwidths of links upstream from the token-holding node idle because the method only splits the original trail into two trails and leaves the upstream trail unsplit. In this paper, we propose a novel token-passing MAC method for further improving trail throughputs. Our proposed method recursively splits the upstream trail, and consequently the original trail can be split into more than two trails. In the proposed method, an appropriate setting of upstream/downstream token-holding times of all nodes is a key factor to successfully accommodate an input traffic. Therefore, we tackle a problem (called a token-holding time decision problem) where we optimize token-holding times of all nodes so that input traffic is successfully accommodated. We formulate the problem as a linear programming model. Numerical examples on maximum effective throughput show that the proposed method is more superior as the ratio of short-hop traffic is higher in input traffic patterns.	[Fukushima, Yukinobu; Yokohira, Tokumi] Okayama Univ, Grad Sch Nat Sci & Technol, Kita Ku, Okayama, Okayama 7008530, Japan; [Chen, Wenjie] Nomura Res Inst, Chiyoda Ku, Tokyo, Japan	Fukushima, Y (reprint author), Okayama Univ, Grad Sch Nat Sci & Technol, Kita Ku, Tushimanaka 3-1-1, Okayama, Okayama 7008530, Japan.	fukusima@okayama-u.ac.jp; yokohira@okayama-u.ac.jp					GROTSCHEL M, 1981, COMBINATORICA, V1, P169, DOI 10.1007/BF02579273; Chen WJ, 2012, IEICE T COMMUN, VE95B, P2330, DOI 10.1587/transcom.E95.B.2330; CHLAMTAC I, 1992, IEEE T COMMUN, V40, P1171, DOI 10.1109/26.153361; [Anonymous], 2005, IEEE COMMUN MAG; Chen W., 2011, GLOBECOM 2011; Chlamtac I, 2003, LECT NOTES COMPUT SC, V2601, P634; Fang J., 2004, ICC 2004, P1699; Fukushima Y., 2009, ITC CSCC 2009; Gumaste A., 2008, OFC NFOEC 2008, P1, DOI 10.1109/OFC.2008.4528378; Gumaste A., 2004, OSA J OPT NETW, V3, P261; Gumaste A, 2003, HPSR 2003: WORKSHOP ON HIGH PERFORMANCE SWITCHING AND ROUTING, P251; IBM, ILOG CPLEX OPT; Karmarkar N, 1984, STOC 84, P302; Tran N. C., 2007, OECC IOOC 2007; VanderHorn N. A., 2007, THESIS IOWA STATE U	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1387-974X	1572-8188		PHOTONIC NETW COMMUN	Photonic Netw. Commun.	OCT	2015	30	2					178	189		10.1007/s11107-015-0509-z		12	Computer Science, Information Systems; Optics; Telecommunications	Computer Science; Optics; Telecommunications	CR7JV	WOS:000361526700005		
J	Ashihara, H; Ludwig, IA; Katahira, R; Yokota, T; Fujimura, T; Crozier, A				Ashihara, Hiroshi; Ludwig, Iziar A.; Katahira, Riko; Yokota, Takao; Fujimura, Tatsuhito; Crozier, Alan			Trigonelline and related nicotinic acid metabolites: occurrence, biosynthesis, taxonomic considerations, and their roles in planta and in human health	PHYTOCHEMISTRY REVIEWS			English	Review						Pyridine alkaloids; Occurrence; Biosynthesis; Pyridine nucleotide cycle; Coffee	PYRIDINE-NUCLEOTIDE CYCLE; CELL-SUSPENSION-CULTURES; ADENOSYL-L-METHIONINE; NAD BIOSYNTHESIS; COFFEA-ARABICA; ARABIDOPSIS-THALIANA; TOBACCO ALKALOIDS; ENZYME-ACTIVITIES; GLYCINE-MAX; RHIZOBIUM-MELILOTI	This review describes the occurrence and biosynthesis of trigonelline (N-methylnicotinic acid) and related nicotinic acid metabolites. High concentrations of trigonelline are found in seeds of coffee, and some members of the Fabaceae, while trace amounts occur in many other species. In contrast, the occurrence of other pyridine alkaloids derived from nicotinic acid is limited. Nicotinic acid, a precursor of the secondary pyridine metabolites, is derived from pyridine nucleotides. In planta, pyridine nucleotide biosynthesis de novo is initiated from aspartic acid. The degradation of NAD and its regeneration from the catabolites is called the pyridine nucleotide cycle (PNC). Isotopic labelling and enzymatic studies indicate a seven-component PNC VII pathway is the major route. All plants examined convert exogenous nicotinic acid to trigonelline and/or nicotinic acid N-glucoside (NaG). In general, NaG formation is restricted to ferns and selected orders of angiosperms, whereas other plants produce trigonelline. The biosynthesis of other pyridine alkaloids, of which many details remain to be resolved, is discussed briefly. The potential in planta roles of trigonelline, including detoxification, nyctinasty and host selection are discussed. Coffee beverage is the major food containing trigonelline and some vegetables also contain trigonelline. The possible effects of trigonelline on health mediated via hypoglycaemic, neuroprotective, anti-cancer, estrogenic, and antibacterial activities are reviewed. Finally, potential genetic manipulation of biosynthetic pathways to create trigonelline- and vitamin B-3-rich plants and agricultural uses of trigonelline-rich genetically modified crops and trees are discussed.	[Ashihara, Hiroshi] Ochanomizu Univ, Dept Biol, Tokyo 1128610, Japan; [Ludwig, Iziar A.; Crozier, Alan] Univ Glasgow, Coll Med Vet & Life Sci, Sch Med, Plant Prod & Human Nutr Grp, Glasgow G12 8QQ, Lanark, Scotland; [Katahira, Riko] Kobe Shoin Womens Univ, Dept Lifestyle Studies, Kobe, Hyogo 6570015, Japan; [Yokota, Takao] Teikyo Univ, Dept Biosci, Utsunomiya, Tochigi 3208551, Japan; [Fujimura, Tatsuhito] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Ashihara, H (reprint author), Ochanomizu Univ, Dept Biol, Tokyo 1128610, Japan.	ashihara.hiroshi@ocha.ac.jp			Japanese Society for the Promotion of Science [16570031, 22510226]; Asahi Breweries Foundation, Japan	Our research cited in this review was supported by the Grant-in-Aid for Scientific Research from the Japanese Society for the Promotion of Science (Nos. 16570031 and 22510226) and by research grants from the Asahi Breweries Foundation, Japan to Hiroshi Ashihara.	HIBI N, 1994, PLANT CELL, V6, P723, DOI 10.1105/tpc.6.5.723; Dulyaninova NG, 2000, BBA-PROTEIN STRUCT M, V1478, P211, DOI 10.1016/S0167-4838(00)00045-5; Zheng XQ, 2004, PLANT SCI, V166, P807, DOI 10.1016/j.plantsci.2003.11.024; Lang R, 2010, ANAL CHEM, V82, P1486, DOI 10.1021/ac902616k; Ashihara H, 2011, PHYTOCHEM LETT, V4, P235, DOI 10.1016/j.phytol.2011.04.005; Matsui A, 2008, PLANT PHYSIOL BIOCH, V46, P104, DOI 10.1016/j.plaphy.2007.10.008; Bessman MJ, 1996, J BIOL CHEM, V271, P25059; GRIFFITH T, 1962, BIOCHEMISTRY-US, V1, P336, DOI 10.1021/bi00908a021; TAGUCHI H, 1989, AGR BIOL CHEM TOKYO, V53, P2867; Minorsky PV, 2002, PLANT PHYSIOL, V128, P7, DOI 10.1104/pp.900014; Zheng XQ, 2008, PHYTOCHEMISTRY, V69, P390, DOI 10.1016/j.phytochem.2007.08.008; Ashihara H, 2013, ADV BOT RES, V68, P111, DOI 10.1016/B978-0-12-408061-4.00004-3; DeBoer KD, 2009, PLANT MOL BIOL, V69, P299, DOI 10.1007/s11103-008-9425-2; SAKAN T, 1959, B CHEM SOC JPN, V32, P315, DOI 10.1246/bcsj.32.315; TRAMONTANO WA, 1985, ENVIRON EXP BOT, V25, P83, DOI 10.1016/0098-8472(85)90051-6; FU P, 1972, PHYTOCHEMISTRY, V11, P95, DOI 10.1016/S0031-9422(00)89973-2; Stasolla C, 2003, J PLANT PHYSIOL, V160, P1271, DOI 10.1078/0176-1617-01169; Zhang XJ, 2003, J BIOL CHEM, V278, P13503, DOI 10.1074/jbc.M300073200; UEDA M, 1995, PHYTOCHEMISTRY, V39, P817, DOI 10.1016/0031-9422(95)00064-E; Gaur V, 2013, PHARM BIOL, V51, P550, DOI 10.3109/13880209.2012.747547; Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670; Berglund T, 1996, FEBS LETT, V380, P188, DOI 10.1016/0014-5793(96)00027-0; NISHITANI H, 1995, BIOSCI BIOTECH BIOCH, V59, P1336; Jambunathan N, 2006, PLANTA, V224, P1, DOI 10.1007/s00425-005-0183-y; Yin YL, 2011, NAT PROD COMMUN, V6, P1835; Briggs AG, 2011, TRENDS PLANT SCI, V16, P372, DOI 10.1016/j.tplants.2011.03.008; Nakayama T, 2004, CHEMOECOLOGY, V14, P199, DOI 10.1007/s00049-004-0272-6; Ashihara H, 2011, PLANT PHYSIOL BIOCH, V49, P275, DOI 10.1016/j.plaphy.2010.12.008; Ashihara H, 2012, J PLANT RES, V125, P781, DOI 10.1007/s10265-012-0490-x; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Zheng XQ, 2004, PHYSIOL PLANTARUM, V122, P404, DOI 10.1111/j.1399-3054.2004.00422.x; Qiu YL, 1999, TRENDS PLANT SCI, V4, P26, DOI 10.1016/S1360-1385(98)01361-2; LEETE E, 1973, PHYTOCHEMISTRY, V12, P593, DOI 10.1016/S0031-9422(00)84449-0; BERGLUND T, 1994, FEBS LETT, V351, P145, DOI 10.1016/0014-5793(94)00850-7; WAGNER R, 1986, PLANTA, V167, P226, DOI 10.1007/BF00391419; GHOLSON RK, 1966, NATURE, V212, P933, DOI 10.1038/212933a0; WILLEKE U, 1979, PHYTOCHEMISTRY, V18, P105, DOI 10.1016/S0031-9422(00)90924-5; LEETE E, 1976, J AM CHEM SOC, V98, P6326, DOI 10.1021/ja00436a043; ARDITTI J, 1979, AM J BOT, V66, P1105, DOI 10.2307/2442577; Furukawa M, 2002, PHYTOCHEMISTRY, V59, P767, DOI 10.1016/S0031-9422(02)00020-1; FU P, 1970, PHYTOCHEMISTRY, V9, P2443, DOI 10.1016/S0031-9422(00)85760-X; Francis D, 2001, PLANT GROWTH REGUL, V33, P1, DOI 10.1023/A:1010762111585; Yin YL, 2008, PHYTOCHEMISTRY, V69, P2891, DOI 10.1016/j.phytochem.2008.10.002; IYER RSR, 1956, NATURWISSENSCHAFTEN, V43, P251; Ashihara H, 2010, PHYTOCHEMISTRY, V71, P47, DOI 10.1016/j.phytochem.2009.09.033; Kurnasov O, 2003, CHEM BIOL, V10, P1195, DOI 10.1016/j.chembiol.2003.11.011; NASU S, 1982, J BIOL CHEM, V257, P626; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Allred KF, 2009, J NUTR, V139, P1833, DOI 10.3945/jn.109.108001; WAGNER R, 1986, PLANTA, V168, P408, DOI 10.1007/BF00392369; TRAMONTANO WA, 1983, PHYTOCHEMISTRY, V22, P673, DOI 10.1016/S0031-9422(00)86960-5; Noctor G, 2011, ADV BOT RES, V58, P153, DOI 10.1016/B978-0-12-386479-6.00002-0; EVANS LS, 1981, AM J BOT, V68, P1282, DOI 10.2307/2443053; PAILER M, 1962, MONATSH CHEM, V93, P403; Kalbin G, 1997, EUR J BIOCHEM, V249, P465, DOI 10.1111/j.1432-1033.1997.00465.x; Ashihara H, 2005, PLANT SCI, V169, P107, DOI 10.1016/j.plantsci.2005.03.001; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; TARR JB, 1982, PLANT PHYSIOL, V69, P553, DOI 10.1104/pp.69.3.553; MATA R, 1990, J NAT PROD, V53, P1212, DOI 10.1021/np50071a012; WAGNER R, 1985, PLANTA, V165, P532, DOI 10.1007/BF00398100; Ashihara H, 1999, ADV BOT RES, V30, P117; RADWAN SS, 1980, PLANTA, V147, P340, DOI 10.1007/BF00379843; Ueda M, 2000, PHYTOCHEMISTRY, V53, P39, DOI 10.1016/S0031-9422(99)00467-7; Sasamoto H, 2014, PHYTOCHEM LETT, V7, P38, DOI 10.1016/j.phytol.2013.09.008; HOHL U, 1988, APPL MICROBIOL BIOT, V28, P319; Chen X, 2004, BIOL PLANTARUM, V48, P531, DOI 10.1023/B:BIOP.0000047148.20309.88; Kajikawa M, 2009, PLANT MOL BIOL, V69, P287, DOI 10.1007/s11103-008-9424-3; Ashihara H, 2014, NAT PROD COMMUN, V9, P795; TRAMONTANO WA, 1986, ENVIRON EXP BOT, V26, P197, DOI 10.1016/0098-8472(86)90030-4; BRAY L, 1991, PHYSIOL PLANTARUM, V83, P136, DOI 10.1034/j.1399-3054.1991.830120.x; Hsieh CY, 1998, CANCER RES, V58, P3833; TRAMONTANO WA, 1982, PHYTOCHEMISTRY, V21, P1201, DOI 10.1016/0031-9422(82)80111-8; Tramontano WA, 1997, PHYTOCHEMISTRY, V44, P1037, DOI 10.1016/S0031-9422(96)00715-7; TAGUCHI H, 1983, BIOCHEM BIOPH RES CO, V113, P569, DOI 10.1016/0006-291X(83)91763-1; VIANI R, 1974, J FOOD SCI, V39, P1216, DOI 10.1111/j.1365-2621.1974.tb07357.x; UPMEIER B, 1988, ARCH BIOCHEM BIOPHYS, V262, P445, DOI 10.1016/0003-9861(88)90396-7; Hunt L, 2004, NEW PHYTOL, V163, P31, DOI 10.1111/j.1469-8137.2004.01087.x; PREISS J, 1958, J BIOL CHEM, V233, P493; MANN DF, 1974, J BIOL CHEM, V249, P6817; van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207; UPMEIER B, 1988, PHYTOCHEMISTRY, V27, P3489, DOI 10.1016/0031-9422(88)80754-4; Hirakawa N, 2005, BIOSCI BIOTECH BIOCH, V69, P653, DOI 10.1271/bbb.69.653; IMAI T, 1987, ARCH BIOCHEM BIOPHYS, V254, P241, DOI 10.1016/0003-9861(87)90100-7; GUSTAFSON FG, 1949, SCIENCE, V110, P279, DOI 10.1126/science.110.2855.279; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Katahira R, 2009, PLANTA, V231, P35, DOI 10.1007/s00425-009-1023-2; Ky CL, 2001, FOOD CHEM, V75, P223, DOI 10.1016/S0308-8146(01)00204-7; Suzuki-Yamamoto M, 2006, PHYSIOL PLANTARUM, V128, P405, DOI 10.1111/j.1399-3054.2006.00753.x; Shoji T, 2010, PLANT CELL, V22, P3390, DOI 10.1105/tpc.110.078543; YANG KS, 1965, J AM CHEM SOC, V87, P4184, DOI 10.1021/ja01096a032; MANN DF, 1974, PLANT PHYSIOL, V53, P603, DOI 10.1104/pp.53.4.603; WAGNER KG, 1992, INT REV CYTOL, V134, P1; TAGUCHI H, 1985, AGR BIOL CHEM TOKYO, V49, P3467; DAWSON RF, 1953, J AM CHEM SOC, V75, P5114, DOI 10.1021/ja01116a502; Jimenez JI, 2008, P NATL ACAD SCI USA, V105, P11329, DOI 10.1073/pnas.0802273105; Turner WL, 2004, PLANT PHYSIOL, V135, P1243, DOI 10.1104/pp.104.040428; Taguchi H, 1997, BIOSCI BIOTECH BIOCH, V61, P720; Koshiro Y, 2006, PLANT SCI, V171, P242, DOI 10.1016/j.plantsci.2006.03.017; EVANS LS, 1979, SCIENCE, V203, P1122, DOI 10.1126/science.203.4385.1122; Cho YK, 1999, PHYTOCHEMISTRY, V52, P1235, DOI 10.1016/S0031-9422(99)00410-0; Sinclair SJ, 2000, PLANT MOL BIOL, V44, P603, DOI 10.1023/A:1026590521318; BOIVIN C, 1990, PLANT CELL, V2, P1157; MIZUSAKI S, 1970, PHYTOCHEMISTRY, V9, P549, DOI 10.1016/S0031-9422(00)85688-5; UPMEIER B, 1988, Z NATURFORSCH C, V43, P835; SAITOH F, 1985, PHYTOCHEMISTRY, V24, P477, DOI 10.1016/S0031-9422(00)80751-7; Bertrand B, 2003, THEOR APPL GENET, V107, P387, DOI 10.1007/s00122-003-1203-6; Daglia M, 2002, J AGR FOOD CHEM, V50, P1225, DOI 10.1021/jf010958t; BOIVIN C, 1991, J BACTERIOL, V173, P2809; Al-Mehdi AB, 2000, NAT MED, V6, P100; Schippers JHM, 2008, PLANT CELL, V20, P2909, DOI 10.1105/tpc.107.056341; Noctor G, 2006, J EXP BOT, V57, P1603, DOI 10.1093/jxb/erj202; Wang GD, 2007, PLANT J, V49, P1020, DOI 10.1111/j.1365-313X.2006.03013.x; Blunden G, 2005, BIOCHEM SYST ECOL, V33, P904, DOI 10.1016/j.bse.2005.01.005; Dobrzanska M, 2002, J BIOL CHEM, V277, P50482, DOI 10.1074/jbc.M205207200; HOSOKAWA Y, 1983, BIOCHEM BIOPH RES CO, V111, P188; FROST GM, 1967, J BIOL CHEM, V242, P887; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Hashida SN, 2007, PLANT J, V49, P694, DOI 10.1111/j.1365-313X.2006.02989.x; Katoh A, 2006, PLANT PHYSIOL, V141, P851, DOI 10.1104/pp.106.081091; IMAI T, 1973, J BIOCHEM-TOKYO, V73, P139; MAZZAFERA P, 1991, PHYTOCHEMISTRY, V30, P2309, DOI 10.1016/0031-9422(91)83637-Z; Petracco M, 2005, J CHEM EDUC, V82, P1161; WALLER GR, 1966, J BIOL CHEM, V241, P4411; Casal S, 2000, FOOD CHEM, V68, P481, DOI 10.1016/S0308-8146(99)00228-9; Katoh A, 2004, FRONT BIOSCI, V9, P1577, DOI 10.2741/1350; JOHNSON RD, 1974, PHYTOCHEMISTRY, V13, P1493, DOI 10.1016/0031-9422(74)80314-6; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Ashihara H, 2008, NAT PROD COMMUN, V3, P1423; Matsui A, 2007, PHYSIOL PLANTARUM, V131, P191, DOI 10.1111/j.1399-3054.2007.00959.x; GOLDMANN A, 1991, MOL PLANT MICROBE IN, V4, P571, DOI 10.1094/MPMI-4-571; LEETE E, 1978, J CHEM SOC CHEM COMM, P610, DOI 10.1039/c39780000610; Rajasekaran LR, 2001, CAN J PLANT SCI, V81, P487; Ogawa T, 2005, J BIOL CHEM, V280, P25277, DOI 10.1074/jbc.M503536200; Heuser F, 2007, ENG LIFE SCI, V7, P343, DOI 10.1002/elsc.200720203; LAMARTINIERE CA, 1995, CARCINOGENESIS, V16, P2833, DOI 10.1093/carcin/16.11.2833; Ashihara H, 2012, PLANT PHYSIOL BIOCH, V60, P190, DOI 10.1016/j.plaphy.2012.08.007; Arlt A, 2013, ONCOGENE, V32, P4825, DOI 10.1038/onc.2012.493; Yoshinari O, 2009, BIOSCI BIOTECH BIOCH, V73, P1033, DOI 10.1271/bbb.80805; Stadler RH, 2002, J AGR FOOD CHEM, V50, P1192, DOI 10.1021/jf011234k; Mazzuca S, 2000, PLANTA, V211, P127, DOI 10.1007/s004250000272; FRIESEN JB, 1990, TETRAHEDRON LETT, V31, P6295; Yuyama S, 1999, ADV EXP MED BIOL, V467, P723; WAGNER R, 1986, PHYSIOL PLANTARUM, V68, P667, DOI 10.1111/j.1399-3054.1986.tb03415.x; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; JOSHI JG, 1960, J BIOL CHEM, V235, P2981; WALLER GR, 1966, ANAL BIOCHEM, V16, P277, DOI 10.1016/0003-2697(66)90156-4; Lee G, 2008, ENVIRON EXP BOT, V63, P19, DOI 10.1016/j.envexpbot.2007.10.009; Almeida AAP, 2006, J AGR FOOD CHEM, V54, P8738, DOI 10.1021/jf0617317; Smith AR, 2006, TAXON, V55, P705; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; Shimizu MM, 2000, PLANT BIOLOGY, V2, P605, DOI 10.1055/s-2000-16645; JAKOBY WB, 1990, J BIOL CHEM, V265, P20715; Zheng XQ, 2005, J EXP BOT, V56, P1615, DOI 10.1093/jxb/eri156; KOSTER S, 1989, Z NATURFORSCH C, V44, P623; Turner WL, 2005, BIOCHEM J, V385, P217; Ashihara H, 2008, PLANT PHYSIOL BIOCH, V46, P752, DOI 10.1016/j.plaphy.2008.04.013; ADRIAN J, 1991, ADV EXP MED BIOL, V289, P49; Bremer B, 2009, BOT J LINN SOC, V161, P105; Ashihara H, 2011, PLANT METABOLISM BIO, P163; Ashihara H, 2014, COFFEE HLTH DIS PREV; Ashihara H., 2011, HDB EXP PHARM, V200, P11; Barz W., 1985, Primary and secondary metabolism of plant cell cultures, P186; CHARRIER A, 1985, P13; CLIFFORD M N, 1985, P305; Corol DT, 2012, J AGR FOOD CHEM, V60, P471; Goossens A, 2003, P NATL ACAD SCI USA, V100, P8595, DOI 10.1073/pnas.1032967100; HANSON AD, 1995, ENV PLANT B, P189; Harborne J. B., 1984, PLANT CHEMOSYSTEMATI; Hesse M., 2002, ALKALOIDS NATURES CU; IMAI T, 1979, J BIOCHEM-TOKYO, V85, P887; JACKANIC.TM, 1966, J BIOL CHEM, V241, P1296; Jahns E, 1891, ARCH PHARM, V229, P669, DOI DOI 10.1002/ARDP.18912290812; Johns E, 1885, BER DEUT CHEM GES, V18, P2518; Moat AG, 1987, PYRIDINE NUCLEOTID B, P1; Narayana Murthy UM, 2007, J BIOL CHEM, V282, P18254, DOI 10.1074/JBC.M701428200; ROBINSON TREVOR, 1965, PHYTOCHEMISTRY, V4, P67, DOI 10.1016/S0031-9422(00)86147-6; Shoji T, 2011, PLANT METABOLISM BIO, P191, DOI DOI 10.1002/9781119991311.CH7; TAGUCHI H, 1986, Vitamins (Kyoto), V60, P537; Tohoda C., 2005, NEUROSIGNALS, V14, P34; Tohoda C, 1999, BIOL PHARM BULL, V22, P679; Tomlinson PB, 1994, BOT MANGROVES; USDA Foreign Agricultural Service, 2013, USDA FOR AGR SERV CI, P1; WADA H, 1971, TETRAHEDRON LETT, P2655; Waller G. R., 1981, BIOCH PLANTS, V7, P317; YANG K. S., 1965, PHYTOCHEMISTRY, V4, P881, DOI 10.1016/S0031-9422(00)86266-4; Zhou J., 2011, FUND CLIN PHARM, V27, P279; Zrenner R, 2011, PLANT METABOLISM BIO, P135	187	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1568-7767	1572-980X		PHYTOCHEM REV	Phytochem. Rev.	OCT	2015	14	5					765	798		10.1007/s11101-014-9375-z		34	Plant Sciences	Plant Sciences	CR8TH	WOS:000361626400004		
J	Ueno, K; Sugimoto, Y; Zwanenburg, B				Ueno, Kotomi; Sugimoto, Yukihiro; Zwanenburg, Binne			The genuine structure of alectrol: end of a long controversy	PHYTOCHEMISTRY REVIEWS			English	Review						Cowpea; Germination; Stereochemistry; Striga gesnerioides; Strigolactone	STRIGA-GESNERIOIDES SEEDS; ROOT PARASITIC PLANTS; GERMINATION STIMULANT; VIGNA-UNGUICULATA; SYNTHETIC DISPROOF; SORGHUM-BICOLOR; OROBANCHE-MINOR; LUTEA LOUR; RED-CLOVER; STRIGOLACTONES	Alectrol was first isolated from root exudates of cowpea (Vigna unguiculata), a genuine host of a root parasitic weed Striga gesnerioides, as a germination stimulant for seeds of the parasite. The proposed structure, an isomer of strigol, was disproven by chemical synthesis. Recently, another structure, namely orobanchyl acetate, was proposed. Surprisingly, however, the synthetic compound having this proposed structure for alectrol was not active in inducing germination of S. gesnerioides seeds although it was active toward seeds of other root parasitic weeds such as S. hermonthica and Orobanche minor. Detailed studies on H-1 NMR, mass and CD spectra of naturally occurring alectrol, re-isolated from cowpea root exudates, revealed that the genuine structure of the germination stimulant is not orobanchyl acetate but its stereoisomer ent-2'-epi-orobanchyl acetate. Accordingly, the structure of natural orobanchol was revised to ent-2'-epi-orobanchol 12 years after a tentative structure of orobanchol was proposed. Strict stereochemical requirements of strigolactones for germination induction of S. gesnerioides seeds, authentic samples of synthetic strigolactones and advanced analytical instruments made the structural assignment possible, thus ending a 20 years controversy concerning the true structure of alectrol.	[Ueno, Kotomi; Sugimoto, Yukihiro] Kobe Univ, Grad Sch Agr Sci, Nada Ku, Kobe, Hyogo 6578501, Japan; [Zwanenburg, Binne] Radboud Univ Nijmegen, Inst Mol & Mat, Cluster Organ Chem, NL-6525 AJ Nijmegen, Netherlands	Sugimoto, Y (reprint author), Kobe Univ, Grad Sch Agr Sci, Nada Ku, Kobe, Hyogo 6578501, Japan.	yukihiro@kobe-u.ac.jp; B.Zwanenburg@science.ru.nl			Asia Africa Science Platform Program of the Japan Society for the Promotion of Science; JST/JICA; Science and Technology Research Partnership for Sustainable Development (SATREPS); Ministry of Education, Science, and Culture of Japan [11J01777, 23405023, 24658111, 25292065]	We thank Emeritus professor Kenji Mori (The University of Tokyo, Japan) for the generous gifts of the synthetic orobanchol isomers, orobanchol (9), 2'-epi-orobanchol (2'-epi-9), 4-epi-orobanchol (4-epi-9) and 4,2'-bisepi-orobanchol (4,2'-bisepi-9). The work was supported, in part, by grants from the Asia Africa Science Platform Program of the Japan Society for the Promotion of Science, JST/JICA, Science and Technology Research Partnership for Sustainable Development (SATREPS), and Grants-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (Nos. 11J01777, 23405023, 24658111 and 25292065).	Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; BROOKS DW, 1985, J ORG CHEM, V50, P628, DOI 10.1021/jo00205a014; Xie XN, 2009, PHYTOCHEMISTRY, V70, P211, DOI 10.1016/j.phytochem.2008.12.013; SIAME BA, 1993, J AGR FOOD CHEM, V41, P1486, DOI 10.1021/jf00033a025; Zwanenburg B, 2009, PEST MANAG SCI, V65, P478, DOI 10.1002/ps.1706; Chen VX, 2010, CHEM-EUR J, V16, P13941, DOI 10.1002/chem.201002817; Nomura S, 2013, PLANT CELL REP, V32, P829, DOI 10.1007/s00299-013-1429-y; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Matsuura H, 2008, PLANT GROWTH REGUL, V54, P31, DOI 10.1007/s10725-007-9224-9; Akiyama K, 2010, PLANT CELL PHYSIOL, V51, P1104, DOI 10.1093/pcp/pcq058; Wigchert SCM, 1999, J AGR FOOD CHEM, V47, P1705, DOI 10.1021/jf981006z; Parker C, 2009, PEST MANAG SCI, V65, P453, DOI 10.1002/ps.1713; Alder A, 2012, SCIENCE, V335, P1348, DOI 10.1126/science.1218094; Xie X, 2007, J AGR FOOD CHEM, V55, P8067, DOI 10.1021/jf0715121; Xie XN, 2008, TETRAHEDRON LETT, V49, P2066, DOI 10.1016/j.tetlet.2008.01.131; HAUCK C, 1992, J PLANT PHYSIOL, V139, P474; COOK CE, 1972, J AM CHEM SOC, V94, P6198, DOI 10.1021/ja00772a048; Seto Y, 2012, PLANT CELL PHYSIOL, V53, P1843, DOI 10.1093/pcp/pcs142; Welzel P, 1999, CHEM COMMUN, P2017, DOI 10.1039/a901530b; Mori K, 1998, TETRAHEDRON LETT, V39, P6023, DOI 10.1016/S0040-4039(98)01238-6; Seto Y, 2014, P NATL ACAD SCI USA, V111, P1640, DOI 10.1073/pnas.1314805111; Motonami N, 2013, PHYTOCHEMISTRY, V93, P41, DOI 10.1016/j.phytochem.2013.02.017; Xie X, 2008, PHYTOCHEMISTRY, V69, P427, DOI 10.1016/j.phytochem.2007.07.017; BROWN R, 1952, BIOCHEM J, V50, P596; Ueno K, 2011, J AGR FOOD CHEM, V59, P9226, DOI 10.1021/jf202418a; Ueno K, 2011, J AGR FOOD CHEM, V59, P10485, DOI 10.1021/jf2024193; Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Tsuchiya Y, 2009, CURR OPIN PLANT BIOL, V12, P556, DOI 10.1016/j.pbi.2009.07.018; Zwanenburg B, 2013, MOL PLANT, V6, P38, DOI 10.1093/mp/sss141; COOK CE, 1966, SCIENCE, V154, P1189, DOI 10.1126/science.154.3753.1189; Sugimoto Y, 1998, J ORG CHEM, V63, P1259, DOI 10.1021/jo9718408; Yokota T, 1998, PHYTOCHEMISTRY, V49, P1967, DOI 10.1016/S0031-9422(98)00419-1; BROWN R, 1952, BIOCHEM J, V52, P571; Takikawa H, 2009, TETRAHEDRON LETT, V50, P4549, DOI 10.1016/j.tetlet.2009.05.078; Parker C, 2012, WEED SCI, V60, P269, DOI 10.1614/WS-D-11-00068.1; MULLER S, 1992, J PLANT GROWTH REGUL, V11, P77, DOI 10.1007/BF00198018; Xie XN, 2013, MOL PLANT, V6, P153, DOI 10.1093/mp/sss139; Butler L. G., 1995, Allelopathy: organisms, processes, and applications., P158; HeideJorgensen HS, 2008, PARASITIC FLOWERING PLANTS, P1; Hirayama K, 1999, EUR J ORG CHEM, P2211; Matsui J, 1999, EUR J ORG CHEM, P2195; Matsui J, 1999, EUR J ORG CHEM, P2201	42	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1568-7767	1572-980X		PHYTOCHEM REV	Phytochem. Rev.	OCT	2015	14	5					835	847		10.1007/s11101-014-9380-2		13	Plant Sciences	Plant Sciences	CR8TH	WOS:000361626400006		
J	Guo, L; Wu, Y; Chen, J; Hirano, Y; Tanikawa, T; Li, WT; Cui, XH				Guo, Li; Wu, Yuan; Chen, Jin; Hirano, Yasuhiro; Tanikawa, Toko; Li, Wentao; Cui, Xihong			Calibrating the impact of root orientation on root quantification using ground-penetrating radar	PLANT AND SOIL			English	Article						Coarse root; Field plot scale; Nondestructive root method; Root angle; Root diameter; Root biomass	AFFECT DETECTION ACCURACY; TREE ROOTS; BIOMASS; SYSTEMS	Ground-penetrating radar (GPR) has provided a non-invasive means for field root investigation. However, the horizontal cross angle (x) of root orientation intersecting a survey line considerably impacts the amplitude area (A) reflected from a root and impairs the accuracy of GPR-based root quantification. Prediction of A(90A degrees) (the value of A scanning at x = 90A degrees) from multiple A(x) measurements could correct such impact. Previous method of A(90A degrees) prediction focused on target roots at field point scale. The aim of this study is to develop a method to predict A(90A degrees) at field plot scale. A(90A degrees) was predicted by a pair of A(x) measured at two arbitrary scanning lines together with an estimated soil background amplitude area. Three independent datasets were employed to test the proposed method. The field experiment included radar data collected for six roots of Caragana microphylla in a sandy-clay soil at four cross angles (30A degrees, 45A degrees, 60A degrees, and 90A degrees). The sand box experiment included radar data for 12 dowels at 13 cross angles (0A degrees to 180A degrees, in 15A degrees steps). The simulation experiment included A(x) of 46 simulated roots at 13 cross angles (0A degrees to 180A degrees, in 15A degrees steps). For all experiments, A(90A degrees) was accurately estimated. Root orientation could also be determined. After correcting the impact of cross angle, the accuracy of root diameter estimation improved. Correlation coefficient between actual and estimated root diameters increased from 0.77 to 0.81, with RMSE declining from 9.53 to 7.05 mm. A method of correcting the influence of root orientation on root GPR signal at the field plot scale has been established. This method enhances root quantification using GPR.	[Guo, Li; Chen, Jin] Beijing Normal Univ, Coll Global Change & Earth Syst Sci, Beijing 100875, Peoples R China; [Guo, Li; Chen, Jin] Joint Ctr Global Change Studies, Beijing 100875, Peoples R China; [Wu, Yuan; Li, Wentao; Cui, Xihong] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resources, Beijing 100875, Peoples R China; [Hirano, Yasuhiro] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan; [Tanikawa, Toko] Forestry & Forest Prod Res Inst, Kansai Res Ctr, Fushimi, Kyoto 6120855, Japan	Chen, J (reprint author), Beijing Normal Univ, Coll Global Change & Earth Syst Sci, Beijing 100875, Peoples R China.	chenjin@bnu.edu.cn			National Natural Science Foundation of China [41401378]; Fundamental Research Funds for the Central Universities [2013NT39]; Ministry of Education, Culture, Sports, Science and Technology, Japan [22380090, 25252027]	This study was supported by the National Natural Science Foundation of China (Grant No. 41401378) and the Fundamental Research Funds for the Central Universities (Grant No. 2013NT39). Y.H. and T.T. acknowledge financial supports from the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Grant No. 22380090, 25252027). We gratefully thank Masako Dannoura, Hidetoshi Ikeno, and Keitaro Yamase for their valuable comments and suggestions that have helped improve the manuscript. We also thank two anonymous reviewers for their valuable comments to improve the manuscript.	Guo L, 2013, PLANT SOIL, V372, P487, DOI 10.1007/s11104-013-1751-8; Cui XH, 2011, SCI CHINA EARTH SCI, V54, P711, DOI 10.1007/s11430-010-4103-z; [Anonymous], 2009, PLANT SOIL, DOI DOI 10.1007/S11104-008-9845-4; Tanikawa T, 2014, PLANT SOIL, V380, P445, DOI 10.1007/s11104-014-2136-3; Zhu SP, 2014, REMOTE SENS-BASEL, V6, P5754, DOI 10.3390/rs6065754; Bassuk Nina, 2011, Arboriculture & Urban Forestry, V37, P160; Giannopoulos A, 2005, CONSTR BUILD MATER, V19, P755, DOI 10.1016/j.conbuildmat.2005.06.007; Nadezhdina N, 2003, J EXP BOT, V54, P1511, DOI 10.1093/jxb/erg154; Zenone T, 2008, FUNCT PLANT BIOL, V35, P1047, DOI 10.1071/FP08062; Cermak J, 2000, PLANT SOIL, V219, P103, DOI 10.1023/A:1004736310417; Guo L, 2013, PLANT SOIL, V371, P503, DOI 10.1007/s11104-013-1710-4; Wu Y, 2014, PLANT SOIL, V380, P441, DOI 10.1007/s11104-014-2124-7; Butnor JR, 2001, TREE PHYSIOL, V21, P1269; Hruska J, 1999, TREE PHYSIOL, V19, P125; Isaac ME, 2013, ECOL EVOL, V3, P1330, DOI 10.1002/ece3.543; Tanikawa T, 2013, PLANT SOIL, V373, P317, DOI 10.1007/s11104-013-1798-6; Cui XH, 2013, IEEE T GEOSCI REMOTE, V51, P3410, DOI 10.1109/TGRS.2012.2224351; Dannoura M, 2008, PLANT BIOSYST, V142, P375, DOI 10.1080/11263500802150951; Barton CVM, 2004, TREE PHYSIOL, V24, P1323; Hirano Y, 2012, PLANT SOIL, V360, P363, DOI 10.1007/s11104-012-1252-1; Guo L, 2013, PLANT SOIL, V362, P1, DOI 10.1007/s11104-012-1455-5; Stover DB, 2007, ECOLOGY, V88, P1328, DOI 10.1890/06-0989; Borden KA, 2014, AGROFOREST SYST, V88, P657, DOI 10.1007/s10457-014-9722-5; Butnor JR, 2011, MEASURING ROOTS UPDA, P213; Gregory P, 2006, PLANT ROOTS GROWTH A; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Jol HM, 2009, GROUND PENETRATING RADAR THEORY AND APPLICATIONS, P1; Stokes A, 2002, J ARBORICULT, V28, P2; Waisel Y, 2002, PLAND ROOTS HIDDEN H; Wu Y, 2014, PLANT SOIL, V383, P155, DOI 10.1007/s11104-014-2139-0	30	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0032-079X	1573-5036		PLANT SOIL	Plant Soil	OCT	2015	395	1-2					289	305		10.1007/s11104-015-2563-9		17	Agronomy; Plant Sciences; Soil Science	Agriculture; Plant Sciences	CS0NJ	WOS:000361757400022		
J	Shao, JF; Che, J; Chen, RF; Ma, JF; Shen, RF				Shao, Ji Feng; Che, Jing; Chen, Rong Fu; Ma, Jian Feng; Shen, Ren Fang			Effect of in planta phosphorus on aluminum-induced inhibition of root elongation in wheat	PLANT AND SOIL			English	Article						In planta; Phosphorus; Aluminum; Wheat root; Cell wall; Split-root; Re-rooting	CELL-WALL; ACID SOILS; ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; ORGANIC-ACIDS; AL RESISTANCE; TOXICITY; TOLERANCE; EXUDATION; GROWTH	Both aluminum (Al) toxicity and phosphorus (P) deficiency are limiting factors of crop production on acid soils. Although Al-P interaction has been extensively studied, the results are controversial. The aim of this study is to investigate the effect of in planta P on Al-induced inhibition of root elongation in wheat (Triticum aestivum L.). Roots of wheat (cv. Atlas 66) with different internal P concentrations were prepared by two methods; split-root and re-rooting in a hydroponic solution using three different P levels (0, 25 and 250 mu M) to avoid direct precipitation of Al-P in the solution. Al toxicity was evaluated by root elongation inhibition and callose induction. The Al and P concentrations in the root tips were also compared among different treatments. Both split-root and re-rooting methods generated roots with different P concentrations in the tips when exposed to different P levels. Lower P in the root tips resulted in less Al-induced inhibition of the root elongation, less callose content and less Al accumulation, while higher root P caused a higher Al-induced inhibition of the root elongation, increased callose content and Al accumulation in the root tips. Furthermore, Al in the root cell sap was not altered by different P concentrations, but Al in the root cell wall was increased with increasing in planta P concentrations. Al toxicity in wheat is associated with P in the root cell wall; lower root P enhanced Al tolerance, while higher root P aggravated Al toxicity in wheat.	[Shao, Ji Feng; Che, Jing; Chen, Rong Fu; Ma, Jian Feng; Shen, Ren Fang] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing 210008, Jiangsu, Peoples R China; [Shao, Ji Feng; Che, Jing] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Che, Jing; Ma, Jian Feng] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan	Shen, RF (reprint author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing 210008, Jiangsu, Peoples R China.	rfshen@issas.ac.cn			Nation Key Basic Research Program of China [2014CB441000]; Natural Science Foundation of China [41025005]; Joint Research Program at the Institute of Plant Science and Resources, Okayama University	This investigation was financially supported by the Nation Key Basic Research Program of China (No. 2014CB441000) and the Natural Science Foundation of China (No. 41025005). This research was also supported in part by Joint Research Program implemented at the Institute of Plant Science and Resources, Okayama University.	Zheng SJ, 2005, PLANT PHYSIOL, V138, P297, DOI 10.1104/pp.105.059667; Yang JL, 2011, ANN BOT-LONDON, V107, P371, DOI 10.1093/aob/mcq254; Ma JF, 2014, PLANT SOIL, V381, P1, DOI 10.1007/s11104-014-2073-1; Liao H, 2006, PLANT PHYSIOL, V141, P674, DOI 10.1104/pp.105.076497; POLLE E, 1978, CROP SCI, V18, P823; Zhu XF, 2012, PLANTA, V236, P989, DOI 10.1007/s00425-012-1652-8; Ryan PR, 2001, ANNU REV PLANT PHYS, V52, P527, DOI 10.1146/annurev.arplant.52.1.527; KOCHIAN LV, 1995, ANNU REV PLANT PHYS, V46, P237, DOI 10.1146/annurev.arplant.46.1.237; Iqbal MT, 2014, COMMUN SOIL SCI PLAN, V45, P437, DOI 10.1080/00103624.2013.870189; Nakagawa T, 2003, J PLANT NUTR, V26, P619, DOI 10.1081/PLN-120017669; Ward CL, 2011, J PLANT PHYSIOL, V168, P459, DOI 10.1016/j.jplph.2010.08.005; Rounds MA, 2008, CURR BIOL, V18, P1495, DOI 10.1016/j.cub.2008.08.050; Ruiz-Herrera LF, 2013, PLANT SOIL, V371, P593, DOI 10.1007/s11104-013-1722-0; Sanchez-Calderon L, 2005, PLANT CELL PHYSIOL, V46, P174, DOI 10.1093/pcp/pci011; FOY CD, 1967, SOIL SCI SOC AM PRO, V31, P513; Ma JF, 2007, INT REV CYTOL, V264, P225, DOI 10.1016/S0074-7696(07)64005-4; Gaume A, 2001, PLANT SOIL, V234, P73, DOI 10.1023/A:1010535132296; Fernandes JC, 2013, PLANT SCI, V205, P111, DOI 10.1016/j.plantsci.2013.01.013; Horst WJ, 1997, PLANT SOIL, V192, P23, DOI 10.1023/A:1004204120863; Sun QB, 2008, ANN BOT-LONDON, V102, P795, DOI 10.1093/aob/mcn166; Xia JX, 2010, P NATL ACAD SCI USA, V107, P18381, DOI 10.1073/pnas.1004949107; RYAN PR, 1993, J EXP BOT, V44, P437, DOI 10.1093/jxb/44.2.437; Ma JF, 2004, PLANT CELL PHYSIOL, V45, P583, DOI 10.1093/pcp/pch060; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; Chen RF, 2012, J SCI FOOD AGR, V92, P995, DOI 10.1002/jsfa.4566; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1; Horst WJ, 1999, PLANT SOIL, V215, P163, DOI 10.1023/A:1004439725283; Jiang HX, 2009, PHYSIOL PLANTARUM, V137, P298, DOI 10.1111/j.1399-3054.2009.01288.x; KOHLE H, 1985, PLANT PHYSIOL, V77, P544, DOI 10.1104/pp.77.3.544; He G, 2010, ACTA PHYSIOL PLANT, V33, P1285; Horst W.J., 1995, J PLANT NUTR SOIL SC, V158, P419; Iqbal T, 2014, PLANT SOIL, V384, P21, DOI 10.1007/s11104-013-1962-z; Maejima E, 2014, J PLANT PHYSIOL, V171, P9, DOI 10.1016/j.jplph.2013.09.012; Marschner P, 2011, MINERAL NUTR HIGHER; TAN KZ, 1990, PLANT SOIL, V124, P15, DOI 10.1007/BF00010926	35	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0032-079X	1573-5036		PLANT SOIL	Plant Soil	OCT	2015	395	1-2					307	315		10.1007/s11104-015-2566-6		9	Agronomy; Plant Sciences; Soil Science	Agriculture; Plant Sciences	CS0NJ	WOS:000361757400023		
J	Ruiu, F; Picarella, ME; Imanishi, S; Mazzucato, A				Ruiu, Fabrizio; Picarella, Maurizio Enea; Imanishi, Shunsuke; Mazzucato, Andrea			A transcriptomic approach to identify regulatory genes involved in fruit set of wild-type and parthenocarpic tomato genotypes	PLANT MOLECULAR BIOLOGY			English	Article						Fruit set; Ovary development; Parthenocarpic mutants; Solanum lycopersicum L.; Transcription factors; Transcriptome profiling	GENOME-WIDE IDENTIFICATION; AUXIN RESPONSE; SOLANUM-LYCOPERSICON; OVULE DEVELOPMENT; GIBBERELLIN METABOLISM; EXPRESSION ANALYSIS; SEEDLESS FRUITS; DOWN-REGULATION; ARABIDOPSIS; GROWTH	The tomato parthenocarpic fruit (pat) mutation associates a strong competence for parthenocarpy with homeotic transformation of anthers and aberrancy of ovules. To dissect this complex floral phenotype, genes involved in the pollination-independent fruit set of the pat mutant were investigated by microarray analysis using wild-type and mutant ovaries. Normalized expression data were subjected to one-way ANOVA and 2499 differentially expressed genes (DEGs) displaying a > 1.5 log-fold change in at least one of the pairwise comparisons analyzed were detected. DEGs were categorized into 20 clusters and clusters classified into five groups representing transcripts with similar expression dynamics. The "regulatory function" group (685 DEGs) contained putative negative or positive fruit set regulators, "pollination-dependent" (411 DEGs) included genes activated by pollination, "fruit growth-related" (815 DEGs) genes activated at early fruit growth. The last groups listed genes with different or similar expression pattern at all stages in the two genotypes. qRT-PCR validation of 20 DEGs plus other four selected genes assessed the high reliability of microarray expression data; the average correlation coefficient for the 20 DEGs was 0.90. In all the groups were evidenced relevant transcription factors encoding proteins regulating meristem differentiation and floral organ development, genes involved in metabolism, transport and response of hormones, genes involved in cell division and in primary and secondary metabolism. Among pathways related to secondary metabolites emerged genes related to the synthesis of flavonoids, supporting the recent evidence that these compounds are important at the fruit set phase. Selected genes showing a de-regulated expression pattern in pat were studied in other four parthenocarpic genotypes either genetically anonymous or carrying lesions in known gene sequences. This comparative approach offered novel insights for improving the present molecular understanding of fruit set and parthenocarpy in tomato.	[Ruiu, Fabrizio; Picarella, Maurizio Enea; Mazzucato, Andrea] Univ Tuscia, Dept Sci & Technol Agr Forestry Nat & Energy DAFN, I-01100 Viterbo, Italy; [Imanishi, Shunsuke] Natl Agr & Food Res Org NARO, NARO Inst Vegetable & Tea Sci, Tsu, Mie 5142392, Japan	Mazzucato, A (reprint author), Univ Tuscia, Dept Sci & Technol Agr Forestry Nat & Energy DAFN, Via SC de Lellis Snc, I-01100 Viterbo, Italy.	mazz@unitus.it					Molesini B, 2009, PLANT PHYSIOL, V149, P534, DOI 10.1104/pp.108.131367; PNUELI L, 1994, PLANT CELL, V6, P175; Mazzucato A, 1998, DEVELOPMENT, V125, P107; Mazzucato A, 2013, PLANT PHYSIOL BIOCH, V72, P125, DOI 10.1016/j.plaphy.2013.05.012; Ruan YL, 2012, TRENDS PLANT SCI, V17, P656, DOI 10.1016/j.tplants.2012.06.005; Vivian-Smith A, 2001, DEVELOPMENT, V128, P2321; de Jong M, 2009, PLANT J, V57, P160, DOI 10.1111/j.1365-313X.2008.03671.x; Rubin G, 2009, PLANT CELL, V21, P3567, DOI 10.1105/tpc.109.067041; Munos S, 2011, PLANT PHYSIOL, V156, P2244, DOI 10.1104/pp.111.173997; Ito T, 2000, PLANT CELL, V12, P1541, DOI 10.1105/tpc.12.9.1541; MAPELLI S, 1978, PLANT CELL PHYSIOL, V19, P1281; Gomez P, 1999, PLANTA, V209, P172, DOI 10.1007/s004250050619; Martinelli F, 2009, J EXP BOT, V60, P3873, DOI 10.1093/jxb/erp227; Elliott RC, 1996, PLANT CELL, V8, P155, DOI 10.1105/tpc.8.2.155; Bowman JL, 1999, DEVELOPMENT, V126, P2387; Matsuo S, 2012, J EXP BOT, V63, P5569, DOI 10.1093/jxb/ers207; Goetz M, 2007, PLANT PHYSIOL, V145, P351, DOI 10.1104/pp.107.104174; Pattison RJ, 2012, PLANT J, V70, P585, DOI 10.1111/j.1365-313X.2011.04895.x; Nesi N, 2002, PLANT CELL, V14, P2463, DOI 10.1105/tpc.004127; Schijlen EGWM, 2007, PLANT PHYSIOL, V144, P1520, DOI 10.1104/pp.107.100305; Tsai WC, 2005, PLANT CELL PHYSIOL, V46, P1125, DOI 10.1093/pcp/pci125; Avivi Y, 2000, PLANT PHYSIOL, V124, P541, DOI 10.1104/pp.124.2.541; Mazzucato A, 2008, PHYSIOL PLANTARUM, V132, P526, DOI 10.1111/j.1399-3054.2007.01035.x; Medina M, 2013, PLANT BIOTECHNOL J, V11, P770, DOI 10.1111/pbi.12069; Park SO, 2005, DEVELOPMENT, V132, P841, DOI 10.1242/dev.01654; Audran-Delalande C, 2012, PLANT CELL PHYSIOL, V53, P659, DOI 10.1093/pcp/pcs022; Bachem CWB, 2001, PLANT J, V25, P595, DOI 10.1046/j.1365-313x.2001.00993.x; Ingrosso I, 2011, PLANT PHYSIOL BIOCH, V49, P1092, DOI 10.1016/j.plaphy.2011.07.012; Testa G, 2002, SEX PLANT REPROD, V14, P269, DOI 10.1007/s00497-001-0122-4; Serrani JC, 2008, PLANT J, V56, P922, DOI 10.1111/j.1365-313X.2008.03654.x; Olimpieri I, 2008, THEOR APPL GENET, V118, P151, DOI 10.1007/s00122-008-0884-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Rieu I, 2008, PLANT J, V53, P488, DOI 10.1111/j.1365-313X.2007.03356.x; Chen QY, 1999, DEVELOPMENT, V126, P2715; de Jong M, 2011, J EXP BOT, V62, P617, DOI 10.1093/jxb/erq293; Tadege M, 2011, PLANT CELL, V23, P2125, DOI 10.1105/tpc.111.085340; Varaud E, 2011, PLANT CELL, V23, P973, DOI 10.1105/tpc.110.081653; Marti C, 2007, PLANT J, V52, P865, DOI 10.1111/j.1365-313X.2007.03282.x; Ampomah-Dwamena C, 2002, PLANT PHYSIOL, V130, P605, DOI 10.1104/pp.005223; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375; Joung JG, 2009, PLANT PHYSIOL, V151, P1758, DOI 10.1104/pp.109.145169; Otsuga D, 2001, PLANT J, V25, P223, DOI 10.1046/j.1365-313x.2001.00959.x; Wu J, 2011, PLANT CELL REP, V30, P2059, DOI 10.1007/s00299-011-1113-z; Wang H, 2009, PLANT CELL, V21, P1428, DOI 10.1105/tpc.108.060830; Dorcey E, 2009, PLANT J, V58, P318, DOI 10.1111/j.1365-313X.2008.03781.x; Sotelo-Silveira M, 2013, PLANT PHYSIOL, V162, P779, DOI 10.1104/pp.113.218214; Geuten K, 2010, PLANT CELL, V22, P2562, DOI 10.1105/tpc.110.076026; Shuai B, 2002, PLANT PHYSIOL, V129, P747, DOI 10.1104/pp.010926; Schoenbohm C, 2000, BIOL CHEM, V381, P749, DOI 10.1515/BC.2000.095; Tabata R, 2010, PLANT CELL PHYSIOL, V51, P164, DOI 10.1093/pcp/pcp176; Shinozaki Y, 2015, PLANT J, V83, P237, DOI 10.1111/tpj.12882; Wang H, 2005, PLANT CELL, V17, P2676, DOI 10.1105/tpc.105.033415; WEIGEL D, 1994, CELL, V78, P203, DOI 10.1016/0092-8674(94)90291-7; Vriezen WH, 2008, NEW PHYTOL, V177, P60, DOI 10.1111/j.1469-8137.2007.02254.x; Yao JL, 2001, P NATL ACAD SCI USA, V98, P1306, DOI 10.1073/pnas.031502498; Henriksson E, 2005, PLANT PHYSIOL, V139, P509, DOI 10.1104/pp.105.063461; Ariizumi T, 2013, BREEDING SCI, V63, P3, DOI 10.1270/jsbbs.63.3; Popescu SC, 2007, P NATL ACAD SCI USA, V104, P4730, DOI 10.1073/pnas.0611615104; Sanders PM, 1999, SEX PLANT REPROD, V11, P297, DOI 10.1007/s004970050158; Lora J, 2011, P NATL ACAD SCI USA, V108, P5461, DOI 10.1073/pnas.1014514108; Olimpieri I, 2007, PLANTA, V226, P877, DOI 10.1007/s00425-007-0533-z; Mounet F, 2012, J EXP BOT, V63, P4901, DOI 10.1093/jxb/ers167; Galon Y, 2010, MOL PLANT, V3, P653, DOI 10.1093/mp/ssq019; Adamski NM, 2009, P NATL ACAD SCI USA, V106, P20115, DOI 10.1073/pnas.0907024106; PHILOUZE J, 1991, EUPHYTICA, V56, P121, DOI 10.1007/BF00042054; Arnaud N, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00093; Carbonell-Bejerano P, 2010, PLANT PHYSIOL, V154, P163, DOI 10.1104/pp.110.160044; Ding JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070080; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; GILLASPY G, 1993, PLANT CELL, V5, P1439, DOI 10.1105/tpc.5.10.1439; Gomez MD, 2014, J EXP BOT, V65, P4515, DOI 10.1093/jxb/eru093; Huang ZJ, 2013, MOL GENET GENOMICS, V288, P111, DOI 10.1007/s00438-013-0733-0; Kiyohara Shunsuke, 2011, Plant Signal Behav, V6, P1351; Koltunow AM, 2002, PLANT REPROD, P221; Maharjan PM, 2014, PLANT J, V80, P797, DOI 10.1111/tpj.12678; Mazzucato A, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0222-8; Mejia N, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-57; Nwafor CC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1030; Pascual L, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-67; Philouze J, 1978, TOMATO GENET COOP RP, V28, P12; Preston JC, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00080; Schwabe W. W., 1981, Horticultural Abstracts, V51, P661; Tang N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125355; Tiwari A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-143	85	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-4412	1573-5028		PLANT MOL BIOL	Plant Mol.Biol.	OCT	2015	89	3					263	278		10.1007/s11103-015-0367-1		16	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CS0NM	WOS:000361757700006		
J	Miyazaki, S; Sato, Y; Asano, T; Nagamura, Y; Nonomura, K				Miyazaki, Saori; Sato, Yutaka; Asano, Tomoya; Nagamura, Yoshiaki; Nonomura, Ken-Ichi			Rice MEL2, the RNA recognition motif (RRM) protein, binds in vitro to meiosis-expressed genes containing U-rich RNA consensus sequences in the 3 '-UTR	PLANT MOLECULAR BIOLOGY			English	Article						RRM; Meiosis; Post-transcriptional regulation; SELEX; Oryza sativa	XENOPUS OOCYTE MATURATION; YB-1 MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; SYNAPTONEMAL COMPLEX; GERM-CELLS; TRANSLATION; REPLICATION; HUR; NANOS; PABP	Post-transcriptional gene regulation by RNA recognition motif (RRM) proteins through binding to cis-elements in the 3'-untranslated region (3'-UTR) is widely used in eukaryotes to complete various biological processes. Rice MEIOSIS ARRESTED AT LEPTOTENE2 (MEL2) is the RRM protein that functions in the transition to meiosis in proper timing. The MEL2 RRM preferentially associated with the U-rich RNA consensus, UUAGUU[U/A][U/G][A/U/G]U, dependently on sequences and proportionally to MEL2 protein amounts in vitro. The consensus sequences were located in the putative looped structures of the RNA ligand. A genome-wide survey revealed a tendency of MEL2-binding consensus appearing in 3'-UTR of rice genes. Of 249 genes that conserved the consensus in their 3'-UTR, 13 genes spatiotemporally co-expressed with MEL2 in meiotic flowers, and included several genes whose function was supposed in meiosis; such as Replication protein A and OsMADS3. The proteome analysis revealed that the amounts of small ubiquitin-related modifier-like protein and eukaryotic translation initiation factor3-like protein were dramatically altered in mel2 mutant anthers. Taken together with transcriptome and gene ontology results, we propose that the rice MEL2 is involved in the translational regulation of key meiotic genes on 3'-UTRs to achieve the faithful transition of germ cells to meiosis.	[Miyazaki, Saori; Nonomura, Ken-Ichi] Natl Inst Genet, Expt Farm, Mishima, Shizuoka 4118540, Japan; [Miyazaki, Saori; Nonomura, Ken-Ichi] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Genet, Mishima, Shizuoka 4118540, Japan; [Sato, Yutaka; Nagamura, Yoshiaki] Natl Inst Agrobiol Sci, Genome Resource Unit, Agrogenom Res Ctr, Tsukuba, Ibaraki 3058602, Japan; [Asano, Tomoya] Kanazawa Univ, Div Funct Genom, Adv Sci Res Ctr, Kanazawa, Ishikawa 9200934, Japan	Miyazaki, S (reprint author), Shizuoka Univ, Off Promot Global Educ Programs, Naka Ku, Hamamatsu, Shizuoka 4328561, Japan.	miyazaki.saori@shizuoka.ac.jp; satoyu@affrc.go.jp; tomoya_asano@blueberryeye.co.jp; nagamura@nias.affrc.go.jp; knonomur@nig.ac.jp			Japan Society for the Promotion of Science (JSPS), KAKENHI [21678001, 24770048, 25252004]; JSPS	We thank M. Nakano, N. Furuya, M. Eiguchi, Y. Tamaki, M. Mochizuki and S. Saeki for help with experimental work and growing plants. We also appreciate the valuable discussions with Dr. T. Nishino (NIG, SOKENDAI) and Dr. Y. Ninomiya (NIG) for protein and statistics works. This work was supported by Japan Society for the Promotion of Science (JSPS), KAKENHI (Grants-in-Aid for Scientific Research) Nos. 21678001, 24770048 and 25252004, and by JSPS Bilateral Program.	Shen YJ, 2008, NUCLEIC ACIDS RES, V36, P3150, DOI 10.1093/nar/gkn158; Jacobs GH, 2009, NUCLEIC ACIDS RES, V37, pD72, DOI 10.1093/nar/gkn763; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Deveshwar P, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-78; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Pagano JM, 2007, J BIOL CHEM, V282, P8883, DOI 10.1074/jbc.M700079200; Eliseeva IA, 2012, RNA BIOL, V9, P1473, DOI 10.4161/rna.22711; Hori T, 2005, NUCLEIC ACIDS RES, V33, P190, DOI 10.1093/nar/gki153; Cheng CH, 2006, GENE DEV, V20, P2067, DOI 10.1101/gad.1430406; Kadyrova LY, 2007, DEVELOPMENT, V134, P1519, DOI 10.1242/dev.002212; Bartrand AJ, 2006, GENETICS, V172, P27, DOI 10.1534/genetics.105.047845; Parisi M, 2000, CURR BIOL, V10, pR81, DOI 10.1016/S0960-9822(00)00283-9; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Vera Y, 2002, J ANDROL, V23, P622; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Zhao WM, 2001, EMBO J, V20, P2315, DOI 10.1093/emboj/20.9.2315; Asano T, 2011, METHODS MOL BIOL, V744, P225, DOI 10.1007/978-1-61779-123-9_16; Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431; Chang L, 2009, CELL RES, V19, P768, DOI 10.1038/cr.2009.52; Manna S, 2015, BIOCHIMIE, V113, P93, DOI 10.1016/j.biochi.2015.04.004; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X; Collier B, 2005, EMBO J, V24, P2656, DOI 10.1038/sj.emboj.7600738; Hu LF, 2011, PLANT CELL, V23, P515, DOI 10.1105/tpc.110.074369; Lorkovic ZJ, 2002, NUCLEIC ACIDS RES, V30, P623, DOI 10.1093/nar/30.3.623; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Osman K, 2009, EMBO J, V28, P394, DOI 10.1038/emboj.2008.295; Lin YT, 2006, RNA, V12, P1486, DOI 10.1261/rna.42206; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Clifford DM, 2004, J BIOL CHEM, V279, P6163, DOI 10.1074/jbc.M306943200; Kant CR, 2005, PLANT MOL BIOL, V57, P1, DOI 10.1007/s11103-004-5828-x; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Nonomura KI, 2004, MOL GENET GENOMICS, V271, P121, DOI 10.1007/s00438-003-0934-z; Wang M, 2010, PLANT CELL, V22, P417, DOI 10.1105/tpc.109.070789; Sato Y, 2013, NUCLEIC ACIDS RES, V41, pD1206, DOI 10.1093/nar/gks1125; Maines JZ, 1999, NAT CELL BIOL, V1, P171; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Lyabin DN, 2011, RNA BIOL, V8, P883, DOI 10.4161/rna.8.5.16022; Chang YX, 2009, PLANT PHYSIOL, V151, P2162, DOI 10.1104/pp.109.142877; Arumugam K, 2012, MOL REPROD DEV, V79, P553, DOI 10.1002/mrd.22060; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Dassi E, 2013, NUCLEIC ACIDS RES, V41, P3201, DOI 10.1093/nar/gkt017; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Moore FL, 2003, P NATL ACAD SCI USA, V100, P538, DOI 10.1073/pnas.0234478100; Tsui SL, 2000, GENOMICS, V65, P266, DOI 10.1006/geno.2000.6169; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI DOI 10.1093/NAR/GKQ310; Nonomura KI, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001265; Serrentino ME, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003416; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	54	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-4412	1573-5028		PLANT MOL BIOL	Plant Mol.Biol.	OCT	2015	89	3					293	307		10.1007/s11103-015-0369-z		15	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CS0NM	WOS:000361757700008		
J	Imamura, S; Kawase, Y; Kobayashi, I; Sone, T; Era, A; Miyagishima, SY; Shimojima, M; Ohta, H; Tanaka, K				Imamura, Sousuke; Kawase, Yasuko; Kobayashi, Ikki; Sone, Toshiyuki; Era, Atsuko; Miyagishima, Shin-ya; Shimojima, Mie; Ohta, Hiroyuki; Tanaka, Kan			Target of rapamycin (TOR) plays a critical role in triacylglycerol accumulation in microalgae	PLANT MOLECULAR BIOLOGY			English	Article						Chlamydomonas reinhardtii; Cyanidioschyzon merolae; Lipid droplet; Microalga; Target of rapamycin; Triacylglycerol	ALGA CYANIDIOSCHYZON-MEROLAE; RED ALGA; CHLAMYDOMONAS-REINHARDTII; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; SIGNALING PATHWAY; SEQUENCE; NITROGEN; GROWTH; INHIBITION	Most microalgae produce triacylglycerol (TAG) under stress conditions such as nitrogen depletion, but the underlying molecular mechanism remains unclear. In this study, we focused on the role of target of rapamycin (TOR) in TAG accumulation. TOR is a serine/threonine protein kinase that is highly conserved and plays pivotal roles in nitrogen and other signaling pathways in eukaryotes. We previously constructed a rapamycin-susceptible Cyanidioschyzon merolae, a unicellular red alga, by expressing yeast FKBP12 protein to evaluate the results of TOR inhibition (Imamura et al. in Biochem Biophys Res Commun 439:264-269, 2013). By using this strain, we here report that rapamycin-induced TOR inhibition results in accumulation of cytoplasmic lipid droplets containing TAG. Transcripts for TAG synthesis-related genes, such as glycerol-3-phosphate acyltransferase and acyl-CoA:diacylglycerol acyltransferase (DGAT), were increased by rapamycin treatment. We also found that fatty acid synthase-dependent de novo fatty acid synthesis was required for the accumulation of lipid droplets. Induction of TAG and up-regulation of DGAT gene expression by rapamycin were similarly observed in the unicellular green alga, Chlamydomonas reinhardtii. These results suggest the general involvement of TOR signaling in TAG accumulation in divergent microalgae.	[Imamura, Sousuke; Kawase, Yasuko; Kobayashi, Ikki; Sone, Toshiyuki; Tanaka, Kan] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Imamura, Sousuke; Era, Atsuko; Miyagishima, Shin-ya; Ohta, Hiroyuki; Tanaka, Kan] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol CREST, Saitama 3320012, Japan; [Era, Atsuko; Miyagishima, Shin-ya] Natl Inst Genet, Dept Cell Genet, Mishima, Shizuoka 4118540, Japan; [Shimojima, Mie; Ohta, Hiroyuki] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Ohta, Hiroyuki] Tokyo Inst Technol, Earth Life Sci Inst, Meguro Ku, Tokyo 1528551, Japan	Imamura, S (reprint author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, 4259-R1 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	simamura@res.titech.ac.jp; kntanaka@res.titech.ac.jp	Imamura, Sousuke/D-3638-2015	Imamura, Sousuke/0000-0002-3040-4757	Ministry of Education, Culture, Sports, Science and Technology of Japan [22681010, 24117521, 25440129, 26117711, 24248061]	We thank Ms. A. Ishiwata and Dr. M. Iwai for their technical assistance and technical advice, respectively. This study was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grants-in-Aid 22681010, 24117521, 25440129 and 26117711 to S.I. and Grants-in-Aid 24248061 to K.T.).	Beck T, 1999, NATURE, V402, P689; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; Watanabe S, 2011, J GEN APPL MICROBIOL, V57, P69; Henriques R, 2014, J EXP BOT, V65, P2691, DOI 10.1093/jxb/eru049; Fujii G, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv063; Perez-Perez ME, 2010, PLANT PHYSIOL, V152, P1874, DOI 10.1104/pp.109.152520; Imamura S, 2013, BIOCHEM BIOPH RES CO, V439, P264, DOI 10.1016/j.bbrc.2013.08.045; Ohta N, 1998, NUCLEIC ACIDS RES, V26, P5190, DOI 10.1093/nar/26.22.5190; Dismukes GC, 2008, CURR OPIN BIOTECH, V19, P235, DOI 10.1016/j.copbio.2008.05.007; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Imamura S, 2008, EMBO J, V27, P2317, DOI 10.1038/emboj.2008.151; Parmar A, 2011, BIORESOURCE TECHNOL, V102, P10163, DOI 10.1016/j.biortech.2011.08.030; Boyle NR, 2012, J BIOL CHEM, V287, P15811, DOI 10.1074/jbc.M111.334052; Imamura S, 2009, P NATL ACAD SCI USA, V106, P12548, DOI 10.1073/pnas.0902790106; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Iwai M, 2014, PLANT BIOTECHNOL J, V12, P808, DOI 10.1111/pbi.12210; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Scott Stuart A, 2010, Curr Opin Biotechnol, V21, P277, DOI 10.1016/j.copbio.2010.03.005; Imamura S, 2010, PLANT CELL PHYSIOL, V51, P707, DOI 10.1093/pcp/pcq043; Crespo JL, 2005, PLANT PHYSIOL, V139, P1736, DOI 10.1104/pp.105.070847; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; NISHIDA I, 1993, PLANT MOL BIOL, V21, P267, DOI 10.1007/BF00019943; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Caldana C, 2013, PLANT J, V73, P897, DOI 10.1111/tpj.12080; Ricoult SJH, 2013, EMBO REP, V14, P242, DOI 10.1038/embor.2013.5; Li XB, 2012, PLANT CELL, V24, P4670, DOI 10.1105/tpc.112.105106; Ohta N, 2003, DNA RES, V10, P67, DOI 10.1093/dnares/10.2.67; Ohnuma M, 2008, PLANT CELL PHYSIOL, V49, P117, DOI 10.1093/pcp/pcm157; Fujii G, 2013, FEBS LETT, V587, P3354, DOI 10.1016/j.febslet.2013.08.031; Chisti Y, 2008, TRENDS BIOTECHNOL, V26, P126, DOI 10.1016/j.tibtech.2007.12.002; Chantranupong L, 2015, CELL, V161, P67, DOI 10.1016/j.cell.2015.02.041; Chen JE, 2012, J BIOTECHNOL, V162, P28, DOI 10.1016/j.jbiotec.2012.05.009; Harris EH, 1989, CHLAMYDONZONAS SOURC; Madeira JB, 2015, MOL CELL BIOL, V35, P737, DOI 10.1128/MCB.01314-14; Nozaki H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-28	35	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-4412	1573-5028		PLANT MOL BIOL	Plant Mol.Biol.	OCT	2015	89	3					309	318		10.1007/s11103-015-0370-6		10	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CS0NM	WOS:000361757700009		
J	Ogawa, R				Ogawa, Rei			Reply: Analysis of the Surgical Treatments of 63 Keloids on the Cartilaginous Part of the Auricle: Effectiveness of the Core Excision Method	PLASTIC AND RECONSTRUCTIVE SURGERY			English	Letter									Nippon Med Sch, Dept Plast Reconstruct & Aesthet Surg, Bunkyo Ku, Tokyo 1138603, Japan	Ogawa, R (reprint author), Nippon Med Sch, Dept Plast Reconstruct & Aesthet Surg, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	r.ogawa@nms.ac.jp					Ogawa R, 2009, ANN PLAS SURG, V62, P104, DOI 10.1097/SAP.0b013e3181855172; Chong Y, 2015, DERMATOL SURG, V41, P415, DOI 10.1097/DSS.0000000000000176; Huang C, 2012, INT WOUND J, V11, P517	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0032-1052	1529-4242		PLAST RECONSTR SURG	Plast. Reconstr. Surg.	OCT	2015	136	4					569E	569E		10.1097/PRS.0000000000001596		1	Surgery	Surgery	CS0KE	WOS:000361747100001		
J	Hara, H; Mihara, M; Ohtsu, H; Narushima, M; Iida, T; Koshima, I				Hara, Hisako; Mihara, Makoto; Ohtsu, Hiroshi; Narushima, Mitsunaga; Iida, Takuya; Koshima, Isao			Indication of Lymphaticovenous Anastomosis for Lower Limb Primary Lymphedema	PLASTIC AND RECONSTRUCTIVE SURGERY			English	Article							LOWER-EXTREMITY LYMPHEDEMA; INDOCYANINE GREEN LYMPHOGRAPHY; RESOLUTION MR LYMPHANGIOGRAPHY; VENOUS ANASTOMOSIS; CANCER-TREATMENT; FLAP TRANSFER; DIAGNOSIS; SECONDARY; CLASSIFICATION; MALFORMATIONS	Background: Lymphedema can be classified as either primary or secondary. In the present study, the authors investigated the efficacy of lymphaticovenous anastomosis for correcting primary lower limb lymphedema and to determine its indications and contraindications. Methods: The authors retrospectively examined patients with primary lower limb lymphedema who underwent lymphaticovenous anastomosis between April of 2009 and September of 2013. Anastomosis efficacy was evaluated using lower limb circumference measurements at five anatomical locations. Lymphedema staging was determined using modified leg dermal backflow stage. The authors added two categories to the standard leg dermal backflow staging system: no backflow and distal backflow. Lymphaticovenous anastomosis was performed under local anesthesia, except in pediatric cases. Results: The authors evaluated 62 patients (79 lower limbs). Lower limb circumference increased after lymphaticovenous anastomosis in patients with an onset age of 1 year or later and before age 11 years, but it significantly decreased in patients with an onset age older than 11 years. The presence of lymphedema for a longer period did not negatively impact lymphaticovenous anastomosis efficacy. In particular, lymphaticovenous anastomosis was effective in the leg dermal backflow stage 2 and no backflow group. Conclusions: For patients developing lymphedema before 11 years of age, the indications should be considered carefully. However, lymphaticovenous anastomosis was effective in patients developing lymphedema after the age of 11 years. Regardless, due to its low level of invasiveness, lymphaticovenous anastomosis may be considered for patients who are refractory to conservative treatment, even if they have early-onset lymphedema. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.	Tokyo Univ Hosp, Dept Plast & Reconstruct Surg, Tokyo 1138655, Japan; Saiseikai Kawaguchi Gen Hosp, Dept Vasc Surg, Kawaguchi, Saitama, Japan; Juntendo Univ, Leading Ctr Dev & Res Canc Med, Grad Sch Med, Tokyo, Japan	Hara, H (reprint author), Tokyo Univ Hosp, Dept Plast & Reconstruct Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	hisakohara.prs@gmail.com					Sapountzis S, 2014, MICROSURG, V34, P439, DOI 10.1002/micr.22235; Hara H, 2013, PLAST RECONSTR SURG, V132, P1612, DOI 10.1097/PRS.0b013e3182a97edc; Mihara M, 2012, J PLAST RECONSTR AES, V65, P1551, DOI 10.1016/j.bjps.2012.05.026; Liu NF, 2013, ACAD RADIOL, V20, P218, DOI 10.1016/j.acra.2012.09.014; Hara H, 2012, ANN PLAS SURG, V68, P300, DOI 10.1097/SAP.0b013e318212f19c; OBRIEN BM, 1990, PLAST RECONSTR SURG, V85, P562, DOI 10.1097/00006534-199004000-00011; RUSTGI AK, 1985, SURGERY, V97, P714; KINMONTH JB, 1976, ANN ROY COLL SURG, V58, P278; Hara H, 2012, J PLAST RECONSTR AES, V65, pE305, DOI 10.1016/j.bjps.2012.04.058; Lee BB, 2013, INT ANGIOL, V32, P541; Liu NF, 2012, EUR J VASC ENDOVASC, V44, P345, DOI 10.1016/j.ejvs.2012.06.019; Demirtas Y, 2010, J RECONSTR MICROSURG, V26, P137, DOI 10.1055/s-0029-1243299; Hara H, 2013, J PLAST RECONSTR AES, V66, P1780, DOI 10.1016/j.bjps.2013.04.043; Chan VSH, 2014, ANN PLAS SURG, V72, P180, DOI 10.1097/SAP.0b013e31825b3d1e; Mihara M, 2012, MICROSURG, V32, P580, DOI 10.1002/micr.22022; Maegawa J, 2010, MICROSURG, V30, P437, DOI 10.1002/micr.20772; Koshima I, 2000, J RECONSTR MICROSURG, V16, P437; Becker C, 2012, CLIN PLAST SURG, V39, P377, DOI 10.1016/j.cps.2012.08.001; Lohrmann C, 2006, AM J ROENTGENOL, V187, P556, DOI 10.2214/AJR.05.1750; Mihara M, 2014, ANN PLAS SURG, V72, P204, DOI 10.1097/SAP.0b013e3182586b79; Blatt J, 2014, J PEDIAT HEMATOL ONC, V36, P587, DOI 10.1097/MPH.0000000000000260; Hara H, 2014, MICROSURG, V34, P224, DOI 10.1002/micr.22138; Liu XL, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005413; Mihara M, 2014, BRIT J SURG, V101, P1391, DOI 10.1002/bjs.9588; Mihara M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038182; Pons G, 2014, J PLAST RECONSTR AES, V67, P119, DOI 10.1016/j.bjps.2013.06.005; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, p314E, DOI 10.1097/PRS.0b013e3182268da8; Zeltzer AA, 2014, PLAST RECONSTR SURG, V134, p491E, DOI 10.1097/PRS.0000000000000441	28	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0032-1052	1529-4242		PLAST RECONSTR SURG	Plast. Reconstr. Surg.	OCT	2015	136	4					883	893		10.1097/PRS.0000000000001631		11	Surgery	Surgery	CS0GP	WOS:000361736600001		
J	Matsuzawa, T				Matsuzawa, Tetsuro			Sweet-potato washing revisited: 50th anniversary of the Primates article	PRIMATES			English	Editorial Material									[Matsuzawa, Tetsuro] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan; [Matsuzawa, Tetsuro] Japan Monkey Ctr, Inuyama, Aichi, Japan	Matsuzawa, T (reprint author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan.	matsuzawa.tetsuro.8w@kyoto-u.ac.jp					Kawai M, 1965, PRIMATES, V6, P1, DOI DOI 10.1007/BF01794457	1	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0032-8332	1610-7365		PRIMATES	Primates	OCT	2015	56	4					285	287		10.1007/s10329-015-0492-0		3	Zoology	Zoology	CS1DT	WOS:000361803500001		
J	Hashimoto, C; Isaji, M; Koops, K; Furuichi, T				Hashimoto, Chie; Isaji, Mina; Koops, Kathelijne; Furuichi, Takeshi			First records of tool-set use for ant-dipping by Eastern chimpanzees (Pan troglodytes schweinfurthii) in the Kalinzu Forest Reserve, Uganda	PRIMATES			English	Article						Chimpanzee; Pan troglodytes schweinfurthii; Tool set; Ant-dipping; Invention; Culture; Kalinzu	WILD CHIMPANZEES; ARMY ANTS; DIET; PREDATION; CULTURE; ECOLOGY; BONOBOS; GUINEA; CONGO; NIMBA	Chimpanzees at numerous study sites are known to prey on army ants by using a single wand to dip into the ant nest or column. However, in Goualougo (Republic of Congo) in Central Africa, chimpanzees use a different technique, use of a woody sapling to perforate the ant nest, then use of a herb stem as dipping tool to harvest the army ants. Use of a tool set has also been found in Guinea, West Africa: at Seringbara in the Nimba Mountains and at nearby Bossou. There are, however, no reports for chimpanzees in East Africa. We observed use of such a tool set in Kalinzu, Uganda, for the first time by Eastern chimpanzees. This behavior was observed among one group of chimpanzees at Kalinzu (S-group) but not among the adjacent group (M-group) with partly overlapping ranging areas despite the fact that the latter group has been under intensive observation since 1997. In Uganda, ant-dipping has not been observed in the northern three sites (Budongo, Semliki, and Kibale) but has been observed or seems to occur in the southern sites (Kalinzu and Bwindi), which suggests that ant-dipping was invented by and spread from the southern region after the northern and southern forest blocks became separated. Use of a tool-set by only one group at Kalinzu further suggests that this behavior was recently invented and has not yet spread to the other group via migrating females.	[Hashimoto, Chie; Isaji, Mina; Furuichi, Takeshi] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan; [Koops, Kathelijne] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland; [Koops, Kathelijne] Univ Cambridge, Dept Archaeol & Anthropol, Cambridge, England	Hashimoto, C (reprint author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan.	hashimoto.chie.2n@kyoto-u.ac.jp			Japan Ministry of the Environment Global Environment Research Fund [F-061, D-1007]; JSPS [17570193, 19405015, 40379011, 17255005, 22255007, 26257408, 24255010, 21255006, 25257409, 25257407]; JSPS Asia-Africa Science Platform Program; JSPS HOPE project of the Primate Research Institute (PRI) of Kyoto University; Lucie Burgers Foundation for Comparative Behaviour Research (The Netherlands); Homerton College (Cambridge); MEXT [20002001, 24000001]; National Forestry Authority of Uganda; Uganda National Council for Science and Technology; JSPS Grant-in-Aid for Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation; MEXT special grant "Human Evolution'';  [JSPS-U04-PWS]	We thank the National Forestry Authority of Uganda and the Uganda National Council for Science and Technology for permits and support for the research. We thank the research assistants and other workers in Bushenyi, Uganda, for support for data collection and maintenance of the study sites. We thank, Dr. T. Kano, Dr. T. Matsuzawa, and other members of the Primate Research Institute for support and encouragement. This study was financially supported by the Japan Ministry of the Environment Global Environment Research Fund (F-061 to Nishida; D-1007 to Furuichi), JSPS Grants-in-Aid for Scientific Research (17570193, 19405015, 40379011 to Hashimoto; 17255005, 22255007, 26257408 to Furuichi; 24255010 to Yamagiwa; 21255006, 25257409 to Ihobe; 25257407 to Yumoto), the JSPS Asia-Africa Science Platform Program (2009-2011, 2012-2014 to Furuichi), the JSPS HOPE project of the Primate Research Institute (PRI) of Kyoto University (to Matsuzawa), a MEXT special grant "Human Evolution'' and a JSPS Grant-in-Aid for Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation (to the Primate Research Institute, Kyoto University). K. Koops was supported by grants from the Lucie Burgers Foundation for Comparative Behaviour Research (The Netherlands) and Homerton College (Cambridge) and by MEXT (#20002001, #24000001) and JSPS-U04-PWS grants to T. Matsuzawa.	MCGREW WC, 1974, J HUM EVOL, V3, P501, DOI 10.1016/0047-2484(74)90010-4; Hashimoto C, 2000, PRIMATES, V41, P103, DOI 10.1007/BF02557466; Humle T, 2002, AM J PRIMATOL, V58, P133, DOI 10.1002/ajp.10055; Schoning C, 2008, J HUM EVOL, V55, P48, DOI 10.1016/j.jhevol.2007.12.002; Koops K, 2015, AM J PRIMATOL, V77, P319, DOI 10.1002/ajp.22347; Koops K, 2013, ANIM BEHAV, V85, P175, DOI 10.1016/j.anbehav.2012.10.022; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; HASHIMOTO C, 1995, PRIMATES, V36, P477, DOI 10.1007/BF02382870; Furuichi T, 2004, INT J PRIMATOL, V25, P755, DOI 10.1023/B:IJOP.0000029121.25284.7f; Schoning C, 2005, OIKOS, V110, P231, DOI 10.1111/j.0030-1299.2005.13672.x; BREWER SM, 1990, FOLIA PRIMATOL, V54, P100, DOI 10.1159/000156429; Fox EA, 2004, AM J PHYS ANTHROPOL, V125, P162, DOI 10.1002/ajpa.10386; Sanz CM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0416; Stanford CB, 2003, INT J PRIMATOL, V24, P901, DOI 10.1023/A:1024689008159; Mulavwa M, 2008, DEV PRIMATOL-PROG PR, P121, DOI 10.1007/978-0-387-74787-3_7; Hashimoto C, 2006, DEV PRIMATOL, P247; Basabose AK, 2002, AM J PRIMATOL, V58, P1, DOI 10.1002/ajp.10049; Spagnoletti N, 2012, ANIM BEHAV, V83, P1285, DOI 10.1016/j.anbehav.2012.03.002; SUGIYAMA Y, 1995, PRIMATES, V36, P193, DOI 10.1007/BF02381345; Sanz C, 2004, AM NAT, V164, P567, DOI 10.1086/424803; BOESCH C, 1990, FOLIA PRIMATOL, V54, P86, DOI 10.1159/000156428; Fox Elizabeth A., 1999, P99, DOI 10.1017/CBO9780511542305.005; Furuichi T, 2015, BEHAVIOUR, V152, P425, DOI 10.1163/1568539X-00003226; Hamilton CA, 1984, DEFORESTATION UGANDA; Hashimoto C., 1999, AFR STUDY MONOGR, V20, P229; Howard PC, 1991, NATURE CONSERVATION; Kawai M, 1965, PRIMATES, V6, P1, DOI DOI 10.1007/BF01794457; Koops K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12456; Koops K, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0508; McGrew WC, 2004, CULTURED CHIMPANZEE; McGrew WC, 1992, CHIMPANZEE MAT CULTU; Sanz CM, 2009, AM J PRIMATOL, V72, P17	32	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0032-8332	1610-7365		PRIMATES	Primates	OCT	2015	56	4					301	305		10.1007/s10329-015-0478-y		5	Zoology	Zoology	CS1DT	WOS:000361803500004		
J	Anderson, JR; Gallup, GG				Anderson, James R.; Gallup, Gordon G., Jr.			Mirror self-recognition: a review and critique of attempts to promote and engineer self-recognition in primates	PRIMATES			English	Review						Great apes; Lesser apes; Monkeys; Self-recognition; Awareness; Mirror-guided behavior; Mark test	CHIMPANZEES PAN-TROGLODYTES; MONKEYS CEBUS-APELLA; RHESUS-MONKEYS; IMAGE STIMULATION; NONHUMAN-PRIMATES; GORILLA-GORILLA; SMALL APES; BEHAVIOR; MARK; REFLECTIONS	We review research on reactions to mirrors and self-recognition in nonhuman primates, focusing on methodological issues. Starting with the initial demonstration in chimpanzees in 1970 and subsequent attempts to extend this to other species, self-recognition in great apes is discussed with emphasis on spontaneous manifestations of mirror-guided self-exploration as well as spontaneous use of the mirror to investigate foreign marks on otherwise nonvisible body parts-the mark test. Attempts to show self-recognition in other primates are examined with particular reference to the lack of convincing examples of spontaneous mirror-guided self-exploration, and efforts to engineer positive mark test responses by modifying the test or using conditioning techniques. Despite intensive efforts to demonstrate self-recognition in other primates, we conclude that to date there is no compelling evidence that prosimians, monkeys, or lesser apes-gibbons and siamangs-are capable of mirror self-recognition.	[Anderson, James R.] Kyoto Univ, Grad Sch Letters, Dept Psychol, Sakyo Ku, Kyoto 6068501, Japan; [Gallup, Gordon G., Jr.] SUNY Albany, Dept Psychol, Albany, NY 12222 USA	Anderson, JR (reprint author), Kyoto Univ, Grad Sch Letters, Dept Psychol, Sakyo Ku, Kyoto 6068501, Japan.	j.r.anderson@psy.bun.kyoto-u.ac.jp					Allen M, 2008, J INTEGR BIOSCI, V5, P19; AMSTERDA.B, 1972, DEV PSYCHOBIOL, V5, P297, DOI 10.1002/dev.420050403; Anderson JR, 1999, ANIMAL MODELS HUMAN, P175, DOI 10.1037/10335-011; Anderson James R., 1994, P315, DOI 10.1017/CBO9780511565526.023; GALLUP GG, 1968, PSYCHOL BULL, V70, P782, DOI 10.1037/h0026777; Gold K, 2009, ROBOT AUTON SYST, V57, P384, DOI 10.1016/j.robot.2008.07.006; POVINELLI DJ, 1993, J COMP PSYCHOL, V107, P347, DOI 10.1037/0735-7036.107.4.347; Hauser MD, 2001, AM J PRIMATOL, V53, P131; Anderson JR, 1997, ANIM BEHAV, V54, P1563, DOI 10.1006/anbe.1997.0548; ANDERSON JR, 1986, J COMP PSYCHOL, V100, P237, DOI 10.1037//0735-7036.100.3.237; GALLUP GC, 1971, PSYCHOL REC, V21, P69; Feinberg TE, 2005, CONSCIOUS COGN, V14, P661, DOI 10.1016/j.concog.2005.01.002; Reiss D, 2001, P NATL ACAD SCI USA, V98, P5937, DOI 10.1073/pnas.101086398; Anderson JR, 2011, AM J PRIMATOL, V73, P603, DOI 10.1002/ajp.20950; Gallup GG, 1995, ANIM BEHAV, V50, P1525, DOI 10.1016/0003-3472(95)80008-5; Shillito DJ, 1999, ANIM BEHAV, V57, P999, DOI 10.1006/anbe.1998.1062; Keenan JP, 2001, NATURE, V409, P305, DOI 10.1038/35053167; Carbone L, 2014, NATURE, V513, P195, DOI 10.1038/nature13679; Hyatt CW, 1998, AM J PRIMATOL, V45, P307, DOI 10.1002/(SICI)1098-2345(1998)45:3<307::AID-AJP7>3.0.CO;2-#; Kitchen A, 1996, P NATL ACAD SCI USA, V93, P7405, DOI 10.1073/pnas.93.14.7405; HAUSER MD, 1995, P NATL ACAD SCI USA, V92, P10811, DOI 10.1073/pnas.92.23.10811; HEMELRIJK CK, 1989, BEHAVIOUR, V111, P305, DOI 10.1163/156853989X00727; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; LIN AC, 1992, J COMP PSYCHOL, V106, P120, DOI 10.1037//0735-7036.106.2.120; CALHOUN S, 1988, AM J PRIMATOL, V15, P361, DOI 10.1002/ajp.1350150409; GALLUP GG, 1991, J COMP PSYCHOL, V105, P376, DOI 10.1037/0735-7036.105.4.376; GALLUP GG, 1980, FOLIA PRIMATOL, V33, P210; Nielsen M, 2004, INFANT BEHAV DEV, V27, P342, DOI 10.1016/j.infbeh.2003.12.006; Platek SM, 2003, SCHIZOPHR RES, V65, P147, DOI 10.1016/S0920-9964(02)000494-2; de Veer MW, 2003, NEUROPSYCHOLOGIA, V41, P229, DOI 10.1016/S0028-3932(02)00153-7; ANDERSON JR, 1989, PRIMATES, V30, P581, DOI 10.1007/BF02380884; ANDERSON JR, 1984, DEV PSYCHOBIOL, V17, P35, DOI 10.1002/dev.420170104; Plotnik JM, 2006, P NATL ACAD SCI USA, V103, P17053, DOI 10.1073/pnas.0608062103; van Veluw SJ, 2014, BRAIN IMAGING BEHAV, V8, P24, DOI 10.1007/s11682-013-9266-8; HEYES CM, 1994, ANIM BEHAV, V47, P909, DOI 10.1006/anbe.1994.1123; De Lathouwers M, 2004, AM J PRIMATOL, V64, P411, DOI 10.1002/ajp.20089; MAESTRIPIERI D, 1992, ANIM BEHAV, V44, P967, DOI 10.1016/S0003-3472(05)80592-5; NICHOLSON IS, 1995, PRIMATES, V36, P515, DOI 10.1007/BF02382873; Meador KJ, 2000, NEUROLOGY, V55, P816; Povinelli DJ, 1997, ANIM BEHAV, V53, P1083, DOI 10.1006/anbe.1996.0303; Bard KA, 2006, INFANCY, V9, P191, DOI 10.1207/s15327078in0902_6; Posada S, 2007, AM J PRIMATOL, V69, P576, DOI 10.1002/ajp.20355; MENZEL EW, 1985, J COMP PSYCHOL, V99, P211, DOI 10.1037//0735-7036.99.2.211; InoueNakamura N, 1997, JPN PSYCHOL RES, V39, P266, DOI 10.1111/1468-5884.00059; Roma PG, 2007, AM J PRIMATOL, V69, P989, DOI 10.1002/ajp.20404; Heschl A, 2006, PRIMATES, V47, P187, DOI 10.1007/s10329-005-0170-8; Butler D, 2014, PSYCHON B REV, V21, P590, DOI 10.3758/s13423-013-0559-0; Ujhelyi M, 2000, J COMP PSYCHOL, V114, P253, DOI 10.1037//0735-7036.114.3.253; Toda K, 2015, CURR BIOL, V25, pR64, DOI 10.1016/j.cub.2014.12.005; ITAKURA S, 1987, PRIMATES, V28, P149, DOI 10.1007/BF02382568; Chang LT, 2015, CURR BIOL, V25, P212, DOI 10.1016/j.cub.2014.11.016; WALRAVEN V, 1995, PRIMATES, V36, P145, DOI 10.1007/BF02381922; Gallup GG, 1997, ANN NY ACAD SCI, V818, P73, DOI 10.1111/j.1749-6632.1997.tb48247.x; GALLUP GG, 1982, AM J PRIMATOL, V2, P237, DOI 10.1002/ajp.1350020302; Gallup GG, 2003, SELF IN NEUROSCIENCE AND PSYCHIATRY, P147, DOI 10.1017/CBO9780511543708.008; Gallup Jr GG, 2011, OXFORD HDB SELF, P80; Heschl A, 2009, INT J COMP PSYCHOL, V22, P221; Hyatt Charles W., 1994, P248, DOI 10.1017/CBO9780511565526.017; Kartner J, 2012, MONOGR SOC RES CHILD, V77; LEDBETTER DH, 1982, AM J PRIMATOL, V2, P307, DOI 10.1002/ajp.1350020309; LETHMATE J, 1973, Zeitschrift fuer Tierpsychologie, V33, P248; Mead G. H., 1934, MIND SELF SOC; Miles HLW, 1994, SELF AWARENESS ANIMA, P254, DOI 10.1017/CBO9780511565526.018; Parker ST, 1994, SELF AWARENESS ANIMA, P301, DOI 10.1017/CBO9780511565526.021; Patterson Francine G.P., 1994, P273, DOI 10.1017/CBO9780511565526.019; Platek SM, 2002, SCHIZOPHR RES, V57, P311; Povinelli Daniel J., 1994, P291, DOI 10.1017/CBO9780511565526.020; PREMACK D., 1978, BEHAVIORAL BRAIN SCI, VIV, P515, DOI DOI 10.1017/S0140525X00076512; Prior H, 2008, PLOS BIOL, V6, P1642, DOI 10.1371/journal.pbio.0060202; Rajala AZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012865; Shumaker RW, 2002, COGNITIVE ANIMAL, P335; Soler M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086193; Suarez SD, 1981, J HUM EVOL, V10, P157; Suddendorf T, 2009, P R SOC B, DOI [10.1098/rspb.1754, DOI 10.1098/RSPB.1754]; Swartz Karyl B., 1994, P189, DOI 10.1017/CBO9780511565526.013; Westergaard G.C., 1994, Human Evolution, V9, P273, DOI 10.1007/BF02435514	76	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0032-8332	1610-7365		PRIMATES	Primates	OCT	2015	56	4					317	326		10.1007/s10329-015-0488-9		10	Zoology	Zoology	CS1DT	WOS:000361803500007		
J	Wada, K; Li, BG; Watanabe, K				Wada, Kazuo; Li, Baoguo; Watanabe, Kunio			Affiliative interactions between one-male units in a band of Sichuan snub-nosed monkeys (Rhinopithecus roxellana) living in the Qinling Mountains, China	PRIMATES			English	Article						Rhinopithecus roxellana; Infant handling; One-male units; Multi-layered social structure; Affiliative encounters	FREE-RANGING BAND; SOCIAL-ORGANIZATION; BEHAVIOR; BIETI	We studied affiliative behaviors that occurred within and between one-male units (OMUs) in a band of Sichuan snub-nosed monkeys (Rhinopithecus roxellana) living in the Qinling Mountains, China for 3 years from 2002 to 2004. During the birth season, females handling infants of other females affiliatively interacted with females in neighboring OMUs as well as with females in their own OMU. After these interactions, affiliative encounters occurred without conflict between the OMUs. In the mating season, females sometimes presented their genitals to males of other OMUs. These interactions may facilitate the maintenance of a higher level social organization, a band. Therefore, the band composed of OMUs and all male group(s) is the basic unit of social structure of this species. Almost all other Asian colobines have OMUs that either maintain distance from each other or engage in territorial defense, so these OMUs would not be expected to form a band. Contrary to these species, the 3 species of Rhinopithecus spp. inhabiting China form a band composed of OMUs, because infants and females may function as a bridge connecting OMUs.	[Wada, Kazuo] Kyoto Univ, Primate Res Inst, Cooperat Res Program, Inuyama, Aichi 4848506, Japan; [Li, Baoguo] NW Univ Xian, Coll Life Sci, Xian 710069, Peoples R China; [Watanabe, Kunio] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 4848506, Japan	Wada, K (reprint author), Kyoto Univ, Primate Res Inst, Cooperat Res Program, Kanrin 41-2, Inuyama, Aichi 4848506, Japan.	wadakaz@mc.ccnw.ne.jp			Cooperative Research Program of Primate Research Institute of Kyoto University	Drs. Michael A. Huffman and Yamato Tsuji of the Primate Research Institute of Kyoto University carefully revised our paper and gave us valuable suggestions concerning biological points. Drs. Hideshi Ogawa, Yongcheng Long and an anonymous reviewer provided many valuable and candid suggestions. We wish to express sincerely our gratitude to all these people. This study was supported by the Cooperative Research Program of the Primate Research Institute of Kyoto University.	Matsuda I, 2010, AM J PHYS ANTHROPOL, V142, P235, DOI 10.1002/ajpa.21218; Zhang P, 2008, AM J PRIMATOL, V70, P1013, DOI 10.1002/ajp.20591; Ren BP, 2003, INT J PRIMATOL, V24, P575; Cui LW, 2008, AM J PRIMATOL, V70, P169, DOI 10.1002/ajp.20471; BLEISCH W, 1993, FOLIA PRIMATOL, V60, P72, DOI 10.1159/000156677; Kirkpatrick RC, 1998, INT J PRIMATOL, V19, P13, DOI 10.1023/A:1020302809584; Wada K, 2009, MAMMALIA, V73, P81, DOI 10.1515/MAMM.2009.023; Qi XG, 2008, AM J PRIMATOL, V70, P311, DOI 10.1002/ajp.20480; KUMMER H, 1984, ANIM BEHAV, V32, P965, DOI 10.1016/S0003-3472(84)80208-0; Brent LJN, 2008, AM J PRIMATOL, V70, P101, DOI 10.1002/ajp.20478; Zhang P, 2006, PRIMATES, V47, P374, DOI 10.1007/s10329-006-0178-8; Zhao DP, 2005, FOLIA PRIMATOL, V76, P172, DOI 10.1159/000084379; Zhang P, 2008, AM J PRIMATOL, V70, P634, DOI 10.1002/ajp.20537; Grueter CC, 2010, BEHAV ECOL, V21, P63, DOI 10.1093/beheco/arp149; KAWAI M, 1983, Primates, V24, P13, DOI 10.1007/BF02381450; MAESTRIPIERI D, 1994, INT J PRIMATOL, V15, P531, DOI 10.1007/BF02735970; Murai T, 2004, THESIS HOKKAIDO U; Newton Paul N., 1994, P311; Ren RM, 2000, FIELD STUDY RHINOPIT; Ren RM, 1998, NATURAL HIST DOUCS S, P269; Vogel C., 1984, P361; YEAGER CP, 1992, AM J PRIMATOL, V26, P133, DOI 10.1002/ajp.1350260207; Yeager Carey P., 2000, P496, DOI 10.1017/CBO9780511542589.020; Zhang Peng, 2003, Acta Zoologica Sinica, V49, P727	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0032-8332	1610-7365		PRIMATES	Primates	OCT	2015	56	4					327	337		10.1007/s10329-015-0475-1		11	Zoology	Zoology	CS1DT	WOS:000361803500008		
J	Bloch, M; Hayashi, M; Thangaraj, A				Bloch, Matthieu; Hayashi, Masahito; Thangaraj, Andrew			Error-Control Coding for Physical-Layer Secrecy	PROCEEDINGS OF THE IEEE			English	Article						Channel resolvability; error-control coding; physical-layer security; privacy amplification	WIRE-TAP CHANNEL; PRIVACY AMPLIFICATION; POLAR CODES; MEMORYLESS CHANNELS; COMMON INFORMATION; LDPC CODES; CAPACITY; RECONCILIATION; RESOLVABILITY; CONSTRUCTION	The renewed interest for physical-layer security techniques has put forward a new role for error-control codes. In addition to ensuring reliability, carefully designed codes have been shown to provide a level of information-theoretic secrecy, by which the amount of information leaked to an adversary may be controlled. The ability to achieve informationtheoretic secrecy relies on the study of alternative coding mechanisms, such as channel resolvability and privacy amplification, in which error-control codes are exploited as a means to shape the distribution of stochastic processes. This use of error-control codes, which goes much beyond that of correcting errors, creates numerous new design challenges. The objective of this paper is threefold. First, the paper aims at providing system engineers with explicit tools to build simple secrecy codes in order to stimulate interest and foster their integration in communication system prototypes. Second, it aims at providing coding and information theorists with a synthetic overview of the theoretical concepts and techniques for secrecy. Finally, it aims at highlighting the open challenges and opportunities faced for the integration of these codes in practical systems.	[Bloch, Matthieu] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA; [Hayashi, Masahito] Nagoya Univ, Grad Sch Math, Nagoya, Aichi 4648602, Japan; [Hayashi, Masahito] Natl Univ Singapore, Ctr Quantum Technol, Singapore 117543, Singapore; [Thangaraj, Andrew] Indian Inst Technol, Madras 600036, Tamil Nadu, India	Bloch, M (reprint author), Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA.	matthieu.bloch@ece.gatech.edu			MEXT [23246071]; National Institue of Information and Communication Technology (NICT), Japan;  [NSF-CIF-1320298];  [ANR-13-BS03-0008]	The work of M. Bloch was supported in part by the NSF-CIF-1320298 and ANR-13-BS03-0008 grants. The work of M. Hayashi was supported in part by a MEXT Grant-in-Aid for Science Research (A) 23246071 and by the National Institue of Information and Communication Technology (NICT), Japan.	AHLSWEDE R, 1993, IEEE T INFORM THEORY, V39, P1121, DOI 10.1109/18.243431; Baldi M, 2012, IEEE T INF FOREN SEC, V7, P883, DOI 10.1109/TIFS.2012.2187515; Tal I, 2013, IEEE INT SYMP INFO, P1561, DOI 10.1109/ISIT.2013.6620489; Koyluoglu OO, 2010, 2010 IEEE 21ST INTERNATIONAL SYMPOSIUM ON PERSONAL INDOOR AND MOBILE RADIO COMMUNICATIONS (PIMRC), P2698, DOI 10.1109/PIMRC.2010.5671797; Thangaraj A, 2007, IEEE T INFORM THEORY, V53, P2933, DOI 10.1109/TIT.2007.901143; Hayashi M, 2008, IEEE T INFORM THEORY, V54, P4619, DOI 10.1109/TIT.2008.928985; Bassily R, 2013, IEEE SIGNAL PROC MAG, V30, P16, DOI 10.1109/MSP.2013.2260875; Hu XY, 2005, IEEE T INFORM THEORY, V51, P386, DOI 10.1109/TIT.2004.839541; Andersson M, 2010, CONF REC ASILOMAR C, P2045, DOI 10.1109/ACSSC.2010.5757907; Bennett CH, 1995, IEEE T INFORM THEORY, V41, P1915, DOI 10.1109/18.476316; Muramatsu J, 2009, 2009 IEEE INFORMATION THEORY WORKSHOP (ITW 2009), P105, DOI 10.1109/ITW.2009.5351225; Zhang K, 2014, IET COMMUN, V8, P1696, DOI 10.1049/iet-com.2013.0889; Gowtham KR, 2008, 2008 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY PROCEEDINGS, VOLS 1-6, P529, DOI 10.1109/ISIT.2008.4595042; [Anonymous], 2011, P IEEE INT S INF THE; Andersson M, 2010, IEEE COMMUN LETT, V14, P752, DOI 10.1109/LCOMM.2010.08.100875; Tal I, 2013, IEEE T INFORM THEORY, V59, P6562, DOI 10.1109/TIT.2013.2272694; Yasui K, 2007, 2007 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY PROCEEDINGS, VOLS 1-7, P936, DOI 10.1109/ISIT.2007.4557344; Lan L, 2007, IEEE T INFORM THEORY, V53, P2429, DOI 10.1109/TIT.2007.899516; Renes JM, 2011, IEEE T INFORM THEORY, V57, P7377, DOI 10.1109/TIT.2011.2162226; Hayashi M, 2006, IEEE T INFORM THEORY, V52, P1562, DOI 10.1109/TIT.2006.871040; CSISZAR I, 1978, IEEE T INFORM THEORY, V24, P339, DOI 10.1109/TIT.1978.1055892; Pierrot AJ, 2011, IEEE T INF FOREN SEC, V6, P595, DOI 10.1109/TIFS.2011.2158422; Klinc D, 2011, IEEE T INF FOREN SEC, V6, P532, DOI 10.1109/TIFS.2011.2134093; Subramanian A, 2011, IEEE T INF FOREN SEC, V6, P585, DOI 10.1109/TIFS.2011.2148715; Muramatsu J, 2014, IEEE T INFORM THEORY, V60, P2667, DOI 10.1109/TIT.2014.2309140; Sasoglu E, 2013, IEEE INT SYMP INFO, P1117, DOI 10.1109/ISIT.2013.6620400; Tekin E, 2008, IEEE T INFORM THEORY, V54, P2735, DOI 10.1109/TIT.2008.921680; Devetak I, 2005, IEEE T INFORM THEORY, V51, P44, DOI 10.1109/TIT.2004.839515; Pierrot AJ, 2012, 2012 IEEE INFORMATION THEORY WORKSHOP (ITW), P462, DOI 10.1109/ITW.2012.6404716; SLEPIAN D, 1973, IEEE T INFORM THEORY, V19, P471, DOI 10.1109/TIT.1973.1055037; HAN TS, 1993, IEEE T INFORM THEORY, V39, P752, DOI 10.1109/18.256486; Kobayashi D, 2013, IEEE T INFORM THEORY, V59, P8131, DOI 10.1109/TIT.2013.2282673; Han TS, 2005, IEEE T INFORM THEORY, V51, P747, DOI 10.1109/TIT.2004.840860; Mahdavifar H, 2010, IEEE INT SYMP INFO, P913, DOI 10.1109/ISIT.2010.5513514; GOLDWASSER S, 1984, J COMPUT SYST SCI, V28, P270, DOI 10.1016/0022-0000(84)90070-9; Divsalar D, 2009, IEEE J SEL AREA COMM, V27, P876, DOI 10.1109/JSAC.2009.090806; Orlitsky A, 2005, IEEE T INFORM THEORY, V51, P929, DOI 10.1109/TIT.2004.842571; Mahdavifar H, 2011, IEEE T INFORM THEORY, V57, P6428, DOI 10.1109/TIT.2011.2162275; Bloch MR, 2013, IEEE T INFORM THEORY, V59, P8077, DOI 10.1109/TIT.2013.2283722; Hou J, 2014, IEEE INT SYMP INFO, P601; Cuff P, 2013, IEEE T INFORM THEORY, V59, P7071, DOI 10.1109/TIT.2013.2279330; Pradhan AK, 2013, IEEE INT SYMP INFO, P1680, DOI 10.1109/ISIT.2013.6620513; Van Assche G, 2004, IEEE T INFORM THEORY, V50, P394, DOI 10.1109/TIT.2003.822618; MAURER UM, 1993, IEEE T INFORM THEORY, V39, P733, DOI 10.1109/18.256484; ARIMOTO S, 1973, IEEE T INFORM THEORY, V19, P357, DOI 10.1109/TIT.1973.1055007; WYNER AD, 1975, IEEE T INFORM THEORY, V21, P163, DOI 10.1109/TIT.1975.1055346; Hayashi M, 2011, IEEE T INFORM THEORY, V57, P3989, DOI 10.1109/TIT.2011.2110950; Arikan E, 2009, IEEE T INFORM THEORY, V55, P3051, DOI 10.1109/TIT.2009.2021379; Kudekar S, 2011, IEEE T INFORM THEORY, V57, P803, DOI 10.1109/TIT.2010.2095072; Dodis Y, 2008, SIAM J COMPUT, V38, P97, DOI 10.1137/060651380; Watanabe S, 2014, IEEE INT SYMP INFO, P1882, DOI 10.1109/ISIT.2014.6875160; WYNER AD, 1975, AT&T TECH J, V54, P1355; Arikan Erdal, 2010, Proceedings of the 2010 IEEE International Symposium on Information Theory. ISIT 2010, DOI 10.1109/ISIT.2010.5513567; Bellare M., 2012, LECT NOTES COMPUTER, V7417, P294; Bloch M., 2011, PHYS LAYER SECURITY; Bloch M. R., 2012, P 50 ANN ALL C COMM, P565; Bloch M. R., 2012, Proceedings of the 2012 IEEE International Symposium on Information Theory - ISIT, DOI 10.1109/ISIT.2012.6283039; WEGMAN MN, 1981, J COMPUT SYST SCI, V22, P265, DOI 10.1016/0022-0000(81)90033-7; Chou R. A., 2014, IEEE T INF THEORY; Chou R. A., 2013, POLAR CODING SECRET; Cover T. M., 2006, ELEMENTS INFORM THEO; Csiszar I., 1996, Problems of Information Transmission, V32; Gulcu T. C., 2014, ACHIEVING SECRECY CA; Han TS, 2014, IEEE T INFORM THEORY, V60, P6819, DOI 10.1109/TIT.2014.2355811; Hayashi M., 2013, MORE EFFICIENT PRIVA; Hayashi M., 2012, SECURE MULTIPLEX COD; He X., 2010, P 48 ANN ALL C COMM, P1228; He X, 2014, IEEE T INFORM THEORY, V60, P6844, DOI 10.1109/TIT.2014.2359192; He X., 2010, P IEEE GLOB TEL C MI; Hof E., 2010, P IEEE INF THEOR WOR; Korner J., 2011, INFORM THEORY CODING; LEUNGYANCHEONG SK, 1978, IEEE T INFORM THEORY, V24, P451, DOI 10.1109/TIT.1978.1055917; Liang YB, 2009, EURASIP J WIREL COMM, DOI 10.1155/2009/142374; Ling C., 2012, SEMANTICALLY SECURE; Liu Ruoheng, 2007, P IEEE INF THEOR WOR, P337; MacWilliams F J, 1978, THEORY ERROR CORRECT; MAURER UM, 1994, KLUW COMMUN, V276, P271; OZAROW LH, 1984, AT&T TECH J, V63, P2135; Rathi V., 2009, P 2009 43 AS C SIGN, P834; Richardson T., 2008, MODERN CODING THEORY; Ryan W. E., 2009, CHANNEL CODES CLASSI; Sasoglu E., 2012, Proceedings of the 2012 IEEE International Symposium on Information Theory - ISIT, DOI 10.1109/ISIT.2012.6283740; SHANNON CE, 1949, AT&T TECH J, V28, P656; Suresh A. T., 2010, P IEEE INF THEOR WOR; Thrope J., 2005, INP PROGR REP, V53, P42; Vadhan S. P., 2012, FDN TRENDS COMMUNICA, V7; Yassaee M. H., 2012, Proceedings of the 2012 IEEE International Symposium on Information Theory - ISIT, DOI 10.1109/ISIT.2012.6283010	87	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9219	1558-2256		P IEEE	Proc. IEEE	OCT	2015	103	10			SI		1725	1746		10.1109/JPROC.2015.2463678		22	Engineering, Electrical & Electronic	Engineering	CR9NL	WOS:000361683400004		
J	Muramatsu, J; Yoshimura, K; Davis, P; Uchida, A; Harayama, T				Muramatsu, Jun; Yoshimura, Kazuyuki; Davis, Peter; Uchida, Atsushi; Harayama, Takahisa			Secret-Key Distribution Based on Bounded Observability	PROCEEDINGS OF THE IEEE			English	Article						Bounded observability (BO); correlated randomness in optical devices; information-theoretic security; secret-key agreement; secret-key distribution	INFORMATION-THEORETIC SECURITY; PARITY-CHECK MATRICES; SEMICONDUCTOR-LASERS; ADVANTAGE DISTILLATION; PRIVACY AMPLIFICATION; QUANTUM CRYPTOGRAPHY; MATHEMATICAL-THEORY; CORRELATED SOURCES; LINEAR CODES; AGREEMENT	This paper reviews an approach to secret-key distribution based on the bounded observability (BO) model. First, the information-theoretic framework of secret-key agreement from a correlated random source is reviewed. Next, the BO model is introduced. In the context of this model, the BO condition is presented as a necessary and sufficient condition for the possibility of secret-key distribution. This condition describes limits on the information obtained by observation of a random object, and models the practical difficulty of completely observing random physical phenomena. Finally, an implementation of secret-key distribution based on BO in an optical fiber system is described.	[Muramatsu, Jun] NTT Corp, NTT Commun Sci Labs, Kyoto 6190237, Japan; [Yoshimura, Kazuyuki] NTT Corp, NTT Commun Sci Labs, Kanagawa 2430198, Japan; [Davis, Peter] Telecognix Corp, Sakyo Ku, Kyoto 6068314, Japan; [Uchida, Atsushi] Saitama Univ, Dept Informat & Comp Sci, Saitama 3388570, Japan; [Harayama, Takahisa] Waseda Univ, Fac Sci & Engn, Dept Appl Phys, Sch Adv Sci & Engn,Shinjuku Ku, Tokyo 1698555, Japan	Muramatsu, J (reprint author), NTT Corp, NTT Commun Sci Labs, Kyoto 6190237, Japan.	muramatsu.jun@lab.ntt.co.jp; yoshimura.kazuyuki@lab.ntt.co.jp; davis@telecognix.com; auchida@mail.saitama-u.ac.jp; harayama@waseda.jp					AHLSWEDE R, 1993, IEEE T INFORM THEORY, V39, P1121, DOI 10.1109/18.243431; Kschischang FR, 2001, IEEE T INFORM THEORY, V47, P498, DOI 10.1109/18.910572; Muramatsu J, 2006, IEICE T FUND ELECTR, VE89A, P2589, DOI 10.1093/ietfec/e89-a.10.2589; EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; Bennett CH, 1995, IEEE T INFORM THEORY, V41, P1915, DOI 10.1109/18.476316; Liveris AD, 2002, IEEE COMMUN LETT, V6, P440, DOI 10.1109/LCOMM.2002.804244; Aida H, 2012, OPT EXPRESS, V20, P11813, DOI 10.1364/OE.20.011813; CARTER JL, 1979, J COMPUT SYST SCI, V18, P143, DOI 10.1016/0022-0000(79)90044-8; Liu SL, 2003, DESIGN CODE CRYPTOGR, V30, P39, DOI 10.1023/A:1024755209150; Bloch M, 2008, IEEE T INFORM THEORY, V54, P2515, DOI 10.1109/TIT.2008.921908; Jouguet P, 2013, NAT PHOTONICS, V7, P378, DOI [10.1038/nphoton.2013.63, 10.1038/NPHOTON.2013.63]; Korzh B, 2015, NAT PHOTONICS, V9, P163, DOI 10.1038/NPHOTON.2014.327; Uchida A, 2008, NAT PHOTONICS, V2, P728, DOI 10.1038/nphoton.2008.227; Muramatsu J, 2005, IEEE T INFORM THEORY, V51, P3645, DOI 10.1109/TIT.2005.855604; Oowada I, 2009, OPT EXPRESS, V17, P10025, DOI 10.1364/OE.17.010025; Koizumi H, 2013, OPT EXPRESS, V21, P17869, DOI 10.1364/OE.21.017869; Lo HK, 2014, NAT PHOTONICS, V8, P595, DOI 10.1038/NPHOTON.2014.149; SLEPIAN D, 1973, IEEE T INFORM THEORY, V19, P471, DOI 10.1109/TIT.1973.1055037; Muramatsu J, 2006, IEICE T FUND ELECTR, VE89A, P2036, DOI 10.1093/ietfec/e89-a.7.2036; [Anonymous], 1997, ADV CRYPTOLOGY CRYPT, DOI 10.1007/BFb0052243; Muramatsu J, 2012, IEEE T INFORM THEORY, V58, P671, DOI 10.1109/TIT.2011.2173716; Muramatsu J, 2010, LECT NOTES COMPUT SC, V5973, P128, DOI 10.1007/978-3-642-14496-7_11; Muramatsu J, 2006, IEEE T INFORM THEORY, V52, P5140, DOI 10.1109/TIT.2006.883552; Feldman J, 2005, IEEE T INFORM THEORY, V51, P954, DOI 10.1109/TIT.2004.842696; Cachin C, 1997, J CRYPTOL, V10, P97, DOI 10.1007/s001459900023; Braun J, 2014, DESIGN CODE CRYPTOGR, V71, P459, DOI 10.1007/s10623-012-9747-6; Harayama T, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.031803; Van Assche G, 2004, IEEE T INFORM THEORY, V50, P394, DOI 10.1109/TIT.2003.822618; MAURER UM, 1993, IEEE T INFORM THEORY, V39, P733, DOI 10.1109/18.256484; SHANNON CE, 1948, AT&T TECH J, V27, P623; [Anonymous], 2008, P IEEE INT S INF THE; Gisin N, 2002, REV MOD PHYS, V74, P145, DOI 10.1103/RevModPhys.74.145; Bennett C. H., 1984, P IEEE INT C COMP SY, P175; Bloch M., 2006, P IEEE INF THEOR WOR, P116; Bloch M., 2011, PHYS LAYER SECURITY; Brassard G., 1993, ADV CRYPTOLOGY EUROC, V765, P411; Cover T. M., 2006, ELEMENTS INFORM THEO; CSISZAR I, 1982, IEEE T INFORM THEORY, V28, P585, DOI 10.1109/TIT.1982.1056524; Csiszar I., 1996, Problems of Information Transmission, V32; DIFFIE W, 1976, IEEE T INFORM THEORY, V22, P644, DOI 10.1109/TIT.1976.1055638; Gander M. J., 1994, Proceedings. 1994 IEEE International Symposium on Information Theory (Cat. No.94CH3467-8), DOI 10.1109/ISIT.1994.394667; Hassan AA, 1996, DIGIT SIGNAL PROCESS, V6, P207, DOI 10.1006/dspr.1996.0023; Muramatsu J., 2012, P 2012 IEEE INF THEO, P612; Muramatsu J., 2013, B JPN SOC IND APPL M, V23, P11; Murayama T, 2002, J PHYS A-MATH GEN, V35, pL95, DOI 10.1088/0305-4470/35/8/101; Rabin M. O., 2005, P INF THEOR WORKSH A, P34; SHANNON CE, 1949, AT&T TECH J, V28, P656; Yoshimura K, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.070602	48	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9219	1558-2256		P IEEE	Proc. IEEE	OCT	2015	103	10			SI		1762	1780		10.1109/JPROC.2015.2462837		19	Engineering, Electrical & Electronic	Engineering	CR9NL	WOS:000361683400006		
J	Lohwacharin, J; Phetrak, A; Takizawa, S; Kanisawa, Y; Okabe, S				Lohwacharin, Jenyuk; Phetrak, Athit; Takizawa, Satoshi; Kanisawa, Yuuma; Okabe, Sadao			Bacterial growth during the start-up period of pilot-scale biological activated carbon filters: Effects of residual ozone and chlorine and backwash intervals	PROCESS BIOCHEMISTRY			English	Article						Adenosine triphosphate (ATP); Backwashing; Biodegradation; Biological activated carbon (BAC); Chlorine; Ozone	DRINKING-WATER TREATMENT; NUCLEIC-ACID CONTENT; DISTRIBUTION-SYSTEMS; ORGANIC-MATTER; FLOW-CYTOMETRY; BIOFILTRATION; BIOMASS; REMOVAL; BIOFILM; CELLS	This study aimed to evaluate the effects of residual ozone and chlorine and the backwash intervals on bacterial activities and density in pilot-scale biological activated carbon (BAC) filters by employing adenosine triphosphate (ATP) measurement and flow cytometry. The BAC filters received water treated by full-scale coagulation-filtration-ozonation processes. The attached bacterial density on the BAC increased rapidly in the first few weeks. The residual chlorine in the influent water caused ca. 1-log reduction of ATP-per-cell in the bacteria attached on the BAC and in the effluent and backwash waters. Extending the backwash interval made the bacteria attached on the BAC more resistant to ozone and chlorine, as suggested by the higher ATP-per-cell of the attached bacteria and the higher percentage of high-nucleic-acid intact bacteria in the backwash water. However, the attached bacterial density was higher for the shorter backwash interval operation than for the longer one during the high-ozone period. Although no significant difference in DOC removal rates was observed between the two BAC filters, fluorescence excitation-emission matrix analysis revealed that high residual ozone decreased the removal of aromatic proteins and soluble microbial product-like compounds. (C) 2015 Elsevier Ltd. All rights reserved.	[Lohwacharin, Jenyuk; Phetrak, Athit; Takizawa, Satoshi] Univ Tokyo, Grad Sch Engn, Dept Urban Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Kanisawa, Yuuma] Asaka Purificat Plant, Water Qual Management Ctr, Saitama 3510031, Japan; [Okabe, Sadao] Asaka Purificat Adm Off, Saitama 3510031, Japan	Lohwacharin, J (reprint author), Univ Tokyo, Grad Sch Engn, Dept Urban Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	jenyuk@env.t.u-tokyo.ac.jp; phetrak@env.t.u-tokyo.ac.jp; takizawa@env.t.u-tokyo.ac.jp; kanisawa-yuuma@waterworks.metro.tokyo.jp; okabe-sadao@waterworks.metro.tokyo.jp			Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [S-8]; Japan Society for the Promotion of Science (JSPS) [26820221]; JSPS Postdoctoral Fellowship [21-09290]	The authors thank the manager of the WTP for assistance. This study was supported by the Environment Research and Technology Development Fund (S-8) of the Ministry of the Environment, Japan; by a Grant-in-Aid for Scientific Research (#26820221) from the Japan Society for the Promotion of Science (JSPS); and by a JSPS Postdoctoral Fellowship (#21-09290).	Simon FX, 2013, DESALINATION, V316, P8, DOI 10.1016/j.desal.2013.01.023; Liu B, 2012, SCI TOTAL ENVIRON, V414, P508, DOI 10.1016/j.scitotenv.2011.10.049; Chen W, 2003, ENVIRON SCI TECHNOL, V37, P5701, DOI 10.1021/es034354c; Persson F, 2006, ENVIRON TECHNOL, V27, P1037, DOI 10.1080/09593332708618717; WHITESIDE C, 1987, ARCH BIOCHEM BIOPHYS, V257, P464, DOI 10.1016/0003-9861(87)90591-1; Lohwacharin J, 2010, SEP PURIF TECHNOL, V72, P61, DOI 10.1016/j.seppur.2010.01.003; Gillespie S, 2014, WATER RES, V65, P224, DOI 10.1016/j.watres.2014.07.029; WANG JZ, 1995, J AM WATER WORKS ASS, V87, P55; Lohwacharin J, 2014, WATER SCI TECH-W SUP, V14, P165, DOI 10.2166/ws.2013.185; Liao XB, 2013, PROCESS BIOCHEM, V48, P312, DOI 10.1016/j.procbio.2012.12.016; Butterfield PW, 2002, WATER RES, V36, P4391, DOI 10.1016/S0043-1354(02)00148-3; Velten S, 2007, WATER RES, V41, P1973, DOI 10.1016/j.watres.2007.01.021; Xue Z, 2013, ENVIRON SCI TECHNOL, V47, P1365, DOI 10.1021/es304113e; Gibert O, 2013, WATER RES, V47, P1101, DOI 10.1016/j.watres.2012.11.026; Wang JJ, 2013, WATER RES, V47, P2701, DOI 10.1016/j.watres.2013.02.038; Boon N, 2011, WATER RES, V45, P6355, DOI 10.1016/j.watres.2011.09.016; Berney M, 2008, WATER RES, V42, P4010, DOI 10.1016/j.watres.2008.07.017; Velten S, 2011, WATER RES, V45, P6347, DOI 10.1016/j.watres.2011.09.017; Wang YY, 2009, ISME J, V3, P889, DOI 10.1038/ismej.2009.46; Troussellier M, 1999, FEMS MICROBIOL ECOL, V29, P319, DOI 10.1111/j.1574-6941.1999.tb00623.x; Virto R, 2005, APPL ENVIRON MICROB, V71, P5022, DOI 10.1128/AEM.71.9.5022-5028.2005; Lebaron P, 2001, APPL ENVIRON MICROB, V67, P1775, DOI 10.1128/AEM.67.4.1775-1782.2001; Vital M, 2012, WATER RES, V46, P4665, DOI 10.1016/j.watres.2012.06.010; Yapsakli K, 2010, PROCESS BIOCHEM, V45, P355, DOI 10.1016/j.procbio.2009.10.005; Lin T, 2010, J ENVIRON SCI-CHINA, V22, P681, DOI 10.1016/S1001-0742(09)60163-7; van der Wielen PWJJ, 2010, WATER RES, V44, P4860, DOI 10.1016/j.watres.2010.07.016; Hammes F, 2008, WATER RES, V42, P269, DOI 10.1016/j.watres.2007.07.009; Servais P, 2003, AQUAT MICROB ECOL, V33, P41, DOI 10.3354/ame033041; JWWA, 2001, STAND METH EX WAT; Miltner R.J., 1995, J AM WATER WORKS ASS, V90, P71	30	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1359-5113	1873-3298		PROCESS BIOCHEM	Process Biochem.	OCT	2015	50	10					1640	1647		10.1016/j.procbio.2015.06.012		8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Engineering, Chemical	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Engineering	CS0TP	WOS:000361775400020		
J	Fonseca, JGD; Oozeki, T; Ohtake, H; Takashima, T; Ogimoto, K				Fonseca, Joao Gari da Silva, Jr.; Oozeki, Takashi; Ohtake, Hideaki; Takashima, Takumi; Ogimoto, Kazuhiko			Regional forecasts of photovoltaic power generation according to different data availability scenarios: a study of four methods	PROGRESS IN PHOTOVOLTAICS			English	Article						photovoltaic systems; regional power generation; support vector regression; stratified sampling; principal component analysis	SUPPORT VECTOR REGRESSION; JAPAN; MODEL	The development of methods to forecast photovoltaic (PV) power generation regionally is of utmost importance to support the spread of such power systems in current power grids. The objective of this study is to propose and to evaluate methods to forecast regional PV power 1 day ahead of time and to compare their performances. Four forecast methods were regarded, of which two are new ones proposed in this study. Together, they characterize a set of forecast methods that can be applied in different scenarios regarding availability of data and infrastructure to make the forecasts. The forecast methods were based on the use of support vector regression and weather prediction data. Evaluations were performed for 1 year of hourly forecasts using data of 273 PV systems installed in two adjacent regions in Japan, Kanto, and Chubu. The results show the importance of selecting the proper forecast method regarding the region characteristics. For Chubu, the region with a variety of weather conditions, the forecast methods based on single systems' forecasts and the one based on stratified sampling provided the best results. In this case, the best annual normalized root mean square error (RMSE) and mean absolute error (MAE) were 0.25 and 0.15 kWh/kWh(avg), respectively. For Kanto, with homogeneous weather conditions, the four methods performed similarly. In this case, the lowest annual forecast errors were 0.33 kWh/kWh(avg) for the normalized RMSE and 0.202 kWh/kWh(avg) for the normalized MAE. Copyright (C) 2014 John Wiley & Sons, Ltd.	[Fonseca, Joao Gari da Silva, Jr.; Oozeki, Takashi; Ohtake, Hideaki; Takashima, Takumi] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Ogimoto, Kazuhiko] Univ Tokyo, Collaborat Res Ctr Energy Engn CEE, IIS, Tokyo 1538505, Japan	Fonseca, JGD (reprint author), Natl Inst Adv Ind Sci & Technol, AIST Tsukuba Cent 2, Tsukuba, Ibaraki 3058568, Japan.	jon-fonseca@aist.go.jp			New Energy and Industrial Development Organization, Japan; Japan Science and Technology Agency (CREST)	This work was supported by the New Energy and Industrial Development Organization, Japan, in the project Research and Development of PV Performance and Reliability Characterization Technologies, and by the Japan Science and Technology Agency (CREST).	PEREZ R, 1990, SOL ENERGY, V44, P271, DOI 10.1016/0038-092X(90)90055-H; Cao JC, 2008, ENG APPL ARTIF INTEL, V21, P1255, DOI 10.1016/j.engappai.2008.02.003; Willmott CJ, 2005, CLIMATE RES, V30, P79, DOI 10.3354/cr030079; Bacher P, 2009, SOL ENERGY, V83, P1772, DOI 10.1016/j.solener.2009.05.016; Chang CC, 2002, NEURAL COMPUT, V14, P1959, DOI 10.1162/089976602760128081; Pedro HTC, 2012, SOL ENERGY, V86, P2017, DOI 10.1016/j.solener.2012.04.004; Fonseca JGD, 2012, PROG PHOTOVOLTAICS, V20, P874, DOI 10.1002/pip.1152; Fonseca JGDS, 2014, RENEW ENERG, V68, P403, DOI 10.1016/j.renene.2014.02.018; Saito K, 2006, MON WEATHER REV, V134, P1266, DOI 10.1175/MWR3120.1; Chow SKH, 2012, ENERG BUILDINGS, V55, P660, DOI 10.1016/j.enbuild.2012.08.011; Bofinger S, 2006, P 21 EUR PHOT SOL EN; Bracale A, P INT C REN EN POW Q; ERBS DG, 1982, SOL ENERGY, V28, P293, DOI 10.1016/0038-092X(82)90302-4; Fernandez-Jimenez LA, 2012, RENEW ENERG, V44, P311, DOI 10.1016/j.renene.2012.01.108; Fonseca Jr JGS, 2013, P 12 INT C SUST EN T, P2074; Fonseca Jr JGS, 2014, IEEJ T POWER ENERGY, V134, P537; Fonseca Junior J. G. S., 2013, J INT COUNC ELECT EN, V3, P121; Haykin SO, 2008, NEURAL NETWORKS LEAR; Iqbal M, 1984, INTRO SOLAR RAD; Lorenz E, 2008, P 23 EUR PHOT SOL EN, P3285; Lorenz E, 2010, PROGR PHOTOVOLTAICS, V19, P757, DOI [10.1002/pip.1033, DOI 10.1002/PIP.1033]; Marquez R, 2011, ASME 2011 5 INT C EN, P1459; Meti J., 2013, STATE NEW INSTALLATI; Nelson PR, 2003, INTRO STAT ENG EXPT; Paulescu M, 2012, WEATHER MODELING FOR; Pelland S., 2011, PROG PHOTOVOLTAICS, V22, P284; Scholkopf B., 1998, P 8 INT C ART NEUR N, P111; Takahashi M, 2012, P INT C EL ENG 2012, P176; US Energy Information Administration (EIA), TOD IN EN; Vapnik V, 1999, NATURE STAT LEARNING; Yona A, 2008, IEEE POW EN SOC GEN, P1, DOI DOI 10.1109/PES.2008.4596295	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1062-7995	1099-159X		PROG PHOTOVOLTAICS	Prog. Photovoltaics	OCT	2015	23	10					1203	1218		10.1002/pip.2528		16	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	CS3XI	WOS:000362008600001		
J	Tellez, H; Druce, J; Hall, A; Ishihara, T; Kilner, J; Rockett, A				Tellez, Helena; Druce, John; Hall, Allen; Ishihara, Tatsumi; Kilner, John; Rockett, Angus			Low energy ion scattering: surface preparation and analysis of Cu(In,Ga)Se-2 for photovoltaic applications	PROGRESS IN PHOTOVOLTAICS			English	Article						chalcopyrites; low energy ion scattering; surface chemistry; epitaxial films	CUINSE2	Cu(In,Ga)Se-2 (CIGS) single-crystal epitaxial films have been analyzed by low energy ion scattering, which is sensitive to exactly the outermost surface atomic layer, to determine the surface chemistry as a function of preparation conditions. The samples were grown by a hybrid sputtering and evaporation method on cation (A) or anion (B) terminated (111) GaAs substrates and had smooth surfaces. The samples were exposed to excited atomic oxygen or hydrogen beams or were sputtered with 500 eV Ar+ ions. Atomic O* treatment resulted in an otherwise clean, oxidized surface including all film constituents. Atomic H* resulted in strong enhancement of the surface Ga population, probably due to a preexisting Ga native oxide in the outermost atomic layer. Sputtering produced a clean surface that was closest to the bulk composition of the film as measured by energy-dispersive spectroscopy. Copyright (C) 2014 John Wiley & Sons, Ltd.	[Tellez, Helena; Druce, John; Ishihara, Tatsumi; Kilner, John] Kyushu Univ, Int Inst Carbon Neutral Energy Res Wpi I2 CNER, Fukuoka 8190395, Japan; [Tellez, Helena; Kilner, John] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England; [Hall, Allen; Rockett, Angus] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA	Rockett, A (reprint author), Univ Illinois, Dept Mat Sci & Engn, 1304 W Green St, Urbana, IL 61801 USA.	arockett@illinois.edu		Tellez Lozano, Helena/0000-0001-7516-4227	International Institute for Carbon Neutral Energy Research (wpi-I2CNER) - World Premier International Research Center Initiative (WPI), MEXT, Japan; Marie-Curie Intra-European fellowship [PIEF-GA-2010-274999]; US National Science Foundation [DMR 13-12539]	H.T., J.D., J.K., T.I., and A.R. gratefully acknowledge the support of the International Institute for Carbon Neutral Energy Research (wpi-I2CNER), sponsored by the World Premier International Research Center Initiative (WPI), MEXT, Japan. Additionally, H.T. was also funded by a Marie-Curie Intra-European fellowship (PIEF-GA-2010-274999). A.R. gratefully acknowledges the support of the US National Science Foundation under project DMR 13-12539. The samples were grown by D. Liao during his time as a member of the Rockett group, which is much appreciated.	Liao DX, 2003, J APPL PHYS, V93, P9380, DOI 10.1063/1.1570500; Liao DX, 2003, APPL PHYS LETT, V82, P2829, DOI 10.1063/1.1570516; Brongersma HH, 2007, SURF SCI REP, V62, P63, DOI 10.1016/j.surfrep.2006.12.002; SCHMID D, 1993, J APPL PHYS, V73, P2902, DOI 10.1063/1.353020; Jansen WPA, 2004, SURF INTERFACE ANAL, V36, P1469, DOI 10.1002/sia.1921; Tellez H, 2014, J ANAL ATOM SPECTROM, V29, P1361, DOI 10.1039/c3ja50292a; Green MA, 2014, PROG PHOTOVOLTAICS, V22, P1, DOI 10.1002/pip.2452; de Ridder M, 2002, SURF INTERFACE ANAL, V33, P309, DOI 10.1002/sia.1196; Brongersma HH, 2012, CHARACTERIZATION MAT, P2024; Elson AJ, 1990, PHYS REV B, V42, P7518; Emery K., 2014, BEST RECORD CELL EFF; Krum S., 2014, 1 SOLAR SETS THIN FI; Liao D, NANOCHEMISTRY UNPUB; Liao D, 2008, J APPL PHYS, V104; Mauch RH, 1991, 22 IEEE PHOT SPEC C; Rockett A, 1988, 20 IEEE PHOT SPEC C; Weinhardt L, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1861958; Ziegler J. F., 1985, STOPPING RANGE IONS, V1	18	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1062-7995	1099-159X		PROG PHOTOVOLTAICS	Prog. Photovoltaics	OCT	2015	23	10					1219	1227		10.1002/pip.2535		9	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	CS3XI	WOS:000362008600002		
J	Kurtz, S; Muller, M; Jordan, D; Ghosal, K; Fisher, B; Verlinden, P; Hashimoto, J; Riley, D				Kurtz, Sarah; Muller, Matthew; Jordan, Dirk; Ghosal, Kanchan; Fisher, Brent; Verlinden, Pierre; Hashimoto, Jun; Riley, Daniel			Key parameters in determining energy generated by CPV modules	PROGRESS IN PHOTOVOLTAICS			English	Article						energy yield; concentrator PV; performance ratio; acceptance angle; energy rating	SINGLE-JUNCTION; PERFORMANCE; CELLS	We identify the key inputs and measurement data needed for accurate energy rating of concentrator photovoltaic (CPV) modules based on field observations of multiple CPV modules. Acceptance angle is shown to correlate with the observed module-level performance ratio (PR) for the modules studied. Using power ratings based on concentrator standard test conditions, PRs between 90% and 95% were observed during the summers with up to similar to 10% lower PRs during the winters. A module fabricated by Semprius showed 94% +/- 0.7% PR over almost 2 years with seasonal variation in PR of less than 1% showing how a module with relatively large acceptance angle may show very consistent average efficiency (calculated from the energy generated relative to the energy available), potentially simplifying energy ratings. The application of the results for translation of energy rating from one location to another is discussed, concluding that most of the translation differences may be correlated with temperature differences between sites with the largest variation happening when optical efficiency depends on temperature. Copyright (C) 2014 John Wiley & Sons, Ltd.	[Kurtz, Sarah; Muller, Matthew; Jordan, Dirk] Natl Renewable Energy Lab, Golden, CO 80401 USA; [Ghosal, Kanchan; Fisher, Brent] Semprius, Durham, NC USA; [Verlinden, Pierre] Trina Solar, State Key Lab PV Sci & Technol, Changzhou, Peoples R China; [Hashimoto, Jun] Natl Inst Adv Ind Sci & Technol, Fukushima Renewable Energy Inst, Fukushima, Japan; [Riley, Daniel] Sandia Natl Labs, Photovolta & Distributed Syst Dept, Albuquerque, NM 87185 USA	Kurtz, S (reprint author), Natl Renewable Energy Lab, Golden, CO 80401 USA.	sarah.kurtz@nrel.gov			US Department of Energy [DE-AC36-99GO10337]	The authors wish to thank J. Rodriguez for his technical assistance with the tracker and data collection and T. Silverman, M. Deceglie, and J. Wohlgemuth for their useful comments on the manuscript. This work was completed under contract no. DE-AC36-99GO10337 with the US Department of Energy.	Muller M, 2010, AIP CONF PROC, V1277, P307, DOI [10.1063/1.3509218, 10.4067/S0718-71812010000100022]; KURTZ SR, 1991, SOL CELLS, V30, P501, DOI 10.1016/0379-6787(91)90081-Y; [Anonymous], 2012, 618532CDV IEC CENTR; [Anonymous], 2012, 618533 IEC CENTR OFF; Ghosal K, 2014, IEEE J PHOTOVOLT, V4, P703, DOI 10.1109/JPHOTOV.2013.2288026; FAINE P, 1991, SOL CELLS, V31, P259, DOI 10.1016/0379-6787(91)90027-M; Friedman DJ, 2013, IEEE J PHOTOVOLT, V3, P1429, DOI 10.1109/JPHOTOV.2013.2275189; De Soto W, 2006, SOL ENERGY, V80, P78, DOI 10.1016/j.solener.2005.06.010; Peharz G, 2011, SOL ENERG MAT SOL C, V95, P2734, DOI 10.1016/j.solmat.2011.03.030; [Anonymous], 2011, 618531 IEC CENTR OFF; Rodrigo P, 2013, RENEW SUST ENERG REV, V26, P752, DOI 10.1016/j.rser.2013.06.019; [Anonymous], 1998, 61724 IEC; Araki K, 2003, 3 WORLD C PHOT EN CO, P307; Brown A. S., 2002, 29 IEEE PHOT SPEC C, P868; Kenny RP, 2003, PROCEEDINGS OF 3RD WORLD CONFERENCE ON PHOTOVOLTAIC ENERGY CONVERSION, VOLS A-C, P2015, DOI 10.1109/WCPEC.2003.248764; King D., 2004, PHOTOVOLTAIC ARRAY P; Kroposki B, 1994, P 24 IEEE PHOT SPEC, P858; Muller M, 2014, TRANSLATING IN PRESS; Steiner M, 2015, PROG PHOTOVOLTAICS, V23, P385, DOI 10.1002/pip.2458; Verlinden PJ, 2008, P 33 IEEE PHOT SPEC, P1, DOI [10.1109/pvsc.2008.4922912, DOI 10.1109/PVSC.2008.4922912]; Vivar M, 2008, PHOT SPEC C 2008 PVS, P1, DOI 10.1109/pvsc.2008.4922915	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1062-7995	1099-159X		PROG PHOTOVOLTAICS	Prog. Photovoltaics	OCT	2015	23	10					1250	1259		10.1002/pip.2544		10	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	CS3XI	WOS:000362008600005		
J	Kobayashi, T; Yamaguchi, H; Kao, ZJL; Sugimoto, H; Kato, T; Hakuma, H; Nakada, T				Kobayashi, Taizo; Yamaguchi, Hiroshi; Kao, Zacharie Jehl Li; Sugimoto, Hiroki; Kato, Takuya; Hakuma, Hideki; Nakada, Tokio			Impacts of surface sulfurization on Cu(In1-x,Ga-x)Se-2 thin-film solar cells	PROGRESS IN PHOTOVOLTAICS			English	Article						Cu(InGa)Se-2; surface sulfurization; thin film solar cell; admittance spectroscopy	CU(IN,GA)SE-2; PERFORMANCE	In this work, the impacts of surface sulfurization of high-quality Cu(In1-x,Ga-x)Se-2 (CIGS) thin films deposited by three-stage process on the film properties and the cell performance were investigated. The CIGS thin films were sulfurized at 550 degrees C for 30 min using H2S gas. The X-ray photoelectron spectroscopy analysis revealed that sulfur atoms diffused into the CIGS surface layer and that the valence band minimum was lowered by the film sulfurization. The open circuit voltage (V-oc) drastically increased from 0.590 to 0.674V as a result of the sulfurization process. Temperature-dependent current-voltage and capacitance-frequency measurements also revealed that interface recombination was drastically decreased by the lowering of the defect's activation energy level at the vicinity of the buffer/CIGS interface after the sulfurization. Copyright (C) 2014 John Wiley & Sons, Ltd.	[Kobayashi, Taizo; Yamaguchi, Hiroshi; Kao, Zacharie Jehl Li; Nakada, Tokio] Tokyo Univ Sci, Photovolta Sci & Technol Res Div, Res Inst Sci & Technol, Sagamihara, Kanagawa 2520131, Japan; [Sugimoto, Hiroki; Kato, Takuya; Hakuma, Hideki] Showa Shell Sekiyu KK, Atsugi, Kanagawa 2430206, Japan	Kobayashi, T (reprint author), Tokyo Univ Sci, Photovolta Sci & Technol Res Div, Res Inst Sci & Technol, SIC-2-206,5-4-30 Nishihashimoto, Sagamihara, Kanagawa 2520131, Japan.	t.koba.t1977@gmail.com			NEDO as a "Development of Next-generation High-Performance Technology for Photovoltaic Power Generation System" project	This work was supported in part by the NEDO as a "Development of Next-generation High-Performance Technology for Photovoltaic Power Generation System" project.	Serhan J, 2011, THIN SOLID FILMS, V519, P7312, DOI 10.1016/j.tsf.2011.01.095; Zhang SB, 1998, PHYS REV B, V57, P9642, DOI 10.1103/PhysRevB.57.9642; Keranen J, 2001, THIN SOLID FILMS, V387, P80, DOI 10.1016/S0040-6090(01)00789-1; Knecht R, 2013, PHYS STATUS SOLIDI A, V210, P1392, DOI 10.1002/pssa.201228705; Hanna G, 2001, THIN SOLID FILMS, V387, P71, DOI 10.1016/S0040-6090(00)01710-7; Ohashi D, 2001, SOL ENERG MAT SOL C, V67, P261, DOI 10.1016/S0927-0248(00)00290-7; [Anonymous], 2012, P 38 IEEE PHOT SPEC; Kobayashi T, 2013, IEEE J PHOTOVOLT, V3, P1079, DOI 10.1109/JPHOTOV.2013.2249556; Walter T, 1996, J APPL PHYS, V80, P4411, DOI 10.1063/1.363401; Chang SH, 2011, ENERG ENVIRON SCI, V4, P4929, DOI 10.1039/c1ee02341a; Nakada T, 1997, SOL ENERG MAT SOL C, V49, P285, DOI 10.1016/S0927-0248(97)00054-8; Rau U, 1998, SOLID STATE COMMUN, V107, P59, DOI 10.1016/S0038-1098(98)00154-9; Turcu M, 2002, J APPL PHYS, V91, P1391, DOI 10.1063/1.1432126; GABOR AM, 1994, APPL PHYS LETT, V65, P198, DOI 10.1063/1.112670; Kobayashi T, 2013, SOL ENERG MAT SOL C, V119, P129, DOI 10.1016/j.solmat.2013.05.052; [Anonymous], 2013, P 39 IEEE PHOT SPEC; Hamakawa Y., 2003, THIN FILM SOLAR CELL, V93; Jehl Z, 2013, 23 PVSEC 3 O 10 TAIP, V3-O-10; Kobayashi T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FA03; Kobayashi T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NC09; Kushiya K., 1996, P 25 IEEE PHOT SPEC, P989; Nakada T, 2012, P 29 IEEE PHOT SPEC, P527; Schock H.W., 2011, CHALCOGENIDE PHOTOVO; Umeno Y, 2003, PROCEEDINGS OF 3RD WORLD CONFERENCE ON PHOTOVOLTAIC ENERGY CONVERSION, VOLS A-C, P380; Yatsushiro Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NC25	25	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1062-7995	1099-159X		PROG PHOTOVOLTAICS	Prog. Photovoltaics	OCT	2015	23	10					1367	1374		10.1002/pip.2554		8	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	CS3XI	WOS:000362008600017		
J	Ohno, H; Petz, D				Ohno, Hiromichi; Petz, Denes			Examples of conditional SIC-POVMs	QUANTUM INFORMATION PROCESSING			English	Article						Quantum state tomography; SIC-POVM; Conditional SIC-POVM	COMPLETE QUANTUM MEASUREMENTS; STATE DETERMINATION; TIGHT FRAMES; EXISTENCE; GEOMETRY; THEOREM	The state of a quantum system is a density matrix with several parameters. The concern herein is how to recover the parameters. Several possibilities exist for the optimal recovery method, and we consider some special cases. We assume that a few parameters are known and that the others are to be recovered. The optimal positive-operator-valued measure (POVM) for recovering unknown parameters with an additional condition is called a conditional symmetric informationally complete POVM (SIC-POVM). In this paper, we study the existence or nonexistence of conditional SIC-POVMs. We provide a necessary condition for existence and some examples.	[Ohno, Hiromichi] Shinshu Univ, Fac Engn, Dept Math, Nagano 3808553, Japan; [Petz, Denes] Budapest Univ Technol & Econ, Dept Anal, H-1111 Budapest, Hungary	Ohno, H (reprint author), Shinshu Univ, Fac Engn, Dept Math, 4-17-1 Wakasato, Nagano 3808553, Japan.	h_ohno@shinshu-u.ac.jp; petz@math.bme.hu			Hungarian Research Grant [OTKA K104206]; JSPS KAKENHI [25800061]	This work was partially supported by the Hungarian Research Grant OTKA K104206 and JSPS KAKENHI Grant No. 25800061.	Zauner G, 2011, INT J QUANTUM INF, V9, P445, DOI 10.1142/S0219749911006776; Petz D, 2014, IEEE T INFORM THEORY, V60, P351, DOI 10.1109/TIT.2013.2285152; Scott AJ, 2006, J PHYS A-MATH GEN, V39, P13507, DOI 10.1088/0305-4470/39/43/009; Holmes RB, 2004, LINEAR ALGEBRA APPL, V377, P31, DOI 10.1016/j.laa.2003.07.012; Appleby DM, 2011, FOUND PHYS, V41, P564, DOI 10.1007/s10701-010-9458-7; Strohmer T, 2003, APPL COMPUT HARMON A, V14, P257, DOI 10.1016/S1063-5203(03)00023-X; Tropp JA, 2005, IEEE T INFORM THEORY, V51, P188, DOI 10.1109/TIT.2004.839492; VANLINT JH, 1966, K NED AKAD VAN WET A, V69, P335; WOOTTERS WK, 1989, ANN PHYS-NEW YORK, V191, P363, DOI 10.1016/0003-4916(89)90322-9; Singer J, 1938, T AM MATH SOC, V43, P377, DOI 10.2307/1990067; Colin S, 2005, J OPT B-QUANTUM S O, V7, pS778, DOI 10.1088/1464-4266/7/12/051; WELCH LR, 1974, IEEE T INFORM THEORY, V20, P397, DOI 10.1109/TIT.1974.1055219; Parthasarathy KR, 2005, ANN I H POINCARE-PR, V41, P257, DOI 10.1016/j.anihpb.2003.10.009; Ohno H, 2010, J MATH PHYS, V51, DOI 10.1063/1.3481567; Flammia ST, 2006, J PHYS A-MATH GEN, V39, P13483, DOI 10.1088/0305-4470/39/43/007; Appleby DM, 2009, AIP CONF PROC, V1101, P223, DOI 10.1063/1.3109944; IVANOVIC ID, 1981, J PHYS A-MATH GEN, V14, P3241; Bandyopadhyay S, 2002, ALGORITHMICA, V34, P512, DOI 10.1007/s00453-002-0980-7; Scott AJ, 2010, J MATH PHYS, V51, DOI 10.1063/1.3374022; Zhu HJ, 2010, J PHYS A-MATH THEOR, V43, DOI 10.1088/1751-8113/43/30/305305; Petz D, 2012, REP MATH PHYS, V69, P161, DOI 10.1016/S0034-4877(12)60023-8; KUMMERER B, 1987, COMMUN MATH PHYS, V109, P1, DOI 10.1007/BF01205670; Sustik MA, 2007, LINEAR ALGEBRA APPL, V426, P619, DOI 10.1016/j.laa.2007.05.043; Gordon D. M., 1994, ELECTRON J COMB, V1, pR6; Haagerup U, 2011, COMMUN MATH PHYS, V303, P555, DOI 10.1007/s00220-011-1216-y; Klappenecker A., 2005, 2005 IEEE INT S INF, V1, P1740; Kummerer B., 1986, CONSTRUCTION STRUCTU; LANDAU LJ, 1993, LINEAR ALGEBRA APPL, V193, P107, DOI 10.1016/0024-3795(93)90274-R; Paris M. G. A., 2004, QUANTUM STATE ESTIMA; Rehacek J, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.052321; Renes JM, 2004, J MATH PHYS, V45, P2171, DOI 10.1063/1.1737053; Scott AJ, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/5/055308; Zauner G., 1999, THESIS U VIENNA	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1570-0755	1573-1332		QUANTUM INF PROCESS	Quantum Inf. Process.	OCT	2015	14	10					3983	3999		10.1007/s11128-015-1085-y		17	Physics, Multidisciplinary; Physics, Mathematical	Physics	CS1JJ	WOS:000361820000025		
J	Parrish, NF; Fujino, K; Shiromoto, Y; Iwasaki, YW; Ha, H; Xing, JC; Makino, A; Kuramochi-Miyagawa, S; Nakano, T; Siomi, H; Honda, T; Tomonaga, K				Parrish, Nicholas F.; Fujino, Kan; Shiromoto, Yusuke; Iwasaki, Yuka W.; Ha, Hongseok; Xing, Jinchuan; Makino, Akiko; Kuramochi-Miyagawa, Satomi; Nakano, Toru; Siomi, Haruhiko; Honda, Tomoyuki; Tomonaga, Keizo			piRNAs derived from ancient viral processed pseudogenes as transgenerational sequence-specific immune memory in mammals	RNA			English	Article						endogenous viral elements; retrotransposon; piRNA; CRISPR/Cas; paleovirology	BORNA-DISEASE-VIRUS; PIWI-INTERACTING RNAS; PROVIDES ACQUIRED-RESISTANCE; HORIZONTAL GENE-TRANSFER; DROSOPHILA-MELANOGASTER; MOUSE TESTES; HUMAN GENOME; VERTICAL TRANSMISSION; MESSENGER-RNAS; MOSQUITO CELLS	Endogenous bornavirus-like nucleoprotein elements (EBLNs) are sequences within vertebrate genomes derived from reverse transcription and integration of ancient bornaviral nucleoprotein mRNA via the host retrotransposon machinery. While species with EBLNs appear relatively resistant to bornaviral disease, the nature of this association is unclear. We hypothesized that EBLNs could give rise to antiviral interfering RNA in the form of PIWI-interacting RNAs (piRNAs), a class of small RNA known to silence transposons but not exogenous viruses. We found that in both rodents and primates, which acquired their EBLNs independently some 25-40 million years ago, EBLNs are present within piRNA-generating regions of the genome far more often than expected by chance alone (P = 8 x 10(-3) -6 x 10(-8)). Three of the seven human EBLNs fall within annotated piRNA clusters and two marmoset EBLNs give rise to bona fide piRNAs. In both rats and mice, at least two of the five EBLNs give rise to abundant piRNAs in the male gonad. While no EBLNs are syntenic between rodent and primate, some of the piRNA clusters containing EBLNs are; thus we deduce that EBLNs were integrated into existing piRNA clusters. All true piRNAs derived from EBLNs are antisense relative to the proposed ancient bornaviral nucleoprotein mRNA. These observations are consistent with a role for EBLN-derived piRNA-like RNAs in interfering with ancient bornaviral infection. They raise the hypothesis that retrotransposon-dependent virus-to-host gene flow could engender RNA-mediated, sequence-specific antiviral immune memory in metazoans analogous to the CRISPR/Cas system in prokaryotes.	[Parrish, Nicholas F.; Fujino, Kan; Makino, Akiko; Honda, Tomoyuki; Tomonaga, Keizo] Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Kyoto 6068507, Japan; [Shiromoto, Yusuke; Kuramochi-Miyagawa, Satomi; Nakano, Toru] Osaka Univ, Sch Med, Dept Pathol, Osaka 5650871, Japan; [Shiromoto, Yusuke; Kuramochi-Miyagawa, Satomi; Nakano, Toru] Osaka Univ, Grad Sch Frontier Biosci, Osaka 5650871, Japan; [Iwasaki, Yuka W.; Siomi, Haruhiko] Keio Univ, Sch Med, Dept Mol Biol, Tokyo 1608582, Japan; [Ha, Hongseok; Xing, Jinchuan] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; [Makino, Akiko] Kyoto Univ, Inst Virus Res, Ctr Emerging Virus Res, Kyoto 6068507, Japan; [Honda, Tomoyuki; Tomonaga, Keizo] Kyoto Univ, Grad Sch Med, Dept Tumor Viruses, Kyoto 6068507, Japan; [Tomonaga, Keizo] Kyoto Univ, Grad Sch Biostudies, Dept Mammalian Regulatory Network, Kyoto 6068507, Japan	Parrish, NF (reprint author), Vanderbilt Univ, Sch Med, Sect Surg Sci, Nashville, TN 37232 USA.	nicholas.parrish@vanderbilt.edu; tomonaga@virus.kyoto-u.ac.jp	Siomi, Haruhiko/A-7020-2015; 	Siomi, Haruhiko/0000-0001-8690-3822; Xing, Jinchuan/0000-0001-6469-8733	Japan Society for the Promotion of Science short-term postdoctoral fellowship [PE13075]; Funding Program for Next Generation World-Leading Researchers (NEXT program), KAKENHI [26253027, 26670225]; Core-to-Core Program A, Advanced Research Networks from the Japan Society for the Promotion of Science (JSPS); Takeda Science Foundation; KAKENHI grant from the Ministry of Education, Culture, Science, Sports and Technology (MEXT) of Japan [25115508, 25860336]	We thank Masayuki Horie, Cedric Feschotte, Craig B. Wilen, Bryan R. Cullen, Alexei A. Aravin, Andrew Z. Fire, Rafi Ahmed, Arnold J. Levine, Sara Cherry, and P. Jeremy Wang for helpful discussions and/or comments on the manuscript. N.F.P. thanks Bruce R. Levin for encouraging a hunt for a mammalian CRISPR-like immune system. N.F.P. was supported by the Japan Society for the Promotion of Science short-term postdoctoral fellowship award #PE13075. This study was supported in part by Funding Program for Next Generation World-Leading Researchers (NEXT program), KAKENHI grant numbers 26253027 and 26670225, and the Core-to-Core Program A, Advanced Research Networks from the Japan Society for the Promotion of Science (JSPS) (K.T.); grants from Takeda Science Foundation (K.T.); and KAKENHI grant numbers 25115508 and 25860336 from the Ministry of Education, Culture, Science, Sports and Technology (MEXT) of Japan (T.H.).	Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911; An WF, 2006, P NATL ACAD SCI USA, V103, P18662, DOI 10.1073/pnas.0605300103; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307; HAINAUT P, 1990, CANCER RES, V50, P3754; Yu QJ, 2015, J BIOL CHEM, V290, P10191, DOI 10.1074/jbc.M114.612374; Liu HQ, 2010, J VIROL, V84, P11876, DOI 10.1128/JVI.00955-10; Esnault C, 2000, NAT GENET, V24, P363; Upton KR, 2015, CELL, V161, P228, DOI 10.1016/j.cell.2015.03.026; Martin A, 2011, P NATL ACAD SCI USA, V108, P7206, DOI 10.1073/pnas.1016759108; Schnettler E, 2013, J GEN VIROL, V94, P1680, DOI 10.1099/vir.0.053850-0; Beyret E, 2012, CELL RES, V22, P1429, DOI 10.1038/cr.2012.120; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Kawaoka S, 2013, NUCLEIC ACIDS RES, V41, P1581, DOI 10.1093/nar/gks1275; Kreit M, 2014, J VIROL, V88, P3874, DOI 10.1128/JVI.03018-13; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Pittoggi C, 2006, MOL REPROD DEV, V73, P1239, DOI 10.1002/mrd.20550; Geib T, 2003, J VIROL, V77, P4283, DOI 10.1128/JVI.77.7.4283-4290.2003; Kapoor A, 2010, J VIROL, V84, P12628, DOI 10.1128/JVI.01732-10; Matsumoto Y, 2012, CELL HOST MICROBE, V11, P492, DOI 10.1016/j.chom.2012.04.009; Horie M, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0499; Aswad A, 2012, TRENDS ECOL EVOL, V27, P627, DOI 10.1016/j.tree.2012.07.007; Yan Z, 2011, NUCLEIC ACIDS RES, V39, P6596, DOI 10.1093/nar/gkr298; IKEDA H, 1983, VIROLOGY, V128, P127, DOI 10.1016/0042-6822(83)90324-0; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003; Cichocki F, 2010, J IMMUNOL, V185, P2009, DOI 10.4049/jimmunol.1000855; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Tomonaga K, 2002, MICROBES INFECT, V4, P491, DOI 10.1016/S1286-4579(02)01564-2; Maori E, 2007, VIROLOGY, V362, P342, DOI 10.1016/j.virol.2006.11.038; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Assis R, 2009, P NATL ACAD SCI USA, V106, P7079, DOI 10.1073/pnas.0900523106; PRUDHOMME N, 1995, GENETICS, V139, P697; Lee EJ, 2011, RNA, V17, P1090, DOI 10.1261/rna.2565011; Okamoto M, 2003, ARCH VIROL, V148, P1557, DOI 10.1007/s00705-003-0120-y; Marchetto MCN, 2013, NATURE, V503, P525, DOI 10.1038/nature12686; Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695; Khurana JS, 2011, CELL, V147, P1551, DOI 10.1016/j.cell.2011.11.042; Satie AP, 2011, J BIOL CHEM, V286, P23280, DOI 10.1074/jbc.M111.229120; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x; Ishizu H, 2012, GENE DEV, V26, P2361, DOI 10.1101/gad.203786.112; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Fujino K, 2014, P NATL ACAD SCI USA, V111, P13175, DOI 10.1073/pnas.1407046111; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Vourekas A, 2015, GENE DEV, V29, P617, DOI 10.1101/gad.254631.114; Lin CC, 2013, CELL MOL LIFE SCI, V70, P4399, DOI 10.1007/s00018-013-1402-5; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Kobayashi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024403; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Kirino Y, 2007, NAT STRUCT MOL BIOL, V14, P347, DOI 10.1038/nsmb1218; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Goic B, 2013, NAT IMMUNOL, V14, P396, DOI 10.1038/ni.2542; Siomi MC, 2009, CURR OPIN CELL BIOL, V21, P426, DOI 10.1016/j.ceb.2009.02.003; Ballinger MJ, 2012, MOL PHYLOGENET EVOL, V65, P251, DOI 10.1016/j.ympev.2012.06.008; Abyzov A, 2013, GENOME RES, V23, P2042, DOI 10.1101/gr.154625.113; Li XZG, 2013, MOL CELL, V50, P67, DOI 10.1016/j.molcel.2013.02.016; Lukic S, 2011, MOL BIOL EVOL, V28, P3061, DOI 10.1093/molbev/msr141; ZHDANOV VM, 1975, NATURE, V256, P471, DOI 10.1038/256471a0; Rechavi O, 2011, CELL, V147, P1248, DOI 10.1016/j.cell.2011.10.042; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Kerski A, 2012, AVIAN DIS, V56, P471, DOI 10.1637/9879-080511-Reg.1; Ackermann A, 2010, J VIROL, V84, P5438, DOI 10.1128/JVI.00098-10; Reuter M, 2011, NATURE, V480, P264, DOI 10.1038/nature10672; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Wang XJ, 2010, J BIOL CHEM, V285, P14346, DOI 10.1074/jbc.M110.109314; Yamamoto Y, 2013, GENOME RES, V23, P292, DOI 10.1101/gr.137224.112; Hirano T, 2014, RNA, V20, P1223, DOI 10.1261/rna.045310.114; Sharma AK, 2001, BLOOD, V97, P426, DOI 10.1182/blood.V97.2.426; Leger P, 2013, J VIROL, V87, P1631, DOI 10.1128/JVI.02795-12; Mura M, 2004, P NATL ACAD SCI USA, V101, P11117, DOI 10.1073/pnas.0402877101; Arensburger P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-606; Belyi VA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001030; Berry C, 2006, PLOS COMPUT BIOL, V2, P1450, DOI 10.1371/journal.pcbi.0020157; Cooke SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4644; CRICK F H, 1958, Symp Soc Exp Biol, V12, P138; Cullen BR, 2014, J VIROL, V88, P12934, DOI 10.1128/JVI.01179-14; Cullen BR, 2013, CELL HOST MICROBE, V14, P374, DOI 10.1016/j.chom.2013.09.011; Gilbert C., 2010, PLOS BIOL, V8; Guo XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093972; Ha H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-545; Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu HQ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-276; Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470; Ortogero N, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.613232; Pare JM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003865; Sagy Or, 2014, Frontiers in Genetics, V5, P275, DOI 10.3389/fgene.2014.00275; Shimizu A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05074; Tubio JMC, 2014, SCIENCE, V345, P531, DOI 10.1126/science.1251343; Wang W, 2014, MOL CELL, V56, P708, DOI 10.1016/j.molcel.2014.10.016; Watanabe T, 2015, GENOME RES, V25, P368, DOI 10.1101/gr.180802.114; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Yap MW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003968; Zeng M, 2014, SCIENCE, V346, P1486, DOI [10.1126/science.346.6216.1486, 10.1126/science.1257780]; Zhang P, 2015, CELL RES, V25, P193, DOI 10.1038/cr.2015.4	102	0	0	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1355-8382	1469-9001		RNA	RNA	OCT	2015	21	10					1691	1703		10.1261/rna.052092.115		13	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CR7US	WOS:000361557600001		
J	Komeda, J; Watanabe, K				Komeda, Jiryo; Watanabe, Kenta			On extensions of a double covering of plane curves and Weierstrass semigroups of the double covering type	SEMIGROUP FORUM			English	Article						Weierstrass semigroups; Double coverings of curves Weierstrass gap	POINTS	Let C be a smooth plane curve of degree d, P be a point on C, and let p : (C) over tilde -> C be a double covering of the curve C with the branch point P. In this paper, we give a best possible sufficient condition for the double covering pi to extend to a double covering (pi) over tilde : X -> P-2 branched along a reduced divisor of degree six which intersects transversally the curve C at smooth 6d points containing P.	[Komeda, Jiryo] Kanagawa Inst Technol, Dept Math, Atsugi, Kanagawa 2430292, Japan; [Watanabe, Kenta] Osaka Univ, Dept Math Sci, Toyonaka, Osaka 5600043, Japan	Komeda, J (reprint author), Kanagawa Inst Technol, Dept Math, 1030 Shimo Ogino, Atsugi, Kanagawa 2430292, Japan.	komeda@gen.kanagawa-it.ac.jp; goo314kenta@mail.goo.ne.jp			Japan Society for the Promotion Science [24540057, 25400039]	The authors would like to thank Dr. Takeshi Harui and Prof. Akira Ohbuchi for useful discussions about this subject. The first author is partially supported by Grant-in-Aid for Scientific Research (24540057), Japan Society for the Promotion Science. The second author is partially supported by Grant-in-Aid for Scientific Research (25400039), Japan Society for the Promotion Science.	Kang E, 2007, B KOREAN MATH SOC, V44, P369; Watanabe K, 2013, SEMIGROUP FORUM, V86, P395, DOI 10.1007/s00233-012-9464-5; Komeda J, 2011, SEMIGROUP FORUM, V83, P479, DOI 10.1007/s00233-011-9331-9; TORRES F, 1994, MANUSCRIPTA MATH, V83, P39, DOI 10.1007/BF02567599; Oliveira G., 2008, SEMIGROUP FORUM, V77, P77	5	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0037-1912	1432-2137		SEMIGROUP FORUM	Semigr. Forum	OCT	2015	91	2					517	523		10.1007/s00233-015-9718-0		7	Mathematics	Mathematics	CS1MU	WOS:000361831000015		
J	Bauer, RA; Kelemen, L; Nakano, M; Totsuka, A; Zrinyi, M				Bauer, Rita A.; Kelemen, Lorand; Nakano, Masami; Totsuka, Atsushi; Zrinyi, Miklos			Fabrication and electrorotation of a novel epoxy based micromotor working in a uniform DC electric field	SMART MATERIALS AND STRUCTURES			English	Article						micro-electromechanical systems (MEMS); micro-electromotor; electro-rotation; Quincke rotation		We have presented the first direct observation of electric field induced rotation of epoxy based polymer rotors. Polymer disks, hollow cylinders and gears were prepared in few micrometer dimensions as rotors. Electrorotation of these sub-millimeter sized tools was studied under uniform dc electric field. The effects of shape, size and thickness were investigated. The novel epoxy based micro devices show intensive spinning in a uniform dc electric field. The rotational speed of micron-sized polymer rotors can be conveniently tuned in a wide range (between 300 and 3000 rpm) by the electric field intensity, opening new perspectives for their use in several MEMS applications.	[Bauer, Rita A.; Zrinyi, Miklos] Semmelweis Univ, Dept Biophys & Radiat Biol, H-1089 Budapest, Hungary; [Kelemen, Lorand] Hungarian Acad Sci, Biol Res Ctr, H-6726 Szeged, Hungary; [Nakano, Masami; Totsuka, Atsushi] Tohoku Univ, Inst Fluid Sci, Intelligent Fluid Control Syst Lab, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Zrinyi, Miklos] Semmelweis Univ, Dept Biophys & Radiat Biol, MTA SE Mol Biophys Res Grp, H-1089 Budapest, Hungary	Bauer, RA (reprint author), Semmelweis Univ, Dept Biophys & Radiat Biol, Nagyvarad Ter 4, H-1089 Budapest, Hungary.	mikloszrinyi@gmail.com			JSPS [26630084]; Institute of Fluid Science, Tohoku University; Hungarian Science Foundation [OTKA: K 115259, NN 102624]	This research was partially supported by the JSPS Grant-in-Aid for Challenging Exploratory Research: Grant No. 26630084, 2014-2015; the Collaborative Research Project of Institute of Fluid Science, Tohoku University and Hungarian Science Foundation OTKA: K 115259, NN 102624.	Ghalichechian N, 2008, J MICROELECTROMECH S, V17, P632, DOI 10.1109/JMEMS.2008.916346; Zrinyi M, 2011, COLLOID SURFACE A, V382, P192, DOI 10.1016/j.colsurfa.2011.01.047; Peters F, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3134046; Antal M, 2007, COMPOS SCI TECHNOL, V67, P2884, DOI 10.1016/j.compscitech.2007.03.027; Fan L S, 1988, P IEEE INT EL DEV M, P666; Feynman R., 1993, Journal of Microelectromechanical Systems, V2, DOI 10.1109/84.232589; Jones T. B., 1995, ELECTROMECHANICS PAR; Loget G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1550; Nicolaescu M A, 2007, 6 INT C EL POW SYST, P421; Quincke G., 1896, ANN PHYS CHEM, V295, P417; Turcu I J, 1987, PHYSICA A, V20, P3301; Vinhais H F, 2006, ABCM S SERIES MECHAT, V2, P433; Zrinyi M, 2012, SMART MATER STRUCT, V21, P1	13	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0964-1726	1361-665X		SMART MATER STRUCT	Smart Mater. Struct.	OCT	2015	24	10							105010	10.1088/0964-1726/24/10/105010		5	Instruments & Instrumentation; Materials Science, Multidisciplinary	Instruments & Instrumentation; Materials Science	CS1OT	WOS:000361836800010		
J	Short, G; Hirose, K; Kondo, M; Minematsu, N				Short, Greg; Hirose, Keikichi; Kondo, Mariko; Minematsu, Nobuaki			Automatic recognition of Japanese vowel length accounting for speaking rate and motivated by perception analysis	SPEECH COMMUNICATION			English	Article						Vowel length; Automatic recognition; Perception; Duration; Resynthesis; Stimulus continua		Automatic recognition of vowel length in Japanese has several applications in speech processing such as for computer assisted language learning (CALL) systems. Standard automatic speech recognition (ASR) systems make use of hidden Markov models (HMMs) to carry out the recognition. However, HMMs are not particularly well-suited for this problem since classification of vowel length is dependent on prosodic information, and since it is a relative feature affected by changes in the durations of surrounding sounds which vary in part due to changes in speaking rates. That being said, it is not obvious how to design an algorithm to account for these contextual dependencies, since there is still not enough known about how humans perceive the contrast. Therefore, in this paper, we conduct perceptual experiments to further understand the mechanism of human vowel length recognition. In our research, we found that the perceptual boundary is largely affected by the vowels two prior, one prior, and following the vowel for which the length is being recognized. Based on these results and the works of others, we propose an algorithm which does post-processing on alignments output by HMMs to automatically recognize vowel length. The method is primarily composed of two levels of processing dealing first with local dependencies and then long-term dependencies. We test several variations of this algorithm. The method we develop is shown to have superior recognition capabilities and be robust against speaking rate differences producing significant improvements. We test this method on three different databases: a speaking rate database, a native database, and a non-native database. (C) 2015 Elsevier B.V. All rights reserved.	[Short, Greg; Kondo, Mariko] Waseda Univ, Tokyo, Japan; [Hirose, Keikichi; Minematsu, Nobuaki] Univ Tokyo, Tokyo, Japan	Short, G (reprint author), Waseda Univ, Tokyo, Japan.				Japanese Society for the Promotion of Science (JSPS) [26-04006]	This research was funded in part by the fellowship Grant-in-Aid for JSPS Fellows No. 26-04006 awarded by the Japanese Society for the Promotion of Science (JSPS) to the first author. We would like to express our gratitude toward them and the opportunities they have provided.	Matthews WJ, 2011, J EXP PSYCHOL HUMAN, V37, P303, DOI 10.1037/a0019961; Hirata Y, 2004, PHONETICA, V61, P177, DOI 10.1159/000084157; Hirata Y, 2005, J ACOUST SOC AM, V118, P1647, DOI 10.1121/1.2000807; Tsurutani C, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 3 AND 4, P1854; Behne D., 1999, P 14 INT C PHON SCI, V2, P857; Boersma Paul, 2012, PRAAT DOING PHONETIC; Chang C-C, 2011, ACM T INTEL SYST TEC, V2, P3, DOI DOI 10.1145/1961189.1961199; Dommelen W., 1993, J PHONETICS, V21, P367; Fujisaki H., 1977, ONSEI NO BUTSURITEKI, P63; Hirata Y., 2000, J PHONETICS, P565; Hirata Y., 2003, P 2003 TEX LING SOC; Ishi C. T., 2000, TECHNICAL REPORT IEI, V100, P17; Kawai G., 1999, THESIS, V1; Kinoshita K., 2002, P 7 ICSLP; Kozasa T., 2002, J ACOUST SOC AM, P23; Lee A., 2001, P EUR C SPEECH COMM, P1691; NII-SRC, JAP NEWSP ART SENT; Short G., 2012, NONNATIVE JAPANESE L; Short G., 2013, SLATE, P178; Takeyasu H., 2010, PHONOL STUD, P13; Takiguchi I., 2010, SPEECH PROSODY; Team J. D., 2014, JUL DICT KIT; Yamamoto M., 2000, COMPUTER ASSISTED LE, P1	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-6393	1872-7182		SPEECH COMMUN	Speech Commun.	OCT	2015	73						47	63		10.1016/j.specom.2015.07.001		17	Acoustics; Computer Science, Interdisciplinary Applications	Acoustics; Computer Science	CR8BM	WOS:000361576100004		
J	Akiyama, K; Sakai, T; Koyanagi, J; Yoshikawa, H; Sugamoto, K				Akiyama, Keisuke; Sakai, Takashi; Koyanagi, Junichiro; Yoshikawa, Hideki; Sugamoto, Kazuomi			Morphological analysis of the acetabular cartilage surface in elderly subjects	SURGICAL AND RADIOLOGIC ANATOMY			English	Article						Acetabulum; Cartilage; Morphology; 3D-digitizer	HUMAN HIP-JOINT; FEMOROACETABULAR IMPINGEMENT; CONTACT AREAS; THICKNESS; OSTEOARTHRITIS; OSTEOTOMY; SHAPE; CT	The geometry of acetabular cartilage surface plays an important role in hip joint biomechanics. The aim of this study was to analyze the morphology of acetabular articular cartilage surface in elderly donated bodies to science using a 3D-digitizer. Twenty hemipelves from 12 subjects (mean ages 85 years) were scanned with 3D-digitizer. Each acetabular surface model was divided into four regions: anterosuperior (AS), anteroinferior (AI), posterosuperior (PS), and posteroinferior (PI). In the global acetabulum and each region, the acetabular sphere radius and the standard deviation (SD) of the distance from the acetabular sphere center to the acetabular cartilage surface were calculated. In the global acetabulum, the distance between the acetabular surface model and the maximum sphere which did not penetrate over the acetabular surface model was calculated as the inferred femoral head, and then the distribution was mapped at intervals of 0.5 mm. The SD in AS was significantly larger than that in AI (p = 0.006) and PI (p = 0.001). The SD in PS was significantly larger than that in PI (p = 0.005). The closest region (0-0.5 mm) tended to be distributed at anterior or posterosuperior acetabular edge. The contact between the femoral head and acetabulum might start at the periphery of the lunate surface, especially in the anterior or posterosuperior region. From viewpoint of acetabular morphology, the acetabular articular cartilage in the anterior or posterosuperior edge could be more vulnerable due to direct contact mechanism.	[Akiyama, Keisuke] Sumitomo Hosp, Dept Orthopaed Surg, Kita Ku, Osaka 5300005, Japan; [Sakai, Takashi; Yoshikawa, Hideki] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka, Japan; [Koyanagi, Junichiro] Osaka Gen Med Ctr, Dept Orthopaed Surg, Osaka, Japan; [Sugamoto, Kazuomi] Osaka Univ, Grad Sch Med, Dept Orthopaed Biomat Sci, Suita, Osaka, Japan	Akiyama, K (reprint author), Sumitomo Hosp, Dept Orthopaed Surg, Kita Ku, 5-3-20 Nakanoshima, Osaka 5300005, Japan.	k.aki@hotmail.co.jp					Cobb J, 2010, CLIN ORTHOP RELAT R, V468, P2143, DOI 10.1007/s11999-010-1347-z; Gu DY, 2008, MED ENG PHYS, V30, P1024, DOI 10.1016/j.medengphy.2007.12.013; Botter SM, 2008, OSTEOARTHR CARTILAGE, V16, P506, DOI 10.1016/j.joca.2007.08.005; Notzli HP, 2002, J BONE JOINT SURG BR, V84B, P556, DOI 10.1302/0301-620X.84B4.12014; Sokovic M, 2006, J MATER PROCESS TECH, V175, P398, DOI 10.1016/j.jmatprotec.2005.04.047; Akiyama K, 2013, J ORTHOP RES, V31, P1611, DOI 10.1002/jor.22414; Moritomo H, 2000, J HAND SURG-AM, V25A, P520, DOI 10.1053/jhsu.2000.7381; BULLOUGH P, 1968, NATURE, V217, P1290, DOI 10.1038/2171290a0; Adam C, 1998, CLIN BIOMECH, V13, P1, DOI 10.1016/S0268-0033(97)85881-0; Ganz R, 2003, CLIN ORTHOP RELAT R, P112, DOI 10.1097/01.blo.0000096804.78689.c2; Bessho M, 2009, BONE, V45, P226, DOI 10.1016/j.bone.2009.04.241; Chung CY, 2010, OSTEOARTHR CARTILAGE, V18, P312, DOI 10.1016/j.joca.2009.11.004; NINOMIYA S, 1984, J BONE JOINT SURG AM, V66A, P430; AFOKE NYP, 1987, J BONE JOINT SURG BR, V69, P536; Su B, 2008, J EUR CERAM SOC, V28, P2109, DOI 10.1016/j.jeurceramsoc.2008.02.023; Eckstein F, 1997, ACTA ANAT, V158, P192; Nikou C, 2000, LECT NOTES COMPUT SC, V1935, P1188; KURRAT HJ, 1978, J ANAT, V126, P145; McCarthy JC, 2001, CLIN ORTHOP RELAT R, P25; Menschik F, 1997, J BIOMECH, V30, P971, DOI 10.1016/S0021-9290(97)00051-1; Naish JH, 2006, OSTEOARTHR CARTILAGE, V14, P967, DOI 10.1016/j.joca.2006.03.017; Akiyama K, 2010, OSTEOARTHR CARTILAGE, V18, P795, DOI 10.1016/j.joca.2010.03.007; Muller-Gerbl M, 1998, ADV ANAT EMBRYOL CEL, V141, p[III, 1]; PEMBERTO.PA, 1965, J BONE JOINT SURG AM, VA 47, P65; Sahara W, 2005, ACTA ORTHOP, V76, P392; vonEisenhartRothe R, 1997, ANAT EMBRYOL, V195, P279, DOI 10.1007/s004290050047; Wiberg G., 1939, ACTA CHIR SCAND    S, V58, P7; Zilber S, 2004, SURG RADIOL ANAT, V26, P462, DOI 10.1007/s00276-004-0254-y	28	0	0	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	0930-1038	1279-8517		SURG RADIOL ANAT	Surg. Radiol. Anat.	OCT	2015	37	8					963	968		10.1007/s00276-015-1427-6		6	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	CR8YM	WOS:000361640400010		
J	Uchino, A; Saito, N; Ikeda, S; Ishihara, S				Uchino, Akira; Saito, Naoko; Ikeda, Shunsuke; Ishihara, Shoichiro			Ophthalmic artery arising from the anterior cerebral artery diagnosed by MR angiography	SURGICAL AND RADIOLOGIC ANATOMY			English	Article						Anterior cerebral artery; Cerebral arterial variation; Magnetic resonance angiography; Ophthalmic artery	INTERNAL CAROTID-ARTERY; ANOMALOUS ORIGIN; ABNORMAL ORIGIN	Extremely rarely, the ophthalmic artery (OphA) arises from the A1 segment of the anterior cerebral artery (ACA). Discovery of this anomalous OphA during angiography or surgery has been reported in several patients. We report a case in which an OphA of ACA origin was diagnosed by magnetic resonance (MR) angiography and confirmed by selective cerebral angiography. To our knowledge, this is the first report of this variation with MR angiography. Careful observation of MR angiographic images is important for detecting rare arterial variations. Partial maximum-intensity-projection images are useful in identifying tiny anomalous arteries on MR angiography.	[Uchino, Akira; Saito, Naoko] Saitama Med Univ, Int Med Ctr, Dept Diagnost Radiol, Hidaka, Saitama 3501298, Japan; [Ikeda, Shunsuke; Ishihara, Shoichiro] Saitama Med Univ, Int Med Ctr, Dept Intravascular Neurosurg, Hidaka, Saitama 3501298, Japan	Uchino, A (reprint author), Saitama Med Univ, Int Med Ctr, Dept Diagnost Radiol, 1397-1 Yamane, Hidaka, Saitama 3501298, Japan.	auchino@saitama-med.ac.jp					Li YH, 2011, NEUROL MED-CHIR, V51, P579; Uchino A, 2013, SURG RADIOL ANAT, V35, P173, DOI 10.1007/s00276-012-1005-0; LASJAUNIAS P, 1977, NEURORADIOLOGY, V13, P215; Sade B, 2004, AM J NEURORADIOL, V25, P1730; HAMADA J, 1991, J NEUROSURG, V74, P287, DOI 10.3171/jns.1991.74.2.0287; Uchino A, 2013, SURG RADIOL ANAT, V35, P775, DOI 10.1007/s00276-013-1085-5; ISLAK C, 1994, J NEURORADIOLOGY, V21, P46; Hannequin P, 2013, SURG RADIOL ANAT, V35, P269, DOI 10.1007/s00276-012-1028-6; Naeini RM, 2005, AM J ROENTGENOL, V184, P571; Indo M, 2014, J NEUROSURG, V120, P93, DOI 10.3171/2013.9.JNS131030; Komiyama M, 2009, INTERV NEURORADIOL, V15, P363; HASSLER W, 1989, NEURORADIOLOGY, V31, P85; MERCIER P, 1989, SURG RADIOL ANAT, V11, P73, DOI 10.1007/BF02102250; Padget Dorcas Hager, 1948, CONTRIBUTIONS TO EMBRYOLOGY [CARNEGIE INST OF WASHINGTON PUBL], V32, P205	14	0	0	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	0930-1038	1279-8517		SURG RADIOL ANAT	Surg. Radiol. Anat.	OCT	2015	37	8					1009	1012		10.1007/s00276-015-1441-8		4	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	CR8YM	WOS:000361640400018		
J	Shintani, Y; Inoue, M; Funaki, S; Kawamura, T; Minami, M; Okumura, M				Shintani, Yasushi; Inoue, Masayoshi; Funaki, Soichiro; Kawamura, Tomohiro; Minami, Masato; Okumura, Meinoshin			Clinical usefulness of free subcutaneous fat pad for reduction of intraoperative air leakage during thoracoscopic pulmonary resection in lung cancer cases	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Thoracoscopy; Lung cancer; Air leak; Subcutaneous fat pad	LOBECTOMY; SURGERY	Introduction Intraoperative alveolar air leaks remain a significant problem in thoracoscopic surgery (TS) cases. We examined the usefulness of covering damaged lung tissue with a subcutaneous fat pad for preventing postoperative air leakage in patients with non-small cell lung cancer (NSCLC). Methods Patients with NSCLC underwent a thoracoscopic lobectomy or segmentectomy. When alveolar air leakage from the superficial pulmonary parenchyma was found, fibrin glue in combination with an absorbable mesh sheet was applied (S group; n = 100). When leakage originated from deep within the pulmonary parenchyma, a subcutaneous fat pad about 2 x 2 cm in size was harvested from the utility incision and placed on the damaged lung tissue with fibrin glue and sutures (F group; n = 66). Patient characteristics, air leak duration, and chest-tube removal time were analyzed. Results The homogeneity of each group was consistent, with no statistical differences for age, respiratory function, surgical procedures, pathologic stage, and histological type. The air leak duration was significantly shorter (p = 0.015), and the chest tube was removed significantly earlier (p = 0.002) in patients in the F group. Conclusion Use of a free subcutaneous fat pad during pulmonary resection for TS patients with NSCLC reduced the duration of air leakage and chest tube drainage. The present method is easy, safe, and effective for repairing an air leak from remaining lung tissues in such cases.	[Shintani, Yasushi; Inoue, Masayoshi; Funaki, Soichiro; Kawamura, Tomohiro; Minami, Masato; Okumura, Meinoshin] Osaka Univ, Grad Sch Med, Dept Gen Thorac Surg, Suita, Osaka 5650871, Japan	Shintani, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Gen Thorac Surg, 2-2-L5 Yamadaoka, Suita, Osaka 5650871, Japan.	yshintani@thoracic.med.osaka-u.ac.jp					Anegg Udo, 2008, Interact Cardiovasc Thorac Surg, V7, P292; Brunelli A, 2010, ANN THORAC SURG, V90, P204, DOI 10.1016/j.athoracsur.2010.02.054; Yamamoto K, 2010, ANN THORAC SURG, V89, P353, DOI 10.1016/j.athoracsur.2009.10.034; Filosso PL, 2013, INTERACT CARDIOV TH, V16, P661, DOI 10.1093/icvts/ivs571; Ueda K, 2010, J THORAC CARDIOV SUR, V139, P600, DOI 10.1016/j.jtcvs.2009.06.021; Shintani Y, 2014, EUR J CARDIO-THORAC, V46, P324, DOI 10.1093/ejcts/ezt608; Shrager Joseph B, 2009, Thorac Surg Clin, V19, P223, DOI 10.1016/j.thorsurg.2009.02.004	7	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	OCT	2015	29	10					2910	2913		10.1007/s00464-014-4019-3		4	Surgery	Surgery	CS1EN	WOS:000361805500007		
J	Osera, S; Yano, T; Odagaki, T; Oono, Y; Ikematsu, H; Ohtsu, A; Kaneko, K				Osera, Shozo; Yano, Tomonori; Odagaki, Tomoyuki; Oono, Yasuhiro; Ikematsu, Hiroaki; Ohtsu, Atsushi; Kaneko, Kazuhiro			Peritonitis related to percutaneous endoscopic gastrostomy using the direct method for cancer patients	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Peritonitis; Percutaneous endoscopic gastrostomy; Direct method	NECK-CANCER; TUBE PLACEMENT; HEAD; COMPLICATIONS; RISK	Background Percutaneous endoscopic gastrostomy (PEG) using the direct method is generally indicated for cancer patients. However, there are little available data about peritonitis related to this method. The aim of this retrospective analysis was to assess peritonitis related to PEG using the direct method in patients with cancer. Methods We assessed the prevalence of peritonitis and the relationship between peritonitis and patients' backgrounds, as well as the clinical course after peritonitis. Results Between December 2008 and December 2011, peritonitis was found in 9 (2.1 %) of 421 patients. Of the 9 patients with peritonitis, 4 had received PEG prior to chemoradiotherapy. Emergency surgical drainage was required in 1 patient, and the remaining 8 recovered with conservative treatment. Peritonitis occurred within 8 days of PEG for 8 of the 9 patients and occurred within 2 days of suture removal for 4 of the 9 patients. Conclusions Peritonitis related to PEG using the direct method was less frequent for cancer patients. Peritonitis tended to occur within a few days after removal of securing suture and in patients with palliative stage.	[Osera, Shozo; Yano, Tomonori; Odagaki, Tomoyuki; Oono, Yasuhiro; Ikematsu, Hiroaki; Kaneko, Kazuhiro] Natl Canc Ctr Hosp East, Endoscopy Div, Dept Gastroenterol & GI Oncol, Kashiwa, Chiba 2778577, Japan; [Osera, Shozo; Ohtsu, Atsushi] Juntendo Univ, Grad Sch Med, Tokyo, Japan	Yano, T (reprint author), Natl Canc Ctr Hosp East, Endoscopy Div, Dept Gastroenterol & GI Oncol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	shou0122@hotmail.com; toyano@east.ncc.go.jp					Cruz I, 2005, GASTROINTEST ENDOSC, V62, P708, DOI 10.1016/j.gie.2005.06.041; Foster JM, 2007, SURG ENDOSC, V21, P897, DOI 10.1007/s00464-006-9068-9; Richter-Schrag HJ, 2011, CAN J GASTROENTEROL, V25, P201; Hiki N, 2008, J AM COLL SURGEONS, V207, P737, DOI 10.1016/j.jamcollsurg.2008.06.335; BASSETT MR, 1983, OTOLARYNG HEAD NECK, V91, P119; GAUDERER MWL, 1980, J PEDIATR SURG, V15, P872, DOI 10.1016/S0022-3468(80)80296-X; Locher JL, 2011, JPEN-PARENTER ENTER, V35, P365, DOI 10.1177/0148607110377097; Horiuchi A, 2008, ENDOSCOPY, V40, P722, DOI 10.1055/s-2008-1077490; Beer KT, 2005, NUTR CANCER, V52, P29, DOI 10.1207/s15327914nc5201_4; Yagishita A, 2012, EUR J GASTROEN HEPAT, V24, P77, DOI 10.1097/MEG.0b013e32834dfd67; Faias S, 2006, ENDOSCOPY, V38, P745, DOI 10.1055/s-2006-925239; Inoue N, 2005, HOME HLTH CARE ENDOS, V9, P79; Richards DM, 2012, DIGEST DIS SCI, V58, P768; vanBokhorstdevanderSchueren MAE, 1997, HEAD NECK-J SCI SPEC, V19, P419, DOI 10.1002/(SICI)1097-0347(199708)19:5<419::AID-HED9>3.0.CO;2-2	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	OCT	2015	29	10					2941	2946		10.1007/s00464-014-4026-4		6	Surgery	Surgery	CS1EN	WOS:000361805500012		
J	Kishida, Y; Kakushima, N; Kawata, N; Tanaka, M; Takizawa, K; Imai, K; Hotta, K; Matsubayashi, H; Ono, H				Kishida, Yoshihiro; Kakushima, Naomi; Kawata, Noboru; Tanaka, Masaki; Takizawa, Kohei; Imai, Kenichiro; Hotta, Kinichi; Matsubayashi, Hiroyuki; Ono, Hiroyuki			Complications of endoscopic dilation for esophageal stenosis after endoscopic submucosal dissection of superficial esophageal cancer	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Esophageal stenosis; Endoscopic submucosal dissection; Endoscopic dilation	MUCOSAL RESECTION; BALLOON DILATION; STRICTURE; DILATATION; NEOPLASMS; RISK	Background Endoscopic dilation (ED) is used for the treatment of benign strictures caused by reflux esophagitis or anastomotic stenosis after esophagectomy. Esophageal stenosis is a major complication after endoscopic submucosal dissection (ESD) of large superficial esophageal cancer, but little is known regarding the incidence of complications of ED for stenosis caused by esophageal ESD. Methods This was a retrospective study conducted at a single institution. From September 2002 to December 2012, a total of 1,337 ED procedures were performed for stenosis after esophageal ESD in 121 patients. The incidence of complications of ED and related clinical characteristics were analyzed. Results The incidence of bleeding was 0.8 % (1/121) per patient and 0.07 % (1/1,337) per procedure. The incidence of perforation was 4.1 % (5/121) per patient and 0.37 % (5/1,337) per procedure. Perforation occurred at a median of third time of ED procedures (range 2-9 procedures) and at a median of 18 days (range 8-29 days) after ESD. There were no significant characteristics correlated to perforation, such as location, circumferential extent, or diameter of mucosal defect after ESD. The total number of ED procedures was significantly larger among perforation cases (37, range 6-57) compared with those without perforation (7, range 1-70) (p = 0.01), and the treatment duration tended to be longer (190 vs. 69 days, respectively). Conclusions The incidence of bleeding caused by ED for esophageal stenosis after ESD was very low. Relevant risk of perforation should be considered for patients requiring multiple ED procedures.	[Kishida, Yoshihiro; Kakushima, Naomi; Kawata, Noboru; Tanaka, Masaki; Takizawa, Kohei; Imai, Kenichiro; Hotta, Kinichi; Matsubayashi, Hiroyuki; Ono, Hiroyuki] Shizuoka Canc Ctr, Div Endoscopy, Nagaizumi, Shizuoka 4118777, Japan	Kishida, Y (reprint author), Shizuoka Canc Ctr, Div Endoscopy, 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan.	y.kishida@scchr.jp; kakushin-tky@umin.ac.jp					[Anonymous], 2010, GASTROINTEST ENDOSC, DOI [DOI 10.1016/J.GIE.2010.02.040, DOI 10.1016/J.GIE.2010.02.040]]; Boustiere C, 2011, ENDOSCOPY, V43, P445, DOI 10.1055/s-0030-1256317; Coda S, 2009, ENDOSCOPY, V41, P421, DOI 10.1055/s-0029-1214642; Piotet E, 2008, EUR ARCH OTO-RHINO-L, V265, P357, DOI 10.1007/s00405-007-0456-0; Jacobs JW, 2010, DIGEST DIS SCI, V55, P1512, DOI 10.1007/s10620-010-1165-x; Ono S, 2009, ENDOSCOPY, V41, P661, DOI 10.1055/s-0029-1214867; Yoda Y, 2012, SURG ENDOSC, V26, P2877, DOI 10.1007/s00464-012-2273-9; Ezoe Y, 2011, J CLIN GASTROENTEROL, V45, P222, DOI 10.1097/MCG.0b013e3181f39f4e; Tsunada S, 2008, GASTROINTEST ENDOSC, V67, P979, DOI 10.1016/j.gie.2007.12.023; Katada C, 2003, GASTROINTEST ENDOSC, V57, P165, DOI 10.1067/mge.2003.73; Hanaoka N, 2012, ENDOSCOPY, V44, P1007, DOI 10.1055/s-0032-1310107; Mizuta H, 2009, DIS ESOPHAGUS, V22, P626, DOI 10.1111/j.1442-2050.2009.00954.x; Pereira-Lima JC, 1999, AM J GASTROENTEROL, V94, P1497; Anderson MA, 2009, GASTROINTEST ENDOSC, V70, P1060, DOI 10.1016/j.gie.2009.09.040; Veitch AM, 2008, GUT, V57, P1322, DOI 10.1136/gut.2007.142497; Kakushima N, 2008, WORLD J GASTROENTERO, V14, P2962, DOI 10.3748/wjg.14.2962; Kakushima N, 2006, ENDOSCOPY, V38, P412, DOI 10.1055/s-2006-925166; Takahashi H, 2011, ENDOSCOPY, V43, P184, DOI 10.1055/s-0030-1256109; Fujimoto K, 2014, DIGEST ENDOSC, V26, P1, DOI 10.1111/den.12183; Honda M, 2010, ENDOSCOPY, V42, P1092, DOI 10.1055/s-0030-1255741; Wong VWY, 2010, SURG LAPARO ENDO PER, V20, pE25, DOI 10.1097/SLE.0b013e3181c922a7; Kakushima N, 2013, UNITED EUR GASTROENT, V1, P184, DOI 10.1177/2050640613490288; Ota M, 2010, ESOPHAGUS-TOKYO, V7, P101, DOI 10.1007/s10388-010-0236-6	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	OCT	2015	29	10					2953	2959		10.1007/s00464-014-4028-2		7	Surgery	Surgery	CS1EN	WOS:000361805500014		
J	Ishii, K; Kaneko, Y; Funao, H; Ishihara, S; Shinohara, A; Nakanishi, K; Hikata, T; Fujita, N; Iwanami, A; Hosogane, N; Watanabe, K; Nagura, T; Nakamura, M; Toyama, Y; Matsumoto, M				Ishii, Ken; Kaneko, Yasuhito; Funao, Haruki; Ishihara, Shinichi; Shinohara, Akira; Nakanishi, Kazuo; Hikata, Tomohiro; Fujita, Nobuyuki; Iwanami, Akio; Hosogane, Naobumi; Watanabe, Kota; Nagura, Takeo; Nakamura, Masaya; Toyama, Yoshiaki; Matsumoto, Morio			A Novel Percutaneous Guide Wire (S-Wire) for Percutaneous Pedicle Screw Insertion: Its Development, Efficacy, and Safety	SURGICAL INNOVATION			English	Article						Image-guided surgery; spine surgery; neurosurgery	LUMBAR INTERBODY FUSION; STABILIZATION; MANAGEMENT	Purpose. Minimally invasive spine stabilization (MISt) procedures, including MIS-transforaminal lumbar interbody fusion (MIS-TLIF), rely on precise placement of percutaneous pedicle screws (PPS). Serious intraoperative complications associated with PPS placement include great vessel and bowel injuries due to the guide-wire's anterior migration and penetration through the anterior aspect of the vertebral body. To address this issue, we developed a novel percutaneous guide wire (S-wire) and compared the biomechanical characteristics of S-wire and conventional wire in cadaveric spines, and to evaluate the S-wire's efficacy and safety in a clinical trial. Methods. The S-wire is hollow, with braided wires extending at one tip. We compared the push-out and penetration forces of the S-wire and conventional wire in fresh cadaveric lumbar spines, from L1 to L5. Results. Push-out forces caused the braided tip of the S-wire to bend or spread, and thus to resist anterior migration. The mean push-out forces for the S-wire and conventional wire were 15.5 +/- 1.9 and 5.7 +/- 0.8 N, respectively (P < .0001); the mean penetration forces were 69.1 +/- 4.2 and 37.1 +/- 4.8 N, respectively (P < .0005). There was no wire breakage or anterior-wall penetration in a clinical trial of 922 S-wires; interestingly, the pull-out force increased in 780 (84.6%) S-wires after placement. Conclusions. The mean push-out and penetration forces for the S-wire were approximately 3 and 2 times greater than those of conventional wire, respectively. The S-wire effectively prevented guide-wire anterior migration and penetration of the anterior vertebral-body wall. The S-wire device should effectively improve the safety of MISt procedures, including MIS-TLIF and percutaneous kyphoplasty in selected patient with osteoporosis.	[Ishii, Ken; Ishihara, Shinichi; Hikata, Tomohiro; Fujita, Nobuyuki; Iwanami, Akio; Hosogane, Naobumi; Watanabe, Kota; Nagura, Takeo; Nakamura, Masaya; Toyama, Yoshiaki; Matsumoto, Morio] Keio Univ, Tokyo 1608582, Japan; [Ishii, Ken; Kaneko, Yasuhito; Funao, Haruki; Ishihara, Shinichi; Shinohara, Akira; Nakanishi, Kazuo; Hikata, Tomohiro; Fujita, Nobuyuki; Iwanami, Akio; Hosogane, Naobumi] Soc Minimally Invas Spine Stabilizat, Nagoya, Aichi, Japan; [Kaneko, Yasuhito] Kawasaki Municipal Kawasaki Hosp, Kawasaki, Kanagawa, Japan; [Funao, Haruki] Nerima Gen Hosp, Tokyo, Japan; [Funao, Haruki] Johns Hopkins Univ, Baltimore, MD USA; [Shinohara, Akira] Jikei Univ, Kashiwa Hosp, Chiba, Japan; [Nakanishi, Kazuo] Kawasaki Med Univ, Okayama, Japan	Ishii, K (reprint author), Keio Univ, Dept Orthopaed Surg, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	keni8888@z7.keio.jp					Bhatt AD, 2013, CANCER TREAT REV, V39, P142, DOI 10.1016/j.ctrv.2012.08.002; Raley DA, 2012, SPINE, V37, P1092, DOI 10.1097/BRS.0b013e31823c80d8; German JW, 2005, SPINE, V30, pS52, DOI 10.1097/01.brs.0000174501.53285.9d; HARMS J, 1982, Z ORTHOP GRENZGEB, V120, P343, DOI 10.1055/s-2008-1051624; Park Y, 2007, SPINE, V32, P537, DOI 10.1097/01.brs.0000256473.49791.f4; CLOWARD RB, 1953, AM J SURG, V86, P145, DOI 10.1016/0002-9610(53)90421-8; KAPILA S, 1989, AM J ORTHOD DENTOFAC, V96, P100, DOI 10.1016/0889-5406(89)90251-5; Foley KT, 2003, SPINE, V28, pS26, DOI 10.1097/00007632-200308011-00006; CLOWARD RB, 1953, J NEUROSURG, V10, P154, DOI 10.3171/jns.1953.10.2.0154; Foley Kevin T, 2002, Clin Neurosurg, V49, P499; Ishii K, 2012, MB ORTHOP, V25, P33; Ishii K, 2011, SPINE SPINAL CORD, V24, P623; Ishii K, 2012, BONE JOINT NERVE, V2, P361; Khoo LT, 2002, NEUROSURGERY, V51, pS166, DOI 10.1227/01.NEU.0000031068.83783.7B; Logroscino CA, 2009, EUR SPINE J, V18, pS75, DOI 10.1007/s00586-009-0995-8; Mobbs RJ, 2014, J SPINAL DISORD TECH, V27, P390, DOI 10.1097/BSD.0b013e3182999380; Palmisani M, 2009, EUR SPINE J, V18, pS71, DOI 10.1007/s00586-009-0989-6	17	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1553-3506	1553-3514		SURG INNOV	Surg. Innov.	OCT	2015	22	5					469	473		10.1177/1553350614560271		5	Surgery	Surgery	CS0RE	WOS:000361769100003		
J	Nunokawa, S; Minamisawa, M; Nakano, K; Ichikawa, Y; Kotsuki, H				Nunokawa, Shiori; Minamisawa, Masamitsu; Nakano, Keiji; Ichikawa, Yoshiyasu; Kotsuki, Hiyoshizo			Asymmetric Michael Addition Reaction of alpha-Aryl-Substituted Lactams Catalyzed by Chiral Quaternary Ammonium Salts Derived from Cinchona Alkaloids: A New Short Synthesis of (+)-Mesembrine	SYNLETT			English	Article						asymmetric organocatalysis; lactams; Michael addition; cinchona alkaloids; mesembrine	ENANTIOSELECTIVE CONSTRUCTION; ALLYLIC ALKYLATION; STEREOSELECTIVE CONSTRUCTION; CARBON STEREOCENTERS; N-HETEROCYCLES; KETONES; (-)-MESEMBRINE; CYCLIZATIONS; OXINDOLES; CENTERS	The enantioselective Michael addition reaction of alpha-aryl-substituted lactams with electron-deficient olefins was efficiently catalyzed using chiral quaternary ammonium salts derived from cinchona alkaloids. This method was highly useful for the construction of an all-carbon-substituted quaternary carbon stereogenic center at the alpha-position of lactams in good to high yields and with good enantiomeric excess and could be applied to the short synthesis of (+)-mesembrine.	[Nunokawa, Shiori; Minamisawa, Masamitsu; Nakano, Keiji; Ichikawa, Yoshiyasu; Kotsuki, Hiyoshizo] Kochi Univ, Fac Sci, Lab Nat Prod Chem, Kochi 7808520, Japan	Kotsuki, H (reprint author), Kochi Univ, Fac Sci, Lab Nat Prod Chem, Akebono Cho, Kochi 7808520, Japan.	kotsuki@kochi-u.ac.jp			MEXT (Japan) [24105523, 26105743]	We thank Prof. Y. Fukuyama of Tokushima Bunri University for MS/HRMS measurements. The authors are also grateful to Ms. Megumi Kosaka and Mr. Motonari Kobayashi at the Division of Instrumental Analysis, Department of Instrumental Analysis & Cryogenics, Advanced Science Research Center, Okayama University for the elemental analyses. This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas 'Advanced Molecular Transformations by Organocatalysts' from the MEXT (Japan) (No. 24105523 & 26105743).	Christoffers J, 2005, ADV SYNTH CATAL, V347, P1473, DOI 10.1002/adsc.200505165; Poulsen TB, 2006, ANGEW CHEM INT EDIT, V45, P6551, DOI 10.1002/anie.200602275; Geoghegan K, 2013, J ORG CHEM, V78, P3410, DOI 10.1021/jo4000306; [Anonymous], 2007, EUR J ORG CHEM, DOI DOI 10.1002/EJOC.200700318; Steven A, 2007, ANGEW CHEM INT EDIT, V46, P5488, DOI 10.1002/anie.200700612; Nielsen M, 2011, CHEM COMMUN, V47, P632, DOI 10.1039/c0cc02417a; Klein JEMN, 2010, CHEM COMMUN, V46, P937, DOI 10.1039/b923175g; Ishii T, 2004, J AM CHEM SOC, V126, P9558, DOI 10.1021/ja046871g; Gu Q, 2011, CHEM SCI, V2, P1519, DOI 10.1039/c1sc00083g; Shibasaki M, 2007, ORG BIOMOL CHEM, V5, P2027, DOI 10.1039/b704542e; Yeboah EMO, 2011, TETRAHEDRON, V67, P1725, DOI 10.1016/j.tet.2010.12.050; Wang BM, 2011, ACCOUNTS CHEM RES, V44, P1207, DOI 10.1021/ar200082p; Dalpozzo R, 2012, CHEM SOC REV, V41, P7247, DOI 10.1039/c2cs35100e; Zhong FR, 2013, ANGEW CHEM INT EDIT, V52, P943, DOI 10.1002/anie.201208285; Das JP, 2011, CHEM COMMUN, V47, P4593, DOI 10.1039/c0cc05222a; Zhou F, 2010, ADV SYNTH CATAL, V352, P1381, DOI 10.1002/adsc.201000161; Guerard KC, 2009, J ORG CHEM, V74, P2039, DOI 10.1021/jo802728u; Brak K, 2013, ANGEW CHEM INT EDIT, V52, P534, DOI 10.1002/anie.201205449; Roe C, 2008, TETRAHEDRON LETT, V49, P650, DOI 10.1016/j.tetlet.2007.11.137; Riant O, 2007, ORG BIOMOL CHEM, V5, P873, DOI 10.1039/b617746h; Zhang HB, 2014, SYNLETT, V25, P1953, DOI 10.1055/s-0033-1338641; Behenna DC, 2012, NAT CHEM, V4, P130, DOI [10.1038/nchem.1222, 10.1038/NCHEM.1222]; Zhao YH, 2009, ORG LETT, V11, P555, DOI 10.1021/ol802608r; Ilardi EA, 2009, TETRAHEDRON, V65, P3261, DOI 10.1016/j.tet.2008.10.048; Numajiri Y, 2015, ORG LETT, V17, P1082, DOI [10.1021/ol503425t, 10.1021/ol.503425t]; Inokoishi Y, 2010, ORG LETT, V12, P1616, DOI 10.1021/ol100350w; Denmark SE, 2008, ANGEW CHEM INT EDIT, V47, P1560, DOI 10.1002/anie.200604943; Cheong PHY, 2011, CHEM REV, V111, P5042, DOI 10.1021/cr100212h; Mukherjee S, 2007, CHEM REV, V107, P5471, DOI 10.1021/cr0684016; Miyamae N, 2014, ORG BIOMOL CHEM, V12, P5847, DOI 10.1039/c4ob00733f; Repka LM, 2013, J ORG CHEM, V78, P12314, DOI 10.1021/jo4017953; Ishikawa T, 2008, J ORG CHEM, V73, P7498, DOI 10.1021/jo801316s; Shirakawa S, 2013, ANGEW CHEM INT EDIT, V52, P4312, DOI 10.1002/anie.201206835; Arns S, 2007, J ORG CHEM, V72, P9314, DOI 10.1021/jo701833v; Choy J, 2008, SYNTHETIC COMMUN, V38, P3840, DOI 10.1080/00397910802238718; Bella M, 2009, SYNTHESIS-STUTTGART, P1583, DOI 10.1055/s-0029-1216796; Christoffers J, 2005, QUATERNARY STEREOCENTERS: CHALLENGES AND SOLUTIONS FOR ORGANIC SYNTHESIS, P1, DOI 10.1002/3527606858; Das MK, 2015, ORG BIOMOL CHEM, V13, P3585, DOI 10.1039/c5ob00183h; Hong AY, 2013, EUR J ORG CHEM, P2745, DOI 10.1002/ejoc.201201761; Jew SS, 2009, CHEM COMMUN, P7090, DOI 10.1039/b914028j; Kotsuki H., 2013, NEW FUTURE DEV CATAL, P563; Liu YY, 2015, ACCOUNTS CHEM RES, V48, P740, DOI 10.1021/ar5004658; Marcelli T, 2010, SYNTHESIS-STUTTGART, P1229, DOI 10.1055/s-0029-1218699; Maruoka K, 2012, SCI SYNTHESIS ASYMME, V2, P499; Moritaka M, 2012, SYNLETT, P2554, DOI 10.1055/s-0032-1317317; Stephenson GR, 2012, EUR J ORG CHEM, P4716, DOI 10.1002/ejoc.201200687; Trost BM, 2006, SYNTHESIS-STUTTGART, P369, DOI 10.1055/s-2006-926302; Vicatio JL, 2010, RSC CATAL SER, P1	48	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	OCT	2015	26	16					2301	2305		10.1055/s-0035-1560090		5	Chemistry, Organic	Chemistry	CS1KO	WOS:000361823600025		
J	Kanai, M; Shimizu, Y; Morita, Y; Yamamoto, T; Nagai, H				Kanai, Motomu; Shimizu, Yohei; Morita, Yuya; Yamamoto, Tomohiro; Nagai, Hideoki			Chemoselective Boron-Catalyzed Nucleophilic Activation of Carboxylic Acids for Mannich-Type Reactions	SYNLETT			English	Editorial Material									[Kanai, Motomu] Osaka Univ, ISIR, Suita, Osaka 565, Japan; [Kanai, Motomu] Univ Wisconsin, Prof Laura L Kiesslings Lab, Madison, WI 53706 USA; [Kanai, Motomu] Univ Tokyo, Grad Sch Pharmaceut Sci, Prof Masakatsu Shibasakis Lab, Tokyo 1138654, Japan; [Yamamoto, Tomohiro; Nagai, Hideoki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1138654, Japan	Kanai, M (reprint author), Osaka Univ, ISIR, Suita, Osaka 565, Japan.							0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	OCT	2015	26	16					A140	A143				4	Chemistry, Organic	Chemistry	CS1KO	WOS:000361823600003		
J	Patil, NT				Patil, Nitin T.			Young Career Focus: Dr. Nitin T. Patil (CSIR - National Chemical Laboratory, India)	SYNLETT			English	Editorial Material							REACTIVITY; SCAFFOLDS; CASCADE		[Patil, Nitin T.] Univ Gottingen, Gottingen, Germany; [Patil, Nitin T.] Tohoku Univ, Sendai, Miyagi 980, Japan; [Patil, Nitin T.] Prof K C Nicolaous Chem Synth Lab Biopolis, Singapore, Singapore; [Patil, Nitin T.] Scripps Res Inst, La Jolla, CA USA; [Patil, Nitin T.] IICT, Hyderabad, Andhra Pradesh, India; [Patil, Nitin T.] CSIR, NCL, Pune, Maharashtra, India; [Patil, Nitin T.] Indian Acad Sci, Bangalore, Karnataka, India	Patil, NT (reprint author), Univ Gottingen, Gottingen, Germany.						Shinde VS, 2015, CHEM-EUR J, V21, P975, DOI 10.1002/chem.201405061; Patil NT, 2012, CHEM COMMUN, V48, P3094, DOI 10.1039/c2cc17450b; Patil NT, 2013, ANGEW CHEM INT EDIT, V52, P2251, DOI 10.1002/anie.201208738; Patil NT, 2013, CHEM COMMUN, V49, P570, DOI 10.1039/c2cc37623g; Patil NT, 2012, ORG BIOMOL CHEM, V10, P211, DOI 10.1039/c1ob06432k; Bagle PN, 2015, CHEM-EUR J, V21, P3580, DOI 10.1002/chem.201406045	6	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	OCT	2015	26	16					A146	A148				3	Chemistry, Organic	Chemistry	CS1KO	WOS:000361823600005		
J	Fukuta, J; Yamashita, J				Fukuta, Junya; Yamashita, Junko			Effects of cognitive demands on attention orientation in L2 oral production	SYSTEM			English	Article						Cognitive demands; Task complexity; Attention; L2 oral production; Limited-resource; Multiple-resource	TASK COMPLEXITY; RANDOM GENERATION; SPEECH PRODUCTION; LANGUAGE; PERFORMANCE; OUTPUT; CONSCIOUSNESS; INSTRUCTION; HYPOTHESIS; AWARENESS	In the field of second language (L2) acquisition research, the importance of attention to language form has been supported by many researchers. The Task is a critical concept in the field because its features affect 12 learners' attention orientation in L2 performance. This study explored the ways in which two types of cognitive demands (reasoning demand and dual-task demand) influenced the occurrence and orientation of attention in L2 oral production. This was done by analyzing performance scores (accuracy, complexity, and fluency) and verbal protocols (indicators of attention to lexis, syntax, and phonology). The limited-resource model and the multiple-resource model provided theoretical frameworks for this study. The reasoning demand increased accuracy scores, but the dual-task demand did not. Both types of task demands reduced fluency scores, but no effects were found on complexity scores. The verbal protocol analysis suggested that task demands inhibited learners' attention to syntactic encoding. Overall, the results support the limited-resource model, at least in the monologic task condition employed in this study, leading to the suggestion that task demands may need to be eased to help direct learners' attention to linguistic form and thus enhance L2 acquisition. (C) 2015 Elsevier Ltd. All rights reserved.	[Fukuta, Junya; Yamashita, Junko] Nagoya Univ, Chikusa Ku, Nagoya, Aichi 4548601, Japan	Fukuta, J (reprint author), 102 67-1 Takamine Cho, Nagoya, Aichi 4548601, Japan.	fukuta@nagoya-u.jp			Japan Society for Promotion of Science [13J00724]	This research was supported in part by a Grant-in-Aid for Fellows of the Japan Society for the Promotion of Science (13J00724). An earlier version of this paper was presented at the AILA 2014 World Congress. We are thankful to Masatoshi Sugiura, Toru Kinoshita, Ryu Ito, and Shunji Inagaki for their insightful comments. Of course, we are responsible for any remaining errors.	Foster P, 2000, APPL LINGUIST, V21, P354, DOI 10.1093/applin/21.3.354; Izumi S, 2000, TESOL QUART, V34, P239, DOI 10.2307/3587952; Tavakoli P, 2008, LANG LEARN, V58, P439, DOI 10.1111/j.1467-9922.2008.00446.x; Kim Y, 2012, STUD SECOND LANG ACQ, V34, P627, DOI 10.1017/S0272263112000368; Hama M, 2010, STUD SECOND LANG ACQ, V32, P465, DOI 10.1017/S0272263110000045; Kormos J, 2000, LANG LEARN, V50, P343, DOI 10.1111/0023-8333.00120; Declerck M, 2012, BILING-LANG COGN, V15, P782, DOI 10.1017/S1366728911000629; Kim Y, 2009, SYSTEM, V37, P254, DOI 10.1016/j.system.2009.02.003; Izumi S, 2003, APPL LINGUIST, V24, P168, DOI 10.1093/applin/24.2.168; Williams JN, 2005, STUD SECOND LANG ACQ, V27, P269, DOI 10.1017/S0272263105050138; Godfroid A, 2013, STUD SECOND LANG ACQ, V35, P291, DOI 10.1017/S0272263112000897; HOLM S, 1979, SCAND J STAT, V6, P65; MCLAUGHLIN B, 1983, LANG LEARN, V33, P135, DOI 10.1111/j.1467-1770.1983.tb00532.x; Leung JHC, 2011, STUD SECOND LANG ACQ, V33, P33, DOI 10.1017/S0272263110000525; Towse JN, 1998, BEHAV RES METH INS C, V30, P583, DOI 10.3758/BF03209475; Baddeley A, 1998, Q J EXP PSYCHOL-A, V51, P819, DOI 10.1080/027249898391413; Larson-Hall J, 2010, APPL LINGUIST, V31, P368, DOI 10.1093/applin/amp038; Skehan P, 1999, LANG LEARN, V49, P93, DOI 10.1111/1467-9922.00071; Bygate M., 1996, CHALLENGE CHANGE LAN, P136; Cohen J., 1988, STAT POWER ANAL BEHA; Ellis R., 2005, PLANNING TASK PERFOR, P3; Ellis R., 2005, ANAL LEARNER LANGUAG; Ericsson K. A., 1993, PROTOCOL ANAL VERBAL; EVANS FJ, 1978, B PSYCHONOMIC SOC, V12, P35; Foster P., 1996, STUDIES 2 LANGUAGE A, V18, P299, DOI DOI 10.1017/S0272263100015047; FOTOS SS, 1993, APPL LINGUIST, V14, P385, DOI 10.1093/applin/14.4.385; Fukuta J., 2015, LANGUAGE TEACHING RE; Fukuta J., 2014, REPORTS 2013 STUDIES, P75; Garcia Mayo M. P., 2007, INVESTIGATING TASKS; Gass S. M., 2000, STIMULATED RECALL ME; Gilabert R., 2007, IRAL-INT REV APPL LI, V45, P215, DOI DOI 10.1515/IRAL.2007.010; Gilabert R., 2009, IRAL-INT REV APPL LI, V47, P367, DOI DOI 10.1515/IRAL.2009.016; Godfroid A., 2010, COGNITIVE PROCESSING, P169; Ishikawa T., 2008, J ASIA TEFL, V5, P29; Jackson DO, 2013, LANG LEARN, V63, P330, DOI 10.1111/lang.12008; Kormos J., 2006, SPEECH PRODUCTION 2; Krashen S. D., 1985, INPUT HYPOTHESIS ISS; Krashen Stephen D., 1982, PRINCIPLES PRACTICE; Lantolf J., 2006, SOCIOCULTURAL THEORY; Long M. H., 1998, FOCUS FORM CLASSROOM, P15; Long M. H., 1991, FOREIGN LANGUAGE RES, P30; Marsden E, 2013, IRAL-INT REV APPL LI, V51, P271, DOI 10.1515/iral-2013-0012; Plonsky L., 2014, APPL LINGUI IN PRESS, V35; Robinson P., 2005, IRAL-INT REV APPL LI, V43, P1, DOI DOI 10.1515/IRA1.2005.43.1.1; ROBINSON P, 1995, LANG LEARN, V45, P283, DOI 10.1111/j.1467-1770.1995.tb00441.x; ROBINSON P, 1995, LANG LEARN, V45, P99, DOI 10.1111/j.1467-1770.1995.tb00964.x; Robinson P., 2003, HDB 2 LANGUAGE ACQUI, P631, DOI 10.1002/9780470756492.ch19; Robinson R J., 2011, 2 LANGUAGE TASK COMP, P2; Rosa E., 1999, STUDIES 2 LANGUAGE A, V21, P511, DOI DOI 10.1017/S0272263199004015; SCHMIDT RW, 1990, APPL LINGUIST, V11, P129, DOI 10.1093/applin/11.2.129; Skehan P., 2014, PROCESSING PERSPECTI; Skehan P, 1996, APPL LINGUIST, V17, P38, DOI 10.1093/applin/17.1.38; Skehan P., 2001, COGNITION 2 LANGUAGE, P206; Skehan P., 1998, COGNITIVE APPROACH L; Skehan P., 1997, LANG TEACH RES, V1, P185, DOI DOI 10.1177/136216889700100302; VanPatten B., 1990, STUDIES 2ND LANGUAGE, V12, P287, DOI DOI 10.1017/S0272263100009177; Vygotsky L, 1978, MIND SOC DEV HIGHER; Williams J. N., 2004, FORM MEANING CONNECT, P203	58	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0346-251X	1879-3282		SYSTEM	System	OCT	2015	53						1	12		10.1016/j.system.2015.06.010		12	Education & Educational Research; Linguistics	Education & Educational Research; Linguistics	CS0UM	WOS:000361777700001		
J	Kawamoto, T; Endo, T				Kawamoto, Tetsuya; Endo, Toshihiko			Genetic and Environmental Contributions to Personality Trait Stability and Change Across Adolescence: Results From a Japanese Twin Sample	TWIN RESEARCH AND HUMAN GENETICS			English	Article						personality change; adolescence; behavioral genetics; Japanese; twin	MULTIPLE-RATER TWIN; LONGITUDINAL TWIN; ADULT PERSONALITY; YOUNG ADULTHOOD; EARLY-CHILDHOOD; AGE; CONTINUITY; PATTERNS; SELF; IDENTIFICATION	We examined developmental trends and sources of stability and change in adolescent personality by using twin data collected from 1981 to 2010 (273 monozygotic (MZ) and 48 dizygotic (DZ) twin pairs) from a secondary school affiliated with the University of Tokyo. Phenotypic analyses showed high rank-order stability and substantial mean-level increases in neuroticism and declines in extraversion over the adolescent years. Longitudinal bivariate genetic analyses revealed that the best-fitting model for adolescent personality includes additive genetic and non-shared environmental influences. Heritability estimates ranged approximately from 0.30 to 0.60. Additionally, three-year stability in adolescent personality was influenced mainly by genetic factors, and there were both genetic and environmental innovations in mid-adolescence. Our findings suggest that both genetic and environmental effects have significant roles in the etiology of personality development across adolescence.	[Kawamoto, Tetsuya] Japan Soc Promot Sci, Tokyo, Japan; [Kawamoto, Tetsuya; Endo, Toshihiko] Univ Tokyo, Bunkyo Ku, Tokyo 113, Japan	Kawamoto, T (reprint author), Univ Tokyo, Grad Sch Educ 201, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	tk5049@p.u-tokyo.ac.jp			JSPS KAKENHI [26-12061]	Preparation of this manuscript was supported by JSPS KAKENHI Grant Number 26-12061. The author would like to thank Enago (www.enago.jp) for the English language review.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Canals J, 2005, PERS INDIV DIFFER, V39, P179, DOI 10.1016/j.paid.2004.12.012; Blankstein U, 2009, NEUROPSYCHOLOGIA, V47, P599, DOI 10.1016/j.neuropsychologia.2008.10.014; Pullmann H, 2006, EUR J PERSONALITY, V20, P447, DOI 10.1002/per.611; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; Kandler C, 2013, DEV PSYCHOL, V49, P1739, DOI 10.1037/a0030744; Magee CA, 2013, J PERS, V81, P324, DOI 10.1111/j.1467-6494.2012.00802.x; Roberts BW, 2006, PSYCHOL BULL, V132, P1, DOI 10.1037/0033-2909.132.1.1; Klimstra TA, 2009, J PERS SOC PSYCHOL, V96, P898, DOI 10.1037/a0014746; HOFSTEE WKB, 1994, EUR J PERSONALITY, V8, P149, DOI 10.1002/per.2410080302; Bleidorn W, 2009, J PERS SOC PSYCHOL, V97, P142, DOI 10.1037/a0015434; Kandler C, 2010, J PERS, V78, P1565, DOI 10.1111/j.1467-6494.2010.00661.x; Kandler C, 2012, CURR DIR PSYCHOL SCI, V21, P290, DOI 10.1177/0963721412452557; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Blonigen DM, 2008, J PERS, V76, P229, DOI 10.1111/j.1467-6494.2007.00485.x; Chiang MC, 2011, NEUROIMAGE, V54, P2308, DOI 10.1016/j.neuroimage.2010.10.015; Soto CJ, 2011, J PERS SOC PSYCHOL, V100, P330, DOI 10.1037/a0021717; Johnson W, 2005, J PERS, V73, P523, DOI 10.1111/j.1467-6494.2005.00319.x; KENDLER KS, 1993, BEHAV GENET, V23, P21, DOI 10.1007/BF01067551; Lamb ME, 2002, CHILD DEV, V73, P1517, DOI 10.1111/1467-8624.00487; Kendler KS, 2008, PSYCHOL MED, V38, P1567, DOI 10.1017/S003329170800384X; Bleidorn W, 2012, J PERS, V80, P1029, DOI 10.1111/j.1467-6494.2011.00758.x; Watzlawik M, 2009, J ADOLESCENT RES, V24, P561, DOI 10.1177/0743558409338301; Lewis GJ, 2015, PSYCHOL MED, V45, P2171, DOI 10.1017/S0033291715000173; Spengler M, 2012, PERS INDIV DIFFER, V53, P411, DOI 10.1016/j.paid.2012.01.019; Branje SJT, 2007, EUR J PERSONALITY, V21, P45, DOI 10.1002/per.596; Kandler C, 2010, J PERS SOC PSYCHOL, V98, P995, DOI 10.1037/a0019558; MCGUE M, 1993, DEV PSYCHOL, V29, P96, DOI 10.1037/0012-1649.29.1.96; Mensah FK, 2013, J ADOLESCENT HEALTH, V53, P118, DOI 10.1016/j.jadohealth.2012.12.018; Allik J, 2004, EUR J PERSONALITY, V18, P445, DOI 10.1002/per.524; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Turkheimer E, 2014, ANNU REV PSYCHOL, V65, P515, DOI 10.1146/annurev-psych-113011-143752; Silventoinen K, 2008, PEDIATRICS, V121, pE885, DOI 10.1542/peds.2007-1615; De Fruyt F, 2006, J PERS SOC PSYCHOL, V91, P538, DOI 10.1037/0022-3514.91.3.538; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Bratko D, 2007, TWIN RES HUM GENET, V10, P151, DOI 10.1375/twin.10.1.151; Van den Akker AL, 2014, J PERS SOC PSYCHOL, V107, P736, DOI 10.1037/a0037248; Roberts BW, 2000, PSYCHOL BULL, V126, P3, DOI 10.1037/0033-2909.126.1.3; VIKEN RJ, 1994, J PERS SOC PSYCHOL, V66, P722, DOI 10.1037/0022-3514.66.4.722; Bleidorn W, 2014, EUR J PERSONALITY, V28, P244, DOI 10.1002/per.1957; Eysenck H. J., 1975, MANUAL EYSENCK PERSO; Guilford J. P., 1943, GUILFORD MARTIN PERS; Guilford J. P, 1940, INVENTORY FACTORS ST; Guilford J. P., 1943, GUILFORD MARTIN INVE; Guilford J. S., 1976, GUILFORD ZIMMERMAN T; Hopwood CJ, 2011, J PERS SOC PSYCHOL, V100, P545, DOI 10.1037/a0022409; John O. P., 2008, HDB PERSONALITY THEO, V3, P114; Johnson A. M., 2008, SAGE HDB PERSONALITY, V1, P145; Johnson W., 2008, NATURE NURTURE NEW P, P103; McCrae R. R., 2008, HDB PERSONALITY THEO, V3, P159; McCrae RR, 2002, J PERS SOC PSYCHOL, V83, P1456, DOI 10.1037//0022-3514.83.6.1456; Muthen L. K., 2012, MPLUS USERS GUIDE; Natsuno R., 1998, THEORY PRACTICE 5 FA, P156; Shimonaka Y., 1996, 06610148 MIN ED SCI; Tsujioka Y, 2000, NEW METHOD PERSONALI; Waszczuk MA, 2014, JAMA PSYCHIAT, V71, P905, DOI 10.1001/jamapsychiatry.2014.655; Yatabe J., 1975, PSYCHOL ASSESSMENT B, P269	57	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1832-4274	1839-2628		TWIN RES HUM GENET	Twin Res. Hum. Genet.	OCT	2015	18	5					545	556		10.1017/thg.2015.47		12	Genetics & Heredity; Obstetrics & Gynecology	Genetics & Heredity; Obstetrics & Gynecology	CR9FY	WOS:000361660800007		
J	Jelenkovic, A; Yokoyama, Y; Sund, R; Honda, C; Bogl, LH; Aaltonen, S; Ji, FL; Ning, F; Pang, ZC; Ordonana, JR; Sanchez-Romera, JF; Colodro-Conde, L; Burt, SA; Klump, KL; Medland, SE; Montgomery, GW; Kandler, C; McAdams, TA; Eley, TC; Gregory, AM; Saudino, KJ; Dubois, L; Boivin, M; Tarnoki, AD; Tarnoki, DL; Haworth, CMA; Plomin, R; Oncel, SY; Aliev, F; Stazi, MA; Fagnani, C; D'Ippolito, C; Craig, JM; Saffery, R; Siribaddana, SH; Hotopf, M; Sumathipala, A; Rijsdijk, F; Spector, T; Mangino, M; Lachance, G; Gatz, M; Butler, DA; Bayasgalan, G; Narandalai, D; Freitas, DL; Maia, JA; Harden, KP; Tucker-Drob, EM; Kim, B; Chong, Y; Hong, C; Shin, HJ; Christensen, K; Skytthe, A; Kyvik, KO; Derom, CA; Vlietinck, RF; Loos, RJF; Cozen, W; Hwang, AE; Mack, TM; He, MG; Ding, XH; Chang, B; Silberg, JL; Eaves, LJ; Maes, HH; Cutler, TL; Hopper, JL; Aujard, K; Magnusson, PKE; Pedersen, NL; Aslan, AKD; Song, YM; Yang, S; Lee, K; Baker, LA; Tuvblad, C; Bjerregaard-Andersen, M; Beck-Nielsen, H; Sodemann, M; Heikkila, K; Tan, QH; Zhang, DF; Swan, GE; Krasnow, R; Jang, KL; Knafo-Noam, A; Mankuta, D; Abramson, L; Lichtenstein, P; Krueger, RF; Mcgue, M; Pahlen, S; Tynelius, P; Duncan, GE; Buchwald, D; Corley, RP; Huibregtse, BM; Nelson, TL; Whitfield, KE; Franz, CE; Kremen, WS; Lyons, MJ; Ooki, S; Brandt, I; Nilsen, TS; Inui, F; Watanabe, M; Bartels, M; van Beijsterveldt, TCEM; Wardle, J; Llewellyn, CH; Fisher, A; Rebato, E; Martin, NG; Iwatani, Y; Hayakawa, K; Sung, J; Harris, JR; Willemsen, G; Busjahn, A; Goldberg, JH; Rasmussen, F; Hur, YM; Boomsma, DI; Sorensen, TIA; Kaprio, J; Silventoinen, K				Jelenkovic, Aline; Yokoyama, Yoshie; Sund, Reijo; Honda, Chika; Bogl, Leonie H.; Aaltonen, Sari; Ji, Fuling; Ning, Feng; Pang, Zengchang; Ordonana, Juan R.; Sanchez-Romera, Juan F.; Colodro-Conde, Lucia; Burt, S. Alexandra; Klump, Kelly L.; Medland, Sarah E.; Montgomery, Grant W.; Kandler, Christian; McAdams, Tom A.; Eley, Thalia C.; Gregory, Alice M.; Saudino, Kimberly J.; Dubois, Lise; Boivin, Michel; Tarnoki, Adam D.; Tarnoki, David L.; Haworth, Claire M. A.; Plomin, Robert; Oncel, Sevgi Y.; Aliev, Fazil; Stazi, Maria A.; Fagnani, Corrado; D'Ippolito, Cristina; Craig, Jeffrey M.; Saffery, Richard; Siribaddana, Sisira H.; Hotopf, Matthew; Sumathipala, Athula; Rijsdijk, Fruhling; Spector, Timothy; Mangino, Massimo; Lachance, Genevieve; Gatz, Margaret; Butler, David A.; Bayasgalan, Gombojav; Narandalai, Danshiitsoodol; Freitas, Duarte L.; Maia, Jose Antonio; Harden, K. Paige; Tucker-Drob, Elliot M.; Kim, Bia; Chong, Youngsook; Hong, Changhee; Shin, Hyun Jung; Christensen, Kaare; Skytthe, Axel; Kyvik, Kirsten O.; Derom, Catherine A.; Vlietinck, Robert F.; Loos, Ruth J. F.; Cozen, Wendy; Hwang, Amie E.; Mack, Thomas M.; He, Mingguang; Ding, Xiaohu; Chang, Billy; Silberg, Judy L.; Eaves, Lindon J.; Maes, Hermine H.; Cutler, Tessa L.; Hopper, John L.; Aujard, Kelly; Magnusson, Patrik K. E.; Pedersen, Nancy L.; Aslan, Anna K. Dahl; Song, Yun-Mi; Yang, Sarah; Lee, Kayoung; Baker, Laura A.; Tuvblad, Catherine; Bjerregaard-Andersen, Morten; Beck-Nielsen, Henning; Sodemann, Morten; Heikkila, Kauko; Tan, Qihua; Zhang, Dongfeng; Swan, Gary E.; Krasnow, Ruth; Jang, Kerry L.; Knafo-Noam, Ariel; Mankuta, David; Abramson, Lior; Lichtenstein, Paul; Krueger, Robert F.; McGue, Matt; Pahlen, Shandell; Tynelius, Per; Duncan, Glen E.; Buchwald, Dedra; Corley, Robin P.; Huibregtse, Brooke M.; Nelson, Tracy L.; Whitfield, Keith E.; Franz, Carol E.; Kremen, William S.; Lyons, Michael J.; Ooki, Syuichi; Brandt, Ingunn; Nilsen, Thomas Sevenius; Inui, Fujio; Watanabe, Mikio; Bartels, Meike; van Beijsterveldt, Toos C. E. M.; Wardle, Jane; Llewellyn, Clare H.; Fisher, Abigail; Rebato, Esther; Martin, Nicholas G.; Iwatani, Yoshinori; Hayakawa, Kazuo; Sung, Joohon; Harris, Jennifer R.; Willemsen, Gonneke; Busjahn, Andreas; Goldberg, Jack H.; Rasmussen, Finn; Hur, Yoon-Mi; Boomsma, Dorret I.; Sorensen, Thorkild I. A.; Kaprio, Jaakko; Silventoinen, Karri			Zygosity Differences in Height and Body Mass Index of Twins From Infancy to Old Age: A Study of the CODATwins Project	TWIN RESEARCH AND HUMAN GENETICS			English	Article						twins; height; BMI; zygosity differences	ASSISTED REPRODUCTIVE TECHNOLOGY; POPULATION-BASED COHORT; YOUNG MALE TWINS; BIRTH-WEIGHT; ENVIRONMENTAL-FACTORS; GENETIC-REGULATION; INSULIN-SECRETION; LATE ADOLESCENCE; MATERNAL HEIGHT; TWINNING RATES	A trend toward greater body size in dizygotic (DZ) than in monozygotic (MZ) twins has been suggested by some but not all studies, and this difference may also vary by age. We analyzed zygosity differences in mean values and variances of height and body mass index (BMI) among male and female twins from infancy to old age. Data were derived from an international database of 54 twin cohorts participating in the COllaborative project of Development of Anthropometrical measures in Twins (CODATwins), and included 842,951 height and BMI measurements from twins aged 1 to 102 years. The results showed that DZ twins were consistently taller than MZ twins, with differences of up to 2.0 cm in childhood and adolescence and up to 0.9 cm in adulthood. Similarly, a greater mean BMI of up to 0.3 kg/m(2) in childhood and adolescence and up to 0.2 kg/m(2) in adulthood was observed in DZ twins, although the pattern was less consistent. DZ twins presented up to 1.7% greater height and 1.9% greater BMI than MZ twins; these percentage differences were largest in middle and late childhood and decreased with age in both sexes. The variance of height was similar in MZ and DZ twins at most ages. In contrast, the variance of BMI was significantly higher in DZ than in MZ twins, particularly in childhood. In conclusion, DZ twins were generally taller and had greater BMI than MZ twins, but the differences decreased with age in both sexes.	[Jelenkovic, Aline; Sund, Reijo; Aaltonen, Sari; Silventoinen, Karri] Univ Helsinki, Dept Social Res, FIN-00014 Helsinki, Finland; [Jelenkovic, Aline; Rebato, Esther] Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain; [Yokoyama, Yoshie] Osaka City Univ, Dept Publ Hlth Nursing, Osaka 558, Japan; [Honda, Chika; Inui, Fujio; Watanabe, Mikio; Iwatani, Yoshinori; Hayakawa, Kazuo; Silventoinen, Karri] Osaka Univ, Osaka Univ Grad Sch Med, Osaka, Japan; [Bogl, Leonie H.; Aaltonen, Sari; Heikkila, Kauko; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland; [Ji, Fuling; Ning, Feng; Pang, Zengchang] Qingdao Ctr Dis Control & Prevent, Dept Noncommunicable Dis Prevent, Qingdao, Peoples R China; [Ordonana, Juan R.; Colodro-Conde, Lucia] Univ Murcia, Dept Human Anat & Psychobiol, Murcia, Spain; [Ordonana, Juan R.; Sanchez-Romera, Juan F.] IMIB Arrixaca, Murcia, Spain; [Sanchez-Romera, Juan F.] Univ Murcia, Dept Dev & Educ Psychol, Murcia, Spain; [Colodro-Conde, Lucia; Medland, Sarah E.; Montgomery, Grant W.; Martin, Nicholas G.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Burt, S. Alexandra; Klump, Kelly L.] Michigan State Univ, E Lansing, MI 48824 USA; [Kandler, Christian] Univ Bielefeld, Dept Psychol, D-33615 Bielefeld, Germany; [McAdams, Tom A.; Eley, Thalia C.; Plomin, Robert; Rijsdijk, Fruhling] Kings Coll London, Inst Psychiat Psychol & Neurosci, MRC Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Gregory, Alice M.] Univ London, Dept Psychol, London, England; [Saudino, Kimberly J.] Boston Univ, Dept Psychol & Brain Sci, Boston, MA 02215 USA; [Dubois, Lise] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada; [Boivin, Michel] Univ Laval, Ecole Psychol, Quebec City, PQ, Canada; [Boivin, Michel] Tomsk State Univ, Inst of Genet Neurobiol & Social Fdn Child Dev, Tomsk 634050, Russia; [Tarnoki, Adam D.; Tarnoki, David L.] Semmelweis Univ, Dept Radiol & Oncotherapy, H-1085 Budapest, Hungary; [Haworth, Claire M. A.; Sorensen, Thorkild I. A.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Oncel, Sevgi Y.] Kirikkale Univ, Fac Arts & Sci, Dept Stat, Kirikkale, Turkey; [Aliev, Fazil] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychiat, Richmond, VA USA; [Aliev, Fazil] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychol, Richmond, VA USA; [Aliev, Fazil; Silberg, Judy L.; Eaves, Lindon J.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Human & Mol Genet, Richmond, VA USA; [Aliev, Fazil] Karabuk Univ, Dept Actuaria & Risk Management, Karabuk, Turkey; [Stazi, Maria A.; Fagnani, Corrado; D'Ippolito, Cristina] Natl Ctr Epidemiol Surveillance & Hlth Promot, Ist Super Sanita, Rome, Italy; [Craig, Jeffrey M.; Saffery, Richard] Royal Childrens Hosp, Murdoch Childerens Res Inst, Melbourne, Vic, Australia; [Craig, Jeffrey M.; Saffery, Richard] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Siribaddana, Sisira H.; Sumathipala, Athula] Inst Res & Dev, Battaramulla, Sri Lanka; [Siribaddana, Sisira H.] Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Saliyapura, Sri Lanka; [Hotopf, Matthew] South London & Maudsley NHS Fdn Trust, NIHR Mental Hlth Biomed Res Ctr, London, England; [Hotopf, Matthew] Kings Coll London, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England; [Sumathipala, Athula] Keele Univ, Fac Hlth, Sch Primary Care Res, Res Inst Primary Care & Hlth Sci, Keele, Staffs, England; [Spector, Timothy; Mangino, Massimo; Lachance, Genevieve] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Gatz, Margaret; Baker, Laura A.; Tuvblad, Catherine] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Gatz, Margaret; Magnusson, Patrik K. E.; Pedersen, Nancy L.; Aslan, Anna K. Dahl; Lichtenstein, Paul] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Butler, David A.] Natl Acad Sci, Inst Med, Washington, DC 20418 USA; [Bayasgalan, Gombojav; Narandalai, Danshiitsoodol] Hlth Twin Assoc Mongolia, Ulaanbaatar, Mongol Peo Rep; [Narandalai, Danshiitsoodol] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Freitas, Duarte L.] Univ Madeira, Dept Phys Educ & Sport, Funchal, Portugal; [Maia, Jose Antonio] Univ Porto, Fac Sport, CIFI2D, P-4100 Oporto, Portugal; [Harden, K. Paige; Tucker-Drob, Elliot M.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Kim, Bia; Hong, Changhee; Shin, Hyun Jung] Pusan Natl Univ, Dept Psychol, Busan, South Korea; [Christensen, Kaare; Skytthe, Axel] Univ Southern Denmark, Inst Publ Hlth Epidemiol Biostat & Biodemog, Danish Twin Registry, Odense, Denmark; [Christensen, Kaare] Odense Univ Hosp, Dept Biochem & Clin Pharmacol, DK-5000 Odense, Denmark; [Christensen, Kaare] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Kyvik, Kirsten O.] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Kyvik, Kirsten O.] Odense Univ Hosp, Odense Patient Data Explorat Network OPEN, DK-5000 Odense, Denmark; [Derom, Catherine A.; Vlietinck, Robert F.] Univ Hosp Leuven, Ctr Human Genet, Leuven, Belgium; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Cozen, Wendy; Hwang, Amie E.; Mack, Thomas M.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Cozen, Wendy; Mack, Thomas M.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [He, Mingguang; Ding, Xiaohu; Chang, Billy] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [He, Mingguang] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Maes, Hermine H.] Virginia Commonwealth Univ, Psychiat & Massey Canc Ctr, Dept Human & Mol Genet, Richmond, VA USA; [Cutler, Tessa L.; Hopper, John L.] Univ Melbourne, Ctr Biostat & Epidemiol, Australian Twin Registry, Melbourne, Vic, Australia; [Hopper, John L.; Yang, Sarah; Sung, Joohon] Seoul Natl Univ, Sch Publ Hlth, Dept Epidemiol, Seoul, South Korea; [Aujard, Kelly] Univ Melbourne, Ctr Biostat & Epidemiol, Melbourne, Vic, Australia; [Aslan, Anna K. Dahl] Jonkoping Univ, Sch Hlth Sci, Inst Gerontol, Jonkoping, Sweden; [Song, Yun-Mi] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Family Med, Seoul, South Korea; [Yang, Sarah; Sung, Joohon] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea; [Lee, Kayoung] Inje Univ, Coll Med, Busan Paik Hosp, Dept Family Med, Busan, South Korea; [Tuvblad, Catherine] Univ Orebro, Sch Law Psychol & Social Work, SE-70182 Orebro, Sweden; [Bjerregaard-Andersen, Morten] INDEPTH Network, Bandim Hlth Project, Bissau, Guinea Bissau; [Bjerregaard-Andersen, Morten] Statens Serum Inst, Res Ctr Vitamines & Vaccines, DK-2300 Copenhagen, Denmark; [Bjerregaard-Andersen, Morten; Beck-Nielsen, Henning] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark; [Sodemann, Morten] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark; [Tan, Qihua] Univ Southern Denmark, Inst Publ Hlth, Epidemiol Biostat & Biodemog, Odense, Denmark; [Zhang, Dongfeng] Qingdao Univ, Coll Med, Dept Publ Hlth, Qingdao 266071, Peoples R China; [Swan, Gary E.] Stanford Univ, Dept Med, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Krasnow, Ruth] SRI Int, Ctr Hlth Sci, Menlo Pk, CA 94025 USA; [Jang, Kerry L.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Knafo-Noam, Ariel; Abramson, Lior] Hebrew Univ Jerusalem, Jerusalem, Israel; [Mankuta, David] Hebrew Univ Jerusalem, Sch Med, Hadassah Hosp, Dept Obstet & Gynecol, IL-91010 Jerusalem, Israel; [Krueger, Robert F.; McGue, Matt; Pahlen, Shandell] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Tynelius, Per; Rasmussen, Finn] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Duncan, Glen E.; Buchwald, Dedra] Univ Washington, Ctr Clin & Epidemiol Res, Seattle, WA 98195 USA; [Corley, Robin P.; Huibregtse, Brooke M.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Nelson, Tracy L.] Colorado State Univ, Dept Hlth & Exercise Sci, Ft Collins, CO 80523 USA; [Nelson, Tracy L.] Colorado State Univ, Colorado Sch Publ Hlth, Ft Collins, CO 80523 USA; [Whitfield, Keith E.] Duke Univ, Psychol & Neurosci, Durham, NC USA; [Franz, Carol E.; Kremen, William S.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Kremen, William S.] VA San Diego Ctr Excellence Stress & Mental Hlth, La Jolla, CA USA; [Lyons, Michael J.] Boston Univ, Dept Psychol, Boston, MA 02215 USA; [Ooki, Syuichi] Ishikawa Prefectural Nursing Univ, Dept Hlth Sci, Kahoku, Ishikawa, Japan; [Brandt, Ingunn; Nilsen, Thomas Sevenius; Harris, Jennifer R.] Norwegian Inst Publ Hlth, Div Epidemiol, Dept Genes & Environm, Oslo, Norway; [Inui, Fujio] Kio Univ, Fac Hlth Sci, Nara, Japan; [Bartels, Meike; van Beijsterveldt, Toos C. E. M.; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Wardle, Jane; Llewellyn, Clare H.; Fisher, Abigail] UCL, Inst Epidemiol & Hlth Care, Hlth Behav Res Ctr, Dept Epidemiol & Publ Hlth, London, England; [Busjahn, Andreas] HealthTwist GmbH, Berlin, Germany; [Goldberg, Jack H.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Hur, Yoon-Mi] Mokpo Natl Univ, Dept Educ, Jeonnam, South Korea; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Med & Hlth Sci, Novo Nordisk Fdn, Ctr Basic Metab Res,Sect Metab Genet, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Bispebjerg and Frederiksberg Hosp, Inst Prevent Med, Copenhagen, Denmark; [Kaprio, Jaakko] Natl Inst Hlth & Welfare, Helsinki, Finland; [Kaprio, Jaakko] FIMM, Inst Mol Med, Helsinki, Finland	Jelenkovic, A (reprint author), Univ Helsinki, Dept Social Res, Populat Res Unit, POB 18, FIN-00014 Helsinki, Finland.	aline.jelenkovic@helsinki.fi	Montgomery, Grant/B-7148-2008; Craig, Jeffrey/B-3484-2012; 	Montgomery, Grant/0000-0002-4140-8139; Craig, Jeffrey/0000-0003-3979-7849; Huibregtse, Brooke/0000-0003-0977-7249	National Institute of Mental Health [R01 MH58354]; National Institute on Aging [1RO1-AG13662-01A2]; National Institutes of Health [R21 AG039572]; WT Grant Foundation; University of London Central Research fund; Medical Research Council [G81/343, G120/635]; Economic and Social Research Council [RES-000-22-2206]; Institute of Social Psychiatry [06/07-11]; Leverhulme Research Fellowship [RF/2/RFG/2008/0145]; Goldsmiths, University of London; National Research Foundation of Korea [NRF-371-2011-1 B00047]; National Institute of Health [NIA R01 AG018384, R01 AG018386, R01 AG022381, R01 AG022982]; Cooperative Studies Program of the Office of Research & Development of the US Department of Veterans Affairs; Centre of Research Excellence from the National Health and Medical Research Council [grant ID 1079102]; Michigan State University; National Institute of Mental Health (NIMH) [R01-MH081813, R01-MH0820-54, R01-MH092377-02, R21-MH070542-01, R03-MH63851-01]; Eunice Kennedy Shriver National Institute for Child Health and Human Development (NICHD) [R01-HD066040]; MSU Foundation [11-SPG-2518]; California Tobacco-Related Disease Research Program [7RT-0134H, 8RT-0107H, 6RT-0354H]; The National Institutes of Health [1R01ESO15150-01, R01 HD068435, R01 MH062375]; National Natural Science Foundation of China [81125007]; Australian National Health and Medical Research Council [437015, 607358]; Bonnie Babes Foundation [BBF20704]; Financial Markets Foundation for Children [032-2007]; Victorian Government's Operational Infrastructure Support Program; ENGAGE-European Network for Genetic and Genomic Epidemiology; National Institute of Alcohol Abuse and Alcoholism [AA-12502, AA-00145, AA-09203]; Academy of Finland Center of Excellence in Complex Disease Genetics [213506, 129680]; Academy of Finland [100499, 205585, 118555, 141054, 265240, 263278, 264146]; Osaka University's International Joint Research Promotion Program; Kirikkale University Research Grant: KKU [2009/43]; TUBITAK [114C117]; European Research Council (ERC) [240994]; European Union's Seventh Framework Programme ENGAGE Consortium [HEALTH-F4-2007- 201413]; European Union's Seventh Framework Programme BioSHaRE EU [HEALTH-F4-2010-261433]; Seneca Foundation; Regional Agency for Science and Technology, Murcia, Spain [08633/PHCS/08, 15302/PHCS/10]; Ministry of Science and Innovation, Spain [PSI11560-2009]; UK Medical Research Council [G0901245]; UK Biotechnology and Biological Sciences Research Council [31/D19086]; Portuguese agency for research (The Foundation for Science and Technology [FCT] [POCI/DES/56834/2004]; Wellcome Trust; European Community's Seventh Framework Programme; National Institute for Health Research (NIHR) BioResource Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; Netherlands Organization for Scientific Research (NWO); MagW/ZonMW [904-61-090, 985-10-002, 912-10-020, 904-61-193, 480-04-004, 463-06-001, 451-04-034, 400-05-717, Addiction-31160008, Middelgroot-911-09-032, Spinozapremie 56-464-14192]; VU University's Institute for Health and Care Research (EMGO+); ERC [ERC-230374]; Avera Institute, Sioux Falls, South Dakota (USA); Cancer Research UK [C1418/A7974]; Japan Society for the Promotion of Science [15H05105]; Fonds Quebecois de la Recherche sur la Societe et la Culture; Fonds de la Recherche en Sante du Quebec; Social Science and Humanities Research Council of Canada; National Health Research Development Program; Canadian Institutes for Health Research; Sainte-Justine Hospital's Research Center; Canada Research Chair Program;  [FP7-HEALTH-F4-2007];  [201413];  [NIH RC2 HL103416]	This study was conducted within the CODATwins project (Academy of Finland #266592). Support for participating twin projects: The University of Southern California Twin Study is funded by a grant from the National Institute of Mental Health (R01 MH58354). The Carolina African American Twin Study of Aging (CAATSA) was funded by a grant from the National Institute on Aging (grant 1RO1-AG13662-01A2) to K. E. Whitfield. The NAS-NRC Twin Registry acknowledges financial support from the National Institutes of Health (grant No. R21 AG039572). Waves 1-3 of Genesis 12-19 were funded by the WT Grant Foundation, the University of London Central Research fund, and a Medical Research Council Training Fellowship (G81/343) and Career Development Award (G120/635) to Thalia C. Eley. Wave 4 was supported by grants from the Economic and Social Research Council (RES-000-22-2206) and the Institute of Social Psychiatry (06/07-11) to Alice M. Gregory, who was also supported at that time by a Leverhulme Research Fellowship (RF/2/RFG/2008/0145). Wave 5 was supported by funding to Alice M. Gregory from Goldsmiths, University of London. Anthropometric measurements of the Hungarian twins were supported by Medexpert Ltd., Budapest, Hungary. South Korea Twin Registry is supported by National Research Foundation of Korea (NRF-371-2011-1 B00047). Danish Twin Registry is supported by the National Program for Research Infrastructure 2007 from the Danish Agency for Science, Technology and Innovation, The Research Council for Health and Disease, the Velux Foundation, and the US National Institute of Health (P01 AG08761). Since its origin, the East Flanders Prospective Survey has been partly supported by grants from the Fund of Scientific Research, Flanders and Twins, a non-profit Association for Scientific Research in Multiple Births (Belgium). Korean Twin-Family Register was supported by the Global Research Network Program of the National Research Foundation (NRF 2011-220-E00006). Colorado Twin Registry is funded by NIDA center grant DA011015, and Longitudinal Twin Study HD10333. Author Brooke M. Huibregtse is supported by 5T32DA017637-10. Vietnam Era Twin Study of Aging was supported by National Institute of Health grants NIA R01 AG018384, R01 AG018386, R01 AG022381, and R01 AG022982, and, in part, with resources of the VA San Diego Center of Excellence for Stress and Mental Health. The Cooperative Studies Program of the Office of Research & Development of the US Department of Veterans Affairs has provided financial support for the development and maintenance of the Vietnam Era Twin (VET) Registry. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of NIA/NIH, or VA. The Australian Twin Registry is supported by the Centre of Research Excellence (grant ID 1079102) from the National Health and Medical Research Council administered by the University of Melbourne. The Michigan State University Twin Registry has been supported by Michigan State University as well as grants R01-MH081813, R01-MH0820-54, R01-MH092377-02, R21-MH070542-01, and R03-MH63851-01 from the National Institute of Mental Health (NIMH), R01-HD066040 from the Eunice Kennedy Shriver National Institute for Child Health and Human Development (NICHD), and 11-SPG-2518 from the MSU Foundation. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of NIMH, NICHD, or the National Institutes of Health.; California Twin Program was supported by The California Tobacco-Related Disease Research Program (7RT-0134H, 8RT-0107H, and 6RT-0354H) and the National Institutes of Health (1R01ESO15150-01). Guangzhou Twin Eye Study is supported by National Natural Science Foundation of China (grant #81125007). PETS was supported by grants from the Australian National Health and Medical Research Council (grant Nos. 437015 and 607358 to Jeffrey M Craig, and Richard Saffery), the Bonnie Babes Foundation (grant No. BBF20704 to Jeffrey M. Craig), the Financial Markets Foundation for Children (grant No. 032-2007 to Jeffrey M. Craig), and by the Victorian Government's Operational Infrastructure Support Program. Data collection and analyses in Finnish twin cohorts have been supported by ENGAGE-European Network for Genetic and Genomic Epidemiology, FP7-HEALTH-F4-2007, grant agreement No. 201413, National Institute of Alcohol Abuse and Alcoholism (grants AA-12502, AA-00145, and AA-09203 to R J Rose, the Academy of Finland Center of Excellence in Complex Disease Genetics (grant Nos. 213506 and 129680), and the Academy of Finland (grants 100499, 205585, 118555, 141054, 265240, 263278, and 264146 to J Kaprio). K Silventoinen is supported by Osaka University's International Joint Research Promotion Program. S.Y. Oncel and F. Aliev are supported by Kirikkale University Research Grant: KKU, 2009/43 and TUBITAK grant 114C117. Longitudinal Israeli Study of Twins was funded by the Starting grant No. 240994 from the European Research Council (ERC) to Ariel Knafo. Data collection and research stemming from the Norwegian Twin Registry is supported, in part, by the European Union's Seventh Framework Programmes ENGAGE Consortium (grant agreement HEALTH-F4-2007- 201413, and BioSHaRE EU (grant agreement HEALTH-F4-2010-261433). The Murcia Twin Registry is supported by the Seneca Foundation, Regional Agency for Science and Technology, Murcia, Spain (08633/PHCS/08 and 15302/PHCS/10) and Ministry of Science and Innovation, Spain (PSI11560-2009). The Twins Early Development Study (TEDS) is supported by a program grant (G0901245) from the UK Medical Research Council, and the work on obesity in TEDS is supported, in part, by a grant from the UK Biotechnology and Biological Sciences Research Council (31/D19086). Madeira data comes from the following project: Genetic and environmental influences on physical activity, fitness and health: the Madeira family study project reference: POCI/DES/56834/2004 founded by the Portuguese agency for research (The Foundation for Science and Technology [FCT]). The Boston University Twin Project is funded by grants (Nos. R01 HD068435 and R01 MH062375) from the National Institutes of Health to K. Saudino. TwinsUK was funded by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013). The study also receives support from the National Institute for Health Research (NIHR) BioResource Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. University of Washington Twin Registry was supported by the grant NIH RC2 HL103416 (D. Buchwald, PI).; Netherlands Twin Register acknowledges the Netherlands Organization for Scientific Research (NWO) and MagW/ZonMW grants 904-61-090, 985-10-002, 912-10-020, 904-61-193, 480-04-004, 463-06-001, 451-04-034, 400-05-717, Addiction-31160008, Middelgroot-911-09-032, Spinozapremie 56-464-14192, VU University's Institute for Health and Care Research (EMGO+), the ERC (ERC-230374), and the Avera Institute, Sioux Falls, South Dakota (USA). Gemini was supported by a grant from Cancer Research UK (C1418/A7974). The West Japan Twins and Higher Order Multiple Births Registry was supported by Grant-in-Aid for Scientific Research (B) (grant No. 15H05105) from the Japan Society for the Promotion of Science. The Quebec Newborn Twin Study acknowledges financial support from the Fonds Quebecois de la Recherche sur la Societe et la Culture, the Fonds de la Recherche en Sante du Quebec, the Social Science and Humanities Research Council of Canada, the National Health Research Development Program, the Canadian Institutes for Health Research, Sainte-Justine Hospital's Research Center, and the Canada Research Chair Program (Michel Boivin).	Rahman I, 2009, TWIN RES HUM GENET, V12, P286, DOI 10.1375/twin.12.3.286; Rietveld MJH, 2003, BEHAV GENET, V33, P247, DOI 10.1023/A:1023490307170; Vitthala S, 2009, HUM REPROD UPDATE, V15, P45, DOI 10.1093/humupd/dmn045; Hoekstra C, 2010, FERTIL STERIL, V93, P885, DOI 10.1016/j.fertnstert.2008.10.012; Lehtovirta M, 2000, DIABETOLOGIA, V43, P285, DOI 10.1007/s001250050046; Poulsen P, 2006, DIABETES, V55, P1819, DOI 10.2337/db05-1462; Lajunen HR, 2009, INT J OBESITY, V33, P559, DOI 10.1038/ijo.2009.51; Oberg S, 2012, INT J EPIDEMIOL, V41, P1002, DOI 10.1093/ije/dys067; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Benyamin B, 2007, DIABETOLOGIA, V50, P1880, DOI 10.1007/s00125-007-0758-1; Souren NY, 2007, DIABETOLOGIA, V50, P2107, DOI 10.1007/s00125-007-0784-z; Hoekstra C, 2008, HUM REPROD UPDATE, V14, P37, DOI 10.1093/humupd/dmm036; Swerdlow AJ, 1997, LANCET, V350, P1723, DOI 10.1016/S0140-6736(97)05526-8; Reddy UM, 2005, OBSTET GYNECOL, V105, P593, DOI 10.1097/01.AOG.0000153491.09525.dd; Lummaa V, 1998, NATURE, V394, P533, DOI 10.1038/28977; CORNEY G, 1979, ANN HUM GENET, V43, P55; Tandberg A, 2007, ACTA OBSTET GYN SCAN, V86, P833, DOI 10.1080/00016340701417323; Lehtovirta M, 2010, DIABETOLOGIA, V53, P1314, DOI 10.1007/s00125-010-1746-4; Hur YM, 2008, INT J OBESITY, V32, P1455, DOI 10.1038/ijo.2008.144; Eriksen W, 2013, AM J EPIDEMIOL, V177, P1015, DOI 10.1093/aje/kws341; RAMOSARROYO MA, 1988, ACTA GENET MED GEMEL, V37, P229; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/136905203770326402; Pietilainen KH, 1999, INT J OBESITY, V23, P107, DOI 10.1038/sj.ijo.0800767; Buckler JMH, 2004, ANN HUM BIOL, V31, P311, DOI 10.1080/03014460410001670120; Lash MM, 2009, FERTIL STERIL, V91, P1712, DOI 10.1016/j.fertnstert.2008.02.141; Hjelmborg JB, 2014, CANCER EPIDEM BIOMAR, V23, P2303, DOI 10.1158/1055-9965.EPI-13-0568; Helle S, 2004, EVOLUTION, V58, P430, DOI 10.1111/j.0014-3820.2004.tb01658.x; Silventoinen K, 2008, AM J HUM BIOL, V20, P292, DOI 10.1002/ajhb.20717; Ramlau-Hansen CH, 2007, HUM REPROD, V22, P1634, DOI 10.1093/humrep/dem035; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/136905203770326411; Iachine I, 2010, J STAT COMPUT SIM, V80, P365, DOI 10.1080/00949650802641841; Silventoinen K, 2007, TWIN RES HUM GENET, V10, P354, DOI 10.1375/twin.10.2.354; Silventoinen K, 2007, INT J OBESITY, V31, P615, DOI 10.1038/sj.ijo.0803577; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Dube J, 2002, AM J OBSTET GYNECOL, V186, P579, DOI 10.1067/mob.2002.121721; Silventoinen K, 2008, GENET EPIDEMIOL, V32, P341, DOI 10.1002/gepi.20308; Antoniades L, 2003, RHEUMATOLOGY, V42, P791, DOI 10.1093/rheumatology/keg227; Burt SA, 2012, TWIN RES HUM GENET, V15, P746, DOI 10.1017/thg.2012.53; Boomsma D, 2005, RES PERSPECT END INT, P29, DOI 10.1007/3-540-26940-1_2; Poulsen P, 2002, DIABETOLOGIA, V45, P1649, DOI 10.1007/s00125-002-0983-6; Jelenkovic A, 2011, AM J HUM BIOL, V23, P764, DOI 10.1002/ajhb.21208; CORNEY G, 1979, ACTA GENET MED GEMEL, V28, P353; Davies MJ, 2012, NEW ENGL J MED, V366, P1803, DOI 10.1056/NEJMoa1008095; Fauser BCJM, 2005, LANCET, V365, P1807, DOI 10.1016/S0140-6736(05)66478-1; Pietilainen KH, 2001, AM J EPIDEMIOL, V154, P21, DOI 10.1093/aje/154.1.21; Basso O, 2004, JAMA-J AM MED ASSOC, V291, P1564, DOI 10.1001/jama.291.13.1564-c; Verkasalo PK, 1999, CANCER EPIDEM BIOMAR, V8, P271; Johansson S, 2008, EPIDEMIOLOGY, V19, P659, DOI 10.1097/EDE.0b013e31818131b9; Petersen I, 2011, DIABETOLOGIA, V54, P2016, DOI 10.1007/s00125-011-2128-2; Blickstein I., 2005, MULTIPLE PREGNANCY; Bogin B, 2001, GROWTH HUMANITY; Bulmer M. G., 1970, BIOL TWINNING MAN; Campbell D. M., 2005, MULTIPLE PREGNANCY E, P87; Estourgie-van Burk GF, 2006, TWIN RES HUM GENET, V9, P646, DOI 10.1375/twin.9.5.646; Estourgie-van Burk GF, 2010, J PEDIATR-US, V156, P586, DOI 10.1016/j.jpeds.2009.10.045; Falkner F., 1995, MULTIPLE PREGNANCY E, P613; Hur YM, 2009, TWIN RES HUM GENET, V12, P118, DOI 10.1375/twin.12.1.118; Imaizumi Y., 2005, MULTIPLE PREGNANCY, P33; Johansson M, 2001, Twin Res, V4, P400, DOI 10.1375/1369052012588; Loos R J, 2001, Twin Res, V4, P356, DOI 10.1375/1369052012524; Macfarlane A., 2005, MULTIPLE PREGNANCY E, P11; Martin Joyce A, 2015, Natl Vital Stat Rep, V64, P1; NYLANDER PPS, 1981, ACTA GENET MED GEMEL, V30, P189; Silventoinen K., 2015, TWIN RES HUM GENET, V27, P1; Smits J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025239	65	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1832-4274	1839-2628		TWIN RES HUM GENET	Twin Res. Hum. Genet.	OCT	2015	18	5					557	570		10.1017/thg.2015.57		14	Genetics & Heredity; Obstetrics & Gynecology	Genetics & Heredity; Obstetrics & Gynecology	CR9FY	WOS:000361660800008		
J	Yamakoshi, Y; Kasahara, T; Iijima, T; Yuminaka, Y				Yamakoshi, Yoshiki; Kasahara, Toshihiro; Iijima, Tomohiro; Yuminaka, Yasushi			Shear Wave Wavefront Mapping Using Ultrasound Color Flow Imaging	ULTRASONIC IMAGING			English	Article						shear wave; ultrasound color flow imaging; shear elasticity; multilayer piezoelectric actuator	ACOUSTIC RADIATION FORCE; IN-VIVO; TISSUE ELASTICITY; SOFT-TISSUE; ELASTOGRAPHY	A wavefront reconstruction method for a continuous shear wave is proposed. The method uses ultrasound color flow imaging (CFI) to detect the shear wave's wavefront. When the shear wave vibration frequency satisfies the required frequency condition and the displacement amplitude satisfies the displacement amplitude condition, zero and maximum flow velocities appear at the shear wave vibration phases of zero and rad, respectively. These specific flow velocities produce the shear wave's wavefront map in CFI. An important feature of this method is that the shear wave propagation is observed in real time without addition of extra functions to the ultrasound imaging system. The experiments are performed using a 6.5 MHz CFI system. The shear wave is excited by a multilayer piezoelectric actuator. In a phantom experiment, the shear wave velocities estimated using the proposed method and those estimated using a system based on displacement measurement show good agreement.	[Yamakoshi, Yoshiki; Kasahara, Toshihiro; Iijima, Tomohiro; Yuminaka, Yasushi] Gunma Univ, Fac Sci & Technol, Kiryu, Gumma 3768515, Japan	Yamakoshi, Y (reprint author), Gunma Univ, Fac Sci & Technol, 1-5-1 Tenjin Cho, Kiryu, Gumma 3768515, Japan.	yamakoshi@gunma-u.ac.jp					Hoyt K, 2007, ULTRASOUND MED BIOL, V33, P1086, DOI 10.1016/j.ultrasmedbio.2007.01.009; Nightingale K, 2002, ULTRASOUND MED BIOL, V28, P227, DOI 10.1016/S0301-5629(01)00499-9; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Bamber J, 2013, ULTRASCHALL MED, V34, P169, DOI 10.1055/s-0033-1335205; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Hoyt K, 2008, PHYS MED BIOL, V53, P4063, DOI 10.1088/0031-9155/53/15/004; Nightingale K, 2003, ULTRASOUND MED BIOL, V29, P1715, DOI 10.1016/j.ultrasmedbio.2003.08.008; YAMAKOSHI Y, 1990, IEEE T ULTRASON FERR, V37, P45, DOI 10.1109/58.46969; Chen SG, 2009, IEEE T ULTRASON FERR, V56, P55, DOI 10.1109/TUFFC.2009.1005; KASAI C, 1985, IEEE T SON ULTRASON, V32, P458; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Parajuli K, 2013, JPN J APPL PHYS, V52; Sarvazyan P, 1998, ULTRASOUND MED BIOL, V24, P1419; Sarvazyan P, 2011, CURR MED IMAGING REV, V7, P255	15	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0161-7346	1096-0910		ULTRASONIC IMAGING	Ultrason. Imaging	OCT	2015	37	4					323	340		10.1177/0161734614568532		18	Acoustics; Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Engineering; Radiology, Nuclear Medicine & Medical Imaging	CS1KL	WOS:000361823100006		
J	Yamamoto, S; Hoshina, K; Hosaka, A; Shigematsu, K; Watanabe, T				Yamamoto, Satoshi; Hoshina, Katsuyuki; Hosaka, Akihiro; Shigematsu, Kunihiro; Watanabe, Toshiaki			Long-term outcomes of surgical treatment in patients with popliteal artery entrapment syndrome	VASCULAR			English	Article						Popliteal artery entrapment syndrome; vein grafting; musculotendinous section; bypass		The object of the study is to determine the long-term outcomes of surgical treatment of patients with popliteal artery entrapment syndrome at a single institute. We retrospectively reviewed 19 limbs of 16 consecutive patients who underwent surgery for popliteal artery entrapment syndrome at our hospital over the past 36 years. The popliteal artery was stenotic in 11 limbs, occlusive in 7 limbs, and compressed and deviated by the medial head of the gastrocnemius muscle but not damaged in 1 limb. Six limbs were treated with autologous saphenous vein bypass, 10 with bypass or venous patch graft concomitant with musculotendinous section, and 3 limbs underwent musculotendinous section alone. The 10-year cumulative patency of the 13 limbs treated with bypass was 100%, although two of them showed occlusion at 23 and 12 years after surgery. One patient who received a venous patch graft showed occlusion 15 years after surgery. Additionally, one asymptomatic patient with an apparently non-damaged popliteal artery who received preventive musculotendinous section alone showed stenosis of the artery 2 years after musculotendinous section. In conclusion, the bypass patency observed in this study was excellent in the long term. Careful examination of popliteal artery anatomy using imaging studies is essential for selecting the appropriate surgical procedure for popliteal artery entrapment syndrome.	[Yamamoto, Satoshi; Hoshina, Katsuyuki; Hosaka, Akihiro; Shigematsu, Kunihiro; Watanabe, Toshiaki] Tokyo Univ Hosp, Dept Vasc Surg, Tokyo 1138655, Japan	Hoshina, K (reprint author), Tokyo Univ Hosp, Dept Vasc Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	traruba@gmail.com					Pillai J, 2008, J VASC SURG, V48, P1189, DOI 10.1016/j.jvs.2008.06.057; Meier T, 2010, VASA, V39, P189, DOI 10.1024/0301-1526/a000027; RIGNAULT DP, 1985, INT ANGIOL, V4, P341; STEURER J, 1995, EUR J VASC ENDOVASC, V10, P243, DOI 10.1016/S1078-5884(05)80120-0; Levien LJ, 1999, J VASC SURG, V30, P587, DOI 10.1016/S0741-5214(99)70098-4; Ohara N, 2001, CARDIOVASC SURG, V9, P141, DOI 10.1016/S0967-2109(00)00110-1; Turnipseed WD, 2002, J VASC SURG, V35, P910, DOI 10.1067/mva.2002.123752; Lambert AW, 1999, BRIT J SURG, V86, P1365, DOI 10.1046/j.1365-2168.1999.01257.x; Gourgiotis Stavros, 2008, Vasc Health Risk Manag, V4, P83, DOI 10.2147/vhrm.2008.04.01.83; Levien Lewis J, 2003, Semin Vasc Surg, V16, P223, DOI 10.1016/S0895-7967(03)00028-0; Naylor SJ, 2000, VASCULAR SURG, V34, P665, DOI 10.1177/153857440003400635; Pillai J, 2008, J VASC SURG, V48, p61S, DOI 10.1016/j.jvs.2008.09.049	12	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1708-5381	1708-539X		VASCULAR	Vascular	OCT	2015	23	5					449	454		10.1177/1708538114560460		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CS1TK	WOS:000361850400001		
J	Watanabe, T; Tsuruoka, M; Narita, Y; Katsuya, R; Goshima, F; Kimura, H; Murata, T				Watanabe, Takahiro; Tsuruoka, Miyuki; Narita, Yohei; Katsuya, Ryotaro; Goshima, Fumi; Kimura, Hiroshi; Murata, Takayuki			The Epstein-Barr virus BRRF2 gene product is involved in viral progeny production	VIROLOGY			English	Article						EBV; BRRF2; Lytic replication; Phosphorylation	POLYMERASE PROCESSIVITY FACTOR; HUMAN CYTOMEGALOVIRUS; LYTIC REPLICATION; DNA-REPLICATION; LATENCY; BZLF1; IDENTIFICATION; REACTIVATION; PROTEINS; PROMOTER	The Epstein-Barr virus (EBV) predominantly establishes a latent infection in B lymphocytes, and occasionally switches from the latent state to the lytic cycle. In this report, we identified and examined the role of a lytic gene, BRRF2. We first prepared an antibody against BRRF2 and identified the gene product as a viral lytic protein expressed in B95-8 cells with late kinetics. Immunofluorescence revealed that BRRF2 localized in the cytoplasm of cells during the lytic phase. We also found that BRRF2 protein was phosphorylated in lytic cells, but the only viral protein kinase, BGLF4, was not involved in the phosphorylation. Knockout EBV and a repaired strain were then prepared, and we found that BRRF2 disruption did not affect viral gene expression and DNA replication, but decreased virus production. These results demonstrated that BRRF2 is involved in production of infectious progeny, although it is not essential for lytic replication. (C) 2015 Elsevier Inc. All rights reserved.	[Watanabe, Takahiro; Tsuruoka, Miyuki; Narita, Yohei; Katsuya, Ryotaro; Goshima, Fumi; Kimura, Hiroshi; Murata, Takayuki] Nagoya Univ, Grad Sch Med, Dept Virol, Showa Ku, Nagoya, Aichi 4668550, Japan	Murata, T (reprint author), Nagoya Univ, Grad Sch Med, Dept Virol, Showa Ku, Tsurumai Cho 65, Nagoya, Aichi 4668550, Japan.	tmurata@med.nagoya-u.ac.jp	Murata, Takayuki/I-2621-2013; Kimura, Hiroshi/I-2246-2012		Ministry of Education, Culture, Sports, Science and Technology, Japan [30470165, 15K08494, 25293109]; Ministry of Health, Labor and Welfare [H26-Nanchi-013]; Uehara Memorial Research Fund; Takeda Science Foundation; Kanae Foundation for Promotion of Medical Science; Kitamura Memorial Research Fund; General Assembly of the Japanese Association of Medical Sciences	We are grateful to Drs. T. Tsurumi, T. Kanda, S. Ohno, Y. Kawaguchi, W. Hammerschmidt, and H. J. Delecluse for scientific discussions and materials. This work was supported by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (30470165 and 15K08494 to T.M. and 25293109 to H.K.) and the Ministry of Health, Labor and Welfare (H26-Nanchi-013 to H.K.), and partly by the Uehara Memorial Research Fund, the Takeda Science Foundation, the Kanae Foundation for Promotion of Medical Science, the Kitamura Memorial Research Fund and the General Assembly of the Japanese Association of Medical Sciences (to T.M.).	Watanabe T, 2015, VIROLOGY, V483, P44, DOI 10.1016/j.virol.2015.04.007; Johnson DC, 2011, NAT REV MICROBIOL, V9, P382, DOI 10.1038/nrmicro2559; Kinoshita-Kikuta E, 2007, MOL CELL PROTEOMICS, V6, P356, DOI 10.1074/mcp.T600044-MCP200; Amon W, 2005, REV MED VIROL, V15, P149, DOI 10.1002/rmv.456; Bortz E, 2003, J VIROL, V77, P13425, DOI 10.1128/JVI.77.24.13425-13432.2003; Murata T, 2013, J VIROL, V87, P10148, DOI 10.1128/JVI.01002-13; Johannsen E, 2004, P NATL ACAD SCI USA, V101, P16286, DOI 10.1073/pnas.0407320101; Narita Y, 2013, J VIROL, V87, P2120, DOI 10.1128/JVI.02634-12; Cepok S, 2005, J CLIN INVEST, V115, P1352, DOI 10.1172/JCI200523661; Kawashima D, 2013, J VIROL, V87, P6482, DOI 10.1128/JVI.03428-12; Isomura H, 2004, J VIROL, V78, P12788, DOI 10.1128/JVI.78.23.12788-12799.2004; Sugimoto A, 2013, J VIROL, V87, P6693, DOI 10.1128/JVI.00219-13; Song MJ, 2005, P NATL ACAD SCI USA, V102, P3805, DOI 10.1073/pnas.0404521102; Neuhierl B, 2006, J VIROL, V80, P5078, DOI 10.1128/JVI.80.10.5078-5081.2006; Tsurumi T, 2005, REV MED VIROL, V15, P3, DOI 10.1002/rmv.441; Murata T, 2009, VIROLOGY, V389, P75, DOI 10.1016/j.virol.2009.04.007; Daikoku T, 2004, J BIOL CHEM, V279, P54817, DOI 10.1074/jbc.M405911200; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Nakayama S, 2010, J VIROL, V84, P12589, DOI 10.1128/JVI.01394-10; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; Lieberman PM, 2013, NAT REV MICROBIOL, V11, P863, DOI 10.1038/nrmicro3135; Daikoku T, 2005, J VIROL, V79, P3409, DOI 10.1128/JVI.79.6.3409-3418.2005; Murata T, 2014, REV MED VIROL, V24, P142, DOI 10.1002/rmv.1780; Isomura H, 2008, J VIROL, V82, P1638, DOI 10.1128/JVI.01917-07; Murata T, 2014, REV MED VIROL, V24, P242, DOI 10.1002/rmv.1786; Murata T, 2009, J BIOL CHEM, V284, P8033, DOI 10.1074/jbc.M808466200; Chiu YF, 2013, CELL HOST MICROBE, V14, P607, DOI 10.1016/j.chom.2013.11.009; Asai R, 2006, J VIROL, V80, P5125, DOI 10.1128/JVI.02674-05; Hammerschmidt W, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013029; Kawaguchi Y, 2003, J VIROL, V77, P2359, DOI 10.1128/JVI.77.4.2359-2368.2003; Murata Takayuki, 2013, Frontiers in Genetics, V4, P53, DOI 10.3389/fgene.2013.00053	31	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0042-6822			VIROLOGY	Virology	OCT	2015	484						33	40		10.1016/j.virol.2015.05.010		8	Virology	Virology	CR8CG	WOS:000361578100004		
J	Abe, H; Mine, J; Parchariyanon, S; Takemae, N; Boonpornprasert, P; Ubonyaem, N; Patcharasinghawut, P; Nuansrichay, B; Tanikawa, T; Tsunekuni, R; Saito, T				Abe, Haruka; Mine, Junki; Parchariyanon, Sujira; Takemae, Nobuhiro; Boonpornprasert, Prakit; Ubonyaem, Namfon; Patcharasinghawut, Phornnachat; Nuansrichay, Bandit; Tanikawa, Taichiro; Tsunekuni, Ryota; Saito, Takehiko			Co-infection of influenza A viruses of swine contributes to effective shuffling of gene segments in a naturally reared pig	VIROLOGY			English	Article						Swine influenza virus; IAV-S; Co-infection; Surveillance; Thailand; Bayesian MCMC	PANDEMIC H1N1 2009; REASSORTMENT; THAILAND; TRANSMISSION; INFECTION; HUMANS; ORIGIN; CHINA; DIVERSITY; EVOLUTION	Following the 2009 H1N1 pandemic, surveillance activities have been accelerated globally to monitor the emergence of novel reassortant viruses. However, the mechanism by which influenza A viruses of swine (IAV-S) acquire novel gene constellations through reassortment events in natural settings remains poorly understood. To explore the mechanism, we collected 785 nasal swabs from pigs in a farm in Thailand from 2011 to 2014. H3N2, H3N1, H1N1 and H1N2 lAVs-S were isolated from a single co-infected sample by plaque purification and showed a high degree of diversity of the genome. In particular, the H1N1 isolates, possessing a novel gene constellation previously unreported in Thailand, exhibited greater variation in internal genes than H3N2 lAVs-S. A pair of isolates, designated H3N2-B and H1N1-D, was determined to have been initially introduced to the farm. These results demonstrate that numerous IAVs-S with various gene constellations can be created in a single co-infected pig via reassortment (C) 2015 Elsevier Inc. All rights reserved.	[Abe, Haruka; Mine, Junki; Takemae, Nobuhiro; Tanikawa, Taichiro; Tsunekuni, Ryota; Saito, Takehiko] Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Influenza & Prion Dis Res Ctr, Tsukuba, Ibaraki 3050856, Japan; [Abe, Haruka; Mine, Junki; Takemae, Nobuhiro; Tanikawa, Taichiro; Tsunekuni, Ryota; Saito, Takehiko] Thailand Japan Zoonot Dis Collaborat Ctr ZDCC, Bangkok 10900, Thailand; [Parchariyanon, Sujira; Boonpornprasert, Prakit; Ubonyaem, Namfon; Patcharasinghawut, Phornnachat; Nuansrichay, Bandit] Natl Inst Anim Hlth, Bangkok 10900, Thailand	Saito, T (reprint author), Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Influenza & Prion Dis Res Ctr, Tsukuba, Ibaraki 3050856, Japan.	taksaito@affrc.go.jp			Program of the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan	We would like to thank the staff of the National Institute of Animal Health of Thailand for coordinating and supporting pig swab collection in Thailand. This work was supported by a Program of the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan.	Ngo LT, 2012, INFLUENZA OTHER RESP, V6, P6, DOI 10.1111/j.1750-2659.2011.00267.x; Ito T, 1998, J VIROL, V72, P7367; Poonsuk S, 2013, VET MICROBIOL, V167, P314, DOI 10.1016/j.vetmic.2013.09.007; Vijaykrishna D, 2011, NATURE, V473, P519, DOI 10.1038/nature10004; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P9, DOI 10.1007/BF02123572; Zhu HC, 2011, J VIROL, V85, P10432, DOI 10.1128/JVI.05352-11; Kitikoon P, 2011, VIRUS GENES, V43, P1, DOI 10.1007/s11262-011-0597-5; Ghedin E, 2009, J VIROL, V83, P8832, DOI 10.1128/JVI.00773-09; Peacey M, 2010, EMERG INFECT DIS, V16, P1618, DOI 10.3201/eid1610.100116; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132; Hiromoto Y, 2012, VIRUS RES, V169, P175, DOI 10.1016/j.virusres.2012.07.025; WEBSTER RG, 1992, MICROBIOL REV, V56, P152; Vincent A, 2014, ZOONOSES PUBLIC HLTH, V61, P4, DOI 10.1111/zph.12049; Liu W, 2010, CLIN INFECT DIS, V50, P1359, DOI 10.1086/652143; Pappas C, 2008, P NATL ACAD SCI USA, V105, P3064, DOI 10.1073/pnas.0711815105; Takemae N, 2008, INFLUENZA OTHER RESP, V2, P181, DOI 10.1111/j.1750-2659.2008.00062.x; Lam TTY, 2011, J VIROL, V85, P10279, DOI 10.1128/JVI.05262-11; Vincent AL, 2008, ADV VIRUS RES, V72, P127, DOI 10.1016/S0065-3527(08)00403-X; Lee CS, 2008, VIRUS GENES, V37, P168, DOI 10.1007/s11262-008-0251-z; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Fan XH, 2012, J VIROL, V86, P2375, DOI 10.1128/JVI.06824-11; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Salomon R, 2009, CELL, V136, P402, DOI 10.1016/j.cell.2009.01.029; Choi YK, 2005, J VIROL, V79, P10821, DOI 10.1128/JVI.79.16.10821-10825.2005; KIDA H, 1994, J GEN VIROL, V75, P2183, DOI 10.1099/0022-1317-75-9-2183; SCHOLTISSEK C, 1983, VIROLOGY, V129, P521, DOI 10.1016/0042-6822(83)90194-0; Howard WA, 2011, EMERG INFECT DIS, V17, P1049, DOI [10.3201/eid/1706.101886, 10.3201/eid1706.101886]; Manzoor R, 2009, J VIROL, V83, P1572, DOI 10.1128/JVI.01879-08; Karasin AI, 2004, J CLIN MICROBIOL, V42, P4349, DOI 10.1128/JCM.42.9.4349-4354.2004; Lindstrom S, 2012, EMERG INFECT DIS, V18, P834, DOI 10.3201/eid1805.111922; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; TIAN SF, 1985, J VIROL, V53, P771; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Zhou NN, 1999, J VIROL, V73, P8851; Charoenvisal N, 2013, VIRUS GENES, V47, P75, DOI 10.1007/s11262-013-0927-x; Chou YY, 2011, J VIROL, V85, P11235, DOI 10.1128/JVI.05794-11; Brown IH, 2013, CURR TOP MICROBIOL, V370, P133, DOI 10.1007/82_2011_194; Cong YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012591; Freidl GS, 2014, EUROSURVEILLANCE, V19, P1; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Lakdawala SS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002443; Murcia PR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002730; SCHOLTISSEK C, 1990, Medical Principles and Practice, V2, P65; Takemae N, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-537; Thrusfield M., 1995, VET EPIDEMIOLOGY	46	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0042-6822			VIROLOGY	Virology	OCT	2015	484						203	212		10.1016/j.virol.2015.06.002		10	Virology	Virology	CR8CG	WOS:000361578100022		
J	Imure, Y; Molho, M; Chuang, CK; Nagy, PD				Imure, Yoshiyuki; Molho, Melissa; Chuang, Chingkai; Nagy, Peter D.			Cellular Ubc2/Rad6 E2 ubiquitin-conjugating enzyme facilitates tombusvirus replication in yeast and plants	VIROLOGY			English	Article						Host factor; E2 ubiquitin-conjugating enzyme; Virus replication; Cell-free replication; Plant; ESCRT; AAA plus ATPase; Ubiquitin	BUSHY-STUNT-VIRUS; DEPENDENT RNA-POLYMERASE; VIRAL-RNA; ENDOPLASMIC-RETICULUM; ARABIDOPSIS-THALIANA; HOST INTERACTIONS; PROTEIN P-33; FREE-EXTRACT; MODEL HOST; IN-VITRO	Mono- and multi-ubiquitination alters the functions and subcellular localization of many cellular and viral proteins. Viruses can co-opt or actively manipulate the ubiquitin network to support viral processes or suppress innate immunity. Using yeast (Saccharomyces cerevisiae) model host, we show that the yeast Rad6p (radiation sensitive 6) E2 ubiquitin-conjugating enzyme and its plant ortholog, AtUbc2, interact with two tombusviral replication proteins and these E2 ubiquitin-conjugating enzymes could be co-purified with the tombusvirus replicase. We demonstrate that TBSV RNA replication and the mono- and bi-ubiquitination level of p33 is decreased in rad6 Delta yeast. However, plasmid-based expression of AtUbc2p could complement both defects in rad6 Delta yeast. Knockdown of UBC2 expression in plants also decreases tombusvirus accumulation and reduces symptom severity, suggesting that Ubc2p is critical for virus replication in plants. We provide evidence that Rad6p is involved in promoting the subversion of Vps23p and Vps4p ESCRT proteins for viral replicase complex assembly. (C) 2015 Elsevier Inc. All rights reserved.	[Imure, Yoshiyuki; Molho, Melissa; Chuang, Chingkai; Nagy, Peter D.] Univ Kentucky, Dept Plant Pathol, Lexington, KY 40546 USA	Imure, Y (reprint author), Nihon Univ, Coll Bioresource Sci, 1866 Kameino Fujisawa, Fujisawa, Kanagawa 2520880, Japan.	imura@brs.nihon-u.ac.jp; pdnagy2@uky.edu			Nihon University; NSF [MCB 1122039]	The authors thank to Dr. C. Boone (U. Toronto) for Cdc34<SUP>ts</SUP> yeast. This work was supported by a grant for Overseas Researcher from Nihon University to Y. I. and by NSF (MCB 1122039) to PDN.	Wang RYL, 2008, CELL HOST MICROBE, V3, P178, DOI 10.1016/j.chom.2008.02.005; Rajendran KS, 2002, J VIROL, V76, P1707, DOI 10.1128/JVI.76.4.1707-1717.2002; Pogany J, 2008, P NATL ACAD SCI USA, V105, P19956, DOI 10.1073/pnas.0810851105; Huang YW, 2012, CURR OPIN VIROL, V2, P676, DOI 10.1016/j.coviro.2012.10.002; Li ZH, 2008, J VIROL, V82, P6911, DOI 10.1128/JVI.00702-08; den Boon JA, 2010, CELL HOST MICROBE, V8, P77, DOI 10.1016/j.chom.2010.06.010; Shackelford J, 2004, MOL CELL BIOL, V24, P5089, DOI 10.1128/MCB.24.12.5089-5093.2004; Serviene E, 2006, J VIROL, V80, P1231, DOI 10.1128/JVI.80.3.1231-1241.2006; Qin B, 2013, PLANT PHYSIOL BIOCH, V66, P134, DOI 10.1016/j.plaphy.2013.02.013; Li ZJ, 2011, NAT BIOTECHNOL, V29, P361, DOI 10.1038/nbt.1832; Belov GA, 2012, CURR OPIN VIROL, V2, P740, DOI 10.1016/j.coviro.2012.09.006; Barajas D, 2009, J VIROL, V83, P11751, DOI 10.1128/JVI.00789-09; Li ZH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001175; de Castro IF, 2013, CELL MICROBIOL, V15, P24, DOI 10.1111/cmi.12029; Jaag HM, 2010, CELL HOST MICROBE, V7, P74, DOI 10.1016/j.chom.2009.12.009; Wang RYL, 2009, VIROLOGY, V394, P28, DOI 10.1016/j.virol.2009.08.003; Sasvari Z, 2013, J VIROL, V87, P1800, DOI 10.1128/JVI.02003-12; McCartney AW, 2005, PLANT CELL, V17, P3513, DOI 10.1105/tpc.105.036350; Shackelford J, 2005, ESSAYS BIOCHEM, V41, P139, DOI 10.1042/EB0410139; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Panavas T, 2003, VIROLOGY, V314, P315, DOI 10.1016/S0042-6822(03)00436-7; Sharma M, 2011, VIROLOGY, V415, P141, DOI 10.1016/j.virol.2011.04.008; Dinesh-Kumar SP, 2003, METH MOL B, V236, P287; Li ZH, 2009, VIROLOGY, V385, P245, DOI 10.1016/j.virol.2008.11.041; Pogany J, 2005, J VIROL, V79, P4859, DOI 10.1128/JVI.79.8.4859-4869.2005; ELLISON MJ, 1991, J BIOL CHEM, V266, P21150; Panavas T, 2005, VIROLOGY, V338, P81, DOI 10.1016/j.virol.2005.04.025; Jiang Y, 2006, J VIROL, V80, P7394, DOI 10.1128/JVI.02686-05; Pogany J, 2015, J VIROL, V89, P5714, DOI 10.1128/JVI.03711-14; Okumura A, 2006, P NATL ACAD SCI USA, V103, P1440, DOI 10.1073/pnas.0510518103; Xu K, 2015, P NATL ACAD SCI USA, V112, pE1782, DOI 10.1073/pnas.1418971112; Xu L, 2009, PLANT J, V57, P279, DOI 10.1111/j.1365-313X.2008.03684.x; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Cao Y, 2008, PLANT CELL, V20, P2586, DOI 10.1105/tpc.108.062760; Taylor JM, 2006, VIROLOGY, V344, P139, DOI 10.1016/j.virol.2005.09.032; Shulla A, 2012, CURR OPIN VIROL, V2, P725, DOI 10.1016/j.coviro.2012.09.013; Panaviene Z, 2005, J VIROL, V79, P10608, DOI 10.1128/JVI.79.16.10608-10618.2005; Jaag HM, 2009, VIROLOGY, V386, P344, DOI 10.1016/j.virol.2009.01.015; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Stork J, 2011, VIROLOGY, V409, P338, DOI 10.1016/j.virol.2010.10.015; Jonczyk M, 2007, VIROLOGY, V362, P320, DOI 10.1016/j.virol.2007.01.004; Wang RYL, 2009, J VIROL, V83, P3276, DOI 10.1128/JVI.02313-08; Pathak KB, 2008, VIROLOGY, V379, P294, DOI 10.1016/j.virol.2008.06.044; Mendu V, 2010, VIROLOGY, V406, P342, DOI 10.1016/j.virol.2010.07.022; Nagy PD, 2008, ANNU REV PHYTOPATHOL, V46, P217, DOI 10.1146/annurev.phyto.121407.093958; Li ZH, 2011, RNA BIOL, V8, P305, DOI 10.4161/rna.8.2.15391; Pogany J, 2012, J VIROL, V86, P12025, DOI 10.1128/JVI.01303-12; Pogany J, 2008, J VIROL, V82, P5967, DOI 10.1128/JVI.02737-07; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Panavas T, 2005, P NATL ACAD SCI USA, V102, P7326, DOI 10.1073/pnas.0502604102; Lindner HA, 2007, VIROLOGY, V362, P245, DOI 10.1016/j.virol.2006.12.035; Rajendran KS, 2003, J VIROL, V77, P9244, DOI 10.1128/JVI.77.17.9244.9258.2003; Chenon M, 2012, EMBO J, V31, P741, DOI 10.1038/emboj.2011.424; Alcaide-Loridan C, 2012, PLANT PHYSIOL, V160, P72, DOI 10.1104/pp.112.201905; Mine A, 2012, CURR OPIN VIROL, V2, P669, DOI 10.1016/j.coviro.2012.09.014; Strzalka W, 2013, J EXP BOT, V64, P859, DOI 10.1093/jxb/ers368; White KA, 2004, PROG NUCLEIC ACID RE, V78, P187, DOI 10.1016/S0079-6603(04)78005-8; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Serva S, 2006, J VIROL, V80, P2162, DOI 10.1128/JVI.80.5.2162-2169.2006; Sharma M, 2010, J VIROL, V84, P2270, DOI 10.1128/JVI.02003-09; Serviene E, 2005, P NATL ACAD SCI USA, V102, P10545, DOI 10.1073/pnas.0504844102; Usami Y, 2009, BIOCHEM SOC T, V37, P181, DOI 10.1042/BST0370181; Panaviene Z, 2004, J VIROL, V78, P8254, DOI 10.1128/JVI.78.15.8254-8263.2004; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Barajas D, 2010, VIROLOGY, V397, P358, DOI 10.1016/j.virol.2009.11.010; Barajas D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004087; Barajas D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000705; Chuang CK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003944; Kovalev N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004051; Lombardi C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003560; Nagy P.D., 2012, HOST, V2, P685; Nagy P.D., 2008, METHOD MOL BIOL, V451, P55; Nagy P.D., 2014, TRENDS MICROBIOL, V22, P309; Nagy P.D., 2006, VIROLOGY, V344, P211; Nagy P.D., 2012, NAT REV MICROBIOL, V10, P137; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Prasanth K.R., 2014, J VIROL; Sasvari Z, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002438; Sung R, 1991, EMBO J, V10, P2187; Zwirn R, 1997, CURR GENET, V32, P309	80	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0042-6822			VIROLOGY	Virology	OCT	2015	484						265	275		10.1016/j.virol.2015.05.022		11	Virology	Virology	CR8CG	WOS:000361578100029		
J	Isogai, M; Yoshida, T; Shimura, T; Yoshikawa, N				Isogai, Masamichi; Yoshida, Tetu; Shimura, Takuya; Yoshikawa, Nobuyuki			Pollen tubes introduce Raspberry bushy dwarf virus into embryo sacs during fertilization processes	VIROLOGY			English	Article						Raspberry bushy dwarf virus RBDV; Pollen-transmitted virus; Pollen transmission; Vertical transmission by pollen; Horizontal transmission by pollen; Torenia fournieri; Pollen tube; Embryo sac	MOTTLE-MOSAIC-VIRUS; SEED TRANSMISSION; TORENIA-FOURNIERI; YELLOWS DISEASE; RED RASPBERRY; PEA EMBRYO; 1ST REPORT; IN-VITRO; ASSOCIATION; CULTIVARS	We developed a fertilization method in which pollen tubes entered into embryo sacs without any need to contact surrounding female sporophytic cells by using Torenia fournieri (Torenia) plants under the condition of hindering movement of the virus from a stigma, which is the first infection site leading to systemic infection. When RBDV-infected Torenia pollen grains were used for the developed fertilization method, the virus was transmitted to the seeds by pollen tubes germinating from them. On the other hand, no seeds were infected with the virus when Torenia plants were pollinated with healthy Torenia pollen grains in combination with RBDV-infected raspberry pollen grains, which caused the virus infection in the stigma by penetration of their pollen tubes arrested in its style. Our results indicate that vertical transmission of RBDV by pollen occurs in the transport of the virus into embryo sacs by pollen tubes reaching the embryo sacs. (C) 2015 Elsevier Inc. All rights reserved.	[Isogai, Masamichi; Yoshida, Tetu; Shimura, Takuya; Yoshikawa, Nobuyuki] Iwate Univ, Plant Pathol Lab, Fac Agr, Morioka, Iwate 0208550, Japan	Isogai, M (reprint author), Iwate Univ, Plant Pathol Lab, Fac Agr, Ueda 3 Chome 18-8, Morioka, Iwate 0208550, Japan.	isogai@iwate-u.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan [26450051]	This work was supported in part by Grant-in-Aid for Scientific Research 26450051 from the Ministry of Education, Science, Sports, and Culture of Japan.	Isogai M, 2014, VIROLOGY, V452, P247, DOI 10.1016/j.virol.2014.02.001; Isogai M, 2011, J GEN PLANT PATHOL, V77, P304, DOI 10.1007/s10327-011-0323-0; Liu HW, 2014, PLANT PATHOL, V63, P72, DOI 10.1111/ppa.12065; DAUBENY HA, 1982, HORTSCIENCE, V17, P645; Martin RR, 2002, ACTA HORTIC, P265; WANG DW, 1994, PLANT CELL, V6, P777; BARNETT OW, 1970, ANN APPL BIOL, V65, P435, DOI 10.1111/j.1744-7348.1970.tb05512.x; JONES AT, 1982, ANN APPL BIOL, V100, P135, DOI 10.1111/j.1744-7348.1982.tb07200.x; Higashiyama T, 1997, PLANTA, V203, P101, DOI 10.1007/s004250050170; Moreno IM, 2004, J GEN VIROL, V85, P749, DOI 10.1099/vir.0.19540-0; Higashiyama T, 2001, SCIENCE, V293, P1480, DOI 10.1126/science.1062429; Card SD, 2007, AUSTRALAS PLANT PATH, V36, P455, DOI 10.1071/AP07050; BULGER MA, 1990, PLANT DIS, V74, P514, DOI 10.1094/PD-74-0514; Mavric I, 2003, PLANT DIS, V87, P1148, DOI 10.1094/PDIS.2003.87.9.1148D; JONES AT, 1979, J HORTIC SCI, V54, P267; KRANZ E, 1995, PLANT J, V8, P9, DOI 10.1046/j.1365-313X.1995.08010009.x; Amari K, 2009, J GEN VIROL, V90, P1767, DOI 10.1099/vir.0.009647-0; Pasquini G., 2006, Bulletin OEPP, V36, P287; Isogai M, 2012, J GEN PLANT PATHOL, V78, P360, DOI 10.1007/s10327-012-0392-8; Higashiyama T, 1998, PLANT CELL, V10, P2019; Quito-Avila DF, 2012, J VIROL METHODS, V179, P38, DOI 10.1016/j.jviromet.2011.09.016; MURANT AF, 1974, ANN APPL BIOL, V77, P271, DOI 10.1111/j.1744-7348.1974.tb01403.x; Roberts IM, 2003, PROTOPLASMA, V222, P31, DOI 10.1007/s00709-003-0015-5; Fauquet C. M., 2005, VIRUS TAXONOMY, P1063; GUILFORD VIVIAN B., 1952, BULL TORREY BOT CLUB, V79, P6, DOI 10.2307/2482102; Jones A. T., 1980, ACTA HORTIC, V95, P63; Matthews R.E.F., 1992, FUNDAMENTALS PLANT V, P205; Murant A. F., 1976, CMI AAB DESCRIPTION; Murant A. F., 1987, USDA AGR HDB, V631, P229; TAYLOR R. H., 1962, AUSTRALIAN JOUR EXPTL AGRIC AND ANIMAL HUSBANDRY, V2, P86, DOI 10.1071/EA9620086	30	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0042-6822			VIROLOGY	Virology	OCT	2015	484						341	345		10.1016/j.virol.2015.06.028		5	Virology	Virology	CR8CG	WOS:000361578100036		
J	Shimura, K; Miyazato, P; Oishi, S; Fujii, N; Matsuoka, M				Shimura, Kazuya; Miyazato, Paola; Oishi, Shinya; Fujii, Nobutaka; Matsuoka, Masao			Impact of HIV-1 infection pathways on susceptibility to antiviral drugs and on virus spread	VIROLOGY			English	Article						HIV-1; Cell-free; Cell-to-cell; Anti-HIV drug; Integration; Circular HIV-1 DNA	HUMAN-IMMUNODEFICIENCY-VIRUS; TO-CELL TRANSMISSION; ACTIVE ANTIRETROVIRAL THERAPY; RESPONSE CURVE SLOPE; REVERSE-TRANSCRIPTASE INHIBITORS; VIROLOGICAL SYNAPSES; INTEGRASE INHIBITORS; GENE-EXPRESSION; DOWN-REGULATION; RESIDUAL HIV-1	The infection routes of HIV-1 can affect several viral properties, including dissemination, pathogenesis, and immune evasion. In this study, we evaluated the inhibitory activity of a wide variety of anti-HIV drugs, focusing on the impact that different infection pathways have on their efficacy. Compared to cell-free infection, inhibitory activities were reduced in cell-to-cell productive transmission for all drugs tested. We detected weak reporter-expressing target cells after cell-to-cell transmission in the presence of integrase strand transfer inhibitors (INSTIs). Further analysis revealed that this expression was mainly due to unintegrated circular HIV (cHIV) DNAs, consisting of 1-LTR and 2-LTR circles. When in vitro-constructed cHIV DNAs were introduced into cells, the production of infectious and intercellular transmittable virions was observed, suggesting that cHIV DNA could be a source of infectious virus. These results highlight some advantages of the cell-to-cell infection mode for viral expansion, particularly in the presence of anti-retroviral drugs. (C) 2015 Elsevier Inc. All rights reserved.	[Shimura, Kazuya; Miyazato, Paola; Matsuoka, Masao] Kyoto Univ, Inst Virus Res, Kyoto 606, Japan; [Oishi, Shinya; Fujii, Nobutaka] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto, Japan	Shimura, K (reprint author), Kyoto Univ, Inst Virus Res, Lab Virus Control, Sakyo Ku, 53 Shogoin,Kawahara Cho, Kyoto 6068507, Japan.	kshimura@virus.kyoto-u.ac.jp		SHIMURA, Kazuya/0000-0001-7819-5184; Matsuoka, Masao/0000-0002-0473-754X	Ministry of Health and Welfare of Japan [24791021, 15K21084, H24-AIDS-Ippan-007]	We thank David N. Levy for pNLENG1-IRES, Luis M. Agosto and Walther H. Mothes for the protocol for DNA extraction from sorted fixed HIV-1-infected cells, and Linda Kingsbury for proofreading our manuscript. The following reagents were obtained through the NIH AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH: TDF and RAL (from Merck 82 Company, Inc.). This work was supported in part by a Grant-in-Aid for JSPS KAKENHI (to K.S: Nos. 24791021 and 15K21084) and a Grant-in-Aid for Research on HIV/AIDS from the Ministry of Health and Welfare of Japan (Grant no. H24-AIDS-Ippan-007) (to M.M: H24-AIDS-Ippan-007 [Research on HIV/AIDS]).	Abela L. A., 2012, PLOS PATHOG, V8; Agosto LM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003982; Gandhi RT, 2012, JAIDS-J ACQ IMM DEF, V59, P229, DOI 10.1097/QAI.0b013e31823fd1f2; Permanyer M, 2010, TRENDS MICROBIOL, V18, P543, DOI 10.1016/j.tim.2010.09.003; Shimura K, 2008, J VIROL, V82, P764, DOI 10.1128/JVI.01534-07; Deng K, 2012, J VIROL, V86, P11368, DOI 10.1128/JVI.01563-12; Nishikawa H, 2009, INT J BIOCHEM CELL B, V41, P891, DOI 10.1016/j.biocel.2008.08.039; GAO WY, 1993, J CLIN INVEST, V91, P2326, DOI 10.1172/JCI116463; Dale BM, 2013, IMMUNOL REV, V251, P113, DOI 10.1111/imr.12022; GUPTA P, 1989, J VIROL, V63, P2361; Mothes W, 2010, J VIROL, V84, P8360, DOI 10.1128/JVI.00443-10; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; DIMITROV DS, 1993, J VIROL, V67, P2182; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Gandhi M, 2014, NEW ENGL J MED, V371, P248, DOI 10.1056/NEJMct1215532; HAYASHI K, 1985, NUCLEIC ACIDS RES, V13, P3261, DOI 10.1093/nar/13.9.3261; Shimura K, 2010, J BIOL CHEM, V285, P39471, DOI 10.1074/jbc.M110.145789; Fujii N, 2003, ANGEW CHEM INT EDIT, V42, P3251, DOI 10.1002/anie.200351024; Martin N, 2010, J VIROL, V84, P3516, DOI 10.1128/JVI.02651-09; Massanella M, 2009, AIDS, V23, P183, DOI 10.1097/QAD.0b013e32831ef1a3; Sampah MES, 2011, P NATL ACAD SCI USA, V108, P7613, DOI 10.1073/pnas.1018360108; Lu R, 2004, J VIROL, V78, P658, DOI 10.1128/JVI.78.2.658-668.2004; Sahu GK, 2010, J VIROL, V84, P8348, DOI 10.1128/JVI.00362-10; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; De Clercq E, 2002, NAT REV DRUG DISCOV, V1, P13, DOI 10.1038/nrd703; Permanyer M, 2012, J VIROL, V86, P8773, DOI 10.1128/JVI.01044-12; Blanco J, 2004, J BIOL CHEM, V279, P51305, DOI 10.1074/jbc.M408547200; Chun TW, 2015, NAT IMMUNOL, V16, P584, DOI 10.1038/ni.3152; PANGANIBAN AT, 1984, CELL, V36, P673, DOI 10.1016/0092-8674(84)90347-7; Jacque JM, 2006, NATURE, V441, P641, DOI 10.1038/nature04682; Imbeault M, 2009, VIROLOGY, V393, P160, DOI 10.1016/j.virol.2009.07.009; SATO H, 1992, VIROLOGY, V186, P712, DOI 10.1016/0042-6822(92)90038-Q; Durham ND, 2012, J VIROL, V86, P7484, DOI 10.1128/JVI.00230-12; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Kelly J, 2008, VIROLOGY, V372, P300, DOI 10.1016/j.virol.2007.11.007; Piliero PJ, 2004, JAIDS-J ACQ IMM DEF, V37, pS2, DOI 10.1097/01.qai.0000137001.40505.56; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Groot F, 2008, BLOOD, V111, P4660, DOI 10.1182/blood-2007-12-130070; Zhong P, 2013, CURR OPIN VIROL, V3, P44, DOI 10.1016/j.coviro.2012.11.004; MATHEZ D, 1993, ANTIMICROB AGENTS CH, V37, P2206; Carter TL, 2001, BLOOD, V97, P572, DOI 10.1182/blood.V97.2.572; Trinite B, 2013, J VIROL, V87, P12701, DOI 10.1128/JVI.01939-13; DUGAICZYK A, 1975, J MOL BIOL, V96, P171, DOI 10.1016/0022-2836(75)90189-8; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Wu YT, 2003, J VIROL, V77, P10376, DOI 10.1128/JVI.77.19.10376-10382.2003; Van Loock M, 2013, J VIROL METHODS, V187, P238, DOI 10.1016/j.jviromet.2012.11.016; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Tanaka G, 2012, CHEM BIOL, V19, P1437, DOI 10.1016/j.chembiol.2012.09.011; Sharkey ME, 2000, NAT MED, V6, P76; Masuda R, 2012, BIOCONJUGATE CHEM, V23, P1259, DOI 10.1021/bc300084h; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Altenburg JD, 2010, J VIROL, V84, P2563, DOI 10.1128/JVI.00342-09; Agosto LM, 2007, VIROLOGY, V368, P60, DOI 10.1016/j.virol.2007.06.001; Brussel A, 2004, J VIROL, V78, P11263, DOI 10.1128/JVI.78.20.11263-11271.2004; Duncan CJA, 2013, AIDS, V27, P2201, DOI 10.1097/QAD.0b013e3283632ec4; Togami H, 2013, J VIROL, V87, P4322, DOI 10.1128/JVI.03208-12; Cara A, 1996, J BIOL CHEM, V271, P5393; Tamamura H, 2003, ORG BIOMOL CHEM, V1, P3663, DOI 10.1039/b306613b; Cara A, 2002, VIROLOGY, V292, P1, DOI 10.1006/vivro.2001.1243; Bruner KM, 2015, TRENDS MICROBIOL, V23, P192, DOI 10.1016/j.tim.2015.01.013; Donahue DA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-11; Emerson V, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-43; Gandhi RT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000321; Gillirn-Ross L, 2005, J GEN VIROL, V86, P765, DOI 10.1099/vir.0.80570-0; Kuhl BD, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-115; Otaka Akira, 2002, Angew Chem Int Ed Engl, V41, P2937, DOI 10.1002/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J; Puigdomenech I, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-89; Quah B.J., 2010, J VIS EXP, V44, pe2259, DOI DOI 10.3791/2259; Sakurai Y, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-114; Sharkey M., 2011, PLOS PATHOG, V7; Sloan RD, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-52; Thierry S, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0153-9; Titanji BK, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-161; Zhong P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053138	76	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0042-6822			VIROLOGY	Virology	OCT	2015	484						364	376		10.1016/j.virol.2015.06.029		13	Virology	Virology	CR8CG	WOS:000361578100039		
J	Hayashi, N; Izumi, K; Sano, F; Miyoshi, Y; Uemura, H; Kasuya, T; Mukai, A; Hata, M; Inoue, T				Hayashi, Narihiko; Izumi, Koji; Sano, Futoshi; Miyoshi, Yasuhide; Uemura, Hiroji; Kasuya, Takeo; Mukai, Akiko; Hata, Masayuki; Inoue, Tomio			Ten-year outcomes of I-125 low-dose-rate brachytherapy for clinically localized prostate cancer: a single-institution experience in Japan	WORLD JOURNAL OF UROLOGY			English	Article						Prostate cancer; Brachytherapy; Localized; Monotherapy; Asian	ANDROGEN-DEPRIVATION THERAPY; RADICAL PROSTATECTOMY; RADIATION-THERAPY; SURVIVAL OUTCOMES; RISK; RADIOTHERAPY; INTERMEDIATE; MULTICENTER; MEN	To report 10-year outcomes of patients treated with I-125 low-dose-rate brachytherapy (BT) for clinically localized prostate cancer. A group of 1,060 patients with clinically localized prostate cancer treated with I-125 BT between March 2004 and December 2013 at the Yokohama City University Hospital were identified. The records of 743 patients with a minimum of 2 years of follow-up were reviewed. Cohorts were categorized according to National Comprehensive Cancer Network risk classification, and biochemical outcomes plus overall survival were examined. Biochemical failure was defined as nadir prostate-specific antigen (PSA) level + 2 ng/mL. Univariate and multivariate Cox proportional hazards were used to determine predictors of biochemical failure. A total of 743 patients met the criteria with a median follow-up of 54.6 months (range 24-114 months). The median age was 70 years (range 48-83). The 5- and 7-year overall survival rates were 98.8 and 97.6 %, and the 5- and 7-year biochemical failure-free survival rates were 92.6 and 91.0 %, respectively. With regard to distant metastases and survival, the 5- and 7-year metastatic-free survival rates were 98.2 and 95.9 %, respectively. A multivariate analysis revealed that initial PSA (p = 0.005; HR 1.097, 95 % CI 1.028-1.170), age (p = 0.001; HR 0.931, 95 % CI 0.893-0.971), and T stage (T1c vs. T2a) (p = 0.002; HR2.417, 95 % CI 1.319-4.267) were independent predictors of biochemical failure. I-125 low-dose-rate BT resulted in excellent survival and morbidity outcomes for localized prostate cancer at a single institution. Further studies are needed to obtain long-term outcomes.	[Hayashi, Narihiko; Izumi, Koji; Sano, Futoshi; Miyoshi, Yasuhide; Uemura, Hiroji] Yokohama City Univ, Sch Med, Dept Urol, Yokohama, Kanagawa 232, Japan; [Kasuya, Takeo; Mukai, Akiko; Hata, Masayuki; Inoue, Tomio] Yokohama City Univ, Sch Med, Dept Radiol, Yokohama, Kanagawa 232, Japan	Hayashi, N (reprint author), Yokohama City Univ, Sch Med, Dept Urol, Yokohama, Kanagawa 232, Japan.	twnary@yahoo.co.jp					Akaza Hideyuki, 2012, Jpn J Clin Oncol, V42, P226, DOI 10.1093/jjco/hyr194; Cooperberg MR, 2010, J CLIN ONCOL, V28, P1117, DOI 10.1200/JCO.2009.26.0133; Zelefsky MJ, 2012, BJU INT, V110, P1696, DOI 10.1111/j.1464-410X.2012.11385.x; D'Amico AV, 2009, J CLIN ONCOL, V27, P3923, DOI 10.1200/JCO.2008.20.3992; Zelefsky MJ, 2007, INT J RADIAT ONCOL, V67, P327, DOI 10.1016/j.ijrobp.2006.08.056; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Kibel AS, 2012, J UROLOGY, V187, P1259, DOI 10.1016/j.juro.2011.11.084; Morris WJ, 2013, CANCER-AM CANCER SOC, V119, P1537, DOI 10.1002/cncr.27911; HOLM HH, 1981, J UROLOGY, V125, P385; Kimura T, 2014, INT J UROL, V21, P473, DOI 10.1111/iju.12347; Williams S, 2013, LANCET ONCOL, V14, pE524, DOI 10.1016/S1470-2045(13)70451-0; Taira AV, 2011, INT J RADIAT ONCOL, V79, P1336, DOI 10.1016/j.ijrobp.2010.01.005; Potters L, 2008, J UROLOGY, V179, pS20, DOI 10.1016/j.juro.2008.03.133; Schroeck FR, 2008, EUR UROL, V54, P785, DOI 10.1016/j.eururo.2008.06.063; Cooperberg MR, 2010, CANCER-AM CANCER SOC, V116, P5226, DOI 10.1002/cncr.25456; Jones CU, 2011, NEW ENGL J MED, V365, P107, DOI 10.1056/NEJMoa1012348; Ueno S, 2006, INT J UROL, V13, P1494, DOI 10.1111/j.1442-2042.2006.01604.x; Grimm P, 2012, BJU INT, V109, P22, DOI 10.1111/j.1464-410X.2011.10827.x; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; Walz J, 2007, J CLIN ONCOL, V25, P3576, DOI 10.1200/JCO.2006.10.3820; Cooperberg MR, 2009, J CLIN ONCOL, V27, P4306, DOI 10.1200/JCO.2008.21.5228; Gwede CK, 2006, CANCER, V107, P620; Konaka H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-110; Marshall RA, 2014, UROL ONCOL, V32	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0724-4983	1433-8726		WORLD J UROL	World J. Urol.	OCT	2015	33	10					1519	1526		10.1007/s00345-015-1480-0		8	Urology & Nephrology	Urology & Nephrology	CS1QH	WOS:000361841900019		
J	Mibu, H; Tanaka, N; Hosokawa, Y; Kumamoto, H; Margami, N; Hirao, Y; Fujimoto, K				Mibu, Hisakazu; Tanaka, Nobumichi; Hosokawa, Yukinari; Kumamoto, Hiromi; Margami, Nagaaki; Hirao, Yoshihiko; Fujimoto, Kiyohide			Estimated functional renal parenchymal volume predicts the split renal function following renal surgery	WORLD JOURNAL OF UROLOGY			English	Article						Renal function; Renal volume; Nephrectomy; Nephron-sparing surgery; 3-D image reconstruction	NEPHRON-SPARING SURGERY; CELL CARCINOMA; PARTIAL NEPHRECTOMY; RADICAL NEPHRECTOMY; TERM; PRESERVATION; KIDNEY	The change in functional renal volume (FRV) has an absolute influence on renal function after nephrectomy (Nx) or nephron-sparing surgery (NSS). In this study, we prospectively examined whether the postoperative renal function following Nx and NSS could be accurately predicted and assessed the reproducibility of our newly developed 3-D image reconstruction system (Kashihara) to measure the FRV. We enrolled 98 patients who underwent Nx and 41 patients who underwent NSS from April 2006 to September 2009 to predict postoperative FRV and renal function. FRV was measured before and after (1 month and 1 year) renal surgery. The postoperative estimated glomerular filtration rate (eGFR) was predicted from the preoperative eGFR calculated from the serum creatinine (sCr) level and the ratio of the postoperative/preoperative FRV. To assess the reproducibility and accuracy of our newly developed 3-dimensional (3-D) image reconstruction system, FRV was measured by five examiners using images obtained by CT (five cases) and MRI (five cases). Significant correlation was found both for FRV and for renal function between the predictive values and the actually measured values at 1 month and 1 year after surgery, not only in the Nx group, but also in the NSS group. The accuracy and reproducibility could be confirmed both with CT and MRI studies. The postoperative FRV and renal function could be predicted preoperatively using a 3-D image reconstructive system, preoperative routine diagnostic imaging, and preoperative sCr level.	[Mibu, Hisakazu; Tanaka, Nobumichi; Hosokawa, Yukinari; Kumamoto, Hiromi; Hirao, Yoshihiko; Fujimoto, Kiyohide] Nara Med Univ, Dept Urol, Kashihara, Nara 6348522, Japan; [Mibu, Hisakazu] Nara Prefectural Gojyo Hosp, Dept Urol, Gojyo, Nara, Japan; [Hosokawa, Yukinari] Kikkoukai Tane Hosp, Dept Urol, Osaka, Japan; [Kumamoto, Hiromi] Saiseikai Nara Hosp, Dept Urol, Nara, Japan; [Margami, Nagaaki] Nara Med Univ, Dept Radiol, Nara, Japan	Tanaka, N (reprint author), Nara Med Univ, Dept Urol, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	sendo@naramed-u.ac.jp			Osaka Kidney Foundation [OKF08-0001]	The present study was supported by a Grant from the Osaka Kidney Foundation (OKF08-0001).	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; LICHT MR, 1994, J UROLOGY, V152, P39; Ibrahim HN, 2009, NEW ENGL J MED, V360, P459, DOI 10.1056/NEJMoa0804883; ANDERSON RG, 1991, J UROLOGY, V145, P11; Hirao Y, 2002, JPN J CLIN ONCOL, V32, P95, DOI 10.1093/jjco/hyf023; Joniau S, 2006, NAT CLIN PRACT UROL, V3, P198, DOI 10.1038/ncpuro0458; Mir MC, 2013, UROLOGY, V82, P263, DOI 10.1016/j.urology.2013.03.068; Kunzel B, 2013, CAN J UROL, V20, P6714; Lau WKO, 2000, MAYO CLIN PROC, V75, P1236; Simmons MN, 2012, J UROLOGY, V187, P1667, DOI 10.1016/j.juro.2011.12.068; Funahashi Y, 2009, UROLOGY, V74, P708, DOI 10.1016/j.urology.2008.11.008; Tanaka N, 2004, UROLOGY, V64, P904, DOI 10.1016/j.urology.2004.07.006; HIGASHIHARA E, 1990, J UROLOGY, V143, P239; Clark ATD, 2008, EUR UROL, V54, P143, DOI 10.1016/j.eururo.2008.03.037; STEINBACH F, 1992, J UROLOGY, V148, P24; Gilbert Scott M, 2003, Curr Oncol Rep, V5, P239, DOI 10.1007/s11912-003-0116-5; Novick AC, 2004, CLIN CANCER RES, V10, p6322S, DOI 10.1158/1078-0432.CCR-050003	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0724-4983	1433-8726		WORLD J UROL	World J. Urol.	OCT	2015	33	10					1571	1577		10.1007/s00345-014-1470-7		7	Urology & Nephrology	Urology & Nephrology	CS1QH	WOS:000361841900025		
J	Sharifi-Rad, J; Hoseini-Alfatemi, SM; Sharifi-Rad, M; da Silva, JAT				Sharifi-Rad, Javad; Hoseini-Alfatemi, Seyedeh Mahsan; Sharifi-Rad, Majid; da Silva, Jaime A. Teixeira			Antibacterial, antioxidant, antifungal and anti-inflammatory activities of crude extract from Nitraria schoberi fruits	3 BIOTECH			English	Article						Agar disc diffusion method; Antifungal activity; Anti-inflammatory activity; Antioxidant activity; Antimicrobial activity; Zygophyllaceae	RESISTANT STAPHYLOCOCCUS-AUREUS; MEDICINAL-PLANTS; PSEUDOMONAS-AERUGINOSA; ANTIMICROBIAL ACTIVITY; NATURAL-PRODUCTS; DRUG DISCOVERY; ESSENTIAL OILS; INFECTIONS; FLAVONOIDS; AGENTS	This study is the first comprehensive investigation of the antibacterial, antioxidant, antifungal and anti-inflammatory activities of a crude extract from Nitraria schoberi L. (Zygophyllaceae) fruits. The extract was tested against four Gram-negative (Pseudomonas aeruginosa, Enterobacter aerogenes, Klebsiella pneumoniae and Acinetobacter lwoffii) and one Gram-positive (Staphylococcus aureus) bacteria using the agar disc diffusion and microdilution methods. P. aeruginosa was inhibited the most (widest inhibition zone) while K. pneumonia showed the largest MIC value. The antioxidant activity of fruits (0.02 mg/mL vs. 0.04, 0.06 and 1.00 mg/mL for alpha-tocopherol, butylated hydroxyanisole and ascorbic acid, respectively) was determined by the paired diene method. The antifungal activity of N. schoberi fruits was tested against different fungi, including Aspergillus niger and Candida albicans, with 300 mu g/mL of fruit extract being the most effective concentration. The percentage of anti-inflammatory activity assayed for N. schoberi fruit extract at 100, 200 and 500 mu g/mL was 36.12, 59.89 and 88.33 %, respectively. N. schoberi fruits possess potent antibacterial, antioxidant, antifungal and anti-inflammatory properties, and may be used as an antibacterial and antifungal to treat diseases and/or as a protective agent against disorders associated with oxidative stress and inflammation.	[Sharifi-Rad, Javad] Zabol Univ Med Sci, Zabol Med Plants Res Ctr, Zabol, Iran; [Sharifi-Rad, Javad] Zabol Univ Med Sci, Fac Pharm, Dept Pharmacognosy, Zabol, Iran; [Hoseini-Alfatemi, Seyedeh Mahsan] Shahid Beheshti Univ Med Sci, Mofid Children Hosp, Pediat Infect Res Ctr, Tehran, Iran; [Sharifi-Rad, Majid] Univ Zabol, Fac Nat Resources, Dept Range & Watershed Management, Zabol, Iran; [da Silva, Jaime A. Teixeira] Miki Cho Post Off, Miki, Kagawa 7610799, Japan	Sharifi-Rad, J (reprint author), Zabol Univ Med Sci, Fac Pharm, Dept Pharmacognosy, Zabol, Iran.	javad.sharifirad@gmail.com; m.hoseinialfatemi@gmail.com		Sharifi-Rad, Javad/0000-0002-7301-8151	Department of Range and Watershed Management, Faculty of Natural Resources, University of Zabol	The authors are very grateful to Department of Range and Watershed Management, Faculty of Natural Resources, University of Zabol for supports in this study.	Ahmed Z, 2013, SAUDI J BIOL SCI, V20, P79, DOI 10.1016/j.sjbs.2012.10.005; Chopra I, 2007, J ANTIMICROB CHEMOTH, V59, P587, DOI 10.1093/jac/dkm006; Alfatemi SMH, 2015, 3 BIOTECH, V5, P39, DOI 10.1007/s13205-014-0197-x; Tepe B, 2004, FOOD CHEM, V84, P519, DOI 10.1016/S0308-8146(03)00267-X; Bouayed J, 2007, FOOD CHEM, V104, P364, DOI 10.1016/j.foodchem.2006.11.069; Perry G, 2000, FREE RADICAL BIO MED, V28, P831, DOI 10.1016/S0891-5849(00)00158-1; Kim JS, 2006, DIAGN MICR INFEC DIS, V56, P289, DOI 10.1016/j.diagmicrobio.2006.05.003; Ahmad I, 2001, J ETHNOPHARMACOL, V74, P113, DOI 10.1016/S0378-8741(00)00335-4; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Lavigne JP, 2013, INT J ANTIMICROB AG, V41, P130, DOI 10.1016/j.ijantimicag.2012.10.010; Balunas MJ, 2005, LIFE SCI, V78, P431, DOI 10.1016/j.lfs.2005.09.012; AURELI P, 1992, J FOOD PROTECT, V55, P344; Jeyaraj M, 2013, J IND ENG CHEM, V19, P1299, DOI 10.1016/j.jiec.2012.12.031; Ray GT, 2013, DIAGN MICR INFEC DIS, V76, P24, DOI 10.1016/j.diagmicrobio.2013.02.020; HAVSTEEN B, 1983, BIOCHEM PHARMACOL, V32, P1141, DOI 10.1016/0006-2952(83)90262-9; Pottinger PS, 2013, MED CLIN N AM, V97, P601, DOI 10.1016/j.mcna.2013.02.005; Mabona U, 2013, J ETHNOPHARMACOL, V148, P45, DOI 10.1016/j.jep.2013.03.056; Wright GD, 2010, CURR OPIN MICROBIOL, V13, P589, DOI 10.1016/j.mib.2010.08.005; Zecconi A, 2013, IMMUNOL LETT, V150, P12, DOI 10.1016/j.imlet.2013.01.004; Rad J. S., 2014, International Journal of Biosciences (IJB), V4, P217; Patwardhan B, 2005, J ETHNOPHARMACOL, V100, P50, DOI 10.1016/j,jep.2005.06.006; Garn H, 2013, J ALLERGY CLIN IMMUN, V131, P1465, DOI 10.1016/j.jaci.2013.04.031; Arif T, 2009, J ASIAN NAT PROD RES, V11, P621, DOI 10.1080/10286020902942350; Choi CW, 2002, PLANT SCI, V163, P1161, DOI 10.1016/S0168-9452(02)00332-1; Clinical and Laboratory Standards Institute (CLSI), 2010, M100S20 CLSI; Hadj SJ, 2011, FOOD CHEM, V124, P486, DOI [10.1016/j.foodchem.2010.06.059, DOI 10.1016/J.FOODCHEM.2010.06.059]; Hyun E, 2004, BRIT J PHARMACOL, V143, P618, DOI 10.1038/sj.bjp.0705854; LINGNERT H, 1979, Journal of Food Processing and Preservation, V3, P87, DOI 10.1111/j.1745-4549.1979.tb00574.x; Nivas D., 2010, Pharmacognosy Journal, V2, P151; O'Malley M, 2009, J HAND SURG-AM, V34A, P504, DOI 10.1016/j.jhsa.2008.11.021; Padmanabhan P, 2012, INT J APP BASIC MED, V2, P109; Rad JS, 2014, J BIOL ACTIVE PRODUC, V4, P44; Rad Javad Sharifi, 2013, Anc Sci Life, V33, P109, DOI 10.4103/0257-7941.139050; Rad JS, 2013, AM J ADVAN DRUG DELI, V1, P1; Rathinavelu S, 2003, MICROBES INFECT, V5, P651, DOI 10.1016/S1286-4579(03)00099-6; Senejoux F, 2012, J ETHNOPHARMACOL, V141, P629, DOI 10.1016/j.jep.2011.08.012; Sharifi-Rad J, 2015, J FOOD SAFETY, V35, P19, DOI 10.1111/jfs.12139; Suo YR, 2010, EUR J LIPID SCI TECH, V112, P390, DOI 10.1002/ejlt.200900062; Tam PYI, 2013, PEDIATR CLIN N AM, V60, P437, DOI 10.1016/j.pcl.2012.12.009; Thitilertdecha N., 2008, FOOD SCI TECHNOLOGY, V41, P2029, DOI DOI 10.1016/J.LWT.2008.01.017; Tulyaganov TS, 2003, CHEM NAT COMPD+, V39, P292, DOI 10.1023/A:1025482821368; Wayne PA, 2006, CLSIM7A7, V7th	42	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	2190-5738	2190-572X		3 BIOTECH	3 Biotech	OCT	2015	5	5					677	684		10.1007/s13205-014-0266-1		8	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CR6ML	WOS:000361461400010		
J	Onishi, Y; Prihanto, AA; Yano, S; Takagi, K; Umekawa, M; Wakayama, M				Onishi, Yohei; Prihanto, Asep A.; Yano, Shigekazu; Takagi, Kazuyoshi; Umekawa, Midori; Wakayama, Mamoru			Effective treatment for suppression of acrylamide formation in fried potato chips using L-asparaginase from Bacillus subtilis	3 BIOTECH			English	Article						Asparaginase; Bacillus subtilis; Acrylamide; Mitigation; Potato chips	FRENCH FRIES; MAILLARD REACTION; ESCHERICHIA-COLI; FOODS; REDUCTION; PRODUCTS	It has been reported that acrylamide, a potential carcinogen, is formed from the reaction of L-asparagine (L-Asn) and reducing sugars contained in foods during heating processes and free asparagine is a limiting factor for acrylamide formation. It has been reported that potato products such as potato chips, which are made through heating processes, contain high levels of acrylamide. To decrease the amount of L-Asn in potatoes using L-asparaginase, effective treatment conditions of sliced potatoes with the enzyme have been investigated. By treating sliced potatoes with Bacillus subtilis L-asparaginase II (BAsnase; 4 U/g potato), appriximately 40 % of L-Asn in the sliced potatoes was converted into L-aspartic acid (L-Asp). To make this enzyme more effective, prior to enzymatic treatment, sliced potatoes were freeze-thawed, dried at 90 A degrees C for 20 min, and vacuum treated for 10 min under decompressed condition, resulting in the hydrolysis of approximately 90 % of L-Asn to L-Asp. The acrylamide content of BAsnase-treated fried potato chips decreased to below 20 % of that of BAsnase-untreated fried potato chips. Treatment conditions examined in this study were found to be effective to suppress the formation of acrylamide in fried potato chips.	[Onishi, Yohei; Prihanto, Asep A.; Umekawa, Midori; Wakayama, Mamoru] Ritsumeikan Univ, Fac Life Sci, Dept Biotechnol, Shiga 5258577, Japan; [Yano, Shigekazu] Yamagata Univ, Grad Sch Sci & Engn, Dept Biochem Engn, Yonezawa, Yamagata 9928510, Japan; [Takagi, Kazuyoshi] Ritsumeikan Univ, Fac Life Sci, Dept Appl Chem, Shiga 5258577, Japan	Wakayama, M (reprint author), Ritsumeikan Univ, Fac Life Sci, Dept Biotechnol, 1-1-1 Nojihigashi, Shiga 5258577, Japan.	wakayama@sk.ritsumei.ac.jp			Directorate General of Higher Education (DGHE), Ministry of Education and Culture, Republic of Indonesia	The second author is grateful to Directorate General of Higher Education (DGHE), Ministry of Education and Culture, Republic of Indonesia, for financial support.	Rydberg P, 2003, J AGR FOOD CHEM, V51, P7012, DOI [10.1021/jf034649+, 10.1021/jf034649]; Amrein TM, 2003, J AGR FOOD CHEM, V51, P5556, DOI 10.1021/jf034344v; Amrein TM, 2004, J AGR FOOD CHEM, V52, P4282, DOI 10.1021/jf049648b; Zyzak DV, 2003, J AGR FOOD CHEM, V51, P4782, DOI 10.1021/jf034180i; Pedreschi F, 2008, FOOD CHEM, V109, P386, DOI 10.1016/j.foodchem.2007.12.057; CLAVELL LA, 1986, NEW ENGL J MED, V315, P657, DOI 10.1056/NEJM198609113151101; CEDAR H, 1967, J BIOL CHEM, V242, P3753; Stadler RH, 2002, NATURE, V419, P449, DOI 10.1038/419449a; Rommens CM, 2008, PLANT BIOTECHNOL J, V6, P843, DOI 10.1111/j.1467-7652.2008.00363.x; Bunger A, 2003, FOOD RES INT, V36, P161, DOI 10.1016/S0963-9969(02)00131-X; Pedreschi F, 2006, FOOD RES INT, V39, P40, DOI 10.1016/j.foodres.2005.06.001; Yaylayan VA, 2003, J AGR FOOD CHEM, V51, P1753, DOI 10.1021/jf0261506; Becalski A, 2003, J AGR FOOD CHEM, V51, P802, DOI 10.1021/jf020889y; Mottram DS, 2002, NATURE, V419, P448, DOI 10.1038/419448a; Pedreschi F, 2007, J FOOD ENG, V79, P1287, DOI 10.1016/j.jfoodeng.2006.04.014; Hendriksen HV, 2009, J AGR FOOD CHEM, V57, P4168, DOI 10.1021/jf900174q; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Rosen J, 2002, ANALYST, V127, P880, DOI 10.1039/b204938d; Ishihara K, 2006, BIOSCI BIOTECH BIOCH, V70, P1616, DOI 10.1271/bbb.50680; Jia MM, 2013, J AGR FOOD CHEM, V61, P9428, DOI 10.1021/jf402636w; Onishi Y, 2011, ANN MICROBIOL, V61, P517, DOI 10.1007/s13213-010-0167-4; Prihanto AA, 2014, BIOTECH, V3; Theantana T., 2009, International Journal of Integrative Biology, V7, P1; Tsutsumiuchi K, 2004, J FOOD HYG SOC JPN, V45, P95; Yano S, 2008, ANN MICROBIOL, V58, P711	25	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	2190-5738	2190-572X		3 BIOTECH	3 Biotech	OCT	2015	5	5					783	789		10.1007/s13205-015-0278-5		7	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CR6ML	WOS:000361461400020		
J	Oda, E				Oda, Eiji			High-sensitivity C-reactive protein, but not white blood cell count, independently predicted incident diabetes in a Japanese health screening population	ACTA DIABETOLOGICA			English	Article						Incident diabetes; High-sensitivity CRP; White blood cell count; Non-obese population; Inflammation	MIDDLE-AGED MEN; METABOLIC SYNDROME; ADIPOSE-TISSUE; INSULIN-RESISTANCE; INFLAMMATORY MARKERS; POSTMENOPAUSAL WOMEN; LEUKOCYTE COUNT; RISK; OBESITY; DISEASE	Aims To compare high-sensitivity C-reactive protein (hs-CRP) and white blood cell count (WBC) as a predictor of incident diabetes in a population where obesity is not prevalent. Methods This is a retrospective 6-year follow-up study in a Japanese health screening population including 1874 men and 1094 women. Using Cox regression methods, hazard ratios (HRs) of incident diabetes for hs-CRP and WBC adjusting for fasting plasma glucose (FPG), hemoglobin A1c (HbA1c) and other confounders were calculated, and using areas under receiver operating characteristic curve (AUCs), diabetes-predicting abilities of hs-CRP and WBC were compared. Diabetes was defined as FPG a parts per thousand yen 126 mg/dL and HbA1c a parts per thousand yen 6.5 % or use of antidiabetic medication. Results During the 6-year follow-up period (mean +/- A SD, 4.8 +/- A 1.7 years), 71 men (3.8 %) and 19 women (1.7 %) developed incident diabetes. The fully adjusted HRs [95 % confidence intervals (CIs)] of incident diabetes for each 1 SD increase in log hs-CRP and WBC were 1.20 (0.92-1.56) (p = 0.174) and 1.01 (0.78-1.30) (p = 0.946), respectively. The fully adjusted HRs (95 % CIs) of incident diabetes for the highest tertile of hs-CRP and WBC compared with the lowest tertile were 2.57 (1.05-6.27) (p = 0.039) and 1.20 (0.53-2.70) (p = 0.665), respectively. The AUCs (95 % CIs) of hs-CRP and WBC for the discrimination of incident diabetes were 0.73 (0.68-0.77) and 0.67 (0.62-0.72), respectively. Conclusions Hs-CRP, but not WBC, was independently associated with incident diabetes in a Japanese health screening population where obesity is not prevalent.	Tachikawa Med Ctr, Med Check Ctr, Nagaoka, Niigata 9400053, Japan	Oda, E (reprint author), Tachikawa Med Ctr, Med Check Ctr, Nagachou 2-2-16, Nagaoka, Niigata 9400053, Japan.	ijie@venus.sannet.ne.jp					Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702; Fadini GP, 2012, ACTA DIABETOL, V49, P445, DOI 10.1007/s00592-012-0402-5; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Oda E, 2010, INTERNAL MED, V49, P117, DOI 10.2169/internalmedicine.49.2670; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Freeman DJ, 2002, DIABETES, V51, P1596, DOI 10.2337/diabetes.51.5.1596; Margolis KL, 2005, ARCH INTERN MED, V165, P500, DOI 10.1001/archinte.165.5.500; Jung CH, 2008, INT J CARDIOL, V129, P266, DOI 10.1016/j.ijcard.2007.07.092; Oda E, 2012, ACTA DIABETOL, V49, P89, DOI 10.1007/s00592-011-0309-6; Bains RK, 2004, ENDOCRINOLOGY, V145, P2666, DOI 10.1210/en.2003-1608; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Tamakoshi K, 2007, CIRC J, V71, P479, DOI 10.1253/circj.71.479; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Thorand B, 2003, ARCH INTERN MED, V163, P93, DOI 10.1001/archinte.163.1.93; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI2000319246; Han TS, 2002, DIABETES CARE, V25, P2016, DOI 10.2337/diacare.25.11.2016; Wannamethee SG, 2007, DIABETES CARE, V30, P1200, DOI 10.2337/dc06-2416; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Chao C, 2010, ARCH INTERN MED, V170, P1557, DOI 10.1001/archinternmed.2010.312; Barzilay JI, 2001, DIABETES, V50, P2384, DOI 10.2337/diabetes.50.10.2384; Doi Y, 2005, DIABETES CARE, V28, P2497, DOI 10.2337/diacare.28.10.2497; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Hu FB, 2004, DIABETES, V53, P693, DOI 10.2337/diabetes.53.3.693; Twig G, 2013, DIABETES CARE, V36, P276, DOI 10.2337/dc11-2298; Nakanishi S, 2003, DIABETES CARE, V26, P2754, DOI 10.2337/diacare.26.10.2754; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Ford ES, 2002, AM J EPIDEMIOL, V155, P57, DOI 10.1093/aje/155.1.57; Oda E, 2009, INTERNAL MED, V48, P953, DOI 10.2169/internalmedicine.48.1890; Laaksonen DE, 2004, DIABETOLOGIA, V47, P1403, DOI 10.1007/s00125-004-1472-x; Wang ZQ, 2007, DIABETES RES CLIN PR, V76, P37, DOI 10.1016/j.diabres.2006.07.018; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JC126498; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430	34	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	0940-5429	1432-5233		ACTA DIABETOL	Acta Diabetol.	OCT	2015	52	5					983	990		10.1007/s00592-015-0788-y		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CR4YR	WOS:000361346500019		
J	Tawara, D; Nagahata, M; Takano, N; Kinoshita, H; Abe, S				Tawara, Daisuke; Nagahata, Masahiro; Takano, Naoki; Kinoshita, Hideaki; Abe, Shinichi			Probabilistic analysis of mechanical behaviour of mandibular trabecular bone using a calibrated stochastic homogenization model	ACTA MECHANICA			English	Article							FINITE-ELEMENT-ANALYSIS; BIOMECHANICAL ANALYSIS; REMODELING SIMULATION; MULTISCALE SIMULATION; COMPUTED-TOMOGRAPHY; ELASTIC-MODULI; ORAL IMPLANTS; SPECIMENS; PREDICTION; ARCHITECTURE	Surgical success of drilling in oral implantology depends on the sense of force on the fingers or feeling of a dental clinician, which is related to the quality of trabecular bone in the jawbone expressed by apparent mechanical characteristics. As the mechanical properties of trabecular bone depend on the bone volume fraction, microstructure, and many other factors closely related to individual differences, a probabilistic numerical procedure to assess drilling force is proposed. Using a micro-CT-based jawbone model, a first-order perturbation-based stochastic homogenization method was employed to estimate the possible scattering of apparent mechanical properties of the trabecular bone region. The complicated drilling problem was simplified to sequential linear static FEAs, to which the predicted apparent Young's modulus and shearing moduli in the drilling direction were applied. The FEAs demonstrated that the homogenized mechanical properties showed anisotropy, which might lead to differences in the drilling forces at different drilling angles. The numerically estimated drilling forces were shown by the expected value, 50 %-probability result, and 90%-probability result and revealed that one patient among two or ten patients would probably have poor bone quality. There was a remarkable difference in the drilling forces between the expected value and the 90%-probability result.	[Tawara, Daisuke] Ryukoku Univ, Fac Sci & Technol, Dept Mech & Syst Engn, Otsu, Shiga 5202194, Japan; [Nagahata, Masahiro] Keio Univ, Grad Sch Sci & Technol, Yokohama, Kanagawa 2238522, Japan; [Takano, Naoki] Keio Univ, Dept Mech Engn, Yokohama, Kanagawa 2238522, Japan; [Kinoshita, Hideaki] Tokyo Dent Coll, Dept Dent Mat Sci, Chiyoda Ku, Tokyo 1010061, Japan; [Abe, Shinichi] Tokyo Dent Coll, Dept Anat, Chiyoda Ku, Tokyo 1010061, Japan	Tawara, D (reprint author), Ryukoku Univ, Fac Sci & Technol, Dept Mech & Syst Engn, 1-5 Yokotani, Otsu, Shiga 5202194, Japan.	datawara@rins.ryukoku.ac.jp			JSPS [24360047]	This work was supported by JSPS Grant-in-Aid for Scientific Research (B), Grant Number 24360047.	Adachi T, 2001, J BIOMECH ENG-T ASME, V123, P403, DOI 10.1115/1.1392315; ODGAARD A, 1991, J BIOMECH, V24, P691, DOI 10.1016/0021-9290(91)90333-I; Limbert G, 2010, J BIOMECH, V43, P1251, DOI 10.1016/j.jbiomech.2010.01.003; Keyak JH, 2001, MED ENG PHYS, V23, P165, DOI 10.1016/S1350-4533(01)00045-5; Kim SJ, 2010, J APPL ORAL SCI, V18, P522, DOI 10.1590/S1678-77572010000500016; ASHMAN RB, 1989, J BIOMECH, V22, P895, DOI 10.1016/0021-9290(89)90073-0; Dempster DM, 2000, J BONE MINER RES, V15, P20, DOI 10.1359/jbmr.2000.15.1.20; WEINANS H, 1992, J BIOMECH, V25, P1425, DOI 10.1016/0021-9290(92)90056-7; Pothuaud L, 2000, J MICROSC-OXFORD, V199, P149, DOI 10.1046/j.1365-2818.2000.00725.x; Reingewirtz Y, 1997, CLIN ORAL IMPLAN RES, V8, P189, DOI 10.1034/j.1600-0501.1997.080305.x; Sansalone V, 2010, J BIOMECH, V43, P1857, DOI 10.1016/j.jbiomech.2010.03.034; Ulrich D, 1998, J BIOMECH, V31, P1187, DOI 10.1016/S0021-9290(98)00118-3; Albrektsson T, 2008, PERIODONTOL 2000, V47, P15, DOI 10.1111/j.1600-0757.2007.00247.x; Yeniyol S, 2013, OR SURG OR MED OR PA, V116, P550, DOI 10.1016/j.oooo.2013.07.001; Takano N, 2001, INT J SOLIDS STRUCT, V38, P6333, DOI 10.1016/S0020-7683(00)00418-2; Kopperdahl DL, 1998, J BIOMECH, V31, P601, DOI 10.1016/S0021-9290(98)00057-8; Jaecques SVN, 2004, BIOMATERIALS, V25, P1683, DOI 10.1016/S0142-9612(03)00516-7; LINDE F, 1989, J BIOMECH, V22, P485, DOI 10.1016/0021-9290(89)90209-1; CARTER DR, 1977, J BONE JOINT SURG AM, V59, P954; LINDE F, 1992, J BIOMECH, V25, P359, DOI 10.1016/0021-9290(92)90255-Y; KEYAK JH, 1994, J BIOMED MATER RES, V28, P1329, DOI 10.1002/jbm.820281111; Morgan EF, 2003, J BIOMECH, V36, P897, DOI 10.1016/S0021-9290(03)00071-X; Augustin G, 2008, ARCH ORTHOP TRAUM SU, V128, P71, DOI 10.1007/s00402-007-0427-3; Thomsen JS, 2002, BONE, V31, P136, DOI 10.1016/S8756-3282(02)00801-3; Basaruddin KS, 2015, COMPUT METHOD BIOMEC, V18, P162, DOI 10.1080/10255842.2013.785537; FELDKAMP LA, 1989, J BONE MINER RES, V4, P3; HVID I, 1989, J BIOMECH, V22, P837, DOI 10.1016/0021-9290(89)90067-5; Karim L, 2011, J ORTHOP RES, V29, P1; Lambert PM, 1997, INT J ORAL MAXILLOF, V55, P12; Lekholm U, 1985, PATIENT SELECTION PR, P199; Mathieu V, 2014, J BIOMECH, V47, P3, DOI 10.1016/j.jbiomech.2013.09.021; Matsunaga S, 2013, DENT MATER J, V32, P425, DOI 10.4012/dmj.2012-281; Nakano T, 2005, J HARD TISSUE BIOL, V14, P363, DOI 10.2485/jhtb.14.363; Pistoia W, 2001, J BIOMECH ENG-T ASME, V123, P176, DOI 10.1115/1.1352734; Sui J, 2014, J MATER PROCESS TECH, V214, P1018, DOI 10.1016/j.jmatprotec.2013.11.001; Takano N, 2003, MODEL SIMUL MATER SC, V11, P137, DOI 10.1088/0965-0393/11/2/303; Takano N, 2010, INT J MECH SCI, V52, P229, DOI 10.1016/j.ijmecsci.2009.09.013; Tawara D., 2008, JAPANESE J CLIN BIOM, V29, P7; Tawara D., 2010, J JPN SOC BONE MORPH, V20, pS100; van der Linden JC, 2001, J BIOMECH, V34, P1573, DOI 10.1016/S0021-9290(01)00146-4; Van Rietbergen B, 1999, J BIOMECH, V32, P165, DOI 10.1016/S0021-9290(98)00150-X; van Rietbergen B, 2002, CLIN BIOMECH, V17, P81, DOI 10.1016/S0268-0033(01)00110-3; Wilmes B, 2008, J OROFAC ORTHOP, V69, P51, DOI 10.1007/s00056-008-0726-5; Wolfram U, 2010, J MECH MED BIOL, V10, P139, DOI 10.1142/S0219519410003241; Yoshiwara Yuto, 2011, Journal of Biomechanical Science and Engineering, V6, DOI 10.1299/jbse.6.270	45	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-5970	1619-6937		ACTA MECH	Acta Mech.	OCT	2015	226	10					3275	3287		10.1007/s00707-015-1381-8		13	Mechanics	Mechanics	CR4YS	WOS:000361346600005		
J	Takai, K; Taniguchi, M				Takai, Keisuke; Taniguchi, Makoto			Microsurgical resection of an intramedullary glomus arteriovenous malformation in the high cervical spinal cord: retrograde dissection techniques of the nidus located between spinal tracts	ACTA NEUROCHIRURGICA			English	Article						Arteriovenous malformation; Arteriovenous fistula; Arteriovenous shunt; Vascular anatomy; Classification; Surgical treatment		Spinal intramedullary arteriovenous malformations (AVMs) fed by an anterior spinal artery are surgically challenging vascular lesions. We herein presented microsurgical resection techniques for an intramedullary glomus AVM located in the lateral part of the high cervical spinal cord with an operative video. These techniques included (1) a lateral suboccipital approach via cervical hemilaminectomy in the lateral position; (2) retrograde dissection of the AVM located between the spinal tracts; (3) coagulation and division of multiple narrow sulcal branches of the anterior spinal artery. Patients who underwent these techniques achieved good outcomes with minimal bleeding and morbidity.	[Takai, Keisuke; Taniguchi, Makoto] Tokyo Metropolitan Neurol Hosp, Dept Neurosurg, Fuchu, Tokyo 1830042, Japan	Takai, K (reprint author), Tokyo Metropolitan Neurol Hosp, Dept Neurosurg, 2-6-1 Musashidai, Fuchu, Tokyo 1830042, Japan.	takai-nsu@umin.ac.jp					Krings T, 2010, CLIN NEURORADIOL, V20, P5, DOI 10.1007/s00062-010-9036-6; Takai K, 2011, J NEUROSURG-SPINE, V15, P654, DOI 10.3171/2011.8.SPINE11155; Bostrom A, 2009, J NEUROSURG-SPINE, V10, P423, DOI 10.3171/2009.1.SPINE08355; Rhoton AL, 2000, NEUROSURGERY, V47, pS155, DOI 10.1097/00006123-200009001-00017; Ushikoshi S, 2000, INTERV NEURORADIOL, V6, P203; Velat GJ, 2012, J NEUROSURG-SPINE, V16, P523, DOI 10.3171/2012.3.SPINE11982	6	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	OCT	2015	157	10					1659	1664		10.1007/s00701-015-2531-4		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CR5NK	WOS:000361389600006		
J	Ogawa, Y; Watanabe, M; Tominaga, T				Ogawa, Yoshikazu; Watanabe, Mika; Tominaga, Teiji			Prognostic factors of craniopharyngioma with special reference to autocrine/paracrine signaling: underestimated implication of growth hormone receptor	ACTA NEUROCHIRURGICA			English	Article						Autocrine; Craniopharyngioma; Growth hormone receptor; Paracrine; Prognostic factor	TRANSSPHENOIDAL APPROACH; GH REPLACEMENT; EXPRESSION; INVOLVEMENT; EXPERIENCE; MANAGEMENT; RECURRENCE; CARCINOMA	Craniopharyngioma is a slow-growing tumor classified as benign, but tight adhesion and significant local infiltration to the vital structures are common. In spite of improvement of modern microsurgery techniques and precise anatomical understanding not few cases of this tumor recur, and long-term tumor control and maintenance of quality of life are sometimes difficult. However, very little is known about the effects of the molecular characters of craniopharyngioma on the prognosis. Ninety eight cases of craniopharyngioma surgically treated at the Department of Neurosurgery, Tohoku University Hospital and Kohnan Hospital from April 1996 to May 2014, 45 males and 53 females aged from 2 to 80 years (mean, 40.84 years) were retrospectively reviewed, and postoperative outcomes and the possible involvement of the autocrine/paracrine mechanism were investigated. The patients were followed up at intervals of 6 months to assess tumor recurrence, and clinical outcomes were correlated with the findings of immunohistochemical examinations used growth hormone receptor (GHR) and downstream hormones. The follow-up period ranged from 3 to 209 months. Hormone expression was examined in 88 patients, of which 46 specimens (52.3 %) showed high expression of GHR. The GHR high expression group had a significantly shorter duration of postoperative stable disease compared with the low expression group (logrank test, p = 0.007). Simultaneous high expression of growth hormone (GH) and GHR was found in 33 specimens (37.5 %), and the high expression group had a significantly shorter duration of postoperative stable disease compared with the low expression group (logrank test, p = 0.011). No other hormones showed statistically significant differences in outcomes. High expression of GHR is associated with shorter duration of postoperative stable disease in patients with craniopharyngioma. If the surgical specimens were craniopharyngiomas with high GHR expression, GH supplementation would be introduced quite prudently.	[Ogawa, Yoshikazu] Kohnan Hosp, Dept Neurosurg, Taihaku Ku, Sendai, Miyagi 9828523, Japan; [Watanabe, Mika] Tohoku Univ, Grad Sch Med, Dept Pathol, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Aoba Ku, Sendai, Miyagi 9808574, Japan	Ogawa, Y (reprint author), Kohnan Hosp, Dept Neurosurg, Taihaku Ku, 4-20-1 Nagamachiminami, Sendai, Miyagi 9828523, Japan.	yogawa@kohnan-sendai.or.jp					Agozzino L, 2006, ULTRASTRUCT PATHOL, V30, P143, DOI 10.1080/01913120500408018; Prieto R, 2013, WORLD NEUROSURG, V79, P733, DOI 10.1016/j.wneu.2012.07.033; Fahlbusch R, 1999, J NEUROSURG, V90, P237, DOI 10.3171/jns.1999.90.2.0237; Mortini P, 2011, J NEUROSURG, V114, P1350, DOI 10.3171/2010.11.JNS10670; Cavallo LM, 2009, J NEUROSURG, V111, P578, DOI 10.3171/2009.2.JNS081026; Puget S, 2007, J NEUROSURG, V106, P3, DOI 10.3171/ped.2007.106.1.3; Karavitaki N, 2006, CLIN ENDOCRINOL, V64, P556, DOI 10.1111/j.1365-2265.2006.02508.x; Li Q, 2013, J CLIN NEUROSCI, V20, P153, DOI 10.1016/j.jocn.2012.04.014; De Divitiis E, 2007, NEUROSURGERY, V61, P219, DOI [10.1227/01.neu.0000303220.55393.73, 10.1227/01.NEU.0000280113.98151.24]; Karavitaki N, 2006, ENDOCR REV, V27, P371, DOI 10.1210/er.2006-0002; Olsson DS, 2012, EUR J ENDOCRINOL, V166, P1061, DOI 10.1530/EJE-12-0077; Jacobsen J, 2004, BJU INT, V93, P297, DOI 10.1111/j.1464-410X.2004.04605.x; Couldwell WT, 2004, NEUROSURGERY, V55, P539, DOI 10.1227/01.NEU.0000134287.19377.A2; Bonsnjak R, 2013, RADIOL ONCOL, V47, P266; Boongird A, 2009, NEUROPATHOLOGY, V29, P591, DOI 10.1111/j.1440-1789.2008.00986.x; Cavallo LM, 2013, NEUROSURG REV, V36, P27, DOI 10.1007/s10143-012-0403-4; Chai CY, 2008, J CLIN PATHOL, V61, P658, DOI 10.1136/jcp.2007.050666; Chung TT, 2005, CLIN ENDOCRINOL, V63, P274, DOI 10.1111/j.1365-2265.2005.02338.x; Duo D, 2003, CLIN NEUROPATHOL, V57, P115; Fukunaga S, 2006, ONCOLOGY-BASEL, V71, P204, DOI 10.1159/000106070; HOFFMAN HJ, 1994, PEDIATR NEUROSURG, V21, P44, DOI 10.1159/000120861; Hofmann BM, 2010, NEUROSURGERY, V67, P617, DOI 10.1227/01.NEU.0000372918.68453.5B; Losa M, 2004, J NEUROL NEUROSUR PS, V75, P889, DOI 10.1136/jnnp.2003.012781; Muller HJ, 2008, HORM RES PAEDIAT, V73, P175; Ogawa Y, 2014, ENDOCR PATHOL, V25, P422, DOI 10.1007/s12022-014-9328-5; Ogawa Y, 2014, CLIN NEUROL NEUROSUR, V125, P41, DOI 10.1016/j.clineuro.2014.07.014; Shen L, 2015, NEUROL SCI, V6	27	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	OCT	2015	157	10					1731	1740		10.1007/s00701-015-2519-0		10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CR5NK	WOS:000361389600016		
J	Matsumura, H; Kato, N; Hosoo, H; Fujiwara, Y				Matsumura, Hideaki; Kato, Noriyuki; Hosoo, Hisayuki; Fujiwara, Yusuke			Subarachnoid hemorrhage due to anterior inferior cerebellar artery aneurysms associated with Gamma Knife surgery for vestibular schwannomas	ACTA NEUROCHIRURGICA			English	Letter							RADIATION		[Matsumura, Hideaki; Kato, Noriyuki; Hosoo, Hisayuki; Fujiwara, Yusuke] Natl Hosp Org, Mito Med Ctr, Dept Neurosurg, Ibaraki 3113193, Japan	Matsumura, H (reprint author), Natl Hosp Org, Mito Med Ctr, Dept Neurosurg, 280 Sakuranosato, Ibaraki 3113193, Japan.	hidematsu4@gmail.com					Akamatsu Y, 2009, J NEUROSURG, V110, P543, DOI 10.3171/2008.8.JNS08177; Fajardo LF, 2005, ACTA ONCOL, V44, P13, DOI 10.1080/0284186051007440; Stone HB, 2003, LANCET ONCOL, V4, P529, DOI 10.1016/S1470-2045(03)01191-4; Nanney AD, 2014, WORLD NEUROSURG, V81, P511, DOI 10.1016/j.wneu.2013.10.044; Sunderland G, 2014, BRIT J NEUROSURG, V28, P536, DOI 10.3109/02688697.2013.847168; Takao T, 2006, ACTA NEUROCHIR, V148, P1317, DOI 10.1007/s00701-006-0912-4	6	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	OCT	2015	157	10					1765	1767		10.1007/s00701-015-2552-z		3	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CR5NK	WOS:000361389600020		
J	Yamazaki, T; Yamamoto, T; Hatayama, T; Zaboronok, A; Ishikawa, E; Akutsu, H; Matsuda, M; Kato, N; Matsumura, A				Yamazaki, Tomosato; Yamamoto, Tetsuya; Hatayama, Toru; Zaboronok, Alexander; Ishikawa, Eiichi; Akutsu, Hiroyoshi; Matsuda, Masahide; Kato, Noriyuki; Matsumura, Akira			Abducent nerve palsy treated by microvascular decompression: a case report and review of the literature	ACTA NEUROCHIRURGICA			English	Article						Abducent nerve palsy; Microvascular decompression; Neurovascular compression syndrome; Retrosigmoid approach	SUPERIOR OBLIQUE MYOKYMIA; VASCULAR COMPRESSION; NEUROVASCULAR COMPRESSION; BASILAR ARTERY; DOLICHOECTASIA; RATES	Too few cases of isolated abducent nerve palsy caused by neurovascular compression syndrome have been reported. We here report on a case of abducent nerve palsy caused by neurovascular compression syndrome that was successfully treated by microvascular decompression (MVD). A 46-year-old male presented with a 6-month history of right-sided persistent abducent nerve palsy. High-resolution magnetic resonance imaging revealed a neurovascular contact of the vertebral artery with the right abducent nerve. MVD was performed via a retrosigmoid craniotomy, with remarkable improvement of the palsy. Our report suggests that MVD might be considered as an optional treatment if the symptoms progress or persist.	[Yamazaki, Tomosato; Kato, Noriyuki] Mito Med Ctr, Natl Hosp Org, Dept Neurosurg, Mito, Ibaraki, Japan; [Yamazaki, Tomosato; Yamamoto, Tetsuya; Zaboronok, Alexander; Ishikawa, Eiichi; Akutsu, Hiroyoshi; Matsuda, Masahide; Matsumura, Akira] Univ Tsukuba, Fac Med, Dept Neurosurg, Tsukuba, Ibaraki 3058575, Japan; [Hatayama, Toru] Mito Brain Heart Ctr, Dept Neurosurg, Mito, Ibaraki, Japan	Yamamoto, T (reprint author), Univ Tsukuba, Fac Med, Dept Neurosurg, Tennodai 1-1-1, Tsukuba, Ibaraki 3058575, Japan.	yamamoto_neurosurg@md.tsukuba.ac.jp					KING AJ, 1995, EYE, V9, P476; Sandvand KA, 2008, J NEUROL NEUROSUR PS, V79, P100, DOI 10.1136/jnnp.2007.124321; Goldenberg-Cohen N, 2004, AM J OPHTHALMOL, V137, P365, DOI 10.1016/S0002-9394(03)00898-5; WILKINS RH, 1985, NEUROL CLIN, V3, P359; Narai H, 2000, NEUROLOGY, V55, P453; Kang S, 2013, NEUROLOGY, V80, pE134, DOI 10.1212/WNL.0b013e318289706f; Suzuki K, 2008, SURG NEUROL, V70, P210, DOI 10.1016/j.surneu.2007.04.001; Kato H, 2010, J NEUROL SCI, V295, P135, DOI 10.1016/j.jns.2010.05.001; Inoue T, 2012, J NEUROSURG, V117, P1166, DOI 10.3171/2012.9.JNS112361; Kalkanis SN, 2003, NEUROSURGERY, V52, P1251, DOI 10.1227/01.NEU.0000065129.25359; Zhu Y, 2005, J NEURO-OPHTHALMOL, V25, P134, DOI 10.1097/01.WNO.0000165319.75310.5A; Hashimoto M, 2004, J NEURO-OPHTHALMOL, V24, P237, DOI 10.1097/00041327-200409000-00012; SMOKER WRK, 1986, AM J NEURORADIOL, V7, P61; Taniguchi A, 2011, J NEUROL, V258, P2271, DOI 10.1007/s00415-011-6081-2; Ohtsuka K, 1996, AM J OPHTHALMOL, V122, P416; Scharwey K, 2000, OPHTHALMOLOGICA, V214, P426, DOI 10.1159/000027537; Tsai TH, 2011, AM J OPHTHALMOL, V152, P1067, DOI 10.1016/j.ajo.2011.05.031; Harsh GR, 2005, NEUROSURGERY, V57, pE13; Jannetta P J, 1981, Clin Neurosurg, V28, P445; Menovsky T, 2007, J NEUROSURG, V107, P1231; Nakagawa H, 1991, Neurol Med Chir (Tokyo), V31, P45, DOI 10.2176/nmc.31.45	21	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	OCT	2015	157	10					1801	1805		10.1007/s00701-015-2530-5		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CR5NK	WOS:000361389600028		
J	Hatanaka, R; Takai, K; Iijima, A; Taniguchi, M				Hatanaka, Ryo; Takai, Keisuke; Iijima, Akira; Taniguchi, Makoto			Intracranial dural arteriovenous fistula associated with a spinal tumor: a case report	ACTA NEUROCHIRURGICA			English	Letter							SINUS; MENINGIOMA		[Hatanaka, Ryo; Takai, Keisuke; Taniguchi, Makoto] Tokyo Metropolitan Neurol Hosp, Dept Neurosurg, Fuchu, Tokyo 1830042, Japan; [Iijima, Akira] Japan Community Healthcare Org, Tokyo Shinjuku Med Ctr, Dept Neuroendovasc Therapy, Tokyo, Japan	Takai, K (reprint author), Tokyo Metropolitan Neurol Hosp, Dept Neurosurg, 2-6-1 Musashidai, Fuchu, Tokyo 1830042, Japan.	takai-nsu@umin.ac.jp					CHAUDHARY MY, 1982, AM J NEURORADIOL, V3, P13; BORDEN JA, 1995, J NEUROSURG, V82, P166, DOI 10.3171/jns.1995.82.2.0166; Enatsu R, 2012, CLIN NEUROL NEUROSUR, V114, P1010, DOI 10.1016/j.clineuro.2012.01.017; Hanaoka M, 2011, NEUROSURGERY, V68, pE575, DOI 10.1227/NEU.0b013e3182039803; Horinaka N, 2003, ACTA NEUROCHIR, V145, P501, DOI 10.1007/s00701-003-0030-5; Sakaki T, 1996, J NEUROSURG, V84, P113, DOI 10.3171/jns.1996.84.1.0113; Toledo Maria M, 2010, Neurosurgery, V67, P205, DOI 10.1227/01.NEU.0000370089.94032.4F; Vilela P, 2001, NEURORADIOLOGY, V43, P816	8	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	OCT	2015	157	10					1825	1827		10.1007/s00701-015-2533-2		3	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CR5NK	WOS:000361389600032		
J	Kameda, S; Suzuki, H; Cho, Y; Koga, S; Yamada, M; Nakamura, T; Hiroi, T; Sawada, H; Honda, R; Morota, T; Honda, C; Takei, A; Takamatsu, T; Okumura, Y; Sato, M; Yasuda, T; Shibasaki, K; Ikezawa, S; Sugita, S				Kameda, S.; Suzuki, H.; Cho, Y.; Koga, S.; Yamada, M.; Nakamura, T.; Hiroi, T.; Sawada, H.; Honda, R.; Morota, T.; Honda, C.; Takei, A.; Takamatsu, T.; Okumura, Y.; Sato, M.; Yasuda, T.; Shibasaki, K.; Ikezawa, S.; Sugita, S.			Detectability of hydrous minerals using ONC-T camera onboard the Hayabusa2 spacecraft	ADVANCES IN SPACE RESEARCH			English	Article						Hayabusa2; Spectroscopy; ONC; Chondrites; Asteroid	162173 1999 JU3	The Hayabusa2 spacecraft has three framing cameras (ONC-T, ONC-W1, and ONC-W2) for optical navigation to asteroid 1999 JU(3). The ONC-T is a telescopic camera with seven band-pass filters in the visible and near-infrared range. These filters are placed on a wheel, which rotates to put a selected filter for different observations, enabling multiband imaging. Previous ground-based observations suggesting that hydrous materials may be present on the surface of 1999 JU(3) and distributed in relatively limited areas. The presence of hydrous minerals indicates that this asteroid experienced only low to moderate temperatures during its formation, suggesting that primordial materials are preserved. In order to find the best sampling sites, we will perform reflectance spectroscopic observations using the ONC-T near the asteroid after arrival. Finding regions rich in hydrous minerals is the key for this remote sensing observation. In preparation for this, we conducted ground-based experiments for the actual ONC-T flight model to confirm the detectability of the absorption band of Fe-rich serpentine. As a result, we detected the absorption band near 0.7 mu m by reflectance spectroscopy of CM2 chondrites, such as Murchison and Nogoya, which are known to contain the Fe-rich serpentine, and did not detect any 0.7 mu m absorption in Jbilet Winselwan CM2 chondrite with decomposed Fe-rich serpentine. (C) 2015 COSPAR. Published by Elsevier Ltd. All rights reserved.	[Kameda, S.; Cho, Y.; Takei, A.; Takamatsu, T.; Okumura, Y.; Sato, M.; Yasuda, T.; Shibasaki, K.; Ikezawa, S.] Rikkyo Univ, Dept Phys, Toshima Ku, Tokyo 1718501, Japan; [Suzuki, H.] Meiji Univ, Dept Phys, Tama Ku, Kawasaki, Kanagawa 2148571, Japan; [Koga, S.; Sugita, S.] Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Yamada, M.] Chiba Inst Technol, Planetary Explorat Res Ctr, Narashino, Chiba 2750016, Japan; [Nakamura, T.] Tohoku Univ, Grad Sch Sci, Div Earth & Planetary Mat Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Hiroi, T.] Brown Univ, Dept Earth Environm & Planetary Sci, Providence, RI 02912 USA; [Sawada, H.] Japan Aerosp Explorat Agcy, JAXA Space Explorat Ctr, HAYABUSA2 Project, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Honda, R.] Kochi Univ, Nat Sci Cluster Sci Unit, Kochi, Kochi 7808520, Japan; [Morota, T.] Nagoya Univ, Grad Sch Envirom Studies, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Honda, C.] Univ Aizu, Res Ctr Adv Informat Sci & Technol, Aizu Wakamatsu, Fukushima 9658580, Japan	Kameda, S (reprint author), Rikkyo Univ, Dept Phys, Toshima Ku, 3-34-1 Nishi Ikebukuro, Tokyo 1718501, Japan.	kameda@rikkyo.ac.jp					Cloutis EA, 2011, ICARUS, V216, P309, DOI 10.1016/j.icarus.2011.09.009; VILAS F, 1994, ICARUS, V111, P456, DOI 10.1006/icar.1994.1156; Tsuda Y, 2013, ACTA ASTRONAUT, V91, P356, DOI 10.1016/j.actaastro.2013.06.028; Vilas F, 2008, ASTRON J, V135, P1101, DOI 10.1088/0004-6256/135/4/1101; Ishiguro M, 2010, ICARUS, V207, P714, DOI 10.1016/j.icarus.2009.12.035; Binzel RP, 2001, ICARUS, V151, P139, DOI 10.1006/icar.2001.6613; Campins H, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/2/26; Ishiguro M, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/74; Lazzaro D., 2013, ASTRON ASTROPHYS, P549; Moskovitz NA, 2013, ICARUS, V224, P24, DOI 10.1016/j.icarus.2013.02.009; Nakamura T., 2014, ANTARCTIC METEORITES, VXXXVII, P54; Sugita S., 2013, LPICO, V1719, P2591; Zellner F., 1985, ICARUS, V61, P1355	13	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0273-1177	1879-1948		ADV SPACE RES	Adv. Space Res.	OCT 1	2015	56	7					1519	1524		10.1016/j.asr.2015.06.037		6	Astronomy & Astrophysics; Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences	Astronomy & Astrophysics; Geology; Meteorology & Atmospheric Sciences	CR5RT	WOS:000361402300021		
J	Islam, KK; Jose, S; Tani, M; Hyakumura, K; Krott, M; Sato, N				Islam, K. K.; Jose, S.; Tani, Masakazu; Hyakumura, Kimihiko; Krott, Max; Sato, Noriko			Does actor power impede outcomes in participatory agroforestry approach? Evidence from Sal forests area, Bangladesh	AGROFORESTRY SYSTEMS			English	Article						Actors power analysis; Sustainable management; Participatory forestry; Social, economic and ecological outcomes	COMMUNITY FORESTRY; LIVELIHOODS; MANAGEMENT; PEOPLE; EXPERIENCE; PROGRAM; POLICY	Over the last two decades, participatory forestry practices have gained a remarkable shift from top down traditional forest management to more people-oriented approaches in Bangladesh. The new approaches have involved many actors; however, their relative role or actor power has not been investigated thoroughly. Hence, the study was undertaken to identify the relative role of actors in participatory agroforestry program (PAP) and assess how the interests of powerful actors influence the social, economic and ecological outcomes of PAP. Using different quantitative and qualitative data collection techniques, the study identified twenty actors, representing a diversity of interests in PAP in Madhupur Sal forests area. The actors' power analysis suggested that the forest department evidenced itself as the most powerful and influential actor in every dimensions of power. The study argues that PAP has no doubt led a new elucidation of forest management with a strategy to include local people so as to improve Sal forests condition and livelihoods of local communities. At the same time, exercising of power especially from the powerful actors has strictly controlled the empowerment and access of local people, and apparently reduced the participants' opportunities to maximize outcomes of PAP. So, there is an immediate need to empower local participants, by which they can easily play the central role in decision making and governing all of their development activities.	[Islam, K. K.] Bangladesh Agr Univ, Dept Agroforestry, Mymensingh 2202, Bangladesh; [Islam, K. K.; Sato, Noriko] Kyushu Univ, Fac Agr, Forest Policy Lab, Hakozaki Higashi Ku, Fukuoka 8128581, Japan; [Jose, S.] Univ Missouri, Ctr Agroforestry, Columbia, MO 65211 USA; [Tani, Masakazu] Kyushu Univ, Fac Design, Dept Environm Design, Fukuoka 8158540, Japan; [Hyakumura, Kimihiko] Kyushu Univ, Inst Trop Agr, Higashi Ku, Fukuoka 8128581, Japan; [Krott, Max] Univ Gottingen, D-37077 Gottingen, Germany	Islam, KK (reprint author), Bangladesh Agr Univ, Dept Agroforestry, Mymensingh 2202, Bangladesh.	kamrulbau@gmail.com					Alam M, 2008, INT FOREST REV, V10, P29, DOI 10.1505/ifor.10.1.29; West WF, 2004, PUBLIC ADMIN REV, V64, P66, DOI 10.1111/j.1540-6210.2004.00347.x; Charnley S, 2007, ANNU REV ANTHROPOL, V36, P301, DOI 10.1146/annurev.anthro.35.081705.123143; Muhammed N, 2008, J ENVIRON MANAGE, V88, P83, DOI 10.1016/j.jenvman.2007.01.029; Bowler DE, 2012, FRONT ECOL ENVIRON, V10, P29, DOI 10.1890/110040; Maryudi A, 2012, FOREST POLICY ECON, V14, P1, DOI 10.1016/j.forpol.2011.07.017; Nygren A, 2005, WORLD DEV, V33, P639, DOI 10.1016/j.worlddev.2004.11.002; Islam K. K., 2012, Journal of Forestry Research (Harbin), V23, P323, DOI 10.1007/s11676-012-0260-6; Siry JP, 2005, FOREST POLICY ECON, V7, P551, DOI 10.1016/j.forpol.2003.09.003; Arts B, 2004, POLICY SCI, V37, P339, DOI 10.1007/s11077-005-0156-9; BBS, 2013, DISTR STAT TANG; BBS, 2011, BANGL LIT SURV; Brown FP, 2009, THESIS U KWAZULU NAT; Castro A.P., 2001, ENVIRON SCI POLICY, V4, P229, DOI DOI 10.1016/S1462-9011(01)00022-3; Devkota M, 2010, THESIS U GOTTINGEN G; Devkota M, 2011, INT FOREST REV, V8, P377; FD, 2014, LAND AND FOR AR; Fisher RJ, 2007, INT C PART FOR MAN B; Gain P, 2002, LAST FOREST BANGLADE; Glimour D, 2003, J FOR LIVELIHOOD, V2, P1; Hobley M, 1996, PARTICIPATORY FOREST, P337; Islam KK, 2012, SOUTH FORESTS, V74, P89, DOI 10.2989/20702620.2012.701434; Islam K. K., 2010, American-Eurasian Journal of Agricultural & Environmental Sciences, V9, P427; Islam KK, 2012, IFOREST, V5, P171, DOI 10.3832/ifor0578-005; Islam K.K., 2011, INT J SOCIAL FORESTR, V4, P153; Islam KK, 2014, OPEN J FOR, V4, P1; Islam Kazi Kamrul, 2013, International Journal of Biodiversity Science Ecosystem Services & Management, V9, P30, DOI 10.1080/21513732.2012.748692; Islam KK, 2013, SUSTAIN FOR, V32, P412; Itubo FI, 2011, THESIS U GOTTINGEN G; Karmacharya M, 2008, DECENTRALIZATION FOR, P177; Khadka M, 2010, THESIS U GOTTINGEN G; Krott M, 2008, ALLG FORST JAGDZTG, V179, P57; Krott M., 2005, FOREST POLICY ANAL; Krott M, 2014, FOREST POLICY ECON, V49, P34, DOI 10.1016/j.forpol.2013.04.012; Larson AM, 2004, EUR J DEV RES, V16, P1, DOI DOI 10.1080/09578810410001688707; Malla Y. B., 2000, Unasylva (English ed.), V51, P37; Maryudi A, 2011, THESIS U GOTTINGEN G; Nath TK, 2010, SOC NATUR RESOUR, V23, P1093, DOI 10.1080/08941920802653521; NSP, 2008, FRAM MAN PLAN MADH N; Ojha HR, 2008, C ENV GOV DEM HELD M; Ostrom E, 1990, GOVERNING COMMONS EV, P280; Ostrom E., 2008, DECENTRALIZATION FOR, P44; Parasad R, 2003, ENV DEV SUSTAIN, V5, P353; Ribot JC, 2004, WAITING DEMOCRACY PO, P140; Ribot JC, 2002, DEMOCRACY GOVERNANCE, P1; Safa MS, 2004, SMALL SCALE FOREST E, V3, P223; Salam Md. Abdus, 2005, Environment Development and Sustainability, V7, P209, DOI 10.1007/s10668-005-7313-3; Sarin M, 2003, LOCAL FOREST MANAGEM, P55; Schusser C, 2013, THESIS U GOTTINGEN G; Sekhar NU, 2003, 30 NORW U LIF SCI DE; Shackleton S., 2002, ODI NAT RESOUR PERSP, V76, P1; Shahbaz B, 2009, HUM GEOGR SER, V25, P15; Thoms CA, 2006, POLICY MATTERS, V14, P169; Timsina NP, 2003, GEOGR J, V169, P236; Webber M, 1964, BASIC CONCEPT SOCIOL; Wiersum KF, 1984, E W CTR WORKING PAPE	56	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-4366	1572-9680		AGROFOREST SYST	Agrofor. Syst.	OCT	2015	89	5					885	899		10.1007/s10457-015-9822-x		15	Agronomy; Forestry	Agriculture; Forestry	CR6IK	WOS:000361449300010		
J	Chang, MO; Suzuki, T; Kitajima, M; Takaku, H				Chang, Myint Oo; Suzuki, Tomoyuki; Kitajima, Masayuki; Takaku, Hiroshi			Baculovirus Infection of Human Monocyte-Derived Dendritic Cells Restricts HIV-1 Replication	AIDS RESEARCH AND HUMAN RETROVIRUSES			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; EFFICIENT GENE-TRANSFER; MAMMALIAN-CELLS; IMMUNE-RESPONSES; T-CELLS; NK-CELL; ALPHA-INTERFERON; ANTITUMOR IMMUNITY; UP-REGULATION	Acquired immune deficiency syndrome (AIDS) is mainly caused by infection with human immunodeficiency virus-1 (HIV-1) and still poses a global threat for which we lack a protective or therapeutic vaccine. Dendritic cells (DCs) play a major role in the onset of HIV infection, providing one of the primary sites of HIV replication, and also act as viral reservoirs in vivo. Previous studies have shown that baculovirus (BV) induces strong host immune responses against infections and malignancies. In this study, we infected human monocyte-derived DCs with recombinant BV (AcCAG-gag) and showed that AcCAG-gag-infected human DCs underwent maturation and produced interferon alpha and other proinflammatory cytokines accompanied by increases in the mRNA and protein expression levels of APOBEC3 (A3A, A3F, and A3G), proteins associated with the inhibition of HIV-1 replication. Surprisingly, HIV-1 inhibition is also observed in human DCs infected with a wild-type BV, as determined by the production of inflammatory cytokines, the expression of A3, and a reduction in the p24 level. Our findings outline the mechanism underlying the inhibition of HIV-1 in BV-infected human DCs and pave the way for the use of BV as an effective tool for immunotherapy against HIV-1.	[Chang, Myint Oo; Takaku, Hiroshi] Chiba Inst Technol, High Technol Res Ctr, Narashino, Chiba 2750016, Japan; [Suzuki, Tomoyuki; Kitajima, Masayuki; Takaku, Hiroshi] Chiba Inst Technol, Dept Life & Environm Sci, Narashino, Chiba 2750016, Japan; [Kitajima, Masayuki] Natl Ctr Global Hlth & Med, Res Inst, Dept Immunol & Pathol, Chiba, Japan; [Takaku, Hiroshi] Chiba Inst Technol, Res Inst, Narashino, Chiba 2750016, Japan	Takaku, H (reprint author), Chiba Inst Technol, Res Inst, 2-17-1 Tsudanuma, Narashino, Chiba 2750016, Japan.	c_myintoo@hotmail.com; hiroshi.takaku@it-chiba.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan [09309011]; Ministry of Health, Labor and Welfare of Japan; Supporting Program for Creating University Ventures from the Japan Science and Technology Agency, Japan; Research and Development Program for New Bio-industry Initiatives from the Ministry of Agriculture, Forestry and Fisheries of Japan	We thank Drs. Ryuichi Sugiyama and Hitoshi Suzuki for the excellent technical assistance provided in the confocal microscopy studies and Ms. Mari Fujisaki for the helpful work she contributed to this research study. We wish to thank Profs. N. Miyano-Kurosaki and K. Hashimoto for their participation in helpful discussions. This work was supported in part by a Grant-in-Aid for High Technology Research (No. 09309011) from the Ministry of Education, Science, Sports, and Culture of Japan, by a Grant-in-Aid for AIDS research from the Ministry of Health, Labor and Welfare of Japan, by a grant from the Supporting Program for Creating University Ventures from the Japan Science and Technology Agency, Japan, and by a grant from the Research and Development Program for New Bio-industry Initiatives from the Ministry of Agriculture, Forestry and Fisheries of Japan.	Abe T, 2003, J IMMUNOL, V171, P1133; Abe T, 2009, J VIROL, V83, P7629, DOI 10.1128/JVI.00679-09; Peng G, 2007, BLOOD, V110, P393, DOI 10.1182/blood-2006-10-051763; Pion M, 2006, J EXP MED, V203, P2887, DOI 10.1081/jem.20061519; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1081/jem.20030422; Abe T, 2010, CURR GENE THER, V10, P226; Jost S, 2014, J VIROL, V88, P8349, DOI 10.1128/JVI.00924-14; Li XY, 2007, J BIOL CHEM, V282, P32065, DOI 10.1074/jbc.M703423200; Strauss R, 2007, MOL THER, V15, P193, DOI 10.1038/sj.mt.6300008; Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237; Wang FX, 2008, J GEN VIROL, V89, P722, DOI 10.1099/vir.0.83530-0; HOFMANN C, 1995, P NATL ACAD SCI USA, V92, P10099, DOI 10.1073/pnas.92.22.10099; Koning FA, 2011, J VIROL, V85, P13448, DOI 10.1128/JVI.00775-11; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Abe T, 2005, J VIROL, V79, P2847, DOI 10.1128/JVI.79.5.2847-2858.2005; Jost S, 2012, MICROBES INFECT, V14, P904, DOI 10.1016/j.micinf.2012.05.001; Kataoka C, 2012, J VIROL, V86, P2610, DOI 10.1128/JVI.06704-11; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; Hart DNJ, 1997, BLOOD, V90, P3245; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Chen KY, 2006, J VIROL, V80, P7645, DOI 10.1128/JVI.00206-06; LAUDE H, 1992, J VIROL, V66, P743; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Boyce FM, 1996, P NATL ACAD SCI USA, V93, P2348, DOI 10.1073/pnas.93.6.2348; Burleigh L, 2006, J VIROL, V80, P2949, DOI 10.1128/JVI.80.6.2949-2957.2006; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Dong SC, 2010, J VIROL, V84, P5351, DOI 10.1128/JVI.02517-09; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Long G, 2006, J VIROL, V80, P8830, DOI 10.1128/JVI.00880-06; Wang XX, 2012, J VIROL, V86, P3777, DOI 10.1128/JVI.06594-11; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; Suzuki T, 2010, CELL IMMUNOL, V262, P35, DOI 10.1016/j.cellimm.2009.12.005; Buonaguro L, 2006, J VIROL, V80, P9134, DOI 10.1128/JVI.00050-06; Berger G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002221; CAPOBIANCHI MR, 1993, AIDS RES HUM RETROV, V9, P957, DOI 10.1089/aid.1993.9.957; Chang MO, 2012, J INNATE IMMUN, V4, P579, DOI 10.1159/000339402; Chang MO, 2012, J INNATE IMMUN, V4, P187, DOI 10.1159/000329226; Coleman CM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-51; Facciabene A, 2004, J VIROL, V78, P8663, DOI 10.1128/JVI.78.16.8663-8672.2004; Fujihira A, 2014, GENE THER, V21, P849, DOI 10.1038/gt.2014.59; GRONER A, 1984, INTERVIROLOGY, V21, P203, DOI 10.1159/000149522; Hitchman RB, 2011, J INVERTEBR PATHOL, V107, pS49, DOI 10.1016/j.jip.2011.05.005; Kitajima M, 2006, BIOCHEM BIOPH RES CO, V343, P378, DOI 10.1016/j.bbrc.2006.02.167; Kitajima M, 2008, CLIN VACCINE IMMUNOL, V15, P376, DOI 10.1128/CVI.00285-07; Kitajima M, 2008, MOL THER, V16, P261, DOI 10.1038/sj.mt.6300364; Matilainen H, 2005, J VIROL, V79, P15452, DOI 10.1128/JVI.79.24.15452-15459.2005; Mbisa JL, 2010, J VIROL, V84, P5250, DOI 10.1128/JVI.02358-09; Rivera-Gonzalez GC, 2011, J INVERTEBR PATHOL, V107, pS59, DOI 10.1016/j.jip.2011.05.006; Sarkis C, 2000, P NATL ACAD SCI USA, V97, P14638, DOI 10.1073/pnas.260472897; Schutz A, 2006, VACCINE, V24, P7190, DOI 10.1016/j.vaccine.2006.06.044; Shoji I, 1997, J GEN VIROL, V78, P2657; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Suzuki T, 2010, CELL MOL IMMUNOL, V7, P440, DOI 10.1038/cmi.2010.48; van Loo ND, 2001, J VIROL, V75, P961, DOI 10.1128/JVI.75.2.961-970.2001; VOLKMAN LE, 1983, APPL ENVIRON MICROB, V45, P1085	56	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0889-2229	1931-8405		AIDS RES HUM RETROV	Aids Res. Hum. Retrovir.	OCT 1	2015	31	10					1023	1031		10.1089/aid.2015.0060		9	Immunology; Infectious Diseases; Virology	Immunology; Infectious Diseases; Virology	CR5PL	WOS:000361395500012		
J	Takeda, N; Morita, H; Fujita, D; Inuzuka, R; Taniguchi, Y; Imai, Y; Hirata, Y; Komuro, I				Takeda, Norifumi; Morita, Hiroyuki; Fujita, Daishi; Inuzuka, Ryo; Taniguchi, Yuki; Imai, Yasushi; Hirata, Yasunobu; Komuro, Issei			Congenital contractural arachnodactyly complicated with aortic dilatation and dissection: Case report and review of literature	AMERICAN JOURNAL OF MEDICAL GENETICS PART A			English	Article						congenital contractural arachnodactyly; Beals syndrome; fibrillin-2; splice mutation; aortic aneurysm	MARFAN-SYNDROME; FBN2 MUTATIONS; FIBRILLIN GENE; PHENOTYPE; PROBANDS; FAMILY	Congenital contractural arachnodactyly (CCA) is a connective tissue disease caused by mutations of the FBN2, which encodes fibrillin-2. CCA patients have a marfanoid habitus; however, aortic dilatation and/or dissection as observed in Marfan syndrome have been rarely documented. Here, we report on a Japanese familial case of CCA resulting from a FBN2 splicing mutation (IVS32+5ga), which leads to exon 32 being skipped, and the patients developed aortic dilatation and type A dissection. Although CCA patients have been believed to have favorable prognoses, repetitive aortic imaging studies must be performed in some patients to detect possible aortic disease early, and genetic testing of FBN2 might be useful to identify such high-risk patients. (c) 2015 Wiley Periodicals, Inc.	[Takeda, Norifumi; Morita, Hiroyuki; Fujita, Daishi; Komuro, Issei] Tokyo Univ Hosp, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; [Morita, Hiroyuki] Tokyo Univ Hosp, Dept Translat Res Healthcare & Clin Sci, Bunkyo Ku, Tokyo 1138655, Japan; [Inuzuka, Ryo] Tokyo Univ Hosp, Dept Pediat, Bunkyo Ku, Tokyo 1138655, Japan; [Taniguchi, Yuki] Tokyo Univ Hosp, Dept Orthoped Surg, Bunkyo Ku, Tokyo 1138655, Japan; [Imai, Yasushi] Jichi Med Univ, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan; [Hirata, Yasunobu] Tokyo Teishin Hosp, Chiyoda Ku, Tokyo, Japan	Komuro, I (reprint author), Tokyo Univ Hosp, Dept Cardiovasc Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	komuro-tky@umin.ac.jp			Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan	Grant sponsor: Research on Rare and Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan; Grant sponsor: Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Nishimura A, 2007, AM J MED GENET A, V143A, P694, DOI 10.1002/ajmg.a.31639; Jensen SA, 2012, STRUCTURE, V20, P215, DOI 10.1016/j.str.2011.12.008; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; Callewaert BL, 2009, HUM MUTAT, V30, P334, DOI 10.1002/humu.20854; Gupta PA, 2002, HUM MUTAT, V19, P39, DOI 10.1002/humu.10017; Gupta PA, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.012880; Frederic MY, 2009, HUM MUTAT, V30, P181, DOI 10.1002/humu.20794; PUTNAM EA, 1995, NAT GENET, V11, P456, DOI 10.1038/ng1295-456; Faivre L, 2007, AM J HUM GENET, V81, P454, DOI 10.1086/520125; Park ES, 1998, AM J MED GENET, V78, P350, DOI 10.1002/(SICI)1096-8628(19980724)78:4<350::AID-AJMG9>3.0.CO;2-P; Davis MR, 2012, MOL GENET METAB, V107, P635, DOI 10.1016/j.ymgme.2012.07.023; Maslen C, 1997, AM J HUM GENET, V60, P1389, DOI 10.1086/515472; Bolar N, 2012, CURR OPIN PEDIATR, V24, P498, DOI 10.1097/MOP.0b013e3283557d4c; Fujita D, 2014, PEDIATR INT, V56, P484, DOI 10.1111/ped.12423	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4825	1552-4833		AM J MED GENET A	Am. J. Med. Genet. A	OCT	2015	167	10					2382	2387		10.1002/ajmg.a.37162		6	Genetics & Heredity	Genetics & Heredity	CR2TS	WOS:000361184100023		
J	Afifi, HH; Fukai, R; Miyake, N; el Din, AAG; Eid, MM; Eid, OM; Thomas, MM; El-Badry, TH; Tosson, AMS; Abdel-Salam, GMH; Matsumoto, N				Afifi, Hanan H.; Fukai, Ryoko; Miyake, Noriko; el Din, Amina A. Gamal; Eid, Maha M.; Eid, Ola M.; Thomas, Manal M.; El-Badry, Tarek H.; Tosson, Angie M. S.; Abdel-Salam, Ghada M. H.; Matsumoto, Naomichi			De Novo 17q24.2-q24.3 microdeletion presenting with generalized hypertrichosis terminalis, gingival fibromatous hyperplasia, and distinctive facial features	AMERICAN JOURNAL OF MEDICAL GENETICS PART A			English	Article						hypertrichosis terminalis; gingival hyperplasia; coarse face; distinctive facial features; 17q24.2-q24.3 microdeletion; gingival biopsy		Generalized hypertrichosis is a feature of several genetic disorders, and the nosology of these entities is still provisional. Recent studies have implicated chromosome 17q24.2-q24.3 microdeletion and the reciprocal microduplication in a very rare form of congenital generalized hypertrichosis terminalis (CGHT) with or without gingival hyperplasia. Here, we report on a 5-year-old Egyptian girl born to consanguineous parents. The girl presented with CGHT and gingival hyperplasia for whom we performed detailed clinical, pathological, and molecular studies. The girl had coarse facies characterized by bilateral epicanthic folds, thick and abundant eyelashes, a broad nose, full cheeks, and lips that constituted the distinctive facial features for this syndrome. Biopsy of the gingiva showed epithelial marked acanthosis and hyperkeratosis with hyperplastic thick collagen bundles and dense fibrosis in the underlying tissues. Array analysis indicated a 17q24.2-q24.3 chromosomal microdeletion. We validated this microdeletion by real-time quantitative PCR and confirmed a perfect co-segregation of the disease phenotype within the family. In summary, this study indicates that 17q24.2-q24.3 microdeletion caused CGHT with gingival hyperplasia and distinctive facies, which should be differentiated from the autosomal recessive type that lacks the distinctive facies. (c) 2015 Wiley Periodicals, Inc.	[Afifi, Hanan H.; Thomas, Manal M.; Abdel-Salam, Ghada M. H.] Natl Res Ctr, Human Genet & Genome Res Div, Dept Clin Genet, Cairo, Egypt; [Fukai, Ryoko; Miyake, Noriko; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 232, Japan; [el Din, Amina A. Gamal] Natl Res Ctr, Div Med Res, Dept Pathol, Cairo, Egypt; [Eid, Maha M.; Eid, Ola M.] Natl Res Ctr, Human Genet & Genome Res Div, Human Cytogenet Dept, Cairo, Egypt; [El-Badry, Tarek H.] Natl Res Ctr, Human Genet & Genome Res Div, Orodental Genet Dept, Cairo, Egypt; [Tosson, Angie M. S.] Cairo Univ, Fac Med, Dept Pediat, Cairo, Egypt	Abdel-Salam, GMH (reprint author), Natl Res Ctr, Human Genet & Genome Res Div, Dept Clin Genet, El Tahrir St, Cairo, Egypt.	ghada.abdelsalam@yahoo.com			Ministry of Health, Labour and Welfare of Japan; Takeda Science Foundation; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan	Grant sponsor: Ministry of Health, Labour and Welfare of Japan; Grant sponsor: the Takeda Science Foundation; the Japan Science and Technology Agency; Grant sponsor: the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Anavi Y, 1989, DEV MED CHILD NEUROL, V1, P538; Sun M, 2009, AM J HUM GENET, V84, P807, DOI 10.1016/j.ajhg.2009.04.018; Stankiewicz P, 2010, AM J MED GENET A, V152A, P1089, DOI 10.1002/ajmg.a.33216; Bancroft JD, 2002, THEORY PRACTICE HIST, P173; BONDESON J, 1993, AM J MED GENET, V47, P198; Canun S, 2003, AM J MED GENET A, V116A, P278, DOI 10.1002/ajmg.a.10883; DeStefano GM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004333; Douzgou S, 2009, CLIN DYSMORPHOL, V18, P205, DOI 10.1097/MCD.0b013e32832dc393; Fantauzzo KA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003002; FIGUERA LE, 1995, NAT GENET, V10, P202, DOI 10.1038/ng0695-202; Jang SI, 2007, J BIOL CHEM, V282, P20245, DOI 10.1074/jbc.M701609200; Laurence JZ, 1857, LANCET, V70, P48; Wechsler D., 1989, WECHSLER PRESCHOOL P; Wendelin DS, 2003, J AM ACAD DERMATOL, V48, P161, DOI 10.1067/mjd.2003.100	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4825	1552-4833		AM J MED GENET A	Am. J. Med. Genet. A	OCT	2015	167	10					2418	2424		10.1002/ajmg.a.37185		7	Genetics & Heredity	Genetics & Heredity	CR2TS	WOS:000361184100030		
J	Takasawa, K; Takishima, S; Morioka, C; Nishioka, M; Ohashi, H; Aoki, Y; Shimohira, M; Kashimada, K; Morio, T				Takasawa, Kei; Takishima, Shigeru; Morioka, Chikako; Nishioka, Masato; Ohashi, Hirofumi; Aoki, Yoko; Shimohira, Masayuki; Kashimada, Kenichi; Morio, Tomohiro			Improved growth velocity of a patient with Noonan-like syndrome with loose anagen hair (NS/LAH) without growth hormone deficiency by low-dose growth hormone therapy	AMERICAN JOURNAL OF MEDICAL GENETICS PART A			English	Article						NS/LAH; GH therapy; SHOC2; GHD; GHI	FINAL HEIGHT DATA; GH THERAPY; MUTATIONS; PATHWAY; DISORDERS; CHILDREN	Noonan-like syndrome with loose anagen hair (NS/LAH; OMIM 607721) is caused by a heterozygous c.4A>G mutation in SHOC2. Most cases exhibit both growth hormone deficiency (GHD) and growth hormone insensitivity (GHI) and thus require a high dose of growth hormone (GH) therapy (e.g., 35-40 mu g/kg/day). We report on a genetically diagnosed NS/LAH patient manifesting severe short stature (-3.85 SDs) with low serum level of IGF1, 30ng/ml. The peak levels of GH stimulation tests were within the normal range, and GHI was not observed in the IGF1 generation test. However, with low-dose GH therapy (25 mu g/kg/day) for two years, IGF1 level and height were remarkably improved (IGF1: 117ng/ml, height SDs: -2.20 SDs). Further, catch-up of motor development and improvement of the proportion of extending limbs to trunk were observed (the Developmental Quotient score increased from 68 to 98 points, and the relative sitting height ratio decreased from 0.62 to 0.57). Our results suggest that endocrinological causes for short stature are variable in NS/LAH and that GH therapy should be considered as a possible treatment for delayed development in NS/LAH. (c) 2015 Wiley Periodicals, Inc.	[Takasawa, Kei; Takishima, Shigeru; Morioka, Chikako; Kashimada, Kenichi; Morio, Tomohiro] Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, Tokyo 1138510, Japan; [Takasawa, Kei; Nishioka, Masato; Shimohira, Masayuki] Kawaguchi Municipal Med Ctr, Dept Pediat, Kawaguchi, Saitama, Japan; [Ohashi, Hirofumi] Saitama Childrens Med Ctr, Div Med Genet, Saitama, Japan; [Aoki, Yoko] Tohoku Univ, Sch Med, Div Med Genet, Sendai, Miyagi 980, Japan	Kashimada, K (reprint author), Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	kkashimada.ped@tmd.ac.jp					Roberts AE, 2013, LANCET, V381, P333, DOI 10.1016/S0140-6736(12)61023-X; Capalbo D, 2012, AM J MED GENET A, V158A, P856, DOI 10.1002/ajmg.a.35234; Romano AA, 2009, J CLIN ENDOCR METAB, V94, P2338, DOI 10.1210/jc.2008-2094; Mazzanti L, 2013, AM J MED GENET A, V161, P2756, DOI 10.1002/ajmg.a.36255; Cordeddu V, 2009, NAT GENET, V41, P1022, DOI 10.1038/ng.425; Binder G, 2005, J CLIN ENDOCR METAB, V90, P5377, DOI 10.1210/jc.2005-0995; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Tartaglia M, 2011, BEST PRACT RES CL EN, V25, P161, DOI 10.1016/j.beem.2010.09.002; Malaquias AC, 2012, AM J MED GENET A, V158A, P2700, DOI 10.1002/ajmg.a.35519; Tartaglia M, 2010, ANN NY ACAD SCI, V1214, P99, DOI 10.1111/j.1749-6632.2010.05790.x; Aoki Y, 2008, HUM MUTAT, V29, P992, DOI 10.1002/humu.20748; Serra-Nedelec AD, 2012, P NATL ACAD SCI USA, V109, P4257, DOI 10.1073/pnas.1119803109; Bertelloni S, 2013, HORM-INT J ENDOCRINO, V12, P86; Ferreira LV, 2005, J CLIN ENDOCR METAB, V90, P5156, DOI 10.1210/jc.2005-2559; Blum W F, 1994, Acta Paediatr Suppl, V399, P117; Capalbo D, 2013, ITAL J PEDIATR, V38, DOI 10.1186/1824-7288-38-48; Dahlgren J, 2009, HORM RES, V72, P46, DOI 10.1159/000243779; Mazzanti L, 2003, AM J MED GENET A, V118A, P279, DOI 10.1002/ajmg.a.10928; Richmond EJ, 2008, PITUITARY, V11, P115, DOI 10.1007/s11102-008-0105-7; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4825	1552-4833		AM J MED GENET A	Am. J. Med. Genet. A	OCT	2015	167	10					2425	2429		10.1002/ajmg.a.37191		5	Genetics & Heredity	Genetics & Heredity	CR2TS	WOS:000361184100031		
J	Sato, T; Muroya, K; Asakura, Y; Yachie, A; Nishimura, G; Aida, N; Machida, J; Tanaka, Y; Hasegawa, T; Adachi, M				Sato, Takeshi; Muroya, Koji; Asakura, Yumi; Yachie, Akihiro; Nishimura, Gen; Aida, Noriko; Machida, Jiro; Tanaka, Yukichi; Hasegawa, Tomonobu; Adachi, Masanori			Polyostotic osteolysis and hypophosphatemic rickets with elevated serum fibroblast growth factor 23: A case report	AMERICAN JOURNAL OF MEDICAL GENETICS PART A			English	Article						polyostotic osteolysis; hypophosphatemic rickets; fibroblast growth factor 23		We report on a boy who presented with hypophosphatemic rickets with elevated serum fibroblast growth factor 23 (FGF23) and polyostotic osteolytic lesions at age 2 years. Tumor-induced hypophosphatemic rickets was suspected; however, bone biopsy for osteolytic changes revealed no tumorous change, except for irregularly dilated vessels associated with osteoclasts and fibrous proliferation. Venous sampling failed to point to FGF23-producing foci. After alfacalcidol and phosphate supplementation, the rachitic skeletal changes improved, but FGF23 increased and new osteolytic lesions developed. Serum levels of neopterin and a few cytokines, including plasma transforming growth factor- and soluble tumor necrosis factor receptor type II, were elevated. At age 4 years, high doses of phosphate resulted in increased serum phosphate levels, decreased neopterin and cytokines, decreased FGF23, and stabilization of osteolysis. We excluded germline mutations in PHEX, FGF23, DMP1, and ENPP1 (genes for hereditary hypophosphatemic rickets) and somatic mutations in the GNAS and HRAS/KRAS (the disease-causing genes for McCune-Albright syndrome and linear nevus sebaceous syndrome, respectively). We could not perform octreotide scintigraphy or fluorodeoxyglucose-positron emission tomography, and thus could not completely exclude occult FGF23-producing tumors. However, considering the course of the disease, it is intriguing to assume that dysregulation of osteoclast-macrophage lineage may have induced increased neopterin levels, increased cytokine levels, osteolytic process, and possibly FGF23 overproduction. (c) 2015 Wiley Periodicals, Inc.	[Sato, Takeshi; Muroya, Koji; Asakura, Yumi; Adachi, Masanori] Kanagawa Childrens Med Ctr, Dept Endocrinol & Metab, Yokohama, Kanagawa 2328555, Japan; [Sato, Takeshi; Hasegawa, Tomonobu] Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Yachie, Akihiro] Kanazawa Univ, Sch Med, Inst Med Pharmaceut & Hlth Sci, Dept Pediat, Kanazawa, Ishikawa 920, Japan; [Nishimura, Gen] Tokyo Metropolitan Childrens Med Ctr, Dept Radiol, Tokyo, Japan; [Aida, Noriko] Kanagawa Childrens Med Ctr, Dept Radiol, Yokohama, Kanagawa 2328555, Japan; [Machida, Jiro] Kanagawa Childrens Med Ctr, Dept Orthoped Surg, Yokohama, Kanagawa 2328555, Japan; [Tanaka, Yukichi] Kanagawa Childrens Med Ctr, Dept Pathol, Yokohama, Kanagawa 2328555, Japan	Muroya, K (reprint author), Kanagawa Childrens Med Ctr, Dept Endocrinol & Metab, Minami Ku, Mutsukawa 2-138-4, Yokohama, Kanagawa 2328555, Japan.	kmuroya@kcmc.jp					Hagendoorn J, 2006, NAT CLIN PRACT ONCOL, V3, P693, DOI 10.1038/ncponc0660; Shimizu M, 2010, RHEUMATOLOGY, V49, P1645, DOI 10.1093/rheumatology/keq133; Groesser L, 2012, NAT GENET, V44, P783, DOI 10.1038/ng.2316; Moller G, 1999, J BONE JOINT SURG BR, V81B, P501, DOI 10.1302/0301-620X.81B3.9468; Yasui T, 2011, J BONE MINER RES, V26, P1447, DOI 10.1002/jbmr.357; Riminucci M, 2003, J CLIN INVEST, V112, P683, DOI 10.1172/JC120031899; Berdowska A, 2001, J CLIN PHARM THER, V26, P319, DOI 10.1046/j.1365-2710.2001.00358.x; Dupond JL, 2010, BONE, V46, P873, DOI 10.1016/j.bone.2009.11.015; Hardegger F, 1985, J Bone Joint Surg Br, V67, P88; Hoffman WH, 2005, AM J MED GENET A, V134A, P233, DOI 10.1002/ajmg.a.30599; Patel Dipak V, 2005, Clin Med Res, V3, P65; Venkatramani R, 2011, PEDIATR BLOOD CANCER, V56, P667, DOI 10.1002/pbc.22948	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4825	1552-4833		AM J MED GENET A	Am. J. Med. Genet. A	OCT	2015	167	10					2430	2434		10.1002/ajmg.a.37193		5	Genetics & Heredity	Genetics & Heredity	CR2TS	WOS:000361184100032		
J	Akazawa, Y; Inaba, Y; Hachiya, A; Motoki, N; Matsuzaki, S; Minatoya, K; Morisaki, T; Morisaki, H; Kosaki, K; Kosho, T; Koike, K				Akazawa, Yohei; Inaba, Yuji; Hachiya, Akira; Motoki, Noriko; Matsuzaki, Satoshi; Minatoya, Kenji; Morisaki, Takayuki; Morisaki, Hiroko; Kosaki, Kenjiro; Kosho, Tomoki; Koike, Kenichi			Reversible cerebral vasoconstriction syndrome and posterior reversible encephalopathy syndrome in a boy with Loeys-Dietz syndrome	AMERICAN JOURNAL OF MEDICAL GENETICS PART A			English	Article						Loeys-Dietz syndrome (LDS); reversible cerebral vasoconstriction syndrome (RCVS); posterior reversible encephalopathy syndrome (PRES); endothelial dysfunction	MARFAN-SYNDROME; ARTERY DISSECTION; AORTIC-ANEURYSMS; MOUSE MODEL; MUTATIONS; OSTEOARTHRITIS; DYSFUNCTION; IMPAIRMENT; SPECTRUM; PATIENT	Loeys-Dietz syndrome (LDS) is an autosomal dominant connective tissue disorder, caused by heterozygous mutations in TGFBR1 or TGFBR2 and characterized by vascular complications (cerebral, thoracic, and abdominal arterial aneurysms and/or dissections) and skeletal manifestations. We here report the first patient with LDS presenting with reversible cerebral vasoconstriction syndrome (RCVS), a clinico-radiological condition characterized by recurrent thunderclap headaches, with or without neurological symptoms, and reversible vasoconstriction of cerebral arteries. The patient was a 9-year-old boy with a heterozygous TGFBR2 mutation, manifesting camptodactyly, talipes equinovarus, and lamboid craniosynostosis. He complained of severe recurrent headaches 2 months after total aortic replacement for aortic root dilatation and a massive Stanford type B aortic dissection. A thoracic CT scan revealed a left subclavian artery dissection. Brain MRI and MRA detected bilateral internal carotid artery constriction along with a cortical subarachnoid hemorrhage without intracranial aneurysms. Subsequently, he developed visual disturbance and a generalized seizure associated with multiple legions of cortical and subcortical increased signals including the left posterior lobe, consistent with posterior reversible encephalopathy syndrome (PRES), a condition characterized by headaches, visual disorders, seizures, altered mentation, consciousness disturbances, focal neurological signs, and vasogenic edema predominantly in the white matter of the posterior lobe. Vasoconstriction of the internal carotid artery was undetectable 2 months later, and he was diagnosed as having RCVS. Endothelial dysfunction, associated with impaired TGF- signaling, might have been attributable to the development of RCVS and PRES. (c) 2015 Wiley Periodicals, Inc.	[Akazawa, Yohei; Inaba, Yuji; Hachiya, Akira; Motoki, Noriko; Matsuzaki, Satoshi; Koike, Kenichi] Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano 3908621, Japan; [Minatoya, Kenji] Natl Cerebral & Cardiovasc Ctr, Dept Vasc Surg, Suita, Osaka, Japan; [Morisaki, Takayuki; Morisaki, Hiroko] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Biosci & Genet, Suita, Osaka, Japan; [Kosaki, Kenjiro] Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Kosho, Tomoki] Shinshu Univ, Sch Med, Dept Med Genet, Matsumoto, Nagano 3908621, Japan	Inaba, Y (reprint author), Shinshu Univ, Sch Med, Dept Pediat, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	inabay@shinshu-u.ac.jp; ktomoki@shinshu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25460405]; Japan Foundation for Pediatric Research; Medical Research Encouragement Prize of The Japan Medical Association; Research on Intractable Diseases, Ministry of Health, Labour and Welfare, Japan	Grant sponsor: Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grant number: #25460405; Grant sponsor: Japan Foundation for Pediatric Research; Grant sponsor: Medical Research Encouragement Prize of The Japan Medical Association; Grant sponsor: Research on Intractable Diseases, Ministry of Health, Labour and Welfare, Japan.	Calabrese LH, 2007, ANN INTERN MED, V146, P34; Ducros A, 2012, LANCET NEUROL, V11, P906, DOI 10.1016/S1474-4422(12)70135-7; Ducros A, 2007, BRAIN, V130, P3091, DOI 10.1093/brain/awm256; Rykken JB, 2014, SEMIN ULTRASOUND CT, V35, P118, DOI 10.1053/j.sult.2013.09.007; MacCarrick G, 2014, GENET MED, V16, P576, DOI 10.1038/gim.2014.11; Ducros A, 2010, PRESSE MED, V39, P312, DOI 10.1016/j.lpm.2009.09.009; Wilson DG, 1999, CIRCULATION, V99, P909; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744; Singhal AB, 2011, ARCH NEUROL-CHICAGO, V68, P1005, DOI 10.1001/archneurol.2011.68; Boileau C, 2012, NAT GENET, V44, P916, DOI 10.1038/ng.2348; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; van de Laar IMBH, 2012, J MED GENET, V49, P47, DOI 10.1136/jmedgenet-2011-100382; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Chung AWY, 2007, BRIT J PHARMACOL, V150, P1075, DOI 10.1038/sj.bjp.0707181; Marra A, 2014, MED HYPOTHESES, V82, P619, DOI 10.1016/j.mehy.2014.02.022; Lindsay ME, 2012, NAT GENET, V44, P922, DOI 10.1038/ng.2349; Chen Shih-Pin, 2010, Ther Adv Neurol Disord, V3, P161, DOI 10.1177/1756285610361795; Chen SP, 2011, EXPERT REV NEUROTHER, V11, P1265, DOI [10.1586/ern.11.112, 10.1586/ERN.11.112]; Gallo Elena M, 2014, J Clin Invest, V124, P448, DOI 10.1172/JCI69666; Loeys BL, 2013, GENEREVIEWS, P1993; Mawet J, 2013, NEUROLOGY, V81, P821, DOI 10.1212/WNL.0b013e3182a2cbe2; Mehdi A, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0443-2; Mitchell LA, 2014, J NEUROINTERV SURG, V6, DOI 10.1136/neurintsurg-2012-010521.rep; Regalado ES, 2012, CIRC RES, V109, P680; Soltanolkotabi M, 2011, INTERV NEURORADIOL, V17, P486; STOESSL AJ, 1985, STROKE, V16, P734; Syyong HT, 2009, BRIT J PHARMACOL, V158, P1597, DOI 10.1111/j.1476-5381.2009.00439.x; Takata M, 2014, HEART VESSELS, V29, P478, DOI 10.1007/s00380-013-0393-3; Yang HHC, 2010, VASC PHARMACOL, V52, P37, DOI 10.1016/j.vph.2009.10.005	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4825	1552-4833		AM J MED GENET A	Am. J. Med. Genet. A	OCT	2015	167	10					2435	2439		10.1002/ajmg.a.37202		5	Genetics & Heredity	Genetics & Heredity	CR2TS	WOS:000361184100033		
J	Hayashi, A; Kumada, T; Furukawa, O; Nozaki, F; Hiejima, I; Shibata, M; Kusunoki, T; Fujii, T				Hayashi, Anri; Kumada, Tomohiro; Furukawa, Oki; Nozaki, Fumihito; Hiejima, Ikuko; Shibata, Minoru; Kusunoki, Takashi; Fujii, Tatsuya			Severe acute abdomen caused by symptomatic Meckel's diverticulum in three children with trisomy 18	AMERICAN JOURNAL OF MEDICAL GENETICS PART A			English	Article						18 trisomy; Meckel's; diverticulum; children; acute abdomen		Meckel's diverticulum (MD) is the most prevalent congenital anomaly of the gastrointestinal tract and often presents a diagnostic challenge. Patients with trisomy 18 frequently have MD, but the poor prognosis and lack of consensus regarding management for neonates has meant that precise information on the clinical manifestations in infants and children with MD is lacking. We describe the cases of three children with trisomy 18 who developed symptomatic MD. Intussusception was diagnosed in Patient 1, intestinal volvulus in Patient 2, and gastrointestinal bleeding in Patient 3. All three patients underwent surgical treatment and only the Patient 1 died due to pulmonary hypertensive crisis. The other two patients experienced no further episodes of abdominal symptoms. In patients with trisomy 18, although consideration of postoperative complications and prognosis after surgical treatment is necessary, symptomatic MD should carry a high index of suspicion in patients presenting with acute abdomen. (c) 2015 Wiley Periodicals, Inc.	[Hayashi, Anri; Kumada, Tomohiro; Nozaki, Fumihito; Hiejima, Ikuko; Shibata, Minoru; Kusunoki, Takashi; Fujii, Tatsuya] Shiga Med Ctr Children, Dept Pediat, Moriyama, Shiga 5240022, Japan; [Furukawa, Oki] Shiga Med Univ, Dept Pediat, Otus, Japan	Hayashi, A (reprint author), Shiga Med Ctr Children, Dept Pediat, Moriyama, Shiga 5240022, Japan.	anri520@msn.com					Levy AD, 2004, RADIOGRAPHICS, V24, P565, DOI 10.1148/rg.242035187; Kosho T, 2013, AM J MED GENET A, V161A, P1531, DOI 10.1002/ajmg.a.35990; Kumada T, 2013, AM J MED GENET A, V161A, P696, DOI 10.1002/ajmg.a.35763; Sagar J, 2006, J ROY SOC MED, V99, P501, DOI 10.1258/jrsm.99.10.501; Kosho T, 2006, AM J MED GENET A, V140A, P937, DOI 10.1002/ajmg.a.31175; Carey JC., 2010, MANAGEMENT GENETIC S, P807, DOI DOI 10.1002/9780470893159.CH54; John JP, 2005, ANN SURG, V241, P529; Jones KL., 2013, SMITHS RECOGNIZABLE, V7th, P14; Jung HR, 2013, PEDIATE GASTROENTERO, V16, P41; Kaneko Y, 2008, AM J MED GENET A, V146A, P1370; Kosho T, 2008, AM J MED GENET A, V146A, P1369, DOI 10.1002/ajmg.a.32355; Maria M, 2008, PEDIAT SURG INT, V24, P575; OSBORNE MP, 1978, POSTGRAD MED J, V54, P692; Stig S, 2006, J PEDIATR SURG, V41, P1014	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4825	1552-4833		AM J MED GENET A	Am. J. Med. Genet. A	OCT	2015	167	10					2447	2450		10.1002/ajmg.a.37098		4	Genetics & Heredity	Genetics & Heredity	CR2TS	WOS:000361184100036		
J	Poelmans, S; Kawamoto, T; Cristofoli, F; Politis, C; Vermeesch, J; Bailleul-Forestier, I; Hens, G; Devriendt, K; Verdonck, A; Carels, C				Poelmans, Simon; Kawamoto, Tatsuro; Cristofoli, Francesca; Politis, Constantinus; Vermeesch, Joris; Bailleul-Forestier, Isabelle; Hens, Greet; Devriendt, Koenraad; Verdonck, Anna; Carels, Carine			Genotypic and phenotypic variation in six patients with solitary median maxillary central incisor syndrome	AMERICAN JOURNAL OF MEDICAL GENETICS PART A			English	Article						Single Maxillary Median Central Incisor (SMMCI); Holoprosencephaly (HPE); Copy Number Variation (CNV); Exome Sequencing (ES); mutation analysis	7Q TERMINAL DELETION; CLINICAL SPECTRUM; TOOTH DEVELOPMENT; MIDLINE DEFECTS; SMMCI SYNDROME; SHORT STATURE; SIX3 GENE; MUTATION; DUPLICATION; MONOSOMY	Solitary Median Maxillary Central Incisor occurs in 1 of 50,000 live births. It is the mildest manifestation of the holoprosencephaly spectrum and is genetically heterogeneous. Here we report six patients with solitary median maxillary central incisor, and a range of other phenotypic anomalies with different degrees of severity, varying from mild signs of holoprosencephaly to associated intellectual disability, and with different genetic background. Using array comparative genomic hybridization, pathogenic copy number variants were found in three of the six patients. Two patients had a deletion at the 18p11 chromosomal region that includes TGIF1 while the other patient had a deletion at 7q36, including the SHH gene. In one patient, a mutation in SIX3 was detected with exome sequencing, while in the two remaining patients all known holoprosencephaly genes were excluded using multiplex ligation-dependent probe amplification and sequencing, and remain unsolved. One of the two latter patients had isolated solitary median maxillary central incisor without other visible dentofacial anomalies, while the other had clinical features not part of the known holoprosencephaly spectrum. (c) 2015 Wiley Periodicals, Inc.	[Poelmans, Simon; Verdonck, Anna; Carels, Carine] Katholieke Univ Leuven, Dept Oral Sci Orthodont, Leuven, Belgium; [Poelmans, Simon; Verdonck, Anna; Carels, Carine] Univ Hosp Leuven, Dent, Leuven, Belgium; [Kawamoto, Tatsuro; Carels, Carine] Radboudumc, Coll Dent, Dept Orthodont & Craniofacial Biol, Nijmegen, Netherlands; [Kawamoto, Tatsuro] Tokyo Med & Dent Univ, Grad Sch, Dept Maxillofacial Reconstruct & Funct, Div Maxillofacial Neck Reconstruct,Maxillofacial, Tokyo, Japan; [Cristofoli, Francesca; Vermeesch, Joris; Devriendt, Koenraad] Katholieke Univ Leuven, Dept Human Genet, Leuven, Belgium; [Cristofoli, Francesca; Vermeesch, Joris; Devriendt, Koenraad] Univ Hosp Leuven, Ctr Human Genet, Leuven, Belgium; [Politis, Constantinus] Katholieke Univ Leuven, Dept Oral & Maxillofacial Surg, Leuven, Belgium; [Politis, Constantinus; Hens, Greet] Univ Hosp Leuven, Leuven, Belgium; [Bailleul-Forestier, Isabelle] Katholieke Univ Leuven, Dept Oral Hlth Sci Paediat Dent & Special Care, Leuven, Belgium; [Bailleul-Forestier, Isabelle] Univ Hosp Leuven, Dent, Leuven, Belgium; [Bailleul-Forestier, Isabelle] Univ Toulouse 3, Hop Toulouse, Dept Paediat Dent, F-31062 Toulouse, France; [Hens, Greet] Katholieke Univ Leuven, Dept Otorhinolaryngol Head & Neck Surg, Leuven, Belgium	Carels, C (reprint author), Katholieke Univ Leuven, Dept Oral Sci Orthodont, Leuven, Belgium.	carine.carels@uzleuven.be	Carels, C.E.L./H-8020-2014				Lacbawan F, 2009, J MED GENET, V46, P389, DOI 10.1136/jmg.2008.063818; Kantaputra PN, 2006, AM J MED GENET A, V140A, P2598, DOI 10.1002/ajmg.a.31386; Domene S, 2008, HUM MOL GENET, V17, P3919, DOI 10.1093/hmg/ddn294; Hardcastle Z, 1998, DEVELOPMENT, V125, P2803; Lin DH, 2007, DEV DYNAM, V236, P1307, DOI 10.1002/dvdy.21127; Argiropoulos B, 2011, AM J MED GENET A, V155A, P885, DOI 10.1002/ajmg.a.33918; AUGHTON DJ, 1991, J MED GENET, V28, P530, DOI 10.1136/jmg.28.8.530; Balci S, 2011, AM J MED GENET A, V155A, P1129, DOI 10.1002/ajmg.a.33868; BOUDAILLIEZ B, 1983, J GENET HUM, V31, P239; Chen CP, 2012, GENET COUNSEL, V23, P1; Chen CP, 1999, PRENATAL DIAG, V19, P986, DOI 10.1002/(SICI)1097-0223(199910)19:10<986::AID-PD672>3.0.CO;2-H; DOLAN LM, 1981, J MED GENET, V18, P396, DOI 10.1136/jmg.18.5.396; El-Jaick KB, 2007, BIRTH DEFECTS RES A, V79, P573, DOI 10.1002/bdra.20380; Frints SGM, 1998, AM J MED GENET, V75, P153, DOI 10.1002/(SICI)1096-8628(19980113)75:2<153::AID-AJMG6>3.0.CO;2-U; Frints SGM, 1998, GENET COUNSEL, V9, P5; Fryns J. P., 1993, Genetic Counseling, V4, P37; Hall RK, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-12; Hall RK, 1997, ORAL SURG ORAL MED O, V84, P651, DOI 10.1016/S1079-2104(97)90368-1; Hehr U, 2010, HUM GENET, V127, P555, DOI 10.1007/s00439-010-0797-4; Kamnasaran D, 2005, GENOMICS, V85, P608, DOI 10.1016/j.ygeno.2005.01.010; MASUNO M, 1990, JPN J HUM GENET, V35, P311, DOI 10.1007/BF01883753; Miertus J, 2006, HUM GENET, V119, P154, DOI 10.1007/s00439-005-0124-7; Miura Mari, 1993, Pediatric Dentistry, V15, P214; Moog U, 2001, GENET COUNSEL, V12, P287; MUENKE M, 1994, P NATL ACAD SCI USA, V91, P8102, DOI 10.1073/pnas.91.17.8102; Nanni L, 2001, AM J MED GENET, V102, P1, DOI 10.1002/1096-8628(20010722)102:1<1::AID-AJMG1336>3.0.CO;2-U; Naudi Antoniella Busuttil, 2007, Spec Care Dentist, V27, P12, DOI 10.1111/j.1754-4505.2007.tb00321.x; Pasquier L, 2000, EUR J HUM GENET, V8, P797, DOI 10.1038/sj.ejhg.5200540; Sanchez ZJ, 2008, AN PEDIAT BARC, V68, P273; Strehle EM, 2012, GENE, V506, P387, DOI 10.1016/j.gene.2012.06.087; Taine L, 1997, ANN GENET-PARIS, V40, P158; Taniguchi K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002524; TAVIN E, 1994, INT J PEDIATR OTORHI, V28, P199, DOI 10.1016/0165-5876(94)90012-4; Tubbs RS, 2004, J CHILD NEUROL, V19, P544; Yang HC, 2005, ASIAN PAC J ALLERGY, V23, P159; Zahnleiter D, 2011, EUR J MED GENET, V54, pE521, DOI 10.1016/j.ejmg.2011.06.007	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4825	1552-4833		AM J MED GENET A	Am. J. Med. Genet. A	OCT	2015	167	10					2451	2458		10.1002/ajmg.a.37207		8	Genetics & Heredity	Genetics & Heredity	CR2TS	WOS:000361184100037		
J	Suzumori, N; Kagami, M; Kumagai, K; Goto, S; Matsubara, K; Sano, S; Sugiura-Ogasawara, M				Suzumori, Nobuhiro; Kagami, Masayo; Kumagai, Kyoko; Goto, Shinobu; Matsubara, Keiko; Sano, Shinichiro; Sugiura-Ogasawara, Mayumi			Clinical and molecular findings in a patient with 46,XX/47,XX,+14 mosaicism caused by postzygotic duplication of a paternally derived chromosome 14	AMERICAN JOURNAL OF MEDICAL GENETICS PART A			English	Letter							UNIPARENTAL DISOMY		[Suzumori, Nobuhiro; Kumagai, Kyoko; Goto, Shinobu; Sugiura-Ogasawara, Mayumi] Nagoya City Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Nagoya, Aichi 4678601, Japan; [Suzumori, Nobuhiro; Kumagai, Kyoko; Goto, Shinobu] Nagoya City Univ, Grad Sch Med Sci, Div Clin & Mol Genet, Nagoya, Aichi 4678601, Japan; [Kagami, Masayo; Matsubara, Keiko; Sano, Shinichiro] Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Tokyo, Japan	Suzumori, N (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Div Clin & Mol Genet, Nagoya, Aichi 4678601, Japan.	og.n.suz@med.nagoya-cu.ac.jp; kagami-ms@ncchd.go.jp					Kagami M, 2008, NAT GENET, V40, P237, DOI 10.1038/ng.2007.56; Kagami M, 2008, PLACENTA, V29, P760, DOI 10.1016/j.placenta.2008.06.001; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Hur Yun Jung, 2012, Korean J Pediatr, V55, P393, DOI 10.3345/kjp.2012.55.10.393; Kagami M, 2015, EUR J HUM GENET, DOI [10.1038/ejhg.2015.13, DOI 10.1038/EJHG.2015.13]; Kagami M, 2015, EUR J HUM GENET, V23, P1062, DOI 10.1038/ejhg.2014.234; Lynch M Fran, 2004, J Perinatol, V24, P121; Salas-Labadia C, 2014, MOL CYTOGENET, V7, DOI 10.1186/s13039-014-0065-8; Suzumori N, 2010, AM J MED GENET A, V152A, P3189, DOI 10.1002/ajmg.a.33719	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4825	1552-4833		AM J MED GENET A	Am. J. Med. Genet. A	OCT	2015	167	10					2474	2477		10.1002/ajmg.a.37194		4	Genetics & Heredity	Genetics & Heredity	CR2TS	WOS:000361184100041		
J	Yoshioka, E; Yamaguchi, M; Shiraishi, A; Kono, T; Ohta, K; Ohashi, Y				Yoshioka, Eriko; Yamaguchi, Masahiko; Shiraishi, Atsushi; Kono, Tomoko; Ohta, Kiyohiko; Ohashi, Yuichi			Influence of Eyelid Pressure on Fluorescein Cross Mack Staining of Ocular Surface in Dry Eyes	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article							SUPERIOR LIMBIC KERATOCONJUNCTIVITIS; MEIBOMIAN GLAND DYSFUNCTION; BOTULINUM-TOXIN; CONJUNCTIVOCHALASIS; BLEPHAROSPASM; MOVEMENT; DISEASE; SURGERY; AGE	PURPOSE: To determine the relationship between eyelid pressure during blinking and the fluorescein staining of the cornea and conjunctiva in dry eye patients. DESIGN: Cross-sectional prospective study. METHODS: The pressure of the upper and lower eyelids was measured with a specially designed blepahrotensiometer in 130 eyes of 65 dry eye patients (D group) and in 58 eyes of 31 normal controls (N group). The correlations between the location and degree of ocular surface staining scores and the eyelid pressure were calculated for the D group. RESULTS: The pressures of the upper and lower eyelids were significantly higher in the D group than in the N group (upper P <.0001, lower P = .0040). The lower eyelid pressure was significantly correlated with the ocular surface staining scores for the inferior cornea (r = 0.19, P = .0307) and conjunctiva (r = 0.19, P = .0252). CONCLUSIONS: The significant correlation between the eyelid pressure and the ocular surface staining suggests that mechanical friction on the ocular surface by the eyelids may be one of the factors that affects the fluorescein staining of the inferior ocular surface. (C) 2015 by Elsevier Inc. All rights reserved.	[Yoshioka, Eriko; Yamaguchi, Masahiko; Shiraishi, Atsushi; Kono, Tomoko; Ohta, Kiyohiko; Ohashi, Yuichi] Ehime Univ, Grad Sch Med, Dept Ophthalmol, Toon, Ehime 7910295, Japan; [Shiraishi, Atsushi] Ehime Univ, Grad Sch Med, Dept Stem Cell Biol, Toon, Ehime 7910295, Japan; [Ohashi, Yuichi] Ehime Univ, Grad Sch Med, Dept Infect Dis, Toon, Ehime 7910295, Japan	Shiraishi, A (reprint author), Ehime Univ, Grad Sch Med, Dept Ophthalmol, Toon, Ehime 7910295, Japan.	shiraia@m.ehime-u.ac.jp					Souchier M, 2008, BRIT J OPHTHALMOL, V92, P819, DOI 10.1136/bjo.2007.133900; Koh S, 2003, AM J OPHTHALMOL, V136, P513, DOI 10.1016/S0002-9394(03)00317-9; DOANE MG, 1980, AM J OPHTHALMOL, V89, P507; Bron AJ, 2004, EXP EYE RES, V78, P347, DOI 10.1016/j.exer.2003.09.019; Yokoi N, 2003, AM J OPHTHALMOL, V135, P303, DOI 10.1016/S0002-9394(02)01975-X; Goto E, 2003, INVEST OPHTH VIS SCI, V44, P1897, DOI 10.1167/iovs.02-0818; Macri A, 2000, ARCH OPHTHALMOL-CHIC, V118, P1632; Cher I, 2003, CLIN EXP OPHTHALMOL, V31, P183, DOI 10.1046/j.1442-9071.2003.00633.x; Lemp MA, 2007, OCUL SURF, V5, P75; Yamaguchi M, 2006, AM J OPHTHALMOL, V141, P669, DOI 10.1016/j.ajo.2005.11.004; Dal Pizzol MM, 2009, ARQ BRAS OFTALMOL, V72, P308; Ehrmann K, 2001, Cont Lens Anterior Eye, V24, P65, DOI 10.1016/S1367-0484(01)80015-1; Francis IC, 2006, EYE, V20, P166, DOI 10.1038/sj.eye.6701830; Hirotani Yumi, 2003, Nippon Ganka Gakkai Zasshi, V107, P363; Horwath-Winter J, 2003, BRIT J OPHTHALMOL, V87, P54, DOI 10.1136/bjo.87.1.54; Kakizaki H, 2003, ACTA OPHTHALMOL SCAN, V81, P669, DOI 10.1046/j.1600-0420.2003.00141.x; Kheirkhah A, 2007, CORNEA, V26, P685, DOI 10.1097/ICO.0b013e31805771c6; Kim JC, 2009, CORNEA, V28, P752; Korb Donald R., 2002, CLAO Journal, V28, P211; MATHERS WD, 1992, CURR EYE RES, V11, P517, DOI 10.3109/02713689209001807; PRICE J, 1993, J CLIN NEURO-OPHTHAL, V13, P67; Qian JG, 2006, J PLAST RECONSTR AES, V59, P878, DOI 10.1016/j.bjps.2005.11.009; Sakai E, 2012, EYE CONTACT LENS, V38, P326, DOI 10.1097/ICL.0b013e318268610a; SHIMAZAKI J, 1995, ARCH OPHTHALMOL-CHIC, V113, P1266; SHORE JW, 1985, AM J OPHTHALMOL, V99, P415; Snellen H, 1869, ALBRECHT GRAFES ARCH, V2, P199; Spiera H, 1997, J RHEUMATOL, V24, P1842; Uchino Y, 2012, JPN J OPHTHALMOL, V56, P8, DOI 10.1007/s10384-011-0099-y; VIHLEN FS, 1983, INVEST OPHTH VIS SCI, V24, P1367; Yamamoto Y, 2015, CURR EYE RES; Yokoi Norihiko, 2008, Dev Ophthalmol, V41, P138, DOI 10.1159/000131086	31	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9394	1879-1891		AM J OPHTHALMOL	Am. J. Ophthalmol.	OCT	2015	160	4					685	692		10.1016/j.ajo.2015.06.028		8	Ophthalmology	Ophthalmology	CR7BR	WOS:000361503400009		
J	Sekiya, F; Sugimoto, A				Sekiya, Fumiki; Sugimoto, Akihiro			Fitting discrete polynomial curve and surface to noisy data	ANNALS OF MATHEMATICS AND ARTIFICIAL INTELLIGENCE			English	Article						Curve fitting; Surface fitting; Discrete polynomial curve; Discrete polynomial surface; Local optimal; Outliers	RANDOM SAMPLE CONSENSUS; HYPERPLANE RECOGNITION; ALGORITHM; MODEL; REGRESSION; DIMENSION; RANSAC	Fitting geometric models such as lines, circles or planes is an essential task in image analysis and computer vision. This paper deals with the problem of fitting a discrete polynomial curve to given 2D integer points in the presence of outliers. A 2D discrete polynomial curve is defined as a set of integer points lying between two polynomial curves. We formulate the problem as a discrete optimization problem in which the number of points included in the discrete polynomial curve, i.e., the number of inliers, is maximized. We then propose a robust method that effectively achieves a solution guaranteeing local maximality by using a local search, called rock climbing, with a seed obtained by RANSAC. We also extend our method to deal with a 3D discrete polynomial surface. Experimental results demonstrate the effectiveness of our proposed method.	[Sekiya, Fumiki] Chiba Univ, Grad Sch Adv Integrat Sci, Chiba, Japan; [Sugimoto, Akihiro] Natl Inst Informat, Tokyo, Japan	Sekiya, F (reprint author), Chiba Univ, Grad Sch Adv Integrat Sci, Chiba, Japan.	sekiya@nii.ac.jp; sugimoto@nii.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japanese-French joint research project called the SAKURA program	This work is in part supported by Grant-in-Aid for Scientific Research of the Ministry of Education, Culture, Sports, Science and Technology of Japan and by a Japanese-French joint research project called the SAKURA program.	Abdoulaye S., 2013, INT J; Aiger D, 2011, LECT NOTES COMPUT SC, V6607, P223, DOI 10.1007/978-3-642-19867-0_19; Andres E, 2008, THEOR COMPUT SCI, V406, P8, DOI 10.1016/j.tcs.2008.07.025; ROUSSEEUW PJ, 1984, J AM STAT ASSOC, V79, P871, DOI 10.2307/2288718; Raguram R, 2008, LECT NOTES COMPUT SC, V5303, P500, DOI 10.1007/978-3-540-88688-4_37; NARULA SC, 1982, INT STAT REV, V50, P317, DOI 10.2307/1402501; Beckermann B, 2000, NUMER MATH, V85, P553, DOI 10.1007/s002110000145; Torr PHS, 2000, COMPUT VIS IMAGE UND, V78, P138, DOI 10.1006/cviu.1999.0832; Andres E, 2003, GRAPH MODELS, V65, P92, DOI 10.1016/S1524-0703(03)00004-3; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; DUDA RO, 1972, COMMUN ACM, V15, P11, DOI 10.1145/361237.361242; Chum O, 2003, LECT NOTES COMPUT SC, V2781, P236; XU L, 1993, CVGIP-IMAG UNDERSTAN, V57, P131, DOI 10.1006/cviu.1993.1009; BRESENHAM JE, 1965, IBM SYST J, V4, P25; BRESENHAM J, 1977, COMMUN ACM, V20, P100, DOI 10.1145/359423.359432; Brimkov VE, 2007, IMAGE VISION COMPUT, V25, P1631, DOI 10.1016/j.imavis.2006.06.013; Buzer L., 2002, Discrete Geometry for Computer Imagery. 10th International Conference, DGCI 2002. Proceedings (Lecture Notes in Computer Science Vol.2301); Charrier E, 2008, LECT NOTES COMPUT SC, V4992, P346, DOI 10.1007/978-3-540-79126-3_31; Dexet M, 2009, DISCRETE APPL MATH, V157, P476, DOI 10.1016/j.dam.2008.05.030; Gerard Y, 2011, LECT NOTES COMPUT SC, V6607, P83, DOI 10.1007/978-3-642-19867-0_7; Hough P. V. C., 1962, U. S. patent, Patent No. [3,069,654, 3069654, US3069654 A]; Largeteau-Skapin G, 2012, INT C PATT RECOG, P3774; Largeteau-Skapin G., 2013, LNCS, V7749, P241; Phan M.S., 2013, LNCS, V7749, P253; Provot L, 2011, LECT NOTES COMPUT SC, V6636, P144, DOI 10.1007/978-3-642-21073-0_15; Provot L, 2011, LECT NOTES COMPUT SC, V6607, P284, DOI 10.1007/978-3-642-19867-0_24; Rousseeuw P. J., 2005, ROBUST REGRESSION OU; Sekiya F., 2012, LNCS, V7655, P59; Spall J. C., 2005, INTRO STOCHASTIC SEA; Toutant J.L., 2013, DISCRET APPL MATH; Zrour R, 2011, LECT NOTES COMPUT SC, V6607, P358, DOI 10.1007/978-3-642-19867-0_30; Zrour R, 2011, INT J IMAG SYST TECH, V21, P45, DOI 10.1002/ima.20269	32	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1012-2443	1573-7470		ANN MATH ARTIF INTEL	Ann. Math. Artif. Intell.	OCT	2015	75	1-2					135	162		10.1007/s10472-014-9425-7		28	Computer Science, Artificial Intelligence; Mathematics, Applied	Computer Science; Mathematics	CR6IS	WOS:000361450200008		
J	Kobayashi, K; Tsuchiya, T				Kobayashi, Kenta; Tsuchiya, Takuya			A PRIORI ERROR ESTIMATES FOR LAGRANGE INTERPOLATION ON TRIANGLES	APPLICATIONS OF MATHEMATICS			English	Article						finite element method; Lagrange interpolation; circumradius condition; minimum angle condition; maximum angle condition	FINITE-ELEMENT METHOD	We present the error analysis of Lagrange interpolation on triangles. A new a priori error estimate is derived in which the bound is expressed in terms of the diameter and circumradius of a triangle. No geometric conditions on triangles are imposed in order to get this type of error estimates. To derive the new error estimate, we make use of the two key observations. The first is that squeezing a right isosceles triangle perpendicularly does not reduce the approximation property of Lagrange interpolation. An arbitrary triangle is obtained from a squeezed right triangle by a linear transformation. The second key observation is that the ratio of the singular values of the linear transformation is bounded by the circumradius of the target triangle.	[Kobayashi, Kenta] Hitotsubashi Univ, Grad Sch Commerce & Management, Kunitachi, Tokyo 1868601, Japan; [Tsuchiya, Takuya] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan	Kobayashi, K (reprint author), Hitotsubashi Univ, Grad Sch Commerce & Management, Kunitachi, Tokyo 1868601, Japan.	kenta.k@r.hit-u.ac.jp; tsuchiya@math.sci.ehime-u.ac.jp			JSPS [25400198, 26400201, 23340023]	The authors are supported by JSPS Grant-in-Aid for Scientific Research (C) 25400198 and (C) 26400201. The second author is partially supported by JSPS Grant-in-Aid for Scientific Research (B) 23340023.	Brandts J, 2008, COMPUT MATH APPL, V55, P2227, DOI 10.1016/j.camwa.2007.11.010; ZLAMAL M, 1968, NUMER MATH, V12, P394, DOI 10.1007/BF02161362; Liu XF, 2010, J MATH SCI-U TOKYO, V17, P27; BABUSKA I, 1976, SIAM J NUMER ANAL, V13, P214; Brenner S. C., 2008, TEXTS APPL MATH, V15; Brezis H, 2011, UNIVERSITEXT, P1; Ciarlet P.G., 2002, CLASSICS APPL MATH, V40; Ern A., 2004, APPL MATH SCI, V159; Fournier J. J. F., 2003, PURE APPL MATH, V140; Hannukainen A, 2012, NUMER MATH, V120, P79, DOI 10.1007/s00211-011-0403-2; Horn R. A., 1991, TOPICS MATRIX ANAL; JAMET P, 1976, REV FR AUTOMAT INFOR, V10, P43; Kobayashi K, 2015, JPN J IND APPL MATH, V32, P65, DOI 10.1007/s13160-014-0161-5; Krizek M., 1991, APPL MATH, V36, P223; Shenk N.A., 1994, MATH COMPUT, V63, P105, DOI 10.2307/2153564; Tsuchiya T., 2015, ARXIV150800119; Kobayashi K, 2014, JPN J IND APPL MATH, V31, P193, DOI 10.1007/s13160-013-0128-y; Yamamoto T., 2010, ELEMENTS MATRIX ANAL; Zenisek A., 1969, APL MAT, V14, P355	19	0	0	ACAD SCIENCES CZECH REPUBLIC, INST MATHEMATICS	PRAHA 1	ZITNA 25, PRAHA 1, 115 67, CZECH REPUBLIC	0862-7940	1572-9109		APPL MATH-CZECH	Appl. Mat.	OCT	2015	60	5					485	499				15	Mathematics, Applied	Mathematics	CR4YW	WOS:000361347000003		
J	Nakajima, A; Yang, L; Matsuda, E; Nagano, A; Sameshima, H; Ikenoue, T				Nakajima, Akira; Yang, Li; Matsuda, Emiko; Nagano, Ayako; Sameshima, Hiroshi; Ikenoue, Tsuyomu			Intracerebral Antioxidant Ability of Neonatal Rats After Acute Hypoxic-Ischemic Brain Injury Estimated Using the Brain Homogenate-ESR Method	APPLIED MAGNETIC RESONANCE			English	Article							INHIBITS LIPID-PEROXIDATION; FREE-RADICAL SCAVENGER; MATURE RATS; DAMAGE; MICRODIALYSIS; CAPACITY; HIPPOCAMPUS; GENERATION; EDARAVONE	The intracerebral antioxidant ability of neonatal rats after acute hypoxic-ischemic (HI) brain injury was estimated using the brain homogenate-ESR method after intraperitoneal injection of 3-methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine-1-oxyl, blood-brain-barrier permeable stable cyclic nitroxide. Seven-day-old Wistar rats were subjected to a modified Levine's procedure for producing HI brain injury. The rats 7 days after HI insult were ranked in severe, mild and normal groups based on their brain damage. The severe brain damage was observed with high probability. The intracerebral antioxidant ability of the normal and mild groups was same as that of the control rats. On the other hand, the antioxidant ability in the ligated side of the cerebral hemisphere of the severe group was significantly lower than that of the control rats. The HI insult resulted in the oxidative stress and the insufficient supply of the endogenous antioxidants, which caused the significant decrease in the intracerebral antioxidant ability. The brain homogenate-ESR method can be easily conducted for a large number of neonatal rats at regular time intervals, which indicates the usefulness of the method to evaluate the intracerebral antioxidant ability of neonatal rats.	[Nakajima, Akira] Miyazaki Univ, Frontier Sci Res Ctr, Dept Biotechnol, Kiyotake, Miyazaki 8891692, Japan; [Yang, Li; Matsuda, Emiko; Nagano, Ayako; Sameshima, Hiroshi; Ikenoue, Tsuyomu] Miyazaki Univ, Fac Med, Dept Reprod & Dev Med, Sect Obstet & Gynecol, Kiyotake, Miyazaki 8891692, Japan	Nakajima, A (reprint author), Miyazaki Univ, Frontier Sci Res Ctr, Dept Biotechnol, Kiyotake, Miyazaki 8891692, Japan.	akanaka@med.miyazaki-u.ac.jp					Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Bobko AA, 2007, FREE RADICAL BIO MED, V42, P404, DOI 10.1016/j.freeradbiomed.2006.11.007; Ikeda T, 2001, BEHAV BRAIN RES, V118, P17, DOI 10.1016/S0166-4328(00)00287-4; LEVINE S, 1960, AM J PATHOL, V36, P1; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Noor JI, 2007, NEUROSCI LETT, V414, P5, DOI 10.1016/j.neulet.2006.10.024; MORTOLA JP, 1992, AM J PHYSIOL, V263, pR267; Katalinic V, 2005, COMP BIOCHEM PHYS C, V140, P47, DOI 10.1016/j.cca.2005.01.005; Hayashi Y, 2004, BRAIN RES, V1025, P29, DOI 10.1016/j.brainres.2004.07.067; Ikeda T, 2002, NEUROSCI LETT, V329, P33, DOI 10.1016/S0304-3940(02)00573-6; Ikeno S, 2000, J Obstet Gynaecol Res, V26, P227; Miura Y, 2001, BBA-GEN SUBJECTS, V1525, P167, DOI 10.1016/S0304-4165(00)00184-7; Nakajima A, 2015, J OBSTET GYNAECOL RE, V41, P884, DOI 10.1111/jog.12660; Nakajima A, 2014, APPL MAGN RESON, V45, P1417, DOI 10.1007/s00723-014-0590-y; Nakajima A, 2011, APPL MAGN RESON, V40, P535, DOI 10.1007/s00723-011-0230-8; Noor JI, 2005, AM J OBSTET GYNECOL, V193, P1703, DOI 10.1016/j.ajog.2005.03.069; Ota A, 1998, AM J OBSTET GYNECOL, V179, P1075, DOI 10.1016/S0002-9378(98)70218-2; Ota A, 1997, AM J OBSTET GYNECOL, V177, P519, DOI 10.1016/S0002-9378(97)70139-X; Shea TB, 2003, J NEUROSCI METH, V125, P55, DOI 10.1016/S0165-0270(03)00028-1; Siqueira IR, 2005, INT J DEV NEUROSCI, V23, P663, DOI 10.1016/j.ijdevneu.2005.03.001; Ueda Y, 2004, NEUROCHEM RES, V29, P1695, DOI 10.1023/B:NERE.0000035804.80383.a1; Ueda Y, 2006, EXP BRAIN RES, V169, P117, DOI 10.1007/s00221-005-0122-y; Xia X.Y., 2002, J OBSTET GYNECOL RES, V28, P320; Yokoyama H, 2004, MAGN RESON IMAGING, V22, P1305, DOI 10.1016/j.jmri.2004.09.003	24	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0937-9347	1613-7507		APPL MAGN RESON	Appl. Magn. Reson.	OCT	2015	46	10					1079	1088		10.1007/s00723-015-0710-3		10	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CR6PL	WOS:000361469500002		
J	Kasai, K; Ishikawa, T; Nakamura, T; Miura, T				Kasai, Kosuke; Ishikawa, Takashi; Nakamura, Toshiya; Miura, Tomisato			Antibacterial properties of l-amino acid oxidase: mechanisms of action and perspectives for therapeutic applications	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Review						Antibacterial protein; L-amino acid oxidase; Multidrug-resistant bacteria; Hydrogen peroxide	RESISTANT STAPHYLOCOCCUS-AUREUS; FLOUNDER PLATICHTHYS-STELLATUS; ROCKFISH SEBASTES-SCHLEGELI; HARE APLYSIA-CALIFORNICA; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; CDNA CLONING; SNAKE-VENOM; SKIN MUCUS; SEA HARE	Venom, the mucus layer covering the body surface, ink glands, mammary glands, milk, and various animal secretory functions as both a physical and chemical defense barrier against bacteria and virus infections. Previously, several studies reported that l-amino acid oxidases (LAAOs) present in animal secretary fluids have strong antimicrobial activities and selective cytotoxic activities against Gram-positive and Gram-negative bacteria, various pathogenic bacteria, viruses, and parasite species. These LAAOs catalyze oxidative deamination of an l-amino acid substrate with the generation of hydrogen peroxide. The antibacterial activity of LAAOs is completely inhibited by catalase; thus, LAAOs kill bacteria by the hydrogen peroxide generated from the oxidation of l-amino acid substrates. This review focuses on the selective, specific, and local antibacterial actions of various LAAOs that may be used as novel therapeutic agents against infectious diseases. LAAOs that are suitable leads for combating multidrug-resistant bacterial infections are also studied.	[Kasai, Kosuke; Miura, Tomisato] Hirosaki Univ, Grad Sch Hlth Sci, Dept Pathol Anal, Div Med Life Sci, Aomori, Japan; [Ishikawa, Takashi; Nakamura, Toshiya] Hirosaki Univ, Grad Sch Hlth Sci, Dept Biomed Sci, Div Med Life Sci, Aomori, Japan	Miura, T (reprint author), Hirosaki Univ, Grad Sch Hlth Sci, Dept Pathol Anal, Div Med Life Sci, Aomori, Japan.	tomisato@hirosaki-u.ac.jp	Kasai, Kosuke/F-2147-2013				Ohtsu I, 2010, J BIOL CHEM, V285, P17479, DOI 10.1074/jbc.M109.081356; Chu CC, 1997, P NATL ACAD SCI USA, V94, P2507, DOI 10.1073/pnas.94.6.2507; Kitani Y, 2008, COMP BIOCHEM PHYS B, V149, P394, DOI 10.1016/j.cbpb.2007.10.013; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Zhong SR, 2009, TOXICON, V54, P763, DOI 10.1016/j.toxicon.2009.06.004; Nagashima Y, 2009, COMP BIOCHEM PHYS B, V154, P55, DOI 10.1016/j.cbpb.2009.05.006; Li RJ, 2014, FISH SHELLFISH IMMUN, V41, P356, DOI 10.1016/j.fsi.2014.09.017; Cohen-Nahum K, 2010, INFECTION, V38, P41, DOI 10.1007/s15010-009-8460-5; Puiffe ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054589; WELLNER D, 1960, J BIOL CHEM, V235, P2013; Ande SR, 2006, APOPTOSIS, V11, P1439, DOI 10.1007/s10495-006-7959-9; Toyama MH, 2006, TOXICON, V47, P47, DOI 10.1016/j.toxicon.2005.09.008; Tempone AG, 2001, BIOCHEM BIOPH RES CO, V280, P620, DOI 10.1006/bbrc.2000.4175; Vargas LJ, 2013, TOXICON, V64, P1, DOI 10.1016/j.toxicon.2012.11.027; Wang H, 2001, ANTIMICROB AGENTS CH, V45, P1515, DOI 10.1128/AAC.45.5.1515-1521.2001; Sun YP, 2002, J BIOL CHEM, V277, P19080, DOI 10.1074/jbc.M200936200; Aloush V, 2006, ANTIMICROB AGENTS CH, V50, P43, DOI 10.1128/AAC.50.1.43-48.2006; Wang FH, 2011, FISH SHELLFISH IMMUN, V30, P1095, DOI 10.1016/j.fsi.2011.02.004; [Anonymous], 2011, BIOCHIMIE, DOI [DOI 10.1016/J.BIOCHI.2011.01.009, 10.1016/J.BIOCHI.2011.01.009]; Stabeli RG, 2004, BIOORGAN MED CHEM, V12, P2881, DOI 10.1016/j.bmc.2004.03.049; Yang CA, 2011, FEBS J, V278, P3381, DOI 10.1111/j.1742-4658.2011.08262.x; Vatansever F, 2013, FEMS MICROBIOL REV, V37, P955, DOI 10.1111/1574-6976.12026; Seppala H, 1997, NEW ENGL J MED, V337, P441, DOI 10.1056/NEJM199708143370701; Hanane-Fadila ZM, 2014, J BIOCHEM MOL TOXIC, V28, P347, DOI 10.1002/jbt.21571; Ehara T, 2002, FEBS LETT, V531, P509, DOI 10.1016/S0014-5793(02)03608-6; Lee ML, 2014, BASIC CLIN PHARMACOL, V114, P336, DOI 10.1111/bcpt.12155; Gomez D, 2008, APPL MICROBIOL BIOT, V79, P925, DOI 10.1007/s00253-008-1499-x; Boyce JM, 2005, LANCET INFECT DIS, V5, P653, DOI 10.1016/S1473-3099(05)70243-7; Yang HC, 2005, J EXP BIOL, V208, P3609, DOI 10.1242/jeb.01795; Lukasheva EV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P1152, DOI 10.1023/A:1020967408229; Izidoro LFM, 2006, BIOORGAN MED CHEM, V14, P7034, DOI 10.1016/j.bmc.2006.06.025; Huycke MM, 1998, EMERG INFECT DIS, V4, P239; Ande SR, 2008, YEAST, V25, P349, DOI 10.1002/yea.1592; Fridkin SK, 2001, CLIN INFECT DIS, V32, P108, DOI 10.1086/317542; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Wang MG, 2004, ANTIMICROB AGENTS CH, V48, P1295, DOI 10.1128/AAC.48.4.1295-1299.2004; CLIFFORD DP, 1982, MOL CELL BIOCHEM, V49, P143; Samel M, 2008, COMP BIOCHEM PHYS B, V149, P572, DOI 10.1016/j.cbpb.2007.11.008; Ko KC, 2012, ANTIMICROB AGENTS CH, V56, P1725, DOI 10.1128/AAC.05874-11; Butzke D, 2004, CELL DEATH DIFFER, V11, P608, DOI 10.1038/sj.cdd.4401385; COHEN ML, 1982, ANTIMICROB AGENTS CH, V21, P210; Torres AFC, 2010, TOXICON, V55, P795, DOI 10.1016/j.toxicon.2009.11.013; Du XY, 2002, TOXICON, V40, P659; Faruque ASG, 2007, J HEALTH POPUL NUTR, V25, P241; Franca SC, 2007, BIOCHEM BIOPH RES CO, V355, P302, DOI 10.1016/j.bbrc.2006.12.217; Izidoro L. F., 2014, BIOMED RES INT, V2014, DOI [10.1155/2014/19675424738050, DOI 10.1155/2014/196754]; Kasai K, 2010, FEBS J, V277, P453, DOI 10.1111/j.1742-4658.2009.07497.x; Kasai K, 2015, APPL MICROBIOL BIOT, V99, P6693, DOI 10.1007/s00253-015-6428-1; Kitani Y, 2007, FEBS J, V274, P125, DOI 10.1111/j.1742-4658.2006.05570.x; Kitani Y, 2007, FISH SHELLFISH IMMUN, V23, P1178, DOI 10.1016/j.fsi.2007.04.005; Kunishima H, 2010, J INFECT CHEMOTHER, V16, P414, DOI 10.1007/s10156-010-0076-2; Lee ML, 2011, COMP BIOCHEM PHYS C, V153, P237, DOI 10.1016/j.cbpc.2010.11.001; Li RJ, 2013, FISH SHELLFISH IMMUN, V35, P1867, DOI 10.1016/j.fsi.2013.09.026; Manchanda Vikas, 2010, J Glob Infect Dis, V2, P291, DOI 10.4103/0974-777X.68538; Meenakshisundaram Ramachandran, 2009, AIDS Res Ther, V6, P25, DOI 10.1186/1742-6405-6-25; Murakawa M, 2001, CELL DEATH DIFFER, V8, P298, DOI 10.1038/sj.cdd.4400811; Nagaoka K, 2014, ANIM SCI J, V85, P976, DOI 10.1111/asj.12237; Nagaoka K, 2009, FASEB J, V23, P2514, DOI 10.1096/fj.08-126466; Nakamura A, 2012, J INFECT CHEMOTHER, V18, P90, DOI 10.1007/s10156-011-0302-6; OBARA K, 1992, EUR J BIOCHEM, V209, P1, DOI 10.1111/j.1432-1033.1992.tb17254.x; Okubo BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033639; Pelgrift RY, 2013, ADV DRUG DELIVER REV, V65, P1803, DOI 10.1016/j.addr.2013.07.011; PERUMAL S R, 2006, BMC INFECT DIS, V6, P100; Petzelt C, 2002, NEOPLASIA, V4, P49, DOI 10.1038/sj.neo.7900202; SKARNES RC, 1970, NATURE, V225, P1072, DOI 10.1038/2251072a0; Soto SM, 2003, ANTIMICROB AGENTS CH, V47, P421, DOI 10.1128/AAC.47.1.421-425.2003; Stapleton PD, 1999, ANTIMICROB AGENTS CH, V43, P1206; STILES BG, 1991, TOXICON, V29, P1129, DOI 10.1016/0041-0101(91)90210-I; Suhr SM, 1999, J BIOCHEM-TOKYO, V125, P305; UEDA N, 1992, J CLIN INVEST, V90, P2593, DOI 10.1172/JCI116154; Munoz LJV, 2014, INT J BIOL MACROMOL, V69, P200, DOI 10.1016/j.ijbiomac.2014.05.039; WELLNER D, 1961, J BIOL CHEM, V236, P2357; Zhang YJ, 2003, BIOCHEM BIOPH RES CO, V309, P598, DOI 10.1016/j.bbrc.2003.08.044; Zhao Y, 2005, TOXICON, V46, P619, DOI 10.1016/j.toxicon.2005.06.022	74	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	OCT	2015	99	19					7847	7857		10.1007/s00253-015-6844-2		11	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CQ8ER	WOS:000360839800004		
J	Hama, S; Ogino, C; Kondo, A				Hama, Shinji; Ogino, Chiaki; Kondo, Akihiko			Enzymatic synthesis and modification of structured phospholipids: recent advances in enzyme preparation and biocatalytic processes	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Review						Bioreactor; Enzyme production; Lecithin; Phospholipases; Phospholipid modification	HIGH-LEVEL EXPRESSION; D-CATALYZED TRANSPHOSPHATIDYLATION; POLYUNSATURATED FATTY-ACID; BIOMASS SUPPORT PARTICLES; BIODIESEL-FUEL PRODUCTION; CONJUGATED LINOLEIC-ACID; WHOLE-CELL BIOCATALYSTS; RHIZOPUS-ORYZAE CELLS; ASPERGILLUS-ORYZAE; PICHIA-PASTORIS	Phospholipids (PLs) containing specific polar head groups and fatty acids, artificially synthesized from a complex mixture of natural PLs, have considerable industrial applications. The biocatalytic approaches to synthesizing structured PLs are of great interest because the enzymes used show high selectivity and performance under mild conditions, leading to the generation of products that cannot easily be obtained by chemical catalysis. Although the limited supply of phospholipases (e.g., phospholipase D) has thus far been an obstacle to the widespread use of enzymatic processing, recent advances in enzyme preparation have opened up various applications for PL modification. In this review, attempts to increase the productivity and utility of microbial phospholipases and lipases are presented. We also summarize recent developments in enzyme-catalyzed modification of PLs, focusing particularly on the relevant reactions, bioreactor design, and novel proof-of-concept experiments.	[Hama, Shinji] Bioenergy Corp, Res & Dev Lab, Amagasaki, Hyogo 6600053, Japan; [Ogino, Chiaki; Kondo, Akihiko] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Kobe, Hyogo 6578501, Japan	Kondo, A (reprint author), Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	akondo@kobe-u.ac.jp	Ogino, Chiaki/G-9932-2014	Ogino, Chiaki/0000-0002-8906-7724	Japan Science and Technology Agency, Japan	This work was supported by grants-in-aid from the Cross-ministerial Strategic Innovation Promotion Program (SIP) from Japan Science and Technology Agency, Japan.	Adlercreutz D, 2002, BIOTECHNOL BIOENG, V78, P403, DOI 10.1002/bit.10225; Sugiyama M, 2002, J BIOL CHEM, V277, P20051, DOI 10.1074/jbc.M200264200; Ogino C, 2004, APPL MICROBIOL BIOT, V64, P823, DOI 10.1007/s00253-003-1552-8; Guo Z, 2005, BIOTECHNOL ADV, V23, P203, DOI 10.1016/j.biotechadv.2005.02.001; Yang B, 2008, J AM OIL CHEM SOC, V85, P421, DOI 10.1007/s11746-008-1225-y; Ogino C, 1999, J BIOCHEM, V125, P263; Durban MA, 2007, APPL MICROBIOL BIOT, V74, P634, DOI 10.1007/s00253-006-0712-z; De Maria L, 2007, APPL MICROBIOL BIOT, V74, P290, DOI 10.1007/s00253-006-0775-x; Fukuda H, 2008, TRENDS BIOTECHNOL, V26, P668, DOI 10.1016/j.tibtech.2008.08.001; Driouch H, 2010, BIOTECHNOL BIOENG, V105, P1058, DOI 10.1002/bit.22614; D'Arrigo P, 2010, MOLECULES, V15, P1354, DOI 10.3390/molecules15031354; Liang MH, 2013, PROG LIPID RES, V52, P395, DOI 10.1016/j.plipres.2013.05.002; Hama S, 2006, J BIOSCI BIOENG, V101, P328, DOI 10.1263/jbb.101.328; Watanabe I, 1999, BIOSCI BIOTECH BIOCH, V63, P820, DOI 10.1271/bbb.63.820; Balcao VM, 1996, ENZYME MICROB TECH, V18, P392, DOI 10.1016/0141-0229(95)00125-5; Iwasaki Y, 2003, J AM OIL CHEM SOC, V80, P653, DOI 10.1007/s11746-003-0754-5; Joshi A, 2006, EUR J LIPID SCI TECH, V108, P363, DOI 10.1002/ejlt.200600016; Tanaka T, 2012, APPL MICROBIOL BIOT, V95, P577, DOI 10.1007/s00253-012-4175-0; Lee SY, 2003, TRENDS BIOTECHNOL, V21, P45, DOI 10.1016/S0167-7799(02)00006-9; Doig SD, 2003, EUR J LIPID SCI TECH, V105, P359, DOI 10.1002/ejlt.200390074; Cabezas DM, 2009, EUR J LIPID SCI TECH, V111, P993, DOI 10.1002/ejlt.200900001; ROBERTS IN, 1992, GENE, V122, P155, DOI 10.1016/0378-1119(92)90043-O; Cansell M, 2003, LIPIDS, V38, P551, DOI 10.1007/s11745-003-1341-0; Casado V, 2012, METHODS MOL BIOL, V861, P495, DOI 10.1007/978-1-61779-600-5_29; Driouch H, 2012, BIOTECHNOL BIOENG, V109, P462, DOI 10.1002/bit.23313; Seo KH, 2004, BIOTECHNOL LETT, V26, P1475, DOI 10.1023/B:BILE.0000044447.15205.90; VANDENBERGH CJ, 1987, EUR J BIOCHEM, V170, P241; Matsumoto Y, 2013, FEBS J, V280, P3780, DOI 10.1111/febs.12366; Patil VV, 2010, SEP PURIF TECHNOL, V75, P138, DOI 10.1016/j.seppur.2010.08.006; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; Sugimori D, 2012, FEBS OPEN BIO, V2, P318, DOI 10.1016/j.fob.2012.09.006; da Silva TL, 2014, APPL MICROBIOL BIOT, V98, P1043, DOI 10.1007/s00253-013-5389-5; Takemori D, 2012, PROTEIN EXPRES PURIF, V81, P145, DOI 10.1016/j.pep.2011.10.002; BEKKERS ACAPA, 1991, BIOCHIM BIOPHYS ACTA, V1089, P345, DOI 10.1016/0167-4781(91)90175-L; Ramrakhiani L, 2011, APPL BIOCHEM BIOTECH, V164, P991, DOI 10.1007/s12010-011-9190-6; Baeza-Jimenez R, 2013, J CHEM TECHNOL BIOT, V88, P1859, DOI 10.1002/jctb.4040; Baeza-Jimenez R, 2012, GRASAS ACEITES, V63, P44, DOI 10.3989/gya.045211; Beer HD, 1996, BIOCHEM J, V319, P351; Bi YH, 2015, J AGR FOOD CHEM, V63, P1558, DOI 10.1021/jf505296k; Cabezas DM, 2011, J AM OIL CHEM SOC, V88, P443, DOI 10.1007/s11746-010-1684-9; Casado V, 2014, J MOL CATAL B-ENZYM, V99, P14, DOI 10.1016/j.molcatb.2013.10.011; Casado V, 2013, FOOD BIOPROD PROCESS, V91, P599, DOI 10.1016/j.fbp.2013.02.002; Chen S, 2013, BIOSCI BIOTECH BIOCH, V77, P1939, DOI 10.1271/bbb.130388; Chojnacka A, 2009, BIOTECHNOL LETT, V31, P705, DOI 10.1007/s10529-009-9915-6; Correia-Ledo D, 2010, J AM CHEM SOC, V132, P15120, DOI 10.1021/ja105921g; Cui ZC, 2012, EXTREMOPHILES, V16, P619, DOI 10.1007/s00792-012-0461-0; Damnjanovic J, 2013, J BIOSCI BIOENG, V116, P271, DOI 10.1016/j.jbiosc.2013.03.008; D'Arrigo P, 2005, ENZYME MICROB TECH, V37, P435, DOI 10.1016/j.enzmictec.2005.03.021; D'Arrigo P, 2012, J MOL CATAL B-ENZYM, V84, P132, DOI 10.1016/j.molcatb.2012.04.011; Dippe M, 2008, CHEM PHYS LIPIDS, V152, P71, DOI 10.1016/j.chemphyslip.2008.01.005; Duan ZQ, 2013, J BIOTECHNOL, V163, P45, DOI 10.1016/j.jbiotec.2012.10.022; Estiasih T., 2013, International Food Research Journal, V20, P843; Fernandez-Lafuente R, 2010, J MOL CATAL B-ENZYM, V62, P197, DOI 10.1016/j.molcatb.2009.11.010; Garcia HS, 2008, GRASAS ACEITES, V59, P368, DOI 10.3989/gya.2008.v59.i4.531; Hama S, 2015, BIOCHEM ENG J, V96, P1, DOI 10.1016/j.bej.2014.12.013; Hama S, 2008, APPL MICROBIOL BIOT, V79, P1009, DOI 10.1007/s00253-008-1502-6; Hama S, 2010, APPL MICROBIOL BIOT, V87, P537, DOI 10.1007/s00253-010-2519-1; Hama S, 2011, APPL MICROBIOL BIOT, V90, P1731, DOI 10.1007/s00253-011-3234-2; Hara F, 1996, J AM OIL CHEM SOC, V73, P657, DOI 10.1007/BF02518123; Hara F, 1997, J AM OIL CHEM SOC, V74, P1129, DOI 10.1007/s11746-997-0035-y; Hartmann M, 2000, APPL MICROBIOL BIOT, V54, P390; Hossen M, 2005, EUR J LIPID SCI TECH, V107, P730, DOI 10.1002/ejit.200501190; HUGEJENSEN B, 1989, LIPIDS, V24, P781, DOI 10.1007/BF02544584; Kim IH, 2010, J AM OIL CHEM SOC, V87, P1293, DOI 10.1007/s11746-010-1609-7; Kim IH, 2007, ENZYME MICROB TECH, V40, P1130, DOI 10.1016/j.enzmictec.2006.08.018; Li X, 2014, INT J MOL SCI, V15, P15244, DOI 10.3390/ijms150915244; Lim CW, 2015, BIOTECHNOL PROGR, V31, P35, DOI 10.1002/btpr.2009; Liu AX, 2015, APPL BIOCHEM BIOTECH, V175, P3195, DOI 10.1007/s12010-015-1492-7; Liu N, 2012, APPL BIOCHEM BIOTECH, V168, P1108, DOI 10.1007/s12010-012-9845-y; Liu YH, 2014, J AGR FOOD CHEM, V62, P5354, DOI 10.1021/jf405836x; Marsaoui N, 2013, WORLD J MICROB BIOT, V29, P2233, DOI 10.1007/s11274-013-1388-z; NAKAJIMA J, 1994, BIOTECHNOL BIOENG, V44, P1193, DOI 10.1002/bit.260441006; Nakazawa Y, 2011, APPL BIOCHEM BIOTECH, V165, P1494, DOI 10.1007/s12010-011-9370-4; NISHIO T, 1988, AGR BIOL CHEM TOKYO, V52, P2631; Ochoa AA, 2013, BIOTECHNOL PROGR, V29, P230, DOI 10.1002/btpr.1648; Ogino C, 2014, PROCESS BIOCHEM, V49, P1078, DOI 10.1016/j.procbio.2014.03.025; Ogino C, 2007, ENZYME MICROB TECH, V41, P156, DOI 10.1016/j.enzmictec.2006.12.011; Ogino C, 2003, J MOL CATAL B-ENZYM, V23, P107, DOI 10.1016/S1381-1177(03)00077-8; OKAHATA Y, 1995, J CHEM SOC PERK T 1, P919, DOI 10.1039/p19950000919; Okazaki F, 2012, APPL MICROBIOL BIOT, V96, P81, DOI 10.1007/s00253-012-4158-1; Pinsolle A, 2014, COLLOID SURFACE B, V115, P157, DOI 10.1016/j.colsurfb.2013.11.036; Ramchuran SO, 2006, APPL MICROBIOL BIOT, V71, P463, DOI 10.1007/s00253-005-0160-1; Shiba Y, 2001, BIOSCI BIOTECH BIOCH, V65, P94, DOI 10.1271/bbb.65.94; Song JK, 1999, J BIOTECHNOL, V72, P103, DOI 10.1016/S0168-1656(99)00096-6; Song JK, 2005, J AM OIL CHEM SOC, V82, P691, DOI 10.1007/s11746-005-1131-0; Song S, 2012, FOOD CHEM, V135, P373, DOI 10.1016/j.foodchem.2012.05.020; Truan D, 2013, PROTEIN EXPRES PURIF, V90, P40, DOI 10.1016/j.pep.2012.11.005; Vikbjerg AF, 2006, EUR J LIPID SCI TECH, V108, P802, DOI 10.1002/ejlt.200600138; Vikbjerg AF, 2005, J AM OIL CHEM SOC, V82, P237, DOI 10.1007/s11746-005-1061-x; Vikbjerg AF, 2005, BIOTECHNOL PROGR, V21, P397, DOI 10.1021/bp049633y; Vikbjerg AF, 2005, J MOL CATAL B-ENZYM, V36, P14, DOI 10.1016/j.molcatb.2005.07.0052; Vikbjerg AF, 2007, J BIOTECHNOL, V128, P545, DOI 10.1016/j.jbiotec.2006.11.006; Wongsakul S, 2004, EUR J LIPID SCI TECH, V106, P665, DOI 10.1002/ejlt.200401035; Yamamoto Y, 2011, NEW BIOTECHNOL, V28, P1, DOI 10.1016/j.nbt.2010.06.014; Yamamoto Y, 2008, J AM OIL CHEM SOC, V85, P313, DOI 10.1007/s11746-008-1206-1; Yon JO, 2008, BIOTECHNOL BIOPROC E, V13, P102, DOI 10.1007/s12257-007-0188-4; Yu DY, 2013, LWT-FOOD SCI TECHNOL, V50, P519, DOI 10.1016/j.lwt.2012.08.014; Zhan JF, 2013, BRAZ J CHEM ENG, V30, P721, DOI 10.1590/S0104-66322013000400004; Zhang L, 2008, J MEMBRANE SCI, V325, P895, DOI 10.1016/j.memsci.2008.09.009; Zhao T, 2014, FOOD CHEM, V157, P132, DOI 10.1016/j.foodchem.2014.02.024	100	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	OCT	2015	99	19					7879	7891		10.1007/s00253-015-6845-1		13	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CQ8ER	WOS:000360839800006		
J	Kitaoka, M				Kitaoka, Motomitsu			Diversity of phosphorylases in glycoside hydrolase families	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Review						Phosphorylase; Glycoside hydrolase family; Sugar 1-phosphate; Practical preparation of sugars; Carbohydrate active enzymes	VALIDATED ANTITUBERCULOSIS TARGET; BACILLUS-SELENITIREDUCENS MLS10; BETA-GALACTOSIDE PHOSPHORYLASES; N-BIOSE PHOSPHORYLASE; SUCROSE PHOSPHORYLASE; CELLOBIOSE PHOSPHORYLASE; TREHALOSE PHOSPHORYLASE; 4-O-BETA-D-MANNOSYL-D-GLUCOSE PHOSPHORYLASE; CLOSTRIDIUM-PHYTOFERMENTANS; MYCOBACTERIUM-TUBERCULOSIS	Phosphorylases are useful catalysts for the practical preparation of various sugars. The number of known specificities was 13 in 2002 and is now 30. The drastic increase in available genome sequences has facilitated the discovery of novel activities. Most of these novel phosphorylase activities have been identified through the investigations of glycoside hydrolase families containing known phosphorylases. Here, the diversity of phosphorylases in each family is described in detail.	Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	Kitaoka, M (reprint author), Natl Agr & Food Res Org, Natl Food Res Inst, 2-1-12 Kannondai, Tsukuba, Ibaraki 3058642, Japan.	mkitaoka@affrc.go.jp			Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry [25010A]	The author thanks Dr. Shinya Fushinobu for providing the information on nucleoside phosphorylases. The author would like to thank Enago (www.enago.jp) for the English language review. This work was supported by the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry (25010A).	Abe K, 2015, J APPL GLYCOSCI, V62, P47; Aeling KA, 2012, J IND MICROBIOL BIOT, V39, P1597, DOI 10.1007/s10295-012-1169-y; Aerts D, 2011, CARBOHYD RES, V346, P1860, DOI 10.1016/j.carres.2011.06.024; ALBRECHT GJ, 1971, PHYTOCHEMISTRY, V10, P1293, DOI 10.1016/S0031-9422(00)84330-7; Andersson U, 2001, J BIOL CHEM, V276, P42707, DOI 10.1074/jbc.M108279200; Pugmire MJ, 2002, BIOCHEM J, V361, P1, DOI 10.1042/0264-6021:3610001; Ciocchini AE, 2007, P NATL ACAD SCI USA, V104, P16492, DOI 10.1073/pnas.0708025104; Jung JH, 2014, J BACTERIOL, V196, P1122, DOI 10.1128/JB.01222-13; Ladeveze S, 2015, ACTA CRYSTALLOGR D, V71, P1335, DOI 10.1107/S1399004715006604; Nihira T, 2012, CARBOHYD RES, V361, P49, DOI 10.1016/j.carres.2012.08.006; Ha SJ, 2013, METAB ENG, V15, P134, DOI 10.1016/j.ymben.2012.11.005; Liu Y, 2015, CARBOHYD RES, V401, P1, DOI 10.1016/j.carres.2014.10.014; Sawano T, 2013, FEBS J, V280, P4463, DOI 10.1111/febs.12408; Senoura T, 2011, BIOCHEM BIOPH RES CO, V408, P701, DOI 10.1016/j.bbrc.2011.04.095; Hidaka M, 2009, J BIOL CHEM, V284, P7273, DOI 10.1074/jbc.M808525200; Ohdan K, 2006, BIOCATAL BIOTRANSFOR, V24, P77, DOI 10.1080/10242420600598152; Jaito N, 2014, BIOSCI BIOTECH BIOCH, V78, P263, DOI 10.1080/09168451.2014.882760; Saburi W, 2015, BIOSCI BIOTECH BIOCH, V79, P969, DOI 10.1080/09168451.2015.1012146; Nihira T, 2013, J BIOL CHEM, V288, P27366, DOI 10.1074/jbc.M113.469080; Nishimoto M, 2009, CARBOHYD RES, V344, P2573, DOI 10.1016/j.carres.2009.09.031; O'Neill EC, 2015, CARBOHYD RES, V403, P23, DOI 10.1016/j.carres.2014.06.010; You C, 2013, P NATL ACAD SCI USA, V110, P7182, DOI 10.1073/pnas.1302420110; Syson K, 2011, J BIOL CHEM, V286, P38298, DOI 10.1074/jbc.M111.279315; Yamamoto Y, 2013, BIOSCI BIOTECH BIOCH, V77, P1949, DOI 10.1271/bbb.130411; Nakai H, 2013, CURR OPIN CHEM BIOL, V17, P301, DOI 10.1016/j.cbpa.2013.01.006; Luley-Goedl C, 2010, BIOTECHNOL J, V5, P1324, DOI 10.1002/biot.201000217; Kitaoka M, 2005, APPL ENVIRON MICROB, V71, P3158, DOI 10.1128/AEM.71.6.3158-3162.2005; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Leiba J, 2013, J BIOL CHEM, V288, P16546, DOI 10.1074/jbc.M112.398503; Ohdan K, 2007, J BIOTECHNOL, V127, P496, DOI 10.1016/j.jbiotec.2006.07.023; Kitaoka M, 2012, BIOSCI BIOTECH BIOCH, V76, P343, DOI 10.1271/bbb.110772; Kawahara R, 2012, J BIOL CHEM, V287, P42389, DOI 10.1074/jbc.M112.390336; Hidaka M, 2006, BIOCHEM J, V398, P37, DOI 10.1042/BJ20060274; Maruta K, 2002, BIOSCI BIOTECH BIOCH, V66, P1976; Syson K, 2014, BIOCHEMISTRY-US, V53, P2494, DOI 10.1021/bi500183c; Kitaoka M, 2002, TRENDS GLYCOSCI GLYC, V14, P35; Hidaka M, 2004, STRUCTURE, V12, P937, DOI 10.1016/j.str.2004.03.027; Macdonald SS, 2015, J BIOL CHEM, V290, P4887, DOI 10.1074/jbc.M114.621110; Veleti SK, 2014, BIOORGAN MED CHEM, V22, P1404, DOI 10.1016/j.bmc.2013.12.058; Elbein AD, 2010, J BIOL CHEM, V285, P9803, DOI 10.1074/jbc.M109.033944; Bacik JP, 2012, CHEM BIOL, V19, P1471, DOI 10.1016/j.chembiol.2012.09.016; Yao WL, 2015, CARBOHYD RES, V401, P5, DOI 10.1016/j.carres.2014.10.017; Ladeveze S, 2013, J BIOL CHEM, V288, P32370, DOI 10.1074/jbc.M113.483628; De Groeve MRM, 2009, PROTEIN ENG DES SEL, V22, P393, DOI 10.1093/protein/gzp017; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Egloff MP, 2001, STRUCTURE, V9, P689, DOI 10.1016/S0969-2126(01)00626-8; Kalscheuer R, 2010, NAT CHEM BIOL, V6, P376, DOI 10.1038/nchembio.340; Nakae S, 2013, J MOL BIOL, V425, P4468, DOI 10.1016/j.jmb.2013.08.002; Reichenbecher M, 1997, EUR J BIOCHEM, V247, P262, DOI 10.1111/j.1432-1033.1997.00262.x; Puchart V, 2015, BIOTECHNOL ADV, V33, P261, DOI 10.1016/j.biotechadv.2015.02.002; Chaen H, 1999, J APPL GLYCOSCI, V46, P423; Chen C, 2011, ENZYME MICROB TECH, V49, P59, DOI 10.1016/j.enzmictec.2011.03.010; Chiku K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114882; Chomvong K, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-85; Cori GT, 1938, J BIOL CHEM, V123, P375; De Bruyn F, 2015, BIOTECHNOL BIOENG, V112, P1594, DOI 10.1002/bit.25570; Derensy-Dron D, 1999, BIOTECHNOL APPL BIOC, V29, P3; Desai SH, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0232-6; Doudoroff M, 1943, J BIOL CHEM, V151, P351; Drepper A, 1996, FEBS LETT, V388, P177, DOI 10.1016/0014-5793(96)00554-6; Ehrmann MA, 1998, FEMS MICROBIOL LETT, V169, P81, DOI 10.1016/S0378-1097(98)00467-4; Fischer EH, 2013, BIOCHEM BIOPH RES CO, V430, P865, DOI 10.1016/j.bbrc.2012.10.024; FITTING C, 1952, J BIOL CHEM, V199, P153; Goldemberg SH, 1966, J BIOL CHEM, V241, P45; Hamura K, 2013, CARBOHYD RES, V379, P21, DOI 10.1016/j.carres.2013.06.010; Hanes CS, 1940, PROC R SOC SER B-BIO, V128, P421, DOI 10.1098/rspb.1940.0020; Hildebrand A, 2015, APPL ENVIRON MICROB, V81, P597, DOI 10.1128/AEM.02885-14; Hildebrand A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123006; HUTTERMA.A, 1973, NATURE-NEW BIOL, V245, P64; Igarashi K, 2005, Patent WO, Patent No. 2005111206; Kawaguchi T, 1998, J FERMENT BIOENG, V85, P144, DOI 10.1016/S0922-338X(97)86758-X; KITAMOTO Y, 1988, FEMS MICROBIOL LETT, V55, P147, DOI 10.1111/j.1574-6968.1988.tb13924.x; KITAO S, 1992, J FERMENT BIOENG, V73, P179, DOI 10.1016/0922-338X(92)90157-P; Li L, 2015, CHEM COMMUN, V51, P10310, DOI 10.1039/c5cc03746h; Luley-Goedl C, 2010, CARBOHYD RES, V345, P1492, DOI 10.1016/j.carres.2010.03.035; Luley-Goedl C, 2010, FOOD TECHNOL BIOTECH, V48, P276; MARECHAL LR, 1972, J BIOL CHEM, V247, P3223; MARECHAL LR, 1967, BIOCHIM BIOPHYS ACTA, V146, P417, DOI 10.1016/0005-2744(67)90226-4; McCready RM, 1944, J AM CHEM SOC, V66, P560, DOI 10.1021/ja01232a019; Morimoto K, 2015, J BIOSCI BIOENG, V119, P652, DOI 10.1016/j.jbiosc.2014.11.011; Nakajima M, 2010, BIOSCI BIOTECH BIOCH, V74, P1652, DOI 10.1271/bbb.100263; Nakajima M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092353; Nakajima M, 2010, ENZYME MICROB TECH, V46, P315, DOI 10.1016/j.enzmictec.2009.12.007; Nakajima M, 2008, APPL ENVIRON MICROB, V74, P6333, DOI 10.1128/AEM.02846-07; Nakajima M, 2009, APPL MICROBIOL BIOT, V83, P109, DOI 10.1007/s00253-008-1838-y; Nakajima M, 2008, APPL MICROBIOL BIOT, V78, P465, DOI 10.1007/s00253-007-1319-8; Nakajima M, 2009, J BIOL CHEM, V284, P19220, DOI 10.1074/jbc.M109.007666; Nam YW, 2015, J BIOL CHEM, V290, P19281, DOI [10.1080/09168451.2015.1012146, DOI 10.1080/09168451.2015.1012146]; Nihira T, 2014, J APPL GLYCOSCI, V61, P59; Nihira T., 2014, Journal of Applied Glycoscience, V61, P75; Nihira T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086548; Nihira T, 2012, APPL MICROBIOL BIOT, V93, P1513, DOI 10.1007/s00253-011-3515-9; Nihira T, 2013, FEBS LETT, V587, P3556, DOI 10.1016/j.febslet.2013.09.014; Nihira T, 2012, CARBOHYD RES, V360, P25, DOI 10.1016/j.carres.2012.07.014; Nihira T, 2012, CARBOHYD RES, V350, P94, DOI 10.1016/j.carres.2011.12.019; Nihira T, 2013, FEBS LETT, V587, P3382, DOI 10.1016/j.febslet.2013.08.038; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2101, DOI 10.1271/bbb.70320; Nishimoto M, 2012, J MOL CATAL B-ENZYM, V74, P97, DOI 10.1016/j.molcatb.2011.09.004; Ogawa Y, 2014, INT J BIOL MACROMOL, V64, P415, DOI 10.1016/j.ijbiomac.2013.12.027; Okada S, 2014, FEBS J, V281, P778, DOI 10.1111/febs.12622; Park JK, 2000, J BIOL CHEM, V275, P33077, DOI 10.1074/jbc.M001042200; Saito K, 1998, APPL MICROBIOL BIOT, V50, P193, DOI 10.1007/s002530051276; Sengupta S, 2015, J BIOMOL STRUCT DYN, P1; Sengupta S, 2014, MOL BIOL REP, V41, P3549, DOI 10.1007/s11033-014-3068-y; SHETH K, 1969, J BIOL CHEM, V244, P457; Sih CJ, 1955, P MONT ACAD SCI, V15, P21; SILVERST.R, 1967, J BIOL CHEM, V242, P1338; SPRANG S, 1979, J MOL BIOL, V131, P523, DOI 10.1016/0022-2836(79)90006-8; Sprogoe D, 2004, BIOCHEMISTRY-US, V43, P1156, DOI 10.1021/bi0356395; TITANI K, 1977, P NATL ACAD SCI USA, V74, P4762, DOI 10.1073/pnas.74.11.4762; Touhara KK, 2014, J BIOL CHEM, V289, P18067, DOI 10.1074/jbc.M114.573212; Van der Borght J, 2010, BIOTECHNOL J, V5, P986, DOI 10.1002/biot.201000203; Verhaeghe T, 2014, APPL MICROBIOL BIOT, V98, P7027, DOI 10.1007/s00253-014-5621-y; VOET JG, 1970, J BIOL CHEM, V245, P1020; Weyler C, 2015, APPL BIOCHEM BIOTECH, V175, P3729, DOI 10.1007/s12010-015-1540-3; Wildberger P, 2014, CHEM COMMUN, V50, P436, DOI 10.1039/c3cc47249c; Yamamoto T, 2004, J BIOSCI BIOENG, V98, P99, DOI 10.1263/jbb.98.99; Yamamoto T, 2011, BIOSCI BIOTECH BIOCH, V75, P1208, DOI 10.1271/bbb.110116	118	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	OCT	2015	99	20					8377	8390		10.1007/s00253-015-6927-0		14	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CR6YA	WOS:000361493200006		
J	Iwai, M; Kawakami, T; Ikemoto, T; Fujiwara, D; Takenaka, S; Nakazawa, M; Ueda, M; Sakamoto, T				Iwai, Marin; Kawakami, Takuya; Ikemoto, Takeshi; Fujiwara, Daisuke; Takenaka, Shigeo; Nakazawa, Masami; Ueda, Mitsuhiro; Sakamoto, Tatsuji			Molecular characterization of a Penicillium chrysogenum exo-rhamnogalacturonan lyase that is structurally distinct from other polysaccharide lyase family proteins	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Exo-acting rhamnogalacturonan lyase; Nucleotide sequence; Overexpression; Penicillium chrysogenum; Unsaturated galacturonosyl rhamnose	HAIRY RAMIFIED REGIONS; PLANT-CELL WALL; ASPERGILLUS-ACULEATUS; BACILLUS-SUBTILIS; ENZYME; PECTIN; OVEREXPRESSION; ACETYLESTERASE; IDENTIFICATION; LEPIDIMOIDE	We previously described an endo-acting rhamnogalacturonan (RG) lyase, termed PcRGL4A, of Penicillium chrysogenum 31B. Here, we describe a second RG lyase, called PcRGLX. We determined the cDNA sequence of the Pcrglx gene, which encodes PcRGLX. Based on analyses using a BLAST search and a conserved domain search, PcRGLX was found to be structurally distinct from known RG lyases and might belong to a new polysaccharide lyase family together with uncharacterized fungal proteins of Nectria haematococca, Aspergillus oryzae, and Fusarium oxysporum. The Pcrglx cDNA gene product (rPcRGLX) expressed in Escherichia coli demonstrated specific activity against RG but not against homogalacturonan. Divalent cations were not essential for the enzymatic activity of rPcRGLX. rPcRGLX mainly released unsaturated galacturonosyl rhamnose (Delta GR) from RG backbones used as the substrate from the initial stage of the reaction, indicating that the enzyme can be classified as an exo-acting RG lyase (EC 4.2.2.24). This is the first report of an RG lyase with this mode of action in Eukaryota. rPcRGLX acted synergistically with PcRGL4A to degrade soybean RG and released Delta GR. This Delta GR was partially decorated with galactose (Gal) residues, indicating that rPcRGLX preferred oligomeric RGs to polymeric RGs, that the enzyme did not require Gal decoration of RG backbones for degradation, and that the enzyme bypassed the Gal side chains of RG backbones. These characteristics of rPcRGLX might be useful in the determination of complex structures of pectins.	[Iwai, Marin; Kawakami, Takuya; Ikemoto, Takeshi; Nakazawa, Masami; Ueda, Mitsuhiro; Sakamoto, Tatsuji] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Sakai, Osaka 5998531, Japan; [Fujiwara, Daisuke] Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Sakai, Osaka 5998531, Japan; [Takenaka, Shigeo] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Vet Sci, Izumisano, Osaka 5988531, Japan	Sakamoto, T (reprint author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Sakai, Osaka 5998531, Japan.	sakamoto@biochem.osakafu-u.ac.jp			JSPS KAKENHI [25450135]	This work was supported by JSPS KAKENHI grant number 25450135.	SAKAI T, 1993, ADV APPL MICROBIOL, V39, P213, DOI 10.1016/S0065-2164(08)70597-5; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Voragen AGJ, 2009, STRUCT CHEM, V20, P263, DOI 10.1007/s11224-009-9442-z; Wong D, 2008, PROTEIN J, V27, P30, DOI 10.1007/s10930-007-9105-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ochiai A, 2007, APPL ENVIRON MICROB, V73, P3803, DOI 10.1128/AEM.00147-07; Saranpuetti C, 2006, J BIOSCI BIOENG, V102, P452, DOI 10.1263/jbb.102.452; KOFOD LV, 1994, J BIOL CHEM, V269, P29182; Laatu M, 2003, J BACTERIOL, V185, P1642, DOI 10.1128/JB.185.5.1642-1649.2003; Lara-Marquez A, 2011, BIOTECHNOL LETT, V33, P859, DOI 10.1007/s10529-011-0520-0; Mutter M, 1996, PLANT PHYSIOL, V110, P73, DOI 10.1104/pp.110.1.73; Silva IR, 2014, APPL MICROBIOL BIOT, V98, P4521, DOI 10.1007/s00253-013-5483-8; SCHOLS HA, 1990, CARBOHYD RES, V206, P105, DOI 10.1016/0008-6215(90)84010-R; MUTTER M, 1994, PLANT PHYSIOL, V106, P241, DOI 10.1104/pp.106.1.241; Itoh T, 2006, J MOL BIOL, V360, P573, DOI 10.1016/j.jmb.2006.04.047; THIBAULT JF, 1993, CARBOHYD RES, V238, P271, DOI 10.1016/0008-6215(93)87019-O; KAUPPINEN S, 1995, J BIOL CHEM, V270, P27172; Yoshino-Yasuda S, 2012, FOOD SCI TECHNOL RES, V18, P901; van den Berg MA, 2008, NAT BIOTECHNOL, V26, P1161, DOI 10.1038/nbt.1498; Mutter M, 1998, PLANT PHYSIOL, V117, P153, DOI 10.1104/pp.117.1.153; McKie VA, 2001, BIOCHEM J, V355, P167, DOI 10.1042/0264-6021:3550167; Silva IR, 2011, ENZYME MICROB TECH, V49, P160, DOI 10.1016/j.enzmictec.2011.04.015; Jayani RS, 2005, PROCESS BIOCHEM, V40, P2931, DOI 10.1016/j.procbio.2005.03.026; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Bonnin E, 2014, APPL MICROBIOL BIOT, V98, P519, DOI 10.1007/s00253-013-5388-6; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; FRY SC, 1993, PLANT PHYSIOL, V103, P1, DOI 10.1104/pp.103.1.1; HASEGAWA K, 1992, PLANT PHYSIOL, V100, P1059, DOI 10.1104/pp.100.2.1059; Iwai M, 2015, MOL BIOTECHNOL, V57, P539, DOI 10.1007/s12033-015-9847-4; Martinez-Martinez I, 2008, PROTEINS, V71, P379, DOI 10.1002/prot.21705; Sakamoto T, 2013, APPL MICROBIOL BIOT, V97, P2895, DOI 10.1007/s00253-012-4154-5; SEARLEVANLEEUWEN MJF, 1992, APPL MICROBIOL BIOT, V38, P347; Shinozaki A, 2014, ENZYME MICROB TECH, V58-59, P80, DOI 10.1016/j.enzmictec.2014.03.005; Sukhumsirchart W, 2009, BIOSCI BIOTECH BIOCH, V73, P268, DOI 10.1271/bbb.80287	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	OCT	2015	99	20					8515	8525		10.1007/s00253-015-6600-7		11	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CR6YA	WOS:000361493200017		
J	Kawatsu, M; Morimoto, G; Kagami, M				Kawatsu, Masayuki; Morimoto, Gen; Kagami, Maiko			Seasonal changes in the water bird community in Lake Inba: Influence of floating-leaved macrophytes on habitat selection	AQUATIC BOTANY			English	Article						Water chestnuts; Trapa; Eutrophic lake; Egrets; Floating-leaved macrophytes; Water birds	SUBMERGED MACROPHYTES; TACHYBAPTUS-RUFICOLLIS; AQUATIC MACROPHYTES; EUTROPHIC LAKE; SHALLOW LAKES; JAPAN; PLANT; PHYTOPLANKTON; MANIPULATION; JAPONICA	The abundance of the floating-leaved macrophytes, especially Trapa spp., has increased in many eutrophic lakes, butits effects on waterbirds is not clear. By covering the water surface with their floating-leaves, these macrophytes exert effects that differ from those of submerged macrophytes. In this study, we investigated seasonal changes in the species composition and habitat selection of the waterbird community in the shallow, eutrophic Lake Inba in relation to the presence/absence of native floating-leaved macrophytes (Trapa spp.). The results indicated higher abundances of the eastern spot-billed duck (Anas zonorhyncha), the little grebe (Tachybaptus ruficollis), the great egret (Egretta alba), theintermediate egret (Egretta intermedia), and the Eurasian coot (Fulica atra) in Trapa beds, whereas the great cormorant Phalacrocorax carbo was more abundant in the open water without macrophytes. Both great egrets and intermediate egrets seemed to actively choose the Trapa beds as a feeding habitat that allowed them to catch the small fish swimming beneath these plants. Eurasian coots utilized Trapa spp. as food directly, by grazing on its fruits and leaves. Little grebes selected Trapa beds for nesting, especially when their flock size was larger. Conversely, Trapa beds prevented the foraging behavior of great cormorants. In Lake Inba, with its suddenly deep shoreline and lack of shallow areas, there are few potential feeding habitats for waterbirds in the littoral zones. Therefore, Trapa beds might provide an alternative habitat for these species, thus serving as an important ecotone between terrestrial and aquatic ecosystems. (C) 2015 Elsevier B.V. All rights reserved.	[Kawatsu, Masayuki; Kagami, Maiko] Toho Univ, Funabashi, Chiba 274, Japan; [Morimoto, Gen] Yamashina Inst Ornithol, Abiko, Chiba 2701145, Japan; [Morimoto, Gen] Toho Univ, Dept Life Sci, Wildlife Conservat Ctr, Funabashi, Chiba 2748510, Japan	Kagami, M (reprint author), Toho Univ, Funabashi, Chiba 274, Japan.	kagami@env.sci.toho-u.ac.jp			Foundation of River and Watershed Environment Management [23-1251-011];  [25281052]	We are grateful to On Saito and Maiko Hiroi for supporting field survey. This study was supported by Foundation of River and Watershed Environment Management (23-1251-011) and Grant-in-Aid for Scientific Research (B) (25281052).	Colwell MA, 2000, WATERBIRDS, V23, P45; Mitchell SF, 1998, ECOL STU AN, V131, P175; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Caraco NF, 2002, ECOL APPL, V12, P1496, DOI 10.2307/3099987; Perrow MR, 1997, HYDROBIOLOGIA, V342, P241, DOI 10.1023/A:1017007911190; Takahashi T, 2006, FISHERIES SCI, V72, P477, DOI 10.1111/j.1444-2906.2006.01175.x; Takamura N, 2003, ECOL RES, V18, P381, DOI 10.1046/j.1440-1703.2003.00563.x; Borgmann K.L, 2011, REV HUMAN DISTURBANC; Brostrom G., 2011, GLMMML GEN LINEAR MO; Emura N., 2005, RES B KAGOSHIMA U FO, V33, P29; FOX AD, 1994, BIRD STUDY, V41, P15; HANSON MA, 1994, HYDROBIOLOGIA, V279, P457, DOI 10.1007/BF00027877; HARGEBY A, 1994, HYDROBIOLOGIA, V279, P83, DOI 10.1007/BF00027843; Hattori A, 2001, ECOL RES, V16, P543, DOI 10.1046/j.1440-1703.2001.00416.x; HOYER MV, 1994, HYDROBIOLOGIA, V297, P107; Itoh S, 1984, JPN J ORNITHOL, V33, P13; Kameda Kayoko, 2002, Japanese Journal of Ornithology, V51, P12, DOI 10.3838/jjo.51.12; Kosugi A, 1960, J YAMASHINA I ORNITH, V2, P89; KURIHARA M, 1991, VEGETATIO, V97, P117, DOI 10.1007/BF00035385; LAURIDSEN TL, 1994, HYDROBIOLOGIA, V275, P233; Li K.Y., 2009, LIMNOLOGY, V11, P95; MENON GK, 1981, WILSON BULL, V93, P549; Nakamura T., 1995, BIRDS LIFE JAPAN COL; Nemoto F, 2012, LIMNOLOGY, V13, P289, DOI 10.1007/s10201-012-0376-6; Nishihiro J, 2014, ECOL RES, V29, P981, DOI 10.1007/s11284-014-1186-6; Ornithological Society of Japan, 2012, CHECK LIST JAP BIRDS, V7th revised; Paillisson JM, 2006, BIODIVERS CONSERV, V15, P3469, DOI 10.1007/s10531-004-2939-2; Santoul F, 2004, VIE MILIEU, V54, P31; Sato Nolbuhiko, 1996, Journal of the Yamashina Institute for Ornithology, V28, P19; Siratori K, 2006, IKITEIRU INBA NUMA; Sondergaard M, 1998, ECOL STU AN, V131, P298; Takumi Yoshihisa, 1998, Japanese Journal of Ecology (Tokyo), V48, P17; Tojo Hitoshi, 1996, Japanese Journal of Ornithology, V45, P141, DOI 10.3838/jjo.45.141; TSUCHIYA T, 1989, AQUAT BOT, V36, P87, DOI 10.1016/0304-3770(89)90094-6; Ueda Koju, 1994, Strix, V13, P65; VANDONK E, 1994, PROC INT ASSOC THEOR, V25, P2139	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3770	1879-1522		AQUAT BOT	Aquat. Bot.	OCT	2015	126						32	37		10.1016/j.aquabot.2015.06.003		6	Plant Sciences; Marine & Freshwater Biology	Plant Sciences; Marine & Freshwater Biology	CR3VM	WOS:000361261200005		
J	Chen, SM; Du, JW; Jin, YM; Qiu, L; Du, ZH; Li, DD; Chen, HY; Watanabe, C; Umezaki, M				Chen, Shao-Ming; Du, Jian-Wei; Jin, Yu-Ming; Qiu, Li; Du, Zhong-Hua; Li, Dan-Dan; Chen, Hai-Yun; Watanabe, Chiho; Umezaki, Masahiro			Risk Factors for Severe Hand-Foot-Mouth Disease in Children in Hainan, China, 2011-2012	ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH			English	Article						hand-foot-mouth disease; risk factor; socioeconomic status; Hainan; China	ENTEROVIRUS 71 INFECTION; PULMONARY-EDEMA; OUTBREAK; ENCEPHALOMYELITIS; TAIWAN	The incidence of severe/fatal cases of hand-foot-mouth disease (HFMD) has increased in South Asia. In China, Hainan Province had the highest incidence of mortality associated with HFMD in 2011. This study investigated the risk factors for severe HFMD in Hainan. The HFMD survey database for Hainan Province for 2011 and 2012 was analyzed, and the biological and behavioral characteristics of severe (n = 980) and nonsevere (n = 1679) HFMD were compared. The association between each explanatory variable and the severity of HFMD was investigated using a logistic regression model after adjusting for confounders. Human enterovirus 71 infection, a peak body temperature >39 degrees C, living outside urban areas, visiting a village clinic, low birth weight, never breastfed, cared for by grandparents, and caregiver with <6 years of education were associated with severe HFMD. Individual characteristics that are generally shared by children in households of low socioeconomic status tended to increase the risk of severe HFMD.	[Chen, Shao-Ming; Du, Jian-Wei; Jin, Yu-Ming; Qiu, Li; Du, Zhong-Hua; Li, Dan-Dan; Chen, Hai-Yun] Hainan Ctr Dis Control & Prevent, Haikou, Hainan, Peoples R China; [Chen, Shao-Ming; Watanabe, Chiho; Umezaki, Masahiro] Univ Tokyo, Tokyo 1130033, Japan	Umezaki, M (reprint author), Univ Tokyo, Grad Sch Med, Sch Int Hlth, Dept Human Ecol, Tokyo 1130033, Japan.	umezaki@humeco.m.u-tokyo.ac.jp			Hainan Provincial Science and Technology Department in China [813254]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by Hainan Provincial Science and Technology Department in China (No. 813254).	Liu ML, 2005, J GEN VIROL, V86, P3263, DOI 10.1099/vir.0.81195-0; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; [Anonymous], 2000, CLIN INFECT DIS, DOI DOI 10.1086/314032; Cui ZH, 2012, BRIT J NUTR, V108, P1292, DOI 10.1017/S0007114511006891; Raqib R, 2007, AM J CLIN NUTR, V85, P845; Ryu WS, 2010, J CLIN MICROBIOL, V48, P2490, DOI 10.1128/JCM.02369-09; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Wang SM, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/876241; Hsueh C, 2000, MODERN PATHOL, V13, P1200, DOI 10.1038/modpathol.3880222; SHI LY, 1993, B WORLD HEALTH ORGAN, V71, P723; Yang TC, 2012, EUR J PEDIATR, V171, P1359, DOI 10.1007/s00431-012-1731-7; Wong KT, 2008, J NEUROPATH EXP NEUR, V67, P162, DOI 10.1097/nen.0b013e318163a990; Cao MH, 2010, ANHUI J PREVENTIVE M, V16, P19; Chandra Ranjit Kumar, 1997, American Journal of Clinical Nutrition, V66, p460S; Chang LY, 1998, LANCET, V352, P367, DOI 10.1016/S0140-6736(98)24031-1; Guo YP, 2013, CHIN J CHILD HLTH CA, V21, P736; Jiang Q, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-324; Jin Yan, 2012, Disease Surveillance, V27, P676; Kit Lam Sai, 2002, Asia Pac J Public Health, V14, P6; Li YP, 2013, EUR J PEDIATR, V172, P661, DOI 10.1007/s00431-013-1939-1; Ma HL, 2010, PEDIATR INFECT DIS J, V29, P524, DOI 10.1097/INF.0b013e3181cdd178; Ministry of Health of the People's Republic of China, 2011, CLIN EXP TREATM CONS; Ministry of Health of the People's Republic of China, 2009, HAND FOOT MOUTH DIS; Ministry of Health of the People's Republic of China, HAND FOOT MOUTH DIS; National Bureau of Statistics of the People's Republic of China, INT PROV STAT CLASS; Wang Ying, 2011, Disease Surveillance, V26, P424; Wen X, 2011, ASIA-PAC J PUBLIC HE, DOI [10.1177/1010539511430523, DOI 10.1177/1010539511430523]; World Health Organization, INF YOUNG CHILD FEED; World Health Organization (WHO), GUID CLIN MAN PUBL H	30	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1010-5395	1941-2479		ASIA-PAC J PUBLIC HE	Asia-Pac. J. Public Health	OCT	2015	27	7					715	722		10.1177/1010539515579123		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CR6WT	WOS:000361489600004		
J	Itahashi, S; Uno, I; Hayami, H; Fujita, S				Itahashi, Syuichi; Uno, Itsushi; Hayami, Hiroshi; Fujita, Shin-ichi			Variation of the ratio of nitrate to non-seasalt sulfate in precipitation over East Asia with emissions from China	ATMOSPHERIC ENVIRONMENT			English	Article						Precipitation chemistry; Nitrate to non-seasalt sulfate ratio (NO3-/nss-SO42-); NOx-SO2 emission ratio (NOx/SO2); Community multi-scale air quality (CMAQ) model; East Asia	WET DEPOSITION; AIR-QUALITY; REGIONS; JAPAN	Changes in anthropogenic emissions in East Asia will cause substantial variations in the precipitation chemistry. In particular, the effects of changes in China, where NOx emissions have been rising continuously and SO2 emissions peaked in 2005-2006, are important. The absolute chemical concentration in precipitation is inherently linked to the amount of precipitation; therefore, in this work we d) used the ratio of nitrate (NO3-) to non-seasalt sulfate (nss-SO42-) concentration in precipitation on an equivalent basis (hereinafter, Ratio). Here, we extend the method our previous study (Itahashi et al., 2014a) to Korea and China. We analyzed the long-term behavior of Ratio in precipitation during 2000-2011 and investigated the factors responsible for variations of Ratio in precipitation by using a model simulation with sensitivity analysis for emission changes in China. Ratio over Japan, Korea, and China decreased slightly or remained constant during 2000-2005 (first 6 years of 2000-2011) and subsequently increased during 2006-2011 (last 6 years of 2000-2011). Linear regression analysis of the observations showed significant increases in Ratio during 2006-2011: +3.4 +/- 1.0%/year, +13.2 +/- 4.1%/year, and +9.8 +/- 2.5%/year for Japan, Korea, and China, respectively (each p < 0.05). These variations in Ratio corresponded closely to the changes in the NOx/SO2 emission ratio in China. This suggests that anthropogenic emissions from China were responsible for most of the variation in precipitation chemistry in East Asia. Model simulations for 2000-2011 and their reproducibility were validated by comparison with the observation dataset, and they captured the observed features well. Sensitivity analysis of emissions from China in the model simulation for 2009-2011 clarified that the increase in NOx emissions from China contributed to 55-60% of the increase in Ratio in China and around 50-55% in Korea and Japan; the contribution of the increase in NOx emissions was smaller in the region downwind of China. In contrast, the decline in SO2 emissions from China contributed below 40% in China and around 40-45% in Japan; the effect was larger in the region downwind of China. (C) 2015 The Authors. Published by Elsevier Ltd.	[Itahashi, Syuichi; Hayami, Hiroshi; Fujita, Shin-ichi] Cent Res Inst Elect Power Ind, Environm Sci Res Lab, Abiko, Chiba 2701194, Japan; [Uno, Itsushi] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan	Itahashi, S (reprint author), Cent Res Inst Elect Power Ind, Environm Sci Res Lab, 1646 Abiko, Abiko, Chiba 2701194, Japan.	isyuichi@criepi.denken.or.jp; uno@riam.kyushu-u.ac.jp; haya@criepi.denken.or.jp; fujiz@criepi.denken.or.jp	Kyushu, RIAM/F-4018-2015				Byun D, 2006, APPL MECH REV, V59, P51, DOI 10.1115/1.2128636; Itahashi S, 2014, ATMOS CHEM PHYS, V14, P3623, DOI 10.5194/acp-14-3623-2014; Ge BZ, 2014, ENVIRON POLLUT, V187, P10, DOI 10.1016/j.envpol.2013.12.014; Akimoto H, 2003, SCIENCE, V302, P1716, DOI 10.1126/science.1092666; Kurokawa J, 2013, ATMOS CHEM PHYS, V13, P11019, DOI 10.5194/acp-13-11019-2013; Itahashi S, 2014, ATMOS ENVIRON, V92, P171, DOI 10.1016/j.atmosenv.2014.04.022; EANET, 2000, QUAL ASS QUAL CONTR; EANET, 2000, TECHN MAN WET DEP MO; Fujita S., 2013, J JPN SOC ATMOS ENV, P12; Fujita S, 2000, ATMOS ENVIRON, V34, P525, DOI 10.1016/S1352-2310(99)00261-7; Fujita SI, 2003, TELLUS B, V55, P23, DOI 10.1034/j.1600-0889.2003.00001.x; Itahashi S, 2012, ATMOS CHEM PHYS, V12, P2631, DOI 10.5194/acp-12-2631-2012; Takahashi A, 2000, ATMOS ENVIRON, V34, P4551, DOI 10.1016/S1352-2310(00)00145-X; U. S. NAPAP (National Acid Precipitation Assessment Program), 1991, US NAT AC PREC PROGR, VI	14	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	OCT	2015	118						87	97		10.1016/j.atmosenv.2015.07.032		11	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CR5UM	WOS:000361409900008		
J	Fukushima, S; Zhang, DZ				Fukushima, Satoshi; Zhang, Daizhou			Comparison in size and elemental composition of dust particles deposited to the surface and suspended in the air on the southwest Japan coast	ATMOSPHERIC ENVIRONMENT			English	Article						Individual particle analysis; Dust; Sea salt; Sulfate; Dry deposition	SEA-SALT; STORM PARTICLES; SIMULATION; CHINA; TRANSPORT; SULFATE; PACIFIC; AEROSOL; OCEAN; MODEL	Input of dust to the ocean via the atmosphere is one of the key processes driving the development of marine ecosystems. It is usually estimated with dust concentration and deposition velocity on the assumption that particles settling to the marine surface are similar in composition to those in the air. In this study, we compared suspended and dry deposited dust particles which were collected at a seaside site on the southwestern Japan coast in two Asian dust episodes. Results show that particles mixed with sea salt and sulfate occupied 47-67% of the suspended dust particles while the percentage was 15-26% for the deposited particles. Sulfur and sodium contents in the deposited particles were apparently less than in the suspended particles. The mode size of the suspended ones, 2-3 mu m, was a little smaller than that of the dry deposited ones, 3-5 mu m. However, after being weighted by deposition velocity, it was similar to the latter one. These results support particle size as the key factor in determining the dry deposition and indicate the difference of suspended and deposited dust particles in the mixture with sea salt and sulfate in the marine atmosphere. (C) 2015 Elsevier Ltd. All rights reserved.	[Fukushima, Satoshi; Zhang, Daizhou] Prefectural Univ Kumamoto, Fac Environm & Symbiot Sci, Kumamoto 8628502, Japan	Zhang, DZ (reprint author), Prefectural Univ Kumamoto, Fac Environm & Symbiot Sci, Kumamoto 8628502, Japan.	dzzhang@pu-kumamoto.ac.jp			Japan Society for the Promotion of Sciences [21510021]; Steel Foundation for Environmental Protection Technology [C-24-5]	This study was supported by the Japan Society for the Promotion of Sciences (21510021), and the observations were funded by the Steel Foundation for Environmental Protection Technology (C-24-5). The authors thank Prof. J. Morrow for the assistance in grammar and word editing.	Hojati S, 2012, CATENA, V88, P27, DOI 10.1016/j.catena.2011.09.002; Tanaka TY, 2005, J METEOROL SOC JPN, V83A, P255, DOI 10.2151/jmsj.83A.255; Wu F, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL054406; Zhang DZ, 1999, ATMOS ENVIRON, V33, P3213, DOI 10.1016/S1352-2310(99)00116-8; Okada K, 2001, J AEROSOL SCI, V32, P1269, DOI 10.1016/S0021-8502(01)00062-3; Zhang DZ, 2008, TELLUS B, V60, P641, DOI 10.1111/j.1600-0889.2008.00358.x; Fan XB, 1996, ATMOS ENVIRON, V30, P347, DOI 10.1016/1352-2310(95)00271-Y; Wang SH, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050415; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Osada K, 2014, ATMOS CHEM PHYS, V14, P1107, DOI 10.5194/acp-14-1107-2014; In HJ, 2002, ATMOS ENVIRON, V36, P4173, DOI 10.1016/S1352-2310(02)00361-8; Chadwick OA, 1999, NATURE, V397, P491, DOI 10.1038/17276; Inomata Y, 2009, ATMOS ENVIRON, V43, P4503, DOI 10.1016/j.atmosenv.2009.06.048; Kawahata H, 2003, J OCEANOGR, V59, P663, DOI 10.1023/B:JOCE.0000009595.79408.13; Niimura N, 1998, J METEOROL SOC JPN, V76, P275; OKADA K, 1990, ATMOS ENVIRON A-GEN, V24, P1369, DOI 10.1016/0960-1686(90)90043-M; Okada K, 2004, ATMOS ENVIRON, V38, P6927, DOI 10.1016/j.atmosenv.2004.03.078; Seinfeld J.H., 1997, ATMOSPHERIC CHEM PHY; Sun WY, 2013, AEROSOL AIR QUAL RES, V13, P1641, DOI 10.4209/aaqr.2013.06.0208; Tegen I., 1994, J GEOPHYS RES, V99; Trochkine D., 2003, WATER AIR SOIL POLL, V3, P161, DOI 10.1023/A:1023286306728; VDI, 1997, VDI DIN HDB REINH LU; Zhang D., 2005, EOS T AGU, V86, P523, DOI 10.1029/2005EO500003; Zhang DZ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003869; Zhang DZ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020087; Zhang DZ, 2006, J METEOROL SOC JPN, V84, P939, DOI 10.2151/jmsj.84.939; Zhou G., 1996, J GEOLOG SOC JAPAN, V102, P787	27	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	OCT	2015	118						157	163		10.1016/j.atmosenv.2015.07.041		7	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CR5UM	WOS:000361409900015		
J	Wada, T; Fujisaki, Y				Wada, Takayuki; Fujisaki, Yasumasa			A stopping rule for stochastic approximation	AUTOMATICA			English	Article						Stochastic approximation; Randomized algorithms; Adaptive control; System identification	SUBGRADIENT METHODS; GRADIENT; SYSTEMS	A stochastic approximation algorithm is a recursive procedure to find the solution to an unknown nonlinear equation via noisy measurements. In this paper, we present a stopping rule for a stochastic approximation. We show that there is a high probability that the distance between the exact solution and the candidate solution is less than a specified tolerance level when the stochastic approximation stops according to our stopping rule. Furthermore, the number of recursions required by the stopping rule is a polynomial function of the problem size. (C) 2015 Elsevier Ltd. All rights reserved.	[Wada, Takayuki; Fujisaki, Yasumasa] Osaka Univ, Dept Informat & Phys Sci, Suita, Osaka 5650871, Japan	Wada, T (reprint author), Osaka Univ, Dept Informat & Phys Sci, 1-5 Yamadaoka, Suita, Osaka 5650871, Japan.	t-wada@ist.osaka-u.ac.jp; fujisaki@istosaka-u.ac.jp			JSPS [24760344, 15K18088, 26420416]	This work was partially supported by the Grant-in-Aid for Young Scientists (B), 24760344 and 15K18088 and the Grant-in-Aid for Scientific Research (C), 26420416, JSPS. The material in this paper was not presented at any conference. This paper was recommended for publication in revised form by Associate Editor Tongwen Chen under the direction of Editor fan R. Petersen.	Yousefian F, 2012, AUTOMATICA, V48, P56, DOI 10.1016/j.automatica.2011.09.043; KIEFER J, 1952, ANN MATH STAT, V23, P462, DOI 10.1214/aoms/1177729392; ROBBINS H, 1951, ANN MATH STAT, V22, P400, DOI 10.1214/aoms/1177729586; Huang MY, 2010, IEEE T AUTOMAT CONTR, V55, P235, DOI 10.1109/TAC.2009.2036291; Nedic A, 2009, IEEE T AUTOMAT CONTR, V54, P48, DOI 10.1109/TAC.2008.2009515; Chen HF, 2004, IEEE T AUTOMAT CONTR, V49, P583, DOI 10.1109/TAC.2004.825613; Huang MY, 2010, AUTOMATICA, V46, P1571, DOI 10.1016/j.automatica.2010.06.016; Benveniste A, 1990, ADAPTIVE ALGORITHMS; Borkar V. S., 2008, STOCHASTIC APPROXIMA; BURKHOLDER DL, 1956, ANN MATH STAT, V27, P1044, DOI 10.1214/aoms/1177728072; Butcher M., 2008, 17 IFAC WORLD C, P4400; Chen H., 2002, STOCHASTIC APPROXIMA; Chen HF, 2010, IEEE T AUTOMAT CONTR, V55, P868, DOI 10.1109/TAC.2010.2041997; FABIAN V, 1968, ANN MATH STAT, V39, P1327, DOI 10.1214/aoms/1177698258; Glynn P. W., 1992, ANN APPL PROBAB, V2, P180, DOI 10.1214/aoap/1177005777; Kushner H. J., 1997, STOCHASTIC APPROXIMA; Mu BQ, 2013, AUTOMATICA, V49, P2744, DOI 10.1016/j.automatica.2013.06.022; Nevelson M. B., 1976, STOCHASTIC APPROXIMA; PFLUG GC, 1990, MONATSH MATH, V110, P297, DOI 10.1007/BF01301683; Rugh W., 1995, LINEAR SYSTEM THEORY; SIELKEN RL, 1973, Z WAHRSCHEINLICHKEIT, V26, P67, DOI 10.1007/BF00533961; Spall J., 2003, INTRO STOCHASTIC SEA; SPALL JC, 1992, IEEE T AUTOMAT CONTR, V37, P332, DOI 10.1109/9.119632; STROUP DF, 1982, Z WAHRSCHEINLICHKEIT, V60, P535, DOI 10.1007/BF00535715; Tempo R., 2013, COMMUNICATIONS CONTR; Tsypkin Y., 1973, AUTOMAT REM CONTR, V12, P83; Wada T, 2010, IEEE DECIS CONTR P, P4171, DOI 10.1109/CDC.2010.5717389; YIN G, 1988, SYST CONTROL LETT, V11, P107, DOI 10.1016/0167-6911(88)90083-7; YIN G, 1990, J OPTIMIZ THEORY APP, V67, P151, DOI 10.1007/BF00939741	29	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0005-1098	1873-2836		AUTOMATICA	Automatica	OCT	2015	60						1	6		10.1016/j.automatica.2015.06.029		6	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	CR1GT	WOS:000361073600001		
J	Zeng, HB; He, Y; Wu, M; She, JH				Zeng, Hong-Bing; He, Yong; Wu, Min; She, Jinhua			New results on stability analysis for systems with discrete distributed delay	AUTOMATICA			English	Article						Systems with time delay; Integral inequality; Stability; Lyapunov-Krasovskii functional	TIME-VARYING DELAY; INTEGRAL INEQUALITY; ROBUST STABILITY; STABILIZATION	The integral inequality technique is widely used to derive delay-dependent conditions, and various integral inequalities have been developed to reduce the conservatism of the conditions derived. In this study, a new integral inequality was devised that is tighter than existing ones. It was used to investigate the stability of linear systems with a discrete distributed delay, and a new stability condition was established. The results can be applied to systems with a delay belonging to an interval, which may be unstable when the delay is small or nonexistent. Three numerical examples demonstrate the effectiveness and the smaller conservatism of the method. (C) 2015 Elsevier Ltd. All rights reserved.	[Zeng, Hong-Bing] Hunan Univ Technol, Sch Elect & Informat Engn, Zhuzhou 412007, Peoples R China; [He, Yong; Wu, Min; She, Jinhua] China Univ Geosci, Sch Automat, Wuhan 430074, Peoples R China; [She, Jinhua] Tokyo Univ Technol, Sch Engn, Tokyo 1920982, Japan	Zeng, HB (reprint author), Hunan Univ Technol, Sch Elect & Informat Engn, Zhuzhou 412007, Peoples R China.	9804zhb@163.com; heyong08@cug.edu.cn; wumin@cug.edu.cn; she@cs.teu.ac.jp			National Natural Science Foundation of China [61125301, 61210011, 61304064, 61273157]; Natural Science Foundation of Hunan Province [2015JJ3064, 2015JJ5021]	This work was supported in part by the National Natural Science Foundation of China (61125301, 61210011, 61304064, 61273157), and the Natural Science Foundation of Hunan Province (2015JJ3064, 2015JJ5021). The material in this paper was not presented at any conference. This paper was recommended for publication in revised form by Associate Editor Keqin Gu under the direction of Editor Andre L. Tits.	Seuret A, 2013, AUTOMATICA, V49, P2860, DOI 10.1016/j.automatica.2013.05.030; Park P, 2007, AUTOMATICA, V43, P1855, DOI 10.1016/j.automatica.2007.02.022; Han QL, 2005, AUTOMATICA, V41, P2171, DOI 10.1016/j.automatica.2005.08.005; Kao CY, 2007, AUTOMATICA, V43, P959, DOI 10.1016/j.automatica.2006.12.006; Wu M, 2004, AUTOMATICA, V40, P1435, DOI 10.1016/j.automatica.2004.03.004; Park M, 2015, AUTOMATICA, V55, P204, DOI 10.1016/j.automatica.2015.03.010; Zhang XM, 2014, IET CONTROL THEORY A, V8, P1054, DOI 10.1049/iet-cta.2013.0840; Seuret A, 2014, 2014 EUROPEAN CONTROL CONFERENCE (ECC), P448, DOI 10.1109/ECC.2014.6862453; Chen WH, 2007, AUTOMATICA, V43, P95, DOI 10.1016/j.automatica.2006.07.019; Kim JH, 2011, AUTOMATICA, V47, P2118, DOI 10.1016/j.automatica.2011.05.023; Sun J, 2010, AUTOMATICA, V46, P466, DOI 10.1016/j.automatica.2009.11.002; Fridman E, 2002, IEEE T AUTOMAT CONTR, V47, P1931, DOI 10.1109/TAC.2002.804462; Gu K., 2003, STABILITY TIME DELAY; Zeng H. B., 2015, IEEE T AUTOMATIC CON	14	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0005-1098	1873-2836		AUTOMATICA	Automatica	OCT	2015	60						189	192		10.1016/j.automatica.2015.07.017		4	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	CR1GT	WOS:000361073600024		
J	Watanabe, S				Watanabe, Shigeru			Common experience modifies the reinforcing properties of methamphetamine-injected cage mates but not morphine-injected cage mates in C57 mice	BEHAVIOURAL PHARMACOLOGY			English	Article						common experience; conditioned place preference; empathy; methamphetamine; morphine; mouse; social reinforcement	CONDITIONED PLACE PREFERENCE; ADOLESCENT MALE RATS; JUVENILE RATS; SOCIAL-INTERACTION; C57BL/6J MICE; PAIN; BEHAVIOR; COCAINE; REWARD; EMPATHY	The aim of this study was to determine whether previous exposure to a drug affects the social facilitation of conditioned place preference (CPP) for a drug-injected cage mate. Twenty-two male C57/BL6J mice received drug injections (methamphetamine or morphine) and 22 male C57/BL6J mice received saline injections. All 44 mice then received CPP training, during which one compartment of a conventional CPP apparatus was associated with a drug-injected cage mate (stimulus mouse) and the other compartment was associated with a saline-injected cage mate (stimulus mouse). The subject mice did not receive any drug injection during this CPP training. Time spent in the compartment associated with the drug-injected cage mate was measured before and after training. Subject mice that had previously received methamphetamine injections showed an increase in the time spent in the compartment associated with the methamphetamine-injected cage mate after CPP training. This effect was not observed in subject mice that had previously received saline injections. Subject mice did not show an increase in the time spent in the compartment associated with the morphine-injected cage mate irrespective of whether they had previously received morphine or saline injections. Therefore, in agreement with previous reports, common experience with methamphetamine induced reinforcing properties, but that with morphine did not.	[Watanabe, Shigeru] Keio Univ, Dept Psychol, Tokyo 108, Japan; [Watanabe, Shigeru] Keio Univ, Ctr Adv Res Log & Sensibil, Tokyo 108, Japan	Watanabe, S (reprint author), Keio Univ, Dept Psychol, Minato Ku, Mita 2-15-45, Tokyo 108, Japan.	swat@flet.keio.ac.jp					CHURCH RM, 1959, J COMP PHYSIOL PSYCH, V52, P132, DOI 10.1037/h0043531; Ma YY, 2006, EXP NEUROL, V200, P343, DOI 10.1016/j.expneurol.2006.02.117; PANKSEPP J, 1985, BEHAV NEUROSCI, V99, P441, DOI 10.1037/0735-7044.99.3.441; Wongwitdecha N, 1996, PHARMACOL BIOCHEM BE, V53, P531, DOI 10.1016/0091-3057(95)02046-2; Panksepp JB, 2007, GENES BRAIN BEHAV, V6, P661, DOI 10.1111/j.1601-183X.2006.00295.x; Douglas LA, 2004, DEV PSYCHOBIOL, V45, P153, DOI 10.1002/dev.20025; Thiel KJ, 2009, PSYCHOPHARMACOLOGY, V204, P391, DOI 10.1007/s00213-009-1470-2; CALCAGNETTI DJ, 1992, PHYSIOL BEHAV, V51, P667, DOI 10.1016/0031-9384(92)90101-7; Thiel KJ, 2008, DRUG ALCOHOL DEPEN, V96, P202, DOI 10.1016/j.drugalcdep.2008.02.013; Cole SL, 2013, ADDICT BIOL, V18, P274, DOI 10.1111/j.1369-1600.2011.00426.x; Watanabe S, 2011, BEHAV PHARMACOL, V22, P203, DOI 10.1097/FBP.0b013e328345c815; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Peartree NA, 2012, PHYSIOL BEHAV, V105, P749, DOI 10.1016/j.physbeh.2011.10.001; Preis MA, 2012, EUR J PAIN, V16, P1311, DOI 10.1002/j.1532-2149.2012.00119.x; Atsak P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021855; ANTONITI.JJ, 1964, J GENET PSYCHOL, V105, P223; Brodkin ES, 2004, BRAIN RES, V1002, P151, DOI 10.1016/j.brainres.2003.12.013; Coventry TL, 1997, BEHAV PHARMACOL, V8, P575, DOI 10.1097/00008877-199711000-00015; El Rawas R, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00063; Fritz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026761; GLYNN TJ, 1989, J SCHOOL HEALTH, V59, P181; Grotewold SK, 1981, ANIM BEHAV, V29, P259; HUMPHREYS AP, 1981, ANIM BEHAV, V29, P259, DOI 10.1016/S0003-3472(81)80173-X; Kennedy BC, 2011, BEHAV PHARMACOL, V22, P147, DOI 10.1097/FBP.0b013e328343d7dd; Kennedy BC, 2012, PSYCHOPHARMACOLOGY, V219, P923, DOI 10.1007/s00213-011-2421-2; Nabben T, 1999, J DRUG ISSUES, V29, P627; Pearson BL, 2010, BEHAV BRAIN RES, V213, P189, DOI 10.1016/j.bbr.2010.04.054; Loo P. L. P. van, 2001, Journal of Applied Animal Welfare Science, V4, P91, DOI 10.1207/S15327604JAWS0402_1; VANDERSCHUREN LJMJ, 1995, PSYCHOPHARMACOLOGY, V117, P225, DOI 10.1007/BF02245191; Watanabe S, 2013, PHARMACOL BIOCHEM BE, V103, P440, DOI 10.1016/j.pbb.2012.10.001; Watanabe S, 2014, BEHAV PROCESS, V103, P1, DOI 10.1016/j.beproc.2013.10.005; WATANABE S, 1986, BEHAV PROCESS, V13, P269, DOI 10.1016/0376-6357(86)90089-6; WESTERME.J, 1974, ARCH GEN PSYCHIAT, V31, P237; Yates JR, 2013, DRUG ALCOHOL DEPEN, V129, P240, DOI 10.1016/j.drugalcdep.2013.02.024	34	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0955-8810	1473-5849		BEHAV PHARMACOL	Behav. Pharmacol.	OCT	2015	26	7			SI		636	641		10.1097/FBP.0000000000000137		6	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	CR3FI	WOS:000361215700003		
J	Hasebe, S; Ago, Y; Nishiyama, S; Oka, S; Hashimoto, H; Takuma, K; Matsuda, T				Hasebe, Shigeru; Ago, Yukio; Nishiyama, Saki; Oka, Satoshi; Hashimoto, Hitoshi; Takuma, Kazuhiro; Matsuda, Toshio			Pharmacological profile of encounter-induced hyperactivity in isolation-reared mice	BEHAVIOURAL PHARMACOLOGY			English	Article						antidepressant; (2) adrenoceptor; depression model; 5-HT4 receptor; isolation-reared mouse	INDUCED ABNORMAL BEHAVIORS; WEANING SOCIAL-ISOLATION; 5-HT4 RECEPTOR AGONIST; FORCED SWIMMING TEST; AGGRESSIVE-BEHAVIOR; ENVIRONMENTAL ENRICHMENT; SUCROSE CONSUMPTION; PREFRONTAL CORTEX; NEGATIVE SYMPTOMS; VENTRAL STRIATUM	We have recently found that isolation-reared mice show hyperactivity during an encounter with an intruder. However, it is not known whether encounter-induced hyperactivity may model some aspects of psychiatric disorders. The present study examined the pharmacological profile of encounter-induced hyperactivity in isolation-reared mice. Encounter-induced hyperactivity was reduced by acute administration of various antidepressants including the tricyclic antidepressant desipramine (10mg/kg), the selective serotonin (5-HT) reuptake inhibitors fluvoxamine (10mg/kg) and paroxetine (10mg/kg), the 5-HT/noradrenaline reuptake inhibitors venlafaxine (10mg/kg) and duloxetine (10mg/kg), the antipsychotic drug risperidone (0.01mg/kg), the 5-HT2 antagonist ritanserin (1mg/kg), and the glucocorticoid receptor antagonist RU-43044 (30mg/kg). The (2) adrenoceptor agonist clonidine (0.03mg/kg) and the 5-HT4 receptor agonist BIMU8 (30mg/kg) also reduced encounter-induced hyperactivity. The effect of desipramine was blocked by the (2) adrenoceptor antagonist idazoxan (0.3mg/kg). The effect of fluvoxamine was blocked by the 5-HT4 receptor antagonist GR125487 (3mg/kg), but not the 5-HT1A receptor antagonist WAY100635 (1mg/kg), the 5-HT3 receptor antagonist azasetron (3mg/kg), or the 5-HT6 receptor antagonist SB399885 (3mg/kg). The effect of venlafaxine was blocked by the simultaneous administration of idazoxan (0.3mg/kg) and GR125487 (3mg/kg), but not by either compound alone. These findings suggest that encounter-induced hyperactivity in isolation-reared mice is a robust model for testing the pharmacological profile of antidepressants, although the range of antidepressants tested is limited and some nonantidepressants are also effective. The present study also shows a key role of (2) and 5-HT4 receptors in the antidepressant effect in this model.	[Hasebe, Shigeru; Ago, Yukio; Nishiyama, Saki; Oka, Satoshi; Takuma, Kazuhiro; Matsuda, Toshio] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Med Pharmacol, Suita, Osaka 5650871, Japan; [Hashimoto, Hitoshi] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol Neuropharmacol, Suita, Osaka 5650871, Japan; [Hashimoto, Hitoshi] Osaka Univ, Grad Sch Pharmaceut Sci, iPS Cell Based Res Project Brain Neuropharmacol, Suita, Osaka 5650871, Japan; [Hashimoto, Hitoshi; Matsuda, Toshio] Osaka Univ, United Grad Sch Child Dev, Suita, Osaka 5650871, Japan; [Hashimoto, Hitoshi; Matsuda, Toshio] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka, Japan; [Hashimoto, Hitoshi; Matsuda, Toshio] Chiba Univ, Chiba, Japan; [Hashimoto, Hitoshi; Matsuda, Toshio] Univ Fukui, Fukui, Japan; [Takuma, Kazuhiro] Osaka Univ, Dept Pharmacol, Grad Sch Dent, Suita, Osaka 5650871, Japan	Matsuda, T (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, Lab Med Pharmacol, 1-6 Yamada Oka, Suita, Osaka 5650871, Japan.	matsuda@phs.osaka-u.ac.jp			KAKENHI [25460099, 26293020, 26670122]; Neuropsychiatry Drug Discovery Consortium (NDDC); Dainippon Sumitomo Pharma Co. Ltd, Japan; Osaka University; Funding Program for Next Generation World-Leading Researchers [LS081]; Uehara Memorial Foundation, Japan; Takeda Science Foundation, Japan; JSPS Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers [S2603]	A part of this work was supported by KAKENHI [25460099 (Y.A.), 26293020 (H.H.), and 26670122 (H.H.)], and research funds from the Neuropsychiatry Drug Discovery Consortium (NDDC) established by Dainippon Sumitomo Pharma Co. Ltd, Japan with Osaka University (T.M., H.H.), the Funding Program for Next Generation World-Leading Researchers [Grant No. LS081 (H.H.)], the Uehara Memorial Foundation, Japan (H.H.), the Takeda Science Foundation, Japan (Y.A.), and the JSPS Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers (Grant number S2603) (H.H., T.M.).	Ago Y, 2005, EUR J PHARMACOL, V520, P86, DOI 10.1016/j.ejphar.2005.08.011; Ago Y, 2005, NEUROPSYCHOPHARMACOL, V30, P43, DOI 10.1038/sj.npp.1300567; Akhondzadeh S, 2008, PROG NEURO-PSYCHOPH, V32, P1879, DOI 10.1016/j.pnpbp.2008.08.020; Sakaue M, 2002, JPN J PHARMACOL, V89, P89, DOI 10.1254/jjp.89.89; Ago Y, 2007, J PHARMACOL SCI, V104, P153, DOI 10.1254/jphs.FP0070325; Pinna G, 2003, P NATL ACAD SCI USA, V100, P2035, DOI 10.1073/pnas.00337642100; Mendez-David I, 2014, NEUROPSYCHOPHARMACOL, V39, P1366, DOI 10.1038/npp.2013.332; Pinna G, 2008, NEUROCHEM RES, V33, P1990, DOI 10.1007/s11064-008-9718-5; CERVO L, 1991, EUR J PHARMACOL, V193, P309, DOI 10.1016/0014-2999(91)90144-F; Araki R, 2014, INT J NEUROPSYCHOPH, V17, P883, DOI 10.1017/S1461145713001582; Sakaue M, 2001, EUR J PHARMACOL, V432, P163, DOI 10.1016/S0014-2999(01)01511-4; Brenes JC, 2009, BEHAV BRAIN RES, V198, P199, DOI 10.1016/j.bbr.2008.10.036; Ago Y, 2013, NEUROPSYCHOPHARMACOL, V38, P1535, DOI 10.1038/npp.2013.52; Carr GV, 2011, PSYCHOPHARMACOLOGY, V213, P265, DOI 10.1007/s00213-010-2097-z; Kawasaki T, 2011, NEUROPHARMACOLOGY, V60, P397, DOI 10.1016/j.neuropharm.2010.10.009; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; Redrobe JP, 1996, EUR J PHARMACOL, V318, P213, DOI 10.1016/S0014-2999(96)00772-8; Ago Y, 2012, J PHARMACOL SCI, V118, P295, DOI 10.1254/jphs.11200SC; Singh SP, 2010, BRIT J PSYCHIAT, V197, P174, DOI 10.1192/bjp.bp.109.067710; Bockaert J, 2008, NEUROPHARMACOLOGY, V55, P922, DOI 10.1016/j.neuropharm.2008.05.013; Hirano K, 2009, LIFE SCI, V84, P558, DOI 10.1016/j.lfs.2009.01.019; Higashino K, 2014, EUR J PHARMACOL, V729, P86, DOI 10.1016/j.ejphar.2014.02.012; Koike H, 2009, BEHAV BRAIN RES, V202, P114, DOI 10.1016/j.bbr.2009.03.028; Hiramatsu N, 2013, NEUROPHARMACOLOGY, V75, P53, DOI 10.1016/j.neuropharm.2013.06.026; Brenes JC, 2008, NEUROSCI LETT, V436, P278, DOI 10.1016/j.neulet.2008.03.045; Carr GV, 2011, PSYCHOPHARMACOLOGY, V213, P499, DOI 10.1007/s00213-010-1798-7; Svenningsson P, 2007, J NEUROSCI, V27, P4201, DOI 10.1523/JNEUROSCI.3110-06.2007; Ago Y, 2014, J PHARMACOL SCI, V125, P237, DOI 10.1254/jphs.14R05CP; Pascual-Brazo J, 2012, INT J NEUROPSYCHOPH, V15, P631, DOI 10.1017/S1461145711000782; Lucas G, 2007, NEURON, V55, P712, DOI 10.1016/j.neuron.2007.07.041; Ago Y, 2008, NEUROPHARMACOLOGY, V55, P1355, DOI 10.1016/j.neuropharm.2008.08.026; Galeotti N, 1998, J PHARMACOL EXP THER, V286, P1115; Umehara M, 2013, EUR J PHARMACOL, V702, P250, DOI 10.1016/j.ejphar.2013.01.033; Berrocoso E, 2009, INT J NEUROPSYCHOPH, V12, P61, DOI 10.1017/S1461145708008766; CERVO L, 1990, EUR J PHARMACOL, V175, P301, DOI 10.1016/0014-2999(90)90568-Q; Dandekar MP, 2009, NEUROPSYCHOPHARMACOL, V34, P1288, DOI 10.1038/npp.2008.201; DELINISTULA A, 1981, PHARMACOL BIOCHEM BE, V14, P33; De Vry J, 2004, EUR NEUROPSYCHOPHARM, V14, P487, DOI 10.1016/j.euroneuro.2004.01.004; EGAWA T, 1995, JPN J PHARMACOL, V68, P71, DOI 10.1254/jjp.68.71; Guilloux JP, 2006, NEUROPSYCHOPHARMACOL, V31, P2162, DOI 10.1038/sj.npp.1301019; Guo M, 2004, PROG NEURO-PSYCHOPH, V28, P115, DOI 10.1016/j.pnpbp.2003.09.027; Hall FS, 1998, PSYCHOPHARMACOLOGY, V139, P210, DOI 10.1007/s002130050706; Hall FS, 1998, J NEUROSCI METH, V79, P47, DOI 10.1016/S0165-0270(97)00155-6; HERITCH AJ, 1990, J PSYCHIAT RES, V24, P251, DOI 10.1016/0022-3956(90)90014-H; Karolewicz B, 2001, EUR J PHARMACOL, V415, P197, DOI 10.1016/S0014-2999(01)00830-5; Koda K, 2011, BRIT J PHARMACOL, V162, P763, DOI 10.1111/j.1476-5381.2010.01080.x; Matsuda T, 2013, BIOL PHARM BULL, V36, P1871; MITCHELL P J, 1992, Journal of Psychopharmacology, V6, P241, DOI 10.1177/026988119200600218; Nelson EB, 2012, CURR PSYCHIAT REP, V14, P619, DOI 10.1007/s11920-012-0315-6; Pinna G, 2005, P NATL ACAD SCI USA, V102, P2135, DOI 10.1073/pnas.0409643102; PONCELET M, 1995, J NEURAL TRANSM-GEN, V102, P83, DOI 10.1007/BF01276504; Rilke O, 2001, PROG NEURO-PSYCHOPH, V25, P1125, DOI 10.1016/S0278-5846(01)00167-1; SANCHEZ C, 1994, EUR J PHARMACOL, V264, P241, DOI 10.1016/0014-2999(94)00470-6; Stone EA, 2011, INT J NEUROPSYCHOPH, V14, P319, DOI 10.1017/S1461145710000507; Tanaka K, 2010, NEUROSCIENCE, V166, P1036, DOI 10.1016/j.neuroscience.2010.01.029; Van den Berg CL, 2000, NEUROPHARMACOLOGY, V39, P969, DOI 10.1016/S0028-3908(99)00216-6; Yildirim E, 2012, PHARMACOL BIOCHEM BE, V101, P278, DOI 10.1016/j.pbb.2011.12.017; Zhang HT, 2009, NEUROPSYCHOPHARMACOL, V34, P1067, DOI 10.1038/npp.2008.184	58	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0955-8810	1473-5849		BEHAV PHARMACOL	Behav. Pharmacol.	OCT	2015	26	7			SI		681	690		10.1097/FBP.0000000000000140		10	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	CR3FI	WOS:000361215700008		
J	Yamaguchi, T; Fujikawa, N; Nimura, S; Tokuoka, Y; Tsuda, S; Aiuchi, T; Kato, R; Obama, T; Itabe, H				Yamaguchi, Tomohiro; Fujikawa, Noriyuki; Nimura, Satomi; Tokuoka, Yutaro; Tsuda, Sonoka; Aiuchi, Toshihiro; Kato, Rina; Obama, Takashi; Itabe, Hiroyuki			Characterization of lipid droplets in steroidogenic MLTC-1 Leydig cells: Protein profiles and the morphological change induced by hormone stimulation	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS			English	Article						Lydig cells; Lipid droplets; Steroidogenesis; 17beta-HSD11; 3beta-HSD1; MLTC-1	DIFFERENTIATION-RELATED PROTEIN; PERILIPIN FAMILY; TUMOR-CELLS; PAT-FAMILY; ADIPOCYTES; LIPOLYSIS; IDENTIFICATION; HEART	Lipid droplets (LDs) are functional subcellular organelles involved in multiple intracellular processes. LDs are found in nearly all types of eukaryotic cells, but their properties are highly variable in different types of tissues. Steroidogenic cells synthesize steroid hormones de novo from the cholesterol deposited in cytosolic LDs. However, the roles of LD proteins in steroidogenesis under pituitary hormone stimulation have not been well elucidated. The protein profile of isolated LDs from the mouse Leydig tumor cell line MLTC-1 was distinct from that of hepatic cells or macrophages. By proteomic analysis of the components using mass spectrometry, two enzymes for steroidogenesis,3 beta-hydroxysteroid dehydrogenase type 1 (3 beta HSD1) and 17 beta-hydroxysteroid dehydrogenase type 11 (17 beta HSD11), were identified in two strong bands in the LD fractions. The LD fraction of MLTC-1 cells also included CYP11A1 and CYP17, suggesting that the LDs contain all the enzymes needed for testosterone synthesis. The steroidogenesis in Leydig cells is activated by luteinizing hormone through a PKA-dependent pathway. Stimulation of MLTC-1 cells with luteinizing hormone or 8-bromo-cAMP caused drastic changes in the morphology of the LDs in the MLTC-1 cells. Upon stimulation, large perinuclear LDs are turned into much smaller LDs and dispersed throughout the cytosol. These results raise the possibility that LDs are involved in a regulatory pathway of steroidogenesis, not just by serving as a storage depot for cholesterol esters, but also by providing enzymes and generating sites for enzymatic activity. (C) 2015 Elsevier B.V. All rights reserved.	[Yamaguchi, Tomohiro; Fujikawa, Noriyuki; Nimura, Satomi; Tokuoka, Yutaro; Tsuda, Sonoka; Aiuchi, Toshihiro; Kato, Rina; Obama, Takashi; Itabe, Hiroyuki] Showa Univ, Sch Pharm, Dept Mol Biol, Div Biol Chem, Shinagawa, Tokyo 1428555, Japan	Yamaguchi, T (reprint author), Showa Univ, Sch Pharm, Dept Mol Biol, Div Biol Chem, 1-5-8 Hatanodai, Shinagawa, Tokyo 1428555, Japan.	tyamag@pharm.showa-u.ac.jp; h-itabe@pharm.showa-u.ac.jp			JSPS KAKENHI [23790098]; MEXT-supported program for the Strategic Research Foundation at Private Universities	This work was supported in part by a grant from JSPS KAKENHI (Grant Number 23790098) to TY and a MEXT-supported program for the Strategic Research Foundation at Private Universities (2010-2014) to HI. We thank Mitsuru Nagasawa, Atsushi Sakurai, Yoshiko Utsunomiya, Tomomi Ohwada, Hitomi Sugai, and Masami Uehara for their technical assistance. Pacific Edit reviewed the manuscript prior to submission.	Ali Yassine Ben, 2005, J Lipid Res, V46, P994, DOI 10.1194/jlr.M400509-JLR200; Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200; Ariotti N, 2012, MOL BIOL CELL, V23, P1826, DOI 10.1091/mbc.E11-10-0847; Kuramoto K, 2012, J BIOL CHEM, V287, P23852, DOI 10.1074/jbc.M111.328708; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Moessinger C, 2011, J BIOL CHEM, V286, P21330, DOI 10.1074/jbc.M110.202424; Hodges BDM, 2010, J LIPID RES, V51, P262, DOI 10.1194/jlr.R003582; Paar M, 2012, J BIOL CHEM, V287, P11164, DOI 10.1074/jbc.M111.316794; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Sato S, 2006, J BIOCHEM, V139, P921, DOI 10.1093/jb/mvj104; Yang L, 2012, J LIPID RES, V53, P1245, DOI 10.1194/jlr.R024117; Hashimoto T, 2012, J CELL SCI, V125, P6127, DOI 10.1242/jcs.113084; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Yamaguchi T, 2006, J BIOL CHEM, V281, P14232, DOI 10.1074/jbc.M601682200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Hsieh K, 2012, J CELL SCI, V125, P4067, DOI 10.1242/jcs.104943; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; CLARK BJ, 1994, J BIOL CHEM, V269, P28314; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Murphy DJ, 2012, PROTOPLASMA, V249, P541, DOI 10.1007/s00709-011-0329-7; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Brasaemle D.L., 2006, CURR PROTOC CELL BIO; Fong TH, 1996, J CELL BIOCHEM, V63, P366, DOI 10.1002/(SICI)1097-4644(19961201)63:3<366::AID-JCB12>3.0.CO;2-F; Horiguchi Y, 2008, ARCH BIOCHEM BIOPHYS, V479, P121, DOI 10.1016/j.abb.2008.08.020; Hu J, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-47; Khor VK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105047; Masuda Y, 2006, BIOCHEM BIOPH RES CO, V346, P454, DOI 10.1016/j.bbrc.2006.05.161; Murphy S, 2009, BBA-MOL CELL BIOL L, V1791, P441, DOI 10.1016/j.bbalip.2008.07.004; Nose F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071542; Panesar NS, 2003, STEROIDS, V68, P245, DOI 10.1016/S0039-128X(02)00183-6; Prasad M., 2014, J BIOL CHEM, V290, P2604; SERVETNICK DA, 1995, J BIOL CHEM, V270, P16970; Takahashi K, 2010, J LIPID RES, V51, P2571, DOI 10.1194/jlr.M004648; Yamasaki M, 1999, J BIOL CHEM, V274, P35293, DOI 10.1074/jbc.274.50.35293	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1388-1981	0006-3002		BBA-MOL CELL BIOL L	Biochim. Biophys. Acta Mol. Cell Biol. Lipids	OCT	2015	1851	10					1285	1295		10.1016/j.bbalip.2015.06.007		11	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CR5SA	WOS:000361403100001		
J	Yamanaka, T; Morimoto, N; Nishida, GM; Kiritani, K; Moriya, S; Liebhold, AM				Yamanaka, Takehiko; Morimoto, Nobuo; Nishida, Gordon M.; Kiritani, Keizi; Moriya, Seiichi; Liebhold, Andrew M.			Comparison of insect invasions in North America, Japan and their Islands	BIOLOGICAL INVASIONS			English	Article						Biological invasion; Invasibility; Invasion pathway; Community composition; Non-native insects; Climatic similarities	BIOLOGICAL-CONTROL; EUROPE; IMPACT; MODEL	Among the various animal taxa that are have established outside their native ranges, invasions by insect species are the most numerous worldwide. In order to better understand the characteristics of insect species that make them more invasion prone, the characteristics of habitats that make them more susceptible to invasions and to understand the pathways that facilitate invasions, we compared the compositions of the native and non-native insect communities among five Pacific regions: North America, the Hawaiian Islands, mainland Japan, Ogasawara and Okinawa Islands. These regions comprise both island and mainland habitats and have historically been subjected to varying activities affecting insect movement. Among the five regions, the oceanic islands, Hawaii and Ogasawara, appear to be the most prone to invasions. Specific insect orders such as the Blattodea, Siphonaptera, Thysanoptera and Hemiptera are disproportionally represented in the non-native insect fauna compared to the native fauna in all regions. A large fraction of the non-native insect species in North America (9.4 %) and Hawaii (13.2 %) were introduced intentionally, as part of biological control programs, which were historically pursued more vigorously in those regions than in Japan. Dominance by individual insect orders within invaded communities can be explained by the historical importance of invasion pathways, some of which were likely similar among regions (e.g., movement on live plants), while other pathways appear more region specific. Translocation of insect species among world regions appears to be affected by climatic similarity, host plant similarity and propagule pressure, though these effects are often confounded.	[Yamanaka, Takehiko] Natl Inst Agroenvironm Sci, Nat Resources Inventory Ctr, Tsukuba, Ibaraki 3058604, Japan; [Morimoto, Nobuo] NARO Inst Livestock & Grassland Sci, Nasu Res Stn, Nasushiobara, Tochigi 3292793, Japan; [Nishida, Gordon M.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Moriya, Seiichi] Natl Agr Res Ctr, Tsukuba, Ibaraki 3058666, Japan; [Liebhold, Andrew M.] USDA Forest Serv, No Res Stn, Morgantown, WV 26505 USA	Yamanaka, T (reprint author), Natl Inst Agroenvironm Sci, Nat Resources Inventory Ctr, 3-1-3 Kannondai, Tsukuba, Ibaraki 3058604, Japan.	apple@affrc.go.jp			National Socio-Environmental Synthesis Center pursuit project, "Globalization of the Live Plant Trade: Informing Efficient Strategies for Reducing Non-Native Pest Invasion Risk''	We thank R. Young and E. Luzader for assistance in compiling records. We also thank The Bernice Pauahi Bishop Museum (BPBM) for providing the newest Hawaiian list. This work was supported in part by the National Socio-Environmental Synthesis Center pursuit project, "Globalization of the Live Plant Trade: Informing Efficient Strategies for Reducing Non-Native Pest Invasion Risk''.	[Anonymous], 2007, ENVIRON CONSERV, DOI DOI 10.1017/S0376892907003815; McGlynn TP, 1999, J BIOGEOGR, V26, P535, DOI 10.1046/j.1365-2699.1999.00310.x; Sax DF, 2001, J BIOGEOGR, V28, P139, DOI 10.1046/j.1365-2699.2001.00536.x; KENKEL NC, 1986, ECOLOGY, V67, P919, DOI 10.2307/1939814; Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Liebhold AM, 2012, FRONT ECOL ENVIRON, V10, P135, DOI 10.1890/110198; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Aukema JE, 2010, BIOSCIENCE, V60, P886, DOI 10.1525/bio.2010.60.11.5; CALTAGIRONE LE, 1981, ANNU REV ENTOMOL, V26, P213, DOI 10.1146/annurev.en.26.010181.001241; Yee TW, 2010, J STAT SOFTW, V32, P1; CALTAGIRONE LE, 1989, ANNU REV ENTOMOL, V34, P1; Arnett RH, 2000, AM INSECTS HDB INSEC; Azuma S., 2002, CHECK LIST INSECT RY; BEIRNE BP, 1975, CAN ENTOMOL, V107, P225; Clausen CP, 1956, BIOL CONTROL INSECT; Clausen CP, 1978, AGR HDB USDA, P480; Cox GW, 1999, ALIEN SPECIES N AM H; FUNASAKI G Y, 1988, Proceedings of the Hawaiian Entomological Society, V28, P105; Haack RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096611; Hayashi K, 1976, TROP MED, V21, P1; Herben T, 2005, ECOL LETT, V8, P909, DOI 10.1111/j.1461-0248.2005.00790.x; Invasive Species Specialist Group (ISSG), 2014, WORLDS 100 WORST AL; Kim K, 1991, PATHWAYS CONSEQUENCE; Kiritani K, 1963, JPN J APPL ENTOMOL Z, V7, P49; Kiritani K, 1983, INSECTARIUM, V20, P240; Kiritani K, 2001, EXTENSION B FOOD FER, V498, P1; Kiritani Keizi, 2003, P44; Liebhold AM, 2013, DIVERS DISTRIB, V19, P1208, DOI 10.1111/ddi.12112; Lindroth C. H., 1957, FAUNAL CONNECTIONS E; Macfarlane R.P., 2010, NZ INVENTORY BIODIVE, V2, P233; MacLeod A, 2010, FOOD SECUR, V2, P49, DOI 10.1007/s12571-010-0054-7; Mattson W, 2007, BIOL INVASIONS, V9, P957, DOI 10.1007/s10530-007-9096-y; Mochizuki A, 2008, RISK MANAGEMENT UTIL, P171; Morimoto Nobuo, 1995, Bulletin of the National Institute of Agro-Environmental Sciences, V12, P87; Moriya S, 2009, GLOBAL SERIOUS PEST; Nishida GM, 2002, HAWAIIAN TERRESTRIAL; Ohbayashi Takashi, 2004, Ogasawara Research, V29, P17; Pitt JPW, 2007, INT J BIOMETEOROL, V51, P295, DOI 10.1007/s00484-006-0066-3; Roques Alain, 2009, V3, P63; Sailer R.I., 1983, P15; Sailer R.I., 1978, Bulletin of the Entomological Society of America, V24, P3; Simberloff D., 1986, Ecological Studies, P3; SPENCE JR, 1988, MEM ENTOMOL SOC CAN, P151; SPENCER N R, 1976, Aquatic Botany, V2, P177, DOI 10.1016/0304-3770(76)90019-X; Vail P. V., 2001, American Entomologist, V47, P24	46	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1387-3547	1573-1464		BIOL INVASIONS	Biol. Invasions	OCT	2015	17	10					3049	3061		10.1007/s10530-015-0935-y		13	Biodiversity Conservation; Ecology	Biodiversity & Conservation; Environmental Sciences & Ecology	CR6MB	WOS:000361460300020		
J	Kodani, S; Komaki, H; Suzuki, M; Kobayakawa, F; Hemmi, H				Kodani, Shinya; Komaki, Hisayuki; Suzuki, Masahiro; Kobayakawa, Fumiya; Hemmi, Hikaru			Structure determination of a siderophore peucechelin from Streptomyces peucetius	BIOMETALS			English	Article						Siderophore; Streptomyces peucetius; Peptide; Biosynthesis; Foroxymithine	COELICOLOR GENOME; NATURAL-PRODUCT; PEPTIDE; BIOSYNTHESIS; ERYTHROCHELIN; DISCOVERY	Previously, Park et al. isolated a new siderophore from Streptomyces peucetius ATCC 27952 based on information of the genome sequence and the structure of the siderophore was deduced to be a cyclic peptide based on MS/MS analysis. To clarify the structure of the siderophore, we cultured S. peucetius with iron deficient medium. Through several chromatographic procedures, the siderophore named peucechelin was isolated with the yield enough to perform NMR experiments. The planar structure of peucechelin was elucidated by the combination of ESI-MS experiment and NMR spectroscopic analyses of the gallium (III) complex. Unlike the previously deduced cyclic structure, the structure was determined to be a linear peptide which was similar to a known siderophore foroxymithine. The stereochemistries of amino acids constituting peucechelin were determined by applying modified Marfey method to the hydrolysate. Since the biosynthetic gene of peucechelin was formerly determined by Park et al. the similar genes were searched using genome data of other streptomycetes. As a result, the similar genes were found in the genome data of S. venezuelae and S. purpureus. Isolation and identification of siderophore was performed from the iron deficient culture of S. venezuelae. The siderophore of S. venezuelae was identified to be known compound foroxymithine by analysis ESI-MS and NMR spectra in the similar manner with peucechelin. Production of foroxymithine was also observed in the iron deficient culture of S. purpureus. Based on the genome data, comparison of the biosynthetic genes of structurally related siderophores peucechelin and foroxymithine was accomplished in discussion.	[Kodani, Shinya; Suzuki, Masahiro; Kobayakawa, Fumiya] Shizuoka Univ, Grad Sch Agr, Suruga Ku, Shizuoka 4228529, Japan; [Komaki, Hisayuki] Natl Inst Technol & Evaluat NBRC, Biol Resource Ctr, Kisarazu, Chiba 2920818, Japan; [Hemmi, Hikaru] Natl Food Res Inst, Natl Agr & Food Res Org NARO, Tsukuba, Ibaraki 3058642, Japan	Kodani, S (reprint author), Shizuoka Univ, Grad Sch Agr, Suruga Ku, Shizuoka 4228529, Japan.	kodani.shinya@shizuoka.ac.jp			Japan Society for the Promotion of Science [25350964]	This study was supported by the Japan Society for the Promotion of Science by Grants-in-aids (Grant No. 25350964).	Ahmad M, 2011, THESIS U WARWICK; Lautru S, 2005, NAT CHEM BIOL, V1, P265, DOI 10.1038/nchembio731; Ahmed E, 2014, MICROB BIOTECHNOL, V7, P196, DOI 10.1111/1751-7915.12117; Seyedsayamdost MR, 2011, J AM CHEM SOC, V133, P11434, DOI 10.1021/ja203577e; Challis GL, 2000, FEMS MICROBIOL LETT, V187, P111, DOI 10.1111/j.1574-6968.2000.tb09145.x; Doroghazi JR, 2014, NAT CHEM BIOL, V10, P963, DOI [10.1038/nchembio.1659, 10.1038/NCHEMBIO.1659]; Harada K, 1996, TETRAHEDRON LETT, V37, P3001, DOI 10.1016/0040-4039(96)00484-4; Kodani S, 2013, NAT PROD RES, V27, P775, DOI 10.1080/14786419.2012.698412; Kodani S, 2015, BIOMETALS, V28, P381, DOI 10.1007/s10534-015-9842-z; Kodani S, 2013, ORG BIOMOL CHEM, V11, P4686, DOI 10.1039/c3ob40536b; Kodani S, 2011, EUR J ORG CHEM, P3191, DOI 10.1002/ejoc.201100189; Lazos O, 2010, CHEM BIOL, V17, P160, DOI 10.1016/j.chembiol.2010.01.011; Park HM, 2013, APPL MICROBIOL BIOT, V97, P1213, DOI 10.1007/s00253-012-4268-9; Pullan ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-175; Robbel L, 2010, FEBS J, V277, P663, DOI 10.1111/j.1742-4658.2009.07512.x; Stephan H, 1993, LIEBIGS ANN CHEM, V1993, P43, DOI 10.1002/jlac.199319930108; UMEZAWA H, 1985, J ANTIBIOT, V38, P1813	17	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0966-0844	1572-8773		BIOMETALS	Biometals	OCT	2015	28	5					791	801		10.1007/s10534-015-9866-4		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CR6CD	WOS:000361430000001		
J	Doi, T; Hara, H; Kajita, M; Kamiya, T; Adachi, T				Doi, Takuya; Hara, Hirokazu; Kajita, Miho; Kamiya, Tetsuro; Adachi, Tetsuo			Zinc regulates expression of IL-23 p19 mRNA via activation of eIF2 alpha/ATF4 axis in HAPI cells	BIOMETALS			English	Article						Zinc; IL-23; Microglia; Activating transcription factor 4; eIF2 alpha; Phosphorylation	ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTOR; CORTICAL-NEURONS; T-CELLS; PROTEIN; BRAIN; INFLAMMATION; NEUROTOXICITY; RECEPTOR; RELEASE	Zinc (Zn2+) is considered to be one of the factors aggravating brain damage after cerebral ischemia. Since Zn2+ activates microglia, immune cells in the brain, this metal is proposed to modulate neuroinflammatory responses in the post-ischemic brain. Interleukin (IL)-23 is a heterodimeric cytokine composed of the p19 subunit unique to IL-23 and the p40 subunit common to IL-12. IL-23 has been shown to play a critical role in the progression of ischemic brain injury. However, whether Zn2+ participates in the expression of IL-23 in microglia remains unknown. In this study, we examined the effect of Zn2+ on IL-23 p19 mRNA expression using rat immortalized microglia HAPI cells. Exposure to Zn2+ dose- and time-dependently induced the expression of IL-23 p19 mRNA in HAPI cells. Inhibitors of MAPK and NF-kappa B pathways failed to suppress this induction. Interestingly, we found that Zn2+ stimulated the phosphorylation of eIF2 alpha and promoted the nuclear accumulation of activating transcription factor 4 (ATF4). Treatment with salubrinal, an eIF2 alpha dephosphorylation inhibitor, enhanced Zn2+-induced ATF4 accumulation and IL-23 p19 mRNA expression. In addition, reporter assay using the IL-23 p19 promoter region revealed that ATF4 directly transactivated IL-23 p19 promoter and that dominant-negative ATF4 suppressed Zn2+-induced activation of IL-23 p19 promoter. Taken together, these findings suggest that Zn2+ up-regulates expression of the IL-23 p19 gene via the eIF2 alpha/ATF4 axis in HAPI cells.	[Doi, Takuya; Hara, Hirokazu; Kajita, Miho; Kamiya, Tetsuro; Adachi, Tetsuo] Gifu Pharmaceut Univ, Lab Clin Pharmaceut, Gifu 5011196, Japan	Hara, H (reprint author), Gifu Pharmaceut Univ, Lab Clin Pharmaceut, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	harah@gifu-pu.ac.jp			Japan Society for the Promotion of Science [26460630]	This work was supported by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (to H.H.; No. 26460630).	Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Liu WC, 2009, J BIOL CHEM, V284, P24006, DOI 10.1074/jbc.M109.025528; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Hara H, 2009, NEUROCHEM RES, V34, P1498, DOI 10.1007/s11064-009-9937-4; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Zhang CY, 2013, CELL MOL IMMUNOL, V10, P84, DOI 10.1038/cmi.2012.57; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Lv M, 2011, NEUROSCIENCE, V176, P162, DOI 10.1016/j.neuroscience.2010.11.066; Goodall JC, 2010, P NATL ACAD SCI USA, V107, P17698, DOI 10.1073/pnas.1011736107; Qi X, 2004, MOL PHARMACOL, V66, P899, DOI 10.1124/mol.104.001339; Wek RC, 2006, BIOCHEM SOC T, V34, P7; He CH, 2001, J BIOL CHEM, V276, P20858, DOI 10.1074/jbc.M101198200; WEISS JH, 1993, NEURON, V10, P43, DOI 10.1016/0896-6273(93)90240-R; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Sensi SL, 1997, J NEUROSCI, V17, P9554; Fujiki K, 2014, ARCH TOXICOL, V88, P403, DOI 10.1007/s00204-013-1129-y; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Kauppinen TM, 2008, J NEUROSCI, V28, P5827, DOI 10.1523/JNEUROSCI.1236-08.2008; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Zeng L, 2010, J IMMUNOL, V185, P2324, DOI 10.4049/jimmunol.0903052; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Sun XY, 2012, J BIOL CHEM, V287, P11174, DOI 10.1074/jbc.M111.309070; Knoch ME, 2008, GLIA, V56, P89, DOI 10.1002/glia.20592; Hua F, 2007, J NEUROIMMUNOL, V190, P101, DOI 10.1016/j.jneuroim.2007.08.014; Iwasaki Y, 2014, DIABETES, V63, P152, DOI 10.2337/db13-0757; Sensi SL, 1999, P NATL ACAD SCI USA, V96, P2414, DOI 10.1073/pnas.96.5.2414; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Takeda A, 2001, BIOMETALS, V14, P343, DOI 10.1023/A:1012982123386; CHRISTINE CW, 1990, J NEUROSCI, V10, P108; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Ho Y, 2008, MOL PHARMACOL, V74, P1141, DOI 10.1124/mol.108.049064; Besser L, 2009, J NEUROSCI, V29, P2890, DOI 10.1523/JNEUROSCI.5093-08.2009; He K, 2010, J NEUROCHEM, V114, P452, DOI 10.1111/j.1471-4159.2010.06762.x; Kabu K, 2006, J IMMUNOL, V177, P1296; Frederickson CJ, 2000, J NUTR, V130, p1471S; Higashi Y, 2011, GLIA, V59, P1933, DOI 10.1002/glia.21235; Kim SM, 2010, NEUROSCIENCE, V169, P1831, DOI 10.1016/j.neuroscience.2010.06.016; Kim YM, 2006, AM J PHYSIOL-LUNG C, V290, P1028; Mise-Omata S, 2007, J IMMUNOL, V179, P6596; Wang LX, 2013, FOOD CHEM TOXICOL, V62, P880, DOI 10.1016/j.fct.2013.10.017; Weinstein JR, 2010, FUTURE NEUROL, V5, P227, DOI 10.2217/fnl.10.1; Zhong Lingying, 2014, Environ Toxicol Pharmacol, V38, P783, DOI 10.1016/j.etap.2014.09.009	46	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0966-0844	1572-8773		BIOMETALS	Biometals	OCT	2015	28	5					891	902		10.1007/s10534-015-9874-4		12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CR6CD	WOS:000361430000009		
J	Yagi, H; Zhang, Y; Yagi-Utsumi, M; Yamaguchi, T; Iida, S; Yamaguchi, Y; Kato, K				Yagi, Hirokazu; Zhang, Ying; Yagi-Utsumi, Maho; Yamaguchi, Takumi; Iida, Shigeru; Yamaguchi, Yoshiki; Kato, Koichi			Backbone H-1, C-13, and N-15 resonance assignments of the Fc fragment of human immunoglobulin G glycoprotein	BIOMOLECULAR NMR ASSIGNMENTS			English	Article						Immunoglobulin G; Fc; Glycoprotein; Mammalian expression system; NMR spectroscopy; Resonance assignment	VARIANT ANTIDANSYL ANTIBODIES; NMR-SPECTROSCOPY; THERAPEUTIC ANTIBODIES; HINGE REGION; BINDING; MODEL; IGG1	The Fc portion of immunoglobulin G (IgG) recruits complements and its cognate receptors, thereby promoting defensive mechanisms in the humoral immune system. These effector functions critically depend on N-glycosylation at the Fc region, which is therefore regarded as a crucial factor in the design and production of therapeutic antibodies. NMR spectroscopy plays a unique role in the characterization of conformational dynamics and intermolecular interactions of IgG-Fc in solutions. Here, we report NMR assignments of the glycosylated Fc fragment (Mr 53 kDa), cleaved from a chimeric antibody with human IgG1 constant regions, which was produced in Chinese hamster ovary cells with uniform C-13- and N-15-labeling.	[Yagi, Hirokazu; Zhang, Ying; Yagi-Utsumi, Maho; Yamaguchi, Takumi; Yamaguchi, Yoshiki; Kato, Koichi] Nagoya City Univ, Grad Sch, Nagoya, Aichi 4678603, Japan; [Yagi, Hirokazu; Zhang, Ying; Yagi-Utsumi, Maho; Yamaguchi, Takumi; Yamaguchi, Yoshiki; Kato, Koichi] Nagoya City Univ, Fac Pharmaceut Sci, Nagoya, Aichi 4678603, Japan; [Zhang, Ying; Yagi-Utsumi, Maho; Yamaguchi, Takumi; Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Zhang, Ying; Yagi-Utsumi, Maho; Yamaguchi, Takumi; Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan; [Iida, Shigeru] Kyowa Hakko Kirin Co Ltd, Chiyoda Ku, Tokyo 1000004, Japan; [Yamaguchi, Yoshiki] RIKEN Global Res Cluster, RIKEN Max Planck Joint Res Ctr, Syst Glycobiol Res Grp, Struct Glycobiol Team, Wako, Saitama 3510198, Japan	Kato, K (reprint author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan.	kkato@phar.nagoya-cu.ac.jp			Nanotechnology Platform Project; National Institute of Biomedical Innovation (NIBIO); Ministry of Education, Culture, Sports, Science and Technology (MEXT) [24249002, 25860053]	We would like to thank Ms. Kumiko Hattori and Ms. Kiyomi Senda (Nagoya City University) for their help with recombinant protein preparation. This work was supported, in part, by the Nanotechnology Platform Project, the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), and Grants-in-Aid for Scientific Research (24249002 and 25860053) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT).	KATO K, 1995, STRUCTURE, V3, P79, DOI 10.1016/S0969-2126(01)00136-8; Latypov RF, 2012, J BIOL CHEM, V287, P1381, DOI 10.1074/jbc.M111.297697; YAMAGUCHI Y, 1995, J IMMUNOL METHODS, V181, P259, DOI 10.1016/0022-1759(95)00010-8; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Matsumiya S, 2007, J MOL BIOL, V368, P767, DOI 10.1016/j.jmb.2007.02.034; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Yamaguchi Y, 2006, BBA-GEN SUBJECTS, V1760, P693, DOI 10.1016/j.bbagen.2005.10.002; Jiang XR, 2011, NAT REV DRUG DISCOV, V10, P101, DOI 10.1038/nrd3365; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Mizushima T, 2011, GENES CELLS, V16, P1071, DOI 10.1111/j.1365-2443.2011.01552.x; Kato K, 2010, PROG NUCL MAG RES SP, V56, P346, DOI 10.1016/j.pnmrs.2010.03.001; Liu D, 2007, BIOMOL NMR ASSIGM, V1, P233, DOI 10.1007/s12104-007-9065-5; Berkowitz SA, 2012, NAT REV DRUG DISCOV, V11, P527, DOI 10.1038/nrd3746; KATO K, 1991, BIOCHEMISTRY-US, V30, P6604, DOI 10.1021/bi00240a033; KATO K, 1993, FEBS LETT, V328, P49, DOI 10.1016/0014-5793(93)80963-U; KATO K, 1991, BIOCHEMISTRY-US, V30, P270, DOI 10.1021/bi00215a037; KIM H, 1994, J MOL BIOL, V236, P300, DOI 10.1006/jmbi.1994.1136; Kneller D, 1993, SPARKY 3; Miyakawa S, 2008, RNA, V14, P1154, DOI 10.1261/rna.1005808; Yamaguchi Y, 2007, COMPREHENSIVE GLYCOS, V3, P745; Yamaguchi Y, 2010, METHOD ENZYMOL, V478, P305, DOI 10.1016/S0076-6879(10)78015-0	22	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1874-2718	1874-270X		BIOMOL NMR ASSIGN	Biomol. NMR Assign.	OCT	2015	9	2					257	260		10.1007/s12104-014-9586-7		4	Biophysics; Spectroscopy	Biophysics; Spectroscopy	CR6FN	WOS:000361440100008		
J	de Sales, BB; Scheid, B; Goncalves, DL; Knychala, MM; Matsushika, A; Bon, EPS; Stambuk, BU				de Sales, Belisa B.; Scheid, Bruna; Goncalves, Davi L.; Knychala, Marilia M.; Matsushika, Akinori; Bon, Elba P. S.; Stambuk, Boris U.			Cloning novel sugar transporters from Scheffersomyces (Pichia) stipitis allowing d-xylose fermentation by recombinant Saccharomyces cerevisiae	BIOTECHNOLOGY LETTERS			English	Article						Bioethanol; Fermentation; Saccharomyces cerevisiae; Scheffersomyces stipitis; Sugar transporter; Xylose	ETHANOL-PRODUCTION; CO-FERMENTATION; HEXOSE TRANSPORTERS; ALCOHOLIC FERMENTATION; GLUCOSE TRANSPORTERS; MIXED SUGARS; YEAST; EXPRESSION; STRAINS; CONSUMPTION	An hxt-null S. cerevisiae strain, lacking the major hexose transporters (hxt1 Delta-hxt7 Delta and gal2 Delta) but having high xylose reductase, xylitol dehydrogenase and xylulokinase activities, was transformed with a genomic DNA library from S. stipitis. Four plasmids allowing growth on xylose contained three genes encoding sugar transporters: the previously characterized XUT1 permease, and two new genes (HXT2.6 and QUP2) not previously identified as xylose transporters. High cell density fermentations with the recombinant strains showed that the XUT1 gene allowed ethanol production from xylose or xylose plus glucose as carbon sources, while the HXT2.6 permease produced both ethanol and xylitol, and the strain expressing the QUP2 gene produced mainly xylitol during xylose consumption. Cloning novel sugar transporters not previously identified in the S. stipitis genome using an hxt-null S. cerevisiae strain with a high xylose-utilizing pathway provides novel promising target genes for improved lignocellulosic ethanol production by yeasts.	[de Sales, Belisa B.; Scheid, Bruna; Goncalves, Davi L.; Knychala, Marilia M.; Stambuk, Boris U.] Univ Fed Santa Catarina, Ctr Ciencias Biol, Dept Bioquim, BR-88040900 Florianopolis, SC, Brazil; [Matsushika, Akinori] Natl Inst Adv Ind Sci & Technol, Res Inst Sustainable Chem, Higashihiroshima, Hiroshima 7390046, Japan; [Bon, Elba P. S.] Univ Fed Rio de Janeiro, Inst Quim, Dept Bioquim, BR-21941909 Rio De Janeiro, RJ, Brazil	Stambuk, BU (reprint author), Univ Fed Santa Catarina, Ctr Ciencias Biol, Dept Bioquim, BR-88040900 Florianopolis, SC, Brazil.	boris.stambuk@ufsc.br			CNPq [490029/2009-4, 551392/2010-0, 307290/2012-3, 478841/2013-2]; FINEP [01.09.0566.00/1421-08]; FAPESC [17293/2009-6]; Japanese International Cooperation Agency (JICA)	This work was supported in part by grants and fellowships from the Brazilian agencies CNPq (Process Nos. 490029/2009-4, 551392/2010-0, 307290/2012-3, and 478841/2013-2), FINEP (Process No. 01.09.0566.00/1421-08) and FAPESC (Process No. 17293/2009-6), and by the Japanese International Cooperation Agency (JICA).	Lee WJ, 2002, APPL MICROBIOL BIOT, V60, P186, DOI 10.1007/s00253-002-1085-6; Nigam JN, 2001, J BIOTECHNOL, V87, P17, DOI 10.1016/S0168-1656(00)00385-0; Hamacher T, 2002, MICROBIOL-SGM, V148, P2783; KILIAN SG, 1988, APPL MICROBIOL BIOT, V27, P545; Katahira S, 2008, ENZYME MICROB TECH, V43, P115, DOI 10.1016/j.enzmictec.2008.03.001; Runquist D, 2009, APPL MICROBIOL BIOT, V82, P123, DOI 10.1007/s00253-008-1773-y; Wohlbach DJ, 2011, P NATL ACAD SCI USA, V108, P13212, DOI 10.1073/pnas.1103039108; Caspeta L, 2013, ENERG ENVIRON SCI, V6, P1077, DOI 10.1039/c3ee24403b; Laluce C, 2012, APPL BIOCHEM BIOTECH, V166, P1908, DOI 10.1007/s12010-012-9619-6; Cadete RM, 2013, ANTON LEEUW INT J G, V103, P421, DOI 10.1007/s10482-012-9822-z; KOTTER P, 1993, APPL MICROBIOL BIOT, V38, P776; Farias D, 2014, APPL BIOCHEM BIOTECH, V172, P361, DOI 10.1007/s12010-013-0546-y; Tanino T, 2012, J BIOSCI BIOENG, V114, P209, DOI 10.1016/j.jbiosc.2012.03.004; Bertilsson M, 2008, BIOPROC BIOSYST ENG, V31, P369, DOI 10.1007/s00449-007-0169-1; Matsushika A, 2009, APPL MICROBIOL BIOT, V84, P37, DOI 10.1007/s00253-009-2101-x; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Kim SR, 2012, TRENDS BIOTECHNOL, V30, P274, DOI 10.1016/j.tibtech.2012.01.005; Jin YS, 2005, APPL ENVIRON MICROB, V71, P8249, DOI 10.1128/AEM.71.12.8249-8256.2005; Goncalves DL, 2014, ENZYME MICROB TECH, V63, P13, DOI 10.1016/j.enzmictec.2014.05.003; Hector RE, 2008, APPL MICROBIOL BIOT, V80, P675, DOI 10.1007/s00253-008-1583-2; Young E, 2011, APPL ENVIRON MICROB, V77, P3311, DOI 10.1128/AEM.02651-10; Parachin NS, 2011, METAB ENG, V13, P508, DOI 10.1016/j.ymben.2011.05.005; Young EM, 2014, P NATL ACAD SCI USA, V111, P131, DOI 10.1073/pnas.1311970111; Nielsen J, 2013, CURR OPIN BIOTECH, V24, P398, DOI 10.1016/j.copbio.2013.03.023; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Young E, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-24; Saloheimo A, 2007, APPL MICROBIOL BIOT, V74, P1041, DOI 10.1007/s00253-006-0747-1; Sedlak M, 2004, YEAST, V21, P671, DOI 10.1002/yea.1060; TOIVOLA A, 1984, APPL ENVIRON MICROB, V47, P1221; Weierstall T, 1999, MOL MICROBIOL, V31, P871, DOI 10.1046/j.1365-2958.1999.01224.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ausubel F.M., 1995, SHORT PROTOCOLS MOL; Cadete RM, 2009, FEMS YEAST RES, V9, P1338, DOI 10.1111/j.1567-1364.2009.00582.x; Diao L, 2013, BMC BIOTECHNOL, V13, P1; DOES AL, 1989, APPL ENVIRON MICROB, V55, P159; Du J, 2010, MOL BIOSYST, V6, P2150; Gardonyi M, 2003, BIOTECHNOL BIOENG, V82, P818, DOI 10.1002/bit.10631; Ha SJ, 2013, APPL ENVIRON MICROB, V79, P1500, DOI 10.1128/AEM.03253-12; Jeffries TW, 2009, FEMS YEAST RES, V9, P793, DOI 10.1111/j.1567-1364.2009.00525.x; KANG YS, 1990, MOL CELL BIOL, V10, P2582; Lin S, 2006, APPL MICROBIOL BIOT, V69, P627; Lobo FP, 2014, GENOME ANNOUNC; Madhavan A, 2009, APPL MICROBIOL BIOT, V82, P1037, DOI 10.1007/s00253-008-1818-2; Moon J, 2013, BIOCATAL AGRIC BIOTE, V2, P247; Nogueira LAH, 2013, ENERG POLICY, V61, P595, DOI 10.1016/j.enpol.2013.05.112; Parambil LK, 2014, BIOTECHNOL LETT, V36, P2443, DOI 10.1007/s10529-014-1629-8; Runquist D, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-5; Nogue VS, 2015, BIOTECHNOL LETT, V37, P761, DOI 10.1007/s10529-014-1756-2; Sarkar N, 2011, RENEW ENERG, V37, P19; Sievers F., 2011, MOL SYST BIOL, V7, P1, DOI DOI 10.1038/MSB.2011.75; Stambuk BU, 2008, J SCI IND RES INDIA, V67, P918; Watanabe T, 2011, BIORESOURCE TECHNOL, V102, P1844, DOI 10.1016/j.biortech.2010.09.087; Young ME, 2012, METAB ENG, V14, P401	53	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0141-5492	1573-6776		BIOTECHNOL LETT	Biotechnol. Lett.	OCT	2015	37	10					1973	1982		10.1007/s10529-015-1893-2		10	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CR1FB	WOS:000361068500008		
J	Takaichi, S; Maoka, T				Takaichi, Shinichi; Maoka, Takashi			Identification and spectroscopic characterization of neurosporene	BIOTECHNOLOGY LETTERS			English	Article						Carotene; Carotenoid; LC-MS; Neurosporene; NMR	CAROTENOIDS; BIOSYNTHESIS	Neurosporene is a carotene and an intermediate in the synthesis of lycopene from phytoene. Its content in carotenogenic organisms is very low; hence, the complete assignments of its spectroscopic data, including NMR, are insufficient. A purple bacterium of Rhodobacter sphaeroides G1C mutant had only one carotenoid. This carotenoid was extracted and purified using silica gel, DEAE-Toyopearl and C-18-HPLC columns. It was identified using its absorption spectra, mass spectra, and H-1- and C-13-NMR spectra, including two-dimensional spectral analyses. The major carotenoid in the Rhodobacter sphaeroides G1C mutant was identified as neurosporene (7,8-dihydro-psi,psi-carotene) using spectroscopic measurements, including complete assignments of its H-1- and C-13-NMR spectral data.	[Takaichi, Shinichi] Nippon Med Sch, Dept Biol, Musashino, Tokyo 1800023, Japan; [Maoka, Takashi] Res Inst Prod Dev, Sakyo Ku, Kyoto 6060805, Japan	Maoka, T (reprint author), Res Inst Prod Dev, Sakyo Ku, Kyoto 6060805, Japan.	takaichi@nms.ac.jp; maoka@mbox.kyoto-inet.or.jp					TAKAICHI S, 1992, METHOD ENZYMOL, V213, P374; Ramaprasad EVV, 2013, BIOTECHNOL LETT, V35, P1093, DOI 10.1007/s10529-013-1181-y; Takaichi Shinichi, 2009, V28, P97; Britton G., 2004, CAROTENOIDS HDB; Englert G, 1995, CAROTENOIDS, V1, P147; Harada Jiro, 2001, Plant and Cell Physiology, V42, P1112, DOI 10.1093/pcp/pce140; SASA T, 1992, PLANT CELL PHYSIOL, V33, P527; SCOLNIK PA, 1980, J BIOL CHEM, V255, P2427; Takaichi S, 2000, PHOTOSYNTH RES, V65, P93, DOI 10.1023/A:1006445503030; Takaichi S, 2014, BIOTECHNOL LETT, V36, P1127, DOI 10.1007/s10529-014-1479-4	10	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0141-5492	1573-6776		BIOTECHNOL LETT	Biotechnol. Lett.	OCT	2015	37	10					2027	2031		10.1007/s10529-015-1884-3		5	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CR1FB	WOS:000361068500015		
J	Matsushita, K; Kent, MT; Vickers, AJ; von Bodman, C; Bernstein, M; Touijer, KA; Coleman, JA; Laudone, VT; Scardino, PT; Eastham, JA; Akin, O; Sandhu, JS				Matsushita, Kazuhito; Kent, Matthew T.; Vickers, Andrew J.; von Bodman, Christian; Bernstein, Melanie; Touijer, Karim A.; Coleman, Jonathan A.; Laudone, Vincent T.; Scardino, Peter T.; Eastham, James A.; Akin, Oguz; Sandhu, Jaspreet S.			Preoperative predictive model of recovery of urinary continence after radical prostatectomy	BJU INTERNATIONAL			English	Article						prostatic neoplasms; urinary incontinence; nomogram; magnetic resonance imaging	QUALITY-OF-LIFE; POSTPROSTATECTOMY INCONTINENCE; RETROPUBIC PROSTATECTOMY; URETHRAL LENGTH; CANCER CONTROL; PRESERVATION; OUTCOMES; IMPACT; TRIAL; MEN	Objective To build a predictive model of urinary continence recovery after radical prostatectomy (RP) that incorporates magnetic resonance imaging (MRI) parameters and clinical data. Patients and Methods We conducted a retrospective review of data from 2 849 patients who underwent pelvic staging MRI before RP from November 2001 to June 2010. We used logistic regression to evaluate the association between each MRI variable and continence at 6 or 12 months, adjusting for age, body mass index (BMI) and American Society of Anesthesiologists (ASA) score, and then used multivariable logistic regression to create our model. A nomogram was constructed using the multivariable logistic regression models. Results In all, 68% (1 742/2 559) and 82% (2 205/2 689) regained function at 6 and 12 months, respectively. In the base model, age, BMI and ASA score were significant predictors of continence at 6 or 12 months on univariate analysis (P < 0.005). Among the preoperative MRI measurements, membranous urethral length, which showed great significance, was incorporated into the base model to create the full model. For continence recovery at 6 months, the addition of membranous urethral length increased the area under the curve (AUC) to 0.664 for the validation set, an increase of 0.064 over the base model. For continence recovery at 12 months, the AUC was 0.674, an increase of 0.085 over the base model. Conclusion Using our model, the likelihood of continence recovery increases with membranous urethral length and decreases with age, BMI and ASA score. This model could be used for patient counselling and for the identification of patients at high risk for urinary incontinence in whom to study changes in operative technique that improve urinary function after RP.	[Matsushita, Kazuhito; von Bodman, Christian; Bernstein, Melanie; Touijer, Karim A.; Coleman, Jonathan A.; Laudone, Vincent T.; Scardino, Peter T.; Eastham, James A.; Sandhu, Jaspreet S.] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10065 USA; [Matsushita, Kazuhito] Juntendo Univ, Grad Sch Med, Dept Urol, Tokyo, Japan; [Matsushita, Kazuhito] St Lukes Int Hosp, Dept Urol, Tokyo, Japan; [Kent, Matthew T.; Vickers, Andrew J.] Mem Sloan Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY USA; [Akin, Oguz] Mem Sloan Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY USA	Sandhu, JS (reprint author), Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, 1275 York Ave, New York, NY 10065 USA.	sandhuj@mskcc.org					Burkhard FC, 2006, J UROLOGY, V176, P189, DOI 10.1016/S0022-5347(06)00574-X; Menon M, 2008, J UROLOGY, V180, P1018, DOI 10.1016/j.juro.2008.05.046; Stephenson AJ, 2006, J NATL CANCER I, V98, P715, DOI 10.1093/jnci/djj190; Nitti VW, 2014, J UROLOGY, V192, P836, DOI 10.1016/j.juro.2014.03.031; Boorjian SA, 2012, EUR UROL, V61, P664, DOI 10.1016/j.eururo.2011.11.053; Schlomm T, 2011, EUR UROL, V60, P320, DOI 10.1016/j.eururo.2011.02.040; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Shariat SF, 2008, CANCER-AM CANCER SOC, V113, P3075, DOI 10.1002/cncr.23908; Paparel P, 2009, EUR UROL, V55, P629, DOI 10.1016/j.eururo.2008.08.057; Karakiewicz PI, 2004, EUR UROL, V46, P188, DOI 10.1016/j.eururo.2004.04.020; Vickers A, 2011, EUR UROL, V59, P317, DOI 10.1016/j.eururo.2010.10.045; Koppie TM, 2007, EUR UROL, V52, P22, DOI 10.1016/j.eururo.2006.12.022; Eastham JA, 1996, J UROLOGY, V156, P1707, DOI 10.1016/S0022-5347(01)65488-0; BRASLIS KG, 1995, EUR UROL, V28, P202; Bauer RM, 2011, EUR UROL, V59, P985, DOI 10.1016/j.eururo.2011.03.020; Johansson E, 2011, LANCET ONCOL, V12, P891, DOI 10.1016/S1470-2045(11)70162-0; Coakley FV, 2002, J UROLOGY, V168, P1032, DOI 10.1097/01.ju.0000025881.75827.a5; Jones JS, 2005, UROLOGY, V65, P1163, DOI 10.1016/j.urology.2004.12.051; Jorion JL, 1997, J UROLOGY, V157, P926, DOI 10.1016/S0022-5347(01)65085-7; Eastham JA, 2007, NAT CLIN PRACT UROL, V4, P138, DOI 10.1038/ncpuro0733; Koppie TM, 2007, EUR UROL, V52, P4; Sandhu Jaspreet S, 2010, Curr Urol Rep, V11, P191, DOI 10.1007/s11934-010-0108-6; von Bodman C, 2012, J UROLOGY, V187, P945, DOI 10.1016/j.juro.2011.10.143	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1464-4096	1464-410X		BJU INT	BJU Int.	OCT	2015	116	4					577	583		10.1111/bju.13087		7	Urology & Nephrology	Urology & Nephrology	CR3GA	WOS:000361217900017		
J	Yamaguchi, O; Kakizaki, H; Homma, Y; Igawa, Y; Takeda, M; Nishizawa, O; Gotoh, M; Yoshida, M; Yokoyama, O; Seki, N; Okitsu, A; Hamada, T; Kobayashi, A; Kuroishi, K				Yamaguchi, Osamu; Kakizaki, Hidehiro; Homma, Yukio; Igawa, Yasuhiko; Takeda, Masayuki; Nishizawa, Osamu; Gotoh, Momokazu; Yoshida, Masaki; Yokoyama, Osamu; Seki, Narihito; Okitsu, Akira; Hamada, Takuya; Kobayashi, Akiko; Kuroishi, Kentarou			Safety and efficacy of mirabegron as 'add-on' therapy in patients with overactive bladder treated with solifenacin: a post-marketing, open-label study in Japan (MILAI study)	BJU INTERNATIONAL			English	Article						mirabegron; solifenacin; beta(3)-adrenoceptor agonist; overactive bladder; add-on; combination therapy	URINARY-TRACT SYMPTOMS; QUALITY-OF-LIFE; BETA(3)-ADRENOCEPTOR AGONIST; DETRUSOR MUSCLE; FUNCTIONAL-ROLE; EXPRESSION; IMPACT; SCORE	Objective To examine the safety and efficacy of mirabegron as 'add-on' therapy to solifenacin in patients with overactive bladder (OAB). Patients and Methods This multicentre, open-label, phase IV study enrolled patients aged >= 20 years with OAB, as determined by an OAB symptom score (OABSS) total of >= 3 points and an OABSS Question 3 score of >= 2 points, who were being treated with solifenacin at a stable dose of 2.5 or 5 mg once daily for at least 4 weeks. Study duration was 18 weeks, comprising a 2-week screening period and a 16-week treatment period. Patients meeting eligibility criteria continued to receive solifenacin (2.5 or 5 mg once daily) and additional mirabegron (25 mg once daily) for 16 weeks. After 8 weeks of treatment, the mirabegron dose could be increased to 50 mg if the patient's symptom improvement was not sufficient, if he/she was agreeable to the dose increase, and the investigator judged that there were no safety concerns. Safety assessments included adverse events (AEs), laboratory tests, vital signs, 12-lead electrocardiogram, QT corrected for heart rate using Fridericia's correction (QTcF) interval and post-void residual (PVR) volume. Efficacy endpoints were changes from baseline in OABSS total score, OAB questionnaire short form (OAB-q SF) score (symptom bother and total health-related quality of life [HRQL] score), mean number of micturitions/24 h, mean number of urgency episodes/24 h, mean number of urinary incontinence (UI) episodes/24 h, mean number of urgency UI episodes/24 h, mean volume voided/micturition, and mean number of nocturia episodes/night. Patients were instructed to complete the OABSS sheets at weeks -2, 0, 8 and 16 (or at discontinuation), OAB-q SF sheets at weeks 0, 8 and 16 (or at discontinuation) and patient voiding diaries at weeks 0, 4, 8, 12 and 16 (or at discontinuation). Results Overall incidence of drug-related treatment-emergent AEs (TEAEs) was 23.3%. Almost all TEAEs were mild or moderate. The most common TEAE was constipation, with similar incidence in the groups receiving a dose increase to that observed in the groups maintained on the original dose. Changes in PVR volume, QTcF interval, pulse rate and blood pressure were not considered to be clinically significant and there were no reports of urinary retention. Significant improvement was seen for changes in efficacy endpoints from baseline to end of treatment (EOT) in all groups (patients receiving solifenacin 2.5 or 5 mg + mirabegron 25 or 50 mg). Conclusions Add-on therapy with mirabegron 25 mg once daily for 16 weeks, with an optional dose increase to 50 mg at week 8, was well tolerated in patients with OAB treated with solifenacin 2.5 mg or 5 mg once daily. There were significant improvements from baseline to EOT in OAB symptoms with combination therapy with mirabegron and solifenacin. Add-on therapy with mirabegron and an antimuscarinic agent, such as solifenacin, may provide an attractive therapeutic option.	[Yamaguchi, Osamu] Nihon Univ, Sch Engn, Div Bioengn & LUTD Res, Koriyama, Fukushima 9638642, Japan; [Kakizaki, Hidehiro] Asahikawa Med Univ, Dept Urol, Asahikawa, Hokkaido, Japan; [Homma, Yukio] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo, Japan; [Igawa, Yasuhiko] Univ Tokyo, Grad Sch Med, Dept Continence Med, Tokyo, Japan; [Takeda, Masayuki] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Urol, Chuo Ku, Yamanashi, Japan; [Nishizawa, Osamu] Shinshu Univ, Dept Urol, Matsumoto, Nagano 390, Japan; [Gotoh, Momokazu] Nagoya Univ, Grad Sch Med, Dept Urol, Nagoya, Aichi 4648601, Japan; [Yoshida, Masaki] Natl Ctr Geriatr & Gerontol, Dept Urol, Obu, Japan; [Yokoyama, Osamu] Univ Fukui, Fac Med Sci, Dept Urol, Fukui 910, Japan; [Seki, Narihito] Mutual Aid Assoc Publ Sch Teachers, Kyushu Cent Hosp, Dept Urol, Fukuoka, Japan; [Okitsu, Akira; Hamada, Takuya; Kobayashi, Akiko; Kuroishi, Kentarou] Astellas Pharma Inc, Tokyo, Japan	Yamaguchi, O (reprint author), Nihon Univ, Sch Engn, Div Bioengn & LUTD Res, Koriyama, Fukushima 9638642, Japan.	yamaosa@ee.ce.nihon-u.ac.jp					Abrams P, 2015, EUR UROL, V67, P577, DOI 10.1016/j.eururo.2014.02.012; Otsuka A, 2008, N-S ARCH PHARMACOL, V377, P473, DOI 10.1007/s00210-008-0274-y; Gotoh M, 2014, INT J UROL, V21, P505, DOI 10.1111/iju.12355; Benner JS, 2010, BJU INT, V105, P1276, DOI 10.1111/j.1464-410X.2009.09036.x; Khullar V, 2013, EUR UROL, V63, P283, DOI 10.1016/j.eururo.2012.10.016; Yamaguchi O, 2007, NEUROUROL URODYNAM, V26, P752, DOI 10.1002/nau.20420; Yamaguchi O, 2014, BJU INT, V113, P951, DOI 10.1111/bju.12649; Herschorn S, 2013, UROLOGY, V82, P313, DOI 10.1016/j.urology.2013.02.077; Coyne KS, 2008, BJU INT, V101, P1388, DOI 10.1111/j.1464-410X.2008.07601.x; Homma Y, 2006, UROLOGY, V68, P318, DOI 10.1016/j.urology.2006.02.042; Igawa Y, 1999, BRIT J PHARMACOL, V126, P819, DOI 10.1038/sj.bjp.0702358; Homma Y, 2005, BJU INT, V96, P1314, DOI 10.1111/j.1464-410X.2005.05835.x; Coyne KS, 2006, J UROLOGY, V176, P627, DOI 10.1016/j.juro.2006.03.088; Nitti VW, 2013, J UROLOGY, V189, P1388, DOI 10.1016/j.juro.2012.10.017; Fujimura T, 1999, J UROLOGY, V161, P680, DOI 10.1016/S0022-5347(01)61994-3; Chapple CR, 2008, EUR UROL, V54, P543, DOI 10.1016/j.eururo.2008.06.047; Nitti VW, 2013, J UROLOGY, V190, P1320, DOI 10.1016/j.juro.2013.05.062; Milsom I, 2001, BJU INT, V87, P760, DOI 10.1046/j.1464-410x.2001.02228.x; Takeda M, 1999, J PHARMACOL EXP THER, V288, P1367; Gotoh M, 2011, UROLOGY, V78, P768, DOI 10.1016/j.urology.2011.06.020; Brubaker L, 2006, UROLOGY, V68, P3, DOI 10.1016/j.urology.2006.05.045; Krauwinkel WJJ, 2013, CLIN PHARM DRUG DEV, V2, P255, DOI 10.1002/cpdd.37; Kullmann FA, 2011, NEUROUROL URODYNAM, V30, P144, DOI 10.1002/nau.20965; Rai BP, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD003193.PUB4; Stewart W. F., 2003, World Journal of Urology, V20, P327; Yamaguchi O, 2015, LUTS, V7, P84, DOI 10.1111/luts.12053	26	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1464-4096	1464-410X		BJU INT	BJU Int.	OCT	2015	116	4					612	622		10.1111/bju.13068		11	Urology & Nephrology	Urology & Nephrology	CR3GA	WOS:000361217900022		
J	Toyoda, H; Miyagawa, T; Koike, A; Kanbayashi, T; Imanishi, A; Sagawa, Y; Kotorii, N; Kotorii, T; Hashizume, Y; Ogi, K; Hiejima, H; Kamei, Y; Hida, A; Miyamoto, M; Imai, M; Fujimura, Y; Tamura, Y; Ikegami, A; Wada, Y; Moriya, S; Furuya, H; Takeuchi, M; Kirino, Y; Meguro, A; Remmers, EF; Kawamura, Y; Otowa, T; Miyashita, A; Kashiwase, K; Khor, SS; Yamasaki, M; Kuwano, R; Sasaki, T; Ishigooka, J; Kuroda, K; Kume, K; Chiba, S; Yamada, N; Okawa, M; Hirata, K; Mizuki, N; Uchimura, N; Shimizu, T; Inoue, Y; Honda, Y; Mishima, K; Honda, M; Tokunaga, K				Toyoda, Hiromi; Miyagawa, Taku; Koike, Asako; Kanbayashi, Takashi; Imanishi, Aya; Sagawa, Yohei; Kotorii, Nozomu; Kotorii, Tatayu; Hashizume, Yuji; Ogi, Kimihiro; Hiejima, Hiroshi; Kamei, Yuichi; Hida, Akiko; Miyamoto, Masayuki; Imai, Makoto; Fujimura, Yota; Tamura, Yoshiyuki; Ikegami, Azusa; Wada, Yamato; Moriya, Shunpei; Furuya, Hirokazu; Takeuchi, Masaki; Kirino, Yohei; Meguro, Akira; Remmers, Elaine F.; Kawamura, Yoshiya; Otowa, Takeshi; Miyashita, Akinori; Kashiwase, Koichi; Khor, Seik-Soon; Yamasaki, Maria; Kuwano, Ryozo; Sasaki, Tsukasa; Ishigooka, Jun; Kuroda, Kenji; Kume, Kazuhiko; Chiba, Shigeru; Yamada, Naoto; Okawa, Masako; Hirata, Koichi; Mizuki, Nobuhisa; Uchimura, Naohisa; Shimizu, Tetsuo; Inoue, Yuichi; Honda, Yutaka; Mishima, Kazuo; Honda, Makoto; Tokunaga, Katsushi			A polymorphism in CCR1/CCR3 is associated with narcolepsy	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Narcolepsy; Chemokine receptor; Neuroinflammation; Genome-wide association study; Complex traits; Microglia	GENOME-WIDE ASSOCIATION; CC-CHEMOKINE RECEPTORS; CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; SLEEP REGULATION; ETHNIC-GROUPS; NEURONS; EXPRESSION; CATAPLEXY; BRAIN	Etiology of narcolepsy-cataplexy involves multiple genetic and environmental factors. While the human leukocyte antigen (HLA)-DRB1*15:01-DQB1*06:02 haplotype is strongly associated with narcolepsy, it is not sufficient for disease development. To identify additional, non-HLA susceptibility genes, we conducted a genome-wide association study (GWAS) using Japanese samples. An initial sample set comprising 409 cases and 1562 controls was used for the GWAS of 525,196 single nucleotide polymorphisms (SNPs) located outside the HLA region. An independent sample set comprising 240 cases and 869 controls was then genotyped at 37 SNPs identified in the GWAS. We found that narcolepsy was associated with a SNP in the promoter region of chemokine (C-C motif) receptor 1 (CCR1) (rs3181077, P = 1.6 x 10(-5), odds ratio [OR] = 1.86). This rs3181077 association was replicated with the independent sample set (P = 0.032, OR = 1.36). We measured mRNA levels of candidate genes in peripheral blood samples of 38 cases and 37 controls. CCR1 and CCR3 mRNA levels were significantly lower in patients than in healthy controls, and CCR1 mRNA levels were associated with rs3181077 genotypes. In vitro chemotaxis assays were also performed to measure monocyte migration. We observed that monocytes from carriers of the rs3181077 risk allele had lower migration indices with a CCR1 ligand. CCR1 and CCR3 are newly discovered susceptibility genes for narcolepsy. These results highlight the potential role of CCR genes in narcolepsy and support the hypothesis that patients with narcolepsy have impaired immune function. (C) 2015 Elsevier Inc. All rights reserved.	[Toyoda, Hiromi; Miyagawa, Taku; Khor, Seik-Soon; Yamasaki, Maria; Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo 1130033, Japan; [Koike, Asako] Hitachi Ltd, Res & Dev Grp, Tokyo, Japan; [Kanbayashi, Takashi; Imanishi, Aya; Sagawa, Yohei; Shimizu, Tetsuo] Akita Univ, Sch Med, Dept Neuropsychiat, Akita 010, Japan; [Kotorii, Nozomu; Hashizume, Yuji; Ogi, Kimihiro; Hiejima, Hiroshi; Uchimura, Naohisa] Kurume Univ, Sch Med, Dept Neuropsychiat, Fukuoka, Japan; [Kotorii, Nozomu; Kotorii, Tatayu] Kotorii Isahaya Hosp, Nagasaki, Japan; [Kamei, Yuichi] Natl Ctr Hosp, Natl Ctr Neurol & Psychiat, Sleep Disorder Ctr, Tokyo, Japan; [Hida, Akiko; Mishima, Kazuo] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Psychophysiol, Tokyo, Japan; [Miyamoto, Masayuki; Hirata, Koichi] Dokkyo Med Univ, Dept Neurol, Mibu, Tochigi, Japan; [Imai, Makoto; Yamada, Naoto] Shiga Univ Med Sci, Dept Psychiat, Otsu, Shiga, Japan; [Fujimura, Yota; Tamura, Yoshiyuki; Chiba, Shigeru] Asahikawa Med Univ, Dept Psychiat & Neurol, Asahikawa, Hokkaido, Japan; [Ikegami, Azusa; Kume, Kazuhiko] Kuwamizu Hosp, Sleep Ctr, Kumamoto, Japan; [Wada, Yamato; Kuroda, Kenji] Hannan Hosp, Dept Psychiat, Osaka, Japan; [Moriya, Shunpei; Ishigooka, Jun] Tokyo Womens Med Univ, Sch Med, Dept Psychiat, Tokyo, Japan; [Furuya, Hirokazu] Natl Omuta Hosp, Neuromuscular Ctr, Dept Neurol, Fukuoka, Japan; [Takeuchi, Masaki; Meguro, Akira; Mizuki, Nobuhisa] Yokohama City Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Yokohama, Kanagawa, Japan; [Takeuchi, Masaki; Kirino, Yohei; Remmers, Elaine F.] NHGRI, Inflammatory Dis Sect, NIH, Bethesda, MD 20892 USA; [Kirino, Yohei] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Yokohama, Kanagawa, Japan; [Kawamura, Yoshiya] Sakae Seijinkai Hosp, Dept Psychiat, Kagawa, Kanagawa, Japan; [Otowa, Takeshi] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Miyashita, Akinori; Kuwano, Ryozo] Niigata Univ, Brain Res Inst, Ctr Bioresources, Dept Mol Genet, Niigata, Japan; [Kashiwase, Koichi] Japanese Red Cross Kanto Koshinetsu Block Blood C, Dept HLA Lab, Tokyo, Japan; [Sasaki, Tsukasa] Univ Tokyo, Grad Sch Educ, Lab Hlth Educ, Tokyo, Japan; [Kume, Kazuhiko] Kumamoto Univ, Inst Mol Genet & Embryol, Dept Stem Cell Biol, Kumamoto, Japan; [Kume, Kazuhiko] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Neuropharmacol, Nagoya, Aichi, Japan; [Okawa, Masako] Shiga Univ Med Sci, Dept Sleep Med, Otsu, Shiga, Japan; [Okawa, Masako] Japan Fdn Neurosci & Mental Hlth, Tokyo, Japan; [Inoue, Yuichi; Honda, Yutaka; Honda, Makoto] Neuropsychiat Res Inst, Japan Somnol Ctr, Tokyo, Japan; [Okawa, Masako; Inoue, Yuichi] Tokyo Med Univ, Dept Somnol, Tokyo 1608402, Japan; [Honda, Makoto] Tokyo Metropolitan Inst Med Sci, Dept Psychiat & Behav Sci, Sleep Disorders Project, Tokyo 113, Japan	Miyagawa, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Human Genet, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	miyagawa-taku@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24890047, 26870117, 23689022, 15H04709, 22133008]; Takeda Science Foundation, Japan; SENSHIN Medical Research Foundation; Alfresa Pharma Corporation; Intramural Research Grant for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry [23-3]	We thank all of the participants in this study. This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan with Grants to H.T. (Grant-in-Aid for Research Activity Start-up, 24890047, and Grant-in-Aid for Young Scientists (B), 26870117), to T.M. (Grants-in-Aid for Young Scientists (A), 23689022, and Grant-in-Aid for Scientific Research (B), 15H04709) and to K.T. (Scientific Research on Innovative Areas, 22133008). T. M. receives research support from Grants-in-Aid from the Takeda Science Foundation, Japan and the SENSHIN Medical Research Foundation. Y.I. receives a commercial research Grant from Alfresa Pharma Corporation. This study was partly supported by an Intramural Research Grant for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry (23-3).	White GE, 2013, PHARMACOL REV, V65, P47, DOI 10.1124/pr.111.005074; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; JUJI T, 1984, TISSUE ANTIGENS, V24, P316, DOI 10.1111/j.1399-0039.1984.tb02144.x; Nishida N, 2007, ANAL BIOCHEM, V364, P78, DOI 10.1016/j.ab.2007.02.005; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Miyagawa T, 2008, NAT GENET, V40, P1324, DOI 10.1038/ng.231; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Cho JH, 2011, NEW ENGL J MED, V365, P1612, DOI 10.1056/NEJMra1100030; Kornum BR, 2011, CURR OPIN NEUROBIOL, V21, P897, DOI 10.1016/j.conb.2011.09.003; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Kornum BR, 2011, NAT GENET, V43, P66, DOI 10.1038/ng.734; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Tabuchi S, 2014, J NEUROSCI, V34, P6495, DOI 10.1523/JNEUROSCI.0073-14.2014; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Cartier L, 2005, BRAIN RES REV, V48, P16, DOI 10.1016/j.brainresrev.2004.07.021; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Dauvilliers Y, 2014, BRAIN BEHAV IMMUN, V37, P260, DOI 10.1016/j.bbi.2013.12.019; Macintyre G, 2010, BIOINFORMATICS, V26, pi524, DOI 10.1093/bioinformatics/btq378; Yang I, 2010, J CLIN NEUROSCI, V17, P6, DOI 10.1016/j.jocn.2009.05.006; Koizumi S, 2013, GLIA, V61, P47, DOI 10.1002/glia.22358; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Yao HH, 2009, J NEUROSCI, V29, P1657, DOI 10.1523/JNEUROSCI.2781-08.2009; Mignot E, 1998, NEUROLOGY, V50, pS16; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Wijnans L, 2013, VACCINE, V31, P1246, DOI 10.1016/j.vaccine.2012.12.015; Lim ASP, 2010, SLEEP, V33, P857; Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x; Dalal J, 2013, GENE DEV, V27, P565, DOI 10.1101/gad.207654.112; Eltayeb S, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-14; Faraco J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003270; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Han F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003880; Hogan D, 2001, J NEUROIMMUNOL, V119, P317, DOI 10.1016/S0165-5728(01)00399-X; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Khan MZ, 2008, CELL DEATH DIFFER, V15, P1663, DOI 10.1038/cdd.2008.95; Khatami R, 2004, LANCET, V363, P1199, DOI 10.1016/S0140-6736(04)15951-5; Kheirandish-Gozal L, 2014, CLIN SCI, V127, P323, DOI 10.1042/CS20130679; Maurovich-Horvat E., 2014, J SLEEP RES; Meucci O, 2000, P NATL ACAD SCI USA, V97, P8075, DOI 10.1073/pnas.090017497; Miller AL, 2006, J IMMUNOL, V176, P2562; Miller E, 2013, BMJ-BRIT MED J, V346, P1794; Ness TL, 2004, J IMMUNOL, V173, P6938; Okun ML, 2004, BRAIN BEHAV IMMUN, V18, P326, DOI 10.1016/j.bbi.2003.11.002; Reaux-Le Goazigo A, 2013, PROG NEUROBIOL, V104, P67; Tanaka S., 2014, HUM IMMUNOL; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Wainwright DA, 2009, ASN NEURO, V1, DOI 10.1042/AN20090017	55	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	OCT	2015	49						148	155		10.1016/j.bbi.2015.05.003		8	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	CR3UF	WOS:000361257900018		
J	Morioka, N; Zhang, FF; Nakamura, Y; Kitamura, T; Hisaoka-Nakashima, K; Nakata, Y				Morioka, Norimitsu; Zhang, Fang Fang; Nakamura, Yoki; Kitamura, Tomoya; Hisaoka-Nakashima, Kazue; Nakata, Yoshihiro			Tumor necrosis factor-mediated downregulation of spinal astrocytic connexin43 leads to increased glutamatergic neurotransmission and neuropathic pain in mice	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Allodynia; Astrocytes; Connexin; Glutamate; GLT-1; Neuropathic pain; Partial sciatic nerve ligation; Spinal cord; Tumor necrosis factor	GAP-JUNCTION PROTEIN; PERIPHERAL-NERVE INJURY; ASTROGLIAL NETWORKS; TNF-ALPHA; MECHANICAL HYPERSENSITIVITY; THERMAL HYPERALGESIA; PRIMARY CULTURES; DELIVERY-SYSTEM; CORD ASTROCYTES; GLUCOSE-UPTAKE	Spinal cord astrocytes are critical in the maintenance of neuropathic pain. Connexin 43 (Cx43) expressed on spinal dorsal horn astrocytes modulates synaptic neurotransmission, but its role in nociceptive transduction has yet to be fully elaborated. In mice, Cx43 is mainly expressed in astrocytes, not neurons or microglia, in the spinal dorsal horn. Hind paw mechanical hypersensitivity was observed beginning 3 days after partial sciatic nerve ligation (PSNL), but a persistent downregulation of astrocytic Cx43 in ipsilateral lumbar spinal dorsal horn was not observed until 7 days post-PSNL, suggesting that Cx43 downregulation mediates the maintenance and not the initiation of nerve injury-induced hypersensitivity. Downregulation of Cx43 expression by intrathecal treatment with Cx43 siRNA also induced mechanical hypersensitivity. Conversely, restoring Cx43 by an adenovirus vector expressing Cx43 (Ad-Cx43) ameliorated PSNL-induced mechanical hypersensitivity. The sensitized state following PSNL is likely maintained by dysfunctional glutamatergic neurotransmission, as Cx43 siRNA-induced mechanical hypersensitivity was attenuated with intrathecal treatment of glutamate receptor antagonists MK801 and CNQX, but not neurokinin-1 receptor antagonist CP96345 or the Ca2+ channel subunit alpha(2)delta(1) blocker gabapentin. The source of this dysfunctional glutamatergic neurotransmission is likely decreased clearance of glutamate from the synapse rather than increased glutamate release into the synapse. Astrocytic expression of glutamate transporter GLT-1, but not GLAST, and activity of glutamate transport were markedly decreased in mice intrathecally injected with Cx43-targeting siRNA but not non-targeting siRNA. Glutamate release from spinal synaptosomes prepared from mice treated with either Cx43-targeting siRNA or non-targeting siRNA was unchanged. Intrathecal injection of Ad-Cx43 in PSNL mice restored astrocytic GLT-1 expression. The cytokine tumor necrosis factor (TNF) has been implicated in the induction of central sensitization, particularly through its actions on astrocytes, in the spinal cord following peripheral injury. Intrathecal injection of TNF in nave mice induced the downregulation of both Cx43 and GLT-1 in spinal dorsal horn, as well as hind paw mechanical hypersensitivity, as observed in PSNL mice. Conversely, intrathecal treatment of PSNL mice with the TNF inhibitor etanercept prevented not only mechanical hypersensitivity but also the downregulation of Cx43 and GLT-1 expression in astrocytes. The current findings indicate that spinal astrocytic Cx43 are essential for the maintenance of neuropathic pain following peripheral nerve injury and suggest modulation of Cx43 as a novel target for developing analgesics for neuropathic pain. (C) 2015 Elsevier Inc. All rights reserved.	[Morioka, Norimitsu; Zhang, Fang Fang; Nakamura, Yoki; Kitamura, Tomoya; Hisaoka-Nakashima, Kazue; Nakata, Yoshihiro] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pharmacol, Minami Ku, Hiroshima 7348553, Japan	Morioka, N (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pharmacol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	mnori@hiroshima-u.ac.jp			 [26460342]	This work was supported by Grant-in-Aid for Scientific Research (C) Grant number 26460342. Experiments were carried out using equipment at the Analysis Center of Life Science, Hiroshima University and the Research Center for Molecular Medicine, Faculty of Medicine, Hiroshima University. We also thank Dr. Aldric T. Hama for his critical reading of the manuscript.	Theis M, 2003, J NEUROSCI, V23, P766; Akiyama T, 2014, PAIN, V155, P80, DOI 10.1016/j.pain.2013.09.011; Pannasch U, 2011, P NATL ACAD SCI USA, V108, P8467, DOI 10.1073/pnas.1016650108; Chew SSL, 2010, EXP NEUROL, V225, P250, DOI 10.1016/j.expneurol.2010.07.014; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022; Ohtori S, 2004, SPINE, V29, P1082, DOI 10.1097/00007632-200405150-00006; Brand-Schieber E, 2005, J NEUROSCI RES, V80, P798, DOI 10.1002/jnr.20474; Milligan ED, 2005, EUR J NEUROSCI, V21, P2136, DOI 10.1111/j.1460-9568.2005.04057.x; Morioka N, 2014, NEUROSCIENCE, V258, P374, DOI 10.1016/j.neuroscience.2013.11.044; Yoon SY, 2013, J PAIN, V14, P205, DOI 10.1016/j.jpain.2012.11.002; Kobayashi Y, 2012, BIOCHEM BIOPH RES CO, V421, P318, DOI 10.1016/j.bbrc.2012.03.153; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Rash JE, 2001, CELL COMMUN ADHES, V8, P315, DOI 10.3109/15419060109080745; Gangoso E, 2012, GLIA, V60, P2040, DOI 10.1002/glia.22418; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Ai ZW, 2000, J CLIN INVEST, V105, P161, DOI 10.1172/JCI7798; Bautista W, 2012, J PHYSIOL-LONDON, V590, P3821, DOI 10.1113/jphysiol.2011.225987; Gao YJ, 2009, J NEUROSCI, V29, P4096, DOI 10.1523/JNEUROSCI.3623-08.2009; Kaneda Y, 2002, MOL THER, V6, P219, DOI 10.1006/mthe.2002.0647; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Zhou ZG, 2010, PAIN, V151, P296, DOI 10.1016/j.pain.2010.06.017; Chen G, 2014, BRAIN, V137, P2193, DOI 10.1093/brain/awu140; Morioka N, 2008, GLIA, V56, P528, DOI 10.1002/glia.20634; Tian YH, 2011, PAIN, V152, P1263, DOI 10.1016/j.pain.2011.01.054; Steinhauser C, 2012, GLIA, V60, P1192, DOI 10.1002/glia.22313; Herve JC, 2012, BBA-BIOMEMBRANES, V1818, P1844, DOI 10.1016/j.bbamem.2011.12.009; Cheng JK, 2006, J PHARMACOL SCI, V100, P471, DOI 10.1254/jphs.CR0050020; Dunlop J, 2003, J NEUROSCI, V23, P1688; Zhang X, 2012, J NEURAL TRANSM, V119, P329, DOI 10.1007/s00702-011-0713-7; Nagy JI, 1999, NEUROSCIENCE, V88, P447, DOI 10.1016/S0306-4522(98)00191-2; Pannasch U, 2013, TRENDS NEUROSCI, V36, P405, DOI 10.1016/j.tins.2013.04.004; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Tanga FY, 2004, NEUROCHEM INT, V45, P397, DOI 10.1016/j.neuint.2003.06.002; Teubner B, 2003, HUM MOL GENET, V12, P13, DOI 10.1093/hmg/ddg001; Persson M, 2005, GLIA, V51, P111, DOI 10.1002/glia.20191; Karpuk N, 2011, J NEUROSCI, V31, P414, DOI 10.1523/JNEUROSCI.5247-10.2011; Theis M, 2005, TRENDS NEUROSCI, V28, P188, DOI 10.1016/j.tins.2005.02.006; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Wu XF, 2011, PAIN, V152, P2605, DOI 10.1016/j.pain.2011.08.003; GIAUME C, 1991, NEURON, V6, P133, DOI 10.1016/0896-6273(91)90128-M; Spataro LE, 2004, J PAIN, V5, P392, DOI 10.1016/j.jpain.2004.06.006; Gosejacob D, 2011, GLIA, V59, P511, DOI 10.1002/glia.21120; Jiang JX, 2005, BBA-BIOMEMBRANES, V1711, P208, DOI 10.1016/j.bbamem.2004.10.001; Xu Q, 2014, NEUROSCI LETT, V563, P45, DOI 10.1016/j.neulet.2014.01.042; Mao JR, 2002, J NEUROSCI, V22, P8312; Zhang FF, 2013, J NEUROSCI RES, V91, P745, DOI 10.1002/jnr.23213; Langer J, 2012, GLIA, V60, P239, DOI 10.1002/glia.21259; Hu YY, 2010, PAIN, V148, P284, DOI 10.1016/j.pain.2009.11.014; Chou AK, 2005, MOL BRAIN RES, V133, P198, DOI 10.1016/j.molbrainres.2004.10.036; Figiel M, 2007, MOL CELL NEUROSCI, V35, P130, DOI 10.1016/j.mcn.2007.02.009; Hannay J, 2007, GENE THER, V14, P671, DOI 10.1038/sj.gt.3302911; Herrero-Gonzalez S, 2009, GLIA, V57, P222, DOI 10.1002/glia.20748; Karki P, 2014, MOL CELL BIOL, V34, P1280, DOI 10.1128/MCB.01176-13; Kasahara H, 2005, METH MOLEC MED, V112, P155, DOI 10.1007/978-1-59259-879-3_9; Kasahara H, 2003, J MOL CELL CARDIOL, V35, P243, DOI 10.1016/S0022-2828(03)00002-6; lacobas D.A., 2004, NEUROCHEM INT, V45, P243; Liao CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079350; Maeda S, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-65; Maeda T, 2008, J PHARMACOL SCI, V108, P341, DOI 10.1254/jphs.08207FP; Meme W, 2006, FASEB J, V20, P494, DOI 10.1096/fj.05-4297fje; Morimoto S, 2012, J PHARMACOL SCI, V118, P455, DOI 10.1254/jphs.11102FP; Morioka N, 2014, BRIT J PHARMACOL, V171, P2854, DOI 10.1111/bph.12614; Morita K, 2008, J PHARMACOL EXP THER, V326, P633, DOI 10.1124/jpet.108.136267; Nakamura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073640; Nakamura Y., 2014, J NEUROSCI RES, V93, P584; Narita M, 2008, NEUROSCIENCE, V152, P477, DOI 10.1016/j.neuroscience.2007.10.039; Ohara R.T., 2008, J NEUROPHYSIOL, V100, P3064; Piao Y, 2009, CANCER GENE THER, V16, P256, DOI 10.1038/cgt.2008.75; Scemes E, 2008, GLIA, V56, P145, DOI 10.1002/glia.20598; Shibata K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023510; Tan-No K, 2000, PAIN, V86, P55, DOI 10.1016/S0304-3959(99)00312-7; Wang HT, 2009, NEUROL RES, V31, P67, DOI 10.1179/016164108X323726; Xin WJ, 2009, MOL PAIN, V5, P15; Xu Q, 2014, NEUROSCI LETT, V566, P194, DOI 10.1016/j.neulet.2014.03.004; Yao MZ, 2003, GENE THER, V10, P1392, DOI 10.1038/sj.gt.3301992; Yaster M, 2011, ANESTHESIOLOGY, V114, P412, DOI 10.1097/ALN.0b013e318205df50	76	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	OCT	2015	49						293	310		10.1016/j.bbi.2015.06.015		18	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	CR3UF	WOS:000361257900031		
J	Kunikawa, K				Kunikawa, Keita			Bernstein-type theorem of translating solitons in arbitrary codimension with flat normal bundle	CALCULUS OF VARIATIONS AND PARTIAL DIFFERENTIAL EQUATIONS			English	Article							MEAN-CURVATURE FLOW; GAUSS IMAGE; SINGULARITIES; MANIFOLDS	We give a proof for a Bernstein-type theorem of complete graphs of translating solitons in higher codimension. In the case of hypersurfaces, Bao-Shi showed that a translating soliton whose image of the Gauss map is contained in a compact subset in an open hemisphere is a hyperplane. This means that there is no nontrivial translating soliton whose slope is bounded. In the present article, we generalize this theorem in arbitrary codimension. Moreover we obtain an optimal growth condition which allows unbounded slopes. As a corollary, our result covers a classical Bernstein-type theorem for minimal submanifolds.	Tohoku Univ, Math Inst, Sendai, Miyagi 9800874, Japan	Kunikawa, K (reprint author), Tohoku Univ, Math Inst, Sendai, Miyagi 9800874, Japan.	sb1m16@math.tohoku.ac.jp					Clutterbuck J, 2007, CALC VAR PARTIAL DIF, V29, P281, DOI 10.1007/s00526-006-0033-1; Xin YL, 2005, ASIAN J MATH, V9, P31; Jost J, 1999, CALC VAR PARTIAL DIF, V9, P277, DOI 10.1007/s005260050142; Wang XJ, 2011, ANN MATH, V173, P1185, DOI 10.4007/annals.2011.173.3.1; Jost J, 2013, CALC VAR PARTIAL DIF, V47, P711, DOI 10.1007/s00526-012-0533-0; Xin YL, 2008, ADV MATH, V219, P1298, DOI 10.1016/j.aim.2008.06.015; SIMONS J, 1968, ANN MATH, V88, P62, DOI 10.2307/1970556; HAMILTON RS, 1995, J DIFFER GEOM, V41, P215; Huisken G, 1999, ACTA MATH-DJURSHOLM, V183, P45, DOI 10.1007/BF02392946; Bao C, 2014, P AM MATH SOC, V142, P4333; Ding Q., 2012, RIGIDITY THEOREMS SE; Gui CF, 2010, DISCRETE CONT DYN S, V28, P441, DOI 10.3934/dcds.2010.28.441; HUISKEN G, 1990, J DIFFER GEOM, V31, P285; Jost J., 2011, GEOMETRY GRASSMANNIA; Lee J. M., 2009, MANIFOLDS DIFFERENTI; Li GH, 2011, MATH PHYS ANAL GEOM, V14, P83, DOI 10.1007/s11040-011-9088-0; Smoczyk K, 2006, CALC VAR PARTIAL DIF, V26, P57, DOI 10.1007/s00526-005-0359-0; Smoczyk K, 2012, SPRINGER PROC MATH, V17, P231, DOI 10.1007/978-3-642-22842-1_9; Xin YL, 2008, CHINESE ANN MATH B, V29, P121, DOI 10.1007/s11401-007-0212-1	19	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-2669	1432-0835		CALC VAR PARTIAL DIF	Calc. Var. Partial Differ. Equ.	OCT	2015	54	2					1331	1344		10.1007/s00526-015-0826-1		14	Mathematics, Applied; Mathematics	Mathematics	CR5OC	WOS:000361391500004		
J	Sato, Y; Wang, ZQ				Sato, Yohei; Wang, Zhi-Qiang			Multiple positive solutions for Schrodinger systems with mixed couplings	CALCULUS OF VARIATIONS AND PARTIAL DIFFERENTIAL EQUATIONS			English	Article							BOUND-STATES; ELLIPTIC-SYSTEMS; R-N; EQUATIONS; EXISTENCE; COMPETITION; UNIQUENESS; SYMMETRY; DOMAINS; WAVES	We study the effects of mixed couplings for nonlinear Schrodinger systems. We show due to the mixed couplings there exist multiple vector positive solutions which exhibit interesting new patterns of co-existence of synchronization and segregation. For a 3-system we show the existence of multiple positive vector solutions with the first two components being synchronized and segregated from the third component. We investigate the asymptotic of these solutions with a large attractive coupling constant.	[Sato, Yohei] Saitama Univ, Dept Math, Sakura Ku, Saitama 3388570, Japan; [Sato, Yohei] Osaka City Univ, Grad Sch Sci, Adv Math Inst, Smiyoshi Ku, Osaka 5588585, Japan; [Wang, Zhi-Qiang] Tianjin Univ, Ctr Appl Math, Tianjin 300072, Peoples R China; [Wang, Zhi-Qiang] Utah State Univ, Dept Math & Stat, Logan, UT 84322 USA	Sato, Y (reprint author), Saitama Univ, Dept Math, Sakura Ku, 255 Shimo Okubo, Saitama 3388570, Japan.	ysato@rimath.saitama-u.ac.jp; zhi-qiang.wang@usu.edu			JSPS;  [NSFC11271201]	The authors are grateful to the referee for a thoughtful reading of the manuscript and for several helpful suggestions. The first author is partially supported by the JSPS Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation "Deepening and Evolution of Mathematics and Physics, Building of International Network Hub based on OCAMI". The second author is supported by NSFC11271201.	Tian RS, 2011, TOPOL METHOD NONL AN, V37, P203; Bartsch T, 2007, J FIX POINT THEORY A, V2, P353, DOI 10.1007/s11784-007-0033-6; Wei J, 2008, ARCH RATION MECH AN, V190, P83, DOI 10.1007/s00205-008-0121-9; Mitchell M, 1997, NATURE, V387, P880; Conti M, 2002, ANN I H POINCARE-AN, V19, P871, DOI 10.1016/S0294-1449(02)00104-X; Chang SM, 2004, PHYSICA D, V196, P341, DOI 10.1016/j.physd.2004.06.002; Byeon J, 1997, J DIFFER EQUATIONS, V136, P136, DOI 10.1006/jdeq.1996.3241; Wei JC, 2007, REND LINCEI-MAT APPL, V18, P279; Lin TC, 2005, ANN I H POINCARE-AN, V22, P403, DOI 10.1016/j.anihpc.2004.03.004; Dancer EN, 2010, ANN I H POINCARE-AN, V27, P953, DOI 10.1016/j.anihpc.2010.01.009; Liu ZL, 2010, ADV NONLINEAR STUD, V10, P175; Sato Y, 2013, ANN I H POINCARE-AN, V30, P1, DOI 10.1016/j.anihpc.2012.05.002; Noris B, 2010, COMMUN PUR APPL MATH, V63, P267; Ambrosetti A, 2007, J LOND MATH SOC, V75, P67, DOI 10.1112/jlms/jdl020; Ruegg C, 2003, NATURE, V423, P62, DOI 10.1038/nature01617; Maia LA, 2006, J DIFFER EQUATIONS, V229, P743, DOI 10.1016/j.jde.2006.07.002; Catrina F, 1999, J DIFFER EQUATIONS, V156, P153, DOI 10.1006/jdeq.1998.3600; Bartsch T, 2010, CALC VAR PARTIAL DIF, V37, P345, DOI 10.1007/s00526-009-0265-y; GIDAS B, 1979, COMMUN MATH PHYS, V68, P209, DOI 10.1007/BF01221125; Lin TC, 2005, COMMUN MATH PHYS, V255, P629, DOI 10.1007/s00220-005-1313-x; Terracini S, 2009, ARCH RATION MECH AN, V194, P717, DOI 10.1007/s00205-008-0172-y; Ambrosetti A, 2007, CALC VAR PARTIAL DIF, V30, P85, DOI 10.1007/s00526-006-0079-0; Sirakov B, 2007, COMMUN MATH PHYS, V271, P199, DOI 10.1007/s00220-006-0179-x; Bartsch T., 2006, J PARTIAL DIFFERENTI, V19, P200; Ikoma N, 2011, CALC VAR PARTIAL DIF, V40, P449, DOI 10.1007/s00526-010-0347-x; KWONG MK, 1989, ARCH RATION MECH AN, V105, P243; Liu J., CALC VAR PD IN PRESS; Liu ZL, 2008, COMMUN MATH PHYS, V282, P721, DOI 10.1007/s00220-008-0546-x; MONTEFUSCO E., 2008, J EUR MATH SOC, V10, P41; Noris B, 2010, P AM MATH SOC, V138, P1681; Sato Y, 2015, DISCRETE CONT DYN-A, V35, P2151, DOI 10.3934/dcds.2015.35.2151; Sato YH, 2015, ADV NONLINEAR STUD, V15, P1; Soave N, 2015, CALC VAR PARTIAL DIF, V53, P689, DOI 10.1007/s00526-014-0764-3; Tavares H, 2011, COMMUN PART DIFF EQ, V36, P1988, DOI 10.1080/03605302.2011.574244; Tavares H, 2012, ANN I H POINCARE-AN, V29, P279, DOI 10.1016/j.anihpc.2011.10.006; Wang ZQ, 2014, J ANAL MATH, V122, P69, DOI 10.1007/s11854-014-0003-z; Wei JC, 2012, COMMUN PUR APPL ANAL, V11, P1003, DOI 10.3934/cpaa.2012.11.1003; Willem M., 1996, PROGRAMME NONLINEAR, V24	38	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-2669	1432-0835		CALC VAR PARTIAL DIF	Calc. Var. Partial Differ. Equ.	OCT	2015	54	2					1373	1392		10.1007/s00526-015-0828-z		20	Mathematics, Applied; Mathematics	Mathematics	CR5OC	WOS:000361391500006		
J	Ohta, S; Palfia, M				Ohta, Shin-ichi; Palfia, Miklos			Discrete-time gradient flows and law of large numbers in Alexandrov spaces	CALCULUS OF VARIATIONS AND PARTIAL DIFFERENTIAL EQUATIONS			English	Article							PROXIMAL POINT ALGORITHM; NONLINEAR MARKOV OPERATORS; CENTER-OF-MASS; HARMONIC MAPS; METRIC-SPACES; SINGULAR SPACES; CURVATURE; CONVEXITY; CONVERGENCE; PROBABILITY	We develop the theory of discrete-time gradient flows for convex functions on Alexandrov spaces with arbitrary upper or lower curvature bounds. We employ different resolvent maps in the upper and lower curvature bound cases to construct such a flow, and show its convergence to a minimizer of the potential function. We also prove a stochastic version, a generalized law of large numbers for convex function valued random variables, which not only extends Sturm's law of large numbers on nonpositively curved spaces to arbitrary lower or upper curvature bounds, but this version seems new even in the Euclidean setting. These results generalize those in nonpositively curved spaces (partly for squared distance functions) due to Bacak, Jost, Sturm and others, and the lower curvature bound case seems entirely new.	[Ohta, Shin-ichi; Palfia, Miklos] Kyoto Univ, Dept Math, Kyoto 6068502, Japan	Palfia, M (reprint author), Kyoto Univ, Dept Math, Kyoto 6068502, Japan.	sohta@math.kyoto-u.ac.jp; palfia.miklos@aut.bme.hu			Canon Foundation;  [23740048]	S. Ohta is supported by the Grant-in-Aid for Young Scientists (B) 23740048; M. Palfia is supported by the Research Fellowship of the Canon Foundation.	Afsari B, 2011, P AM MATH SOC, V139, P655; Ambrosio L., 2008, LECT MATH; Holbrook J, 2012, J RAMANUJAN MATH SOC, V27, P509; Ohta SI, 2007, GEOMETRIAE DEDICATA, V125, P225, DOI 10.1007/s10711-007-9159-3; Sturm KT, 2002, ANN PROBAB, V30, P1195; Nedic A, 2001, SIAM J OPTIMIZ, V12, P109, DOI 10.1137/S1052623499362111; Sturm KT, 2006, ACTA MATH-DJURSHOLM, V196, P65, DOI 10.1007/s11511-006-0002-8; BREZIS H, 1978, ISRAEL J MATH, V29, P329, DOI 10.1007/BF02761171; KARCHER H, 1977, COMMUN PUR APPL MATH, V30, P509, DOI 10.1002/cpa.3160300502; Bhatia R, 2006, LINEAR ALGEBRA APPL, V413, P594, DOI 10.1016/j.laa.2005.08.025; Lim Y, 2014, B LOND MATH SOC, V46, P561, DOI 10.1112/blms/bdu008; Espinola R, 2009, J MATH ANAL APPL, V353, P410, DOI 10.1016/j.jmaa.2008.12.015; Moakher M, 2002, SIAM J MATRIX ANAL A, V24, P1, DOI 10.1137/S0895479801383877; Lawson J, 2011, MATH ANN, V351, P267, DOI 10.1007/s00208-010-0603-6; Bacak M, 2013, ISR J MATH, V194, P689, DOI 10.1007/s11856-012-0091-3; Bento GC, 2014, OPTIMIZATION, V63, P1281, DOI 10.1080/02331934.2012.730050; Mayer UF, 1998, COMMUN ANAL GEOM, V6, P199; KENDALL WS, 1990, P LOND MATH SOC, V61, P371; Arnaudon M, 2012, STOCH PROC APPL, V122, P1437, DOI 10.1016/j.spa.2011.12.011; Ferreira OP, 2002, OPTIMIZATION, V51, P257, DOI 10.1080/02331930290019413; Li C, 2009, J LOND MATH SOC, V79, P663, DOI 10.1112/jlms/jdn087; Arnaudon M, 2005, ANN PROBAB, V33, P1509, DOI 10.1214/009117905000000071; Bacak M., 2014, SIAM J OPTI IN PRESS; Bertsekas D. P., 1996, NEURODYNAMIC PROGRAM; Bertsekas DP, 2011, MATH PROGRAM, V129, P163, DOI 10.1007/s10107-011-0472-0; Bhatia R, 2007, PRINC SER APPL MATH, P1; Burago D., 2001, COURSE METRIC GEOMET; Jost J., 1997, NONPOSITIVE CURVATUR; Jost J, 1995, COMMENT MATH HELV, V70, P659, DOI 10.1007/BF02566027; JOST J., 1998, AMS IP STUD ADV MATH, V8, P1; JOST J, 1994, CALC VAR PARTIAL DIF, V2, P173, DOI 10.1007/BF01191341; KENDALL WS, 1991, J LOND MATH SOC, V43, P567; Korf LA, 2001, MATH OPER RES, V26, P421, DOI 10.1287/moor.26.2.421.10548; Kuwae K, 2009, POTENTIAL THEORY AND STOCHASTICS IN ALBAC: AUREL CORNEA MEMORIAL VOLUME, CONFERENCE PROCEEDINGS, P173; Lytchak A., 2006, ST PETERSB MATH J, V17, P477; Nedic A, 2001, APPL OPTIMIZAT, V54, P223; Ohta S, 2012, ADV GEOM, V12, P571, DOI 10.1515/advgeom-2011-058; Ohta S, 2009, AM J MATH, V131, P475; Perel'man G., 1995, QUASIGEODESICS UNPUB; Petrunin A., 2007, SURVEYS DIFFERENTIAL, VXI, P137; Rockafellar R. T., 1997, CONVEX ANAL; Rockafellar R.T., 1998, VARIATIONAL ANAL; Sturm K., 2003, CONT MATH, V338, P357; Sturm KT, 2001, CALC VAR PARTIAL DIF, V12, P317, DOI 10.1007/PL00009916; Sturm KT, 2005, POTENTIAL ANAL, V23, P225, DOI 10.1007/s11118-004-7740-z; Sturm KT, 2002, POTENTIAL ANAL, V16, P305, DOI 10.1023/A:1014888715237	46	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-2669	1432-0835		CALC VAR PARTIAL DIF	Calc. Var. Partial Differ. Equ.	OCT	2015	54	2					1591	1610		10.1007/s00526-015-0837-y		20	Mathematics, Applied; Mathematics	Mathematics	CR5OC	WOS:000361391500016		
J	Mitake, H; Tran, HV				Mitake, Hiroyoshi; Tran, Hung V.			Large-time behavior for obstacle problems for degenerate viscous Hamilton-Jacobi equations	CALCULUS OF VARIATIONS AND PARTIAL DIFFERENTIAL EQUATIONS			English	Article							BELLMAN EQUATIONS; ADJOINT METHODS; BOUNDARY; SPACE; PDE	Cagnetti, Gomes, Mitake and Tran Ann Inst H Poincare Anal Non Lineaire 32(1):183-200, 2015 introduced a new idea to study the large time behavior for degenerate viscous Hamilton-Jacobi equations. In this paper, we apply the method to study the large-time behavior of the solution to the obstacle problem for degenerate viscous Hamilton-Jacobi equations. We establish the convergence result under rather general assumptions.	[Mitake, Hiroyoshi] Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima 7398527, Japan; [Tran, Hung V.] Univ Chicago, Dept Math, Chicago, IL 60637 USA	Mitake, H (reprint author), Hiroshima Univ, Inst Sustainable Sci & Dev, 1-4-1 Kagamiyama, Higashihiroshima 7398527, Japan.	hiroyoshi-mitake@hiroshima-u.ac.jp; hung@math.uchicago.edu			JST; NSF [DMS-1361236]	The work of HM was partially supported by JST program to disseminate tenure tracking system, and the work of HT was partially supported in part by NSF grant DMS-1361236.	Di Francesco M, 2008, P ROY SOC A-MATH PHY, V464, P155, DOI 10.1098/rspa.2007.0090; Davini A, 2006, SIAM J MATH ANAL, V38, P478, DOI 10.1137/050621955; Tran HV, 2011, CALC VAR PARTIAL DIF, V41, P301, DOI 10.1007/s00526-010-0363-x; Hynd R, 2013, ESAIM CONTR OPTIM CA, V19, P112, DOI 10.1051/cocv/2012001; Barles G, 2001, SIAM J MATH ANAL, V32, P1311, DOI 10.1137/S0036141000369344; Caffarelli LA, 1998, J FOURIER ANAL APPL, V4, P383, DOI 10.1007/BF02498216; Evans LC, 2010, ARCH RATION MECH AN, V197, P1053, DOI 10.1007/s00205-010-0307-9; Pascucci A, 2008, FINANC STOCH, V12, P21, DOI 10.1007/s00780-007-0051-7; Barles G, 2000, SIAM J MATH ANAL, V31, P925, DOI 10.1137/S0036141099350869; Ichihara N, 2013, SIAM J MATH ANAL, V45, P279, DOI 10.1137/110832343; Bardi M., 1997, SYSTEMS CONTROL FDN; Barles G., 1994, MATH APPL, V17; Barles G., 1997, NUMERICAL METHODS FI, P1; Bensoussan A., 1982, STUDIES MATH ITS APP, V12; Bokanowski O, 2010, SIAM J CONTROL OPTIM, V48, P4292, DOI 10.1137/090762075; Cagnetti F, 2015, ANN I H POINCARE-AN, V32, P183, DOI 10.1016/j.anihpc.2013.10.005; Cagnetti F, 2013, ESAIM CONTR OPTIM CA, V19, P754, DOI 10.1051/cocv/2012032; Cagnetti F, 2011, SIAM J MATH ANAL, V43, P2601, DOI 10.1137/100817656; Evans LC, 2001, ARCH RATION MECH AN, V157, P1, DOI 10.1007/PL00004236; Fathi A, 1998, CR ACAD SCI I-MATH, V327, P267, DOI 10.1016/S0764-4442(98)80144-4; Friedman A., 1982, VARIATIONAL PRINCIPL; Ishii H, 2008, ANN I H POINCARE-AN, V25, P231, DOI 10.1016/j.anihpc.2006.09.002; Kinderlehrer D., 1980, INTRO VARIATIONAL IN; Ley O., J MATH PURES APPL, V102, P293; Lions P. L., 1982, RES NOTES MATH, V69; Mitake H., 2015, J MATH PURE IN PRESS; Mitake H, 2008, NODEA-NONLINEAR DIFF, V15, P347, DOI 10.1007/s00030-008-7043-y; Mitake H, 2009, NONLINEAR ANAL-THEOR, V71, P5392, DOI 10.1016/j.na.2009.04.028; Namah G, 1999, COMMUN PART DIFF EQ, V24, P883, DOI 10.1080/03605309908821451; Stroock D. W., 2006, MULTIDIMENSIONAL DIF; Tabet Tchamba T., 2010, ASYMPTOTIC ANAL, V66, P161	31	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-2669	1432-0835		CALC VAR PARTIAL DIF	Calc. Var. Partial Differ. Equ.	OCT	2015	54	2					2039	2058		10.1007/s00526-015-0855-9		20	Mathematics, Applied; Mathematics	Mathematics	CR5OC	WOS:000361391500034		
J	Fila, M; Ishige, K; Kawakami, T				Fila, Marek; Ishige, Kazuhiro; Kawakami, Tatsuki			Existence of positive solutions of a semilinear elliptic equation with a dynamical boundary condition	CALCULUS OF VARIATIONS AND PARTIAL DIFFERENTIAL EQUATIONS			English	Article							LARGE-TIME BEHAVIOR; GLOBAL-SOLUTIONS; PARABOLIC EQUATIONS; LAPLACE EQUATION; BLOW-UP; SYSTEMS	We consider the semilinear elliptic equation -Delta u = u(p), p > 1, u = u(x, t), x is an element of R-+(N), t > 0, with a dynamical boundary condition. We show that, for p < (N+1)/(N-1), there exist no nontrivial nonnegative local-in-time solutions. Furthermore, in the case p > (N + 1)/(N - 1), we determine the optimal slow decay rate at spatial infinity for initial data giving rise to global bounded positive solutions.	[Fila, Marek] Comenius Univ, Dept Appl Math & Stat, Bratislava 84248, Slovakia; [Ishige, Kazuhiro] Tohoku Univ, Math Inst, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Kawakami, Tatsuki] Osaka Prefecture Univ, Dept Math Sci, Sakai, Osaka 5998531, Japan	Ishige, K (reprint author), Tohoku Univ, Math Inst, Aoba Ku, Sendai, Miyagi 9808578, Japan.	fila@fmph.uniba.sk; ishige@math.tohoku.ac.jp; kawakami@ms.osakafu-u.ac.jp			Slovak Research and Development Agency [APVV-0134-10]; VEGA [1/0319/15]; Japan Society for the Promotion of Science [23340035, 24740107]	The first author was supported by the Slovak Research and Development Agency under the contract No. APVV-0134-10 and by the VEGA grant 1/0319/15. The second author was supported by the Grant-in-Aid for for Scientific Research (B)(No. 23340035), from Japan Society for the Promotion of Science. The third author was supported by the Grant-in-Aid for Young Scientists (B) (No. 24740107) from Japan Society for the Promotion of Science.	Amann H., 1997, ACTA MATH U COMENIAN, V66, P321; Gal CG, 2014, P LOND MATH SOC, V108, P1351, DOI 10.1112/plms/pdt057; LEE TY, 1992, T AM MATH SOC, V333, P365, DOI 10.2307/2154114; Fila M, 1997, MATH METHOD APPL SCI, V20, P1325, DOI 10.1002/(SICI)1099-1476(199710)20:15<1325::AID-MMA916>3.0.CO;2-G; ESCHER J, 1992, MATH Z, V210, P413, DOI 10.1007/BF02571805; Fila M, 2012, COMMUN PUR APPL ANAL, V11, P1285, DOI 10.3934/cpaa.2012.11.1285; Vitillaro E, 2006, P LOND MATH SOC, V93, P418, DOI 10.1112/S0024611506015875; Bachar I, 2005, POSITIVITY, V9, P153, DOI 10.1007/s11117-003-2713-9; BARAS P, 1987, J DIFFER EQUATIONS, V68, P238, DOI 10.1016/0022-0396(87)90194-X; Berestycki H., 1994, TOPOL METHOD NONL AN, V4, P59; Brezis H., 1977, COMMUN PART DIFF EQ, V2, P601, DOI 10.1080/03605307708820041; Constantin A, 2002, J EVOL EQU, V2, P97, DOI 10.1007/s00028-002-8081-2; Crank J., 1975, MATH DIFFUSION; ESCHER J, 1994, LECT NOTES PURE APPL, V155, P173; Fila M, 1999, MATH Z, V232, P531, DOI 10.1007/PL00004770; Fila M, 2013, ASYMPTOTIC ANAL, V85, P107, DOI 10.3233/ASY-131183; Fila M, 2013, ADV DIFFERENTIAL EQU, V18, P69; Gazzola F, 2007, CALC VAR PARTIAL DIF, V30, P389, DOI 10.1007/s00526-007-0096-7; Kirane M., 2004, B SOC PARANA MAT, V22, P9; Kirane M, 2002, DIFF EQUAT+, V38, P808, DOI 10.1023/A:1020358228313; KIRANE M., 1992, HOKKAIDO MATH J, V21, P221; Koleva M, 2007, J COMPUT APPL MATH, V202, P414, DOI 10.1016/j.cam.2006.02.037; Koleva M., 2004, LECT NOTES COMPUT SC, V2907, P473, DOI 10.1007/978-3-540-24588-9_54; Lions J. L., 1969, QUELQUES METHODES RE; Quittner P., 2007, BIRKHAUSER ADV TEXTS; Yin ZY, 2003, ARCH MATH, V81, P567, DOI 10.1007/s00013-003-0104-x	26	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-2669	1432-0835		CALC VAR PARTIAL DIF	Calc. Var. Partial Differ. Equ.	OCT	2015	54	2					2059	2078		10.1007/s00526-015-0856-8		20	Mathematics, Applied; Mathematics	Mathematics	CR5OC	WOS:000361391500035		
J	Motonaga, M; Yamamoto, N; Makino, Y; Ando-Makihara, R; Ohe, Y; Takano, M; Hayashi, Y				Motonaga, Masanori; Yamamoto, Noboru; Makino, Yoshinori; Ando-Makihara, Reiko; Ohe, Yuichiro; Takano, Mikihisa; Hayashi, Yoshikazu			Phase I dose-finding and pharmacokinetic study of docetaxel and gefitinib in patients with advanced or metastatic non-small-cell lung cancer: evaluation of drug-drug interaction	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article; Proceedings Paper	15th World Conference of Lung Cancer	OCT 27-31, 2013	Sydney, AUSTRALIA			Phase I study; Docetaxel; Gefitinib; Non-small-cell lung cancer; Drug-drug interaction	MICROSOMAL CYTOCHROME-P-450 ENZYMES; III TRIAL; URINARY METABOLITE; EXOGENOUS CORTISOL; HEALTHY-VOLUNTEERS; RANDOMIZED-TRIAL; SOLID TUMORS; CHEMOTHERAPY; MUTATIONS; EGFR	Docetaxel and gefitinib play key roles in the treatment of non-small-cell lung cancer (NSCLC), and their combination could be of interest. Both drugs are mainly metabolized by CYP3A4, and drug-drug interactions are a major concern. This phase I dose-finding study was designed to assess the tolerability and drug-drug interactions in this combination using full pharmacokinetic (PK) samplings. Docetaxel was intravenously administered on days 1 and 22 at a dose of 45 or 60 mg/m(2). Gefitinib (250 mg/day) was orally administrated starting on day 2. Ten PK samplings of docetaxel were performed on days 1 and 22. Seven PK samplings of gefitinib were performed on day 18 +/- A 3 and on day 22. Twelve patients with advanced or metastatic NSCLC were enrolled without considering EGFR mutation status. The major toxicity was neutropenia. Two patients withdrew from this study due to dose-limiting toxicities; however, the toxicity profiles in this combination were generally acceptable. The docetaxel AUC(0-24) and C (max) did not differ whether administered alone or with gefitinib, and the geometric mean ratios (GMRs) of AUC(0-24) and C (max) (co-administrated/administrated alone) were 0.95 (90 % CI 0.85-1.06) and 0.95 (90 % CI 0.85-1.05), respectively. Furthermore, the GMRs of the steady state gefitinib AUC(0-24) and C (max) were 0.93 (90 % CI 0.84-1.03) and 0.98 (90 % CI 0.88-1.09), respectively. The tolerability of 60 mg/m(2) docetaxel with 250 mg/day gefitinib was confirmed, and we observed no drug-drug interaction in this combination.	[Motonaga, Masanori; Makino, Yoshinori; Ando-Makihara, Reiko; Hayashi, Yoshikazu] Natl Canc Ctr, Dept Pharm, Tokyo, Japan; [Yamamoto, Noboru; Ohe, Yuichiro] Natl Canc Ctr, Dept Thorac Oncol, Chuo Ku, Tokyo, Japan; [Yamamoto, Noboru] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Dept Expt Therapeut, Tokyo, Japan; [Motonaga, Masanori; Takano, Mikihisa] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pharmaceut & Therapeut, Hiroshima, Japan	Yamamoto, N (reprint author), Natl Canc Ctr, Dept Thorac Oncol, Chuo Ku, Tsukiji 5-1-1, Tokyo, Japan.	nbryamam@ncc.go.jp					Andersen Anders, 2006, BMC Clin Pharmacol, V6, P2, DOI 10.1186/1472-6904-6-2; Yamamoto N, 2005, J CLIN ONCOL, V23, P1061, DOI 10.1200/JCO.2005.11.036; Engels FK, 2004, CLIN PHARMACOL THER, V75, P448, DOI 10.1016/j.clpt.2004.01.001; Inoue A, 2013, ANN ONCOL, V24, P54, DOI 10.1093/annonc/mds214; Maruyama R, 2008, J CLIN ONCOL, V26, P4244, DOI 10.1200/JCO.2007.15.0185; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Faivre L, 2011, J CHROMATOGR B, V879, P2345, DOI 10.1016/j.jchromb.2011.06.026; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Fossella FV, 2000, J CLIN ONCOL, V18, P2354; Swaisland HC, 2005, CLIN PHARMACOKINET, V44, P1067, DOI 10.2165/00003088-200544100-00005; GUENGERICH FP, 1991, J PHARMACOL EXP THER, V256, P1189; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; HUNT CM, 1992, BIOCHEM PHARMACOL, V44, P275, DOI 10.1016/0006-2952(92)90010-G; GUENGERICH FP, 1989, ANNU REV PHARMACOL, V29, P241; Clarke SJ, 1999, CLIN PHARMACOKINET, V36, P99, DOI 10.2165/00003088-199936020-00002; Gridelli C, 2011, LUNG CANCER, V71, P249, DOI 10.1016/j.lungcan.2010.12.008; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Ohe Y, 2007, ANN ONCOL, V18, P317, DOI 10.1093/annonc/mdl377; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Bruno R, 1998, J CLIN ONCOL, V16, P187; Yamamoto N, 2000, J CLIN ONCOL, V18, P2301; CORTES JE, 1995, J CLIN ONCOL, V13, P2643; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; EXTRA JM, 1993, CANCER RES, V53, P1037; Ferlay J, 2013, GLOBOCAN 2012 V1 0, V11; KOLARS JC, 1992, J CLIN INVEST, V90, P1871, DOI 10.1172/JCI116064; Mahatthanatrakul W, 2007, J CLIN PHARM THER, V32, P161, DOI 10.1111/j.1365-2710.2007.00811.x; Mahatthanatrakul W, 2012, J CLIN PHARM THER, V37, P221, DOI 10.1111/j.1365-2710.2011.01271.x; Manegold Christian, 2005, Clin Lung Cancer, V6, P343, DOI 10.3816/CLC.2005.n.013; Ranson Malcolm, 2002, J Clin Oncol, V20, P2240, DOI 10.1200/JCO.2002.10.112; Taguchi T, 1994, Gan To Kagaku Ryoho, V21, P1997; Tan AR, 2013, CANCER CHEMOTH PHARM, V71, P1635, DOI 10.1007/s00280-013-2164-3; U. S. Department of Health and Human Services Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER), 2003, GUID IND BIOAV BIOEQ; US Department of Health and Human Services. Food and Drug Administration. Guidance for Industry, 2012, GUID IND DRUG INT ST	37	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	OCT	2015	76	4					713	721		10.1007/s00280-015-2837-1		9	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CR6YN	WOS:000361494600005		
J	Mukai, H; Masuda, N; Ishiguro, H; Mitsuma, A; Shibata, T; Yamamura, J; Toi, M; Watabe, A; Sarashina, A; Uttenreuther-Fischer, M; Ando, Y				Mukai, Hirofumi; Masuda, Norikazu; Ishiguro, Hiroshi; Mitsuma, Ayako; Shibata, Takashi; Yamamura, Jun; Toi, Masakazu; Watabe, Aiko; Sarashina, Akiko; Uttenreuther-Fischer, Martina; Ando, Yuichi			Phase I trial of afatinib plus vinorelbine in Japanese patients with advanced solid tumors, including breast cancer	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Afatinib; Dose escalation; Phase I; Japanese; Vinorelbine	CELL LUNG-CANCER; ERBB FAMILY BLOCKER; EGFR MUTATIONS; OPEN-LABEL; BIBW 2992; THERAPY; GEFITINIB; ERLOTINIB	This phase I trial assessed afatinib, an irreversible ErbB family blocker, plus vinorelbine in Japanese patients with advanced solid tumors not amenable to standard treatment. Primary objectives were evaluation of safety and the maximum tolerated dose (MTD) of once-daily (QD) afatinib plus weekly intravenous vinorelbine. Secondary objectives included pharmacokinetic assessments and preliminary efficacy. Dose finding utilized a 3 + 3 design, with a starting dose of afatinib 20 mg QD plus vinorelbine 25 mg/m(2) weekly. Seventeen patients were enrolled. Dose level 2 (afatinib 40 mg and vinorelbine 25 mg/m(2)) exceeded the MTD; dose-limiting toxicities (DLTs) were considered vinorelbine-related. Dose finding continued with modified dose levels; dose level 2a: afatinib 40 mg and a reduced dose of vinorelbine 20 mg/m(2) and dose level 3: afatinib 40 mg and vinorelbine 25 mg/m(2) allowing omission of vinorelbine for grade a parts per thousand yen2 neutropenia/thrombocytopenia and afatinib dose modification for adverse events (AEs). At dose level 3, 1/6 patients had a DLT (upper abdominal pain requiring afatinib dose reduction). Overall, the most frequent treatment-related AEs (any/grade 3 and 4) were: neutropenia (100/71 %), leukopenia (100/59 %), diarrhea (94/0 %), anemia (71/12 %) and stomatitis (65/0 %). Two patients with breast cancer achieved a partial response; eight patients (various cancer indications) had stable disease. Pharmacokinetic analyses suggested no relevant drug-drug interactions. Afatinib 40 mg QD plus vinorelbine 25 mg/m(2) weekly was tolerated in Japanese patients when dose modifications for known AEs for either compound were allowed. Tumor shrinkage was also observed. This dose schedule was recommended for phase II/III trials in Japanese patients.	[Mukai, Hirofumi] Hosp East, Natl Canc Ctr, Div Hematol Oncol, Kashiwa, Chiba, Japan; [Masuda, Norikazu] Osaka Natl Hosp, Dept Surg Breast Oncol, Osaka, Japan; [Ishiguro, Hiroshi] Kyoto Univ Hosp, Outpatient Oncol Unit, Kyoto 606, Japan; [Mitsuma, Ayako; Shibata, Takashi; Ando, Yuichi] Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi, Japan; [Yamamura, Jun] Sakai City Hosp, Dept Mammary Gland & Internal Secret Surg, Sakai, Osaka, Japan; [Toi, Masakazu] Kyoto Univ Hosp, Dept Breast Surg, Kyoto 606, Japan; [Watabe, Aiko] Nippon Boehringer Ingelheim Co Ltd, Clin Trial Management Dept, Tokyo, Japan; [Sarashina, Akiko] Nippon Boehringer Ingelheim Co Ltd, Clin PK PD Dept, Kobe, Hyogo, Japan; [Uttenreuther-Fischer, Martina] Boehringer Ingelheim Pharma GmbH & Co KG, TA Oncol, Biberach, Germany	Mukai, H (reprint author), Hosp East, Natl Canc Ctr, Div Hematol Oncol, Kashiwa, Chiba, Japan.	hrmukai@east.ncc.go.jp			Nippon Boehringer Ingelheim Co. Ltd.; Boehringer Ingelheim	The authors would like to acknowledge the support of all trial investigators, clinical trial support staff and participating patients and their families. This study was supported by Nippon Boehringer Ingelheim Co. Ltd. The authors were fully responsible for all content and editorial decisions, and were involved at all stages of manuscript development and have approved the final version. Medical writing assistance, supported financially by Boehringer Ingelheim, was provided by Christine Arris and Caroline Allinson of GeoMed, an Ashfield Company, part of UDG Healthcare plc, during the preparation of this article.	Zhang HT, 2007, J CLIN INVEST, V117, P2051, DOI 10.1172/JCI32278; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Solca F, 2012, J PHARMACOL EXP THER, V343, P342, DOI 10.1124/jpet.112.197756; Lin NU, 2012, BREAST CANCER RES TR, V133, P1057, DOI 10.1007/s10549-012-2003-y; Hotta K, 2010, J THORAC ONCOL, V5, P179, DOI 10.1097/JTO.0b013e3181ca12e0; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Machiels JPH, 2015, LANCET ONCOL, V16, P583, DOI 10.1016/S1470-2045(15)70124-5; Katakami N, 2013, J CLIN ONCOL, V31, P3335, DOI 10.1200/JCO.2012.45.0981; Bahleda R, 2011, J CLIN ONCOL, V29; Boehringer Ingelheim, 2013, GIL PRESCR INF; Capasso A, 2012, CURR DRUG TARGETS, V13, P1065; European Medicines Agency, 2014, GIOTR EUR PUBL ASS R; European Medicines Agency, 2013, AF EUR PUBL ASS REP; European Medicines Agency, 2013, GIOTR SUMM PROD CHAR; GlaxoSmithKline, 2002, NAV VIN TARTR INJ PR; Goss GD, 2014, ANN ONCOL, V25; Harbeck N, 2014, SAN ANT BREAST CANC; Hollebecque A, 2013, EUR J CANC, V49; MHRA, 2010, VIN 10 MG ML CONC SO; Pharmaceuticals and Medical Devices Agency J, 2005, NEW DRUGS APPR FY 20; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Yang JCH SL, 2014, J CLIN ONCOL, V32, P32	24	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	OCT	2015	76	4					739	750		10.1007/s00280-015-2826-4		12	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CR6YN	WOS:000361494600008		
J	Kuwako, T; Imai, H; Masuda, T; Miura, Y; Seki, K; Yoshino, R; Kaira, K; Utsugi, M; Shimizu, K; Sunaga, N; Tomizawa, Y; Ishihara, S; Ishizuka, T; Mogi, A; Hisada, T; Minato, K; Takise, A; Saito, R; Yamada, M				Kuwako, Tomohito; Imai, Hisao; Masuda, Tomomi; Miura, Yosuke; Seki, Kaori; Yoshino, Reiko; Kaira, Kyoichi; Utsugi, Mitsuyoshi; Shimizu, Kimihiro; Sunaga, Noriaki; Tomizawa, Yoshio; Ishihara, Shinichi; Ishizuka, Takao; Mogi, Akira; Hisada, Takeshi; Minato, Koichi; Takise, Atsushi; Saito, Ryusei; Yamada, Masanobu			First-line gefitinib treatment in elderly patients (aged >= 75 years) with non-small cell lung cancer harboring EGFR mutations	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Non-small cell lung cancer; Advanced non-small cell lung cancer; First-line chemotherapy; EGFR mutations; Gefitinib; Elderly patients	GROWTH-FACTOR RECEPTOR; CARBOPLATIN-PACLITAXEL; GENE-MUTATIONS; PHASE-III; TRIAL; ADENOCARCINOMA; CHEMOTHERAPY; GUIDELINE; TUMORS; OLDER	The efficacy of gefitinib [an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor] in elderly patients with non-small cell lung cancer (NSCLC) and EGFR mutation has not been elucidated. Therefore, the objective of this study was to investigate the efficacy and feasibility of gefitinib in elderly chemotherapy-naive patients with NSCLC harboring sensitive EGFR mutations. We retrospectively evaluated the clinical effects of gefitinib as a first-line treatment for elderly (a parts per thousand yen75 years) NSCLC patients with EGFR mutations (exon 19 deletion or exon 21 L858R mutation). All patients were initially treated with gefitinib (250 mg/day) at seven institutions. Between January 2006 and December 2012, 62 patients (17 men, 45 women) with a median age of 80 years (range, 75-89 years) were included in our analysis. The overall response and disease control rates were 61.2 and 83.8 %, respectively, and the median progression-free survival and overall survival were 13.2 and 19.0 months, respectively. Common adverse events included rash, diarrhea, and liver dysfunction. Major grade 3 or 4 toxicities included skin rash (3.2 %) and increased levels of aspartate aminotransferase or alanine aminotransferase (21.0 %). Gefitinib treatment was discontinued owing to adverse events of liver dysfunction in 3 patients, drug-induced pneumonitis in 2, and diarrhea in 1. First-line gefitinib could be a preferable standard treatment in elderly patients with advanced NSCLC harboring sensitive EGFR mutations.	[Kuwako, Tomohito; Imai, Hisao; Masuda, Tomomi; Seki, Kaori; Sunaga, Noriaki; Hisada, Takeshi; Yamada, Masanobu] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 3718511, Japan; [Miura, Yosuke; Minato, Koichi] Gunma Prefectural Canc Ctr, Div Resp Med, Ohta, Gunma, Japan; [Yoshino, Reiko; Saito, Ryusei] Natl Hosp Org Nishigunma Hosp, Div Resp Med, Gunma, Japan; [Kaira, Kyoichi] Gunma Univ, Grad Sch Med, Dept Oncol Clin Dev, Maebashi, Gunma 3718511, Japan; [Utsugi, Mitsuyoshi] Kiryu Kosei Gen Hosp, Div Internal Med, Kiryu, Gunma, Japan; [Shimizu, Kimihiro] Gunma Univ, Grad Sch Med, Dept Thorac Visceral Organ Surg, Maebashi, Gunma 3718511, Japan; [Ishihara, Shinichi] Isesaki City Hosp, Div Internal Med, Gunma, Japan; [Ishizuka, Takao] Publ Tomioka Gen Hosp, Div Internal Med, Gunma, Japan; [Mogi, Akira] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gunma 3718511, Japan; [Takise, Atsushi] Maebashi Red Cross Hosp, Div Resp Med, Maebashi, Gunma, Japan	Imai, H (reprint author), Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, 3-39-15 Showa Machi, Maebashi, Gunma 3718511, Japan.	m06701014@gunma-u.ac.jp					Yatabe Y, 2006, J MOL DIAGN, V8, P335, DOI 10.2353/jmoldx.2006.050104; Inoue A, 2009, J CLIN ONCOL, V27, P1394, DOI 10.1200/JCO.2008.18.7658; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Maemondo M, 2012, J THORAC ONCOL, V7, P1417, DOI 10.1097/JTO.0b013e318260de8b; Peters S, 2012, ANN ONCOL, V23, P56, DOI 10.1093/annonc/mds226; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Uruga H, 2010, INTERNAL MED, V49, P103, DOI 10.2169/internalmedicine.49.2531; Inoue A, 2013, ANN ONCOL, V24, P54, DOI 10.1093/annonc/mds214; Kudoh S, 2006, J CLIN ONCOL, V24, P3657, DOI 10.1200/JCO.2006.06.1044; Ebi N, 2008, J THORAC ONCOL, V3, P1166, DOI 10.1097/JTO.0b013e318186a88d; Han JY, 2012, J CLIN ONCOL, V30, P1122, DOI 10.1200/JCO.2011.36.8456; Davidoff AJ, 2010, J CLIN ONCOL, V28, P2191, DOI 10.1200/JCO.2009.25.4052; Gridelli C, 2005, CHEST, V128, P947, DOI 10.1378/chest.128.2.947; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Pfister DG, 2004, J CLIN ONCOL, V22, P330, DOI 10.1200/JCO.2004.09.053; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Owonikoko TK, 2007, J CLIN ONCOL, V25, P5570, DOI 10.1200/JCO.2007.12.5435; Asami K, 2011, CLIN LUNG CANCER, V12, P387, DOI 10.1016/j.cllc.2011.02.004; Fujita S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-185; Morita S, 2009, CLIN CANCER RES, V15, P4493, DOI 10.1158/1078-0432.CCR-09-0391; Takahashi K, 2014, CANCER CHEMOTH PHARM, V74, P721, DOI 10.1007/s00280-014-2548-z; Tateishi K, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0450-2	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	OCT	2015	76	4					761	769		10.1007/s00280-015-2841-5		9	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CR6YN	WOS:000361494600010		
J	Shukuya, T; Ko, R; Mori, K; Kato, M; Yagishita, S; Kanemaru, R; Honma, Y; Shibayama, R; Koyama, R; Shimada, N; Takahashi, K				Shukuya, Takehito; Ko, Ryo; Mori, Keita; Kato, Motoyasu; Yagishita, Shigehiro; Kanemaru, Ryota; Honma, Yuichiro; Shibayama, Rina; Koyama, Ryo; Shimada, Naoko; Takahashi, Kazuhisa			Prognostic factors in non-small cell lung cancer patients who are recommended to receive single-agent chemotherapy (docetaxel or pemetrexed) as a second- or third-line chemotherapy: in the era of oncogenic drivers and molecular-targeted agents	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Non-small cell lung cancer; Oncogenic driver; Molecular-targeted agents; Chemotherapy; Prognostic factor	PHASE-III TRIAL; ADENOCARCINOMA; MUTATIONS	Docetaxel or pemetrexed monotherapy is recommended either as a second-line treatment for non-small cell lung cancer (NSCLC) patients without EGFR mutation or ALK fusion genes or as a third-line treatment for patients with EGFR mutation or ALK fusion. However, efficacy and survival for these two settings have not been compared, leaving it unclear whether these two populations can be included in the same clinical trials. Moreover, prognostic factors for patients who are recommended to receive docetaxel/pemetrexed monotherapy are largely unknown. Docetaxel or pemetrexed was administered to 67 EGFR wild-type patients as a second-line treatment following one platinum-based combination chemotherapy and to 17 EGFR mutant patients as a third-line treatment following EGFR tyrosine kinase inhibitors and one platinum-based combination chemotherapy. Docetaxel and pemetrexed were administered at 60 and 500 mg/m(2), respectively, every 3 weeks until disease progression, intolerable toxicity, or patient refusal. Overall survivals (OSs) between the two groups were compared using the log-rank test, and prognostic factors were evaluated via Cox's proportional hazards models. The median OS was 345.5 days in the EGFR wild-type second-line group and 616 days in the EGFR mutant third-line group. Multivariate analyses revealed that the stage before first-line treatment, performance status, and EGFR status were significant prognostic factors. When planning clinical studies of NSCLC patients recommended to receive docetaxel or pemetrexed as single-agent chemotherapy, the EGFR status and stage before first-line treatment should be considered as stratification factors of randomized clinical studies.	[Shukuya, Takehito; Ko, Ryo; Kato, Motoyasu; Yagishita, Shigehiro; Kanemaru, Ryota; Honma, Yuichiro; Shibayama, Rina; Koyama, Ryo; Shimada, Naoko; Takahashi, Kazuhisa] Juntendo Univ, Grad Sch Med, Dept Resp Med, Bunkyo Ku, Tokyo 1138431, Japan; [Mori, Keita] Shizuoka Canc Ctr, Clin Trial Coordinat Off, Shizuoka 4118777, Japan	Shukuya, T (reprint author), Juntendo Univ, Grad Sch Med, Dept Resp Med, Bunkyo Ku, 3-1-3 Hongo, Tokyo 1138431, Japan.	tshukuya@juntendo.ac.jp					American Cancer Society, 2007, CANC FACTS FIG 2007; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095; Fossella FV, 2000, J CLIN ONCOL, V18, P2354; Imielinski M, 2014, J CLIN INVEST, V124, P1582, DOI 10.1172/JCI72763; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Garon EB, 2014, LANCET, V384, P665, DOI 10.1016/S0140-6736(14)60845-X; Vijayvergia N, 2014, CANCER CHEMOTH PHARM, V74, P437, DOI 10.1007/s00280-014-2517-6; Berge EM, 2014, SEMIN ONCOL, V41, P110, DOI 10.1053/j.seminoncol.2013.12.006; Hanna NH, 2013, J CLIN ONCOL S, V31; Japan Lung Cancer Society, GUID TREATM LUNG CAN; Kohler J, 2013, ONKOLOGIE, V36, P510, DOI 10.1159/000354627; Mok TS, 2014, ANN ONCOL, V25, pv1; NCCN.org, 2015, NCCN CLIN PRACT GUID; Reck M, 2014, LANCET ONCOL, V15, P143, DOI 10.1016/S1470-2045(13)70586-2	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	OCT	2015	76	4					771	776		10.1007/s00280-015-2843-3		6	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CR6YN	WOS:000361494600011		
J	Fujita, K; Yoshino, E; Kawara, K; Maeda, K; Kusuhara, H; Sugiyama, Y; Yokoyama, T; Kaneta, T; Ishida, H; Sasaki, Y				Fujita, Ken-ichi; Yoshino, Etsuko; Kawara, Kaori; Maeda, Kazuya; Kusuhara, Hiroyuki; Sugiyama, Yuichi; Yokoyama, Taro; Kaneta, Toshikado; Ishida, Hiroo; Sasaki, Yasutsuna			A clinical pharmacokinetic microdosing study of docetaxel with Japanese patients with cancer	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Docetaxel; Microdose study; Pharmacokinetics; alpha(1)-acid glycoprotein	HEALTHY-SUBJECTS; ORAL MICRODOSE; LUNG-CANCER; IPILIMUMAB; NIVOLUMAB; INHIBITOR; MELANOMA; IMPACT	Whether microdosing studies can be used to evaluate the human pharmacokinetics of new anticancer drugs remains unclear. The disposition of docetaxel in cancer patients is linear in terms of dose proportionality. We examined whether the pharmacokinetics of docetaxel in a clinically relevant therapeutic dose could be predicted from the pharmacokinetics of a microdose of docetaxel in Japanese patients with cancer. A microdose of docetaxel (100 mu g/patient) was given by 5-min intravenous infusion on day 1, followed by a therapeutic dose of docetaxel (60-75 mg m(-2)), given by 1-h intravenous infusion on day 8. Plasma docetaxel was analyzed by liquid chromatography-tandem mass spectrometry. A two-compartment pharmacokinetic model was used to calculate the area under the plasma concentration-time curve from time 0 to infinity (AUC(0-inf)). Nine patients received both a microdose and therapeutic dose of docetaxel. The AUC(0-inf) after microdosing was 3640 +/- A 1150 ng h L-1, while that after therapeutic dosing adjusted to 100 mg/patient was 2230 +/- A 757 A mu g h L-1. The ratio of docetaxel clearance in therapeutic dose to that in microdose was 1.8 (P = 0.0041). Plasma alpha(1)-acid glycoprotein concentrations negatively correlated with docetaxel clearance at therapeutic dose, whereas the trend was weak at microdose. Docetaxel clearance showed marginal nonlinearity between microdose and therapeutic dose, presumably because of saturation of plasma protein binding; however, the magnitude was within twofold, allowing practically acceptable extrapolation.	[Fujita, Ken-ichi; Kawara, Kaori; Yokoyama, Taro; Kaneta, Toshikado; Ishida, Hiroo; Sasaki, Yasutsuna] Saitama Med Univ, Int Med Center, Comprehens Canc Ctr, Dept Med Oncol, Saitama 3501298, Japan; [Yoshino, Etsuko] Saitama Med Univ, Int Med Center, Comprehens Canc Ctr, Dept Clin Res Support Ctr, Saitama 3501298, Japan; [Maeda, Kazuya; Kusuhara, Hiroyuki; Sugiyama, Yuichi] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Mol Pharmacokinet, Bunkyo Ku, Tokyo 1130033, Japan; [Sugiyama, Yuichi] RIKEN, RIKEN Res Cluster Innovat, RIKEN Innovat Ctr, Sugiyama Lab,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Fujita, Ken-ichi; Sasaki, Yasutsuna] Showa Univ, Inst Mol Oncol, Shinagawa Ku, Tokyo 1428555, Japan; [Kaneta, Toshikado; Ishida, Hiroo; Sasaki, Yasutsuna] Showa Univ, Sch Med, Dept Med Oncol, Shinagawa Ku, Tokyo 1428666, Japan	Fujita, K (reprint author), Saitama Med Univ, Int Med Center, Comprehens Canc Ctr, Dept Med Oncol, 1397-1 Yamane, Saitama 3501298, Japan.	k.fujita@med.showa-u.ac.jp			New Energy and Industrial Technology Development Organization (NEDO), Japan; Ministry of Health, Labour and Welfare of Japan [23-A-16]; Japan Society for the Promotion of Science (JSPS) [23590198]	This study is a part of the Research Project for the Establishment of Evolutional Drug Development with the Use of Microdose Clinical Trials, sponsored by the New Energy and Industrial Technology Development Organization (NEDO), Japan. This study was also supported in part by a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan [23-A-16], and in part by a Grant-in-Aid for Scientific Research (C) [23590198] from the Japan Society for the Promotion of Science (JSPS).	Maeda K, 2011, CLIN PHARMACOL THER, V90, P263, DOI 10.1038/clpt.2011.108; Urien S, 1996, INVEST NEW DRUG, V14, P147; van der Veldt AAM, 2013, CLIN CANCER RES, V19, P4163, DOI 10.1158/1078-0432.CCR-12-3779; Ieiri I, 2011, PHARMACOGENET GENOM, V21, P495, DOI 10.1097/FPC.0b013e3283489ce2; Lappin G, 2006, CLIN PHARMACOL THER, V80, P203, DOI 10.1016/j.clpt.2006.05.008; Kusuhara H, 2012, BRIT J PHARMACOL, V166, P1793, DOI 10.1111/j.1476-5381.2012.01887.x; Clarke SJ, 1999, CLIN PHARMACOKINET, V36, P99, DOI 10.2165/00003088-199936020-00002; Kiyotani K, 2008, CANCER SCI, V99, P967, DOI 10.1111/j.1349-7006.2008.00765.x; Sugiyama Y, 2011, ADV DRUG DELIVER REV, V63, P494, DOI 10.1016/j.addr.2010.09.010; Kusuhara H, 2011, CLIN PHARMACOL THER, V89, P837, DOI 10.1038/clpt.2011.36; Nieuweboer AJM, 2014, CANCER RES, V74, P3137, DOI 10.1158/0008-5472.CAN-13-3634; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; Food and Drug Administration, 2014, HIGHL PRESCR INF DOC; Food and Drug Administration (FDA). Center for Drug Evaluation and Research (CDER), 2006, GUID IND INV REV EXP; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI 10.1056/NEJMoa1504030; McLeod HL, 1998, CANCER CHEMOTH PHARM, V42, P155, DOI 10.1007/s002800050799; Minami H, 2009, CANCER SCI, V100, P144, DOI 10.1111/j.1349-7006.2009.00992.x; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	OCT	2015	76	4					793	801		10.1007/s00280-015-2844-2		9	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CR6YN	WOS:000361494600014		
J	Bol, GM; Khan, R; van Voss, MRH; Tantravedi, S; Korz, D; Kato, Y; Raman, V				Bol, Guus Martinus; Khan, Raheela; van Voss, Marise Rosa Heerma; Tantravedi, Saritha; Korz, Dorian; Kato, Yoshinori; Raman, Venu			PLGA nanoparticle formulation of RK-33: an RNA helicase inhibitor against DDX3	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						DDX3; PLGA; RK-33; Nanoparticles; Drug release	SMALL-MOLECULE INHIBITOR; DRUG-DELIVERY; REPLICATION; GENERATION; DISCOVERY; GENES; CELLS	The DDX3 helicase inhibitor RK-33 is a newly developed anticancer agent that showed promising results in preclinical research (Bol et al. EMBO Mol Med, 7(5):648-649, 2015). However, due to the physicochemical and pharmacological characteristics of RK-33, we initiated development of alternative formulations of RK-33 by preparing sustained release nanoparticles that can be administered intravenously. In this study, RK-33 was encapsulated in poly(lactic-co-glycolic acid) (PLGA), one of the most well-developed biodegradable polymers, using the emulsion solvent evaporation method. Hydrodynamic diameter of RK-33-PLGA nanoparticles was about 245 nm with a negative charge, and RK-33-PLGA nanoparticles had a payload of 1.4 % RK-33. RK-33 was released from the PLGA nanoparticles over 7 days (90 +/- A 5.7 % released by day 7) and exhibited cytotoxicity to human breast carcinoma MCF-7 cells in a time-dependent manner. Moreover, RK-33-PLGA nanoparticles were well tolerated, and systemic retention of RK-33 was markedly improved in normal mice. PLGA nanoparticles have a potential as a parenteral formulation of RK-33.	[Bol, Guus Martinus; Khan, Raheela; van Voss, Marise Rosa Heerma; Tantravedi, Saritha; Korz, Dorian; Kato, Yoshinori; Raman, Venu] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Div Canc Imaging Res, Baltimore, MD 21205 USA; [Bol, Guus Martinus; van Voss, Marise Rosa Heerma; Raman, Venu] Univ Med Ctr Utrecht, Ctr Canc, Dept Pathol, NL-3508 GA Utrecht, Netherlands; [Kato, Yoshinori; Raman, Venu] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21205 USA	Kato, Y (reprint author), Hoshi Univ, Sch Pharm & Pharmaceut Sci, Life Sci Tokyo Adv Res Ctr L StaR, Shinagawa Ku, Tokyo 142, Japan.	ykato@mri.jhu.edu; vraman2@jhmi.edu		Bol, Guus/0000-0002-4021-3823; Kato, Yoshinori/0000-0002-6218-8710	Dr. Saal van Swanenberg foundation; Dutch cancer society [UU 2010-4856]; DoD Idea Award [W81XWH-10-1-0603]	This work was supported by the Dr. Saal van Swanenberg foundation (G.B.), the Dutch cancer society (UU 2010-4856) (G.B.), DoD Idea Award (W81XWH-10-1-0603) (V.R.).	Li Y, 2006, CANCER RES, V66, P8520, DOI 10.1158/0008-5472.CAN-05-4364; Hans ML, 2002, CURR OPIN SOLID ST M, V6, P319, DOI 10.1016/S1359-0286(02)00117-1; Dhar S, 2008, P NATL ACAD SCI USA, V105, P17356, DOI 10.1073/pnas.0809154105; Huang JS, 2004, BIOCHEM BIOPH RES CO, V315, P950, DOI 10.1016/j.bbrc.2004.01.151; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Sun MN, 2011, BBA-MOL CELL RES, V1813, P438, DOI 10.1016/j.bbamcr.2011.01.003; Radi M, 2012, BIOORG MED CHEM LETT, V22, P2094, DOI 10.1016/j.bmcl.2011.12.135; Lee CS, 2008, NUCLEIC ACIDS RES, V36, P4708, DOI 10.1093/nar/gkn454; Maga G, 2008, J MED CHEM, V51, P6635, DOI 10.1021/jm8008844; Yedavalli VSRK, 2008, J MED CHEM, V51, P5043, DOI 10.1021/jm800332m; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Bol GM, 2015, EMBO MOL MED, V7, P648, DOI 10.15252/emmm.201404368; Danhier F, 2009, J CONTROL RELEASE, V133, P11, DOI 10.1016/j.jconrel.2008.09.086; Boddy AV, 2005, CLIN CANCER RES, V11, P7834, DOI 10.1158/1078-0432.CCR-05-0803; Kumar R, 2008, ORG LETT, V10, P4681, DOI 10.1021/ol8020176; Sun M, 2008, CELL DEATH DIFFER, V15, P1887, DOI 10.1038/cdd.2008.124; Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001; Danhier F, 2010, J CONTROL RELEASE, V148, P135, DOI 10.1016/j.jconrel.2010.08.027; Cruciat CM, 2013, SCIENCE, V339, P1436, DOI 10.1126/science.1231499; Belon CA, 2010, BIOCHEMISTRY-US, V49, P1822, DOI 10.1021/bi901974a; Bol GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063548; Botlagunta M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017563; Coe RA, 1996, J PHARMACEUT BIOMED, V14, P1733, DOI 10.1016/0731-7085(96)01832-8; DENHARTIGH J, 1985, J PHARMACEUT BIOMED, V3, P417, DOI 10.1016/0731-7085(85)80055-8; Kondaskar A., 2010, ACS MED CHEM LETT, V2, P252, DOI DOI 10.1021/ML100281B	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	OCT	2015	76	4					821	827		10.1007/s00280-015-2851-3		7	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CR6YN	WOS:000361494600017		
J	Otsuka, K; Hata, A; Takeshita, J; Okuda, C; Kaji, R; Masago, K; Fujita, S; Katakami, N				Otsuka, Kyoko; Hata, Akito; Takeshita, Jumpei; Okuda, Chiyuki; Kaji, Reiko; Masago, Katsuhiro; Fujita, Shiro; Katakami, Nobuyuki			EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancer	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						EGFR mutation; EGFR-TKI rechallenge; Bevacizumab; Acquired resistance; T790M	GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITOR; RANDOMIZED PHASE-3 TRIAL; OPEN-LABEL; ACQUIRED-RESISTANCE; 1ST-LINE TREATMENT; GEFITINIB RESISTANCE; ACTIVATING MUTATIONS; COMPLEX MUTATIONS; ERLOTINIB	Efficacies of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) rechallenge have been demonstrated in EGFR-mutant non-small cell lung cancer (NSCLC). However, their efficacies were only moderate. Some preclinical studies suggested synergistic effects of bevacizumab to EGFR-TKI in TKI-resistant models. We retrospectively evaluated clinical efficacy and safety of EGFR-TKI rechallenge with bevacizumab. Rebiopsy was performed on all studied cases to examine T790M-resistant mutation status. Between January 2010 and June 2014, a total of 24 EGFR-mutant NSCLC patients who had been previously treated with EGFR-TKIs (gefitinib, erlotinib, and/or afatinib) received EGFR-TKI rechallenge with bevacizumab. Twenty-two (92 %) patients underwent erlotinib and two (8 %) gefitinib as rechallenge EGFR-TKIs in combination with bevacizumab. Three patients achieved partial response, and 18 had stable disease, resulting in the response rate (RR) of 13 % and disease control rate (DCR) of 88 %, respectively. The median progression-free survival (PFS) was 4.1 [95 % confidence interval (CI) 2.3-4.9] months, and the median overall survival (OS) was 13.5 (95 % CI 9.7-27.4) months. The RR, DCR, median PFS, and median OS for T790M-positive versus T790M-negative were 0 versus 18 % (p = 0.530), 86 versus 88 % (p = 1.00), 3.3 versus 4.1 months (p = 0.048), and 15.1 versus 13.5 months (p = 0.996), respectively. Severe adverse events (a parts per thousand yengrade 3): grade 3 of 1 (4 %) rash; grade 3 of 1 (4 %) paronychia; grade 3 of 1 (4 %) hypertension; and grade 3 of 1 (4 %) anemia, were observed. EGFR-TKI rechallenge with bevacizumab demonstrated higher DCR and modestly longer PFS than historical data on EGFR-TKI rechallenge alone. Its activity was notably higher in T790M-negative population.	[Otsuka, Kyoko; Hata, Akito; Takeshita, Jumpei; Okuda, Chiyuki; Kaji, Reiko; Masago, Katsuhiro; Fujita, Shiro; Katakami, Nobuyuki] Inst Biomed Res & Innovat, Div Integrated Oncol, Chuo Ku, Kobe, Hyogo 6500047, Japan	Hata, A (reprint author), Inst Biomed Res & Innovat, Div Integrated Oncol, Chuo Ku, 2-2 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	a-hata@fbri.org					Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Asahina H, 2010, ONCOLOGY-BASEL, V79, P423, DOI 10.1159/000326488; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Oxnard GR, 2011, CLIN CANCER RES, V17, P1616, DOI 10.1158/1078-0432.CCR-10-2692; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Wang W, 2009, CLIN CANCER RES, V15, P6630, DOI 10.1158/1078-0432.CCR-09-1001; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Sequist LV, 2015, NEW ENGL J MED, V372, P1700, DOI 10.1056/NEJMoa1413654; Naumov GN, 2009, CLIN CANCER RES, V15, P3484, DOI 10.1158/1078-0432.CCR-08-2904; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Oxnard GR, 2011, CLIN CANCER RES, V17, P5530, DOI 10.1158/1078-0432.CCR-10-2571; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Hata A, 2010, J THORAC ONCOL, V5, P1524, DOI 10.1097/JTO.0b013e3181e8b3c5; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Oh IJ, 2012, LUNG CANCER, V77, P121, DOI 10.1016/j.lungcan.2012.01.012; Besse B, 2014, ANN ONCOL, V25, P1475, DOI 10.1093/annonc/mdu123; Hata A, 2011, LUNG CANCER, V74, P268, DOI 10.1016/j.lungcan.2011.03.010; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Kaira K, 2010, LUNG CANCER, V68, P99, DOI 10.1016/j.lungcan.2009.05.006; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Chmielecki J, 2011, SCI TRANSL MED, V3, P9059; Hata A, 2013, J THORAC ONCOL, V8, pE27, DOI 10.1097/JTO.0b013e318282e047; Hata A, 2013, CANCER-AM CANCER SOC, V119, P4325, DOI 10.1002/cncr.28364; Hata A, 2015, J THORAC ON IN PRESS; Hata A, 2011, J THORAC ONCOL, V6, P1144, DOI 10.1097/JTO.0b013e31821b1194; Heon S, 2012, J CLIN ONCOL S, V30; Ichihara E, 2009, CANCER RES, V69, P5091, DOI 10.1158/0008-5472.CAN-08-4204; Ichihara E, 2015, J THORAC ONCOL, V10, P486, DOI 10.1097/JTO.0000000000000434; Ji W, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-606; Koizumi T, 2012, CLIN LUNG CANCER, V13, P458, DOI 10.1016/j.cllc.2012.01.006; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Seto T, 2014, LANCET ONCOL, V15, P1236, DOI 10.1016/S1470-2045(14)70381-X; Tabara K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041017; The National Comprehensive Cancer Network, 2015, NCCN CLIN PRACT GUID; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1	44	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	OCT	2015	76	4					835	841		10.1007/s00280-015-2867-8		7	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CR6YN	WOS:000361494600019		
J	Nakagama, Y; Kaneko, Y; Ono, H				Nakagama, Yu; Kaneko, Yukihiro; Ono, Hiroshi			Reversible diaphragmatic paralysis caused by a malpositioned chest tube	CARDIOLOGY IN THE YOUNG			English	Article						Diaphragmatic paralysis; phrenic nerve palsy; chest tube; pleural drainage; reversible	PHRENIC-NERVE INJURY; PEDIATRIC CARDIAC-SURGERY; INTERCOSTAL DRAINAGE	We report a case of reversible diaphragmatic paralysis caused by a malpositioned chest tube, a diagnosis to consider when unexplained respiratory failure occurs following drainage of pleural effusion. Prompt recognition and removal of the tube led to full recovery of diaphragm function.	[Nakagama, Yu] Yaizu City Hosp, Dept Pediat, Yaizu, Shizuoka 4258505, Japan; [Nakagama, Yu; Kaneko, Yukihiro; Ono, Hiroshi] Natl Med Ctr Children & Mothers, Dept Pediat Cardiol & Cardiovasc Surg, Tokyo, Japan	Nakagama, Y (reprint author), Yaizu City Hosp, Dept Pediat, 1000 Doubara, Yaizu, Shizuoka 4258505, Japan.	yuu.nakagama@hospital.yaizu.shizuoka.jp					Nahum E, 2001, PEDIATR RADIOL, V31, P444, DOI 10.1007/s002470100428; ARYA H, 1991, ARCH DIS CHILD, V66, P441; Williams O, 2003, ARCH DIS CHILD, V88, P72; AYALON A, 1979, J PEDIATR SURG, V14, P473, DOI 10.1016/S0022-3468(79)80020-2; Hwang MS, 2005, INT J CARDIOL, V99, P129, DOI 10.1016/j.ijcard.2003.10.060; Marinelli PV, 1981, PEDIATRICS, V67, P551; ODITA JC, 1992, PEDIATR RADIOL, V22, P379, DOI 10.1007/BF02016263; PALOMEQUEK A D C, 1990, Intensive Care Medicine, V16, P138; Philipps AF, 1981, AJR, V136, P834; Smith BM, 2013, ANN THORAC SURG, V96, P938, DOI 10.1016/j.athoracsur.2013.05.057	10	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1047-9511	1467-1107		CARDIOL YOUNG	Cardiol. Young	OCT	2015	25	7					1382	1384		10.1017/S1047951114002546		3	Cardiac & Cardiovascular Systems; Pediatrics	Cardiovascular System & Cardiology; Pediatrics	CR5LT	WOS:000361384800025		
J	Higeno, R; Inamura, N; Kayatani, F				Higeno, Ryota; Inamura, Noboru; Kayatani, Futoshi			Unilateral absence of the pulmonary artery: a report of two cases that presented different clinical courses	CARDIOLOGY IN THE YOUNG			English	Article						Absence of the pulmonary artery; prostaglandin E-1; computed tomography; emphysema		We recently diagnosed two cases of isolated unilateral absence of the pulmonary artery just after birth. Through the therapy, we could not prevent obstruction of the pulmonary artery and lead to complications. There have been no symptoms attributed to isolated unilateral absence of the pulmonary artery so far. We should carefully consider the strategy for therapeutic intervention for asymptomatic cases.	[Higeno, Ryota; Inamura, Noboru; Kayatani, Futoshi] Osaka Med Ctr & Res Inst Maternal & Child Hlth, Dept Pediat Cardiol, Osaka 5941101, Japan	Higeno, R (reprint author), Osaka Med Ctr & Res Inst Maternal & Child Hlth, Dept Pediat Cardiol, Izumi Ku, 840 Murodo Cho, Osaka 5941101, Japan.	higeno@ped.med.osaka-u.ac.jp					Kruzliak P, 2013, ARCH CARDIOVASC DIS, V106, P448, DOI 10.1016/j.acvd.2013.05.004; Frentzel O., VIRCHOWS ARCH PATH A, V43, P420; Ghanbari H, 2009, CIRC-CARDIOVASC IMAG, V2, pE46, DOI 10.1161/CIRCIMAGING.108.825745; Krammoh EK, 2010, PEDIATR CARDIOL, V31, P607, DOI 10.1007/s00246-010-9689-6; Nabo MMH, 2011, HEART LUNG CIRC, V20, P587, DOI 10.1016/j.hlc.2011.04.038; Welch K, 2005, ANN THORAC SURG, V79, P1399, DOI 10.1016/j.athoracsur.2003.10.037	6	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1047-9511	1467-1107		CARDIOL YOUNG	Cardiol. Young	OCT	2015	25	7					1399	1402		10.1017/S1047951114002091		4	Cardiac & Cardiovascular Systems; Pediatrics	Cardiovascular System & Cardiology; Pediatrics	CR5LT	WOS:000361384800031		
J	Okabe, T; Yakushiji, T; Igawa, W; Ono, M; Kido, T; Ebara, S; Yamashita, K; Yamamoto, MH; Saito, S; Hoshimoto, K; Amemiya, K; Isomura, N; Araki, H; Ochiai, M				Okabe, Toshitaka; Yakushiji, Tadayuki; Igawa, Wataru; Ono, Morio; Kido, Takehiko; Ebara, Seitaro; Yamashita, Kennosuke; Yamamoto, Myong Hwa; Saito, Shigeo; Hoshimoto, Koichi; Amemiya, Kisaki; Isomura, Naoei; Araki, Hiroshi; Ochiai, Masahiko			The Efficacy of Tolvaptan in Congestive Heart Failure Patients with and Without Hypoalbuminemia: A Pilot Study	CARDIOVASCULAR THERAPEUTICS			English	Article						Diuretics; Heart failure; Hypoalbuminemia; Tolvaptan	DIURETIC RESISTANCE; LOOP DIURETICS; SERUM-ALBUMIN; MULTICENTER; DYSFUNCTION; FUROSEMIDE; CRITERIA; DISEASE; BINDING	Background: Heart failure (HF) with hypoalbuminemia is associated with poor response to conventional therapy. We investigated whether tolvaptan, a potent aquaretic agent, might be of benefit in HF patients with hypoalbuminemia. MethodsWe prospectively enrolled 40 patients hospitalized for HF. Patients received conventional therapy including loop diuretics. We subsequently added tolvaptan in the range of 3.75-15mg daily and it was discontinued after improvement of HF symptoms. We compared clinical and laboratory data in HF patients with and without hypoalbuminemia (defined as serum albumin <3.0g/dL). ResultsTolvaptan was administered in 18 HF patients with hypoalbuminemia (Group A) and 22 HF patients without hypoalbuminemia (Group B). The mean serum albumin was 2.630.27 and 3.46 +/- 0.25g/dL, respectively. The average urine output on tolvaptan increased significantly in both groups (1644.4 +/- 797.6-3011.6 +/- 1453.8mL/day, P=0.004; 1459 +/- 612.7-2112.2 +/- 724.5mL/day, P=0.008; respectively). In addition, we observed higher urine output on therapy in Group A than in Group B (P=0.015). There was a moderate negative correlation between serum albumin and average urine output on tolvaptan (r=-0.42, P=0.007). ConclusionsThe addition of tolvaptan to low dose loop diuretics might be an effective strategy for treatment of HF patients with hypoalbuminemia.	[Okabe, Toshitaka] Showa Univ, Northern Yokohama Hosp, Div Cardiol, Tsuzuki Ku, Yokohama, Kanagawa 2248503, Japan; [Okabe, Toshitaka] Showa Univ, Northern Yokohama Hosp, Cardiac Catheterizat Labs, Tsuzuki Ku, Yokohama, Kanagawa 2248503, Japan	Okabe, T (reprint author), Showa Univ, Northern Yokohama Hosp, Div Cardiol, Tsuzuki Ku, 35-1 Chigasaki Chuo, Yokohama, Kanagawa 2248503, Japan.	alone_with_music@hotmail.com					Huang ZQ, 2013, CURR DRUG METAB, V14, P226; Lau GT, 2002, AM J CARDIOL, V90, P1405, DOI 10.1016/S0002-9149(02)02886-2; Cox ZL, 2014, J CARD FAIL, V20, P611, DOI 10.1016/j.cardfail.2014.05.007; Cardenas A, 2012, J HEPATOL, V56, P571, DOI 10.1016/j.jhep.2011.08.020; Kitsios GD, 2014, J CRIT CARE, V29, P253, DOI 10.1016/j.jcrc.2013.10.004; Udelson JE, 2008, J AM COLL CARDIOL, V52, P1540, DOI 10.1016/j.jacc.2008.08.013; Sato N, 2010, AM HEART J, V159, P949, DOI 10.1016/j.ahj.2010.03.019; Arques S, 2011, ARCH CARDIOVASC DIS, V104, P502, DOI 10.1016/j.acvd.2011.06.003; Jentzer JC, 2010, J AM COLL CARDIOL, V56, P1527, DOI 10.1016/j.jacc.2010.06.034; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Vasan RS, 2000, CIRCULATION, V101, P2118; Dharmaraj R, 2009, PEDIATR NEPHROL, V24, P775, DOI 10.1007/s00467-008-1062-0; Imamura T, 2013, CIRC J, V77, P397, DOI 10.1253/circj.CJ-12-0971; Arques S, 2011, J CARD FAIL, V17, P451, DOI 10.1016/j.cardfail.2011.02.010; Arques S, 2005, AM J CARDIOL, V96, P104, DOI 10.1016/j.amjcard.2005.02.054; Chalasani N, 2001, J AM SOC NEPHROL, V12, P1010; Clarke MM, 2013, PHARMACOTHERAPY, V33, P583, DOI 10.1002/phar.1241; Fonarow GC, 2007, AM HEART J, V153, P1021, DOI 10.1016/j.ahj.2007.03.012; Ghoerghiade M, 2007, JAMA-J AM MED ASSOC, V297, P1332; Huang JX, 2012, J MOL RECOGNIT, V25, P642, DOI 10.1002/jmr.2221; JCS Joint Working Group, 2011, CIRC J, V77, P2157; Kamierczak E, 1999, INT J CARDIOL, V68, P69; Nakayama M, 2011, AM J CARDIOL, V108, P391, DOI 10.1016/j.amjcard.2011.03.062; Sakaida I, 2014, HEPATOL RES, V44, P73, DOI 10.1111/hepr.12098	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5914	1755-5922		CARDIOVASC THER	Cardiovasc. Ther.	OCT	2015	33	5					275	281		10.1111/1755-5922.12142		7	Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy	Cardiovascular System & Cardiology; Pharmacology & Pharmacy	CR6XR	WOS:000361492200004		
J	Yasuyama, K; Hase, H; Shiga, S				Yasuyama, Kouji; Hase, Hiroaki; Shiga, Sakiko			Neuroanatomy of pars intercerebralis neurons with special reference to their connections with neurons immunoreactive for pigment-dispersing factor in the blow fly Protophormia terraenovae	CELL AND TISSUE RESEARCH			English	Article						Pars intercerebralis neurons; Pigment-dispersing factor; Synapsin; Photoperiodism; Electron microscopy; Blow fly (Protophormia terraenovae)	NERVOUS-SYSTEM; DROSOPHILA-MELANOGASTER; RETROCEREBRAL COMPLEX; SYNAPTIC CONNECTIONS; CIRCADIAN-RHYTHMS; WILD-TYPE; ADULT; LATERALIS; ABLATION; RECEPTOR	Input regions of pars intercerebralis (PI) neurons are examined by confocal and electron microscopies with special reference to their connections with neurons immunoreactive for pigment-dispersing factor (PDF) in the blow fly, Protophormia terraenovae. PI neurons are a prerequisite for ovarian development under long-day conditions. Backfills from the cardiac recurrent nerve after severance of the posterior lateral tracts labeled thin fibers derived from the PI neurons in the superior medial protocerebrum. These PI fibers were mainly synapsin-negative and postsynaptic to unknown varicose profiles containing dense-core vesicles. Backfilled fibers in the periesophageal neuropils, derived from the PI neurons or neurons with somata in the subesophageal zone, were varicose and some were synapsin-positive. Electron microscopy revealed the presence of both presynaptic and postsynaptic sites in backfilled fibers in the periesophageal neuropils. Many PDF-immunoreactive varicosities were found in the superior medial and lateral protocerebrum and double-labeling showed that 60-88 % of PDF-immunoreactive varicosities were also synapsin-immunoreactive. Double-labeling with the backfills and PDF immunocytochemistry showed that the PI fibers and PDF-immunoreactive varicosities were located close to each other in the superior medial protocerebrum. Results of triple-labeling of PI neurons, PDF-immunoreactive neurons and synapsin-immunoreactive terminals demonstrated that the synapsin-positive PDF-immunoreactive varicosities contacted the PI fibers. These data suggest that PI neurons receive synaptic contacts from PDF-immunoreactive fibers, which are derived from circadian clock neurons, of small ventral lateral neurons (previously called OL2) or posterior dorsal (PD) neurons with somata in the pars lateralis.	[Yasuyama, Kouji] Kawasaki Med Univ, Dept Nat Sci, Div Biol, Kurashiki, Okayama 7010192, Japan; [Hase, Hiroaki; Shiga, Sakiko] Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, Osaka 5588585, Japan	Shiga, S (reprint author), Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, Osaka 5588585, Japan.	shigask@sci.osaka-cu.ac.jp			Japan Society for Promotion of Science [24370032]	This work was supported by a Grant-in Aid for Scientific Research (B) 24370032 by the Japan Society for Promotion of Science to K.Y. and S.S.	Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Shiga S, 2000, NATURWISSENSCHAFTEN, V87, P125, DOI 10.1007/s001140050689; DAVIS NT, 1985, CELL TISSUE RES, V240, P593, DOI 10.1007/BF00216349; Birse RT, 2011, J EXP BIOL, V214, P4201, DOI 10.1242/jeb.062091; de Velasco B, 2007, DEV BIOL, V302, P309, DOI 10.1016/j.ydbio.2006.09.035; Ito K, 2014, NEURON, V81, P755, DOI 10.1016/j.neuron.2013.12.017; Cavanaugh DJ, 2014, CELL, V157, P689, DOI 10.1016/j.cell.2014.02.024; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; Beck S.D., 1980, INSECT PHOTOPERIODIS; AGNATI LF, 1986, ACTA PHYSIOL SCAND, V128, P201, DOI 10.1111/j.1748-1716.1986.tb07967.x; Hamanaka Y, 2007, CELL TISSUE RES, V329, P581, DOI 10.1007/s00441-007-0433-3; Hamanaka Y, 2005, J COMP NEUROL, V491, P390, DOI 10.1002/cne.20712; HELFRICHFORSTER C, 1993, J COMP NEUROL, V337, P177, DOI 10.1002/cne.903370202; Hermann-Luibl C, 2015, CURR OPIN INSECT SCI, V7, P1; KONO Y, 1975, J INSECT PHYSIOL, V21, P249, DOI 10.1016/0022-1910(75)90021-9; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; Leitinger G, 1999, BRAIN RES, V823, P11, DOI 10.1016/S0006-8993(98)01339-0; Luo JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099732; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; NASSEL DR, 1993, J COMP NEUROL, V331, P183, DOI 10.1002/cne.903310204; Numata H, 1995, ENVIRON ENTOMOL, V24, P1633; Raabe M, 1989, RECENT DEV INSECT NE; Sakai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088175; SAUNDERS DS, 1981, PHYSIOL ENTOMOL, V6, P99, DOI 10.1111/j.1365-3032.1981.tb00264.x; Saunders D.S., 2002, INSECT CLOCKS; Shafer O. T., 2014, CURR OPIN INSECT SCI, V1, P73, DOI DOI 10.1016/J.COIS.2014.05.002; Shiga S, 2000, CELL TISSUE RES, V299, P427, DOI 10.1007/s004410050041; Shiga S, 2009, J EXP BIOL, V212, P867, DOI 10.1242/jeb.027003; Yasuyama K, 2006, J COMP NEUROL, V494, P331, DOI 10.1002/cne.20812	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	OCT	2015	362	1					33	43		10.1007/s00441-015-2192-x		11	Cell Biology	Cell Biology	CR6PQ	WOS:000361470000004		
J	Ekino, S; Sonoda, K; Inui, S				Ekino, Shigeo; Sonoda, Kayoko; Inui, Seiji			Origin of IgM(+)IgG(+) lymphocytes in the bursa of Fabricius	CELL AND TISSUE RESEARCH			English	Article						Bursa of Fabricius; Maternal IgG; IgM(+)IgG(+) B cells; Immune complex; Complement; Chick	FOLLICULAR DENDRITIC CELLS; IGG-BEARING CELLS; B-MEMORY CELLS; ENVIRONMENTAL ANTIGENS; GERMINAL-CENTERS; COMPLEMENT RECEPTORS; LYMPHOID FOLLICLES; IMMUNE-COMPLEXES; MATERNAL IGG; FC-RECEPTOR	IgM(+)IgG(+) B cells were detected, by immunofluorescence staining of single cells, in the bursa of Fabricius after hatching. To study the role of maternal IgG (MIgG) in this emergence of IgM(+)IgG(+) B cells, MIgG-free chicks were established from surgically bursectomized hens. Deprivation of MIgG in chicks completely prevented the appearance of IgM(+)IgG(+) B cells in the bursa 1 week after hatching. However, introduction of fluorescein-isothiocyanate-labeled MIgG to MIgG-free chick embryos on day 18 of incubation retrieved IgM(+)IgG(+) B cells in the bursa 1 week after hatching. Thus, IgM(+)IgG(+) B cells are induced by the binding of MIgG to IgM(+) B cells in the bursa after hatching. Nevertheless, no binding of MIgG to IgM(+) B cells was observed in the bursa of chick embryos in which B-cell proliferation and differentiation were independent of external antigens (Ags). Additionally, the binding of MIgG to IgM(+) B cells after hatching was prevented by the isolation of the bursa from environmental stimuli by bursal duct ligation. Therefore, Ag stimulation from the external environment to the bursa is indispensable for the binding of MIgG to IgM(+) B cells in the bursa. Taken together, the data demonstrate that IgM(+)IgG(+) B cells are generated by Ag-dependent binding of MIgG to IgM(+) B cells in the bursa after hatching.	[Ekino, Shigeo; Sonoda, Kayoko] Kumamoto Univ, Grad Sch Med Sci, Dept Histol, Honjo, Kumamoto, Japan; [Inui, Seiji] Kumamoto Univ, Sch Hlth Sci, Dept Immunol & Hematol, Kuhonji, Kumamoto, Japan	Ekino, S (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Histol, Honjo, Kumamoto, Japan.	ekino@gpo.kumamoto-u.ac.jp; inui@kumamoto-u.ac.jp			Nisshin Seifun Group in Japan	This work was supported in part by the Nisshin Seifun Group in Japan.	TEW JG, 1990, IMMUNOL REV, V117, P185, DOI 10.1111/j.1600-065X.1990.tb00573.x; YOKOYAMA H, 1993, POULTRY SCI, V72, P275; Mage RG, 2006, DEV COMP IMMUNOL, V30, P137, DOI 10.1016/j.dci.2005.06.017; OLAH I, 1978, POULTRY SCI, V57, P1445; LYDYARD PM, 1976, J EXP MED, V144, P79, DOI 10.1084/jem.144.1.79; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; BOCKMAN DE, 1973, AM J ANAT, V136, P455, DOI 10.1002/aja.1001360406; GLICK B, 1956, POULTRY SCI, V35, P224; St Paul M, 2013, VET IMMUNOL IMMUNOP, V152, P191, DOI 10.1016/j.vetimm.2012.10.013; THOMPSON CB, 1987, CELL, V48, P369, DOI 10.1016/0092-8674(87)90188-7; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; West AP, 2004, IMMUNITY, V20, P601, DOI 10.1016/S1074-7613(04)00113-X; KLAUS GGB, 1977, IMMUNOLOGY, V33, P31; GODING JW, 1976, J IMMUNOL METHODS, V13, P215, DOI 10.1016/0022-1759(76)90068-5; Fearon DT, 2000, ANNU REV IMMUNOL, V18, P393, DOI 10.1146/annurev.immunol.18.1.393; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; Keestra AM, 2013, DEV COMP IMMUNOL, V41, P316, DOI 10.1016/j.dci.2013.04.009; Ratcliffe MJH, 2006, DEV COMP IMMUNOL, V30, P101, DOI 10.1016/j.dci.2005.06.018; KOWALCZYK K, 1985, IMMUNOLOGY, V54, P755; Brownlie R, 2011, CELL TISSUE RES, V343, P121, DOI 10.1007/s00441-010-1026-0; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Viertlboeck BC, 2007, P NATL ACAD SCI USA, V104, P11718, DOI 10.1073/pnas.0702011104; Bhalla D. K., 1983, BIOMEDICAL RES APPLI, V3, P79; Brambell FWR, 1970, TRANSMISSION PASSIVE, V18, P20; Cater RH, 1992, SCIENCE, V256, P105; CHEN CLH, 1982, J IMMUNOL, V129, P2580; Cooper MD, 1972, CURRENT PROBLEMS IMM, V1, P33; Ekino S, 2012, CELL TISSUE RES, V348, P537, DOI 10.1007/s00441-012-1407-7; EKINO S, 1980, AUST J EXP BIOL MED, V58, P289, DOI 10.1038/icb.1980.28; EKINO S, 1979, IMMUNOLOGY, V37, P811; EKINO S, 1985, IMMUNOLOGY, V55, P405; EKINO S, 1995, J IMMUNOL, V155, P4551; EKINO S, 1993, EUR J IMMUNOL, V23, P772, DOI 10.1002/eji.1830230331; EKINO S, 1979, LYMPHOLOGY, V12, P247; Ekinol S, 2014, INT REV CEL MOL BIO, V312, P101, DOI 10.1016/B978-0-12-800178-3.00004-X; FULLER R, 1973, BRIT POULTRY SCI, V14, P221, DOI 10.1080/00071667308416020; GABRIELS.AE, 1973, IMMUNOLOGY, V25, P179; GAJLPECZ.KJ, 1969, J EXP MED, V130, P1367, DOI 10.1084/jem.130.6.1367; GROSSI CE, 1977, DEV COMP IMMUNOL, V1, P157, DOI 10.1016/S0145-305X(77)80008-6; Haycock KH, 1992, STATVIEW; HOUSSAINT E, 1987, IMMUNOLOGY, V62, P463; Imamura K, 2009, COMP IMMUNOL MICROB, V32, P419, DOI 10.1016/j.cimid.2007.12.002; KIMURA N, 1986, POULTRY SCI, V65, P1801; KINCADE PW, 1971, J IMMUNOL, V106, P371; KLAUS GGB, 1978, IMMUNOLOGY, V34, P643; Koch G, 1989, RECENT ADV AVIAN IMM, P67; Laursen SB, 1998, IMMUNOLOGY, V94, P587; Maeda K, 1995, CURR TOP MICROBIOL, V201, P119; OKUMURA K, 1976, EUR J IMMUNOL, V6, P467, DOI 10.1002/eji.1830060704; PAPAMICHAIL M, 1975, SCAND J IMMUNOL, V4, P343, DOI 10.1111/j.1365-3083.1975.tb02635.x; PINK JR, 1983, HYBRIDOMA, V2, P287, DOI 10.1089/hyb.1983.2.287; Ratcliffe M J, 1990, Semin Immunol, V2, P217; RATCLIFFE MJH, 1990, EUR J IMMUNOL, V20, P1073, DOI 10.1002/eji.1830200519; Rhee KJ, 2005, J EXP MED, V201, P55, DOI 10.1084/jem.20041849; ROSE ME, 1981, DEV COMP IMMUNOL, V5, P15, DOI 10.1016/S0145-305X(81)80003-1; SCHAFFNE.T, 1974, CELL IMMUNOL, V13, P304, DOI 10.1016/0008-8749(74)90247-0; Sonoda K, 2013, CELL TISSUE RES, V354, P813, DOI 10.1007/s00441-013-1701-z; SORVARI R, 1977, IMMUNOLOGY, V32, P499; SORVARI T, 1975, NATURE, V253, P217, DOI 10.1038/253217a0; Speth C, 2008, FUNDAMENTAL IMMUNOLO, P1047; THORBECK.GJ, 1968, IMMUNOLOGY, V15, P123; THUNOLD S, 1981, SCAND J IMMUNOL, V14, P145, DOI 10.1111/j.1365-3083.1981.tb00194.x; Van den Berg T K, 1995, Curr Top Microbiol Immunol, V201, P49; Yasuda M, 2002, ANAT REC, V266, P207, DOI 10.1002/ar.10062; Yasuda M, 1998, COMP IMMUNOL MICROB, V21, P179, DOI 10.1016/S0147-9571(98)00007-1; Yasuda M, 1998, COMP IMMUNOL MICROB, V21, P191, DOI 10.1016/S0147-9571(98)00006-X	66	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	OCT	2015	362	1					153	162		10.1007/s00441-015-2196-6		10	Cell Biology	Cell Biology	CR6PQ	WOS:000361470000013		
J	Suzuki, K; Fukusumi, Y; Yamazaki, M; Kaneko, H; Tsuruga, K; Tanaka, H; Ito, E; Matsui, K; Kawachi, H				Suzuki, Koichi; Fukusumi, Yoshiyasu; Yamazaki, Mihoko; Kaneko, Hiroshi; Tsuruga, Kazushi; Tanaka, Hiroshi; Ito, Etsuro; Matsui, Katsuyuki; Kawachi, Hiroshi			Alteration in the podoplanin-ezrin-cytoskeleton linkage is an important initiation event of the podocyte injury in puromycin aminonucleoside nephropathy, a mimic of minimal change nephrotic syndrome	CELL AND TISSUE RESEARCH			English	Article						Proteinuria; Podocyte; Nephrotic syndrome; Glycoprotein; Sialic acid	GLOMERULAR EPITHELIAL-CELL; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; PROTEINURIC STATES; SLIT DIAPHRAGM; PA2.26 ANTIGEN; RENAL DAMAGE; RAT MODEL; NEPHRIN; EXPRESSION	Podoplanin was identified as a protein associated with the transformation of arborized foot processes of glomerular epithelial cells (podocytes) to flat feet. However, the function of podoplanin in the podocyte is not yet fully clarified. In this study, we analyzed the molecular nature of podoplanin, and its expression in rat nephrotic models and patients with minimal change nephrotic syndrome (MCNS). We demonstrated here that podoplanin has two forms: one contains abundant sialic acid and the other a lesser amount of sialic acid. Podoplanin bound ezrin to interact with the cytoskeleton. The silencing of podoplanin in cultured podocytes caused a change in the cell shape and the distribution of ezrin and actin. The expression of podoplanin was clearly reduced before the onset of proteinuria in puromycin aminonucleoside (PAN) nephropathy, a mimic of MCNS, and the decrease in the expression of podoplanin became more evident at the proteinuric stage. Podoplanin was detected in normal urine samples, and the amount of urinary podoplanin markedly increased on day 1 of PAN nephropathy. Urinary ezrin was also detected. The amount of the phosphorylated ezrin was reduced, while the amount of the podoplanin-interacting ezrin increased. The podoplanin expression was reduced in a patient with active-phase MCNS. It is conceivable that the alteration of the podoplanin-ezrin-cytoskeleton linkage is an important event of the podocyte injury in MCNS.	[Suzuki, Koichi; Fukusumi, Yoshiyasu; Yamazaki, Mihoko; Kaneko, Hiroshi; Kawachi, Hiroshi] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cell Biol, Inst Nephrol, Niigata 9518510, Japan; [Suzuki, Koichi; Tsuruga, Kazushi; Tanaka, Hiroshi; Ito, Etsuro] Hirosaki Univ, Grad Sch Med, Dept Pediat, Hirosaki, Aomori, Japan; [Matsui, Katsuyuki] Teikyo Univ, Sch Med, Dept Internal Med 4, Kawasaki, Kanagawa, Japan	Kawachi, H (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Cell Biol, Inst Nephrol, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	kawachi@med.niigata-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23390224, 24790839]	This work was supported by Grant-Aids for Scientific Research (B: 23390224 to H.K.) and Grant-Aid for Young Scientists (B: 24790839 to Y.F.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors wish to thank Ms. Mutsumi Kayaba and Ms. Yukina Kitazawa for their excellent technical assistance and Mr. Masaaki Nameta for his help in the electron microscopic analysis.	Nakatsue T, 2005, KIDNEY INT, V67, P2239, DOI 10.1111/j.1523-1755.2005.00328.x; Tryggvason K, 1999, J AM SOC NEPHROL, V10, P2440; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x; Scholl FG, 1999, J CELL SCI, V112, P4601; Matsui K, 2003, J AM SOC NEPHROL, V14, P1981, DOI 10.1097/01.ASN.0000076078.50889.43; Kerjaschki D, 2001, J CLIN INVEST, V108, P1583, DOI 10.1172/JCI14629; Miyauchi N, 2006, J AM SOC NEPHROL, V17, P2748, DOI 10.1681/ASN.2005121293; OKUDA S, 1986, KIDNEY INT, V29, P502, DOI 10.1038/ki.1986.28; Vanderbilt JN, 2008, AM J RESP CELL MOL, V39, P253, DOI 10.1165/rcmb.2008-0049OC; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; MICHAEL AF, 1970, LAB INVEST, V23, P649; Martin-Villar E, 2005, INT J CANCER, V113, P899, DOI 10.1002/ijc.20656; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Kerjaschki D, 2004, J AM SOC NEPHROL, V15, P603, DOI 10.1097/01.ASN.0000113316.52371.2E; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Takeda T, 2000, MOL BIOL CELL, V11, P3219; FISHMAN JA, 1985, AM J PATHOL, V118, P398; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI12539; Somlo S, 2000, NAT GENET, V24, P333, DOI 10.1038/74139; Mahtab EAF, 2008, DEV DYNAM, V237, P847, DOI 10.1002/dvdy.21463; Kawachi H, 2003, J AM SOC NEPHROL, V14, P46, DOI 10.1097/01.ASN.0000037401.02391.76; Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Macconi D, 2006, AM J PATHOL, V168, P42, DOI 10.2353/ajpath.2006.050398; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; BERTANI T, 1986, KIDNEY INT, V30, P488, DOI 10.1038/ki.1986.212; BERTRAM JF, 1990, CELL TISSUE RES, V260, P555, DOI 10.1007/BF00297236; BreitenederGeleff S, 1997, AM J PATHOL, V151, P1141; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; CHAREST PM, 1985, P NATL ACAD SCI USA, V82, P8508, DOI 10.1073/pnas.82.24.8508; Clegg GR, 2005, AM J PHYSIOL-LUNG C, V289, pL382, DOI 10.1152/ajplung.00476.2004; Doublier S, 2001, AM J PATHOL, V158, P1723, DOI 10.1016/S0002-9440(10)64128-4; Han GD, 2003, J AM SOC NEPHROL, V14, P3111, DOI 10.1097/01.ASN.0000097371.64671.65; Hashimoto T, 2007, KIDNEY INT, V72, P954, DOI 10.1038/sj.ki.5002454; Hugo C, 1998, KIDNEY INT, V54, P1934, DOI 10.1046/j.1523-1755.1998.00195.x; Kawachi H, 2000, CLIN EXP NEPHROL, V4, P161, DOI 10.1007/s101570070017; KAWACHI H, 1992, CLIN EXP IMMUNOL, V88, P399; Kawachi H, 2000, KIDNEY INT, V57, P1949, DOI 10.1046/j.1523-1755.2000.00044.x; Kriz W, 1998, CLIN EXP NEPHROL, V2, P85, DOI 10.1007/BF02479929; Matsui K, 1998, J AM SOC NEPHROL, V9, P2013; Orlando RA, 2001, J AM SOC NEPHROL, V12, P1589; Otaki Y, 2008, AM J PHYSIOL-RENAL, V295, pF1376, DOI 10.1152/ajprenal.00075.2008; RYAN GB, 1975, KIDNEY INT, V8, P219, DOI 10.1038/ki.1975.105; Smoyer WE, 1998, J MOL MED-JMM, V76, P172, DOI 10.1007/s001090050206; WEENING JJ, 1983, KIDNEY INT, V24, P152, DOI 10.1038/ki.1983.139; Zhu Lixin, 2007, Am J Physiol Cell Physiol, V293, pC874, DOI 10.1152/ajpcell.00111.2007	49	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	OCT	2015	362	1					201	213		10.1007/s00441-015-2178-8		13	Cell Biology	Cell Biology	CR6PQ	WOS:000361470000017		
J	Iwanaga, J; Saga, T; Tabira, Y; Nakamura, M; Kitashima, S; Watanabe, K; Kusukawa, J; Yamaki, KI				Iwanaga, Joe; Saga, Tsuyoshi; Tabira, Yoko; Nakamura, Moriyoshi; Kitashima, Sadaharu; Watanabe, Koichi; Kusukawa, Jingo; Yamaki, Koh-Ichi			The clinical anatomy of accessory mental nerves and foramina	CLINICAL ANATOMY			English	Review						anatomy and histology; diagnosis; embryology; innervation; oral surgical procedures; chin; review	BEAM COMPUTED-TOMOGRAPHY; BUCCAL FORAMEN; POSITION; IMAGES; CT	Since three-dimensional computed tomography was developed, many researchers have described accessory mental foramina. The anatomical and radiological findings have been discussed, but details of accessory mental nerves (AMNs) have only been researched in a small number of anatomical and clinical cases. For this article, we reviewed the literature relating to accessory mental foramina (AMFs) and nerves to clarify aspects important for clinical situations. The review showed that the distribution pattern of the AMN can differ according to the position of the accessory mental foramen, and the reported incidence of AMFs differs among observation methods. A review of clinical cases also revealed that injury to large AMF can result in paresthesia. This investigation did not reveal all aspects of AMNs and AMFs, but will be useful for diagnosis and treatment by many dentists and oral and maxillofacial surgeons. Clin. Anat. 28:848-856, 2015. (c) 2015 Wiley Periodicals, Inc.	[Iwanaga, Joe; Saga, Tsuyoshi; Tabira, Yoko; Nakamura, Moriyoshi; Kitashima, Sadaharu; Watanabe, Koichi; Kusukawa, Jingo; Yamaki, Koh-Ichi] Kurume Univ, Sch Med, Dept Anat, Kurume, Fukuoka 8300011, Japan; [Iwanaga, Joe; Nakamura, Moriyoshi; Kitashima, Sadaharu; Kusukawa, Jingo] Kurume Univ, Sch Med, Dent & Oral Med Ctr, Kurume, Fukuoka 8300011, Japan	Iwanaga, J (reprint author), Kurume Univ, Sch Med, Dept Anat, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	iwanaga_jyou@med.kurume-u.ac.jp					Ahmed S, 2014, ORAL SURG, V8, P51; Al-Khateeb T, 2007, SURG RADIOL ANAT, V29, P231, DOI 10.1007/s00276-007-0199-z; Alsaad K, 2003, INT J ORAL MAX SURG, V32, P325, DOI 10.1054/ijom.2002.0334; Won SY, 2014, CLIN ANAT, V27, P598, DOI 10.1002/ca.22310; Singh R, 2010, INT J MORPHOL, V28, P1141, DOI 10.4067/S0717-95022010000400025; Hu KS, 2007, J ORAL MAXIL SURG, V65, P2288, DOI 10.1016/j.jams.2007.06.658; Naitoh Munetaka, 2009, Okajimas Folia Anatomica Japonica, V86, P25; GERSHENSON A, 1986, ACTA ANAT, V126, P21; Arx T, 2014, ORAL SURG, V7, P216; Balcioglu HA, 2011, INT J PEDIATR OTORHI, V75, P1436, DOI 10.1016/j.ijporl.2011.08.010; Boronat Lopez A, 2006, MED ORAL PATOL ORAL, V11, pE510; Budhiraja V, 2013, ISRN ANAT, V2013; Cairankaya LB, 2008, J CONT DENT PRACT, V9, P98; Clemente CD, 1984, GRAYS ANATOMY 13 AM, P1168; Concepcion M, 2000, J ENDODONT, V26, P619, DOI 10.1097/00004770-200010000-00010; Fuakami K, 2011, SURG RADIOL ANAT, V33, P141, DOI 10.1007/s00276-010-0719-0; Gamoh S, 2014, OPEN J RADIOL, V4, P173; Goregen M, 2013, TURK J MED SCI, V43, P479, DOI 10.3906/sag-1206-105; Gupta S, 2012, NJMR, V2, P28; Haktanir A, 2010, SURG RADIOL ANAT, V32, P351, DOI 10.1007/s00276-009-0572-1; Hasan T., 2010, INT J ANAT VARIATION, V3, P167; Hoque MM, 2014, BANGLADESH J ANAT, V11, P7; Igarashi C, 2004, ORAL RADIOL, V20, P68, DOI 10.1007/s11282-004-0012-1; Imada TSN, 2014, CLIN ORAL IMPLAN RES, V25, pE94, DOI 10.1111/clr.12066; Jaju PP, 2013, SDJ, V8, P32; Jha AK, 2012, SURG RADIOL ANAT, V34, P469, DOI 10.1007/s00276-011-0892-9; Kalender A, 2012, CLIN ANAT, V25, P584, DOI 10.1002/ca.21277; Kamijo Y, 1967, ORAL ANATOMY, V1st; Katakami K, 2008, J ENDODONT, V34, P1441, DOI 10.1016/j.joen.2008.08.033; Kulkarni Sudhindra, 2011, J Indian Soc Periodontol, V15, P70, DOI 10.4103/0972-124X.82270; Lauhr G, 2015, SURG RADIOL ANAT, V37, P403, DOI 10.1007/s00276-014-1347-x; Mamatha NS, 2013, J CLIN DIAGN RES, V7, P2078; Mraiwa Nuri, 2003, Clin Implant Dent Relat Res, V5, P219, DOI 10.1111/j.1708-8208.2003.tb00204.x; Naitoh M, 2011, CLIN ORAL IMPLAN RES, V22, P1415, DOI 10.1111/j.1600-0501.2010.02116.x; Naitoh M, 2009, ORAL SURG ORAL MED O, V107, P289, DOI 10.1016/j.tripleo.2008.09.010; Neves Frederico Sampaio, 2014, Oral Maxillofac Surg, V18, P419, DOI 10.1007/s10006-013-0428-z; Oliveira-Santos C, 2011, J ORAL REHABIL, V38, P595, DOI 10.1111/j.1365-2842.2010.02186.x; Orhan AI, 2013, J CRANIOFAC SURG, V24, pE365, DOI 10.1097/SCS.0b013e3182902f49; Pancer B, 2014, IMPLANT DENT, V23, P116, DOI 10.1097/ID.0000000000000056; Paraskevas George, 2015, Oral Maxillofac Surg, V19, P177, DOI 10.1007/s10006-014-0474-1; Patil S, 2013, SURG RADIOL ANAT, V35, P323, DOI 10.1007/s00276-012-1044-6; Prabodha LBL, 2006, GALLE MED J, V11, P13; Radlanski RJ, 2002, EUR J ORAL SCI, V110, P452, DOI 10.1034/j.1600-0722.2002.21353.x; Rai R, 2014, INT J HLTH BIOMED RE, V2, P144; Ramadhan Anwar, 2010, Stomatologija, V12, P93; RIESENFELD A, 1956, AM J PHYS ANTHROPOL, V14, P85, DOI 10.1002/ajpa.1330140122; Roopa R, 2002, INDIAN J DENT RES, V14, P57; Santos O, 2013, BRAZ ORAL RES, V27, P128, DOI 10.1590/S1806-83242013005000003; Sawyer DR, 1998, ARCH ORAL BIOL, V43, P417, DOI 10.1016/S0003-9969(98)00012-0; Sekerci AE, 2014, J DENT IMPLANT, V4, P101; Shukla RK, 2015, INT J ANAT RES, V3, P899; Sihler C, 1895, ARCH MIKROS ANAT ENT, V46, P709, DOI 10.1007/BF02906674; Simonton FV, 1923, AM J PHYS ANTHROPOL, V6, P413, DOI 10.1002/ajpa.1330060407; Singh R, 2011, INT J EXP CLIN ANAT, V5, P23; Sisman Y, 2012, DENTOMAXILLOFAC RAD, V41, P558, DOI 10.1259/dmfr/63250313; Smartt JM, 2005, PLAST RECONSTR SURG, V116, p14E, DOI 10.1097/01.PRS.0000169940.69315.9C; Sutton R N, 1974, Aust Dent J, V19, P167; Thakur G, 2011, BMJ CASE REPORTS, DOI [10.1136/bcr.09.2010.3326, DOI 10.1136/BCR.09.2010.3326]; Toh Hidetoshi, 1992, Okajimas Folia Anatomica Japonica, V69, P85; Tomografia FMAEM, 2013, INT J MORPHOL, V31, P1104; Torres Marianna Guanaes Gomes, 2015, Imaging Sci Dent, V45, P61, DOI 10.5624/isd.2015.45.1.61; Udhaya K, 2013, J Clin Diagn Res, V7, P1547, DOI 10.7860/JCDR/2013/6060.3207; Zarei R, 2013, GLOBAL J MED RES STU, V1, P17	63	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0897-3806	1098-2353		CLIN ANAT	Clin. Anat.	OCT	2015	28	7					848	856		10.1002/ca.22597		9	Anatomy & Morphology	Anatomy & Morphology	CR3OK	WOS:000361242400010		
J	Mori, S; Nishii, T; Takaya, T; Kashio, K; Kasamatsu, A; Takamine, S; Ito, T; Fujiwara, S; Kono, AK; Hirata, KI				Mori, Shumpei; Nishii, Tatsuya; Takaya, Tomofumi; Kashio, Kazuhiro; Kasamatsu, Akira; Takamine, Sachiko; Ito, Tatsuro; Fujiwara, Sei; Kono, Atsushi K.; Hirata, Ken-Ichi			Clinical structural anatomy of the inferior pyramidal space reconstructed from the living heart: Three-dimensional visualization using multidetector-row computed tomography	CLINICAL ANATOMY			English	Review						inferior pyramidal space; atrioventricular septum; Koch triangle; central fibrous body; computed tomography; three-dimensional anatomy; living heart anatomy	ATRIOVENTRICULAR JUNCTIONS; CONDUCTION SYSTEM; CARDIAC ANATOMY; CORRELATIVE ANATOMY; ATRIAL MUSCULATURE; ACCESSORY PATHWAYS; CATHETER ABLATION; FREE-WALL; VALVE; ELECTROPHYSIOLOGIST	The inferior pyramidal space (IPS) comprises the epicardial visceral adipose tissue wedged between the bottoms of the four cardiac chambers from the postero-inferior epicardial surface of the heart. Understanding the complex anatomy around the IPS is important for clinical cardiologists. Although leading anatomists and radiologists have clarified the anatomy of the IPS in detail, few studies have demonstrated this anatomy in three dimensions. The aim of this study was to visualize the three-dimensional anatomy of the IPS reconstructed from the living heart using multidetector-row computed tomography. We also developed an original paper model of the IPS to enhance understanding of its intricate structure. Clin. Anat. 28:878-887, 2015. (c) 2014 Wiley Periodicals, Inc.	[Mori, Shumpei; Takaya, Tomofumi; Kashio, Kazuhiro; Kasamatsu, Akira; Takamine, Sachiko; Ito, Tatsuro; Fujiwara, Sei; Hirata, Ken-Ichi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 657, Japan; [Nishii, Tatsuya; Kono, Atsushi K.] Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo 657, Japan	Mori, S (reprint author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 657, Japan.	shumpei_8@hotmail.com					Adachi M, 2009, PACE, V32, pS182, DOI 10.1111/j.1540-8159.2008.02290.x; Anderson RH, 2000, ANAT REC, V260, P81, DOI 10.1002/1097-0185(20000901)260:1<81::AID-AR90>3.0.CO;2-3; Anderson RH, 2009, CLIN ANAT, V22, P47, DOI 10.1002/ca.20741; Sanchez-Quintana D, 2001, J CARDIOVASC ELECTR, V12, P210, DOI 10.1046/j.1540-8167.2001.00210.x; TITUS JL, 1973, CIRCULATION, V47, P170; Anderson RH, 2013, J CARDIOVASC TRANSL, V6, P118, DOI 10.1007/s12265-012-9434-z; Anderson RH, 2013, J CARDIOVASC TRANSL, V6, P187, DOI 10.1007/s12265-012-9433-0; Cabrera JA, 1998, J CARDIOVASC ELECTR, V9, P1186, DOI 10.1111/j.1540-8167.1998.tb00091.x; Anderson RH, 2014, ANAT REC, V297, P1414, DOI 10.1002/ar.22949; ANGELINI A, 1988, BRIT HEART J, V59, P712; Katti K, 2012, CLIN ANAT, V25, P379, DOI 10.1002/ca.21236; Asirvatham SJ, 2009, J CARDIOVASC ELECTR, V20, P955, DOI 10.1111/j.1540-8167.2009.01472.x; Sanchez-Quintana D, 1997, J CARDIOVASC ELECTR, V8, P1396, DOI 10.1111/j.1540-8167.1997.tb01036.x; Anderson RH, 2003, HEART, V89, P949, DOI 10.1136/heart.89.8.949; Kim JS, 2001, CIRC RES, V88, P395; Anderson RH, 1999, CLIN ANAT, V12, P362, DOI 10.1002/(SICI)1098-2353(1999)12:5<362::AID-CA6>3.0.CO;2-F; Mazgalev TN, 2001, CIRCULATION, V103, P2660; Anderson RH, 2004, J ANAT, V205, P159, DOI 10.1111/j.0021-8782.2004.00330.x; Asirvatham SJ, 2009, J CARDIOVASC ELECTR, V20, P113, DOI 10.1111/j.1540-8167.2008.01344.x; BECKER AE, 1982, J THORAC CARDIOV SUR, V83, P461; Bhatnagar Kunwar P, 2006, Clin Anat, V19, P510, DOI 10.1002/ca.20195; Cosio FG, 1999, CIRCULATION, V100, pE31; DEAN JW, 1994, J AM COLL CARDIOL, V24, P1725; Farre J, 2010, PACE, V33, P497, DOI 10.1111/j.1540-8159.2009.02644.x; JACKMAN WM, 1989, PACE, V12, P204, DOI 10.1111/j.1540-8159.1989.tb02648.x; Kozlowski D, 1998, PACE, V21, P163, DOI 10.1111/j.1540-8159.1998.tb01081.x; KUCK KH, 1992, CIRCULATION, V86, P1743; MASSING GK, 1976, CIRCULATION, V53, P609; Saremi F, 2007, RADIOGRAPHICS, V27, P1539, DOI 10.1148/rg.276075003; SCHEINMAN MM, 1992, J AM COLL CARDIOL, V20, P1220; Shapiro LB, 1998, CLIN ANAT, V11, P75, DOI 10.1002/(SICI)1098-2353(1998)11:2<75::AID-CA1>3.0.CO;2-R; WIDRAN J, 1951, CIRCULATION, V4, P863	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0897-3806	1098-2353		CLIN ANAT	Clin. Anat.	OCT	2015	28	7					878	887		10.1002/ca.22483		10	Anatomy & Morphology	Anatomy & Morphology	CR3OK	WOS:000361242400014		
J	Suzuki, D; Otsubo, H; Watanabe, T; Kamiya, T; Nagoya, S; Yamashita, T; Shino, K				Suzuki, Daisuke; Otsubo, Hidenori; Watanabe, Takafumi; Kamiya, Tomoaki; Nagoya, Satoshi; Yamashita, Toshihiko; Shino, Konsei			Ultrastructure of the three anterior cruciate ligament bundles	CLINICAL ANATOMY			English	Article						ACL; collagen fibril; ultrastructure; three bundles; mass average diameter	COLLAGEN FIBRILS; TENDON; MORPHOMETRY; ELECTRON; ANATOMY	The anterior cruciate ligament (ACL) can be morphologically separated into not only two, but three bundles: the anteromedial-medial bundle (AM-MB), the anteromedial-lateral bundle (AM-LB), and the posterolateral bundle (PLB). Our hypothesis was that the three bundles differ in their microstructures. The purpose of this study was to clarify the microstructural differences among the three bundles. The normal ACLs of six fresh frozen cadavers were harvested. After the AM-MB, AM-LB, and PLB were identified, their fibril structures were analyzed using a transmission electron microscope. The fibril orientation, distribution pattern, and the mass average diameter of the fibrils (MAD) were compared among the AM-MBs, AM-LBs, and PLBs. The AM-MB and AM-LB fibrils were arranged mostly in the longitudinal direction, while the PLB fibrils were not aligned in a uniform direction. The fibril diameter distribution pattern of AM-MBs showed a bi-modal pattern due to the existence of small-diameter (30-40 nm) and large-diameter fibrils (70-80 nm), while that of the AM-LBs and PLBs had a unimodal pattern with one prominent high peak at a diameter of 50-60 nm. The mean MAD of the AM-MBs (83.2-11.2 nm) was significantly larger than that of the PLBs (66.8-7.7 nm), while it showed no significant difference compared to that of the AM-LBs (77.6-12.3 nm). The three ACL bundles have different ultrastructures. The AM-MB predominantly includes thick, uni-directionally oriented fibrils like tendons, while the PLB consists of thinner, multi-directionally oriented fibrils. The AM-LB shows an intermediate structure between the AM-MB and the PLB. Clin. Anat. 28:910-916, 2015. (c) 2015 Wiley Periodicals, Inc.	[Suzuki, Daisuke; Nagoya, Satoshi] Sapporo Med Univ, Dept Musculoskeletal Biomech & Surg Dev, Sapporo, Hokkaido 0608556, Japan; [Otsubo, Hidenori; Kamiya, Tomoaki; Yamashita, Toshihiko] Sapporo Med Univ, Sch Med, Dept Orthoped Surg, Sapporo, Hokkaido 0608556, Japan; [Watanabe, Takafumi] Shinshu Univ, Fac Agr, Kami, Nagano, Japan; [Shino, Konsei] Yukioka Hosp, Sports Orthopaed Ctr, Osaka, Japan	Suzuki, D (reprint author), Sapporo Med Univ, Dept Musculoskeletal Biomech & Surg Dev, Chuo Ku, South 1 West 17, Sapporo, Hokkaido 0608556, Japan.	daisuke@sapmed.ac.jp					HART RA, 1992, J ORTHOPAED RES, V10, P96, DOI 10.1002/jor.1100100112; NOYES FR, 1976, J BONE JOINT SURG AM, V58, P1074; Hashemi J, 2008, J ORTHOP RES, V26, P945, DOI 10.1002/jor.20621; Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x; Mae T, 2013, ARTHROSCOPY, V29, P213, DOI 10.1016/j.arthro.2012.08.012; Kato Y, 2012, ARTHROSCOPY, V28, P247, DOI 10.1016/j.arthro.2011.07.019; MOMMERSTEEG TJA, 1995, J ANAT, V187, P461; Chandrashekar N, 2006, J BIOMECH, V39, P2943, DOI 10.1016/j.jbiomech.2005.10.031; Fujie H, 2011, KNEE SURG SPORT TR A, V19, pS47, DOI 10.1007/s00167-011-1513-1; PARRY DAD, 1978, PROC R SOC SER B-BIO, V203, P305, DOI 10.1098/rspb.1978.0107; Otsubo H, 2012, KNEE SURG SPORT TR A, V20, P127, DOI 10.1007/s00167-011-1576-z; ARNOCZKY SP, 1983, CLIN ORTHOP RELAT R, P19; Baek GH, 1998, CLIN ORTHOP RELAT R, P205; BUTLER DL, 1992, J BIOMECH, V25, P511, DOI 10.1016/0021-9290(92)90091-E; ENWEMEKA CS, 1992, TISSUE CELL, V24, P499, DOI 10.1016/0040-8166(92)90066-G; Flint H, 1984, CONNECT TISSUE RES, V13, P69; GIRGIS FG, 1975, CLIN ORTHOP RELAT R, P216; Hadjicostas PT, 2008, KNEE SURG SPORT TR A, V16, P1099, DOI 10.1007/s00167-008-0603-1; JONES PN, 1991, CONNECT TISSUE RES, V26, P11, DOI 10.3109/03008209109152160; JOZSA L, 1989, MATRIX, V9, P140; NEURATH MF, 1992, ACTA ORTHOP SCAND, V63, P507, DOI 10.3109/17453679209154724; Norwood L A, 1979, Am J Sports Med, V7, P23, DOI 10.1177/036354657900700106; Oakes Barry W., 1993, P209; Rumian AP, 2007, J ORTHOP RES, V25, P458, DOI 10.1002/jor.20218; Shino K, 2005, OPER TECH ORTHOP, V15, P130, DOI 10.1053/j.oto.2004.10.012; Strocchi R, 1996, Ital J Anat Embryol, V101, P213	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0897-3806	1098-2353		CLIN ANAT	Clin. Anat.	OCT	2015	28	7					910	916		10.1002/ca.22586		7	Anatomy & Morphology	Anatomy & Morphology	CR3OK	WOS:000361242400018		
J	Matsui, K; Mori, A; Ikeda, R				Matsui, K.; Mori, A.; Ikeda, R.			Langerhans cell-like dendritic cells stimulated with an adjuvant direct the development of Th1 and Th2 cells in vivo	CLINICAL AND EXPERIMENTAL IMMUNOLOGY			English	Article						IFN-gamma; IL-4; Langerhans cells; Th1; Th2	REGULATORY T-CELLS; ALLERGIC DISEASES; BONE-MARROW; E-CADHERIN; SKIN; ACTIVATION; EXPRESSION; IMMUNOTHERAPY; INFLAMMATION; RECEPTORS	It is well known that Langerhans cells (LCs) work as the primary orchestrators in the polarization of immune responses towards a T helper type 1 (Th1) or Th2 milieu. In this study, we attempted to generate LCs from murine bone marrow cells and elicit a Th1- or Th2-prone immune response through the LCs after stimulation with Th1 or Th2 adjuvant. LCs were generated from murine bone marrow cells using granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-4 and transforming growth factor (TGF)-, and were obtained as I-A(d) positive cells. Mice were primed with Th1/Th2 adjuvant- and ovalbumin (OVA)-pulsed LCs and then given a booster injection of OVA 2 days later via the hind footpad. Five days after the OVA injection, the cytokine response in the draining popliteal lymph nodes was investigated by reverse transcription-polymerase chain reaction (RT-PCR) flow cytometry and enzyme-linked immunosorbent assay (ELISA). The generated LCs expressed typical LC surface markers, E-cadherin and Langerin, and were classified accordingly as LC-like dendritic cells (LDCs). Administration of Th1 adjuvant, cytosine-phosphate-guanosine (CpG)-DNA- and OVA-pulsed LDCs into the hind footpads of mice induced a Th1-prone immune response, as represented by up-regulation of IFN- production and down-regulation of IL-4 production in the lymph node cells. Conversely, Th2 adjuvant, histamine-pulsed LDCs induced a Th2-prone immune response, as represented by up-regulation of IL-4 production and down-regulation of IFN- production. These results suggest that LDCs may be used as a substitute for LCs and have the ability to induce the development of Th1 and Th2 cells in vivo. Our experimental system would therefore be useful for screening of inhibitors of Th1/Th2 differentiation in order to control allergic disease.	[Matsui, K.; Mori, A.; Ikeda, R.] Meiji Pharmaceut Univ, Dept Microbial Sci & Host Def, Tokyo 2048588, Japan	Matsui, K (reprint author), Meiji Pharmaceut Univ, Dept Microbial Sci & Host Def, 2-522-1 Noshio, Tokyo 2048588, Japan.	kmatsui@my-pharm.ac.jp			JSPS KAKENHI [26460238]	This work was supported by JSPS KAKENHI Grant number 26460238.	Dunford PJ, 2006, J IMMUNOL, V176, P7062; Herrick CA, 2003, NAT REV IMMUNOL, V3, P405, DOI 10.1038/nri1084; Erhardt A, 2011, J IMMUNOL, V186, P5284, DOI 10.4049/jimmunol.1003750; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Caron G, 2001, J IMMUNOL, V167, P3682; TANG AM, 1993, NATURE, V361, P82, DOI 10.1038/361082a0; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; KATZ SI, 1979, NATURE, V282, P324, DOI 10.1038/282324a0; Garn H, 2007, IMMUNOBIOLOGY, V212, P441, DOI 10.1016/j.imbio.2007.03.006; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Stoitzner P, 2003, J INVEST DERMATOL, V120, P266, DOI 10.1046/j.1523-1747.2003.12042.x; Monteiro P, 2011, J IMMUNOL, V186, P4618, DOI 10.4049/jimmunol.1004151; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Creticos PS, 2006, NEW ENGL J MED, V355, P1445, DOI 10.1056/NEJMoa052916; Imai T, 1999, INT IMMUNOL, V11, P81, DOI 10.1093/intimm/11.1.81; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Hirahara K, 2006, J IMMUNOL, V177, P4488; Cowden JM, 2010, J INVEST DERMATOL, V130, P1023, DOI 10.1038/jid.2009.358; Baatar D, 2007, J IMMUNOL, V178, P4891; Takahara K, 2002, INT IMMUNOL, V14, P433, DOI 10.1093/intimm/14.5.433; Sells RE, 2010, J INVEST DERMATOL, V130, P2697, DOI 10.1038/jid.2010.292; Matsui K, 2012, J INVEST ALLERG CLIN, V22, P80; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Barrett AW, 1996, CRIT REV ORAL BIOL M, V7, P36; DesFraissinette A, 1989, J DERMATOL, V16, P255; Feili-Hariri M, 2005, J LEUKOCYTE BIOL, V78, P656, DOI 10.1189/jlb.1104631; Jakob T, 1997, J IMMUNOL, V159, P2693; Kay AB, 2001, NEW ENGL J MED, V344, P30; Klinman Dennis M, 2004, Nat Rev Immunol, V4, P249, DOI 10.1038/nri1329; Lundberg K, 2011, EUR J PHARMACOL, V651, P197, DOI 10.1016/j.ejphar.2010.10.065; MacPherson GG, 1999, CURR TOP MICROBIOL, V236, P33; Menges M, 2005, J LEUKOCYTE BIOL, V77, P535, DOI 10.1189/jlb.0804473; Okamoto T, 2009, CLIN EXP IMMUNOL, V157, P27, DOI 10.1111/j.1365-2249.2009.03958.x; STEINMAN R, 1989, BIOESSAYS, V10, P145, DOI 10.1002/bies.950100503	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9104	1365-2249		CLIN EXP IMMUNOL	Clin. Exp. Immunol.	OCT	2015	182	1					101	107		10.1111/cei.12671		7	Immunology	Immunology	CR6MV	WOS:000361462500011		
J	Yamane, T; Seto, A; Suzuki, T; Yokota, K; Li, CP; Mimura, T; Kuji, I				Yamane, Tomohiko; Seto, Akira; Suzuki, Tomonari; Yokota, Kazuhiro; Li, Chih-Ping; Mimura, Toshihide; Kuji, Ichiei			Orbital IgG4-Related Disease Detected by 11C-Methionine PET/CT	CLINICAL NUCLEAR MEDICINE			English	Editorial Material							SYSTEMIC-DISEASE; F-18-FDG PET/CT; C-11-METHIONINE; INFLAMMATION	A 64-year-old man presented with a complaint of left exophthalmos. Whole-body F-18-FDG PET/CT showed increased uptake in the soft tissue masses in the orbits, peripancreas, and left renal hilum. C-11-methionine (MET) PET/CT of the head and neck showed increased uptake in the orbits, and the SUVmax of the left orbital lesion was 7.0. The patient was finally diagnosed as IgG4-related disease by the results of increased serum IgG4 and the biopsy of the orbital lesion. Although C-11-MET is generally considered as a tumor-specific tracer, fibrous tissues of IgG4-related disease may be visualized by C-11-MET PET/CT.	[Yamane, Tomohiko; Kuji, Ichiei] Saitama Med Univ, Saitama Int Med Ctr, Dept Nucl Med, Hidaka 3501298, Japan; [Seto, Akira] Saitama Med Univ Hosp, Fac Med, Dept Nucl Med, Moroyama, Saitama, Japan; [Suzuki, Tomonari] Saitama Med Univ, Saitama Int Med Ctr, Dept Neurooncol, Hidaka 3501298, Japan; [Yokota, Kazuhiro; Mimura, Toshihide] Saitama Med Univ Hosp, Fac Med, Dept Rheumatol & Appl Immunol, Moroyama, Saitama, Japan; [Li, Chih-Ping] Saitama Med Univ, Saitama Int Med Ctr, Dept Pathol, Hidaka 3501298, Japan	Yamane, T (reprint author), Saitama Med Univ, Saitama Int Med Ctr, Dept Nucl Med, 1397-1 Yamane, Hidaka 3501298, Japan.	yamane_t@saitama-med.ac.jp					Plaza JA, 2011, ARCH OPHTHALMOL-CHIC, V129, P421, DOI 10.1001/archophthalmol.2011.16; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Deshpande V, 2012, MODERN PATHOL, V25, P1181, DOI 10.1038/modpathol.2012.72; Norikane T, 2012, CLIN NUCL MED, V37, P108, DOI 10.1097/RLU.0b013e31823933c1; Wallace ZS, 2012, SURV OPHTHALMOL, V57, P26, DOI 10.1016/j.survophthal.2011.07.004; Zhang JJ, 2014, EUR J NUCL MED MOL I, V41, P1624, DOI 10.1007/s00259-014-2729-3; Nakamoto Y, 2013, EUR J NUCL MED MOL I, V40, P708, DOI 10.1007/s00259-012-2333-3; Zhao S, 2008, J NUCL MED, V49, P135, DOI 10.2967/jnumed.107.044578	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-9762	1536-0229		CLIN NUCL MED	Clin. Nucl. Med.	OCT	2015	40	10					826	827		10.1097/RLU.0000000000000842		2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CR6JB	WOS:000361451300018		
J	Kambe, J; Kakimoto, Y; Araki, O				Kambe, Jun; Kakimoto, Yuta; Araki, Osamu			Phase reset affects auditory-visual simultaneity judgment	COGNITIVE NEURODYNAMICS			English	Article						Simultanity judgement; Phase resetting; Electroencephalograpy; Intertrial coherence	AUDIOVISUAL SIMULTANEITY; NEURONAL OSCILLATIONS; ALPHA-RHYTHMS; PERCEPTION; PRESTIMULUS; CORTEX; BRAIN; HUMANS; EEG; SYNCHRONY	We continuously receive the external information from multiple sensors simultaneously. The brain must judge a source event of these sensory informations and integrate them. It is thought that judging the simultaneity of such multisensory stimuli is an important cue when we discriminate whether the stimuli are derived from one event or not. Although previous studies have investigated the correspondence between an auditory-visual (AV) simultaneity perceptions and the neural responses, there are still few studies of this. Electrophysiological studies have reported that ongoing oscillations in human cortex affect perception. Especially, the phase resetting of ongoing oscillations has been examined as it plays an important role in multisensory integration. The aim of this study was to investigate the relationship of phase resetting for the judgment of AV simultaneity judgement tasks. The subjects were successively presented with auditory and visual stimuli with intervals that were controlled as and they were asked to report whether they perceived them simultaneously or not. We investigated the effects of the phase of ongoing oscillations on simultaneity judgments with AV stimuli with SOAs in which the detection rate of asynchrony was 50 %. It was found that phase resetting at the beta frequency band in the brain area that related to the modality of the following stimulus occurred after preceding stimulus onset only when the subjects perceived AV stimuli as simultaneous. This result suggested that beta phase resetting occurred in areas that are related to the subsequent stimulus, supporting perception multisensory stimuli as simultaneous.	[Kambe, Jun; Kakimoto, Yuta; Araki, Osamu] Tokyo Univ Sci, Dept Appl Phys, Tokyo 162, Japan	Kakimoto, Y (reprint author), Tokyo Univ Sci, Dept Appl Phys, Tokyo 162, Japan.	ykaki@rs.kagu.tus.ac.jp					Keil J, 2012, CEREB CORTEX, V22, P221, DOI 10.1093/cercor/bhr125; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Babiloni C, 2006, CEREB CORTEX, V16, P1690, DOI 10.1093/cercor/bhj104; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Thorne JD, 2011, J NEUROSCI, V31, P3853, DOI 10.1523/JNEUROSCI.6176-10.2011; Hanslmayr S, 2007, NEUROIMAGE, V37, P1465, DOI 10.1016/j.neuroimage.2007.07.011; Haenschel C, 2000, P NATL ACAD SCI USA, V97, P7645, DOI 10.1073/pnas.120162397; Stone JV, 2001, P ROY SOC B-BIOL SCI, V268, P31; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; Mathewson KE, 2009, J NEUROSCI, V29, P2725, DOI 10.1523/JNEUROSCI.3963-08.2009; Lakatos P, 2009, NEURON, V64, P419, DOI 10.1016/j.neuron.2009.10.014; Senkowski D, 2006, CEREB CORTEX, V16, P1556, DOI 10.1093/cercor/bhj091; Bushara KO, 2001, J NEUROSCI, V21, P300; Senkowski D, 2008, TRENDS NEUROSCI, V31, P401, DOI 10.1016/j.tins.2008.05.002; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Schroeder CE, 2008, TRENDS COGN SCI, V12, P106, DOI 10.1016/j.tics.2008.01.002; ALHO K, 1994, ELECTROEN CLIN NEURO, V91, P353, DOI 10.1016/0013-4694(94)00173-1; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Dugue L, 2011, J NEUROSCI, V31, P11889, DOI 10.1523/JNEUROSCI.1161-11.2011; VanRullen R, 2003, TRENDS COGN SCI, V7, P207, DOI 10.1016/S1364-6613(03)00095-0; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Romei V, 2010, J NEUROSCI, V30, P8692, DOI 10.1523/JNEUROSCI.0160-10.2010; Zampini M, 2005, PERCEPT PSYCHOPHYS, V67, P531, DOI 10.3758/BF03193329; Naue N, 2011, J NEUROSCI, V31, P7729, DOI 10.1523/JNEUROSCI.1076-11.2011; Franciotti R, 2011, NEUROSCIENCE, V193, P182, DOI 10.1016/j.neuroscience.2011.07.018; Le Van Quyen M, 2007, TRENDS NEUROSCI, V30, P365, DOI 10.1016/j.tins.2007.05.006; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Sakowitz OW, 2005, COGNITIVE BRAIN RES, V23, P316, DOI 10.1016/j.cogbrainres.2004.10.012; Senkowski D, 2007, EXP BRAIN RES, V177, P184, DOI 10.1007/s00221-006-0664-7; VanRullen R, 2006, J NEUROSCI, V26, P502, DOI 10.1523/JNEUROSCI.4654-05.2006; Woods D L, 1995, Electroencephalogr Clin Neurophysiol Suppl, V44, P102	33	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1871-4080	1871-4099		COGN NEURODYNAMICS	Cogn. Neurodynamics	OCT	2015	9	5					487	493		10.1007/s11571-015-9342-4		7	Neurosciences	Neurosciences & Neurology	CR6GC	WOS:000361441800003		
J	Kano, Y; Matsuda, N; Nonaka, M; Fujio, M; Kuwabara, H; Kono, T				Kano, Yukiko; Matsuda, Natsurni; Nonaka, Maiko; Fujio, Miyuki; Kuwabara, Hitoshi; Kono, Toshiaki			Sensory phenomena related to tics, obsessive-compulsive symptoms and global functioning in Tourette syndrome	COMPREHENSIVE PSYCHIATRY			English	Article							PREMONITORY URGE; PHENOMENA SCALE; DISORDER; ADOLESCENTS; VALIDATION; DIMENSIONS; UNIVERSITY; IMPACT	Objectives: Sensory phenomena, including premonitory urges, are experienced by patients with Tourette syndrome (TS) and obsessive-compulsive disorder (OCD). The goal of the present study was to investigate such phenomena related to tics, obsessive-compulsive symptoms (OCS), and global functioning in Japanese patients with TS. Methods: Forty-one patients with TS were assessed using the University of Sao Paulo Sensory Phenomena Scale (USP-SPS), the Premonitory Urge for Tics Scale (PUTS), the Yale Global Tic Severity Scale (YGTSS), the Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS), and the Global Assessment of Functioning (GAF) Scale. Results: USP-SPS and PUTS total scores were significantly correlated with YGTSS total and vocal tics scores. Additionally, both sensory phenomena severity scores were significantly correlated with DY-BOCS total OCS scores. Of the six dimensional OCS scores, the USP-SPS scores were significantly correlated with measures of aggression and sexual/religious dimensions. Finally, the PUTS total scores were significantly and negatively correlated with GAF scores. Conclusions: By assessing premonitory urges and broader sensory phenomena, and by viewing OCS from a dimensional approach, this study provides significant insight into sensory phenomena related to tics, OCS, and global functioning in patients with TS. (C) 2015 Elsevier Inc. All rights reserved.	[Kano, Yukiko] Univ Tokyo, Grad Sch Med, Dept Child Neuropsychiat, Bukyo Ku, Tokyo 1138655, Japan; [Matsuda, Natsurni; Nonaka, Maiko] Tokyo Univ Hosp, Dept Child Psychiat, Bukyo Ku, Tokyo 1138655, Japan; [Fujio, Miyuki] Univ Tokyo, Grad Sch Educ, Course Clin Psychol, Bukyo Ku, Tokyo 1130033, Japan; [Kuwabara, Hitoshi] Univ Tokyo, Disabil Serv Off, Bukyo Ku, Tokyo 1130033, Japan; [Kono, Toshiaki] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Forens Psychiat, Kodaira, Tokyo 1878551, Japan	Kano, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Child Neuropsychiat, Bukyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kano-tky@umin.ac.jp			Grant for Comprehensive Research on Disability, Health, and Welfare from the Ministry of Health, Labour, and Welfare, Japan [H20-006, H22-004, H26-Seishin-Ippan007]; Research Grant for Nervous and Mental Disorders from the Ministry of Health, Labour, and Welfare, Japan [17A-2, 20B-6]; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP from the Ministry of Health, Labour, and Welfare, Japan [23-1]; Ministry of Education, Culture, Sports, Science and Technology, Japan [26118704]	The present study was partly supported by a Grant for Comprehensive Research on Disability, Health, and Welfare (H20-006, H22-004 and H26-Seishin-Ippan007), a Research Grant for Nervous and Mental Disorders (17A-2 and 20B-6), and an Intramural Research Grant (23-1) for Neurological and Psychiatric Disorders of NCNP, all from the Ministry of Health, Labour, and Welfare, Japan. Further support was received from a Grant-in-Aid for Scientific Research on Innovative Areas (grant number 26118704; Adolescent Mind & Self-Regulation) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Prado HD, 2008, CNS SPECTRUMS, V13, P425; LECKMAN JF, 1994, AM J PSYCHIAT, V151, P675; Stewart SE, 2007, BIOL PSYCHIAT, V61, P285, DOI 10.1016/j.biopsych.2006.08.040; Crossley E, 2013, PSYCHIAT RES, V209, P705, DOI 10.1016/j.psychres.2013.04.019; Kwak C, 2003, MOVEMENT DISORD, V18, P1530, DOI 10.1002/mds.10618; Specht MW, 2013, BEHAV RES THER, V51, P24, DOI 10.1016/j.brat.2012.09.009; Woods DW, 2005, J DEV BEHAV PEDIATR, V26, P397, DOI 10.1097/00004703-200512000-00001; Steinberg T, 2010, J NEURAL TRANSM, V117, P277, DOI 10.1007/s00702-009-0353-3; Rosario MC, 2009, CNS SPECTRUMS, V14, P315; Ferrao YA, 2012, PSYCHIAT RES, V197, P253, DOI 10.1016/j.psychres.2011.09.017; de Alvarenga PG, 2012, CNS SPECTRUMS, V17, P87, DOI 10.1017/S1092852912000491; Bloch MH, 2008, AM J PSYCHIAT, V165, P1532, DOI 10.1176/appi.ajp.2008.08020320; Martino D, 2013, INT REV NEUROBIOL, V112, P1, DOI 10.1016/B978-0-12-411546-0.00001-9; Rosario-Campos MC, 2006, MOL PSYCHIATR, V11, P495, DOI 10.1038/sj.mp.4001798; Labad J, 2008, DEPRESS ANXIETY, V25, P832, DOI 10.1002/da.20332; Eddy C. M., 2013, BEHAV MODIF, V38, P264; Hounie Ana Gabriela, 2006, Adv Neurol, V99, P22; Inoko K, 2006, JPN J CHILD ADOELSC, V47, P38; Kano Y, 2015, PSYCHIAT RES, V226, P156, DOI 10.1016/j.psychres.2014.12.041; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; Nikolajsen KH, 2011, NORD J PSYCHIAT, V65, P244, DOI 10.3109/08039488.2010.533386; Reese HE, 2014, BEHAV THER, V45, P177, DOI 10.1016/j.beth.2013.09.002; Sampaio AS, 2014, COMPR PSYCHIAT, V55, P1330, DOI 10.1016/j.comppsych.2014.02.008; Sutherland Owens AN, 2011, SCI WORLD J, V11, P736, DOI [10.1100/tsw.2011.57., DOI 10.1100/TSW.2011.57]	26	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0010-440X	1532-8384		COMPR PSYCHIAT	Compr. Psychiat.	OCT	2015	62						141	146		10.1016/j.comppsych.2015.07.006		6	Psychiatry	Psychiatry	CR4XM	WOS:000361343400018		
J	Mitsui, N; Asakura, S; Shimizu, Y; Fujii, Y; Kako, Y; Tanaka, T; Oba, K; Inoue, T; Kusumi, I				Mitsui, Nobuyuki; Asakura, Satoshi; Shimizu, Yusuke; Fujii, Yutaka; Kako, Yuki; Tanaka, Teruaki; Oba, Koji; Inoue, Takeshi; Kusumi, Ichiro			Temperament and character profiles of Japanese university students with depressive episodes and ideas of suicide or self-harm: a PHQ-9 screening study (vol 54, pg 1215, 2013)	COMPREHENSIVE PSYCHIATRY			English	Correction									[Mitsui, Nobuyuki; Asakura, Satoshi; Shimizu, Yusuke; Fujii, Yutaka; Kako, Yuki; Tanaka, Teruaki; Kusumi, Ichiro] Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan; [Asakura, Satoshi; Fujii, Yutaka] Hokkaido Univ, Hlth Care Ctr, Sapporo, Hokkaido, Japan; [Oba, Koji] Univ Tokyo, Sch Publ Hlth, Dept Biostat, Tokyo, Japan; [Inoue, Takeshi] Tokyo Med Sch, Dept Psychiat, Tokyo, Japan	Mitsui, N (reprint author), Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan.						Mitsui N, 2013, COMPR PSYCHIAT, V54, P1215, DOI 10.1016/j.comppsych.2013.05.014	1	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0010-440X	1532-8384		COMPR PSYCHIAT	Compr. Psychiat.	OCT	2015	62						218	218		10.1016/j.comppsych.2015.07.005		1	Psychiatry	Psychiatry	CR4XM	WOS:000361343400027		
J	Muramatsu, M; Terada, K; Kawada, T; Yashiro, K; Takahashi, K; Takase, S				Muramatsu, M. u; Terada, K.; Kawada, T.; Yashiro, K.; Takahashi, K.; Takase, S.			Characterization of time-varying macroscopic electro-chemo-mechanical behavior of SOFC subjected to Ni-sintering in cermet microstructures	COMPUTATIONAL MECHANICS			English	Article						Solid oxide fuel cell (SOFC); Electrochemical potential; Sintering of Ni; Phase-field method; Homogenization method	OXIDE FUEL-CELL; DOPED LANTHANUM CHROMITES; CHEMICALLY-INDUCED STRESSES; STABILIZED ZIRCONIA; THERMAL-EXPANSION; PLANAR SOFC; SIMULATION; CONDUCTIVITY; EVOLUTION; ANODE	In order to perform stress analyses of a solid oxide fuel cell (SOFC) under operation, we propose a characterization method of its time-varying macroscopic electro-chemo-mechanical behavior of electrodes by considering the time-varying geometries of anode microstructures due to Ni-sintering. The phase-field method is employed to simulate the micro-scale morphology change with time, from which the time-variation of the amount of triple-phase boundaries is directly predicted. Then, to evaluate the time-variation of the macroscopic oxygen ionic and electronic conductivities and the inelastic properties of the anode electrode, numerical material tests based on the homogenization method are conducted for each state of sintered microstructures. In these homogenization analyses, we also have to consider the dependencies of the properties of constituent materials on the temperature and/or the oxygen potential that is supposed to change within an operation period. To predict the oxygen potential distribution in an overall SOFC structure under long-period operation, which determines reduction-induced expansive/contractive deformation of oxide materials, an unsteady problem of macroscopic oxygen ionic and electronic conductions is solved. Using the calculated stress-free strains and the homogenized mechanical properties, both of which depend on the operational environment, we carry out the macroscopic stress analysis of the SOFC.	[Muramatsu, M. u; Kawada, T.; Yashiro, K.] Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Terada, K.] Tohoku Univ, Int Res Inst Disaster Sci, Aoba Ku, Sendai, Miyagi 9800845, Japan; [Takahashi, K.; Takase, S.] Tohoku Univ, Dept Civil Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan	Muramatsu, M (reprint author), Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, Aza Aoba 6-6-01, Sendai, Miyagi 9808579, Japan.	muramatsu@ee.mech.tohoku.ac.jp			New Energy and Industrial Technology Development Organization (NEDO), Japan	This work was carried out as a part of the research project "Technology development for SOFC commercialization promotion. Basic study on rapid evaluation method of SOFC durability", which was supported by the New Energy and Industrial Technology Development Organization (NEDO), Japan.	Yasuda I, 2000, ELECTROCHEMISTRY, V68, P526; Baniassadi M, 2011, ACTA MATER, V59, P30, DOI 10.1016/j.actamat.2010.08.012; Steinbach I, 1996, PHYSICA D, V94, P135, DOI 10.1016/0167-2789(95)00298-7; Wilson JR, 2009, ELECTROCHEM COMMUN, V11, P1052, DOI 10.1016/j.elecom.2009.03.010; Terada K, 2010, COMPUT MECH, V46, P269, DOI 10.1007/s00466-009-0400-9; Yakabe H, 2001, J POWER SOURCES, V102, P144, DOI 10.1016/S0378-7753(01)00792-3; TAI LW, 1995, SOLID STATE IONICS, V76, P273, DOI 10.1016/0167-2738(94)00245-N; YASUDA I, 1993, J ELECTROCHEM SOC, V140, P1699, DOI 10.1149/1.2221626; Jiao ZJ, 2013, J ELECTROCHEM SOC, V160, pF709, DOI 10.1149/2.139306jes; Terada K, 2013, COMPUT MECH, V52, P1199, DOI 10.1007/s00466-013-0872-5; Atkinson A, 1997, SOLID STATE IONICS, V95, P249, DOI 10.1016/S0167-2738(96)00588-7; Haering C, 2005, SOLID STATE IONICS, V176, P261, DOI 10.1016/j.ssi.2004.07.039; Haile SM, 2003, ACTA MATER, V51, P5981, DOI 10.1016/j.actamat.2003.08.004; TAI LW, 1995, SOLID STATE IONICS, V76, P259, DOI 10.1016/0167-2738(94)00244-M; Yasuda I, 1996, J ELECTROCHEM SOC, V143, P1583, DOI 10.1149/1.1836683; Chan SH, 2001, J POWER SOURCES, V93, P130, DOI 10.1016/S0378-7753(00)00556-5; Zhang YX, 2012, INT J HYDROGEN ENERG, V37, P3392, DOI 10.1016/j.ijhydene.2011.11.020; Lin CK, 2007, J POWER SOURCES, V164, P238, DOI 10.1016/j.jpowsour.2006.10.089; Atkinson A, 2007, MATER SCI TECH-LOND, V23, P1135, DOI 10.1179/026708307X232910; Liu LL, 2012, CERAM INT, V38, P5425, DOI 10.1016/j.ceramint.2012.03.053; PARK JH, 1989, J ELECTROCHEM SOC, V136, P2867, DOI 10.1149/1.2096302; Marina OA, 2002, SOLID STATE IONICS, V149, P21, DOI 10.1016/S0167-2738(02)00140-6; Khaleel MA, 2004, J POWER SOURCES, V130, P136, DOI 10.1016/j.jpowsour.2003.11.074; Wang YU, 2006, ACTA MATER, V54, P953, DOI 10.1016/j.actamat.2005.10.032; Fukuda Y, 2009, ECS TRANSACTIONS, V25, P2375, DOI 10.1149/1.3205790; Ferguson JR, 1996, J POWER SOURCES, V58, P109, DOI 10.1016/0378-7753(95)02269-4; Nakajo A, 2009, J POWER SOURCES, V193, P203, DOI 10.1016/j.jpowsour.2008.12.050; Chen HY, 2011, J POWER SOURCES, V196, P1333, DOI 10.1016/j.jpowsour.2010.08.010; Yu JH, 2007, J POWER SOURCES, V163, P926, DOI 10.1016/j.jpowsour.2006.10.017; Tietz F, 1999, IONICS, V5, P129, DOI 10.1007/BF02375916; Hall DJ, 1999, IEEE T ENERGY CONVER, V14, P749, DOI 10.1109/60.790946; Li Q, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4738230; Lin CK, 2009, J POWER SOURCES, V192, P515, DOI 10.1016/j.jpowsour.2009.03.010; Atkinson A, 2000, SOLID STATE IONICS, V129, P259, DOI 10.1016/S0167-2738(99)00331-8; Terada K, 2011, ECS TRANSACTIONS, V35, P923, DOI 10.1149/1.3570073; Ullmann H, 2000, SOLID STATE IONICS, V138, P79, DOI 10.1016/S0167-2738(00)00770-0; Grew KN, 2012, J POWER SOURCES, V199, P1, DOI 10.1016/j.jpowsour.2011.10.010; KAWADA T, 1990, J ELECTROCHEM SOC, V137, P3042, DOI 10.1149/1.2086156; Asp K., 2006, Acta Materialia, V54, DOI 10.1016/j.actamat.2005.11.005; Emmerich H, 2009, DIFFUSE INTERFACE AP; Fergus JW, 2004, SOLID STATE IONICS, V171, P1, DOI 10.1016/j.ssi.2004.04.010; Haering C, 2005, SOLID STATE IONICS, V176, P253, DOI 10.1016/j.ssi.2004.07.038; Huang K, 2009, WOODHEAD PUBL SER EN, P1, DOI 10.1533/9781845696511; Koyama M., 2008, J COMPUT CHEM JPN, V7, P55, DOI 10.2477/jccj.H1923; Liu L, 2010, J POWER SOURCES, V195, P2310, DOI 10.1016/j.jpowsour.2009.10.064; Nayar A, 1997, THE METAL DATABOOK; OHayre R, 2009, FUEL CELL FUNDAMENTA; Provatas N., 2010, PHASE FIELD METHODS; Sanchez-Palencia E., 1980, LECT NOTES PHYS, V127; Sasagawa T, 2012, T JSCES, V2012; Suquet P., 1987, HOMOGENIZATION TECHN, V272, P193, DOI 10.1007/3-540-17616-0_15; Terada K, 2014, ADV COMPOS MATER, V23, P421, DOI 10.1080/09243046.2014.915098	52	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0178-7675	1432-0924		COMPUT MECH	Comput. Mech.	OCT	2015	56	4					653	676		10.1007/s00466-015-1193-7		24	Mathematics, Interdisciplinary Applications; Mechanics	Mathematics; Mechanics	CR4ZL	WOS:000361348500006		
J	Bui, TQ				Tinh Quoc Bui			Extended isogeometric dynamic and static fracture analysis for cracks in piezoelectric materials using NURBS	COMPUTER METHODS IN APPLIED MECHANICS AND ENGINEERING			English	Article						Piezoelectric; Dynamic fracture; Crack propagation; Isogeometric analysis; NURBS; Extended finite element method	FINITE-ELEMENT-METHOD; FUNCTIONALLY GRADED PLATES; TIME-DOMAIN BEM; BOUNDARY-CONDITIONS; X-FEM; IMPERMEABLE CRACKS; SOLIDS; MECHANICS; CERAMICS; XIGA	Accurate numerical modeling of multifield piezoelectric materials is challenging because of the inherent electro-mechanical coupling effect and material anisotropic behaviors. The modeling becomes even more difficult especially for problems with non-smooth solutions like crack under dynamic loading. We present in this paper an extension of the extended isogeometric analysis (XIGA) for simulation of two-dimensional fracture mechanics problems in piezoelectric materials under dynamic and static coupled electromechanical loads. The discretization of problem domain is based on basis functions generated from NURBS, which are used for both geometric description and approximation of solution field variables. To capture the discontinuity across the crack-faces and the singularity at the crack-tip, the isogeometric approximation is locally enriched by discontinuous Heaviside function and asymptotic crack-tip branch functions. The sixfold enrichment functions particularly suitable for electromechanical crack- tip singularity of piezoelectric materials are used. To evaluate the generalized fracture parameters, a domain-form of electromechanical interaction integral is employed. For dynamic analysis, the implicit time integration scheme considering inertial effect is taken. Five numerical examples for single and mixed-modes of impermeable cracks are considered and the generalized fracture parameters under dynamic and static loads are analyzed. The accuracy and effectiveness of the proposed XIGA are illustrated through numerical investigations of the generalized dynamic and static fracture parameters. Numerical results are validated against the reference solutions derived from the boundary element methods. The effects of some numerical aspect ratios on generalized fracture parameters are also investigated. Additionally, we present some numerical results of quasi-static crack propagation in piezoelectric solids using the developed XIGA, taking fracture toughness anisotropy of polarized electroelastic materials into account, and employing the maximum modified hoop stress intensity factor criterion for predicting the growing direction of crack. (C) 2015 Elsevier B.V. All rights reserved.	Tokyo Inst Technol, Dept Mech & Environm Informat, Meguro Ku, Tokyo 1528552, Japan	Bui, TQ (reprint author), Tokyo Inst Technol, Dept Mech & Environm Informat, Meguro Ku, 2-12-2-W8-22 O Okayama, Tokyo 1528552, Japan.	tinh.buiquoc@gmail.com	Bui, Tinh Quoc/H-6752-2014	Bui, Tinh Quoc/0000-0002-6426-6639	Japan Society for the Promotion of Science [26-04055, P14055]	The support of the Grant-in-Aid for Scientific Research (No. 26-04055)-Japan Society for the Promotion of Science (ID No. P14055) is gratefully acknowledged. The author is also grateful to Prof. Sohichi Hirose (Director of the Department of Mechanical and Environmental Informatics, Tokyo Institute of Technology, Japan) for his support throughout the course of this work.	Wang BL, 2003, INT J ENG SCI, V41, P633, DOI 10.1016/S0020-7225(02)00149-0; Yin SH, 2014, COMPOS STRUCT, V118, P121, DOI 10.1016/j.compstruct.2014.07.028; PISARENKO GG, 1985, J AM CERAM SOC, V68, P259, DOI 10.1111/j.1151-2916.1985.tb15319.x; Rao BN, 2008, INT J SOLIDS STRUCT, V45, P5237, DOI 10.1016/j.ijsolstr.2008.05.020; Xu XL, 2000, ACTA MATER, V48, P1865, DOI 10.1016/S1359-6454(99)00469-3; Koo B, 2013, COMPUT METHOD APPL M, V253, P505, DOI 10.1016/j.cma.2012.08.014; Abendroth M, 2002, INT J FRACTURE, V114, P359, DOI 10.1023/A:1015725725879; Li C, 2013, ENG FRACT MECH, V97, P52, DOI 10.1016/j.engfracmech.2012.10.019; Fries TP, 2010, INT J NUMER METH ENG, V84, P253, DOI 10.1002/nme.2914; Lei J, 2015, EUR J MECH A-SOLID, V49, P146, DOI 10.1016/j.euromechsol.2014.07.010; Ghorashi SS, 2015, COMPUT STRUCT, V147, P138, DOI 10.1016/j.compstruc.2014.09.017; Meschke G, 2007, COMPUT METHOD APPL M, V196, P2338, DOI 10.1016/j.cma.2006.11.016; Janski L, 2010, INT J NUMER METH ENG, V81, P1492, DOI 10.1002/nme.2742; Benson DJ, 2010, INT J NUMER METH ENG, V83, P765, DOI 10.1002/nme.2864; Hughes TJR, 2005, COMPUT METHOD APPL M, V194, P4135, DOI 10.1016/j.cma.2004.10.008; Wang DD, 2010, COMPUT METHOD APPL M, V199, P2425, DOI 10.1016/j.cma.2010.03.032; Kumar S, 1996, ACTA MATER, V44, P173, DOI 10.1016/1359-6454(95)00175-3; Kumar S, 1997, ACTA MATER, V45, P849, DOI 10.1016/S1359-6454(96)00175-9; PAK YE, 1992, INT J FRACTURE, V54, P79, DOI 10.1007/BF00040857; Bhardwaj G, 2015, J BRAZ SOC MECH SCI, V37, P1065, DOI 10.1007/s40430-014-0232-1; Haasemann G, 2011, INT J NUMER METH ENG, V86, P598, DOI 10.1002/nme.3120; Valizadeh N, 2013, COMPOS STRUCT, V99, P309, DOI 10.1016/j.compstruct.2012.11.008; De Luycker E, 2011, INT J NUMER METH ENG, V87, P541, DOI 10.1002/nme.3121; PARTON VZ, 1976, ACTA ASTRONAUT, V3, P671, DOI 10.1016/0094-5765(76)90105-3; Li C, 2014, INT J SOLIDS STRUCT, V51, P2096, DOI 10.1016/j.ijsolstr.2014.02.014; Kuna M, 2010, ENG FRACT MECH, V77, P309, DOI 10.1016/j.engfracmech.2009.03.016; Sladek J, 2007, INT J FRACTURE, V145, P313, DOI 10.1007/s10704-007-9130-1; SOSA HA, 1990, INT J SOLIDS STRUCT, V26, P1, DOI 10.1016/0020-7683(90)90090-I; Kuna M, 2006, ARCH APPL MECH, V76, P725, DOI 10.1007/s00419-006-0059-z; Bhardwaj G, 2015, COMPUT METHOD APPL M, V284, P186, DOI 10.1016/j.cma.2014.08.015; Fernandez-Mendez S, 2004, COMPUT METHOD APPL M, V193, P1257, DOI 10.1016/j.cma.2003.12.019; PAK YE, 1990, J APPL MECH-T ASME, V57, P647, DOI 10.1115/1.2897071; Laborde P, 2005, INT J NUMER METH ENG, V64, P354, DOI 10.1002/nme.1370; Kuna M, 1998, COMP MATER SCI, V13, P67, DOI 10.1016/S0927-0256(98)00047-0; Garcia-Sanchez F, 2007, COMP MATER SCI, V39, P179, DOI 10.1016/j.commatsci.2006.03.021; Cheng JQ, 2000, SMART MATER STRUCT, V9, P824, DOI 10.1088/0964-1726/9/6/312; Bechet E, 2009, INT J NUMER METH ENG, V77, P1535, DOI 10.1002/nme.2455; PARK SB, 1995, J AM CERAM SOC, V78, P1475, DOI 10.1111/j.1151-2916.1995.tb08840.x; Liew KM, 2007, INT J NUMER METH ENG, V69, P729, DOI 10.1002/nme.1786; Sladek J, 2008, INT J SOLIDS STRUCT, V45, P4523, DOI 10.1016/j.ijsolstr.2008.03.027; Jia Y, 2015, IMA J APPL MATH, V80, P608, DOI 10.1093/imamat/hxu004; Enderlein M, 2005, INT J FRACTURE, V134, P191, DOI 10.1007/s10704-005-0522-9; Bhardwaj G, 2015, COMPOS STRUCT, V126, P347, DOI 10.1016/j.compstruct.2015.02.066; Liu P, 2013, COMP MATER SCI, V69, P542, DOI 10.1016/j.commatsci.2012.11.009; Bhattacharya S, 2013, COMPUT MECH, V52, P799, DOI 10.1007/s00466-013-0845-8; Rajapakse RKND, 2001, ENG ANAL BOUND ELEM, V25, P771, DOI 10.1016/S0955-7997(01)00058-3; Sladek J, 2007, CMES-COMP MODEL ENG, V19, P247; Pan E, 1999, ENG ANAL BOUND ELEM, V23, P67, DOI 10.1016/S0955-7997(98)00062-9; Wunsche M, 2010, ENG ANAL BOUND ELEM, V34, P377, DOI 10.1016/j.enganabound.2009.11.004; Liu P, 2014, INT J SOLIDS STRUCT, V51, P2167, DOI 10.1016/j.ijsolstr.2014.02.024; Liu P, 2012, COMPUT METHOD APPL M, V233, P68, DOI 10.1016/j.cma.2012.04.008; Gruebner O, 2003, ENG FRACT MECH, V70, P1399, DOI 10.1016/S0013-7944(02)00117-0; Chen WQ, 1999, J MECH PHYS SOLIDS, V47, P1459, DOI 10.1016/S0022-5096(98)00114-8; Shindo Y, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3088855; Bayesteh H, 2015, EUR J MECH A-SOLID, V51, P123, DOI 10.1016/j.euromechsol.2014.12.004; Belytschko T, 2009, MODEL SIMUL MATER SC, V17, DOI 10.1088/0965-0393/17/4/043001; Bui Q.T., 2013, FINITE ELEM ANAL DES, V69, P19; Bui QT., 2012, COMP MATER SCI, V62, P243; Garcia-Sanchu F, 2008, COMPUT METHOD APPL M, V197, P3108, DOI 10.1016/j.cma.2008.02.013; Ghorashi S. S, 2011, INT J NUMERICAL METH, V89, P1069; HAO TH, 1994, ENG FRACT MECH, V47, P793; Janski L., 2011, IUTAM S MULT MOD FAT, P163; Lei J., 2015, INT J FRACTURE, V189, P111; McMeeking M. R., 1990, INT J ENG SCI, V28, P605; Nguyen MN, 2014, COMPUT GEOTECH, V62, P257, DOI 10.1016/j.compgeo.2014.08.003; Piegl L, 1997, NURBS BOOK; Shama K., 2013, ENG FRACT MECH, V104, P114; Shojaee S., 2012, COMPOS STRUCT, V94, P677; Singh I. V., 2015, J MECH SCI TECHNOL, V29, P1141; Suo Z, 1992, MECH PHY SOLIDS, V40, P739, DOI DOI 10.1016/0022-5096(92)90002-J; Valizadeh N, 2013, INT J APPL MECH, V5, DOI 10.1142/S1758825113500178; Yin S. H., 2015, EUR J MECH A UNPUB; Yu TT, 2015, INT J SOLIDS STRUCT, V67-68, P205, DOI 10.1016/j.ijsolstr.2015.03.037; Yu T. T., 2015, INT J MECH IN PRESS; Yu TT, 2015, FINITE ELEM ANAL DES, V96, P1, DOI 10.1016/j.finel.2014.11.003	75	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0045-7825	1879-2138		COMPUT METHOD APPL M	Comput. Meth. Appl. Mech. Eng.	OCT 1	2015	295						470	509		10.1016/j.cma.2015.07.005		40	Engineering, Multidisciplinary; Mathematics, Interdisciplinary Applications; Mechanics	Engineering; Mathematics; Mechanics	CR6YO	WOS:000361494700022		
J	Shima, K; Tanizaki, H; Endo, Y; Fujisawa, A; Tanioka, M; Miyachi, Y; Kabashima, K				Shima, Kaori; Tanizaki, Hideaki; Endo, Yuichiro; Fujisawa, Akihiro; Tanioka, Miki; Miyachi, Yoshiki; Kabashima, Kenji			Immediate hypersensitivity caused by cetylpyridinium chloride in a throat spray	CONTACT DERMATITIS			English	Editorial Material						immediate hypersensitivity; cetylpyridinium chloride; throat spray	CONTACT-DERMATITIS; GLOVES		[Shima, Kaori; Tanizaki, Hideaki; Endo, Yuichiro; Fujisawa, Akihiro; Tanioka, Miki; Miyachi, Yoshiki; Kabashima, Kenji] Kyoto Univ, Dept Dermatol, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan	Shima, K (reprint author), Kyoto Univ, Dept Dermatol, Grad Sch Med, Sakyo Ku, 54 Shogoin,Kawahara Cho, Kyoto 6068507, Japan.						Ponten A, 2013, CONTACT DERMATITIS, V68, P103, DOI 10.1111/cod.12010; Steinkjer B, 1998, CONTACT DERMATITIS, V39, P29, DOI 10.1111/j.1600-0536.1998.tb05808.x	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0105-1873	1600-0536		CONTACT DERMATITIS	Contact Dermatitis	OCT	2015	73	4					248	+		10.1111/cod.12418		2	Allergy; Dermatology	Allergy; Dermatology	CR6SQ	WOS:000361478100005		
J	Desebbe, O; Joosten, A; Suehiro, K				Desebbe, Olivier; Joosten, Alexandre; Suehiro, Koichi			Next Generation of Method-Comparison Studies: Standardization of Data Presentation and Clinical Application Are a Goal to Reach	CRITICAL CARE MEDICINE			English	Letter							CARDIAC-OUTPUT; AGREEMENT		[Desebbe, Olivier] Clin Sauvegarde, Dept Anesthesiol & Crit Care, Lyon, France; [Desebbe, Olivier] Univ Lyon 1, EA 4169, INSERM, CNRS UMS 3453,US 7, F-69365 Lyon, France; [Joosten, Alexandre] Free Univ Brussels, Erasme Univ Hosp, Dept Anesthesiol & Crit Care, Brussels, Belgium; [Suehiro, Koichi] Osaka City Univ, Dept Anesthesiol, Grad Sch Med, Osaka 558, Japan	Desebbe, O (reprint author), Clin Sauvegarde, Dept Anesthesiol & Crit Care, Lyon, France.						Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; Wagner JY, 2015, CRIT CARE MED, V43, P1423, DOI 10.1097/CCM.0000000000000979; Squara P, 2009, INTENS CARE MED, V35, P1801, DOI 10.1007/s00134-009-1570-9; BLAND JM, 1986, LANCET, V1, P307; Cecconi M, 2009, CRIT CARE, V13, DOI 10.1186/cc7129	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	OCT	2015	43	10					E468	E469		10.1097/CCM.0000000000001130		2	Critical Care Medicine	General & Internal Medicine	CR5DJ	WOS:000361359700017		
J	Lin, HJ; Wu, CP; Peng, CK; Lin, SH; Uchida, S; Yang, SS; Huang, KL				Lin, Hsueh-Ju; Wu, Chin-Pyng; Peng, Chung-Kan; Lin, Shih-Hua; Uchida, Shinich; Yang, Sung-Sen; Huang, Kun-Lun			With-No-Lysine Kinase 4 Mediates Alveolar Fluid Regulation in Hyperoxia-Induced Lung Injury	CRITICAL CARE MEDICINE			English	Article						acute lung injury; alveolar fluid clearance; epithelial ion channels; sodium-potassium-chloride cotransporter; STE20; SPS1-related proline; alanine-rich kinase	NF-KAPPA-B; RESPIRATORY-DISTRESS-SYNDROME; HYDROSTATIC PULMONARY-EDEMA; EPITHELIAL SODIUM-CHANNEL; INTESTINAL INFLAMMATION; RICH KINASE; TRANSPORT; MICE; CLEARANCE; PATHWAY	Objectives: To investigate mechanisms involved in the regulation of epithelial ion channels and alveolar fluid clearance in hyperoxia-induced lung injury. Design: Laboratory animal experiments. Setting: Animal care facility procedure room in a medical center. Subjects: Wild-type, STE20/SPS1-related proline/alanine-rich kinase knockout (SPAK(-/-)), and with-no-lysine kinase 4 knockin (WNK4(D561A/+)) mice. Interventions: Mice were exposed to room air or 95% hyperoxia for 60 hours. Measurements and Main Results: Exposure to hyperoxia for 60 hours increased the lung expression of with-no-lysine kinase 4 and led to STE20/SPS1-related proline/alanine-rich kinase and sodium-potassium-chloride cotransporter phosphorylation, which resulted in the suppression of alveolar fluid clearance and increase of lung edema. WNK4(D561A/+) mice at the baseline presented an abundance of epithelium sodium channel and high levels of STE20/SPS1-related proline/alanine-rich kinase and sodium-potassium-chloride cotransporter phosphorylation. Compared with the wild-type group, hyperoxia caused greater epithelium sodium channel expression in WNK4(D561A/+) mice, but no significant difference in STE20/SPS1-related proline/alanine-rich kinase and sodium-potassium-chloride cotransporter phosphorylation. The functional inactivation of sodium-potassium-chloride cotransporter by gene knockout in SPAK(-/-) mice yielded a lower severity of lung injury and longer animal survival, whereas constitutive expression of with-no-lysine kinase 4 exacerbated the hyperoxia-induced lung injury. Pharmacologic inhibition of sodium-potassium-chloride cotransporter by inhaled furosemide improved animal survival in WNK4(D561A/+) mice. By contrast, inhibition of epithelium sodium channel exacerbated the hyperoxia-induced lung injury and animal death. Conclusions: With-no-lysine kinase 4 plays a crucial role in the regulation of epithelial ion channels and alveolar fluid clearance, mainly via phosphorylation and activation of STE20/SPS1-related proline/alanine-rich kinase and sodium-potassium-chloride cotransporter.	[Lin, Hsueh-Ju; Yang, Sung-Sen; Huang, Kun-Lun] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Lin, Hsueh-Ju; Huang, Kun-Lun] Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan; [Wu, Chin-Pyng] Landseed Hosp, Dept Crit Care Med, Taoyuan, Taiwan; [Peng, Chung-Kan; Huang, Kun-Lun] Triserv Gen Hosp, Div Pulm & Crit Care, Dept Med, Natl Def Med Ctr, Taipei, Taiwan; [Lin, Shih-Hua; Yang, Sung-Sen] Triserv Gen Hosp, Div Nephrol, Natl Def Med Ctr, Taipei, Taiwan; [Uchida, Shinich] Tokyo Med & Dent Univ, Grad Sch Med, Dept Nephrol, Tokyo, Japan	Huang, KL (reprint author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	kun@ndmctsgh.edu.tw			National Science Council, Taiwan [NSC-99-2314-B-706-001, NSC-100-2314-B016-018-MY3, NSC-102-2314-B-016-028-MY2]; Research Fund of Tri-Service General Hospital [TSGH-C-100-041-008, TSGH-C-101-085]; Research Fund of Landseed Hospital [LSH-2014-02]; Japan-Taiwan Joint Research Program, Interchange Association, Japan; National Science Council; Tri-Service General Hospital	Supported, in part, by grants from the National Science Council, Taiwan (NSC-99-2314-B-706-001, NSC-100-2314-B016-018-MY3, and NSC-102-2314-B-016-028-MY2), the Research Fund of Tri-Service General Hospital (TSGH-C-100-041-008 and TSGH-C-101-085), the Research Fund of Landseed Hospital (LSH-2014-02), and the Japan-Taiwan Joint Research Program, Interchange Association, Japan.; Drs. H.-J. Lin, Peng, S.-H. Lin, Yang, and Huang received support for article research from the National Science Council and Tri-Service General Hospital. Dr. Wu received support for article research from the National Science Council. Dr. Uchida received support for article research.	Matthay MA, 2014, AM J RESP CRIT CARE, V189, P1301, DOI 10.1164/rccm.201403-0535OE; Andrade L, 2007, AM J PHYSIOL-RENAL, V292, pF586, DOI 10.1152/ajprenal.00102.2006; Sartori C, 2002, EUR RESPIR J, V20, P1299, DOI 10.1183/09031936.02.00401602; Yang SS, 2007, CELL METAB, V5, P331, DOI 10.1016/j.cmet.2007.03.009; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Perkins GD, 2006, AM J RESP CRIT CARE, V173, P281, DOI 10.1164/rccm.200508-13020C; Ring AM, 2007, P NATL ACAD SCI USA, V104, P4025, DOI 10.1073/pnas.0611728104; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Wu SY, 2012, CRIT CARE MED, V40, P553, DOI 10.1097/CCM.0b013e318232d776; Sartori C, 2002, NEW ENGL J MED, V346, P1631, DOI 10.1056/NEJMoa013183; Johnston AM, 2000, ONCOGENE, V19, P4290, DOI 10.1038/sj.onc.1203784; Egli M, 2004, J PHYSIOL-LONDON, V560, P857, DOI 10.1113/jphysiol.2004.066704; Pittet JF, 2001, J IMMUNOL, V166, P6301; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Uchida S, 2010, PFLUG ARCH EUR J PHY, V460, P695, DOI 10.1007/s00424-010-0848-7; Richardson C, 2008, J CELL SCI, V121, P3293, DOI 10.1242/jcs.029223; Delpire E, 2008, BIOCHEM J, V409, P321, DOI 10.1042/BJ20071324; Yue P, 2013, BBA-MOL CELL RES, V1833, P2101, DOI 10.1016/j.bbamcr.2013.05.004; Factor P, 2000, HUM GENE THER, V11, P2231, DOI 10.1089/104303400750035753; Yang SS, 2010, J AM SOC NEPHROL, V21, P1868, DOI 10.1681/ASN.2009121295; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376; BIANCO S, 1993, ALLERGY, V48, P570, DOI 10.1111/j.1398-9995.1993.tb00750.x; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Frank JA, 2000, J APPL PHYSIOL, V89, P1255; Fronius Martin, 2013, Curr Mol Pharmacol, V6, P13; Geng Y, 2009, J BIOL CHEM, V284, P14020, DOI 10.1074/jbc.M900142200; Ghosal S, 1996, THORAX, V51, P1229, DOI 10.1136/thx.51.12.1229; Herrero R, 2013, AM J PHYSIOL-LUNG C, V305, pL377, DOI 10.1152/ajplung.00271.2012; Ji WH, 2012, PEDIATR INT, V54, P735, DOI 10.1111/j.1442-200X.2012.03662.x; Kim Y, 2011, J KOREAN MED SCI, V26, P317, DOI 10.3346/jkms.2011.26.3.317; Lytle C, 1995, AM J PHYSIOL-CELL PH, V269, pC1496; Matthay MA, 2007, NAT MED, V13, P780, DOI 10.1038/nm0707-780; Nguyen M, 2007, J EXP MED, V204, P1383, DOI 10.1084/jem.20061205; Perkins GD, 2014, AM J RESP CRIT CARE, V189, P674, DOI [10.1164/rccm.201308-1549OC, 10.1164/rccm.201308-15490C]; Randrianarison N, 2007, J PHYSIOL-LONDON, V582, P777, DOI 10.1113/jphysiol.2007.131078; Sakuma T, 1996, J APPL PHYSIOL, V80, P1681; Schmitz ML, 2001, TRENDS BIOCHEM SCI, V26, P186, DOI 10.1016/S0968-0004(00)01753-9; Topper JN, 1997, J CLIN INVEST, V99, P2941, DOI 10.1172/JCI119489; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wong HR, 2002, SHOCK, V17, P274, DOI 10.1097/00024382-200204000-00006; Yan Y, 2008, AM J PATHOL, V173, P1013, DOI 10.2353/ajpath.2008.080339; Yan YT, 2008, WORLD J GASTROENTERO, V14, P6115, DOI 10.3748/wjg.14.6115; Zaher TE, 2007, FREE RADICAL BIO MED, V42, P897, DOI 10.1016/j.freeradbiomed.2007.01.021	44	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	OCT	2015	43	10					E412	E419		10.1097/CCM.0000000000001144		8	Critical Care Medicine	General & Internal Medicine	CR5DJ	WOS:000361359700002		
J	Takeshita, M; Suzuki, K; Kikuchi, J; Izumi, K; Kurasawa, T; Yoshimoto, K; Amano, K; Takeuchi, T				Takeshita, Masaru; Suzuki, Katsuya; Kikuchi, Jun; Izumi, Keisuke; Kurasawa, Takahiko; Yoshimoto, Keiko; Amano, Koichi; Takeuchi, Tsutomu			Infliximab and etanercept have distinct actions but similar effects on cytokine profiles in rheumatoid arthritis	CYTOKINE			English	Article						Rheumatoid arthritis; Infliximab; Etanercept; Interleukin-6; Interferon-gamma	NECROSIS-FACTOR-ALPHA; LYMPHOTOXIN-ALPHA; INTERFERON-GAMMA; TNF-ALPHA; ANKYLOSING-SPONDYLITIS; PERIPHERAL-BLOOD; DOUBLE-BLIND; PLASMA IL-6; T-CELL; THERAPY	Objective: Pro-inflammatory cytokines, especially TNF alpha, play a central role in the pathogenesis of rheumatoid arthritis (RA). The available TNF inhibitors are only slightly different from one another in terms of clinical efficacy, at least at the group level, but their structures and modes of action are not identical. Infliximab (IFX) and etanercept (ETN) differ in their ability to induce antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity, and in their ability to bind TNFO. The purpose of our study was to elucidate the different cytokine pathways through which these two drugs enact their clinical efficacy. Methods: Serum from 44 RA patients treated with IFX and 24 patients treated with ETN was studied. All patients had been given these biologics at identical dosages and intervals for one year. The concentrations of 11 inflammatory cytokines and their receptors (IL-1 beta, IL-2, IL-6, IL-6R, IL-8, IL-10, IL-12, TNF alpha, TNF beta, IFN gamma, and GM-CSF) were measured at weeks 0, 22, and 54 using a high-sensitivity electro-chemiluminescence assay. Cytokine profiles were analyzed along with clinical efficacy. Results: IL-6 was significantly decreased in the ETN + MTX and IFX + MTX groups, although not in the ETN-only group; this change was consistent with changes in disease activity. IFN gamma was gradually increased only in the non-remission subgroup of the IFX group, and not at all in the ETN group. TNF(3 increased after starting IFX regardless of clinical efficacy. Conclusion: IL-6 inhibition is a pathway affected by both IFX and ETN. In addition, IFN gamma increase is a distinctive feature of the inefficacy of IFX. (C) 2015 Elsevier Ltd. All rights reserved.	[Takeshita, Masaru; Suzuki, Katsuya; Kikuchi, Jun; Izumi, Keisuke; Kurasawa, Takahiko; Yoshimoto, Keiko; Takeuchi, Tsutomu] Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol,Shinjuku Ku, Tokyo 1608582, Japan; [Amano, Koichi] Saitama Med Univ, Saitama Med Ctr, Div Rheumatol Clin Immunol, Kawagoe, Saitama 3508550, Japan	Takeuchi, T (reprint author), Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	takeshita@a5.keio.jp; katsuyas@z5.keio.jp; j_kiku_chi@yahoo.co.jp; izuksk@gmail.com; gunshi.soutak@gmail.com; keikoy@a8.keio.jp; amanokoi@saitama-med.ac.jp; tsutake@z5.keio.jp	Takeuchi, Tsutomu/L-2327-2013	Takeuchi, Tsutomu/0000-0003-1111-8218	Pfizer Japan Inc.; Mitsubishi Tanabe Pharma Co.; Takeda Pharmaceutical Co. Ltd.	We especially thank Ms. Harumi Kondo and Ms. Megumi Sawada for their assistance. This work has been supported by an institutional research grant and a research grant from Pfizer Japan Inc. Tsutomu Takeuchi has received grants from Pfizer Japan Inc., Mitsubishi Tanabe Pharma Co., and Takeda Pharmaceutical Co. Ltd., and has received income from Pfizer Japan Inc., Mitsubishi Tanabe Pharma Co., and Takeda Pharmaceutical Co. Ltd.	McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Charles P, 1999, J IMMUNOL, V163, P1521; Yeo L, 2011, ANN RHEUM DIS, V70, P2022, DOI 10.1136/ard.2011.153312; Catrina AI, 2005, ARTHRITIS RHEUM, V52, P61, DOI 10.1002/art.20764; Buch MH, 2004, ANN RHEUM DIS, V63, P1344, DOI 10.1136/ard.2003.014878; Nishina N, 2013, CLIN RHEUMATOL, V32, P1661, DOI 10.1007/s10067-013-2309-0; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Zou J, 2003, ANN RHEUM DIS, V62, P561, DOI 10.1136/ard.62.6.561; Raza K, 2005, ARTHRITIS RES THER, V7, pR784, DOI 10.1186/ar1733; Takeuchi T, 2012, ANN RHEUM DIS, V71, P1583, DOI 10.1136/annrheumdis-2011-201069; Ohshima S, 1999, J CLIN IMMUNOL, V19, P305, DOI 10.1023/A:1020543625282; Furst DE, 2006, SEMIN ARTHRITIS RHEU, V36, P159, DOI 10.1016/j.semarthrit.2006.02.001; van der Heijde D, 2006, ARTHRITIS RHEUM, V54, P1063, DOI 10.1002/art.21655; Singh JA, 2009, CAN MED ASSOC J, V181, P787, DOI 10.1503/cmaj.091391; Inoue E, 2007, ANN RHEUM DIS, V66, P407, DOI 10.1136/ard.2006.054205; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; ELLIOTT MJ, 1993, ARTHRITIS RHEUM, V36, P1681, DOI 10.1002/art.1780361206; Meyer O, 2009, JOINT BONE SPINE, V76, P464, DOI 10.1016/j.jbspin.2009.03.012; Zivojinovic SM, 2012, J RHEUMATOL, V39, P18, DOI 10.3899/jrheum.110697; SHARP JT, 1971, ARTHRITIS RHEUM, V14, P706, DOI 10.1002/art.1780140605; Gerards AH, 2003, RHEUMATOLOGY, V42, P1189, DOI 10.1093/rheumatology/keg323; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Calmon-Hamaty F, 2011, CYTOKINE, V53, P207, DOI 10.1016/j.cyto.2010.10.010; Drynda S, 2002, ANN RHEUM DIS, V61, P254, DOI 10.1136/ard.61.3.254; Fabre S, 2008, CLIN EXP IMMUNOL, V153, P188, DOI 10.1111/j.1365-2249.2008.03691.x; Kennedy WP, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0467-3; Ma X, 2013, BIOMED REP, V1, P177; Maurice MM, 1999, ARTHRITIS RHEUM, V42, P2166, DOI 10.1002/1529-0131(199910)42:10<2166::AID-ANR18>3.0.CO;2-K; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mesko B, 2013, GENOME MED, V5, DOI 10.1186/gm463; Neregard P, 2014, SCAND J RHEUMATOL, V43, P85, DOI 10.3109/03009742.2013.834964; Ortigosa LCM, 2014, ACTA DERM-VENEREOL, V94, P26, DOI 10.2340/00015555-1650; Schuerwegh AJ, 2003, RHEUMATOLOGY, V42, P541, DOI 10.1093/rheumatology/keg171; Takeuchi T, 2011, ANN RHEUM DIS, V70, P1208, DOI 10.1136/ard.2011.153023; van Baarsen LGM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2912; Veys EM, 1997, ARTHRITIS RHEUM, V40, P62, DOI 10.1002/art.1780400110; Zou JX, 2003, ARTHRITIS RHEUM, V48, P780, DOI 10.1002/art.10847	37	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	OCT	2015	75	2					222	227		10.1016/j.cyto.2015.04.011		6	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	CR3TQ	WOS:000361256400004		
J	Tanaka, T; Obana, M; Mohri, T; Ebara, M; Otani, Y; Maeda, M; Fujio, Y				Tanaka, Tomohiro; Obana, Masanori; Mohri, Tomomi; Ebara, Masaki; Otani, Yuta; Maeda, Makiko; Fujio, Yasushi			Interleukin-27 induces the endothelial differentiation in Sca-1+cardiac resident stem cells	CYTOKINE			English	Article						Interleukin-27; Cardiac stem cells; Signal transduction; Endothelial differentiation	SIGNAL TRANSDUCER; TRANSCRIPTION 3; GROWTH-FACTOR; ACTIVATOR; RECEPTOR; HEART; IL-27; AMELIORATION; INFARCTION; CYTOKINES	Cytokines play important roles in cardiac repair and regeneration. Recently, we demonstrated that interleukin (IL)-6 family cytokines induce the endothelial differentiation of Sca-1+ cardiac resident stem cells through STAT3/Pim-1 signaling pathway. In contrast, the biological functions of IL-12 family cytokines in heart remain to be elucidated, though they show structural homology with IL-6. In the present study, we examined the effects of IL-12 family cytokines on the transdifferentiation of cardiac Sca-1+ cells into cardiac cells. RT-PCR analyses revealed that IL-27 receptor alpha (IL-27R alpha), but not IL-12R or IL-23R, was expressed in cardiac Sca-1+ cells. The transcript expression of IL-27 was elevated in murine hearts in cardiac injury models. Intriguingly, IL-27 stimulation for 14 days induced the endothelial cell (EC) marker genes, such as CD-31 and VE-cadherin. Immunoblot analyses clarified that IL-27 treatment rapidly phosphorylated STAT3. IL-27 upregulated the expression of Pim-1, but the overexpression of dominant negative STAT3 abrogated the induction of Pim-1 by IL-27. Finally, adenoviral transfection of dominant negative Pim-1 inhibited IL-27-induced EC differentiation of cardiac Sca-1+ cells. These findings demonstrated that IL-27 promoted the commitment of cardiac stem cells into the EC lineage, possibly leading to neovascularization as a novel biological function. IL-27 could not only regulate the inflammation but also contribute to the maintenance of the tissue homeostasis through stem cell differentiation at inflammatory sites. (C) 2015 The Authors. Published by Elsevier Ltd.	[Tanaka, Tomohiro; Obana, Masanori; Mohri, Tomomi; Ebara, Masaki; Otani, Yuta; Maeda, Makiko; Fujio, Yasushi] Osaka Univ, Lab Clin Sci & Biomed, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan	Fujio, Y (reprint author), Osaka Univ, Lab Clin Sci & Biomed, Grad Sch Pharmaceut Sci, 1-6 Yamada Oka, Suita, Osaka 5650871, Japan.	fujio@phs.osaka-u.ac.jp			MEXT/JSPS KAKENHI Grant [23390057, 26293054]	This study was supported by MEXT/JSPS KAKENHI Grant Numbers 23390057 and 26293054.	Fitzgerald DC, 2007, J IMMUNOL, V179, P3268; Sugiyama N, 2008, ANN RHEUM DIS, V67, P1461, DOI 10.1136/ard.2007.077537; Niedbala W, 2008, ANN RHEUM DIS, V67, P1474, DOI 10.1136/ard.2007.083360; Mohri T, 2009, ARTERIOSCL THROM VAS, V29, P754, DOI 10.1161/ATVBAHA.108.174870; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj/onc/1205260; Funamoto M, 2000, J BIOL CHEM, V275, P10561, DOI 10.1074/jbc.275.14.10561; Fujio Y, 2000, CIRCULATION, V101, P660; Sprecher CA, 1998, BIOCHEM BIOPH RES CO, V246, P82, DOI 10.1006/bbrc.1998.8576; Dankbar B, 2000, BLOOD, V95, P2630; Jones LL, 2011, IMMUNOL RES, V51, P5, DOI 10.1007/s12026-011-8209-y; Obana M, 2010, CIRCULATION, V121, P684, DOI 10.1161/CIRCULATIONAHA.109.893677; Yamashita T, 2011, CARDIOVASC RES, V91, P640, DOI 10.1093/cvr/cvr148; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Mohri T, 2006, J BIOL CHEM, V281, P6442, DOI 10.1074/jbc.M508969200; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Pflanz S, 2004, J IMMUNOL, V172, P2225; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Jafarzadeh A, 2011, CYTOKINE, V56, P153, DOI 10.1016/j.cyto.2011.06.014; lwakura T, 2011, J MOL CELL CARDIOL, V51, P207; Miyazaki Y, 2008, BIOCHEM BIOPH RES CO, V373, P397, DOI 10.1016/j.bbrc.2008.06.038; Osugi T, 2002, J BIOL CHEM, V277, P6676, DOI 10.1074/jbc.M108246200	24	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	OCT	2015	75	2					365	372		10.1016/j.cyto.2015.06.009		8	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	CR3TQ	WOS:000361256400022		
J	Inoue, Y; Kato, K; Kamata, S; Ishikawa, K; Nakamura, M				Inoue, Yukako; Kato, Kei; Kamata, Seiko; Ishikawa, Kumiko; Nakamura, Makoto			Reproducibility in the global indices for multifocal visual evoked potentials and Humphrey visual fields in controls and glaucomatous eyes within a 2-year period	DOCUMENTA OPHTHALMOLOGICA			English	Article						Multifocal visual evoked potential; Area under the receiver operating characteristic curve; Signal-to-noise ratio; Test-retest variability; Reproducibility	STANDARD AUTOMATED PERIMETRY; OBJECTIVE PERIMETRY; OCULAR HYPERTENSION; VEP; VARIABILITY; DAMAGE; TESTS; SENSITIVITY; PROGRESSION	Purpose In previous studies, we applied receiver operating characteristic curve analysis to the signal-to-noise ratio distributions in the signal and noise windows of multifocal VEP (mfVEP) response. The areas under the curve thus obtained (SNR-AUC) were found to quantitatively detect glaucomatous visual field damage. The present study evaluated the reproducibility of SNR-AUC and the Humphrey visual field (HVF) global indices in 37 eyes with primary open angle glaucoma (POAG; POAG group) and in 30 controls (control group) within a 2-year period. Methods The HVF SITA standard 24-2 and mfVEP were recorded at three separate sessions for each individual. The intersession variability for SNR-AUC, mean deviation (MD), and pattern standard deviation (PSD) was evaluated using the repeated measures of analysis of variance and Bland-Altman plots. The logarithmically converted coefficients of variation (CV) of PSD and SNR-AUC were compared between the control and POAG groups. Linear regression analyses were performed on the logarithmic CV of SNR-AUC against the average MD, PSD, and SNR-AUC. Results SNR-AUC in the POAG group was significantly lower and its CV was greater compared with the control group (P < 0.0001). MD value recorded at the third visit had significantly improved than that at the first visit in the control group (analysis of variance, P = 0.03), whereas PSD value was significantly worse in the POAG group (P = 0.024). In the POAG group, SNR-AUC CV increased as the glaucoma stage became more advanced when evaluated by any functional parameters tested (i.e., MD, PSD, or SNR-AUC). Conclusions The SNR-AUC of mfVEP showed a high reproducibility in control group, whereas it fluctuated more in the POAG group according to the disease severity. MD in the control group and PSD in POAG group fluctuated among sessions during the 2-year period.	[Inoue, Yukako; Kato, Kei; Kamata, Seiko; Ishikawa, Kumiko; Nakamura, Makoto] Kobe Univ, Grad Sch Med, Dept Surg, Div Ophthalmol,Chou Ku, Kobe, Hyogo 6500017, Japan	Nakamura, M (reprint author), Kobe Univ, Grad Sch Med, Dept Surg, Div Ophthalmol,Chou Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	manakamu@med.kobe-u.ac.jp			Ministry of Education, Culture, Sports, and Science and Technology of Japanese government [22390324, 20592043]	This study was supported in part by Grants-in-Aid 22390324 (A.N., M.N.)and 20592043 (M.N., A.N.) from the Ministry of Education, Culture, Sports, and Science and Technology of the Japanese government.	Anderson D, 1992, AUTOMATED STATIC PER, P143; HEIJL A, 1987, ARCH OPHTHALMOL-CHIC, V105, P1544; Russell RA, 2012, INVEST OPHTH VIS SCI, V53, P5985, DOI 10.1167/iovs.12-10428; Hood DC, 2007, PROG RETIN EYE RES, V26, P688, DOI 10.1016/j.preteyeres.2007.08.001; Ishikawa K, 2011, DOC OPHTHALMOL, V122, P29, DOI 10.1007/s10633-010-9252-z; Gardiner SK, 2013, OPHTHALMOLOGY, V120, P724, DOI 10.1016/j.ophtha.2012.09.056; Hood DC, 2003, PROG RETIN EYE RES, V22, P201, DOI 10.1016/S1350-9462(02)00061-7; Balachandran C, 2006, J GLAUCOMA, V15, P110, DOI 10.1097/00061198-200604000-00006; BASELER HA, 1994, ELECTROEN CLIN NEURO, V90, P65, DOI 10.1016/0013-4694(94)90114-7; Bjerre A, 2004, INVEST OPHTH VIS SCI, V45, P4035, DOI 10.1167/iovs.04-0099; BLAND JM, 1986, LANCET, V1, P307; Chen CS, 2003, J GLAUCOMA, V12, P399, DOI 10.1097/00061198-200310000-00002; Fortune B, 2007, INVEST OPHTH VIS SCI, V48, P1173, DOI 10.1167/iovs.06-0561; Fortune B, 2006, J GLAUCOMA, V15, P131, DOI 10.1097/00061198-200604000-00010; Gardiner SK, 2008, OPTOMETRY VISION SCI, V85, P1043, DOI 10.1097/OPX.0b013e31818b9b40; Goldberg I, 2002, AM J OPHTHALMOL, V133, P29, DOI 10.1016/S0002-9394(01)01294-6; Graham SL, 2005, ARCH OPHTHALMOL-CHIC, V123, P729, DOI 10.1001/archopht.123.6.729; HEIJL A, 1989, ARCH OPHTHALMOL-CHIC, V107, P81; Hood DC, 2004, INVEST OPHTH VIS SCI, V45, P492, DOI 10.1167/iovs.03-0602; Klistorner A, 2000, OPHTHALMOLOGY, V107, P2283, DOI 10.1016/S0161-6420(00)00367-5; Klistorner A, 2005, DOC OPHTHALMOL, V111, P159, DOI 10.1007/s10633-005-5363-3; Klistorner AI, 1998, INVEST OPHTH VIS SCI, V39, P937; Meigen T, 2007, VISION RES, V47, P1445, DOI 10.1016/j.visres.2007.01.026; Nakamura M, 2014, DOC OPHTHALMOL, V128, P179, DOI 10.1007/s10633-014-9431-4; Nakamura M, 2011, DOC OPHTHALMOL, V123, P93, DOI 10.1007/s10633-011-9285-y; Wangsupadilok B, 2009, DOC OPHTHALMOL, V118, P139, DOI 10.1007/s10633-008-9149-2	26	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0012-4486	1573-2622		DOC OPHTHALMOL	Doc. Ophthalmol.	OCT	2015	131	2					115	124		10.1007/s10633-015-9506-x		10	Ophthalmology	Ophthalmology	CR4ZP	WOS:000361348900004		
J	Yu, YD; Ren, HT; Kharrazi, A; Ma, TJ; Zhu, B				Yu, Yadong; Ren, Hongtao; Kharrazi, Ali; Ma, Tieju; Zhu, Bing			Exploring socioeconomic drivers of environmental pressure on the city level: The case study of Chongqing in China	ECOLOGICAL ECONOMICS			English	Article						Socioeconomic drivers; Environmental pressure; Chongqing; Structural decomposition analysis	STRUCTURAL DECOMPOSITION ANALYSIS; GREENHOUSE-GAS EMISSIONS; URBAN METABOLISM; ECONOMIC-GROWTH; CO-BENEFITS; DRIVING FORCES; ENERGY; CITIES; CONSUMPTION; CARBON	Exploring the socioeconomic drivers of environmental pressures in cities is vital for national and global environmental management. The unique features of the mega-city of Chongqing make it a valuable case study to examine environmental pressures from rapid economic development at the city level. This paper reveals the socioeconomic drivers of environmental pressures in Chongqing during the period of 2000-2010 for energy consumption and air, water, and land emissions. Results indicate that Chongqing's environmental pressures increased for energy consumption and CO2 emissions white decreased for SO2, soot, waste water, and solid waste discharge. The main direct contributors, from the producer perspective, to the overall change of environmental pressures were the manufacturing, electricity and water, and construction sectors. From the consumer perspective, the most significant contributors were gross fixed capital formation and net export. In general, changes of per capita final demand and environmental pressure intensity were the most prominent drivers for increasing and reducing environmental pressure. Final demand structure and final demand composition also contributed towards stabilizing environmental pressures while production structure and residential population had a negligible effect. In this light, we suggest approaches for policymakers to systemically balance between different drivers and to reduce environmental pressures in cities. (C) 2015 Elsevier B.V. All rights reserved.	[Yu, Yadong; Ren, Hongtao; Ma, Tieju] E China Univ Sci & Technol, Sch Business, Shanghai 200237, Peoples R China; [Yu, Yadong] E China Univ Sci & Technol, Social & Publ Adm Sch, Shanghai 200237, Peoples R China; [Kharrazi, Ali] Univ Tokyo, Grad Sch Publ Policy, Tokyo 1130033, Japan; [Kharrazi, Ali; Ma, Tieju; Zhu, Bing] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Zhu, Bing] Tsinghua Univ, Dept Chem Engn, Beijing 100084, Peoples R China	Yu, YD (reprint author), E China Univ Sci & Technol, Sch Business, Meilong Rd 130, Shanghai 200237, Peoples R China.	artonry@gmail.com; 18916488290@189.cn; ali@pp.u-tokyo.ac.jp; tjma@ecust.edu.cn; bingzhu@tsinghua.edu.cn			China Postdoctoral Science Foundation [2014M561420]; Fundamental Research Funds for Central Universities in China [WN1424001]; National Nature Science Foundation of China [71125002]	This research is funded by China Postdoctoral Science Foundation (2014M561420), the Fundamental Research Funds for the Central Universities in China (WN1424001), and National Nature Science Foundation of China (71125002).	Holdren JP, 2008, SCIENCE, V319, P424, DOI 10.1126/science.1153386; Tian X, 2013, ENERG POLICY, V53, P279, DOI 10.1016/j.enpol.2012.10.054; Niemeijer D, 2008, ECOL INDIC, V8, P14, DOI 10.1016/j.ecolind.2006.11.012; Chen B, 2014, ECOL INDIC, V47, P1, DOI 10.1016/j.ecolind.2014.09.020; Niza S, 2009, J IND ECOL, V13, P384, DOI 10.1111/j.1530-9290.2009.00130.x; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Peters GP, 2008, ECOL ECON, V65, P13, DOI 10.1016/j.ecolecon.2007.10.014; Fischer-Kowalski M, 2011, J IND ECOL, V15, P855, DOI 10.1111/j.1530-9290.2011.00366.x; Jiang MM, 2011, ECOL MODEL, V222, P2149, DOI 10.1016/j.ecolmodel.2011.04.012; Yu YD, 2013, ECOL INDIC, V24, P177, DOI 10.1016/j.ecolind.2012.06.007; Chen B, 2015, ECOL INFORM, V26, P1, DOI 10.1016/j.ecoinf.2014.09.010; York R, 2003, ECOL ECON, V46, P351, DOI 10.1016/S0921-8009(03)00188-5; Peters GP, 2007, ENVIRON SCI TECHNOL, V41, P5939, DOI 10.1021/es070108f; Brizga J, 2014, ECOL ECON, V98, P22, DOI 10.1016/j.ecolecon.2013.12.001; Dhakal S, 2009, ENERG POLICY, V37, P4208, DOI 10.1016/j.enpol.2009.05.020; Gielen D, 2001, ECOL ECON, V39, P257, DOI 10.1016/S0921-8009(01)00206-3; Okadera T, 2006, ECOL ECON, V58, P221, DOI 10.1016/j.ecolecon.2005.07.005; Zhang ZY, 2011, ECOL ECON, V70, P2494, DOI 10.1016/j.ecolecon.2011.08.011; Liu Z, 2012, ENERGY, V37, P245, DOI 10.1016/j.energy.2011.11.040; Zucaro A, 2014, ECOL INDIC, V47, P16, DOI 10.1016/j.ecolind.2014.04.022; Liang S, 2013, ENVIRON SCI TECHNOL, V47, P12894, DOI 10.1021/es402458u; Lenzen M, 2007, ECOL ECON, V61, P27, DOI 10.1016/j.ecolecon.2006.05.018; Chen SQ, 2012, ENVIRON SCI TECHNOL, V46, P4498, DOI 10.1021/es204662k; Liang S, 2011, ENERG POLICY, V39, P2910, DOI 10.1016/j.enpol.2011.02.069; Chen SQ, 2015, APPL ENERG, V138, P99, DOI 10.1016/j.apenergy.2014.10.055; Druckman A, 2009, ECOL ECON, V68, P2066, DOI 10.1016/j.ecolecon.2009.01.013; Su B, 2012, ENERG ECON, V34, P177, DOI 10.1016/j.eneco.2011.10.009; Yamakawa A, 2011, ECON SYST RES, V23, P303, DOI 10.1080/09535314.2010.549461; WOLMAN A, 1965, SCI AM, V213, P179; Liang S, 2014, ENVIRON SCI TECHNOL, V48, P1103, DOI 10.1021/es4042429; ARROW K, 1995, SCIENCE, V268, P520, DOI 10.1126/science.268.5210.520; Doll CNH, 2013, J CLEAN PROD, V58, P61, DOI 10.1016/j.jclepro.2013.07.006; de Oliveira JAP, 2013, J CLEAN PROD, V58, P1, DOI 10.1016/j.jclepro.2013.08.011; Zhao W, 2010, RESOUR CONSERV RECY, V54, P377, DOI 10.1016/j.resconrec.2009.09.003; Steinberger JK, 2010, ECOL ECON, V70, P425, DOI 10.1016/j.ecolecon.2010.09.014; Liu F, 2013, J CLEAN PROD, V58, P25, DOI 10.1016/j.jclepro.2013.03.024; Chen B, 2014, ECOL INDIC, V47, P5, DOI 10.1016/j.ecolind.2014.09.021; Dietzenbacher E., 1998, ECON SYST RES, V10, P307, DOI DOI 10.1080/09535319800000023; Dietzenbacher E., 2000, ECON SYST RES, V12, P497; EUROSTAT, 2001, EC WID MAT FLOW ACC; de Freitas LC, 2011, ECOL ECON, V70, P1459, DOI 10.1016/j.ecolecon.2011.02.011; Hendrickson C., 1998, ENVIRON SCI TECHNOL, V32, P184, DOI DOI 10.1021/ES983471I; Huang P., 2014, YANGTZE RIVER EC BEL; Intergovernmental Panel for Climate Change (IPCC), 2006, 2006 IPCC GUIDELINES, V4; Kennedy CA, 2015, P NATL ACAD SCI USA, V112, P5985, DOI 10.1073/pnas.1504315112; Liu Q., 2010, CHINAS CONSTANT PRIC; United Nations Department for Economic and Social Affairs Statistics Division (UNDESASD), 1999, HDB INP OUTP TABL CO; Van der Voet E., 2005, 166 CML U GRAF BEDR; Wiedmann TO, 2015, P NATL ACAD SCI USA, V112, P6271, DOI 10.1073/pnas.1220362110	49	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8009	1873-6106		ECOL ECON	Ecol. Econ.	OCT	2015	118						123	131		10.1016/j.ecolecon.2015.07.019		9	Ecology; Economics; Environmental Sciences; Environmental Studies	Environmental Sciences & Ecology; Business & Economics	CR3UJ	WOS:000361258300013		
J	Nishio, K; Yanagishita, T; Yoshida, M; Hayakawa, T; Masuda, H				Nishio, Kazuyuki; Yanagishita, Takashi; Yoshida, Masahiro; Hayakawa, Tomohiro; Masuda, Hideki			Enlargement of surface area of Al by electrochemical insertion and deinsertion of Li	ELECTROCHEMISTRY COMMUNICATIONS			English	Article						Nanoporous film; Electrochemical alloying; Electrochemical dealloying; Lithiation; Delithiation	ETCH TUNNELS; ALUMINUM; GROWTH; FABRICATION; BEHAVIOR; ACID	Enlargement of the surface area of Al foils was carried out through the electrochemical insertion and deinsertion of Li. The electrochemical insertion and deinsertion of Li generated a fine porous structure on the surface of the Al foils. The specific surface area increased with the number of insertion and deinsertion cycles of Li and reached 300. This process can be applied to the effective enlargement of the surface area of Al foils, which is essential for increasing the capacitance of Al electrolytic capacitors. (C) 2015 Elsevier B.V. All rights reserved.	[Nishio, Kazuyuki] Tokyo Univ Technol, Sch Engn, Dept Appl Chem, Hachioji, Tokyo 1920982, Japan; [Yanagishita, Takashi; Yoshida, Masahiro; Hayakawa, Tomohiro; Masuda, Hideki] Tokyo Metropolitan Univ, Grad Sch Urban Environm Sci, Dept Appl Chem, Hachioji, Tokyo 1920397, Japan	Nishio, K (reprint author), Tokyo Univ Technol, Sch Engn, Dept Appl Chem, 1404-1 Katakura, Hachioji, Tokyo 1920982, Japan.	nishiokzyk@stf.teu.ac.jp			Light Metal Educational Foundation [19]	We acknowledge the financial support of The Light Metal Educational Foundation Fellowship Grant (No. 19).	Cortie MB, 2005, GOLD BULL, V38, P14; Ono S, 2009, CORROS SCI, V51, P2364, DOI 10.1016/j.corsci.2009.06.021; DUNN CG, 1971, J ELECTROCHEM SOC, V118, P381, DOI 10.1149/1.2408057; DYER CK, 1981, J ELECTROCHEM SOC, V128, P300, DOI 10.1149/1.2127408; Hebert KR, 2001, J ELECTROCHEM SOC, V148, pB236, DOI 10.1149/1.1369368; Magaino S, 2000, ELEC SOC S, V99, P73; Makino T, 2007, J ELECTROCHEM SOC, V154, pC132, DOI 10.1149/1.2404785; Nishio K, 2007, ELECTROCHEM SOLID ST, V10, pC60, DOI 10.1149/1.2767531; Nishio K, 2013, ECS ELECTROCHEM LETT, V2, pC1, DOI 10.1149/2.009301eel; Nishio K, 2013, ECS ELECTROCHEM LETT, V2, pC43, DOI 10.1149/2.007311eel; Ono S, 2011, CORROS SCI, V53, P3521, DOI 10.1016/j.corsci.2011.06.024; TERRYN H, 1991, CORROS SCI, V32, P1173, DOI 10.1016/0010-938X(91)90130-H	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1388-2481	1873-1902		ELECTROCHEM COMMUN	Electrochem. Commun.	OCT	2015	59						13	15		10.1016/j.elecom.2015.06.017		3	Electrochemistry	Electrochemistry	CR3RP	WOS:000361251100004		
J	Tominaga, M; Noda, N; Hashiguchi, T; Mizuta, H; Kawai, D; Togami, M				Tominaga, Masato; Noda, Natsuki; Hashiguchi, Terutaka; Mizuta, Hiroyuki; Kawai, Daisuke; Togami, Makoto			Improvement of laccase bioelectrocatalyst at a phosphate templating graphene nanoplatelet plate electrode	ELECTROCHEMISTRY COMMUNICATIONS			English	Article						Laccase; Electron transfer; Pore; Graphene; Template	BILIRUBIN OXIDASE; MULTICOPPER OXIDASES; TRAMETES-VERSICOLOR; FUEL-CELLS; ELECTROCATALYSTS; SUPERCAPACITORS; REDUCTION; GRAPHITE; WINDOW; LAYERS	A simple method, using an additive compound, for improving bioelectrocatalytic current based on a direct electron transfer reaction between laccase (Lac) and a graphene nanoplatelet-film electrode was demonstrated. Sodium dihydrogen phosphate (NaH2PO4), sodium dodecyl sulfate (SDS), or glucose as an additive compound was added to the paste of graphene nanoplatelet for preparation process of a graphene nanoplatelet-film electrode. The additive compound was eluted eventually. The development of porous structure was detected by adsorption and desorption isotherms of N-2, when NaH2PO4 was used. Furthermore, an improvement of bioelectrocatalytic current and the positive potential shift of the onset potential of O-2 reduction were observed. (C) 2015 Elsevier B.V. All rights reserved.	[Tominaga, Masato; Noda, Natsuki; Hashiguchi, Terutaka; Mizuta, Hiroyuki; Togami, Makoto] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan; [Tominaga, Masato] Kumamoto Inst Photoelectro Organ Phoen, Kumamoto 8620901, Japan; [Kawai, Daisuke] Toho Gas Co Ltd, Tech Res Inst, Solut Technol Grp, Nagoya, Aichi 4768501, Japan	Tominaga, M (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan.	masato@gpo.kumamoto-u.ac.jp			Research Foundation from Toho Gas Co., Ltd.; Ministry of Education, Culture, Sports, Science and Technology, Japan [24550159]	This work was partially supported by a Research Foundation from Toho Gas Co., Ltd. M.T. acknowledges a Grant-in-Aid for Scientific Research (No. 24550159) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Dwivedi UN, 2011, J MOL CATAL B-ENZYM, V68, P117, DOI 10.1016/j.molcatb.2010.11.002; Piontek K, 2002, J BIOL CHEM, V277, P37663, DOI 10.1074/jbc.M204571200; Wen YY, 2015, CHEM-EUR J, V21, P80, DOI 10.1002/chem.201404779; Barton SC, 2004, CHEM REV, V104, P4867, DOI 10.1021/cr020719k; TUINSTRA F, 1970, J CHEM PHYS, V53, P1126, DOI 10.1063/1.1674108; Tsujimura S, 2014, J AM CHEM SOC, V136, P14432, DOI 10.1021/ja5053736; TUINSTRA F, 1970, J COMPOS MATER, V4, P492; Mano N, 2013, BIOSENS BIOELECTRON, V50, P478, DOI 10.1016/j.bios.2013.07.014; Leech D, 2012, ELECTROCHIM ACTA, V84, P223, DOI 10.1016/j.electacta.2012.02.087; Shleev S, 2005, BIOSENS BIOELECTRON, V20, P2517, DOI 10.1016/j.bios.2004.10.003; Cracknell JA, 2008, CHEM REV, V108, P2439, DOI 10.1021/cr0680639; Shleev S, 2012, ELECTROANAL, V24, P1524, DOI 10.1002/elan.201200188; Jeon MK, 2012, J POWER SOURCES, V216, P400, DOI 10.1016/j.jpowsour.2012.05.107; Shleev S, 2005, BIOELECTROCHEMISTRY, V67, P115, DOI 10.1016/j.bioelechem.2005.02.004; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Huang CC, 2013, CHEMSUSCHEM, V6, P2330, DOI 10.1002/cssc.201300457; BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126; Johnson DL, 2003, BIOCHEMISTRY-US, V42, P10229, DOI 10.1021/bi034268p; Lide D.R., 1997, HDB CHEM PHYS, V77th; Matijosyte I, 2008, INORG CHIM ACTA, V361, P1202, DOI 10.1016/j.ica.2007.05.029; Tominaga M, 2015, ANAL CHEM, V87, P5417, DOI 10.1021/acs.analchem.5b00858; Tominaga M, 2006, CHEM LETT, V35, P1174, DOI 10.1246/cl.2006.1174; Tsujimura S, 2005, J ELECTROANAL CHEM, V576, P113, DOI 10.1016/j.jelechem.2004.09.031	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1388-2481	1873-1902		ELECTROCHEM COMMUN	Electrochem. Commun.	OCT	2015	59						32	35		10.1016/j.elecom.2015.06.018		4	Electrochemistry	Electrochemistry	CR3RP	WOS:000361251100009		
J	Panomsuwan, G; Saito, N; Ishizaki, T				Panomsuwan, Gasidit; Saito, Nagahiro; Ishizaki, Takahiro			Electrocatalytic oxygen reduction activity of boron-doped carbon nanoparticles synthesized via solution plasma process	ELECTROCHEMISTRY COMMUNICATIONS			English	Article						Heteroatom-doped carbon; Electrocatalyst; Oxygen reduction reaction; Solution plasma process	METAL-FREE ELECTROCATALYSTS; ALKALINE-MEDIUM; FUEL-CELLS; CATALYSTS; GRAPHENE; BLACK; NANOTUBES; BATTERIES; MEDIA	The synthesis of boron-doped carbon nanopartides (BCNP) has been achieved through a solution plasma process without the addition of a metal catalyst source using a mixture of benzene and triphenyl borate as precursor. The electrocatalytic activity toward the oxygen reduction reaction (ORR) of BCNP can be improved in terms of onset potential and current density compared to that of undoped carbon nanoparticles in alkaline solution. Moreover, BCNP possesses superior long-term durability and tolerance to methanol oxidation in the ORR. (C) 2015 Elsevier B.V. All rights reserved.	[Panomsuwan, Gasidit; Ishizaki, Takahiro] Shibaura Inst Technol, Fac Engn, Dept Mat Sci & Engn, Koto Ku, Tokyo 1358548, Japan; [Panomsuwan, Gasidit] Chulalongkorn Univ, Petr & Petrochem Coll, NU PPC Plasma Chem Technol Lab, Bangkok 10330, Thailand; [Saito, Nagahiro] Nagoya Univ, Grad Sch Engn, Dept Mat Phys & Energy Engn, Nagoya, Aichi 4648603, Japan; [Saito, Nagahiro] Nagoya Univ, Inst Innovat Future Soc, Social Innovat Design Ctr, Nagoya, Aichi 4648603, Japan; [Saito, Nagahiro; Ishizaki, Takahiro] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan	Panomsuwan, G (reprint author), Shibaura Inst Technol, Fac Engn, Dept Mat Sci & Engn, Koto Ku, 3-7-5 Toyosu, Tokyo 1358548, Japan.	i036050@sic.shibaura-it.ac.jp					Sheng ZH, 2012, J MATER CHEM, V22, P390, DOI 10.1039/c1jm14694g; Kang J, 2014, J POWER SOURCES, V261, P156, DOI 10.1016/j.jpowsour.2014.03.072; Cheon JY, 2014, J AM CHEM SOC, V136, P8875, DOI 10.1021/ja503557x; Gong KP, 2009, SCIENCE, V323, P760, DOI 10.1126/science.1168049; Manoj B, 2012, INT J ELECTROCHEM SC, V7, P3127; Panomsuwan G, 2015, PHYS CHEM CHEM PHYS, V17, P6227, DOI 10.1039/c4cp05995f; Yu DS, 2010, J PHYS CHEM LETT, V1, P2165, DOI 10.1021/jz100533t; Panomsuwan G, 2015, J MATER CHEM A, V3, P9972, DOI 10.1039/c5ta00244c; Panomsuwan G, 2015, PHYS CHEM CHEM PHYS, V17, P13794, DOI 10.1039/c5cp00171d; Cheng FY, 2012, CHEM SOC REV, V41, P2172, DOI 10.1039/c1cs15228a; Wu JB, 2013, ACCOUNTS CHEM RES, V46, P1848, DOI 10.1021/ar300359w; Yao Z, 2012, CHEM COMMUN, V48, P1027, DOI 10.1039/c2cc16192c; Bo XJ, 2013, PHYS CHEM CHEM PHYS, V15, P2459, DOI 10.1039/c2cp43541a; YEAGER E, 1984, ELECTROCHIM ACTA, V29, P1527, DOI 10.1016/0013-4686(84)85006-9; Panomsuwan G, 2014, J MATER CHEM A, V2, P18677, DOI 10.1039/c4ta03010a; Jiao Y, 2014, J AM CHEM SOC, V136, P4394, DOI 10.1021/ja500432h; Yang F, 2014, CATAL SCI TECHNOL, V4, P3168, DOI 10.1039/c4cy00437j; Yang LJ, 2011, ANGEW CHEM INT EDIT, V50, P7132, DOI 10.1002/anie.201101287; Bing YH, 2010, CHEM SOC REV, V39, P2184, DOI 10.1039/b912552c; Pootawang P, 2012, MATER LETT, V80, P1, DOI 10.1016/j.matlet.2012.04.077; Jeon IY, 2013, ADV MATER, V25, P6138, DOI 10.1002/adma.201302753; Zheng Y, 2011, J AM CHEM SOC, V133, P20116, DOI 10.1021/ja209206c; Zheng Y, 2013, ANGEW CHEM INT EDIT, V52, P3110, DOI 10.1002/anie.201209548; Jo G, 2012, ELECTROCHEM COMMUN, V25, P101, DOI 10.1016/j.elecom.2012.09.025; Sa YJ, 2014, ANGEW CHEM INT EDIT, V53, P4102, DOI 10.1002/anie.201307203; Wood KN, 2014, ENERG ENVIRON SCI, V7, P1212, DOI 10.1039/c3ee44078h; Chen ZW, 2011, ENERG ENVIRON SCI, V4, P3167, DOI 10.1039/c0ee00558d; Yang DS, 2012, J AM CHEM SOC, V134, P16127, DOI 10.1021/ja306376s; Cheng YH, 2014, ELECTROCHIM ACTA, V143, P291, DOI 10.1016/j.electacta.2014.08.001; Deam N., 2014, J MATER CHEM A, V2, P4085; He YJ, 2014, J MATER CHEM A, V2, P1721, DOI 10.1039/c3ta13906a; Hu XL, 2013, J ALLOY COMPD, V552, P351, DOI 10.1016/j.jallcom.2012.08.033; Liang Hai-Wei, 2014, Nat Commun, V5, P4973, DOI 10.1038/ncomms5973; Petrach Elaine, 2009, Journal of Fuel Cell Science and Technology, V6, DOI 10.1115/1.3005580; Thai NM, 2015, J ELECTROCHEM SOC, V162, pA1445, DOI 10.1149/2.0291508jes; Xing W, 2014, ROTATING ELECTRODE METHODS AND OXYGEN REDUCTION ELECTROCATALYSTS, P1; Zhang J., 2008, PEM FUEL CELL ELECTR	37	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1388-2481	1873-1902		ELECTROCHEM COMMUN	Electrochem. Commun.	OCT	2015	59						81	85		10.1016/j.elecom.2015.07.005		5	Electrochemistry	Electrochemistry	CR3RP	WOS:000361251100021		
J	Hayashi, S; Komoda, N				Hayashi, Shinichi; Komoda, Norihisa			Data Location Optimization for Improvement of Tiered Storage Performance	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						tiered storage; data location optimization; dynamic tier control; I/O performance		We propose a new method for tiered storage and evaluate its characteristics. In this method, the fast tier is divided into two areas and the data in each area are managed on the basis of two I/O (input/output) measurement periods. When I/Os to these areas increase, the proposed method allocates the frequently accessed areas to a fast tier in advance, thereby improving storage I/O performance. We evaluate the proposed method by simulating storage I/Os and data migration between tiers. When I/O locality is high or frequently accessed areas rarely move, the proposed method is more effective and improves storage I/O performance by up to 44%. (C) 2015 Wiley Periodicals, Inc.	[Hayashi, Shinichi] Hitachi Ltd, Tokyo, Japan; [Komoda, Norihisa] Osaka Univ, Elect Engn, Grad Sch Engn, Suita, Osaka 565, Japan; [Komoda, Norihisa] Osaka Univ, Dept Informat Syst Engn, Fac Engn, Suita, Osaka 565, Japan	Hayashi, S (reprint author), Hitachi Ltd, Tokyo, Japan.						Emaru H, 2011, J INF PROCESS, V52, P2234; EMC Corporation, 2012, FULL AUT STOR TIER V; Fisher N, 2012, COMPUTING, V94, P21, DOI 10.1007/s00607-011-0163-y; Hayashi S, 2012, P FORUM INFORM TECHN, V1, P271; Hewlett-Packard Development Company, 2012, HP 3PAR AD OPT SOFTW; Horiuchi Y., 2012, IDEMA JAPAN NEWS 201, V106, P1; Jo H, 2009, P 2009 INT C PAR PRO, P375; Matsuzawa K, 2012, INFORM PROCESSING SO, P1; Narayanan D, 2008, ACM T STORAGE, V4, P253; No J, 2012, J PARALLEL DISTRIB C, V72, P1680; Payer H., 2009, P 1 WORKSH INT SOL S, V1, P1; Schmidt G, 2012, IBM SYSTEM STORAGE D; Sudo A, 2011, P 73 NAT CONV INF P, V1, P31; Suk J, 2009, HPCC: 2009 11TH IEEE INTERNATIONAL CONFERENCE ON HIGH PERFORMANCE COMPUTING AND COMMUNICATIONS, P539; Sukigara T, 2011, HITACHI HYORON, V93, P44; Zhang G, 2010, P 2010 IEEE POW EN S, P1; Zhang G., 2010, P 3 INT C CLOUD COMP, P148	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	OCT	2015	98	10					1	11		10.1002/ecj.11696		11	Engineering, Electrical & Electronic	Engineering	CR4NC	WOS:000361309100001		
J	Asayama, R; Wang, J; Fujiwara, O				Asayama, Ryota; Wang, Jianqing; Fujiwara, Osamu			Calculation of Whole-Body Average SARs in Pregnant Woman and Child Simultaneously Exposed to Multiple Radio-Frequency Waves in Real Environment	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						RF waves from base station antennas; multiple RF simultaneous exposures; pregnant woman model; child model; whole-body average SARs	GHZ; MHZ	There are few published papers on the whole-body average specific absorption rates (WBA-SARs) in humans for simultaneous exposure to multiple radio frequencies (RFs). In order to evaluate human safety of radiowaves in real environments, in this paper we calculate the WBA-SARs in models of a pregnant woman and 3-year-old child for multiple RF exposure, using measured results on electric field intensities from multiple base station antennas installed for cellular phones with four different radiowave frequencies in an underground shopping mall and with five radiowave frequencies in the neighborhood of an elementary school. The Japan Ministry of Internal Affairs and Communications officially reported these data in 2008. Statistical analyses show that the squared sum ratio of the measured electric field to the corresponding Japanese guideline for the general public is smaller than one-hundredth and one-thousand at most in the underground shopping mall and elementary school areas, respectively. As a result, we found that the WBA-SARs in the pregnant woman and 3-year-old child models calculated at each of the frequencies for base station antennas in both areas are significantly lower than the The International Commission on Non-Ionizing Radiation Protection (ICNIRP) basic restriction (0.08 W/kg) for the general public, and that the sum of the WBA-SARs never exceeds one-hundredth of 0.08 W/kg for simultaneous exposure to multiple RF. (C) 2015 Wiley Periodicals, Inc.	[Asayama, Ryota] Nagoya Inst Technol, Grad Sch Engn, Nagoya, Aichi, Japan; [Wang, Jianqing] Nagoya Inst Technol, Fac Engn, Nagoya, Aichi, Japan; [Fujiwara, Osamu] Nagoya Inst Technol, Elect Engn, Nagoya, Aichi, Japan	Asayama, R (reprint author), Nagoya Inst Technol, Grad Sch Engn, Nagoya, Aichi, Japan.						Nagaoka T, 2007, PHYS MED BIOL, V52, P6731, DOI 10.1088/0031-9155/52/22/012; Asayama R, 2013, IEEJ T FM, V133, P7; Asayama R, 2012, TECHN M EL COMP IEEJ, P115; Gabriel C., 1996, ALOETR19960037 BROOK; Ahlbom A, 1998, HEALTH PHYS, V74, P494; Ministry of Internal Affairs and Communications, INV REP MEAS EL FIEL; Ministry of Posts and Telecommunications Telecommunication Technology Council Reply, 1990, PROT GUID HUM BOD EX; Miwa H, 2011, IEEJ T FM, V131, P89, DOI 10.1541/ieejfms.131.89; Nagaoka T, 2008, PHYS MED BIOL, V53, P6695, DOI 10.1088/0031-9155/53/23/004; Nagamatsu Toshiya, 2008, Bulletin of the Physical Fitness Research Institute, P1; Nagaya Yoshio, 2008, IEICE Transactions on Communications, VJ91-B; WHO, 2006 RES AG RAD FREQ	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	OCT	2015	98	10					12	20		10.1002/ecj.11710		9	Engineering, Electrical & Electronic	Engineering	CR4NC	WOS:000361309100002		
J	Ichinotsubo, T; Nakamura, Y; Saga, R; Tsuji, H				Ichinotsubo, Takeo; Nakamura, Yu; Saga, Ryosuke; Tsuji, Hiroshi			Analysis of Offshore Software Development by Process Growth Visualization	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						knowledge management; learning support; visualization; data mining; offshore software development; capability maturity model integration		To create criteria for the activities involved in offshore software development, this paper proposes a method to visualize the status of an organization. The basic premises in this research are that there are 12 capabilities and each capability has five levels. First, this paper introduces a knowledge management system called SPICE, which has a visualization function. The function includes the growth path of an individual, the growth path of a group, and a dependency structure. Then, to explain the use of method in the realm of offshore software development, this paper describes an experimental analysis and the accompanying visualization. The future possibilities of the method are also examined in detail. (C) 2015 Wiley Periodicals, Inc.	[Ichinotsubo, Takeo; Nakamura, Yu] Osaka Prefecture Univ, Elect & Informat Engn, Grad Sch Engn, Sakai, Osaka, Japan; [Nakamura, Yu] Osaka Prefecture Univ, Dept Intelligent Informat Engn, Sakai, Osaka, Japan; [Saga, Ryosuke] Osaka Prefecture Univ, Engn, Grad Sch Engn, Sakai, Osaka, Japan; [Tsuji, Hiroshi] Osaka Prefecture Univ, Grad Sch Engn, Sakai, Osaka, Japan	Ichinotsubo, T (reprint author), Osaka Prefecture Univ, Elect & Informat Engn, Grad Sch Engn, Sakai, Osaka, Japan.				 [23500049];  [13370017]	This research benefited greatly from discussions and collaborative development with Kenichi Tamano, Ratanak Chan, Pen Chanveasna, Gen Ushibuse, and Hirosuke Aoki. Professors D. Albert and A. Tiwana offered abundant advice while they were in residence during this research. This research received support from Scientific Grants-in-Aid C (Topic Number 23500049) and A (Topic Number 13370017).	Aspray W, 2006, GLOBALIZATION OFFSHO; CMMI Project Team, CMMI DEV VERS 3 1; Humphrey W., 1989, MANAGING SOFTWARE PR; Japan Electronics and Information Technology Industries Association (JEITA), 2006, SURV AN REC OFFSH SO; Mayer B, 2005, UNSPOKEN REVOLUTION, P121; Meyer B, 2007, LECT NOTES COMPUTER, V4716; Nakamura Y, 2012, TECHN M INF SYST, P39; Nakamura Y, 2010, P 2 INT S AW COMP, P233; Nakamura Yu, 2011, Knowledge-Based and Intelligent Information and Engineering Systems. Proceedings 15th International Conference, KES 2011, DOI 10.1007/978-3-642-23866-6_28; Sato T, 1979, JAPAN J ED TECHNOLOG, V4, P9; Tsuji H, 2008, J IPSJ, V49, P551	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	OCT	2015	98	10					21	30		10.1002/ecj.11723		10	Engineering, Electrical & Electronic	Engineering	CR4NC	WOS:000361309100003		
J	Otsuka, T; Deng, D; Ito, T				Otsuka, Takanobu; Deng, Deyue; Ito, Takayuki			Text Filtering for Harmful Document Classification Using Three-Word Co-Occurrence and Large-Scale Data Processing	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						text filtering; three-word co-occurrence; large-scale data processing		Young people are increasingly using the Internet. However, this creates the problem that the material they encounter may adversely affect them. Therefore we propose a method of automatically classifying harmful sentences. Research on information filtering has been improving the performance of filters by introducing co-occurrence information. Extended from two words co-occurrence information, which is commonly studied in such work, we have created training data using co-occurrence information with three words. However, compared with two-word co-occurrence information, the processing time becomes a problem because of the increase in the amount of training data. In addition, we have found that noise caused by the increase in co-occurrences exceeds the capacity of double-precision floating-point calculations. We improved processing speed by implementing a text filtering system with three-word co-occurrence using a Bayesian filter in order to parallelize a fast MyISAM database. In addition, by using BigDecimal to remove the noise caused by the increase in the number of co-occurrences, we achieved a high F-value. (C) 2015 Wiley Periodicals, Inc.	[Otsuka, Takanobu] Nagoya Inst Technol Gokiso, Grad Sch Informat Sci, Nagoya, Aichi, Japan; [Deng, Deyue; Ito, Takayuki] Nagoya Inst Technol Gokiso, Master Technobusiness Adm Program, Nagoya, Aichi, Japan	Otsuka, T (reprint author), Nagoya Inst Technol Gokiso, Grad Sch Informat Sci, Nagoya, Aichi, Japan.				Advanced Research Assistance Fund of the Cabinet Office of the Japanese Government	This research was supported in part by a Scientific Grant-in-Aid from the Advanced Research Assistance Fund of the Cabinet Office of the Japanese Government ().	Ando S, 2010, 2010 IEEE/ACIS 9th International Conference on Computer and Information Science (ICIS 2010), DOI 10.1109/ICIS.2010.96; Ando S, 2010, IPSJ 72 NAT C 50 ANN; [Anonymous], 2004, BIGDECIMAL CLASS JAV; Caruana R., 2006, ICML 2006 P 23 INT C, V2006, P161, DOI DOI 10.1145/1143844.1143865; Fujii Y, 2012, 74 NAT C IPSJ; Graham P, 2003, P 2003 SPAM C; John GH, 1995, P 11 C UNC ART INT, V1, P338; Manning C.D., 1999, FDN STAT NATURAL LAN; Zhang H, 2004, FLAIRS2004 C	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	OCT	2015	98	10					31	40		10.1002/ecj.11729		10	Engineering, Electrical & Electronic	Engineering	CR4NC	WOS:000361309100004		
J	Okaya, M; Takahashi, T				Okaya, Masaru; Takahashi, Tomoichi			Evacuation Guidance and Agent Behavior in Evacuation Simulations	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						evacuation simulation; evacuation announcement; information propagation		Evacuation guidance and announcements are important for occupants to exit buildings during an emergency. However, it has been reported that such guidance and announcements have not been used effectively in real cases. The National Institute of Standards and Technology published reports on the World Trade Center collapse on September 11, 2001. The reports include data on evacuation behaviors of occupants and how they obtained information during their egress. After the Great East Japan Earthquake, the Japanese government conducted an investigation into how people behaved during that disaster. The evacuation behaviors of people are similar in both cases. The behaviors are categorized into three groups: instant evacuation, evacuation after tasks are completed, and emergent evacuation. We present a system in which evacuation guidance is implemented as a form of agent communication and show how the content of guidance alters the escape time. (C) 2015 Wiley Periodicals, Inc.	[Okaya, Masaru] Meijo Univ, Grad Sch Sci, Nagoya, Aichi, Japan; [Takahashi, Tomoichi] Meijo Univ, Fac Sci, Nagoya, Aichi, Japan	Okaya, M (reprint author), Meijo Univ, Grad Sch Sci, Nagoya, Aichi, Japan.				Japan Society for the Promotion of Science [24500186]	This research was supported by a Japan Society for the Promotion of Science Grant-in-Aid, No. 24500186.	Averill JD, 2005, NISTNCSTAR 1 7 OCCUP; Cabinet of the Japanese Government, 2011, STUD COMM LESS LEARN; Drabek TE, HUMAN SIDE DISASTER, V95, P859; Okaya M, 2012, IEEE INT S SAF SEC R; Okaya M, 2012, 1 INT WORKSH PATT RE; Omoto H, 2012, IEICE J, V95, P859; Pan X, 2006, THESIS STANFORD U; Pelechano N, 2006, IEEE COMP GRAPH APPL; Pelechano N, 2007, BUILDING SIMULATION 2007, VOLS 1-3, PROCEEDINGS, P1514; Ripley A., 2008, UNTHINKABLE WHO SURV; Tokyo Fire and Disaster Management Department, 2006, APPR DISPL SYST PRIO	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	OCT	2015	98	10					41	48		10.1002/ecj.11731		8	Engineering, Electrical & Electronic	Engineering	CR4NC	WOS:000361309100005		
J	Watanuki, T; Nozawa, A				Watanuki, Takuya; Nozawa, Akio			Analysis of TV Viewing Modes Based on Stress Coping Style	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						television; hemodynamic parameter; mode of viewing; autonomic nervous system; preference		In this research, based on the stress coping style as expressed by hemodynamic parameters, we evaluated the modes of television viewing with the aim of estimating different modes of watching television. The central nervous system was assessed by means of electroencephalograms (EEG). The autonomic nervous system was assessed using the nasal skin temperature (NST) and the heart rate variability (HRV) with spectral analysis. In the spectral analysis of the HRV, the high-frequency components (HF) were evaluated. The cardiovascular system was assessed using the mean pressure (MP), the heart rate (HR), the stroke volume (SV), the cardiac output (CO), and the total peripheral resistance (TPR). The multiple mood scale (MMS) and visual analog scale (VAS) were administered to evaluate psychological status. It was found that modes of television viewing could not be distinguished using only the television content preference. It became clear that the modes of television viewing could be distinguished on the basis of the stress coping style using hemodynamic parameters. (C) 2015 Wiley Periodicals, Inc.	[Watanuki, Takuya; Nozawa, Akio] Aoyama Gakuin Univ, Elect & Elect Engn, Grad Sch Sci & Engn, Tokyo 150, Japan; [Nozawa, Akio] Aoyama Gakuin Univ, Dept Elect & Elect Engn, Tokyo 150, Japan	Watanuki, T (reprint author), Aoyama Gakuin Univ, Elect & Elect Engn, Grad Sch Sci & Engn, Tokyo 150, Japan.						Fujiwara K, 1989, NHK BROADCAST RES IN, V6, P2; Michimori A., 1992, 10 S HUM INT, V10, P233; Nishigaki T., 2001, CAN TELEVISION FLOUR; Nomura S, 2011, IEEJ T EIS, V131, P146; Ono K., 1990, RES REPORTS, V18, P153; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Sawada H., 1998, HEMODYNAMIC REACTION, V1, P187; Takahashi Y, 1999, B JAPAN SOC SCI DES, V46, P71; TERASAKI M, 1992, JPN J PSYCHOL, V62, P350; Tomomune Y, 2001, BROADCAST RES SURV, V51, P2	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	OCT	2015	98	10					49	56		10.1002/ecj.11732		8	Engineering, Electrical & Electronic	Engineering	CR4NC	WOS:000361309100006		
J	Kondo, M; Yokogawa, T; Sato, Y; Arimoto, K				Kondo, Masafumi; Yokogawa, Tomoyuki; Sato, Yoichiro; Arimoto, Kazutami			High-Speed Performance Evaluation of a Large-Scale Shared-Bus Digital System	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						stochastic timed Petri net (STPN); incidence matrix; Petri net simulation; ordering; Cuthill-McKee algorithm		To evaluate the performance of a large-scale digital system, the system can be modeled by stochastic timed Petri nets (STPN) and a performance index can be estimated based on the number of iterations in a Petri net simulation. When the performance evaluation is carried out in a large distributed environment, parallel calculation with incidence matrices for the STPN can make the Petri net simulation more efficient. In this paper, we propose an ordering method for the incidence matrices to reduce the communication costs in the parallel calculation of matrix operations. For this purpose, we first propose a method of blocking the incidence matrices based on the structure of the system by taking into consideration synchronous and asynchronous buses as structural elements. We also propose a method for converting submatrices of the incidence matrices into band matrices. This method is based on breadth-first search in the STPN as represented by the submatrices. Finally, we demonstrate the benefits of ordering on the time required for a performance evaluation by carrying out a performance evaluation using the incidence matrices generated under the proposed method. In addition, we show that the ordering method can reduce the communication costs in a large distributed environment by estimating the utilization rate of calculation nodes. (C) 2015 Wiley Periodicals, Inc.	[Kondo, Masafumi] Kawasaki Univ Med Welf, Fac Hlth Sci & Technol, Kawasaki, Kanagawa, Japan; [Yokogawa, Tomoyuki; Sato, Yoichiro; Arimoto, Kazutami] Okayama Prefectural Univ, Fac Comp Sci & Syst Engn, Okayama, Japan	Kondo, M (reprint author), Kawasaki Univ Med Welf, Fac Hlth Sci & Technol, Kawasaki, Kanagawa, Japan.						Ueno K, 2012, IEEE SYM PARA DISTR, P1925, DOI 10.1109/IPDPSW.2012.240; GEORGE A, 1973, SIAM J NUMER ANAL, V10, P345, DOI 10.1137/0710032; Teehan P, 2007, IEEE DES TEST COMPUT, V24, P418, DOI 10.1109/MDT.2007.151; Cuthill E., 1969, P 24 NAT C ACM, P157, DOI DOI 10.1145/800195.805928; George A., 1981, COMPUTER SOLUTION LA; Ino M, 1983, PRACTICAL GRAPH THEO; Kondo M, 2012, P IEICE GEN C 2012, pS3; Kondo M, 2013, T IEICE D, VJ96-D, P913; Krstic M, 2007, IEEE DES TEST COMPUT, V24, P430, DOI 10.1109/MDT.2007.164; Kudoh M, 2002, IPSJ TECH REP ARC, V2002, P151; Moore S, 2002, PR INT SYMP ADV RES, P69; Murata K, 1991, PAR COMP SOFTW WORKS; Najibi M, 2007, IEEE COMP SOC ANN, P422, DOI 10.1109/ISVLSI.2007.80; Rahman MAU, 2009, ICCIT: 2009 FOURTH INTERNATIONAL CONFERENCE ON COMPUTER SCIENCES AND CONVERGENCE INFORMATION TECHNOLOGY, VOLS 1 AND 2, P841; Seceleanu T, 2004, 647 TUCS; Tashiro K, 2007, IEICE TECH REP VLD, V106, P57; Ueno K, 2011, IPSJ TECH REP HPC, V2011, P1; Xie A, 1999, P 2 WORKSH HARDW DES, P35; Yoo A., 2005, P 2005 ACM IEEE C SU, P25	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	OCT	2015	98	10					57	66		10.1002/ecj.11743		10	Engineering, Electrical & Electronic	Engineering	CR4NC	WOS:000361309100007		
J	Takekita, Y; Fabbri, C; Kato, M; Nonen, S; Sakai, S; Sunada, N; Koshikawa, Y; Wakeno, M; Okugawa, G; Kinoshita, T; Serretti, A				Takekita, Yoshiteru; Fabbri, Chiara; Kato, Masaki; Nonen, Shinpei; Sakai, Shiho; Sunada, Naotaka; Koshikawa, Yosuke; Wakeno, Masataka; Okugawa, Gaku; Kinoshita, Toshihiko; Serretti, Alessandro			Antagonist and partial agonist at the dopamine D2 receptors in drug-naive and non-drug-naive schizophrenia: a randomized, controlled trial	EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE			English	Article						Schizophrenia; Perospirone; Aripiprazole; Antipsychotic medication history; Response; Drug naive	POSITRON-EMISSION-TOMOGRAPHY; PSYCHIATRY WFSBP GUIDELINES; LONG-TERM TREATMENT; HUMAN BRAIN; SCHIZOAFFECTIVE DISORDER; TREATMENT RESPONSE; SEX-DIFFERENCES; BIOLOGICAL TREATMENT; WORLD FEDERATION; C-11 RACLOPRIDE	Few data are available on the efficacy and safety of antipsychotics with different dopamine D2 receptor (D2-R)-binding properties in drug-naive and non-drug-naive schizophrenia. Thus, we aimed to assess whether antipsychotic medication history influences efficacy and tolerability in schizophrenia, based on a randomized controlled study of antipsychotics with mechanisms involving either full antagonism or partial agonism of D2-R. Patients with schizophrenia were recruited and given perospirone or aripiprazole in a 12-week, flexible-dose, open-label, randomized controlled study. Data were analyzed after dividing the patients into antipsychotic-na < ve and antipsychotic-treated group according to antipsychotic medication histories. Efficacy and safety were evaluated using the Positive and Negative Syndrome Scale (PANSS), the Drug-Induced Extrapyramidal Symptoms Scale, and the Barnes Akathisia Rating Scale. In patients receiving perospirone, the antipsychotic-naive group (n = 22) showed greater symptom improvement than that shown by the antipsychotic-treated group (n = 29), as assessed by efficacy evaluation scales such as the PANSS total, positive, and excited component score (p = .006, p < .001, p = .003, respectively). In patients receiving aripiprazole, however, there was no significant difference in efficacy between the antipsychotic-naive (n = 18) and antipsychotic-treated (n = 31) groups. No significant intra-group or inter-group difference was noted with respect to any of the tolerability-related parameters assessed. The present study data support the hypothesis that antipsychotic medication history may influence efficacy in patients who receive a D2-R full antagonist but not a D2-R partial agonist.	[Takekita, Yoshiteru; Fabbri, Chiara; Serretti, Alessandro] Univ Bologna, Dept Biomed & NeuroMotor Sci, I-40123 Bologna, Italy; [Takekita, Yoshiteru; Kato, Masaki; Sakai, Shiho; Sunada, Naotaka; Koshikawa, Yosuke; Wakeno, Masataka; Okugawa, Gaku; Kinoshita, Toshihiko] Kansai Med Univ, Dept Neuropsychiat, Moriguchi, Osaka 5708506, Japan; [Nonen, Shinpei] Hyogo Univ Hlth Sci, Dept Pharm, Chuo Ku, Kobe, Kobe 6508530, Japan	Takekita, Y (reprint author), Univ Bologna, Dept Biomed & NeuroMotor Sci, Viale Carlo Pepoli 5, I-40123 Bologna, Italy.	takekity@takii.kmu.ac.jp			Japan Society for the Promotion of Science (JSPS) [KAKEN 23791357]	This work was supported by Grant-in-Aid for Young Scientists (B) (KAKEN 23791357) from Japan Society for the Promotion of Science (JSPS). The authors thank the patients and their families who participated in this study. They also thank Junichi Azuma, professor of pharmacy at Hyogo University of Health Sciences, for providing useful comments and suggestions on the drafted study protocol.	Washida K, 2013, NEUROPSYCH DIS TREAT, V9, P861, DOI 10.2147/NDT.S45697; Kaasinen V, 2001, AM J PSYCHIAT, V158, P308, DOI 10.1176/appi.ajp.158.2.308; Kishi T, 2013, CNS DRUGS, V27, P731, DOI 10.1007/s40263-013-0085-7; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Inoue A, 1997, EUR J PHARMACOL, V321, P105, DOI 10.1016/S0014-2999(96)00920-X; Pohjalainen T, 1998, AM J PSYCHIAT, V155, P768; MACKAY AVP, 1982, ARCH GEN PSYCHIAT, V39, P991; Kim JH, 2011, EUR NEUROPSYCHOPHARM, V21, P885, DOI 10.1016/j.euroneuro.2011.03.009; Cordon RD, 2012, EUR ARCH PSY CLIN N, V262, P139, DOI 10.1007/s00406-011-0220-8; Silvestri S, 2000, PSYCHOPHARMACOLOGY, V152, P174, DOI 10.1007/s002130000532; Emsley R, 2013, J CLIN PSYCHOPHARM, V33, P80, DOI 10.1097/JCP.0b013e31827bfcc1; Tadokoro S, 2012, SCHIZOPHRENIA BULL, V38, P1012, DOI 10.1093/schbul/sbr006; Jordan S, 2002, EUR J PHARMACOL, V441, P137, DOI 10.1016/S0014-2999(02)01532-7; Potkin SG, 2003, ARCH GEN PSYCHIAT, V60, P681, DOI 10.1001/archpsyc.60.7.681; Jager M, 2007, EUR ARCH PSY CLIN N, V257, P47, DOI 10.1007/s00406-006-0683-1; Inoue M, 2001, LIFE SCI, V69, P1079, DOI 10.1016/S0024-3205(01)01205-X; Robinson DG, 1999, AM J PSYCHIAT, V156, P544; Kaasinen V, 2000, NEUROBIOL AGING, V21, P683, DOI 10.1016/S0197-4580(00)00149-4; Gafoor R, 2010, J CLIN PSYCHOPHARM, V30, P600, DOI 10.1097/JCP.0b013e3181f198da; ANTONINI A, 1993, ARCH NEUROL-CHICAGO, V50, P474; Iyo M, 2013, J CLIN PSYCHOPHARM, V33, P398, DOI 10.1097/JCP.0b013e31828ea95c; Hasan A, 2012, WORLD J BIOL PSYCHIA, V13, P318, DOI 10.3109/15622975.2012.696143; Hasan A, 2013, WORLD J BIOL PSYCHIA, V14, P2, DOI 10.3109/15622975.2012.739708; Azorin JM, 2006, INT CLIN PSYCHOPHARM, V21, P49, DOI 10.1097/01.yic.0000177020.26311.a7; BARNES TRE, 1989, BRIT J PSYCHIAT, V154, P672, DOI 10.1192/bjp.154.5.672; Cervenka S, 2008, INT J NEUROPSYCHOPH, V11, P671, DOI 10.1017/S1461145707008358; Cohen J., 1988, STAT POWER ANAL BEHA; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Inada T, 1996, EVALUATION DIAGNOSIS; Inagaki A, 2006, JPN J CLIN PSYCHOPHA, V9, P249; Kishi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088049; Kuwabara H, 2012, J NUCL MED, V53, P805, DOI 10.2967/jnumed.111.098186; Kwon JS, 2009, PSYCHIAT CLIN NEUROS, V63, P73, DOI 10.1111/j.1440-1819.2008.01907.x; LEE T, 1978, NATURE, V274, P897, DOI 10.1038/274897a0; Okugawa G, 2009, PSYCHIAT CLIN NEUROS, V63, P322, DOI 10.1111/j.1440-1819.2009.01947.x; Parellada E, 2004, PSYCHIAT RES-NEUROIM, V130, P79, DOI 10.1016/j.pscychresns.2003.05.001; RINNE JO, 1993, J CEREBR BLOOD F MET, V13, P310; Sekine Y, 2006, J CLIN PSYCHOPHARM, V26, P531, DOI 10.1097/01.jcp.0000236659.93415.4a; Shiwa T, 2003, J PHARMACOL SCI, V93, P114, DOI 10.1254/jphs.93.114; Sirota P, 2006, HUM PSYCHOPHARM CLIN, V21, P227, DOI 10.1002/hup.763; Takayama T, 2012, JPN J CLIN PSYCHOPHA, V15, P1347; Takekita Y, 2013, PROG NEURO-PSYCHOPH, V40, P110, DOI 10.1016/j.pnpbp.2012.09.010; Taylor D, 2011, MAUDSLEY PRESCRIBING	43	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0940-1334	1433-8491		EUR ARCH PSY CLIN N	Eur. Arch. Psych. Clin. Neurosci.	OCT	2015	265	7					579	588		10.1007/s00406-015-0605-1		10	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	CR5QB	WOS:000361397100005		
J	Watanabe, K; Kouzaki, M; Ando, R; Akima, H; Moritani, T				Watanabe, Kohei; Kouzaki, Motoki; Ando, Ryosuke; Akima, Hiroshi; Moritani, Toshio			Non-uniform recruitment along human rectus femoris muscle during transcutaneous electrical nerve stimulation	EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY			English	Article						Neuromuscular compartment; Bi-articular muscles; Multi-channel surface electromyogram; M-wave	STIFF-LEGGED GAIT; SPATIAL-DISTRIBUTION; ELECTRODE LOCATION; QUADRICEPS; ORDER; ARCHITECTURE; POTENTIALS; ANATOMY	To test the hypothesis that motor units with different axonal excitability levels are localized in specific portions of the rectus femoris (RF) muscle using transcutaneous electrical nerve stimulation. M-waves were elicited by transcutaneous electrical nerve stimulation and detected from 24 sites along longitudinal line of the muscle. The stimulation was applied to the femoral nerve, and the current level was gradually increased. The central locus activation, which is calculated from the spatial distribution of M-waves, appeared at the proximal regions at low stimulation level and then moved to the middle site of the muscle with an increase in the stimulation level. The results reveal that groups of motor units activated at different stimulation levels are located in different positions in the proximal-distal muscle direction. Our results suggest that motor unit properties in proximal and other regions are not uniform within the RF muscle.	[Watanabe, Kohei] Chukyo Univ, Sch Int Liberal Studies, Lab Neuromuscular Biomech, Showa Ku, Nagoya, Aichi 4668666, Japan; [Kouzaki, Motoki] Kyoto Univ, Grad Sch Human & Environm Studies, Neurophysiol Lab, Kyoto, Japan; [Ando, Ryosuke; Akima, Hiroshi] Nagoya Univ, Grad Sch Educ & Human Dev, Nagoya, Aichi 4648601, Japan; [Ando, Ryosuke] Japan Soc Promot Sci, Tokyo, Japan; [Akima, Hiroshi] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi 4648601, Japan; [Moritani, Toshio] Kyoto Univ, Appl Physiol Lab, Grad Sch Human & Environm Studies, Kyoto, Japan	Watanabe, K (reprint author), Chukyo Univ, Sch Int Liberal Studies, Lab Neuromuscular Biomech, Showa Ku, Nagoya, Aichi 4668666, Japan.	wkohei@lets.chukyo-u.ac.jp			JSPS KAKENHI [24800071, 26750309]; Japanese Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP Project) [14533567]	This research was supported in part by JSPS KAKENHI, a Grant-Aid for Research Activity Start-up (No. 24800071) and Young Scientist B (No. 26750309). This work was supported by the Japanese Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP Project ID 14533567).	Reinbolt JA, 2008, J BIOMECH, V41, P2362, DOI 10.1016/j.jbiomech.2008.05.030; Rodriguez-Falces J, 2013, MUSCLE NERVE, V48, P752, DOI 10.1002/mus.23811; Maffiuletti NA, 2011, EUR J APPL PHYSIOL, V111, P2391, DOI 10.1007/s00421-011-2133-7; KERRIGAN DC, 1991, AM J PHYS MED REHAB, V70, P294; Miokovic T, 2012, J APPL PHYSIOL, V113, P1545, DOI 10.1152/japplphysiol.00611.2012; Gregory CM, 2005, PHYS THER, V85, P358; Farina D, 2008, J ELECTROMYOGR KINES, V18, P16, DOI 10.1016/j.jelekin.2006.08.005; Rodriguez-Falces J, 2013, EUR J APPL PHYSIOL, V113, P3069, DOI 10.1007/s00421-013-2736-2; Gyftopoulos S, 2008, AM J ROENTGENOL, V190, pW182, DOI 10.2214/AJR.07.2947; Mesin L, 2011, J BIOMECH, V44, P1096, DOI 10.1016/j.jbiomech.2011.01.031; Botter A, 2011, EUR J APPL PHYSIOL, V111, P2461, DOI 10.1007/s00421-011-2093-y; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; BOTTERMAN BR, 1983, J PHYSIOL-LONDON, V338, P355; CLAMANN HP, 1974, J NEUROPHYSIOL, V37, P1328; GARLAND SJ, 1994, MUSCLE NERVE, V17, P581, DOI 10.1002/mus.880170604; HASSELMAN CT, 1995, AM J SPORT MED, V23, P493, DOI 10.1177/036354659502300421; Hennings K, 2007, CLIN NEUROPHYSIOL, V118, P283, DOI 10.1016/j.clinph.2006.10.017; Hodson-Tole EF, 2013, J ELECTROMYOGR KINES, V23, P43, DOI 10.1016/j.jelekin.2012.08.003; Hogrel JY, 1998, J ELECTROMYOGR KINES, V8, P305, DOI 10.1016/S1050-6411(97)00043-6; KNAFLITZ M, 1990, J APPL PHYSIOL, V68, P1657; Matta TT, 2014, CLIN PHYSIOL FUNCT I, V35, P210; ROY SH, 1986, J APPL PHYSIOL, V61, P1510; Schiefer MA, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026006; Sung DH, 2003, ARCH PHYS MED REHAB, V84, P1028, DOI 10.1016/S0003-9993(03)00029-7; Watanabe K, 2014, MUSCLE NERVE, V50, P794, DOI 10.1002/mus.24232; Watanabe K, 2014, J BIOMECH, V47, P3502, DOI 10.1016/j.jbiomech.2014.09.001; Watanabe K, 2013, MUSCLE NERVE, V48, P226, DOI 10.1002/mus.23739; Watanabe K, 2015, MUSCLE NERVE, V52, P404, DOI 10.1002/mus.24544; Yang DP, 1999, PLAST RECONSTR SURG, V104, P102, DOI 10.1097/00006534-199907000-00014	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-6319	1439-6327		EUR J APPL PHYSIOL	Eur. J. Appl. Physiol.	OCT	2015	115	10					2159	2165		10.1007/s00421-015-3196-7		7	Physiology; Sport Sciences	Physiology; Sport Sciences	CR6QA	WOS:000361471000013		
J	Goma, M; Kimura, Y; Shimura, H; Kaneshige, M; Kobayashi, T; Kikuchi, M; Terada, N				Goma, Masaki; Kimura, Yoshinori; Shimura, Hiroki; Kaneshige, Masahiro; Kobayashi, Tetsuro; Kikuchi, Masashi; Terada, Nobuyuki			Orthostatic response of cephalic blood flow using a mini laser Doppler blood flowmeter and hemodynamics of a new active standing test	EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY			English	Article						Arterial blood pressure; Cephalic blood flow; Initial orthostatic hypotension; Laser Doppler flowmeter; Orthostatic challenge	POSTURAL CHANGE; SQUATTING TEST; PRESSURE; HYPOTENSION; MECHANISMS; EXERCISE; REFLEXES; STRESS; HUMANS; PROBE	Cephalic hemodynamic assessment is important in initial orthostatic hypotension. We sought to investigate cephalic blood flow (CBF) in the earlobe using a mini laser Doppler flowmeter (LDF) during orthostatic challenge. In addition, we clarified hemodynamic differences during a new active standing protocol using a footstool standing test (FST) with bending of the legs on the footstool in the sitting position to reduce the load of the squatting posture in the conventional squat standing test (SST). Ten healthy men (21 +/- A 0.5 years) performed the SST after a 1 min squat and the FST after a 1 min load consisting of bending the legs on a footstool in the sitting position. Earlobe CBF, beat-to-beat arterial blood pressure (ABP), mean arterial blood pressure (MAP), and heart rate (HR) were recorded during each test. Earlobe CBF showed a transient fall synchronized with the ABP during each test. No significant differences in the recovery times (RTs) of CBF and MAP were observed during the SST (CBF 12.9 +/- A 0.6 s vs. MAP 12.1 +/- A 0.5 s, P = 0.313) and FST (CBF 10.6 +/- A 0.4 s vs. MAP 10.1 +/- A 0.8 s, P = 0.552). Although the CBF and ABP decreases were not different in each test, the HR increase was significantly lower with the FST (24 +/- A 2 bpm) than with the SST (31 +/- A 3 bpm, P < 0.005). Earlobe CBF reflects the compensatory ABP regulatory response during standing and is potentially useful for estimating the orthostatic ABP response indirectly. Furthermore, the FST is a low-load protocol that can be an effective protocol for a standing test of cardiac function.	[Goma, Masaki] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Cyuo, Yamanashi 4093898, Japan; [Goma, Masaki; Kimura, Yoshinori] Pioneer Corp, Div Res & Dev, Saiwai Ku, Kawasaki, Kanagawa 2120031, Japan; [Shimura, Hiroki] Fukushima Med Univ, Sch Med, Dept Lab Med, Fukushima, Fukushima 9601295, Japan; [Kaneshige, Masahiro; Kobayashi, Tetsuro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Internal Med 3, Cyuo, Yamanashi 4093898, Japan; [Kobayashi, Tetsuro] Okinaka Mem Inst Med Res, Minato Ku, Tokyo 1058470, Japan; [Kikuchi, Masashi; Terada, Nobuyuki] Toyo Univ, Dept Biomed Engn, Kawagoe, Saitama 3508585, Japan	Goma, M (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, 1110 Shimokato, Cyuo, Yamanashi 4093898, Japan.	masaki_goma@post.pioneer.co.jp			Pioneer Corporation	Financial support of collaboration for this study was provided by the Pioneer Corporation. M. Goma and Y. Kimura are employed by Pioneer Corporation.	Barantke M, 2008, J CARDIOVASC ELECTR, V19, P1296, DOI 10.1111/j.1540-8167.2008.01257.x; OBEID AN, 1990, J MED ENG TECHNOL, V14, P178, DOI 10.3109/03091909009009955; Thomas KN, 2009, J APPL PHYSIOL, V107, P506, DOI 10.1152/japplphysiol.91650.2008; IMHOLZ BPM, 1990, CARDIOVASC RES, V24, P214, DOI 10.1093/cvr/24.3.214; Tanaka H, 1996, CLIN PHYSIOL, V16, P157, DOI 10.1111/j.1475-097X.1996.tb00565.x; Peuker ET, 2002, CLIN ANAT, V15, P35, DOI 10.1002/ca.1089; Shi XR, 2003, GERONTOLOGY, V49, P279, DOI 10.1159/000071708; Vaddadi G, 2007, MED J AUSTRALIA, V187, P299; SPRANGERS RLH, 1991, J APPL PHYSIOL, V70, P523; Thrasher TN, 2005, AM J PHYSIOL-REG I, V288, pR819, DOI 10.1152/ajpregu.00813.2004; DEMUL FFM, 1984, APPL OPTICS, V23, P2970; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; BORST C, 1984, CLIN SCI, V67, P321; BONNER R, 1981, APPL OPTICS, V20, P2097, DOI 10.1364/AO.20.002097; LOW PA, 1983, MAYO CLIN PROC, V58, P583; van der Velde N, 2007, BLOOD PRESS MONIT, V12, P167, DOI 10.1097/MBP.0b013e3280b083bd; Wieling W, 2007, CLIN SCI, V112, P157, DOI 10.1042/CS20060091; BORST C, 1982, AM J PHYSIOL, V243, pH676; Convertino VA, 1998, AVIAT SPACE ENVIR MD, V69, P875; LIPSITZ LA, 1989, NEW ENGL J MED, V321, P952; OIMOMI M, 1985, Diabetes Research and Clinical Practice, V1, P81, DOI 10.1016/S0168-8227(85)80032-2; Philips JC, 2011, AUTON NEUROSCI-BASIC, V162, P3, DOI 10.1016/j.autneu.2011.03.001; Rickards CA, 2003, EUR J APPL PHYSIOL, V90, P449, DOI 10.1007/s00421-003-0852-0; ROSSBERG F, 1988, EUR J APPL PHYSIOL O, V57, P93, DOI 10.1007/BF00691245; Rowell L, 1993, HUMAN CARDIOVASCULAR, P443; Scheen AJ, 2012, CLIN AUTON RES, V22, P35, DOI 10.1007/s10286-011-0140-8; Serov AN, 2006, IEEE T BIO-MED ENG, V53, P2067, DOI 10.1109/TBME.2006.877106; TOSKA K, 1994, AM J PHYSIOL, V266, pH199; Tschakovsky ME, 2011, AM J PHYSIOL-HEART C, V301, pH2102, DOI 10.1152/ajpheart.00571.2011; Wieling W, 1996, J PHYSIOL-LONDON, V494, P601; Yamaguchi H, 1996, ACTA PAEDIATR, V85, P577, DOI 10.1111/j.1651-2227.1996.tb14090.x	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-6319	1439-6327		EUR J APPL PHYSIOL	Eur. J. Appl. Physiol.	OCT	2015	115	10					2167	2176		10.1007/s00421-015-3197-6		10	Physiology; Sport Sciences	Physiology; Sport Sciences	CR6QA	WOS:000361471000014		
J	Takahashi, K; Takeuchi, M; Sato, Y; Sato, H; Mizuno, K; Hashimoto, S; Kobayashi, M; Terai, S				Takahashi, Kazuya; Takeuchi, Manabu; Sato, Yuichi; Sato, Hiroki; Mizuno, Kenichi; Hashimoto, Satoru; Kobayashi, Masaaki; Terai, Shuji			Evaluation of esophageal motility after endoscopic submucosal dissection for superficial esophageal cancer	EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY			English	Article						endoscopic submucosal dissection; esophageal motility; high-resolution manometry	SQUAMOUS-CELL NEOPLASMS; PRESSURE TOPOGRAPHY; WEAK PERISTALSIS; MANOMETRY; STRICTURE; CLASSIFICATION; CLEARANCE; INJECTION; CARCINOMA; IMPEDANCE	IntroductionEndoscopic submucosal dissection (ESD) is a standard treatment for superficial esophageal cancer. Some patients complain of dysphagia after ESD even without any postoperative strictures. Although ineffective esophageal motility might be associated with dysphagia after ESD, its effect on esophageal motility after ESD remains unknown. Therefore, we aimed to elucidate esophageal motility after ESD and the cause of dysphagia using high-resolution manometry (HRM).Patients and methodsSeventy-six patients (men/women, 64/12; mean age, 71.2 years) who had undergone ESD for superficial esophageal cancer were enrolled. The results of ESD were retrospectively investigated using endoscopic images from the ESD and patient questionnaire for dysphagia. Each patient underwent HRM, and the results were evaluated using metrics and contraction patterns, according to the Chicago classification.ResultsData were obtained from 71 patients. The circumferential mucosal defect ratio (=0.284, P=0.017), number of ESD (=0.346, P=0.003), and number of endoscopic balloon dilatations (EBDs) (=0.416, P<0.001) were correlated with the number of weak contraction with large breaks on HRM. The circumferential mucosal defect (odds ratio=1.074, P<0.001) and number of EBDs (odds ratio=1.200, P=0.035) were also significant predictors for dysphagia after ESD.ConclusionCircumferential mucosal defect ratio, EBD, and repeated ESD were predictors for impaired esophageal motility after ESD. Because circumferential mucosal defect ratios and EBD were also correlated with dysphagia after ESD, impaired esophageal motility could explain dysphagia after ESD.	[Takahashi, Kazuya; Takeuchi, Manabu; Sato, Yuichi; Sato, Hiroki; Terai, Shuji] Niigata Univ, Med & Dent Hosp, Div Gastroenterol & Hepatol, Niigata, Niigata 9518510, Japan; [Mizuno, Kenichi; Hashimoto, Satoru; Kobayashi, Masaaki] Niigata Univ, Med & Dent Hosp, Dept Endoscopy, Niigata, Niigata 9518510, Japan	Takeuchi, M (reprint author), Niigata Univ, Med & Dent Hosp, Div Gastroenterol & Hepatol, Niigata, Niigata 9518510, Japan.	manabu@med.niigata-u.ac.jp					Roman S, 2011, AM J GASTROENTEROL, V106, P349, DOI 10.1038/ajg.2010.384; Bredenoord AJ, 2012, NEUROGASTROENT MOTIL, V24, P57, DOI 10.1111/j.1365-2982.2011.01834.x; Ribolsi M, 2014, AM J GASTROENTEROL, V109, P46, DOI 10.1038/ajg.2013.373; Ono S, 2009, ENDOSCOPY, V41, P661, DOI 10.1055/s-0029-1214867; Fujishiro M, 2009, DIGEST ENDOSC, V21, P109, DOI 10.1111/j.1443-1661.2009.00837.x; Beaumont H, 2009, ENDOSCOPY, V41, P2, DOI 10.1055/s-0028-1103451; Hashimoto S, 2011, GASTROINTEST ENDOSC, V74, P1389, DOI 10.1016/j.gie.2011.07.070; Mizuta H, 2009, DIS ESOPHAGUS, V22, P626, DOI 10.1111/j.1442-2050.2009.00954.x; Miyashita M, 1997, AM J SURG, V174, P442, DOI 10.1016/S0002-9610(97)00116-5; Yamaguchi N, 2011, GASTROINTEST ENDOSC, V73, P1115, DOI 10.1016/j.gie.2011.02.005; Bulsiewicz WJ, 2009, AM J GASTROENTEROL, V104, P2721, DOI 10.1038/ajg.2009.467; Honda M, 2010, ENDOSCOPY, V42, P1092, DOI 10.1055/s-0030-1255741; Kumar N, 2012, J CLIN GASTROENTEROL, V46, P375, DOI 10.1097/MCG.0b013e31823d3403; Bu BG, 2013, WORLD J GASTROENTERO, V19, P4781, DOI 10.3748/wjg.v19.i29.4781; Fox M, 2012, NEUROGASTROENT MOTIL, V24, P48, DOI 10.1111/j.1365-2982.2011.01835.x; Ghoshal UC, 1998, J GASTROEN HEPATOL, V13, P1033, DOI 10.1111/j.1440-1746.1998.tb00566.x; Hemmink GJM, 2013, EUR J GASTROEN HEPAT, V25, P1024, DOI 10.1097/MEG.0b013e32836283dc; Honda M, 2011, J GASTROENTEROL, V46, P866, DOI 10.1007/s00535-011-0400-3; Malhi-Chowla N, 2001, MAYO CLIN PROC, V76, P987; Nasr I, 2010, NEUROGASTROENT MOTIL, V22, P520, DOI 10.1111/j.1365-2982.2009.01451.x; Oyama Tsuneo, 2005, Clin Gastroenterol Hepatol, V3, pS67, DOI 10.1016/S1542-3565(05)00291-0; Sun FH, 2014, J CARDIOTHORAC SURG, V9, DOI 10.1186/1749-8090-9-78; Takeuchi M, 2010, ESOPHAGUS-TOKYO, V7, P173, DOI 10.1007/s10388-010-0241-9; Tutuian R, 2004, AM J GASTROENTEROL, V99, P1011, DOI 10.1111/j.1572-0241.2004.30035.x; Xiao YL, 2012, AM J GASTROENTEROL, V107, P1647, DOI 10.1038/ajg.2012.286	25	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0954-691X	1473-5687		EUR J GASTROEN HEPAT	Eur. J. Gastroenterol. Hepatol.	OCT	2015	27	10					1187	1192		10.1097/MEG.0000000000000431		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CR2YP	WOS:000361197200012		
J	Fujiwara, K; Yasui, S; Yokosuka, O				Fujiwara, Keiichi; Yasui, Shin; Yokosuka, Osamu			Appropriate diagnostic criteria for fulminant autoimmune hepatitis	EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY			English	Letter							FAILURE; UTILITY		[Fujiwara, Keiichi; Yasui, Shin; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba 2608670, Japan	Fujiwara, K (reprint author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	fujiwara-cib@umin.ac.jp					Alvarez F., 1999, Journal of Hepatology, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Hennes EM, 2008, HEPATOLOGY, V48, P169, DOI 10.1002/hep.22322; Yeoman AD, 2009, HEPATOLOGY, V50, P538, DOI 10.1002/hep.23042; Fujiwara K, 2011, LIVER INT, V31, P1013, DOI 10.1111/j.1478-3231.2011.02524.x; Fujiwara K, 2013, HEPATOL INT, V7, P335, DOI 10.1007/s12072-012-9402-3; Mendizabal M, 2015, EUR J GASTROEN HEPAT, V27, P644, DOI 10.1097/MEG.0000000000000353	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0954-691X	1473-5687		EUR J GASTROEN HEPAT	Eur. J. Gastroenterol. Hepatol.	OCT	2015	27	10					1230	1231		10.1097/MEG.0000000000000441		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CR2YP	WOS:000361197200022		
J	Takenaka, H; Ouchi, H; Sai, K; Kawamoto, R; Murayama, R; Kurokawa, H; Miyazaki, M				Takenaka, Hirotaka; Ouchi, Hajime; Sai, Keiichi; Kawamoto, Ryo; Murayama, Ryosuke; Kurokawa, Hiroyasu; Miyazaki, Masashi			Ultrasonic measurement of the effects of light irradiation and presence of water on the polymerization of self-adhesive resin cement	EUROPEAN JOURNAL OF ORAL SCIENCES			English	Article						elastic modulus; moisture condition; polymerization reaction; self-adhesive resin cement; ultrasonic velocity	DENTIN; BONE; RESTORATIONS; COMPOSITES; VELOCITY; SYSTEMS; LESIONS; MODEL	Self-adhesive resin cements are useful in restorations because they reduce the number of clinical steps involved in the restoration process. This study evaluated, using ultrasonic measurements, the influence of light irradiation and the presence of water on the polymerization behavior and elastic modulus of a self-adhesive resin cement. A self-adhesive resin cement (RelyX Unicem 2 Automix) or a resin cement (RelyX ARC) was inserted into a transparent mold on a sample stage, and the presence of water and effect of light-irradiation were evaluated. The transit time of a sonic wave through the cement disk was divided by the specimen thickness to obtain the sonic velocity, and longitudinal and shear waves were used to determine the elastic modulus. When the resin cements were light-irradiated, the sonic velocity rapidly increased and plateaued at 2,500-2,700ms(-1). When the cements were not irradiated, the rates of increase in the sonic velocity were reduced. When water was applied to the sample stage, the sonic velocity was reduced. The elastic modulus values of the specimens ranged from 9.9 to 15.9GPa after 24h. The polymerization behavior of self-adhesive resin cements is affected by the polymerization mode and the presence of water.	[Takenaka, Hirotaka; Ouchi, Hajime; Sai, Keiichi; Kawamoto, Ryo; Murayama, Ryosuke; Kurokawa, Hiroyasu; Miyazaki, Masashi] Nihon Univ, Sch Dent, Dept Operat Dent, Tokyo 1018310, Japan	Miyazaki, M (reprint author), Nihon Univ, Sch Dent, Dept Operat Dent, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018310, Japan.	miyazaki.masashi@nihon-u.ac.jp			Japan Society for the Promotion of Science [20592237, 15K11130, 26861607]; Sato Fund; Dental Research Center, Nihon University School of Dentistry	This study was supported partly by Grant-in-Aid for Scientific Research (C) (20592237, 15K11130) and Grant-in-Aid for Young Scientists (B) (26861607) from the Japan Society for the Promotion of Science. This project was also supported partly by Sato Fund and Grant from the Dental Research Center, Nihon University School of Dentistry.	Philippidis TP, 2005, ULTRASONICS, V43, P584, DOI 10.1016/j.ultras.2004.12.001; Arrais CAG, 2009, J PROSTHET DENT, V101, P128, DOI 10.1016/S0022-3913(09)60008-1; Oyar P, 2014, J PROSTHET DENT, V112, P211, DOI 10.1016/j.prosdent.2013.10.024; Radovic I, 2008, J ADHES DENT, V10, P251; Guarda GB, 2010, J APPL ORAL SCI, V18, P244, DOI 10.1590/S1678-77572010000300008; Matalon S, 2007, ORAL SURG ORAL MED O, V103, P109, DOI 10.1016/j.tripleo.2006.07.023; Suh BI, 2003, J ADHES DENT, V5, P267; Yanikoglu FC, 2000, CARIES RES, V34, P225; Vrochari AD, 2009, DENT MATER, V25, P1104, DOI 10.1016/j.dental.2009.02.015; Salz U, 2005, J ADHES DENT, V7, P7; Arrais CAG, 2009, J DENT, V37, P219, DOI 10.1016/j.jdent.2008.11.016; Feracane JL, 2011, J ORAL REHABIL, V38, P295; Fernandes Virgílio Vilas Boas Jr, 2015, Int J Esthet Dent, V10, P146; Gerth HUV, 2006, DENT MATER, V22, P934, DOI 10.1016/j.dental.2005.10.004; Hagan CP, 2015, ULTRASONICS, V56, P279, DOI 10.1016/j.ultras.2014.08.008; Hill Edward E, 2007, Dent Clin North Am, V51, P643, DOI 10.1016/j.cden.2007.04.002; Labouret S, 1998, ULTRASONICS, V36, P205, DOI 10.1016/S0041-624X(97)00116-9; Lee KI, 2007, ULTRASONICS, V46, P323, DOI 10.1016/j.ultras.2007.01.012; Madruga FC, 2013, DENT MATER, V29, P413, DOI 10.1016/j.dental.2013.01.004; Manso Adriana P, 2011, Dent Clin North Am, V55, P311, DOI 10.1016/j.cden.2011.01.011; Mazzitelli C, 2010, EUR J ORAL SCI, V118, P80, DOI 10.1111/j.1600-0722.2009.00703.x; NG SY, 1989, ARCH ORAL BIOL, V34, P341, DOI 10.1016/0003-9969(89)90107-6; Pegoraro Thiago A, 2007, Dent Clin North Am, V51, P453, DOI 10.1016/j.cden.2007.02.003; Russo DS, 2014, AM J DENT, V27, P323; Tagtekin DA, 2005, CARIES RES, V39, P139, DOI 10.1159/000083160; Takubo C, 2010, EUR J ORAL SCI, V118, P417, DOI 10.1111/j.1600-0722.2010.00753.x; Tango Rubens Nisie, 2007, J Prosthodont, V16, P480, DOI 10.1111/j.1532-849X.2007.00234.x; Vlad MD, 2012, J MATER SCI-MATER M, V23, P1563, DOI 10.1007/s10856-012-4636-0; Weiser F, 2015, J PROSTHODONT, V24, P100, DOI 10.1111/jopr.12192; Yasuda G, 2007, EUR J ORAL SCI, V115, P87, DOI 10.1111/j.1600-0722.2007.00425.x; Yasuda Genta, 2008, J Oral Sci, V50, P481	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-8836	1600-0722		EUR J ORAL SCI	Eur. J. Oral Sci.	OCT	2015	123	5					369	374		10.1111/eos.12205		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CR6XD	WOS:000361490800010		
J	Nakamura, K; Katsuda, Y; Ankyu, S; Harada, A; Tenkumo, T; Kanno, T; Niwano, Y; Egusa, H; Milleding, P; Ortengren, U				Nakamura, Keisuke; Katsuda, Yusuke; Ankyu, Shuhei; Harada, Akio; Tenkumo, Taichi; Kanno, Taro; Niwano, Yoshimi; Egusa, Hiroshi; Milleding, Percy; Ortengren, Ulf			Cutting efficiency of diamond burs operated with electric high-speed dental handpiece on zirconia	EUROPEAN JOURNAL OF ORAL SCIENCES			English	Article						cutting efficiency; diamond burs; leucite; lithium disilicate; zirconia	FRACTURE STRENGTH; CLINICAL SUCCESS; IN-VITRO; CROWNS; RESTORATION; PORCELAIN	Zirconia-based dental restorations are becoming used more commonly. However, limited attention has been given to the difficulties experienced, concerning cutting, in removing the restorations when needed. The aim of the present study was to compare the cutting efficiency of diamond burs, operated using an electric high-speed dental handpiece, on zirconia (Zir) with those on lithium disilicate glass-ceramic (LD) and leucite glass-ceramic (L). In addition, evaluation of the cutting efficiency of diamond burs on Zir of different thicknesses was performed. Specimens of Zir were prepared with thicknesses of 0.5, 1.0, 2.0, and 4.0mm, and specimens of LD and L were prepared with a thickness of 1.0mm. Cutting tests were performed using diamond burs with super coarse (SC) and coarse (C) grains. The handpiece was operated at 150,000rpm with a cutting force of 0.9N. The results demonstrated that cutting of Zir took about 1.5- and 7-fold longer than cutting of LD and L, respectively. The SC grains showed significantly higher cutting efficiency on Zir than the C grains. However, when the thickness of Zir increased, the cutting depth was significantly decreased. As it is suggested that cutting of zirconia is time consuming, this should be taken into consideration in advance when working with zirconia restorations.	[Nakamura, Keisuke; Milleding, Percy; Ortengren, Ulf] Univ Gothenburg, Dept Prosthet Dent Dent Mat Sci, Inst Odontol, Gothenburg, Sweden; [Nakamura, Keisuke; Niwano, Yoshimi] Tohoku Univ, Grad Sch Dent, Lab Redox Regulat, Sendai, Miyagi 9808575, Japan; [Katsuda, Yusuke; Ankyu, Shuhei; Harada, Akio; Kanno, Taro; Egusa, Hiroshi] Tohoku Univ, Grad Sch Dent, Div Mol & Regenerat Prosthodont, Sendai, Miyagi 9808575, Japan; [Tenkumo, Taichi] Tohoku Univ, Grad Sch Dent, Liaison Ctr Innovat Dent, Sendai, Miyagi 9808575, Japan; [Ortengren, Ulf] Arctic Univ Norway, Dept Clin Dent, Fac Hlth Sci, Tromso, Norway	Nakamura, K (reprint author), Tohoku Univ, Grad Sch Dent, Lab Redox Regulat, Aoba Ku, 4-1 Seiryo, Sendai, Miyagi 9808575, Japan.	keisuke@m.tohoku.ac.jp			JSPS KAKENHI [25462981]	The authors would like to thank 3M ESPE for generously supplying the zirconia blocks for this study, and Shofu for supplying the diamond burs for the preliminary experiment of this study. This research was supported by JSPS KAKENHI Grant-in-Aid for Scientific Research (C), 25462981, 2014.	Beuer F, 2012, DENT MATER, V28, P449, DOI 10.1016/j.dental.2011.11.024; Le M, 2015, J ORAL REHABIL, V42, P467, DOI 10.1111/joor.12272; Nakamura K, 2015, ACTA ODONTOL SCAND, V73, P602, DOI 10.3109/00016357.2015.1007479; Yin L, 2003, WEAR, V255, P975, DOI 10.1016/S0043-1648(03)00195-9; Larsson C, 2007, J ORAL REHABIL, V34, P702, DOI 10.1111/j.1365-2842.2007.01770.x; Siegel SC, 2000, J AM DENT ASSOC, V131, P1706; Miyazaki T, 2013, J PROSTHODONT RES, V57, P236, DOI 10.1016/j.jpor.2013.09.001; Johansson C, 2014, ACTA ODONTOL SCAND, V72, P145, DOI 10.3109/00016357.2013.822098; Stober T, 2014, J ORAL REHABIL, V41, P314, DOI 10.1111/joor.12139; Yin L, 2012, J MECH BEHAV BIOMED, V16, P55, DOI 10.1016/j.jmbbm.2012.07.011; Choi C, 2010, J PROSTHET DENT, V103, P101, DOI 10.1016/S0022-3913(10)60013-3; Christensen GJ, 2011, J AM DENT ASSOC, V142, P668; Christensen GJ, 2002, J AM DENT ASSOC, V133, P1433; Larsson C, 2014, INT J PROSTHODONT, V27, P33, DOI 10.11607/ijp.3647; Nakamura K, 2015, J MECH BEHAV BIOMED, V47, P49, DOI 10.1016/j.jmbbm.2015.03.007; Ohkuma K, 2011, DENT MATER J, V30, P511, DOI 10.4012/dmj.2010-152; Siegel SC, 1996, J AM DENT ASSOC, V127, P763; Siegel S C, 1999, J Prosthodont, V8, P240, DOI 10.1111/j.1532-849X.1999.tb00045.x; Siegel S C, 1999, J Prosthodont, V8, P3, DOI 10.1111/j.1532-849X.1999.tb00002.x	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-8836	1600-0722		EUR J ORAL SCI	Eur. J. Oral Sci.	OCT	2015	123	5					375	380		10.1111/eos.12211		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CR6XD	WOS:000361490800011		
J	Ciepal, I; Klos, B; Kistryn, S; Stephan, E; Biegun, A; Bodek, K; Deltuva, A; Epelbaum, E; Eslami-Kalantari, M; Fonseca, AC; Golak, J; Kalantar-Nayestanaki, N; Kamada, H; Khatri, G; Kirillov, D; Kirillov, D; Kliczewski, S; Kozela, A; Kravcikova, M; Machner, H; Magiera, A; Martinska, G; Messchendorp, J; Nogga, A; Parol, W; Ramazani-Moghaddam-Arani, A; Roy, BJ; Sakai, H; Sauer, PU; Sekiguchi, K; Sitnik, I; Siudak, R; Skibinski, R; Sworst, R; Urban, J; Witaa, H; Zejma, J				Ciepal, I.; Klos, B.; Kistryn, St.; Stephan, E.; Biegun, A.; Bodek, K.; Deltuva, A.; Epelbaum, E.; Eslami-Kalantari, M.; Fonseca, A. C.; Golak, J.; Kalantar-Nayestanaki, N.; Kamada, H.; Khatri, G.; Kirillov, Da.; Kirillov, Di.; Kliczewski, St.; Kozela, A.; Kravcikova, M.; Machner, H.; Magiera, A.; Martinska, G.; Messchendorp, J.; Nogga, A.; Parol, W.; Ramazani-Moghaddam-Arani, A.; Roy, B. J.; Sakai, H.; Sauer, P. U.; Sekiguchi, K.; Sitnik, I.; Siudak, R.; Skibinski, R.; Sworst, R.; Urban, J.; Witaa, H.; Zejma, J.			Investigation of the Deuteron Breakup on Proton Target in the Forward Angular Region at 130 MeV	FEW-BODY SYSTEMS			English	Article							ELASTIC-SCATTERING; ANALYZING POWERS; CROSS-SECTIONS; FORCES; SEARCH; SYSTEM; COSY	A set of differential cross-section data of the (1) H(d, pp)n breakup reaction at 130 MeV deuteron beam energy has been measured in the domain of very forward polar angles with the use of the Germanium Wall detector at the Forschungszentrum Julich. The data obtained for over 1000 kinematical points (112 geometries) are compared with the theoretical predictions based on various models of the three-nucleon (3N) dynamics. They comprise: the realistic nucleon-nucleon potentials alone or combined with the three-nucleon force (3NF), the coupled-channel calculations with the explicit treatment of the Delta-isobar excitation and finally, the potentials derived from chiral perturbation theory. In the part of the phase space studied, the Coulomb interaction between protons has a strong impact on the differential cross section of the breakup reaction. The strongest Coulomb effects are found in regions where the relative energy of the two protons is the smallest. In these regions the data are well reproduced exclusively by calculations which include the electromagnetic repulsion between protons. In spite of the dominance of the Coulomb force in the phase space studied, the contribution of 3NF effects is also observed.	[Ciepal, I.; Kliczewski, St.; Kozela, A.; Siudak, R.] PAS, Inst Nucl Phys, PL-31342 Krakow, Poland; [Ciepal, I.; Kistryn, St.; Bodek, K.; Golak, J.; Khatri, G.; Magiera, A.; Parol, W.; Skibinski, R.; Sworst, R.; Witaa, H.; Zejma, J.] Jagiellonian Univ, Inst Phys, PL-30348 Krakow, Poland; [Klos, B.; Stephan, E.] Univ Silesia, PL-40007 Katowice, Poland; [Biegun, A.; Kalantar-Nayestanaki, N.; Messchendorp, J.] Univ Groningen, KVI CART, NL-9747 AA Groningen, Netherlands; [Eslami-Kalantari, M.] Yazd Univ, Fac Phys, Yazd, Iran; [Ramazani-Moghaddam-Arani, A.] Univ Kashan, Fac Phys, Kashan, Iran; [Nogga, A.] Forschungszentrum Julich, Inst Kernphys, D-52425 Julich, Germany; [Epelbaum, E.] Ruhr Univ Bochum, Inst Theoret Phys 2, D-44780 Bochum, Germany; [Deltuva, A.] Vilnius Univ, Inst Theoret Phys & Astron, LT-01108 Vilnius, Lithuania; [Sauer, P. U.] Leibniz Univ Hannover, Inst Theoret Phys, D-30167 Hannover, Germany; [Fonseca, A. C.] Univ Lisbon, Ctr Fis Nucl, P-1649003 Lisbon, Portugal; [Kamada, H.] Kyushu Inst Technol, Dept Phys, Kitakyushu, Fukuoka 8048550, Japan; [Roy, B. J.] Bhabha Atom Res Ctr, Div Nucl Phys, Mumbai 400085, Maharashtra, India; [Kirillov, Da.; Kirillov, Di.; Sitnik, I.] JINR, Dubna 141980, Russia; [Kravcikova, M.] Tech Univ, Kosice 04101, Slovakia; [Martinska, G.; Urban, J.] Safarik Univ, Kosice 04154, Slovakia; [Sakai, H.] Univ Tokyo, Bunkyo Ku, Tokyo 1130033, Japan; [Sekiguchi, K.] Tohoku Univ, Sendai, Miyagi 9808578, Japan; [Machner, H.] Univ Duisburg Essen, Fachbereich Phys, D-47048 Duisburg, Germany	Ciepal, I (reprint author), PAS, Inst Nucl Phys, PL-31342 Krakow, Poland.	izabela.ciepal@ifj.edu.pl	Deltuva, Arnoldas/M-3749-2013	Deltuva, Arnoldas/0000-0002-0732-7749	Polish National Science Center [DEC-2013/10/M/ST2/00420];  [N N202 174635];  [2012/05/E/ST2/02313]	This work was partially supported by the Polish science funds as research Projects No. N N202 174635 (2008-2010) and No. 2012/05/E/ST2/02313 (2013-2016). This study was also supported by the Polish National Science Center under Grant No. DEC-2013/10/M/ST2/00420. The numerical calculations of the Cracow-Bochum group have been performed on the supercomputer clusters of the JSC, Julich, Germany.	Cadman RV, 2001, PHYS REV LETT, V86, P967, DOI 10.1103/PhysRevLett.86.967; Deltuva A, 2003, PHYS REV C, V68, DOI 10.1103/PhysRevC.68.024005; FUJITA J, 1957, PROG THEOR PHYS, V17, P360, DOI 10.1143/PTP.17.360; Deltuva A, 2009, PHYS REV C, V80, DOI 10.1103/PhysRevC.80.064002; Deltuva A, 2005, PHYS REV C, V72, DOI 10.1103/PhysRevC.72.054004; Hatanaka K, 2002, PHYS REV C, V66, DOI 10.1103/PhysRevC.66.044002; Deltuva A, 2003, PHYS REV C, V67, DOI 10.1103/PhysRevC.67.034001; Epelbaum E, 2002, PHYS REV C, V66, DOI 10.1103/PhysRevC.66.064001; Epelbaum E, 2004, EUR PHYS J A, V19, P125, DOI 10.1140/epja/i2003-10096-0; Sekiguchi K, 2004, PHYS REV C, V70, DOI 10.1103/PhysRevC.70.014001; Nogga A, 2003, PHYS REV C, V67, DOI 10.1103/PhysRevC.67.034004; Ermisch K, 2001, PHYS REV LETT, V86, P5862, DOI 10.1103/PhysRevLett86.5862; Sakai H, 2000, PHYS REV LETT, V84, P5288, DOI 10.1103/PhysRevLett.84.5288; Witala H, 1998, PHYS REV LETT, V81, P1183, DOI 10.1103/PhysRevLett.81.1183; Pudliner BS, 1997, PHYS REV C, V56, P1720, DOI 10.1103/PhysRevC.56.1720; SHIMIZU H, 1982, NUCL PHYS A, V382, P242, DOI 10.1016/0375-9474(82)90134-8; WIRINGA RB, 1995, PHYS REV C, V51, P38, DOI 10.1103/PhysRevC.51.38; STOKS VGJ, 1994, PHYS REV C, V49, P2950, DOI 10.1103/PhysRevC.49.2950; Betigeri M, 1999, NUCL INSTRUM METH A, V421, P447, DOI 10.1016/S0168-9002(98)01176-0; Ciepal I., 2013, FEW-BODY SYST, V601, P1; Ciepal I., 2012, EPJ WEB C, V37, P09011; Ciepal I, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.017001; Coon SA, 2001, FEW-BODY SYST, V30, P131, DOI 10.1007/s006010170022; Deltuva A, 2006, PHYS REV C, V73, DOI 10.1103/PhysRevC.73.057001; Deltuva A, 2005, PHYS REV C, V71, DOI 10.1103/PhysRevC.71.054005; Entem DR, 2002, PHYS LETT B, V524, P93, DOI 10.1016/S0370-2693(01)01363-6; Epelbaum E., 2014, ARXIV14124623NUCLTH; Epelbaum E, 2014, ARXIV14120142NUCLTH; Epelbaum E., 2006, PROG PART NUCL PHYS, V57, P645; Ermisch K, 2003, PHYS REV C, V68, DOI 10.1103/PhysRevC.68.051001; Eslami-Kalantari M, 2010, EPJ Web of Conferences, V3, DOI 10.1051/epjconf/20100305010; FADDEEV LD, 1961, SOV PHYS JETP-USSR, V12, P1014; Garske W., 1999, UNTERSUCHUNG PI0 PI; Golak J, 2014, EUR PHYS J A, V50, DOI 10.1140/epja/i2014-14177-7; Hassan A, 1999, NUCL INSTRUM METH A, V425, P403, DOI 10.1016/S0168-9002(98)01411-9; JAECKLE V, 1994, NUCL INSTRUM METH A, V349, P15, DOI 10.1016/0168-9002(94)90602-5; Kalantar-Nayestanaki N, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/1/016301; Kistryn S, 2003, PHYS REV C, V68, DOI 10.1103/PhysRevC.68.054004; Kistryn S, 2005, PHYS REV C, V72, DOI 10.1103/PhysRevC.72.044006; Kistryn S, 2006, PHYS LETT B, V641, P23, DOI 10.1016/j.physletb.2006.08.013; Machleidt R, 1996, PHYS REV C, V53, pR1483; Maier R, 1997, NUCL INSTRUM METH A, V390, P1, DOI 10.1016/S0168-9002(97)00324-0; Mermod P, 2004, PHYS LETT B, V597, P243, DOI 10.1016/j.physletb.2004.07.028; Nemoto S, 1998, PHYS REV C, V58, P2599, DOI 10.1103/PhysRevC.58.2599; Skibinski R, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.054005; Stephan E, 2013, EUR PHYS J A, V49, DOI 10.1140/epja/i2013-13036-5; Stephan E., 2013, PHYS REV C, V82; Witala H., 2014, J PHYS G, V41, P1; Yukawa H., 1935, Proceedings of the Physico-Mathematical Society of Japan, V17; Zolnierczuk P. A., 1998, DATA ANAL SOFTWARE G	50	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0177-7963	1432-5411		FEW-BODY SYST	Few-Body Syst.	OCT	2015	56	10					665	690		10.1007/s00601-015-1014-8		26	Physics, Multidisciplinary	Physics	CR5OY	WOS:000361393900004		
J	Furui, S				Furui, Sadataka			Cartan's Supersymmetry and Weak and Electromagnetic Interactions	FEW-BODY SYSTEMS			English	Article							WEINBERG 3-HIGGS-DOUBLET MODEL; TRIALITY SYMMETRY; MASS TERMS; OCTONION	We apply the Cartan's supersymmetric model to the weak interaction of hadrons. The electromagnetic currents are transformed by G (12), G (123), G (13), G (132) and the factor is inserted between or when the photon is replaced by , and between or when the photon is replaced by Z. Electromagnetic currents in the Higgs boson H (0) decay into 2 and decay into and in which leptons are replaced by quarks are also studied. A possibility that the boson near the theshold GeV) is the Higgs boson partner h (0) is discussed. We adopt Dirac lepton neutrinos and Majorana quark neutrinos, and construct a model that satisfy the Z (3) symmetry of the lepton sector and the quark sector, by adding two right-handed neutrinos whose left-handed partner cannot be detected by our electro-magnetic detectors.	Teikyo Univ, Grad Sch, Utsunomiya, Tochigi 3200003, Japan	Furui, S (reprint author), Teikyo Univ, Grad Sch, 2-17-12 Toyosatodai, Utsunomiya, Tochigi 3200003, Japan.	furui@umb.teikyo-u.ac.jp					Furui S, 2012, FEW-BODY SYST, V52, P171, DOI 10.1007/s00601-011-0274-1; Aad G, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.032003; Olive KA, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/9/090001; Aad G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.152001; SCHECHTER J, 1980, PHYS REV D, V22, P2227, DOI 10.1103/PhysRevD.22.2227; Abazov VM, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.031103; Aranda A, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.033001; Branco G. C., 2013, ARXIV13041360HEPPH; Cartan E., 1966, THEORY SPINORS; Furui S, 2014, FEW-BODY SYST, V55, P1083, DOI 10.1007/s00601-014-0897-0; Furui S., 2014, ARXIV14093761HEPTH; Furui S, 2012, FEW-BODY SYST, V53, P343, DOI 10.1007/s00601-012-0322-5; Furui S, 2013, FEW-BODY SYST, V54, P2097, DOI 10.1007/s00601-013-0719-9; Furui S, 2012, INT J MOD PHYS A, V27, DOI 10.1142/S0217751X12501588; Green A. M., 2003, ARXIVHEPLAT0312007; Hestenes D., 1986, CLIFFORD ALGEBRAS TH, P321; Kaffas A. W. E., 2007, NUCL PHYS B, V775, P45; Labelle P., 2010, SUPERSYMMETRY DEMYST; LOUNESTO P, 1993, FOUND PHYS, V23, P1203, DOI 10.1007/BF01883677; Lounesto P., 2001, CLIFFORD ALGEBRAS SP; McNeile C., 2004, ARXIVHEPLAT0404010; Mielke EW, 2001, INT J THEOR PHYS, V40, P171, DOI 10.1023/A:1003787428183; Morisi S., 2013, NUCL PART PHYS, V40, DOI 10.1088/0954-3899/40/8/085004; The CMS collaboration, 2012, ARXIV12055736V3HEPEX; Zarrinkamar S, 2010, INT J MOD PHYS E, V19, P459, DOI 10.1142/S0218301310014881; Zarrinkamar S, 2010, FEW-BODY SYST, V48, P183, DOI 10.1007/s00601-010-0103-y; Zarrinkamar S, 2010, FEW-BODY SYST, V47, P207, DOI 10.1007/s00601-009-0082-z; Zarrinkamar S, 2009, INT J MOD PHYS E, V18, P1781, DOI 10.1142/S021830130901383X	28	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0177-7963	1432-5411		FEW-BODY SYST	Few-Body Syst.	OCT	2015	56	10					703	711		10.1007/s00601-015-1016-6		9	Physics, Multidisciplinary	Physics	CR5OY	WOS:000361393900007		
J	Ikegami, T; Takemura, A; Choi, E; Suda, A; Tomonaga, S; Badruzzaman, M; Furuse, M				Ikegami, Taro; Takemura, Akihiro; Choi, Eunjung; Suda, Atsushi; Tomonaga, Shozo; Badruzzaman, Muhammad; Furuse, Mitsuhiro			Increase in telencephalic dopamine and cerebellar norepinephrine contents by hydrostatic pressure in goldfish: the possible involvement in hydrostatic pressure-related locomotion	FISH PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Brain; Fish; Hydrostatic pressure; Monoamine; Swimming	LIPOPHRYS-PHOLIS L; EEL ANGUILLA-ANGUILLA; CARASSIUS-AURATUS; EUROPEAN EEL; PARKINSONIAN-SYNDROME; TYROSINE-HYDROXYLASE; PLATICHTHYS-FLESUS; EFFERENT NEURONS; PURKINJE-CELLS; RAINBOW-TROUT	Fish are faced with a wide range of hydrostatic pressure (HP) in their natural habitats. Additionally, freshwater fish are occasionally exposed to rapid changes inHPdue to heavy rainfall, flood and/or dam release. Accordingly, variations in HP are one of the most important environmental cues for fish. However, little information is available on how HP information is perceived and transmitted in the central nervous system of fish. The present study examined the effect of HP (water depth of 1.3 m) on the quantities of monoamines and their metabolites in the telencephalon, optic tectum, diencephalon, cerebellum (including partial mesencephalon) and vagal lobe (including medulla oblongata) of the goldfish, Carassius auratus, using high-performance liquid chromatography. HP affected monoamine and metabolite contents in restricted brain regions, including the telencephalon, cerebellum and vagal lobe. In particular, HP significantly increased the levels of dopamine (DA) in the telencephalon at 15 min and that of norepinephrine (NE) in the cerebellum at 30 min. In addition, HP also significantly increased locomotor activity at 15 and 30 min after HP treatment. It is possible that HP indirectly induces locomotion in goldfish via telencephalic DA and cerebellar NE neuronal activity.	[Ikegami, Taro; Takemura, Akihiro; Choi, Eunjung] Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, Nishihara, Okinawa 9030213, Japan; [Suda, Atsushi; Furuse, Mitsuhiro] Kyushu Univ, Grad Sch Bioresource & Bioenvironmental Sci, Lab Regulat Metab & Behav, Fukuoka 8128581, Japan; [Tomonaga, Shozo] Kyoto Univ, Grad Sch Agr, Lab Nutr Sci Anim, Kyoto 6068502, Japan	Ikegami, T (reprint author), Univ Ryukyus, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Nishihara, Okinawa 9030215, Japan.	taron2017@hotmail.com			Japan Society for the Promotion of Science [10J02886, 12J02083]	We would like to thank Ms. Chihiro Yamauchi, University of the Ryukyus, and Dr. Yoriko Akimoto, Mr. Takahiro Nakashita, Mr. Seiya Mochinaga and Mr. Takeshi Yoshihara, Kyushu University, for their support and help in sampling. Dr. Sethu Selvaraj, Kyushu University, Dr. Takeshi Onuma, Osaka University, and Mr. Makoto Yoshida, The University of Tokyo, provided stimulating discussions and helpful advice. This study was supported by a Grant-in-Aid for JSPS fellows (Grant Numbers 10J02886 and 12J02083) to TI from the Japan Society for the Promotion of Science.	Lillesaar C, 2011, J CHEM NEUROANAT, V41, P294, DOI 10.1016/j.jchemneu.2011.05.009; SOMOZA GM, 1991, GEN COMP ENDOCR, V82, P103, DOI 10.1016/0016-6480(91)90301-L; Fraser PJ, 2002, NATURE, V415, P495, DOI 10.1038/415495a; FRASER PJ, 1994, NATURE, V371, P383, DOI 10.1038/371383b0; BLOCK BA, 1992, J EXP BIOL, V166, P267; De Pedro N, 1998, PEPTIDES, V19, P505, DOI 10.1016/S0196-9781(97)00469-5; HORNBY PJ, 1990, BRAIN BEHAV EVOLUT, V35, P49, DOI 10.1159/000115856; RAFFAELLI D, 1990, MAR BEHAV PHYSIOL, V16, P249; KAH O, 1983, CELL TISSUE RES, V234, P319, DOI 10.1007/BF00213771; Fraser PJ, 2003, J VESTIBUL RES-EQUIL, V13, P235; Takemura A, 2010, J FISH BIOL, V76, P7, DOI 10.1111/j.1095-8649.2009.02481.x; CORIO M, 1991, J CHEM NEUROANAT, V4, P79, DOI 10.1016/0891-0618(91)90033-9; Vetillard A, 2002, J COMP NEUROL, V449, P374, DOI 10.1002/cne.10296; Vidal B, 2004, BIOL REPROD, V71, P1491, DOI 10.1095/biolreprod.104.030627; ATEMA J, 1971, BRAIN BEHAV EVOLUT, V4, P273, DOI 10.1159/000125438; BONN U, 1987, J HIRNFORSCH, V28, P529; CONTESTABILE A, 1986, EXP BRAIN RES, V63, P301; Damasceno-Oliveira A, 2006, J FISH BIOL, V68, P1300, DOI 10.1111/j.1095-8649.2006.01015.x; Damasceno-Oliveira A, 2007, GEN COMP ENDOCR, V153, P385, DOI 10.1016/j.ygcen.2007.05.017; Dietrich M, 2002, BRAIN RES BULL, V57, P393, DOI 10.1016/S0361-9230(01)00698-0; FENWICK JC, 1970, COMP BIOCHEM PHYSIOL, V32, P803, DOI 10.1016/0010-406X(70)90830-3; Finger TE, 2008, J COMP PHYSIOL A, V194, P135, DOI 10.1007/s00359-007-0276-0; FREMBERG M, 1977, CELL TISSUE RES, V176, P1; GARDETTE R, 1987, NEUROSCIENCE, V23, P491, DOI 10.1016/0306-4522(87)90072-8; GEFFARD M, 1984, J NEUROCHEM, V42, P1593, DOI 10.1111/j.1471-4159.1984.tb12747.x; GIBSON RN, 1992, NATO ADV SCI INST SE, V236, P63; GIBSON RN, 1984, T AM FISH SOC, V113, P479, DOI 10.1577/1548-8659(1984)113<479:HPATRB>2.0.CO;2; GIBSON R N, 1970, Animal Behaviour, V18, P539, DOI 10.1016/0003-3472(70)90050-3; Gnegy ME, 2012, BASIC NEUROCHEMISTRY: PRINCIPLES OF MOLECULAR, CELLULAR, AND MEDICAL NEUROBIOLOGY, 8THEDITION, P283; Godo OR, 2000, FISH RES, V48, P127, DOI 10.1016/S0165-7836(00)00177-6; GOPING G, 1995, BRAIN RES, V687, P35, DOI 10.1016/0006-8993(95)00391-3; GOTOW T, 1990, J COMP NEUROL, V292, P255, DOI 10.1002/cne.902920208; Hensler JG, 2012, BASIC NEUROCHEMISTRY: PRINCIPLES OF MOLECULAR, CELLULAR, AND MEDICAL NEUROBIOLOGY, 8THEDITION, P300; Ikenaga T, 2005, J COMP NEUROL, V487, P300, DOI 10.1002/cne.20553; Ikenaga T, 2006, CEREBELLUM, V5, P268, DOI 10.1080/14734220600930588; JANSSEN J, 1980, CAN J FISH AQUAT SCI, V37, P177, DOI 10.1139/f80-023; Kapsimali M, 2000, J COMP NEUROL, V419, P320, DOI 10.1002/(SICI)1096-9861(20000410)419:3<320::AID-CNE5>3.0.CO;2-F; Koizumi I, 2013, ZOOL SCI, V30, P375, DOI 10.2108/zsj.30.375; LEE M, 1985, BRAIN RES, V361, P107, DOI 10.1016/0006-8993(85)91280-6; Linard B, 1996, FISH PHYSIOL BIOCHEM, V15, P41, DOI 10.1007/BF01874836; MACDONALD AG, 1987, COMP BIOCHEM PHYS A, V88, P543, DOI 10.1016/0300-9629(87)90078-8; Matsumoto N, 2007, BRAIN BEHAV EVOLUT, V70, P105, DOI 10.1159/000102972; McCleave JD, 1999, ICES J MAR SCI, V56, P510, DOI 10.1006/jmsc.1999.0478; Mok EYM, 1998, PHYSIOL BEHAV, V64, P227, DOI 10.1016/S0031-9384(98)00038-9; MORITA Y, 1980, J COMP NEUROL, V191, P119, DOI 10.1002/cne.901910107; NILSSON GE, 1989, COMP BIOCHEM PHYS C, V94, P223, DOI 10.1016/0742-8413(89)90170-9; NISHI K, 1991, NEUROSCI LETT, V123, P244, DOI 10.1016/0304-3940(91)90941-L; NORTHCOTT SJ, 1991, J FISH BIOL, V39, P25, DOI 10.1111/j.1095-8649.1991.tb04338.x; NORTHCOTT SJ, 1991, J EXP MAR BIOL ECOL, V148, P35, DOI 10.1016/0022-0981(91)90145-M; NORTHCOTT SJ, 1991, J EXP MAR BIOL ECOL, V148, P47, DOI 10.1016/0022-0981(91)90146-N; Nunn AD, 2010, ECOL FRESHW FISH, V19, P153, DOI 10.1111/j.1600-0633.2009.00399.x; OLCESE JM, 1979, GEN COMP ENDOCR, V38, P309, DOI 10.1016/0016-6480(79)90064-9; POLLARD HB, 1992, FASEB J, V6, P3108; Pollard HB, 1996, EXP NEUROL, V142, P170, DOI 10.1006/exnr.1996.0188; ROBERTS BL, 1992, J EXP BIOL, V167, P171; Sebert ME, 2008, HYDROBIOLOGIA, V602, P27, DOI 10.1007/s10750-008-9288-1; SEBERT P, 1986, COMP BIOCHEM PHYS C, V84, P155, DOI 10.1016/0742-8413(86)90182-9; SEBERT P, 1985, EXPERIENTIA, V41, P1429, DOI 10.1007/BF01950018; STRAHLENDORF JC, 1989, NEUROSCIENCE, V30, P117, DOI 10.1016/0306-4522(89)90358-8; Takemura A, 2010, GEN COMP ENDOCR, V166, P513, DOI 10.1016/j.ygcen.2010.01.001; Takemura A, 2012, GEN COMP ENDOCR, V175, P173, DOI 10.1016/j.ygcen.2011.11.019; Tanaka H, 2005, MAR ECOL PROG SER, V291, P307, DOI 10.3354/meps291307; Thompson RH, 2008, EUR J NEUROSCI, V27, P1452, DOI 10.1111/j.1460-9568.2008.06125.x; Weinreb O, 2007, NAT PROTOC, V2, P3016, DOI 10.1038/nprot.2007.393; WOLLMUTH LP, 1989, J COMP PHYSIOL B, V159, P83, DOI 10.1007/BF00692686; YOSHIDA M, 1983, EXPERIENTIA, V39, P1171, DOI 10.1007/BF01943167	66	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0920-1742	1573-5168		FISH PHYSIOL BIOCHEM	Fish Physiol. Biochem.	OCT	2015	41	5					1105	1115		10.1007/s10695-015-0072-7		11	Biochemistry & Molecular Biology; Fisheries; Physiology	Biochemistry & Molecular Biology; Fisheries; Physiology	CR7OC	WOS:000361539100003		
J	Kurokawa, Y; Matsuura, N; Kimura, Y; Adachi, S; Fujita, J; Imamura, H; Kobayashi, K; Yokoyama, Y; Shaker, MN; Takiguchi, S; Mori, M; Doki, Y				Kurokawa, Yukinori; Matsuura, Nariaki; Kimura, Yutaka; Adachi, Shinichi; Fujita, Junya; Imamura, Hiroshi; Kobayashi, Kenji; Yokoyama, Yuhki; Shaker, Mohammed Nouri; Takiguchi, Shuji; Mori, Masaki; Doki, Yuichiro			Multicenter large-scale study of prognostic impact of HER2 expression in patients with resectable gastric cancer	GASTRIC CANCER			English	Article						Human epidermal growth factor receptor 2; Epidermal growth factor receptor 2; ERBB2; Trastuzumab; Heterogeneity	GROWTH-FACTOR RECEPTORS; CLINICAL-SIGNIFICANCE; TRASTUZUMAB TREATMENT	Although some small-scale studies have suggested that human epidermal growth factor receptor 2 (HER2)-positive status in gastric cancer is associated with poor outcomes, the prognostic value of HER2 is still controversial. Since intratumoral HER2 heterogeneity is also an important issue, a multicenter large-scale study was conducted to evaluate the prognostic impacts of HER2 expression and intratumoral heterogeneity in gastric cancer. This study included 1,148 gastric cancer patients who underwent gastrectomy in 11 institutions. HER2 expression was centrally evaluated with immunohistochemistry and fluorescence in situ hybridization, and intratumoral HER2 heterogeneity was evaluated for HER2-positive tumors. Overall survival was compared between HER2-positive and HER2-negative patients and between the homogeneous and heterogeneous groups. The HER2-positive rate was 15.7 %, and HER2 expression was significantly associated with histological type. HER2 expression scores obtained by immunohistochemistry showed a distinct influence on survival, and HER2-positive patients showed much poorer survival than HER2-negative patients [hazard ratio (HR) 1.59, 95 % confidence interval (CI) 1.24-2.02; P < 0.001). The subgroup analysis by pathological tumor stage showed a similar trend of poor survival in HER2-positive patients. Both intestinal type and diffuse type showed significant poor survival in HER2-positive patients. Cox multivariate analysis revealed that HER2 expression was an independent prognostic factor (HR 1.96, 95 % CI 1.51-2.55; P < 0.001). HER2 heterogeneity was observed in 75.4 % of HER2-positive cases, but the prognosis in the heterogeneous group was similar to that in the homogeneous group. Our study demonstrated that HER2 overexpression is an independent prognostic factor in patients with any stage of resectable gastric cancer. Intratumoral HER2 heterogeneity did not affect prognosis.	[Kurokawa, Yukinori; Takiguchi, Shuji; Mori, Masaki; Doki, Yuichiro] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka 5650871, Japan; [Matsuura, Nariaki; Yokoyama, Yuhki; Shaker, Mohammed Nouri] Osaka Univ, Grad Sch Med & Hlth Sci, Dept Mol Pathol, Suita, Osaka 5650871, Japan; [Kimura, Yutaka] Sakai Municipal Hosp, Dept Surg, Osaka, Japan; [Adachi, Shinichi] Ikeda City Hosp, Dept Surg, Osaka, Japan; [Fujita, Junya] NTT West Osaka Hosp, Dept Surg, Osaka, Japan; [Imamura, Hiroshi] Toyonaka City Hosp, Dept Surg, Osaka, Japan; [Kobayashi, Kenji] Kinki Cent Hosp, Dept Surg, Itami, Hyogo, Japan	Kurokawa, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, 2-2-E2 Yamadaoka, Suita, Osaka 5650871, Japan.	ykurokawa@gesurg.med.osaka-u.ac.jp			Chugai Pharmaceutical	This work was supported by Chugai Pharmaceutical. The authors thank Y. Hayashi for her review of this report on behalf of Chugai Pharmaceutical.	Bang YJ, 2010, LANCET, V376, P1302; Begnami MD, 2011, J CLIN ONCOL, V29, P3030, DOI 10.1200/JCO.2010.33.6313; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Lee HE, 2013, EUR J CANCER, V49, P1448, DOI 10.1016/j.ejca.2012.10.018; Kataoka Y, 2013, GASTRIC CANCER, V16, P84, DOI 10.1007/s10120-012-0150-9; Janjigian YY, 2012, ANN ONCOL, V23, P2656, DOI 10.1093/annonc/mds104; Qiu MZ, 2014, INT J CANCER, V134, P2468, DOI 10.1002/ijc.28559; SESHADRI R, 1993, J CLIN ONCOL, V11, P1936; Shitara K, 2013, GASTRIC CANCER, V16, P261, DOI 10.1007/s10120-012-0179-9; Terashima M, 2012, CLIN CANCER RES, V18, P5992, DOI 10.1158/1078-0432.CCR-12-1318; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; Kim KC, 2011, ANN SURG ONCOL, V18, P2833, DOI 10.1245/s10434-011-1695-2; Dawood S, 2010, J CLIN ONCOL, V28, P92, DOI 10.1200/JCO.2008.19.9844; Chung H, 2009, EJC SUPPL, V7, P364; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Jorgensen JT, 2012, J CANCER, V3, P137, DOI 10.7150/jca.4090; Nishikawa K, 2012, J CLIN ONCOL S4, V30, P10; Sobin LH, 2009, TNM CLASSIFICATION M; Wang YL, 2002, HEPATO-GASTROENTEROL, V49, P1172	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	OCT	2015	18	4					691	697		10.1007/s10120-014-0430-7		7	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CR6WL	WOS:000361488800002		
J	Shoda, K; Masuda, K; Ichikawa, D; Arita, T; Miyakami, Y; Watanabe, M; Konishi, H; Imoto, I; Otsuji, E				Shoda, Katsutoshi; Masuda, Kiyoshi; Ichikawa, Daisuke; Arita, Tomohiro; Miyakami, Yuko; Watanabe, Miki; Konishi, Hirotaka; Imoto, Issei; Otsuji, Eigo			HER2 amplification detected in the circulating DNA of patients with gastric cancer: a retrospective pilot study	GASTRIC CANCER			English	Article						HER2 gene amplification; Gastric cancer; Cell-free DNA; Trastuzumab; Liquid biopsy	BREAST-CANCER; PLASMA DNA; HETEROGENEITY; HYBRIDIZATION; CHEMOTHERAPY; TRASTUZUMAB; POLYSOMY; SURVIVAL	We used real-time quantitative polymerase chain reaction (rqPCR) to detect human epidermal growth factor receptor 2 (HER2) amplification in the circulating cell-free DNA (cfDNA) of patients with gastric cancer (GC), which shows the spatial and temporal intrinsic heterogeneity of HER2 expression/copy number during progression, for liquid biopsy and treatment monitoring. We first enrolled 52 patients with advanced GC who underwent surgery and 40 healthy volunteers. For patients with GC, plasma cfDNA was obtained before surgery (43 patients) and during postoperative treatment (nine of 43 patients). After ribonuclease P RNA component H1 (RPPH1) had been selected as a reference gene for HER2 CN assessment by rqPCR in GC tumours and plasma, plasma HER2-to-RPPH1 ratios were determined retrospectively in a development cohort and an additional independent validation cohort. The HER2-to-RPPH1 ratio of GC tissues determined by rqPCR was concordant with routinely determined HER2 status. The plasma HER2-to-RPPH1 ratio was significantly higher for patients with HER2-positive tumours than for those with HER2-negative tumours. The sensitivity and specificity of the plasma HER2-to-RPPH1 ratio test were 0.539 and 0.967, respectively, in the development cohort, and 0.667 and 1.000, respectively, in the validation cohort. HER2 amplifications acquired and lost during tumour progression and treatment, respectively, were apparently detected by repeated assessments of plasma HER2-to-RPPH1 ratios during postoperative treatment. Our preliminary data demonstrated the potential clinical use of circulating cfDNA to detect HER2 amplification as a therapeutic marker to detect and monitor HER2 CN status for effective molecular targeted therapy in patients with GC.	[Shoda, Katsutoshi; Ichikawa, Daisuke; Arita, Tomohiro; Konishi, Hirotaka; Otsuji, Eigo] Kyoto Prefectural Univ Med, Dept Surg, Div Digest Surg, Kamigyo Ku, Kyoto 6028566, Japan; [Shoda, Katsutoshi; Masuda, Kiyoshi; Imoto, Issei] Univ Tokushima, Dept Human Genet, Grad Sch, Inst Hlth Biosci, Tokushima 7708503, Japan; [Miyakami, Yuko; Watanabe, Miki] Univ Tokushima, Fac Med, Student Lab, Tokushima 7708503, Japan	Ichikawa, D (reprint author), Kyoto Prefectural Univ Med, Dept Surg, Div Digest Surg, Kamigyo Ku, 465 Kawaramach Hirokoji Kajiicho, Kyoto 6028566, Japan.	ichikawa@koto.kpu-m.ac.jp; issehgen@tokushima-u.ac.jp			JSPS KAKENHI [23390325, 25560368]; Chugai Pharmaceutical (Tokyo, Japan)	We thank the Support Center for Advanced Medical Sciences, Institute of Health Biosciences and Institute for Genome Research of the University of Tokushima Graduate School for technical assistance. This work was supported by JSPS KAKENHI grant numbers 23390325 and 25560368 (Issei Imoto), and was partially funded by Chugai Pharmaceutical (Tokyo, Japan) (Eigo Otsuji). The funders had no role in the study design, data collection and interpretation nor in decision to publish or manuscript preparation. All authors contributed to the final manuscript.	Onsum MD, 2013, AM J PATHOL, V183, P1446, DOI 10.1016/j.ajpath.2013.07.015; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Bang YJ, 2010, LANCET, V376, P1302; Page K, 2011, BRIT J CANCER, V104, P1342, DOI 10.1038/bjc.2011.89; Lee HE, 2013, EUR J CANCER, V49, P1448, DOI 10.1016/j.ejca.2012.10.018; Park KU, 2009, CLIN CHEM LAB MED, V47, P530, DOI 10.1515/CCLM.2009.126; Vanden Bempt I, 2008, J CLIN ONCOL, V26, P4869, DOI 10.1200/JCO.2007.13.4296; Cho EY, 2013, MODERN PATHOL, V26, P677, DOI 10.1038/modpathol.2012.205; Ruschoff J, 2012, MODERN PATHOL, V25, P637, DOI 10.1038/modpathol.2011.198; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Tomita H, 2007, ANTICANCER RES, V27, P2737; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Gevensleben H, 2013, CLIN CANCER RES, V19, P3276, DOI 10.1158/1078-0432.CCR-12-3768; Sorensen BS, 2010, ANTICANCER RES, V30, P2463; Okines AFC, 2010, EUR J CANCER, V46, P1949, DOI 10.1016/j.ejca.2010.05.003; Gomez-Martin C, 2013, J CLIN ONCOL, V31, P4445, DOI 10.1200/JCO.2013.48.9070; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Takada H, 2005, CANCER SCI, V96, P100, DOI 10.1111/j.1349-7006.2005.00016.x; Tsujiura M, 2014, WORLD J GASTROENTERO, V20, P3265, DOI 10.3748/wjg.v20.i12.3265; Hanna WM, 2014, MODERN PATHOL, V27, P4, DOI 10.1038/modpathol.2013.103; Bechmann T, 2013, J CANCER RES CLIN, V139, P995, DOI 10.1007/s00432-013-1413-5; Hayashi N, 2012, INT J CLIN ONCOL, V17, P96, DOI 10.1007/s10147-011-0260-0; Ichikawa D, 2004, ANTICANCER RES, V24, P2477; Jacquemier J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-351; Krishnamurti U, 2009, MODERN PATHOL, V22, P1044, DOI 10.1038/modpathol.2009.61; Leary RJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004742; Scartozzi M, 2007, EXPERT OPIN PHARMACO, V8, P797, DOI 10.1517/14656566.8.6.797; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sobin LH, 2009, TNM CLASSIFICATION M, P73	30	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	OCT	2015	18	4					698	710		10.1007/s10120-014-0432-5		13	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CR6WL	WOS:000361488800003		
J	Saito, T; Nakanishi, H; Mochizuki, Y; Ito, S; Ito, Y; Misawa, K; Yatabe, Y; Yamamichi, K; Kondo, E				Saito, Takuya; Nakanishi, Hayao; Mochizuki, Yoshinari; Ito, Seiji; Ito, Yuichi; Misawa, Kazunari; Yatabe, Yasushi; Yamamichi, Keigo; Kondo, Eisaku			Preferential HER2 expression in liver metastases and EGFR expression in peritoneal metastases in patients with advanced gastric cancer	GASTRIC CANCER			English	Article						Gastric cancer; Peritoneal metastases; Liver metastases; EGFR; HER2; Molecular targeting therapy; Immunohistochemistry	GROWTH-FACTOR RECEPTOR; BREAST-CANCER; CELL-LINES; CHEMOTHERAPY; CETUXIMAB; TRIAL; TRASTUZUMAB	Despite recent clinical trials, the sensitivity and resistance of metastatic gastric cancer to anti-HER2 and anti-EGFR therapy are still unclear. To clarify the HER2 and EGFR expression status in the metastatic sites, we immunohistochemically compared HER2 and EGFR expression between primary and metastatic tumors from 52 gastric cancer patients with liver metastases and 85 patients with peritoneal metastases. The HER2 positivity rate of primary and metastatic tumors in patients with liver metastases, especially with intestinal-type histology (70.6 and 80.0 %, respectively), was significantly higher than in primary and metastatic tumors (22.4 and 16.4 %, respectively) in patients with peritoneal metastases. HER2 positivity of the primary tumor and liver metastases showed good concordance (87.5 %) in patients with liver metastases. In contrast, the EGFR positivity rate of metastatic tumors (70.1 %) in patients with peritoneal metastases was significantly higher than that of metastatic tumors (37.5 %) in patients with liver metastases. HER2 and EGFR expression tended to be mutually exclusive, and HER2/EGFR double-positive cases were rare in patients with liver or peritoneal metastases. In four such patients with HER2/EGFR double-positive primary tumors, the HER2- and EGFR-positive areas were separate, and corresponding liver metastasis was only positive for HER2 and peritoneal metastasis only positive for EGFR. These results indicate that HER2 and EGFR are preferentially expressed in the liver and peritoneal metastases, respectively, which would be potential targets for anti-HER2 and anti-EGFR molecular therapy in metastatic gastric cancer patients.	[Saito, Takuya; Kondo, Eisaku] Nagoya Univ, Grad Sch Med, Dept Epidemiol, Program Hlth & Community Med, Nagoya, Aichi 4648601, Japan; [Nakanishi, Hayao; Kondo, Eisaku] Aichi Canc Ctr, Div Oncol Pathol, Res Inst, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Mochizuki, Yoshinari] Komaki Municipal Hosp, Dept Surg, Komaki, Japan; [Ito, Seiji; Ito, Yuichi; Misawa, Kazunari] Cent Hosp, Aichi Canc Ctr, Dept Surg Gastroenterol, Nagoya, Aichi, Japan; [Yatabe, Yasushi] Cent Hosp, Aichi Canc Ctr, Dept Pathol & Mol Diagnost, Nagoya, Aichi, Japan; [Yamamichi, Keigo] Osaka Saiseikai Izuo Hosp, Dept Surg, Osaka, Japan	Nakanishi, H (reprint author), Aichi Canc Ctr, Div Oncol Pathol, Res Inst, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	hnakanis@aichi-cc.jp			Ministry of Education, Science, Sports, Culture and Technology, Japan	We thank Ms. M. Yoshimura, N. Shibata and Miss N. Saito for their expert technical assistance. This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, Culture and Technology, Japan.	Tajiri R, 2014, HUM PATHOL, V45, P725, DOI 10.1016/j.humpath.2013.11.004; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Bang YJ, 2010, LANCET, V376, P1302; Goldstein NS, 2001, CANCER, V92, P1331, DOI 10.1002/1097-0142(20010901)92:5<1331::AID-CNCR1455>3.0.CO;2-M; Yasumoto K, 2011, CLIN CANCER RES, V17, P3619, DOI 10.1158/1078-0432.CCR-10-2475; Guan ZZ, 2013, J CLIN ONCOL, V31, P1947, DOI 10.1200/JCO.2011.40.5241; Sawaki A, 2012, GASTRIC CANCER, V15, P313, DOI 10.1007/s10120-011-0118-1; Bozzetti C, 2011, BRIT J CANCER, V104, P1372, DOI 10.1038/bjc.2011.121; Kataoka Y, 2013, GASTRIC CANCER, V16, P84, DOI 10.1007/s10120-012-0150-9; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Carlsson J, 2004, BRIT J CANCER, V90, P2344, DOI 10.1038/sj.bjc.6601881; Ohtsu A, 2008, J GASTROENTEROL, V43, P256, DOI 10.1007/s00535-008-2177-6; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Onn A, 2004, CLIN CANCER RES, V10, P136, DOI 10.1158/1078-0432.CCR-0373-3; Atkins D, 2004, J HISTOCHEM CYTOCHEM, V52, P893, DOI 10.1369/jhc.3A6195.2004; Sliwkowski MX, 1999, SEMIN ONCOL, V26, P60; Terashima M, 2012, CLIN CANCER RES, V18, P5992, DOI 10.1158/1078-0432.CCR-12-1318; Yokoyama H, 2006, BRIT J CANCER, V95, P1504, DOI 10.1038/sj.bjc.6603459; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; Kim KC, 2011, ANN SURG ONCOL, V18, P2833, DOI 10.1245/s10434-011-1695-2; Tejpar S, 2012, J CLIN ONCOL, V30, P3570, DOI 10.1200/JCO.2012.42.2592; Oh HS, 2014, GASTRIC CANCER, V17, P402, DOI 10.1007/s10120-013-0288-0; Lordick F, 2013, LANCET ONCOL, V14, P490, DOI 10.1016/S1470-2045(13)70102-5; Doi T, 2003, P AN M AM SOC CLIN, V22, P258; Gao FF, 2014, AM J CLIN PATHOL, V141, P102, DOI 10.1309/AJCP6CXS8OSRHXIR; Hara M, 2008, CANCER SCI, V99, P1471, DOI 10.1111/j.1349-7006.2008.00821.x; Khoury T, 2009, MODERN PATHOL, V22, P1454; Nakanishi H, 2005, CLIN EXP METASTAS, V22, P137, DOI 10.1007/s10585-005-6526-z; Oshima Y, 2014, GASTRIC CANCER, V17, P450, DOI 10.1007/s10120-013-0290-6	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	OCT	2015	18	4					711	719		10.1007/s10120-014-0417-4		9	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CR6WL	WOS:000361488800004		
J	Hatakeyama, K; Yamakawa, Y; Fukuda, Y; Ohshima, K; Wakabayashi-Nakao, K; Sakura, N; Tanizawa, Y; Kinugasa, Y; Yamaguchi, K; Terashima, M; Mochizuki, T				Hatakeyama, Keiichi; Yamakawa, Yushi; Fukuda, Yorikane; Ohshima, Keiichi; Wakabayashi-Nakao, Kanako; Sakura, Naoki; Tanizawa, Yutaka; Kinugasa, Yusuke; Yamaguchi, Ken; Terashima, Masanori; Mochizuki, Tohru			A novel splice variant of XIAP-associated factor 1 (XAF1) is expressed in peripheral blood containing gastric cancer-derived circulating tumor cells	GASTRIC CANCER			English	Article						Alternative splicing; Circulating tumor cells; Gastric cancer; Nonsense-mediated mRNA decay; Quantitative real-time polymerase chain reaction (qRT-PCR)	MESSENGER-RNA DECAY; X-LINKED INHIBITOR; GASTROINTESTINAL CANCER; PROGNOSTIC BIOMARKER; APOPTOTIC STRESSES; PANCREATIC-CANCER; COLON-CANCER; FACTOR-I; GENE; IDENTIFICATION	XIAP-associated factor 1 (XAF1) is ubiquitously expressed in normal tissues, but its suppression in cancer cells is strongly associated with tumor progression. Although downregulation of XAF1 is observed in tumors, its expression profile in the peripheral blood of cancer patients has not yet been investigated. Here, we identified a novel XAF1 splice variant in cancer cells and then investigated the expression level of this variant in peripheral blood containing gastric cancer-derived circulating tumor cells (CTCs). To identify splice variants, RT-PCR and DNA sequencing were performed in mRNAs extracted from many cancer cells. We then carried out quantitative RT-PCR to investigate expression in peripheral blood from all 96 gastric cancer patients and 22 healthy volunteers. The XAF1 variant harbored a premature termination codon (PTC) and was differentially expressed in highly metastatic cancer cells versus the parental cells, and that nonsense-mediated mRNA decay (NMD) was suppressed in the variant-expressing cells. Furthermore, splice variants of XAF1 were upregulated in peripheral blood containing CTCs. In XAF1 variant-expressing patients, the expression levels of other NMD-targeted genes also increased, suggesting that the NMD pathway was suppressed in CTCs. Our study identified a novel splice variant of XAF1 in cancer cells. This variant was regulated through the NMD pathway and accumulated in NMD-suppressed metastatic cancer cells and peripheral blood containing CTCs. The presence of XAF1 transcripts harboring the PTC in the peripheral blood may be useful as an indicator of NMD inhibition in CTCs.	[Hatakeyama, Keiichi; Yamakawa, Yushi; Ohshima, Keiichi; Wakabayashi-Nakao, Kanako; Sakura, Naoki; Mochizuki, Tohru] Shizuoka Canc Ctr, Res Inst, Div Med Genet, Shizuoka, Japan; [Yamakawa, Yushi; Tanizawa, Yutaka; Terashima, Masanori] Shizuoka Canc Ctr Hosp, Div Gastr Surg, Shizuoka 4118777, Japan; [Yamakawa, Yushi; Kinugasa, Yusuke] Shizuoka Canc Ctr Hosp, Div Colon & Rectal Surg, Shizuoka, Japan; [Yamaguchi, Ken] Shizuoka Canc Ctr Hosp, Shizuoka, Japan; [Yamaguchi, Ken] Res Inst, Shizuoka, Japan	Terashima, M (reprint author), Shizuoka Canc Ctr Hosp, Div Gastr Surg, 1077 Shimonagakubo,Nagaizumi Cho, Shizuoka 4118777, Japan.	m.terashima@scchr.jp			Regional Innovation Cluster Program; Japan Society for the Promotion of Science KAKENHI [23701092, 25710013]	This research was supported by a Grant-in-Cooperation of the Regional Innovation Cluster Program 2010 and Japan Society for the Promotion of Science KAKENHI 23701092 and 25710013. The authors thank Yuko Watanabe, Kaori Kanto, and Tomomi Ide for their technical assistance, Keita Mori for statistical advice, and Dr. Takashi Sugino for comments on the clinicopathological data.	Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Bonomi S, 2013, NUCLEIC ACIDS RES, V41, P8665, DOI 10.1093/nar/gkt579; Helo P, 2009, CLIN CHEM, V55, P765, DOI 10.1373/clinchem.2008.117952; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; SAVAGNER P, 1994, MOL BIOL CELL, V5, P851; Huang LL, 2011, MOL CELL, V43, P950, DOI 10.1016/j.molcel.2011.06.031; Danila DC, 2014, EUR UROL, V65, P1191, DOI 10.1016/j.eururo.2013.07.006; Leaman DW, 2002, J BIOL CHEM, V277, P28504, DOI 10.1074/jbc.M204851200; Fang XL, 2006, INT J CANCER, V118, P2485, DOI 10.1002/ijc.21636; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Schulze K, 2013, INT J CANCER, V133, P2165, DOI 10.1002/ijc.28230; Zhang ZY, 2013, CANCER LETT, V336, P34, DOI 10.1016/j.canlet.2013.04.021; Liston P, 2001, NAT CELL BIOL, V3, P128, DOI 10.1038/35055027; Huang J, 2010, CANCER SCI, V101, P559, DOI 10.1111/j.1349-7006.2009.01396.x; Chan WK, 2007, EMBO J, V26, P1820, DOI 10.1038/sj.emboj.7601628; Fong WG, 2000, GENOMICS, V70, P113, DOI 10.1006/geno.2000.6364; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Pastor F, 2010, NATURE, V465, P227, DOI 10.1038/nature08999; Garcia-Olmo DC, 2004, HISTOL HISTOPATHOL, V19, P575; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Neuert G, 2013, SCIENCE, V339, P584, DOI 10.1126/science.1231456; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Zou B, 2012, MOL CARCINOGEN, V51, P422, DOI 10.1002/mc.20807; Plenchette S, 2007, CURR OPIN INVEST DR, V8, P469; Valacca C, 2010, J CELL BIOL, V191, P87, DOI 10.1083/jcb.201001073; Meng SD, 2004, P NATL ACAD SCI USA, V101, P9393, DOI 10.1073/pnas.0402993101; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Arora V, 2007, J BIOL CHEM, V282, P26202, DOI 10.1074/jbc.M700776200; Reu FJ, 2006, J CLIN ONCOL, V24, P3771, DOI 10.1200/JCO.2005.03.4074; Zou B, 2006, GASTROENTEROLOGY, V131, P1835, DOI 10.1053/j.gastro.2006.09.050; Sun PH, 2011, CANCER LETT, V310, P170, DOI 10.1016/j.canlet.2011.06.037; Hoffmann AC, 2007, J SURG ONCOL, V95, P51, DOI 10.1002/jso.20630; Wang D, 2011, MOL CELL BIOL, V31, P3670, DOI 10.1128/MCB.05704-11; Yie SM, 2008, ANN SURG ONCOL, V15, P3073, DOI 10.1245/s10434-008-0069-x; Huang PL, 2003, J CANCER RES CLIN, V129, P192, DOI 10.1007/s00432-003-0425-y; Gardner LB, 2010, MOL CANCER RES, V8, P295, DOI 10.1158/1541-7786.MCR-09-0502; Lee MG, 2006, ONCOGENE, V25, P5807, DOI 10.1038/sj.onc.1209867; Chung SK, 2007, GASTROENTEROLOGY, V132, P2459, DOI 10.1053/j.gastro.2007.04.024; Krebs MG, 2012, J THORAC ONCOL, V7, P306, DOI 10.1097/JTO.0b013e31823c5c16; Wang JD, 2006, GASTROENTEROLOGY, V130, P747, DOI 10.1053/j.gastro.2005.12.017; Bertazza L, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-111; Birney E, 2004, NUCLEIC ACIDS RES, V32, pD468, DOI 10.1093/nar/gkh038; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Bruning Oskar, 2011, BMC Res Notes, V4, P438, DOI 10.1186/1756-0500-4-438; Byun DS, 2003, CANCER RES, V63, P7068; Cao M, 2009, CLIN EXP METASTAS, V26, P751, DOI 10.1007/s10585-009-9274-7; Cao WG, 2011, J SURG ONCOL, V103, P110, DOI 10.1002/jso.21777; Fujita Yasuki, 2006, Gastric Cancer, V9, P308, DOI 10.1007/s10120-006-0398-z; Furuta K, 2012, CANCER SCI, V103, P221, DOI 10.1111/j.1349-7006.2011.02132.x; Gakhar G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085143; Gradilone A, 2010, BJU INT, V106, P710, DOI 10.1111/j.1464-410X.2009.09130.x; Hatakeyama K, 2011, PROTEOMICS, V11, P2275, DOI 10.1002/pmic.201100016; Hosokawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067466; Hristozova T, 2011, ANN ONCOL, V22, P1878, DOI 10.1093/annonc/mdr130; Ishigami S, 2008, J SURG RES, V148, P205, DOI 10.1016/j.jss.2007.08.013; Ivanov I, 2007, ONCOGENE, V26, P2873, DOI 10.1038/sj.onc.1210098; Kutun S., 2010, Experimental Oncology, V32, P263; Maquat LE, 2002, CURR BIOL, V12, pR196, DOI 10.1016/S0960-9822(02)00747-9; Micali OC, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-52; Mitchell Michael J, 2013, Front Oncol, V3, P44, DOI 10.3389/fonc.2013.00044; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; Partridge M, 2003, CLIN CANCER RES, V9, P5287; Pino MS, 2008, CLIN CANCER RES, V14, P4943, DOI 10.1158/1078-0432.CCR-08-0436; Powell AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033788; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Tani H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055684; Terashima M, 2014, J CLIN ONCOL S15, V32; Tu SP, 2009, INT J CANCER, V125, P688, DOI 10.1002/ijc.24282; Wang JD, 2006, J BIOL CHEM, V281, P2451, DOI 10.1074/jbc.M505890200; Wang SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099259; Yin WH, 2006, BIOCHEM BIOPH RES CO, V339, P1148, DOI 10.1016/j.bbrc.2005.11.128; Zhang WJ, 2010, INT J ONCOL, V36, P1031, DOI 10.3892/ijo_00000584; Zhao LN, 2013, J CANCER RES THER, V9, P29, DOI 10.4103/0973-1482.110353	76	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	OCT	2015	18	4					751	761		10.1007/s10120-014-0426-3		11	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CR6WL	WOS:000361488800008		
J	Uehara, Y; Inoue, M; Fukuda, K; Yamakoshi, H; Hosoi, Y; Kanda, H; Oshima, M; Iwabuchi, Y; Shibata, H				Uehara, Yoshihiko; Inoue, Masahiro; Fukuda, Koji; Yamakoshi, Hiroyuki; Hosoi, Yoshio; Kanda, Hiroaki; Oshima, Masanobu; Iwabuchi, Yoshiharu; Shibata, Hiroyuki			Inhibition of beta-catenin and STAT3 with a curcumin analog suppresses gastric carcinogenesis in vivo	GASTRIC CANCER			English	Article						Analog; beta-Catenin; Curcumin; Gastric cancer; Signal transducer and activator of transcription 3	PROSTAGLANDIN E-2 PATHWAY; HELICOBACTER-PYLORI; SIGNAL TRANSDUCER; BREAST-CANCER; PHASE-II; ACTIVATION; EXPRESSION; GO-Y030; WNT; TUMORIGENESIS	Potent chemotherapy for advanced gastric cancer has not been completely established. Many molecularly targeted therapies are under investigation, but their therapeutic outcomes are not promising because they do not target specific and/or critical targets of gastric carcinogenesis. Although the molecular basis of gastric carcinogenesis remains poorly understood, nuclear localization of beta-catenin was observed in approximately 50 % of gastric cancer specimens. Recent studies have suggested that activation of signal transducer and activator of transcription 3 (STAT3) contributes to gastric carcinogenesis in a mouse model. A newly synthesized curcumin analog has inhibitory potential against beta-catenin and STAT3. Using a transgenic mouse model of gastric cancer in which beta-catenin, cyclooxygenase 2, and microsomal prostaglandin E synthase 1 activation is induced, we examined a curcumin analog with the most enhanced potential for treating gastric cancer through oral administration. Inhibition of these targets was demonstrated using microarray and immunohistochemical analyses. The curcumin analog GO-Y031 decreased the incidence of gastric carcinogenesis to 54.5 % of that of the control (50.0 % vs 91.7 %, p = 0.043), and tumor size was reduced to 51.6 % of that of the control (1.6 mm vs 3.1 mm, p = 0.03). beta-Catenin and STAT3 levels were suppressed to 26.2 % (p = 0.00023) and 44.8 % (p = 0.025), respectively, of those of the control. Moreover, macrophage infiltration was suppressed with GO-Y031. beta-Catenin and STAT3 can be pharmacologically inhibited in vivo with a curcumin analog, which effectively inhibits beta-catenin and STAT3.	[Uehara, Yoshihiko; Hosoi, Yoshio] Tohoku Univ, Dept Cell Biol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Inoue, Masahiro; Fukuda, Koji; Shibata, Hiroyuki] Akita Univ, Grad Sch Med, Dept Clin Oncol, Akita 0108543, Japan; [Yamakoshi, Hiroyuki; Iwabuchi, Yoshiharu] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Organ Chem, Sendai, Miyagi 980, Japan; [Kanda, Hiroaki] Japanese Fdn Canc Res, Inst Canc, Div Pathol, Tokyo 170, Japan; [Oshima, Masanobu] Kanazawa Univ, Canc Res Inst, Div Genet, Kanazawa, Ishikawa 920, Japan	Shibata, H (reprint author), Akita Univ, Grad Sch Med, Dept Clin Oncol, Hondo 1-1-1, Akita 0108543, Japan.	hiroyuki@med.akita-u.ac.jp			Japan Society for the Promotion of Science [22501041]; Cancer Research Institute of Kanazawa University; Nippon Carbide Industries (Tokyo, Japan)	This study was partially supported by the Japan Society for the Promotion of Science [Grant-in-Aid for Scientific Research (C) 22501041 to Y.U., Y.I., and H.S.], the Joint Research Project of the Cancer Research Institute of Kanazawa University (M.O. and H.S.), and Nippon Carbide Industries (Tokyo, Japan). The authors also thank Enago (http://www.enago.jp) for review and revision of the language.	Anand M, 2011, HAEMATOL-HEMATOL J, V96, P253, DOI 10.3324/haematol.2010.027086; Lo HW, 2010, MOL CANCER RES, V8, P232, DOI 10.1158/1541-7786.MCR-09-0391; Page BDG, 2011, EXPERT OPIN THER PAT, V21, P65, DOI 10.1517/13543776.2011.539205; Bang YJ, 2010, LANCET, V376, P1302; Nero TL, 2014, NAT REV CANCER, V14, P248, DOI 10.1038/nrc3690; Kudo C, 2011, ANTICANCER RES, V31, P3719; Lin L, 2011, BRIT J CANCER, V105, P212, DOI 10.1038/bjc.2011.200; Yuan ZL, 2004, MOL CELL BIOL, V24, P9390, DOI 10.1128/MCB.24.21.9390-9400.2004; De R, 2009, ANTIMICROB AGENTS CH, V53, P1592, DOI 10.1128/AAC.01242-08; Sun WJ, 2010, J CLIN ONCOL, V28, P2947, DOI 10.1200/JCO.2009.27.7988; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Tye H, 2012, CANCER CELL, V22, P466, DOI 10.1016/j.ccr.2012.08.010; Hong JI, 2004, CARCINOGENESIS, V25, P1671, DOI 10.1093/carcin/bgh165; Naor D, 2002, CRIT REV CL LAB SCI, V39, P527, DOI 10.1080/10408360290795574; Clements WM, 2002, CANCER RES, V62, P3503; Dahmke IN, 2014, FOOD CHEM, V151, P514, DOI 10.1016/j.foodchem.2013.11.102; Chung SS, 2014, INT J ONCOL, V44, P403, DOI 10.3892/ijo.2013.2195; Oshima H, 2004, EMBO J, V23, P1669, DOI 10.1038/sj.emboj.7600170; Aggarwal BB, 2006, ANN NY ACAD SCI, V1091, P151, DOI 10.1196/annals.1378.063; Sansone P, 2012, J CLIN ONCOL, V30, P1005, DOI 10.1200/JCO.2010.31.8907; Dalwadi H, 2005, CLIN CANCER RES, V11, P7674, DOI 10.1158/1078-0432.CCR-05-1205; Hutzen B, 2009, INT J ONCOL, V35, P867, DOI 10.3892/ijo_00000401; Yamamoto H, 2014, WORLD J GASTROENTERO, V20, P3927, DOI 10.3748/wjg.v20.i14.3927; Udhayakumar G, 2011, MOL CELL BIOCHEM, V357, P283, DOI 10.1007/s11010-011-0899-x; Li J, 2013, J CLIN ONCOL, V31, P3219, DOI 10.1200/JCO.2013.48.8585; Ohori H, 2006, MOL CANCER THER, V5, P2563, DOI 10.1158/1535-7163.MCT-06-0174; Sintara K, 2010, WORLD J GASTROENTERO, V16, P4039, DOI 10.3748/wjg.v16.i32.4039; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Jurenka JS, 2009, ALTERN MED REV, V14, P141; Ishimoto T, 2010, CANCER SCI, V101, P673, DOI 10.1111/j.1349-7006.2009.01430.x; Oshima H, 2006, GASTROENTEROLOGY, V131, P1086, DOI 10.1053/j.gastro.2006.07.014; Mahady GB, 2002, ANTICANCER RES, V22, P4179; Han C, 2006, J BIOL CHEM, V281, P24831, DOI 10.1074/jbc.M602201200; Armanious H, 2010, INT J CLIN EXP PATHO, V3, P654; Behrens J, 2000, ANN NY ACAD SCI, V910, P21; Shibata H, 2009, CANCER SCI, V100, P956, DOI 10.1111/j.1349-7006.2009.01127.x; Fragoso MA, 2012, PLOS ONE, DOI [10.1371/journal.pone.0046892, DOI 10.1371/J0URNAL.P0NE.0046892]; Gang EJ, 2013, ONCOGENE, DOI [10.1038/onc.2013.169, DOI 10.1038/0NC.2013.169]; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1994, IARC MONOGRAPHS EVAL, V61, P77; Itadani H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-615; Kudo Chieko, 2011, BMC Pharmacology, V11, P4, DOI 10.1186/1471-2210-11-4; McMurray John S, 2012, JAKSTAT, V1, P263, DOI 10.4161/jkst.22682; Oshima H, 2009, CANCER RES, V69, P2729, DOI 10.1158/0008-5472.CAN-08-4394; Shibata H, 2012, CURCUMIN BIOSYNTHESI, P177; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Yan S, 2008, CANCER LETT, V271, P85, DOI 10.1016/j.canlet.2008.05.035	47	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	OCT	2015	18	4					774	783		10.1007/s10120-014-0434-3		10	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CR6WL	WOS:000361488800010		
J	Goto, O; Fujimoto, A; Shimoda, M; Ochiai, Y; Matsuda, T; Takeuchi, H; Kawakubo, H; Maehata, T; Uraoka, T; Kameyama, K; Kitagawa, Y; Yahagi, N				Goto, Osamu; Fujimoto, Ai; Shimoda, Masayuki; Ochiai, Yasutoshi; Matsuda, Tatsuo; Takeuchi, Hiroya; Kawakubo, Hirofumi; Maehata, Tadateru; Uraoka, Toshio; Kameyama, Kaori; Kitagawa, Yuko; Yahagi, Naohisa			Estimation of subepithelial lateral extent in submucosal early gastric cancer: retrospective histological analysis	GASTRIC CANCER			English	Article						Early gastric cancer; Endoscopic full-thickness resection; Subepithelial extent	FULL-THICKNESS RESECTION; WALL-INVERSION SURGERY; FEASIBILITY; TUMOR	Endoscopic full-thickness resection (EFTR) is expected to make possible minimally invasive local resection of early gastric cancer (EGC). However, no consensus exists regarding how far an optimal safety margin should be set in determining the resection area by endoscopy. We aimed to investigate the optimal lateral margin of EGC which could be a candidate for EFTR by measuring the subepithelial extent (SE) of tumors. In 60 surgically resected submucosal EGCs 4 cm or smaller, 595 prepared slides which showed lateral tumor borders both on the epithelial surface and on the subepithelial layer were assessed. The distance between the epithelial and the subepithelial tumor edge was measured under microscopic observation, followed by analyses of the relationship between the measured SE and the histological characteristics. The average and the median SE were 1.1 mm (standard deviation 1.8 mm) and 0.3 mm (range 0-12.3 mm), respectively. The 99th percentile was 8.8 mm. With regard to the histological type, the median SE was significantly greater in diffuse-type tumor than in intestinal-type tumor (0.9 mm vs 0 mm, p < 0.0001). With regard to the location of the subepithelilal tumor edge, the median SE was significantly greater in the submucosal layer than in the mucosal layer (2.6 mm vs 0.3 mm, p < 0.0001). In most lesions, the SE was less than 1 cm. A safety margin may be set at 1 cm in EFTR of submucosal EGC.	[Goto, Osamu; Fujimoto, Ai; Ochiai, Yasutoshi; Matsuda, Tatsuo; Uraoka, Toshio; Yahagi, Naohisa] Keio Univ, Sch Med, Div Res & Dev Minimally Invas Treatment, Ctr Canc,Shinjuku Ku, Tokyo 1608582, Japan; [Shimoda, Masayuki] Keio Univ, Sch Med, Dept Pathol, Tokyo 1608582, Japan; [Matsuda, Tatsuo; Takeuchi, Hiroya; Kawakubo, Hirofumi; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Tokyo 1608582, Japan; [Kameyama, Kaori] Keio Univ, Sch Med, Div Diagnost Pathol, Tokyo 1608582, Japan	Yahagi, N (reprint author), Keio Univ, Sch Med, Div Res & Dev Minimally Invas Treatment, Ctr Canc,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	yahagi.keio@gmail.com					Abe N, 2009, SURG ENDOSC, V23, P1908, DOI 10.1007/s00464-008-0317-y; Kitagawa Y, 2013, J CLIN ONCOL, V31, P3704, DOI 10.1200/JCO.2013.50.3789; Goto O, 2011, GASTRIC CANCER, V14, P183, DOI 10.1007/s10120-011-0014-8; Mitsui T, 2014, GASTRIC CANCER, V17, P594, DOI 10.1007/s10120-013-0291-5; Nunobe S, 2012, GASTRIC CANCER, V15, P338, DOI 10.1007/s10120-012-0146-5; Takeuchi H, 2013, ANN SURG ONCOL, V20, P522, DOI 10.1245/s10434-012-2602-1; Schlag C, 2013, ENDOSCOPY, V45, P4, DOI 10.1055/s-0032-1325760; Hiki N, 2008, SURG ENDOSC, V22, P1729, DOI 10.1007/s00464-007-9696-8; Zhou PH, 2011, SURG ENDOSC, V25, P2926, DOI 10.1007/s00464-011-1644-y; Goto O, 2015, GASTRIC CANCER, V18, P440, DOI 10.1007/s10120-014-0358-y; Goto O, 2015, GASTRIC CANCER, V18, P434, DOI 10.1007/s10120-014-0406-7; Japanese Gastric Cancer Association, 2011, GASTRIC CANCER, V14, P113, DOI [10.1007/s10120-011-0042-4, DOI 10.1007/S10120-011-0042-4]]; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Mitsui T, 2013, SURG LAPARO ENDO PER, V23, pE217, DOI 10.1097/SLE.0b013e31828e3f94; Mori H, 2014, SURG ENDOSC, V28, P683, DOI 10.1007/s00464-013-3266-z; Seto Y, 1999, HEPATO-GASTROENTEROL, V46, P2673	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	OCT	2015	18	4					810	816		10.1007/s10120-014-0427-2		7	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CR6WL	WOS:000361488800014		
J	Satoh, T; Lee, KH; Rha, SY; Sasaki, Y; Park, SH; Komatsu, Y; Yasui, H; Kim, TY; Yamaguchi, K; Fuse, N; Yamada, Y; Ura, T; Kim, SY; Munakata, M; Saitoh, S; Nishio, K; Morita, S; Yamamoto, E; Zhang, QW; Kim, JM; Kim, YH; Sakata, Y				Satoh, Taroh; Lee, Kyung Hee; Rha, Sun Young; Sasaki, Yasutsuna; Park, Se Hoon; Komatsu, Yoshito; Yasui, Hirofumi; Kim, Tae-You; Yamaguchi, Kensei; Fuse, Nozomu; Yamada, Yasuhide; Ura, Takashi; Kim, Si-Young; Munakata, Masaki; Saitoh, Soh; Nishio, Kazuto; Morita, Satoshi; Yamamoto, Eriko; Zhang, Qingwei; Kim, Jung-mi; Kim, Yeul Hong; Sakata, Yuh			Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer	GASTRIC CANCER			English	Article						Nimotuzumab; Anti-EGFR; Irinotecan; Second-line therapy; Advanced gastric cancer	GROWTH-FACTOR RECEPTOR; ADVANCED ESOPHAGOGASTRIC CANCER; MONOCLONAL-ANTIBODY H-R3; CELL LUNG-CANCER; SUPPORTIVE CARE; CHEMOTHERAPY PLUS; 1ST-LINE THERAPY; EGFR ANTIBODY; CISPLATIN; CAPECITABINE	This multicenter, randomized phase II trial was conducted to compare the efficacy and safety of nimotuzumab plus irinotecan (N-IRI) versus irinotecan alone (IRI) in patients with advanced gastric cancer (AGC) showing disease progression after previous 5-fluorouracil-based therapy. Irinotecan-naive patients (n = 82) received N-IRI (nimotuzumab 400 mg weekly plus irinotecan 150 mg/m(2) biweekly) or IRI (irinotecan 150 mg/m(2) biweekly) until disease progression. The primary endpoint was progression-free survival (PFS), and the secondary endpoints were overall survival (OS), response rate (RR), safety, tolerability, and the correlation between efficacy and tumor epidermal growth factor receptor (EGFR) expression. Of 83 patients, 40 and 43 patients were randomly assigned to the N-IRI and IRI groups, respectively. In the N-IRI/IRI treatment group, median PFS was 73.0/85.0 days (P = 0.5668), and median OS and RR at 18 months were 250.5/232.0 days (P = 0.9778) and 18.4/10.3 %, respectively. Median PFS and OS in the EGFR 2+/3+ subgroups were 118.5/59.0 and 358.5/229.5 days, respectively. The RR was 33.3/0.0 % in the N-IRI/IRI treatment group. The incidence of grade 3 or higher adverse events was 77.5/64.3 %. No adverse events of grade 3 or higher skin rash or grade 3 or higher infusion-related reaction were reported. There was no superiority of N-IRI over IRI alone in terms of PFS in 5-fluorouracil-refractory AGC patients. However, N-IRI showed potential improvement in the EGFR 2+/3+ subgroup based on improved RR, PFS, and OS.	[Satoh, Taroh] Kinki Univ, Fac Med, Med Oncol, Osaka, Japan; [Lee, Kyung Hee] Yeungnam Univ Hosp, Internal Med, Hematooncol, Daegu, South Korea; [Rha, Sun Young] Yonsei Univ, Coll Med, Yonsei Canc Res Inst, Med Oncol,Internal Med, Seoul, South Korea; [Sasaki, Yasutsuna] Saitama Med Univ, Int Med Ctr, Med Oncol, Saitama, Japan; [Park, Se Hoon] Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Hematoloncol, Seoul, South Korea; [Komatsu, Yoshito] Hokkaido Univ Hosp, Div Canc Chemotherapy, Sapporo, Hokkaido, Japan; [Yasui, Hirofumi] Shizuoka Canc Ctr, Div GI Oncol, Shizuoka, Japan; [Kim, Tae-You] Seoul Natl Univ Hosp, Internal Med, Hematol Oncol, Seoul 110744, South Korea; [Yamaguchi, Kensei] Saitama Canc Ctr, Dept Gastroenterol, Saitama, Japan; [Fuse, Nozomu] Natl Canc Ctr Hosp East, Gastrointestinal Oncol, Chiba, Japan; [Yamada, Yasuhide] Natl Canc Ctr, Gastrointestinal Oncol, Tokyo, Japan; [Ura, Takashi] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan; [Kim, Si-Young] Kyung Hee Univ Hosp, Dept Med Oncol & Hematol, Seoul, South Korea; [Munakata, Masaki; Sakata, Yuh] Misawa Municipal Hosp, Internal Med, Aomori, Japan; [Saitoh, Soh] Aomori Prefectural Cent Hosp, Med Oncol & Gastroenterol, Aomori, Japan; [Nishio, Kazuto] Kinki Univ, Sch Med, Dept Genome Biol, Osaka 589, Japan; [Morita, Satoshi] Yokohama City Univ, Dept Biostat & Epidemiol, Yokohama, Kanagawa, Japan; [Yamamoto, Eriko] Daiichi Sankyo Co Ltd, Clin Dev Dept 2, Tokyo, Japan; [Zhang, Qingwei] Daiichi Sankyo Co Ltd, Clin Data & Biostat Dept, Tokyo, Japan; [Kim, Jung-mi] Kuhnil Pharm Co Ltd, Med & Regulatory Affairs Dept, Seoul, South Korea; [Kim, Yeul Hong] Korea Univ, Anam Hosp, Dept Internal Med, Sect Hematooncol, Seoul 136705, South Korea	Kim, YH (reprint author), Korea Univ, Anam Hosp, Sect Hematooncol, Dept Internal Med, 126-1 Anam Dong 5ga, Seoul 136705, South Korea.	yhk0215@korea.ac.kr			Daiichi Sankyo Co., Ltd., Japan; Kuhnil Pharm. Co., Ltd., Republic of Korea	We thank all the patients, their families, and the institutions involved in this study. The authors also thank the following individual board members for their contributions to this report: Independent Data Monitoring Committee, Keiichi Nagao, Noriyuki Masuda, Ichinosuke Hyodo, Baek-Yeol Ryoo, Young Iee Park, and Hong Suk Song; Efficacy Evaluation Committee, Atsushi Sato, Junji Tanaka, and Dae Young Zang; and Medical Advisors, Yutaka Ariyoshi and Kiyohiko Hatake. This trial was supported by a grant from Daiichi Sankyo Co., Ltd., Japan, and Kuhnil Pharm. Co., Ltd., Republic of Korea.	Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Bang YJ, 2010, LANCET, V376, P1302; Goldstein NS, 2001, CANCER, V92, P1331, DOI 10.1002/1097-0142(20010901)92:5<1331::AID-CNCR1455>3.0.CO;2-M; Chun JH, 2004, JPN J CLIN ONCOL, V34, P8, DOI 10.1093/jjco/hyh006; Garrido G, 2011, CANCER BIOL THER, V11, P373, DOI 10.4161/cbt.11.4.14097; Akashi Y, 2008, BRIT J CANCER, V98, P749, DOI 10.1038/sj.bjc.6604222; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Kang YK, 2009, ANN ONCOL, V20, P666, DOI 10.1093/annonc/mdn717; Rodriguez MO, 2010, CANCER BIOL THER, V9, P343; Glimelius B, 1997, ANN ONCOL, V8, P163, DOI 10.1023/A:1008243606668; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Cappuzzo F, 2005, J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Crombet T, 2003, J IMMUNOTHER, V26, P139, DOI 10.1097/00002371-200303000-00006; Terashima M, 2012, CLIN CANCER RES, V18, P5992, DOI 10.1158/1078-0432.CCR-12-1318; Talavera A, 2009, CANCER RES, V69, P5851, DOI 10.1158/0008-5472.CAN-08-4518; Kim MA, 2008, HISTOPATHOLOGY, V52, P738, DOI 10.1111/j.1365-2559.2008.03021.x; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Waddell T, 2013, LANCET ONCOL, V14, P481, DOI 10.1016/S1470-2045(13)70096-2; Wagner AD, 2006, J CLIN ONCOL, V24, P2903, DOI 10.1200/JCO.2005.05.0245; Lee SH, 2003, ONCOGENE, V22, P6942, DOI 10.1038/sj.onc.1206749; Lordick F, 2013, LANCET ONCOL, V14, P490, DOI 10.1016/S1470-2045(13)70102-5; Kang JH, 2012, J CLIN ONCOL, V30, P1513, DOI 10.1200/JCO.2011.39.4585; Kodera Y, 2007, ANTICANCER RES, V27, P2667; Thuss-Patience PC, 2011, EUR J CANCER, V47, P2306, DOI 10.1016/j.ejca.2011.06.002; Crombet T, 2004, J CLIN ONCOL, V22, P1646, DOI 10.1200/JCO.2004.03.089; MURAD AM, 1993, CANCER, V72, P37, DOI 10.1002/1097-0142(19930701)72:1<37::AID-CNCR2820720109>3.0.CO;2-P; Crombet-Ramos T, 2002, INT J CANCER, V101, P567, DOI 10.1002/ijc.10647; Hironaka Shuichi, 2006, Gastric Cancer, V9, P14, DOI 10.1007/s10120-005-0351-6; Okamoto W, 2013, CANCER CHEMOTH PHARM, V72, P1063, DOI 10.1007/s00280-013-2277-8; Ramos TC, 2006, CANCER BIOL THER, V5, P375	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	OCT	2015	18	4					824	832		10.1007/s10120-014-0420-9		9	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CR6WL	WOS:000361488800016		
J	Yasuda, A; Yasuda, T; Imamoto, H; Kato, H; Nishiki, K; Iwama, M; Makino, T; Shiraishi, O; Shinkai, M; Imano, M; Furukawa, H; Okuno, K; Shiozaki, H				Yasuda, Atsushi; Yasuda, Takushi; Imamoto, Haruhiko; Kato, Hiroaki; Nishiki, Kohei; Iwama, Mitsuru; Makino, Tomoki; Shiraishi, Osamu; Shinkai, Masayuki; Imano, Motohiro; Furukawa, Hiroshi; Okuno, Kiyokata; Shiozaki, Hitoshi			A newly modified esophagogastrostomy with a reliable angle of His by placing a gastric tube in the lower mediastinum in laparoscopy-assisted proximal gastrectomy	GASTRIC CANCER			English	Article						Proximal gastrectomy; Esophagogastrostomy; Gastric tube	JEJUNAL POUCH INTERPOSITION; CANCER; CARDIA; RECONSTRUCTION; ADENOCARCINOMA; COMPLICATIONS; CARCINOMA; REFLUX	An optimal reconstruction method for proximal gastrectomy (PG) remains elusive. Esophagogastrostomy (EG) is technically simple but suffers from the disadvantage of gastroesophageal reflux. Jejunal interposition (JI) has a low rate of gastroesophageal reflux, but the procedure is more complicated, and delayed gastric emptying is a problem. We created a modified EG and have used the modified technique for PG since 2006. The procedure involves shaping the remnant stomach into a gastric conduit. The EG is performed high on the anterior wall, and the conduit is kept straight by applying a circular stapler inserted from the anterior wall of the antrum. The tip of the gastric conduit is then inserted into the lower mediastinum, creating a sharp angle of His. In this retrospective cohort study, the clinical and physiological outcomes were compared between 25 patients who underwent this procedure and 21 patients who underwent JI from 2001 to 2005. Laparoscopic procedures were performed more frequently, and residual food and bile reflux were less common in the EG group than in the JI group. No significant differences in remnant gastritis or reflux esophagitis were observed between the two groups. However, the late complication of intestinal obstruction occurred only in the JI group. The modified EG technique has advantages over the JI technique because of its simplicity and low incidence of residual food and bile reflux. The next step would be to explore this technique further by a prospective multi-institutional study to confirm the reproducibility of its benefits. Miniabstract: The modified EG technique has advantages over the JI technique because of its simplicity, high rate of laparoscopy use, and low incidence of gastroesophageal reflux.	[Yasuda, Atsushi; Yasuda, Takushi; Imamoto, Haruhiko; Kato, Hiroaki; Nishiki, Kohei; Iwama, Mitsuru; Makino, Tomoki; Shiraishi, Osamu; Shinkai, Masayuki; Furukawa, Hiroshi; Okuno, Kiyokata; Shiozaki, Hitoshi] Kinki Univ, Fac Med, Dept Surg, Osaka, Osaka 5898511, Japan; [Imano, Motohiro] Kinki Univ Hosp, Ctr Canc, Osaka, Osaka 5898511, Japan	Yasuda, A (reprint author), Kinki Univ, Fac Med, Dept Surg, 377-2 Ohno Higashi, Osaka, Osaka 5898511, Japan.	a-yasuda@surg.med.kindai.ac.jp					Adachi Y, 1999, GASTRIC CANCER, V2, P40, DOI 10.1007/s101200050019; Kunisaki C, 2006, ANN SURG ONCOL, V13, P221, DOI 10.1245/ASO.2006.04.028; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Okabayashi T, 2000, CANCER, V89, P2555, DOI 10.1002/1097-0142(20001215)89:12<2555::AID-CNCR6>3.0.CO;2-R; BEMELMAN WA, 1995, J AM COLL SURGEONS, V180, P461; Kong SH, 2004, JPN J CLIN ONCOL, V34, P1, DOI 10.1093/jjco/hyh009; Shiraishi N, 2002, WORLD J SURG, V26, P1150, DOI 10.1007/s00268-002-6369-6; Hsu CP, 1997, AM J GASTROENTEROL, V92, P1347; DEMEESTER TR, 1976, ANN SURG, V184, P459, DOI 10.1097/00000658-197610000-00009; Association JGC., 2011, GASTRIC CANCER, V14, P101; Association JGC, 2011, GASTRIC CANCER, V14, P113; BEMELMAN WA, 1988, AM J PHYSIOL, V254, pG168; D'Journo XB, 2008, DIS ESOPHAGUS, V21, P377, DOI 10.1111/j.1442-2050.2008.00849.x; Furukawa H, 1998, ANN SURG ONCOL, V5, P338, DOI 10.1007/BF02303497; Ichikawa D, 2012, LANGENBECK ARCH SURG, V397, P57, DOI 10.1007/s00423-011-0840-5; Ikeda Y, 2002, J AM COLL SURGEONS, V195, P578, DOI 10.1016/S1072-7515(02)01291-7; Iwata T, 2006, HEPATO-GASTROENTEROL, V53, P301; Katsube T, 2005, EJSO, V31, P1036, DOI 10.1016/j.ejso.2005.07.009; Kim DJ, 2012, GASTRIC CANC; Kubo Makoto, 2002, Gastric Cancer, V5, P83, DOI 10.1007/s101200200014; Nakane Y, 2004, HEPATO-GASTROENTEROL, V51, P1867; Norio Shiraisi, 1998, GASTRIC CANCER, P78; STADAAS J, 1970, ACTA CHIR SCAND, V136, P611; Takeshita K, 2007, SURG TODAY, V37, P754, DOI 10.1007/s00595-007-3497-5; Ueno M, 2004, HEPATO-GASTROENTEROL, V51, P916	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	OCT	2015	18	4					850	858		10.1007/s10120-014-0431-6		9	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CR6WL	WOS:000361488800019		
J	Kunisaki, C; Makino, H; Kimura, J; Takagawa, R; Ota, M; Kosaka, T; Akiyama, H; Endo, I				Kunisaki, Chikara; Makino, Hirochika; Kimura, Jun; Takagawa, Ryo; Ota, Mitsuyoshi; Kosaka, Takashi; Akiyama, Hirotoshi; Endo, Itaru			Application of reduced-port laparoscopic total gastrectomy in gastric cancer preserving the pancreas and spleen	GASTRIC CANCER			English	Article						Gastric cancer; Laparoscopic total gastrectomy; Reduced-port gastrectomy	ASSISTED DISTAL GASTRECTOMY; SURGICAL OUTCOMES; INSERTED ANVIL; ESOPHAGOJEJUNOSTOMY; EXPERIENCE	The feasibility of using reduced-port laparoscopic total gastrectomy (RPLTG) for the treatment of gastric cancer remains unclear. This study aimed to address the potentially important advantages of this surgical technique. Between April 2002 and February 2014, 90 patients underwent laparoscopy-assisted total gastrectomies, performed by a single surgeon. Of these, 45 patients underwent RPLTG and 45 patients underwent conventional laparoscopy-assisted total gastrectomy (CLATG). Short-term outcomes were compared to evaluate the feasibility of RPLTG for gastric cancer. There were several significant differences between the RPLTG and CLATG groups in short-term outcomes: the mean total operation durations were significantly longer in the RPLTG group (319.0 min) than in the CLATG group (259.0 min). However, the mean volume of blood loss, the degree of lymph node dissection, and the number of dissected lymph nodes did not differ between the two groups. We have shown that RPLTG could be an acceptable and satisfactory procedure for the treatment of gastric cancer requiring total gastrectomy for surgeons sufficiently experienced in CLATG.	[Kunisaki, Chikara; Makino, Hirochika; Kimura, Jun; Takagawa, Ryo; Ota, Mitsuyoshi] Yokohama City Univ, Dept Surg, Gastroenterol Ctr, Minami Ku, Yokohama, Kanagawa 2320024, Japan; [Kosaka, Takashi; Akiyama, Hirotoshi; Endo, Itaru] Yokohama City Univ, Dept Surg Gastroenterol, Yokohama, Kanagawa 232, Japan	Kunisaki, C (reprint author), Yokohama City Univ, Dept Surg, Gastroenterol Ctr, Minami Ku, 4-57 Urafune Cho, Yokohama, Kanagawa 2320024, Japan.	s0714@med.yokohama-cu.ac.jp					Kunisaki C, 2012, SURG ENDOSC, V26, P804, DOI 10.1007/s00464-011-1956-y; Park DJ, 2012, SURG ENDOSC, V26, P1548, DOI 10.1007/s00464-011-2065-7; Lee SI, 2006, J AM COLL SURGEONS, V202, P874, DOI 10.1016/j.jamcollsurg.2006.02.028; LaFemina J, 2013, ANN SURG ONCOL, V20, P2975, DOI 10.1245/s10434-013-2978-6; Kunisaki C, 2011, SURG ENDOSC, V25, P1300, DOI 10.1007/s00464-010-1367-5; Zhao YL, 2011, SURG ENDOSC, V25, P2960, DOI 10.1007/s00464-011-1652-y; Lee SW, 2010, J AM COLL SURGEONS, V211, P33, DOI 10.1016/j.jamcollsurg.2010.03.018; Vinuela EF, 2012, ANN SURG, V255, P446, DOI 10.1097/SLA.0b013e31824682f4; Huang JL, 2010, DIGEST SURG, V27, P291, DOI 10.1159/000281818; Takiguchi S, 2013, WORLD J SURG, V37, P2379, DOI 10.1007/s00268-013-2121-7; Association JGC, 2011, GASTRIC CANCER, V14, P113; Ebihara Y, 2013, LANGENBECK ARCH SURG, V398, P475, DOI 10.1007/s00423-013-1051-z; Fukunaga T, 2013, ANN SURG ONCOL, V20, P2676, DOI 10.1245/s10434-013-2930-9; Ito H, 2014, SURG ENDOSC, V28, P1929, DOI 10.1007/s00464-014-3417-x; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Jeong O, 2012, SURG ENDOSC, V26, P3418, DOI 10.1007/s00464-012-2356-7; Kawamura H, 2013, INT SURG, V98, P247, DOI 10.9738/INTSURG-D-12-00025; Kawamura H, 2013, GASTRIC CANCER, V16, P602, DOI 10.1007/s10120-012-0212-z; Kim KH, 2013, DIGEST SURG, V30, P348, DOI 10.1159/000354653; Kunisaki C, 2012, DIGEST SURG, V29, P261, DOI 10.1159/000341677; Omori T, 2011, SURG ENDOSC, V25, P2400, DOI 10.1007/s00464-010-1563-3	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	OCT	2015	18	4					868	875		10.1007/s10120-014-0441-4		8	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CR6WL	WOS:000361488800021		
J	Haruta, S; Shinohara, H; Ueno, M; Udagawa, H; Sakai, Y; Uyama, I				Haruta, Shusuke; Shinohara, Hisashi; Ueno, Masaki; Udagawa, Harushi; Sakai, Yoshiharu; Uyama, Ichiro			Anatomical considerations of the infrapyloric artery and its associated lymph nodes during laparoscopic gastric cancer surgery	GASTRIC CANCER			English	Article						Infrapyloric artery; Station no.6; Lymphadenectomy; Laparoscopic surgery; Gastric cancer	DISSECTION; GASTRECTOMY	Little is known about the vascular and lymphatic distribution of the pyloric antrum in the stomach. We focused on the infrapyloric region containing the infrapyloric artery (IPA) and lymph nodes. The anatomy of the IPA and its associated lymph nodes was clinically elucidated during 156 laparoscopic gastrectomies. Most of the arteries originated from the anterior superior pancreatoduodenal artery (ASPDA, 64.2 %) or the root of the right gastroepiploic artery (RGEA, 23.1 %), but a small portion originated from the gastroduodenal artery (GDA, 12.7 %). The average lengths from the pyloric ring to the IPA proximal branch were 21.8 mm from the ASPDA, 20.6 mm from the RGEA and 9.0 mm from the GDA, a significantly shorter length than the other 2 variations. On average, 2.5 out of 10.0 nodes existed along the IPA. One patient, whose tumor was located close to the pylorus, had a metastatic node in this section. The IPA most commonly originates from the ASPDA and is associated with a certain number of lymph nodes. Vascular distribution from the IPA depends on the anatomic variation.	[Haruta, Shusuke; Shinohara, Hisashi; Ueno, Masaki; Udagawa, Harushi] Toranomon Gen Hosp, Dept Surg Gastroenterol, Minato Ku, Tokyo 1058470, Japan; [Haruta, Shusuke; Uyama, Ichiro] Fujita Hlth Univ, Dept Surg, Toyoake, Aichi, Japan; [Sakai, Yoshiharu] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan	Shinohara, H (reprint author), Toranomon Gen Hosp, Dept Surg Gastroenterol, Minato Ku, 2-2-2 Toranomon, Tokyo 1058470, Japan.	shinohara@toranomon.gr.jp					Obama K, 2011, SURGERY, V149, P15, DOI 10.1016/j.surg.2010.04.014; Shinohara H, 2013, GASTRIC CANCER, V16, P615, DOI 10.1007/s10120-012-0229-3; Kanaya S, 2011, SURG ENDOSC, V25, P3928, DOI 10.1007/s00464-011-1792-0; Noshiro H, 2005, SURG ENDOSC, V19, P1592, DOI 10.1007/s00464-005-0175-9; SASAKO M, 1995, BRIT J SURG, V82, P346, DOI 10.1002/bjs.1800820321; Cova E, 1904, ARCH ITAL ANAT EMBRI, V3, P485; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; KURODA C, 1982, ACTA RADIOL DIAGN, V23, P479; LIBERSKI SM, 1990, GASTROENTEROLOGY, V99, P252; Maruyama K, 1931, ANN SURG, V1989, P596; Polya E, 1911, ZENTRALBL CHIR, V38, P892; SAWAI K, 1995, AM J SURG, V170, P285, DOI 10.1016/S0002-9610(05)80015-7; Takamuro T, 1998, JPN J GASTROENTEROL, V31, P825; Uyama I, 2000, GASTRIC CANCER, V3, P50, DOI 10.1007/PL00011690; VANDAMME JPJ, 1988, ACTA ANAT, V131, P89; von Navratil D, 1903, Z KLIN CHIR, V69, P421; Wilkie D, 1911, SURG GYNECOL OBSTET, V3, P399	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	OCT	2015	18	4					876	880		10.1007/s10120-014-0424-5		5	Oncology; Gastroenterology & Hepatology	Oncology; Gastroenterology & Hepatology	CR6WL	WOS:000361488800022		
J	Bannai, S; Tokunaga, HO				Bannai, Shinzo; Tokunaga, Hiro-o			Geometry of bisections of elliptic surfaces and Zariski -plets for conic arrangements	GEOMETRIAE DEDICATA			English	Article						Rational elliptic surfaces; Mordell-Weil group; Zariski N-plet; Dihedral covers	DIHEDRAL COVERS; SECTIONS	In this article, we study the geometry of bisections of certain rational elliptic surfaces. As an application, we give examples of Zariski -plets for conic arrangements, which generalize Namba-Tsuchihashi's result.	[Bannai, Shinzo] Ibaraki Natl Coll Technol, Dept Nat Sci, Hitachinaka, Ibaraki 1920397, Japan; [Tokunaga, Hiro-o] Tokyo Metropolitan Univ, Dept Math & Informat Sci, Grad Sch Sci & Engn, Hachioji, Tokyo 1920397, Japan	Bannai, S (reprint author), Ibaraki Natl Coll Technol, Dept Nat Sci, 866 Nakane, Hitachinaka, Ibaraki 1920397, Japan.	sbannai@ge.ibaraki-ct.ac.jp; tokunaga@tmu.ac.jp			JSPS [25610007]	Part of this article was done during the second author's visit to Ruhr Universitat Bochum in September 2012. He thanks for Professor P. Heinzner for his hospitality. The second author is partly supported by JSPS Grants-in-Aid for Scientific Research 25610007 (Challenging Exploratory Research). Also the authors thank the referee for his/her valuable comments on the first draft of this paper.	MIRANDA R, 1986, MATH Z, V193, P537, DOI 10.1007/BF01160474; HORIKAWA E, 1975, INVENT MATH, V31, P43, DOI 10.1007/BF01389865; KODAIRA K, 1963, ANN MATH, V78, P1, DOI 10.2307/1970500; Tokunaga H, 2014, J MATH SOC JPN, V66, P613, DOI 10.2969/jmsj/06620613; Namba M, 2004, GEOMETRIAE DEDICATA, V104, P97, DOI 10.1023/B:GEOM.0000022858.29934.42; ZARISKI O, 1958, P NATL ACAD SCI USA, V44, P791, DOI 10.1073/pnas.44.8.791; ARTAL BARTOLO E., 2008, ADV STUD PURE MATH, V50, P1; Barth W., 2004, ERGEBNISSE MATH IHRE, V4; Miranda R., 1989, BASIC THEORY ELLIPTI; Oguiso K., 1991, COMMENT MATH U ST PA, V40, P83; Shioda T., 1992, COMMENT MATH U ST PA, V41, P169; Shioda T., 1990, COMMENT MATH U ST PA, V39, P211; Silverman J.H., 1985, GRADUATE TEXTS MATH, V106; Silverman Joseph H., 1994, GRADUATE TEXTS MATH, V151; Tokunaga H., 2010, J SINGUL, V2, P170, DOI 10.5427/jsing.2010.2k; Tokunaga H, 1997, MATH ANN, V308, P633, DOI 10.1007/s002080050094; Tokunaga HO, 2012, KODAI MATH J, V35, P78; Tokunaga HO, 2004, J MATH KYOTO U, V44, P255; TOKUNAGA HO, 1994, CAN J MATH, V46, P1299, DOI 10.4153/CJM-1994-074-4	19	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0046-5755	1572-9168		GEOMETRIAE DEDICATA	Geod. Dedic.	OCT	2015	178	1					219	237		10.1007/s10711-015-0054-z		19	Mathematics	Mathematics	CR6ZW	WOS:000361498100015		
J	Sawai, H				Sawai, Hiroshi			Vaisman structures on compact solvmanifolds	GEOMETRIAE DEDICATA			English	Article						Locally conformal Kahler structure; Solvmanifold; Vaisman structure	CONFORMAL KAHLER STRUCTURES; MANIFOLDS; NILMANIFOLDS	Let be a compact Hermitian manifold and the fundamental 2-form of . A Hermitian manifold is said to be locally conformal Kahler if there exists a closed 1-form such that . In this paper, we prove that a Vaisman structure on compact locally conformal Kahler solvmanifolds is depend on only the form of the fundamental 2-form .	Numazu Coll, Natl Inst Technol, Numazu, Shizuoka 4108501, Japan	Sawai, H (reprint author), Numazu Coll, Natl Inst Technol, 3600 Ooka, Numazu, Shizuoka 4108501, Japan.	sawai@numazu-ct.ac.jp					Kasuya H, 2013, B LOND MATH SOC, V45, P15, DOI 10.1112/blms/bds057; BENSON C, 1990, P AM MATH SOC, V108, P971, DOI 10.2307/2047955; Sawai H, 2007, TOPOL APPL, V154, P3125, DOI 10.1016/j.topol.2007.08.006; Sawai H, 2012, OSAKA J MATH, V49, P1087; CORDERO LA, 1986, GEOMETRIAE DEDICATA, V21, P187; Belgun FA, 2000, MATH ANN, V317, P1, DOI 10.1007/s002080050357; Hasegawa K, 2006, OSAKA J MATH, V43, P131; Oeljeklaus K, 2005, ANN I FOURIER, V55, P161; Ornea L, 2011, CONTEMP MATH, V542, P135; Sawai H, 2007, GEOMETRIAE DEDICATA, V125, P93, DOI 10.1007/s10711-007-9140-1; Dragomir S., 1998, LOCALLY CONFORMAL KA; Hattori A., 1960, J FS U TOKYO, V8, P289; Tricerri F., 1982, REND SEM MAT U POLIT, V40, P81; Vaisman I., 1979, REND MAT, V12, P263	14	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0046-5755	1572-9168		GEOMETRIAE DEDICATA	Geod. Dedic.	OCT	2015	178	1					389	404		10.1007/s10711-015-0062-z		16	Mathematics	Mathematics	CR6ZW	WOS:000361498100023		
J	Yokouchi, H; Baba, T; Misawa, S; Sawai, S; Beppu, M; Kitahashi, M; Oshitari, T; Kuwabara, S; Yamamoto, S				Yokouchi, Hirotaka; Baba, Takayuki; Misawa, Sonoko; Sawai, Setsu; Beppu, Minako; Kitahashi, Masayasu; Oshitari, Toshiyuki; Kuwabara, Satoshi; Yamamoto, Shuichi			Correlation between serum level of vascular endothelial growth factor and subfoveal choroidal thickness in patients with POEMS syndrome	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						POEMS syndrome; Vascular endothelial growth factor (VEGF); Subfoveal choroidal thickness; Foveal thickness	INTRAOCULAR-PRESSURE; AXIAL LENGTH; SKIN CHANGES; ENDOCRINOPATHY; POLYNEUROPATHY; RANIBIZUMAB; VEGF	The study was conducted to determine whether serum vascular endothelial growth factor (VEGF) levels are significantly correlated with subfoveal choroidal thickness (CT) and foveal thickness (FT) in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome. In this cross-sectional observational case series, we studied 31 eyes of 16 treatment-na < ve patients with POEMS syndrome with no evidence of fundus abnormalities. Subfoveal CT and FT were measured using enhanced depth imaging optical coherence tomography (EDI-OCT), and correlations between serum VEGF levels and subfoveal CT and FT were determined. The mean subfoveal CT was 417.9 +/- 73.5 mu m (right eye, 416.7 +/- 81.2 mu m; left eye, 419.0 +/- 68.1 mu m), and the mean FT was 243.8 +/- 35.2 mu m (right eye, 248.8 +/- 22.0 mu m; left eye, 239.1 +/- 44.6 mu m). There was a significant positive correlation between the serum VEGF level and subfoveal CT (right eye, r = 0.58, p = 0.021; left eye, r = 0.60, p = 0.012), but the correlation between the level of serum VEGF and FT was not significant (right eye, r = 0.007, p > 0.05; left eye, r = 0.25, p > 0.05). The significant correlation between the serum VEGF level and subfoveal CT in patients with POEMS syndrome suggests that choroidal thickness is influenced by the level of serum VEGF. These results not only aid in an understanding of the pathogenesis of ocular changes in patients with POEMS syndrome, but also offer clues regarding the pathogenesis of other choroidal diseases.	[Yokouchi, Hirotaka; Baba, Takayuki; Kitahashi, Masayasu; Oshitari, Toshiyuki; Yamamoto, Shuichi] Chiba Univ, Grad Sch Med, Dept Ophthalmol, Chuo Ku, Chiba, Chiba 2600856, Japan; [Misawa, Sonoko; Sawai, Setsu; Beppu, Minako; Kuwabara, Satoshi] Chiba Univ, Grad Sch Med, Neurol, Chiba, Chiba 2600856, Japan; [Sawai, Setsu] Chiba Univ, Grad Sch Med, Mol Diag, Chiba, Chiba 2600856, Japan; [Sawai, Setsu] Chiba Univ Hosp, Div Lab Med & Clin Genet, Chiba, Japan	Yokouchi, H (reprint author), Chiba Univ, Grad Sch Med, Dept Ophthalmol, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2600856, Japan.	yokouchi123@peace.ocn.ne.jp					Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048; Ding XY, 2011, INVEST OPHTH VIS SCI, V52, P9555, DOI 10.1167/iovs.11-8076; Yamada Y, 2013, ANN HEMATOL, V92, P245, DOI 10.1007/s00277-012-1583-2; Kaushik M, 2011, OPHTHALMOLOGY, V118, P778, DOI 10.1016/j.ophtha.2010.08.013; Ikuno Y, 2009, INVEST OPHTH VIS SCI, V50, P3876, DOI 10.1167/iovs.08-3325; Hata M, 2012, JPN J OPHTHALMOL, V56, P564, DOI 10.1007/s10384-012-0173-0; BARDWICK PA, 1980, MEDICINE, V59, P311; Ferrara N, 2006, RETINA-J RET VIT DIS, V26, P859, DOI 10.1097/01.iae.0000242842.14624.e7; Lowe J, 2007, EXP EYE RES, V85, P425, DOI 10.1016/j.exer.2007.05.008; Watanabe O, 1996, LANCET, V347, P702, DOI 10.1016/S0140-6736(96)91261-1; Dispenzieri A, 2007, BLOOD REV, V21, P285, DOI 10.1016/j.blre.2007.07.004; Chakraborty R, 2011, INVEST OPHTH VIS SCI, V52, P5121, DOI 10.1167/iovs.11-7364; Dispenzieri A, 2003, BLOOD, V101, P2496, DOI 10.1182/blood-2002-07-2299; Chong DY, 2007, J NEURO-OPHTHALMOL, V27, P180; Nakajima H, 2007, J NEUROL, V254, P531, DOI 10.1007/s00415-006-0268-y; Sekiguchi Y, 2013, J NEUROL NEUROSUR PS, V84, P1346, DOI 10.1136/jnnp-2012-304874	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	OCT	2015	253	10					1641	1646		10.1007/s00417-014-2843-8		6	Ophthalmology	Ophthalmology	CR5QC	WOS:000361397200002		
J	Inoue, M; Shiraga, F; Shirakata, Y; Morizane, Y; Kimura, S; Hirakata, A				Inoue, Makoto; Shiraga, Fumio; Shirakata, Yukari; Morizane, Yuki; Kimura, Shuhei; Hirakata, Akito			Subretinal injection of recombinant tissue plasminogen activator for submacular hemorrhage associated with ruptured retinal arterial macroaneurysm	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						Retinal arterial macroaneurysm; Subretinal injection; Submacular hemorrhage; Recombinant tissue plasminogen activator; Vitrectomy	MANAGEMENT; GAS; DEGENERATION; DISPLACEMENT	To evaluate the surgical outcomes of small-gauge vitrectomy with subretinal injection of recombinant tissue plasminogen activator (rt-PA) for a submacular hemorrhage caused by a ruptured retinal arterial macroaneurysm (RAM). Non-comparative, consecutive case-series performed at two ophthalmological institutions. We examined 22 eyes of 22 patients with a submacular hemorrhage associated with a RAM but without a preretinal or sub-internal limiting membrane hemorrhage at the fovea. During 25-gauge vitrectomy, approximately 4000-8000 IU of rt-PA was injected subretinally, followed by the injection of air or 10 % sulfur hexafluoride as a tamponade. The patients maintained an upright position for 1 hour, then turned to a facedown position for 1 to 3 days. The best-corrected visual acuity (BCVA) and postoperative complications were evaluated. The average interval from the onset of symptoms to surgery was 8.4 +/- 7.6 days, and the average size of the subretinal hemorrhage was 3.4 +/- 1.0 disc diameters. The submacular hemorrhage was displaced from the foveal area in all eyes after 1 week. The mean baseline BCVA was 1.41 +/- 0.41 logMAR units, and it improved to 0.91 +/- 0.43 at 1 month and to 0.64 +/- 0.45 at the final visit (P = 0.0001, P < 0.0001 respectively). A macular hole was detected intraoperatively in two eyes and postoperatively in two eyes, and both were closed by internal limiting membrane peeling or a second vitrectomy. Small-gauge vitrectomy with subretinal rt-PA injection and gas tamponade were effective in displacing a submacular hemorrhage associated with a RAM.	[Inoue, Makoto; Hirakata, Akito] Kryorin Univ, Sch Med, Kryorin Eye Ctr, Mitaka, Tokyo 1818611, Japan; [Shiraga, Fumio; Morizane, Yuki; Kimura, Shuhei] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Ophthalmol, Okayama, Japan; [Shirakata, Yukari] Kagawa Univ, Fac Med, Dept Ophthalmol, Takamatsu, Kagawa 760, Japan	Inoue, M (reprint author), Kryorin Univ, Sch Med, Kryorin Eye Ctr, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	inoue@eye-center.org					Hassan AS, 1999, OPHTHALMOLOGY, V106, P1900, DOI 10.1016/S0161-6420(99)90399-8; Hesse L, 1999, GRAEF ARCH CLIN EXP, V237, P273, DOI 10.1007/s004170050232; LEWIS H, 1991, AM J OPHTHALMOL, V111, P197; Chen CY, 2007, RETINA-J RET VIT DIS, V27, P321, DOI 10.1097/01.iae.0000237586.48231.75; Berrocal MH, 1996, AM J OPHTHALMOL, V122, P486; JOHNSON MW, 1992, OPHTHALMOLOGY, V99, P515; Hochman MA, 1997, SURV OPHTHALMOL, V42, P195, DOI 10.1016/S0039-6257(97)00089-1; Hillenkamp J, 2010, GRAEF ARCH CLIN EXP, V248, P5, DOI 10.1007/s00417-009-1158-7; TOTH CA, 1991, ARCH OPHTHALMOL-CHIC, V109, P723; Haupert CL, 2001, AM J OPHTHALMOL, V131, P208, DOI 10.1016/S0002-9394(00)00734-0; RABB MF, 1988, SURV OPHTHALMOL, V33, P73, DOI 10.1016/0039-6257(88)90160-9; Hattenbach LO, 2001, OPHTHALMOLOGY, V108, P1485, DOI 10.1016/S0161-6420(01)00648-0; GLATT H, 1982, AM J OPHTHALMOL, V94, P762, DOI 10.1016/0002-9394(82)90301-4; JOHNSON MW, 1991, RETINA-J RET VIT DIS, V11, P250, DOI 10.1097/00006982-199111020-00011; Tonotsuka T, 2003, JPN J OPHTHALMOL, V47, P498, DOI 10.1016/S0021-5155(03)00104-7; BENNER JD, 1994, OPHTHALMOLOGY, V101, P672; Johnson M W, 2000, Curr Opin Ophthalmol, V11, P201, DOI 10.1097/00055735-200006000-00009; Tennant Matthew T S, 2002, Ophthalmol Clin North Am, V15, P445, DOI 10.1016/S0896-1549(02)00049-4	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	OCT	2015	253	10					1663	1669		10.1007/s00417-014-2861-6		7	Ophthalmology	Ophthalmology	CR5QC	WOS:000361397200005		
J	Kasai, K; Takahashi, G; Kumegawa, K; Dogru, M				Kasai, Kozue; Takahashi, Genichiro; Kumegawa, Koichi; Dogru, Murat			Measurement of early changes in anterior chamber morphology after cataract extraction measured by anterior segment optical coherence tomography	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						Anterior chamber depth; Phacoemulsification; Early after cataract; Anterior segment optical coherence tomography	PRIMARY ANGLE-CLOSURE; INTRAOCULAR-LENS IMPLANTATION; LASER PERIPHERAL IRIDOTOMY; ULTRASOUND BIOMICROSCOPY; PHACOEMULSIFICATION; GLAUCOMA; SURGERY; CONFIGURATION; DEPTH; EYES	To evaluate the serial changes in anterior chamber depth (ACD) and angle parameters early after cataract surgery using anterior segment optical coherence tomography (ASOCT). This was a retrospective chart review, case-control study; 150 eyes of 106 patients who underwent cataract surgery. Based on ACD and angle findings, the eyes were classified into two groups, open-angle eyes (87 eyes) and narrow-angle eyes (63 eyes). ASOCT was used to measure ACD and angle parameters (angle opening distance, angle recess area, trabecular iris space area, and trabecular iris angle (TIA [1]). Serial changes in each group were measured before and 1 day, 1 week, and 1 month after cataract surgery, and the differences between the two groups were compared. ACD and all angle parameters in both groups at each examination time after cataract surgery were significantly different from the preoperative values (p < 0.01). In addition, all angle parameters significantly differed between the two groups at each examination time after cataract surgery (p < 0.001). However, ACD after surgery was not significantly different, irrespective of ACD before surgery. ACD and TIA500 both showed significantly greater changes from before surgery to 1 day after surgery in narrow-angle eyes compared to open-angle eyes (p < 0.001). Cataract surgery increases ACD and all angle parameters early after the surgery. However, the degree of angle widening in narrow-angle eyes was not as much as that in open-angle eyes, suggesting that factors other than the lens influence the angle closure.	[Kasai, Kozue; Takahashi, Genichiro; Kumegawa, Koichi] Jikei Univ, Sch Med, Katsushika Med Ctr, Dept Ophthalmol,Katsushika Ku, Tokyo 1258506, Japan; [Kasai, Kozue; Dogru, Murat] Tokyo Dent Coll, Ichikawa Gen Hosp, Dept Ophthalmol, Chiba, Japan	Kasai, K (reprint author), Jikei Univ, Sch Med, Katsushika Med Ctr, Dept Ophthalmol,Katsushika Ku, 6-41-2 Aoto, Tokyo 1258506, Japan.	kozue_message@yahoo.co.jp					Aptel F, 2014, J REFRACT SURG, V30, P354, DOI 10.3928/1081597X-20140326-01; Muller M, 2006, J CATARACT REFR SURG, V32, P1803, DOI 10.1016/j.jcrs.2006.07.014; Memarzadeh F, 2007, AM J OPHTHALMOL, V144, P464, DOI 10.1016/j.ajo.2007.04.009; Gunning FP, 1998, J CATARACT REFR SURG, V24, P1347; Nolan WP, 2008, J GLAUCOMA, V17, P455, DOI 10.1097/IJG.0b013e3181650f31; Cleary G, 2010, J CATARACT REFR SURG, V36, P790, DOI 10.1016/j.jcrs.2009.11.028; Nonaka A, 2006, OPHTHALMOLOGY, V113, P437, DOI 10.1016/j.ophtha.2005.11.018; Roberts TV, 2000, J CATARACT REFR SURG, V26, P1012, DOI 10.1016/S0886-3350(00)00358-8; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Seki M, 2012, BRIT J OPHTHALMOL, V96, P1108, DOI 10.1136/bjophthalmol-2012-301496; Ang LPK, 2000, OPHTHALMOLOGY, V107, P2092, DOI 10.1016/S0161-6420(00)00360-2; Radhakrishnan S, 2005, ARCH OPHTHALMOL-CHIC, V123, P1053, DOI 10.1001/archopht.123.8.1053; Dawczynski J, 2007, EUR J OPHTHALMOL, V17, P363; Gazzard G, 2003, OPHTHALMOLOGY, V110, P630, DOI 10.1016/S0161-6420(02)01893-6; Kakoulidis K, 2011, Cesk Slov Oftalmol, V67, P111; Kim Martha, 2011, Korean J Ophthalmol, V25, P77, DOI 10.3341/kjo.2011.25.2.77; Kucumen RB, 2008, J CATARACT REFR SURG, V34, P1694, DOI 10.1016/j.jcrs.2008.05.049; Nonaka A, 2005, OPHTHALMOLOGY, V112, P974, DOI 10.1016/j.ophtha.2004.12.042; Park HYL, 2012, GRAEF ARCH CLIN EXP, V250, P1673, DOI 10.1007/s00417-012-1998-4; Pereira FAS, 2003, OPHTHALMOLOGY, V110, P1799, DOI 10.1016/S0161-6420(03)00623-7; Tai MC, 2010, J CATARACT REFR SURG, V36, P1758, DOI 10.1016/j.jcrs.2010.05.011; Yan Pi-song, 2009, Zhonghua Yan Ke Za Zhi, V45, P809	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	OCT	2015	253	10					1751	1756		10.1007/s00417-015-3135-7		6	Ophthalmology	Ophthalmology	CR5QC	WOS:000361397200016		
J	Shiba, T; Takahashi, M; Shiba, C; Hori, Y				Shiba, Tomoaki; Takahashi, Mao; Shiba, Chieko; Hori, Yuichi			Accurate evaluation of relationships among serum lipoprotein lipase mass, visceral fat, and retinal nerve fiber layer thickness	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Letter							HEAD		[Shiba, Tomoaki; Shiba, Chieko; Hori, Yuichi] Toho Univ, Sch Med, Dept Ophthalmol, Ota Ku, Tokyo 1438541, Japan; [Takahashi, Mao] Toho Univ, Sakura Med Ctr, Ctr Cardiovasc, Chiba 2748510, Japan	Shiba, T (reprint author), Toho Univ, Sch Med, Dept Ophthalmol, Ota Ku, 6-11-1 Omori Nishi, Tokyo 1438541, Japan.	tomoaki-s@med.toho-u.ac.jp					Saiki A, 2005, J ATHEROSCLER THROMB, V12, P163; Leung DYL, 2010, OPHTHALMOLOGY, V117, P471, DOI 10.1016/j.ophtha.2009.08.016; Watanabe H, 1999, ATHEROSCLEROSIS, V145, P45, DOI 10.1016/S0021-9150(99)00012-X; Shibata M, 2011, EXP EYE RES, V93, P818, DOI 10.1016/j.exer.2011.09.014; Endo Kei, 2004, J Atheroscler Thromb, V11, P341; Leung CKS, 2005, INVEST OPHTH VIS SCI, V46, P891, DOI 10.1167/iovs.04-1107; Shiba C, 2014, GRAEFES ARCH CLIN EX, DOI [10.1007/s00417-014-2898-6, DOI 10.1007/S00417-014-2898-6]	7	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	OCT	2015	253	10					1825	1826		10.1007/s00417-015-2995-1		2	Ophthalmology	Ophthalmology	CR5QC	WOS:000361397200030		
J	Wei, KM; Guo, S; Zeng, DZ; Xu, K; Li, KQ				Wei, Kaimin; Guo, Song; Zeng, Deze; Xu, Ke; Li, Keqiu			Exploiting Small World Properties for Message Forwarding in Delay Tolerant Networks	IEEE TRANSACTIONS ON COMPUTERS			English	Article						Delay tolerant networks; small-world phenomenon; relay node; social-aware routing	HUMAN-MOBILITY	In Delay Tolerant Networks (DTNs), the connections between mobile nodes are always disrupted and constant end-to-end paths rarely exist. In order to cope with these communication challenges, most existing DTN routing algorithms favour the "multi-hop forwarding" fashion where a message can be forwarded by multiple relay nodes in the hope that one of the employed relay nodes can deliver the message to the destination node. Since aggressively employing relay nodes may incur the intolerable delivery cost in DTNs, it is meaningful to design a cost-efficient routing algorithm that can achieve a high delivery performance. In this paper, we first design a novel delivery metric to measure the forwarding capability of nodes. Then, we utilize small-world properties to design the principles of relay node selection, e.g., limiting the number of relays and finding the appropriate relay nodes, and further develop a cost-efficient social-aware forwarding algorithm called TBSF. Extensive simulations on real mobility traces are conducted to evaluate the performance of TBSF, and the results demonstrate its efficiency and usefulness.	[Wei, Kaimin; Xu, Ke] Beihang Univ, State Key Lab Software Dev Environm, Beijing 100191, Peoples R China; [Guo, Song] Univ Aizu, Sch Comp Sci & Engn, Aizu Wakamatsu, Fukushima, Japan; [Zeng, Deze] China Univ Geosci, Sch Comp Sci, Wuhan 430074, Peoples R China; [Li, Keqiu] Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Peoples R China	Wei, KM (reprint author), Beihang Univ, State Key Lab Software Dev Environm, Beijing 100191, Peoples R China.	sguo@u-aizu.ac.jp; dazzae@gmail.com; kexu@nlsde.buaa.edu.cn; keqiu@dlut.edu.cn			National High Technology Research and Development Program of China (863 Program) [2012AA011005]; State Key Lab of Software Development Environment [SKLSDE-2011ZX-02]; Research Fund for the Doctoral Program of Higher Education of China [20111102110019]; NSFC [61432002, 61225010, 61402425]; Fundamental Research Funds for National University, China University of Geosciences, Wuhan [CUG14065, CUGL150829]	Our work was supported by the fund of the National High Technology Research and Development Program of China (863 Program)(Grant No. 2012AA011005), the fund of the State Key Lab of Software Development Environment (Grant No. SKLSDE-2011ZX-02) and Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20111102110019). Keqiu Li's work is supported by NSFC under Grant Nos. of 61432002 and 61225010. Deze Zeng's work was supported by the NSFC (Grant No. 61402425), the Fundamental Research Funds for National University, China University of Geosciences, Wuhan (Grant No. CUG14065, CUGL150829).	Wu J, 2014, IEEE T COMPUT, V63, P383, DOI 10.1109/TC.2012.209; Wei KM, 2014, IEEE COMMUN SURV TUT, V16, P556, DOI 10.1109/SURV.2013.042313.00103; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wei KM, 2013, J COMMUN NETW-S KOR, V15, P504, DOI 10.1109/JCN.2013.000090; Cacciapuoti AS, 2012, AD HOC NETW, V10, P1520, DOI 10.1016/j.adhoc.2011.07.006; Vastardis N, 2013, IEEE COMMUN SURV TUT, V15, P1355, DOI 10.1109/SURV.2012.060912.00108; Eagle N, 2006, PERS UBIQUIT COMPUT, V10, P255, DOI 10.1007/s00779-005-0046-3; Karagiannis T, 2010, IEEE T MOBILE COMPUT, V9, P1377, DOI 10.1109/TMC.2010.99; Chaintreau A, 2007, IEEE T MOBILE COMPUT, V6, P606, DOI 10.1109/TMC.2007.1060; Spyropoulos T, 2009, IEEE T MOBILE COMPUT, V8, P1132, DOI 10.1109/TMC.2008.172; Banerjee A, 2012, IEEE T VEH TECHNOL, V61, P2659, DOI 10.1109/TVT.2012.2197768; Cao Y, 2013, IEEE T VEH TECHNOL, V62, P2339, DOI 10.1109/TVT.2013.2238958; Dubois-Ferriere H., 2003, P 4 ACM INT S MOB AD, P257; Fall K., 2003, P ACM SIGCOMM, P27, DOI DOI 10.1145/863955.863960; Helmy A, 2003, IEEE COMMUN LETT, V7, P490, DOI 10.1109/LCOMM.2003.818887; HUI P, 2008, P 9 ACM INT S MOB AD, P241, DOI DOI 10.1145/1374618.1374652; Li F., 2009, P 6 ANN IEEE COMM SO, P1, DOI 10.1109/ICUT.2009.5405702; Li Z., 2012, IEEE WIREL COMMUN, V1, P93; Meroni P., 2008, DATA SET UNIMI PMTR; Milgram S., 1967, PSYCHOL TODAY, V2, P60, DOI DOI 10.1145/335305.335325; Mtibaa A., 2010, P IEEE INFOCOM, P1, DOI DOI 10.1109/INFCOM.2010.5462261; Nguyen A.-D., 2012, P ACM INT C MOD AN S, P377; Polat BK, 2011, PERVASIVE MOB COMPUT, V7, P189, DOI 10.1016/j.pmcj.2011.01.002; Scott J., 2009, DATA SET CAMBRIDGE H; Vahdat A., 2002, CS200006 DUK U; Wang X. F., 2003, IEEE CIRCUITS SYSTEM, V3, P6, DOI DOI 10.1109/MCAS.2003.1228503; Wei K., 2013, P IEEE ICCCN, P1; Wu J., 2013, P IEEE INFOCOM, P138; Zhao JC, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.016105	29	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	0018-9340	1557-9956		IEEE T COMPUT	IEEE Trans. Comput.	OCT	2015	64	10					2809	2818		10.1109/TC.2015.2389807		10	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	CR6TM	WOS:000361480400007		
J	Namba, K; Lombardi, F				Namba, Kazuteru; Lombardi, Fabrizio			Parallel Decodable Two-Level Unequal Burst Error Correcting Codes	IEEE TRANSACTIONS ON COMPUTERS			English	Article						Error correcting code (ECC); unequal error protection (UEP) code; burst error correction; parallel decoder	PROTECTION CODES	Approximate (or inexact) computing is an attractive paradigm for digital processing at nanometric scales for applications in which imprecision in computation can be tolerated for improvements in other computational figures of merit, such as power consumption, circuit complexity and delay. The same principles of approximate computing are investigated in this manuscript for storage protection using an unequal protection code (UEP). In the proposed UEP code, the codeword is divided into two partitions; these partitions have different error protection functions. This paper presents a new class of two-level burst error correcting UEP codes and its parallel decoder. The proposed code is more efficient than an existing code in term of code rate, area and power consumption for the parallel decoder.	[Namba, Kazuteru] Chiba Univ, Grad Sch Adv Integrat Sci, Chiba, Japan; [Lombardi, Fabrizio] Northeastern Univ, Dept Elect & Comp Engn, Boston, MA 02115 USA	Namba, K (reprint author), Chiba Univ, Grad Sch Adv Integrat Sci, Chiba, Japan.	namba@ieee.org; lombardi@ece.neu.edu					Lu SL, 2004, COMPUTER, V37, P67; Satoh S, 2000, IEEE ELECTR DEVICE L, V21, P310, DOI 10.1109/55.843160; MASNICK B, 1967, IEEE T INFORM THEORY, V13, P600, DOI 10.1109/TIT.1967.1054054; Liang JH, 2013, IEEE T COMPUT, V62, P1760, DOI 10.1109/TC.2012.146; GILBERT EN, 1960, AT&T TECH J, V39, P1253; Du K., 2012, P DATE, P1257; Dutta A., 2007, P 22 IEEE INT S DEF, P3; Dutta A., 2012, P IEEE IFIP 20 INT C, P287; Fujiwara E., 2006, CODE DESIGN DEPENDAB; Gupta S. N., 1975, JMATH SCI, V10, P21; Gupta V., 2011, P INT S LOW POW EL D, P409; Han JM, 2013, PROCEEDINGS OF 2013 CHINA INTERNATIONAL CONFERENCE ON INSURANCE AND RISK MANAGEMENT, P1; Namba K, 2001, IEEE INT SYMP DEFECT, P299; Palem K. V., 2009, P CASES, P1, DOI 10.1145/1629395.1629397; Palem K. V., 2003, P INT C COMP ARCH SY, P113, DOI 10.1145/951710.951712; Venkatesan R, 2011, 2011 IEEE/ACM INTERNATIONAL CONFERENCE ON COMPUTER-AIDED DESIGN (ICCAD), P667, DOI [10.1109/ICCAD.2011.6105401, 10.1109/ICCSN.2011.6014980]; Yang XB, 2011, 2011 IEEE/ACM INTERNATIONAL CONFERENCE ON COMPUTER-AIDED DESIGN (ICCAD), P21; Yuan DF, 2000, IEEE WCNC, P1253	18	1	1	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	0018-9340	1557-9956		IEEE T COMPUT	IEEE Trans. Comput.	OCT	2015	64	10					2902	2911		10.1109/TC.2014.2378290		10	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	CR6TM	WOS:000361480400014		
J	Hayashi, M				Hayashi, Masahito			Quantum Wiretap Channel With Non-Uniform Random Number and Its Exponent and Equivocation Rate of Leaked Information	IEEE TRANSACTIONS ON INFORMATION THEORY			English	Article						Exponential rate; non-asymptotic setting; secret key agreement; universal hash function; quantum wiretap channel	PRIVACY AMPLIFICATION; CLASSICAL CAPACITY; BROADCAST CHANNELS; STRONG CONVERSE; STEINS LEMMA; ENTROPY	A usual code for quantum wiretap channel requires an auxiliary random variable subject to the perfect uniform distribution. However, it is difficult to prepare such an auxiliary random variable. We propose a code that requires only an auxiliary random variable subject to a non-uniform distribution instead of the perfect uniform distribution. Further, we evaluate the exponential decreasing rate of leaked information and derive its equivocation rate. For practical constructions, we also discuss the security when our code consists of a linear error correcting code.	[Hayashi, Masahito] Nagoya Univ, Grad Sch Math, Nagoya, Aichi 464860, Japan; [Hayashi, Masahito] Natl Univ Singapore, Ctr Quantum Technol, Singapore 117548, Singapore	Hayashi, M (reprint author), Natl Univ Singapore, Ctr Quantum Technol, Singapore 117548, Singapore.	masahito@math.nagoya-u.ac.jp			National Institute of Information and Communication Technology, Japan; MEXT [20686026]; Singapore Ministry of Education; National Research Foundation through the Research Centres of Excellence programme;  [23246071]	M. Hayashi was supported in part by the National Institute of Information and Communication Technology, Japan, in part by the Grant-in-Aid for Scientific Research (A) under Grant 23246071, in part by the Grant-in-Aid for Young Scientists (A) through MEXT under Grant 20686026, in part by the Singapore Ministry of Education, and in part by the National Research Foundation through the Research Centres of Excellence programme. This paper was presented at the IEEE International Symposium on Information Theory.	Tal I, 2013, IEEE INT SYMP INFO, P1561, DOI 10.1109/ISIT.2013.6620489; Hayashi M, 2009, IEEE T INFORM THEORY, V55, P4947, DOI 10.1109/TIT.2009.2030478; Hayashi M, 2013, IEEE T INFORM THEORY, V59, P7728, DOI 10.1109/TIT.2013.2278971; Muller-Lennert M, 2013, J MATH PHYS, V54, DOI 10.1063/1.4838856; CARTER JL, 1979, J COMPUT SYST SCI, V18, P143, DOI 10.1016/0022-0000(79)90044-8; Hayashi M, 2006, IEEE T INFORM THEORY, V52, P1562, DOI 10.1109/TIT.2006.871040; Hayashi M, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.012329; CSISZAR I, 1978, IEEE T INFORM THEORY, V24, P339, DOI 10.1109/TIT.1978.1055892; Devetak I, 2005, IEEE T INFORM THEORY, V51, P44, DOI 10.1109/TIT.2004.839515; Hayashi M, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.022307; HAN TS, 1993, IEEE T INFORM THEORY, V39, P752, DOI 10.1109/18.256486; Tsurumaru T, 2013, IEEE T INFORM THEORY, V59, P4700, DOI 10.1109/TIT.2013.2250576; Winter A, 2003, LECT NOTES COMPUT SC, V2898, P35; Polyanskiy Y, 2010, IEEE T INFORM THEORY, V56, P2307, DOI 10.1109/TIT.2010.2043769; Devetak I, 2005, COMMUN MATH PHYS, V256, P287, DOI 10.1007/s00220-005-1317-6; Frank RL, 2013, J MATH PHYS, V54, DOI 10.1063/1.4838835; Hayashi M, 2011, IEEE T INFORM THEORY, V57, P3989, DOI 10.1109/TIT.2011.2110950; Wilde MM, 2014, COMMUN MATH PHYS, V331, P593, DOI 10.1007/s00220-014-2122-x; WYNER AD, 1975, AT&T TECH J, V54, P1355; Bellare M., 2012, LECT NOTES COMPUTER, V7417, P294; Bloch M., P IEEE IN PRESS; Csiszar I., 1996, Problems of Information Transmission, V32; Ekrem E, 2012, IEEE T INFORM THEORY, V58, P5699, DOI 10.1109/TIT.2012.2204534; Gallager R.G., 1968, INFORM THEORY RELIAB; Hayashi M, 2015, COMMUN MATH PHYS, V333, P335, DOI 10.1007/s00220-014-2174-y; Hayashi M, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.062301; Hayashi M., 2012, P 50 ANN ALL C COMM, P954; Hayashi M, 2002, J PHYS A-MATH GEN, V35, P10759, DOI 10.1088/0305-4470/35/50/307; Hayashi M, 2014, IEEE T INFORM THEORY, V60, P6702, DOI 10.1109/TIT.2014.2337884; Hayashi Masahito, 2006, QUANTUM INFORM INTRO; KORNER J, 1980, IEEE T INFORM THEORY, V26, P670, DOI 10.1109/TIT.1980.1056275; Krawczyk H., 1994, LECT NOTES COMPUTER, V839, P129; Ling C, 2014, IEEE T INFORM THEORY, V60, P6399, DOI 10.1109/TIT.2014.2343226; Ogawa T, 2000, IEEE T INFORM THEORY, V46, P2428, DOI 10.1109/18.887855; Ozel O., 2011, P 49 ANN ALL C ALL H, P1120; Rathi V., 2011, Proceedings of the 2011 IEEE International Symposium on Information Theory - ISIT, DOI 10.1109/ISIT.2011.6033992; Renner R., 2005, SECURITY QUANTUM KEY; Tessaro S., 2012, 2012022 CRYPT EPRINT; Tomamichel M., 2014, CORRELATION DETECTIO; Tyagi H., 2014, SEMANTICALLY SECURE; Watanabe S, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.012326	41	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9448	1557-9654		IEEE T INFORM THEORY	IEEE Trans. Inf. Theory	OCT	2015	61	10					5595	5622		10.1109/TIT.2015.2464215		28	Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	CR6VT	WOS:000361486800025		
J	Koshijima, K; Hino, H; Murata, N				Koshijima, Kensuke; Hino, Hideitsu; Murata, Noboru			Change-Point Detection in a Sequence of Bags-of-Data	IEEE TRANSACTIONS ON KNOWLEDGE AND DATA ENGINEERING			English	Article						Change-point detection; entropy estimator; Earth Mover's Distance; anomaly detection	TIME-SERIES; ALGORITHM	In this paper, the limitation that is prominent in most existing works of change-point detection methods is addressed by proposing a nonparametric, computationally efficient method. The limitation is that most works assume that each data point observed at each time step is a single multi-dimensional vector. However, there are many situations where this does not hold. Therefore, a setting where each observation is a collection of random variables, which we call a bag of data, is considered. After estimating the underlying distribution behind each bag of data and embedding those distributions in a metric space, the change-point score is derived by evaluating how the sequence of distributions is fluctuating in the metric space using a distance-based information estimator. Also, a procedure that adaptively determines when to raise alerts is incorporated by calculating the confidence interval of the change-point score at each time step. This avoids raising false alarms in highly noisy situations and enables detecting changes of various magnitudes. A number of experimental studies and numerical examples are provided to demonstrate the generality and the effectiveness of our approach with both synthetic and real datasets.	[Koshijima, Kensuke; Murata, Noboru] Waseda Univ, Sch Sci & Engn, Shinjuku Ku, Tokyo 169, Japan; [Koshijima, Kensuke; Murata, Noboru] Inst Syst Informat Technol & Nanotechnol ISIT, Sawara Ku, Fukuoka, Japan; [Hino, Hideitsu] Univ Tsukuba, Dept Comp Sci, Tsukuba, Ibaraki, Japan	Koshijima, K (reprint author), Waseda Univ, Sch Sci & Engn, Shinjuku Ku, 3-4-1 Ohkubo, Tokyo 169, Japan.	kensuke.koshijima@gmail.com; hinohide@cs.tsukuba.ac.jp; noboru.murata@eb.waseda.ac.jp		Murata, Noboru/0000-0002-4258-6877	JSPS KAKENHI [25120009, 25870811, 26120504]; Proactive Response Against Cyber-attacks Through International Collaborative Exchange (PRACTICE), Ministry of Internal Affairs and Communications, Japan	The authors would like to express our special thanks to the editor and reviewers whose comments led to valuable improvements of the manuscripts. The authors are also grateful to Ken Takano and Takahiro Nukushina for helping programming. Part of this work was supported by JSPS KAKENHI Nos. 25120009, 25870811, and 26120504, and by Proactive Response Against Cyber-attacks Through International Collaborative Exchange (PRACTICE), Ministry of Internal Affairs and Communications, Japan.	Akoglu L., 2010, P ARM SCI C, P77; Sun JM, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P687; Liu S, 2013, NEURAL NETWORKS, V43, P72, DOI 10.1016/j.neunet.2013.01.012; Moskvina V, 2003, COMMUN STAT-SIMUL C, V32, P319, DOI 10.1081/SAC-120017494; Rubner Y, 2000, INT J COMPUT VISION, V40, P99, DOI 10.1023/A:1026543900054; Desobry F, 2005, IEEE T SIGNAL PROCES, V53, P2961, DOI 10.1109/TSP.2005.851098; Arroyo J, 2009, INT J FORECASTING, V25, P192, DOI 10.1016/j.ijforecast.2008.07.003; Bhattacharyya S, 2011, DECIS SUPPORT SYST, V50, P602, DOI 10.1016/j.dss.2010.08.008; RUBIN DB, 1981, ANN STAT, V9, P130, DOI 10.1214/aos/1176345338; Patcha A, 2007, COMPUT NETW, V51, P3448, DOI 10.1016/j.comnet.2007.02.001; Gustafsson F, 1996, IEEE T AUTOMAT CONTR, V41, P66, DOI 10.1109/9.481608; Reiss A, 2012, IEEE INT SYM WRBL CO, P108, DOI 10.1109/ISWC.2012.13; Basseville M., 1993, DETECTION ABRUPT CHA; Brockwell P.J., 2009, TIME SERIES THEORY M; Chandola V, 2009, ACM COMPUT SURV, V41, DOI 10.1145/1541880.1541882; Csurka G., 2004, WORKSH STAT LEARN CO, V1, P1, DOI DOI 10.1234/12345678; DAVY M, 2002, ACOUST SPEECH SIG PR, P1313; Fujimaki R., 2005, P 11 ACM SIGKDD INT, P401, DOI 10.1145/1081870.1081917; Hino H, 2013, NEURAL NETWORKS, V46, P260, DOI 10.1016/j.neunet.2013.06.005; Ide T, 2004, P 10 ACM SIGKDD INT, DOI 10.1145/1014052.1014102; Ide T, 2007, PROCEEDINGS OF THE SEVENTH SIAM INTERNATIONAL CONFERENCE ON DATA MINING, P515; Klimt B, 2004, LECT NOTES COMPUT SC, V3201, P217; Kohonen T., 2001, LEARNING VECTOR QUAN; Levina E., 2001, P IEEE 8 INT C COMP, V2, P251, DOI DOI 10.1109/ICCV.2001.937632; Murata N., 2013, P 6 WORKSH INF THEOR, P22; Takeuchi J, 2006, IEEE T KNOWL DATA EN, V18, P482, DOI 10.1109/TKDE.2006.1599387	26	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1041-4347	1558-2191		IEEE T KNOWL DATA EN	IEEE Trans. Knowl. Data Eng.	OCT 1	2015	27	10					2632	2644		10.1109/TKDE.2015.2426693		13	Computer Science, Artificial Intelligence; Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	CR3PL	WOS:000361245300004		
J	Kalegele, K; Sasai, K; Takahashi, H; Kitagata, G; Kinoshita, T				Kalegele, Khamisi; Sasai, Kazuto; Takahashi, Hideyuki; Kitagata, Gen; Kinoshita, Tetsuo			Four Decades of Data Mining in Network and Systems Management	IEEE TRANSACTIONS ON KNOWLEDGE AND DATA ENGINEERING			English	Article						Data Mining; network and systems management; machine learning	WIRELESS SENSOR NETWORKS; INTRUSION-DETECTION; ANOMALY DETECTION; FAULT-DETECTION; INTERNET; MODEL; GENERATION; ALGORITHM; FRAMEWORK; FAILURE	How has the interdisciplinary data mining field been practiced in Network and Systems Management (NSM)? In Science and Technology, there is a wide use of data mining in areas like bioinformatics, genetics, Web, and, more recently, astroinformatics. However, the application in NSM has been limited and inconsiderable. In this article, we provide an account of how data mining has been applied in managing networks and systems for the past four decades, presumably since its birth. We look into the field's applications in the key NSM activities-discovery, monitoring, analysis, reporting, and domain knowledge acquisition. In the end, we discuss our perspective on the issues that are considered critical for the effective application of data mining in the modern systems which are characterized by heterogeneity and high dynamism.	[Kalegele, Khamisi] Nelson Mandela African Inst Sci & Technol, Sch Computat & Commun Sci & Engn, Arusha, Tanzania; [Sasai, Kazuto; Takahashi, Hideyuki; Kitagata, Gen; Kinoshita, Tetsuo] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi 9808577, Japan	Kalegele, K (reprint author), Nelson Mandela African Inst Sci & Technol, Sch Computat & Commun Sci & Engn, Arusha, Tanzania.	khamisi.kalegele@nm-aist.ac.tz; kazuto@riec.tohoku.ac.jp; hideyuki@riec.tohoku.ac.jp; minatsu@riec.tohoku.ac.jp; kino@riec.tohoku.ac.jp					Agrawal R., 1994, P 20 INT C VER LARG, V1215, P487; Agrawal R., 1993, P 1993 ACM SIGMOD IN, V22, P207, DOI DOI 10.1145/170035.170072; Al-Naamany A. M., 2005, Journal of Network and Systems Management, V13, DOI 10.1007/s10922-005-1843-8; Andrzejak A., 2005, Journal of Network and Systems Management, V13, DOI 10.1007/s10922-005-4440-y; Fu S, 2007, SYM REL DIST SYST, P175; Ma S, 2002, IEEE J SEL AREA COMM, V20, P726; [Anonymous], 2012, PROC INT CONF SOFTW; Fu QA, 2009, IEEE DATA MINING, P149, DOI 10.1109/ICDM.2009.60; ROOS JG, 1994, 10TH ANNIVERSARY, IMTC/94 - ADVANCED TECHNOLOGIES IN I & M, CONFERENCE PROCEEDINGS, VOLS 1-3 AND SUPPLEMENT, P1115; Wang W, 2013, IEEE T SERV COMPUT, V6, P76, DOI 10.1109/TSC.2011.34; Jiang GF, 2006, IEEE T DEPEND SECURE, V3, P312, DOI 10.1109/TDSC.2006.52; Ye YF, 2010, IEEE T SYST MAN CY C, V40, P298, DOI 10.1109/TSMCC.2009.2037978; HOMCE GT, 1989, IEEE T IND APPL, V25, P986, DOI 10.1109/28.44232; Ohta S, 2008, J NETW SYST MANAG, V16, P399, DOI 10.1007/s10922-008-9102-4; Makanju A, 2013, 2013 IFIP/IEEE INTERNATIONAL SYMPOSIUM ON INTEGRATED NETWORK MANAGEMENT (IM 2013), P962; Kalegele K, 2013, 2013 INTERNATIONAL JOINT CONFERENCE ON AWARENESS SCIENCE AND TECHNOLOGY & UBI-MEDIA COMPUTING (ICAST-UMEDIA), P226; Kiciman E, 2005, IEEE T NEURAL NETWOR, V16, P1027, DOI 10.1109/TNN.2005.853411; Au WH, 2003, IEEE T EVOLUT COMPUT, V7, P532, DOI 10.1109/TEVC.2003.819264; Ahmed AA, 2013, J NETW SYST MANAG, V21, P218, DOI 10.1007/s10922-012-9236-2; Sasisekharan R, 1996, IEEE EXPERT, V11, P37, DOI 10.1109/64.482956; Bhuyan MH, 2014, IEEE COMMUN SURV TUT, V16, P303, DOI 10.1109/SURV.2013.052213.00046; [Anonymous], 2008, CISC VIS NETW IND GL; Li T, 2010, IEEE T SYST MAN CY A, V40, P90, DOI 10.1109/TSMCA.2009.2030161; Zhang J, 2008, IEEE T SYST MAN CY C, V38, P649, DOI 10.1109/TSMCC.2008.923876; Fu XY, 2012, SYM REL DIST SYST, P71, DOI 10.1109/SRDS.2012.40; Makanju A, 2012, IEEE T KNOWL DATA EN, V24, P1921, DOI 10.1109/TKDE.2011.138; Ramadas M, 2003, LECT NOTES COMPUT SC, V2820, P36; Qin XZ, 2003, LECT NOTES COMPUT SC, V2820, P73; Mahmood AN, 2008, IEEE T KNOWL DATA EN, V20, P752, DOI 10.1109/TKDE.2007.190725; Paradis L, 2007, J NETW SYST MANAG, V15, P171, DOI 10.1007/s10922-007-9062-0; Conradie L, 1996, THIRD INTERNATIONAL WORKSHOP ON SERVICES IN DISTRIBUTED AND NETWORKED ENVIRONMENTS, PROCEEDINGS, P10; Xu YM, 2013, J NETW SYST MANAG, V21, P384, DOI 10.1007/s10922-012-9237-1; Lo D, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P557; GhasemiGol M, 2010, J NETW SYST MANAG, V18, P265, DOI 10.1007/s10922-010-9165-x; Mah BA, 1997, IEEE INFOCOM SER, P592; Tiwana MI, 2014, J NETW SYST MANAG, V22, P235, DOI 10.1007/s10922-013-9284-2; Bozdogan C, 2013, 2013 IFIP/IEEE INTERNATIONAL SYMPOSIUM ON INTEGRATED NETWORK MANAGEMENT (IM 2013), P1233; Hood CS, 1997, IEEE T RELIAB, V46, P333, DOI 10.1109/24.664004; Du XJ, 2006, J NETW SYST MANAG, V14, P243, DOI 10.1007/s10922-006-9027-8; Lee YJ, 2013, IEEE T KNOWL DATA EN, V25, P1460, DOI 10.1109/TKDE.2012.99; Murray A, 1997, IEEE T SIGNAL PROCES, V45, P2821, DOI 10.1109/78.650108; Schultz MG, 2001, P IEEE S SECUR PRIV, P38, DOI 10.1109/SECPRI.2001.924286; Zhuang WW, 2012, IEEE T SYST MAN CY C, V42, P1784, DOI 10.1109/TSMCC.2012.2222025; Yan H, 2012, IEEE ACM T NETWORK, V20, P1734, DOI 10.1109/TNET.2012.2188837; Jiang GF, 2006, CLUSTER COMPUT, V9, P385, DOI 10.1007/s10586-006-0008-1; Bashar A, 2014, J NETW SYST MANAG, V22, P174, DOI 10.1007/s10922-013-9289-x; Nunez M, 2002, IEEE J SEL AREA COMM, V20, P736, DOI 10.1109/JSAC.2002.1003040; Mabu S, 2011, IEEE T SYST MAN CY C, V41, P130, DOI 10.1109/TSMCC.2010.2050685; Xu Q, 2012, IEEE INTELL SYST, V27, P44; Dentcheva D, 1998, LECT NOTES ECON MATH, V458, P22; Arlitt M., 1995, SYNTHETIC WORKLOAD M; Barbara D, 2001, SIGMOD RECORD, V30, P15; Bhattacharyya D. K., 2013, NETWORK ANOMALY DETE; Bhuyan M. H., 2013, COMPUTER J; Brodie M., 2005, Journal of Network and Systems Management, V13, DOI 10.1007/s10922-005-4443-8; Cabrera J. B. D., 2002, Journal of Network and Systems Management, V10, DOI 10.1023/A:1015910917349; Chakrabarti S., 2006, ACM SIGKDD; Chao C. S., 2001, Journal of Network and Systems Management, V9, DOI 10.1023/A:1011315125608; CHOI H.-K., 1999, P 7 INT C NETW PROT, P327; Cohen W W, 1995, ICML, V95, P115; Cunningham Hamish, 2002, 40 ANN M ASS COMP LI; Dua S, 2013, DATA MINING FOR BIOINFORMATICS, P1; Eick S. G., 1993, Proceedings Visualization '93. (Cat. No.93CH3354-8), DOI 10.1109/VISUAL.1993.398870; Ertoz L., 2004, NEXT GENERATION DATA; Freire E., 2007, P LAT AM NETW OP MAN, P57; Gao F., 2000, P INT C COMM TECHN, V1, P91; Gardner R., 1997, P INT C INF COMM SIG, V3, P1423, DOI 10.1109/ICICS.1997.652226; Garg P. K., 2003, Journal of Network and Systems Management, V11, DOI 10.1023/A:1023723100328; Garroppo R G, 2011, IEEE Transactions on Network and Service Management, V8, DOI 10.1109/TNSM.2011.011211.1000010; Gaspery L., 1999, P GLOB TEL C, V3, P1997; Gorodetsky V., 2008, P IEEE WIC ACM INT C, V3, P562; Hall M., 2009, ACM SIGKDD EXPLORATI, V11, P10, DOI DOI 10.1145/1656274.1656278; Han J., 2006, MORGAN KAUFMANN SERI; Helmer G. G., 1998, P IEEE INF TECHN C S, P121; Hu Y., 2005, Journal of Network and Systems Management, V13, DOI 10.1007/s10922-005-6264-1; Jiang Y., 2013, IEEE T NETWORK MANAG, V10, P312; Kalegele K., 2013, P IEICE TECH COMM MO, P1; Kalegele K., 2012, INT J INTELL SCI, V2, P190; Kalegele Khamisi, 2013, International Journal of Intelligent Systems Technologies and Applications, V12; Kangping L., 2000, P 3 WORLD C INT CONT, V1, P715; Kirov N., 2011, REV NAT CTR DIGITIZA, V19, P7; Knudson D. O., 1978, Proceedings of COMPSAC 78 Computer Software and Applications Conference; LaPatra J. W., 1988, P 22 AS C SIGN SYST, V1, P92; Li L., 2010, P 3 INT C ADV COMP T, V5, P184; Li W., 2005, P ICSC C COMP INT ME, P37; Li Y., 2007, P 2007 INF ASS SEC W, P221; Masud M. M., 2008, ACM T MANAGE INF SYS, V2, P16; Mattison R., 1997, DATA WAREHOUSING DAT; Murayama Y, 1997, PROCEEDINGS OF THE SECOND IFCIS INTERNATIONAL CONFERENCE ON COOPERATIVE INFORMATION SYSTEMS - COOPIS'97, P47, DOI 10.1109/COOPIS.1997.613801; Nunez M., 2006, IEEE J SEL AREA COMM, V20, P736; Oh S. H., 2005, P 3 ACIS INT C SOFTW, P220; Park S., 2000, P AC IND WORK C RES, P331; PEEL C, 1992, PROCEEDINGS OF THE 1992 IEEE INTERNATIONAL SYMPOSIUM ON INTELLIGENT CONTROL, P560, DOI 10.1109/ISIC.1992.225045; Prismmicrosys, 2007, EV KNOWL; Rouillard JP, 2004, USENIX Association Proceedings of the Eighteenth Large Installation System Administration Conference, P133; Schoorl A., 1999, P IEEE PAC RIM C COM, P593; Sperotto A., 2012, IEEE Transactions on Network and Service Management, V9, DOI 10.1109/TNSM.2012.031512.110146; Sun C., 2013, P 9 JOINT M FDN SOFT, P576; Tang Y., 2006, P 1 INT C COMM NETW, P1; Thottan M., 1999, Journal of Network and Systems Management, V7, DOI 10.1023/A:1018713732192; Verma D. C., 2009, PRINCIPLES COMPUTER; Xu W., 2010, P 27 INT C MACH LEAR, P37; Yang T., 2005, P INT C NEUR NETW BR, V2, P1045; Youdong Z., 2008, P 5 INT C FUZZ SYST, V4, P445; Zarei R., 2014, J NETW SYST MANAG, V23, P89; Zarei R, 2015, J NETW SYST MANAG, V23, P89, DOI 10.1007/s10922-013-9279-z; Zhang Z., 2001, P 2001 IEEE WORKSH I, P85; Zhao K., 2006, P 12 ACM SIGKDD INT, P892, DOI 10.1145/1150402.1150524; Zhou B., 2009, ACM T KNOWL DISCOV D, V3, DOI 10.1145/1552303.1552306	109	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1041-4347	1558-2191		IEEE T KNOWL DATA EN	IEEE Trans. Knowl. Data Eng.	OCT 1	2015	27	10					2700	2716		10.1109/TKDE.2015.2426713		17	Computer Science, Artificial Intelligence; Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	CR3PL	WOS:000361245300009		
J	Dinh, ND; Tuyen, ND; Fujita, G; Funabashi, T				Nguyen Duy Dinh; Nguyen Duc Tuyen; Fujita, Goro; Funabashi, Toshihisa			Adaptive notch filter solution under unbalanced and/or distorted point of common coupling voltage for three-phase four-wire shunt active power filter with sinusoidal utility current strategy	IET GENERATION TRANSMISSION & DISTRIBUTION			English	Article							NONSINUSOIDAL LINE VOLTAGES; NONIDEAL MAINS VOLTAGE; REAL-TIME; COMPENSATION; SYSTEMS; LOADS; SYNCHRONIZATION; SIGNAL	In this study, the three-phase four-wire shunt active power filter (ShAPF) dealing with non-ideal point of common coupling (PCC) voltages will be presented. The instantaneous power theory is applied to design the ShAPF controller which shows reliable performances. An adaptive notch filter (ANF) is proposed to process those unbalanced and/or distorted PCC voltage. The power balance among utility, load and ShAPF while applying ANF is clarified by an in-depth explanation. The simulation results prove that the ANF can successfully facilitate the ShAPF in terms of compensating unbalanced/distorted current of loads under a non-ideal PCC voltage circumstance.	[Nguyen Duy Dinh; Nguyen Duc Tuyen; Fujita, Goro] Shibaura Inst Technol, Power Syst Lab, Tokyo 1358548, Japan; [Funabashi, Toshihisa] Nagoya Univ, EcoTopia, Nagoya, Aichi 4648603, Japan	Tuyen, ND (reprint author), Shibaura Inst Technol, Power Syst Lab, Tokyo 1358548, Japan.	m609504@shibaura-it.ac.jp			Ministry of the Environment, Japan [F-1201]	This work was financially supported by the Environment Research and Technology Development Fund (F-1201) of the Ministry of the Environment, Japan.	Aderes M., 1997, IEEE T POWER ELECTR, V12, P318; Mojiri M, 2004, IEEE T AUTOMAT CONTR, V49, P314, DOI 10.1109/TAC.2003.821414; Yazdani D, 2009, IEEE T POWER ELECTR, V24, P674, DOI 10.1109/TPEL.2008.2010321; Ucar M, 2008, ELECTR POW SYST RES, V78, P58, DOI 10.1016/j.epsr.2006.12.008; WATANABE EH, 1993, IEEE T POWER DELIVER, V8, P697, DOI 10.1109/61.216877; Abdusalam M, 2009, ELECTR POW SYST RES, V79, P759, DOI 10.1016/j.epsr.2008.10.009; Kale M, 2005, ELECTR POW SYST RES, V74, P363, DOI 10.1016/j.epsr.2004.10.014; Mojiri M, 2007, IEEE T INSTRUM MEAS, V56, P2470, DOI 10.1109/TIM.2007.908631; RIEDLE BD, 1986, IEEE T AUTOMAT CONTR, V31, P316, DOI 10.1109/TAC.1986.1104263; Mojiri M, 2007, IEEE T CIRCUITS-II, V54, P338, DOI 10.1109/TCSII.2006.889724; Kim H, 2002, IEEE T POWER ELECTR, V17, P701, DOI 10.1109/TPEL.2002.802185; Lascu C, 2007, IEEE T POWER ELECTR, V22, P1826, DOI 10.1109/TPEL.2007.904060; Singh B, 1999, IEEE T IND ELECTRON, V46, P960, DOI 10.1109/41.793345; Yazdani D, 2008, IEEE T POWER ELECTR, V23, P2181, DOI 10.1109/TPEL.2008.926045; Akagi H, 1996, IEEE T IND APPL, V32, P1312, DOI 10.1109/28.556633; Biricik S, 2014, IET POWER ELECTRON, V7, P1895, DOI 10.1049/iet-pel.2013.0924; Dixon JW, 1995, IEEE T IND ELECTRON, V42, P636, DOI 10.1109/41.475504; Ghamri A, 2012, ELECTR POW COMPO SYS, V40, P383, DOI 10.1080/15325008.2011.639127; Chang GW, 2005, IEE P-ELECT POW APPL, V152, P182, DOI 10.1049/ip-epa:20045017; Chen CC, 2000, IEEE T POWER DELIVER, V15, P1258, DOI 10.1109/61.891512; El-Habrouk M, 2000, IEE P-ELECT POW APPL, V147, P403, DOI 10.1049/ip-epa:20000522; Huang S.J., 1999, ELECTR POW SYST RES, V49, P125; Karimi-Ghartemani M, 2004, IEEE T POWER SYST, V19, P1263, DOI 10.1109/TPWRS.2004.831280; Komatsu Y, 1999, INT J ELECTRON, V86, P1249, DOI 10.1080/002072199132789; Lin BR, 2004, IEEE T IND ELECTRON, V51, P1009, DOI 10.1109/TIE.2004.834960; Mojiri M, 2007, IEEE T SIGNAL PROCES, V55, P85, DOI 10.1109/TSP.2006.885686; Rafiei SMR, 2001, IEEE T POWER DELIVER, V16, P297, DOI 10.1109/61.915499; Rafiei SMR, 2002, IEEE T POWER DELIVER, V17, P815, DOI 10.1109/TPWRD.2002.1022809; AREDES M, 1995, IEEE T POWER DELIVER, V10, P1649, DOI 10.1109/61.400952; Yazdani D., 2009, THESIS QUEENS U KING	30	0	0	INST ENGINEERING TECHNOLOGY-IET	HERTFORD	MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND	1751-8687	1751-8695		IET GENER TRANSM DIS	IET Gener. Transm. Distrib.	OCT 1	2015	9	13					1580	1596		10.1049/iet-gtd.2014.1017		17	Engineering, Electrical & Electronic	Engineering	CR7IE	WOS:000361521600008		
J	Shiina, T; Yamada, Y; Aarnink, A; Suzuki, S; Masuya, A; Ito, S; Ido, D; Yamanaka, H; Iwatani, C; Tsuchiya, H; Ishigaki, H; Itoh, Y; Ogasawara, K; Kulski, JK; Blancher, A				Shiina, Takashi; Yamada, Yukiho; Aarnink, Alice; Suzuki, Shingo; Masuya, Anri; Ito, Sayaka; Ido, Daisuke; Yamanaka, Hisashi; Iwatani, Chizuru; Tsuchiya, Hideaki; Ishigaki, Hirohito; Itoh, Yasushi; Ogasawara, Kazumasa; Kulski, Jerzy K.; Blancher, Antoine			Discovery of novel MHC-class I alleles and haplotypes in Filipino cynomolgus macaques (Macaca fascicularis) by pyrosequencing and Sanger sequencing	IMMUNOGENETICS			English	Article						Cynomolgus macaque; Major histocompatibility complex; MHC; Polymorphism; Haplotype; Next generation sequencing; NGS; Sanger sequencing	MAJOR HISTOCOMPATIBILITY COMPLEX; PIG-TAILED MACAQUES; ASIAN POPULATIONS; RHESUS MACAQUES; HIGH-RESOLUTION; GENOMIC REGION; DIVERSITY; GENES; POLYMORPHISM; EVOLUTION	Although the low polymorphism of the major histocompatibility complex (MHC) transplantation genes in the Filipino cynomolgus macaque (Macaca fascicularis) is expected to have important implications in the selection and breeding of animals for medical research, detailed polymorphism information is still lacking for many of the duplicated class I genes. To better elucidate the degree and types of MHC polymorphisms and haplotypes in the Filipino macaque population, we genotyped 127 unrelated animals by the Sanger sequencing method and high-resolution pyrosequencing and identified 112 different alleles, 28 at cynomolgus macaque MHC (Mafa)-A, 54 at Mafa-B, 12 at Mafa-I, 11 at Mafa-E, and seven at Mafa-F alleles, of which 56 were newly described. Of them, the newly discovered Mafa-A8*01:01 lineage allele had low nucleotide similarities (< 86 %) with primate MHC class I genes, and it was also conserved in the Vietnamese and Indonesian populations. In addition, haplotype estimations revealed 17 Mafa-A, 23 Mafa-B, and 12 Mafa-E haplotypes integrated with 84 Mafa-class I haplotypes and Mafa-F alleles. Of these, the two Mafa-class I haplotypes, F/A/E/B-Hp1 and F/A/E/B-Hp2, had the highest haplotype frequencies at 10.6 and 10.2 %, respectively. This suggests that large scale genetic screening of the Filipino macaque population would identify these and other high-frequency Mafa-class I haplotypes that could be used as MHC control animals for the benefit of biomedical research.	[Shiina, Takashi; Yamada, Yukiho; Suzuki, Shingo; Masuya, Anri; Ito, Sayaka; Kulski, Jerzy K.] Tokai Univ, Sch Med, Div Basic Med Sci & Mol Med, Dept Mol Life Sci, Isehara, Kanagawa 2591143, Japan; [Yamada, Yukiho; Ido, Daisuke; Yamanaka, Hisashi] Ina Res Inc, Ina, Nagano 3994501, Japan; [Aarnink, Alice; Blancher, Antoine] Univ Toulouse 3, Hop Rangueil, Immunogenet Mol Lab, Immunol Lab,Fac Med Purpan, F-31059 Toulouse 9, France; [Iwatani, Chizuru; Tsuchiya, Hideaki] Shiga Univ Med Sci, Sch Med, Res Ctr Anim Life Sci, Otsu, Shiga 5202192, Japan; [Ishigaki, Hirohito; Itoh, Yasushi; Ogasawara, Kazumasa] Shiga Univ Med Sci, Dept Pathol, Otsu, Shiga 5202192, Japan; [Kulski, Jerzy K.] Univ Western Australia, Ctr Forens Sci, Nedlands, WA 6008, Australia	Shiina, T (reprint author), Tokai Univ, Sch Med, Div Basic Med Sci & Mol Med, Dept Mol Life Sci, 143 Shimokasuya, Isehara, Kanagawa 2591143, Japan.	tshiina@is.icc.u-tokai.ac.jp			MEXT KAKENHI [221S0002]; JSPS KAKENHI [21300155]; program "Research Center Network for Realization of Regenerative Medicine" in Japan Agency for Medical Research and Development (AMED); Adaptable and Seamless Technology transfer Program in AMED	We are grateful to Dr. Atsushi Toyoda at Center for Information Biology, Comparative Genomics Laboratory, National Institute of Genetics for making sequence data and Mr. Masayuki Tanaka, Mr. Hideki Hayashi, and Mr. Tadayuki Sato at the Education and Research Support Center, Research and Development Division, Tokai University for their technical support. This work was supported by MEXT KAKENHI (no. 221S0002), JSPS KAKENHI (no. 21300155), and was partially supported by the program "Research Center Network for Realization of Regenerative Medicine" in Japan Agency for Medical Research and Development (AMED) and from Adaptable and Seamless Technology transfer Program in AMED.	Aarnink A, 2011, IMMUNOGENETICS, V63, P703, DOI 10.1007/s00251-011-0550-8; Budde ML, 2010, IMMUNOGENETICS, V62, P773, DOI 10.1007/s00251-010-0481-9; Shiina T, 2004, TISSUE ANTIGENS, V64, P631, DOI 10.1111/j.1399-0039.2004.00327.x; Klimanskaya I, 2006, NATURE, V444, P481, DOI 10.1038/nature05142; Blancher A, 2006, IMMUNOGENETICS, V58, P269, DOI 10.1007/s00251-006-0102-9; Wiseman RW, 2009, NAT MED, V15, P1322, DOI 10.1038/nm.2038; Daza-Vamenta R, 2004, GENOME RES, V14, P1501, DOI 10.1101/gr.2134504; Muhl T, 2002, J IMMUNOL, V169, P3438; Karl JA, 2008, IMMUNOGENETICS, V60, P37, DOI 10.1007/s00251-007-0267-x; Wegner KM, 2009, MOL ECOL, V18, P1818, DOI 10.1111/j.1365-294X.2009.04173.x; Watanabe A, 2007, GENOMICS, V89, P402, DOI 10.1016/j.ygeno.2006.11.002; Kono A, 2014, J IMMUNOL, V192, P3239, DOI 10.4049/jimmunol.1302745; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Boyson JE, 1996, J IMMUNOL, V156, P4656; de Groot NG, 2012, IMMUNOGENETICS, V64, P615, DOI 10.1007/s00251-012-0617-1; Kulski JK, 2004, MOL BIOL EVOL, V21, P2079, DOI 10.1093/molbev/msh216; Tosi AJ, 2007, MOL PHYLOGENET EVOL, V42, P498, DOI 10.1016/j.ympev.2006.08.002; Kawamoto Y, 2008, J MED PRIMATOL, V37, P45, DOI 10.1111/j.1600-0684.2007.00225.x; Leuchte N, 2004, TISSUE ANTIGENS, V63, P529, DOI 10.1111/j.0001-2815.2004.0222.x; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1234, DOI 10.1093/nar/gks1140; O'Leary CE, 2009, IMMUNOGENETICS, V61, P689, DOI 10.1007/s00251-009-0397-4; Goodridge JP, 2013, J IMMUNOL, V191, P3553, DOI 10.4049/jimmunol.1300081; Shiina T, 2009, J HUM GENET, V54, P15, DOI 10.1038/jhg.2008.5; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Blancher A, 2008, J HERED, V99, P254, DOI 10.1093/jhered/esn003; Lafont BAP, 2003, J IMMUNOL, V171, P875; Kita YF, 2012, IMMUNOGENETICS, V64, P187, DOI 10.1007/s00251-011-0572-2; Gardner MB, 2008, ILAR J, V49, P220; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Babik W, 2009, MOL ECOL RESOUR, V9, P713, DOI 10.1111/j.1755-0998.2009.02622.x; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Otting N, 2005, P NATL ACAD SCI USA, V102, P1626, DOI 10.1073/pnas.0409084102; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Otting N, 2007, IMMUNOGENETICS, V59, P367, DOI 10.1007/s00251-007-0201-2; Kulski JK, 2002, IMMUNOL REV, V190, P95, DOI 10.1034/j.1600-065X.2002.19008.x; Anzai T, 2003, P NATL ACAD SCI USA, V100, P7708, DOI 10.1073/pnas.1230533100; Arikata M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037220; Blancher A, 2012, IMMUNOGENETICS, V64, P605, DOI 10.1007/s00251-012-0613-5; Blancher A, 2014, IMMUNOGENETICS, V66, P219, DOI 10.1007/s00251-014-0764-7; BOYSON JE, 1995, IMMUNOGENETICS, V41, P59; Campbell KJ, 2009, IMMUNOGENETICS, V61, P177, DOI 10.1007/s00251-008-0351-x; Ericsen AJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0478-z; Fuentes A, 2011, MONKEYS EDGE ECOLOGY; Karl JA, 2009, METHODS, V49, P11, DOI 10.1016/j.ymeth.2009.05.002; Kita YF, 2009, IMMUNOGENETICS, V61, P635, DOI 10.1007/s00251-009-0390-y; Krebs KC, 2005, J IMMUNOL, V175, P5230; Lafont BAP, 2004, IMMUNOGENETICS, V56, P142, DOI 10.1007/s00251-004-0663-4; Lawrence J, 2012, TISSUE ANTIGENS, V79, P306, DOI 10.1111/j.1399-0039.2011.01829.x; Pendley CJ, 2008, IMMUNOGENETICS, V60, P339, DOI 10.1007/s00251-008-0292-4; Piontkivska H, 2003, MOL BIOL EVOL, V20, P601, DOI 10.1093/molbev/msg064; Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sano K, 2006, TISSUE ANTIGENS, V67, P297, DOI 10.1111/j.1399-0039.2006.00577.x; Shiina T, 1999, IMMUNOL REV, V167, P193, DOI 10.1111/j.1600-065X.1999.tb01392.x; Shiina T, 2006, GENETICS, V173, P1555, DOI 10.1534/genetics.106.057034; Uda A, 2004, IMMUNOGENETICS, V56, P155, DOI 10.1007/s00251-004-0683-0; Urvater JA, 2000, J IMMUNOL, V164, P1386; Vallender EJ, 2013, ILAR J, V54, P154, DOI 10.1093/ilar/ilt044; Vallender EJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0507-y; Watanabe Y, 1997, IMMUNOGENETICS, V46, P135, DOI 10.1007/s002510050252; Wiseman RW, 2007, J VIROL, V81, P349, DOI 10.1128/JVI.01841-06; Wu J, 2008, TISSUE ANTIGENS, V72, P29, DOI 10.1111/j.1399-0039.2008.01057.x	63	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0093-7711	1432-1211		IMMUNOGENETICS	Immunogenetics	OCT	2015	67	10					563	578		10.1007/s00251-015-0867-9		16	Genetics & Heredity; Immunology	Genetics & Heredity; Immunology	CR7OX	WOS:000361541300002		
J	Sekiguchi, Y; Saito, S; Takahashi, K; Sato, C				Sekiguchi, Y.; Saito, S.; Takahashi, K.; Sato, C.			Flexibility and Poisson effect on detachment of gecko-inspired adhesives	INTERNATIONAL JOURNAL OF ADHESION AND ADHESIVES			English	Article						Biological adhesion; Novel adhesives; Elastic modulus; Detachment; Gecko	SETAL ARRAYS; FOOT-HAIR; SURFACES; CONTACT; STIFFNESS; BEHAVIOR; FORCE; MICRO; SHAPE; BEAM	Geckos and some insects can easily adhere to and detach from surfaces with micro/nanoscale hair structures on their foot, called setae and spatulas. Here, a model is developed to describe the detachment of the seta. In this model, the seta is assumed to be a beam whose tip adheres to a surface. When normal and tangential forces are applied to the root of the beam, a moment is generated at the contact tip and detachment occurs. The detachment conditions depend heavily on flexibility of the hair. The effects of Young's modulus and aspect ratio of length versus thickness of the beam on the detachment condition are theoretically investigated. The Poisson effect on the detachment conditions was also examined with the experimental results using fabricated silicone rubber beam arrays. (C) 2015 Elsevier Ltd. All rights reserved.	[Sekiguchi, Y.; Sato, C.] Tokyo Inst Technol, Precis & Intelligence Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Saito, S.] Tokyo Inst Technol, Dept Mech & Aerosp Engn, Meguro Ku, Tokyo 1528552, Japan; [Takahashi, K.] Tokyo Inst Technol, Dept Int Dev Engn, Meguro Ku, Tokyo 1528552, Japan	Sekiguchi, Y (reprint author), Tokyo Inst Technol, Precis & Intelligence Lab, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan.	sekigucht.y.aa@m.titech.ac.jp	Sekiguchi, Yu/E-4977-2014	Sekiguchi, Yu/0000-0003-3290-7021	JSPS KAKENHI [25889020]	This work was supported by JSPS KAKENHI Grant number 25889020.	STORK NE, 1980, J EXP BIOL, V88, P91; WALKER G, 1993, INT J ADHES ADHES, V13, P3, DOI 10.1016/0143-7496(93)90002-Q; Arzt E, 2003, P NATL ACAD SCI USA, V100, P10603, DOI 10.1073/pnas.1534701100; Murphy MP, 2007, J ADHES SCI TECHNOL, V21, P1281, DOI 10.1163/156856107782328380; Zhao BX, 2008, LANGMUIR, V24, P1517, DOI 10.1021/la702126k; MADERSON PF, 1964, NATURE, V203, P780, DOI 10.1038/203780a0; Huang JC, 2012, INT J ADHES ADHES, V36, P25, DOI 10.1016/j.ijadhadh.2012.03.001; Sekiguchi Y, 2012, J ADHES SCI TECHNOL, V26, P2615, DOI 10.1080/01694243.2012.691034; Bhushan B, 2007, J ADHES SCI TECHNOL, V21, P1213, DOI 10.1163/156856107782328353; Kovalev AE, 2012, SOFT MATTER, V8, P7560, DOI 10.1039/c2sm25431j; Sauer RA, 2011, J ADHESION, V87, P624, DOI 10.1080/00218464.2011.596084; Gao HJ, 2005, MECH MATER, V37, P275, DOI 10.1016/j.mechmat.2004.03.008; Maeno Y, 2012, J ADHESION, V88, P243, DOI 10.1080/00218464.2012.655177; Davies J, 2009, INT J ADHES ADHES, V29, P380, DOI 10.1016/j.ijadhadh.2008.07.009; Takahashi K, 2006, INT J ADHES ADHES, V26, P639, DOI 10.1016/j.ijadhadh.2005.12.002; Autumn K, 2006, J EXP BIOL, V209, P3558, DOI 10.1242/jeb.02469; TAKAHASHI K, 1995, J ADHES SCI TECHNOL, V9, P1451, DOI 10.1163/156856195X00121; Sauer RA, 2009, COMPUT METHOD BIOMEC, V12, P627, DOI 10.1080/10255840902802917; Sauer RA, 2014, FINITE ELEM ANAL DES, V86, P120, DOI 10.1016/j.finel.2014.03.009; Spuskanyuk AV, 2008, ACTA BIOMATER, V4, P1669, DOI 10.1016/j.actbio.2008.05.026; Hu CC, 2014, J APPL PHYS, V116, DOI 10.1063/1.4892628; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; Zhang F, 2011, INT J ADHES ADHES, V31, P583, DOI 10.1016/j.ijadhadh.2011.06.002; Rodriguez I, 2013, J ADHESION, V89, P921, DOI 10.1080/00218464.2013.767198; Autumn K, 2000, NATURE, V405, P681; Emura K, 2014, IOP CONF SER-MAT SCI, V61, DOI 10.1088/1757-899X/61/1/012041; Spolenak R, 2005, P ROY SOC A-MATH PHY, V461, P305, DOI 10.1098/rspa.2004.1326; Wang M, 2010, P 16 S MICR ASS TECH, V16, P435	28	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0143-7496	1879-0127		INT J ADHES ADHES	Int. J. Adhes. Adhes.	OCT	2015	62						55	62		10.1016/j.ijadhadh.2015.06.011		8	Engineering, Chemical; Materials Science, Multidisciplinary	Engineering; Materials Science	CR5RP	WOS:000361401900009		
J	Sakurai, S; Takashima, H; Waseda, K; Gosho, M; Kurita, A; Ando, H; Maeda, K; Suzuki, A; Fujimoto, M; Amano, T				Sakurai, Shinichiro; Takashima, Hiroaki; Waseda, Katsuhisa; Gosho, Masahiko; Kurita, Akiyoshi; Ando, Hirohiko; Maeda, Kazuyuki; Suzuki, Akihiro; Fujimoto, Masanobu; Amano, Tetsuya			Influence of plaque characteristics on fractional flow reserve for coronary lesions with intermediate to obstructive stenosis: insights from integrated-backscatter intravascular ultrasound analysis	INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING			English	Article						Fractional flow reserve; Integrated backscatter intravascular ultrasound; Plaque characteristics	TISSUE CHARACTERIZATION; MEDICAL THERAPY; INTERVENTION; REVASCULARIZATION; TOMOGRAPHY; ANGIOPLASTY; HISTOLOGY; SEVERITY; DISEASE	The aim of this study was to determine the correlation between the fractional flow reserve (FFR) values and volumetric intravascular ultrasound (IVUS) parameters derived from classic gray-scale IVUS and integrated backscatter (IB)-IVUS, taking into account known confounding factors. Patients with unstable angina pectoris with the frequent development of vulnerable plaques often showed the discrepancy between the FFR value and the quantitative coronary angiography findings. Our target population was 107 consecutive subjects with 114 isolated lesions who were scheduled for elective coronary angiography. The FFR was calculated as the mean distal coronary pressure divided by the mean aortic pressure during maximal hyperemia. Various volumetric parameters such as lipid plaque volume (LPV) and percentage of LPV (%LPV) were measured using IB-IVUS. Simple and multivariate linear regression analysis was employed to evaluate the correlation between FFR values and various classic gray-scale IVUS and IB-IVUS parameters. The Akaike information criterion (AIC) was used to compare the goodness of fit in an each model. Both the %LPV (r = -0.24; p = 0.01) and LPV (r = -0.40; p < 0.01) were significantly correlated with the FFR value. Only the LPV (AIC = -147.0; p = 0.006) and %LPV (AIC = -152.9; p = 0.005) proved to be independent predictors for the FFR value even after the adjustment of known confounding factors. The volumetric assessment by IB-IVUS could provide better information in terms of the relationship between plaque morphology and the FFR values as compared to the classic IVUS 2-dimensional gray-scale analysis.	[Sakurai, Shinichiro; Takashima, Hiroaki; Waseda, Katsuhisa; Kurita, Akiyoshi; Ando, Hirohiko; Maeda, Kazuyuki; Suzuki, Akihiro; Fujimoto, Masanobu; Amano, Tetsuya] Aichi Med Univ, Dept Cardiol, Nagakute, Aichi 4801195, Japan; [Gosho, Masahiko] Univ Tsukuba, Fac Med, Dept Clin Trial & Clin Epidemiol, Tsukuba, Ibaraki, Japan	Amano, T (reprint author), Aichi Med Univ, Dept Cardiol, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	amanot@aichi-med-u.ac.jp					AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akaike H, 1985, CELEBRATION STAT, P1; Okubo M, 2008, CIRC J, V72, P1631, DOI 10.1253/circj.CJ-07-0936; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Takagi A, 1999, CIRCULATION, V100, P250; Lopez-Palop R, 2013, CATHETER CARDIO INTE, V81, pE186, DOI 10.1002/ccd.24459; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; TOBIS JM, 1989, CIRCULATION, V80, P873; Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604; Amano T, 2007, J AM COLL CARDIOL, V49, P1149, DOI 10.1016/j.jacc.2006.12.028; PIJLS NHJ, 1993, CIRCULATION, V87, P1354; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Pijls NHJ, 2013, CIRC J, V77, P561, DOI 10.1253/circj.CJ-13-0161; Kawasaki M, 2010, CIRC J, V74, P2641, DOI 10.1253/circj.CJ-10-0547; Okubo M, 2008, ULTRASOUND MED BIOL, V34, P655, DOI 10.1016/j.ultrasmedbio.2007.09.015; Kawasaki M, 2005, J AM COLL CARDIOL, V45, P1946, DOI 10.1016/j.jacc.2004.09.081; Kawasaki M, 2002, CIRCULATION, V105, P2487, DOI 10.1061/01.CIR.0000017200.47342.10; Waksman R, 2013, J AM COLL CARDIOL, V61, P917, DOI 10.1016/j.jacc.2012.12.012; Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41; Ben-Dor Itsik, 2012, Cardiovasc Revasc Med, V13, P177, DOI 10.1016/j.carrev.2011.12.003; Nakamura Masato, 2014, Cardiovasc Interv Ther, V29, P300, DOI 10.1007/s12928-014-0259-3; Versteeg D, 2008, HEART, V94, P770, DOI 10.1136/hrt.2007.117259; Yang HM, 2014, CATHETER CARDIO INTE, V83, P386, DOI 10.1002/ccd.25088	24	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1569-5794	1573-0743		INT J CARDIOVAS IMAG	Int. J. Cardiovasc. Imaging	OCT	2015	31	7					1295	1301		10.1007/s10554-015-0699-6		7	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CR6YP	WOS:000361494800003		
J	Perri, F; Ohta, T; Critelli, S				Perri, Francesco; Ohta, Tohru; Critelli, Salvatore			Characterization of submarine canyon bathymetries in northern Ionian Sea, Italy, using sediment geochemical variation induced by transportation distance and basin depth (vol 104, pg 1353, 2015)	INTERNATIONAL JOURNAL OF EARTH SCIENCES			English	Correction									[Perri, Francesco; Critelli, Salvatore] Univ Calabria, Dipartimento Biol Ecol & Sci Terra, I-87036 Arcavacata Di Rende, CS, Italy; [Ohta, Tohru] Waseda Univ, Fac Educ & Integrated Arts & Sci, Dept Earth Sci, Shinjuku Ku, Tokyo 1698050, Japan	Perri, F (reprint author), Univ Calabria, Dipartimento Biol Ecol & Sci Terra, Via P Bucci, I-87036 Arcavacata Di Rende, CS, Italy.	francesco.perri@unical.it; tohta@waseda.jp; salvatore.critelli@unical.it		Perri, Francesco/0000-0002-1364-744X			PERRI F, 2015, INT J EARTH SCI GEOL, V104, P1353, DOI DOI 10.1007/S00531-015-1150-X	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1437-3254	1437-3262		INT J EARTH SCI	Int. J. Earth Sci.	OCT	2015	104	7					1907	1907		10.1007/s00531-015-1231-x		1	Geosciences, Multidisciplinary	Geology	CR6XB	WOS:000361490400012		
J	Pei, Y; Zheng, SQ; Tan, Y; Takagi, H				Pei, Yan; Zheng, Shaoqiu; Tan, Ying; Takagi, Hideyuki			Effectiveness of approximation strategy in surrogate-assisted fireworks algorithm	INTERNATIONAL JOURNAL OF MACHINE LEARNING AND CYBERNETICS			English	Article						Fireworks algorithm; Fitness landscape approximation; Elite strategy; Surrogate-assisted fireworks algorithm; Dimensionality reduction	EVOLUTIONARY COMPUTATION; DIFFERENTIAL EVOLUTION; OPTIMIZATION; FUSION	We investigate the effectiveness of approximation strategy in a surrogate-assisted fireworks algorithm, which obtains the elite from approximate fitness landscape to enhance its optimization performance. We study the effectiveness of approximation strategy from the aspects of approximation method, sampling data selection method and sampling size. We discuss and analyse the optimization performance of each method. For the approximation method, we use least square approximation, spline interpolation, Newton interpolation, and support vector regression to approximate fitness landscape of fireworks algorithm in projected lower dimensional, original and higher dimensional search space. With regard to the sampling data selection method, we define three approaches, i.e., best sampling method, distance near the best fitness individual sampling method, and random sampling method to investigate each sampling method's performance. With regard to sample size, this is set as 3, 5, and 10 sampling data in both the approximation method and sampling method. We discuss and compare the optimization performance of each method using statistical tests. The advantages of the fireworks algorithm, a number of open topics, and new discoveries arising from evaluation results, such as multi-production mechanism of the fireworks algorithm, optimization performance of each method, elite rank, interpolation times and extrapolation times of elites are analysed and discussed.	[Pei, Yan] Univ Aizu, Div Comp Sci, Aizu Wakamatsu, Fukushima 9658580, Japan; [Zheng, Shaoqiu; Tan, Ying] Peking Univ, Sch Elect Engn & Comp Sci, Dept Machine Intelligence, Key Lab Machine Percept,Minist Educ, Beijing 100871, Peoples R China; [Takagi, Hideyuki] Kyushu Univ, Fac Design, Fukuoka 8158540, Japan	Pei, Y (reprint author), Univ Aizu, Div Comp Sci, Aizu Wakamatsu, Fukushima 9658580, Japan.	peiyan@u-aizu.ac.jp; zhengshaoqiu@pku.edu.cn; ytan@pku.edu.cn; takagi@design.kyushu-u.ac.jp			JSPS, Japan [23500279]; Natural Science Foundation of China (NSFC) [61375119, 61170057]; National Key Basic Research Development Plan (973 Plan) Project of China [2015CB352302]	This work was supported by the JSPS Grant-in-Aid for Scientific Research (23500279), Japan. This work was also supported by the Natural Science Foundation of China (NSFC) under grant no. 61375119 and 61170057, and partially supported by National Key Basic Research Development Plan (973 Plan) Project of China with grant no. 2015CB352302.	Jin Y, 2005, SOFT COMPUT, V9, P3, DOI 10.1007/S00500-003-0328-5; Zhang JQ, 2009, IEEE T EVOLUT COMPUT, V13, P945, DOI 10.1109/TEVC.2009.2014613; Takagi H, 2001, P IEEE, V89, P1275, DOI 10.1109/5.949485; Qin AK, 2009, IEEE T EVOLUT COMPUT, V13, P398, DOI 10.1109/TEVC.2008.927706; Ong YS, 2010, IEEE COMPUT INTELL M, V5, P24, DOI 10.1109/MCI.2010.936309; Brest J, 2006, IEEE T EVOLUT COMPUT, V10, P646, DOI 10.1109/TEVC.2006.872133; Zheng YJ, 2013, APPL SOFT COMPUT, V13, P4253, DOI 10.1016/j.asoc.2013.07.004; Gong WY, 2011, IEEE T SYST MAN CY B, V41, P397, DOI 10.1109/TSMCB.2010.2056367; Hazewinkel M., 2001, ENCY MATH; Janecek Andreas, 2011, International Journal of Swarm Intelligence Research, V2, DOI 10.4018/jsir.2011100102; Kashan AH, 2015, COMPUT OPER RES, V55, P99, DOI 10.1016/j.cor.2014.10.011; Pei Y, 2014, NAT COMPUT, V13, P79, DOI 10.1007/s11047-013-9409-2; Pei Y, 2015, 2015 IEEE C EV COMP, P2215; Pei Y, 2012, 2012 IEEE INT C SYST, P1322; Pei Y, 2013, IEEE SYS MAN CYBERN, P1329, DOI 10.1109/SMC.2013.230; Pei Y, 2012, 2012 IEEE CONGRESS O, P2934; Pei Y., 2013, EVOLUTIONARY INTELLI, V6, P27; Pei Y, 2015, SCI WORLD J; Pei Y, 2014, THESIS KYUSHU U JAPA; Pei Y, 2012, INT CONF GENET EVOL, P400, DOI 10.1109/ICGEC.2012.74; Pei Y, 2013, FDN GEN ALG 12 FOGA, P173; Sadollah A, 2015, APPL SOFT COMPUT, V30, P58, DOI 10.1016/j.asoc.2015.01.050; Suganthan P.N., 2005, 20050052005 KANGAL, V2005; Takagi H., 2003, J OF JAPAN SOCIETY F, V15, P219; Tan Y, 2010, LECT NOTES COMPUT SC, V6145, P355; Zhang B, 2014, 2014 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P3200; Zheng SQ, 2013, 2013 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P2069; Zheng YJ, 2015, COMPUT OPER RES, V55, P1, DOI 10.1016/j.cor.2014.10.008	28	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1868-8071	1868-808X		INT J MACH LEARN CYB	Int. J. Mach. Learn. Cybern.	OCT	2015	6	5					795	810		10.1007/s13042-015-0388-8		16	Computer Science, Artificial Intelligence	Computer Science	CR6ST	WOS:000361478400007		
J	Ohnuma, H; Sato, Y; Hirakawa, M; Okagawa, Y; Osuga, T; Hayashi, T; Sato, T; Miyanishi, K; Kobune, M; Takimoto, R; Sagawa, T; Hori, M; Someya, M; Nakata, K; Sakata, K; Takayama, T; Kato, J				Ohnuma, Hiroyuki; Sato, Yasushi; Hirakawa, Masahiro; Okagawa, Yutaka; Osuga, Takahiro; Hayashi, Tsuyoshi; Sato, Tsutomu; Miyanishi, Koji; Kobune, Masayoshi; Takimoto, Rishu; Sagawa, Tamotsu; Hori, Masakazu; Someya, Masanori; Nakata, Kensei; Sakata, Koh-ichi; Takayama, Tetsuji; Kato, Junji			A Phase 1/2 Study of Definitive Chemoradiation Therapy Using Docetaxel, Nedaplatin, and 5-Fluorouracil (DNF-R) for Esophageal Cancer	INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS			English	Article							SQUAMOUS-CELL CARCINOMA; CONCURRENT CHEMORADIOTHERAPY; RADIATION-THERAPY; II TRIAL; CISPLATIN; RADIOTHERAPY; INFUSION; TAXOTERE; TAXOL; I/II	Purpose: Patient survival in esophageal cancer (EC) remains poor. The purpose of this study was to investigate a regimen of definitive chemoradiation therapy (CRT) that exerts good local control of EC. We performed a phase 1/2 study to assess the safety and efficacy of CRT with docetaxel, nedaplatin, and 5-fluorouracil (DNF-R). Methods and Materials: Eligible patients presented with stage IB to IV EC. Patients received 2 cycles of docetaxel (20, 30, or 40 mg/m 2) and nedaplatin (50 mg/m 2) on days 1 and 8 and a continuous infusion of 5-fluorouracil (400 mg/m(2) /day) on days 1 to 5 and 8 to 12, every 5 weeks, with concurrent radiation therapy (59.4 Gy/33 fractions). The recommended dose (RD) was determined using a 3 + 3 design. Results: In the phase 1 study, the dose-limiting toxicities were neutropenia and thrombocytopenia. The RD of docetaxel was determined to be 20 mg/m 2. In the phase 2 study, grade 3 to 4 acute toxicities included neutropenia (42.8%), febrile neutropenia (7.14%), thrombocytopenia (17.9%), and esophagitis (21.4%). Grade 3 to 4 late radiation toxicity included esophagostenosis (10.7%). The complete response rate was 82.1% (95% confidence interval: 67.9-96.3%). Both the median progression-free survival and overall survival were 41.2 months. Conclusions: DNF-R showed good tolerability and strong antitumor activity, suggesting that it is a potentially effective therapeutic regimen for EC. (C) 2015 Elsevier Inc. All rights reserved.	[Ohnuma, Hiroyuki; Sato, Yasushi; Hirakawa, Masahiro; Okagawa, Yutaka; Osuga, Takahiro; Hayashi, Tsuyoshi; Sato, Tsutomu; Miyanishi, Koji; Kobune, Masayoshi; Takimoto, Rishu; Kato, Junji] Sapporo Med Univ, Sch Med, Dept Med Oncol & Hematol, Sapporo, Hokkaido 0608543, Japan; [Kobune, Masayoshi] Hokkaido Canc Ctr, Div Gastroenterol, Sapporo, Hokkaido, Japan; [Hori, Masakazu; Someya, Masanori; Nakata, Kensei; Sakata, Koh-ichi] Sapporo Med Univ, Sch Med, Dept Radiol, Sapporo, Hokkaido 0608543, Japan; [Takayama, Tetsuji] Univ Tokushima, Dept Gastroenterol & Oncol, Tokushima 770, Japan	Kato, J (reprint author), Sapporo Med Univ, Sch Med, Dept Med Oncol & Hematol, Chuo Ku, South 1,West 16, Sapporo, Hokkaido 0608543, Japan.	jkato@sapmed.ac.jp					Ohtsu A, 1999, J CLIN ONCOL, V17, P2915; Minsky BD, 2002, J CLIN ONCOL, V20, P1167, DOI 10.1200/JCO.20.5.1167; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; Li QQ, 2010, DIS ESOPHAGUS, V23, P253, DOI 10.1111/j.1442-2050.2009.01003.x; HENNEQUIN C, 1995, BRIT J CANCER, V71, P1194, DOI 10.1038/bjc.1995.232; AJANI JA, 1994, J NATL CANCER I, V86, P1086, DOI 10.1093/jnci/86.14.1086; Higuchi K, 2014, INT J RADIAT ONCOL, V89, P872, DOI 10.1016/j.ijrobp.2014.03.030; Kato K, 2013, JPN J CLIN ONCOL, V43, P608, DOI 10.1093/jjco/hyt048; Shim HJ, 2012, CANCER CHEMOTH PHARM, V70, P683, DOI 10.1007/s00280-012-1962-3; Muro K, 2004, ANN ONCOL, V15, P955, DOI 10.1093/annonc/mdh231; Kato K, 2011, INT J RADIAT ONCOL, V81, P684, DOI 10.1016/j.ijrobp.2010.06.033; Hennequin C, 1996, CANCER RES, V56, P1842; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Ishida K, 2004, JPN J CLIN ONCOL, V34, P615, DOI 10.1093/jjco/hyh107; Nishimura Y, 2002, INT J RADIAT ONCOL, V53, P134, DOI 10.1016/S0360-3016(01)02813-9; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; CHAFFEY JT, 1971, CANCER RES, V31, P1613; Mason KA, 1999, CLIN CANCER RES, V5, P4191; Ruhstaller T, 2009, ANN ONCOL, V20, P1522, DOI 10.1093/annonc/mdp045; Choong NW, 2011, MED ONCOL, V28, pS152, DOI 10.1007/s12032-010-9658-1; Choy Hak, 1992, International Journal of Radiation Oncology Biology Physics, V24, P274; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Hihara J, 2008, ANTICANCER RES, V27, P2597; Japan Esophageal Society, 2009, ESOPHAGUS, V6, P71, DOI DOI 10.1007/S10388-009-0193-0]; KOBAYASHI H, 1991, INVEST NEW DRUG, V9, P313; Matsumoto H, 2014, ANTICANCER RES, V34, P3759; Mauer AM, 1998, J CLIN ONCOL, V16, P159; Miyazaki T, 2015, CANCER CHEMOTH PHARM, V75, P449, DOI 10.1007/s00280-014-2659-6; Mukherjee S, 2003, CLIN ONCOL-UK, V15, P115, DOI 10.1053/clon.2003.0218; Nakajima TE, 2009, JPN J CLIN ONCOL, V39, P37, DOI 10.1093/jjco/hyn125; SASAKI Y, 1991, CANCER RES, V51, P1472; Sato Y, 2006, CANCER CHEMOTH PHARM, V58, P570, DOI 10.1007/s00280-006-0193-x; Wood MD, 2013, J THORAC ONCOL, V8, P487, DOI 10.1097/JTO.0b013e3182829bf3	33	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0360-3016	1879-355X		INT J RADIAT ONCOL	Int. J. Radiat. Oncol. Biol. Phys.	OCT 1	2015	93	2					382	390		10.1016/j.ijrobp.2015.05.041		9	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	CR3RF	WOS:000361250100022		
J	Inohara, H				Inohara, Hidenori			Phase 2 Study of Docetaxel, Cisplatin, and Concurrent Radiation for Technically Resectable Stage III-IV Squamous Cell Carcinoma of the Head and Neck Reply	INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS			English	Letter									Osaka Univ, Fac Med, Dept Otorhinolaryngol Head & Neck Surg, Suita, Osaka, Japan	Inohara, H (reprint author), Osaka Univ, Fac Med, Dept Otorhinolaryngol Head & Neck Surg, Suita, Osaka, Japan.						King AD, 2004, RADIOLOGY, V230, P720, DOI 10.1148/radiol.2303030157; Dignam JJ, 2008, J CLIN ONCOL, V26, P4027, DOI 10.1200/JCO.2007.12.9866; Inohara H, 2015, INT J RADIAT ONCOL, V91, P934, DOI 10.1016/j.ijrobp.2014.12.032; Lee KC, 2008, INT J RADIAT ONCOL, V71, P187, DOI 10.1016/i.ijrobp.2007.09.023; Puthiyottil SSV, 2015, INT J RADIAT ONCOL, V93, P469, DOI 10.1016/j.ijrobp.2015.05.031	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0360-3016	1879-355X		INT J RADIAT ONCOL	Int. J. Radiat. Oncol. Biol. Phys.	OCT 1	2015	93	2					470	471		10.1016/j.ijrobp.2015.05.029		3	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	CR3RF	WOS:000361250100038		
J	Park, N; Li, X; Tsuji, N				Park, Nokeun; Li, Xiang; Tsuji, Nobuhiro			Microstructure and Mechanical Properties of Co21Cr22Cu22Fe21Ni14 Processed by High Pressure Torsion and Annealing	JOM			English	Article							HIGH-ENTROPY ALLOYS; SEVERE PLASTIC-DEFORMATION; SOLID-SOLUTION; PHASE-STABILITY; GRAIN-GROWTH; SYSTEM; AG; CU; RECRYSTALLIZATION; DUCTILITY	The strengthening mechanisms of Co21Cr22Cu22Fe21Ni14 multiple-principal element alloy processed by high pressure torsion (HPT) and annealing were examined. Two face-centered cubic (FCC) phases were observed in the as-cast alloy; one was a Cu-rich phase and the other was a Cu-lean one. In the HPT process, the microhardness increased from 190 HV to 470 HV at a strain of 157 due to strain hardening and grain refinement hardening. X-ray diffraction showed that the lattice parameters of the two FCC phases became closer to each other at higher HPT strain, indicating the alloying of Cu into the Cu-lean matrix. The HPT processed specimens were annealed at 500A degrees C, 550A degrees C, 600A degrees C, and 650A degrees C. The microhardness increased to 540 HV after annealing at temperatures lower than 650A degrees C, whereas it decreased when the specimen was annealed at 650A degrees C. The mean grain size of the specimens annealed at temperatures lower than 650A degrees C was much smaller than 100 nm, and Cu-rich clusters with sizes ranging from 2 nm to 32 nm were distributed homogeneously. The reasons for the formation of the Cu-rich nano-clusters were discussed from a perspective of the positive mixing enthalpy of Cu in the alloy and thermalenergy for Cu diffusion at a given temperature. The dissolution and partitioning of two FCC phases played a key role in strengthening the Co21Cr22Cu22Fe21Ni14 system.	[Park, Nokeun] Yeungnam Univ, Sch Mat Sci & Engn, Gyongsan 38541, South Korea; [Park, Nokeun; Li, Xiang; Tsuji, Nobuhiro] Kyoto Univ, Dept Mat Sci & Engn, Sakyo Ku, Kyoto 6068501, Japan; [Tsuji, Nobuhiro] Kyoto Univ, ESISM, Sakyo Ku, Kyoto 6068501, Japan	Park, N (reprint author), Yeungnam Univ, Sch Mat Sci & Engn, Gyongsan 38541, South Korea.	nokeun_park@yu.ac.kr; li.xiang.63c@st.kyoto-u.ac.jp; nobuhiro-tsuji@mtl.kyoto-u.ac.jp	Tsuji, Nobuhiro/F-7951-2010	Tsuji, Nobuhiro/0000-0002-2132-1327	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [2201, 24246114, 26630365]; Elements Strategy Initiative for Structural Materials (ESISM) through the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [22102002]	This study was supported financially by the Grant-in-Aid for Scientific Research on Innovative Area, "Bulk Nanostructured Metals" (Area No. 2201), the Grant-in-Aid for Scientific Research (A) (No. 24246114), the Grant-in-Aid for Challenging Exploratory Research (No. 26630365), and the Elements Strategy Initiative for Structural Materials (ESISM), all through the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (Contact No. 22102002). All the support is gratefully appreciated.	Tsuji N, 2002, SCRIPTA MATER, V47, P893, DOI 10.1016/S1359-6462(02)00282-8; Yeh JW, 2004, ADV ENG MATER, V6, P299, DOI 10.1002/adem.200300567; Tong CJ, 2005, METALL MATER TRANS A, V36A, P881, DOI 10.1007/s11661-005-0283-0; Zhang KB, 2012, INTERMETALLICS, V22, P24, DOI 10.1016/j.intermet.2011.10.010; Zhang F, 2014, CALPHAD, V45, P1, DOI 10.1016/j.calphad.2013.10.006; Tsai KY, 2013, ACTA MATER, V61, P4887, DOI 10.1016/j.actamat.2013.04.058; Botcharova E, 2003, J ALLOY COMPD, V351, P119, DOI 10.1016/S0925-8388(02)01025-3; Schuh B, 2015, ACTA MATER, V96, P258, DOI 10.1016/j.actamat.2015.06.025; Zhu C, 2013, ACTA MATER, V61, P2993, DOI 10.1016/j.actamat.2013.01.059; Liu WH, 2013, SCRIPTA MATER, V68, P526, DOI 10.1016/j.scriptamat.2012.12.002; Valiev RZ, 2000, PROG MATER SCI, V45, P103, DOI 10.1016/S0079-6425(99)00007-9; Takeuchi A, 2000, MATER T JIM, V41, P1372; Ohsaki S, 2007, ACTA MATER, V55, P2885, DOI 10.1016/j.actamat.2006.12.027; Park N, 2015, METALL MATER TRANS A, V46A, P1481, DOI 10.1007/s11661-014-2594-5; Zhang Y, 2008, ADV ENG MATER, V10, P534, DOI 10.1002/adem.200700240; UENISHI K, 1991, MAT SCI ENG A-STRUCT, V134, P1342, DOI 10.1016/0921-5093(91)90987-X; Wu Z, 2014, INTERMETALLICS, V46, P131, DOI 10.1016/j.intermet.2013.10.024; Xu J, 1996, J APPL PHYS, V79, P3935, DOI 10.1063/1.361820; Yeh JW, 2013, JOM-US, V65, P1759, DOI 10.1007/s11837-013-0761-6; Otto F, 2013, ACTA MATER, V61, P5743, DOI 10.1016/j.actamat.2013.06.018; Zhang Y, 2014, PROG MATER SCI, V61, P1, DOI 10.1016/j.pmatsci.2013.10.001; Gao MC, 2013, JOM-US, V65, P1749, DOI 10.1007/s11837-013-0788-8; Durga A, 2012, T INDIAN I METALS, V65, P375, DOI 10.1007/s12666-012-0138-5; Gao MC, 2014, JOM-US, V66, P1964, DOI 10.1007/s11837-014-1136-3; Ji W, 2015, INTERMETALLICS, V56, P24, DOI 10.1016/j.intermet.2014.08.008; Joshi M, 2014, IOP CONF SER-MAT SCI, V63, DOI 10.1088/1757-899X/63/1/012074; Khamsuk S, 2012, J MATER SCI, V47, P7841, DOI 10.1007/s10853-012-6661-2; Park N, 2015, METALL MATER TRANS A, V46A, P3308, DOI 10.1007/s11661-015-2915-3; Sauvage X, 2005, ACTA MATER, V53, P2127, DOI 10.1016/j.actamat.2005.01.024; Sun YF, 2011, SCRIPTA MATER, V65, P489, DOI 10.1016/j.scriptamat.2011.06.005; Suryanarayana C, 2001, PROG MATER SCI, V46, P1, DOI 10.1016/S0079-6425(99)00010-9; Wert JA, 2007, MATER TODAY, V10, P24, DOI 10.1016/S1369-7021(07)70206-7; Yao MJ, 2014, SCRIPTA MATER, V72-73, P5, DOI 10.1016/j.scriptamat.2013.09.030; Zhang F, 2015, J PHASE EQUILIB DIFF, V36, P1, DOI DOI 10.1007/S11669-014-0360-4	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1047-4838	1543-1851		JOM-US	JOM	OCT	2015	67	10					2303	2309		10.1007/s11837-015-1586-2		7	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering; Mineralogy; Mining & Mineral Processing	Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy; Mining & Mineral Processing	CR6WO	WOS:000361489100024		
J	Coyle, RJ; Sweatman, K; Arfaei, B				Coyle, Richard J.; Sweatman, Keith; Arfaei, Babak			Thermal Fatigue Evaluation of Pb-Free Solder Joints: Results, Lessons Learned, and Future Trends	JOM			English	Article							SN-AG-CU; ALLOYS; SNAGCU; MICROSTRUCTURE; EVOLUTION; SIZE; TIN	Thermal fatigue is a major source of failure of solder joints in surface mount electronic components and it is critically important in high reliability applications such as telecommunication, military, and aeronautics. The electronic packaging industry has seen an increase in the number of Pb-free solder alloy choices beyond the common near-eutectic Sn-Ag-Cu alloys first established as replacements for eutectic SnPb. This paper discusses the results from Pb-free solder joint reliability programs sponsored by two industry consortia. The characteristic life in accelerated thermal cycling is reported for 12 different Pb-free solder alloys and a SnPb control in 9 different accelerated thermal cycling test profiles in terms of the effects of component type, accelerated thermal cycling profile and dwell time. Microstructural analysis on assembled and failed samples was performed to investigate the effect of initial microstructure and its evolution during accelerated thermal cycling test. A significant finding from the study is that the beneficial effect of Ag on accelerated thermal cycling reliability (measured by characteristic lifetime) diminishes as the severity of the accelerated thermal cycling, defined by greater Delta T, higher peak temperature, and longer dwell time increases. The results also indicate that all the Pb-free solders are more reliable in accelerated thermal cycling than the SnPb alloy they have replaced. Suggestions are made for future work, particularly with respect to the continued evolution of alloy development for emerging application requirements and the value of using advanced analytical methods to provide a better understanding of the effect of microstructure and its evolution on accelerated thermal cycling performance.	[Coyle, Richard J.] Alcatel Lucent Bell Labs, Murray Hill, NJ 07974 USA; [Sweatman, Keith] Nihon Super, Osaka, Japan; [Arfaei, Babak] Universal Instruments Corp, Conklin, NY USA	Coyle, RJ (reprint author), Alcatel Lucent Bell Labs, Murray Hill, NJ 07974 USA.	richard.coyle@alcatel-lucent.com					Albrecht H. J., 2009, P SMTA INT C SAN DIE, P308; Nogita K, 2005, MATER TRANS, V46, P2419, DOI 10.2320/matertrans.46.2419; Kinyanjui R, 2005, J MATER RES, V20, P2914, DOI 10.1557/JMR.2005.0361; [Anonymous], 2006, P 56 EL COMP TECHN C; Arfaei B, 2009, J ELECTRON MATER, V38, P2617, DOI 10.1007/s11664-009-0932-y; Mattila TT, 2010, IEEE T COMPON PACK T, V33, P629, DOI 10.1109/TCAPT.2010.2051268; Nogita K, 2008, SCRIPTA MATER, V59, P191, DOI 10.1016/j.scriptamat.2008.03.002; [Anonymous], 2012, P 62 ECTC MAY 29 JUN; [Anonymous], 2005, ROUND ROBIN TESTING; Lehman LP, 2010, ACTA MATER, V58, P3546, DOI 10.1016/j.actamat.2010.01.030; Moon KW, 2000, J ELECTRON MATER, V29, P1122, DOI 10.1007/s11664-000-0003-x; [Anonymous], 2009, P EL COMP TECHN C IE; [Anonymous], 2006, IPC9701A INST PRINT; Terashima S, 2003, J ELECTRON MATER, V32, P1527, DOI 10.1007/s11664-003-0125-z; [Anonymous], 2012, P 13 IEEE INT C THER; Zhang Y, 2008, PROCEEDINGS OF INTERNATIONAL CONFERENCE ON PULPING, PAPERMAKING AND BIOTECHNOLOGY 2008: ICPPB '08, VOL I, P99; Lin F, 2011, J ALLOY COMPD, V509, P6666, DOI 10.1016/j.jallcom.2011.03.134; Arfaei B, 2012, J ELECTRON MATER, V41, P362, DOI 10.1007/s11664-011-1756-0; Anderson IE, 2007, J MATER SCI-MATER EL, V18, P55, DOI 10.1007/s10854-006-9011-9; Arfaei B, 2013, J APPL PHYS, V114, DOI 10.1063/1.4826437; Arfaei B., 2012, P ASME INT MECH ENG; Arfaei B., 2013, P EL COMP TECHN C LA; Bieler TR, 2008, IEEE T COMPON PACK T, V31, P370, DOI 10.1109/TCAPT.2008.916835; Bradley E, 2007, LEAD-FREE ELECTRONICS: INEMI PROJECTS LEAD TO SUCCESSFUL MANUFACTURING, P211, DOI 10.1002/9780470171479.ch5; Bridgman PW, 1925, P AM ACAD ARTS SCI, V60, P305, DOI 10.2307/25130058; Clech J.-P., 2009, P SMTA INT C SAN DIE, P393; Coyle R., 2014, P ELECT COMP TECHN C, P425; Coyle R., 2010, P SMTA INT C ORL FL, P548; Coyle R., 2009, P 2009 SMTAI C SAN D, P384; Coyle R., 2014, P SMTA INT C CHIC IL, P547; Coyle R., P SMTA INT C ORL FL, P376; Coyle Richard, 2013, P SMTA INT C FT WORT, P490; Coyle R, 2011, IEEE T COMP PACK MAN, V1, P1583, DOI 10.1109/TCPMT.2011.2140109; Coyle Richard, 2013, P SMTA INT C FT WORT, P470; Coyle Richard, 2011, J SMTA, V25, P28; Coyle Richard, 2011, J SMTA, V24, P27; Darveaux R., 2008, P 2008 IEEE EL COMP, P113; Dunford S., 2004, P 54 EL COMP TECHN C, P726; Engelmaier W., 1989, SURFACE MOUNT SOLDER, V1, P14, DOI 10.1108/eb037660; George E., 2012, P INT S MICR SAN DIE; Henshall G., 2009, P INST PRINT CIRC, pS05; Henshall G., 2008, J SMTA, V21, P11; Henshall Gregory, 2012, P SMTA INT C ORL FL, P335; Kang S.K., 2004, P 54 EL COMP TECHN C, P661; Kang S.K., 2010, RC25045 IBM; Maleki M, 2014, J ELECTRON MATER, V43, P1026, DOI 10.1007/s11664-014-3017-5; Manock J., 2008, J SURF MT TECHNOL, V21, P36; Parker Richard, 2012, P SMTA INT C ORL FL, P348; RAYNE JA, 1960, PHYS REV, V120, P1658, DOI 10.1103/PhysRev.120.1658; Sweatman K., 2012, P SMTA INT 2012 OCT, P359; Sweatman K., 2014, P SMTA INT C CHIC IL, P561; Wilcox J., 2014, P SMTA INT C CHIC IL, P122; Yin L., 2011, J ELECT MAT, V41, P241; Yoon S., 2005, P 55 EL COMP TECHN C, P1210	54	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1047-4838	1543-1851		JOM-US	JOM	OCT	2015	67	10					2394	2415		10.1007/s11837-015-1595-1		22	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering; Mineralogy; Mining & Mineral Processing	Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy; Mining & Mineral Processing	CR6WO	WOS:000361489100036		
J	Liang, FY; Oshima, M; Huang, HX; Liu, H; Takagi, S				Liang, Fuyou; Oshima, Marie; Huang, Huaxiong; Liu, Hao; Takagi, Shu			Numerical Study of Cerebroarterial Hemodynamic Changes Following Carotid Artery Operation: A Comparison Between Multiscale Modeling and Stand-Alone Three-Dimensional Modeling	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						multiscale model; cerebroarterial hemodynamics; boundary conditions; clinical data; parameter optimization	FLUID-STRUCTURE INTERACTION; ONE-DIMENSIONAL MODEL; WALL SHEAR-STRESS; BLOOD-FLOW; CEREBRAL ANEURYSMS; COMPUTATIONAL HEMODYNAMICS; INTRACRANIAL ANEURYSMS; BOUNDARY-CONDITIONS; SIMULATIONS; CIRCULATION	Free outflow boundary conditions have been widely adopted in hemodynamic model studies, they, however, intrinsically lack the ability to account for the regulatory mechanisms of systemic hemodynamics and hence carry a risk of producing incorrect results when applied to vascular segments with multiple outlets. In the present study, we developed a multiscale model capable of incorporating global cardiovascular properties into the simulation of blood flows in local vascular segments. The multiscale model was constructed by coupling a three-dimensional (3D) model of local arterial segments with a zero-one-dimensional (0-1-D) model of the cardiovascular system. Numerical validation based on an idealized model demonstrated the ability of the multiscale model to preserve reasonable pressure/flow wave transmission among different models. The multiscale model was further calibrated with clinical data to simulate cerebroarterial hemodynamics in a patient undergoing carotid artery operation. The results showed pronounced hemodynamic changes in the cerebral circulation following the operation. Additional numerical experiments revealed that a stand-alone 3D model with free outflow conditions failed to reproduce the results obtained by the multiscale model. These results demonstrated the potential advantage of multiscale modeling over single-scale modeling in patient-specific hemodynamic studies. Due to the fact that the present study was limited to a single patient, studies on more patients would be required to further confirm the findings.	[Liang, Fuyou; Liu, Hao] Shanghai Jiao Tong Univ, Sch Naval Architecture Ocean & Civil Engn, SJTU CU Int Cooperat Res Ctr, Shanghai 200240, Peoples R China; [Oshima, Marie] Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan; [Huang, Huaxiong] York Univ, Dept Math & Stat, Toronto, ON M3J 1P3, Canada; [Liu, Hao] Chiba Univ, Grad Sch Engn, Chiba, Chiba 2638522, Japan; [Takagi, Shu] Univ Tokyo, Dept Mech Engn, Tokyo 1138654, Japan	Liang, FY (reprint author), Shanghai Jiao Tong Univ, Sch Naval Architecture Ocean & Civil Engn, SJTU CU Int Cooperat Res Ctr, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	fuyouliang@sjtu.edu.cn			National Natural Science Foundation of China [81370438]; SJTU Medical-Engineering Cross-cutting Research Project [YG2012MS24]	The study was supported in part by the National Natural Science Foundation of China (Grant No. 81370438) and the SJTU Medical-Engineering Cross-cutting Research Project (Grant No. YG2012MS24). Special thanks to Dr. S. Yamada for providing the clinical data and to Mr. M. Kobayashi for his help with 3D model construction.	Moghadam ME, 2013, J COMPUT PHYS, V244, P63, DOI 10.1016/j.jcp.2012.07.035; Grinberg L, 2011, ANN BIOMED ENG, V39, P297, DOI 10.1007/s10439-010-0132-1; Blanco PJ, 2013, MED ENG PHYS, V35, P652, DOI 10.1016/j.medengphy.2012.07.011; Mynard JP, 2013, ATHEROSCLEROSIS, V227, P259, DOI 10.1016/j.atherosclerosis.2013.01.026; Cebral JR, 2011, AM J NEURORADIOL, V32, P264, DOI 10.3174/ajnr.A2274; Chong W, 2014, AM J NEURORADIOL, V35, P136, DOI 10.3174/ajnr.A3790; Alastruey J, 2007, J BIOMECH, V40, P1794, DOI 10.1016/j.jbiomech.2006.07.008; Liang FY, 2009, J BIOMECH, V42, P692, DOI 10.1016/j.jbiomech.2009.01.010; Reymond P, 2009, AM J PHYSIOL-HEART C, V297, pH208, DOI 10.1152/ajpheart.00037.2009; Pennati G, 2011, INTERFACE FOCUS, V1, P297, DOI 10.1098/rsfs.2010.0021; Moore S, 2006, J BIOMECH, V39, P1454, DOI 10.1016/j.biomech.2005.04.005; Morales HG, 2014, J BIOMECH, V47, P2362, DOI 10.1016/j.jbiomech.2014.04.025; Xiao N, 2014, INT J NUMER METH BIO, V30, P204, DOI 10.1002/cnm.2598; Torii R, 2010, INT J NUMER METH BIO, V26, P336, DOI 10.1002/cnm.1289; Evju O, 2013, J BIOMECH, V46, P2802, DOI 10.1016/j.jbiomech.2013.09.004; Pereira VM, 2013, J BIOMECH, V46, P1531, DOI [10.1016/j.jbiomech.2013.03.024, 10.1016/j.jbidmech.2013.03.024]; Kim HJ, 2010, ANN BIOMED ENG, V38, P3195, DOI 10.1007/s10439-010-0083-6; Alastruey J, 2008, INT J NUMER METH FL, V56, P1061, DOI 10.1002/fld.1606; van Ooij P, 2012, NMR BIOMED, V25, P14, DOI 10.1002/nbm.1706; Muller LO, 2014, INT J NUMER METH BIO, V30, P681, DOI 10.1002/cnm.2622; Liang FY, 2009, MED BIOL ENG COMPUT, V47, P743, DOI 10.1007/s11517-009-0449-9; Oshima M, 2012, CURR PHARM BIOTECHNO, V13, P2153; Mynard JP, 2008, COMMUN NUMER METH EN, V24, P367, DOI 10.1002/cnm.1117; Morbiducci U, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001886; Cebral JR, 2005, AM J NEURORADIOL, V26, P2550; Reymond P, 2011, AM J PHYSIOL-HEART C, V301, pH1173, DOI 10.1152/ajpheart.00821.2010; Geers AJ, 2014, J BIOMECH, V47, P178, DOI 10.1016/j.jbiomech.2013.09.033; Valencia A, 2009, INT J COMPUT FLUID D, V23, P649, DOI 10.1080/10618560903476386; Alastruey J, 2011, J BIOMECH, V44, P2250, DOI 10.1016/j.jbiomech.2011.05.041; Appanaboyina S, 2008, INT J COMPUT FLUID D, V22, P669, DOI 10.1080/10618560802495255; Castro M, 2009, ACAD RADIOL, V16, P1201, DOI 10.1016/j.acra.2009.03.022; Chung B, 2015, ANN BIOMED ENG, V43, P122, DOI 10.1007/s10439-014-1093-6; Cousins W, 2012, J COMPUT PHYS, V231, P6086, DOI 10.1016/j.jcp.2012.04.038; David T, 2003, INT J NUMER METH FL, V43, P701, DOI 10.1002/fld.495; Dong JL, 2013, INT J NUMER METH BIO, V29, P476, DOI 10.1002/cnm.2529; Formaggia Luca, 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P273, DOI 10.1080/10255840600857767; Formaggia L, 2013, J COMPUT PHYS, V244, P97, DOI 10.1016/j.jcp.2012.08.001; Huang PG, 2015, INT J NUMER METH BIO, V31, DOI 10.1002/cnm.2701; Liang F., 2011, BIOMEDICAL ENG ONLIN, V10, P1; Morbiducci U, 2010, ANN BIOMED ENG, V38, P3688, DOI 10.1007/s10439-010-0102-7; Mut F, 2014, INT J NUMER METH BIO, V30, P135, DOI 10.1002/cnm.2594; Passerini T, 2009, J ENG MATH, V64, P319, DOI 10.1007/s10665-009-9281-3; Tokuda S., 2007, THESIS U TOKYO BUNKY; Torii R, 2011, INT J NUMER METH FL, V65, P324, DOI 10.1002/fld.2448; Tricerri P, 2015, COMPUT MECH, V55, P479, DOI 10.1007/s00466-014-1117-y; WESTERHO.N, 1972, CARDIOVASC RES, V6, P648, DOI 10.1093/cvr/6.6.648; Xiang J, 2014, AM J NEURORADIOL, V35, P1849, DOI 10.3174/ajnr.A3710; Xiang J, 2014, J BIOMECH, V47, P3882, DOI 10.1016/j.jbiomech.2014.09.034	48	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	OCT	2015	137	10							101011	10.1115/1.4031457		12	Biophysics; Engineering, Biomedical	Biophysics; Engineering	CR5MC	WOS:000361385900011		
J	Tabata, Y; Murai, N; Sasaki, T; Taniguchi, S; Suzuki, S; Yamazaki, K; Ito, M				Tabata, Yoshikuni; Murai, Norio; Sasaki, Takeo; Taniguchi, Sachie; Suzuki, Shuichi; Yamazaki, Kazuto; Ito, Masashi			Multiparametric Phenotypic Screening System for Profiling Bioactive Compounds Using Human Fetal Hippocampal Neural Stem/Progenitor Cells	JOURNAL OF BIOMOLECULAR SCREENING			English	Article						multiparametric phenotypic screening; bioactive compound library; fingerprinting; human neural stem/progenitor cells; cell fate	STEM-CELLS; NEURONAL DIFFERENTIATION; DOPAMINE AGONISTS; SMALL-MOLECULE; NEUROGENESIS; MTOR; ACTIVATION; AMITRIPTYLINE; PROGENITORS; RECEPTORS	Stem cell research has been progressing rapidly, contributing to regenerative biology and regenerative medicine. In this field, small-molecule compounds affecting stem cell proliferation/differentiation have been explored to understand stem cell biology and support regenerative medicine. In this study, we established a multiparametric screening system to detect bioactive compounds affecting the cell fate of human neural stem/progenitor cells (NSCs/NPCs), using human fetal hippocampal NSCs/NPCs, HIP-009 cells. We examined effects of 410 compounds, which were collected based on mechanisms of action (MOAs) and chemotypes, on HIP-009's cell fate (self-renewal, neuronal and astrocytic differentiation) and morphology by automated multiparametric assays and profiled induced cellular phenotypes. We found that this screening classified compounds with the same MOAs into subgroups according to additional pharmacological effects (e.g., mammalian target of rapamycin complex 1 [mTORC1] inhibitors and mTORC1/mTORC2 dual inhibitors among mTOR inhibitors). Moreover, it identified compounds that have off-target effects under matrix analyses of MOAs and structure similarities (e.g., neurotropic effects of amitriptyline among tri- and tetracyclic compounds). Therefore, this automated, medium-throughput and multiparametric screening system is useful for finding compounds that affect the cell fate of human NSCs/NPCs for supporting regenerative medicine and to fingerprint compounds based on human stem cells' multipotency, leading to understanding of stem cell biology.	[Tabata, Yoshikuni; Murai, Norio; Taniguchi, Sachie; Suzuki, Shuichi; Yamazaki, Kazuto; Ito, Masashi] Eisai & Co Ltd, Eisai Prod Creat Syst, Next Generat Syst CFU, Tsukuba, Ibaraki 3002635, Japan; [Sasaki, Takeo] Eisai & Co Ltd, Eisai Prod Creat Syst, Global Discovery Res Neurosci & Gen Med PCU, Tsukuba, Ibaraki 3002635, Japan	Yamazaki, K (reprint author), Eisai & Co Ltd, Eisai Prod Creat Syst, 5-1-3 Tokodai, Tsukuba, Ibaraki 3002635, Japan.	k5-yamazaki@hhc.eisai.co.jp					Gu F, 2005, J NEUROSCI RES, V81, P163, DOI 10.1002/jnr.20561; Magri L, 2011, CELL STEM CELL, V9, P447, DOI 10.1016/j.stem.2011.09.008; Schneider JW, 2008, NAT CHEM BIOL, V4, P408, DOI 10.1038/nchembio.95; Jang SW, 2009, CHEM BIOL, V16, P644, DOI 10.1016/j.chembiol.2009.05.010; Sato A, 2010, NEUROSCI LETT, V470, P115, DOI 10.1016/j.neulet.2009.12.067; Han J, 2008, MOL CELL NEUROSCI, V39, P118, DOI 10.1016/j.mcn.2008.06.003; Petrik D, 2012, FASEB J, V26, P3148, DOI 10.1096/fj.11-201426; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Langle D, 2014, ACS CHEM BIOL, V9, P57, DOI 10.1021/cb4008277; Tadori Y, 2011, EUR J PHARMACOL, V666, P43, DOI 10.1016/j.ejphar.2011.05.050; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9; Woehrmann MH, 2013, MOL BIOSYST, V9, P2604, DOI 10.1039/c3mb70245f; Magri L, 2013, CELL MOL LIFE SCI, V70, P2887, DOI 10.1007/s00018-012-1196-x; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Li WL, 2012, STEM CELLS, V30, P61, DOI 10.1002/stem.768; Young DW, 2008, NAT CHEM BIOL, V4, P59, DOI 10.1038/nchembio.2007.53; Esfandiari F, 2012, STEM CELLS DEV, V21, P3233, DOI 10.1089/scd.2011.0678; Lange C, 2011, NEUROSCI LETT, V488, P36, DOI 10.1016/j.neulet.2010.10.076; Athanasoulia AP, 2014, PITUITARY, V17, P240, DOI 10.1007/s11102-013-0496-y; Chadwick W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021660; Fukushima K, 2014, J BIOMOL SCREEN, V19, P1174, DOI 10.1177/1087057114541149; Gobello C, 2006, THERIOGENOLOGY, V66, P1560, DOI 10.1016/j.theriogenology.2006.02.005; Hansen TVO, 2000, J NEUROCHEM, V75, P1870, DOI 10.1046/j.1471-4159.2000.0751870.x; Heilker R, 2014, TRENDS PHARMACOL SCI, V35, P510, DOI 10.1016/j.tips.2014.07.003; Kim MY, 2010, NEUROSCIENCE, V170, P8, DOI 10.1016/j.neuroscience.2010.07.020; Pertz H., 1999, ERGOT GENUS CLAVICEP, P411; Werling LL, 2007, EXP NEUROL, V207, P248, DOI 10.1016/j.expneurol.2007.06.013; Yuan HH, 2015, MOL NEUROBIOL, V51, P512, DOI 10.1007/s12035-014-8717-6	28	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1087-0571	1552-454X		J BIOMOL SCREEN	J. Biomol. Screen	OCT	2015	20	9					1074	1083		10.1177/1087057115598119		10	Biochemical Research Methods; Biotechnology & Applied Microbiology; Chemistry, Analytical	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry	CR8MA	WOS:000361605800002		
J	Kayama, K; Okada, T; Fuwa, K; Nagano, N; Hosono, S; Takahashi, S; Takahashi, S				Kayama, Kazunori; Okada, Tomoo; Fuwa, Kazumasa; Nagano, Nobuhiko; Hosono, Shigeharu; Takahashi, Shigeru; Takahashi, Shori			Apolipoprotein A-V concentration in preterm infants	JOURNAL OF CLINICAL LIPIDOLOGY			English	Article						Apolipoprotein A-V; Preterm infants; Cord blood; Very low-density lipoprotein; Triglyceride	LOW-DENSITY-LIPOPROTEIN; METABOLIC SYNDROME; SEVERE HYPERTRIGLYCERIDEMIA; KOREAN MEN; TRIGLYCERIDES; POLYMORPHISM; ASSOCIATION; GENE; CHOLESTEROL; DEFICIENCY	BACKGROUND: Fetal organs require much lipid for growth, but the cord blood had low TG concentrations, compared to adult serum. We investigated the association between the concentration of apolipoprotein A-V (apoA-V) and lipid profile in cord blood and neonatal serum. OBJECTIVE: ApoA-V was identified as an important determinant of plasma triglyceride concentrations. We sought to determine the association between serum apoA-V concentrations and lipoprotein profile in preterm infants and its early postnatal change. METHODS: Sixty-three neonates (35 males and 28 females; 15 term and 48 preterm) were included. Serum lipoprotein profile and apoA-V concentrations were determined at birth and 1 month. RESULTS: Cord blood apoA-V concentrations in appropriate-for-gestational age infants were extremely low (13.1 +/- 3.4 ng/mL in term infants, 4.4 +/- 0.9 ng/mL in preterm infants) compared with adult values, and those of small-for-gestational age infants were further low (6.4 +/- 4.2 ng/mL, 2.2 +/- 1.3 ng/mL, respectively). During the first month, serum apoA-V concentration markedly increased, and the concentration of preterm appropriate-for-gestational age infants caught up, whereas that of preterm small-for-gestational age infants did not. At birth, apoA-V concentration positively correlated with gestational age (r = 0.354, P = .0069) but not with birth weight Z-score. ApoA-V concentration had a positive association with very low density lipoprotein triglyceride concentrations (r = 0.646, P < .0001), and the relationships still remained at 1 month (r = 0.283, P = .0348). CONCLUSIONS: ApoA-V in neonates was unique in its serum concentration and in the association with lipoprotein profile. (C) 2015 National Lipid Association. All rights reserved.	[Kayama, Kazunori; Okada, Tomoo; Fuwa, Kazumasa; Nagano, Nobuhiko; Hosono, Shigeharu; Takahashi, Shigeru; Takahashi, Shori] Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Itabashi Ku, Tokyo 1738610, Japan; [Okada, Tomoo] Kanagawa Inst Technol, Dept Nutr & Life Sci, Atsugi, Kanagawa, Japan	Okada, T (reprint author), Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Itabashi Ku, 30-1 Oyaguchi Kamicho, Tokyo 1738610, Japan.	tomo@med.email.ne.jp					Abe Y, 2009, J ATHEROSCLER THROMB, V16, P121; Perez-Martinez P, 2009, AM J CLIN NUTR, V89, P391, DOI 10.3945/ajcn.2008.26363; Okazaki M, 2005, ARTERIOSCL THROM VAS, V25, P578, DOI 10.1161/01.ATV.0000155017.60171.88; Grosskopf I, 2005, ARTERIOSCL THROM VAS, V25, P2573, DOI 10.1161/01.ATV.0000186189.26141.12; Shu X, 2007, J LIPID RES, V48, P1445, DOI 10.1194/jlr.C700002-JLR200; Fujita H, 2008, J PERINATOL, V28, P335, DOI 10.1038/jp.2008.8; van der Vliet HN, 2001, J BIOL CHEM, V276, P44512, DOI 10.1074/jbc.M106888200; KOBAYASHI J, 1993, CLIN CHIM ACTA, V216, P113, DOI 10.1016/0009-8981(93)90144-S; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Oliva CP, 2005, ARTERIOSCL THROM VAS, V25, P411, DOI 10.1161/01.ATV.0000153087.36428.dd; Dallinga-Thie GM, 2006, DIABETOLOGIA, V49, P1505, DOI 10.1007/s00125-006-0261-0; Schaap FG, 2004, J BIOL CHEM, V279, P27941, DOI 10.1074/jbc.M403240200; Yonezawa R, 2009, METABOLISM, V58, P704, DOI 10.1016/j.metabol.2009.02.004; AVERNA MR, 1991, BIOL NEONATE, V60, P187; Cardona F, 2009, ATHEROSCLEROSIS, V206, P148, DOI 10.1016/j.atherosclerosis.2009.02.024; Gesteiro E, 2011, EUR J PEDIATR, V170, P1551, DOI 10.1007/s00431-011-1473-y; Grallert H, 2007, J LIPID RES, V48, P2614, DOI 10.1194/jlr.M700011-JLR200; Hahne P, 2008, J INTERN MED, V264, P452, DOI 10.1111/j.1365-2796.2008.01987.x; Hirano T, 2007, METABOLISM, V56, P462, DOI 10.1016/j.metabol.2006.11.002; Huang Xian-sheng, 2009, Atherosclerosis, V204, pe99, DOI 10.1016/j.atherosclerosis.2008.11.019; Hyun YJ, 2009, ATHEROSCLEROSIS, V205, P568, DOI 10.1016/j.atherosclerosis.2008.12.035; Ishihara M, 2005, J LIPID RES, V46, P2015, DOI 10.1194/jlr.D500018-JLR200; Jang Y, 2004, AM J CLIN NUTR, V80, P832; Kisfali P, 2008, CIRC J, V72, P40, DOI 10.1253/circj.72.40; Moreno-Luna R, 2007, J CLIN ENDOCR METAB, V92, P2280, DOI 10.1210/jc.2006-1802; Ogawa Y, 1998, ACTA NEONAT JPN, V34, P624; van der Vliet HN, 2002, BIOCHEM BIOPH RES CO, V295, P1156, DOI 10.1016/S0006-291X(02)00808-2; Zhao TF, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-120	28	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1933-2874	1876-4789		J CLIN LIPIDOL	J. Clin. Lipidol.	OCT	2015	9	5					647	651		10.1016/j.jacl.2015.06.006		5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CR5WQ	WOS:000361415500005		
J	Wakabayashi, I; Daimon, T				Wakabayashi, Ichiro; Daimon, Takashi			Alcohol-independent beneficial cardiometabolic profile of individuals with hyper-HDL cholesterolemia in Japanese men and women	JOURNAL OF CLINICAL LIPIDOLOGY			English	Article						Alcohol; Cardiovascular disease; Diabetes mellitus; Dyslipidemia; Hyper-HDL cholesterolemia; Metabolic syndrome; Obesity	DENSITY-LIPOPROTEIN CHOLESTEROL; LIPID-ACCUMULATION PRODUCT; CORONARY-HEART-DISEASE; POSTMENOPAUSAL WOMEN; METABOLIC SYNDROME; DIABETES-MELLITUS; HYPERTENSION; METAANALYSIS; MANAGEMENT; OBESITY	BACKGROUND: There is limited information on characterization of individuals with hyper-high-density lipoprotein (HDL) cholesterolemia. OBJECTIVES: The purpose of this study was to investigate the cardiometabolic profile of individuals with hyper-HDL cholesterolemia in comparison with the profile of individuals with normo-HDL cholesterolemia. METHODS: The subjects were Japanese men and women who had hyper-HDL cholesterolemia (>= 100 mg/dL) and their control subjects who had normal IML cholesterol levels (>= 40 and <80 mg/dL) and were matched for age or age and alcohol consumption. The cardiometabolic profiles were compared between the hyper- and normo-HDL cholesterolemic groups. RESULTS: Both in men and women, body mass index, waist-to-height ratio, triglycerides, low-density lipoprotein cholesterol, and hemoglobin A1c were significantly lower in subjects with hyper-HDL cholesterolemia than in subjects with normo-HDL cholesterolemia, whereas systolic and diastolic blood pressure levels were not significantly different between the 2 groups. In generalized estimating equation with adjustment for smoking and regular exercise, odds ratios of the hyper- vs normo-HDL cholesterolemic groups were significantly lower than the reference level of 1.00 for high body mass index, high waist-to-height ratio, hypertriglyceridemia, hyper-low-density lipoprotein cholesterolemia, high lipid accumulation product, and metabolic syndrome. The previously mentioned results were obtained both in age-matched analysis and in age- and alcohol intake-matched analysis, although the percentage of regular drinkers was significantly higher in the hyper-HDL cholesterolemic group than in the age-matched control group. CONCLUSIONS: Hyper-HDL cholesterolemia was inversely associated with obesity, dyslipidemia, and metabolic syndrome in the analysis using alcohol intake-matched subject groups. Therefore, the association of hyper-HDL cholesterolemia with lower cardiometabolic risk is thought to be independent of habitual alcohol drinking. (C) 2015 National Lipid Association. All rights reserved.	[Wakabayashi, Ichiro] Hyogo Coll Med, Dept Environm & Prevent Med, Nishinomiya, Hyogo 6638501, Japan; [Daimon, Takashi] Hyogo Coll Med, Div Biostat, Nishinomiya, Hyogo 6638501, Japan	Wakabayashi, I (reprint author), Hyogo Coll Med, Dept Environm & Prevent Med, Mukogawa Cho 1-1, Nishinomiya, Hyogo 6638501, Japan.	wakabaya@hyo-med.ac.jp			Japan Society for the Promotion of Science [24390171]	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (no. 24390171).	Juren AJ, 2013, J CLIN LIPIDOL, V7, P194, DOI 10.1016/j.jacl.2013.02.003; Taylor B, 2009, ADDICTION, V104, P1981, DOI 10.1111/j.1360-0443.2009.02694.x; Mancia G, 2007, J HYPERTENS, V25, P1105, DOI 10.1097/HJH.0b013e3281fc975a; Mineo C, 2012, CIRC RES, V111, P1079, DOI 10.1161/CIRCRESAHA.111.258673; MIZOI Y, 1983, PHARMACOL BIOCHEM BE, V18, P127, DOI 10.1016/0091-3057(83)90159-4; Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x; [Anonymous], 2005, J JPN SOC INT MED, V94, P794; Link JJ, 2007, CURR PROB CARDIOLOGY, V32, P268, DOI 10.1016/j.cpcardiol.2007.01.004; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Rimm EB, 1999, BRIT MED J, V319, P1523; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Bays HE, 2014, J CLIN LIPIDOL, V8, pS1, DOI 10.1016/j.jacl.2014.10.002; Collins P, 2008, INT J CARDIOL, V124, P275, DOI 10.1016/j.ijcard.2007.06.009; Diabetes A. American, 2010, DIABETES CARE S1, V33, pS62; Hata Y, 1986, Nihon Ronen Igakkai Zasshi, V23, P413; Hsieh SD, 2006, PREV MED, V42, P135, DOI 10.1016/j.ypmed.2005.08.007; Investigating Committee of Guideline for Diagnosis and Treatment of Hyperlipidemias Japan Atherosclerosis Society, 1997, J JPN ATHEROSCLER SO, V25, P1; Kahn Henry S, 2005, BMC Cardiovasc Disord, V5, P26, DOI 10.1186/1471-2261-5-26; Kashiwagi A, 2012, DIABETOL INT, V3, P8, DOI DOI 10.1007/S13340-012-0069-8; Kinoshita M, 1996, ATHEROSCLEROSIS, V120, P75, DOI 10.1016/0021-9150(95)05684-X; Klatsky AL, 2003, J CARDIOVASC RISK, V10, P21, DOI 10.1097/01.hjr.0000051960.68260.79; Maruyama T, 2003, ATHEROSCLEROSIS, V166, P177, DOI 10.1016/S0021-9150(02)00327-1; National Cholesterol Education Program (NCEP), 2002, CIRCULATION, V106, P3143, DOI DOI 10.2215/CJN.04131206; SUDDENDORF RF, 1989, PUBLIC HEALTH REP, V104, P615; Matsuzawa Y, 2002, CIRC J, V66, P987; Wakabayashi I., 2013, INTERDISIPLINARY CON, VI, P145; Wakabayashi I, 2014, J ATHEROSCLER THROMB, V21, P282; Wang H, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-176; Wehr E, 2011, OBESITY, V19, P1873, DOI 10.1038/oby.2011.42	29	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1933-2874	1876-4789		J CLIN LIPIDOL	J. Clin. Lipidol.	OCT	2015	9	5					684	691		10.1016/j.jacl.2015.07.002		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CR5WQ	WOS:000361415500010		
J	Kakuda, H; Matoba, M; Nakatoh, H; Nagao, S; Takekoshi, N				Kakuda, Hirokazu; Matoba, Munetoshi; Nakatoh, Hideaki; Nagao, Shin; Takekoshi, Noboru			Effects of change in high-density lipoprotein cholesterol by statin switching on glucose metabolism and renal function in hypercholesterolemia	JOURNAL OF CLINICAL LIPIDOLOGY			English	Article						Statin; HDL cholesterol; Glucose metabolism; Renal function	GLOMERULAR-FILTRATION-RATE; TYPE-2 DIABETES-MELLITUS; CARDIOVASCULAR EVENTS; RANDOMIZED-TRIALS; INSULIN-SECRETION; LDL CHOLESTEROL; HDL-CHOLESTEROL; DISEASE; RISK; PITAVASTATIN	BACKGROUND: Recent reports have suggested that high-density lipoprotein (HDL) is metabolically related to glucose metabolism and renal function. Statin administration clinically increases HDL cholesterol (HDL-C). OBJECTIVE: To confirm that change in HDL-C by statin switching is associated with glucose metabolism and renal function in hypercholesterolemic patients. METHODS: In hypercholesterolemic outpatients (n = 129) who had taken either statin, as atorvastatin, pitavastatin, or rosuvastatin and switched to another statin, the relationship of change in HDL-C to glycated hemoglobin and estimated glomerular filtration rate (eGFR) was assessed. RESULTS: Change in HDL-C did not significantly correlate with change in HbA1c, eGFR calculated from creatinine (eGFRcre), and eGFR calculated from cystatin C (eGFRcys). The subjects were then divided into 2 groups by change in HDL-C: no change or decrease in HDL-C (HD group) and increase in HDL-C (HI group). In the HI group, apolipoprotein A-1 (Apo A-1) and eGFRs were significantly increased by statin switching. There were significant differences in changes in HDL-C, Apo A-1, lipoprotein lipase, glycated hemoglobin, and eGFR calculated from creatinine between the groups. In the patients with impaired glucose tolerance or diabetes, change in HbA1c was also significant between the groups. CONCLUSIONS: Our data suggest that an increase in HDL-C due to statin switching is associated with improvement in glucose metabolism and renal function. (C) 2015 National Lipid Association. All rights reserved.	[Kakuda, Hirokazu] Kakuda Clin, Kahoku, Ishikawa 9291215, Japan; [Matoba, Munetoshi] Matoba Clin, Kanazawa, Ishikawa, Japan; [Nakatoh, Hideaki] Nakatoh Clin, Kanazawa, Ishikawa, Japan; [Nagao, Shin] Nagao Clin, Haku San, Ishikawa, Japan; [Takekoshi, Noboru] Kanazawa Med Univ, Div Cardiol, Kanazawa, Ishikawa, Japan	Kakuda, H (reprint author), Kakuda Clin, Takamatsu Na 15-1, Kahoku, Ishikawa 9291215, Japan.	hirkakud@yahoo.co.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Durrington PN, 2001, ARTERIOSCL THROM VAS, V21, P473; Kearney PM, 2008, LANCET, V371, P117; Drew BG, 2009, CIRCULATION, V119, P2103, DOI 10.1161/CIRCULATIONAHA.108.843219; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Nichols GA, 2011, AM J CARDIOL, V108, P1124, DOI 10.1016/j.amjcard.2011.05.047; Fryirs MA, 2010, ARTERIOSCL THROM VAS, V30, P1642, DOI 10.1161/ATVBAHA.110.207373; Brunham LR, 2008, J CLIN INVEST, V118, P403, DOI 10.1172/JCI33296; Acharjee S, 2013, J AM COLL CARDIOL, V62, P1826, DOI 10.1016/j.jacc.2013.07.051; Saku K, 2011, CIRC J, V75, P1493, DOI 10.1253/circj.CJ-10-1281; Mackness B, 2003, CIRCULATION, V107, P2775, DOI 10.1161/01.CIR.0000070954.00271.13; Yamashita S, 2010, J ATHEROSCLER THROMB, V17, P436; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993; Kakuda H, 2014, SCAND J CLIN LAB INV, V74, P285, DOI 10.3109/00365513.2014.882015; Arnaboldi L, 2015, ATHEROSCLEROSIS SUPP, V16, P1, DOI 10.1016/S1567-5688(14)70002-9; Athyros Vasilios G, 2007, Open Cardiovasc Med J, V1, P8, DOI 10.2174/1874192400701010008; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Dullaart RPF, 2012, ATHEROSCLEROSIS, V222, P567, DOI 10.1016/j.atherosclerosis.2012.03.037; Getz GS, 2010, ARTERIOSCL THROM VAS, V30, P1497, DOI 10.1161/ATVBAHA.110.210583; Horio M, 2011, CLIN EXP NEPHROL, V15, P868, DOI 10.1007/s10157-011-0525-y; Kimura K, 2010, J ATHEROSCLER THROMB, V17, P601; MOORHEAD JF, 1982, LANCET, V2, P1309; Perticone F, 2010, CIRCULATION, V122, P379, DOI 10.1161/CIRCULATIONAHA.110.940932; von Eckardstein A, 2011, CURR OPIN LIPIDOL, V22, P26, DOI 10.1097/MOL.0b013e3283412279	26	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1933-2874	1876-4789		J CLIN LIPIDOL	J. Clin. Lipidol.	OCT	2015	9	5					709	715		10.1016/j.jacl.2015.07.007		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CR5WQ	WOS:000361415500014		
J	Nakamura, M; Aoki, Y; Enna, G; Oguro, K; Wada, H				Nakamura, Makito; Aoki, Yasutomo; Enna, Genichirou; Oguro, Kaoru; Wada, Hiroshi			Polyurethane damping material	JOURNAL OF ELASTOMERS AND PLASTICS			English	Article						Polyether-aromatic polyester; damping material; dynamical mechanical analysis; thermoplastic polyurethane; shape memorizing polyurethane; tan		The mechanical and damping properties of thermoplastic polyurethanes (TPUs) prepared by polyether-aromatic polyester polyols were studied. Dynamic viscoelastic properties (E and tan ) were mainly investigated using a dynamical mechanical analysis. By increasing the content of the aromatic ester component of soft segment in each segmented PU, the value of tan increased, and the width of the peak narrowed with the same hard segment contents. It was desired that interaction between hard and soft segment in U-Fine (UF)-A and UF-B is uniform, and the degree of phase separation between hard and soft segment in UF-A and UF-B advanced in comparison with TPU-A. Tensile strength and abrasion resistance of UF-B (ester component content of polyether-ester polyol = 20.3 mol%) showed superior data compared with other commercial damping materials.	[Nakamura, Makito; Aoki, Yasutomo; Oguro, Kaoru] Asahi Glass Co Ltd, Technol Management Gen Div, Kashima Tech Ctr, AGC Chem,Polymer Mat Dev Off, Kamisu 3140195, Japan; [Enna, Genichirou] Asahi Glass Co Ltd, Kashima Plant, Environm & Safety Div, Environm Management Grp, Kamisu 3140195, Japan; [Wada, Hiroshi] Asahi Glass Co Ltd, AGC Chem, Polyurethanes Div, Kamisu 3140195, Japan	Nakamura, M (reprint author), Asahi Glass Co Ltd, Technol Management Gen Div, Kashima Tech Ctr, AGC Chem,Polymer Mat Dev Off, 25 Touwada, Kamisu 3140195, Japan.	makito-nakamura@agc.com					Takahashi T, 1996, J APPL POLYM SCI, V60, P1061; Lin JR, 1998, J APPL POLYM SCI, V69, P1563, DOI 10.1002/(SICI)1097-4628(19980822)69:8<1563::AID-APP11>3.0.CO;2-W; Li FK, 1997, J APPL POLYM SCI, V64, P1511, DOI 10.1002/(SICI)1097-4628(19970523)64:8<1511::AID-APP8>3.0.CO;2-K; Chase D, 1997, Patent, Patent No. [5,632,045A, 563245]; Hiles M, 1984, Patent, Patent No. [4,808,496A, 4808496]; Karall G, 2001, Patent, Patent No. [6,202,217B1, 6202217]; Kwan YH, 2000, J APPL POLYM SCI, V75, P604; Woods G, 1990, ICI POLYURETHANES BO, P177; Wright P, 1969, SOLID POLYURETHANE E, P180	9	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0095-2443	1530-8006		J ELASTOM PLAST	J. Elastomer Plast.	OCT	2015	47	6					515	522		10.1177/0095244314526739		8	Materials Science, Multidisciplinary; Polymer Science	Materials Science; Polymer Science	CR7KJ	WOS:000361528100004		
J	Kordolemis, A; Aravas, N; Giannakopoulos, AE				Kordolemis, A.; Aravas, N.; Giannakopoulos, A. E.			Pretwisted Beams in Axial Tension and Torsion: Analogy with Dipolar Gradient Elasticity and Applications to Textile Materials	JOURNAL OF ENGINEERING MECHANICS			English	Article						Coupled tension-torsion; Dipolar gradient elasticity; Textile yarns	CROSS-SECTIONS; INITIAL TWIST; EXTENSION; BEHAVIOR; BARS	A technical theory for pretwisted beams that accounts for variable twist (constrained warping) is based on an approximate displacement field that is defined completely in terms of two unknown functions: the axial displacement w(1)(z) and the rotation phi(z) of the cross section about the centroidal axis of the beam, z being the coordinate along the axis of the beam. The primary unknowns are determined by minimizing the potential energy of the beam. The problem is then formulated in terms of w(1)(z), and an analogue between the technical theory and a one-dimensional dipolar gradient elasticity model is presented. The application of the theory to textile materials is discussed. (C) 2015 American Society of Civil Engineers.	[Kordolemis, A.; Giannakopoulos, A. E.] Univ Thessaly, Dept Civil Engn, Volos 38334, Greece; [Aravas, N.] Univ Thessaly, Dept Mech Engn, Volos 38334, Greece; [Aravas, N.] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, Fukuoka 8190395, Japan	Kordolemis, A (reprint author), Univ Thessaly, Dept Civil Engn, Volos 38334, Greece.	alkordol@uth.gr			European Union (European Social Fund-ESF); Greek national funds through the operational program Education and Lifelong Learning of the National Strategic Reference Framework (NSRF)-Research Funding Program titled "Heraclitus II. Investing in Knowledge Society through the European Social Fund"	This research has been cofinanced by the European Union (European Social Fund-ESF) and Greek national funds through the operational program Education and Lifelong Learning of the National Strategic Reference Framework (NSRF)-Research Funding Program titled "Heraclitus II. Investing in Knowledge Society through the European Social Fund."	Tsepoura KG, 2002, ARCH APPL MECH, V72, P483, DOI 10.1007/S00419-002-0231-Z; Jiang WG, 2001, EUR J MECH A-SOLID, V20, P501, DOI 10.1016/S0997-7538(00)01131-1; KRENK S, 1986, COMPUT STRUCT, V24, P1, DOI 10.1016/0045-7949(86)90330-5; KRENK S, 1983, J APPL MECH-T ASME, V50, P137; Papargyri-Beskou S, 2009, INT J SOLIDS STRUCT, V46, P3751, DOI 10.1016/j.ijsolstr.2009.05.002; Liu KC, 2009, J SOUND VIB, V321, P115, DOI 10.1016/j.jsv.2008.09.016; Giannakopoulos AE, 2013, INT J SOLIDS STRUCT, V50, P3922, DOI 10.1016/j.ijsolstr.2013.08.003; Wajchman D, 2008, IEEE T ULTRASON FERR, V55, P832, DOI 10.1109/TUFFC.2008.717; OKUBO H, 1954, Q APPL MATH, V11, P488; dell'Isola F, 2009, P R SOC A, V465, P2177, DOI 10.1098/rspa.2008.0530; ROSEN A, 1980, J APPL MECH-T ASME, V47, P389; Suiker ASJ, 2000, ACTA MECH, V142, P223, DOI 10.1007/BF01190020; OKUBO H, 1951, Q APPL MATH, V9, P263; KOSMATKA JB, 1992, J APPL MECH-T ASME, V59, P146, DOI 10.1115/1.2899420; REISSNER E, 1968, J MATH PHYS CAMB, V47, P1; SHIELD RT, 1982, J APPL MECH-T ASME, V49, P779; King MJ, 2005, INT J SOLIDS STRUCT, V42, P3867, DOI 10.1016/j.ijsolstr.2004.10.030; Georgiadis HG, 2004, J ELASTICITY, V74, P17, DOI 10.1023/B:ELAS.0000026094.95688.c5; MINDLIN RD, 1964, ARCH RATION MECH AN, V16, P51; MALYUGIN DV, 1991, J MAGN MAGN MATER, V97, P193, DOI 10.1016/0304-8853(91)90180-I; KRENK S, 1983, INT J SOLIDS STRUCT, V19, P67, DOI 10.1016/0020-7683(83)90038-0; HODGES DH, 1980, J APPL MECH-T ASME, V47, P393; Boisse P, 2011, COMPOS SCI TECHNOL, V71, P683, DOI 10.1016/j.compscitech.2011.01.011; Georgiadis HG, 2000, WAVE MOTION, V31, P333, DOI 10.1016/S0165-2125(99)00035-9; KRENK S, 1981, INT J NUMER METH ENG, V17, P1407, DOI 10.1002/nme.1620170909; Biot MA, 1939, J APPL PHYS, V10, P860, DOI 10.1063/1.1707272; Vardoulakis I, 1996, INT J SOLIDS STRUCT, V33, P4531, DOI 10.1016/0020-7683(95)00277-4; CASAL P, 1972, CR ACAD SCI A MATH, V274, P1571; CASAL P, 1963, CR HEBD ACAD SCI, V256, P3820; Casal P, 1961, CAHIER GROUPE FRANCA, VVI, P31; Chu C., 1951, P 1 US NAT C APPL ME, P265; Goodier J. N., 1962, HDB ENG MECH; Hearle J.W.S., 1969, STRUCTURAL MECH FIBE; Knowles J. K., 1960, Q APPL MATH, V17, P409; Mindlin R.D., 1968, International Journal of Solids and Structures, V4, DOI 10.1016/0020-7683(68)90036-X; OKUBO H, 1953, J APPL MECH-T ASME, V20, P273; Rosen A., 1991, APPLIED MECHANICS RE, V44, P483; ROSEN A, 1983, J APPL MECH-T ASME, V50, P321; Sokolnikoff I.S., 1956, MATH THEORY ELASTICI; Song O, 2006, THIN WALLED COMPOSIT; Vardoulakis I., 1995, BIFURCATION ANAL GEO; Vlasov VZ, 1961, THIN WALLED ELASTIC; Wagner H., 1936, 807 NACA, V807; WASHIZU K, 1964, J MATH PHYS CAMB, V43, P111	44	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0733-9399	1943-7889		J ENG MECH	J. Eng. Mech.	OCT	2015	141	10							04015036	10.1061/(ASCE)EM.1943-7889.0000917		13	Engineering, Mechanical	Engineering	CR6RQ	WOS:000361475400005		
J	Phusing, D; Suzuki, K				Phusing, Daraporn; Suzuki, Kiichi			Cyclic Behaviors of Granular Materials under Generalized Stress Condition Using DEM	JOURNAL OF ENGINEERING MECHANICS			English	Article						Discrete-element method; Cyclic stress path; Three-dimensional stress	MEDIA	Most behaviors of granular materials have been studied under the limit conditions of stress paths such as cyclic triaxial compression and extension tests. Furthermore, the macrobehavior and micromechanical response of granular materials under more comprehensive cyclic loading tests in the generalized stress condition are not well understood. The objectives of this paper are to ensure the ability of the Discrete Element Method (DEM), to simulate the macrobehavior of granular materials under various cyclic stress paths of the generalized stress condition, and to explore the micromechanical response. To this end, four different cyclic stress paths under generalized stress simulations, following the stress-controlled method on a sample of spheres, were conducted. To check the validity of DEM results, the experimental results of the real sand under cyclic stress programs were used. The macrobehaviors, indicated by the stress-strain-dilation relationship and the directions of principal strain increment vectors, are described. A qualitative comparison of the stress-strain-dilation between the DEM and experimental results under triaxial cyclic loading shows a similarity tendency. Furthermore, micromechanical responses, which are indicated by coordination number and sliding contact fraction, are used to explain the macrobehavior in cyclic loading. Additionally, the macro-micro relationship is explained using the relationship between the stress ratio and the fabric structures of all contacts, and of only the strong contacts. The result shows that the unique macro-micro relationship does not depend on the generalized cyclic stress path or the number of cycles. (C) 2015 American Society of Civil Engineers.	[Phusing, Daraporn; Suzuki, Kiichi] Saitama Univ, Dept Civil & Environm Engn, Saitama 3388570, Japan	Phusing, D (reprint author), Saitama Univ, Dept Civil & Environm Engn, Saitama 3388570, Japan.	daraporn.p@gmail.com			Monbukagakusho Scholarship (MEXT)	This research was supported by the Monbukagakusho Scholarship (MEXT), which allows the first author to do this research at Saitama University, Saitama, Japan. Additionally, the authors are grateful to Prof. Matthew R. Kuhn from the University of Portland for making a free source code (Oval) available.	Thornton C, 1998, PHILOS T R SOC A, V356, P2763; Sitharam TG, 2002, INT J NUMER ANAL MET, V26, P1167, DOI 10.1002/nag.240; CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47; Hu MY, 2010, GRANUL MATTER, V12, P469, DOI 10.1007/s10035-010-0206-7; Antony SJ, 2004, COMP MATER SCI, V29, P494, DOI 10.1016/j.commatsci.2003.12.007; Sazzad MM, 2012, INT J GEOMECH, V12, P220, DOI 10.1061/(ASCE)GM.1943-5622.0000133; Ng TT, 2004, INT J SOLIDS STRUCT, V41, P5871, DOI 10.1016/j.ijsolstr.2004.05.050; Habib P, 1953, P 3 INT C SOIL MECH, V1, P131; Kuhn M. R, 2006, OVAL OVALPLOT PROGRA; Nakai T, 2003, DEFORMATION CHARACTERISTICS OF GEOMATERIALS, P1087; Nakai T., 1996, P 3 AS PAC S ADV ENG, P421; Nakai T., 2001, P 10 INT C COMP METH, P367; O'sullivan C., 2011, PARTICULATE DISCRETE, P181; Phusing D., 2015, INT J GEOME IN PRESS; Satake M., 1982, P IUTAM S DEF FAIL G, P63; Sitharam T. G., 2003, GEOTECHNICAL GEOLOGI, V21, P297, DOI 10.1023/B:GEGE.0000006036.00597.0b; Suzuki K., 2006, INT J GEOMECH, P356, DOI 10.1061/(ASCE)1532-3641(2006)6:5(356); Tatsuoka F., 1974, SOILS FOUND, V14, P51; Wang J., 2005, THESIS U NOTTINGHAM	19	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0733-9399	1943-7889		J ENG MECH	J. Eng. Mech.	OCT	2015	141	10							04015034	10.1061/(ASCE)EM.1943-7889.0000921		12	Engineering, Mechanical	Engineering	CR6RQ	WOS:000361475400003		
J	Wang, WL; Wu, QY; Wang, ZM; Niu, LX; Wang, C; Sun, MC; Hu, HY				Wang, Wen-Long; Wu, Qian-Yuan; Wang, Zheng-Ming; Niu, Li-Xia; Wang, Chao; Sun, Ming-Chao; Hu, Hong-Ying			Adsorption removal of antiviral drug oseltamivir and its metabolite oseltamivir carboxylate by carbon nanotubes: Effects of carbon nanotube properties and media	JOURNAL OF ENVIRONMENTAL MANAGEMENT			English	Article						Antiviral drug; Oseltamivir; Oseltamivir carboxylate; Carbon nanotubes; Adsorption	ACTIVATED CARBON; AQUEOUS-SOLUTIONS; ORGANIC CONTAMINANTS; AROMATIC-COMPOUNDS; BISPHENOL-A; TAMIFLU; KINETICS; WATER; NANOMATERIALS; CARBAMAZEPINE	This investigation evaluated the adsorption behavior of the antiviral drugs of oseltamivir (OE) and its metabolites (i.e., oseltamivir carboxylate (OC)) on three types of carbon nanotubes (CNTs) including single-walled CNT (SWCNT), multi-walled CNT (MWCNT), and carboxylated SWCNT (SWCNT-COOH). CNTs can efficiently remove more than 90% of the OE and OC from aqueous solution when the initial concentration was lower than 10(-4) mmol/L The Polanyi Manes model depicted the adsorption isotherms of OE and OC on CNTs better than the Langmuir and Freundlich models. The properties of OE/OC and the characteristics of CNTs, particularly the oxygen functional groups (e.g., SWCNT-COOH) played important roles during the adsorption processes. OE showed a higher adsorption affinity than OC. By comparing the different adsorbates adsorption on each CNT and each adsorbate adsorption on different CNTs, the adsorption mechanisms of hydrophobic interaction, electrostatic interaction, van der Waals force, and H-bonding were proposed as the contributing factors for OE and OC adsorption on CNTs. Particularly, for verifying the contribution of electrostatic interaction, the changes of adsorption partition efficiency (K-d) of OE and OC on CNTs were evaluated by varying pH from 2 to 11 and the importance of isoelectric point (pH(IEP)) of CNTs on OE and OC adsorption was addressed. (C) 2015 Elsevier Ltd. All rights reserved.	[Wang, Wen-Long; Niu, Li-Xia; Hu, Hong-Ying] Tsinghua Univ, Environm Simulat & Pollut Control State Key joint, State Environm Protect Key Lab Microorganism Appl, Sch Environm, Beijing 100084, Peoples R China; [Wang, Wen-Long; Wu, Qian-Yuan; Niu, Li-Xia; Hu, Hong-Ying] Tsinghua Univ, Grad Sch Shenzhen, Shenzhen Lab Microorganism Applicat & Risk Contro, Shenzhen 518055, Peoples R China; [Wang, Zheng-Ming; Sun, Ming-Chao] Natl Inst Adv Ind Sci & Technol, Environm Management Technol Res Inst, Tsukuba, Ibaraki 3058569, Japan; [Wang, Chao] Technol & Higher Educ Inst Hong Kong, Fac Sci & Technol, Hong Kong, Hong Kong, Peoples R China; [Sun, Ming-Chao] Sichuan Univ, Coll Architecture & Environm, Chengdu 610065, Sichuan, Peoples R China	Wu, QY (reprint author), Tsinghua Univ, Grad Sch Shenzhen, Shenzhen Lab Microorganism Applicat & Risk Contro, Shenzhen 518055, Peoples R China.	wuqianyuan@tsinghua.edu.cn; zm-wang@aist.go.jp			National High-Tech Research and Development Program (863) of China [SS2013AA061805]; Science Fund for Creative Research Groups [21221004]; Collaborative Innovation Center for Regional Environmental Quality, China; AIST, Japan; Technological and Higher Education Institute of Hong Kong	This study was supported by the National High-Tech Research and Development Program (863) of China (No. SS2013AA061805), the Science Fund for Creative Research Groups (No. 21221004) and the Collaborative Innovation Center for Regional Environmental Quality, China, and was partially supported by the water project of AIST, Japan. The authors thank the Technological and Higher Education Institute of Hong Kong for their partial financial support. Dr. Hao-Yi Wu in AIST is grateful for the assistance in ATR-FT-IR measurement.	Accinelli C, 2010, CHEMOSPHERE, V79, P891, DOI 10.1016/j.chemosphere.2010.02.022; Chen GC, 2011, J HAZARD MATER, V188, P156, DOI 10.1016/j.jhazmat.2011.01.095; Yang K, 2008, ENVIRON SCI TECHNOL, V42, P7931, DOI 10.1021/es801463v; Zhang SJ, 2010, ENVIRON SCI TECHNOL, V44, P6377, DOI 10.1021/es100874y; Liu Y, 2008, LANGMUIR, V24, P11625, DOI 10.1021/la801839b; Lerman I, 2013, ENVIRON POLLUT, V182, P169, DOI 10.1016/j.envpol.2013.07.010; Yang K, 2010, CHEM REV, V110, P5989, DOI 10.1021/cr100059s; Chen GC, 2009, WATER RES, V43, P2409, DOI 10.1016/j.watres.2009.03.002; Pan B, 2008, ENVIRON SCI TECHNOL, V42, P9005, DOI 10.1021/es801777n; Goncalves C, 2011, ENVIRON SCI TECHNOL, V45, P4307, DOI 10.1021/es1032629; Singer AC, 2007, ENVIRON HEALTH PERSP, V115, P102, DOI 10.1289/ehp.9574; Yu ZR, 2008, WATER RES, V42, P2873, DOI 10.1016/j.watres.2008.02.020; MANES M, 1969, J PHYS CHEM-US, V73, P584, DOI 10.1021/j100723a018; Ho YS, 2006, J HAZARD MATER, V136, P681, DOI 10.1016/j.jhazmat.2005.12.043; Singer AC, 2008, ENVIRON HEALTH PERSP, V116, P1563, DOI 10.1289/ehp.11310; Ghosh GC, 2010, ENVIRON HEALTH PERSP, V118, P103, DOI 10.1289/ehp.0900930; Azuma T, 2012, ENVIRON SCI TECHNOL, V46, P12873, DOI 10.1021/es303203c; Apul OG, 2013, WATER RES, V47, P1648, DOI 10.1016/j.watres.2012.12.031; Ward P, 2005, J ANTIMICROB CHEMOTH, V55, P5, DOI 10.1093/jac/dki018; Carabineiro SAC, 2011, WATER RES, V45, P4583, DOI 10.1016/j.watres.2011.06.008; Lin DH, 2008, ENVIRON SCI TECHNOL, V42, P7254, DOI 10.1021/es801297u; Zhang D, 2010, ENVIRON SCI TECHNOL, V44, P3806, DOI 10.1021/es903851q; Moreno-Castilla C, 2004, CARBON, V42, P83, DOI 10.1016/j.carbon.2003.09.022; Yang K, 2009, ENVIRON POLLUT, V157, P1095, DOI 10.1016/j.envpol.2008.11.007; Prasse C, 2010, ENVIRON SCI TECHNOL, V44, P1728, DOI 10.1021/es903216p; Chen W, 2007, ENVIRON SCI TECHNOL, V41, P8295, DOI 10.1021/es071230h; Wang F, 2010, ENVIRON SCI TECHNOL, V44, P6985, DOI 10.1021/es101326j; Yang K, 2006, ENVIRON SCI TECHNOL, V40, P1855, DOI 10.1021/es052208w; Sheng GD, 2010, J HAZARD MATER, V178, P505, DOI 10.1016/j.jhazmat.2010.01.110; Yan H, 2006, CHEMOSPHERE, V62, P142, DOI 10.1016/j.chemosphere.2005.03.075; Wang XL, 2008, ENVIRON SCI TECHNOL, V42, P3207, DOI 10.1021/es702971g; Gupta VK, 2013, ADV COLLOID INTERFAC, V193, P24, DOI 10.1016/j.cis.2013.03.003; Oleszczuk P, 2009, ENVIRON SCI TECHNOL, V43, P9167, DOI 10.1021/es901928q; Pan B, 2008, ENVIRON SCI TECHNOL, V42, P5480, DOI 10.1021/es8001184; Yu F, 2011, J HAZARD MATER, V192, P1370, DOI 10.1016/j.jhazmat.2011.06.048; Chen GC, 2008, ENVIRON SCI TECHNOL, V42, P8297, DOI 10.1021/es801376w; Ji LL, 2009, ENVIRON SCI TECHNOL, V43, P2322, DOI 10.1021/es803268b; Fick J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000986; Hu YH, 2004, IND ENG CHEM RES, V43, P708, DOI 10.1021/ie030757+; Leknes H, 2012, SCI TOTAL ENVIRON, V414, P632, DOI 10.1016/j.scitotenv.2011.11.004; Sacca ML, 2009, CHEMOSPHERE, V75, P28, DOI 10.1016/j.chemosphere.2008.11.060; Wang Z, 2009, ENVIRON SCI TECHNOL, V44, P978, DOI DOI 10.1021/ES902775U; Zhou XY, 2014, J HAZARD MATER, V273, P61, DOI 10.1016/j.jhazmat.2014.03.029	43	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0301-4797	1095-8630		J ENVIRON MANAGE	J. Environ. Manage.	OCT 1	2015	162						326	333		10.1016/j.jenvman.2015.07.043		8	Environmental Sciences	Environmental Sciences & Ecology	CR3WU	WOS:000361264600035		
J	Evrard, O; Laceby, JP; Lepage, H; Onda, Y; Cerdan, O; Ayrault, S				Evrard, Olivier; Laceby, J. Patrick; Lepage, Hugo; Onda, Yuichi; Cerdan, Olivier; Ayrault, Sophie			Radiocesium transfer from hillslopes to the Pacific Ocean after the Fukushima Nuclear Power Plant accident: A review	JOURNAL OF ENVIRONMENTAL RADIOACTIVITY			English	Review						Fukushima; Cesium; Soil; Sediment; Forest; Modelling	SOIL-EROSION MODEL; VERTICAL-DISTRIBUTION; RIVER SYSTEMS; PADDY FIELDS; SENSITIVITY-ANALYSIS; SEDIMENT TRANSPORT; SELECTIVE SORPTION; RADIOACTIVE CESIUM; SUSPENDED SEDIMENT; DEPTH DISTRIBUTION	The devastating tsunami triggered by the Great East Japan Earthquake on March 11, 2011 inundated the Fukushima Dai-ichi Nuclear Power Plant (FDNPP) resulting in a loss of cooling and a series of explosions releasing the largest quantity of radioactive material into the atmosphere since the Chernobyl nuclear accident. Although 80% of the radionuclides from this accidental release were transported over the Pacific Ocean, 20% were deposited over Japanese coastal catchments that are subject to frequent typhoons. Among the radioisotopes released during the FDNPP accident, radiocesium (Cs-134 and Cs-137) is considered the most serious current and future health risk for the local population. The goal of this review is to synthesize research relevant to the transfer of FDNPP derived radiocesium from hillslopes to the Pacific Ocean. After radiocesium fallout deposition on vegetation and soils, the contamination may remain stored in forest canopies, in vegetative litter on the ground, or in the soil. Once radiocesium contacts soil, it is quickly and almost irreversibly bound to fine soil particles. The kinetic energy of raindrops instigates the displacement of soil particles, and their bound radiocesium, which may be mobilized and transported with overland flow. Soil erosion is one of the main processes transferring particle-bound radiocesium from hillslopes through rivers and streams, and ultimately to the Pacific Ocean. Accordingly this review will summarize results regarding the fundamental processes and dynamics that govern radiocesium transfer from hillslopes to the Pacific Ocean published in the literature within the first four years after the FDNPP accident. The majority of radiocesium is reported to be transported in the particulate fraction, attached to fine particles. The contribution of the dissolved fraction to radiocesium migration is only relevant in base flows and is hypothesized to decline over time. Owing to the hydro-meteorological context of the Fukushima region, the most significant transfer of particulate-bound radiocesium occurs during major rainfall and runoff events (e.g. typhoons and spring snowmelt). There may be radiocesium storage within catchments in forests, floodplains and even within hillslopes that may be remobilized and contaminate downstream areas, even areas that did not receive fallout or may have been decontaminated. Overall this review demonstrates that characterizing the different mechanisms and factors driving radiocesium transfer is important. In particular, the review determined that quantifying the remaining catchment radiocesium inventory allows for a relative comparison of radiocesium transfer research from hillslope to catchment scales. Further, owing to the variety of mechanisms and factors, a transdisciplinary approach is required involving geomorpholog-ists, hydrologists, soil and forestry scientists, and mathematical modellers to comprehensively quantify radiocesium transfers and dynamics. Characterizing radiocesium transfers from hillslopes to the Pacific Ocean is necessary for ongoing decontamination and management interventions with the objective of reducing the gamma radiation exposure to the local population. (C) 2015 Elsevier Ltd. All rights reserved.	[Evrard, Olivier; Laceby, J. Patrick; Lepage, Hugo; Ayrault, Sophie] Unite Mixte Rech 8212 CEA CNRS UVSQ IPSL, LSCE, Gif Sur Yvette, France; [Onda, Yuichi] Univ Tsukuba, Grad Sch Life & Environm Sci, CRIED, Tsukuba, Ibaraki, Japan; [Cerdan, Olivier] Bur Rech Geol & Minieres, F-45060 Orleans, France	Evrard, O (reprint author), Unite Mixte Rech 8212 CEA CNRS UVSQ IPSL, LSCE, Gif Sur Yvette, France.	Olivier.Evrard@lsce.ipsl.fr		Laceby, John Patrick/0000-0003-4066-8737	French National Research Agency (ANR) [ANR-11-RSNR-0002]	We would like to thank the anonymous reviewers for their comments and feedback on the manuscript. This work has been supported by the French National Research Agency (ANR) in the framework of AMORAD project (ANR-11-RSNR-0002).	Akai J, 2013, PHYS CHEM EARTH, V58-60, P57, DOI 10.1016/j.pce.2013.04.010; Akama A., 2013, JPN J FOR ENV, V55, P105; Tanaka K, 2013, J RADIOANAL NUCL CH, V295, P2007, DOI 10.1007/s10967-012-2192-1; He Q, 1997, APPL RADIAT ISOTOPES, V48, P677, DOI 10.1016/S0969-8043(96)00302-8; SAWHNEY BL, 1972, CLAY CLAY MINER, V20, P93, DOI 10.1346/CCMN.1972.0200208; Evrard O, 2014, ENVIRON SCI TECHNOL, V48, P9334, DOI 10.1021/es501890n; Le Petit G, 2014, PURE APPL GEOPHYS, V171, P629, DOI 10.1007/s00024-012-0581-6; Kuroda K, 2013, J ENVIRON RADIOACTIV, V122, P37, DOI 10.1016/j.jenvrad.2013.02.019; Loffredo N, 2014, SCI TOTAL ENVIRON, V493, P701, DOI 10.1016/j.scitotenv.2014.06.059; Hilton RG, 2008, NAT GEOSCI, V1, P759, DOI 10.1038/ngeo333; Evrard O, 2012, J ENVIRON RADIOACTIV, V114, P54, DOI 10.1016/j.jenvrad.2012.01.024; Motha JA, 2002, HYDROL PROCESS, V16, P1983, DOI 10.1002/hyp.397; Issa OM, 2006, EARTH SURF PROC LAND, V31, P929, DOI 10.1002/esp.1303; Matsunaga T, 2013, SCI TOTAL ENVIRON, V447, P301, DOI 10.1016/j.scitotenv.2012.12.087; Tsuji H, 2014, WATER RES, V60, P15, DOI 10.1016/j.watres.2014.04.024; Thakur P, 2013, SCI TOTAL ENVIRON, V458, P577, DOI 10.1016/j.scitotenv.2013.03.105; Yoshimura K, 2015, J ENVIRON RADIOACTIV, V139, P362, DOI 10.1016/j.jenvrad.2014.07.019; Kinouchi T, 2015, J ENVIRON RADIOACTIV, V139, P407, DOI 10.1016/j.jenvrad.2014.07.022; Long NQ, 2012, J ENVIRON RADIOACTIV, V111, P53, DOI 10.1016/j.jenvrad.2011.11.018; Vandaele K, 1996, GEOMORPHOLOGY, V16, P161, DOI 10.1016/0169-555X(95)00141-Q; Fujiwara T, 2012, J ENVIRON RADIOACTIV, V113, P37, DOI 10.1016/j.jenvrad.2012.04.007; NEARING MA, 1989, T ASAE, V32, P1587; Matsuda N, 2015, J ENVIRON RADIOACTIV, V139, P427, DOI 10.1016/j.jenvrad.2014.10.001; Tanaka K, 2013, J RADIOANAL NUCL CH, V295, P1927, DOI 10.1007/s10967-012-2160-9; Tanaka K, 2015, J ENVIRON RADIOACTIV, V139, P390, DOI 10.1016/j.jenvrad.2014.05.002; Ueda S, 2013, J ENVIRON RADIOACTIV, V118, P96, DOI 10.1016/j.jenvrad.2012.11.009; Schwantes JM, 2012, ENVIRON SCI TECHNOL, V46, P8621, DOI 10.1021/es300556m; Morgan RPC, 1998, EARTH SURF PROC LAND, V23, P527, DOI 10.1002/(SICI)1096-9837(199806)23:6<527::AID-ESP868>3.0.CO;2-5; Achim P, 2014, PURE APPL GEOPHYS, V171, P645, DOI 10.1007/s00024-012-0578-1; GOVERS G, 1985, CATENA, V12, P35, DOI 10.1016/S0341-8162(85)80003-5; Nakanishi T, 2014, J ENVIRON RADIOACTIV, V128, P9, DOI 10.1016/j.jenvrad.2013.10.019; TAMURA T, 1964, NUCL SAFETY, V5, P262; Phillips JM, 2000, HYDROL PROCESS, V14, P2589, DOI 10.1002/1099-1085(20001015)14:14<2589::AID-HYP94>3.3.CO;2-4; Sakaguchi A, 2015, J ENVIRON RADIOACTIV, V139, P379, DOI 10.1016/j.jenvrad.2014.05.011; Shozugawa K, 2012, ENVIRON POLLUT, V163, P243, DOI 10.1016/j.envpol.2012.01.001; Lepage H, 2015, J ENVIRON RADIOACTIV, V147, P157, DOI 10.1016/j.jenvrad.2015.05.003; Masson O, 2011, ENVIRON SCI TECHNOL, V45, P7670, DOI 10.1021/es2017158; Koarashi J, 2012, SCI TOTAL ENVIRON, V431, P392, DOI 10.1016/j.scitotenv.2012.05.041; Tagami K, 2011, SCI TOTAL ENVIRON, V409, P4885, DOI 10.1016/j.scitotenv.2011.07.067; Kozai N, 2012, J NUCL SCI TECHNOL, V49, P473, DOI [10.1080/002231312012677131, 10.1080/00223131.2012.677131]; Kanasashi T, 2015, J ENVIRON RADIOACTIV, V139, P398, DOI 10.1016/j.jenvrad.2014.06.018; Yoshida N, 2012, SCIENCE, V336, P1115, DOI 10.1126/science.1219493; Steinhauser G, 2014, ENVIRON SCI TECHNOL, V48, P4649, DOI 10.1021/es405654c; Kobayashi T, 2013, J NUCL SCI TECHNOL, V50, P255, DOI 10.1080/00223131.2013.772449; Endo S, 2013, J ENVIRON RADIOACTIV, V116, P59, DOI 10.1016/j.jenvrad.2012.08.018; RENARD KG, 1991, J SOIL WATER CONSERV, V46, P30; Yoshihara T, 2013, J ENVIRON RADIOACTIV, V115, P60, DOI 10.1016/j.jenvrad.2012.07.002; Van Oost K, 2012, P NATL ACAD SCI USA, V109, P19492, DOI 10.1073/pnas.1211162109; He Q, 1996, J ENVIRON RADIOACTIV, V30, P117, DOI 10.1016/0265-931X(96)89275-7; Bu WT, 2013, BIOGEOSCIENCES, V10, P2497, DOI 10.5194/bg-10-2497-2013; Chartin C., 2013, ANTHROPOCENE, V1, P23; Chino M, 2011, J NUCL SCI TECHNOL, V48, P1129, DOI 10.3327/jnst.48.1129; Evrard O., 2014, SCI REP, V4; Evrard O., 2013, SCI REP, V3; Fan QH, 2014, J ENVIRON RADIOACTIV, V138, P92, DOI 10.1016/j.jenvrad.2014.08.009; Fan QH, 2014, APPL GEOCHEM, V48, P93, DOI 10.1016/j.apgeochem.2014.07.012; Fujii K, 2014, SOIL SCI PLANT NUTR, V60, P751, DOI 10.1080/00380768.2014.926781; Gonze MA, 2014, ENVIRON SCI TECHNOL, V48, P11268, DOI 10.1021/es502590s; Groell J, 2014, INT J ENVIRON POLLUT, V55, P67, DOI 10.1504/IJEP.2014.065906; Hasegawa M, 2013, J ENVIRON RADIOACTIV, V126, P8, DOI 10.1016/j.jenvrad.2013.06.006; Hashimoto S., 2012, JAPAN SCI REP, V2; Iwagami S., 2015, TEMPORAL CH IN PRESS; Iwasaki T, 2015, J ENVIRON RADIOACTIV, V139, P416, DOI 10.1016/j.jenvrad.2014.05.012; Jagercikova M, 2015, J SOIL SEDIMENT, V15, P81, DOI 10.1007/s11368-014-0982-5; Kakiuchi H., 2012, SCI REP, V2; Kato H, 2012, J ENVIRON RADIOACTIV, V111, P59, DOI 10.1016/j.jenvrad.2011.10.003; Kato H., 2012, GEOPHYS RES LETT, V39; Kawamura H, 2011, J NUCL SCI TECHNOL, V48, P1349, DOI 10.3327/jnst.48.1349; Kikawada Y., 2014, J RADIOANAL NUCL CHE, P1; Kitamura A, 2014, ANTHROPOCENE, V5, P22; Kitamura A., 2015, NUCL SCI ENG, V179, P105; Koarashi J., 2012, SCI REP, V2; Koizumi A, 2013, ENVIRON SCI TECHNOL, V47, P9612, DOI 10.1021/es401422g; Kurikami Hiroshi, 2013, Transactions of the American Nuclear Society, V109; Kurikami H, 2014, J ENVIRON RADIOACTIV, V137, P10, DOI 10.1016/j.jenvrad.2014.06.013; Laceby J.P., 2015, HYDROL EARTH S UNPUB; Lepage H, 2014, J ENVIRON RADIOACTIV, V130, P44, DOI 10.1016/j.jenvrad.2013.12.011; Lepage H., 2014, TRACKING ORIGIN DISP; Ministry of Education C., 2012, SPORTS SCI TECHN MEX; Minoura K, 2014, NAT HAZARDS, V73, P1843, DOI 10.1007/s11069-014-1171-y; Mishra S, 2015, J SOIL SEDIMENT, V15, P374, DOI 10.1007/s11368-014-0985-2; Mori K., 2014, INT ENV MOD SOFTW SO; Mouri G, 2014, ENVIRON POLLUT, V187, P31, DOI 10.1016/j.envpol.2013.12.018; Nagao S., 2013, BIOGEOSCI DISCUSS, V10, P2767, DOI DOI 10.5194/BGD-10-2767-2013; Nagao S., 2014, J RADIOANAL NUCL CHE, P1; Nakao A, 2014, SCI TOTAL ENVIRON, V468, P523, DOI 10.1016/j.scitotenv.2013.08.062; Nemoto K., 2013, AGR IMPLICATIONS FUK, P19, DOI DOI 10.1007/978-4-431-54328-2; Niimura N, 2015, J ENVIRON RADIOACTIV, V139, P234, DOI 10.1016/j.jenvrad.2013.12.020; Nishikiori T, 2015, SCI TOTAL ENVIRON, V502, P611, DOI 10.1016/j.scitotenv.2014.09.063; Onishi Y., 2014, SIMULATION SEDIMENT; Pratama M.A., 2015, SCI REP, P5; Saito K, 2015, J ENVIRON RADIOACTIV, V139, P308, DOI 10.1016/j.jenvrad.2014.02.014; Saito K, 2015, J ENVIRON RADIOACTIV, V139, P240, DOI 10.1016/j.jenvrad.2014.10.009; Saito T, 2014, J ENVIRON RADIOACTIV, V138, P11, DOI 10.1016/j.jenvrad.2014.07.025; Sakai M, 2014, ENVIRON POLLUT, V187, P112, DOI 10.1016/j.envpol.2014.01.002; Sansone U, 1996, SCI TOTAL ENVIRON, V186, P257, DOI 10.1016/0048-9697(96)05120-0; Satou Y, 2015, J RADIOANAL NUCL CH, V303, P1197, DOI 10.1007/s10967-014-3562-7; Schneider S., 2013, SCI REP, V3; Shimizu Y., 2003, ANN J HYDRAUL ENG, V47, P643; Shinomiya Y, 2014, SOIL SCI PLANT NUTR, V60, P765, DOI 10.1080/00380768.2014.949852; Shiozawa S, 2013, AGR IMPLICATIONS FUK, P49; Takahashi J, 2015, J ENVIRON RADIOACTIV, V139, P351, DOI 10.1016/j.jenvrad.2014.07.004; Takeda A, 2014, J ENVIRON RADIOACTIV, V137, P119, DOI 10.1016/j.jenvrad.2014.06.022; Tanaka K., 2013, PLOS ONE, V8; Tanaka Kimiko, 2014, J NUCL SCI TECHNOL, P1; Tazoe H, 2012, RADIAT PROT DOSIM, V152, P198, DOI 10.1093/rpd/ncs222; Teramage MT, 2014, J ENVIRON RADIOACTIV, V137, P37, DOI 10.1016/j.jenvrad.2014.06.017; Teramage MT, 2014, SCI TOTAL ENVIRON, V490, P435, DOI 10.1016/j.scitotenv.2014.05.034; TORN D, 1987, CATENA, V14, P149; UNSCEAR, 2000, SOURC EFF ION RAD SO; Wakahara T, 2014, ENVIRON SCI-PROC IMP, V16, P2580, DOI [10.1039/c4em00262h, 10.1039/C4EM00262H]; Wauters J, 1996, APPL GEOCHEM, V11, P589, DOI 10.1016/0883-2927(96)00027-3; Wetherbee GA, 2012, ENVIRON SCI TECHNOL, V46, P2574, DOI 10.1021/es203217u; WISCHMEIER WALTER H., 1958, TRANS AMER GEOPHYS UNION, V39, P285; Yamada S, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/1/014013; Yamaguchi M, 2014, J ENVIRON RADIOACTIV, V135, P135, DOI 10.1016/j.jenvrad.2014.04.011; Yamaguchi N, 2012, SCI TOTAL ENVIRON, V425, P128, DOI 10.1016/j.scitotenv.2012.02.037; Yamashiki Y., 2014, SCI REP, V4; Yoshida N, 2012, ELEMENTS, V8, P201, DOI 10.2113/gselements.8.3.201; Yoshihara T, 2014, J ENVIRON RADIOACTIV, V138, P220, DOI 10.1016/j.jenvrad.2014.09.002; Yoshihara T, 2014, J ENVIRON RADIOACTIV, V127, P34, DOI 10.1016/j.jenvrad.2013.09.007; Yoshikawa N, 2014, SCI TOTAL ENVIRON, V481, P252, DOI 10.1016/j.scitotenv.2014.01.129; Yoshimura K, 2015, J ENVIRON RADIOACTIV, V139, P370, DOI 10.1016/j.jenvrad.2014.08.021	123	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0265-931X	1879-1700		J ENVIRON RADIOACTIV	J. Environ. Radioact.	OCT	2015	148						92	110		10.1016/j.jenvrad.2015.06.018		19	Environmental Sciences	Environmental Sciences & Ecology	CR2LT	WOS:000361162100012		
J	Curguz, Z; Stojanovska, Z; Zunic, ZS; Kolarz, P; Ischikawa, T; Omori, Y; Mishra, R; Sapra, BK; Vaupotic, J; Ujic, P; Bossew, P				Curguz, Z.; Stojanovska, Z.; Zunic, Z. S.; Kolarz, P.; Ischikawa, T.; Omori, Y.; Mishra, R.; Sapra, B. K.; Vaupotic, J.; Ujic, P.; Bossew, P.			Long-term measurements of radon, thoron and their airborne progeny in 25 schools in Republic of Srpska	JOURNAL OF ENVIRONMENTAL RADIOACTIVITY			English	Article						Indoor air; Radon; Thoron; Radon progenies; Thoron progenies; Equilibrium factor; Primary schools; Nuclear track detectors	PRONE AREA ROMANIA; INDOOR RADON; BALKAN REGION; DWELLINGS; MACEDONIA; HOUSE	This article reports results of the first investigations on indoor radon, thoron and their decay products concentration in 25 primary schools of Banja Luka, capital city of Republic Srpska. The measurements have been carried out in the period from May 2011 to April 2012 using 3 types of commercially available nuclear track detectors, named: long-term radon monitor (GAMMA 1)- for radon concentration measurements (C-Rn); radon-thoron discriminative monitor (RADUET) for thoron concentration measurements (C-Tn); while equilibrium equivalent radon concentration (EERC) and equilibrium equivalent thoron concentrations (EETC) measured by Direct Radon Progeny Sensors/Direct Thoron Progeny Sensors (DRPS/DTPS) were exposed in the period November 2011 to April 2012. In each school the detectors were deployed at 10 cm distance from the wall. The obtained geometric mean concentrations were C-Rn = 99 Bq m(-3) and C-Tn = 51 Bq m(-3) for radon and thoron gases respectively. Those for equilibrium equivalent radon concentration (EERC) and equilibrium equivalent thoron concentrations (EETC) were 11.2 Bq m(-3) and 0.4 Bq m(-3), respectively. The correlation analyses showed weak relation only between C-Rn and C-Tn as well as between C-Tn and EETC. The influence of the school geographical locations and factors linked to buildings characteristic in relation to measured concentrations were tested. The geographical location and floor level significantly influence C-Rn while C-Tn depend only from building materials (ANOVA, p <= 0.05). The obtained geometric mean values of the equilibrium factors were 0.123 for radon and 0.008 for thoron. (C) 2015 Elsevier Ltd. All rights reserved.	[Curguz, Z.] Univ East Sarajevo, Fac Transport & Traff Engn, Doboj 74000, Bosnia & Herceg; [Stojanovska, Z.] Goce Delcev Univ, Fac Med Sci, Stip, Macedonia; [Zunic, Z. S.; Ujic, P.] Univ Belgrade, Inst Nucl Sci Vinca, Belgrade 11000, Serbia; [Kolarz, P.] Univ Belgrade, Inst Phys, Belgrade 11000, Serbia; [Ischikawa, T.; Omori, Y.] Fukushima Med Univ, Dept Radiat Phys & Chem, Fukushima 9601295, Japan; [Mishra, R.; Sapra, B. K.] Bhabha Atom Res Ctr, Radiol Phys & Advisory Div, Bombay 400085, Maharashtra, India; [Vaupotic, J.] Jozef Stefan Inst, Radon Ctr, Ljubljana 1000, Slovenia; [Bossew, P.] German Fed Off Radiat Protect, D-10318 Berlin, Germany	Ujic, P (reprint author), Univ Belgrade, Inst Nucl Sci Vinca, Belgrade 11000, Serbia.	ujic@vinca.rs			Ministry of Science and Technology of Republic of Srpska [19/06-020/961-132/11]; Ministry of Education, Science and Technological Development of the Republic of Serbia [P 171020, III 45003, P 41028, P 171018]	The authors acknowledge the support given by the Ministry of Science and Technology of Republic of Srpska within the project 19/06-020/961-132/11 and the support of the Ministry of Education, Science and Technological Development of the Republic of Serbia within the projects P 171020, III 45003, P 41028 and P 171018.	Stojanovska Z, 2013, RADIAT MEAS, V49, P57, DOI 10.1016/j.radmeas.2012.11.023; Urosevic V, 2008, J ENVIRON RADIOACTIV, V99, P1829, DOI 10.1016/j.jenvrad.2008.07.010; Vaupotic J, 2010, RADIAT PROT DOSIM, V141, P383, DOI 10.1093/rpd/ncq251; Gulan L, 2012, RADIAT PROT DOSIM, V152, P189, DOI 10.1093/rpd/ncs221; Zunic ZS, 2010, NUKLEONIKA, V55, P419; DOI M, 1994, HEALTH PHYS, V66, P43, DOI 10.1097/00004032-199401000-00006; Mishra R, 2014, RADIAT PROT DOSIM, V160, P164, DOI 10.1093/rpd/ncu083; McLaughlin J, 2011, RADIAT PROT DOSIM, V145, P189, DOI 10.1093/rpd/ncr067; Janik M, 2013, J RADIAT RES, V54, P597, DOI 10.1093/jrr/rrs129; Cosma C, 2013, J ENVIRON RADIOACTIV, V116, P174, DOI 10.1016/j.jenvrad.2012.09.006; Bossew P, 2014, J ENVIRON RADIOACTIV, V127, P141, DOI 10.1016/j.jenvrad.2013.09.015; Yamada Y, 2006, J TOXICOL ENV HEAL A, V69, P723, DOI 10.1080/15287390500261265; Mayya YS, 2012, RADIAT PROT DOSIM, V152, P18, DOI 10.1093/rpd/ncs196; Cosma C, 2015, J ENVIRON RADIOACTIV, V140, P141, DOI 10.1016/j.jenvrad.2014.11.007; Curguz Z, 2013, ROM J PHYS, V58, pS90; Curguz Z., 2013, ROM J PHYS, V58, P1221; ICRP, 1994, ICRP PUBL, V66; Mishra R, 2008, RADIAT MEAS, V43, P1408, DOI 10.1016/j.radmeas.2008.03.002; Mishra R, 2009, J AEROSOL SCI, V40, P1, DOI 10.1016/j.jaerosci.2008.08.001; Stojanovska Z, 2014, RADIAT PROT DOSIM, V162, P152, DOI 10.1093/rpd/ncu249; Tokonami S, 2005, REV SCI INSTRUM, V76; UNSCEAR, 2000, SOURC EFF ION RAD; UNSCEAR, 2006, EFF ION RAD; Vaupotic J., 2012, RADIAT PROT DOSIM, V152, P242; World Health Organization, 2009, WHO HDB IND RAD PUBL; Zhou W., 2000, HEALTH PHYS, V35, P365	26	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0265-931X	1879-1700		J ENVIRON RADIOACTIV	J. Environ. Radioact.	OCT	2015	148						163	169		10.1016/j.jenvrad.2015.06.026		7	Environmental Sciences	Environmental Sciences & Ecology	CR2LT	WOS:000361162100019		
J	Shimamura, Y; Nishiyama, T; Taketa, T; Fujita, Y				Shimamura, Y.; Nishiyama, T.; Taketa, T.; Fujita, Y.			Gastroenterology: Acute left-sided appendicitis with intestinal malrotation	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Editorial Material									[Shimamura, Y.; Fujita, Y.] St Lukes Int Hosp, Div Gastroenterol, Tokyo, Japan; [Nishiyama, T.] St Lukes Int Hosp, Div Radiol, Tokyo, Japan; [Taketa, T.] St Lukes Int Hosp, Div Surg, Tokyo, Japan	Shimamura, Y (reprint author), St Lukes Int Hosp, Div Gastroenterol, Tokyo, Japan.							0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	OCT	2015	30	10					1446	1446		10.1111/jgh.12969		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CR6XM	WOS:000361491700002		
J	Sato, S; Chiba, T; Nakamura, S; Matsumoto, T				Sato, Shoko; Chiba, Toshimi; Nakamura, Shotaro; Matsumoto, Takayuki			Changes in cytokine profile may predict therapeutic efficacy of infliximab in patients with ulcerative colitis	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						IL-6; IL-8; infliximab; MIP-1; ulcerative colitis	INFLAMMATORY-BOWEL-DISEASE; ENHANCED EXPRESSION; CROHNS-DISEASE; MUCOSA; CELLS; INTERLEUKIN-8; PATHOGENESIS; BIOMARKERS; INDUCTION; APOPTOSIS	Background and AimInfliximab is an established therapy for ulcerative colitis (UC). The aim of this study was to examine various serum cytokine levels and to identify possible markers predictive of therapeutic efficacy of infliximab for UC patients. MethodsTwenty-one patients with moderately active UC were given intravenous infliximab (5mg/kg) at 0, 2, and 6 weeks as induction therapy. The serum levels of 17 cytokines were determined using a Bio-Plex suspension array system before and 8 weeks after induction therapy. Partial Mayo score (PMS) and serum C-reactive protein levels were used for the determination of clinical activities at 0 and 8 weeks after the treatment. The overall therapeutic effect was determined at 26 weeks according to the PMS. ResultsThe median value of the PMS decreased significantly 8 weeks after the treatment (from 6 to 1.5, P<0.05). However, C-reactive protein levels did not change significantly. Levels of serum interleukin (IL)-8 (P<0.05) and macrophage inflammatory protein-1 (P<0.005) significantly decreased 8 weeks after the induction. Serum levels of the other 15 cytokines did not change significantly. At 26 weeks, 13 of 20 patients (65%) were responders while 7 patients were non-responders. Levels of serum IL-6 at 8 weeks were significantly lower in responders than in non-responders (P<0.05). ConclusionsSerum IL-8 and macrophage inflammatory protein-1 seem to be sensitive markers for UC patients treated with infliximab, while IL-6 at 8 weeks after induction therapy may be predictive of subsequent response to infliximab.	[Sato, Shoko; Chiba, Toshimi; Nakamura, Shotaro; Matsumoto, Takayuki] Iwate Med Univ, Sch Med, Div Gastroenterol, Dept Internal Med, Morioka, Iwate 0208505, Japan	Sato, S (reprint author), Iwate Med Univ, Sch Med, Div Gastroenterol, Dept Internal Med, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	salt_pepper_ss@yahoo.co.jp			Ministry of Education, Culture, Sports, Sciences, and Technology of Japan [25460418]	This study was supported by Grants-in-aid from the Ministry of Education, Culture, Sports, Sciences, and Technology of Japan No. 25460418 (SN).	Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Atreya R, 2000, NAT MED, V6, P583; Banks C, 2003, J PATHOL, V199, P28, DOI 10.1002/path.1245; Sandborn WJ, 2013, ALIMENT PHARM THER, V37, P204, DOI 10.1111/apt.12145; Yamamoto M, 2000, J IMMUNOL, V164, P4878; Daig R, 1996, GUT, V38, P216, DOI 10.1136/gut.38.2.216; Rismo R, 2012, SCAND J GASTROENTERO, V47, P538, DOI 10.3109/00365521.2012.667146; Sandborn WJ, 2009, GASTROENTEROLOGY, V137, P1250, DOI [10.1053/j.gastro.2009.06.061, 10.1053/j.gastro.2009.08.069]; Geremia A, 2014, AUTOIMMUN REV, V13, P3, DOI 10.1016/j.autrev.2013.06.004; Lewis JD, 2011, GASTROENTEROLOGY, V140, P1817, DOI 10.1053/j.gastro.2010.11.058; Hisamatsu T, 2013, PHARMACOL THERAPEUT, V137, P283, DOI 10.1016/j.pharmthera.2012.10.008; Gaur U, 2003, BIOCHEM PHARMACOL, V66, P1403, DOI 10.1016/S0006-2952(03)00490-8; Lewis JD, 2008, INFLAMM BOWEL DIS, V14, P1660, DOI 10.1002/ibd.20520; Grimm MC, 1996, J LEUKOCYTE BIOL, V59, P804; Kezic S, 2012, J ALLERGY CLIN IMMUN, V129, P1031, DOI 10.1016/j.jaci.2011.12.989; Parkes M, 2012, DIGEST DIS, V30, P330, DOI 10.1159/000338119; Mitoma H, 2008, ARTHRITIS RHEUM, V58, P1248, DOI 10.1002/art.23447; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Arias MT, 2015, CLIN GASTROENTEROL H, V13, P531, DOI 10.1016/j.cgh.2014.07.055; Armuzzi A, 2013, INFLAMM BOWEL DIS, V19, P1065, DOI 10.1097/MIB.0b013e3182802909; Chen ZT, 2011, J GASTROEN HEPATOL, V26, P924, DOI 10.1111/j.1440-1746.2011.06662.x; Grimm MC, 1996, INFLAMM BOWEL DIS, V2, P88, DOI 10.1002/ibd.3780020204; IZZO RS, 1992, AM J GASTROENTEROL, V87, P1447; Kai Y, 2005, GASTROENTEROLOGY, V128, P922, DOI 10.1053/j.gastro.2005.01.013; Kasugai S, 2013, J GASTROEN HEPATOL, V2, P818; Sato K, 2009, HEPATO-GASTROENTEROL, V56, P1016	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	OCT	2015	30	10					1467	1472		10.1111/jgh.13008		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CR6XM	WOS:000361491700008		
J	Kitamura, Y; Yoshihara, M; Ito, M; Boda, T; Matsuo, T; Kotachi, T; Tanaka, S; Chayama, K				Kitamura, Yoko; Yoshihara, Masaharu; Ito, Masanori; Boda, Tomoyuki; Matsuo, Taiji; Kotachi, Takahiro; Tanaka, Shinji; Chayama, Kazuaki			Diagnosis of Helicobacter pylori-induced gastritis by serum pepsinogen levels	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						gastritis; Helicobacter pylori; pepsinogen	CANCER; INFECTION; JAPANESE; INFLAMMATION; ERADICATION; PREVALENCE; MUCOSA	Background and AimGastric cancer develops due to atrophic gastritis induced by Helicobacter pylori (H.pylori) infection. Serum levels of pepsinogen (PG) are known to be excellent markers for evaluating the degree of atrophic gastritis. We investigated whether chronic gastritis could be diagnosed by evaluating serum PG levels. MethodsA total of 4483 patients (average age, 49.7 years; 2879 men) were included in this study. Fasting serum samples were collected and anti-H.pylori antibody and PG levels were evaluated. We evaluated the endoscopic atrophy grade or histological extent of gastritis, and calculated the diagnostic capability of this serum marker. ResultsA total of 4483 patients, were diagnosed as being positive (4160) or negative (323) for H.pylori-induced gastritis. In patients with H.pylori-induced gastritis, the PG II levels were higher and the PG I/II ratios were lower than among those without H.pylori gastritis. A cut-off values of (i) PG I/II 5; (ii) PG II 10 or PG I/II 5; (iii) PG II 12 or PG I/II 4.5 showed high sensitivity and accuracy (over 90%) for diagnosing H.pylori-induced gastritis. Moreover, in a mass screening of healthy subjects, a cut-off value of PG I/II 4.5 might be better for diagnosing the presence of gastritis because of a sensitivity and specificity >80%. ConclusionsThe presence of H.pylori-induced gastritis can be evaluated using serum PG levels.	[Kitamura, Yoko; Ito, Masanori; Boda, Tomoyuki; Kotachi, Takahiro; Chayama, Kazuaki] Hiroshima Univ, Dept Gastroenterol & Metab, Hiroshima 7348551, Japan; [Matsuo, Taiji; Tanaka, Shinji] Hiroshima Univ Hosp, Dept Endoscopy, Hiroshima, Japan; [Yoshihara, Masaharu] Hiroshima Univ, Hlth Serv Ctr, Higashihiroshima 724, Japan	Ito, M (reprint author), Hiroshima Univ, Dept Gastroenterol & Metab, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	maito@hiroshima-u.ac.jp					Matsuo T, 2011, HELICOBACTER, V16, P415, DOI 10.1111/j.1523-5378.2011.00889.x; Miki K, 2009, DIGEST ENDOSC, V21, P134, DOI 10.1111/j.1443-1661.2009.00845.x; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Naito Y, 2005, DIGESTION, V72, P164, DOI 10.1159/000088396; Boda T, 2014, HELICOBACTER, V19, P1, DOI 10.1111/hel.12101; Fujiwara Y, 2009, J GASTROENTEROL, V44, P518, DOI 10.1007/s00535-009-0047-5; Asaka M, 2010, HELICOBACTER, V15, P1, DOI 10.1111/j.1523-5378.2009.00738.x; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Fuccio L, 2009, ANN INTERN MED, V151, P121; Asaka M, 2013, INT J CANCER, V132, P1272, DOI 10.1002/ijc.27965; Yoshihara M, 1998, AM J GASTROENTEROL, V93, P1090; Kato T, 2013, DIGEST ENDOSC, V25, P508, DOI 10.1111/den.12031; Asaka M, 2014, J GASTROENTEROL, V49, P1, DOI 10.1007/s00535-013-0897-8; Fukase K, 2008, LANCET, V372, P350; Kim S, 2004, DIGEST LIVER DIS, V36, P286, DOI 10.1016/j.dld.2003.09.021; Kimura K, 1969, ENDOSCOPY, V3, P87, DOI DOI 10.1055/S-0028-1098086; Kiyohira K, 2003, J GASTROENTEROL, V38, P332, DOI 10.1007/s005350300060; Miki Kazumasa, 2006, Gastric Cancer, V9, P245, DOI 10.1007/s10120-006-0397-0; Ministry of Health Labour and Welfare, 2012, VIT STAT JAP; Nomura S, 2013, DIGEST ENDOSC, V25, P136, DOI 10.1111/j.1443-1661.2012.01357.x	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	OCT	2015	30	10					1473	1477		10.1111/jgh.12987		5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CR6XM	WOS:000361491700009		
J	Yamada, S; Okamura, T; Kobayashi, S; Tanaka, E; Nakayama, J				Yamada, Shigenori; Okamura, Takuma; Kobayashi, Satoshi; Tanaka, Eiji; Nakayama, Jun			Reduced gland mucin-specific O-glycan in gastric atrophy: A possible risk factor for differentiated-type adenocarcinoma of the stomach	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						chronic atrophic gastritis; immunohistochemistry; mucin; O-glycan	HELICOBACTER-PYLORI INFECTION; LINKED N-ACETYLGLUCOSAMINE; IMMUNOHISTOCHEMICAL-DEMONSTRATION; INTESTINAL METAPLASIA; MONOCLONAL-ANTIBODY; MUCOUS CELLS; CANCER; CARCINOMA; CARCINOGENESIS; EXPRESSION	Background and AimsO-glycans exhibiting terminal 1,4-linked N-acetylglucosamine (GlcNAc) are attached to MUC6 in gastric gland mucins and serve as a tumor suppressor for gastric adenocarcinoma. Gastric atrophy is associated with risk for gastric cancer. However, the significance of GlcNAc expression in pyloric glands of chronic atrophic gastritis remains unknown. Here, we asked whether reduced GlcNAc expression in chronic atrophic gastritis is associated with risk for gastric cancer. MethodsWe quantitatively analyzed expression of GlcNAc relative to MUC6 in pyloric glands by immunohistochemistry in 67 patients with normal mucosa, 70 with chronic atrophic gastritis, 68 with intramucosal differentiated-type adenocarcinoma, and 11 with intramucosal undifferentiated-type adenocarcinoma. We also compared the Ki-67 labeling index in gastric epithelial cells between chronic atrophic gastritis and normal gastric mucosa with respect to GlcNAc reduction. ResultsIn normal pyloric mucosa, GlcNAc was co-expressed with MUC6. By contrast, in chronic atrophic gastritis, pyloric gland GlcNAc expression was significantly reduced relative to MUC6. In intramucosal gastric cancer, GlcNAc expression in pyloric glands found just beneath differentiated-type adenocarcinoma was also reduced relative to MUC6. However, pyloric glands present beneath undifferentiated-type adenocarcinoma exhibited no GlcNAc decrease. The Ki-67 labeling index in chronic atrophic gastritis showing GlcNAc reduction was significantly increased relative to that in normal gastric mucosa. ConclusionsBecause GlcNAc prevents the gastric cancer development, reduced GlcNAc expression in chronic atrophic gastritis is a possible risk factor for differentiated-type adenocarcinoma of the stomach.	[Yamada, Shigenori; Okamura, Takuma; Kobayashi, Satoshi; Nakayama, Jun] Shinshu Univ, Dept Mol Pathol, Grad Sch Med, Matsumoto, Nagano 3908621, Japan; [Yamada, Shigenori; Okamura, Takuma; Kobayashi, Satoshi; Tanaka, Eiji] Shinshu Univ, Dept Gastroenterol, Sch Med, Matsumoto, Nagano 3908621, Japan; [Kobayashi, Satoshi] Iiyama Red Cross Hosp, Dept Gastroenterol, Iiyama, Japan	Nakayama, J (reprint author), Shinshu Univ, Dept Mol Pathol, Grad Sch Med, Asahi 3-1-1, Matsumoto, Nagano 3908621, Japan.	jnaka@shinshu-u.ac.jp			Japan Society for the Promotion of Science [24390086]	This work was supported by a Grant-in-Aid for Scientific Research 24390086 from the Japan Society for the Promotion of Science (to JN). The authors thank Dr Elise Lamar for editing the manuscript.	Hatakeyama M, 2014, CELL HOST MICROBE, V15, P306, DOI 10.1016/j.chom.2014.02.008; Kawakubo M, 2004, SCIENCE, V305, P1003, DOI 10.1126/science.1099250; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Shiratsu K, 2014, CANCER SCI, V105, P126, DOI 10.1111/cas.12305; Ota H, 1998, HISTOCHEM CELL BIOL, V110, P113, DOI 10.1007/s004180050272; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; NAKAMURA K, 1968, GANN, V59, P251; Asaka M, 2013, INT J CANCER, V132, P1272, DOI 10.1002/ijc.27965; Iwaya Y, 2014, HISTOPATHOLOGY, V64, P536, DOI 10.1111/his.12296; CORREA P, 1992, CANCER RES, V52, P6735; Ferreira B, 2006, J HISTOCHEM CYTOCHEM, V54, P585, DOI 10.1369/jhc.5A6836.2006; Ishihara K, 1996, BIOCHEM J, V318, P409; Karasawa F, 2012, J CLIN INVEST, V122, P923, DOI 10.1172/JCI59087; LIPKIN M, 1985, J NATL CANCER I, V75, P613; MARSHALL BJ, 1995, ANN MED, V27, P565, DOI 10.3109/07853899509002470; MORRIS A, 1987, AM J GASTROENTEROL, V82, P192; Nakamura N, 1998, J HISTOCHEM CYTOCHEM, V46, P793; Nakayama J, 2014, ACTA HISTOCHEM CYTOC, V47, P1, DOI 10.1267/ahc.13034; Nakayama J, 1999, P NATL ACAD SCI USA, V96, P8991, DOI 10.1073/pnas.96.16.8991; Omachi T, 2007, CANCER LETT, V246, P167, DOI 10.1016/j.canlet.2006.02.013; OTA H, 1991, HISTOCHEM J, V23, P22, DOI 10.1007/BF01886504; Shimizu T, 1996, Helicobacter, V1, P197, DOI 10.1111/j.1523-5378.1996.tb00040.x; Tatematsu M, 2003, CANCER SCI, V94, P135, DOI 10.1111/j.1349-7006.2003.tb01409.x; VAINIO H, 1994, ENVIRON HEALTH PERSP, V102, P590; WARREN JR, 1983, LANCET, V1, P1273; Yoshida T, 2014, INT J CANCER, V134, P1445, DOI 10.1002/ijc.28470; Zhang MX, 2001, J HISTOCHEM CYTOCHEM, V49, P587	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	OCT	2015	30	10					1478	1484		10.1111/jgh.13000		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CR6XM	WOS:000361491700010		
J	Yuan, FF; Berndtsson, R; Zhang, L; Uvo, CB; Hao, ZC; Wang, XP; Yasuda, H				Yuan, Feifei; Berndtsson, Ronny; Zhang, Linus; Uvo, Cintia Bertacchi; Hao, Zhenchun; Wang, Xinping; Yasuda, Hiroshi			Hydro Climatic Trend and Periodicity for the Source Region of the Yellow River	JOURNAL OF HYDROLOGIC ENGINEERING			English	Article						Climate change; Streamflow decrease; Yellow River source region	FLOOD FREQUENCY-ANALYSIS; WAVELET ANALYSIS; UNITED-STATES; BASIN; VARIABILITY; MONSOON; CHINA; 20TH-CENTURY; STREAMFLOWS; RAINFALL	The hydrology of the Yellow River source region is expected to be affected by coming climate change. This will have repercussions for the 110million basin inhabitants. Consequently, precipitation, temperature, and streamflow trends and periodicities during the last 50years were investigated to identify significant changes in time and space over the study area. Results showed that mean annual temperature increased for all stations and it had an accelerated increasing trend during the last decade. Mean annual precipitation trends varied depending on the station; however, they were generally slightly decreasing. Annual streamflow decreased markedly, especially from the 1990s, but showed recovery during recent years. Statistically significant changes in trend occurred for temperature in 1998 and for streamflow in 1990. Based on the streamflow change point, seasonal analysis results showed that precipitation mainly decreased during the summer monsoon period (July-September) and temperature increased throughout the year. Corresponding to the weakened monsoon period the average runoff depth is decreasing by 0.74mm/year over the whole area. Statistically significant 2- to 4-year periodicities for mean areal precipitation and temperature occurred over the area. For streamflow, an even stronger 8-year periodicity was revealed from the end of the 1960s to the beginning of the 1990s. Frequency analysis investigated the magnitudes of mean annual precipitation and discharge corresponding to a given frequency. Hydroclimatic trends and linkages at each subbasin were investigated to further improve the understanding of observed streamflow changes. The investigated results have important implications for future water availability in the Yellow River source region.	[Yuan, Feifei; Berndtsson, Ronny; Zhang, Linus; Uvo, Cintia Bertacchi] Lund Univ, Dept Water Resources Engn, SE-22100 Lund, Sweden; [Berndtsson, Ronny] Lund Univ, Ctr Middle Eastern Studies, SE-22100 Lund, Sweden; [Hao, Zhenchun] Hohai Univ, State Key Lab Hydrol Water Resources & Hydraul En, Nanjing 210098, Jiangsu, Peoples R China; [Wang, Xinping] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Shapotou Desert Res & Expt Stn, Lanzhou 730000, Gansu, Peoples R China; [Yasuda, Hiroshi] Tottori Univ, Arid Land Res Ctr, Tottori 6800001, Japan	Yuan, FF (reprint author), Lund Univ, Dept Water Resources Engn, POB 118, SE-22100 Lund, Sweden.	Feifei.yuan@tvrl.lth.se			Natural Science Foundation of China [40830639]; MECW project (Science Research Council) at the Center for Middle Eastern Studies, Lund University [2009-1056]; Chinese Academy of Sciences Visiting Professorship for Senior International Scientists [2012T1Z0029]	Funding from the Key Program of Natural Science Foundation of China (Grant No. 40830639) and the MECW project (Science Research Council No. 2009-1056) at the Center for Middle Eastern Studies, Lund University, are gratefully acknowledged. The second author acknowledges support from the Chinese Academy of Sciences Visiting Professorship for Senior International Scientists (Grant No. 2012T1Z0029).	Griffis VW, 2007, J HYDROL ENG, V12, P482, DOI 10.1061/(ASCE)1084-0699(2007)12:5(482); Coulibaly P, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002667; Ding YH, 2005, METEOROL ATMOS PHYS, V89, P117, DOI 10.1007/s00703-005-0125-z; Yang T, 2008, HYDROL PROCESS, V22, P3829, DOI 10.1002/hyp.6993; Burn DH, 2002, J HYDROL, V255, P107, DOI 10.1016/S0022-1694(01)00514-5; Tang QH, 2008, J CLIMATE, V21, P1790, DOI 10.1175/2007JCLI1854.1; Hu YR, 2011, HYDROL PROCESS, V25, P3399, DOI 10.1002/hyp.8069; Torrence C, 1999, J CLIMATE, V12, P2679, DOI 10.1175/1520-0442(1999)012<2679:ICITEM>2.0.CO;2; Lan YC, 2010, QUATERN INT, V226, P60, DOI 10.1016/j.quaint.2010.03.006; Zheng HX, 2009, WATER RESOUR RES, V45, DOI 10.1029/2007WR006665; Collins KA, 2008, J HYDROL ENG, V13, P1146, DOI 10.1061/(ASCE)1084-0699(2008)13:12(1146); Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Immerzeel WW, 2010, SCIENCE, V328, P1382, DOI 10.1126/science.1183188; Qian W, 2002, THEOR APPL CLIMATOL, V73, P151, DOI 10.1007/s00704-002-0679-3; Liu CM, 2004, HYDROL PROCESS, V18, P2337, DOI 10.1002/hyp.5534; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Yang T, 2010, J HYDROL, V380, P386, DOI 10.1016/j.jhydrol.2009.11.013; Vogel RM, 1996, J HYDROL ENG, V1, P69, DOI 10.1061/(ASCE)1084-0699(1996)1:2(69); CGIAR-CSI (Consortium for Spatial Information), 2008, SRTM 90M DIG EL DAT; Chen X. D., 1996, HYDROLOGY YELLOW RIV; Cong ZT, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR006852; COSTA JE, 1978, WATER RESOUR RES, V14, P626, DOI 10.1029/WR014i004p00626; Fischer T, 2012, CLIMATIC CHANGE, V110, P783, DOI 10.1007/s10584-011-0123-8; IPCC, 2013, CLIM CHANG 2013 PHYS; Jiang P, 2013, J HYDROL, V479, P75, DOI 10.1016/j.jhydrol.2012.11.041; Kendall M. G., 1975, RANK CORRELATION MEA; Liang S, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR007971; Mavromatis T, 2011, THEOR APPL CLIMATOL, V104, P13, DOI 10.1007/s00704-010-0320-9; Rana A, 2012, CLIM DYNAM, V38, P45, DOI 10.1007/s00382-011-1083-4; Sato Y, 2008, HYDROL PROCESS, V22, P1618, DOI 10.1002/hyp.6730; Tang Q, 2008, HYDROL PROCESS, V22, P451, DOI 10.1002/hyp.6624; Taylor W. A., 2000, CHANGE POINT ANAL PO; Westmacott JR, 1997, J HYDROL, V202, P263, DOI 10.1016/S0022-1694(97)00073-5; Zhang Q, 2013, J HYDROL ENG, V18, P689, DOI 10.1061/(ASCE)HE.1943-5584.0000653; Zheng HX, 2007, HYDROL PROCESS, V21, P886, DOI 10.1002/hyp.6280; Zhou Huakun, 2005, Grassland Science, V51, P191, DOI 10.1111/j.1744-697X.2005.00028.x	36	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	1084-0699	1943-5584		J HYDROL ENG	J. Hydrol. Eng.	OCT	2015	20	10								10.1061/(ASCE)HE.1943-5584.0001182		10	Engineering, Civil; Environmental Sciences; Water Resources	Engineering; Environmental Sciences & Ecology; Water Resources	CR6TU	WOS:000361481300018		
J	Jiang, GJ; Huang, M; Xu, CH; Wang, XW				Jiang, Guanjie; Huang, Min; Xu, Chunhui; Wang, Xingwei			GA-SA/CPM/Markov based dynamic risk-management planning for virtual enterprises	JOURNAL OF INTELLIGENT MANUFACTURING			English	Article						Virtual enterprise; Dynamic risk-management planning; Genetic algorithm; Simulated annealing; Critical path method; Markov process	OPTIMIZATION; SELECTION; SYSTEMS; MODEL	A virtual enterprise (VE) is always in an environment with unpredictable change and dynamic markets. Therefore, a VE is more susceptible to risks. Minimizing risk in the operation of a project and ensuring success are major issues to concern in VEs. This paper develops a novel three-level dynamic risk-management planning model for VEs focusing on project organization mode and dynamic features of risk with the objective to maximize the completion probability under the constraints of cost, due date, and quality. The first level adopts non-linear integer programming techniques, the second level is about risk evaluation for the whole project based on network analysis, and the third level is on a Markov process based single process risk evaluation. An algorithm of integrated genetic algorithm plus simulated annealing/critical path method/Markov (GA-SA/CPM/Markov) is then designed to solve the problem and compared with GA and SA respectively. Experimental results show that the proposed algorithm is effective and the three-level model can deal with dynamic risks for VEs.	[Jiang, Guanjie; Huang, Min; Wang, Xingwei] Northeastern Univ, Coll Informat Sci & Engn, Shenyang 110819, Liaoning, Peoples R China; [Jiang, Guanjie; Huang, Min; Wang, Xingwei] Northeastern Univ, State Key Lab Synthet Automat Proc Ind, Shenyang 110819, Liaoning, Peoples R China; [Jiang, Guanjie] Univ Sci & Technol Liaoning, Sch Elect & Informat Engn, Anshan 114051, Liaoning, Peoples R China; [Huang, Min] Chinese Acad Sci, SIA, Shenyang 110819, Liaoning, Peoples R China; [Xu, Chunhui] Chiba Inst Technol, Dept Risk Sci Finance & Management, Chiba 2750016, Japan	Huang, M (reprint author), Northeastern Univ, Coll Informat Sci & Engn, Shenyang 110819, Liaoning, Peoples R China.	mhuang@mail.neu.edu.cn			National Science Foundation for Distinguished Young Scholars of China [71325002, 61225012]; National Natural Science Foundation of China [71071028, 70931001, 71021061]; Specialized Research Fund of the Doctoral Program of Higher Education for the Priority Development Areas [20120042130003]; Specialized Research Fund for the Doctoral Program of Higher Education [20110042110024]; Fundamental Research Funds for the Central Universities [N110204003, N120104001]; Fundamental Research Funds for State Key Laboratory of Synthetical Automation for Process Industries [2013ZCX11]	This work is supported by the National Science Foundation for Distinguished Young Scholars of China under Grant Nos. 71325002 and 61225012; the National Natural Science Foundation of China under Grant Nos. 71071028, 70931001 and 71021061; the Specialized Research Fund of the Doctoral Program of Higher Education for the Priority Development Areas under Grant No. 20120042130003; the Specialized Research Fund for the Doctoral Program of Higher Education under Grant No. 20110042110024; the Fundamental Research Funds for the Central Universities under Grant Nos. N110204003 and N120104001; the Fundamental Research Funds for State Key Laboratory of Synthetical Automation for Process Industries under Grant No. 2013ZCX11. At the same time, the authors would like to thank the anonymous reviewers and the editor for constructive comments and suggestions.	Ip WH, 2003, COMPUT OPER RES, V30, P213, DOI 10.1016/S0305-0548(01)00092-2; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Cowing MM, 2004, RELIAB ENG SYST SAFE, V86, P269, DOI 10.1016/j.ress.2004.02.003; Mun J, 2009, COMPUT IND ENG, V56, P888, DOI 10.1016/j.cie.2008.09.022; BOEHM BW, 1991, IEEE SOFTWARE, V8, P32, DOI 10.1109/52.62930; Camarinha-Matos LM, 2003, COMPUT IND, V51, P139, DOI 10.1016/S0166-3615(03)00033-2; Goren HG, 2010, J INTELL MANUF, V21, P575, DOI 10.1007/s10845-008-0205-2; Soares AL, 2000, J INTELL MANUF, V11, P253, DOI 10.1023/A:1008967209167; Yu VF, 2010, COMPUT IND ENG, V58, P288, DOI 10.1016/j.cie.2009.10.007; Zhang DY, 2012, J INTELL MANUF, V23, P1351, DOI 10.1007/s10845-011-0527-3; Katzy BR, 2001, J INTELL MANUF, V12, P121, DOI 10.1023/A:1011248409830; Camarinha-Matos LM, 2001, J INTELL MANUF, V12, P133, DOI 10.1023/A:1011200526669; Huang M, 2008, INT J PROD ECON, V116, P104, DOI 10.1016/j.ijpe.2008.06.008; Kierzkowski Z, 2005, HUM FACTOR ERGON MAN, V15, P49, DOI 10.1002/hfm.20012; Park KH, 1999, COMPUT IND ENG, V37, P441, DOI 10.1016/S0360-8352(99)00113-8; Chan FTS, 2007, OMEGA-INT J MANAGE S, V35, P417, DOI 10.1016/j.omega.2005.08.004; Hallikas J, 2002, INT J PROD ECON, V78, P45, DOI 10.1016/S0925-5273(01)00098-6; Huang M, 2011, EXPERT SYST APPL, V38, P13208, DOI 10.1016/j.eswa.2011.04.135; Chen HN, 2010, MATH PROBL ENG, DOI 10.1155/2010/572404; Li Y, 2007, DECIS SUPPORT SYST, V42, P2043, DOI 10.1016/j.dss.2004.11.008; Bier VM, 1999, RISK ANAL, V19, P83, DOI 10.1111/j.1539-6924.1999.tb00391.x; Yen CH, 2004, J INTELL MANUF, V15, P701, DOI 10.1023/B:JIMS.0000037718.43289.62; Martinez MT, 2001, INT J PROD ECON, V74, P225, DOI 10.1016/S0925-5273(01)00129-3; Cardoso HL, 2005, LECT NOTES ARTIF INT, V3451, P14; Bernus P., 1999, P IFAC WORLD C, VA, P189; Carter M. W., 2001, OPERATIONS RES PRACT; Haimes Y.Y., 2009, RISK MODELING ASSESS; Ibe O., 2008, MARKOV PROCESSESTO; Kliem R. L., REDUCING PROJECT RIS; Michalewicz Z., 1994, GENETIC ALGORITHMS D; Treleven M., 1988, J OPERATIONS MANAGEM, V7, P93, DOI 10.1016/0272-6963(81)90007-3	31	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0956-5515	1572-8145		J INTELL MANUF	J. Intell. Manuf.	OCT	2015	26	5					899	910		10.1007/s10845-014-0905-8		12	Computer Science, Artificial Intelligence; Engineering, Manufacturing	Computer Science; Engineering	CR6VO	WOS:000361486200006		
J	Takahashi, N; Nojima, I; Araki, T; Takasugi, M; Sakane, T; Kodera, A; Ikeda, M; Tsukahara, H				Takahashi, Nobumasa; Nojima, Ikuko; Araki, Tooru; Takasugi, Mizue; Sakane, Tomoko; Kodera, Aya; Ikeda, Masanori; Tsukahara, Hirokazu			Evaluation of rapid immunochromatographic tests for norovirus in neonatal and infant faecal specimens	JOURNAL OF INTERNATIONAL MEDICAL RESEARCH			English	Article						Norovirus; immunochromatography; rapid detection test; specificity; false positive; neonate	INTENSIVE-CARE-UNIT; PSEUDO-OUTBREAK; IMMUNOASSAY; ASSAY	Objectives To compare the diagnostic performance of two norovirus rapid immunochromatographic kits (QuickNavi (R)-Norovirus [QN] and QuickNavi (R)-Norovirus 2 [QN2]; Denka Seiken, Niigata, Japan) for neonatal and infant faecal specimens. Methods Monthly faecal samples were collected from infants from birth to 12 months of age, and tested for norovirus using QN and QN2. Real-time reverse transcription polymerase chain reaction (RT-PCR) was used as the gold standard for norovirus detection. The diagnostic performance of the kits was calculated. Results A total of 343 specimens from 81 infants were analysed. In all samples, the specificity of QN and QN2 was 80% (275/343) and 99% (339/343), respectively. In infants aged <1 month, the specificity of QN was 33% (23/70), increasing to 93% at 4 months of age. Specificity of QN2 was 94% in infants between 0 and 12 months of age. Conclusions QN2 offers improved performance and is more useful than QN for the diagnosis of norovirus infection in the neonatal and infant period.	[Takahashi, Nobumasa; Nojima, Ikuko; Araki, Tooru; Takasugi, Mizue; Sakane, Tomoko; Kodera, Aya; Ikeda, Masanori] Fukuyama Med Ctr, Dept Paediat, Fukuyama, Hiroshima, Japan; [Tsukahara, Hirokazu] Okayama Univ Hosp, Dept Paediat, Okayama, Japan	Takahashi, N (reprint author), Fukuyama Med Ctr, Dept Paediat, 4-14-17 Okinogami, Fukuyama, Hiroshima, Japan.	takahashi_nobumasa@fukuyama-hosp.go.jp			Denka Seiken Co., Ltd.	This study was supported in part by Denka Seiken Co., Ltd.	Sommer C, 2009, EUR J CLIN MICROBIOL, V28, P1133, DOI 10.1007/s10096-009-0735-3; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Turcios-Ruiz RM, 2008, J PEDIATR-US, V153, P339, DOI 10.1016/j.jpeds.2008.04.015; Armbrust Sven, 2009, BMC Res Notes, V2, P96, DOI 10.1186/1756-0500-2-96; Gastelum DT, 2009, INFECT CONT HOSP EP, V30, P890, DOI 10.1086/605545; Hayashi Kuniki, 2005, Kansenshogaku Zasshi, V79, P276; IEVEN M, 1994, DIAGN MICR INFEC DIS, V18, P157, DOI 10.1016/0732-8893(94)90085-X; Kohler H, 2008, J PEDIATR GASTR NUTR, V46, P471, DOI 10.1097/MPG.0b013e318162c453; Niizuma T, 2013, J INFECT CHEMOTHER, V19, P171, DOI 10.1007/s10156-012-0439-y; RAND KH, 1985, AM J CLIN PATHOL, V84, P748; RUBENSTEIN AS, 1982, J CLIN MICROBIOL, V15, P938; Saito Yuji, 2014, Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi, V24, P45; Takahashi N, 2010, J PEDIAT INFECT DIS, V22, P223; Tanaka T, 2009, IGAKU YAKUGAKU TOKYO, V61, P779; THOMAS EE, 1994, AM J CLIN PATHOL, V101, P742; Wiechers C, 2008, J PERINATOL, V28, P79, DOI 10.1038/sj.jp.7211849	16	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0300-0605	1473-2300		J INT MED RES	J. Int. Med. Res.	OCT	2015	43	5					648	652		10.1177/0300060515592902		5	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CR8HT	WOS:000361592500006		
J	Mihara, R; Komasawa, N; Matsunami, S; Minami, T				Mihara, Ryosuke; Komasawa, Nobuyasu; Matsunami, Sayuri; Minami, Toshiaki			The effect of extraction angle on endotracheal tube extubation force: Simulation and randomized clinical trial	JOURNAL OF INTERNATIONAL MEDICAL RESEARCH			English	Article						Extubation force; extraction angle; simulation; randomized clinical trial	GENERAL-ANESTHESIA; TRACHEAL EXTUBATION; DIFFICULT AIRWAY; RESPIRATORY COMPLICATIONS; EMERGENCE; LIDOCAINE; MANAGEMENT; PRESSURE; CLAIMS; COUGH	Objective To evaluate the extraction force generated at different extubation angles using a manikin simulation and a randomized clinical trial. Methods Simulations were performed on a manikin to assess the force generated at extubation angles of 0 degrees, 30 degrees, 45 degrees, 60 degrees, 90 degrees and 120 degrees relative to the ground. The trial compared extraction force and changes in vital signs in patients undergoing general anaesthesia with tracheal intubation followed by extubation at 60 degrees or 90 degrees. Results The simulation study found that the extubation force was significantly lower at 45 degrees and 60 degrees than at all other extraction angles. In the trial, extubation at 60 degrees resulted in significantly lower extraction force and systolic blood pressure elevation (n=23) than extubation at 90 degrees (n=23). Conclusion Findings in a manikin simulation were confirmed by those of a randomized clinical trial, where extubation at 60 degrees required less force than 90 degrees, and was accompanied by less SBP elevation. Extubation at 60 degrees is less invasive than extubation at 90 degrees.	[Mihara, Ryosuke; Komasawa, Nobuyasu; Matsunami, Sayuri; Minami, Toshiaki] Osaka Med Coll, Dept Anaesthesia, Takatsuki, Osaka 5698686, Japan	Komasawa, N (reprint author), Osaka Med Coll, Dept Anaesthesia, Daigaku Machi 2-7, Takatsuki, Osaka 5698686, Japan.	ane078@poh.osaka-med.ac.jp					Minogue SC, 2004, ANESTH ANALG, V99, P1253, DOI 10.1213/01.ANE.0000132779.27085.52; STOUT DM, 1987, ANESTHESIOLOGY, V67, P419, DOI 10.1097/00000542-198709000-00025; Peterson GN, 2005, ANESTHESIOLOGY, V103, P33, DOI 10.1097/00000542-200507000-00009; Popat M, 2012, ANAESTHESIA, V67, P318, DOI 10.1111/j.1365-2044.2012.07075.x; Cook TM, 2010, ANAESTHESIA, V65, P556, DOI 10.1111/j.1365-2044.2010.06331.x; MILLER KA, 1995, ANESTH ANALG, V80, P149, DOI 10.1097/00000539-199501000-00025; Artime CA, 2014, RESP CARE, V59, P991, DOI 10.4187/respcare.02926; BIDWAI AV, 1979, ANESTHESIOLOGY, V51, P171, DOI 10.1097/00000542-197908000-00020; Cavallone LF, 2013, ANESTH ANALG, V116, P368, DOI 10.1213/ANE.0b013e31827ab572; Diachun CAB, 2001, J CLIN ANESTH, V13, P447, DOI 10.1016/S0952-8180(01)00299-9; Estebe JP, 2004, BRIT J ANAESTH, V92, P361, DOI 10.1093/bja/aeh078; Gardner A, 2005, AUST CRIT CARE, V18, P158, DOI 10.1016/S1036-7314(05)80029-3; GONZALEZ RM, 1994, ANESTH ANALG, V79, P792; Koga K, 1998, ANAESTHESIA, V53, P540, DOI 10.1046/j.1365-2044.1998.00397.x; Komasawa N, 2015, J EMERG MED, V48, P241, DOI 10.1016/j.jemermed.2014.06.064; Komasawa N, 2014, PEDIATR INT, V56, P634, DOI 10.1111/ped.12373; LEECH P, 1974, BRIT J ANAESTH, V46, P315, DOI 10.1093/bja/46.4.315-a; Owen R, 2009, RESUSCITATION, V80, P1296, DOI 10.1016/j.resuscitation.2009.08.007; Pompei L, 2013, CURR OPIN CRIT CARE, V19, P359, DOI 10.1097/MCC.0b013e3283632ede; Wagner JL, 2014, BMC ANESTHESIOL, V24, P74; Yoo YC, 2011, ACTA ANAESTH SCAND, V55, P1215, DOI 10.1111/j.1399-6576.2011.02529.x	21	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0300-0605	1473-2300		J INT MED RES	J. Int. Med. Res.	OCT	2015	43	5					653	660		10.1177/0300060515592904		8	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CR8HT	WOS:000361592500007		
J	Vijayaprasath, G; Murugan, R; Palanisamy, S; Prabhu, NM; Mahalingam, T; Hayakawa, Y; Ravi, G				Vijayaprasath, G.; Murugan, R.; Palanisamy, S.; Prabhu, N. M.; Mahalingam, T.; Hayakawa, Y.; Ravi, G.			Structural, optical and antibacterial activity studies of neodymium doped ZnO nanoparticles	JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS			English	Article							MAGNETIC-PROPERTIES; SOL-GEL; HYDROTHERMAL SYNTHESIS; COMBUSTION SYNTHESIS; ND; NANOPHOSPHORS; TEMPERATURE; NANORODS	Trivalent neodymium doped ZnO (Zn1-xNdxO, x = 0.0, 0.03, 0.06 and 0.09) nanoparticles (NPs) synthesized by co-precipitation method with improved optical and antibacterial performance is reported. X-ray diffraction pattern indicates most of Nd3+ ions are incorporated in Zn2+ ions of ZnO lattice and hence there is no secondary peak of NdO3 in synthesized ZnO NPs. Fourier transform infrared spectroscopy analysis of synthesized NPs exhibits similar patterns in Zn/Nd-O bands observed at 480 cm(-1). High resolution scanning electron microscopy images revealed the formation of spindle like morphology and the incorporation of Nd ions is confirmed by energy dispersive spectra analysis. UV-visible absorption spectra of pure and Nd doped ZnO NPs showed the variation of the band gap in the range of 3.06-2.65 eV. Raman analysis confirmed the formation of wurtzite structure of NPs was distorted due to Nd substitution in ZnO matrix. X-ray photoelectron spectroscopy confirmed the Nd incorporation in the ZnO lattice as Nd3+. The prepared Nd doped ZnO NPs showed potential application in antibacterial activities.	[Vijayaprasath, G.; Murugan, R.; Ravi, G.] Alagappa Univ, Sch Phys, Karaikkudi 630004, Tamil Nadu, India; [Palanisamy, S.; Prabhu, N. M.] Alagappa Univ, Dept Anim Hlth & Management, Karaikkudi 630004, Tamil Nadu, India; [Mahalingam, T.] Ajou Univ, Dept Elect & Comp Engn, Suwon 443749, South Korea; [Hayakawa, Y.] Shizuoka Univ, Elect Res Inst, Hamamatsu, Shizuoka 4328011, Japan	Ravi, G (reprint author), Alagappa Univ, Sch Phys, Karaikkudi 630004, Tamil Nadu, India.	gravicrc@gmail.com			UGC, New Delhi, India [F. 41-933/2012 (SR)]; DST-PURSE	The authors G. Ravi and G. Vijayaprasath gratefully acknowledge the UGC, New Delhi, India [Ref. No. F. 41-933/2012 (SR)] towards the financial support to carry out this work. The authors express their sincere thanks to Department of Industrial Chemistry, Alagappa University for extending HRSEM (Funded by DST-PURSE) facility. The work was carried out as the cooperative research projects of the Research Institute of Electronics, Shizuoka University, Japan.	Al-Gaashani R, 2013, CERAM INT, V39, P2283, DOI 10.1016/j.ceramint.2012.08.075; Karunakaran C, 2010, J ALLOY COMPD, V508, P587, DOI 10.1016/j.jallcom.2010.08.128; Scepanovic M, 2010, J RAMAN SPECTROSC, V41, P914, DOI 10.1002/jrs.2546; Singhal A, 2012, J ALLOY COMPD, V515, P12, DOI 10.1016/j.jallcom.2011.11.103; Reddy DA, 2011, PHYSICA B, V406, P1944, DOI 10.1016/j.physb.2011.02.062; Tam KH, 2008, THIN SOLID FILMS, V516, P6167, DOI 10.1016/j.tsf.2007.11.081; Yayapao O, 2013, MATER LETT, V90, P83, DOI 10.1016/j.matlet.2012.09.027; Xian FL, 2013, OPT LASER TECHNOL, V45, P508, DOI 10.1016/j.optlastec.2012.06.002; Vegard L, 1921, Z PHYS, V5, P17, DOI 10.1007/BF01349680; Zheng JH, 2012, CRYST RES TECHNOL, V47, P713, DOI 10.1002/crat.201200026; Liu B, 2004, J AM CHEM SOC, V126, P8124, DOI 10.1021/ja048195o; Shahmoradi B, 2010, NANOSCALE, V2, P1160, DOI 10.1039/c0nr00069h; KOIDL P, 1977, PHYS REV B, V15, P2493, DOI 10.1103/PhysRevB.15.2493; Roy B, 2012, MATER CHARACT, V70, P1, DOI 10.1016/j.matchar.2012.04.015; An W, 2008, J PHYS CHEM C, V112, P5747, DOI 10.1021/jp711105d; Cao YL, 2009, SENSOR ACTUAT B-CHEM, V138, P480, DOI 10.1016/j.snb.2009.03.015; Xiong HM, 2009, ANGEW CHEM INT EDIT, V48, P2727, DOI 10.1002/anie.200805590; Reddy AJ, 2011, SPECTROCHIM ACTA A, V81, P53, DOI 10.1016/j.saa.2011.05.043; DENTON AR, 1991, PHYS REV A, V43, P3161, DOI 10.1103/PhysRevA.43.3161; Wang DD, 2012, NANO LETT, V12, P3994, DOI 10.1021/nl301226k; Ghosh M, 2009, J APPL PHYS, V106, DOI 10.1063/1.3243341; Kumar V, 2014, CHEM ENG J, V255, P541, DOI 10.1016/j.cej.2014.06.027; Subramanian M, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/10/105410; Coppa BJ, 2003, APPL PHYS LETT, V82, P400, DOI 10.1063/1.1536264; Wang Y, 2010, COLLOID SURFACE A, V372, P165, DOI 10.1016/j.colsurfa.2010.10.014; Basavalingu B, 2013, J ALLOY COMPD, V552, P382, DOI 10.1016/j.jallcom.2012.10.091; Bouloudenine M., 2005, APPL PHYS LETT, V87; Caglar M, 2012, APPL SURF SCI, V258, P3039, DOI 10.1016/j.apsusc.2011.11.033; Chandrasekhar M, 2014, J ALLOY COMPD, V584, P417, DOI 10.1016/j.jallcom.2013.08.149; Chao LC, 2009, PHYSICA B, V404, P1301, DOI 10.1016/j.physb.2008.12.013; Chauhan S, 2013, J MATER SCI-MATER EL, V24, P5102, DOI 10.1007/s10854-013-1530-6; Chun-Ming L., 2007, CHINESE PHYS, V16, P95, DOI 10.1088/1009-1963/16/1/017; Cullity B.D., 2001, ELEMENTS XRAY DIFFRA; Dhar S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.037205; Hlaing Oo W. M., 2005, Applied Physics Letters, V86, DOI 10.1063/1.1866511; Huang SP, 2009, J ALLOY COMPD, V486, pL24, DOI 10.1016/j.jallcom.2009.07.033; Klug H.P., 1954, XRAY DIFFRACTION PRO; Kripal R, 2011, SPECTROCHIM ACTA A, V79, P1605, DOI 10.1016/j.saa.2011.05.019; Kumar S, 2014, MATER RES BULL, V51, P217, DOI 10.1016/j.materresbull.2013.12.031; Kumar S.S., 2013, INT NANO LETT, V3, P30, DOI DOI 10.1186/2228-5326-3-30; Mhlongo GH, 2011, J PHYS CHEM C, V115, P17625, DOI 10.1021/jp201142d; Prakoso S. P., 2012, MAT SCI APPL, V03, P530; Kumar S, 2012, J RARE EARTH, V30, P761, DOI 10.1016/S1002-0721(12)60126-4; Shin RH, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.091501; Vijayaprasath G., 2014, J PHYS CHEM C, V118, P9715; Vijayaraghavan R., 2008, SCI TECHNOL ADV MAT, V9, P432; Wang J., 2013, PHYS CHEM CHEM PHYS, V5, P17793; Wu SZ, 2011, J PHYS CONF SER, V263, DOI 10.1088/1742-6596/263/1/012022; Zhang J, 2014, MATER TECHNOL, V29, P262, DOI 10.1179/1753555713Y.0000000122; Zung L., 2010, J NANOPART RES, V12, P1625	50	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0957-4522	1573-482X		J MATER SCI-MATER EL	J. Mater. Sci.-Mater. Electron.	OCT	2015	26	10					7564	7576		10.1007/s10854-015-3393-5		13	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Engineering; Materials Science; Physics	CR6VV	WOS:000361487100034		
J	Ho, LN; Nishikawa, H				Ho, Li-Ngee; Nishikawa, Hiroshi			Effect of porous copper on the properties of electrically conductive adhesives	JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS			English	Article							PERCOLATION-THRESHOLD; EPOXY COMPOSITE; RESIN; FILLERS; SHAPE; SIZE	In this study, effect of porous Cu as conductive filler on the properties of electrically conductive adhesive (ECA) was investigated. Four types of Cu fillers which included a porous Cu, a submicron-sized Cu, and two different types of micron-sized Cu fillers were applied as conductive fillers in ECA. Cu fillers in this study were characterized by using scanning electron microscope, X-ray diffraction and nitrogen adsorption. Properties of the Cu filled ECAs in this study were investigated in terms of electrical resistivity and shear strength of the ECA joint. Significant difference could be found in the electrical percolation threshold of the ECAs prepared in this study. Lowest percolation filler content was observed in the porous Cu filled ECA, whereas relatively high percolation filler content was found in the micron-size Cu filled ECAs. Thermal reliability of the ECAs was evaluated under hygrothermal aging at 85 A degrees C/85 % RH for 1000 h.	[Ho, Li-Ngee; Nishikawa, Hiroshi] Osaka Univ, Joining & Welding Res Inst, Ibaraki, Osaka 5670047, Japan; [Ho, Li-Ngee] Univ Malaysia Perlis, Sch Mat Engn, Arau 02600, Perlis, Malaysia	Ho, LN (reprint author), Osaka Univ, Joining & Welding Res Inst, 11-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.	holingee@yahoo.com			 [23-01376]	This work was supported by Grant-in-Aid for JSPS fellows (23-01376). We would like to thank N. Terada from Harima Chemical Inc. for kindly providing us the phenolic resin in this study. Besides, we would like to express our gratitude to Assoc. Prof. Dr. H. Abe for the use of instruments for BET surface area and rheological property measurement.	Li L, 1997, IEEE T COMPON PACK A, V20, P3, DOI 10.1109/95.558537; Jiang HJ, 2005, J ELECTRON MATER, V34, P1432, DOI 10.1007/s11664-005-0202-6; Mamunya YP, 2002, EUR POLYM J, V38, P1887, DOI 10.1016/S0014-3057(02)00064-2; Xue QZ, 2004, EUR POLYM J, V40, P323, DOI 10.1016/j.europolymj.2003.10.011; Zhang ZL, 2012, ACS APPL MATER INTER, V4, P1295, DOI 10.1021/am3002605; Huang YD, 2002, COMPOS SCI TECHNOL, V62, P2153, DOI 10.1016/S0266-3538(02)00148-3; Davies LW, 2007, COMPOS SCI TECHNOL, V67, P1892, DOI 10.1016/j.compscitech.2006.10.014; Papargyris DA, 2008, COMPOS SCI TECHNOL, V68, P1854, DOI 10.1016/j.compscitech.2008.01.010; Li Y, 2006, MAT SCI ENG R, V51, P1, DOI 10.1016/j.mser.2006.01.001; Gao H, 2012, J MATER SCI-MATER EL, V23, P22, DOI 10.1007/s10854-011-0388-8; Lee HH, 2005, INT J ADHES ADHES, V25, P437, DOI 10.1016/j.ijadhadh.2004.11.008; Suriati G, 2011, J MATER SCI-MATER EL, V22, P56, DOI 10.1007/s10854-010-0082-2; Hu CQ, 2007, J CRYST GROWTH, V306, P390, DOI 10.1016/j.jcrysgro.2007.05.047; Baron A, 2009, INT J ADHES ADHES, V29, P1, DOI 10.1016/j.ijadhadh.2007.02.008; Chen DP, 2010, J MATER SCI-MATER EL, V21, P486, DOI 10.1007/s10854-009-9943-y; Clay M, 2012, MATER LETT, V88, P143, DOI 10.1016/j.matlet.2012.08.040; Ho LN, 2011, J MATER SCI-MATER EL, V22, P735, DOI 10.1007/s10854-010-0202-z; Ho LN, 2010, J ADHESION, V86, P805, DOI 10.1080/00218464.2010.498310; Ho LN, 2010, J ELECTRON MATER, V39, P115, DOI 10.1007/s11664-009-0946-5; Ho LN, 2012, J ELECTRON MATER, V41, P2527, DOI 10.1007/s11664-012-2102-x; Ho LN, 2013, J ADHESION, V89, P847, DOI 10.1080/00218464.2013.775039; Ho LN, 2011, J MATER SCI-MATER EL, V22, P538, DOI 10.1007/s10854-010-0174-z; Kim SS, 2011, J ELECTRON MATER, V40, P232, DOI 10.1007/s11664-010-1421-z; Lai ZH, 1996, IEEE T COMPON PACK B, V19, P644; LI Y, 2010, EL COND ADH NAN, P1; Liu L, 2006, J APPL POLYM SCI, V99, P3172, DOI 10.1002/app.22859; Lu DQ, 2000, IEEE T ELECTRON PACK, V23, P185, DOI 10.1109/6104.873246; Moczo J, 2008, J IND ENG CHEM, V14, P535, DOI 10.1016/j.jiec.2008.06.011; Tao Y, 2012, SCI CHINA TECHNOL SC, V55, P28, DOI 10.1007/s11431-011-4651-2; Jeong WJ, 2005, MATER TRANS, V46, P2276, DOI 10.2320/matertrans.46.2276; Wu HP, 2007, COMPOS SCI TECHNOL, V67, P1116, DOI 10.1016/j.compscitech.2006.05.017	31	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0957-4522	1573-482X		J MATER SCI-MATER EL	J. Mater. Sci.-Mater. Electron.	OCT	2015	26	10					7771	7779		10.1007/s10854-015-3423-3		9	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Engineering; Materials Science; Physics	CR6VV	WOS:000361487100061		
J	Shimura, K; Miyazawa, T; Hanaoka, T; Hirata, S				Shimura, Katsuya; Miyazawa, Tomohisa; Hanaoka, Toshiaki; Hirata, Satoshi			Fischer-Tropsch synthesis over alumina supported bimetallic Co-Ni catalyst: Effect of impregnation sequence and solution	JOURNAL OF MOLECULAR CATALYSIS A-CHEMICAL			English	Article						Fischer-Tropsch synthesis; Bimetallic catalyst; Cobalt; Nickel; Alumina	COBALT CATALYSTS; PARTICLE-SIZE; HYDROGENATION ACTIVITY; CO/AL2O3 CATALYSTS; ALLOY CATALYSTS; SELECTIVITY; PROMOTER; DEACTIVATION; REDUCIBILITY; DISPERSION	The effect of Ni substitution on the Fischer Tropsch (FT) synthesis activity and selectivity of alumina supported cobalt (Co/Al2O3) catalyst was investigated with a continuous stirred tank reactor at 230 degrees C and I MPa. Bimetallic Co-Ni/Al(2)O(3)catalysts were prepared by an impregnation method. Total amount of supported metal was fixed at 20 wt%. Influence of the Co/Ni ratio, impregnation sequences and solutions on the structure and activity of Co-Ni/Al(2)O(3)catalyst was systematically studied. Low Ni-loading slightly increased CO conversion rate at nearly constant C5+ selectivity, but excess Ni-loading largely decreased CO conversion rate and C5+ selectivity. The catalytic activity did not depend on impregnation sequence, when Ni-loading amount was low. However, when Co was substituted with large amount of Ni, catalysts prepared by sequential impregnation method (Ni first and then Co) showed higher activity than those prepared by co-impregnation method and reverse sequential impregnation method (Co first and then Ni). These results indicate that catalysts with a Co-rich surface would be better than those with a Ni-rich surface. Impregnation solution also influenced the catalytic activity. Co Ni/Al(2)O(3)catalysts prepared by co-impregnation method using aqueous NH3 solution (Co + Ni/Al2O3-A) showed higher activity than those prepared using pure water or aqueous HNO3 solution. The best catalyst was Co(19 wt%) + Ni(1 wt%)/Al2O3-A, which exhibited 1.6 times as high activity as Co(20 wt%)/Al2O3 catalyst prepared by a conventional impregnation method. The variation of catalytic activity with the kind of impregnation solution would be attributed to the differences in CO adsorption amount and/or electron density of surface Co metal sites. (C) 2015 Elsevier B.V. All rights reserved.	[Shimura, Katsuya; Miyazawa, Tomohisa; Hanaoka, Toshiaki; Hirata, Satoshi] Natl Inst Adv Ind Sci & Technol, Biomass Refinery Res Ctr, Hiroshima 7390046, Japan	Shimura, K (reprint author), Natl Inst Adv Ind Sci & Technol, Biomass Refinery Res Ctr, Kagamiyama 3-11-32, Hiroshima 7390046, Japan.	katsuya-shimura@aist.go.jp			Japan Prize Foundation	This work was partially supported by a research grant from the Japan Prize Foundation. The authors are deeply grateful to Mr. Hideyuki Yokoyama for his experimental assistance.	Bae JW, 2008, ENERG FUEL, V22, P2885, DOI 10.1021/ef800155v; Zhang QH, 2010, CHEMCATCHEM, V2, P1030, DOI 10.1002/cctc.201000071; Park SJ, 2012, APPL CATAL A-GEN, V419, P148, DOI 10.1016/j.apcata.2012.01.022; Ma WP, 2012, APPL CATAL A-GEN, V437, P1, DOI 10.1016/j.apcata.2012.05.037; Khodakov AY, 2007, CHEM REV, V107, P1692, DOI 10.1021/cr050972v; Wang SR, 2013, FUEL, V108, P597, DOI 10.1016/j.fuel.2013.02.021; Park SJ, 2009, J MOL CATAL A-CHEM, V298, P81, DOI 10.1016/j.molcata.2008.10.017; Rohr F, 2000, CATAL TODAY, V58, P247, DOI 10.1016/S0920-5861(00)00258-3; Park JY, 2012, APPL CATAL A-GEN, V411, P15, DOI 10.1016/j.apcata.2011.10.010; Jahangiri H, 2014, CATAL SCI TECHNOL, V4, P2210, DOI 10.1039/c4cy00327f; Rane S, 2010, APPL CATAL A-GEN, V388, P160, DOI 10.1016/j.apcata.2010.08.038; Borg O, 2007, J CATAL, V248, P89, DOI 10.1016/j.jcat.2007.03.008; Saib AM, 2010, CATAL TODAY, V154, P271, DOI 10.1016/j.cattod.2010.02.008; Kogelbauer A, 1996, J CATAL, V160, P125, DOI 10.1006/jcat.1996.0130; Tsakoumis NE, 2010, CATAL TODAY, V154, P162, DOI 10.1016/j.cattod.2010.02.077; Fischer N, 2013, J CATAL, V299, P67, DOI 10.1016/j.jcat.2012.11.013; Bezemer GL, 2006, J AM CHEM SOC, V128, P3956, DOI 10.1021/ja058282w; Jacobs G, 2002, APPL CATAL A-GEN, V233, P263, DOI 10.1016/S0926-860X(02)00195-3; Rytter E, 2010, IND ENG CHEM RES, V49, P4140, DOI 10.1021/ie100308f; Hanaoka T, 2010, FUEL PROCESS TECHNOL, V91, P859, DOI 10.1016/j.fuproc.2009.09.012; Sousa-Aguiar EF, 2011, CATAL SCI TECHNOL, V1, P698, DOI 10.1039/c1cy00116g; Das TK, 2003, FUEL, V82, P805, DOI 10.1016/S0016-2361(02)00361-7; Jacobs G, 2012, TOP CATAL, V55, P811, DOI 10.1007/s11244-012-9856-5; HO SW, 1990, J PHYS CHEM-US, V94, P6396, DOI 10.1021/j100379a045; Jacobs G, 2009, APPL CATAL A-GEN, V361, P137, DOI 10.1016/j.apcata.2009.04.007; Zhang JL, 2003, FUEL, V82, P581, DOI 10.1016/S0016-2361(02)00331-9; JOHNSON BG, 1991, J CATAL, V128, P231, DOI 10.1016/0021-9517(91)90080-N; Lesaint C, 2008, APPL CATAL A-GEN, V351, P131, DOI 10.1016/j.apcata.2008.09.008; Bae JW, 2009, CATAL COMMUN, V10, P1358, DOI 10.1016/j.catcom.2009.02.023; Morales F, 2007, J CATAL, V246, P91, DOI 10.1016/j.jcat.2006.11.014; SCHANKE D, 1995, J CATAL, V156, P85, DOI 10.1006/jcat.1995.1234; Luque R, 2012, ENERG ENVIRON SCI, V5, P5186, DOI 10.1039/c1ee02238e; Calderone VR, 2011, GREEN CHEM, V13, P1950, DOI 10.1039/c0gc00919a; ISHIHARA T, 1992, J CATAL, V136, P232, DOI 10.1016/0021-9517(92)90122-X; Jalama K, 2011, APPL CATAL A-GEN, V395, P1, DOI 10.1016/j.apcata.2011.01.002; IGLESIA E, 1992, J CATAL, V137, P212, DOI 10.1016/0021-9517(92)90150-G; Prieto G, 2009, J CATAL, V266, P129, DOI 10.1016/j.jcat.2009.06.001; Cronauer DC, 2011, CATAL LETT, V141, P968, DOI 10.1007/s10562-011-0620-4; Fan L, 1997, CATAL TODAY, V36, P295, DOI 10.1016/S0920-5861(96)00242-8; Hanaoka Toshiaki, 2011, Journal of the Japan Institute of Energy, V90, DOI 10.3775/jie.90.1072; ISHIHARA T, 1990, APPL CATAL, V66, P267, DOI 10.1016/S0166-9834(00)81644-9; ISHIHARA T, 1991, J CATAL, V130, P202, DOI 10.1016/0021-9517(91)90104-C; Jean-Marie A, 2011, CHEM COMMUN, V47, P10767, DOI 10.1039/c1cc13800f; Jermwongratanachai T, 2013, APPL CATAL A-GEN, V464, P165, DOI 10.1016/j.apcata.2013.05.040; Liu CC, 2012, J MOL CATAL A-CHEM, V363, P335, DOI 10.1016/j.molcata.2012.07.009; Liu YY, 2009, FUEL PROCESS TECHNOL, V90, P901, DOI 10.1016/j.fuproc.2009.04.004; Ma CC, 2012, CHEM ENG J, V191, P534, DOI 10.1016/j.cej.2012.03.024; Martinez A, 2009, J CATAL, V263, P292, DOI 10.1016/j.jcat.2009.02.021; Miyazawa T, 2014, CATAL COMMUN, V57, P36, DOI 10.1016/j.catcom.2014.07.037; Shimura K, 2014, J MOL CATAL A-CHEM, V394, P22, DOI 10.1016/j.molcata.2014.06.034; Sun XY, 2010, APPL CATAL A-GEN, V377, P134, DOI 10.1016/j.apcata.2010.01.029; VADA S, 1995, J CATAL, V153, P224, DOI 10.1006/jcat.1995.1125; vandeLoosdrecht L, 1997, APPL CATAL A-GEN, V150, P365; Wang SR, 2013, ENERG FUEL, V27, P3961, DOI 10.1021/ef400726m; Zhang YH, 2005, J MOL CATAL A-CHEM, V237, P172, DOI 10.1016/j.molcata.2005.04.057	55	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-1169	1873-314X		J MOL CATAL A-CHEM	J. Mol. Catal. A-Chem.	OCT	2015	407						15	24		10.1016/j.molcata.2015.06.013		10	Chemistry, Physical	Chemistry	CR3UP	WOS:000361258900003		
J	Tsubouchi, N; Hashimoto, H; Ohtsuka, Y				Tsubouchi, Naoto; Hashimoto, Hiroyuki; Ohtsuka, Yasuo			High catalytic performance of magnesium cations-added limonite in the decomposition of ammonia in a simulated syngas-rich fuel gas	JOURNAL OF MOLECULAR CATALYSIS A-CHEMICAL			English	Article						Hot gas cleanup; Ammonia decomposition; Syngas-rich fuel gas; Limonite; Magnesium cation	HIGH-TEMPERATURE; HOT GAS; GASIFICATION GAS; REMOVAL; SULFUR; IRON	Catalytic decomposition of 2000 ppm NH3 with an Australian limonite ore, which is composed mostly of goethite (alpha-FeOOH), has been studied from a viewpoint of hot gas cleanup with a vertical, cylindrical quartz reactor at 750-850 degrees C under a high space velocity of 45,000 h(-1). It has already been reported that the limonite achieves the almost complete decomposition of NH3 in inert He at 500 degrees C and shows very stable performance in the reaction at 750 degrees C in the coexistence of 50-500 ppm H2S or at 850 degrees C in the presence of fuel gas components produced in an air-blown coal gasification process. In the coexistence of a high concentration of syngas (50% CO/25% H-2) produced with an O-2-blown coal gasifier, the limonite is deactivated almost completely because of the remarkable occurrence of carbon deposition from the CO. On the other hand, the addition of small amounts of CO2 and H2O, which are always included in actual coal-derived fuel gas, to the syngas improves the activity of the limonite, and conversions of NH3-N-2 at 750 and 850 degrees C become about 65% and almost 100% without carbon deposition, respectively. When several limonite-based catalysts with alkali metal and alkaline earth metal cations are prepared by the impregnation method and then used in the NH3 decomposition at 750 degrees C in 50% CO/25% H-2/5% CO2/3% H2O, fine particles of MgO derived from Mg cations can work more effectively as the promoter, and the 3 mass% Mg-added limonite maintains the high and stable NH3 conversion of almost 100% for 25 h. In this case, no significant carbon deposition takes place. It is probable that MgO with strong basicity suppresses the carbon formation from CO, and that the limonite-based composite catalyst thus shows the superior performance in the decomposition of NH3 in syngas-rich fuel gas that simulates product gas in O-2-blown coal gasification. (C) 2015 Elsevier B.V. All rights reserved.	[Tsubouchi, Naoto] Hokkaido Univ, Ctr Adv Res Energy & Mat, Sapporo, Hokkaido 0608628, Japan; [Hashimoto, Hiroyuki; Ohtsuka, Yasuo] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan	Tsubouchi, N (reprint author), Hokkaido Univ, Ctr Adv Res Energy & Mat, Sapporo, Hokkaido 0608628, Japan.	tsubon@eng.hokudai.ac.jp	Tsubouchi, Naoto/D-8112-2012	Tsubouchi, Naoto/0000-0001-8236-8252	Steel Foundation for Environmental Protection Technology	The present work was supported in part by the Steel Foundation for Environmental Protection Technology. The authors acknowledge the supply of limonite from Kobe Steel Ltd., and Mitsubishi Chemical Corp. in Japan.	Wang WY, 2000, IND ENG CHEM RES, V39, P4075, DOI 10.1021/ie000275n; LEPPALAHTI J, 1991, FUEL PROCESS TECHNOL, V29, P43, DOI 10.1016/0378-3820(91)90016-6; Dou BL, 2002, IND ENG CHEM RES, V41, P4195, DOI 10.1021/ie010913h; Simell P, 1996, CATAL TODAY, V27, P55, DOI 10.1016/0920-5861(95)00172-7; Bradford MCJ, 1999, CATAL REV, V41, P1, DOI 10.1081/CR-100101948; Benson S., 2001, CCC47 IEA COAL RES; Dittler A., 1999, HIGH TEMPERATURE GAS, VII; Future Energy GmbH, 2005, MEGA GSP TECHN; Henderson C., 2003, CCC74 IEA COAL RES; Ismagilov ZR, 2001, CATAL TODAY, V69, P351, DOI 10.1016/S0920-5861(01)00389-3; Mills S.J., 2006, CCC113 IEA COAL RES; Mitchell S.C., 1998, CCC12 IEA COAL RES; MOJTAHEDI W, 1995, FUEL, V74, P1698, DOI 10.1016/0016-2361(95)00152-U; Murakami K., 2011, P 48 C JAP I EN COAL; Ohtsuka Y, 2009, POWDER TECHNOL, V190, P340, DOI 10.1016/j.powtec.2008.08.012; Ohtsuka Y, 2004, FUEL, V83, P685, DOI 10.1016/j.fuel.2003.05.002; Schmidt P., 1996, HIGH TEMPERATURE GAS; Thambimuthu K., 1993, IEACR53; Tsubouchi N, 2007, ENERG FUEL, V21, P3063, DOI 10.1021/ef070096j; Tsubouchi N., 2008, P 25 ANN INT PITTSB; Tsubouchi N, 2008, POWDER TECHNOL, V180, P184, DOI 10.1016/j.powtec.2007.03.028; Tsubouchi N., 2005, ADV GAS CLEANING TEC, P483; Tsubouchi N, 2005, CATAL LETT, V105, P203, DOI 10.1007/s10562-005-8691-8; Wasaka S., 2003, P 2003 GAS TECHN C S; Xu CB, 2005, FUEL, V84, P1957, DOI 10.1016/j.fuel.2005.03.019	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-1169	1873-314X		J MOL CATAL A-CHEM	J. Mol. Catal. A-Chem.	OCT	2015	407						75	80		10.1016/j.molcata.2015.06.023		6	Chemistry, Physical	Chemistry	CR3UP	WOS:000361258900011		
J	Osawa, T; Agata, R; Mouri, A				Osawa, Tsutomu; Agata, Ryohei; Mouri, Aid			Studies of the dissociation activities of methane and carbon dioxide over supported nickel catalyst	JOURNAL OF MOLECULAR CATALYSIS A-CHEMICAL			English	Article						Nickel; Methane; Hydrogen-deuterium exchange; CO2 dissociation reaction	SYNTHESIS GAS; CO2; HYDROGEN; CERIA; CH4; CONVERSION; OXIDATION; NI/AL2O3; SYNGAS; CE	Pulse experiments for testing the dissociation activity of CH4 and CO2 were carried out on supported Ni catalysts (Ni/Al2O3, Ni/La2O3, and Ni/CeO2) with or without pre-adsorbed species on the catalysts. The CO2 pulse on Ni/Al2O3 produced a small amount of CO without pre-adsorbed species, while a CO2 pulse produced more CO in the presence of CH x species on Ni/Al2O3. The CH x species on Ni/Al2O3 promote the dissociation of CO2 on the catalyst. The production of CO by the CH4 pulse was low on Ni/Al2O3 regardless of the presence of adsorbed species by the pre-pulse of CO2, while both H-2 and CO were effectively produced on Ni/CeO2. (C) 2015 Elsevier B.V. All rights reserved.	[Osawa, Tsutomu; Agata, Ryohei; Mouri, Aid] Toyama Univ, Grad Sch Sci & Engn Res, Gofu Ku, Toyama 9308555, Japan	Osawa, T (reprint author), Toyama Univ, Grad Sch Sci & Engn Res, Gofu Ku, Toyama 9308555, Japan.	osawa@sci.u-toyama.ac.jp					Bradford MCJ, 1996, APPL CATAL A-GEN, V142, P73, DOI 10.1016/0926-860X(96)00065-8; Zhu JQ, 2013, INT J HYDROGEN ENERG, V38, P117, DOI 10.1016/j.ijhydene.2012.07.136; Chen JX, 2005, J MOL CATAL A-CHEM, V235, P302, DOI 10.1016/j.molcata.2005.04.023; Wei JM, 2000, APPL CATAL A-GEN, V196, pL167, DOI 10.1016/S0926-860X(99)00504-9; ERDOHELYI A, 1993, J CATAL, V141, P287, DOI 10.1006/jcat.1993.1136; Ross JRH, 1996, CATAL TODAY, V30, P193, DOI 10.1016/0920-5861(96)00035-1; Hu YH, 2004, ADV CATAL, V48, P297, DOI 10.1016/S0360-0564(04)48004-3; Koo KY, 2012, CATAL TODAY, V185, P126, DOI 10.1016/j.cattod.2011.07.027; Bradford MCJ, 1999, CATAL REV, V41, P1, DOI 10.1081/CR-100101948; Tomishige K, 1998, CATAL TODAY, V45, P35, DOI 10.1016/S0920-5861(98)00238-7; Cai XL, 2008, J NAT GAS CHEM, V17, P98, DOI 10.1016/S1003-9953(08)60033-X; Chen W, 2013, APPL CATAL B-ENVIRON, V136, P260, DOI 10.1016/j.apcatb.2013.01.044; ROSTRUPNIELSEN JR, 1993, J CATAL, V144, P38, DOI 10.1006/jcat.1993.1312; CHOUDHARY VR, 1991, J CATAL, V130, P411, DOI 10.1016/0021-9517(91)90124-M; YAO HC, 1984, J CATAL, V86, P254, DOI 10.1016/0021-9517(84)90371-3; Faria EC, 2014, CATAL TODAY, V228, P138, DOI 10.1016/j.cattod.2013.10.058; Pompeo F, 2009, INT J HYDROGEN ENERG, V34, P2260, DOI 10.1016/j.ijhydene.2008.12.057; Li HS, 2011, J NAT GAS CHEM, V20, P1, DOI 10.1016/S1003-9953(10)60156-9; Matsumoto H., 1976, SHOKUBAI, V18, P71; Osawa T, 2014, APPL CATAL A-GEN, V474, P100, DOI 10.1016/j.apcata.2013.07.047; Osawa T, 2009, J MOL CATAL A-CHEM, V298, P111, DOI 10.1016/j.molcata.2008.09.030; Osawa T, 2007, REACT KINET CATAL L, V90, P93, DOI 10.1007/s11144-007-5001-z; Ozkara-Aydinoglu S, 2010, CATAL COMMUN, V11, P1165, DOI 10.1016/j.catcom.2010.07.001; Rostrup-Nielsen JR, 2002, ADV CATAL, V47, P65, DOI 10.1016/S0360-0564(02)47006-X; Rotaru CG, 2015, APPL CATAL A-GEN, V494, P29, DOI 10.1016/j.apcata.2015.01.024; TAKITA Y, 1987, B CHEM SOC JPN, V60, P2757, DOI 10.1246/bcsj.60.2757	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-1169	1873-314X		J MOL CATAL A-CHEM	J. Mol. Catal. A-Chem.	OCT	2015	407						163	168		10.1016/j.molcata.2015.06.034		6	Chemistry, Physical	Chemistry	CR3UP	WOS:000361258900022		
J	Uehara, M; Kokuryo, S; Sasaguri, M; Tominaga, K				Uehara, Masataka; Kokuryo, Shinya; Sasaguri, Masaaki; Tominaga, Kazuhiro			Emergency Cricothyroidotomy for Difficult Airway Management After Asynchronous Bilateral Neck Dissections: A Case Report and Literature Review	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Review							RAPID 4-STEP TECHNIQUE; SURGICAL CRICOTHYROIDOTOMY; CRICOTHYROTOMY TECHNIQUE; RANDOMIZED CROSSOVER; STANDARD; IDENTIFICATION; TRACHEOSTOMY; TRACHEOTOMY; OBSTRUCTION; HEMORRHAGE	Purpose: This report describes a case that required emergency cricothyroidotomy for an upper airway obstruction owing to laryngeal edema after asynchronous bilateral neck dissections. Patient and Methods: A 57-year-old man was diagnosed with multicentric squamous cell carcinoma of the tongue (T1 and 2N0M0), and partial glossectomy with primary closure was performed. Three months after surgery, secondary metastases in the right cervical lymph nodes were detected, and a right radical neck dissection was performed. Contrast-enhanced computed tomographic (CT) scan taken 2 weeks after the right neck dissection visualized a possible third metastasis in the left cervical lymph node. Four weeks after the right radical neck dissection, left supraomohyoid neck dissection was carried out. In this surgery, the left internal jugular vein (IJV) was preserved. Nine hours after surgery, severe swelling of the face and pharynx was recognized, resulting in a stoppage of respiration and then an emergency cricothyroidotomy. Results: The patient's life was saved without any encephalopathy or airway trouble. Contrast-enhanced CT scan taken the next day confirmed the preserved left IJV patency. Conclusion: Oral and maxillofacial surgeons should be aware of the possibility of life-threatening laryngeal edema associated with bilateral neck dissections even if the unilateral IJV is preserved and should know the procedure for emergency cricothyroidotomy. (C) 2015 American Association of Oral and Maxillofacial Surgeons	[Uehara, Masataka; Sasaguri, Masaaki; Tominaga, Kazuhiro] Kyushu Dent Univ, Dept Sci Phys Funct, Div Maxillofacial Surg, Kitakyushu, Fukuoka 8038580, Japan; [Kokuryo, Shinya] Kyushu Dent Univ, Dept Sci Phys Funct, Div Oral Med, Kitakyushu, Fukuoka 8038580, Japan	Uehara, M (reprint author), Kyushu Dent Univ, Dept Sci Phys Funct, Div Maxillofacial Surg, 2-6-1 Manazuru, Kitakyushu, Fukuoka 8038580, Japan.	r12uehara@fa.kyu-dent.ac.jp					Elliott DSJ, 2010, ANAESTHESIA, V65, P889, DOI 10.1111/j.1365-2044.2010.06425.x; JOHNSON DR, 1993, AM J EMERG MED, V11, P207, DOI 10.1016/0735-6757(93)90125-U; MCQUARRIE DG, 1977, AM J SURG, V134, P455, DOI 10.1016/0002-9610(77)90377-4; Melker JS, 2005, ANN OTO RHINOL LARYN, V114, P525; Isaacs JH, 1997, AM SURGEON, V63, P346; EIBLING DE, 1995, AM J OTOLARYNG, V16, P260, DOI 10.1016/0196-0709(95)90154-X; AHN C, 1989, J SURG ONCOL, V40, P252, DOI 10.1002/jso.2930400410; Aslani A, 2012, ANESTH ANALG, V114, P987, DOI 10.1213/ANE.0b013e31824970ba; MCGILL J, 1982, ANN EMERG MED, V11, P361, DOI 10.1016/S0196-0644(82)80362-4; Brofeldt BT, 1996, ACAD EMERG MED, V3, P1060, DOI 10.1111/j.1553-2712.1996.tb03355.x; Bair AE, 2003, J EMERG MED, V24, P151, DOI 10.1016/S0736-4679(02)00715-1; Ward MJA, 2011, HEAD NECK-J SCI SPEC, V33, P587, DOI 10.1002/hed.21309; Aydin O, 2008, AURIS NASUS LARYNX, V35, P308, DOI 10.1016/j.anl.2007.08.008; BEAHRS OH, 1977, SURG CLIN N AM, V57, P663; Bennett BL, 2011, MIL MED, V176, P1311; Bezalel S, 2015, AM J MED, V128, P120, DOI 10.1016/j.amjmed.2014.07.011; BRANTIGAN CO, 1976, J THORAC CARDIOV SUR, V71, P72; BROWN AMS, 1990, BRIT J ORAL MAX SURG, V28, P272, DOI 10.1016/0266-4356(90)90066-T; Chan TC, 1999, J EMERG MED, V17, P957, DOI 10.1016/S0736-4679(99)00123-7; Chung MK, 2009, OTOLARYNG HEAD NECK, V141, P730, DOI 10.1016/j.otohns.2009.08.031; COLE RR, 1988, LARYNGOSCOPE, V98, P131; Davis DP, 1999, J EMERG MED, V17, P17, DOI 10.1016/S0736-4679(98)00118-8; Dimitriadis JC, 2008, ANAESTHESIA, V63, P1204, DOI 10.1111/j.1365-2044.2008.05631.x; Doepp F, 2003, ACTA OTO-LARYNGOL, V123, P994, DOI 10.1080/00016480310000764; ERLANDSON M J, 1989, Journal of Emergency Medicine, V7, P115, DOI 10.1016/0736-4679(89)90254-0; Francois B, 2003, CHEST, V123, P151, DOI 10.1378/chest.123.1.151; Gaisford JC, 1977, RECONSTRUCTIVE PLAST, P2598; Goumas P, 1997, J LARYNGOL OTOL, V111, P354; GREISZ H, 1982, CRIT CARE MED, V10, P387, DOI 10.1097/00003246-198206000-00012; Gulsen S, 2010, J KOREAN NEUROSURG S, V47, P174, DOI 10.3340/jkns.2010.47.3.174; HAWKINS ML, 1995, AM SURGEON, V61, P52; Helm Matthias, 2005, Best Pract Res Clin Anaesthesiol, V19, P623, DOI 10.1016/j.bpa.2005.06.002; Holmes JF, 1998, ANN EMERG MED, V32, P442, DOI 10.1016/S0196-0644(98)70173-8; Hyodo Y, 2002, PRACT OTOL KYOTO, V95; Jackson C, 1921, SURG GYNECOL OBSTET, V32, P392; Kamasaki N, 2003, INT J ORAL MAX SURG, V32, P91, DOI 10.1054/ijom.2002.0312; Kanji H, 2012, ACAD EMERG MED, V19, pE1061, DOI 10.1111/j.1553-2712.2012.01436.x; Khanna S, 2012, ANN PLAS SURG, V69, P474, DOI 10.1097/SAP.0b013e31824a2171; KRESS TD, 1982, ANN EMERG MED, V11, P197, DOI 10.1016/S0196-0644(82)80497-6; Lacquiere A, 2009, ANAESTHESIA, V64, P447, DOI 10.1111/j.1365-2044.2009.05899_1.x; LINGEMAN RE, 1977, ANN OTO RHINOL LARYN, V86, P737; Mamede R C, 2001, Sao Paulo Med J, V119, P181, DOI 10.1590/S1516-31802001000500006; Piper SN, 2000, RESUSCITATION, V43, P217, DOI 10.1016/S0300-9572(99)00153-7; Quick E, 2013, J FORENSIC SCI, V58, pS264, DOI 10.1111/1556-4029.12026; Raj P, 2002, J LARYNGOL OTOL, V116, P227; Schaumann N, 2005, ANESTHESIOLOGY, V102, P7, DOI 10.1097/00000542-200501000-00005; Shetty K, 2013, ANAESTH INTENS CARE, V41, P623; SISE MJ, 1984, ANN SURG, V200, P13, DOI 10.1097/00000658-198407000-00002; Soleimanpour Hassan, 2012, J Cardiovasc Thorac Res, V4, P73, DOI 10.5681/jcvtr.2012.018; Suárez-Fernández María J, 2010, Clin Ophthalmol, V4, P95; Walls R M, 1988, Emerg Med Clin North Am, V6, P725	51	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	OCT	2015	73	10							2066.e1	10.1016/j.joms.2015.06.152		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CR3MO	WOS:000361237300038		
J	Hara, T; Purwati, EM; Tainosyo, A; Kawakami, T; Hojo, H; Aimoto, S				Hara, Toshiaki; Purwati, Euis Maras; Tainosyo, Akira; Kawakami, Toru; Hojo, Hironobu; Aimoto, Saburo			Site-specific labeling of synthetic peptide using the chemoselective reaction between N-methoxyamino acid and isothiocyanate	JOURNAL OF PEPTIDE SCIENCE			English	Article						site-specific labeling; N-methoxyamino acid; isothiocyanate; human beta-defensin	AMINO-ACID; CHEMICAL-SYNTHESIS; NEOGLYCOPEPTIDES; DEFENSINS	Site-specific labeling of synthetic peptides carrying N-methoxyglycine (MeOGly) by isothiocyanate is demonstrated. A nonapeptide having MeOGly at its N-terminus was synthesized by the solid-phase method and reacted with phenylisothiocyanate under various conditions. In acidic solution, the reaction specifically gave a peptide having phenylthiourea structure at its N-terminus, leaving side chain amino group intact. The synthetic human beta-defensin-2 carrying MeOGly at its N-terminus or the side chain amino group of Lys(10) reacted with phenylisothiocyanate or fluorescein isothiocyanate also at the N-methoxyamino group under the same conditions, demonstrating that this method is generally useful for the site-specific labeling of linear synthetic peptides as well as disulfide-containing peptides. Copyright (C) 2015 European Peptide Society and John Wiley & Sons, Ltd.	[Hara, Toshiaki] Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka 5600043, Japan; [Purwati, Euis Maras; Tainosyo, Akira; Kawakami, Toru; Hojo, Hironobu; Aimoto, Saburo] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Aimoto, S (reprint author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	aimoto@protein.osaka-u.ac.jp					Hoover DM, 2000, J BIOL CHEM, V275, P32911, DOI 10.1074/jbc.M006098200; Langenhan JM, 2005, P NATL ACAD SCI USA, V102, P12305, DOI 10.1073/pnas.0503270102; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Pazgier M, 2007, CURR PHARM DESIGN, V13, P3096, DOI 10.2174/138161207782110381; Ahmed A, 2006, J AM CHEM SOC, V128, P14224, DOI 10.1021/ja064686s; Bark SJ, 2000, J AM CHEM SOC, V122, P3567, DOI 10.1021/ja000217t; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Carrasco MR, 2003, J ORG CHEM, V68, P195, DOI 10.1021/jo026641p; Carrasco MR, 2003, J ORG CHEM, V68, P8853, DOI 10.1021/jo034984x; Carrasco MR, 2002, TETRAHEDRON LETT, V43, P5727, DOI 10.1016/S0040-4039(02)01212-1; Carrasco MR, 2006, BIOPOLYMERS, V84, P414, DOI 10.1002/bip.20496; Carrasco MR, 2006, ORG LETT, V8, P3529, DOI 10.1021/ol061289d; CHERSI A, 1990, BIOCHIM BIOPHYS ACTA, V1034, P333, DOI 10.1016/0304-4165(90)90060-A; Chino N, 2006, INT J PEPT RES THER, V12, P203, DOI 10.1007/s10989-006-9018-3; Filira F, 2003, ORG BIOMOL CHEM, V1, P3059, DOI 10.1039/b306142f; Sameiro M, 2009, CHEM REV, V109, P190, DOI 10.1021/cr0783840; Peri F, 1998, TETRAHEDRON, V54, P12269, DOI 10.1016/S0040-4020(98)00763-7	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1075-2617	1099-1387		J PEPT SCI	J. Pept. Sci.	OCT	2015	21	10					765	769		10.1002/psc.2803		5	Biochemistry & Molecular Biology; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CR6SM	WOS:000361477700003		
J	Xue, J; Wang, WX; Hu, JF; Zhang, JZ; Wu, SJ				Xue, Jia; Wang, Wen-Xue; Hu, Jun-Feng; Zhang, Jia-Zheng; Wu, Su-Jun			Influence of fiber length on the tensile behavior of fiber metal laminates with discontinuous reinforcement	JOURNAL OF REINFORCED PLASTICS AND COMPOSITES			English	Article						Hybrid; laminate; discontinuous reinforcement; strength	ARRAYED CHOPPED STRANDS; GLASS/EPOXY COMPOSITES; PROGRESSIVE FAILURE; PSEUDO-DUCTILITY; SIMULATION; PREPREG; FRACTURE; PLY	In this paper, the influence of fiber length on the tensile behavior of fiber metal laminate, which is fabricated with unidirectionally arrayed chopped strand plies and aluminum sheets and named as unidirectionally arrayed chopped strand/aluminum laminate, was investigated based on finite element analysis and experiment. The unidirectionally arrayed chopped strand ply is made by introducing slits into carbon fiber reinforced plastic prepreg where continuous fibers are arrayed unidirectionally. The fiber length is one of the most fundamental factors in tailoring the unidirectionally arrayed chopped strand/aluminum laminate to achieve the desired mechanic behaviors for specific applications. With longer fiber length, the mechanical behaviors of the bulk laminate should be more favorable, while the formability would be better with short fiber. Two-dimensional finite element models, with intra-laminar cohesive zone elements inserted into the slits of unidirectionally arrayed chopped strand plies and inter-laminar cohesive zone elements inserted into the all interfaces of unidirectionally arrayed chopped strand/aluminum laminate, respectively, were developed for the analysis of unidirectionally arrayed chopped strand/aluminum laminates with different fiber lengths under tension. Typical numerical results were validated by experimental results, which confirm that the tensile behaviors of the unidirectionally arrayed chopped strand/aluminum laminates with various different fiber lengths can be well predicted by present numerical modeling method.	[Xue, Jia; Zhang, Jia-Zheng] COMAC, Beijing Aeronaut Sci & Technol Res Inst, Beijing, Peoples R China; [Xue, Jia; Wu, Su-Jun] Beihang Univ, Sch Mat Sci & Engn, Beijing 100191, Peoples R China; [Wang, Wen-Xue; Hu, Jun-Feng] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 816, Japan	Xue, J (reprint author), COMAC, Beijing Aeronaut Sci & Technol Res Inst, Future Sic Tech Pk, Beijing, Peoples R China.	xuejia@comac.cc	Kyushu, RIAM/F-4018-2015		Grant-in Aid for Scientific Research (B) of Japan [22360052]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was partially supported by Grant-in Aid for Scientific Research (B) (22360052) of Japan.	Abdullah MR, 2015, MATER DESIGN, V66, P446, DOI 10.1016/j.matdes.2014.03.058; Alderliesten RC, 2015, MATER DESIGN, V66, P421, DOI 10.1016/j.matdes.2014.06.068; Xue J, 2011, COMPOS PART A-APPL S, V42, P986, DOI 10.1016/j.compositesa.2011.04.001; Czel G, 2015, COMPOS SCI TECHNOL, V106, P110, DOI 10.1016/j.compscitech.2014.10.022; Chen JF, 2014, COMPOS PART A-APPL S, V61, P185, DOI 10.1016/j.compositesa.2014.02.013; Cortes P, 2006, COMPOS PART B-ENG, V37, P163, DOI 10.1016/j.compositesb.2005.06.002; Turon A, 2007, ENG FRACT MECH, V74, P1665, DOI 10.1016/j.engfracmech.2006.08.025; Benzeggagh ML, 1996, COMPOS SCI TECHNOL, V56, P439, DOI 10.1016/0266-3538(96)00005-X; Chen JF, 2014, COMPOS STRUCT, V114, P64, DOI 10.1016/j.compstruct.2014.03.046; Chen X, 2014, FINITE ELEM ANAL DES, V81, P32, DOI 10.1016/j.finel.2013.11.005; Czel G, 2013, COMPOS PART A-APPL S, V52, P23, DOI 10.1016/j.compositesa.2013.04.006; Grail G, 2015, COMPOS SCI TECHNOL, V106, P100, DOI 10.1016/j.compscitech.2014.11.006; Li H, 2014, COMPOS PART A-APPL S, V57, P108, DOI 10.1016/j.compositesa.2013.11.003; Li H, 2013, COMPOS PART A-APPL S, V45, P127, DOI 10.1016/j.compositesa.2012.09.009; Malkin R, 2013, COMPOS PART A-APPL S, V54, P107, DOI 10.1016/j.compositesa.2013.07.008; Priesnitz K, 2014, INT J SOLIDS STRUCT, V51, P2470, DOI 10.1016/j.ijsolstr.2014.03.016; Spronk SWF, 2015, INT J FATIGUE, V70, P428, DOI 10.1016/j.ijfatigue.2014.07.004; Taketa I, 2008, COMPOS PART A-APPL S, V39, P1884, DOI 10.1016/j.compositesa.2008.09.012; Taketa I, 2011, COMPOS PART B-ENG, V42, P1764, DOI 10.1016/j.compositesb.2011.01.021; Vlot A., 2001, FIBRE METAL LAMINATE; Vlot A, 2001, GLARE HIST DEV NEW A; Wang W, 2007, 48 AIAA ASME ASCE AH; Xue J, 2015, J REINF PLAST COMP, V34, P364, DOI 10.1177/0731684415571659; Xue J, 2015, APPL COMPOS MATER, V22, P489, DOI 10.1007/s10443-014-9419-y; Yu GC, 2015, COMPOS STRUCT, V119, P757, DOI 10.1016/j.compstruct.2014.09.054	25	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0731-6844	1530-7964		J REINF PLAST COMP	J. Reinf. Plast. Compos.	OCT	2015	34	20					1651	1661		10.1177/0731684415594890		11	Materials Science, Composites; Polymer Science	Materials Science; Polymer Science	CR8HL	WOS:000361591700001		
J	Gilmore, A				Gilmore, Alex			Research into practice: The influence of discourse studies on language descriptions and task design in published ELT materials	LANGUAGE TEACHING			English	Article							CONVERSATION ANALYSIS; ESL; 2ND; COMPETENCE; SEQUENCES; TEXTBOOKS; JAPANESE; GRAMMAR; CORPORA; ENGLISH	Discourse studies is a vast multidisciplinary, and rapidly expanding area of research, embracing a range of approaches including discourse analysis, corpus analysis, conversation analysis, interactional sociolinguistics, critical discourse analysis, genre analysis and multimodal discourse analysis. Each approach offers its own unique perspective on discourse, focusing variably on text, context or a range of semiotic modes. Together, they provide foreign language teachers and material designers with new insights into language, and are beginning to have an observable impact on published English Language Teaching (ELT) materials. This paper examines the ways in which the four approaches with the strongest links to the ELT profession (corpus analysis, conversation analysis, discourse analysis and genre analysis) have found their way into language learning materials, and offers some suggestions on how discourse studies may influence ELT classrooms in the future.	Univ Tokyo, Dept Civil Engn, English Acad Purposes, Tokyo 1138654, Japan	Gilmore, A (reprint author), Univ Tokyo, Dept Civil Engn, English Acad Purposes, Tokyo 1138654, Japan.	alexgilmore@mac.com					Adolphs S, 2013, ROUTL ADV CORPUS LIN, V15, P1; Aijmer K., 2009, CORPORA LANGUAGE TEA; Allwright D., 1991, CLASSROOM INTRO CLAS; Altman R., 1990, DEV COMMUNICATIVE CO, P95; Anderson K., 2004, DO THINGS WORDS; Cullen R, 2007, TESOL QUART, V41, P361; Meunier F, 2007, LANG COMPUT, V61, P119; Barraja-Rohan AM, 2011, LANG TEACH RES, V15, P479, DOI 10.1177/1362168811412878; CARRELL PL, 1985, TESOL QUART, V19, P727, DOI 10.2307/3586673; Henry A, 1998, TESOL QUART, V32, P147, DOI 10.2307/3587913; Gilmore A, 2009, ELT J, V63, P363, DOI 10.1093/elt/ccn056; Huth T, 2006, LANG TEACH RES, V10, P53, DOI 10.1191/1362168806lr184oa; Tomlinson B, 2012, LANG TEACHING, V45, P143, DOI 10.1017/S0261444811000528; Clancy PM, 1996, J PRAGMATICS, V26, P355, DOI 10.1016/0378-2166(95)00036-4; SACKS H, 1974, LANGUAGE, V50, P696, DOI 10.2307/412243; Crookes G, 1997, MOD LANG J, V81, P67, DOI 10.2307/329161; [Anonymous], 2011, MAT DEV LANGUAGE TEA; Curl TS, 2008, RES LANG SOC INTERAC, V41, P129, DOI 10.1080/08351810802028613; Stubbe M, 2003, DISCOURSE STUD, V5, P351, DOI 10.1177/14614456030053004; Wray A, 2000, APPL LINGUIST, V21, P463, DOI 10.1093/applin/21.4.463; Hyon S, 1996, TESOL QUART, V30, P693, DOI 10.2307/3587930; SCHEGLOFF EA, 1986, HUM STUD, V9, P111, DOI 10.1007/BF00148124; O'Keeffe A, 2003, TESOL QUART, V37, P389; Hyland K, 2008, ENGL SPECIF PURP, V27, P4, DOI 10.1016/j.esp.2007.06.001; Austin W, 2008, QUAL HEALTH RES, V18, P557, DOI 10.1177/1049732307308514; Baker P., 2006, USING CORPORA DISCOU; Baldry A. P., 2000, MULTIMODALITY MULTIM; Bardovi-Harlig K., 1991, ELT J, V45, P4, DOI 10.1093/elt/45.1.4; Barraja-Rohan A. M., 1997, TALK COURSE COMMUNIC; Basturkmen H., 2001, ELT J, V55, P4, DOI 10.1093/elt/55.1.4; Bazerman C., 1988, SHAPING WRITTEN KNOW; Belcher D. D., 2004, ANNU REV APPL LINGUI, V24, P165, DOI [10.1017/S026719050400008X, DOI 10.1017/S026719050400008X]; Belton A., 1988, ENGLISH LANGUAGE RES, V2, P79; Bernsten S. G., 2002, THESIS U ILLINOIS UR; Bhatia V. K, 2008, ADV DISCOURSE STUDIE; Bhatia V. K., 1993, ANAL GENRE LANGUAGE; Bhatia V. K., 2004, WORLDS WRITTEN DISCO; Biber D., 2009, OXFORD HDB LINGUISTI, P159; Blommaert J., 2005, DISCOURSE; Boulton A., 2012, CORPUS INFORMED RES, P261; Bouton L. F., 1996, PRAGMATICS LANGUAGE, V7, P1; Bowles H, 2006, ENGL SPECIF PURP, V25, P332, DOI 10.1016/j.esp.2005.03.003; Boxer D., 1995, ELT J, V49, P44, DOI DOI 10.1093/ELT/49.1.44; Bradford B., 1988, INTONATION CONTEXT; Brazil D., 1985, HDB DISCOURSE ANAL, V2; Brazil D., 1985, COMMUNICATIVE VALUE; Brazil D., 1980, DISCOURSE INTONATION; Brazil D., 1994, PRONUNCIATION ADV LE; Brown Gillian, 1983, DISCOURSE ANAL; Burns A., 1996, SEE WHAT YOU MEAN US; Burns A., 2010, DOING ACTION RES GUI; Burns A., 1998, ANNU REV APPL LINGUI, V18, P102; Burton G., 2012, CORPORA, V7, P91; Cameron D, 2001, WORKING SPOKEN DISCO; CARRELL PL, 1987, TESOL QUART, V21, P461, DOI 10.2307/3586498; Carter R, 2006, CAMBRIDGE GRAMMAR EN; Carter R., 1997, EXPLORING SPOKEN ENG; Carter R., 2003, IATEFL C BRIGHT UK; Carter R., 1995, ELT J, V<IT>49</IT>, P207, DOI 10.1093/elt/49.3.207; Carter R., 1998, ELT J, V52, P43, DOI DOI 10.1093/ELT/52.1.43; Cauldwell R., 2013, PHONOLOGY LISTENING; Cheng W., 2007, LANG AWARE, V16, P190, DOI 10.2167/la455.0; Connor U., 2004, DISCOURSE PROFESSION; Connor U., 1996, CONTRASTIVE RHETORIC; Cook G., 1989, DISCOURSE; Crandall E., 2004, ELT J, V58, P38, DOI DOI 10.1093/ELT/58.1.38; Cunningham S., 1998, CUTTING EDGE INTERME; DE BEAUGRANDE R., 1980, TEXT DISCOURSE PROCE; Dornyei Z., 1992, CONVERSATION DIALOGU; Eggins S., 1997, ANAL CASUAL CONVERSA; Eggins S., 1990, NAT CTR ENGL LANG TE; Fairclough N, 1989, LANGUAGE POWER; Feak C. B., 2010, ENGLISH LANGUAGE TEA, P279; Flowerdew J., 1994, ACAD LISTENING; Flowerdew J., 2013, DISCOURSE ENGLISH LA; Flowerdew L, 2008, ADV DISCOURSE STUDIE, P115; Flowerdew L., 2004, DISCOURSE PROFESSION, P11, DOI http://dx.doi.org/10.1075/scl.16.02flo; Gabrielatos C, 2006, 7 TEACH LANG CORP C; Gairns R., 2006, NATURAL ENGLISH ELEM; Gilmore A, 2007, THESIS NOTTINGHAM U; Gilmore A., 2007, LANG TEACHING, V40, P97, DOI DOI 10.1017/S0261444807004144; Gilmore A, 2011, LANG LEARN, V61, P786, DOI 10.1111/j.1467-9922.2011.00634.x; Gilmore A, 2009, TESOL CLASSROOM PRAC, P155; Gilmore A, 2010, PERSPECTIVES LANGUAG; Gollin J., 1998, ENGLISH LANGUAGE TEA, V52, P88, DOI DOI 10.1093/ELT/52.1.88; Gouverneur C., 2008, PHRASEOLOGY FOREIGN, P223; Grant L., 2001, IRAL-INT REV APPL LI, V39, P39, DOI 10.1515/iral.39.1.39; Green G, 1995, MONOGRAPH SERIES, V6, P1; Grice HP, 1975, SYNTAX SEMANTICS, V3; Groom N., 2009, LANGUAGE TEACHER, V33, P26; Gumperz John J., 1982, DISCOURSE STRATEGIES; Halliday M. A. K., 1978, LANGUAGE SOCIAL SEMI; Hamp-Lyons L., 2006, STUDY WRITING; Hanamura N., 1998, AUSTR REV APPL L S15, P29; Handford M., 2010, LANGUAGE BUSINESS M; Handford M., 2011, BUSINESS ADVANTAGE U; Harris ZS, 1952, LANGUAGE, V28, P1, DOI 10.2307/409987; Hasan R., 1976, COHESION ENGLISH; Hatch E., 1992, DISCOURSE LANGUAGE E; Hewings M., 2007, ENGLISH PRONUNCIATIO; Hidalgo A. C., 1995, GETTING STARTED MAT; HOLMES J, 1988, APPL LINGUIST, V9, P21, DOI 10.1093/applin/9.1.21; Howatt A. P. R., 1984, HIST ENGLISH LANGUAG; Hughes R, 1998, TESOL QUART, V32, P263, DOI 10.2307/3587584; Hutchby I., 2008, CONVERSATION ANAL; Hyland K., 2003, 2 LANGUAGE WRITING; Hyland K., 2002, ANNU REV APPL LINGUI, V22, P113; Hyland Ken, 2009, ACAD DISCOURSE; Iedema Rick, 2003, VISUAL COMMUNICATION, V2, P29, DOI DOI 10.1177/1470357203002001751; Johns T., 1991, ENGLISH LANGUAGE RES, V4, P1; Jones R., 2012, DISCOURSE ANAL RESOU; Kay S., 2001, INSIDE OUT INTERMEDI; Koprowski M., 2005, ELT J, V59, P322, DOI 10.1093/elt/cci061; KRESS G., 2010, MULTIMODALITY SOCIAL; Kucera H., 1967, COMPUTATIONAL ANAL P; Lam P. W. Y., 2009, APPL LINGUIST, V31, P260; Lee D. Y. W., 2008, ADV DISCOURSE STUDIE, P86; Leech Geoffrey N, 1983, PRINCIPLES PRAGMATIC; Levinson S, 1983, PRAGMATICS; Lillis T. M., 2010, ACAD WRITING GLOBAL; Littlejohn A. P., 1992, THESIS LANCASTER U; Lynch T., 2004, STUDY LISTENING; Martin James R., 2003, WORKING DISCOURSE ME; McCarthy M., 2010, ENGLISH IDIOMS USE A; McCarthy M, 2008, LANG TEACHING, V41, P563; McCarthy M., 1991, DISCOURSE ANAL LANGU; McCarthy M., 2002, ENGLISH IDIOMS USE I; McCarthy M., 2004, TOUCHSTONE; McCarthy M., 1994, LANGUAGE DISCOURSE; Meier A. J, 1997, ELT J, V51, P21; Mindt D, 1996, USING CORPORA LANGUA, P232; Mori J, 2005, JAPANESE LANGUAGE LI, V39, P255; Mukherjee J., 2006, PLANING GLUING PAINT, P205; Nguyen H., 2012, JALT J, V34, P151; Nguyen M. T. T., 2011, RELC J, V42, P17; Nolasco R., 1987, CONVERSATION; Nunan D., 1991, LANGUAGE TEACHING ME; Parise P., 2009, STUDENT REACTIONS CO; Pearson E., 1986, ITL REV APPL LINGUIS, V74, P47; Perry F. L., 2005, RES APPL LINGUISTICS; Porter D., 1981, ENGLISH LANGUAGE TEA, V36, P37, DOI DOI 10.1093/ELT/36.1.37; Prowse P., 2011, MAT DEV LANGUAGE TEA, V2nd, P151; Recski L.J., 2006, LITERATURAY LINGUIST, V17, P303; Richards J. C., 1990, LANGUAGE TEACHING MA; Richards J. C., 2006, RELC J, V37, P5, DOI 10.1177/0033688206063470; Riggenbach H., 1999, DISCOURSE ANAL LANGU, V1; Romer U, 2006, Z ANGLIST AM, V54, P121; Ruhlemann C., 2009, LANGUAGE COMPUTERS, V21, P415; Rundell M, 1992, ENGL TODAY, V8, P9, DOI 10.1017/S026607840000626X; Rundell M., 1992, ENGL TODAY, V8, P45, DOI 10.1017/S0266078400006751; Rundell M., 1992, ENGL TODAY, V8, P31; Rundell M., 1996, TALK EX SPEC C NEW T; Rundell M., 1992, ENGL TODAY, V8, P21, DOI 10.1017/S0266078400006520; Sacks H, 1995, LECT CONVERSATION; Schegloff E, 1993, RES LANG SOC INTERAC, V26, P99, DOI DOI 10.1207/S15327973RLSI2601_5; SCHEGLOFF EA, 1988, J PRAGMATICS, V12, P55, DOI 10.1016/0378-2166(88)90019-7; Schegloff E. A., 2002, ANNU REV APPL LINGUI, V22, P3, DOI DOI 10.1017/S0267190502000016; Schegloff E. A., 1973, SEMIOTICA, V8, P289, DOI 10.1515/semi.1973.8.4.289; Schegloff Emanuel A., 2007, SEQUENCE ORG INTERAC, V1; Schmidt R., 2001, COGNITION 2 LANGUAGE, P3, DOI DOI 10.1017/CB09781139524780.003; Schmidt R., 1986, TALKING LEARN CONVER, P237; SCHMIDT RW, 1990, APPL LINGUIST, V11, P129, DOI 10.1093/applin/11.2.129; Scott P. J., 1987, THESIS U YORK; SCOTTON CM, 1988, APPL LINGUIST, V9, P372, DOI 10.1093/applin/9.4.372; Searle J. R., 1969, SPEECH ACTS ESSAY PH; Seedhouse P., 2005, LANG TEACHING, V38, P165, DOI DOI 10.1017/S0261444805003010; Sheldon L. E., 1987, 126 ELT, V126; Shortall T., 2007, CORPORA, V2, P157, DOI 10.3366/cor.2007.2.2.157; Shortall T., 2003, LANGUAGE TEACHER, V27, P27; Sinclair J., 1975, ANAL DISCOURSE; Slade D., 1986, PROSPECT, V2, P68; Stock P., 1992, ENGL TODAY, V8, P32; Swales J. M., 2000, ENGLISH TODAY RES WO; Swales J. M., 1994, ACAD WRITING GRADUAT; Swales John, 1990, GENRE ANAL; Thornbury S., 2006, CONSERVATION DESCRIP; Thurston J., 1997, EXPLORING ACAD ENGLI; Toffler A., 1970, FUTURE SHOCK; Ur P., 1991, COURSE LANGUAGE TEAC; van Dijk T. A., 2007, DISCOURSE STUDIES; van Dijk Teun, 2011, DISCOURSE STUDIES MU; van Leeuwen T, 1996, READING IMAGES GRAMM; Vellenga H., 2004, TEACHING ENGLISH 2 F, V8, P1; Wajnryb R., 1996, 9 ED C SYDN; Wallace M. J., 2004, STUDY SKILLS ENGLISH; Williams M., 1997, PSYCHOL LANGUAGE TEA; WILLIAMS M, 1988, APPL LINGUIST, V9, P45, DOI 10.1177/109821408800900405; Willis J., 1988, COLLINS COBUILD ENGL; WOLFSON N, 1986, TESOL QUART, V20, P689, DOI 10.2307/3586519; Wong J., 2010, CONVERSATION ANAL 2; Wong J., 2007, CONVERSATION ANAL LA, P271; Wong J., 2002, IRAL-INT REV APPL LI, V40, P37, DOI DOI 10.1515/IRAL.2002.003; Young L, 1994, ACAD LISTENING RES P, P159; Young R. F., 2002, ANNU REV APPL LINGUI, V22, P243; Zhang S, 2008, APPL MATH MECH, V29, P1	195	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0261-4448	1475-3049		LANG TEACHING	Lang. Teach.	OCT	2015	48	4					506	530		10.1017/53261444815000269		25	Education & Educational Research; Linguistics; Language & Linguistics	Education & Educational Research; Linguistics	CR4LU	WOS:000361304700004		
J	Avis, D; Tiwary, HR				Avis, David; Tiwary, Hans Raj			On the extension complexity of combinatorial polytopes	MATHEMATICAL PROGRAMMING			English	Article							TRIANGULAR ELIMINATION	In this paper we extend recent results of Fiorini et al. on the extension complexity of the cut polytope and related polyhedra. We first describe a lifting argument to show exponential extension complexity for a number of NP-complete problems including subset-sum and three dimensional matching. We then obtain a relationship between the extension complexity of the cut polytope of a graph and that of its graph minors. Using this we are able to show exponential extension complexity for the cut polytope of a large number of graphs, including those used in quantum information and suspensions of cubic planar graphs.	[Avis, David] McGill Univ, Gerad, Montreal, PQ H3A 2A7, Canada; [Avis, David] McGill Univ, Sch Comp Sci, Montreal, PQ H3A 2A7, Canada; [Avis, David] Kyoto Univ, Grad Sch Informat, Sakyo Ku, Kyoto 6068501, Japan; [Tiwary, Hans Raj] Univ Libre Bruxelles, Dept Math, B-1050 Brussels, Belgium	Tiwary, HR (reprint author), Charles Univ Prague, Dept Appl Math KAM, Inst Theoret Comp Sci ITI, Malostranske Nam 25, CR-11800 Prague 1, Czech Republic.	avis@cs.mcgill.ca; hans.raj.tiwary@ulb.ac.be			NSERC; JSPS; FNRS, Belgium	Research of the first author is supported by the NSERC and JSPS. The second author was supported by FNRS, Belgium as a postdoctoral researcher during this research.	RAZBOROV AA, 1992, THEOR COMPUT SCI, V106, P385, DOI 10.1016/0304-3975(92)90260-M; De Wolf R, 2003, SIAM J COMPUT, V32, P681, DOI 10.1137/S0097539702407345; Avis D, 2008, MATH PROGRAM, V112, P303, DOI 10.1007/s10107-006-0018-z; Avis D, 2005, J PHYS A-MATH GEN, V38, P10971, DOI 10.1088/0305-4470/38/50/007; BARAHONA F, 1983, OPER RES LETT, V2, P107, DOI 10.1016/0167-6377(83)90016-0; Bell J.S., 1964, Physics, V1; Corman T. H., 2009, INTRO ALGORITHMS; Deza M., 1997, ALGORITHMS COMBINATO, V15; Fiorini S., 2012, STOC, P95; Garey M. R., 1976, Theoretical Computer Science, V1, DOI 10.1016/0304-3975(76)90059-1; Garey M.R., 1979, COMPUTERS INTRACTABI; Karp R., 1972, COMPLEXITY COMPUTER, P85, DOI DOI 10.1007/978-1-4684-2001-2_; Pokutta S., 2013, OPTIMIZATION ONLINE; YANNAKAKIS M, 1991, J COMPUT SYST SCI, V43, P441, DOI 10.1016/0022-0000(91)90024-Y; Ziegler G., 1995, GRADUATE TEXTS MATH, V152	15	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5610	1436-4646		MATH PROGRAM	Math. Program.	OCT	2015	153	1			SI		95	115		10.1007/s10107-014-0764-2		21	Computer Science, Software Engineering; Operations Research & Management Science; Mathematics, Applied	Computer Science; Operations Research & Management Science; Mathematics	CR6QT	WOS:000361473100007		
J	Noguchi, S; Mori, T; Nakagawa, T; Itamoto, K; Haraguchi, T; Mizuno, T				Noguchi, Shunsuke; Mori, Takashi; Nakagawa, Takayuki; Itamoto, Kazuhito; Haraguchi, Tomoya; Mizuno, Takuya			DNA methylation contributes toward silencing of antioncogenic microRNA-203 in human and canine melanoma cells	MELANOMA RESEARCH			English	Article						5-aza-2-deoxycitidine; DNA methylation; human and canine; melanoma; microRNA-203	EXPRESSION; CANCER; TARGETS; THERAPY; DOGS	Melanoma is a poor-prognosis cancer in both humans and dogs. We have elucidated the antitumor mechanisms of antioncogenic microRNA (miR)-203 which is downregulated in human melanoma, as well as in canine melanoma. The aim of this study was to clarify the mechanism of this downregulation. We focused on epigenetic aberration of miR-203 transcription. Treatment with 5-aza-2-deoxycitidine (5-aza) markedly upregulated the expression level of miR-203 in almost all of the cell lines tested. Furthermore, bisulfite sequencing or methylation-specific PCR showed DNA methylation of CpG islands upstream of the miR-203 coding region (MIR203) in both human and canine melanoma cells, as well as in canine clinical specimens, but not in human normal melanocytes. The results of a luciferase activity assay showed obvious suppression of the transcription of miR-203 by DNA methylation. The use of the luciferase activity assay for CREB1 and an inhibition assay of miR-203 function performed with an miR-203 inhibitor confirmed the contribution of miR-203 upregulation toward the negative regulation of the target gene of miR-203. These results indicate that canine melanoma might be a preclinical model of human melanoma for epigenetic studies. In addition, this study suggests that agents that can demethylate MIR203 could be a common promising therapeutic agent for the treatment of human and canine melanomas.	[Noguchi, Shunsuke; Mizuno, Takuya] Yamaguchi Univ, Joint Fac Vet Med, Lab Mol Diagnost & Therapeut, Yamaguchi 7538515, Japan; [Itamoto, Kazuhito; Haraguchi, Tomoya] Yamaguchi Univ, Joint Fac Vet Med, Div Surg, Lab Small Anim Clin Sci, Yamaguchi 7538515, Japan; [Noguchi, Shunsuke; Mizuno, Takuya] Yamaguchi Univ, United Grad Sch Vet Sci, Biomed Sci Ctr Translat Res, Yamaguchi 7538515, Japan; [Mori, Takashi] Gifu Univ, Fac Appl Biol Sci, Lab Vet Clin Oncol, Gifu, Japan; [Nakagawa, Takayuki] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Vet Surg, Tokyo, Japan	Noguchi, S (reprint author), Yamaguchi Univ, Joint Fac Vet Med, Dept Mol Diagnost & Therapeut, 1677-1 Yoshida, Yamaguchi 7538515, Japan.	snoguchi@yamaguchi-u.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan.	Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Sun BS, 2008, HEPATOLOGY, V48, P1834, DOI 10.1002/hep.22531; Noguchi S, 2014, J INVEST DERMATOL, V134, P461, DOI 10.1038/jid.2013.310; Noguchi S, 2012, J BIOL CHEM, V287, P11769, DOI 10.1074/jbc.M111.325027; Eggermont AMM, 2011, EUR J CANCER, V47, P2150, DOI 10.1016/j.ejca.2011.06.052; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; Chim CS, 2011, J CELL MOL MED, V15, P2760, DOI 10.1111/j.1582-4934.2011.01274.x; Nguyen CT, 2002, CANCER RES, V62, P6456; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; van Kempen LC, 2012, VIRCHOWS ARCH, V461, P441, DOI 10.1007/s00428-012-1309-9; Zhang J, 2009, BLOOD, V113, P4586, DOI 10.1182/blood-2008-09-178186; Cho WCS, 2012, EXPERT OPIN THER TAR, V16, P747, DOI 10.1517/14728222.2012.696102; Noguchi S, 2011, CANCER LETT, V307, P211, DOI 10.1016/j.canlet.2011.04.005; Cannell IG, 2008, BIOCHEM SOC T, V36, P1224, DOI 10.1042/BST0361224; Chim CS, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-197; Cho WCS, 2010, BBA-REV CANCER, V1805, P209, DOI 10.1016/j.bbcan.2009.11.003; Gillard M, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12170; Kaddar T, 2009, BIOL CELL, V101, P511, DOI 10.1042/BC20080213; Nie J, 2014, CANCER LETT, V354, P12, DOI 10.1016/j.canlet.2014.08.010; Noguchi S, 2013, VET COMP ONCOL, V11, P113, DOI 10.1002/vco.306; Noguchi S, 2014, VET COMP ONCOL; Simpson RM, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12185; Wong KY, 2011, BRIT J HAEMATOL, V154, P569, DOI 10.1111/j.1365-2141.2011.08782.x	24	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0960-8931	1473-5636		MELANOMA RES	Melanoma Res.	OCT	2015	25	5					390	398		10.1097/CMR.0000000000000183		9	Oncology; Dermatology; Medicine, Research & Experimental	Oncology; Dermatology; Research & Experimental Medicine	CR2YC	WOS:000361195800003		
J	Shimizu, A; Kaira, K; Kato, M; Yasuda, M; Takahashi, A; Tominaga, H; Oriuchi, N; Nagamori, S; Kanai, Y; Oyama, T; Asao, T; Ishikawa, O				Shimizu, Akira; Kaira, Kyoichi; Kato, Madoka; Yasuda, Masahito; Takahashi, Ayumi; Tominaga, Hideyuki; Oriuchi, Noboru; Nagamori, Shushi; Kanai, Yoshikatsu; Oyama, Tetsunari; Asao, Takayuki; Ishikawa, Osamu			Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma	MELANOMA RESEARCH			English	Article						amino acid transporter; cutaneous; LAT1; malignant melanoma; prognostic factor	CELL LUNG-CANCER; CD98 EXPRESSION; HEAVY-CHAIN; PROSTATE-CANCER; LESIONS; TUMORS; ASCT2; INHIBITION; METABOLISM; MARKER	Amino acid transporters play a crucial role in the development and invasiveness of cancer cells. However, it remains unclear whether or not the expression of l-type amino acid transporter 1 (LAT1) has prognostic significance in patients with cutaneous melanoma. A total of 128 patients with cutaneous melanoma were evaluated. Tumor sections were stained by immunohistochemistry for LAT1, CD98, Ki-67, and microvessel density determined by CD34 and p53. We also analyzed 30 specimens of patients with melanocytic nevi as negative controls. LAT1 and CD98 were highly expressed in 58% (75/128) and 75% (97/128), respectively. The rates of positivity for LAT1 in the melanocytic nevi were 0% (0/30). The expression of LAT1 was associated significantly with tumor thickness, T factor, CD98 expression, cell proliferation (Ki-67), and microvessel density (CD34). By Spearman's rank test, LAT1 expression was correlated with CD98, Ki-67, and CD34. By univariate analysis, tumor thickness, ulceration, disease staging, LAT1, and CD34 showed a significant relationship with overall survival and disease-free survival. Furthermore, a multivariate analysis confirmed that LAT1 was an independent prognostic factor for predicting a poor prognosis. This study had a small sample size. LAT1 can serve as a significant prognostic factor to predict a poor outcome and it may therefore play an important role in the aggressiveness of cutaneous melanoma.	[Shimizu, Akira; Kato, Madoka; Yasuda, Masahito; Takahashi, Ayumi; Ishikawa, Osamu] Gunma Univ, Dept Dermatol, Grad Sch Med, Maebashi, Gunma 3718511, Japan; [Kaira, Kyoichi; Asao, Takayuki] Gunma Univ, Dept Oncol Clin Dev, Grad Sch Med, Maebashi, Gunma 3718511, Japan; [Oriuchi, Noboru] Gunma Univ, Dept Diagnost Radiol & Nucl Med, Grad Sch Med, Maebashi, Gunma 3718511, Japan; [Oyama, Tetsunari] Gunma Univ, Dept Diagnost Pathol, Grad Sch Med, Maebashi, Gunma 3718511, Japan; [Tominaga, Hideyuki] Fukushima Med Univ, Adv Clin Res Ctr, Fukushima, Japan; [Nagamori, Shushi; Kanai, Yoshikatsu] Osaka Univ, Grad Sch Med, Div Biosyst Pharmacol, Osaka, Japan	Shimizu, A (reprint author), Gunma Univ, Dept Dermatol, Grad Sch Med, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	shimizuakira@gunma-u.ac.jp; kkaira1970@yahoo.co.jp			advanced research for medical products Mining Programme of the National Institute of Biomedical Innovation (NIBIO); Ministry of Education, Culture, Sports, Science and Technology, Japan [26461154]; National Hospital Organization Policy Based Medical Services	This work was supported in part by advanced research for medical products Mining Programme of the National Institute of Biomedical Innovation (NIBIO) and Grant 26461154 (K.K.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and the National Hospital Organization Policy Based Medical Services.	Elorza A, 2012, MOL CELL, V48, P681, DOI 10.1016/j.molcel.2012.09.017; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Kaira K, 2009, ANN SURG ONCOL, V16, P3473, DOI 10.1245/s10434-009-0685-0; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Kaira K, 2011, AM J TRANSL RES, V3, P468; Ichinoe M, 2011, PATHOL INT, V61, P281, DOI 10.1111/j.1440-1827.2011.02650.x; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Shimizu K, 2014, BRIT J CANCER, V110, P2030, DOI 10.1038/bjc.2014.88; Kaira K, 2010, J CLIN ONCOL, V28, P3746, DOI 10.1200/JCO.2009.27.4662; MCGIVAN JD, 1994, BIOCHEM J, V299, P321; Li RL, 2003, ANTICANCER RES, V23, P3413; OXENDER DL, 1963, NATURE, V197, P765, DOI 10.1038/197765a0; Imai H, 2010, ANTICANCER RES, V30, P4819; Wang Q, 2011, CANCER RES, V71, P7525, DOI 10.1158/0008-5472.CAN-11-1821; Nawashiro H, 2006, INT J CANCER, V119, P484, DOI 10.1002/ijc.21866; Furuya M, 2012, CANCER SCI, V103, P382, DOI 10.1111/j.1349-7006.2011.02151.x; Kaira K, 2009, LUNG CANCER, V66, P120, DOI 10.1016/j.lungcan.2008.12.015; Sakata T, 2009, PATHOL INT, V59, P7, DOI 10.1111/j.1440-1827.2008.02319.x; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43; Cantor JM, 2012, J CELL SCI, V125, P1373, DOI 10.1242/jcs.096040; Wang Q, 2014, INT J CANCER, V135, P1060, DOI 10.1002/ijc.28749; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Kaira K, 2012, BRIT J CANCER, V107, P632, DOI 10.1038/bjc.2012.310; Kaira K, 2008, BRIT J CANCER, V98, P742, DOI 10.1038/sj.bjc.6604235; Marsden JR, 2010, J PLAST RECONSTR AES, V63, P1401, DOI 10.1016/j.bjps.2010.07.006; Toyoda M, 2014, BRIT J CANCER, V110, P2506, DOI 10.1038/bjc.2014.178; Fukumoto S, 2013, BIOCHEM BIOPH RES CO, V439, P103, DOI 10.1016/j.bbrc.2013.08.020; Hirano K, 2014, PATHOL RES PRACT, V210, P634, DOI 10.1016/j.prp.2014.05.001; Kaira K, 2008, PATHOL RES PRACT, V204, P553, DOI 10.1016/j.prp.2008.02.003; Kaira K, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-482; Kim CS, 2010, BIOL PHARM BULL, V33, P1117; Kim CS, 2008, BIOL PHARM BULL, V31, P1096, DOI 10.1248/bpb.31.1096; Ohkame H, 2001, J SURG ONCOL, V78, P271; Ohkame H, 2001, J SURG ONCOL, V78, P265, DOI 10.1002/jso.1165; Suzuki S, 2014, BRIT J CANCER, V110, P1985, DOI 10.1038/bjc.2014.142; Toyoda M, 2014, HEAD NECK IN PRESS, DOI [10.1002/hed.23797, DOI 10.1002/HED.23797]; Hawryluk EB, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015388	37	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0960-8931	1473-5636		MELANOMA RES	Melanoma Res.	OCT	2015	25	5					399	405		10.1097/CMR.0000000000000181		7	Oncology; Dermatology; Medicine, Research & Experimental	Oncology; Dermatology; Research & Experimental Medicine	CR2YC	WOS:000361195800004		
J	Mori, S; Araki, M; Ishii, S; Hirane, M; Fukushima, K; Tomimatsu, A; Takahashi, K; Fukushima, N; Tsujiuchi, T				Mori, Shiori; Araki, Mutsumi; Ishii, Shuhei; Hirane, Miku; Fukushima, Kaori; Tomimatsu, Ayaka; Takahashi, Kaede; Fukushima, Nobuyuki; Tsujiuchi, Toshifumi			LPA signaling through LPA receptors regulates cellular functions of endothelial cells treated with anticancer drugs	MOLECULAR AND CELLULAR BIOCHEMISTRY			English	Article						Lysophosphatidic acid; LPA receptor; Cell motility; Endothelial cells; Anticancer drugs	LYSOPHOSPHATIDIC ACID RECEPTORS; EPITHELIAL WB-F344 CELLS; OVARIAN-CANCER CELLS; MOTILE ACTIVITY; ANGIOGENESIS; EXPRESSION; INDUCTION; MIGRATION; PROLIFERATION; RESISTANCE	Lysophosphatidic acid (LPA) signaling via LPA receptors provides a variety of cellular functions, including angiogenesis. In this study, to assess an involvement of LPA receptors in cell motile activities of endothelial cells during chemotherapy, F-2 cells were treated with cisplatin (CDDP) and doxorubicin (DOX) at a concentration of 0.01 mu M every 24 h for at least 1 month. The treatment of CDDP and DOX inhibited the expression levels of the LPA receptor-1 (Lpar1), Lpar2, and Lpar3 genes in F-2 cells. The cell motile activities of CDDP and DOX treated cells were relatively lower than those of untreated cells. Next, we investigated whether cancer cells could stimulate the cell motile activities of F-2 cells treated with CDDP and DOX. For cell motility assay, CDDP- and DOX-treated cells were co-cultured with pancreatic cancer PANC-1 cells. The cell motile activities of CDDP- and DOX-treated cells were significantly enhanced by the existence of PANC-1 cells, correlating with the LPA receptor expressions. In addition, the elevated cell motile activities were suppressed by the pretreatment of an autotaxin inhibitor S32826. These results suggest that LPA signaling via LPA receptors may regulate the cell motile activities of F-2 cells treated with anticancer drugs.	[Mori, Shiori; Araki, Mutsumi; Ishii, Shuhei; Hirane, Miku; Fukushima, Kaori; Tomimatsu, Ayaka; Takahashi, Kaede; Tsujiuchi, Toshifumi] Kinki Univ, Fac Sci & Engn, Dept Life Sci, Div Mol Oncol, Higashiosaka, Osaka 5778502, Japan; [Fukushima, Nobuyuki] Kinki Univ, Fac Sci & Engn, Dept Life Sci, Div Mol Neurobiol, Higashiosaka, Osaka 5778502, Japan	Tsujiuchi, T (reprint author), Kinki Univ, Fac Sci & Engn, Dept Life Sci, Div Mol Oncol, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	ttujiuch@life.kindai.ac.jp			JSPS KAKENHI [24590493]; Faculty of Science and Engineering, Kinki University	This work was supported by JSPS KAKENHI Grant Number 24590493 and by Grants from the Faculty of Science and Engineering, Kinki University.	Aikawa S, 2015, J BIOCHEM, V157, P81, DOI 10.1093/jb/mvu077; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Shida D, 2003, CANCER RES, V63, P1706; Samadi N, 2011, BIOCHIMIE, V93, P61, DOI 10.1016/j.biochi.2010.08.002; Hu YL, 2001, J NATL CANCER I, V93, P762, DOI 10.1093/jnci/93.10.762; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Fujita T, 2003, CANCER LETT, V192, P161, DOI 10.1016/S0304-3835(02)00713-9; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Yu SX, 2008, J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378; Tanabe E, 2012, BIOCHEM BIOPH RES CO, V428, P105, DOI 10.1016/j.bbrc.2012.10.015; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Barbayianni E, 2013, EXPERT OPIN THER PAT, V23, P1123, DOI 10.1517/13543776.2013.796364; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; Brindley DN, 2013, BBA-MOL CELL BIOL L, V1831, P74, DOI 10.1016/j.bbalip.2012.08.015; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Goetzl EJ, 1999, CANCER RES, V59, P5370; Hayashi M, 2012, CANCER LETT, V316, P91, DOI 10.1016/j.canlet.2011.10.030; Inoue S, 2013, MOL CELL BIOCHEM, V383, P173, DOI 10.1007/s11010-013-1765-9; Kitayoshi M, 2012, BIOCHEM BIOPH RES CO, V422, P339, DOI 10.1016/j.bbrc.2012.05.012; Okabe K, 2011, CANCER LETT, V309, P236, DOI 10.1016/j.canlet.2011.06.020; Panupinthu N, 2010, BRIT J CANCER, V102, P941, DOI 10.1038/sj.bjc.6605588; Shano S, 2008, BBA-MOL CELL RES, V1783, P748, DOI 10.1016/j.bbamcr.2007.11.013; Tsujiuchi T, 2014, HISTOL HISTOPATHOL, V29, P313; Tsujiuchi T, 2014, J RECEPT SIG TRANSD, V34, P149, DOI 10.3109/10799893.2013.876042	27	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-8177	1573-4919		MOL CELL BIOCHEM	Mol. Cell. Biochem.	OCT	2015	408	1-2					147	154		10.1007/s11010-015-2490-3		8	Cell Biology	Cell Biology	CR6XK	WOS:000361491500014		
J	Uchinaka, A; Hamada, Y; Mori, S; Miyagawa, S; Saito, A; Sawa, Y; Matsuura, N; Yamamoto, H; Kawaguchi, N				Uchinaka, Ayako; Hamada, Yoshinosuke; Mori, Seiji; Miyagawa, Shigeru; Saito, Atsuhiro; Sawa, Yoshiki; Matsuura, Nariaki; Yamamoto, Hirofumi; Kawaguchi, Naomasa			SVVYGLR motif of the thrombin-cleaved N-terminal osteopontin fragment enhances the synthesis of collagen type III in myocardial fibrosis	MOLECULAR AND CELLULAR BIOCHEMISTRY			English	Article						Osteopontin; SVVYGLR peptide; Collagen type III; Fibrosis	IMPROVES CARDIAC-FUNCTION; PEPTIDE SVVYGLR; DILATED CARDIOMYOPATHY; MYOFIBROBLAST DIFFERENTIATION; CONTRACTILE ACTIVITY; INFLAMMATION; EXPRESSION; INTEGRIN; DISEASE; HEART	Osteopontin (OPN) is involved in various physiological processes such as inflammatory and wound healing. However, little is known about the effects of OPN on these tissues. OPN is cleaved by thrombin, and cleavage of the N-terminal fragment exposes a SVVYGLR sequence on its C-terminus. In this study, we examined the effects of the thrombin-cleaved OPN fragments on fibroblasts and myocardial fibrosis, particularly the role of the SVVYGLR sequence. The recombinant thrombin-cleaved OPN fragments (N-terminal fragment [N-OPN], C-terminal fragment [C-OPN], and the N-terminal fragment lacking the SVVYGLR sequence [Delta SV N-OPN]) were added to fibroblasts, and the cellular motility, signal activity, and production of collagen were evaluated. A sustained-release gel containing an OPN fragment or SVVYGLR peptide was transplanted into a rat model of ischemic cardiomyopathy and the quantities and ratio of collagen type I (COL I) and type III (COL III) were estimated. N-OPN significantly promoted fibroblast migration. Smad signal activity, expression of smooth muscle actin (SMA), and the production of COL III were enhanced by N-OPN and SVVYGLR peptide. Conversely, Delta SV N-OPN and C-OPN had no effect. In vivo, the expression level of N-OPN was associated with COL III distribution, and the COL III/COL I ratio was significantly increased by the sustained-release gel containing N-OPN or SVVYGLR peptide. The cardiac function was also significantly improved by the N-OPN- or SVVYGLR peptide-released gel treatment. The N-terminal fragment of thrombin-cleaved OPN-induced Smad signal activation, SMA expression, and COL III production, and its SVVYGLR sequence influences this function.	[Uchinaka, Ayako; Hamada, Yoshinosuke; Kawaguchi, Naomasa] Osaka Univ, Grad Sch Med, Dept Cardiovasc Pathol, Div Hlth Sci, Suita, Osaka 5650871, Japan; [Mori, Seiji; Matsuura, Nariaki; Yamamoto, Hirofumi] Osaka Univ, Grad Sch Med, Dept Mol Pathol, Div Hlth Sci, Suita, Osaka 5650871, Japan; [Miyagawa, Shigeru; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 5650871, Japan; [Saito, Atsuhiro] Osaka Univ, Grad Sch Med, Med Ctr Translat Res, Suita, Osaka 5650871, Japan	Kawaguchi, N (reprint author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Pathol, Div Hlth Sci, 1-7 Yamada Oka, Suita, Osaka 5650871, Japan.	kawaguch@sahs.med.osaka-u.ac.jp					Kitamura M, 2001, CLIN CARDIOL, V24, P325; Lenga Y, 2008, CIRC RES, V102, P319, DOI 10.1161/CIRCRESAHA.107.160408; YOSHIKANE H, 1992, JPN CIRC J, V56, P899; Uchinaka A, 2013, CARDIOVASC RES, V99, P102, DOI 10.1093/cvr/cvt088; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Hinz B, 2001, MOL BIOL CELL, V12, P2730; Dobaczewski M, 2010, CIRC RES, V107, P418, DOI 10.1161/CIRCRESAHA.109.216101; Pauschinger M, 1999, CIRCULATION, V99, P2750; WEBER KT, 1989, J AM COLL CARDIOL, V13, P1637; Tsukui T, 2013, AM J PATHOL, V183, P758, DOI 10.1016/j.ajpath.2013.06.005; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Hamada Y, 2004, DENT MATER J, V23, P650; Ito K, 2009, MATRIX BIOL, V28, P11, DOI 10.1016/j.matbio.2008.10.002; Smith LL, 1996, J BIOL CHEM, V271, P28485; Hamada Y, 2007, DENT MATER J, V26, P487; Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2; Wolak T, 2009, KIDNEY INT, V76, P32, DOI 10.1038/ki.2009.90; Renault MA, 2010, CIRC-HEART FAIL, V3, P431, DOI 10.1161/CIRCHEARTFAILURE.109.898114; Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5; Weber KT, 2013, NAT REV CARDIOL, V10, P15, DOI 10.1038/nrcardio.2012.158; LAPIERE CM, 1977, CONNECT TISSUE RES, V5, P21, DOI 10.3109/03008207709152608; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Tabata Y, 1999, TISSUE ENG, V5, P127, DOI 10.1089/ten.1999.5.127; Egusa H, 2009, BIOMATERIALS, V30, P4676, DOI 10.1016/j.biomaterials.2009.05.032; Barry ST, 2000, BIOCHEM BIOPH RES CO, V267, P764, DOI 10.1006/bbrc.1999.2032; Hamada Y, 2003, BIOCHEM BIOPH RES CO, V310, P153, DOI 10.1016/j.bbrc.2003.09.001; O'Regan A, 2000, INT J EXP PATHOL, V81, P373, DOI 10.1046/j.1365-2613.2000.00163.x; MARIJIANOWSKI MMH, 1995, J AM COLL CARDIOL, V25, P1263, DOI 10.1016/0735-1097(94)00557-7; BISHOP JE, 1990, J MOL CELL CARDIOL, V22, P1157, DOI 10.1016/0022-2828(90)90079-H; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; Collins AR, 2004, J AM COLL CARDIOL, V43, P1698, DOI 10.1016/j.jacc.2003.11.058; Duerr GD, 2014, BIOMED RES INT, DOI 10.1155/2014/124063; Hinz Boris, 2010, F1000 Biol Rep, V2, P78, DOI 10.3410/B2-78; Lopez BA, 2013, CARDIOVASC RES, V99, P111, DOI 10.1093/cvr/cvt100; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Subramanian V, 2007, AM J PHYSIOL-HEART C, V292, pH673, DOI 10.1152/ajpheart.00569.2006; Uchinaka A, 2014, TISSUE ENG PT A, V20, P3073, DOI [10.1089/ten.TEA.2013.0763, 10.1089/ten.tea.2013.0763]; Xie ZL, 2004, HYPERTENSION, V44, P826, DOI 10.1161/01.HYP.0000148458.03202.48	40	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-8177	1573-4919		MOL CELL BIOCHEM	Mol. Cell. Biochem.	OCT	2015	408	1-2					191	203		10.1007/s11010-015-2495-y		13	Cell Biology	Cell Biology	CR6XK	WOS:000361491500019		
J	Shenton, MR; Ohyanagi, H; Wang, ZX; Toyoda, A; Fujiyama, A; Nagata, T; Feng, Q; Han, B; Kurata, N				Shenton, Matthew R.; Ohyanagi, Hajime; Wang, Zi-Xuan; Toyoda, Atsushi; Fujiyama, Asao; Nagata, Toshifumi; Feng, Qi; Han, Bin; Kurata, Nori			Rapid turnover of antimicrobial-type cysteine-rich protein genes in closely related Oryza genomes	MOLECULAR GENETICS AND GENOMICS			English	Article						CRP; Cysteine; Evolution; Gene cluster; Oryza	CELL-SPECIFIC GENE; SELF-INCOMPATIBILITY; ARABIDOPSIS-THALIANA; FLOWERING PLANTS; EXPRESSION; IDENTIFICATION; ALIGNMENT; PEPTIDES; MAIZE; TRANSCRIPTOMES	Defensive and reproductive protein genes undergo rapid evolution. Small, cysteine-rich secreted peptides (CRPs) act as antimicrobial agents and function in plant intercellular signaling and are over-represented among reproductively expressed proteins. Because of their roles in defense, reproduction and development and their presence in multigene families, CRP variation can have major consequences for plant phenotypic and functional diversification. We surveyed the CRP genes of six closely related Oryza genomes comprising Oryza sativa ssp. japonica and ssp. indica, Oryza glaberrima and three accessions of Oryza rufipogon to observe patterns of evolution in these gene families and the effects of variation on their gene expression. These Oryza genomes, like other plant genomes, have accumulated large reservoirs of CRP sequences, comprising 26 groups totaling between 676 and 843 genes, in contrast to antimicrobial CRPs in animal genomes. Despite the close evolutionary relationships between the genomes, we observed rapid changes in number and structure among CRP gene families. Many CRP sequences are in gene clusters generated by local duplications, have undergone rapid turnover and are more likely to be silent or specifically expressed. By contrast, conserved CRP genes are more likely to be highly and broadly expressed. Variable CRP genes created by repeated duplication, gene modification and inactivation can gain new functions and expression patterns in newly evolved gene copies. For the CRP proteins, the process of gain/loss by deletion or duplication at gene clusters seems to be an important mechanism in evolution of the gene families, which also contributes to their expression evolution.	[Shenton, Matthew R.; Ohyanagi, Hajime; Nagata, Toshifumi; Kurata, Nori] Natl Inst Genet, Plant Genet Lab, Mishima, Shizuoka 4118540, Japan; [Toyoda, Atsushi; Fujiyama, Asao] Natl Inst Genet, Comparat Genom Lab, Mishima, Shizuoka 4118540, Japan; [Ohyanagi, Hajime] Mitsubishi Space Software Co Ltd, Tsukuba, Ibaraki 3050032, Japan; [Wang, Zi-Xuan; Feng, Qi; Han, Bin] Chinese Acad Sci, Natl Ctr Gene Res, Shanghai 200233, Peoples R China; [Kurata, Nori] Grad Univ Adv Studies, Sch Life Sci, Dept Genet, SOKENDAI, Mishima, Shizuoka 4118540, Japan; [Toyoda, Atsushi; Fujiyama, Asao; Kurata, Nori] Res Org Informat & Syst, Transdisciplinary Res Integrat Ctr, Minato Ku, Tokyo 1050001, Japan	Kurata, N (reprint author), Natl Inst Genet, Plant Genet Lab, Yata 1111, Mishima, Shizuoka 4118540, Japan.	nkurata@nig.ac.jp			Transdisciplinary Research Integration Center (TRIC) of the Research Organization of Information and Systems; National BioResource Project, Japan (NBRP); National BioResource Project Japan (NBRP)	This work was supported partly from a grant by the Transdisciplinary Research Integration Center (TRIC) of the Research Organization of Information and Systems, and partly from the National BioResource Project, Japan (NBRP). We would like to thank Drs. Masahiro Fujita (NIG) and Qiang Zhao (CAS) for their help to register genome sequences. This work was funded by a grant from the Transdisciplinary Research Integration Center (TRIC) of the Research Organization of Information and Systems for the project "Genetic Function Systems", and by the National BioResource Project Japan (NBRP) for the project "Rice Bioresources".	Amien S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000388; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Wheeler MJ, 2009, NATURE, V459, P992, DOI 10.1038/nature08027; Marshall E, 2011, J EXP BOT, V62, P1677, DOI 10.1093/jxb/err002; Tang L, 2010, MOL PHYLOGENET EVOL, V54, P266, DOI 10.1016/j.ympev.2009.08.007; Light S, 2013, MOL BIOL EVOL, V30, P2645, DOI 10.1093/molbev/mst157; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Hara K, 2009, PLANT CELL PHYSIOL, V50, P1019, DOI 10.1093/pcp/pcp068; Stec B, 2006, CELL MOL LIFE SCI, V63, P1370, DOI 10.1007/s00018-005-5574-5; Ammiraju JSS, 2006, GENOME RES, V16, P140, DOI 10.1101/gr.3766306; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Boland M, 2013, ADV FOOD NUTR RES, V68, P59, DOI 10.1016/B978-0-12-394294-4.00004-3; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; de Graaf BHJ, 2003, J EXP BOT, V54, P55, DOI 10.1093/jxb/erg002; Chae K, 2007, J BIOL CHEM, V282, P33845, DOI 10.1074/jbc.M703997200; Edstam MM, 2011, MOL PLANT, V4, P947, DOI 10.1093/mp/ssr019; Wang MH, 2014, NAT GENET, V46, P982, DOI 10.1038/ng.3044; Tsukamoto T, 2010, PLANT J, V62, P571, DOI 10.1111/j.1365-313X.2010.04177.x; Naito K, 2009, NATURE, V461, P1130, DOI 10.1038/nature08479; Costa LM, 2014, SCIENCE, V344, P168, DOI 10.1126/science.1243005; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; Gutierrez-Marcos JF, 2004, PLANT CELL, V16, P1288, DOI 10.1105/tpc.019778; Davidson RM, 2012, PLANT J, V71, P492, DOI 10.1111/j.1365-313X.2012.05005.x; Mergaert P, 2003, PLANT PHYSIOL, V132, P161, DOI 10.1104/pp.102.018192; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Jose-Estanyol M, 2004, PLANT PHYSIOL BIOCH, V42, P355, DOI 10.1016/j.plaphy.2004.03.009; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Ammiraju JSS, 2008, PLANT CELL, V20, P3191, DOI 10.1105/tpc.108.063727; Boutrot F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-86; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Bedinger Patricia A, 2010, Plant Signal Behav, V5, P1342; de Carvalho A, 2011, CURR PHARM DESIGN, V17, P4270; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Finn R. D., 2010, NUCLEIC ACIDS RES S1, V38, pD211, DOI DOI 10.1093/NAR/GKP985; Jacquemin J, 2013, MOL PLANT, V7, P642; Kawahara Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049423; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Matsuyama T, 1999, PLANT CELL PHYSIOL, V40, P469; Mizuno H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-683; Nallu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060355; Schmidt A, 2011, ACTA CRYSTALLOGR F, V67, P424, DOI 10.1107/S1744309110052607; SVENSSON B, 1992, BIOCHEMISTRY-US, V31, P8767, DOI 10.1021/bi00152a012; Takeuchi H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001449; Xu HL, 1999, P NATL ACAD SCI USA, V96, P2554, DOI 10.1073/pnas.96.5.2554; Zimmermann R, 2010, PLANT PHYSIOL, V152, P356, DOI 10.1104/pp.109.149054	51	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-4615	1617-4623		MOL GENET GENOMICS	Mol. Genet. Genomics	OCT	2015	290	5					1753	1770		10.1007/s00438-015-1028-4		18	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CR7TW	WOS:000361555200009		
J	Maegawa, K; Takii, R; Ushimaru, T; Kozaki, A				Maegawa, Kentaro; Takii, Rumi; Ushimaru, Takashi; Kozaki, Akiko			Evolutionary conservation of TORC1 components, TOR, Raptor, and LST8, between rice and yeast	MOLECULAR GENETICS AND GENOMICS			English	Article						Target of rapamycin; Raptor; LST8; Rice; Saccharomyces cerevisiae; TORC1	CELL-GROWTH CONTROL; PLANT-GROWTH; RAPAMYCIN TOR; TARGET; ARABIDOPSIS; KINASE; EXPRESSION; PROTEINS; NUTRIENT; PATHWAY	Target of rapamycin (TOR) is a conserved eukaryotic serine/threonine kinase that functions as a central controller of cell growth. TOR protein is structurally defined by the presence several conserved domains such as the HEAT repeat, focal adhesion target (FAT), FKBP12/rapamycin binding (FRB), kinase, and FATC domains starting from the N-terminus. In most eukaryotes, TOR forms two distinct physical and functional complexes, which are termed as TOR complex 1 (TORC1) and TORC2. However, plants contain only TORC1 components, i.e., TOR, Raptor, and LST8. In this study, we analyzed the gene structure and functions of TORC components in rice to understand the properties of the TOR complex in plants. Comparison of the locations of introns in these genes among rice and other eukaryotes showed that they were well conserved among plants except for Chlamydomonas. Moreover, the intron positions in the coding sequence of human Raptor and LST8 were closer to those of plants than of fly or nematode. Complementation tests of rice TOR (OsTOR) components in yeast showed that although OsTOR did not complement yeast tor mutants, chimeric TOR, which consisted of the HEAT repeat and FAT domain from yeast and other regions from rice, rescued the tor mutants, indicating that the HEAT repeat and FAT domains are important for species-specific signaling. OsRaptor perfectly complemented a kog1 (yeast Raptor homolog) mutant, and OsLST8 partially complemented an lst8 mutant. Together, these data suggest the importance of the N-terminal region of the TOR, HEAT, and FAT domains for functional diversification of the TOR complex.	[Maegawa, Kentaro; Takii, Rumi; Ushimaru, Takashi; Kozaki, Akiko] Shizuoka Univ, Dept Biol, Suruga Ku, Shizuoka 4228529, Japan	Kozaki, A (reprint author), Shizuoka Univ, Dept Biol, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.	sakozak@ipc.shizuoka.ac.jp					Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Menand B, 2002, P NATL ACAD SCI USA, V99, P6422, DOI 10.1073/pnas.092141899; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Mahfouz MM, 2006, PLANT CELL, V18, P477, DOI 10.1105/tpc.105.035931; Bai XC, 2010, CELL MOL LIFE SCI, V67, P239, DOI 10.1007/s00018-009-0163-7; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Liu YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011883; Deprost D, 2007, EMBO REP, V8, P864, DOI 10.1038/sj.embor.7401043; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Watanabe R, 2011, J NUCL MED, V52, P497, DOI 10.2967/jnumed.111.089623; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Diaz-Troya S, 2008, EUKARYOT CELL, V7, P212, DOI 10.1128/EC.00361-07; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Moreau M, 2012, PLANT CELL, V24, P463, DOI 10.1105/tpc.111.091306; Caldana C, 2013, PLANT J, V73, P897, DOI 10.1111/tpj.12080; Robaglia C, 2012, CURR OPIN PLANT BIOL, V15, P301, DOI 10.1016/j.pbi.2012.01.012; Anderson GH, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-12; Leiber RM, 2010, PLANT CELL, V22, P1898, DOI 10.1105/tpc.109.073007; You DJ, 2010, MOL CELLS, V30, P527, DOI 10.1007/s10059-010-0155-3; Robaglia C, 2004, BIOCHEM SOC T, V32, P581; Helliwell SB, 1998, GENETICS, V148, P99; Xiong Y, 2013, NATURE, V496, P181, DOI 10.1038/nature12030; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Xiong Y, 2012, J BIOL CHEM, V287, P2836, DOI 10.1074/jbc.M111.300749; Caldana C, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-7; Jacinto E, 2008, IUBMB LIFE, V60, P483, DOI 10.1002/iub.56; Jacquemin J, 2011, MOL BIOL EVOL, V28, P3139, DOI 10.1093/molbev/msr144; Nakashima A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002223	31	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-4615	1617-4623		MOL GENET GENOMICS	Mol. Genet. Genomics	OCT	2015	290	5					2019	2030		10.1007/s00438-015-1056-0		12	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CR7TW	WOS:000361555200030		
J	Bailey, DL; Pichler, BJ; Guckel, B; Barthel, H; Beer, AJ; Bremerich, J; Czernin, J; Drzezga, A; Franzius, C; Goh, V; Hartenbach, M; Iida, H; Kjaer, A; la Fougere, C; Ladefoged, CN; Law, I; Nikolaou, K; Quick, HH; Sabri, O; Schafer, J; Schafers, M; Wehrl, HF; Beyer, T				Bailey, D. L.; Pichler, B. J.; Gueckel, B.; Barthel, H.; Beer, A. J.; Bremerich, J.; Czernin, J.; Drzezga, A.; Franzius, C.; Goh, V.; Hartenbach, M.; Iida, H.; Kjaer, A.; la Fougere, C.; Ladefoged, C. N.; Law, I.; Nikolaou, K.; Quick, H. H.; Sabri, O.; Schaefer, J.; Schaefers, M.; Wehrl, H. F.; Beyer, T.			Combined PET/MRI: Multi-modality Multi-parametric Imaging Is Here	MOLECULAR IMAGING AND BIOLOGY			English	Review						PET/MRI; Hybrid imaging; Molecular imaging; PET/CT; PET; MRI; Quantification; Attenuation correction; Oncology; Neurology; Cardiology; Multi-parametric imaging	STANDARDIZED UPTAKE VALUES; GA-68-LABELED PSMA LIGAND; RECURRENT PROSTATE-CANCER; PEDIATRIC DOSAGE CARD; ATTENUATION CORRECTION; INTERNATIONAL WORKSHOP; ALZHEIMERS-DISEASE; INTEGRATED PET/MR; MOTION CORRECTION; ARTERY-DISEASE	This paper summarises key themes and discussions from the 4th international workshop dedicated to the advancement of the technical, scientific and clinical applications of combined positron emission tomography (PET)/magnetic resonance imaging (MRI) systems that was held in Tubingen, Germany, from February 23 to 27, 2015. Specifically, we summarise the three days of invited presentations from active researchers in this and associated fields augmented by round table discussions and dialogue boards with specific topics. These include the use of PET/MRI in cardiovascular disease, paediatrics, oncology, neurology and multi-parametric imaging, the latter of which was suggested as a key promoting factor for the wider adoption of integrated PET/MRI. Discussions throughout the workshop and a poll taken on the final day demonstrated that attendees felt more strongly that PET/MRI has further advanced in both technical versatility and acceptance by clinical and research-driven users from the status quo of last year. Still, with only minimal evidence of progress made in exploiting the true complementary nature of the PET and MRI-based information, PET/MRI is still yet to achieve its potential. In that regard, the conclusion of last year's meeting "the real work has just started" still holds true.	[Bailey, D. L.] Royal N Shore Hosp, Dept Nucl Med, Sydney, NSW, Australia; [Bailey, D. L.] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [Pichler, B. J.; Wehrl, H. F.] Univ Tubingen, Werner Siemens Imaging Ctr, Dept Preclin Imaging & Radiopharm, Tubingen, Germany; [Gueckel, B.; Schaefer, J.] Univ Tubingen, Dept Intervent & Diagnost Radiol, Tubingen, Germany; [Barthel, H.; Sabri, O.] Univ Leipzig, Dept Nucl Med, D-04109 Leipzig, Germany; [Beer, A. J.] Univ Ulm, Dept Nucl Med, D-89069 Ulm, Germany; [Bremerich, J.] Univ Basel Hosp, Dept Radiol & Nucl Med, Cardiothorac Sect, CH-4031 Basel, Switzerland; [Czernin, J.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Drzezga, A.] Univ Hosp Cologne, Dept Nucl Med, Cologne, Germany; [Franzius, C.] Ctr Nucl Med & PET CT, Ctr Morphol & Mol Diagnost ZeMoDi, MR & PET MRI, Bremen, Germany; [Goh, V.] Kings Coll London, Div Imaging Sci & Biomed Engn, London WC2R 2LS, England; [Goh, V.] Guys & St Thomas NHS Fdn Trust, Dept Radiol, London, England; [Hartenbach, M.] Med Univ Vienna, Div Nucl Med, A-1090 Vienna, Austria; [Iida, H.] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Investigat Radiol, Osaka, Japan; [Kjaer, A.; Ladefoged, C. N.; Law, I.] Rigshosp, Dept Clin Physiol, Nucl Med & PET, DK-2100 Copenhagen, Denmark; [Kjaer, A.] Rigshosp, Cluster Mol Imaging, DK-2100 Copenhagen, Denmark; [Kjaer, A.] Univ Copenhagen, Copenhagen, Denmark; [la Fougere, C.] Univ Tubingen, Dept Nucl Med & Mol Imaging, Tubingen, Germany; [Quick, H. H.] Univ Duisburg Essen, Erwin L Hahn Inst MR Imaging, Essen, Germany; [Quick, H. H.] Univ Hosp Essen, High Field & Hybrid MR Imaging, Essen, Germany; [Schaefers, M.] Univ Hosp Munster, Dept Nucl Med, Munster, Germany; [Beyer, T.] Med Univ Vienna, Gen Hosp Vienna, Ctr Med Phys & Biomed Engn, A-1090 Vienna, Austria	Beyer, T (reprint author), Med Univ Vienna, Gen Hosp Vienna, Ctr Med Phys & Biomed Engn, 4L Waehringer Guertel 18-20, A-1090 Vienna, Austria.	thomas.beyer@meduniwien.ac.at			Bayer HealthCare; GE Healthcare; Hermes Medical Solutions; Mediso Medical Imaging Systems; mim Software; Mirada Medical; Pi.pmod Biomedical Image Quantification; RAPID Biomedical; Siemens Healthcare	We would further like to acknowledge the generous support of the workshop sponsors: Bayer HealthCare, GE Healthcare, Hermes Medical Solutions, Mediso Medical Imaging Systems, mim Software, Mirada Medical, Pi.pmod Biomedical Image Quantification and RAPID Biomedical and Siemens Healthcare.	Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Afshar-Oromieh A, 2015, EUR J NUCL MED MOL I, V42, P197, DOI 10.1007/s00259-014-2949-6; Heusch P, 2013, EUR J RADIOL, V82, P870, DOI 10.1016/j.ejrad.2013.01.008; Wildgruber M, 2013, THERANOSTICS, V3, P865, DOI 10.7150/thno.5771; Catana C, 2011, J NUCL MED, V52, P154, DOI 10.2967/jnumed.110.079343; Stauss J, 2008, EUR J NUCL MED MOL I, V35, P1581, DOI 10.1007/s00259-008-0826-x; Kolh P, 2014, EUR HEART J, V35, P3235, DOI 10.1093/eurheartj/ehu422; Hicks RJ, 2009, EUR J NUCL MED MOL I, V36, P10, DOI 10.1007/s00259-008-0966-z; Petibon Y, 2013, PHYS MED BIOL, V58, P2085, DOI 10.1088/0031-9155/58/7/2085; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Lassmann M, 2014, EUR J NUCL MED MOL I, V41, P1636, DOI 10.1007/s00259-014-2817-4; Delso G, 2014, J NUCL MED, V55, P780, DOI 10.2967/jnumed.113.130880; Kudomi N, 2013, J CEREBR BLOOD F MET, V33, P440, DOI 10.1038/jcbfm.2012.188; Schafers M, 2010, J NUCL MED, V51, P663, DOI 10.2967/jnumed.109.065698; Kim JH, 2012, J NUCL MED, V53, P1878, DOI 10.2967/jnumed.112.104109; Kershah S, 2013, MOL IMAGING BIOL, V15, P776, DOI 10.1007/s11307-013-0629-8; Oehmigen M, 2014, J NUCL MED, V55, P1361, DOI 10.2967/jnumed.114.139147; Hartenbach M, 2014, CLIN CANCER RES, V20, P3244, DOI 10.1158/1078-0432.CCR-13-2653; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Blumhagen JO, 2014, MED PHYS, V41, DOI 10.1118/1.4861097; Wehrl HF, 2014, NEUROIMAGE, V89, P271, DOI 10.1016/j.neuroimage.2013.11.044; Bailey DL, 2015, MOL IMAGING BIOL, V17, P297, DOI 10.1007/s11307-014-0818-0; Osborn EA, 2013, JACC-CARDIOVASC IMAG, V6, P1327, DOI 10.1016/j.jcmg.2013.09.014; Becker H, 2009, LAB CHIP, V9, P2119, DOI 10.1039/b911553f; Barthel H, 2011, LANCET NEUROL, V10, P424, DOI 10.1016/S1474-4422(11)70077-1; Gelfand MJ, 2011, J NUCL MED, V52, P318, DOI 10.2967/jnumed.110.084327; Riedl V, 2014, J NEUROSCI, V34, P6260, DOI 10.1523/JNEUROSCI.0492-14.2014; Martinez-Moller A, 2009, J NUCL MED, V50, P520, DOI 10.2967/jnumed.108.054726; Hofmann M, 2008, J NUCL MED, V49, P1875, DOI 10.2967/jnumed.107.049353; Lassmann M, 2008, EUR J NUCL MED MOL I, V35, P1666, DOI 10.1007/s00259-008-0799-9; Nensa F, 2013, RADIOLOGY, V268, P366, DOI 10.1148/radiol.13130231; Afshar-Oromieh A, 2014, EUR J NUCL MED MOL I, V41, P887, DOI 10.1007/s00259-013-2660-z; Wehrl HF, 2013, NAT MED, V19, P1184, DOI 10.1038/nm.3290; Bailey DL, 2013, MOL IMAGING BIOL, V15, P361, DOI 10.1007/s11307-013-0623-1; Andersen FL, 2014, NEUROIMAGE, V84, P206, DOI 10.1016/j.neuroimage.2013.08.042; Sander CY, 2013, P NATL ACAD SCI USA, V110, P11169, DOI 10.1073/pnas.1220512110; Paulus DH, 2014, MED PHYS, V41, DOI 10.1118/1.4881317; Iguchi S, 2013, NUCL INSTRUM METH A, V702, P111, DOI 10.1016/j.nima.2012.08.037; Bailey DL, 2014, MOL IMAGING BIOL, V16, P295, DOI 10.1007/s11307-014-0725-4; Botnar RM, 2015, ROFO-FORTSCHR RONTG, V187, P92, DOI 10.1055/s-0034-1385451; Bulluck H, 2015, CIRC J, V79, P487, DOI 10.1253/circj.CJ-15-0054; Czernin J., 2007, J NUCL MED S1, V48, P78; Delso G, 2015, J NUCL MED, V56, P417, DOI 10.2967/jnumed.114.149997; Drzezga A, 2014, J NUCL MED, V55, p47S, DOI 10.2967/jnumed.113.129254; Dukart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018111; Eder Matthias, 2014, Pharmaceuticals (Basel), V7, P779, DOI 10.3390/ph7070779; Fieseler M, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-S1-S2; Izquierdo-Garcia D, 2014, J NUCL MED, V55, P1825, DOI 10.2967/jnumed.113.136341; Kalender WA, 2014, PHYS MED BIOL, V59, pR129, DOI 10.1088/0031-9155/59/3/R129; Kellman P, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-2; Kjaer A, 2015, BIOMED RES INT, V2015; Kudomi N, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-41; Magnoni M, 2015, J CARDIOL, V65, P261, DOI 10.1016/j.jjcc.2015.01.004; Nensa F, 2014, EUR HEART J, V35, P2173, DOI 10.1093/eurheartj/ehu086; Nensa F, 2015, J NUCL MED, V56, P255, DOI 10.2967/jnumed.114.147744; Pedersen SF, 2014, CLIN PHYSIOL FUNCT I, V34, P413, DOI 10.1111/cpf.12105; Pica S, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0099-4; Purz S, 2014, J NUCL MED, V55, p32S, DOI 10.2967/jnumed.113.129304; Quick HH, 2014, J MAGN RESON IMAGING, V39, P243, DOI 10.1002/jmri.24523; Ripa Rasmus S, 2013, Am J Nucl Med Mol Imaging, V3, P361; Ripa RS, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0415-3; Schafer JF, 2014, RADIOLOGY, V273, P220, DOI 10.1148/radiol.14131732; Uslu L, 2015, J NUCL MED, V56, P274, DOI 10.2967/jnumed.114.146290	63	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1536-1632	1860-2002		MOL IMAGING BIOL	Mol. Imaging. Biol.	OCT	2015	17	5					595	608		10.1007/s11307-015-0886-9		14	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CR6XP	WOS:000361492000001		
J	Lee, JE; Chung, KY; Lee, KD; Gen, M				Lee, Jeong-Eun; Chung, Kyung-Yong; Lee, Kang-Dae; Gen, Mitsuo			A multi-objective hybrid genetic algorithm to minimize the total cost and delivery tardiness in a reverse logistics	MULTIMEDIA TOOLS AND APPLICATIONS			English	Article						Multi-objective reverse logistics network (mo-RLN); Pri-awGA (priority-based GA with adaptive weight approach); Multi-objective hybrid genetic algorithm (mo-hGA); Fuzzy logic controller (FLC)	SUPPLY CHAIN; NETWORK DESIGN; INVENTORY CONTROL; MODEL; TIME; SERVICE; OPTIMIZATION; MULTIPERIOD; PERSPECTIVE; DEMAND	In the recent environmental protection the reverse logistics of the used product is one of the most important research topics. The reverse logistics is the process flow of used-products that are collected to be reproduced so that they can be sold again to customers after some processing. We propose a multi-objective hybrid genetic algorithm (mo-hGA) combined with Fuzzy Logic Controller (FLC) for efficiently dealing with multi-objective reverse logistics network (mo-RLN) problem. The aim of this paper is firstly to formulate mo-RLN model, and secondly to optimize it by mo-hGA method proposed with reusable system configuration. In particular two objective functions to be minimized total costs of mo-RLN, (i.e. fixed opening cost, transportation cost and inventory cost) and also minimized delivery tardiness in all periods are considered in the model. We will clear each objective function (i.e. total costs and total delivery tardiness), computational time and number of Pareto solutions with LINGO, pri-awGA (priority-based GA with adaptive weight approach) and mo-hGA proposed with numerical examples. For demonstrating the effectiveness of the proposed model, we evaluate with the numerical examples and simulate it with a bottles distilling/sale company as a case study in Busan, Korea.	[Lee, Jeong-Eun] Dong Eui Univ, Dept Accounting, Busan, South Korea; [Chung, Kyung-Yong] Sangji Univ, Sch Comp Informat Engn, Wonju 220702, Gangwon Do, South Korea; [Lee, Kang-Dae] Yonsei Univ, Dept Packaging, Wonju, Kangwon Do, South Korea; [Gen, Mitsuo] Fuzzy Log Syst Inst, Iizuka, Fukuoka, Japan	Lee, KD (reprint author), Yonsei Univ, Dept Packaging, 234 Maeji Heungup, Wonju, Kangwon Do, South Korea.	leeje@deu.ac.kr; dragonhci@hanmail.net; pimeson@yonsei.ac.kr; gen@flsi.or.jp			Yonsei University; Japan Society of Promotion of Science (JSPS) [245102190001]; Taiwan National Science Council (NSC) [101-2811-E-007-004]	This work was partly supported by the Yonsei University Research Fund of 2012, by the Grant-in-Aid for Scientific Research (C) (No.245102190001) of the Japan Society of Promotion of Science (JSPS) and Taiwan National Science Council (NSC 101-2811-E-007-004).	Altiparmak F., 2006, COMPUT IND ENG, V51, P197; Xu JP, 2008, INFORM SCIENCES, V178, P2022, DOI 10.1016/j.ins.2007.11.025; Pishvaee MS, 2010, FUZZY SET SYST, V161, P2668, DOI 10.1016/j.fss.2010.04.010; Pati RK, 2008, OMEGA-INT J MANAGE S, V36, P405, DOI 10.1016/j.omega.2006.04.014; Sha DY, 2006, J OPER RES SOC, V57, P52, DOI 10.1057/palgrave.jors.2601949; Farahani RZ, 2008, INT J PROD ECON, V111, P229, DOI 10.1016/j.ijpe.2006.11.028; Alumur SA, 2012, EUR J OPER RES, V220, P67, DOI 10.1016/j.ejor.2011.12.045; Lee DH, 2009, TRANSPORT RES E-LOG, V45, P61, DOI 10.1016/j.tre.2008.08.002; Galand L, 2010, EUR J OPER RES, V204, P303, DOI 10.1016/j.ejor.2009.10.015; Ulku MA, 2012, EUR J OPER RES, V221, P110, DOI 10.1016/j.ejor.2012.03.021; Lee JE, 2009, COMPUT IND ENG, V56, P951, DOI 10.1016/j.cie.2008.09.021; Pishvaee MS, 2010, COMPUT OPER RES, V37, P1100, DOI 10.1016/j.cor.2009.09.018; Lin L, 2009, SOFT COMPUT, V13, P157, DOI 10.1007/s00500-008-0303-2; Keren B, 2009, OMEGA-INT J MANAGE S, V37, P801, DOI 10.1016/j.omega.2008.07.006; Ko HJ, 2007, COMPUT OPER RES, V34, P346, DOI 10.1016/j.cor.2005.03.004; Barnes-Schuster D, 2006, EUR J OPER RES, V174, P1664, DOI 10.1016/j.ejor.2002.08.002; de Brito MP, 2009, EUR J OPER RES, V194, P85, DOI 10.1016/j.ejor.2007.11.063; Du F, 2008, COMPUT OPER RES, V35, P2617, DOI 10.1016/j.cor.2006.12.020; Gen M, 2008, DECIS ENG, P1; Gen M., 1997, GENETIC ALGORITHM EN; Gen M., 2000, GENETIC ALGORITHMS E; Glock CH, 2012, INT J PROD ECON, V136, P37, DOI 10.1016/j.ijpe.2011.09.007; Grubbstrom RW, 2011, INT J PROD ECON, V143, P395; Kim YK, 2005, J KOREAN I IND ENG, V31, P180; Ko M, 2010, APPL SOFT COMPUT, V10, P661, DOI 10.1016/j.asoc.2009.09.004; Lin L, 2005, COMPLEX INT, V11, P73; LINDO Systems Inc, 2003, LINGO MOD LANG OPT; Min H, 2008, INT J PROD ECON, V113, P176, DOI 10.1016/j.ijpe.2007.01.017; Moed MC, 1991, P IEEE INT C TOOLS A, P500, DOI 10.1109/TAI.1991.167032; Ray S, 2004, EUR J OPER RES, V153, P769, DOI 10.1016/S0377-2217(02)00655-0; Salcedo CAG, 2013, EUR J OPER RES, V224, P261, DOI 10.1016/j.ejor.2012.07.029; PARK KYUNG SAM, 2009, [korean management review, 경영학연구], V38, P1251; Tempelmeier H, 2006, EUR J OPER RES, V174, P600, DOI 10.1016/j.ejor.2005.01.044; Xu NX, 2011, INT J PROD ECON, V133, P719, DOI 10.1016/j.ijpe.2011.05.026	34	5	5	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1380-7501	1573-7721		MULTIMED TOOLS APPL	Multimed. Tools Appl.	OCT	2015	74	20					9067	9085		10.1007/s11042-013-1594-6		19	Computer Science, Information Systems; Computer Science, Software Engineering; Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CR6XU	WOS:000361492600027		
J	Sri-Indrasutdhi, V; Tsui, CKM; Chuaseeharonnachai, C; Yamaguchi, K; Suetrong, S; Okane, I; Nakagiri, A; Boonyuen, N				Sri-Indrasutdhi, Veera; Tsui, Clement K. M.; Chuaseeharonnachai, Charuwan; Yamaguchi, Kaoru; Suetrong, Satinee; Okane, Izumi; Nakagiri, Akira; Boonyuen, Nattawut			Helicocentralis hyalina gen. et sp nov., an aero-aquatic helicosporous fungus (Leotiomycetes, Ascomycota) in Thailand	MYCOLOGICAL PROGRESS			English	Article						Aero-aquatic fungi; Freshwater; Dothideomycetes; Helicocentralis hyalina; Helicosporous hyphomycetes; Leotiomycetes; Molecular phylogeny; Wood; Thailand	TUBEUFIACEAE; HELICOMA; TELEOMORPHS; PHYLOGENIES; SEQUENCES; FORESTS	During a survey of aero-aquatic fungi in Thailand, an undescribed helicosporous fungus was discovered. It is characterized by the presence of branched and septate hyphae with hyaline conidiophores that are micronematous or semi-macronematous, acrogenous and holoblastic. Conidia are hyaline and centrifugally coiled (excentric), helicoid or circinate, coiled 2-3 times clockwise or counterclockwise. After comparison of morphological and molecular characters with other aero-aquatic, helicosporous fungi, introduction of a new genus and species is proposed, Helicocentralis hyalina gen. et sp. nov. Phylogenetic analyses based on the combined sequence data from the small and large nuclear subunit ribosomal DNA (SSU and LSU), as well as internal transcribed spacer (ITS) rDNA sequence data, the fungus groups within the Leotiomycetes class with strong statistical support. The new genus is not related to other helicosporous hyphomycete genera (Helicoma, Helicomyces, Helicoon, and Helicosporium), which belong in the Tubeufiaceae, Dothideomycetes. Within the Leotiomycetes, our new fungus is distantly related to Helicodendron paradoxum (the type species). The new fungus is also compared morphologically to six similar helicosporous genera from Dothideomycetes and Leotiomycetes.	[Sri-Indrasutdhi, Veera; Chuaseeharonnachai, Charuwan; Suetrong, Satinee; Boonyuen, Nattawut] NSTDA, BIOTEC, Fungal Biodivers Lab, Amphoe Khlong Luang 12120, Pathum Thani, Thailand; [Tsui, Clement K. M.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 1Z4, Canada; [Yamaguchi, Kaoru] NITE, Biol Resource Ctr NBRC, Kisarazu, Chiba 2920818, Japan; [Okane, Izumi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Nakagiri, Akira] Tottori Univ, Fac Agr, Fungus Mushroom Resource & Res Ctr, Tottori, Tottori 6808553, Japan	Sri-Indrasutdhi, V (reprint author), NSTDA, BIOTEC, Fungal Biodivers Lab, 113 Thailand Sci Pk, Amphoe Khlong Luang 12120, Pathum Thani, Thailand.	Veera@biotec.or.th			Bioresources Research Network (BRN) [P-00-20194]	This research was conducted under collaboration between the National Center for Genetic Engineering and Biotechnology (BIOTEC, Thailand) and the NITE Biological Resource Center (NBRC, Japan). Financial support by the Bioresources Research Network (BRN, P-00-20194) is gratefully acknowledged. Dr. Nattawut Boonyuen wishes to thank Dr. Somsak Sivichai who initiated the project of aero-aquatic fungi as a Thai freshwater fungi at BIOTEC. We gratefully thank Dr. Lily Eurwilaichitr, Dr. Kanyawim Kirtikara from BIOTEC, Prof. Dr. Morakot Tanticharoen from King Mongkut's University of Technology Thonburi, Dr. Ken-ichiro Suzuki and Dr. Hiroko Kawasaki from NITE Biological Resource Center for their interest in aero-aquatic fungi under the collaborative project between BIOTEC and NITE. Panthita Ruangareerate from Genome Technology Research Unit, BIOTEC is thanked for RAxML. We also acknowledge Prof. Dr. E.B. Gareth Jones, from King Saud University, Saudi Arabia, for his pre-submission comments.	ABDULLAH S K, 1980, Irish Naturalists' Journal, V20, P49; Suetrong S, 2011, FUNGAL DIVERS, V51, P163, DOI 10.1007/s13225-011-0138-5; FIELD JI, 1983, T BRIT MYCOL SOC, V81, P365; Tsui CKM, 2010, MYCOSCIENCE, V51, P144, DOI 10.1007/s10267-009-0019-x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Zhao GZ, 2007, FUNGAL DIVERS, V26, P313; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Boonmee S, 2011, FUNGAL DIVERS, V51, P63, DOI 10.1007/s13225-011-0147-4; FISHER PJ, 1979, T BRIT MYCOL SOC, V72, P57; Tsui CKM, 2006, MOL PHYLOGENET EVOL, V39, P587, DOI 10.1016/j.ympev.2006.01.025; Gonczol J, 2003, FUNGAL DIVERS, V12, P19; Barlocher F., 1978, ARCH HYDROBIOL, V81, P269; Baschien C, 2013, FUNGAL BIOL-UK, V117, P660, DOI 10.1016/j.funbio.2013.07.004; Boonmee S, 2014, FUNGAL DIVERS, V68, P239, DOI 10.1007/s13225-014-0304-7; Boonyuen N, 2011, MYCOLOGIA, V103, P1351, DOI 10.3852/11-102; Chuaseeharonnachai C, 2014, MYCOSPHERE, V5, P313, DOI 10.5943/mycosphere/5/2/5; Chuaseeharonnachai C, 2013, CRYPTOGAMIE MYCOL, V34, P183, DOI 10.782/crym.v34.iss2.2013.183; Ellis MB, 1971, DEMATIACEOUS HYPHOMY; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Fisher P. J., 1981, The fungal community. Its organization and role in the ecosystem, P709; FISHER PJ, 1983, T BRIT MYCOL SOC, V81, P656; Gams W, 1998, CBS COURSE MYCOLOGY; GOOS RD, 1986, MYCOLOGIA, V78, P744, DOI 10.2307/3807519; GOOS RD, 1985, MYCOLOGIA, V77, P606, DOI 10.2307/3793359; HALL T.A., 2004, BIOEDIT; Hawksworth DL, 1995, AINSWORTH BISBYS DIC; HOLUBOVAJECHOVA V, 1991, MYCOTAXON, V41, P445; Markovskaja Svetlana, 2012, Botanica Lithuanica, V18, P123, DOI 10.2478/v10279-012-0014-6; NAWAWI A, 1985, Malayan Nature Journal, V39, P75; Nylander JAA, 2004, MRMODELTEST 2 PROGRA; Rambaut A, 1996, SE A1 SEQUENCE ALIGN; Sanchez RM, 2012, MYCOLOGIA, V104, P223, DOI 10.3852/11-105; Sanchez RM, 2010, MYCOTAXON, V111, P131, DOI 10.5248/111.131; Swofford DL, 2002, PAUP 4B10 PHYLOGENET; Tsui CKM, 2006, MYCOLOGIA, V98, P94, DOI 10.3852/mycologia.98.1.94; van Beverwijk AL, 1951, J MICROB, V17, P9; White TJ, 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1139/B07-071; Yamaguchi K, 2012, MYCOLOGIA, V104, P1109, DOI 10.3852/11-253	40	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-416X	1861-8952		MYCOL PROG	Mycol. Prog.	OCT	2015	14	10							81	10.1007/s11557-015-1103-6		12	Mycology	Mycology	CR6XX	WOS:000361492900003		
J	Yamamoto, K; Degawa, Y; Hirose, D; Fukuda, M; Yamada, A				Yamamoto, Kohei; Degawa, Yousuke; Hirose, Dai; Fukuda, Masaki; Yamada, Akiyoshi			Morphology and phylogeny of four Endogone species and Sphaerocreas pubescens collected in Japan	MYCOLOGICAL PROGRESS			English	Article						Endogonales; Zygosporangial morphology; Mucoromycotina; nrLSU phylogeny	ARBUSCULAR MYCORRHIZAL FUNGI; NEW-ZEALAND; ECTOMYCORRHIZAL FUNGI; PLANTS; PINUS; FLAMMICORONA; AUSTRALIA; GENUS; NOV; DNA	The order Endogonales within Mucoromycotina includes several ectomycorrhizal species and endophytes of lower land plants. As such, this order is a key taxon for investigation of the evolutionary process of plant-fungal symbioses. However, no taxonomic study of Endogonales based on morphological and phylogenetic data has been performed, and the geographic distribution of this order in Asia remains largely unknown. We collected E. incrassata, E. pisiformis, E. flammicorona, and E. lactiflua from forests in Japan, thus representing their first description in Asia. Collected sporocarps were examined microscopically to observe details of hyphal structures, particularly in zygosporangia and gametangia. In addition, we collected Japanese Sphaerocreas pubescens, recently reported to be related to Endogone-like mycobionts of liverworts, and described its morphology. Species were also analyzed phylogenetically based on large-subunit nuclear ribosomal RNA gene sequences. The phylogenetic relationships of the four Endogone species were supported by their zygosporangial morphogenesis: group A, comprising E. incrassata and E. pisiformis, formed homogametic zygosporangia with pale-colored sporangiothecia, whereas species in group B, E. flammicorona and E. lactiflua, formed heterogametic zygosporangia with orange-colored sporangiothecia. Sphaerocreas pubescens was phylogenetically close to Densospora solicarpa, which is an uncertain zygomycotan ectomycorrhizal fungus; however, the relationship between the "Sphaerocreas/Densospora" clade and Endogone was unclear.	[Yamamoto, Kohei; Yamada, Akiyoshi] Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, Dept Biosci & Food Prod Sci, Minami Minowa, Nagano 3994598, Japan; [Degawa, Yousuke] Univ Tsukuba, Sugadaira Montane Res Ctr, Nagano 3862204, Japan; [Hirose, Dai] Nihon Univ, Coll Pharm, Funabashi, Chiba 2748555, Japan; [Fukuda, Masaki; Yamada, Akiyoshi] Shinshu Univ, Fac Agr, Dept Biosci & Biotechnol, Minami Minowa, Nagano 3994598, Japan; [Yamada, Akiyoshi] Shinshu Univ, Inst Mt Sci, Div Terr Ecosyst, Minami Minowa, Nagano 3994598, Japan	Yamamoto, K (reprint author), Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, Dept Biosci & Food Prod Sci, Minami Minowa, Nagano 3994598, Japan.	kohei081@yahoo.co.jp			Japan Society for the Promotion of Science (JSPS) [14J09199]	We are grateful to the members of the Mycorrhiza Laboratory, Shinshu University, and the Laboratory of Mycology, Sugadaira, and Mr. Yusuke Takashima for donation of the specimens and support for our sampling. Mr. Tetsuo Muroi kindly provided valuable literature regarding Endogonales. We also thank Dr. Kentaro Hosaka (TNS), Mr. Daisuke Sakuma (OSA), and Dr. Takamichi Orihara (KPM), who allowed access to the herbarium specimens and deposits of our specimens. In addition, we thank the technical staff of the Division of Instrumental Analysis, Research Center for Human and Environmental Sciences, Shinshu University, for DNA sequencing. This study was supported in part by a Research Fellowship for Young Scientists (No. 14J09199) from the Japan Society for the Promotion of Science (JSPS).	HALL IR, 1977, T BRIT MYCOL SOC, V68, P341; Kruger M, 2009, NEW PHYTOL, V183, P212, DOI 10.1111/j.1469-8137.2009.02835.x; MORTON JB, 1990, MYCOTAXON, V37, P471; Taylor DL, 1999, MOL ECOL, V8, P1837, DOI 10.1046/j.1365-294x.1999.00773.x; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; O'Donnell K, 2001, MYCOLOGIA, V93, P286, DOI 10.2307/3761650; Field KJ, 2015, NEW PHYTOL, V205, P743, DOI 10.1111/nph.13024; Desiro A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0207; SIMON L, 1993, NATURE, V363, P67, DOI 10.1038/363067a0; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Wagner L, 2013, PERSOONIA, V30, P77, DOI 10.3767/003158513X666268; Dunstan WA, 1998, MYCORRHIZA, V8, P71, DOI 10.1007/s005720050215; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Bidartondo MI, 2011, BIOL LETTERS, V7, P574, DOI 10.1098/rsbl.2010.1203; Walther G, 2013, PERSOONIA, V30, P11, DOI 10.3767/003158513X665070; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Tedersoo L, 2013, FUNGAL BIOL REV, V27, P83, DOI 10.1016/j.fbr.2013.09.001; CHUCHOU M, 1988, SOIL BIOL BIOCHEM, V20, P883, DOI 10.1016/0038-0717(88)90098-3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Atkinson GF, 1918, BROOKLYN BOT GARD ME, V1, P1; BERCH SM, 1984, CAN J BOT, V62, P170; BERCH SM, 1983, MYCOLOGIA, V75, P328, DOI 10.2307/3792820; Bucholtz F, 1901, HEDWIGIA, V40, P304; Bucholtz F, 1912, BERHERFTE BOT CENT 2, V39, P147; CHUCHOU M, 1984, NEW ZEAL J BOT, V22, P525; CHUCHOU M, 1979, NEW ZEAL J FOR SCI, V9, P344; Clemencon H, 2009, METHODS WORKING MACR; Degawa Y, 2004, STUD MYCOL, P567; Desiro A, 2015, NEW PHYTOL, V205, P1464, DOI 10.1111/nph.13136; Dodge CW, 1928, COMP MORPHOLOGY FUNG; FASSI BRUNO, 1965, ALLIONIA [TURIN], V11, P7; Fischer E, 1997, NATURL PFLANZ, VI, P278; GERDEMAN.JW, 1970, MYCOLOGIA, V62, P1204, DOI 10.2307/3757743; TRAPPE JM, 1972, T BRIT MYCOL SOC, V59, P403; GIBSON JL, 1986, MYCOLOGIA, V78, P941, DOI 10.2307/3807435; GODFREY ROSEMARY M., 1957, TRANS BRIT MYCOL SOC, V40, P117; Gourley CO, 1982, P N S I SCI, V32, P75; Hirose D, 2014, MYCOSCIENCE, V55, P221, DOI 10.1016/j.myc.2013.09.002; Hirose D, 2012, MYCOSCIENCE, V53, P256, DOI 10.1007/s10267-011-0160-1; Jiang XZ, 2011, FUNGAL DIVERS, V46, P43, DOI 10.1007/s13225-010-0076-7; KANOUSE BESSIE B., 1936, MYCOLOGIA, V28, P47, DOI 10.2307/3754067; Katoh K., 2008, BRIEF BIOINFORM, V9, P276, DOI DOI 10.1093/BIB/BBN013; KOSKE RE, 1986, MYCOTAXON, V26, P125; Lihnell D, 1937, SVEN BOT TIDSKR, V31, P150; Link HF, 1809, MAG GES NATURF FREUN, V3, P3; May T, 1997, AUSTRALAS MYCOL NEWS, V16, P35; McGee Peter A., 2002, Australian Systematic Botany, V15, P115, DOI 10.1071/SB00038; McGee PA, 1996, AUST SYST BOT, V9, P329, DOI 10.1071/SB9960329; MCGEE PA, 1986, T BRIT MYCOL SOC, V87, P123; NICOLSON TH, 1968, MYCOLOGIA, V60, P313, DOI 10.2307/3757161; Osmundson TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062419; FASSI B., 1969, Allionia, V15, P105; Pap G, 1990, NOT BOT HORTI AGROBO, V20, P17; Pasaban PM, 1993, B SOC MICOLOGICA MAD, V18, P41; Paz I, 2013, YESCA, V25, P137; Pegler DN, 1993, BRIT TRUFFLES; PETCH T., 1925, Ann. Roy. Bat. Gard., V9, P313; Barroetaveña C., 2003, Bosque, V24, P3, DOI 10.4067/S0717-92002003000100001; Rimington WR, 2015, NEW PHYTOL, V205, P1394, DOI 10.1111/nph.13221; Saccardo PA, 1882, MICHELIA, V2, P564; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Tandy PA, 1975, THESIS U ADELAIDE; TANDY PA, 1975, AUST J BOT, V23, P849, DOI 10.1071/BT9750849; Tedersoo L, 2007, THESIS U TARTU; Thaxter R., 1922, P AM ACAD ARTS SCI, V57, P291, DOI DOI 10.2307/20025921; Trappe JM, 1974, MYCOLOGIA MEMOIR, V5, P1; Trappe J. M., 1982, Methods and principles of mycorrhizal research., P1; TRAPPE JM, 1979, MYCOLOGIA, V71, P206, DOI 10.2307/3759234; Vila J, 1994, B SOC CATALANA MICOL, V16-17, P213; WALKER C, 1985, T BRIT MYCOL SOC, V84, P353; WARCUP JH, 1990, MYCOL RES, V94, P173; WARCUP JH, 1985, NEW PHYTOL, V99, P267, DOI 10.1111/j.1469-8137.1985.tb03655.x; White TJ, 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1139/B07-071; Wu CG, 1997, MYCOTAXON, V64, P179; YAO YJ, 1992, MYCOTAXON, V45, P109; Yao YJ, 1996, GENERA ENDOGONALES; Yao Y.-J., 1995, Kew Bulletin, V50, P349, DOI 10.2307/4110641	79	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-416X	1861-8952		MYCOL PROG	Mycol. Prog.	OCT	2015	14	10							86	10.1007/s11557-015-1111-6		17	Mycology	Mycology	CR6XX	WOS:000361492900008		
J	Chen, YH; Nara, K; Wen, ZG; Shi, L; Xia, Y; Shen, ZG; Lian, CL				Chen, Yahua; Nara, Kazuhide; Wen, Zhugui; Shi, Liang; Xia, Yan; Shen, Zhenguo; Lian, Chunlan			Growth and photosynthetic responses of ectomycorrhizal pine seedlings exposed to elevated Cu in soils	MYCORRHIZA			English	Article						Copper uptake; ECM fungi; Heavy metal-contaminated soils; Metal toxicity; Photosynthesis; Pine (Pinus densiflora)	MYCORRHIZAL INFECTION; SYLVESTRIS SEEDLINGS; PICEA-GLAUCA; HEAVY-METALS; SCLERODERMA-FLAVIDUM; BANKSIANA SEEDLINGS; EUCALYPTUS-GLOBULUS; NICKEL TOXICITY; LACTARIUS-RUFUS; ZINC TOLERANCE	It is still controversial whether ectomycorrhizal (ECM) mycelia filter out toxic metals in nutrient absorption of host trees. In this study, pine (Pinus densiflora) seedlings colonized by Cu-sensitive and Cu-tolerant ECM species were exposed to a wide spectrum of soil Cu concentrations to investigate functions of ECM fungi under Cu stress. The photosynthetic rates of intact needles were monitored in situ periodically. The biomass and elements of plants were also measured after harvest. The ameliorating effect of ECM infection on host plants exposed to toxic stress was metal concentration specific. Under lower-level Cu stress, ECM fungi increased seedling performance, while ECM seedlings accumulated more Cu than nonmycorrhizal (NM) seedlings. Under higher-level Cu stress, photosynthesis decreased well before visible symptoms of Cu toxicity appeared. The reduced photosynthesis and biomass in ECM seedlings compared to NM seedlings under higher Cu conditions were also accompanied by lower phosphorus in needles. There was no marked difference between the two fungal species. Our results indicate that the two ECM fungi studied in our system may not have an ability to selectively eliminate Cu in nutrient absorption and may not act as effective barriers that decrease toxic metal uptake into host plants.	[Chen, Yahua; Wen, Zhugui; Shi, Liang; Xia, Yan; Shen, Zhenguo; Lian, Chunlan] Nanjing Agr Univ, Collaborated Lab Plant Mol Ecol, Nanjing 210095, Jiangsu, Peoples R China; [Nara, Kazuhide] Univ Tokyo, Grad Sch Frontier Sci, Dept Nat Environm Studies, Kashiwa, Chiba 2778563, Japan; [Lian, Chunlan] Univ Tokyo, Asian Nat Environm Sci Ctr, Nishitokyo, Tokyo 1880002, Japan	Lian, CL (reprint author), Nanjing Agr Univ, Collaborated Lab Plant Mol Ecol, Nanjing 210095, Jiangsu, Peoples R China.	lian@anesc.u-tokyo.ac.jp			National Natural Science Foundation of China [NSFC-GDNSF U1133004, 31371545]; Japan Society for the Promotion of Science (JSPS) [P08432]; Science Foundation of Jiangsu Province, China [BE2014742, BE2013709, CX(14)2095]	This research was funded by the National Natural Science Foundation of China (NSFC-GDNSF U1133004, 31371545); the Japan Society for the Promotion of Science (JSPS, P08432); and the Science Foundation of Jiangsu Province, China (BE2014742; BE2013709, CX(14)2095).	Adriaensen K, 2004, NEW PHYTOL, V161, P549, DOI 10.1046/j.1469-8137.2003.00941.x; Adriaensen K, 2006, MYCORRHIZA, V16, P553, DOI 10.1007/s00572-006-0072-7; JONES MD, 1988, NEW PHYTOL, V108, P451, DOI 10.1111/j.1469-8137.1988.tb04186.x; Mendez MO, 2008, ENVIRON HEALTH PERSP, V116, P278, DOI 10.1289/ehp.10608; JONES MD, 1986, NEW PHYTOL, V102, P429, DOI 10.1111/j.1469-8137.1986.tb00820.x; Krznaric E, 2009, ENVIRON POLLUT, V157, P1581, DOI 10.1016/j.envpol.2008.12.030; Roy S, 2007, CAN J BOT, V85, P237, DOI 10.1139/B07-017; Martin F, 2002, NEW PHYTOL, V153, P345, DOI 10.1046/j.0028-646X.2001.00313.x; BRADLEY R, 1982, NEW PHYTOL, V91, P197, DOI 10.1111/j.1469-8137.1982.tb03306.x; Jourand P, 2014, J PLANT PHYSIOL, V171, P164, DOI 10.1016/j.jplph.2013.10.011; Toler HD, 2005, WATER AIR SOIL POLL, V164, P155, DOI 10.1007/s11270-005-2718-z; Adriaensen K, 2005, APPL ENVIRON MICROB, V71, P7279, DOI 10.1128/AEM.71.11.7279-7284.2005; Jourand P, 2010, TREE PHYSIOL, V30, P1311, DOI 10.1093/treephys/tpq070; Jentschke G, 2000, PHYSIOL PLANTARUM, V109, P107, DOI 10.1034/j.1399-3054.2000.100201.x; Huang LB, 2012, ANN BOT-LONDON, V110, P223, DOI 10.1093/aob/mcs115; Bellion M, 2006, FEMS MICROBIOL LETT, V254, P173, DOI 10.1111/j.1574-6968.2005.00044.x; Bois G, 2006, TREE PHYSIOL, V26, P1185; de Andrade SAL, 2008, INT J PHYTOREMEDIAT, V10, P1, DOI 10.1080/15226510701827002; BRADLEY R, 1981, NATURE, V292, P335, DOI 10.1038/292335a0; BROWN MT, 1985, NEW PHYTOL, V99, P101, DOI 10.1111/j.1469-8137.1985.tb03640.x; BUCKING H, 1994, PLANT SOIL, V167, P203, DOI 10.1007/BF00007946; CLINT GM, 1992, NEW PHYTOL, V121, P555, DOI 10.1111/j.1469-8137.1992.tb01125.x; Colpaert JV, 2011, ANN FOREST SCI, V68, P17, DOI 10.1007/s13595-010-0003-9; COLPAERT JV, 1993, NEW PHYTOL, V123, P325, DOI 10.1111/j.1469-8137.1993.tb03742.x; COLPAERT JV, 1992, PLANT SOIL, V143, P201, DOI 10.1007/BF00007874; DENNY HJ, 1987, NEW PHYTOL, V106, P545, DOI 10.1111/j.1469-8137.1987.tb00132.x; DIXON RK, 1988, SOIL BIOL BIOCHEM, V20, P555, DOI 10.1016/0038-0717(88)90072-7; DIXON RK, 1988, PLANT SOIL, V105, P265, DOI 10.1007/BF02376791; Estaun V, 2007, AFINIDAD, V64, P167; Frey B, 2000, PLANT CELL ENVIRON, V23, P1257, DOI 10.1046/j.1365-3040.2000.00637.x; Gohre V, 2006, PLANTA, V223, P8; Hartley-Whitaker J, 2000, PLANT SOIL, V218, P31, DOI 10.1023/A:1014989422241; Hartley-Whitaker J, 2000, ENVIRON TOXICOL CHEM, V19, P694, DOI 10.1897/1551-5028(2000)019<0694:TEOCAZ>2.3.CO;2; Huang J, 2015, MICROB ECOL, V69, P768, DOI 10.1007/s00248-014-0484-4; Huang Y, 2004, J ENVIRON SCI-CHINA, V16, P414; INGESTAD T, 1985, PHYSIOL PLANTARUM, V65, P109, DOI 10.1111/j.1399-3054.1985.tb02368.x; Jentschke G, 1999, TREE PHYSIOL, V19, P23; JONES MD, 1988, NEW PHYTOL, V108, P461, DOI 10.1111/j.1469-8137.1988.tb04187.x; JONES MD, 1986, WATER AIR SOIL POLL, V31, P441, DOI 10.1007/BF00630862; Khan G., 2000, CHEMOSPHERE, V41, P197, DOI DOI 10.1016/S0045-6935(99)00412-9; Kim CG, 2004, WATER AIR SOIL POLL, V155, P189, DOI 10.1023/B:WATE.0000026527.34649.3c; Kozdroj J, 2007, ECOTOXICOLOGY, V16, P449, DOI 10.1007/s10646-007-0149-x; Krupa P, 2007, WATER AIR SOIL POLL, V182, P83, DOI 10.1007/s11270-006-9323-7; LI XL, 1991, PLANT SOIL, V136, P49, DOI 10.1007/BF02465219; Marschner P, 1996, PLANT SOIL, V178, P239, DOI 10.1007/BF00011589; Murphy J., 1962, ANAL CHIM ACTA, V27, P31, DOI DOI 10.1016/S0003-2670(00)88444-5; Nguyen H, 2006, PLANT BIOLOGY, V8, P646, DOI 10.1055/s-2006-924106; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Taiz L., 2010, PLANT PHYSL; Van Tichelen KK, 2001, NEW PHYTOL, V150, P203, DOI 10.1046/j.1469-8137.2001.00081.x; WALLACE A, 1984, J PLANT NUTR, V7, P603, DOI 10.1080/01904168409363225; Wu F, 2011, ENVIRON EARTH SCI, V64, P761, DOI 10.1007/s12665-010-0897-4; Zimmer D, 2009, INT J PHYTOREMEDIAT, V11, P200, DOI 10.1080/15226510802378483	53	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6360	1432-1890		MYCORRHIZA	Mycorrhiza	OCT	2015	25	7					561	571		10.1007/s00572-015-0629-4		11	Mycology	Mycology	CR6QI	WOS:000361471900005		
J	Uchida, S; Shumyatsky, GP				Uchida, Shusaku; Shumyatsky, Gleb P.			Deceivingly dynamic: Learning-dependent changes in stathmin and microtubules	NEUROBIOLOGY OF LEARNING AND MEMORY			English	Article						Biphasic; Stathmin; Microtubules; Hippocampus; Dentate gyrus; Memory consolidation; Contextual fear conditioning; AMPAR	LONG-TERM POTENTIATION; POSTTRAUMATIC-STRESS-DISORDER; CONTEXTUAL FEAR MEMORY; TAU TRANSGENIC MICE; SYNAPTIC PLASTICITY; DENDRITIC SPINES; AMPA RECEPTORS; NEURONAL PLASTICITY; TUBULIN ACETYLATION; COGNITIVE DEFICITS	Microtubules, one of the major cytoskeletal structures, were previously considered stable and only indirectly involved in synaptic structure and function in mature neurons. However, recent evidence demonstrates that microtubules are dynamic and have an important role in synaptic structure, synaptic plasticity, and memory. In particular, learning induces changes in microtubule turnover and stability, and pharmacological manipulation of microtubule dynamics alters synaptic plasticity and long-term memory. These learning-induced changes in microtubules are controlled by the phosphoprotein stathmin, whose only known cellular activity is to negatively regulate microtubule formation. During the first eight hours following learning, changes in the phosphorylation of stathmin go through two phases causing biphasic shifts in microtubules stability/instability. These shifts, in turn, regulate memory formation by controlling in the second phase synaptic transport of the GluA2 subunit of AMPA receptors. Improper regulation of stathmin and microtubule dynamics has been observed in aged animals and in patients with Alzheimer's disease and depression. Thus, recent work on stathmin and microtubules has identified new molecular players in the early stages of memory encoding. (C) 2015 Elsevier Inc. All rights reserved.	[Uchida, Shusaku; Shumyatsky, Gleb P.] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; [Uchida, Shusaku] Yamaguchi Univ, Grad Sch Med, Dept Neurosci, Div Neuropsychiat, Ube, Yamaguchi 7558505, Japan	Shumyatsky, GP (reprint author), Rutgers State Univ, Dept Genet, 145 Bevier Rd, Piscataway, NJ 08854 USA.	s-uchida@yamaguchi-u.ac.jp; gleb@biology.rutgers.edu			National Science Foundation; National Institutes of Health; Whitehall Foundation; March of Dimes; New Jersey Commission on Brain Injury	We thank Ted Abel and members of the Shumyatsky lab for comments on the manuscript. Work described here was supported by the National Science Foundation, the National Institutes of Health, Whitehall Foundation, March of Dimes, and the New Jersey Commission on Brain Injury.	Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; Gu JP, 2008, J NEUROSCI, V28, P12120, DOI 10.1523/JNEUROSCI.2509-08.2008; Dunn S, 2008, J CELL SCI, V121, P1085, DOI 10.1242/jcs.026492; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; MARKLUND U, 1994, EUR J BIOCHEM, V225, P53, DOI 10.1111/j.1432-1033.1994.00053.x; Saetre P, 2011, SYNAPSE, V65, P971, DOI 10.1002/syn.20933; Nakajima K, 2012, NEURON, V76, P945, DOI 10.1016/j.neuron.2012.10.012; DiPaolo G, 1997, FEBS LETT, V416, P149, DOI 10.1016/S0014-5793(97)01188-5; Witte H, 2008, J CELL BIOL, V180, P619, DOI [10.1083/jcb.200707042, 10.1083/icb.200707042]; le Gouvello S, 1998, J IMMUNOL, V161, P1113; Behar M, 2010, CURR OPIN GENET DEV, V20, P684, DOI 10.1016/j.gde.2010.09.007; Hayashi K, 2006, J NEUROCHEM, V99, P237, DOI 10.1111/j.1471-4159.2006.04113.x; KHAWAJA S, 1988, J CELL BIOL, V106, P141, DOI 10.1083/jcb.106.1.141; Zhang B, 2012, J NEUROSCI, V32, P3601, DOI 10.1523/JNEUROSCI.4922-11.2012; Dent EW, 2011, CURR OPIN NEUROBIOL, V21, P175, DOI 10.1016/j.conb.2010.08.013; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Colin E, 2008, EMBO J, V27, P2124, DOI 10.1038/emboj.2008.133; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; Hara Y, 2012, J NEUROSCI, V32, P7336, DOI 10.1523/JNEUROSCI.0605-12.2012; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Malleret G, 2010, J NEUROSCI, V30, P3813, DOI 10.1523/JNEUROSCI.1330-09.2010; Fukushima H, 2008, J NEUROSCI, V28, P9910, DOI 10.1523/JNEUROSCI.2625-08.2008; Trifilieff P, 2006, LEARN MEMORY, V13, P349, DOI 10.1101/lm.80206; Yu I, 2015, J BIOL CHEM, V290, P17163, DOI 10.1074/jbc.R115.637447; Small SA, 2004, P NATL ACAD SCI USA, V101, P7181, DOI 10.1073/pnas.0400285101; Barten DM, 2012, J NEUROSCI, V32, P7137, DOI 10.1523/JNEUROSCI.0188-12.2012; Yin XL, 2011, NEURON, V70, P310, DOI 10.1016/j.neuron.2011.02.049; Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Rao-Ruiz P, 2011, NAT NEUROSCI, V14, P1302, DOI 10.1038/nn.2907; Izquierdo LA, 2002, CELL MOL NEUROBIOL, V22, P269, DOI 10.1023/A:1020715800956; Gradin HM, 1997, MOL CELL BIOL, V17, P3459; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Hu XD, 2008, J NEUROSCI, V28, P13094, DOI 10.1523/JNEUROSCI.3074-08.2008; Palazzo A, 2003, NATURE, V421, P230, DOI 10.1038/421230a; Bianchi M, 2012, P NATL ACAD SCI USA, V109, P1713, DOI 10.1073/pnas.1121485109; Nakayama D, 2015, J NEUROSCI, V35, P819, DOI 10.1523/JNEUROSCI.2525-14.2015; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Bianchi M, 2003, SYNAPSE, V49, P188, DOI 10.1002/syn.10230; MARUTA H, 1986, J CELL BIOL, V103, P571, DOI 10.1083/jcb.103.2.571; Manna T, 2009, J BIOL CHEM, V284, P15640, DOI 10.1074/jbc.M900343200; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Kubik S, 2007, LEARN MEMORY, V14, P758, DOI 10.1101/lm.698107; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Barnes SJ, 2010, J NEUROSCI, V30, P12996, DOI 10.1523/JNEUROSCI.1847-10.2010; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Pandey K, 2011, J MOL NEUROSCI, V45, P1, DOI 10.1007/s12031-011-9506-6; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Fanara P, 2010, NEUROSCIENCE, V168, P167, DOI 10.1016/j.neuroscience.2010.03.031; Liao GJ, 1998, J BIOL CHEM, V273, P9797, DOI 10.1074/jbc.273.16.9797; Fukushima N, 2009, J NEUROCHEM, V109, P683, DOI 10.1111/j.1471-4159.2009.06013.x; Chauvin S, 2015, PROG NEUROBIOL, V126, P1, DOI 10.1016/j.pneurobio.2014.09.002; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Mitsushima D, 2011, P NATL ACAD SCI USA, V108, P12503, DOI 10.1073/pnas.1104558108; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331; Hoerndli FJ, 2013, NEURON, V80, P1421, DOI 10.1016/j.neuron.2013.10.050; Kandel ER, 2014, CELL, V157, P163, DOI 10.1016/j.cell.2014.03.001; Matsuo N, 2008, SCIENCE, V319, P1104, DOI 10.1126/science.1149967; Martel G, 2008, P NATL ACAD SCI USA, V105, P14620, DOI 10.1073/pnas.0807507105; Twelvetrees AE, 2010, NEURON, V65, P53, DOI 10.1016/j.neuron.2009.12.007; Atarod D., 2015, J MOL NEUROSCIENCE; Basheer R, 2005, J NEUROSCI RES, V82, P650, DOI 10.1002/jnr.20675; Beilharz EJ, 1998, J NEUROSCI, V18, P9780; BERETTA L, 1993, J BIOL CHEM, V268, P20076; Boekhoorn K, 2014, DEV NEUROBIOL, V74, P1226, DOI 10.1002/dneu.22200; Brocke B, 2010, AM J MED GENET B, V153B, P243, DOI 10.1002/ajmg.b.30989; Cao CQ, 2013, PROG NEURO-PSYCHOPH, V44, P296, DOI 10.1016/j.pnpbp.2013.04.004; Cardinaux JR, 1997, MOL BRAIN RES, V51, P220, DOI 10.1016/S0169-328X(97)00241-6; CHNEIWEISS H, 1992, J NEUROCHEM, V58, P282, DOI 10.1111/j.1471-4159.1992.tb09308.x; Ch'ng TH, 2011, CURR OPIN NEUROBIOL, V21, P345, DOI 10.1016/j.conb.2011.01.011; Duric V, 2013, INT J NEUROPSYCHOPH, V16, P69, DOI 10.1017/S1461145712000016; Ehlis A. C., 2011, AM J MED GENETICS B; Federighi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080037; Jin LW, 1996, NEUROBIOL AGING, V17, P331, DOI 10.1016/0197-4580(96)00021-8; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Kapitein LC, 2011, J NEUROSCI, V31, P8194, DOI 10.1523/JNEUROSCI.6215-10.2011; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; Larsson N, 1997, MOL CELL BIOL, V17, P5530; Lawler S, 1998, CURR BIOL, V8, pR212, DOI 10.1016/S0960-9822(98)70128-9; Martel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030942; Martel G, 2007, NEUROSCIENCE, V150, P743, DOI 10.1016/j.neuroscience.2007.10.004; Mayford M., 2012, COLD SPRING HARB PER, V1, P4; Merriam EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027688; Mitsuyama Fuyuki, 2008, Italian Journal of Anatomy and Embryology, V113, P17; Morii H, 2006, NEUROSCI LETT, V396, P241, DOI 10.1016/j.neulet.2005.11.043; Ohkawa N, 2007, NEUROSCI RES, V59, P93, DOI 10.1016/j.neures.2007.06.1464; PATURLELAFANECHERE L, 1994, J CELL SCI, V107, P1529; Penzes P, 2009, NEURON, V61, P3, DOI 10.1016/j.neuron.2008.12.018; Piubelli C, 2011, Neuroscience, V176, P349, DOI 10.1016/j.neuroscience.2010.12.043; Peixoto LL, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S5-S5; Porte Y, 2011, HIPPOCAMPUS, V21, P1169, DOI 10.1002/hipo.20844; Rose SPR, 2000, LEARN MEMORY, V7, P1, DOI 10.1101/lm.7.1.1; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Stanciu M, 2001, MOL BRAIN RES, V94, P15, DOI 10.1016/S0169-328X(01)00174-7; Swank MW, 2001, J NEUROSCI, V21, P3383; Trifilieff P, 2007, NEUROBIOL LEARN MEM, V88, P424, DOI 10.1016/j.nlm.2007.05.004; Uchida S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5389; Wong GTH, 2013, AGEING RES REV, V12, P67, DOI 10.1016/j.arr.2012.08.004; Yang C, 2009, BEHAV BRAIN RES, V205, P518, DOI 10.1016/j.bbr.2009.08.008	113	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1074-7427	1095-9564		NEUROBIOL LEARN MEM	Neurobiol. Learn. Mem.	OCT	2015	124				SI		52	61		10.1016/j.nlm.2015.07.011		10	Behavioral Sciences; Neurosciences; Psychology; Psychology, Multidisciplinary	Behavioral Sciences; Neurosciences & Neurology; Psychology	CR5ZG	WOS:000361422300007		
J	Hashimoto, T; Takeuchi, H; Taki, Y; Sekiguchi, A; Nouchi, R; Kotozaki, Y; Nakagawa, S; Miyauchi, CM; Iizuka, K; Yokoyama, R; Shinada, T; Yamamoto, Y; Hanawa, S; Araki, T; Hashizume, H; Kunitoki, K; Kawashima, R				Hashimoto, Teruo; Takeuchi, Hikaru; Taki, Yasuyuki; Sekiguchi, Atsushi; Nouchi, Rui; Kotozaki, Yuka; Nakagawa, Seishu; Miyauchi, Carlos Makoto; Iizuka, Kunio; Yokoyama, Ryoichi; Shinada, Takamitsu; Yamamoto, Yuki; Hanawa, Sugiko; Araki, Tsuyoshi; Hashizume, Hiroshi; Kunitoki, Keiko; Kawashima, Ryuta			Neuroanatomical correlates of the sense of control: Gray and white matter volumes associated with an internal locus of control	NEUROIMAGE			English	Article						Anterior cingulate cortex; MRI; Striatum; Voxel-based morphometry	GENERALIZED SELF-EFFICACY; VOXEL-BASED MORPHOMETRY; INDIVIDUAL-DIFFERENCES; EMOTIONAL STABILITY; ANTERIOR CINGULATE; PERCEIVED CONTROL; YOUNG-ADULTS; BIRTH COHORT; BRAIN; METAANALYSIS	A belief that effort is rewarded can develop incentive, achievement motivation, and self-efficacy. Individuals with such a belief attribute causes of events to themselves, not to external, uncontrollable factors, and are thus said to have an internal locus of control. An internal locus of control is a positive personality trait and has been thoroughly studied in applied psychology, but has not been widely examined in neuroscience. In the present study, correlations between locus of control assessment scores and brain volumes were examined in 777 healthy young adults using magnetic resonance imaging. A whole-brain multiple regression analysis with corrections for the effects of age, gender, and intelligence was conducted. Voxel-based morphometry analyses revealed that gray matter volumes in the anterior cingulate cortex, striatum, and anterior insula positively correlated with higher scores, which indicate an internal LOC. In addition, white matter volumes in the striatum showed significant correlations with an internal locus of control. These results suggest that cognitive, socioemotional, self-regulatory, and reward systems might be associated with internal control orientation. The finding of greater volumes in several brain regions in individuals with a stronger internal locus of control indicates that there is a neuroanatomical basis for the belief that one's efforts are rewarded. (C) 2015 Elsevier Inc. All rights reserved.	[Hashimoto, Teruo; Takeuchi, Hikaru; Taki, Yasuyuki; Hashizume, Hiroshi; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Div Dev Cognit Neurosci, Sendai, Miyagi 9808575, Japan; [Taki, Yasuyuki; Sekiguchi, Atsushi] Tohoku Univ, Tohoku Med Megabank Org, Dept Community Med Supports, Div Med Neuroimaging Anal, Sendai, Miyagi 9808575, Japan; [Taki, Yasuyuki] Tohoku Univ, Inst Dev Aging & Canc, Dept Radiol & Nucl Med, Sendai, Miyagi 9808575, Japan; [Sekiguchi, Atsushi; Nakagawa, Seishu; Miyauchi, Carlos Makoto; Iizuka, Kunio; Yokoyama, Ryoichi; Shinada, Takamitsu; Yamamoto, Yuki; Hanawa, Sugiko; Kunitoki, Keiko; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Dept Funct Brain Imaging, Sendai, Miyagi 9808575, Japan; [Nouchi, Rui] Tohoku Univ, Int Res Inst Disaster Sci, Human & Social Response Res Div, Sendai, Miyagi 9808575, Japan; [Nouchi, Rui; Kotozaki, Yuka; Araki, Tsuyoshi; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Smart Ageing Int Res Ctr, Sendai, Miyagi 9808575, Japan; [Yokoyama, Ryoichi] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan	Hashimoto, T (reprint author), Tohoku Univ, IDAC, Div Dev Cognit Neurosci, Aoba Ku, 4-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.	thashimoto@idac.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [23700306, 25700012]	We thank Yuki Yamada for operating the MRI scanner. This study was supported by a Grant-in-Aid for Young Scientists (B) (KAKENHI 23700306) and a Grant-in-Aid for Young Scientists (A) (KAKENHI 25700012) from the Ministry of Education, Culture, Sports, Science, and Technology for H.T.	Vink M, 2014, HUM BRAIN MAPP, V35, P4415, DOI 10.1002/hbm.22483; Takeuchi H, 2014, BRAIN STRUCT FUNCT, V219, P71, DOI 10.1007/s00429-012-0485-3; Takeuchi H, 2010, NEUROIMAGE, V51, P578, DOI 10.1016/j.neuroimage.2010.02.078; Somerville LH, 2010, CURR OPIN NEUROBIOL, V20, P236, DOI 10.1016/j.conb.2010.01.006; Knutson KM, 2014, HUM BRAIN MAPP, V35, P943, DOI 10.1002/hbm.22225; ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037//0021-843X.87.1.49; Kohn N, 2014, NEUROIMAGE, V87, P345, DOI 10.1016/j.neuroimage.2013.11.001; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; Bollini AM, 2004, BIOL PSYCHOL, V67, P245, DOI 10.1016/j.biopsycho.2003.11.002; Peper JS, 2013, CEREB CORTEX, V23, P1695, DOI 10.1093/cercor/bhs163; Shiflett MW, 2011, PROG NEUROBIOL, V95, P1, DOI 10.1016/j.pneurobio.2011.05.007; Gale CR, 2008, PSYCHOSOM MED, V70, P397, DOI 10.1097/PSY.0b013e31816a719e; Chorpita BF, 1998, PSYCHOL BULL, V124, P3, DOI 10.1037//0033-2909.124.1.3; van den Bos W, 2014, J NEUROSCI, V34, P10298, DOI 10.1523/JNEUROSCI.4105-13.2014; Judge TA, 2002, J PERS SOC PSYCHOL, V83, P693, DOI 10.1037//0022-3514.83.3.693; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Steptoe A, 2001, BRIT J PSYCHOL, V92, P659, DOI 10.1348/000712601162400; Woodward SH, 2006, BIOL PSYCHIAT, V59, P582, DOI 10.1016/j.biopsych.2005.07.033; Lallement JH, 2014, SOC COGN AFFECT NEUR, V9, P342, DOI 10.1093/scan/nss147; Takeuchi H, 2013, CORTEX, V49, P2106, DOI 10.1016/j.cortex.2012.09.007; DeNeve KM, 1998, PSYCHOL BULL, V124, P197, DOI 10.1037/0033-2909.124.2.197; ROTTER JB, 1966, PSYCHOL MONOGR, V80, P1; Fairhurst MT, 2014, NEUROIMAGE, V84, P688, DOI 10.1016/j.neuroimage.2013.09.027; Giuliani NR, 2011, BIOL PSYCHOL, V86, P379, DOI 10.1016/j.biopsycho.2010.11.010; Caspi A, 2005, ANNU REV PSYCHOL, V56, P453, DOI 10.1146/annurev.psych.55.090902.141913; Morandotti N, 2013, PSYCHIAT RES-NEUROIM, V213, P18, DOI 10.1016/j.pscychresns.2013.02.002; May A, 2006, CURR OPIN NEUROL, V19, P407, DOI 10.1097/01.wco.0000236622.91495.21; Yamada M, 2013, P NATL ACAD SCI USA, V110, P4363, DOI 10.1073/pnas.1221681110; Thompson A, 2011, COGN NEUROPSYCHIATRY, V16, P385, DOI 10.1080/13546805.2010.546077; Salvadore G, 2011, NEUROIMAGE, V54, P2643, DOI 10.1016/j.neuroimage.2010.11.011; Takeuchi H, 2010, NEUROIMAGE, V51, P11, DOI 10.1016/j.neuroimage.2010.02.035; Fornito A, 2013, JAMA PSYCHIAT, V70, P1143, DOI 10.1001/jamapsychiatry.2013.1976; Pfeifer JH, 2012, DEV COGN NEUROS-NETH, V2, P55, DOI 10.1016/j.dcn.2011.07.012; Rotge JY, 2009, BIOL PSYCHIAT, V65, P75, DOI 10.1016/j.biopsych.2008.06.019; Thompson A, 2013, PSYCHIAT RES, V206, P200, DOI 10.1016/j.psychres.2012.10.017; Pruessner JC, 2005, NEUROIMAGE, V28, P815, DOI 10.1016/j.neuroimage.2005.06.014; Takeuchi H, 2015, CEREB CORTEX, V25, P1188, DOI 10.1093/cercor/bht315; Judge TA, 2004, HUM PERFORM, V17, P325, DOI 10.1207/s15327043hup1703_4; Ansell EB, 2012, BIOL PSYCHIAT, V72, P57, DOI 10.1016/j.biopsych.2011.11.022; Bjornebekk A, 2013, NEUROIMAGE, V65, P194, DOI 10.1016/j.neuroimage.2012.10.009; Chavez R.S., 2014, SOC COGN AFFECT NEUR; Cheng C, 2013, PSYCHOL BULL, V139, P152, DOI 10.1037/a0028596; Costa Jr P.T., 1992, PSYCHOL ASSESSMENT R; Declerck CH, 2006, BRAIN COGNITION, V62, P143, DOI 10.1016/j.bandc.2006.04.004; Fisher HL, 2013, SCHIZOPHRENIA BULL, V39, P1045, DOI 10.1093/schbul/sbs088; Harsay HA, 2011, DEV COGN NEUROS-NETH, V1, P530, DOI 10.1016/j.dcn.2011.06.005; Judge TA, 2001, J APPL PSYCHOL, V86, P80, DOI 10.1037/0021-9010.86.1.80; Kamahara M., 1982, JAPANESE J ED PSYCHO, V30, P302; Lovden M, 2013, NEUROSCI BIOBEHAV R, V37, P2296, DOI 10.1016/j.neubiorev.2013.02.014; Orfei MD, 2013, SOC COGN AFFECT NEUR, V8, P418, DOI 10.1093/scan/nss016; Raven J., 1998, MANUAL RAVENS PROGR; Salomons TV, 2012, EUR J NEUROSCI, V35, P1481, DOI 10.1111/j.1460-9568.2012.08048.x; Shimomura Y., 1999, REVISED NEO PERSONAL	54	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	OCT 1	2015	119						146	151		10.1016/j.neuroimage.2015.06.061		6	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CR2TB	WOS:000361182400014		
J	Takeuchi, H; Taki, Y; Nouchi, R; Sekiguchi, A; Hashizume, H; Sassa, Y; Kotozaki, Y; Miyauchi, CM; Yokoyama, R; Iizuka, K; Nakagawa, S; Nagase, T; Kunitoki, K; Kawashima, R				Takeuchi, Hikaru; Taki, Yasuyuki; Nouchi, Rui; Sekiguchi, Atsushi; Hashizume, Hiroshi; Sassa, Yuko; Kotozaki, Yuka; Miyauchi, Carlos Makoto; Yokoyama, Ryoichi; Iizuka, Kunio; Nakagawa, Seishu; Nagase, Tomomi; Kunitoki, Keiko; Kawashima, Ryuta			Degree centrality and fractional amplitude of low-frequency oscillations associated with Stroop interference	NEUROIMAGE			English	Article						Resting state; Amplitude of low-frequency fluctuations; Degree centrality; Stroop interference; Dorsolateral prefrontal cortex; Inferior frontal junction	STATE FUNCTIONAL CONNECTIVITY; WORKING-MEMORY PERFORMANCE; INFERIOR FRONTAL JUNCTION; VOXEL-BASED MORPHOMETRY; WHITE-MATTER INTEGRITY; HEALTHY OLDER-ADULTS; COGNITIVE CONTROL; ALZHEIMERS-DISEASE; ANTERIOR CINGULATE; TALAIRACH ATLAS	Stroop paradigms are commonly used as an index of attention deficits and a tool for investigating functions of the frontal lobes and other associated structures. Here we investigated the correlation between resting-state functional magnetic imaging (fMRI) measures [degree centrality (DC)/fractional amplitude of low frequency fluctuations (fALFFs)] and Stroop interference. We examined this relationship in the brains of 958 healthy young adults. DC reflects the number of instantaneous functional connections between a region and the rest of the brain within the entire connectivity matrix of the brain (connectome), and thus how much of the node influences the entire brain areas, while fALFF is an indicator of the intensity of regional brain spontaneous activity. Reduced Stroop interference was associated with larger DC in the left lateral prefrontal cortex, left IFJ, and left inferior parietal lobule as well as larger fALFF in the areas of the dorsal attention network and the precuneus. These findings suggest that Stroop performance is reflected in resting state functional properties of these areas and the network. In addition, default brain activity of the dorsal attention network and precuneus as well as higher cognitive processes represented there, and default stronger global influence of the areas critical in executive functioning underlie better Stroop performance. (C) 2015 Elsevier Inc. All rights reserved.	[Takeuchi, Hikaru; Taki, Yasuyuki; Hashizume, Hiroshi; Sassa, Yuko; Kawashima, Ryuta] Tohoku Univ, Div Dev Cognit Neurosci, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; [Taki, Yasuyuki] Tohoku Univ, Tohoku Med Megabank Org, Dept Community Med Supports, Div Med Neuroimaging Anal, Sendai, Miyagi 9808575, Japan; [Taki, Yasuyuki; Sekiguchi, Atsushi] Tohoku Univ, Inst Dev Aging & Canc, Dept Radiol & Nucl Med, Sendai, Miyagi 9808575, Japan; [Sekiguchi, Atsushi; Miyauchi, Carlos Makoto; Yokoyama, Ryoichi; Iizuka, Kunio; Nakagawa, Seishu; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Dept Funct Brain Imaging, Sendai, Miyagi 9808575, Japan; [Nouchi, Rui] Tohoku Univ, Int Res Inst Disaster Sci, Human & Social Response Res Div, Sendai, Miyagi 9808575, Japan; [Kotozaki, Yuka; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Smart Ageing Int Res Ctr, Sendai, Miyagi 9808575, Japan; [Yokoyama, Ryoichi] Japan Soc Promot Sci, Tokyo, Japan; [Nagase, Tomomi; Kunitoki, Keiko] Tohoku Univ, Fac Med, Sendai, Miyagi 9808575, Japan	Takeuchi, H (reprint author), Tohoku Univ, Div Dev Cognit Neurosci, IDAC, Aoba Ku, 4-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.	takehi@idac.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [23700306, 25700012]; JST/RISTEX; JST/CREST	We thank Yuki Yamada for operating the MRI scanner, Haruka Nouchi for conducting the psychological tests, the other assistants who helped with the experiments and the study, and the participants and all our other colleagues at IDAC, Tohoku University for their support. This study was supported by JST/RISTEX, JST/CREST, and a Grant-in-Aid for Young Scientists (B) (KAKENHI 23700306) and Young Scientists (A) (KAKENHI 25700012) from the Ministry of Education, Culture, Sports, Science, and Technology.	Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Takeuchi H, 2012, NEUROIMAGE, V59, P2899, DOI 10.1016/j.neuroimage.2011.09.064; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; Takeuchi H, 2010, NEUROIMAGE, V51, P578, DOI 10.1016/j.neuroimage.2010.02.078; Kunisato Y, 2011, NEUROSCI LETT, V492, P109, DOI 10.1016/j.neulet.2011.01.067; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Tomasi D, 2013, P NATL ACAD SCI USA, V110, P13642, DOI 10.1073/pnas.1303346110; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Cole MW, 2012, J NEUROSCI, V32, P8988, DOI 10.1523/JNEUROSCI.0536-12.2012; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Xu J, 2014, NEUROSCIENCE, V263, P181, DOI 10.1016/j.neuroscience.2014.01.020; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Duchek JM, 2013, NEUROPSYCHOLOGY, V27, P516, DOI 10.1037/a0033402; Liang X, 2013, P NATL ACAD SCI USA, V110, P1929, DOI 10.1073/pnas.1214900110; Mennes M, 2011, NEUROIMAGE, V54, P2950, DOI 10.1016/j.neuroimage.2010.10.046; Takeuchi H, 2011, NEUROIMAGE, V55, P681, DOI 10.1016/j.neuroimage.2010.11.052; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ren WT, 2013, AM J PSYCHIAT, V170, P1308, DOI 10.1176/appi.ajp.2013.12091148; Kane MJ, 2007, J EXP PSYCHOL LEARN, V33, P615, DOI 10.1037/0278-7393.33.3.615; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Takeuchi H, 2011, NEUROPSYCHOLOGIA, V49, P3466, DOI 10.1016/j.neuropsychologia.2011.08.022; MacLeod CM, 2000, TRENDS COGN SCI, V4, P383, DOI 10.1016/S1364-6613(00)01530-8; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/0096-3445.121.1.15; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Derrfuss J, 2004, NEUROIMAGE, V23, P604, DOI 10.1016/j.neuroimage.2004.06.007; Song M, 2008, NEUROIMAGE, V41, P1168, DOI 10.1016/j.neuroimage.2008.02.036; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.0.CO;2-0; Laird AR, 2005, HUM BRAIN MAPP, V25, P6, DOI 10.1002/hbm.20129; Zou QH, 2013, HUM BRAIN MAPP, V34, P3204, DOI 10.1002/hbm.22136; Birn RM, 2013, NEUROIMAGE, V83, P550, DOI 10.1016/j.neuroimage.2013.05.099; Hugenschmidt CE, 2008, CEREB CORTEX, V18, P433, DOI 10.1093/cercor/bhm080; Brass M, 2005, TRENDS COGN SCI, V9, P314, DOI 10.1016/j.tics.2005.05.001; Jung RE, 2010, HUM BRAIN MAPP, V31, P398, DOI 10.1002/hbm.20874; Takeuchi H, 2010, NEUROIMAGE, V51, P11, DOI 10.1016/j.neuroimage.2010.02.035; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; Posthuma D, 2002, NAT NEUROSCI, V5, P83, DOI 10.1038/nn0202-83; Casanova R, 2007, NEUROIMAGE, V34, P137, DOI 10.1016/j.neuroimage.2006.09.011; Liu X, 2004, NEUROIMAGE, V22, P1097, DOI 10.1016/j.neuroimage.2004.02.033; Wang XJ, 2014, SCHIZOPHR RES, V156, P150, DOI 10.1016/j.schres.2014.03.033; Verbruggen F, 2004, ACTA PSYCHOL, V116, P21, DOI 10.1016/j.actpsy.2003.12.011; Langenecker SA, 2004, NEUROIMAGE, V21, P192, DOI 10.1016/j.neuroimage.2003.08.027; Vandenbossche J, 2012, NEUROSCIENCE, V206, P144, DOI 10.1016/j.neuroscience.2011.12.048; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P319, DOI 10.1111/j.1745-6924.2009.01132.x; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Takeuchi H, 2012, CEREB CORTEX, V22, P2921, DOI 10.1093/cercor/bhr371; Braun U, 2012, NEUROIMAGE, V59, P1404, DOI 10.1016/j.neuroimage.2011.08.044; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Cha J., 2015, BIOMED RES INT, V2015, P1; Chao-Gan Yan, 2010, Front Syst Neurosci, V4, P13, DOI 10.3389/fnsys.2010.00013; Chao-Gan Y., 2013, NEUROIMAGE, V76, P183; Fair Damien A, 2012, Front Syst Neurosci, V6, P80, DOI 10.3389/fnsys.2012.00080; FLOWERS JH, 1975, PERCEPT PSYCHOPHYS, V18, P37, DOI 10.3758/BF03199364; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hakoda Y., 1986, P JAP ED PSYCH 28 AN, P694; Hakoda Y, 1990, KYOIKUSHINRIGAKUKENK, V38, P389; Li YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018954; Luo LQ, 2010, NAT REV NEUROSCI, V11, P718, DOI 10.1038/nrn2912; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037//0033-2909.109.2.163; Maddox WT, 2010, NEUROPSYCHOLOGIA, V48, P2998, DOI 10.1016/j.neuropsychologia.2010.06.008; McNair D. M., 1992, PROFILE MOOD STATES; Murphy SE, 2012, MOL PSYCHIATR, V18, P512, DOI DOI 10.1038/MP; Posthuma D, 2005, HUM BRAIN MAPP, V26, P191, DOI 10.1002/hbm.20156; PRITCHAT.D, 1968, Q J EXP PSYCHOL, V20, P351, DOI 10.1080/14640746808400174; Raven J., 1998, MANUAL RAVENS PROGR; SASAKI M, 1993, JPN J PSYCHOL, V64, P43; Sasaki M., 1985, P JAP ED PSYH 27 ANN, P208; Shen T, 2014, NEUROREPORT, V25, P1302, DOI 10.1097/WNR.0000000000000263; Takeuchi H, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00875; Takeuchi H, 2014, NEUROIMAGE, V99, P312, DOI 10.1016/j.neuroimage.2014.05.031; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021050; Takeuchi H, 2014, HUM BRAIN MAPP, V35, P185, DOI 10.1002/hbm.22167; Traykov L, 2007, COGN BEHAV NEUROL, V20, P219; Turner J.A., 2013, FRONT NEUROSCI, P7; Wang LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036418; Wei DT, 2014, CORTEX, V51, P92, DOI 10.1016/j.cortex.2013.09.004	100	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	OCT 1	2015	119						197	209		10.1016/j.neuroimage.2015.06.058		13	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CR2TB	WOS:000361182400019		
J	Yamasue, H				Yamasue, Hidenori			Using endophenotypes to examine molecules related to candidate genes as novel therapeutics: The "endophenotype-associated surrogate endpoint (EASE)" concept	NEUROSCIENCE RESEARCH			English	Article						Autism spectrum disorder; Dopamine; Neuroimaging; Obsessive-compulsive disorder; Oxytocin; Schizophrenia; Serotonin	OBSESSIVE-COMPULSIVE DISORDER; OXYTOCIN RECEPTOR GENE; AUTISM SPECTRUM DISORDERS; INTRANASAL OXYTOCIN; CLINICAL-TRIALS; SOCIAL-BEHAVIOR; RESONANCE SPECTROSCOPY; BRAIN ACTIVITY; COMMON ALLELE; ADULTS	In this article, a new concept of an "endophenotype-associated surrogate endpoint (EASE)" is proposed. To examine effect of a novel therapeutic molecule on a target phenotype of a genotype associated with the molecule, state-dependent aspect of an endophenotype can be used as a surrogate endpoint. Desired characteristics for EASE are (1) a close relationship to the endophenotype associated with therapeutics, (2) longitudinal changes in illness severity, while the original "endophenotype" is primarily state independent, (3) a physical sign or laboratory measurement that occurs in association with a pathological process and has putative diagnostic and/or prognostic utility, and (4) serves as a substitute for a clinically meaningful endpoint. Advantages are expected for both surrogate endpoints in drug development and endophenotypes in uncovering pathogenesis. EASE are closer to molecules than clinically meaningful endpoints and can respond to administration of the molecule in a more direct manner. Therefore, a statistically significant effect is likely to be observed in clinical trials with smaller sample sizes and shorter durations. As with endophenotypes, reduced heterogeneity might be expected especially in heterogeneous syndromes such as psychiatric disorders. Potential interactions (e.g., elucidating biological mechanisms underlying novel treatments) can be further expected. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Yamasue, Hidenori] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Bunkyo Ku, Tokyo 1138655, Japan; [Yamasue, Hidenori] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Yamasue, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yamasue-tky@umin.ac.jp			Japan Society for the Promotion of Science [26670535]; Adaptable and Seamless Technology Transfer Program; Center of Innovation Program from Japan Science and Technology Agency; Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science, and Technology	My research described in this article was supported by Grants-in-Aid for Scientific Research (KAKENHI) (Grant No. 26670535) from the Japan Society for the Promotion of Science; the Adaptable and Seamless Technology Transfer Program; the Center of Innovation Program from Japan Science and Technology Agency; and the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science, and Technology. In the research, I thank very much with all my research colleagues especially Drs. Yuta Aoki and Takamitsu Watanabe.	Aoki Y, 2015, MOL PSYCHIATR, V20, P447, DOI 10.1038/mp.2014.74; Shahrestani S, 2013, NEUROPSYCHOPHARMACOL, V38, P1929, DOI 10.1038/npp.2013.86; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Gordon I, 2013, P NATL ACAD SCI USA, V110, P20953, DOI 10.1073/pnas.1312857110; Inoue H, 2010, BIOL PSYCHIAT, V68, P1066, DOI 10.1016/j.biopsych.2010.07.019; Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; Fleming TR, 2012, STAT MED, V31, P2973, DOI 10.1002/sim.5403; Shin DJ, 2014, BIOL PSYCHIAT, V75, P606, DOI 10.1016/j.biopsych.2013.09.002; Nakao T, 2014, PSYCHIAT CLIN NEUROS, V68, P587, DOI 10.1111/pcn.12195; Guastella AJ, 2010, BIOL PSYCHIAT, V67, P692, DOI 10.1016/j.biopsych.2009.09.020; Marsala SZ, 2012, CLIN NEUROPHARMACOL, V35, P185, DOI 10.1097/WNF.0b013e31825c034a; van Ijzendoorn MH, 2012, PSYCHONEUROENDOCRINO, V37, P438, DOI 10.1016/j.psyneuen.2011.07.008; Tost H, 2010, P NATL ACAD SCI USA, V107, P13936, DOI 10.1073/pnas.1003296107; Hoexter MQ, 2012, NEUROPSYCHOPHARMACOL, V37, P734, DOI 10.1038/npp.2011.250; Yamasue H, 2011, BIOL PSYCHIAT, V70, pE41, DOI 10.1016/j.biopsych.2011.06.034; Hollander E, 2003, NEUROPSYCHOPHARMACOL, V28, P193, DOI 10.1038/sj.npp.1300021; Watanabe T, 2014, SOC COGN AFFECT NEUR, V9, P767, DOI 10.1093/scan/nst046; Yamasue H, 2013, BRAIN DEV-JPN, V35, P111, DOI 10.1016/j.braindev.2012.08.010; Veening JG, 2013, NEUROSCI BIOBEHAV R, V37, P1445, DOI 10.1016/j.neubiorev.2013.04.012; Sauer C, 2012, NEUROPSYCHOPHARMACOL, V37, P1474, DOI 10.1038/npp.2011.333; Farrell SM, 2012, BIOL PSYCHIAT, V71, P538, DOI 10.1016/j.biopsych.2011.12.023; Furman DJ, 2011, PSYCHONEUROENDOCRINO, V36, P891, DOI 10.1016/j.psyneuen.2010.12.004; Bertolino A, 2004, AM J PSYCHIAT, V161, P1798, DOI 10.1176/appi.ajp.161.10.1798; Domes G, 2013, BIOL PSYCHIAT, V74, P164, DOI 10.1016/j.biopsych.2013.02.007; ELLENBERG SS, 1989, STAT MED, V8, P405, DOI 10.1002/sim.4780080404; Bethlehem RAI, 2013, PSYCHONEUROENDOCRINO, V38, P962, DOI 10.1016/j.psyneuen.2012.10.011; Pauls DL, 2014, NAT REV NEUROSCI, V15, P410, DOI 10.1038/nrn3746; Yamasue H, 2012, J NEUROSCI, V32, P14109, DOI 10.1523/JNEUROSCI.3327-12.2012; Hollander E, 2007, BIOL PSYCHIAT, V61, P498, DOI 10.1016/j.bipsych.2006.05.030; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Aoki Y, 2014, BRAIN, V137, P3073, DOI 10.1093/brain/awu231; Aoki Y., 2015, BRAIN; Aoki Y, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.108; Ashare RL, 2013, DRUG ALCOHOL DEPEN, V133, P852, DOI 10.1016/j.drugalcdep.2013.09.003; Dunn Barbara K, 2012, Semin Oncol Nurs, V28, P99, DOI 10.1016/j.soncn.2012.03.006; Flint J, 2014, TRENDS NEUROSCI, V37, P733, DOI 10.1016/j.tins.2014.08.007; Giakoumaki SG, 2008, NEUROPSYCHOPHARMACOL, V33, P3058, DOI 10.1038/npp.2008.82; GOTTESMA.II, 1973, BRIT J PSYCHIAT, V122, P15, DOI 10.1192/bjp.122.1.15; Grunblatt E, 2014, PROG NEUROBIOL, V121, P114, DOI 10.1016/j.pneurobio.2014.07.003; HILLIS A, 1989, STAT MED, V8, P427, DOI 10.1002/sim.4780080406; JOHN B, 1966, SCIENCE, V152, P711, DOI 10.1126/science.152.3723.711; Lazaro L, 2012, PSYCHIAT RES-NEUROIM, V201, P17, DOI 10.1016/j.pscychresns.2011.01.017; LoParo D, 2015, MOL PSYCHIATR, V20, P640, DOI 10.1038/mp.2014.77; Montag C, 2013, EUR ARCH PSY CLIN N, V263, pS169, DOI 10.1007/s00406-013-0452-x; Roussos P, 2009, BIOL PSYCHIAT, V66, P997, DOI 10.1016/j.biopsych.2009.07.008; Saito Y, 2014, SOC COGN AFFECT NEUR, V9, P1443, DOI 10.1093/scan/nst136; Sauer C, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00045; Tost H., 2011, BIOL PSYCHIAT, V70, pE41; Tukel R, 2015, EUR ARCH PSY CLIN N, V265, P219, DOI 10.1007/s00406-014-0545-1; Watanabe T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039561; Watanabe T, 2013, JAMA PSYCHIAT, V71, P166; WITTES J, 1989, STAT MED, V8, P415, DOI 10.1002/sim.4780080405	52	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	OCT	2015	99						1	7		10.1016/j.neures.2015.05.007		7	Neurosciences	Neurosciences & Neurology	CR8BK	WOS:000361575900001		
J	Moriya, S; Tahara, Y; Sasaki, H; Ishigooka, J; Shibata, S				Moriya, Shunpei; Tahara, Yu; Sasaki, Hiroyuki; Ishigooka, Jun; Shibata, Shigenobu			Housing under abnormal light-dark cycles attenuates day/night expression rhythms of the clock genes Per1, Per2, and Bmal1 in the amygdala and hippocampus of mice	NEUROSCIENCE RESEARCH			English	Article						Abnormal light cycle; Depressive state; Clock gene; Amygdala; Circadian rhythm	CIRCADIAN CLOCK; IN-VIVO; DEPRESSION; DISORDERS; GENETICS; MAMMALS; BRAIN; MOUSE; PHASE; MOOD	Although the results of previous studies have suggested that disruptions in circadian rhythms are involved in the pathogenesis of depression, no studies have examined the interaction of clock gene expression deficit and depression state. In this study, we examined clock gene expression levels and depressive-like behavior in mice housed under 3.5 h light, 3.5 h dark (T=7) conditions to investigate the association between clock gene expression and depressive state. C57BL/6J mice were housed under a T=24 cycle (12 h light, 12 h dark) or a T=7 cycle and clock gene expression levels in the hippocampus and the amygdala were measured by real-time RT-PCR. Depressive state was evaluated by the forced swim test (FST). Although circadian rhythms of Per1 and Per2 clock gene expression in the hippocampus and amygdala were still detected under T=7 conditions, rhythmicity and expression levels of both significantly decreased. Mice housed with a T=7 cycle showed increased immobile time in the FST than those with a T=24 cycle. The present results suggest that the presence of a depressive state around the early active phase of activity may be related to impairment of rhythmicity and expression levels of Per1 and Per2 genes under abnormal light-dark conditions. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Moriya, Shunpei; Tahara, Yu; Sasaki, Hiroyuki; Shibata, Shigenobu] Waseda Univ, Sch Adv Sci & Engn, Lab Physiol & Pharmacol, Shinjuku Ku, Tokyo 1628480, Japan; [Moriya, Shunpei; Ishigooka, Jun] Tokyo Womens Med Univ, Sch Med, Dept Psychiat, Shinjuku Ku, Tokyo 1628666, Japan	Shibata, S (reprint author), Waseda Univ, Sch Adv Sci & Engn, Dept Physiol & Pharmacol, Shinjuku Ku, Tokyo 1628480, Japan.	shibatas@waseda.jp			Council for Science, Technology and Innovation, SIP, "Technologies for creating next-generation agriculture, forestry and fisheries" (Bio-oriented Technology Research Advancement Institution, NARO); Ministry of Education, Culture, Sports, Science and Technology of Japan [26220201]; Department of Psychiatry, Tokyo Women's Medical University, and School of Medicine	We thank the staff of Laboratory of Physiology and Pharmacology, School of Advanced Science and Engineering, Waseda University for help with experiments. The present work was supported by Department of Psychiatry, Tokyo Women's Medical University, and School of Medicine.; This work was partially supported by Council for Science, Technology and Innovation, SIP, "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO) (S.S.), and by a Grant-in-Aid for Scientific Research (S) (26220201) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (S.S.).	Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Jiang WG, 2013, PSYCHOPHARMACOLOGY, V227, P79, DOI 10.1007/s00213-012-2941-4; Narishige S, 2014, BRIT J PHARMACOL, V171, P5858, DOI 10.1111/bph.12890; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Bhattacharjee Y, 2007, SCIENCE, V317, P1488, DOI 10.1126/science.317.5844.1488; Lavebratt C, 2010, AM J MED GENET B, V153B, P570, DOI 10.1002/ajmg.b.31021; Kishi T, 2010, J AFFECT DISORDERS, V126, P167, DOI 10.1016/j.jad.2010.04.003; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Tahara Y, 2012, CURR BIOL, V22, P1029, DOI 10.1016/j.cub.2012.04.009; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; PFLUG B, 1971, INT PHARMACOPSYCHIAT, V6, P187; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; LeGates TA, 2012, NATURE, V491, P594, DOI 10.1038/nature11673; Kronfeld-Schor N, 2012, NEUROPHARMACOLOGY, V62, P101, DOI 10.1016/j.neuropharm.2011.08.020; Soria V, 2010, NEUROPSYCHOPHARMACOL, V35, P1279, DOI 10.1038/npp.2009.230; Altimus CM, 2008, P NATL ACAD SCI USA, V105, P19998, DOI 10.1073/pnas.0808312105; LANDFIELD PW, 1981, SCIENCE, V214, P581, DOI 10.1126/science.6270791; Jun Z.L., 2013, P NATL ACAD SCI USA, V110, P9950; Refinetti R, 1996, J EXP ZOOL, V275, P67, DOI 10.1002/(SICI)1097-010X(19960501)275:1<67::AID-JEZ10>3.3.CO;2-1; Shibata S, 2010, ADV DRUG DELIVER REV, V62, P918, DOI 10.1016/j.addr.2010.06.003; Uz T, 2005, NEUROSCIENCE, V134, P1309, DOI 10.1016/j.neuroscience.2005.05.003; van Donkelaar EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106960; Wen-Gao J., 2011, BRAIN RES, V1399, P25; Wirt-Justice A., 2005, PSYCHOL MED, V25, P939	28	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	OCT	2015	99						16	21		10.1016/j.neures.2015.05.005		6	Neurosciences	Neurosciences & Neurology	CR8BK	WOS:000361575900003		
J	Yamazoe-Umemoto, A; Fujita, K; Lino, Y; Iwasaki, Y; Kimura, KD				Yamazoe-Umemoto, Akiko; Fujita, Kosuke; Lino, Yuichi; Iwasaki, Yuishi; Kimura, Koutarou D.			Modulation of different behavioral components by neuropeptide and dopamine signalings in non-associative odor learning of Caenorhabditis elegans	NEUROSCIENCE RESEARCH			English	Article						Non-associative learning; Neuromodulator; Quantitative behavioral analysis; The nematode Caenorhabditis elegans; Odor gradient	C. ELEGANS; MECHANOSENSORY RESPONSES; CHEMOSENSORY CIRCUIT; MASS-SPECTROMETRY; OLFACTORY MEMORY; NEURAL CIRCUIT; CHEMOTAXIS; SEROTONIN; PLASTICITY; DROSOPHILA	An animal's behavior is modulated by learning; however, the behavioral component modulated by learning and the mechanisms of this modulation have not been fully understood. We show here that two types of neural signalings are required for the modulation of different behavioral components in non-associative odor learning in the nematode Caenorhabditis elegans. We have previously found that C. elegans avoid the repulsive odor 2-nonanone, and preexposure to the odor for 1 h enhances the avoidance behavior as a type of non-associative learning. Systematic quantitative analyses of behavioral components revealed that the odor preexposure caused increases in average duration of straight migration ("runs") only when the animals were migrating away from the odor source within a certain range of bearing, which likely corresponds to odor decrement. Further, genetic analyses revealed that the genes for neuropeptide or dopamine signalings are both required for the enhanced odor avoidance. Neuropeptide signaling genes were required for the preexposure-dependent increase in run duration. In contrast, dopamine signaling genes were required not for the increase in run duration but likely for maintenance of run direction. Our results suggests that multiple behavioral components are regulated by different neuromodulators even in non-associative learning in C. elegans. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Yamazoe-Umemoto, Akiko; Fujita, Kosuke; Kimura, Koutarou D.] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 5600043, Japan; [Lino, Yuichi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Iwasaki, Yuishi] Ibaraki Univ, Dept Intelligent Syst Engn, Hitachi, Ibaraki 3168511, Japan	Kimura, KD (reprint author), Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 5600043, Japan.	kokimura@bio.sci.osaka-u.ac.jp	IINO, YUICHI/G-4962-2014		NIH Office of Research Infrastructure Programs [P40 OD010440]; Osaka University Life Science Young Independent Researcher Support Program through Special Coordination Funds for Promoting Science and Technology from MEXT; Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan;  [20115002];  [23115711]	We thank Drs. J. Pierce-Shimomura, N. Masuda, J. Okubo, M. Fujiwara, A. Takahashi, Y. Ikegaya, M.S. Kitazawa, K. Fujimoto, I. Takeuchi, and members of Kimura and Fujimoto laboratories for their suggestions and comments, S.J. Yamazaki for technical help, and I. Katsura and G.Y. Zheng for critical reading of this manuscript. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440), and by National Bioresource Project funded by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Systems Molecular Ethology" (Grant numbers: 20115002 and 23115711) (Y. lino, Y. Iwasaki and K.D.K.) and the Osaka University Life Science Young Independent Researcher Support Program through Special Coordination Funds for Promoting Science and Technology from MEXT (K.D.K.).	ABRAMS TW, 1984, P NATL ACAD SCI-BIOL, V81, P7956, DOI 10.1073/pnas.81.24.7956; Chao MY, 2004, P NATL ACAD SCI USA, V101, P15512, DOI 10.1073/pnas.0403369101; Kimura KD, 2010, J NEUROSCI, V30, P16365, DOI 10.1523/JNEUROSCI.6023-09.2010; Luo LJ, 2014, NEURON, V82, P1115, DOI 10.1016/j.neuron.2014.05.010; Kindt KS, 2007, NAT NEUROSCI, V10, P568, DOI 10.1038/nn1886; Mohri A, 2005, GENETICS, V169, P1437, DOI 10.1534/genetics.104.036111; Luo LJ, 2014, P NATL ACAD SCI USA, V111, P2776, DOI 10.1073/pnas.1315205111; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Leinwand SG, 2013, NAT NEUROSCI, V16, P1461, DOI 10.1038/nn.3511; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Kass J, 2001, J NEUROSCI, V21, P9265; Sanyal S, 2004, EMBO J, V23, P473, DOI 10.1038/sj.emboj.7600057; RANKIN CH, 1990, BEHAV BRAIN RES, V37, P89, DOI 10.1016/0166-4328(90)90074-O; Ardiel EL, 2010, LEARN MEMORY, V17, P191, DOI 10.1101/lm.960510; Beets I, 2012, SCIENCE, V338, P543, DOI 10.1126/science.1226860; Komuniecki R, 2012, INVERTEBR NEUROSCI, V12, P53, DOI 10.1007/s10158-011-0127-0; Tsunozaki M, 2008, NEURON, V59, P959, DOI 10.1016/j.neuron.2008.07.038; Hu JY, 2004, NEURON, V43, P373, DOI 10.1016/j.neuron.2004.07.011; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216; [Anonymous], 2004, D353987 ASTM; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Kodama E, 2006, GENE DEV, V20, P2955, DOI 10.1101/gad.1479906; Kimura KD, 2004, CURR BIOL, V14, P1291, DOI 10.1016/j.cub.2004.06.060; Hukema RK, 2008, LEARN MEMORY, V15, P829, DOI 10.1101/lm.994408; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; Husson SJ, 2006, J NEUROCHEM, V98, P1999, DOI 10.1111/j.1471-4159.2006.04014.x; Ha HI, 2010, NEURON, V68, P1173, DOI 10.1016/j.neuron.2010.11.025; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Iino Y, 2009, J NEUROSCI, V29, P5370, DOI 10.1523/JNEUROSCI.3633-08.2009; BRENNER S, 1974, GENETICS, V77, P71; Bargmann CI, 2006, WORMBOOK, V25, P1, DOI DOI 10.1895/WORMBOOK; Bargmann C.I., 1993, NEURON, V74, P515, DOI DOI 10.1016/0092-8674(93)80053-H; Borbely E, 2013, NEUROPEPTIDES, V47, P439, DOI 10.1016/j.npep.2013.10.012; Chase D. L., 2007, WORMBOOK, V20, P1, DOI DOI 10.1895/W0RMB00K.1.132.1; Chen ZN, 2013, NEURON, V77, P572, DOI 10.1016/j.neuron.2012.11.025; Husson SJ, 2007, J NEUROCHEM, V102, P246, DOI 10.1111/j.1471-4159.2007.04474.x; Jacob TC, 2003, J NEUROSCI, V23, P2122; Kandel E. R., 2000, PRINCIPLES NEURAL SC, P1227; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kawazoe Y, 2013, NEUROSCI RES, V75, P65, DOI 10.1016/j.neures.2012.04.011; Kunitomo H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3210; Li Chris, 2008, WormBook, P1, DOI 10.1895/wormbook.1.142.1; Lockery SR, 2011, CURR OPIN NEUROBIOL, V21, P782, DOI 10.1016/j.conb.2011.06.009; Nylen P., 1965, MODERN SURFACE COATI; Poling B.E., 2000, PROPERTIES GASES LIQ; Press W.H., 1992, NUMERICAL RECIPES C; RAMSBOTHAM J, 1980, PROG ORG COAT, V8, P113, DOI 10.1016/0300-9440(80)80010-5; Voglis G, 2008, EMBO J, V27, P3288, DOI 10.1038/emboj.2008.252	52	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	OCT	2015	99						22	33		10.1016/j.neures.2015.05.009		12	Neurosciences	Neurosciences & Neurology	CR8BK	WOS:000361575900004		
J	Kato, T; Seki, S; Higashiyama, M; Masuda, Y; Kitamura, S; Yoshida, A				Kato, Takafumi; Seki, Shinichiro; Higashiyama, Makoto; Masuda, Yuji; Kitamura, Seiichiro; Yoshida, Atsushi			Anatomical organization of descending cortical projections orchestrating the patterns of cortically induced rhythmical jaw muscle activity in guinea pigs	NEUROSCIENCE RESEARCH			English	Article						Rhythmical jaw movement; Mastication; Cortical masticatory area; Descending projection; Trigeminal system	TRIGEMINAL MOTOR NUCLEUS; PARVICELLULAR RETICULAR-FORMATION; PRIMARY SOMATOSENSORY CORTEX; DEEP MESENCEPHALIC NUCLEUS; BRAIN-STEM; RED NUCLEUS; CORTICOTHALAMIC PROJECTIONS; HORSERADISH-PEROXIDASE; MASTICATORY AREA; CORTICOBULBAR PROJECTION	Repetitive electrical microstimulation to the cortical masticatory area (CMA) evokes distinct patterns of rhythmical jaw muscle activities (RJMAs) in animals. This study aimed to investigate the characteristics of the descending projections from the CMA, associated with distinct patterns of RJMAs, to the thalamus, midbrain, pons and medulla in guinea pigs. RJMAs with continuous masseter and digastric bursts (CB-RJMAs) and stimulus-locked digastric sub-bursts (SLB-RJMAs) were induced from the anterior and posterior areas of the rostral region of the lateral agranular cortex, and chewing-like RJMAs from the rostral region of the granular cortex. Anterograde tracer, biotinylated dextran amine, was injected into the three cortical areas. The cortical area inducing CB-RJMAs had strong ipsilateral projections to the motor thalamus, red nucleus, midbrain reticular formation, superior colliculus, parabrachial nucleus, and supratrigeminal region, and contralateral projections mainly to the lateral reticular formation around the trigeminal motor nucleus (Vmo). The cortical area inducing SLB-RJMAs had moderate projections to the motor thalamus and lateral reticular formation around the Vmo, but few projections to the midbrain nuclei. The cortical area inducing chewing-like RJMAs had strong projections to the ipsilateral sensory thalamus and contralateral trigeminal sensory nuclei, and moderate projections to the lateral reticular formation. The three cortical areas consistently had few projections to the ventromedial reticular formation. The present study demonstrates that multiple direct and indirect descending projections from the CMA onto the premotor systems connecting the trigeminal motoneurons represent the neuroanatomical repertoires for generating RJMAs during the distinct phases of natural ingestive behavior. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Kato, Takafumi; Yoshida, Atsushi] Osaka Univ, Grad Sch Dent, Dept Oral Anat & Neurobiol, Suita, Osaka, Japan; [Seki, Shinichiro; Kitamura, Seiichiro] Univ Tokushima, Inst Hlth Biosci, Dept Oral & Maxillofacial Anat, Tokushima 770, Japan; [Higashiyama, Makoto] Osaka Univ, Grad Sch Dent, Dept Fixed Prosthodont, Suita, Osaka 5650871, Japan; [Masuda, Yuji] Matsumoto Dent Univ, Grad Sch Oral Med, Dept Oral & Maxillofacial Biol, Nagano, Japan	Kato, T (reprint author), Osaka Univ, Grad Sch Dent, Dept Oral Anat & Neurobiol, Suita, Osaka, Japan.	takafumi@dent.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [21791888, 25670789, 23659869]	This study was supported by Grant-in-aid for Young Scientists (B) (#21791888) and Grant-in-Aid for challenging Exploratory Research (#25670789 and #23659869) of the Japan Society for the Promotion of Science (JSPS).	Alloway KD, 2008, J COMP NEUROL, V510, P100, DOI 10.1002/cne.21782; Tokuno H, 1995, BRAIN RES, V703, P217, DOI 10.1016/0006-8993(95)01079-3; ZHANG GX, 1990, BRAIN RES BULL, V24, P221, DOI 10.1016/0361-9230(90)90209-I; HERKENHAM M, 1979, J COMP NEUROL, V183, P487, DOI 10.1002/cne.901830304; ANGAUT P, 1985, NEUROSCIENCE, V15, P389, DOI 10.1016/0306-4522(85)90221-0; Kato T, 2013, J APPL PHYSIOL, V114, P316, DOI 10.1152/japplphysiol.00895.2012; Killackey HP, 2003, J NEUROSCI, V23, P7381; RAUSELL E, 1991, J NEUROSCI, V11, P210; LIU ZJ, 1993, J NEUROPHYSIOL, V69, P569; MORIMOTO T, 1985, ARCH ORAL BIOL, V30, P673, DOI 10.1016/0003-9969(85)90154-2; Satoh Y, 2007, BRAIN RES, V1165, P60, DOI 10.1016/j.brainres.2007.06.008; Lund JP, 1998, CURR OPIN NEUROBIOL, V8, P718, DOI 10.1016/S0959-4388(98)80113-X; Yoshida A, 2009, J COMP NEUROL, V514, P368, DOI 10.1002/cne.22013; Chang Z, 2009, BRAIN RES, V1275, P43, DOI 10.1016/j.brainres.2009.04.026; Kolta A, 2000, J CHEM NEUROANAT, V19, P175, DOI 10.1016/S0891-0618(00)00061-2; Hatanaka N, 2005, J COMP NEUROL, V492, P401, DOI 10.1002/cne.20730; SCHWARTZ G, 1989, J NEUROPHYSIOL, V62, P273; Tsujimura T, 2012, NEUROSCI LETT, V528, P159, DOI 10.1016/j.neulet.2012.09.005; Yamada Y, 2005, RESP PHYSIOL NEUROBI, V147, P177, DOI 10.1016/j.resp.2005.02.017; INOUE T, 1994, J NEUROPHYSIOL, V71, P2061; Tomita A, 2012, NEUROSCIENCE, V200, P166, DOI 10.1016/j.neuroscience.2011.10.048; Reichova I, 2004, J NEUROPHYSIOL, V92, P2185, DOI 10.1152/jn.00322.2004; BYRD KE, 1981, J MORPHOL, V170, P147, DOI 10.1002/jmor.1051700203; CHANDLER SH, 1990, BRAIN RES, V526, P54, DOI 10.1016/0006-8993(90)90249-B; CHANDLER SH, 1982, J NEUROPHYSIOL, V48, P126; DENIAU JM, 1994, NEUROSCIENCE, V61, P533, DOI 10.1016/0306-4522(94)90432-4; ENOMOTO S, 1987, NEUROSCI LETT, V82, P162, DOI 10.1016/0304-3940(87)90122-4; ENOMOTO S, 1995, NEUROREPORT, V6, P1573; GIUFFRIDA R, 1991, EUR J NEUROSCI, V3, P866, DOI 10.1111/j.1460-9568.1991.tb00098.x; Godefroy JN, 1998, PHYSIOL RES, V47, P489; GOLDBERG LJ, 1982, J NEUROPHYSIOL, V48, P110; Groenewegen HJ, 1999, J CHEM NEUROANAT, V16, P167, DOI 10.1016/S0891-0618(99)00009-5; Guandalini P, 2001, BRAIN RES BULL, V54, P175, DOI 10.1016/S0361-9230(00)00444-5; Hague T., 2010, BRAIN RES, V1346, P69; HUANG CS, 1989, J NEUROPHYSIOL, V61, P635; INOUE T, 1992, NEUROSCI RES, V14, P275; IRIKI A, 1988, DEV BRAIN RES, V44, P189, DOI 10.1016/0165-3806(88)90217-9; Isogai F, 2012, NEUROSCI RES, V74, P239, DOI 10.1016/j.neures.2012.10.009; IWATA K, 1990, BRAIN RES, V507, P337, DOI 10.1016/0006-8993(90)90293-K; Kanayama H, 2010, ARCH ORAL BIOL, V55, P89, DOI 10.1016/j.archoralbio.2009.11.005; LI YQ, 1995, J COMP NEUROL, V356, P563, DOI 10.1002/cne.903560407; LUND JP, 1984, J NEUROPHYSIOL, V52, P1014; Masuda Y, 2002, EXP BRAIN RES, V146, P501, DOI 10.1007/s00221-002-1221-7; Masuda Y, 2005, EXP BRAIN RES, V161, P397, DOI 10.1007/s00221-004-2073-0; Masuda Y, 2001, NEUROSCI RES, V39, P11, DOI 10.1016/S0168-0102(00)00186-3; Masuda Y, 1997, J NEUROPHYSIOL, V77, P2227; MIZUNO N, 1973, J COMP NEUROL, V147, P267, DOI 10.1002/cne.901470208; MORIMOTO T, 1973, Archives of Oral Biology, V18, P361, DOI 10.1016/0003-9969(73)90160-X; NOZAKI S, 1986, J NEUROPHYSIOL, V55, P806; NOZAKI S, 1986, J NEUROPHYSIOL, V55, P826; PANNETON WM, 1979, BRAIN RES, V168, P493, DOI 10.1016/0006-8993(79)90305-6; Paxinos G., 1986, RAT BRAIN STEREOTAXI; REDGRAVE P, 1987, EXP BRAIN RES, V68, P147; Rodriguez M, 2001, J COMP NEUROL, V438, P12, DOI 10.1002/cne.1299; ROUILLER EM, 1991, NEUROSCI LETT, V125, P93, DOI 10.1016/0304-3940(91)90139-K; Sasamoto K, 1990, JPN J ORAL BIOL, V32, P57; SHAMMAHLAGNADO SJ, 1992, NEUROSCIENCE, V50, P403, DOI 10.1016/0306-4522(92)90433-3; SHAMMAHLAGNADO SJ, 1983, NEUROSCIENCE, V9, P391, DOI 10.1016/0306-4522(83)90302-0; Swanson LW, 1992, BRAIN MAPS STRUCTURE; TINDAL JS, 1965, J COMP NEUROL, V124, P259, DOI 10.1002/cne.901240210; Tsumori T, 1997, BRAIN RES, V755, P151, DOI 10.1016/S0006-8993(97)00182-0; TURMAN J, 1994, SYNAPSE, V18, P7, DOI 10.1002/syn.890180103; TURMAN JE, 1994, BRAIN RES, V634, P49, DOI 10.1016/0006-8993(94)90257-7; VEAZEY RB, 1982, J COMP NEUROL, V204, P134, DOI 10.1002/cne.902040204; Waite PM., 2004, RAT NERVOUS SYSTEM, P817; Westberg KG, 1998, J NEUROSCI, V18, P6466; WREE A, 1981, ANAT EMBRYOL, V162, P81, DOI 10.1007/BF00318096; Yamamura K, 2002, BRAIN RES, V944, P40, DOI 10.1016/S0006-8993(02)02705-1; Yasui Y, 1996, NEUROREPORT, V7, P1157, DOI 10.1097/00001756-199604260-00012; YASUI Y, 1985, J COMP NEUROL, V241, P348, DOI 10.1002/cne.902410308; Yasui Y, 2001, BRAIN RES, V923, P187, DOI 10.1016/S0006-8993(01)03196-1	71	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	OCT	2015	99						34	45		10.1016/j.neures.2015.05.006		12	Neurosciences	Neurosciences & Neurology	CR8BK	WOS:000361575900005		
J	Nishimura, M; Sawatari, H; Takemoto, M; Song, WJ				Nishimura, Masataka; Sawatari, Hiroyuki; Takemoto, Makoto; Song, Wen-Jie			Identification of the somatosensory parietal ventral area and overlap of the somatosensory and auditory cortices in mice	NEUROSCIENCE RESEARCH			English	Article						Somatosensory cortex; Auditory cortex; Multimodal integration; Mouse; Optical imaging	TONOTOPIC ORGANIZATION; INSULAR CORTEX; BEHAVING MICE; MOUSE; CONNECTIONS; PLASTICITY; FIELD; REPRESENTATION; INTEGRATION; CIRCUIT	This study aimed to identify the parietal ventral (PV) area of the somatosensory cortex in mice and to determine whether auditory cortex and somatosensory cortex overlap. Using high resolution, voltage-sensitive dye-based imaging, we identified the PV area, which exhibited strong responses to stimulation of distal body parts but weak responses to stimulation of proximal and facial body parts. We further demonstrated a substantial overlap between the auditory and non-primary somatosensory areas, including the PV area. We found statistically significant non-additive integration of auditory and somatosensory inputs in the overlapping region, suggesting convergence of the two input streams at the cellular level. We have thus delineated the PV area in mice for the first time, and have shown that it is a likely site for the integration of auditory and somatic inputs. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Nishimura, Masataka; Sawatari, Hiroyuki; Takemoto, Makoto; Song, Wen-Jie] Kumamoto Univ, Grad Sch Med Sci, Dept Sensory & Cognit Physiol, Kumamoto 8608556, Japan; [Song, Wen-Jie] Kumamoto Univ, Grad Sch Med Sci, HIGO Program, Kumamoto 8608556, Japan	Song, WJ (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Sensory & Cognit Physiol, Kumamoto 8608556, Japan.	song@kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [25290006, 25115725, 25670719, 15H01442]	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Nos. 25290006, 25115725, 25670719, and 15H01442).	Hunt DL, 2006, NEUROSCIENCE, V139, P1507, DOI 10.1016/j.neuroscience.2006.01.023; WOOLSEY TA, 1967, JOHNS HOPKINS MED J, V121, P91; Gogolla N, 2014, NEURON, V83, P894, DOI 10.1016/j.neuron.2014.06.033; Guo W, 2012, J NEUROSCI, V32, P9159, DOI 10.1523/JNEUROSCI.0065-12.2012; Petersen CCH, 2009, ACTA PHYSIOL, V195, P91, DOI 10.1111/j.1748-1716.2008.01925.x; Disbrow E, 2003, J COMP NEUROL, V462, P382, DOI 10.1002/cne.10731; KRUBITZER LA, 1986, J COMP NEUROL, V250, P403, DOI 10.1002/cne.902500402; Rodgers KM, 2008, CEREB CORTEX, V18, P2941, DOI 10.1093/cercor/bhn054; Oertel D, 2004, TRENDS NEUROSCI, V27, P104, DOI 10.1016/j.tins.2003.12.001; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Geissler DB, 2004, EUR J NEUROSCI, V19, P1027, DOI 10.1111/j.1460-9568.2004.03205.x; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Stiebler I, 1997, J COMP PHYSIOL A, V181, P559, DOI 10.1007/s003590050140; Tsukano H, 2013, NEUROSCI LETT, V556, P204, DOI 10.1016/j.neulet.2013.10.015; YOUNG ED, 1995, J NEUROPHYSIOL, V73, P743; Benison AM, 2007, J NEUROPHYSIOL, V97, P200, DOI 10.1152/jn.00673.2006; Donishi T, 2011, NEUROSCIENCE, V174, P200, DOI 10.1016/j.neuroscience.2010.11.041; Ide Y, 2013, COGN NEURODYNAMICS, V7, P67, DOI 10.1007/s11571-012-9224-y; LI CL, 1976, EXP NEUROL, V50, P67, DOI 10.1016/0014-4886(76)90236-3; MURAKAMI F, 1992, NEUROSCI RES, V15, P235, DOI 10.1016/0168-0102(92)90045-E; Nishimura M, 2007, J NEUROPHYSIOL, V97, P927, DOI 10.1152/jn.00689.2006; Nishimura M, 2014, NEUROIMAGE, V89, P181, DOI 10.1016/j.neuroimage.2013.12.014; Qi HX, 2002, J COMP NEUROL, V443, P168, DOI 10.1002/cne.10113; Sawatari H, 2011, EUR J NEUROSCI, V34, P1944, DOI 10.1111/j.1460-9568.2011.07926.x; Shoham D., 1999, NEURON, V24, P1; SONG WJ, 1990, DEV BRAIN RES, V56, P75, DOI 10.1016/0165-3806(90)90166-V; Song WJ, 2006, CEREB CORTEX, V16, P718, DOI 10.1093/cercor/bhj018; STIEBLER I, 1987, NATURWISSENSCHAFTEN, V74, P96, DOI 10.1007/BF00366088; Wu C., 2014, CELL TISSUE RES	29	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	OCT	2015	99						55	61		10.1016/j.neures.2015.06.001		7	Neurosciences	Neurosciences & Neurology	CR8BK	WOS:000361575900007		
J	Yoshimura, M; Ohkubo, J; Hashimoto, H; Matsuura, T; Maruyama, T; Onaka, T; Suzuki, H; Ueta, Y				Yoshimura, Mitsuhiro; Ohkubo, Jun-ichi; Hashimoto, Hirofumi; Matsuura, Takanori; Maruyama, Takashi; Onaka, Tatsushi; Suzuki, Hideaki; Ueta, Yoichi			Effects of a subconvulsive dose of kainic acid on the gene expressions of the arginine vasopressin, oxytocin and neuronal nitric oxide synthase in the rat hypothalamus	NEUROSCIENCE RESEARCH			English	Article						Arginine vasopressin; Oxytocin; Neuronal nitric oxide synthase; Kainic acid; Hypothalamus; Rat	MESSENGER-RNA EXPRESSION; GREEN FLUORESCENT PROTEIN; SUPRAOPTIC NUCLEI; INDUCED SEIZURES; HETERONUCLEAR RNA; PARAVENTRICULAR NUCLEUS; WATER-DEPRIVATION; TRANSGENIC RATS; UP-REGULATION; FOS	Arginine vasopressin (AVP) synthesis in the hypothalamo-neurohypophysial system (HNS) is upregulated by kainic acid (KA)-induced seizure in rats. However, it remains unknown whether a subconvulsive dose of KA affects the HNS. Here we examined the effects of subcutaneous (s.c.) administration of a low dose of KA (4 mg/kg) on the gene expressions of the AVP, oxytocin (OXT) and neuronal nitric oxide synthase (nNOS) in the supraoptic (SON) and paraventricular nuclei (PVN) of the rat hypothalamus, using in situ hybridization histochemistiy. The expression of the AVP gene in the SON and PVN was judged to be up-regulated in KA-treated rats in comparison with saline-treated rats as controls. Next, the expression of the OXT gene was significantly increased in the SON at 6-24h and in the PVN at 6 and 12 h after s.c. administration of KA. Finally, the expression of the nNOS gene was significantly increased in the SON and PVN at 3 and 6 h after s.c. administration of KA. These results suggest that up-regulation of the gene expressions of the AVP, OXT and nNOS in the rat hypothalamus may be differentially affected by peripheral administration of a subconvulsive dose of KA. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Yoshimura, Mitsuhiro; Ohkubo, Jun-ichi; Hashimoto, Hirofumi; Matsuura, Takanori; Maruyama, Takashi; Ueta, Yoichi] Univ Occupat & Environm Hlth, Dept Physiol, Kitakyushu, Fukuoka 8078555, Japan; [Yoshimura, Mitsuhiro; Ohkubo, Jun-ichi; Hashimoto, Hirofumi; Matsuura, Takanori; Maruyama, Takashi; Ueta, Yoichi] Univ Occupat & Environm Hlth, Sch Med, Kitakyushu, Fukuoka 8078555, Japan; [Ohkubo, Jun-ichi; Suzuki, Hideaki] Univ Occupat & Environm Hlth, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Kitakyushu, Fukuoka 8078555, Japan; [Onaka, Tatsushi] Jichi Med Univ, Div Brain & Neurophysiol, Dept Physiol, Shimotsuke 3290498, Japan	Ueta, Y (reprint author), Univ Occupat & Environm Hlth, Sch Med, Dept Physiol, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	yoichi@med.uoeh-u.acjp			Japan Society for the Promotion of Science (JSPS) [25293055]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [25113721]	We thank Ms. Kanako Shoguchi (University of Occupational and Environmental Health, Kitakyushu, Japan) for her technical assistance. This study was supported by a Grant-in-Aid for Scientific Research (B), No. 25293055 to Y.U. from the Japan Society for the Promotion of Science (JSPS) and by a Grant-in-Aid for Scientific Research on Innovative Area, No. 25113721 to Y.U. from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Aguila FA, 2011, BRAIN RES BULL, V86, P239, DOI 10.1016/j.brainresbull.2011.07.020; Erbas O, 2013, PEPTIDES, V40, P141, DOI 10.1016/j.peptides.2012.12.003; OLNEY JW, 1974, BRAIN RES, V77, P507, DOI 10.1016/0006-8993(74)90640-4; HERMAN JP, 1994, J NEUROENDOCRINOL, V6, P433, DOI 10.1111/j.1365-2826.1994.tb00604.x; Clynen E, 2014, MOL NEUROBIOL, V50, P626, DOI 10.1007/s12035-014-8669-x; [Anonymous], 1972, CLIN NEUROPHYSIOL; Kawasaki M, 2005, J NEUROENDOCRINOL, V17, P227, DOI 10.1111/j.1365-2826.2005.01297.x; Ueta Y, 2005, ENDOCRINOLOGY, V146, P406, DOI 10.1210/en.2004-0830; Walls AB, 2014, J CEREBR BLOOD F MET, V34, P1340, DOI 10.1038/jcbfm.2014.88; Sakamoto K, 2008, EPILEPSIA, V49, P982, DOI 10.1111/j.1528-1167.2008.01545.x; Hatakeyama S, 1996, J CHEM NEUROANAT, V11, P243, DOI 10.1016/S0891-0618(96)00166-4; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Yoshimura M, 2013, J NEUROENDOCRINOL, V25, P478, DOI 10.1111/jne.12022; Nylen A, 2001, BRAIN RES, V908, P10, DOI 10.1016/S0006-8993(01)02539-2; Arima H, 1999, J NEUROENDOCRINOL, V11, P337; Arkhipov V, 2008, PHARMACOL BIOCHEM BE, V88, P299, DOI 10.1016/j.pbb.2007.08.012; Bayrakdar ET, 2013, EPILEPSY RES, V105, P13, DOI 10.1016/j.eplepsyres.2012.12.008; Carbajal Daisy, 2004, Drugs R D, V5, P331, DOI 10.2165/00126839-200405060-00004; COLLINS RC, 1980, LIFE SCI, V27, P855, DOI 10.1016/0024-3205(80)90080-6; Croiset G, 1997, BRAIN RES, V759, P18, DOI 10.1016/S0006-8993(97)00070-X; Huang L, 2012, BRAIN BEHAV, V2, P532, DOI 10.1002/brb3.70; Iwanaga M, 2011, BRAIN RES, V1424, P1, DOI 10.1016/j.brainres.2011.09.030; Katoh A, 2011, ENDOCRINOLOGY, V152, P2768, DOI 10.1210/en.2011-0006; Kurose T, 2001, AUTON NEUROSCI-BASIC, V88, P52, DOI 10.1016/S1566-0702(01)00235-1; Mikulecka A, 1999, BEHAV BRAIN RES, V101, P21, DOI 10.1016/S0166-4328(98)00113-2; Nomura M, 1999, NEUROENDOCRINOLOGY, V69, P167, DOI 10.1159/000054416; Ohkubo J, 2014, J NEUROENDOCRINOL, V26, P43, DOI 10.1111/jne.12128; Ohno M, 2012, STRESS, V15, P435, DOI 10.3109/10253890.2011.637185; Orlando GF, 2007, NITRIC OXIDE-BIOL CH, V16, P64, DOI 10.1016/j.niox.2006.05.002; Pereno GL, 2011, EXP TOXICOL PATHOL, V63, P291, DOI 10.1016/j.etp.2010.02.001; Popeski N, 1999, J NEUROENDOCRINOL, V11, P53; Riba-Bosch A, 2004, NEUROSCIENCE, V125, P803, DOI 10.1016/j.neuroscience.2004.02.017; Richmond Charlotte A, 2003, J Neurosci Nurs, V35, P281; Riljak V., 2014, PHYSL RES ACAD SCI B; Riljak V, 2007, PHYSIOL RES, V56, P641; Srisawat R, 2004, NEUROSCI LETT, V369, P191, DOI 10.1016/j.neulet.2004.07.045; Sun Q, 1996, NEUROSCIENCE, V71, P543, DOI 10.1016/0306-4522(95)00466-1; UETA Y, 1995, NEUROSCI RES, V23, P317, DOI 10.1016/0168-0102(95)00956-6; Xiao M, 2005, BRAIN RES, V1038, P150, DOI 10.1016/j.brainres.2005.01.032; Yamamoto Y, 1997, NEUROREPORT, V8, P3907, DOI 10.1097/00001756-199712220-00013; Yoshimura M, 2013, PEPTIDES, V46, P13, DOI 10.1016/j.peptides.2013.04.019	41	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	OCT	2015	99						62	68		10.1016/j.neures.2015.05.002		7	Neurosciences	Neurosciences & Neurology	CR8BK	WOS:000361575900008		
J	Kitazawa, M				Kitazawa, Masakiyo			Rapidity window dependences of higher order cumulants and diffusion master equation	NUCLEAR PHYSICS A			English	Article						Quark-gluon plasma; Fluctuations of conserved charges; Event-by-event analysis	HEAVY-ION COLLISIONS; PROTON MULTIPLICITY DISTRIBUTIONS; QCD PHASE-TRANSITION; CRITICAL-POINT; HIGHER MOMENTS; FREEZE-OUT; FLUCTUATIONS; STAR	We study the rapidity window dependences of higher order cumulants of conserved charges observed in relativistic heavy ion collisions. The time evolution and the rapidity window dependence of the non-Gaussian fluctuations are described by the diffusion master equation. Analytic formulas for the time evolution of cumulants in a rapidity window are obtained for arbitrary initial conditions. We discuss that the rapidity window dependences of the non-Gaussian cumulants have characteristic structures reflecting the non-equilibrium property of fluctuations, which can be observed in relativistic heavy ion collisions with the present detectors. It is argued that various information on the thermal and transport properties of the hot medium can be revealed experimentally by the study of the rapidity window dependences, especially by the combined use, of the higher order cumulants. Formulas of higher order cumulants for a probability distribution composed of sub-probabilities, which are useful for various studies of non-Gaussian cumulants, are also presented. (C) 2015 Elsevier B.V. All rights reserved.	Osaka Univ, Dept Phys, Toyonaka, Osaka 5600043, Japan	Kitazawa, M (reprint author), Osaka Univ, Dept Phys, Toyonaka, Osaka 5600043, Japan.	kitazawa@phys.sci.osaka-u.ac.jp			JSPS KAKENHI [25800148]	The author thanks Masayuki Asakawa, Hirosato Ono and Mild Sakaida for valuable discussions. He also thanks Shinichi Esumi, Volker Koch, Hiroshi Masui and Krzysztof Redlich for useful conversations and encouragements. This work was supported by JSPS KAKENHI (Grant Number 25800148).	Abelev B, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.152301; Aggarwal MM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.022302; Morita K, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.034903; Bass SA, 2000, PHYS REV LETT, V85, P2689, DOI 10.1103/PhysRevLett.85.2689; Adamczyk L, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.092301; Reulet B, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.196601; Bazavov A, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.034509; Karsch F, 2011, PHYS LETT B, V695, P136, DOI 10.1016/j.physletb.2010.10.046; Sakaida M, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.064911; Bazavov A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.192302; Bellwied R, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.202302; Pratt S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.212301; Adamczyk L, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.032302; Jeon S, 2000, PHYS REV LETT, V85, P2076, DOI 10.1103/PhysRevLett.85.2076; Asakawa M, 2000, PHYS REV LETT, V85, P2072, DOI 10.1103/PhysRevLett.85.2072; Bazavov A, 2014, PHYS LETT B, V737, P210, DOI 10.1016/j.physletb.2014.08.034; Kitazawa M, 2014, PHYS LETT B, V728, P386, DOI 10.1016/j.physletb.2013.12.008; Bazavov A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.082301; Gupta S, 2011, SCIENCE, V332, P1525, DOI 10.1126/science.1204621; LEVITOV LS, 1993, JETP LETT+, V58, P230; Bzdak A, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.044904; Stephanov M, 1998, PHYS REV LETT, V81, P4816, DOI 10.1103/PhysRevLett.81.4816; Ejiri S, 2006, PHYS LETT B, V633, P275, DOI 10.1016/j.physletb.2005.11.083; Gustavsson S, 2009, SURF SCI REP, V64, P191, DOI 10.1016/j.surfrep.2009.02.001; Jeon S, 2002, PHYS REV C, V65, DOI 10.1103/PhysRevC.65.044902; Asakawa M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.262301; Aziz MA, 2004, PHYS REV C, V70, DOI 10.1103/PhysRevC.70.034905; Borsanyi S, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.052301; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549; Friman B, 2011, EUR PHYS J C, V71, DOI 10.1140/epjc/s10052-011-1694-2; Gardiner C., 2009, SPRINGER SERIES SYNE; Garg P, 2013, J PHYS G NUCL PARTIC, V40, DOI 10.1088/0954-3899/40/5/055103; Gupta S, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.034001; Herold C, 2014, J PHYS G NUCL PARTIC, V41, DOI 10.1088/0954-3899/41/11/115106; Kitazawa M, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.069902; Kitazawa M, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.024904; Kitazawa M, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.021901; Koch V., ARXIV08102520NUCLTH; Landau L. D., 1980, STAT PHYS 2; Ling B, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.064901; Luo XF, 2013, NUCL PHYS A, V904, p911C, DOI 10.1016/j.nuclphysa.2013.02.163; Luo X., 2015, CPOD2014 BIEL GERM N, VCPOD2014, P019; Luo XF, 2012, CENT EUR J PHYS, V10, P1372, DOI 10.2478/s11534-012-0080-5; Mitchell JT, 2013, NUCL PHYS A, V904, p903C, DOI 10.1016/j.nuclphysa.2013.02.161; Nahrgang M., ARXIV14021238HEPPH; Nakamura A., ARXIV13050760HEPPH; O'Brien E., 2012, QUARK MATT 2012 WASH; Ohnishi Y., UNPUB; Ono H, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.041901; Pratt S., ARXIV14092164NUCLTH; Shuryak EV, 2001, PHYS REV C, V63, DOI 10.1103/PhysRevC.63.064903; STAR Collaboration, STUD PHAS DIAGR QCD; Stephanov MA, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.052301; Stephanov MA, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.032301	54	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0375-9474	1873-1554		NUCL PHYS A	Nucl. Phys. A	OCT	2015	942						65	96		10.1016/j.nuclphysa.2015.07.008		32	Physics, Nuclear	Physics	CR8CN	WOS:000361578800005		
J	Ohtsuki, S; Matsuzaki, N; Mohri, K; Endo, M; Emura, T; Hidaka, K; Sugiyama, H; Takahashi, Y; Ishiyama, K; Kadowaki, N; Takakura, Y; Nishikawa, M				Ohtsuki, Shozo; Matsuzaki, Noriyuki; Mohri, Kohta; Endo, Masayuki; Emura, Tomoko; Hidaka, Kumi; Sugiyama, Hiroshi; Takahashi, Yuki; Ishiyama, Kenichi; Kadowaki, Norimitsu; Takakura, Yoshinobu; Nishikawa, Makiya			Optimal Arrangement of Four Short DNA Strands for Delivery of Immunostimulatory Nucleic Acids to Immune Cells	NUCLEIC ACID THERAPEUTICS			English	Article							PLASMACYTOID DENDRITIC CELLS; BINDING PROTEIN; BACTERIAL-DNA; CPG MOTIFS; TOLL; NANOSTRUCTURES; OLIGODEOXYNUCLEOTIDES; HYDROGEL	Nanosized DNA assemblies are useful for delivering immunostimulatory cytosine-phosphate-guanine (CpG) DNA to immune cells, but little is known about the optimal structure for such delivery. In this study, we designed three different DNA nanostructures using four 55-mer oligodeoxynucleotides (ODNs), that is, tetrapod-like structured DNA (tetrapodna), tetrahedral DNA (tetrahedron), and tetragonal DNA (tetragon), and compared their potencies. Electrophoresis showed that tetrapodna was obtained with high yield and purity, whereas tetrahedron formed multimers at high ODN concentrations. Atomic force microscopy revealed that all preparations were properly constructed under optimal conditions. The thermal stability of tetrapodna was higher than those of the others. Dynamic light scattering analysis showed that all of the assemblies were about 8nm in diameter. Upon addition to mouse macrophage-like RAW264.7 cells, tetrahedron was most efficiently taken up by the cells. Then, a CpG DNA, a ligand for toll-like receptor 9, was linked to these DNA nanostructures and added to RAW264.7 cells. CpG tetrahedron induced the largest amount of tumor necrosis factor-, followed by CpG tetrapodna. Similar results were obtained using human peripheral blood mononuclear cells. Taken together, these results indicate that tetrapodna is the best assembly with the highest yield and high immunostimulatory activity, and tetrahedron can be another useful assembly for cellular delivery if its preparation yield is improved.	[Ohtsuki, Shozo; Matsuzaki, Noriyuki; Mohri, Kohta; Takahashi, Yuki; Takakura, Yoshinobu; Nishikawa, Makiya] Kyoto Univ, Dept Biopharmaceut & Drug Metab, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Endo, Masayuki; Sugiyama, Hiroshi] Kyoto Univ, Inst Integrated Cell Mat Sci ICeMS, Kyoto 6068501, Japan; [Emura, Tomoko; Hidaka, Kumi; Sugiyama, Hiroshi] Kyoto Univ, Dept Chem, Grad Sch Sci, Kyoto 6068501, Japan; [Ishiyama, Kenichi; Kadowaki, Norimitsu] Kyoto Univ, Dept Hematol & Oncol, Grad Sch Med, Kyoto 6068501, Japan	Nishikawa, M (reprint author), Kyoto Univ, Dept Biopharmaceut & Drug Metab, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan.	makiya@pharm.kyoto-u.ac.jp	Sugiyama, Hiroshi/C-7687-2011; Endo, Masayuki/J-5874-2014		Japan Society for the Promotion of Science [26860021, 23390010, 26293008]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [25114706]; Institute for Integrated Cell-Material Sciences, Kyoto University	This work was supported by a Grant-in-Aid for Young Scientists (B) [no. 26860021] to K.M.; Grants-in-Aid for Scientific Research (B) [no. 23390010 and no. 26293008] to M.N. from the Japan Society for the Promotion of Science; Grant-in-Aid for Scientific Research on Innovative Areas Carcinogenic spiral [no. 25114706] to M.N. from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and Cross-Disciplinary Collaborative Research Promotion Project to Y.T. from the Institute for Integrated Cell-Material Sciences, Kyoto University.	Benimetskaya L, 1997, NAT MED, V3, P414, DOI 10.1038/nm0497-414; Mohri K, 2012, ACS NANO, V6, P5931, DOI 10.1021/nn300727j; Tversky JR, 2008, CLIN EXP ALLERGY, V38, P781, DOI 10.1111/j.1365-2222.2008.02954.x; Klinman DM, 1996, P NATL ACAD SCI USA, V93, P2879, DOI 10.1073/pnas.93.7.2879; Hemmi H, 2000, NATURE, V408, P740; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Kawamura K, 2006, BLOOD, V107, P1031, DOI 10.1182/blood-2005-04-1737; Nishikawa M, 2008, IMMUNOLOGY, V124, P247, DOI 10.1111/j.1365-2567.2007.02762.x; Nishikawa M, 2011, BIOMATERIALS, V32, P488, DOI 10.1016/j.biomaterials.2010.09.013; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Li J, 2011, ACS NANO, V5, P8783, DOI 10.1021/nn202774x; Zhang C, 2008, P NATL ACAD SCI USA, V105, P10665, DOI 10.1073/pnas.0803841105; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI [10.1038/nrd3203, 10.1038/nrd3087]; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Li J, 2013, ADV MATER, V25, P4386, DOI 10.1002/adma.201300875; Um SH, 2006, NAT MATER, V5, P797, DOI 10.1038/nmat1741; Endo M, 2010, J AM CHEM SOC, V132, P1592, DOI 10.1021/ja907649w; Vollmer J, 2009, ADV DRUG DELIVER REV, V61, P195, DOI 10.1016/j.addr.2008.12.008; Klinman Dennis M, 2004, Nat Rev Immunol, V4, P249, DOI 10.1038/nri1329; Matsuoka N, 2010, J CONTROL RELEASE, V148, P311, DOI 10.1016/j.jconrel.2010.09.019; Nishikawa M, 2010, ADV DRUG DELIVER REV, V62, P626, DOI 10.1016/j.addr.2010.03.006; Nishikawa M, 2014, J CONTROL RELEASE, V180, P25, DOI 10.1016/j.jconrel.2014.02.001; Siess DC, 2000, J BIOL CHEM, V275, P33655, DOI 10.1074/jbc.M004461200; Uno S, 2013, NANOMEDICINE, V10, P765; Wagner H, 2001, IMMUNITY, V14, P499, DOI 10.1016/S1074-7613(01)00144-3	26	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2159-3337	2159-3345		NUCLEIC ACID THER	Nucl. Acid Ther.	OCT 1	2015	25	5					245	253		10.1089/nat.2014.0524		9	Biochemistry & Molecular Biology; Chemistry, Medicinal; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Research & Experimental Medicine	CR5LN	WOS:000361384000003		
J	Rodriguez-Fernandez, R; Rahajeng, E; Viliani, F; Kushadiwijaya, H; Amiya, RM; Bangs, MJ				Rodriguez-Fernandez, Rodrigo; Rahajeng, Ekowati; Viliani, Francesca; Kushadiwijaya, Haripurnomo; Amiya, Rachel M.; Bangs, Michael J.			Non-communicable disease risk factor patterns among mining industry workers in Papua, Indonesia: longitudinal findings from the Cardiovascular Outcomes in a Papuan Population and Estimation of Risk (COPPER) Study	OCCUPATIONAL AND ENVIRONMENTAL MEDICINE			English	Article							MIDDLE-INCOME COUNTRIES; MYOCARDIAL-INFARCTION; HEALTH-PROMOTION; GLOBAL BURDEN; SYSTEMATIC ANALYSIS; MORTALITY; INTERVENTIONS; WORKPLACE; EXPOSURE; PROGRAMS	Objectives Non-communicable diseases (NCDs) constitute an increasing slice of the global burden of disease, with the South-East Asia region projected to see the highest increase in NCD-related deaths over the next decade. Mining industry employees may be exposed to various factors potentially elevating their NCD risk. This study aimed to assess the distribution and 5-year longitudinal trends of key metabolic NCD risk factors in a cohort of copper-gold mining company workers in Papua, Indonesia. Methods Metabolic indicators of NCD risk were assessed among employees (15 580 at baseline, 6496 prospectively) of a large copper-gold mining operation in Papua, Indonesia, using routinely collected 5-year medical surveillance data. The study cohort comprised individuals aged 18-68 years employed for >= 1 year during 2008-2013. Assessed risk factors were based on repeat measures of cholesterol, blood glucose, blood pressure and body weight, using WHO criteria. Results Metabolic risk indicator rates were markedly high and increased significantly from baseline through 5-year follow-up (p<0.001). Adjusting for gender and age, longer duration of employment (>= 10 years) predicted raised cholesterol (adjusted OR (AOR)=1.13, p=0.003), raised blood pressure (AOR=1.16, p=0.009) and overweight/obesity (AOR=1.14, p=0.001) at baseline; and persistent raised cholesterol (AOR=1.26, p=0.003), and both incident (AOR=1.33, p=0.014) and persistent raised blood glucose (AOR=1.62, p=0.044) at 3-year follow-up. Conclusions Individuals employed for longer periods in a mining operations setting in Papua, Indonesia, may face elevated NCD risk through various routes. Workplace health promotion interventions and policies targeting modifiable lifestyle patterns and environmental exposures present an important opportunity to reduce such susceptibilities and mitigate associated health risks.	[Rodriguez-Fernandez, Rodrigo; Kushadiwijaya, Haripurnomo; Bangs, Michael J.] Int SOS, Publ Hlth & Malaria Control, Mimika, Papua, Indonesia; [Rodriguez-Fernandez, Rodrigo; Amiya, Rachel M.] NCD Asia Pacific Alliance, Tokyo, Japan; [Rahajeng, Ekowati] Minist Hlth, Noncommunicable Dis Control, Jakarta, Indonesia; [Viliani, Francesca] Int SOS, Publ Hlth Consulting Serv & Community Hlth, Copenhagen, Denmark; [Kushadiwijaya, Haripurnomo] Gadjah Mada Univ, Dept Publ Hlth, Fac Med, Yogyakarta, Indonesia; [Amiya, Rachel M.] Univ Tokyo, Grad Sch Med, Dept Family Nursing, Tokyo, Japan	Rodriguez-Fernandez, R (reprint author), Int SOS Freeport Ind Publ Hlth & Malaria Control, Jalan Kertajasa 1, Mimika 99920, Papua, Indonesia.	rod.rodriguez@ncdapa.org			PT Freeport, Freeport McMoRan Copper Gold Inc.	PT Freeport, Freeport McMoRan Copper & Gold Inc.	Allison P. D., 1999, LOGISTIC REGRESSION; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Bjor B, 2010, OCCUP ENVIRON MED, V67, P154, DOI 10.1136/oem.2009.046599; Ketola E, 2000, ANN MED, V32, P239, DOI 10.3109/07853890009011767; Kuoppala J, 2008, J OCCUP ENVIRON MED, V50, P1216, DOI 10.1097/JOM.0b013e31818dbf92; Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Soler RE, 2010, AM J PREV MED, V38, pS237, DOI 10.1016/j.amepre.2009.10.030; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Arena R, 2013, MAYO CLIN PROC, V88, P605, DOI 10.1016/j.mayocp.2013.03.002; Kontis V, 2014, LANCET, V384, P427, DOI 10.1016/S0140-6736(14)60616-4; Davies HW, 2005, EPIDEMIOLOGY, V16, P25, DOI 10.1097/01.ede.0000147121.13399.bf; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Forsberg BC, 2011, HEALTH POLICY PLANN, V26, pi1, DOI 10.1093/heapol/czr050; McMillan DC, 2006, BRIT MED J, V333, P1109, DOI 10.1136/bmj.39042.565035.BE1; Pelletier KR, 2011, J OCCUP ENVIRON MED, V53, P1310, DOI 10.1097/JOM.0b013e3182337748; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Donoghue AM, 2004, OCCUP MED-OXFORD, V54, P283, DOI 10.1093/occmed/kqh072; Bloom DE, 2011, GLOBAL EC BURDEN NON; ENTERLIN.PE, 1972, ANN NY ACAD SCI, V200, P260, DOI 10.1111/j.1749-6632.1972.tb40192.x; Fox J., 1991, REGRESSION DIAGNOSTI; Geaney F, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-370; GREEN KL, 1988, HEALTH EDUC QUART, V15, P473, DOI 10.1177/109019818801500407; Jenkins WD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071312; Kjollesdala MR, 2011, HLTH NUTR, V14, P133; Kleinbaum D.G., 1988, APPL REGRESSION ANAL; Lassen A, 2004, PUBLIC HEALTH NUTR, V7, P263, DOI 10.1079/PHN2003532; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; MCMICHAEL AJ, 1976, J OCCUP ENVIRON MED, V18, P165, DOI 10.1097/00043764-197603000-00009; Mincheva L, 1995, Probl Khig, V20, P47; Peiris D, 2014, J CARDIOVASC TRANSL, V7, P677, DOI 10.1007/s12265-014-9581-5; Sockoll I, 2009, 13E IGA BKK; Stadler K., 2006, THESIS STELLENBOSCH; Stephens C, 2001, WORKER COMMUNITY HLT; Swinburn BA, 2011, LANCET, V27, P804, DOI DOI 10.1016/S0140-6736(11)60813-1; WHO Regional Office for South-East Asia, 2011, NONC DIS S E AS REG; WHO Regional Office for South-East Asia, 2012, REG STRAT TOB CONTR; WHO. World Health Organization, 2011, NONC DIS COUNTR PROF; World Health Organization, 2005, PREV CHRON DIS VIT I; World Health Organization, 2009, GLOB HLTH RISKS MORT; World Health Organization, 2014, NONC DIS COUNTR PROF; World Health Organization, 2012, GLOBAL BURDEN DIS; World Health Organization, 2011, GLOB STAT REP NONC D	44	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1351-0711	1470-7926		OCCUP ENVIRON MED	Occup. Environ. Med.	OCT	2015	72	10					728	735		10.1136/oemed-2014-102664		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CR7AC	WOS:000361498700008		
J	Tokizawa, K; Takahashi, M				Tokizawa, Ken; Takahashi, Masaya			Daytime napping results in an underestimation of thermal strain during exercise in the heat: authors' response	OCCUPATIONAL AND ENVIRONMENTAL MEDICINE			English	Letter							PERCEPTION		[Tokizawa, Ken; Takahashi, Masaya] Natl Inst Occupat Safety & Hlth, Kawasaki, Kanagawa 2148585, Japan	Tokizawa, K (reprint author), Natl Inst Occupat Safety & Hlth, Tama Ku, Nagao 6-21-1, Kawasaki, Kanagawa 2148585, Japan.	tokizawa@h.jniosh.go.jp					CABANAC M, 1971, SCIENCE, V173, P1103, DOI 10.1126/science.173.4002.1103; Schlader ZJ, 2011, PHYSIOL BEHAV, V103, P217, DOI 10.1016/j.physbeh.2011.02.002; Tokizawa K, 2015, OCCUP ENVIRON MED, V72, P521, DOI 10.1136/oemed-2014-102548; Barwood MJ, 2015, SCAND J MED SCI SPOR, V25, P211, DOI 10.1111/sms.12395; Moore Jonathan P, 2015, Occup Environ Med, V72, P753, DOI 10.1136/oemed-2015-103108	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1351-0711	1470-7926		OCCUP ENVIRON MED	Occup. Environ. Med.	OCT	2015	72	10					753	754		10.1136/oemed-2015-103197		2	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CR7AC	WOS:000361498700012		
J	Kruidhof, HM; Roberts, AL; Magdaraog, P; Munoz, D; Gols, R; Vet, LEM; Hoffmeister, TS; Harvey, JA				Kruidhof, H. M.; Roberts, A. L.; Magdaraog, P.; Munoz, D.; Gols, R.; Vet, L. E. M.; Hoffmeister, T. S.; Harvey, J. A.			Habitat complexity reduces parasitoid foraging efficiency, but does not prevent orientation towards learned host plant odours	OECOLOGIA			English	Article						Cotesia glomerata; Pieris brassicae; Learning; Semi-field study; Host location	C-RUBECULA HYMENOPTERA; COTESIA-GLOMERATA; VEGETATION STRUCTURE; NONHOST PLANT; PIERIS-RAPAE; VOLATILES; HERBIVORE; BEHAVIOR; ATTRACTION; BRACONIDAE	It is well known that many parasitic wasps use herbivore-induced plant odours (HIPVs) to locate their inconspicuous host insects, and are often able to distinguish between slight differences in plant odour composition. However, few studies have examined parasitoid foraging behaviour under (semi-)field conditions. In nature, food plants of parasitoid hosts are often embedded in non-host-plant assemblages that confer both structural and chemical complexity. By releasing both na < ve and experienced Cotesia glomerata females in outdoor tents, we studied how natural vegetation surrounding Pieris brassicae-infested Sinapis arvensis and Barbarea vulgaris plants influences their foraging efficiency as well as their ability to specifically orient towards the HIPVs of the host plant species on which they previously had a positive oviposition experience. Natural background vegetation reduced the host-encounter rate of na < ve C. glomerata females by 47 %. While associative learning of host plant HIPVs 1 day prior to foraging caused a 28 % increase in the overall foraging efficiency of C. glomerata, it did not reduce the negative influence of natural background vegetation. At the same time, however, females foraging in natural vegetation attacked more host patches on host-plant species on which they previously had a positive oviposition experience. We conclude that, even though the presence of natural vegetation reduces the foraging efficiency of C. glomerata, it does not prevent experienced female wasps from specifically orienting towards the host-plant species from which they had learned the HIPVs.	[Kruidhof, H. M.; Roberts, A. L.; Hoffmeister, T. S.] Univ Bremen, Populat & Evolutionary Ecol Grp, D-28359 Bremen, Germany; [Kruidhof, H. M.; Roberts, A. L.; Magdaraog, P.; Munoz, D.; Vet, L. E. M.; Harvey, J. A.] Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Wageningen, Netherlands; [Magdaraog, P.] Nagoya Univ, Appl Entomol Lab, Nagoya, Aichi 4648601, Japan; [Gols, R.; Vet, L. E. M.] Wageningen Univ, Entomol Lab, NL-6700 AP Wageningen, Netherlands	Kruidhof, HM (reprint author), Wageningen UR Greenhouse Hort, Bleiswijk, Netherlands.	marjolein.kruidhof@wur.nl			Central Research Development Fund of the University of Bremen	We would like to thank Gregor Disveld for assistance in the greenhouse, Leon Westerd and Joop Woelke for providing insects, Hand Smid for experimental advice, Roeland Courtois for plant species identification, and Donaldo Alvarez, Ana Salgado Arenal and Alvaro Aldoba for field assistance. We would also like to express our gratitude towards Jerome Casas and an anonymous reviewer for their valuable comments. This project was funded by a PostDoc grant for principal investigators to HMK from the Central Research Development Fund of the University of Bremen.	VINSON SB, 1976, ANNU REV ENTOMOL, V21, P109, DOI 10.1146/annurev.en.21.010176.000545; Vos M, 1998, J ANIM ECOL, V67, P774, DOI 10.1046/j.1365-2656.1998.00239.x; Fraser SEM, 2007, J APPL ECOL, V44, P352, DOI 10.1111/j.1365-2664.2006.01266.x; Gu HN, 2003, ECOL ENTOMOL, V28, P422, DOI 10.1046/j.1365-2311.2003.00535.x; Gols R, 2011, J CHEM ECOL, V37, P795, DOI 10.1007/s10886-011-9993-5; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Braasch J, 2012, ENTOMOL EXP APPL, V145, P115, DOI 10.1111/j.1570-7458.2012.01317.x; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Langer V, 1996, ENTOMOL EXP APPL, V80, P365; McCormick AC, 2012, TRENDS PLANT SCI, V17, P303, DOI 10.1016/j.tplants.2012.03.012; Geervliet JBF, 1998, ENTOMOL EXP APPL, V86, P241, DOI 10.1046/j.1570-7458.1998.00286.x; Althoff DM, 2003, ECOL ENTOMOL, V28, P500, DOI 10.1046/j.1365-2311.2003.00533.x; Bezemer TM, 2010, ECOL ENTOMOL, V35, P341, DOI 10.1111/j.1365-2311.2010.01184.x; Gols R, 2005, J ANIM ECOL, V74, P1059, DOI 10.1111/j.1365-2656.2005.01003.x; Bukovinszky T, 2007, J ANIM ECOL, V76, P845, DOI 10.1111/j.1365-2656.2007.01259.x; Bukovinszky T, 2005, J CHEM ECOL, V31, P461, DOI 10.1007/s10886-005-2019-4; Smid HM, 2007, P ROY SOC B-BIOL SCI, V274, P1539, DOI 10.1098/rspb.2007.0305; Coll M, 1996, ECOL ENTOMOL, V21, P141, DOI 10.1111/j.1365-2311.1996.tb01180.x; Scherer S, 2003, LEARN MEMORY, V10, P217, DOI 10.1101/lm.57903; Perfecto I, 2003, ENVIRON ENTOMOL, V32, P163, DOI 10.1603/0046-225X-32.1.163; Hori M, 1997, APPL ENTOMOL ZOOL, V32, P303; VISSER JH, 1978, ENTOMOL EXP APPL, V24, P738; PAPAJ DR, 1990, J CHEM ECOL, V16, P3137, DOI 10.1007/BF00979616; Randlkofer B, 2010, ECOL ENTOMOL, V35, P446, DOI 10.1111/j.1365-2311.2010.01200.x; Hoedjes KM, 2011, P ROY SOC B-BIOL SCI, V278, P889, DOI 10.1098/rspb.2010.2199; Thaler JS, 1999, NATURE, V399, P686, DOI 10.1038/21420; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; Halitschke R, 2008, ECOL LETT, V11, P24, DOI 10.1111/j.1461-0248.2007.01123.x; Geervliet JBF, 1996, J INSECT BEHAV, V9, P525, DOI 10.1007/BF02213877; Hoballah MEF, 2002, J CHEM ECOL, V28, P951, DOI 10.1023/A:1015253600083; Obermaier E, 2008, EUR J ENTOMOL, V105, P233; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; VET LEM, 1991, NETH J ZOOL, V41, P202; Gols R, 2009, OIKOS, V118, P733, DOI 10.1111/j.1600-0706.2008.17231.x; Poelman EH, 2009, FUNCT ECOL, V23, P951, DOI 10.1111/j.1365-2435.2009.01570.x; Askew R.R., 1986, P225; Casas Jerome, 2002, P174, DOI 10.1017/CBO9780511542190.008; Fei MH, 2014, J ANIM ECOL, V83, P234, DOI 10.1111/1365-2656.12122; Feltwell J, 1982, LARGE WHITE BUTTERFL; Geervliet JBF, 1998, BIOL CONTROL, V11, P113, DOI 10.1006/bcon.1997.0585; Godfray H.C.J., 1994, PARASITOIDS BEHAV EV; Hunter MD, 2002, AGR FOREST ENTOMOL, V4, P81, DOI 10.1046/j.1461-9563.2002.00138.x; Jancek S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064432; Kruidhof HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039615; Mauchline AL, 2005, ENTOMOL EXP APPL, V114, P181, DOI 10.1111/j.1570-7458.2005.00237.x; MONTEITH L. G., 1960, CANADIAN ENT, V92, P641; Renwick JAA, 1999, ENTOMOL EXP APPL, V91, P51, DOI 10.1046/j.1570-7458.1999.00465.x; Schroeder R, 2008, BIOSCIENCE, V58, P308, DOI 10.1641/B580406; Soler R, 2007, FUNCT ECOL, V21, P969, DOI 10.1111/j.1365-2435.2007.01309.x; Vanbergen AJ, 2006, J ANIM ECOL, V75, P789, DOI 10.1111/j.1365-2656.2006.1099.x; VET LEM, 1990, J INSECT BEHAV, V3, P471, DOI 10.1007/BF01052012; Vet Louise E.M., 1995, P65; Waschke N, 2013, RECENT ADV CHEM ECOL; Waschke N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085152; Zrelec V, 2013, ECOL EVOL, V3, P4139, DOI 10.1002/ece3.783	56	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0029-8549	1432-1939		OECOLOGIA	Oecologia	OCT	2015	179	2					353	361		10.1007/s00442-015-3346-y		9	Ecology	Environmental Sciences & Ecology	CR6QL	WOS:000361472300005		
J	Mori, AS; Ota, AT; Fujii, S; Seino, T; Kabeya, D; Okamoto, T; Ito, MT; Kaneko, N; Hasegawa, M				Mori, Akira S.; Ota, Aino T.; Fujii, Saori; Seino, Tatsuyuki; Kabeya, Daisuke; Okamoto, Toru; Ito, Masamichi T.; Kaneko, Nobuhiro; Hasegawa, Motohiro			Concordance and discordance between taxonomic and functional homogenization: responses of soil mite assemblages to forest conversion	OECOLOGIA			English	Article						Community reassembly; Ecosystem functioning; Forest restoration; Oribatid mites; Soil arthropods; Taxonomic and functional homogenization	BIOTIC HOMOGENIZATION; BETA-DIVERSITY; ORIBATID MITES; COMMUNITY STRUCTURE; ECOSYSTEM MULTIFUNCTIONALITY; ENVIRONMENTAL-CHANGE; ECOLOGICAL PROCESSES; SPRUCE FOREST; BIODIVERSITY; TRAITS	The compositional characteristics of ecological assemblages are often simplified; this process is termed "biotic homogenization." This process of biological reorganization occurs not only taxonomically but also functionally. Testing both aspects of homogenization is essential if ecosystem functioning supported by a diverse mosaic of functional traits in the landscape is concerned. Here, we aimed to infer the underlying processes of taxonomic/functional homogenization at the local scale, which is a scale that is meaningful for this research question. We recorded species of litter-dwelling oribatid mites along a gradient of forest conversion from a natural forest to a monoculture larch plantation in Japan (in total 11 stands), and collected data on the functional traits of the recorded species to quantify functional diversity. We calculated the taxonomic and functional beta-diversity, an index of biotic homogenization. We found that both the taxonomic and functional beta-diversity decreased with larch dominance (stand homogenization). After further deconstructing beta-diversity into the components of turnover and nestedness, which reflect different processes of community organization, a significant decrease in the response to larch dominance was observed only for the functional turnover. As a result, there was a steeper decline in the functional beta-diversity than the taxonomic beta-diversity. This discordance between the taxonomic and functional response suggests that species replacement occurs between species that are functionally redundant under environmental homogenization, ultimately leading to the stronger homogenization of functional diversity. The insights gained from community organization of oribatid mites suggest that the functional characteristics of local assemblages, which support the functionality of ecosystems, are of more concern in human-dominated forest landscapes.	[Mori, Akira S.; Ota, Aino T.; Fujii, Saori; Ito, Masamichi T.; Kaneko, Nobuhiro] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan; [Seino, Tatsuyuki] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; [Kabeya, Daisuke; Okamoto, Toru; Hasegawa, Motohiro] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan	Mori, AS (reprint author), Yokohama Natl Univ, Grad Sch Environm & Informat Sci, 79-7 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	akira.s.mori@gmail.com			Ministry of Education, Culture, Sports, Science and Technology in Japan; Asahi Glass Foundation	The authors thank the staff of the Insect Ecology Laboratory and the Kiso Experimental Station at the Forestry and Forest Products Research Institute and those at the Soil Ecology Laboratory of Yokohama National University for their help and guidance in the research. Budgetary support was provided by a Grant-in-aid for Scientific Research of the Ministry of Education, Culture, Sports, Science and Technology in Japan (to M. H.) and from the Asahi Glass Foundation (to A. S. M.).	Anderson M.J., 2010, ECOL LETT, V14, P19, DOI DOI 10.1111/J.1461-0248.2010.01552.X; Fleishman E, 2006, ECOL INDIC, V6, P543, DOI 10.1016/j.ecolind.2005.07.005; Mori AS, 2013, BIOL REV, V88, P349, DOI 10.1111/brv.12004; Mori AS, 2013, GLOBAL ECOL BIOGEOGR, V22, P878, DOI 10.1111/geb.12058; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Bokhorst S, 2012, GLOBAL CHANGE BIOL, V18, P1152, DOI 10.1111/j.1365-2486.2011.02565.x; Rodrigues JLM, 2013, P NATL ACAD SCI USA, V110, P988, DOI 10.1073/pnas.1220608110; Makkonen M, 2011, SOIL BIOL BIOCHEM, V43, P377, DOI 10.1016/j.soilbio.2010.11.004; Kaneko N, 1999, ECOL RES, V14, P131, DOI 10.1046/j.1440-1703.1999.00292.x; Leprieur F, 2011, ECOL LETT, V14, P325, DOI 10.1111/j.1461-0248.2011.01589.x; Mori AS, 2015, OECOLOGIA, V177, P533, DOI 10.1007/s00442-014-3111-7; Baselga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P1223, DOI 10.1111/j.1466-8238.2011.00756.x; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; Norkko A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02646; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Lindo Z, 2012, GLOBAL CHANGE BIOL, V18, P2448, DOI 10.1111/j.1365-2486.2012.02725.x; Karp DS, 2012, ECOL LETT, V15, P963, DOI 10.1111/j.1461-0248.2012.01815.x; TAKEDA H, 1987, RES POPUL ECOL, V29, P291, DOI 10.1007/BF02538892; Turnbull MS, 2014, SOIL BIOL BIOCHEM, V68, P366, DOI 10.1016/j.soilbio.2013.10.019; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Coleman DC, 2008, SOIL BIOL BIOCHEM, V40, P271, DOI 10.1016/j.soilbio.2007.08.005; LUXTON M, 1972, PEDOBIOLOGIA, V12, P434; Pasari JR, 2013, P NATL ACAD SCI USA, V110, P10219, DOI 10.1073/pnas.1220333110; Zaitsev AS, 2014, APPL SOIL ECOL, V76, P60, DOI 10.1016/j.apsoil.2013.12.009; Bardgett RD, 2014, NATURE, V515, P505, DOI 10.1038/nature13855; Baiser B, 2012, P ROY SOC B-BIOL SCI, V279, P4772, DOI 10.1098/rspb.2012.1651; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Vellend M, 2013, P NATL ACAD SCI USA, V110, P19456, DOI 10.1073/pnas.1312779110; Lobo D, 2011, DIVERS DISTRIB, V17, P287, DOI 10.1111/j.1472-4642.2010.00739.x; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; TUKEY JW, 1958, ANN MATH STAT, V29, P614; Almeida-Neto M, 2012, GLOBAL ECOL BIOGEOGR, V21, P772, DOI 10.1111/j.1466-8238.2011.00709.x; Legendre P, 2014, GLOBAL ECOL BIOGEOGR, V23, P1324, DOI 10.1111/geb.12207; Edwards KF, 2013, ECOL LETT, V16, P56, DOI 10.1111/ele.12012; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Olden JD, 2006, GLOBAL ECOL BIOGEOGR, V15, P113, DOI 10.1111/j.1466-822x.2006.00214.x; Aoki J., 1983, Bulletin of the Institute of Environmental Science and Technology Yokohama National University, V10, P171; Bardgett RD, 2010, ABOVEGROUND BELOWGRO; Buhler C, 2011, DIVERS DISTRIB, V17, P1089, DOI 10.1111/j.1472-4642.2011.00799.x; D'az S., 2001, TRENDS ECOL EVOL, V16, P646; Farska J, 2014, APPL SOIL ECOL, V75, P71, DOI 10.1016/j.apsoil.2013.11.003; Gagic V, 2015, P BIOL SCI, V282, P2014; Gutierrez-Canovas C, 2013, GLOBAL ECOL BIOGEOGR, V22, P796, DOI 10.1111/geb.12060; Hansen RA, 2000, INVERTEBRATES WEBMAS, P336; Hansen RA, 2000, ECOLOGY, V81, P1120; Hasegawa M, 2013, APPL SOIL ECOL, V83, P125; Jaccard P, 1912, NEW PHYTOL, V11, P37, DOI DOI 10.1111/J.1469-8137.1912.TB05611.X; KANEKO N, 1988, REV ECOL BIOL SOL, V25, P353; McCune JL, 2013, J ECOL, V101, P1542, DOI 10.1111/1365-2745.12156; Nakamura K, 2013, ACAROLOGIA, V53, P41, DOI 10.1051/acarologia/20132081; Pool TK, 2012, DIVERS DISTRIB, V18, P366, DOI 10.1111/j.1472-4642.2011.00836.x; Seguin A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04616; SIEPEL H, 1993, SOIL BIOL BIOCHEM, V25, P1491, DOI 10.1016/0038-0717(93)90004-U; Tobias N, 2011, PLANT ECOL, V213, P431; Trentanovi G, 2013, DIVERS DISTRIB, V19, P738, DOI 10.1111/ddi.12028; Valencia E, 2015, NEW PHYTOL, V206, P660, DOI 10.1111/nph.13268; Villeger S, 2013, GLOBAL ECOL BIOGEOGR, V22, P671, DOI 10.1111/geb.12021; Wall DH, 2013, SOIL ECOLOGY AND ECOSYSTEM SERVICES, P1; Wallwork J. A., 1976, DISTRIBUTION DIVERSI; Zavaleta E, 2009, ANN NY ACAD SCI, V1162, P311, DOI 10.1111/j.1749-6632.2009.04448.x	61	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0029-8549	1432-1939		OECOLOGIA	Oecologia	OCT	2015	179	2					527	535		10.1007/s00442-015-3342-2		9	Ecology	Environmental Sciences & Ecology	CR6QL	WOS:000361472300020		
J	Sughimoto, K; Okauchi, K; Zannino, D; Brizard, CP; Liang, FY; Sugawara, M; Liu, H; Tsubota, K				Sughimoto, Koichi; Okauchi, Kazuki; Zannino, Diana; Brizard, Christian P.; Liang, Fuyou; Sugawara, Michiko; Liu, Hao; Tsubota, Ken-ichi			Total Cavopulmonary Connection is Superior to Atriopulmonary Connection Fontan in Preventing Thrombus Formation: Computer Simulation of Flow-Related Blood Coagulation	PEDIATRIC CARDIOLOGY			English	Article						Fontan; Thrombus; Congenital heart disease; Computer simulation; Hemodynamics	PRIMARY THROMBOPROPHYLAXIS; RANDOMIZED-TRIAL; OPERATION; CONVERSION; CIRCULATION; ANTICOAGULATION; COMPLICATIONS; MULTICENTER; CHILDREN; PATIENT	The classical Fontan route, namely the atriopulmonary connection (APC), continues to be associated with a risk of thrombus formation in the atrium. A conversion to a total cavopulmonary connection (TCPC) from the APC can ameliorate hemodynamics for the failed Fontan; however, the impact of these surgical operations on thrombus formation remains elusive. This study elucidates the underlying mechanism of thrombus formation in the Fontan route by using a two-dimensional computer hemodynamic simulation based on a simple blood coagulation rule. Hemodynamics in the Fontan route was simulated with Navier-Stokes equations. The blood coagulation and the hemodynamics were combined using a particle method. Three models were created: APC with a square atrium, APC with a round atrium, and TCPC. To examine the effects of the venous blood flow velocity, the velocity at rest and during exercise (0.5 and 1.0 W/kg) was measured. The total area of the thrombi increased over time. The APC square model showed the highest incidence for thrombus formation, followed by the APC round, whereas no thrombus was formed in the TCPC model. Slower blood flow at rest was associated with a higher incidence of thrombus formation. The TCPC was superior to the classical APC in terms of preventing thrombus formation, due to significant blood flow stagnation in the atrium of the APC. Thus, local hemodynamic behavior associated with the complex channel geometry plays a major role in thrombus formation in the Fontan route.	[Sughimoto, Koichi; Brizard, Christian P.] Royal Childrens Hosp, Dept Cardiac Surg, Melbourne, Vic, Australia; [Okauchi, Kazuki; Sugawara, Michiko; Liu, Hao; Tsubota, Ken-ichi] Chiba Univ, Grad Sch Engn, Dept Mech Engn, Chiba, Japan; [Okauchi, Kazuki] Hitachi Construct Machinery, Tokyo, Japan; [Zannino, Diana; Brizard, Christian P.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Liang, Fuyou] Shanghai Jiao Tong Univ, Sch Naval Architecture Ocean & Civil Engn NAOCE, Shanghai 200030, Peoples R China; [Liang, Fuyou; Liu, Hao] Shanghai Jiao Tong Univ, Shanghai 200030, Peoples R China; [Liang, Fuyou; Liu, Hao] Shanghai Jiao Tong Univ, Chiba Univ, Int Cooperat Res Ctr, Shanghai 200030, Peoples R China	Tsubota, K (reprint author), Chiba Univ, Grad Sch Engn, Dept Mech Engn, Chiba, Japan.	tsubota@faculty.chiba-u.jp			Inohana Alumni Association of the Chiba University of Medicine [12046]; JSPS [25630046]	This study was partially supported by the Inohana Alumni Association of the Chiba University of Medicine (12046) and a research grant, JSPS (25630046).	EFRON B, 1981, ANN STAT, V9, P586, DOI 10.1214/aos/1176345462; Mavroudis C, 2001, J THORAC CARDIOV SUR, V122, P863, DOI 10.1067/mtc.2001.117840; Odegard KC, 2009, J THORAC CARDIOV SUR, V137, P934, DOI 10.1016/j.jtcvs.2008.09.031; Tamagawa M, 2009, ARTIF ORGANS, V33, P604, DOI 10.1111/j.1525-1594.2009.00782.x; Jacobs ML, 2007, PEDIATR CARDIOL, V28, P457, DOI 10.1007/s00246-007-9006-1; McCrindle BW, 2013, J AM COLL CARDIOL, V61, P346, DOI 10.1016/j.jacc.2012.08.1023; Lardo AC, 1997, J THORAC CARDIOV SUR, V114, P2, DOI 10.1016/S0022-5223(97)70110-7; Wolberg AS, 2012, ANESTH ANALG, V114, P275, DOI 10.1213/ANE.0b013e31823a088c; Koshizuka S, 1998, INT J NUMER METH FL, V26, P751, DOI 10.1002/(SICI)1097-0363(19980415)26:7<751::AID-FLD671>3.0.CO;2-C; Giardini A, 2006, INT J CARDIOL, V113, P341, DOI 10.1016/j.ijcard.2005.11.046; Coon PD, 2001, ANN THORAC SURG, V71, P1990, DOI 10.1016/S0003-4975(01)02472-9; Balling G, 2000, J THORAC CARDIOV SUR, V119, P745, DOI 10.1016/S0022-5223(00)70010-9; HEDRICK M, 1993, J THORAC CARDIOV SUR, V105, P297; Sheikh AM, 2004, J THORAC CARDIOV SUR, V128, P60, DOI 10.1016/j.jtcvs.2004.02.011; Mahle WT, 2003, AM J CARDIOL, V91, P1286, DOI 10.1016/S0002-9149(03)00289-3; Filipovic N, 2008, PHILOS T R SOC A, V366, P3265, DOI 10.1098/rsta.2008.0097; van Son JAM, 1999, EUR J CARDIO-THORAC, V15, P150, DOI 10.1016/S1010-7940(98)00315-7; Tomkiewicz-Pajak L, 2014, J THORAC CARDIOV SUR, V147, P1284, DOI 10.1016/j.jtcvs.2013.06.011; Hjortdal VE, 2003, CIRCULATION, V108, P1227, DOI 10.1161/01.CIR.0000087406.27922.6B; Jin SM, 2007, INT J CARDIOL, V120, P221, DOI 10.1016/j.ijcard.2006.09.020; Cheung YF, 2005, INT J CARDIOL, V102, P509, DOI 10.1016/j.ijcard.2004.05.051; Tsubota K, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.011910; Lardo AC, 1999, J THORAC CARDIOV SUR, V117, P697, DOI 10.1016/S0022-5223(99)70289-8; FONTAN F, 1971, THORAX, V26, P240, DOI 10.1136/thx.26.3.240; Jang WS, 2014, EUR J CARDIO-THORAC, V45, P922, DOI 10.1093/ejcts/ezt511; Gewillig M, 2010, INTERACT CARDIOV TH, V10, P428, DOI 10.1510/icvts.2009.218594; Liang FY, 2014, INT J NUMER METH BIO, V30, P1000, DOI 10.1002/cnm.2641; Monagle P, 2011, J AM COLL CARDIOL, V58, P645, DOI 10.1016/j.jacc.2011.01.061; Rychik J, 2010, YPCSU, V13, P96, DOI [10.1053/j.pcsu.2010.02.006, DOI 10.1053/J.PCSU.2010.02.006]; Tsubota K, 2006, COMPUT METH PROG BIO, V83, P139, DOI 10.1016/j.cmpb.2006.06.005; Weinstein Samuel, 2005, Semin Thorac Cardiovasc Surg, V17, P170, DOI 10.1053/j.semtcvs.2005.02.007	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0172-0643	1432-1971		PEDIATR CARDIOL	Pediatr. Cardiol.	OCT	2015	36	7					1436	1441		10.1007/s00246-015-1180-y		6	Cardiac & Cardiovascular Systems; Pediatrics	Cardiovascular System & Cardiology; Pediatrics	CR6AY	WOS:000361426700017		
J	Ono, S; Ohuchi, H; Miyazaki, A; Abe, T; Kiso, K; Yamada, O				Ono, Shin; Ohuchi, Hideo; Miyazaki, Aya; Abe, Tadaaki; Kiso, Keisuke; Yamada, Osamu			Heterogeneity of Ventricular Sympathetic Nervous Activity is Associated with Clinically Relevant Ventricular Arrhythmia in Postoperative Patients with Tetralogy of Fallot	PEDIATRIC CARDIOLOGY			English	Article						Tetralogy of Fallot; Ventricular arrhythmia; Sympathetic nervous activity; I-123 metaiodobenzylguanidine; Scintigraphy	PREVIOUS MYOCARDIAL-INFARCTION; CONGENITAL HEART-DISEASE; LONG QT SYNDROME; HYPERTROPHIC CARDIOMYOPATHY; SUDDEN-DEATH; REPAIR; TACHYCARDIA; DISPERSION; INTERVAL; TACHYARRHYTHMIAS	This study aimed to clarify whether there is an association between ventricular sympathetic nervous activity (SNA) and clinically relevant ventricular arrhythmia (a run of a parts per thousand yen3 consecutive ventricular beats, RVA) in postoperative patients with tetralogy of Fallot (TOF). We performed a retrospective study in a national referral center of pediatric cardiology in Japan. Twenty-four postoperative TOF patients (13 males, median age 17 years) undergoing myocardial I-123 metaiodobenzylguanidine (MIBG) scintigraphy were included. We measured the heart-to-mediastinum ratio (HMR) and washout ratio (WR) from planar MIBG myocardial scintigraphy. Tomographic images and polar maps were generated with 20 segments. The standard deviation of percentage uptake of 20 segments (SD-uptake) as an index of heterogeneous MIBG uptake to the ventricular myocardium was calculated. We compared these MIBG-derived variables with the patients' clinical profiles, including ECG findings and hemodynamics. Eight of 24 patients had RVA (RVA group), and the other 16 did not have RVA (non-RVA group). There were no significant differences in the HMR (1.9 +/- A 0.5 vs. 2.2 +/- A 0.4) and WR (50 +/- A 5 vs. 42 +/- A 10) between the two groups. SD-uptake was significantly higher in the RVA group than in the non-RVA group (15 +/- A 3 vs. 12 +/- A 3, p = 0.03). QT dispersion (ms) was also higher in the RVA group than in the non-RVA group (53 +/- A 23 vs. 44 +/- A 18, p = 0.04). Multivariate logistic regression showed that SD-uptake and QT dispersion were independent predictors in the RVA group (p = 0.02, p = 0.03). In addition to greater QT dispersion, heterogeneous SNA is associated with RVA in TOF patients postoperatively.	[Ono, Shin; Ohuchi, Hideo; Miyazaki, Aya; Abe, Tadaaki; Yamada, Osamu] Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiol, Suita, Osaka 5658565, Japan; [Kiso, Keisuke] Natl Cerebral & Cardiovasc Ctr, Dept Radiol, Suita, Osaka 5658565, Japan	Ohuchi, H (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiol, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	hohuchi@ncvc.go.jp					PERKIOMAKI JS, 1995, J AM COLL CARDIOL, V26, P174, DOI 10.1016/0735-1097(95)00122-G; INOUE H, 1987, CIRCULATION, V75, P877; GATZOULIS MA, 1995, CIRCULATION, V92, P231; Gatzoulis MA, 2000, LANCET, V356, P975, DOI 10.1016/S0140-6736(00)02714-8; YASUE H, 1994, CIRCULATION, V90, P195; Ohuchi H, 1996, PEDIATR CARDIOL, V17, P7, DOI 10.1007/BF02505805; Villafane J, 2013, J AM COLL CARDIOL, V62, P2155, DOI 10.1016/j.jacc.2013.07.100; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Harrison DA, 1997, J AM COLL CARDIOL, V30, P1368, DOI 10.1016/S0735-1097(97)00316-1; Germano G, 2000, J NUCL MED, V41, P712; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; Khairy P, 2008, CIRCULATION, V117, P363, DOI 10.1161/CIRCULATIONAHA.107.726372; DAE MW, 1995, J NUCL CARDIOL, V2, P151; Daliento L, 1999, HEART, V81, P650; Davos CH, 2002, CIRCULATION, V106, pI69, DOI 10.1161/01.cir.0000032886.55215.15; Galinier M, 1998, EUR HEART J, V19, P1054, DOI 10.1053/euhj.1997.0865; Gatzoulis MA, 1997, CIRCULATION, V95, P401; HENDERSON EB, 1988, CIRCULATION, V78, P1192; KATZ NM, 1982, CIRCULATION, V65, P403; Kelesidis I, 2012, J NUCL CARDIOL, V19, P142, DOI 10.1007/s12350-011-9482-9; Klein T, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0359-1; MULLER KD, 1993, EUR HEART J, V14, P316; Ohuchi H, 2000, CIRCULATION, V102, P2732; Perkiomaki JS, 1997, J AM COLL CARDIOL, V30, P1331, DOI 10.1016/S0735-1097(97)00301-X; PRIORI SG, 1994, CIRCULATION, V89, P1681; Shimizu M, 2002, J NUCL MED, V43, P15; Steeds RP, 2004, QJM-INT J MED, V97, P7, DOI 10.1093/qjmed/hch004; Terai H, 2003, J NUCL CARDIOL, V10, P304, DOI 10.1016/S1071-3581(03)00362-3; Yamashina S, 2007, EUR J NUCL MED MOL I, V34, P62, DOI 10.1007/s00259-007-0441-2	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0172-0643	1432-1971		PEDIATR CARDIOL	Pediatr. Cardiol.	OCT	2015	36	7					1515	1522		10.1007/s00246-015-1195-4		8	Cardiac & Cardiovascular Systems; Pediatrics	Cardiovascular System & Cardiology; Pediatrics	CR6AY	WOS:000361426700029		
J	Terui, K; Nagata, K; Ito, M; Yamoto, M; Shiraishi, M; Taguchi, T; Hayakawa, M; Okuyama, H; Yoshida, H; Masumoto, K; Kanamori, Y; Goishi, K; Urushihara, N; Kawataki, M; Inamura, N; Kimura, O; Okazaki, T; Toyoshima, K; Usui, N				Terui, Keita; Nagata, Kouji; Ito, Miharu; Yamoto, Masaya; Shiraishi, Masayuki; Taguchi, Tomoaki; Hayakawa, Masahiro; Okuyama, Hiroomi; Yoshida, Hideo; Masumoto, Kouji; Kanamori, Yutaka; Goishi, Keiji; Urushihara, Naoto; Kawataki, Motoyoshi; Inamura, Noboru; Kimura, Osamu; Okazaki, Tadaharu; Toyoshima, Katsuaki; Usui, Noriaki			Surgical approaches for neonatal congenital diaphragmatic hernia: a systematic review and meta-analysis	PEDIATRIC SURGERY INTERNATIONAL			English	Review						Congenital diaphragmatic hernia; Video-assisted thoracic surgery; Minimally invasive surgical	TERM-FOLLOW-UP; THORACOSCOPIC REPAIR; RECURRENCE; SURGERY	Purpose The optimal surgical approach for neonatal congenital diaphragmatic hernia (CDH) remains unclear. We conducted a systematic review and meta-analysis of the effectiveness of endoscopic surgery (ES) for neonatal CDH. Methods A systematic literature search was conducted using MEDLINE and the Cochrane Library. Studies that compared surgical approaches for neonatal CDH were selected. Mortality and recurrence of herniation were analyzed as primary endpoints. Each study was evaluated following the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. Results Eight observational studies comparing ES and open surgery (OS) met the criteria. As compared with the OS group, the ES group showed both a significantly lower mortality rate [risk ratio (RR) 0.18, 95 % confidence interval (CI) 0.09-0.38, p < 0.0001] and a significantly higher recurrence rate (RR 3.10, 95 % CI 1.95-4.88, p < 0.00001). However, serious selection bias was seen in seven of the eight studies-because the indication of ES had been determined intentionally, the ES groups may have included less severe cases. Conclusion Although the evidence was insufficient, ES was clearly associated with more recurrence than was OS. Therefore, ES should not be the routine treatment for every neonate. It is crucially important to select suitable cases for ES.	[Terui, Keita; Yoshida, Hideo] Chiba Univ, Grad Sch Med, Dept Pediat Surg, Chiba 2608677, Japan; [Nagata, Kouji; Taguchi, Tomoaki] Kyushu Univ, Dept Pediat Surg, Fukuoka 812, Japan; [Ito, Miharu; Hayakawa, Masahiro] Nagoya Univ Hosp, Ctr Maternal Neonatal Care, Div Neonatol, Nagoya, Aichi, Japan; [Yamoto, Masaya; Urushihara, Naoto] Shizuoka Childrens Hosp, Dept Pediat Surg, Shizuoka, Japan; [Shiraishi, Masayuki] Osaka Univ Lib, Osaka, Japan; [Okuyama, Hiroomi] Osaka Univ, Grad Sch Med, Dept Pediat Surg, Osaka, Japan; [Masumoto, Kouji] Univ Tsukuba, Fac Med, Dept Pediat Surg, Tsukuba, Ibaraki, Japan; [Kanamori, Yutaka] Natl Ctr Child Hlth & Dev, Dept Gen Surg, Tokyo, Japan; [Goishi, Keiji] Natl Ctr Child Hlth & Dev, Dept Maternal & Perinatal Med, Div Neonatol, Tokyo, Japan; [Kawataki, Motoyoshi] Tohoku Univ, Grad Sch Med, Dept Gynecol & Obstet, Sendai, Miyagi 980, Japan; [Inamura, Noboru] Osaka Med Ctr Res Inst Maternal & Child Hlth, Dept Pediat Cardiol, Osaka, Japan; [Kimura, Osamu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat Surg, Kyoto, Japan; [Okazaki, Tadaharu] Juntendo Univ, Urayasu Hosp, Dept Pediat Surg, Chiba, Japan; [Toyoshima, Katsuaki] Kanagawa Childrens Med Ctr, Sect Neonatol, Yokohama, Kanagawa, Japan; [Usui, Noriaki] Osaka Med Ctr & Res Inst Maternal & Child Hlth, Dept Pediat Surg, Osaka, Japan	Terui, K (reprint author), Chiba Univ, Grad Sch Med, Dept Pediat Surg, I-8-1 Inohana, Chiba 2608677, Japan.	kta@cc.rim.or.jp			Ministry of Health, Labour and Welfare of Japan (Health and Labour Sciences Research Grants for Research on Intractable Diseases)	This work was supported by a grant from the Ministry of Health, Labour and Welfare of Japan (Health and Labour Sciences Research Grants for Research on Intractable Diseases).	Atkins D, 2004, BRIT MED J, V328, P1490; Lansdale N, 2010, ANN SURG, V252, P20, DOI 10.1097/SLA.0b013e3181dca0e8; Nam SH, 2013, WORLD J SURG, V37, P2711, DOI 10.1007/s00268-013-2189-0; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Keijzer R, 2010, J PEDIATR SURG, V45, P953, DOI 10.1016/j.jpedsurg.2010.02.017; Bishay M, 2013, ANN SURG, V258, P895, DOI 10.1097/SLA.0b013e31828fab55; Gander JW, 2011, J PEDIATR SURG, V46, P1303, DOI 10.1016/j.jpedsurg.2010.11.048; Tsao K, 2011, J PEDIATR SURG, V46, P1158, DOI 10.1016/j.jpedsurg.2011.03.050; [Anonymous], 2011, NICE INTERVENTIONAL; Gourlay DM, 2009, J PEDIATR SURG, V44, P1702, DOI [10.1016/j.jpedsurg.2008.11.030, 10.1016/j.jpedsurg.2009.11.030]; McHoney M, 2010, J PEDIATR SURG, V45, P355, DOI 10.1016/j.jpedsurg.2009.10.072; Cho SD, 2009, J PEDIATR SURG, V44, P80, DOI 10.1016/j.jpedsurg.2008.10.013; Peetsold MG, 2009, PEDIATR SURG INT, V25, P1, DOI 10.1007/s00383-008-2257-y; Chan E, 2014, J PEDIATR SURG, V49, P694, DOI 10.1016/j.jpedsurg.2014.02.049; van den Hout L, 2009, PEDIATR SURG INT, V25, P733, DOI 10.1007/s00383-009-2425-8; Dingemann C, 2014, EUR J PEDIATR SURG, V24, P14, DOI 10.1055/s-0033-1350060; Vijfhuize S, 2012, EUR J PEDIATR SURG, V22, P364, DOI 10.1055/s-0032-1329532; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Kalfa N, 2007, SURG ENDOSC, V21, P303, DOI 10.1007/s00464-006-0044-1; Lao OB, 2010, J LAPAROENDOSC ADV S, V20, P271, DOI 10.1089/lap.2009.0150; Morini F, 2012, EUR J PEDIATR SURG, V22, P355, DOI 10.1055/s-0032-1329411; Nagata K, 2015, EUR J PEDIATR SURG, V25, P9, DOI 10.1055/s-0034-1395486; Nagata K, 2013, J PEDIATR SURG, V48, P738, DOI 10.1016/j.jpedsurg.2012.12.017; Tanaka T, 2013, PEDIATR SURG INT, V29, P1183, DOI 10.1007/s00383-013-3382-9	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	OCT	2015	31	10					891	897		10.1007/s00383-015-3765-1		7	Pediatrics; Surgery	Pediatrics; Surgery	CR6BB	WOS:000361427000001		
J	Okazaki, T; Okawada, M; Koga, H; Miyano, G; Doi, T; Ogasawara, Y; Yazaki, Y; Nishimura, K; Inada, E; Lane, G; Yamataka, A				Okazaki, Tadaharu; Okawada, Manabu; Koga, Hiroyuki; Miyano, Go; Doi, Takashi; Ogasawara, Yuki; Yazaki, Yuta; Nishimura, Kinya; Inada, Eiichi; Lane, Geoffrey J.; Yamataka, Atsuyuki			Safety of surgery for neonatal congenital diaphragmatic hernia as reflected by arterial blood gas monitoring: thoracoscopic versus open repair	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Congenital diaphragmatic hernia; Thoracoscopic repair; Acidemia; Hypercapnia	VENTILATION; SIZE	Purpose We monitored arterial blood gases during thoracoscopic (TR) and open repair (OR) of congenital diaphragmatic hernia (CDH) to assess the safety of intraoperative hypercapnia and acidosis. Methods We reviewed 30 neonatal CDH cases (OR = 10, TR = 20) diagnosed prenatally or within 6 h of birth at out institution from 2002 to 2014 not requiring inhaled nitric oxide (NO) intraoperatively. OR, routine until 2006 was replaced by TR in 2007. All subjects were managed identically. Results Five TR cases requiring conversion to OR were excluded. Prenatal diagnosis, gestational age at birth, gender, birth weight, and side of CDH were similar. Preoperative PaCO2 and pH were not significantly different. However, while intraoperative increase in mean PaCO2 (38.8-62.8 mmHg; p < 0.01) and decrease in mean pH (7.44-7.25; p < 0.01) were significant in TR, intraoperative PaCO2 was < 70 mmHg in 12/15 cases and intraoperative pH was > 7.20 in 11/15 cases. Both PaCO2 and pH reverted to normal on completion of surgery; pre- and postoperative results were comparable. There were no postoperative complications. Conclusions It would appear that neonatal cases of CDH not requiring NO can tolerate TR, despite transient reversible deterioration in acid/base balance, indicating that TR is safe for the treatment of selected cases of CDH.	[Okazaki, Tadaharu; Ogasawara, Yuki; Yazaki, Yuta] Juntendo Univ, Urayasu Hosp, Dept Pediat, Urayasu, Chiba 2790021, Japan; [Okawada, Manabu; Koga, Hiroyuki; Miyano, Go; Doi, Takashi; Yazaki, Yuta; Lane, Geoffrey J.; Yamataka, Atsuyuki] Juntendo Univ, Sch Med, Dept Pediat Surg, Tokyo 113, Japan; [Nishimura, Kinya; Inada, Eiichi] Juntendo Univ, Sch Med, Dept Anesthesiol, Tokyo 113, Japan	Okazaki, T (reprint author), Juntendo Univ, Urayasu Hosp, Dept Pediat, 2-1-1 Tomioka, Urayasu, Chiba 2790021, Japan.	okazakit@juntendo.ac.jp					Acra MJ, 2003, J PEDIATR SURG, V38, P1563; Tsao K, 2011, J PEDIATR SURG, V46, P1158, DOI 10.1016/j.jpedsurg.2011.03.050; Fishman JR, 2011, J PEDIATR SURG, V46, P458, DOI 10.1016/j.jpedsurg.2010.08.062; Gourlay DM, 2009, J PEDIATR SURG, V44, P1702, DOI [10.1016/j.jpedsurg.2008.11.030, 10.1016/j.jpedsurg.2009.11.030]; McHoney M, 2010, J PEDIATR SURG, V45, P355, DOI 10.1016/j.jpedsurg.2009.10.072; Yang EY, 2005, J PEDIATR SURG, V40, P1369, DOI 10.1016/j.jpedsurg.2005.04.036; Bishay M, 2013, ANN SURG, V258, P785; der Zee Van, 1995, SURG ENDOSC, V9, P1001; Keijzer R, 2011, J PEDIATR SURG, V45, P953; Liem NT, 2010, J LAPAROENDOSC ADV S, V20, P111, DOI 10.1089/lap.2008.0412; Liem NT, 2006, J PEDIATR SURG, V41, P1713, DOI 10.1016/j.jpedsurg.2006.05.043; Okazaki T, 2011, PEDIATR SURG INT, V27, P35, DOI 10.1007/s00383-010-2724-0; Okazaki T, 2008, PEDIATR SURG INT, V24, P1369, DOI 10.1007/s00383-008-2266-x; Okazaki T, 2012, PEDIATR SURG INT, V28, P883, DOI 10.1007/s00383-012-3148-9; SILEN ML, 1995, ANN THORAC SURG, V60, P448, DOI 10.1016/0003-4975(95)00100-Y; Tanaka T, 2013, PEDIATR SURG INT, V29, P1183, DOI 10.1007/s00383-013-3382-9	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	OCT	2015	31	10					899	904		10.1007/s00383-015-3767-z		6	Pediatrics; Surgery	Pediatrics; Surgery	CR6BB	WOS:000361427000002		
J	Tanaka, T; Inamura, N; Ishii, R; Kayatani, F; Yoneda, A; Tazuke, Y; Kubota, A				Tanaka, Tomohiko; Inamura, Noboru; Ishii, Ryo; Kayatani, Futoshi; Yoneda, Akihiro; Tazuke, Yuko; Kubota, Akio			The evaluation of diastolic function using the diastolic wall strain (DWS) before and after radical surgery for congenital diaphragmatic hernia	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Echocardiogram; Congenital diaphragmatic hernia; Diastolic wall strain; Tei index; Diastolic function	HYPOPLASIA; HEART	Objective The measurement of diastolic wall strain (DWS), a new method of evaluating cardiac diastolic function, was employed to evaluate ventricular diastolic function in patients with congenital diaphragmatic hernia (CDH). Materials and methods Eighteen neonates with a CDH who were born and treated in our hospital between September 2009 and January 2013 were studied. The left ventricular posterior wall thickness during the systolic phase (PWs) and diastolic (PWd) phase was measured using M-mode imaging, and the DWS was calculated as (PWs-PWd)/PWs. The Tei index, the isovolumic relaxation time (IRT), and the fraction shortening (FS) were measured as indices of cardiac function in 14, 15, and 18 cases, respectively. Cardiac function was measured before and after surgery. Statistical analyses were performed using the paired t test. Results The pre- and postoperative DWS, Tei index, IRT and FS values were 0.19 +/- A 0.06 and 0.26 +/- A 0.11 (P < 0.01), 0.40 +/- A 0.12 and 0.31 +/- A 0.11 (P < 0.05), 48 +/- A 14 and 39 +/- A 5.0 ms (P < 0.05), 30 +/- A 7.7 and 34 +/- A 7.4 % (P < 0.05), respectively. Conclusion The diastolic and systolic functions were not only measured by the Tei index, IRT and FS values, but also by the DWS value, which improved after surgery. The measurement of DWS is an easy and useful method for evaluating the diastolic function of CDH patients.	[Tanaka, Tomohiko; Inamura, Noboru; Ishii, Ryo; Kayatani, Futoshi] Osaka Med Ctr & Res Inst Maternal & Child Hlth, Dept Pediat Cardiol, Izumi Ku, Osaka 5941101, Japan; [Yoneda, Akihiro; Tazuke, Yuko; Kubota, Akio] Osaka Med Ctr & Res Inst Maternal & Child Hlth, Dept Pediat Surg, Osaka 5941101, Japan	Tanaka, T (reprint author), Osaka Med Ctr & Res Inst Maternal & Child Hlth, Dept Pediat Cardiol, Izumi Ku, 840 Murodo Cho, Osaka 5941101, Japan.	ttanaka@mch.pref.osaka.jp					Ohtani T, 2012, EUR HEART J, V33, P1742, DOI 10.1093/eurheartj/ehs135; BOROW KM, 1982, AM J CARDIOL, V50, P1301, DOI 10.1016/0002-9149(82)90467-2; Metkus AP, 1996, J PEDIATR SURG, V31, P148, DOI 10.1016/S0022-3468(96)90338-3; SIEBERT JR, 1984, J PEDIATR SURG, V19, P567, DOI 10.1016/S0022-3468(84)80105-0; Armstrong MT, 2000, DEV DYNAM, V219, P2226; HASEGAWA T, 1990, J CLIN ULTRASOUND, V18, P705; Inamura N, 2005, J PEDIATR SURG, V40, P1315, DOI 10.1016/j.jpedsurg.2005.05.018; Nagata K, 2015, EUR J PEDIATR SURG, V25, P9, DOI 10.1055/s-0034-1395486; Nii M, 2006, J AM SOC ECHOCARDIOG, V19, P1431, DOI 10.1016/j.echo.2006.05.027; Takeda Y, 2009, J CARD FAIL, V15, P68, DOI 10.1016/j.cardfail.2008.09.004; Tei C, 1995, J Cardiol, V26, P357; Tsujimoto S, 2013, J AM COLL CARDIOL, V61, pE871; TULZER G, 1994, EUR J PEDIATR, V153, P151, DOI 10.1007/BF01958973	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	OCT	2015	31	10					905	910		10.1007/s00383-015-3766-0		6	Pediatrics; Surgery	Pediatrics; Surgery	CR6BB	WOS:000361427000003		
J	Tanaka, A; Shimono, R; Kubo, H; Fujii, T; Miyatake, N				Tanaka, Aya; Shimono, Ryuichi; Kubo, Hiroyuki; Fujii, Takayuki; Miyatake, Nobuyuki			Evaluation of antireflux surgery using multichannel intraluminal impedance-pH measurement in neurologically impaired patients	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Multichannel intraluminal impedance-pH measurement; Gastro-esophageal reflux; Neurologically impaired patients; Antireflux surgery; Esophageal motility	GASTROESOPHAGEAL-REFLUX; NISSEN FUNDOPLICATION; ESOPHAGEAL-TRANSIT; CHILDREN; DYSPHAGIA; IMPACT; ACID	Purpose This study aimed to evaluate esophageal function before and after antireflux surgery (ARS) in neurologically impaired (NI) patients using 24 h multichannel intraluminal impedance (MII)-pH measurement. Methods Seven NI patients (age, 0-33 years; median, 13 years) were assessed before and after ARS using 24 h MII-pH. We described reflux parameters such as pH reflux index, bolus exposure index, number of acidic and nonacidic reflux episodes, mean acid clearance time and median bolus clearance time, and esophageal motility parameters in dry swallows such as bolus presence time (BPT), total bolus transit time (TBTT), and total propagation velocity (TPV). Results The postoperative reflux parameters such as pH reflux index, acid clearance time, bolus exposure index, and the number of acidic reflux episodes significantly decreased (P < 0.05) compared with the preoperative ones. The esophageal motility parameters including all sites of BPTs, TBTT, and TPV did not change in the MII-pH measurement after ARS (P = non-significant). Conclusion ARS effectively reduced gastro-esophageal reflux (GER) in NI patients without the impairment of esophageal motility by MII-pH measurement. MII-pH was useful to detect the subtype of GER before and after ARS and appeared to be appropriate for evaluating esophageal motility.	[Tanaka, Aya; Shimono, Ryuichi; Kubo, Hiroyuki; Fujii, Takayuki] Kagawa Univ, Fac Med, Dept Pediat Surg, Miki, Kagawa 7610793, Japan; [Miyatake, Nobuyuki] Kagawa Univ, Fac Med, Dept Hyg, Miki, Kagawa 7610793, Japan	Shimono, R (reprint author), Kagawa Univ, Fac Med, Dept Pediat Surg, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	shi-mono@med.kagawa-u.ac.jp					HOLLIS JB, 1975, J APPL PHYSIOL, V38, P1161; Lightdale JR, 2013, PEDIATRICS, V131, pE1684, DOI 10.1542/peds.2013-0421; Gossler A, 2007, J PEDIATR SURG, V42, P1486, DOI 10.1016/j.jpedsurg.2007.04.009; Sifrim D, 2004, GUT, V53, P1024, DOI 10.1136/gut.2003.033290; Agrawal A, 2008, J CLIN GASTROENTEROL, V42, P579, DOI 10.1097/MCG.0b013e31815f8e17; Anvari M, 1998, SURG ENDOSC-ULTRAS, V12, P421, DOI 10.1007/s004649900695; Del Buono R, 2006, J PEDIATR GASTR NUTR, V43, P331, DOI 10.1097/01.mpg.0000232333.77805.94; del Genio G, 2012, J CLIN GASTROENTEROL, V46, pE1, DOI 10.1097/MCG.0b013e31822f3735; Fukahori S, 2013, PEDIATR SURG INT, V29, P545, DOI 10.1007/s00383-013-3295-7; Gruebel C, 2008, SURG ENDOSC, V22, P1241, DOI 10.1007/s00464-007-9599-8; Hassall E, 2005, ARCH DIS CHILD, V90, P1047, DOI 10.1136/adc.2004.069674; Hila A, 2011, J CLIN GASTROENTEROL, V45, P862, DOI 10.1097/MCG.0b013e31822a2c61; Kawahara H, 2010, J PEDIATR SURG, V45, P2373, DOI 10.1016/j.jpedsurg.2010.08.034; Kawahara H, 1997, GASTROENTEROLOGY, V113, P399, DOI 10.1053/gast.1997.v113.pm9247456; Lee SL, 2008, ARCH SURG-CHICAGO, V143, P873, DOI 10.1001/archsurg.143.9.873; Lima M, 2004, PEDIATR SURG INT, V20, P114, DOI 10.1007/s00383-003-1101-7; Mauritz FA, 2011, J GASTROINTEST SURG, V15, P1872, DOI 10.1007/s11605-011-1644-1; Mousa HM, 2011, J PEDIATR GASTR NUTR, V52, P129, DOI 10.1097/MPG.0b013e3181ffde67; O'Loughlin EV, 2013, J PEDIATR GASTR NUTR, V56, P46, DOI 10.1097/MPG.0b013e318267c320; Pacilli M, 2014, ARCH DIS CHILD, V99, P516, DOI 10.1136/archdischild-2013-304279; RICHTER JE, 1987, DIGEST DIS SCI, V32, P95, DOI 10.1007/BF01296693; van Wijk MP, 2008, J PEDIAT GASTROENTER, V48, P2; Yigit T, 2006, DIS ESOPHAGUS, V19, P382, DOI 10.1111/j.1442-2050.2006.00591.x	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	OCT	2015	31	10					911	916		10.1007/s00383-015-3768-y		6	Pediatrics; Surgery	Pediatrics; Surgery	CR6BB	WOS:000361427000004		
J	Kawahara, H; Tazuke, Y; Soh, H; Usui, N; Fukuzawa, M				Kawahara, Hisayoshi; Tazuke, Yuko; Soh, Hideki; Usui, Noriaki; Fukuzawa, Masahiro			Causal relationship between delayed gastric emptying and gastroesophageal reflux in patients with neurological impairment	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Gastroesophageal reflux (GER); Combined multichannel intraluminal impedance-pH (MII-pH) monitoring; Delayed gastric emptying (DGE); C-13-breath test	INFANTS; CHILDREN; DISEASE; RIKKUNSHITO; MECHANISMS; PRETERM; ACID	Purpose To investigate the causal relationship between delayed gastric emptying (DGE) and gastroesophageal reflux (GER) in patients with neurological impairment (NI). Methods Subjects included 30 NI patients (age, 1-34 years; median, 6 years). Combined multichannel intraluminal impedance-pH (MII-pH) monitoring and C-13-breath test evaluated acid/non-acid reflux episodes (RE) and gastric emptying rates, respectively. Values are shown with medians and ranges. Results Percentage time for esophageal pH < 4.0 (reflux index: RI) and numbers for total RE and RE > 5 min were 8.3 (0-35.7), 44 (0-129), and 5 (0-22), respectively. Total percentage time and bolus RE numbers were 1.4 (0.0-6.9) and 49 (2-159), respectively. Median bolus clearance time was 16 s (9-45). T (1/2), T (lag), and GEC were 103 s (75-204), 54 s (18-97), and 3.4 (2.3-4.3), respectively. Gastric emptying rates and acid/non-acid reflux parameters were not significantly correlated, except T (1/2) correlated significantly with the numbers of RE > 5 min (p = 0.04). T (1/2) inversely correlated with bolus clearance time (p = 0.01). Reflux parameters between DGE and non-DGE patients were not significantly different, except median bolus clearance time was significantly shorter in DGE patients (p = 0.01). Conclusions NI patients showed a wide range of gastric emptying rates without any significant causal relationship between DGE and GER.	[Kawahara, Hisayoshi] Hamamatsu Univ Sch Med, Dept Pediat Surg, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Tazuke, Yuko; Soh, Hideki; Usui, Noriaki; Fukuzawa, Masahiro] Osaka Med Ctr & Res Inst Maternal & Child Hlth, Dept Pediat Surg, Izumi Ku, Osaka 5941101, Japan	Kawahara, H (reprint author), Hamamatsu Univ Sch Med, Dept Pediat Surg, Higashi Ku, I-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	kawahara@hama-med.ac.jp			JSPS KAKENHI [26462706]	This study was supported by JSPS KAKENHI Grant Number 26462706 [Grant-in-Aid for Scientific Research (C)]. The authors would like to thank Enago (http://www.enago.jp) for the English language review.	Aktas A, 1999, NUCL MED COMMUN, V20, P907; Sullivan PB, 2008, DEV DISABIL RES REV, V14, P128, DOI 10.1002/ddrr.18; Ewer AK, 1996, ARCH DIS CHILD, V75, pF117, DOI 10.1136/fn.75.2.F117; Kawahara H, 2009, PEDIATR SURG INT, V25, P987, DOI 10.1007/s00383-009-2453-4; BILLEAUD C, 1990, EUR J CLIN NUTR, V44, P577; GHOOS YF, 1993, GASTROENTEROLOGY, V104, P1640; Argon M, 2006, CLIN NUCL MED, V31, P262, DOI 10.1097/01.rlu.0000210500.64440.76; CANNON RA, 1993, J NUCL MED, V34, P2120; CARROCCIO A, 1992, SCAND J GASTROENTERO, V27, P799, DOI 10.3109/00365529209011187; Cucchiara S, 1997, AM J GASTROENTEROL, V92, P1103; Di Ciaula A, 2005, WORLD J GASTROENTERO, V11, P7296; DILORENZO C, 1987, ARCH DIS CHILD, V62, P449; Emerenziani Sara, 2005, Curr Gastroenterol Rep, V7, P190, DOI 10.1007/s11894-005-0033-x; Estevao-Costa J, 2001, J PEDIATR GASTR NUTR, V32, P471, DOI 10.1097/00005176-200104000-00015; EULER AR, 1983, J PEDIATR GASTR NUTR, V2, P595, DOI 10.1097/00005176-198311000-00004; Herculano JRL, 2004, DIGEST DIS SCI, V49, P750, DOI 10.1023/B:DDAS.0000030084.01927.a8; HILLEMEIER AC, 1981, J PEDIATR-US, V98, P190; JOLLEY SG, 1987, J PEDIATR SURG, V22, P923, DOI 10.1016/S0022-3468(87)80590-0; Kawahara H, 2014, PEDIATR SURG INT, V30, P927, DOI 10.1007/s00383-014-3565-z; Kawahara H, 2014, J PEDIATR SURG, V49, P1742, DOI 10.1016/j.jpedsurg.2014.09.008; Kawahara H, 1997, GASTROENTEROLOGY, V113, P399, DOI 10.1053/gast.1997.v113.pm9247456; Knatten CK, 2013, J PEDIATR SURG, V48, P1856, DOI 10.1016/j.jpedsurg.2013.03.076; Kusunoki H, 2010, INTERNAL MED, V49, P2195, DOI 10.2169/internalmedicine.49.3803; Machado RS, 2010, PEDIATR SURG INT, V26, P473, DOI 10.1007/s00383-010-2579-4; Omari TI, 2002, GUT, V51, P475, DOI 10.1136/gut.51.4.475; ROSEN PR, 1984, J NUCL MED, V25, P571; SCHWIZER W, 1989, AM J SURG, V157, P74, DOI 10.1016/0002-9610(89)90422-4; Spiroglou K, 2004, PEDIATR NEUROL, V31, P177, DOI 10.1016/j.pediatrneurol.2004.02.007	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	OCT	2015	31	10					917	923		10.1007/s00383-015-3769-x		7	Pediatrics; Surgery	Pediatrics; Surgery	CR6BB	WOS:000361427000005		
J	Miyano, G; Yamoto, M; Morita, K; Kaneshiro, M; Miyake, H; Nouso, H; Koyama, M; Nakajima, H; Fukumoto, K; Urushihara, N				Miyano, Go; Yamoto, Masaya; Morita, Keiichi; Kaneshiro, Masakatsu; Miyake, Hiromu; Nouso, Hiroshi; Koyama, Mariko; Nakajima, Hideaki; Fukumoto, Koji; Urushihara, Naoto			Laparoscopic Toupet fundoplication for gastroesophageal reflux: a series of 131 neurologically impaired pediatric cases at a single children's hospital	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Toupet fundoplication; Gastroesophageal reflux; Laparoscopy	NISSEN FUNDOPLICATION; ANTIREFLUX SURGERY; ROSSETTI; DISEASE; REPAIR; INFANTS; TRIAL	Purpose To present the medium to long-term outcome of the largest pediatric series of laparoscopic Toupet fundoplications (LTF) performed at a single institution. Patients and methods Subjects were 131 neurologically impaired children (81 M, 50 F) who underwent LTF between 2003 and 2013. Our LTF involves full dissection of the crus of the diaphragm to allow the intraabdominal esophagus to be mobilized at least 3-4 cm. Results Preoperative mean fraction time for pH < 4 was 14.6 %. Mean age at LTF was 6.7 years (3 months-18 years). Mean duration of follow-up was 5.7 years (range 1.2-12.1 years). One case required conversion to open surgery. Intra-operative complications were all injuries to the esophagus/gastric wall (n = 4; 3.0 %) including full-thickness perforation (n = 1; 0.8 %). Postoperative complications included pyloric stenosis (n = 4; 3.0 %), dysphagia (n = 1; 0.8 %), incisional hernia (n = 1; 0.8 %), hemorrhage requiring transfusion (n = 1; 0.8 %), recurrence (n = 3; 2.3 % at 11, 13, and 48 months, respectively), and gastrostomy site infection (n = 7; 5.3 %). Mean operative time decreased significantly with experience from 180.8 min for the first quarter of subjects to 150.6 (2nd quarter), 128.6 (3rd) and 109.2 min (4th). Conclusions Our LTF would appear to be safe for treating GERD in children because of reliable outcome and low recurrence.	[Miyano, Go; Yamoto, Masaya; Morita, Keiichi; Kaneshiro, Masakatsu; Miyake, Hiromu; Nouso, Hiroshi; Koyama, Mariko; Nakajima, Hideaki; Fukumoto, Koji; Urushihara, Naoto] Shizuoka Childrens Hosp, Dept Pediat Surg, Aoi Ku, Shizuoka 4208660, Japan	Miyano, G (reprint author), Shizuoka Childrens Hosp, Dept Pediat Surg, Aoi Ku, 860 Urushiyama, Shizuoka 4208660, Japan.	go1993@hotmail.co.jp					Hagedorn C, 2002, J GASTROINTEST SURG, V6, P540, DOI 10.1016/S1091-255X(02)00037-9; Hunter JG, 1996, ANN SURG, V224, P51, DOI 10.1097/00000658-199607000-00008; Koch OO, 2013, SURG ENDOSC, V27, P2383, DOI 10.1007/s00464-013-2803-0; Bloomston Mark, 2003, JSLS, V7, P211; Capito C, 2008, SURG ENDOSC, V22, P875, DOI 10.1007/s00464-007-9603-3; Davis CS, 2010, JSLS-J SOC LAPAROEND, V14, P332, DOI 10.4293/108680810X12924466007007; Esposito C, 2003, SURG ENDOSC, V17, P708, DOI 10.1007/s00464-002-9170-6; Esposito C, 2010, J LAPAROENDOSC ADV A, V20, P661; Fonkalsrud EW, 1998, PEDIATRICS, V101, P419, DOI 10.1542/peds.101.3.419; GEORGESON KE, 1993, PEDIATR ANN, V22, P675; Granderath FA, 2007, DIGEST LIVER DIS, V39, P312, DOI 10.1016/j.dld.2006.11.011; Jobe BA, 1997, SURG ENDOSC-ULTRAS, V11, P1080, DOI 10.1007/s004649900534; Kamolz T, 2002, ENDOSCOPY, V34, P917, DOI 10.1055/s-2002-35309; LOBE TE, 1993, J PEDIATR SURG, V28, P358, DOI 10.1016/0022-3468(93)90231-9; Lundell L, 1996, BRIT J SURG, V83, P830, DOI 10.1002/bjs.1800830633; MCKERNAN JB, 1994, SURG ENDOSC-ULTRAS, V8, P851, DOI 10.1007/BF00843453; Meehan JJ, 1997, J PEDIATR SURG, V32, P426, DOI 10.1016/S0022-3468(97)90597-2; Patti M G, 1997, J Gastrointest Surg, V1, P309, DOI 10.1016/S1091-255X(97)80050-9; Patti MG, 1997, J GASTROINTEST SURG, V1, P314; Rothenberg SS, 2013, J LAPAROENDOSC ADV S, V23, P791, DOI 10.1089/lap.2013.0299; Shariff F, 2010, J LAPAROENDOSC ADV S, V20, P661, DOI 10.1089/lap.2010.0213; Steyaert H, 2003, SURG ENDOSC, V17, P543, DOI 10.1007/s00464-002-9058-5; TOUPET A, 1963, Mem Acad Chir (Paris), V89, P384; Zehetner J, 2006, SURG ENDOSC, V20, P220, DOI 10.1007/s00464-005-0051-7; Zornig C, 2002, SURG ENDOSC, V16, P758, DOI 10.1007/s00464-001-9092-8	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	OCT	2015	31	10					925	929		10.1007/s00383-015-3770-4		5	Pediatrics; Surgery	Pediatrics; Surgery	CR6BB	WOS:000361427000006		
J	Nio, M; Wada, M; Sasaki, H; Tanaka, H				Nio, Masaki; Wada, Motoshi; Sasaki, Hideyuki; Tanaka, Hiromu			Does hepatic hilum morphology influence long-term prognosis in type I/I cyst biliary atresia?	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Biliary atresia; Hepatic hilum morphology; Hepatic duct size; Long-term prognosis	PORTOENTEROSTOMY; SURVIVAL; REMNANTS	Purpose Some patients with cystic biliary atresia (BA) achieve exceptionally good postoperative courses. Early differentiation of pediatric patients with the favorable-type disease can lead to beneficial long-term postoperative management. We examined whether the hepatic hilum morphology affects long-term prognosis in type I/I cyst BA, atresia of the common bile duct with/without a cyst. Methods Of 253 BA patients identified since 1972, 40 were classified as having type I/I cysts and were divided into two subtypes according to hepatic duct size (subtype alpha: n = 18; duct diameter, a parts per thousand yen1 mm and subtype beta: n = 22; duct diameter, < 1 mm) to compare postoperative clinical courses. Results In subtypes alpha and beta, jaundice disappeared in 16 (89 %) and 19 (86 %) patients, respectively (p = 0.81), and 13 (72 %) and 12 (55 %) survived with native livers (p = 0.18) at a mean age of 23.3 and 25.5 years, respectively (p = 0.42). Conclusions There were no significant differences in long-term outcomes between subtypes alpha and beta, although approximately 40 % developed liver failure during the postoperative course. Thus, close long-term follow-up is essential in type I/I cysts, regardless of the hepatic hilum morphology.	[Nio, Masaki; Wada, Motoshi; Sasaki, Hideyuki; Tanaka, Hiromu] Tohoku Univ, Dept Pediat Surg, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808574, Japan	Nio, M (reprint author), Tohoku Univ, Dept Pediat Surg, Grad Sch Med, Aoba Ku, 1-1 Seiryomachi, Sendai, Miyagi 9808574, Japan.	mnio@ped-surg.med.tohoku.ac.jp					Altman RP, 1997, ANN SURG, V226, P348, DOI 10.1097/00000658-199709000-00014; Caponcelli E, 2008, J PEDIATR SURG, V43, P1619, DOI 10.1016/j.jpedsurg.2007.12.058; Superina R, 2011, ANN SURG, V254, P577, DOI 10.1097/SLA.0b013e3182300950; TAN CEL, 1994, J PEDIATR SURG, V29, P1459, DOI 10.1016/0022-3468(94)90144-9; Langenburg SE, 2000, J PEDIATR SURG, V35, P1006, DOI 10.1053/jpsu.2000.6954; CHANDRA RS, 1978, J PEDIATR-US, V93, P196, DOI 10.1016/S0022-3476(78)80495-8; Japanese Biliary Atresia Society, 2013, J JPN SOC PEDIAT SUG, V49, P277; Kasai M, 1976, J JPN SOC PEDIATR SU, V12, P327; LILLY JR, 1987, J PEDIATR SURG, V22, P522, DOI 10.1016/S0022-3468(87)80212-9; Masumoto K, 2011, PEDIATR SURG INT, V27, P99, DOI 10.1007/s00383-010-2715-1; Nio M, 2006, J PEDIATR SURG, V41, P1973, DOI 10.1016/j.jpedsrug.2006.08.019; Suzuki T, 2013, J HEPATO-BIL-PAN SCI, V20, P465, DOI 10.1007/s00534-013-0605-3; Takahashi Y, 2009, J PEDIATR SURG, V44, P2312, DOI 10.1016/j.jpedsurg.2009.07.051	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	OCT	2015	31	10					931	936		10.1007/s00383-015-3771-3		6	Pediatrics; Surgery	Pediatrics; Surgery	CR6BB	WOS:000361427000007		
J	Mochizuki, K; Shinkai, M; Take, H; Kitagawa, N; Usui, H; Miyagi, H; Nakamura, K; Obatake, M				Mochizuki, Kyoko; Shinkai, Masato; Take, Hiroshi; Kitagawa, Norihiko; Usui, Hidehito; Miyagi, Hisayuki; Nakamura, Kaori; Obatake, Masayuki			Impact of an external lengthening procedure on the outcome of long-gap esophageal atresia at our hospitals	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Esophageal lengthening; External traction; Esophageal atresia; Long gap; Children	PRIMARY ANASTOMOSIS; TRACTION; REPAIR	Purpose To demonstrate the outcome of external lengthening for long-gap esophageal atresia (LGEA) at our hospitals. Methods Five patients with LGEA underwent external lengthening between 2010 and 2014 (group A), and 11 patients with LGEA underwent other lengthening techniques between 1990 and 2011 (group B). We compared the procedure and outcome between these two groups. Results The mean birth weight was 2001 g in group A and 2485 g in group B (p = 0.06). The mean age at esophageal reconstruction was 28 days in group A and 227 days in group B (p = 0.03). Although primary esophageal anastomosis without myotomy was feasible in all patients in group A, a myotomy was needed for primary esophageal anastomosis in half of the patients in group B. Anastomotic leakage occurred in none in group A and in six patients in group B (p = 0.03). The mean age at the establishment of full oral feeding was 76 days in group A and 686 days in group B (p = 0.009). Conclusion External traction for LGEA can effectively lengthen the esophagus to enable primary anastomosis at an earlier age. This may facilitate oral intake.	[Mochizuki, Kyoko; Shinkai, Masato; Take, Hiroshi; Kitagawa, Norihiko; Usui, Hidehito; Miyagi, Hisayuki; Nakamura, Kaori] Kanagawa Childrens Med Ctr, Dept Surg, Minami Ku, Yokohama, Kanagawa 2320066, Japan; [Obatake, Masayuki] Nagasaki Univ, Div Pediat Surg, Dept Surg, Grad Sch Biomed Sci, Nagasaki 852, Japan	Mochizuki, K (reprint author), Kanagawa Childrens Med Ctr, Dept Surg, Minami Ku, 2-138-4 Mutsukawa, Yokohama, Kanagawa 2320066, Japan.	kmochizuki@kcmc.jp					Abraham MK, 2013, J PEDIATR SURG, V48, P1819, DOI 10.1016/j.jpedsurg.2013.03.052; Foker JE, 1997, ANN SURG, V226, P533, DOI 10.1097/00000658-199710000-00014; Skarsgard ED, 2004, J PEDIATR SURG, V39, P1712, DOI 10.1016/j.jpedsurg.2004.07.031; Nasr A, 2013, EUR J PEDIATR SURG, V23, P191, DOI 10.1055/s-0033-1347916; Al-Qahtani AR, 2003, J PEDIATR SURG, V38, P737, DOI 10.1010/S0022-3468(03)00040-X; Hadidi AT, 2007, J PEDIATR SURG, V42, P1659, DOI 10.1016/j.jpedsurg.2007.05.019; Lopes MF, 2004, J PEDIATR SURG, V39, P1286, DOI 10.1016/j.jpedsurg.2004.04.028; Mochizuki K, 2012, PEDIATR SURG INT, V28, P851, DOI 10.1007/s00383-012-3151-1; Ortiz R, 2015, EUR J PEDIATR SURG, V25, P20, DOI 10.1055/s-0034-1386645; Singh Amit, 2014, Afr J Paediatr Surg, V11, P35, DOI 10.4103/0189-6725.129212; Tanaka Y, 2013, SURG TODAY, V43, P906, DOI 10.1007/s00595-012-0426-z; Thakkar HS, 2014, J PEDIATR SURG, V49, P1343, DOI 10.1016/j.jpedsurg.2014.03.021; van der Zee DC, 2015, SURG ENDOSC	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	OCT	2015	31	10					937	942		10.1007/s00383-015-3772-2		6	Pediatrics; Surgery	Pediatrics; Surgery	CR6BB	WOS:000361427000008		
J	Morita, K; Yokoi, A; Bitoh, Y; Fukuzawa, H; Okata, Y; Iwade, T; Endo, K; Takemoto, J; Tamaki, A; Maeda, K				Morita, Keiichi; Yokoi, Akiko; Bitoh, Yuko; Fukuzawa, Hiroaki; Okata, Yuichi; Iwade, Tamaki; Endo, Kosuke; Takemoto, Junkichi; Tamaki, Akihiko; Maeda, Kosaku			Severe acquired subglottic stenosis in children: analysis of clinical features and surgical outcomes based on the range of stenosis	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Acquired subglottic stenosis; Laryngotracheal stenosis; Laryngotracheal reconstruction; Children	CRICOTRACHEAL RESECTION; LARYNGOTRACHEAL RECONSTRUCTION; MANAGEMENT	Purpose The present study analyzed the clinical features and surgical outcomes of laryngotracheal reconstruction (LTR) in pediatric patients with severe acquired subglottic stenosis (SGS) based on the range of stenosis. The aim was to clarify the indications for LTR in severe acquired SGS. Methods The medical records of 33 pediatric patients with severe acquired SGS (Myer-Cotton grade III or IV) at our institution between January 1994 and December 2013 were retrospectively reviewed. Results Nine patients had stenosis localized at the subglottis (localized SGS), and twenty-four patients had stenosis extending to the glottis or supraglottis from the subglottis (extended SGS). 66.7 % (6/9) of localized SGS patients were intubated after infancy, and 95.8 % (22/23) of extended SGS patients were intubated in the neonatal period. The duration of intubation was significantly shorter with localized than with extended SGS. Sixteen patients underwent LTR. The operation-specific decannulation rate was 80.0 % (4/5) in the localized SGS group and 14.3 % (1/7) in the extended SGS group. Conclusion The range of stenosis was affected by the period and duration of endotracheal intubation. Surgical outcomes of LTR tended to differ between localized SGS and extended SGS. LTR can be effective for localized SGS.	[Morita, Keiichi; Yokoi, Akiko; Bitoh, Yuko; Fukuzawa, Hiroaki; Okata, Yuichi; Iwade, Tamaki; Endo, Kosuke; Takemoto, Junkichi; Tamaki, Akihiko; Maeda, Kosaku] Kobe Childrens Hosp, Dept Pediat Surg, Suma Ku, Kobe, Hyogo 6540081, Japan	Morita, K (reprint author), Kobe Childrens Hosp, Dept Pediat Surg, Suma Ku, 1-1-1 Takakuradai, Kobe, Hyogo 6540081, Japan.	morita_kch@hp.pref.hyogo.jp					COTTON RT, 1980, ANN OTO RHINOL LARYN, V89, P508; COTTON RT, 1985, J PEDIATR SURG, V20, P845, DOI 10.1016/S0022-3468(85)80053-1; FEARON B, 1972, ANN OTO RHINOL LARYN, V81, P508; George M, 2009, OTOLARYNG HEAD NECK, V141, P225, DOI 10.1016/j.otohns.2009.04.019; George M, 2010, J THORAC CARDIOV SUR, V139, P411, DOI 10.1016/j.jtcvs.2009.05.010; Hartley BEJ, 2000, CLIN OTOLARYNGOL, V25, P342, DOI 10.1046/j.1365-2273.2000.00399.x; Monnier P, 2009, INT J PEDIATR OTORHI, V73, P1217, DOI 10.1016/j.ijporl.2009.05.008; MYER CM, 1994, ANN OTO RHINOL LARYN, V103, P319; White DR, 2005, ARCH OTOLARYNGOL, V131, P896, DOI 10.1001/archotol.131.10.896; Yamamoto K, 2014, INT J PEDIATR OTORHI, V78, P1476, DOI 10.1016/j.ijporl.2014.06.012; Zaima A, 2010, J PEDIATR SURG, V45, P996, DOI 10.1016/j.jpedsurg.2010.02.035	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	OCT	2015	31	10					943	947		10.1007/s00383-015-3773-1		5	Pediatrics; Surgery	Pediatrics; Surgery	CR6BB	WOS:000361427000009		
J	Ieiri, S; Miyoshi, K; Nagata, K; Miyata, J; Kohashi, K; Oda, Y; Taguchi, T				Ieiri, Satoshi; Miyoshi, Kina; Nagata, Kouji; Miyata, Junko; Kohashi, Kennichi; Oda, Yoshinao; Taguchi, Tomoaki			Current clinical features in diagnosis and treatment for immaturity of ganglia in Japan: analysis from 10-year nationwide survey	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Allied disorders of Hirschsprung's disease; Immaturity of ganglia; Enterostomy; Pathological diagnosis	PSEUDO-HIRSCHSPRUNGS DISEASE; INTESTINAL PSEUDOOBSTRUCTION; HYPOGANGLIONOSIS	Background To identify the current clinical features in diagnosis and treatment for immaturity of ganglia (IG) in Japan, we retrospectively analyzed data for patients with IG from the nationwide surveys in Japan. This survey was performed by Japanese Study Group of allied disorders of Hirschsprung's disease (ADHD). Methods In primary research, data on totally 355 cases of ADHD were collected for 10 years (2001-2010). Fifteen patients were IG. All IG patients were confirmed by pathological examination. In secondary research, detail questionnaires were sent and collected. Results Male/female ratio was 9/6 and mean birth weight was 2474 g. All cases (100 %) were onset in neonatal period. Primary symptoms were abdominal distention (86.7 %), vomiting (53.3 %), and late egestion of meconium (26.7 %). An abnormal distention of intestine was recognized in 86.7 % on X-ray, and microcolon was recognized in 58.3 % on contrast enema. Caliber change was recognized in 58.3 % on laparotomy. An enterostomy was made in 13 patients (86.7 %), and an ileostomy was made in 69.2 %. Pathological diagnosis was performed in 100 %. Enterostomy was closed in 100 %. Conclusions Totally, 15 definitive cases of IG in 10 years were collected and analyzed. All cases were onset in the neonatal period and almost all underwent enterostomy, but no mortalities occurred.	[Ieiri, Satoshi; Miyoshi, Kina; Nagata, Kouji; Miyata, Junko; Taguchi, Tomoaki] Kyushu Univ, Fac Med Sci, Dept Pediat Surg Reprod & Dev Med, Higashi Ku, Fukuoka, Fukuoka 8128582, Japan; [Miyoshi, Kina; Kohashi, Kennichi; Oda, Yoshinao] Kyushu Univ, Fac Med, Dept Surg Pathol, Fukuoka, Fukuoka 8128582, Japan; [Ieiri, Satoshi; Taguchi, Tomoaki] Japanese Study Grp Allied Disorders Hirschsprungs, Fukuoka, Japan	Taguchi, T (reprint author), Kyushu Univ, Fac Med Sci, Dept Pediat Surg Reprod & Dev Med, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan.	taguchi@pedsurg.med.kyushu-u.ac.jp			Ministry of Health, Labor Sciences Research Grants	This study was supported by a grant from The Ministry of Health, Labor Sciences Research Grants for Research on intractable disease. The authors thank The Japanese Society of Pediatric Surgeons, The Japanese Society of Pediatric Nutrition, Gastroenterology and Nutrition, and The Japanese Study Group of Pediatric Constipation. They also thank Dr. Brian Quinn for reading the manuscript, and Ms. Masutomi and Ms. Yamazaki of Department of Pediatric Surgery, Kyushu University, for their help in processing the data.	Park SH, 2005, AM J SURG PATHOL, V29, P1017; Taguchi T, 2006, J PEDIATR SURG, V41, P2046, DOI 10.1016/j.jpedsurg.2006.08.004; Taguchi T, 2014, PEDIATR SURG INT, V30, P815, DOI 10.1007/s00383-014-3542-6; Desmet AS, 2014, NEUROGASTROENT MOTIL, V26, P1131, DOI 10.1111/nmo.12371; Ohkubo H, 2013, AM J GASTROENTEROL, V108, P1130, DOI 10.1038/ajg.2013.57; BENTLEY J. F. R., 1966, ARCH DIS CHILDHOOD, V41, P143; Burki T, 2011, PEDIATR SURG INT, V27, P487, DOI 10.1007/s00383-010-2850-8; Kelleher J, 2008, HIRSCHSPRUNGS DIS AL, V3rd, P145, DOI 10.1007/978-3-540-33935-9_11; Muto M, 2014, J PEDIATR SURG, V12, P1799; Okamoto E, 1996, PSEUDO HIRSCHSPRUNGS; Puri P, 1997, J PEDIATR SURG, V32, P149, DOI 10.1016/S0022-3468(97)90170-6; RAVITCH MM, 1958, ANN SURG, V147, P781; Sumiyama K, 2012, GASTROENTEROLOGY, V143, P1152, DOI 10.1053/j.gastro.2012.09.001; Toyosaka A, 1993, Clin Auton Res, V3, P243, DOI 10.1007/BF01829013; Toyosaka A1, 1994, IMMATURITY MYENTERIC, V4, P175; Watanabe Y, 2013, PEDIATR SURG INT, V29, P1127, DOI 10.1007/s00383-013-3378-5; Watanabe Y, 2015, SURG TODAY	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	OCT	2015	31	10					949	954		10.1007/s00383-015-3774-0		6	Pediatrics; Surgery	Pediatrics; Surgery	CR6BB	WOS:000361427000010		
J	Yagi, M; Kohno, M; Asagiri, K; Ikeda, T; Okada, T; Kanada, S; Kawashima, S; Goto, Y; Takano, S; Yasufuku, M; Wada, M				Yagi, M.; Kohno, M.; Asagiri, K.; Ikeda, T.; Okada, T.; Kanada, S.; Kawashima, S.; Goto, Y.; Takano, S.; Yasufuku, M.; Wada, M.			Twenty-year trends in neonatal surgery based on a nationwide Japanese surveillance program	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Neonatal surgery; Nationwide surveillance; Japanese society of pediatric surgeons	CONGENITAL DIAPHRAGMATIC-HERNIA	To discuss the chronological changes observed in a national survey of neonatal surgery in Japan performed every 5 years by the Committee in the Japanese Society of Pediatric Surgeons. We analyzed the data obtained for 20 years from 1993 to 2013 and herein report the chronological changes. The number of summarized cases was least in 1993, with 2806 cases, and subsequently increased to 3753 cases in 2013. The mortality rate among the patients with maternal transport linearly decreased (p = 0.0386). Although the proportion of extremely low birth weight infants linearly increased (p = 0.0014), with an annual rate of +0.39 %, the mortality rate linearly decreased (p = 0.0010), with an annual rate of -1.68 %. Moreover, the overall mortality rate linearly decreased (p = 0.0002), with an annual rate of -0.26 %. Most diseases were observed to exhibit a decline in the mortality rate with the same trend as overall mortality. The decline in the mortality rate was most robust with respect to congenital diaphragmatic hernia (CDH). The mortality rates, except for that of CDH, omphalocele, esophageal atresia, and intestinal perforation, declined to 5 % or lower by 2013. The present findings may be the result of remarkable progress in perinatal management.	[Yagi, M.; Kohno, M.; Asagiri, K.; Ikeda, T.; Okada, T.; Kanada, S.; Kawashima, S.; Goto, Y.; Takano, S.; Yasufuku, M.; Wada, M.] Japanese Soc Pediat Surg, Comm Acad Survey & Adv Med Sci, Tokyo, Japan; [Yagi, M.] Kurume Univ, Sch Med, Dept Pediat Surg, Kururme City, Fukuoka 8300011, Japan	Yagi, M (reprint author), Japanese Soc Pediat Surg, Comm Acad Survey & Adv Med Sci, Tokyo, Japan.	yagimi@med.kurume-u.ac.jp					Agresti A, 1996, INTRO CATEGORICAL DA; Preston IR, 2005, RESP MED, V99, P1501, DOI 10.1016/j.rmed.2005.03.026; Chirdan LB, 2012, SEMIN PEDIATR SURG, V21, P151, DOI 10.1053/j.sempedsurg.2012.01.007; Boat AC, 2010, PEDIAT ANESTH, V21, P765; Catre Dora, 2013, Rev Bras Epidemiol, V16, P943, DOI 10.1590/S1415-790X2013000400014; Davidson A, 2012, PEDIATR ANESTH, V22, P570, DOI 10.1111/j.1460-9592.2012.03887.x; Deprest J, 2006, J PEDIATR SURG, V41, P423, DOI 10.1016/j.jpedsurg.2005.11.036; Faponle A F, 2004, East Afr Med J, V81, P568; Gangopadhyay AN, 2008, INDIAN J PEDIATR, V75, P1025, DOI 10.1007/s12098-008-0205-4; Lee EJ, 2012, J KOREAN ASS PEDIAT, V2006; Teresa M, 2006, ACTA PAEDIATR, V95, P1349, DOI 10.1080/08035250600615135; OECD, 2011, HLTH GLANC 2011; Taguchi T, 2008, SURG TODAY, V38, P379, DOI 10.1007/s00595-007-3657-7; Shew SB, 1999, J PEDIATR SURG, V34, P720; Ventura MT, 2010, ACTA MEDICA PORT, V23, P793	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	OCT	2015	31	10					955	962		10.1007/s00383-015-3775-z		8	Pediatrics; Surgery	Pediatrics; Surgery	CR6BB	WOS:000361427000011		
J	Jimbo, T; Ieiri, S; Obata, S; Uemura, M; Souzaki, R; Matsuoka, N; Katayama, T; Masumoto, K; Hashizume, M; Taguchi, T				Jimbo, Takahiro; Ieiri, Satoshi; Obata, Satoshi; Uemura, Munenori; Souzaki, Ryota; Matsuoka, Noriyuki; Katayama, Tamotsu; Masumoto, Kouji; Hashizume, Makoto; Taguchi, Tomoaki			Effectiveness of short-term endoscopic surgical skill training for young pediatric surgeons: a validation study using the laparoscopic fundoplication simulator	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Pediatric surgeon; Short-term training; Endoscopic surgery; Fundoplication model		Pediatric surgeons require highly advanced skills when performing endoscopic surgery; however, their experience is often limited in comparison to general surgeons. The aim of this study was to evaluate the effectiveness of endoscopic surgery training for less-experienced pediatric surgeons and then compare their skills before and after training. Young pediatric surgeons (n = 7) who participated in this study underwent a 2-day endoscopic skill training program, consisting of lectures, box training and live tissue training. The trainees performed the Nissen construction tasks before and after training using our objective evaluation system. A statistical analysis was conducted using the two-tailed paired Student's t tests. The time for task was 984 +/- A 220 s before training and 645 +/- A 92.8 s after training (p < 0.05). The total path length of both forceps was 37855 +/- A 10586 mm before training and 22582 +/- A 3045 mm after training (p < 0.05). The average velocity of both forceps was 26.1 +/- A 3.68 mm/s before training and 22.9 +/- A 2.47 mm/sec after training (p < 0.1). The right and left balance of suturing was improved after training (p < 0.05). Pediatric surgery trainees improved their surgical skills after receiving short-term training. We demonstrated the effectiveness of our training program, which utilized a new laparoscopic fundoplication simulator.	[Jimbo, Takahiro; Ieiri, Satoshi; Obata, Satoshi; Souzaki, Ryota; Taguchi, Tomoaki] Kyushu Univ, Fac Med Sci, Dept Pediat Surg Reprod & Dev Med, Fukuoka 812, Japan; [Ieiri, Satoshi; Uemura, Munenori; Souzaki, Ryota; Hashizume, Makoto] Kyushu Univ Hosp, Dept Adv Med & Innovat Technol, Fukuoka 812, Japan; [Jimbo, Takahiro; Masumoto, Kouji] Univ Tsukuba, Fac Med, Dept Pediat Surg, Tsukuba, Ibaraki, Japan; [Matsuoka, Noriyuki; Katayama, Tamotsu] Kyoto Kagaku Co Ltd, Kyoto, Japan	Ieiri, S (reprint author), Kyushu Univ, Fac Med Sci, Dept Pediat Surg Reprod & Dev Med, Fukuoka 812, Japan.	satoshi@med.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25293360, 26670765]; Japanese Foundation for Research and Promotion of Endoscopy (JFE); Japanese Consortium of Advanced Surgical Endoscopy (J-CASE)	We thank Brian Quinn for his helpful comments and assistance with the manuscript. This study was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS, No. 25293360 and No. 26670765), The Japanese Foundation for Research and Promotion of Endoscopy (JFE) and Japanese Consortium of Advanced Surgical Endoscopy (J-CASE).	ALAIN JL, 1991, SURG ENDOSC-ULTRAS, V5, P174, DOI 10.1007/BF02653256; Tanoue K, 2008, SURG ENDOSC, V22, P985, DOI 10.1007/s00464-007-9554-8; Barsness KA, 2014, J LAPAROENDOSC ADV A; Beyer-Berjot L, 2014, SURGERY, V156, P676, DOI 10.1016/j.surg.2014.04.044; HOLCOMB GW, 1991, J PEDIATR SURG, V26, P1186, DOI 10.1016/0022-3468(91)90330-V; Ieiri S, 2010, PEDIATR SURG INT, V26, P947, DOI 10.1007/s00383-010-2665-7; Iwanaka T, 2004, J PEDIATR SURG, V39, P1838, DOI 10.1016/j.jpedsurg.2004.08.011; Obata S, 2015, J LAPAROEND IN PRESS; Singh P, 2014, ANN SURG; Takazawa S, 2014, J LAPAROENDOSC ADV A	10	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	OCT	2015	31	10					963	969		10.1007/s00383-015-3776-y		7	Pediatrics; Surgery	Pediatrics; Surgery	CR6BB	WOS:000361427000012		
J	Ieiri, S; Jimbo, T; Koreeda, Y; Obata, S; Uemura, M; Souzaki, R; Kobayashi, Y; Fujie, M; Hashizume, M; Taguchi, T				Ieiri, Satoshi; Jimbo, Takahiro; Koreeda, Yuta; Obata, Satoshi; Uemura, Munenori; Souzaki, Ryota; Kobayashi, Yo; Fujie, Masakatsu G.; Hashizume, Makoto; Taguchi, Tomoaki			The effect of forceps manipulation for expert pediatric surgeons using an endoscopic pseudo-viewpoint alternating system: the phenomenon of economical slow and fast performance in endoscopic surgery	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Pseudo-viewpoint alternation system; Expert surgeon; Fundoplication; Forceps manipulation	MODEL	Endoscopic surgery is performed under a horizontal view in comparison to the vertical view that is associated with open surgery. We developed an endoscopic pseudo-viewpoint alternation system with out any scope action. We investigate the effect of this novel system on forceps manipulation among expert pediatric surgeons. Six expert pediatric surgeons performed a Nissen wrap in a fundoplication simulator either with or without this system. The constructed Nissen wrap was evaluated. The total path length and the average velocity of the forceps were also analyzed. The times required either with or without this system were 587.5 +/- A 122.7 and 634.0 +/- A 212.4 s (p = 0.45), respectively. The total path lengths of right and left forceps either with or without this system were 12,309 +/- A 2495.5 and 15,726 +/- A 5649.6 mm (p = 0.07), 10,091 +/- A 2439.2 and 12,575 +/- A 5511.1 mm (p = 0.11), respectively. The average velocity of the right and left forceps with or without this system were 26.9 +/- A 5.29 and 31.6 +/- A 1.62 mm/s (p = 0.04), 21.6 +/- A 2.48 and 25.5 +/- A 6.48 mm/s (p = 0.15), respectively. There was no significance in the suture balance and suture interval. The endoscopic pseudo-viewpoint alternation system thus made it possible for expert pediatric surgeons to carry out slow and economical forceps manipulation. These effects make it possible for surgeons to perform safe and precise surgery, thus leading to a shortening of operation time.	[Jimbo, Takahiro; Obata, Satoshi; Taguchi, Tomoaki] Kyushu Univ, Dept Pediat Surg Reprod & Dev Med, Fac Med Sci, Fukuoka, Fukuoka 8128582, Japan; [Ieiri, Satoshi; Uemura, Munenori; Souzaki, Ryota; Hashizume, Makoto] Kyushu Univ Hosp, Dept Adv Med & Innovat Technol, Fukuoka, Japan; [Koreeda, Yuta; Kobayashi, Yo; Fujie, Masakatsu G.] Waseda Univ, Fac Engn, Tokyo, Japan	Ieiri, S (reprint author), Kyushu Univ Hosp, Dept Adv Med & Innovat Technol, Fukuoka, Japan.	satoshi@med.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25293360, 26670765]; JFE (The Japanese Foundation for Research and Promotion of Endoscopy); J-CASE (Japanese Consortium of Advanced Surgical Endoscopy)	We thank Brian Quinn for his comments and help with the manuscript. This study was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS, No. 25293360, and No. 26670765), JFE (The Japanese Foundation for Research and Promotion of Endoscopy) and J-CASE (Japanese Consortium of Advanced Surgical Endoscopy).	Tanoue K, 2008, SURG ENDOSC, V22, P985, DOI 10.1007/s00464-007-9554-8; Barsness KA, 2015, J LAPAROENDOSC ADV S, V25, P599, DOI 10.1089/lap.2014.0370; Barsness KA, 2015, J LAPAROENDOSC ADV S, V25, P429, DOI 10.1089/lap.2014.0364; Barsness KA, 2015, J LAPAROENDOSC ADV S, V25, P256, DOI 10.1089/lap.2014.0358; Hashizume M, 2013, FUNDAMENTAL SKILL TR; Ieiri S, 2010, PEDIATR SURG INT, V26, P947, DOI 10.1007/s00383-010-2665-7; Ieiri S, 2013, PEDIATR SURG INT, V29, P501, DOI 10.1007/s00383-013-3276-x; Iwanaka T, 2011, PEDIATR SURG INT, V27, P727, DOI 10.1007/s00383-011-2871-y; Koreeda Y, 2015, INT J COMPUT ASS RAD, V10, P619, DOI 10.1007/s11548-014-1083-z; Uemura M, 2015, SURG ENDOSC, V29, P444, DOI 10.1007/s00464-014-3681-9; Uemura M, 2014, J SURG RES, V188, P8, DOI 10.1016/j.jss.2013.12.009	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	OCT	2015	31	10					971	976		10.1007/s00383-015-3777-x		6	Pediatrics; Surgery	Pediatrics; Surgery	CR6BB	WOS:000361427000013		
J	Okawada, M; Shibuya, S; Doi, T; Miyano, G; Koga, H; Lane, GJ; Okazaki, T; Yamataka, A				Okawada, Manabu; Shibuya, Soichi; Doi, Takashi; Miyano, Go; Koga, Hiroyuki; Lane, Geoffrey J.; Okazaki, Tadaharu; Yamataka, Atsuyuki			Ureteric patency after Deflux(A (R)) injection for the treatment of vesicoureteric reflux in children confirmed by a novel epidural catheter-assisted endoscopic technique	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Vesicoureteral reflux; Deflux (R); Epidural catheter	DEXTRANOMER/HYALURONIC ACID COPOLYMER; OBSTRUCTION	We present EDCAT (epidural catheter-assisted Deflux(A (R)) treatment) for treating vesicoureteral reflux (VUR) and confirming ureteric patency after Deflux(A (R)) treatment. We treated 147 ureters in 101 children (M:F 62:39; VUR a parts per thousand currency sign grade III: n = 72; VUR a parts per thousand yen grade IV: n = 75) using EDCAT between 2011 and 2014. EDCAT involves injecting 1-3 mL of diluted indigo carmine solution through an epidural anesthesia catheter inserted into the Deflux(A (R))-treated ureter and observing for up to 15 min to confirm patency. For EDCAT, mean age was 4.9 years and mean operative time was 30.1 +/- A 12.1 min; overall cure of VUR after initial treatment was 87.7 % for VUR grades I-V, 88.9 % for VUR a parts per thousand currency sign grade III, and 86.6 % for VUR a parts per thousand yen grade IV; VUR was cured in 129/147 after 1 treatment, 7/18 after 2 treatments, 7/11 after 3 treatments, and persistent in 4/4. We experienced 1 case of obstruction after an EDCAT catheter was removed before confirming patency. EDCAT catheters were left overnight in 2 ureters in 2 cases when patency could not be confirmed after 15 min to prevent obstruction. Both did not develop obstruction. Four ureters with recurrence of VUR (all grade a parts per thousand currency sign II) are being observed. EDCAT allows ureteric patency to be confirmed immediately and prevents obstruction.	[Okawada, Manabu; Shibuya, Soichi; Doi, Takashi; Miyano, Go; Koga, Hiroyuki; Lane, Geoffrey J.; Okazaki, Tadaharu; Yamataka, Atsuyuki] Juntendo Univ, Dept Pediat Gen & Urogenital Surg, Sch Med, Bunkyo Ku, Tokyo 1138421, Japan	Okawada, M (reprint author), Juntendo Univ, Dept Pediat Gen & Urogenital Surg, Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	manabu-o@juntendo.ac.jp					Alizadeh F, 2013, J PEDIATR UROL, V9, P488, DOI 10.1016/j.jpurol.2012.11.007; Peters CA, 2010, J UROLOGY, V184, P1134, DOI 10.1016/j.juro.2010.05.065; Skoog SJ, 2010, J UROLOGY, V184, P1145, DOI 10.1016/j.juro.2010.05.066; Kirsch AJ, 2004, J UROLOGY, V171, P2413, DOI 10.1097/01.ju.0000127754.79866.7f; Cerwinka Wolfgang H., 2008, Archivos Espanoles de Urologia, V61, P882; Kaye JD, 2012, J PEDIATR UROL, V8, P297, DOI 10.1016/j.jpurol.2011.02.006; BURBIGE KA, 1991, J UROLOGY, V146, P1352; Capozza N, 2008, Arch Esp Urol, V61, P254; Fujimoto T, 2012, PEDIATR SURG INT, V28, P847, DOI 10.1007/s00383-012-3135-1; Garcia-Aparicio L, 2013, J PEDIATR UROL, V9, P493, DOI 10.1016/j.jpurol.2013.02.007; Kirsch AJ, 2014, UROLOGY, V84, P462, DOI 10.1016/j.urology.2014.04.032; Kirsch AJ, 2003, J UROLOGY, V170, P211, DOI 10.1097/01.ju.0000072523.43060.a0; Routh JC, 2010, PEDIATRICS, V125, P1010, DOI 10.1542/peds.2009-2225; Rubenwolf PC, 2013, UROLOGY, V81, P659, DOI 10.1016/j.urology.2012.11.044	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	OCT	2015	31	10					977	982		10.1007/s00383-015-3778-9		6	Pediatrics; Surgery	Pediatrics; Surgery	CR6BB	WOS:000361427000014		
J	Urushihara, N; Fukumoto, K; Nouso, H; Yamoto, M; Miyake, H; Kaneshiro, M; Koyama, M; Nakajima, H				Urushihara, Naoto; Fukumoto, Koji; Nouso, Hiroshi; Yamoto, Masaya; Miyake, Hiromu; Kaneshiro, Masakatsu; Koyama, Mariko; Nakajima, Hideaki			Hepatic ductoplasty and hepaticojejunostomy to treat narrow common hepatic duct during laparoscopic surgery for choledochal cyst	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Choledochal cyst; Laparoscopy; Hepaticojejunostomy; Narrow hepatic duct; Ductoplasty	MANAGEMENT; EXCISION; OUTCOMES	We describe a novel technique for laparoscopic hepatic ductoplasty and hepaticojejunostomy in choledochal cyst with a narrow common hepatic duct. After complete cyst excision, a longitudinal incision was made in the anterior wall of the narrow common hepatic duct to enlarge the anastomotic opening. Next, the anterior wall was everted, then anchored to the hepatic hilum by suturing. Anchoring of the anterior wall provided a good field of view for creating the anastomosis, and the lumen of the anastomotic region was also secured. We believe that our technique is feasible and useful when the duct size is small.	[Urushihara, Naoto; Fukumoto, Koji; Nouso, Hiroshi; Yamoto, Masaya; Miyake, Hiromu; Kaneshiro, Masakatsu; Koyama, Mariko; Nakajima, Hideaki] Shizuoka Childrens Hosp, Dept Pediat Surg, Aoi Ku, Shizuoka 4208660, Japan	Urushihara, N (reprint author), Shizuoka Childrens Hosp, Dept Pediat Surg, Aoi Ku, 860 Urushiyama, Shizuoka 4208660, Japan.	n-urushihara@i.shizuoka-pho.jp					Palanivelu C, 2008, J AM COLL SURGEONS, V207, P839, DOI 10.1016/j.jamcollsurg.2008.08.004; Urushihara N, 2012, J PEDIATR SURG, V47, P2169, DOI 10.1016/j.jpedsurg.2012.09.001; Diao M, 2013, PEDIATR SURG INT, V29, P317, DOI 10.1007/s00383-013-3266-z; Jung K, 2012, KOREAN J RADIOL, V13, P112; Li SL, 2014, PEDIATR SURG INT, V30, P593, DOI 10.1007/s00383-014-3501-2; Morotomi Y, 1995, PEDIAT SURG INT, V11, P58; Tang ST, 2011, SURG ENDOSC, V25, P416, DOI 10.1007/s00464-010-1183-y; Thanh LN, 2010, J PEDIATR SURG, V45, P540, DOI 10.1016/j.jpedsurg.2009.08.013; Urushihara N, 2011, J LAPAROENDOSC ADV S, V21, P361, DOI 10.1089/lap.2010.0373	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	OCT	2015	31	10					983	986		10.1007/s00383-015-3779-8		4	Pediatrics; Surgery	Pediatrics; Surgery	CR6BB	WOS:000361427000015		
J	Ise, K; Kano, M; Yamashita, M; Ishii, S; Shimizu, H; Nakayama, K; Gotoh, M				Ise, Kazuya; Kano, Makoto; Yamashita, Michitoshi; Ishii, Show; Shimizu, Hirofumi; Nakayama, Kei; Gotoh, Mitsukazu			Surgical closure of the larynx for intractable aspiration pneumonia: cannula-free care and minimizing the risk of developing trachea-innominate artery fistula	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Aspiration pneumonia; Laryngotracheal separation; Trachea-innominate artery fistula; Surgical closure of the larynx	LARYNGOTRACHEAL SEPARATION; TRACHEOESOPHAGEAL DIVERSION	There is a risk of developing a fatal trachea-innominate artery fistula following laryngotracheal separation for the prevention of intractable aspiration pneumonia. We developed a novel technique of surgical closure of the larynx to avoid this complication and provide long-term cannula-free care.	[Ise, Kazuya; Yamashita, Michitoshi; Ishii, Show; Shimizu, Hirofumi; Nakayama, Kei; Gotoh, Mitsukazu] Fukushima Med Univ, Pediat Surg, Fukushima 9601295, Japan; [Kano, Makoto] Ohara Gen Hosp, Dept Otorhinolaryngol Head & Neck, Fukushima 9608611, Japan	Ise, K (reprint author), Fukushima Med Univ, Pediat Surg, 1 Hikarigaoka, Fukushima 9601295, Japan.	kise@fmu.ac.jp					GELMAN JJ, 1994, J AM COLL SURGEONS, V179, P626; EISELE DW, 1988, ANN OTO RHINOL LARYN, V97, P471; Zocratto OB, 2011, DYSPHAGIA, V26, P144, DOI 10.1007/s00455-010-9284-2; LINDEMAN RC, 1975, LARYNGOSCOPE, V85, P157, DOI 10.1288/00005537-197501000-00012; EISELE DW, 1989, AM J SURG, V157, P230, DOI 10.1016/0002-9610(89)90534-5; Fukumoto K, 2011, PEDIATR SURG INT, V27, P67, DOI 10.1007/s00383-010-2710-6; KOSSOWSKA E, 1980, INT J PEDIATR OTORHI, V2, P301, DOI 10.1016/0165-5876(80)90035-X; Miyake N, 2013, ANN OTO RHINOL LARYN, V122, P427; Ninomiya H, 2008, LARYNGOSCOPE, V118, P958, DOI 10.1097/MLG.0b013e3181677095; Sato K, 2006, J LARYNGOL OTOL, V120, P759, DOI 10.1017/S002221510600140X; Schaefer O P, 1995, J Intensive Care Med, V10, P64; Ssto H, 2012, J PEDIATR SURG, V47, P341, DOI [10.1016/j.jpedsurg.2011.11.029, DOI 10.1016/J.JPEDSURG.2011.11.029]; Takano S, 2012, LARYNGOSCOPE, V122, P1273, DOI 10.1002/lary.23306; Takano Y, 1999, CHEST, V116, P1251, DOI 10.1378/chest.116.5.1251; Tatekawa Y, 2010, PEDIATR SURG INT, V26, P553, DOI 10.1007/s00383-010-2567-8; LINDEMAN RC, 1976, ANN OTO RHINOL LARYN, V85, P609	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	OCT	2015	31	10					987	990		10.1007/s00383-015-3780-2		4	Pediatrics; Surgery	Pediatrics; Surgery	CR6BB	WOS:000361427000016		
J	Koga, H; Okawada, M; Doi, T; Miyano, G; Lane, GJ; Yamataka, A				Koga, Hiroyuki; Okawada, Manabu; Doi, Takashi; Miyano, Go; Lane, Geoffrey J.; Yamataka, Atsuyuki			Refining the intraoperative measurement of the distal intrapancreatic part of a choledochal cyst during laparoscopic repair allows near total excision	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Choledochal cyst; Intrapancreatic choledochal cyst; Postoperative pancreatitis; Postoperative stone formation	CHILDREN; SURGERY	During surgery for choledochal cyst (CC), any intrapancreatic CC (IPCC) must also be excised to prevent postoperative pancreatitis and stone formation. We report our technique for laparoscopic total IPCC excision (n = 16; mean age 6.0 years). We insert a fine ureteroscope with a light source into the opened CC through an extra 3.9-mm trocar placed in the epigastrium through a minute incision to identify the pancreatic duct orifice. By pulling the end of the ureteroscope emerging from the trocar gently to withdraw the tip from the pancreatic duct to where distal dissection was ceased under laparoscopic view, the IPCC can be measured. If longer than 5 mm, the distal CC is dissected further caudally until it is less than 5 mm. For accuracy, the distal CC is elevated with a suture that is exteriorized and clamped to provide constant traction. The IPCC was able to be measured in 11/16 (68 %). Initial lengths measured were 3-10 mm (5.2 +/- A 2.7 mm). Final IPCC were all 5 mm or less. Surgery was uncomplicated without any pancreatic duct injury and postoperative recovery was unremarkable. Follow-up MRI at 32 months showed no IPCC in any case. Measuring the IPCC enables total CC excision, thus reducing the potential for postoperative complications.	[Koga, Hiroyuki; Okawada, Manabu; Doi, Takashi; Miyano, Go; Lane, Geoffrey J.; Yamataka, Atsuyuki] Juntendo Univ, Sch Med, Dept Pediat Gen & Urogenital Surg, Bunkyo Ku, Tokyo 1138421, Japan	Koga, H (reprint author), Juntendo Univ, Sch Med, Dept Pediat Gen & Urogenital Surg, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	h-koga@juntendo.ac.jp			Japanese Foundation for Research and Promotion of Endoscopy (JFE) grant	This work was supported by a Japanese Foundation for Research and Promotion of Endoscopy (JFE) grant.	Ando H, 1996, J AM COLL SURGEONS, V183, P317; FARELLO GA, 1995, SURG LAPAROSC ENDOSC, V5, P354; Takeshita N, 2011, ANN SURG, V254, P1050, DOI 10.1097/SLA.0b013e3182243550; Ure BM, 2005, SURG ENDOSC, V19, P1055, DOI 10.1007/s00464-004-2191-6; Takahashi T, 2010, J PEDIATR SURG, V45, P379, DOI 10.1016/j.jpedsurg.2009.10.083; Hong L, 2008, EUR J PEDIATR SURG, V18, P67, DOI 10.1055/s-2008-1038486; Koga H, 2010, J PEDIATR SURG, V45, P397, DOI 10.1016/j.jpedsurg.2009.10.085; Laje P, 2007, J LAPAROENDOSC ADV S, V17, P519, DOI 10.1089/lap.2006.0121; Lee KH, 2009, PEDIATR SURG INT, V25, P355, DOI 10.1007/s00383-009-2343-9; Li Long, 2004, J Pediatr Surg, V39, P1663, DOI 10.1016/j.jpedsurg.2004.07.012; Mabrut JY, 2007, SURGERY, V141, P187, DOI 10.1016/j.surg.2006.06.029; Miyano G, 2011, PEDIATR SURG INT, V27, P463, DOI 10.1007/s00383-010-2846-4	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	OCT	2015	31	10					991	994		10.1007/s00383-015-3781-1		4	Pediatrics; Surgery	Pediatrics; Surgery	CR6BB	WOS:000361427000017		
J	Shibuya, S; Takamizawa, S; Hatata, T; Komori, K; Ogiso, Y; Yoshizawa, K; Yoshizawa, K				Shibuya, Soichi; Takamizawa, Shigeru; Hatata, Tomoko; Komori, Kazutoshi; Ogiso, Yoshifumi; Yoshizawa, Katsumi; Yoshizawa, Kazuki			Extraosseous Ewing sarcoma in the mesentery: the first report of cases in children	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Ewing sarcoma; Mesenteric tumor; Mesenteric lymphangioma; Abdominal mass	NEUROECTODERMAL TUMOR; FAMILY; MESOCOLON; ADULTS	Extraosseous ewing sarcoma (EES) is a rare soft-tissue tumor usually found in the extremities or paraspinal region. We describe the case of a 4-year-old boy with a large cystic mass in the mesentery diagnosed as mesenteric lymphangioma preoperatively and as EES after partial resection and histopathological examination. EES in the mesentery is extremely rare, with only 2 reports described in the English literature. This represents the first report of EES in a child.	[Shibuya, Soichi; Takamizawa, Shigeru; Hatata, Tomoko; Yoshizawa, Katsumi; Yoshizawa, Kazuki] Nagano Childrens Hosp, Dept Surg, Nagano 3998288, Japan; [Komori, Kazutoshi] Nagano Childrens Hosp, Dept Oncol, Nagano 3998288, Japan; [Ogiso, Yoshifumi] Nagano Childrens Hosp, Dept Pathol, Nagano 3998288, Japan	Shibuya, S (reprint author), Nagano Childrens Hosp, Dept Surg, 3100 Toyoshina, Nagano 3998288, Japan.	soshibu@juntendo.ac.jp					Almeida MF, 2014, CASE REP RADIOL, V2014; Ahmad R, 1999, CANCER, V85, P725, DOI 10.1002/(SICI)1097-0142(19990201)85:3<725::AID-CNCR23>3.0.CO;2-2; Kimber C, 1998, J PEDIATR SURG, V33, P39, DOI 10.1016/S0022-3468(98)90357-8; Subbiah V, 2009, CURR TREAT OPTION ON, V10, P126, DOI 10.1007/s11864-009-0104-6; Carpentieri DF, 2005, ARCH PATHOL LAB MED, V129, P866; Yock TI, 2006, J CLIN ONCOL, V24, P3838, DOI 10.1200/JCO.2006.05.9188; Charny CK, 2000, J PEDIATR SURG, V35, P1356, DOI 10.1053/jpsu.2000.9333; Fletcher JA, 1998, J CLIN ONCOL, V16, P1241; Geens Lisanne, 2013, Case Rep Oncol, V6, P293, DOI 10.1159/000351836; Javery O, 2011, AM J ROENTGENOL, V197, pW1015, DOI 10.2214/AJR.11.6667; Keir ST, 2012, PEDIATR BLOOD CANCER, V59, P586, DOI 10.1002/pbc.24016; Laurence V, 2005, AM J CLIN ONCOL-CANC, V28, P301, DOI 10.1097/01.coc.0000156921.28880.e1; Maisonnette F, 2007, GASTROEN CLIN BIOL, V31, P552, DOI 10.1016/S0399-8320(07)89427-9; Murphey MD, 2013, RADIOGRAPHICS, V33, P803, DOI 10.1148/rg.333135005; Turkyilmaz Z, 2012, J PEDIATR SURG, V47, pE1, DOI 10.1016/j.jpedsurg.2012.04.009; Xie Chun-Fang, 2010, Chin J Cancer, V29, P420	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	OCT	2015	31	10					995	999		10.1007/s00383-015-3782-0		5	Pediatrics; Surgery	Pediatrics; Surgery	CR6BB	WOS:000361427000018		
J	Yonekura, T; Kamiyama, M; Kimura, K; Morishita, Y; Yamauchi, K; Ishii, T; Yamaguti, K; Yokoyama, S; Yane, K; Ueda, Y				Yonekura, Takeo; Kamiyama, Masafumi; Kimura, Kouki; Morishita, Yuji; Yamauchi, Katsuji; Ishii, Tomohiro; Yamaguti, Kazue; Yokoyama, Shinya; Yane, Katunari; Ueda, Yoshio			Anterior mediastinal tracheostomy with a median mandibular splitting approach in a Larsen syndrome patient with posterior cervical arthrodesis	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Anterior mediastinal tracheostomy; Larsen syndrome; Median mandibular splitting approach; Posterior cervical arthrodesis	EXENTERATION; MUTATIONS	Larsen syndrome is a rare congenital connective tissue disorder characterized by multiple joint dislocations. A novel anterior mediastinal tracheostomy with a median mandibular splitting approach is presented for the treatment of airway obstruction in a Larsen syndrome patient with posterior cervical arthrodesis.	[Yonekura, Takeo; Kamiyama, Masafumi; Kimura, Kouki; Morishita, Yuji; Yamauchi, Katsuji; Ishii, Tomohiro] Kindai Univ, Nara Hosp, Fac Med, Dept Pediat Surg, Nara 6300293, Japan; [Yamaguti, Kazue] Kindai Univ, Nara Hosp, Fac Med, Dept Oral Surg, Nara 6300293, Japan; [Yokoyama, Shinya] Kindai Univ, Nara Hosp, Fac Med, Dept Cardiovasc Surg, Nara 6300293, Japan; [Yane, Katunari] Kindai Univ, Nara Hosp, Fac Med, Dept Otorhinolaryngol, Nara 6300293, Japan; [Ueda, Yoshio] Kindai Univ, Nara Hosp, Fac Med, Dept Plast Surg, Nara 6300293, Japan	Yonekura, T (reprint author), Kindai Univ, Nara Hosp, Fac Med, Dept Pediat Surg, 1248-1 Otuda Chou, Nara 6300293, Japan.	yonekura@nara.med.kindai.ac.jp					Berthet JP, 2014, ANN THORAC SURG, V98, P1026, DOI 10.1016/j.athoracsur.2014.04.103; Bicknell LS, 2007, J MED GENET, V44, P89, DOI 10.1136/jmg.2006.043687; Conti M, 2010, ANN THORAC SURG, V89, P1588, DOI 10.1016/j.athoracsur.2010.01.044; Gomez-Caro A, 2007, ANN THORAC SURG, V84, P1777, DOI 10.1016/j.athoracsur.2007.08.002; GRILLO HC, 1966, J THORAC CARDIOV SUR, V51, P422; GRILLO HC, 1990, ANN THORAC SURG, V49, P401; Hiromasa K, 2012, OR SURG OR MED OR PA, V114, pE12, DOI 10.1016/j.oooo.2011.08.014; Johnson JT, 1999, OPERATIVE OTOLARYNGO, V1, P294; Johnston CE, 1996, J BONE JOINT SURG AM, V78A, P538; Krakow D, 2004, NAT GENET, V36, P405, DOI 10.1038/ng1319; Martinod E, 2011, INTERACT CARDIOV TH, V12, P672, DOI 10.1510/icvts.2010.260588; ORRINGER MB, 1992, ANN THORAC SURG, V54, P628	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	OCT	2015	31	10					1001	1004		10.1007/s00383-015-3783-z		4	Pediatrics; Surgery	Pediatrics; Surgery	CR6BB	WOS:000361427000019		
J	da Silva, JAT; Tsavkelova, EA; Ng, TB; Parthibhan, S; Dobranszki, J; Cardoso, JC; Rao, MV; Zeng, SJ				da Silva, Jaime A. Teixeira; Tsavkelova, Elena A.; Tzi Bun Ng; Parthibhan, S.; Dobranszki, Judit; Cardoso, Jean Carlos; Rao, M. V.; Zeng, Songjun			Asymbiotic in vitro seed propagation of Dendrobium	PLANT CELL REPORTS			English	Review						Asymbiotic seed germination; Dendrobium propagation; Explant age; Lighting conditions; Organic and inorganic media components; Orchidaceae	PROTOCORM-LIKE BODIES; GREEN POD CULTURE; NUTRIENT-REQUIREMENTS; CARBOHYDRATE SOURCES; TERRESTRIAL ORCHID; GERMINATION; MICROPROPAGATION; GROWTH; MEDICINE; BIOTECHNOLOGY	The ability to germinate orchids from seeds in vitro presents a useful and viable method for the propagation of valuable germplasm, maintaining the genetic heterogeneity inherent in seeds. Given the ornamental and medicinal importance of many species within the genus Dendrobium, this review explores in vitro techniques for their asymbiotic seed germination. The influence of abiotic factors (such as temperature and light), methods of sterilization, composition of basal media, and supplementation with organic additives and plant growth regulators are discussed in context to achieve successful seed germination, protocorm formation, and further seedling growth and development. This review provides both a basis for the selection of optimal conditions, and a platform for the discovery of better ones, that would allow the development of new protocols and the exploration of new hypotheses for germination and conservation of Dendrobium seeds and seedlings.	[Tsavkelova, Elena A.] Moscow MV Lomonosov State Univ, Fac Biol, Dept Microbiol, Moscow 119234, Russia; [Tzi Bun Ng] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Tzi Bun Ng] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Parthibhan, S.; Rao, M. V.] Bharathidasan Univ, Dept Plant Sci, Tiruchchirappalli 620024, Tamil Nadu, India; [Dobranszki, Judit] Univ Debrecen, Res Inst Nyiregyhaza, H-4400 Nyiregyhaza, Hungary; [Cardoso, Jean Carlos] Univ Fed Sao Carlos, Ctr Ciencias Agr, Dept Rural Dev, BR-13600970 Araras City, Brazil; [Zeng, Songjun] Chinese Acad Sci, South China Bot Garden, Key Lab South China Agr Plant Mol Anal & Gene Imp, Guangzhou 510650, Guangdong, Peoples R China	da Silva, JAT (reprint author), POB 7,Miki Cho Post Off,3011-2, Kagawa 7610799, Japan.	jaimetex@yahoo.com; tsavkelova@mail.ru; b021770@mailserv.cuhk.edu.hk; thibhan@gmail.com; dobranszki@freemail.hu; jeancardosoctv@gmail.com; mvrao_456@yahoo.co.in; zengsongjun@scib.ac.cn					Alam MK, 2002, BIOTECHNOLOGY, V1, P111; Ali MJ, 2011, P UMTAS 2011 U MAL S, P770; Alvarez-Pardo V. M., 2006, Horticultura Brasileira, V24, P217, DOI 10.1590/S0102-05362006000200019; Bulpitt CJ, 2007, J ROY SOC MED, V100, P558, DOI 10.1258/jrsm.100.12.558; Vasudevan R, 2010, PLANT GROWTH REGUL, V60, P237, DOI 10.1007/s10725-009-9437-1; da Silva JAT, 2015, PLANT CELL REP, V34, P671, DOI 10.1007/s00299-015-1754-4; VACIN EF, 1949, BOT GAZ, V110, P605, DOI 10.1086/335561; Hossain MM, 2013, CRIT REV PLANT SCI, V32, P69, DOI 10.1080/07352689.2012.715984; Swarts ND, 2009, ANN BOT-LONDON, V104, P543, DOI 10.1093/aob/mcp025; Fay MF, 2009, ANN BOT-LONDON, V104, P359, DOI [10.1093/aob/mcp195, 10.1093/aob/mcp190]; Ng TB, 2012, APPL MICROBIOL BIOT, V93, P1795, DOI 10.1007/s00253-011-3829-7; Nambiar N, 2012, PLANT OMICS, V5, P10; Zeng SJ, 2012, SCI HORTIC-AMSTERDAM, V138, P198, DOI 10.1016/j.scienta.2012.02.026; Kananont N, 2010, SCI HORTIC-AMSTERDAM, V124, P239, DOI 10.1016/j.scienta.2009.11.019; ARDITTI J, 1967, BOT REV, V33, P1, DOI 10.1007/BF02858656; THIMIJAN RW, 1983, HORTSCIENCE, V18, P818; MITRA GC, 1976, INDIAN J EXP BIOL, V14, P350; Chugh S, 2009, SCI HORTIC-AMSTERDAM, V122, P507, DOI 10.1016/j.scienta.2009.07.016; CHU CC, 1975, SCI SINICA, V18, P659; Manz B, 2005, PLANT PHYSIOL, V138, P1538, DOI 10.1104/pp.105.061663; [Anonymous], 1962, PHYSIOL PLANTARUM, DOI DOI 10.1111/J.1399-3054.1962.TB08052.X; Arditti J., 1979, ADV BOT RES, V7, P421, DOI DOI 10.1016/S0065-2296(08)60091-9; Atichart Porntip, 2007, Asian Journal of Plant Sciences, V6, P1065; Bernard N, 1909, ANN SCI NATURELLES B, V9, P1; Buffa W, 2002, ECLET QUIM, V27, P403, DOI 10.1590/S0100-46702002000200033; Bulpitt CJ, 2005, QJM-INT J MED, V98, P625, DOI 10.1093/qjmed/hci094; Campos DM, 2002, ORQUIDEAS MANUAL PRA, P143; Cardoso JC, 2012, HORTIC BRAS, V30, P561, DOI 10.1590/S0102-05362012000300035; Chattopadhyay P, 2012, RES J BIOL, V2, P117; [陈之林 Chen Zhilin], 2004, [植物生理学通讯, Plant Physiology Communications], V40, P342; [崔秋华 Cui Qiuhua], 2012, [西北林学院学报, Journal of Northwest Forestry College], V27, P106; Curtis J, 1936, AM ORCHID SOC B, V5, P42; da Silva JAT, 2014, PLANT CELL TISS ORG, V119, P447, DOI 10.1007/s11240-014-0561-x; da Silva JAT, 2015, PLANTA, V242, P1, DOI 10.1007/s00425-015-2301-9; da Silva JAT, 2014, PLANT CELL REP, V33, P1413, DOI 10.1007/s00299-014-1631-6; Moraes C. P. de, 2010, Revista Brasileira de Biociências, V8, P225; Ding CC, 2004, TROP AGR SCI TECHNOL, V27, P10; Dohling Stadwelson, 2008, Proceedings of the Indian National Science Academy, V74, P167; Dressler Robert L., 2005, Selbyana, V26, P155; [杜刚 DU Gang], 2007, [中药材, Journal of Chinese Medicinal Materials], V30, P1207; Du G, 2012, N HORT, V8, P140; Dutta S, 2011, ASSAM U J SCI TECHNO, V7, P57; Ernst R, 1982, ORCHID BIOL REV PERS, VII, P350; Faria RT, 2004, SEMIN-CIENC AGRAR, V25, P309; Faria Ricardo T. de, 2004, Hortic. Bras., V22, P780, DOI 10.1590/S0102-05362004000400023; Ferreira WD, 2011, IN VITRO CELL DEV-PL, V47, P420, DOI 10.1007/s11627-010-9311-x; Fu ChuanMing, 2012, Guangxi Zhiwu / Guihaia, V32, P238; Galdiano-Junior RF, 2011, CIENTIFICA, V40, P28; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Gong JY, 2015, JIANGSU AGR SCI, V43, P184; Gu S, 2007, MOL ECOL NOTES, V7, P1166, DOI 10.1111/j.1471-8286.2007.01817.x; Guo S, 1990, J CHIN MAT MED, V15, P445; Hajong S, 2010, P INDIAN NATL SCI AC, V76, P1; HARVAIS G, 1972, CAN J BOTANY, V50, P1223; Hazarika RB, 1995, J ORCHID SOC INDIA, V9, P51; Hossain Mohammad Musharof, 2013, Plant Tissue Culture & Biotechnology, V23, P241; Hossain MM, 2013, J PLANT BIOCHEM BIOT, V22, P157, DOI 10.1007/s13562-012-0124-3; Hu Z, 1979, PLANTS, V3, P6; [霍丽丽 Huo Lili], 2010, [植物生理学通讯, Plant Physiology Communications], V46, P1269; Kabir MF, 2013, J ANIM PLANT SCI, V23, P1140; Kaewduangta W., 2011, American-Eurasian Journal of Agricultural & Environmental Sciences, V11, P117; Kamemoto H, 1999, BREEDING DENDROBIUM; Kauth PJ, 2008, FLORICULTURE ORNAMEN, V5, P375; Keel BG, 2011, CASTANEA, V76, P43, DOI 10.2179/09-054.1; Knop W, 1965, LANDW VERSTA, V7, P93; Knudson L, 1922, BOT GAZ, V73, P1, DOI 10.1086/332956; Knudson L, 1921, B REAL SOC ESPANOLA, V21, P250; Kong Q, 2007, INT J HORTIC SCI, V13, P61; Kuehnle AR, 2007, FLOWER BREEDING GENE, P539; Kumar K, 2006, FOLIA HORTIC, V18, P81; Kumar Pankaj, 2011, Taiwania, V56, P23; Lan YT, 2010, AGR SCI TECHNOL, V11, P89; Li C, 2013, N HORTIC, V6, P105; Lin Y, 2011, PLANT CELL TISS ORG, V105, P329, DOI 10.1007/s11240-010-9871-9; [刘石泉 LIU Shiquan], 2008, [亚热带植物科学, Subtropical Plant Science], V37, P57; Liu Zhong-Jian, 2011, Plant Science Journal, V29, P763, DOI 10.3724/SP.J.1142.2011.60763; Lo SF, 2004, IN VITRO CELL DEV, V40, P528; Lo SF, 2004, BIOL PHARM BULL, V27, P731, DOI 10.1248/bpb.27.731; Lone AB, 2008, SEMIN-CIENC AGRAR, V29, P755; Luo JP, 2009, SCI HORTIC-AMSTERDAM, V123, P258, DOI 10.1016/j.scienta.2009.08.008; Luo XQ, 2013, CHIN WILD PLANT RESO, V32, P47; McKendrick S, 2000, IN VITRO GERMINATION; Meng Y, 2012, J NANCHANG U NAT SCI, V36, P385; [莫昭展 MO Zhaozhan], 2007, [安徽农业科学, Journal of Anhui Agricultural Sciences], V35, P9568; Mweetwa AM, 2008, SCI HORTIC-AMSTERDAM, V117, P257, DOI 10.1016/j.scienta.2008.03.035; Ngampanya B, 2010, ACTA HORTIC, V878, P219; Nimoto DH, 1961, AM ORCHID SOC B, V30, P813; Nongdam P, 2014, SCI WORLD J, V2014; Parthibhan S., 2012, African Journal of Plant Science, V6, P383; Paul S, 2012, AOB PLANTS, DOI 10.1093/aobpla/plr032; Qian WenLin, 2013, Journal of Tropical and Subtropical Botany, V21, P240; Rasmussen HN, 1995, TERRESTRIAL ORCHIDS, P460; Roberts DL, 2008, CURR BIOL, V18, pR325, DOI 10.1016/j.cub.2008.02.026; Saiprasad GVS, 2004, SCI HORTIC-AMSTERDAM, V100, P161, DOI 10.1016/j.scienta.2003.08.017; Sharma R, 2005, J PLANT BIOL, V48, P253; Singh A, 2009, ETHNOBOTANICAL LEAFL, V13, P351; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Soares J. S., 2012, Revista Brasileira de Plantas Medicinais, V14, P617, DOI 10.1590/S1516-05722012000400007; Soares JS, 2013, HORTIC BRAS, V31, P63, DOI 10.1590/S0102-05362013000100010; Soares JS, 2014, ENCICLOPEDIA BIOSFER, V10, P1832; Song MKR, 1999, C BRASILEIRO FLORICU, V12, P110; Song XQ, 2004, J GHIZHOU NORMAL U N, V22, P13; Soundararajan T, 2009, THESIS BHARATH U IND, P191; Su Mei Ju, 2012, Cientifica (Jaboticabal), V40, P28; [孙永玉 SUN Yong-Yu], 2009, [植物生理学通讯, Plant Physiology Communications], V45, P1017; Sunitibala H, 2009, INDIAN J BIOTECHNOL, V8, P448; Swangmaneecharern P, 2012, SCI HORTIC-AMSTERDAM, V148, P55, DOI 10.1016/j.scienta.2012.09.013; [唐桂香 TANG Guixiang], 2005, [中国中药杂志, China Journal of Chinese Materia Medica], V30, P1583; Teixeira da Silva JA, 2013, FLORICULTURE ORNAMEN, V7, P1; da Silva JAT, 2014, SCI HORTIC-AMSTERDAM, V175, P74, DOI 10.1016/j.scienta.2014.05.008; TEIXEIRA DA SILVA J.A., 2012, ASIAN AUSTRALASIAN J, V6, P121; Thomale H, 1954, ORCHIDEEN; Udomdee W, 2014, PLANT GROWTH REGUL, V72, P249, DOI 10.1007/s10725-013-9856-x; Vendrame WA, 2008, HORTSCIENCE, V43, P264; Vijayakumar S, 2012, LANKESTERIANA, V12, P131; Vyas S, 2009, SCI HORTIC-AMSTERDAM, V121, P32, DOI 10.1016/j.scienta.2009.01.012; [王莲辉 WANG LianHui], 2007, [植物生理学通讯, Plant Physiology Communications], V43, P894; WOLTER KE, 1968, NATURE, V219, P509, DOI 10.1038/219509a0; [吴慧凤 Wu Huifeng], 2012, [生态学报, Acta Ecologica Sinica], V32, P2491; Xu YZ, 1984, PLANT PHYSL COMMUN, V4, P35; Yam TW, 2009, PLANT BIOTECHNOL REP, V3, P1, DOI 10.1007/s11816-008-0066-3; [杨念 YANG Nian], 2006, [植物生理学通讯, Plant Physiology Communications], V42, P248; Yang QG, 1989, CHINA J CHIN MAT MED, V14, P62; Yang QG, 1989, CHINA J CHIN MAT MED, V14, P19; YE X, 1988, Acta Botanica Yunnanica, V10, P285; [余乐 Yu Le], 2011, [福建林学院学报, Journal of Fujian College of Forestry], V31, P346; Zeng SJ, 2014, CRIT REV BIOTECHNOL, V34, P358, DOI 10.3109/07388551.2013.841117; Zeng SJ, 1998, ACTA HORTI SIN, V25, P75; Zeng SJ, 1996, J CHIN MED MAT, V19, P490; Zeng SJ, 2015, CRIT REV BIOTECHNOL, DOI [10.3109/07388551.2014.993585, DOI 10.3109/07388551.2014.993585]; Zhan QC, 2010, N HORTIC, V16, P137; Zhao Dake, 2013, Journal of Medicinal Plants Research, V7, P2098; Zhao MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072705; Zhou Yin, 2012, Journal of Shanghai Jiaotong University - Agricultural Science, V30, P62	134	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-7714	1432-203X		PLANT CELL REP	Plant Cell Reports	OCT	2015	34	10					1685	1706		10.1007/s00299-015-1829-2		22	Plant Sciences	Plant Sciences	CR6BF	WOS:000361427400002		
J	Mikami, M; Toki, S; Endo, M				Mikami, Masafumi; Toki, Seiichi; Endo, Masaki			Parameters affecting frequency of CRISPR/Cas9 mediated targeted mutagenesis in rice	PLANT CELL REPORTS			English	Article						CRISPR/Cas9; Genome editing; Targeted mutagenesis; Rice; Callus	RNA-GUIDED ENDONUCLEASE; CAS SYSTEM; ARABIDOPSIS-THALIANA; CRISPRCAS SYSTEM; PLANTS; TRANSFORMATION; SPECIFICITY; GENERATION; MUTATIONS; MULTIPLEX	Frequency of CRISPR/Cas9-mediated targeted mutagenesis varies depending on Cas9 expression level and culture period of rice callus. Recent reports have demonstrated that the CRISPR/Cas9 system can function as a sequence-specific nuclease in various plant species. Induction of mutation in proliferating tissue during embryogenesis or in germline cells is a practical means of generating heritable mutations. In the case of plant species in which cultured cells are used for transformation, non-chimeric plants can be obtained when regeneration occurs from mutated cells. Since plantlets are regenerated from both mutated and non-mutated cells in a random manner, any increment in the proportion of mutated cells in Cas9- and guide RNA (gRNA)-expressing cells will help increase the number of plants containing heritable mutations. In this study, we examined factors affecting mutation frequency in rice calli. Following sequential transformation of rice calli with Cas9- and gRNA- expression constructs, the mutation frequency in independent Cas9 transgenic lines was analyzed. A positive correlation between Cas9 expression level and mutation frequency was found. This positive relationship was observed regardless of whether the transgene or an endogenous gene was used as the target for CRISPR/Cas9-mediated mutagenesis. Furthermore, we found that extending the culture period increased the proportion of mutated cells as well as the variety of mutations obtained. Because mutated and non-mutated cells might proliferate equally, these results suggest that a prolonged tissue culture period increases the chance of inducing de novo mutations in non-mutated cells. This fundamental knowledge will help improve systems for obtaining non-chimeric regenerated plants in many plant species.	[Mikami, Masafumi; Toki, Seiichi] Yokohama City Univ, Grad Sch Nanobiosci, Yokohama, Kanagawa 2360027, Japan; [Mikami, Masafumi; Toki, Seiichi; Endo, Masaki] Natl Inst Agrobiol Sci, Agrogen Res Ctr, Plant Genome Engn Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Toki, Seiichi] Yokohama City Univ, Kihara Inst Biol Res, Yokohama, Kanagawa 2440813, Japan	Endo, M (reprint author), Natl Inst Agrobiol Sci, Agrogen Res Ctr, Plant Genome Engn Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	mendo@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries of Japan [PGE1001]; NIAS Strategic Research Fund; Council for Science, Technology and Innovation (CSTI); Bio-oriented Technology Research Advancement Institution, NARO	We thank K. Amagai, R. Aoto, A. Nagashii and F. Suzuki for general experimental technical support. This research was supported by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation PGE1001) and the NIAS Strategic Research Fund. This work was also supported by the Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO).	Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Sugano SS, 2014, PLANT CELL PHYSIOL, V55, P475, DOI 10.1093/pcp/pcu014; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Endo M, 2015, PLANT CELL PHYSIOL, V56, P41, DOI 10.1093/pcp/pcu154; Mao YF, 2013, MOL PLANT, V6, P2008, DOI 10.1093/mp/sst121; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Toki S, 1997, PLANT MOL BIOL REP, V15, P16, DOI 10.1007/BF02772109; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Ansai S, 2014, BIOL OPEN, V3, P362, DOI 10.1242/bio.20148177; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Hyun Y, 2015, PLANTA, V241, P271, DOI 10.1007/s00425-014-2180-5; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Jiang WZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099225; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kuroda M, 2010, BIOSCI BIOTECH BIOCH, V74, P2348, DOI 10.1271/bbb.100465; Wang MB, 2008, RNA, V14, P903, DOI 10.1261/rna.760908; Xu RF, 2014, RICE, V7, DOI 10.1186/s12284-014-0005-6; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806	33	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-7714	1432-203X		PLANT CELL REP	Plant Cell Reports	OCT	2015	34	10					1807	1815		10.1007/s00299-015-1826-5		9	Plant Sciences	Plant Sciences	CR6BF	WOS:000361427400011		
J	Kadota, K; Nishimura, T; Hotta, D; Tozuka, Y				Kadota, Kazunori; Nishimura, Takuro; Hotta, Daiki; Tozuka, Yuichi			Preparation of composite particles of hydrophilic or hydrophobic drugs with highly branched cyclic dextrin via spray drying for dry powder inhalers	POWDER TECHNOLOGY			English	Article						Composite particles; Dry powder inhalers; Highly branched cyclic dextrin; Spray drying	IN-VITRO; AEROSOL DISPERSION; CYSTIC-FIBROSIS; INHALATION; DELIVERY; FORMULATION; NANOPARTICLES; CYCLODEXTRINS; ENHANCEMENT; TOBRAMYCIN	This study aimed to investigate the feasibility of using highly branched cyclic dextrin (HBCD) as an additive agent for dry powder inhalers (DPIs) because the currently approved excipients for pulmonary administration are limited in number. HBCD has a specific assembled structure of 20 to 30 nm in aqueous solution, and the aggregation size of HBCD gradually increased with ethanol concentrations of up to 35% in an ethanol-water solution. This aggregation of HBCD in mixed solution may have considerable potential for application as a new additive agent for DPIs. This aggregation of HBCD with a hydrophilic or hydrophobic drug in a mixed solution was investigated. Thereafter, spray-dried particles (SDPs) of theophylline/HBCD exhibited a halo pattern in X-ray diffraction, indicating that theophylline existed in an amorphous state or fine crystals. The results for each yield and drug content suggested that the mechanism of particle generation also differed between hydrophilic and hydrophobic drugs with HBCD during spray drying. Nevertheless, the average particle size of the SDPs of theophylline/ HBCD or clotrimazole/HBCD prepared at any ethanol concentration was below 7 pm, suggesting that HBCD may be a carrier for DPIs. The average particle size of composite particles spray-dried at 35% ethanol was the smallest, measuring below 5 pm. HBCD may be a potential carrier for DPIs. (C) 2015 Elsevier B.V.All rights reserved.	[Kadota, Kazunori; Nishimura, Takuro; Hotta, Daiki; Tozuka, Yuichi] Osaka Univ Pharmaceut Sci, Takatsuki, Osaka 5691094, Japan	Tozuka, Y (reprint author), Osaka Univ Pharmaceut Sci, 4-20-1 Nasahara, Takatsuki, Osaka 5691094, Japan.	ytozuka@gly.oups.ac.jp			Uehara Foundation (Tokyo, Japan)	This research was supported by a Grant-in-Aid from the Uehara Foundation (Tokyo, Japan). The authors express their gratitude to Masahiro Suzuki (Nikkiso, Osaka, Japan) for their technical support in the particle size distribution for DIS measurements.	Ong HX, 2011, PHARM RES-DORDR, V28, P2327, DOI 10.1007/s11095-011-0462-1; Takata H, 1996, J BACTERIOL, V178, P1600; Tozuka Y, 2010, ADV POWDER TECHNOL, V21, P305, DOI 10.1016/j.apt.2009.12.013; Louey MD, 2004, PHARM RES, V21, P1200, DOI 10.1023/B:PHAM.0000033007.27278.60; Takata H, 1996, CARBOHYD RES, V295, P91, DOI 10.1016/S0008-6215(96)90126-3; Palazzo F, 2013, INT J PHARMACEUT, V440, P273, DOI 10.1016/j.ijpharm.2012.05.045; Pilcer G, 2013, J PHARM SCI-US, V102, P1836, DOI 10.1002/jps.23525; Takii H, 2004, FOOD SCI TECHNOL RES, V10, P428, DOI 10.3136/fstr.10.428; Watts AB, 2008, DRUG DEV IND PHARM, V34, P913, DOI 10.1080/03639040802144211 ; Takii H, 1999, BIOSCI BIOTECH BIOCH, V63, P2045, DOI 10.1271/bbb.63.2045; Vehring R, 2008, PHARM RES, V25, P999, DOI 10.1007/s11095-007-9475-1; Adi H, 2008, J PHARM SCI-US, V97, P3356, DOI 10.1002/jps.21239; Possmayer F, 2001, COMP BIOCHEM PHYS A, V129, P209, DOI 10.1016/S1095-6433(01)00317-8; Pham DD, 2013, INT J PHARMACEUT, V454, P668, DOI 10.1016/j.ijpharm.2013.04.016; Li XJ, 2014, EUR J PHARM SCI, V52, P191, DOI 10.1016/j.ejps.2013.10.016; Giry K, 2006, INT J PHARM, V321, P162, DOI 10.1016/j.ijpharm.2006.05.009; Newhouse MT, 2003, CHEST, V124, P360, DOI 10.1378/chest.124.1.360; Sebti T, 2006, EUR J PHARM BIOPHARM, V63, P51, DOI 10.1016/j.ejpb.2005.11.003; Tascini C, 2004, J CHEMOTHERAPY, V16, P282; Pilcer G, 2010, INT J PHARMACEUT, V392, P1, DOI 10.1016/j.ijpharm.2010.03.017; Zhang J, 2014, INT J PHARMACEUT, V465, P255, DOI 10.1016/j.ijpharm.2014.01.035; Tozuka Y, 2012, EUR J PHARM BIOPHARM, V82, P120, DOI 10.1016/j.ejpb.2012.05.005; Matilainen L, 2008, J CONTROL RELEASE, V126, P10, DOI 10.1016/j.jconrel.2007.11.003; Eggersdorfer ML, 2014, ADV POWDER TECHNOL, V25, P71, DOI 10.1016/j.apt.2013.10.010; Makhlof A, 2008, INT J PHARMACEUT, V357, P280, DOI 10.1016/j.ijpharm.2008.01.025; Assael B.M., 1993, J CRYST FIBROS S, V1569-1993; Borhade V, 2012, INT J PHARMACEUT, V431, P138, DOI 10.1016/j.ijpharm.2011.12.040; Challa R., 2005, AAPS PHARMSCITECH, V6, P329, DOI DOI 10.1208/PT060243.PMID:16353992; Pornputtapitak W, 2014, INT J PHARMACEUT, V462, P19, DOI 10.1016/j.ijpharm.2013.12.030; FDA, 2009, GUID IND NONCL STUD; Fujimori M, 2015, J FOOD ENG, V149, P248, DOI 10.1016/j.jfoodeng.2014.10.010; Gabrielle P., 2010, INT J PHARMACEUT, V392, P1; Haller PD, 2014, MACROMOL RAPID COMM, V35, P2000, DOI 10.1002/marc.201400436; JAWETZ E, 1968, ANNU REV PHARMACOLOG, V8, P151, DOI 10.1146/annurev.pa.08.040168.001055; Klingler C, 2009, INT J PHARMACEUT, V377, P173, DOI 10.1016/j.ijpharm.2009.05.008; Loftsson T, 1996, J PHARM SCI, V85, P1017, DOI 10.1021/js950534b; May S, 2014, PHARM RES-DORDR, V31, P3211, DOI 10.1007/s11095-014-1413-4; Pilcer G, 2013, INT J PHARMACEUT, V451, P112, DOI 10.1016/j.ijpharm.2013.04.069; Pitt K, 2015, CHEM ENG SCI, V122, P384, DOI 10.1016/j.ces.2014.10.006; Reklaitis G.V., 2010, CHEM ENG SCI, V65, P4; Tozuka Y, 2010, INT J PHARMACEUT, V386, P243, DOI 10.1016/j.ijpharm.2009.10.044; WALSH AL, 1995, ANTIMICROB AGENTS CH, V39, P2356	42	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0032-5910	1873-328X		POWDER TECHNOL	Powder Technol.	OCT	2015	283						16	23		10.1016/j.powtec.2015.05.014		8	Engineering, Chemical	Engineering	CR3WH	WOS:000361263300003		
J	Yakub, F; Mori, Y				Yakub, Fitri; Mori, Yasuchika			Comparative study of autonomous path-following vehicle control via model predictive control and linear quadratic control	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART D-JOURNAL OF AUTOMOBILE ENGINEERING			English	Review						Autonomous vehicle; model predictive control; linear quadratic control; path-following control; feedforward controller; manoeuvre control	YAW STABILITY CONTROL; STEERING CONTROL; INTEGRATED CONTROL; SYSTEMS; BRAKING; MOMENT; ANGLE	This paper describes a comparative study of steering and yaw moment control manoeuvres in the model predictive control and linear quadratic control approaches for path-following control of an autonomous vehicle. We present the effectiveness of the model predictive control and linear quadratic control approaches for stability control of the vehicle's lateral position and yaw angle for different control manoeuvres: two-wheel steering, four-wheel steering and direct yaw moment control. We then propose model predictive control with a feedforward controller to minimize the tracking errors of the lateral position and the yaw angle in an active front steering manoeuvre, and these are compared with the results from linear quadratic control that has a feedforward controller. Model predictive control is designed on the basis of the simple yaw-lateral motions of a single-track vehicle with a linear tyre model (i.e. a bicycle model), which is an approximation of the more realistic model of a vehicle with double-track yaw-roll motion with a non-linear tyre model (i.e. the Pacejka model). The linear quadratic controller is designed on the basis of the same approach as adopted for the model predictive controller to achieve a fair comparison. On the basis of a given trajectory, we simulate the manoeuvre of the vehicle at a low speed, a middle speed and a high speed because load transfer effects will influence the roll dynamics especially at a high speed. We also perform simulations on low-road-friction surfaces in a double-lane-change scenario with the aim of following the desired trajectory as closely as possible while maintaining the vehicle stability. The simulation results show that model predictive control through two-wheel steering and four-wheel steering with direct yaw moment control performed better in terms of trajectory tracking at a high forward speed and low road surface variation. The proposed model predictive control with a feedforward controller is shown to be effective in minimizing the trajectory tracking errors. For all control manoeuvres, model predictive control gives a better tracking performance than linear quadratic control does. In addition, when the roll dynamics are considered, model predictive control significantly improves the vehicle stability and the trajectory along the desired path.	[Yakub, Fitri; Mori, Yasuchika] Tokyo Metropolitan Univ, Grad Sch Syst Design, Tokyo 158, Japan; [Yakub, Fitri] Univ Teknol Malaysia, Malaysia Japan Int Inst Technol, Kuala Lumpur, Malaysia	Yakub, F (reprint author), Tokyo Metropolitan Univ, Grad Sch Syst Design, 6-6 Asahigaoka, Tokyo 158, Japan.	mfitri.kl@utm.my		Yakub, Fitri/0000-0002-6603-2406	Asian Human Resource Fund by Tokyo Metropolitan Government	This work was financially supported through the Asian Human Resource Fund by the Tokyo Metropolitan Government (grant number).	Abe M, 1996, VEHICLE SYST DYN, V25, P3, DOI 10.1080/00423119608969184; Ackermann J., 1993, IEEE Transactions on Control Systems Technology, V1, DOI 10.1109/87.221348; Adireddy G, 2011, ASME 2011 DYN SYST C, V2, P877; Sharp RS, 2001, VEHICLE SYST DYN, V35, P101; Leva A, 2007, CONTROL ENG PRACT, V15, P909, DOI 10.1016/j.conengprac.2006.11.009; Park JM, 2009, P I MECH ENG D-J AUT, V223, P1499, DOI 10.1243/09544070JAUTO1149; Rajamani R, 2012, MECH ENG SER, P1, DOI 10.1007/978-1-4614-1433-9; Kamal MAS, 2011, IEEE T INTELL TRANSP, V12, P783, DOI 10.1109/TITS.2011.2112648; Nagai M, 2002, JSAE REV, V23, P309, DOI 10.1016/S0389-4304(02)00189-3; Zou QZ, 2009, AUTOMATICA, V45, P230, DOI 10.1016/j.automatica.2008.06.014; Falcone P, 2008, VEHICLE SYST DYN, V46, P611, DOI 10.1080/00423110802018297; Bemporad A, 1999, LECT NOTES CONTR INF, V245, P207; Tanelli M, 2009, IEEE T IND ELECTRON, V56, P3347, DOI 10.1109/TIE.2009.2018430; GARCIA CE, 1989, AUTOMATICA, V25, P335, DOI 10.1016/0005-1098(89)90002-2; Chen BC, 2001, VEHICLE SYST DYN, V36, P359, DOI 10.1076/vesd.36.4.359.3546; Falcone P, 2007, IEEE T CONTR SYST T, V15, P566, DOI 10.1109/TCST.2007.894653; Nam K, 2012, INT J AUTO TECH-KOR, V13, P1169, DOI 10.1007/s12239-012-0120-6; Mayne DQ, 2000, AUTOMATICA, V36, P789, DOI 10.1016/S0005-1098(99)00214-9; Yoshida H, 2008, VEHICLE SYST DYN, V46, P669, DOI 10.1080/00423110802033072; Anwar S, 2005, P AMER CONTR CONF, P435, DOI 10.1109/ACC.2005.1469974; Arabi S, 2010, WORLD C ENG LOND UK, VII, P1; Bianchi Domenico, 2010, International Journal of Vehicle Autonomous Systems, V8, DOI 10.1504/IJVAS.2010.035792; Borrelli F., 2005, International Journal of Vehicle Autonomous Systems, V3, DOI 10.1504/IJVAS.2005.008237; Camacho E. F., 2007, MODEL PREDICTIVE CON; Canale M, 2006, 2006 AM CONTR C MINN, P1, DOI 10.1109/PIMRC.2006.254174; Chang S, 2008, VEHICLE SYST DYN, V46, P63, DOI 10.1080/00423110701882306; Cole DJ, 2006, VEHICLE SYST DYN, V44, P259, DOI 10.1080/00423110500260159; Conde EC, 2011, MATLAB ENG APPL CONT; Groves KP, 2005, AIAA GUID NAV CONTR, P2901; Hammar G, 2010, THESIS KTH STOCKHOLM; Katriniok A, 2011, 2011 50TH IEEE CONFERENCE ON DECISION AND CONTROL AND EUROPEAN CONTROL CONFERENCE (CDC-ECC), P6828, DOI 10.1109/CDC.2011.6161257; Keen SD, 2006, 8 INT S ADV VEH CONT, P1; Kim W, 2012, VEHICLE SYST DYN, V50, P1001, DOI 10.1080/00423114.2011.597864; Lee JH, 2009, INT J AUTOMOT TECHN, V10, P211, DOI 10.1007/s12239-009-0025-1; MACADAM C, 1981, IEEE T SYST MAN CYB, V11, P393, DOI 10.1109/TSMC.1981.4308705; Maciejowski J. M., 2002, PREDICTIVE CONTROL C; Manfred P, 2007, VEH SYSTEM DYNAMICS, V45, P699; March C, 2007, P I MECH ENG D-J AUT, V221, P377, DOI 10.1243/09544070AUTO152; Matthew OTC, 2014, CONTROL ENG PRACT, V26, P41; Pacejka HB, 2012, TIRE AND VEHICLE DYNAMICS, 3RD EDITION, P1; Viano DC, 2003, 2003010169 SAE; Wang J, 2006, INT J VEHICLE DES, V42, P306, DOI 10.1504/IJVD.2006.010435	42	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4070	2041-2991		P I MECH ENG D-J AUT	Proc. Inst. Mech. Eng. Part D-J. Automob. Eng.	OCT	2015	229	12					1695	1714		10.1177/0954407014566031		20	Engineering, Mechanical; Transportation Science & Technology	Engineering; Transportation	CR8IC	WOS:000361593500009		
J	Tanaka, R; Inoue, S; Shibasaki, H; Ogawa, H; Murakami, T; Ishida, Y				Tanaka, Ryo; Inoue, Shota; Shibasaki, Hiroki; Ogawa, Hiromitsu; Murakami, Takahiro; Ishida, Yoshihisa			An approach to model-following controller design based on a stabilized digital inverse system	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART I-JOURNAL OF SYSTEMS AND CONTROL ENGINEERING			English	Article						Auxiliary output; digital inverse system; linear quadratic regulator; model-following control; unstable zero		This article explains our approach to designing a model-following controller based on a stabilized digital inverse system. We use an inter-sample auxiliary observation output from the model as an input to the inverse system. We then design the inverse system for minimum and non-minimum phase plants. In order to reposition the unstable poles of the inverse system on a stable region, we determine the optimal gain vector using a linear quadratic regulator. We confirm the effectiveness of our proposed method by performing simulations for several plants and conducting an experiment with a direct current motor.	[Tanaka, Ryo] Meiji Univ, Org Strateg Coordinat Res & Intellectual Property, Kawasaki, Kanagawa 2148571, Japan; [Inoue, Shota; Shibasaki, Hiroki; Ogawa, Hiromitsu; Murakami, Takahiro; Ishida, Yoshihisa] Meiji Univ, Dept Elect & Bioinformat, Kawasaki, Kanagawa 2148571, Japan	Tanaka, R (reprint author), Meiji Univ, Org Strateg Coordinat Res & Intellectual Property, Tama Ku, 1-1-1 Higashi Mita, Kawasaki, Kanagawa 2148571, Japan.	rtanaka@meiji.ac.jp					TOMIZUKA M, 1987, J DYN SYST-T ASME, V109, P65; SAIN MK, 1969, IEEE T AUTOMAT CONTR, VAC14, P141, DOI 10.1109/TAC.1969.1099133; Fuwa K, 1997, IEEJ T C, V117C, P720; GODBOLE SS, 1972, IEEE T AUTOMAT CONTR, VAC17, P698, DOI 10.1109/TAC.1972.1100101; Golnaraghi F, 2009, AUTOMATIC CONTROL SY, V9th; Inoue S, 2014, INT J ELECT ELECT EN, V2, P134; Kaizuka H, 1982, SICE T, V18, P209; Kaku Y., 1989, Proceedings. IEEE International Symposium on Intelligent Control 1989 (Cat. No.89TH0282-4), DOI 10.1109/ISIC.1989.238633; KAKU Y, 1988, SYST CONTROL LETT, V11, P123, DOI 10.1016/0167-6911(88)90085-0; Kamiyama M, 1979, SICE T, V15, P313; LEVY S, 1966, IEEE T AUTOMAT CONTR, VAC11, P315, DOI 10.1109/TAC.1966.1098325; Lewis FL, 2012, OPT CONTR 3 ED; MITA T, 1987, INT J CONTROL, V45, P2071, DOI 10.1080/00207178708933868; Naido DS, 2003, OPTIMAL CONTROL SYST; Nakamizo T, 1980, SICE T, V16, P35; SILVERMA.LM, 1971, SIAM J CONTROL, V9, P199, DOI 10.1137/0309017; Tanaka R, 2013, IEEE INT C IND ENG E, P595; Wang R, 2006, ISCIE T, V19, P290; Yamada K, 2003, ISCIE T, V16, P85; Yamada K, 1992, SICE T, V28, P923; Yamada K, 1996, SICE, V32, P862; Yoshikawa T, 1982, SICE T, V18, P792	22	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0959-6518	2041-3041		P I MECH ENG I-J SYS	Proc. Inst. Mech. Eng. Part I-J Syst Control Eng.	OCT	2015	229	9					829	837		10.1177/0959651815585210		9	Automation & Control Systems	Automation & Control Systems	CR6ZL	WOS:000361497000005		
J	Kobara, K; Osaka, H; Takahashi, H; Ito, T; Fujita, D; Watanabe, S				Kobara, Kenichi; Osaka, Hiroshi; Takahashi, Hisashi; Ito, Tomotaka; Fujita, Daisuke; Watanabe, Susumu			Influence of rotational axis height of back support on horizontal force applied to buttocks in a reclining wheelchair	PROSTHETICS AND ORTHOTICS INTERNATIONAL			English	Article						Horizontal force; rotational axis; back support; reclining wheelchair	SHEAR FORCE; SKELETAL-MUSCLES; PRESSURE ULCERS; BLOOD-FLOW; INTERFACE; SKIN; STRESS	Background: Studies have not been conducted to investigate the influence of the height of the rotational axis of a wheelchair's back support on the shear force applied to the buttocks during the reclining motion. Objectives: The purpose of this study was to investigate the influence of the difference in the rotational axis position of back support in the vertical direction on the horizontal force applied to buttocks for preventing decubitus ulcers. Study design: Repeated measures design. Methods: The subjects were 13 healthy adult men without leg and/or trunk diseases. The shear force was measured using a force plate. A comfortable sitting posture in the experimental chair was selected for measurement. The rotational axis was positioned 13cm forward on the horizontal plane from the intersection between the seat and the back support. The axis positions on the vertical plane as two experimental conditions were the seat height and the 7.5-cm upward from the seat height which was nearer to the hip joint. Results: In returning the back support to an upright position, the horizontal force was 12.4 1.6 (percent body weight) under the seat height-axis condition and 10.1 1.8 (percent body weight) under the upward-axis condition (p < 0.01). Conclusion: This result suggested that the wheelchair might have to be capable of adjusting the height of the rotational axis of the back support to reduce the horizontal force applied to buttocks. Clinical relevance This study shows one of the suggestions regarding seating approach for the prevention of decubitus ulcers. There is a possibility of reducing horizontal force applied to buttocks after reclined back support, by adjusting the height of the rotational axis position of wheelchair back support.	[Kobara, Kenichi; Osaka, Hiroshi; Takahashi, Hisashi; Ito, Tomotaka; Fujita, Daisuke; Watanabe, Susumu] Kawasaki Univ Med Welf, Dept Rehabil, Kurashiki, Okayama 7010193, Japan	Kobara, K (reprint author), Kawasaki Univ Med Welf, Dept Rehabil, 288 Matsushima, Kurashiki, Okayama 7010193, Japan.	rptkob@mw.kawasaki-m.ac.jp			Kawasaki University of Medical Welfare	This study was supported by a grant-in-aid from the 2010 Kawasaki University of Medical Welfare's expense budget for medical welfare study and research.	Reenalda J, 2009, ASSIST TECHNOL, V21, P76, DOI 10.1080/10400430903050437; Lahmann NA, 2011, INT J NURS STUD, V48, P1487, DOI 10.1016/j.ijnurstu.2011.07.004; Aissaoui R, 2001, IEEE T NEUR SYS REH, V9, P215, DOI 10.1109/7333.928581; Linder-Ganz E, 2007, ANN BIOMED ENG, V35, P2095, DOI [10.1007/s10439-007-9384-9, 10.1007/S10439-007-9384-9]; Linder-Ganz E, 2006, J BIOMECH, V39, P2725, DOI 10.1016/j.jbiomech.2005.08.010; Ceelen KK, 2008, J BIOMECH, V41, P3399, DOI 10.1016/j.jbiomech.2008.09.016; Akins JS, 2011, J REHABIL RES DEV, V48, P225, DOI 10.1682/JRRD.2009.09.0145; BENNETT L, 1979, ARCH PHYS MED REHAB, V60, P309; Stekelenburg A, 2007, J APPL PHYSIOL, V102, P2002, DOI 10.1152/japplphysiol.01115.2006; Ohura T, 2008, WOUND REPAIR REGEN, V16, P102, DOI 10.1111/j.1524-475X.2007.00325.x; Kobara K, 2014, J PHYS THER SCI, V26, P701, DOI 10.1589/jpts.26.701; Byrne DW, 1996, SPINAL CORD, V34, P255; BENNETT L, 1984, ARCH PHYS MED REHAB, V65, P186; CARLSON JM, 1995, J PROSTHET ORTHOT, V7, P51, DOI 10.1097/00008526-199500720-00005; Dinddale SM, 1974, ARCH PHYS MED REHAB, V55, P147; GILSDORF P, 1990, Journal of Rehabilitation Research and Development, V27, P239, DOI 10.1682/JRRD.1990.07.0239; Goossens RHM, 1997, SCAND J REHABIL MED, V29, P131; Guttmann L, 1976, BEDSORE BIOMECHANICS, P153; HOBSON DA, 1992, J REHABIL RES DEV, V29, P21, DOI 10.1682/JRRD.1992.10.0021; Kobara K, 2009, NIHON GISHI SOGU GAK, V25, P108; Kobara Kenichi, 2013, Disabil Rehabil Assist Technol, V8, P220, DOI 10.3109/17483107.2012.713434; Kobara Kenichi, 2008, Disabil Rehabil Assist Technol, V3, P285, DOI 10.1080/17483100802145332; Kobara K, 2013, PROSTHET ORTHOT INT, V37, P459, DOI 10.1177/0309364613476534; Kobara K, 2007, RIGAKURYOHO KAGAKU, V22, P185, DOI 10.1589/rika.22.185; Kobara Kenichi, 2011, Disabil Rehabil Assist Technol, V6, P299, DOI 10.3109/17483107.2010.522683; Kouchi M, 2000, ANTHROPOMETRIC DATAB; Nakagami G, 2006, J WOUND OSTOMY CONT, V33, P267; National Pressure Ulcer Advisory Panel (NPUAP), UNT NPUAP EPUAP PRES; National Pressure Ulcer Advisory Panel (NPUAP), SHEAR CONTR FACT PRE; Ohura T, 2007, WOUNDS, V19, P310; Sakuta Y, 2006, JSMBE, V44, P101	31	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0309-3646	1746-1553		PROSTHET ORTHOT INT	Prosthet. Orthot. Int.	OCT	2015	39	5					397	404		10.1177/0309364614543547		8	Orthopedics; Rehabilitation	Orthopedics; Rehabilitation	CR6YH	WOS:000361494000007		
J	Hama, S; Ohtsubo, M; Nishiwaki, T; Miura, A; Sanemasu, M; Shimada, N; Fujimoto, Y; Tao, S; Suzuki, T; Hara, D; Iino, E; Kawahama, S; Sato, D				Hama, Seiji; Ohtsubo, Masafumi; Nishiwaki, Tsuyoshi; Miura, Ayu; Sanemasu, Mie; Shimada, Noboru; Fujimoto, Yukio; Tao, Saori; Suzuki, Takahiro; Hara, Daisuke; Iino, Eriko; Kawahama, Shiori; Sato, Daisuke			Effect of post-trochanteric groove support on stance control associated with the pelvic-lumbar system: A preliminary study	PROSTHETICS AND ORTHOTICS INTERNATIONAL			English	Article						Post-trochanteric groove; pelvic corset; pelvis-spine complex; static standing; stroke	RELIABILITY; BALANCE; STROKE; SPINE; TILT	Background: Many stroke and neuromuscular patients with paraplegia or severe hemiparesis cannot control trunk balance. Objective: To support the pelvis/hip of paresis patients, a new pelvic/hip support system was developed bearing a convex pressing member placed over the post-trochanteric groove, a cutaneous landmark sited on the lateral portion of the gluteus maximus muscle and indicating the posterior aspect of the greater trochanter. Study design: Preliminary study. Methods: Stance control differences in two paretic patients (Guillain-Barre syndrome and stroke sequelae) with or without post-trochanteric groove support were examined. The contact pressure on the post-trochanteric groove was examined in eight healthy volunteers using an impact force sensor. The pelvic-lumbar movement was also examined using three-dimensional motion analysis, and the gluteus muscles activity was evaluated using surface electromyography. Results: Without post-trochanteric groove support, total three-dimensional displacement of the sacral marker was longer in the paresis patients than in normal controls, while post-trochanteric groove support decreased this distance. Post-trochanteric groove support provided compression pressure on the post-trochanteric groove, and all subjects showed a more upright trunk position, providing more anterior pelvic tilting. Six of eight subjects showed increased lumbar lordosis. Five of eight subjects showed gluteus maximus and/or gluteus medius muscle activation. Conclusion: The mechanisms of post-trochanteric groove support were suggested to be spino-pelvic coordination and gluteal muscle activation. Clinical relevance The post-trochanteric groove is a cutaneous landmark located behind the pelvis/hip joint. Applying pressure to the post-trochanteric groove from behind pushes the trunk to adopt a more upright position, leading to improved stance control. Underlining mechanisms appear to be spino-pelvic coordination and gluteal muscle activation.	[Hama, Seiji; Sanemasu, Mie; Tao, Saori; Suzuki, Takahiro; Hara, Daisuke; Iino, Eriko; Kawahama, Shiori; Sato, Daisuke] Hibino Hosp, Dept Rehabil, Hiroshima 7313161, Japan; [Hama, Seiji] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Neurosurg, Hiroshima, Japan; [Ohtsubo, Masafumi] Ohtsubo Prosthet & Orthot MFG Co, Yamaguchi, Japan; [Nishiwaki, Tsuyoshi; Miura, Ayu] ASICS Corp, Inst Sport Sci, Amagasaki, Hyogo, Japan; [Shimada, Noboru] Hiroshima Univ Hosp, Dept Rehabil, Hiroshima, Japan; [Fujimoto, Yukio] Hiroshima Univ, Dept Transportat & Environm Engn, Hiroshima, Japan	Hama, S (reprint author), Hibino Hosp, Dept Rehabil, Tomo 7955,Numata Cho, Hiroshima 7313161, Japan.	shama@hiroshima-u.ac.jp			Tsuchiya Foundation; Chugoku Industrial Innovation Center; Hiroshima University; Urabe Co. Ltd. [A1100574]; Corporation Pearl Star Co. Ltd. [A1000412]	This study was supported by the Tsuchiya Foundation, funding from the Chugoku Industrial Innovation Center and funding from the collaborative project of Hiroshima University with Urabe Co. Ltd. (A1100574) and with Corporation Pearl Star Co. Ltd. (A1000412).	ALVISO DJ, 1988, PHYS THER, V68, P1347; Pearson KG, 2008, BRAIN RES REV, V57, P222, DOI 10.1016/j.brainresrev.2007.06.014; Kilbreath SL, 2006, AUST J PHYSIOTHER, V52, P53; Barrey C, 2007, EUR SPINE J, V16, P1459, DOI 10.1007/s00586-006-0294-6; Robbins S, 1995, BRIT J SPORT MED, V29, P242; [Anonymous], 1996, GAIT POSTURE, DOI 10.1016/0966-6362(96)01063-6; Vialle R, 2005, J BONE JOINT SURG AM, V87A, P260, DOI 10.2106/JBJS.D.02043; Bogery RA, 2005, PHYS MED REHABILITAT, P1393; Brandstater ME, 1998, REHABILITATION MED P, P1165; Davies PM, 2000, STEPS TO FOLLOW; GAJDOSIK R, 1985, PHYS THER, V65, P169; GARNETT R, 1981, J PHYSIOL-LONDON, V311, P463; Jung H, 2012, MAN THER, V18, P143, DOI [10.1016/j.math.2012.09.003, DOI 10.1016/J.MATH.2012.09.003]; Kurabayashi J, 2003, J SOC BIOMECHANISMS, V27, P29, DOI 10.3951/sobim.27.29; Le Huec J C, 2011, Eur Spine J, V20 Suppl 5, P558, DOI 10.1007/s00586-011-1939-7; Le Huec J C, 2011, Eur Spine J, V20 Suppl 5, P564, DOI 10.1007/s00586-011-1940-1; McConnell J, 2002, MANUAL THER, V7, P183, DOI 10.1054/math.2002.0478; Moore KL, 2006, CLIN ORIENTED ANATOM; Morris M, 2005, GAIT DISORDERS EVALU, P247; Roussouly Pierre, 2011, Eur Spine J, V20 Suppl 5, P609, DOI 10.1007/s00586-011-1928-x; Sprigle S, 2002, ARCH PHYS MED REHAB, V83, P1597, DOI 10.1053/apmr.2002.35468	21	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0309-3646	1746-1553		PROSTHET ORTHOT INT	Prosthet. Orthot. Int.	OCT	2015	39	5					405	413		10.1177/0309364614536763		9	Orthopedics; Rehabilitation	Orthopedics; Rehabilitation	CR6YH	WOS:000361494000008		
J	Sugita, M; Matsuoka, M; Kikuchi, T				Sugita, Masatake; Matsuoka, Masanari; Kikuchi, Takeshi			Topological and sequence information predict that foldons organize a partially overlapped and hierarchical structure	PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS			English	Article						protein folding; multistate folding; foldon; intermediate state; topology-based model	ACID-BINDING PROTEIN; COARSE-GRAINED MODELS; NONNATIVE INTERACTIONS; FOLDING MECHANISMS; GLOBULAR-PROTEINS; ENERGY LANDSCAPE; MOLTEN GLOBULE; HOMOLOGOUS PROTEINS; HYDROGEN-EXCHANGE; ESCHERICHIA-COLI	It has been suggested that proteins have substructures, called foldons, which can cooperatively fold into the native structure. However, several prior investigations define foldons in various ways, citing different foldon characteristics, thereby making the concept of a foldon ambiguous. In this study, we perform a G model simulation and analyze the characteristics of substructures that cooperatively fold into the native-like structure. Although some results do not agree well with the experimental evidence due to the simplicity of our coarse-grained model, our results strongly suggest that cooperatively folding units sometimes organize a partially overlapped and hierarchical structure. This view makes us easy to interpret some different proposal about the foldon as a difference of the hierarchical structure. On the basis of this finding, we present a new method to assign foldons and their hierarchy, using structural and sequence information. The results show that the foldons assigned by our method correspond to the intermediate structures identified by some experimental techniques. The new method makes it easy to predict whether a protein folds sequentially into the native structure or whether some foldons fold into the native structure in parallel. Proteins 2015; 83:1900-1913. (c) 2015 Wiley Periodicals, Inc.	[Sugita, Masatake; Matsuoka, Masanari; Kikuchi, Takeshi] Ritsumeikan Univ, Coll Life Sci, Dept Bioinformat, Kusatsu, Shiga 5258577, Japan	Kikuchi, T (reprint author), Ritsumeikan Univ, Coll Life Sci, Dept Bioinformat, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan.	tkikuchi@sk.ritsumei.ac.jp			JSPS KAKENHI [26330335]; MEXT (Strategic Research Foundation at Private Universities) [S1011042]	Grant sponsor: JSPS KAKENHI; Grant number: 26330335; Grant sponsor: MEXT (Strategic Research Foundation at Private Universities, 2010-2014); Grant number: S1011042.	C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Pashley CL, 2012, J MOL BIOL, V416, P300, DOI 10.1016/j.jmb.2011.12.041; Panchenko AR, 1996, P NATL ACAD SCI USA, V93, P2008, DOI 10.1073/pnas.93.5.2008; Hukushima K, 1996, INT J MOD PHYS C, V7, P337, DOI 10.1142/S0129183196000272; FERRENBERG AM, 1988, PHYS REV LETT, V61, P2635, DOI 10.1103/PhysRevLett.61.2635; Sulkowska JI, 2008, BIOPHYS J, V95, P3174, DOI 10.1529/biophysj.107.127233; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Watters AL, 2007, CELL, V128, P613, DOI 10.1016/j.cell.2006.12.042; Cheung MS, 2002, P NATL ACAD SCI USA, V99, P685, DOI 10.1073/pnas.022387699; Hills RD, 2009, INT J MOL SCI, V10, P889, DOI 10.3390/ijms10030889; Lindberg MO, 2006, P NATL ACAD SCI USA, V103, P4083, DOI 10.1073/pnas.0508863103; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; JENNINGS PA, 1993, SCIENCE, V262, P892, DOI 10.1126/science.8235610; Kaya H, 2005, PROTEINS, V58, P31, DOI 10.1002/prot.20286; Li HL, 2007, P NATL ACAD SCI USA, V104, P11993, DOI 10.1073/pnas.0705253104; Hu WB, 2013, P NATL ACAD SCI USA, V110, P7684, DOI 10.1073/pnas.1305887110; Hansmann UHE, 1997, CHEM PHYS LETT, V281, P140, DOI 10.1016/S0009-2614(97)01198-6; Wong KB, 2000, J MOL BIOL, V296, P1257, DOI 10.1006/jmbi.2000.3523; Kaya H, 2003, J MOL BIOL, V326, P911, DOI 10.1016/S0022-2836(02)01434-1; Cho JH, 2014, P NATL ACAD SCI USA, V111, P12079, DOI 10.1073/pnas.1402054111; Sugita M, 2014, PROTEINS, V82, P954, DOI 10.1002/prot.24469; Mitsutake A, 2001, BIOPOLYMERS, V60, P96, DOI 10.1002/1097-0282(2001)60:2<96::AID-BIP1007>3.0.CO;2-F; Karanicolas J, 2003, J MOL BIOL, V334, P309, DOI 10.1016/j.jmb.2003.09.047; Liu ZX, 2011, P NATL ACAD SCI USA, V108, P7787, DOI 10.1073/pnas.1019500108; Wallin S, 2007, J MOL BIOL, V368, P884, DOI 10.1016/j.jmb.2007.02.035; Chan HS, 2011, ANNU REV PHYS CHEM, V62, P301, DOI 10.1146/annurev-physchem-032210-103405; Karanicolas J, 2002, PROTEIN SCI, V11, P2351, DOI 10.1110/ps.0205402; Raschke TM, 1999, NAT STRUCT BIOL, V6, P825; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Raschke TM, 1997, NAT STRUCT BIOL, V4, P298, DOI 10.1038/nsb0497-298; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Panchenko AR, 1997, J MOL BIOL, V272, P95, DOI 10.1006/jmbi.1997.1205; Finke JM, 2005, BIOPHYS J, V89, P488, DOI 10.1529/biophysj.105.059147; Sutto L, 2007, P NATL ACAD SCI USA, V104, P19825, DOI 10.1073/pnas.0709922104; Munshi S, 2015, PHYS CHEM CHEM PHYS, V17, P11042, DOI 10.1039/c4cp06102k; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Budyak IL, 2013, STRUCTURE, V21, P476, DOI 10.1016/j.str.2013.01.013; Burns LL, 2001, PROTEINS, V43, P292, DOI 10.1002/prot.1040; BYCROFT M, 1991, BIOCHEMISTRY-US, V30, P8697, DOI 10.1021/bi00099a030; Chattopadhyay K, 2002, BIOCHEMISTRY-US, V41, P4040, DOI 10.1021/bi0120421; Chen T, 2014, PHYS CHEM CHEM PHYS, V16, P6460, DOI 10.1039/c3cp54866j; Connell KB, 2009, J MOL BIOL, V391, P450, DOI 10.1016/j.jmb.2009.05.085; Dalessio PM, 2000, BIOCHEMISTRY-US, V39, P860, DOI 10.1021/bi991937j; Eliezer D, 1996, J MOL BIOL, V263, P531, DOI 10.1006/jmbi.1996.0596; FERRENBERG AM, 1989, PHYS REV LETT, V63, P1195, DOI 10.1103/PhysRevLett.63.1195; Friel CT, 2004, J MOL BIOL, V342, P261, DOI 10.1016/j.jmb.2004.06.076; Fujiwara M, 2000, BIOL PHARM BULL, V23, P1147; Ghosh K, 2009, J AM CHEM SOC, V131, P2306, DOI 10.1021/ja808136x; Gianni S, 2003, P NATL ACAD SCI USA, V100, P13286, DOI 10.1073/pnas.1835776100; Go M., 1985, Advances in Biophysics, V19, P91; Haglund E, 2008, J BIOL CHEM, V283, P27904, DOI 10.1074/jbc.M801776200; Ichimaru T, 2003, PROTEINS, V51, P515, DOI 10.1002/prot.10378; Kamagata K, 2006, J MOL BIOL, V357, P1647, DOI 10.1016/j.jmb.2006.01.072; Kamagata K, 2004, J MOL BIOL, V339, P951, DOI 10.1016/j.jmb.2004.04.015; Kawai Y, 2011, PROTEIN PEPTIDE LETT, V18, P979; Kaya H, 2003, PROTEINS, V52, P524, DOI 10.1002/prot.10478; Khan F, 2003, J MOL BIOL, V333, P169, DOI 10.1016/j.jmb.2003.08.024; Sugita M, 2013, PROTEINS, V81, P1434, DOI 10.1002/prot.24294; KIKUCHI T, 1988, J PROTEIN CHEM, V7, P427, DOI 10.1007/BF01024890; Kim KY, 1998, PROTEIN SCI, V7, P1821; Kurz M, 2003, PROTEINS, V50, P312, DOI 10.1002/prot.10289; Lindberg MO, 2007, CURR OPIN STRUC BIOL, V17, P21, DOI 10.1016/j.sbi.2007.01.008; Liu ZX, 2012, J PHYS CHEM B, V116, P6707, DOI 10.1021/jp211941b; Matsuoka M, 2014, BMC STRUCT BIOL, V14, DOI 10.1186/1472-6807-14-15; Matsuoka Masanari, 2014, BMC Res Notes, V7, P654, DOI 10.1186/1756-0500-7-654; MATTHEWS JM, 1995, BIOCHEMISTRY-US, V34, P6805, DOI 10.1021/bi00020a027; Nishimura C, 2011, J MOL BIOL, V411, P248, DOI 10.1016/j.jmb.2011.05.028; Nishimura C, 2010, J MOL BIOL, V396, P1319, DOI 10.1016/j.jmb.2009.12.040; Nishimura C, 2002, J MOL BIOL, V322, P483, DOI 10.1016/S0022-2836(02)00810-0; OSAPAY K, 1994, J MOL BIOL, V244, P183, DOI 10.1006/jmbi.1994.1718; Ropson IJ, 2009, PROTEINS, V75, P799, DOI 10.1002/prot.22286; Vu DM, 2012, BIOCHEMISTRY-US, V51, P9104, DOI 10.1021/bi301296y; Xu M, 2012, J PHYS CHEM B, V116, P7014, DOI 10.1021/jp3012365; Zarrine-Afsar A, 2008, P NATL ACAD SCI USA, V105, P9999, DOI 10.1073/pnas.0801874105; Zhang ZQ, 2009, BIOPHYS J, V96, pL25, DOI 10.1016/j.bpj.2008.11.004	77	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0887-3585	1097-0134		PROTEINS	Proteins	OCT	2015	83	10					1900	1913		10.1002/prot.24874		14	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CR4NA	WOS:000361308800012		
J	Takizawa, R; Danese, A; Maughan, B; Arseneault, L				Takizawa, R.; Danese, A.; Maughan, B.; Arseneault, L.			Bullying victimization in childhood predicts inflammation and obesity at mid-life: a five-decade birth cohort study	PSYCHOLOGICAL MEDICINE			English	Article						Bullying victimization; epidemiology; inflammation; longitudinal studies; obesity	BODY-MASS INDEX; PSYCHOSOCIAL ADJUSTMENT; LONGITUDINAL COHORT; PEER VICTIMIZATION; PSYCHOTIC SYMPTOMS; DISEASE; HEALTH; ADVERSITY; CHILDREN; ASSOCIATION	Background. We aimed to test whether childhood bullying victimization increases risk for age-related disease at mid-life using biological markers including inflammation and adiposity, independent of other childhood risk factors and key adult variables. Method. The present study was a 50-year prospective longitudinal birth cohort study of all births in Britain in 1 week in 1958. Exposure to bullying was assessed prospectively when participants were aged 7 and 11 years (27.7% occasionally bullied; 14.6% frequently bullied). Blood inflammation biomarkers [C-reactive protein (CRP) and fibrinogen] and adiposity [body mass index (BMI) and waist: hip ratio] were measured at age 45 years. Results. Participants who had been frequently bullied in childhood showed increased levels of CRP at mid-life [beta = 0.07, 95% confidence interval (CI) 0.04-0.10] and higher risk for clinically relevant inflammation cut-off [CRP >3 mg/l: 20.4% v. 15.9%, odds ratio (OR) = 1.35, 95% CI 1.12-1.64]. Women who were bullied in childhood had higher BMI than non-bullied participants and were at increased risk of being obese (BMI >= 30 kg/m(2): occasionally bullied: 26.0% v. 19.4%, OR = 1.45, 95% CI 1.18-1.77; frequently bullied: 26.2% v. 19.4%, OR = 1.41, 95% CI 1.09-1.83). Findings remained significant when controlling for childhood risk factors (e.g. parental social class; participants' BMI and psychopathology in childhood) and key adult variables (e.g. adult social class, smoking, diet and exercise). Conclusions. Bullied children show increases in risk factors for age-related disease in middle adulthood, independent of co-occurring childhood and adult risks. Given the high prevalence of bullying victimization in childhood, tackling this form of psychosocial stress early in life has the potential of reducing risk for age-related disease and its associated burden.	[Takizawa, R.; Danese, A.; Maughan, B.; Arseneault, L.] Kings Coll London, Inst Psychiat Psychol & Neurosci, MRC Social Genet & Dev Psychiat Ctr, London SE5 8AF, England; [Takizawa, R.] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo 1138655, Japan; [Danese, A.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Child & Adolescent Psychiat, London SE5 8AF, England; [Danese, A.] South London & Maudsley NHS Fdn Trust, Natl & Specialist Child Traumat Stress & Anxiety, London, England	Arseneault, L (reprint author), Kings Coll London, Inst Psychiat Psychol & Neurosci, MRC Social Genet & Dev Psychiat Ctr, London SE5 8AF, England.	louise.arseneault@kcl.ac.uk			British Academy [MD120015]; Royal Society; British Academy	The authors thank all the participants in the 1958 NCDS; the Centre for Longitudinal Studies (CLS), Institute of Education for the use of these data; and the Economic and Social Data Service (ESDS) for making them available. However, neither the CLS nor the ESDS bears any responsibility for the analysis or interpretation of these data. We also thank Charlotte Clark and Stephen Stansfeld for the advice about the scoring of the Revised Clinical Interview Schedule and Andrew Pickles for statistical advice. This study received funding from the British Academy (MD120015) to L.A. as a Mid-Career Fellow. R.T. is a Newton International Fellow jointly funded by the Royal Society and the British Academy. The sponsors played no part in the design or conduct of the study, the analysis or interpretation of data, or the writing of the article and the decision to submit it for publication.	Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Takizawa R, 2014, AM J PSYCHIAT, V171, P777, DOI 10.1176/appi.ajp.2014.13101401; Anda RF, 1999, JAMA-J AM MED ASSOC, V282, P1652, DOI 10.1001/jama.282.17.1652; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Ouellet-Morin I, 2011, J AM ACAD CHILD PSY, V50, P574, DOI 10.1016/j.jaac.2011.02.015; Copeland WE, 2014, P NATL ACAD SCI USA, V111, P7570, DOI 10.1073/pnas.1323641111; Cole SW, 2012, P NATL ACAD SCI USA, V109, P20578, DOI 10.1073/pnas.1218253109; Totura CMW, 2009, J ADOLESCENCE, V32, P193, DOI 10.1016/j.adolescence.2008.04.005; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Nansel TR, 2004, ARCH PEDIAT ADOL MED, V158, P730, DOI 10.1001/archpedi.158.8.730; Clark C, 2007, ARCH GEN PSYCHIAT, V64, P668, DOI 10.1001/archpsyc.64.6.668; Schreier A, 2009, ARCH GEN PSYCHIAT, V66, P527, DOI 10.1001/archgenpsychiatry.2009.23; Bond L, 2001, BRIT MED J, V323, P480, DOI 10.1136/bmj.323.7311.480; Ouellet-Morin I, 2011, BIOL PSYCHIAT, V70, P1016, DOI 10.1016/j.biopsych.2011.06.017; Arseneault L, 2011, AM J PSYCHIAT, V168, P65, DOI 10.1176/appi.ajp.2010.10040567; Salmon G, 1998, BRIT MED J, V317, P924; Danese A, 2014, MOL PSYCHIATR, V19, P544, DOI 10.1038/mp.2013.54; Arseneault L, 2010, PSYCHOL MED, V40, P717, DOI 10.1017/S0033291709991383; Van Geel M, 2014, JAMA PEDIATR, V168, P435, DOI 10.1001/jamapediatrics.2013.4143; Midei AJ, 2011, OBES REV, V12, pe159, DOI 10.1111/j.1467-789X.2010.00823.x; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Nansel TR, 2001, JAMA-J AM MED ASSOC, V285, P2094, DOI 10.1001/jama.285.16.2094; Danese A, 2012, PHYSIOL BEHAV, V106, P29, DOI 10.1016/j.physbeh.2011.08.019; Danese A, 2007, P NATL ACAD SCI USA, V104, P1319, DOI 10.1073/pnas.0610362104; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Power C, 2012, BRIT J PSYCHIAT, V201, P199, DOI 10.1192/bjp.bp.111.096032; Conti G, 2012, P NATL ACAD SCI USA, V109, P8866, DOI 10.1073/pnas.1205340109; Ouellet-Morin I, 2013, PSYCHOL MED, V43, P1813, DOI 10.1017/S0033291712002784; Ronning JA, 2009, SOC PSYCH PSYCH EPID, V44, P15, DOI 10.1007/s00127-008-0395-0; Brent DA, 2013, JAMA-J AM MED ASSOC, V309, P1777, DOI 10.1001/jama.2013.4220; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Rosenman S, 2004, SOC PSYCH PSYCH EPID, V39, P695, DOI 10.1007/s00127-004-0802-0; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Babor T. F., 2001, ALCOHOL USE DISORDER; Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; Douglas J., 1964, HOME SCH; Ebrahim S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001561.pub2; Fisher HL, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2683; LEWIS G, 1992, PSYCHOL MED, V22, P465; Matthews KA, 2014, BRAIN BEHAV IMMUN, V36, P29, DOI 10.1016/j.bbi.2013.09.013; Office of Population Censuses and Surveys, 1980, CLASS OCC; Olweus D., 1993, BULLYING SCH WHAT WE; Qualter P, 2015, AGGRESSIVE BEHAV, V41, P109, DOI 10.1002/AB.21580; Seaman SR, 2013, STAT METHODS MED RES, V22, P278, DOI 10.1177/0962280210395740; Shakoor S, 2011, J ABNORM CHILD PSYCH, V39, P379, DOI 10.1007/s10802-010-9463-5; Singh GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065174; Stott D., 1969, SOCIAL ADJUSTMENT CH	51	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0033-2917	1469-8978		PSYCHOL MED	Psychol. Med.	OCT	2015	45	13					2705	2715		10.1017/S0033291715000653		11	Psychology, Clinical; Psychiatry; Psychology	Psychology; Psychiatry	CR2JQ	WOS:000361156000003		
J	Ishii, S; Katagiri, R; Minobe, Y; Kuribara, I; Wada, T; Wada, M; Imai, S				Ishii, Satoko; Katagiri, Ritsuko; Minobe, Yasushi; Kuribara, Isamu; Wada, Takeharu; Wada, Mitsuhiro; Imai, Shigeo			Investigation of the amount of transdermal exposure of newborn babies to phthalates in paper diapers and certification of the safety of paper diapers	REGULATORY TOXICOLOGY AND PHARMACOLOGY			English	Article						Risk assessment; Hazard assessment; Exposure assessment; Diaper; Phthalates; Nonwoven fabric	CHILD-CARE ARTICLES; DI(2-ETHYLHEXYL) PHTHALATE; PERCUTANEOUS-ABSORPTION; RAT; SKIN; METABOLISM; TOXICITY; DIESTERS; INVITRO; TOYS	A risk assessment study of seven phthalates in paper diapers for newborn babies produced in Japan was performed. The diapers were purchased and the contents of the seven phthalates were determined and estimated amounts of exposure were calculated based on the eluted rate into artificial medium of urine or sweat, average weight of infants, and frequency of use. Di-2-ethylhexyl phthalate and di-n-butyl phthalate were detected in the topsheets and determined to be 0.6 mu g/g and 0.2 mu g/g, respectively. The daily estimated exposure volume was calculated to be in the range of 1.86 x 10(-10)-2.98 x 10(-6) mg/kg/day as follows: content of seven phthalates in the topsheet (0.1-1 mu g/g) x eluted rate of phthalates into artificial sweat (0.0006-2.4%) x weight of the topsheet of a diaper (1.5 g) x the number of diapers used per day (12 sheets) x skin absorption rate (0.005-0.1)/average body weight (2.9 kg). For hazard assessment, we used 0.2-300 mg/kg/day for the seven phthalates based on the data available at international agencies. The margin of exposure to the seven phthalates was 6.71 x 10(4)-1.99 x 10(11), indicating that the risk of exposure to phthalates from the diapers produced in Japan was negligible. (C) 2015 Elsevier Inc. All rights reserved.	[Ishii, Satoko; Katagiri, Ritsuko; Minobe, Yasushi; Kuribara, Isamu; Wada, Takeharu] Chem Evaluat & Res Inst, Tokyo 1120004, Japan; [Wada, Mitsuhiro; Imai, Shigeo] Unicharm Corp, Tokyo, Japan	Ishii, S (reprint author), Chem Evaluat & Res Inst, Bunkyo Ku, 1-4-25 Kouraku, Tokyo 1120004, Japan.	ishii-satoko@ceri.jp					Al-Natsheh M, 2015, J CHROMATOGR B, V985, P103, DOI 10.1016/j.jchromb.2015.01.010; Lington AW, 1997, FUND APPL TOXICOL, V36, P79, DOI 10.1006/faat.1997.2286; Earls AO, 2003, J CHROMATOGR A, V983, P237, DOI 10.1016/S0021-9673(02)01736-3; Hopf NB, 2014, TOXICOL LETT, V224, P47, DOI 10.1016/j.toxlet.2013.10.004; Blystone CR, 2010, TOXICOL SCI, V116, P640, DOI 10.1093/toxsci/kfq147; Gray LE, 2009, TOXICOL SCI, V110, P411, DOI 10.1093/toxsci/kfp109; Nagao T, 2000, REPROD TOXICOL, V14, P513, DOI 10.1016/S0890-6238(00)00105-2; Christiansen S, 2010, REPROD TOXICOL, V30, P313, DOI 10.1016/j.reprotox.2010.04.005; ELSISI AE, 1989, FUND APPL TOXICOL, V12, P70, DOI 10.1016/0272-0590(89)90063-8; BARBER ED, 1992, FUND APPL TOXICOL, V19, P493, DOI 10.1016/0272-0590(92)90086-W; Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6; ATSDR (Agency for Toxic Substances and Disease Registry), 2002, TOX PROF DI 2 ETH PH; CERI/NITE, 2006, 204 CERINITE; CERI/NITE, 2005, 11 CERINITE; DeVito MJ, 2002, ENVIRON HEALTH PERSP, V110, P23; ECHA, 2013, EV NEW SCI EV CONC D; ECHA, 2010, REV NEW AV INF DI N; EU SCCS, 2012, SCI COMM CONS SAF NO; EU-CSTEE, 1998, OP PHTHAL MIGR SOFT; EU-RAR, 2004, DIB PHTHAL, V29; EU-RAR, 2008, BIS 2 ETH PHTHAL DEH, V80; EU-RAR, 2003, 1 2 BENZ AC DI C9 11, V36; EU-RAR, 2007, BENZ BUT PHTHAL BBP, V76; EU-RAR, 2003, 1 2 BENZ AC DI C8 10, V35; Hazelton Laboratories, 1968, 161167 WR GRAC CO HA; Huang L., 2011, INT J CHEM, V3, P169; JMOE, 2002, BIS 2 ETH PHTHAL, V1, P361; JMOE, 2011, DI N OCT PHTHAL, V9; JMOE, 2004, BUT BENZ PHTHAL, V3; Kim HS, 2004, J TOXICOL ENV HEAL A, V67, P2045, DOI 10.1080/15287390490514859; MELNICK RL, 1987, TOXICOL IND HEALTH, V3, P99; NG KME, 1992, TOXICOL APPL PHARM, V115, P216, DOI 10.1016/0041-008X(92)90326-N; NICNAS (National Industrial Chemicals Notification and Assessment Scheme), 2008, EX CHEM HAZ ASS REP; NTP-CERHR, 2000, NTPCERHRDINP00; SCOTT RC, 1987, ENVIRON HEALTH PERSP, V74, P223, DOI 10.2307/3430452; Zhu Xiao Bo, 2010, Okajimas Folia Anatomica Japonica, V86, P129	36	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0273-2300	1096-0295		REGUL TOXICOL PHARM	Regul. Toxicol. Pharmacol.	OCT	2015	73	1					85	92		10.1016/j.yrtph.2015.06.010		8	Medicine, Legal; Pharmacology & Pharmacy; Toxicology	Legal Medicine; Pharmacology & Pharmacy; Toxicology	CR5UU	WOS:000361410700009		
J	Yamada, T; Tanaka, Y; Hasegawa, R; Sakuratani, Y; Yamazoe, Y; Ono, A; Hirose, A; Hayashi, M				Yamada, Takashi; Tanaka, Yushiro; Hasegawa, Ryuichi; Sakuratani, Yuki; Yamazoe, Yasushi; Ono, Atsushi; Hirose, Akihiko; Hayashi, Makoto			Authors' response to Letter to the Editor by Jeff Kelsey et al. "Response to 'Development of a category approach to predict the testicular toxicity of chemical substances structurally related to ethylene glycol methyl ether.'" 2015	REGULATORY TOXICOLOGY AND PHARMACOLOGY			English	Letter						Category approach; Repeated-dose toxicity; Testicular toxicity; Methoxyacetic acid; Adverse outcome pathway			[Yamada, Takashi; Tanaka, Yushiro; Hasegawa, Ryuichi; Sakuratani, Yuki] Natl Inst Technol & Evaluat, Kisarazu, Japan	Yamada, T (reprint author), Natl Inst Technol & Evaluat, Kisarazu, Japan.	yamada-takashi@nite.go.jp					Yamada T, 2014, REGUL TOXICOL PHARM, V70, P711, DOI 10.1016/j.yrtph.2014.10.011	1	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0273-2300	1096-0295		REGUL TOXICOL PHARM	Regul. Toxicol. Pharmacol.	OCT	2015	73	1					209	209		10.1016/j.yrtph.2015.07.002		1	Medicine, Legal; Pharmacology & Pharmacy; Toxicology	Legal Medicine; Pharmacology & Pharmacy; Toxicology	CR5UU	WOS:000361410700022		
J	Barber, C; Amberg, A; Custer, L; Dobo, KL; Dobo, KL; Van Gompel, J; Gutsell, S; Harvey, J; Honma, M; Kenyon, MO; Kruhlak, N; Muster, W; Stavitskaya, L; Teasdale, A; Vessey, J; Wichard, J				Barber, Chris; Amberg, Alexander; Custer, Laura; Dobo, Krista L.; Glowienke, Susanne; Van Gompel, Jacky; Gutsell, Steve; Harvey, Jim; Honma, Masamitsu; Kenyon, Michelle O.; Kruhlak, Naomi; Muster, Wolfgang; Stavitskaya, Lidiya; Teasdale, Andrew; Vessey, Jonathan; Wichard, Joerg			Establishing best practise in the application of expert review of mutagenicity under ICH M7	REGULATORY TOXICOLOGY AND PHARMACOLOGY			English	Article						ICH M7; Ames; Genotoxicity; Mutagenicity; Expert rule-based; Statistical; In silico	IN-SILICO SYSTEMS; APPLICABILITY DOMAIN; IMPURITIES; KNOWLEDGE; GENOTOXICITY; METABOLITES; PREDICTION; ADENINE	The ICH M7 guidelines for the assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals allows for the consideration of in silico predictions in place of in vitro studies. This represents a significant advance in the acceptance of (Q)SAR models and has resulted from positive interactions between modellers, regulatory agencies and industry with a shared purpose of developing effective processes to minimise risk. This paper discusses key scientific principles that should be applied when evaluating in silico predictions with a focus on accuracy and scientific rigour that will support a consistent and practical route to regulatory submission. (C) 2015 Elsevier Inc. All rights reserved.	[Barber, Chris; Vessey, Jonathan] Lhasa Ltd, Leeds LS11 5PS, W Yorkshire, England; [Amberg, Alexander] Sanofi Aventis Deutschland GmbH, DSAR Preclin Safety, Frankfurt, Germany; [Custer, Laura] Bristol Myers Squibb, Drug Safety Evaluat, New Brunswick, NJ USA; [Dobo, Krista L.; Kenyon, Michelle O.] Pfizer, Drug Safety Res & Dev, Groton, CT USA; [Glowienke, Susanne] Novartis Inst Biomed Res, Dept Preclin Safety, Basel, Switzerland; [Van Gompel, Jacky] Janssen, Drug Safety Sci, Beerse, Belgium; [Gutsell, Steve] Unilever, Safety & Environm Assurance Ctr, Colworth, Beds, England; [Harvey, Jim] GlaxoSmithkline, Computat Toxicol, Ware, Herts, England; [Honma, Masamitsu] Natl Inst Hlth Sci, Tokyo, Japan; [Kruhlak, Naomi; Stavitskaya, Lidiya] FDA Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Muster, Wolfgang] F Hoffmann La Roche Ltd, Pharma Res & Early Dev, Basel, Switzerland; [Teasdale, Andrew] AstraZeneca, Macclesfield, Cheshire, England; [Wichard, Joerg] Bayer, HealthCare, Genet Toxicol, Berlin, Germany	Barber, C (reprint author), Lhasa Ltd, Granary Wharf House,2 Canal Wharf, Leeds LS11 5PS, W Yorkshire, England.	chris.barber@lhasalimited.org					Judson PN, 2013, TOXICOL RES-UK, V2, P70, DOI 10.1039/c2tx20037f; WADE DR, 1978, MUTAT RES, V58, P217, DOI 10.1016/0165-1218(78)90012-5; Greene N, 2015, REGUL TOXICOL PHARM, V72, P335, DOI 10.1016/j.yrtph.2015.05.008; Tichenor MS, 2012, BIOORG MED CHEM LETT, V22, P7357, DOI 10.1016/j.bmcl.2012.10.076; Naven RT, 2012, EXPERT OPIN DRUG MET, V8, P1579, DOI 10.1517/17425255.2012.724059; CLEMENT B, 1990, BIOCHEM PHARMACOL, V39, P925, DOI 10.1016/0006-2952(90)90209-4; Muller L, 2006, REGUL TOXICOL PHARM, V44, P198, DOI 10.1016/j.yrtph.2005.12.001; Netzeva TI, 2005, ATLA-ALTERN LAB ANIM, V33, P155; Bentzien J, 2010, J CHEM INF MODEL, V50, P274, DOI 10.1021/ci900378x; Hillebrecht A, 2011, CHEM RES TOXICOL, V24, P843, DOI 10.1021/tx2000398; Sahigara F, 2012, MOLECULES, V17, P4791, DOI 10.3390/molecules17054791; Dobo KL, 2012, REGUL TOXICOL PHARM, V62, P449, DOI 10.1016/j.yrtph.2012.01.007; Valinluck V, 2002, CHEM RES TOXICOL, V15, P1595, DOI 10.1021/tx020062y; [Anonymous], 1978, SPECTROSCOPY, DOI DOI 10.1021/J000400A025; JOHNSTON HM, 1979, GENETICS, V92, P1; FEIG AL, 1988, BIOCHEM BIOPH RES CO, V155, P338, DOI 10.1016/S0006-291X(88)81090-8; Benigni R, 2008, MUTAT RES-REV MUTAT, V659, P248, DOI 10.1016/j.mrrev.2008.05.003; SURH YJ, 1994, CHEM-BIOL INTERACT, V92, P351, DOI 10.1016/0009-2797(94)90076-0; Sutter A, 2013, REGUL TOXICOL PHARM, V67, P39, DOI 10.1016/j.yrtph.2013.05.001; GORROD JW, 1993, ENVIRON HEALTH PERSP, V101, P21, DOI 10.2307/3431694; Barber C., 2014, SOC TOX 53 ANN M; EMEA, 1998, COPP CHLOR COPP GLUC; Hanser T, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-21; Mathison B.H., 1995, TOXICOL SCI, V28, P255, DOI 10.1093/toxsci/28.2.255; OECD, 2004, OECD PRINCIPLES VALI; Powley MW, 2015, REGUL TOXICOL PHARM, V71, P295, DOI 10.1016/j.yrtph.2014.12.012; University of Hertfordshire, PESTICIDES PROPERTIE; Williams R., 2014, GEN TOX ASS M NETW D; Wolfenden R, 2007, P NATL ACAD SCI USA, V104, P83, DOI 10.1073/pnas.0609644104	29	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0273-2300	1096-0295		REGUL TOXICOL PHARM	Regul. Toxicol. Pharmacol.	OCT	2015	73	1					367	377		10.1016/j.yrtph.2015.07.018		11	Medicine, Legal; Pharmacology & Pharmacy; Toxicology	Legal Medicine; Pharmacology & Pharmacy; Toxicology	CR5UU	WOS:000361410700039		
J	Tramontana, G; Ichii, K; Camps-Valls, G; Tomelleri, E; Papale, D				Tramontana, Gianluca; Ichii, Kazuito; Camps-Valls, Gustau; Tomelleri, Enrico; Papale, Dario			Uncertainty analysis of gross primary production upscaling using Random Forests, remote sensing and eddy covariance data	REMOTE SENSING OF ENVIRONMENT			English	Article						Upscaling; Uncertainty; Random Forest; MOD17; GPP; Vegetation indices	NET ECOSYSTEM EXCHANGE; LAND-SURFACE TEMPERATURE; TERRESTRIAL GROSS; BIOSPHERE MODEL; MODIS EVI; CLIMATE; EUROPE; FLUXES; CLASSIFICATION; ASSIMILATION	The accurate quantification of carbon fluxes at continental spatial scale is important for future policy decisions in the context of global climate change. However, many elements contribute to the uncertainty of such estimate. In this study, the uncertainties of eight days gross primary production (GPP) predicted by Random Forest (RF) machine learning models were analysed at the site, ecosystem and European spatial scales. At the site level, the uncertainties caused by the missing of key drivers were evaluated. The most accurate predictions of eight days GPP were obtained when all available drivers were used (Pearson's correlation coefficient, rho similar to 0.84; Root Mean Square Error (RMSE) similar to 1.8 g C m(-2) d(-1)). However, when predictions were based on only remotely sensed data the accuracy was close to the optimum (rho similar to 0.8; RMSE similar to 1.9 g C m(-2) d(-1)) and to a commonly used light use efficiency model (MOD17) with parameters optimised for the applied study sites (the MOD17 +, rho similar to 0.79; RMSE similar to 2.04 g C m(-2) d(-1)). Remotely sensed data were key drivers for the accurate prediction of GPP in ecosystems with high variability of green biomass over the phenological cycle (e.g., deciduous broad-leaved forests) or highly affected by the human management (e.g. croplands). In contrast, in the ecosystems with low variability of greenness (e.g., evergreen broad-leaved forests), the predictions were poor when meteorological information were not used. At a European spatial scale, when modelled grids of meteorological, land cover and fPAR data were used as inputs, the propagation of their uncertainty, not accounted in the models training, had significant effects on the uncertainty of the mean annual GPP. At this scale, the effects of meteorological uncertainty were higher than the misclassification error. These findings suggested that a strategy based on satellite-measured data could be a favourable improvement for the spatial upscaling of GPP, because avoiding the propagation of the uncertainties of the modelled grids. (C) 2015 Elsevier Inc. All rights reserved.	[Tramontana, Gianluca; Papale, Dario] Univ Tuscia, Dept Innovat Biol Agrofood & Forest Syst, DIBAF, I-01100 Viterbo, Italy; [Ichii, Kazuito] Japan Agcy Marine Earth Sci & Technol, Dept Environm Geochem Cycle, Yokohama, Kanagawa 2360001, Japan; [Camps-Valls, Gustau] Univ Valencia, Image & Signal Proc Grp ISP, Image Proc Lab, Valencia 46980, Spain; [Tomelleri, Enrico] European Acad Bozen EURAC, Inst Appl Remote Sensing, I-39100 Bolzano, Italy	Tramontana, G (reprint author), Univ Tuscia, Dept Innovat Biol Agrofood & Forest Syst, DIBAF, Via San Camillo de Lellis Snc, I-01100 Viterbo, Italy.	g.tramontana@unitus.it; kazuhito.ichii@gmail.com; gustau.camps@uv.es; enrico.tomelleri@eurac.edu; darpap@unitus.it		Papale, Dario/0000-0001-5170-8648	Max Planck Institute (MPI) for Biogeochemistry; EU project GEOCARBON; Ministry of the Environment of Japan [2-1401]; Spanish Ministry of Economy and Competitiveness (MINECO) under project LIFE-VISION [TIN2012-38102-C03-01]; GHG-Europe project; ICOS-INWIRE	The authors thank Martin Jung, Markus Reichstein and Max Planck Institute (MPI) for Biogeochemistry for their support, discussions and hospitality.; Gianluca Tramontana has been supported by the EU project GEOCARBON. Kazuhito Ichii acknowledges the support by the Environment Research and Technology Development Fund (2-1401) from the Ministry of the Environment of Japan. Gustau Camps-Valls acknowledges the support of the Spanish Ministry of Economy and Competitiveness (MINECO) under project LIFE-VISION TIN2012-38102-C03-01. Enrico Tomelleri acknowledges the financial support of the GHG-Europe project. Dario Papale thanks ICOS-INWIRE for the support.	Sims DA, 2008, REMOTE SENS ENVIRON, V112, P1633, DOI 10.1016/j.rse.2007.08.004; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Desai AR, 2008, AGR FOREST METEOROL, V148, P821, DOI 10.1016/j.agrformet.2007.11.012; Lasslop G, 2010, GLOBAL CHANGE BIOL, V16, P187, DOI 10.1111/j.1365-2486.2009.02041.x; Yang FH, 2007, REMOTE SENS ENVIRON, V110, P109, DOI 10.1016/j.rse.2007.02.016; Haxeltine A, 1996, GLOBAL BIOGEOCHEM CY, V10, P693, DOI 10.1029/96GB02344; Jung M, 2007, BIOGEOSCIENCES, V4, P647; Gao BC, 1996, REMOTE SENS ENVIRON, V58, P257, DOI 10.1016/S0034-4257(96)00067-3; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Papale D, 2006, BIOGEOSCIENCES, V3, P571; Jung M, 2009, BIOGEOSCIENCES, V6, P2001; Papale D, 2003, GLOBAL CHANGE BIOL, V9, P525, DOI 10.1046/j.1365-2486.2003.00609.x; Gislason PO, 2006, PATTERN RECOGN LETT, V27, P294, DOI 10.1016/j.patrec.2005.08.011; Olofsson P, 2008, BIOGEOSCIENCES, V5, P817; Zhao MS, 2005, REMOTE SENS ENVIRON, V95, P164, DOI 10.1016/j.rse.2004.12.011; Wan ZM, 2002, REMOTE SENS ENVIRON, V83, P163, DOI 10.1016/S0034-4257(02)00093-7; Evans JS, 2009, LANDSCAPE ECOL, V24, P673, DOI 10.1007/s10980-009-9341-0; Jung M, 2008, GLOBAL CHANGE BIOL, V14, P2349, DOI 10.1111/j.1365-2486.2008.01647.x; Myneni RB, 2002, REMOTE SENS ENVIRON, V83, P214, DOI 10.1016/S0034-4257(02)00074-3; Heinsch FA, 2006, IEEE T GEOSCI REMOTE, V44, P1908, DOI 10.1109/TGRS.2005.853936; Xiao JF, 2010, REMOTE SENS ENVIRON, V114, P576, DOI 10.1016/j.rse.2009.10.013; Running SW, 1999, REMOTE SENS ENVIRON, V70, P108, DOI 10.1016/S0034-4257(99)00061-9; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Oliveira S, 2012, FOREST ECOL MANAG, V275, P117, DOI 10.1016/j.foreco.2012.03.003; O'Hagan A, 2012, ENVIRON MODELL SOFTW, V36, P35, DOI 10.1016/j.envsoft.2011.03.003; Sjostrom M, 2011, REMOTE SENS ENVIRON, V115, P1081, DOI 10.1016/j.rse.2010.12.013; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Ho TK, 1998, IEEE T PATTERN ANAL, V20, P832; Xiao XM, 2004, REMOTE SENS ENVIRON, V91, P256, DOI 10.1016/j.rse.2004.03.010; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Aubinet M., 2012, EDDY COVARIANCE PRAC; Beer C, 2009, GLOBAL BIOGEOCHEMICA, V23, P1, DOI DOI 10.1029/2008GB003233; Beer C, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029006; Gin C., 2005, REMOTE SENS ENVIRON, V94, P123; Hastie T., 2001, SPRINGER SERIES STAT, P587; Jung M, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002915; Jung M, 2013, PROCEDIA COMPUT SCI, V18, P2337, DOI 10.1016/j.procs.2013.05.405; Jung M., 2011, J GEOPHYS RES, V116, P1; Krinner G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002199; Moffat AM, 2010, GLOBAL CHANGE BIOL, V16, P2737, DOI 10.1111/j.1365-2486.2010.02171.x; Rahman AF, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024127; Running SW, 2000, METHODS IN ECOSYSTEM SCIENCE, P44; Schimel S. D., 1997, P NATL ACAD SCI USA, V94, P8280; Vermote E. F., 1999, MODIS ALGORITHM TECH; Zhao M, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2004JG000004	47	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0034-4257	1879-0704		REMOTE SENS ENVIRON	Remote Sens. Environ.	OCT	2015	168						360	373		10.1016/j.rse.2015.07.015		14	Environmental Sciences; Remote Sensing; Imaging Science & Photographic Technology	Environmental Sciences & Ecology; Remote Sensing; Imaging Science & Photographic Technology	CR5SY	WOS:000361405500028		
J	ElGharbawi, T; Tamura, M				ElGharbawi, Tamer; Tamura, Masayuki			Coseismic and postseismic deformation estimation of the 2011 Tohoku earthquake in Kanto Region, Japan, using InSAR time series analysis and GPS	REMOTE SENSING OF ENVIRONMENT			English	Article						2011 Tohoku earthquake; Boso peninsula; Crustal deformation estimation; Coseismic; Postseismic; InSAR; GPS	TOKYO BAY AREA; RADAR INTERFEROMETRY; PACIFIC COAST; LIQUEFACTION; INTERFEROGRAMS; MOTION; STREAM; FAULT; SOIL	We propose a methodology using interferometric synthetic aperture radar (InSAR) time series analysis and a single GPS station to estimate the coseismic and postseismic crustal deformations in the Kanto region, Japan, which has been affected by the 2011 Tohoku earthquake. The proposed methodology depends on choosing a proper deformation trend(s) to accurately describe the earthquake deformation signature by studying the deformation time series of a single GPS station. The modeled deformation trend is subtracted from the unwrapped phase maps to separate the main deformation signature from the imposed errors. Some deformation components, not described by the model(s), will leak to the residual phase maps which will be subjected to temporal and spatial filtering. The final corrected unwrapped phase maps are estimated by restoring the modeled deformation trend to the filtered residual phase maps and finally the deformation time series is estimated using a least squares technique. The proposed methodology was designed to retrieve complex and fine surface deformations in areas that have been affected by large dominating deformation signatures and contain at a least single GPS station. The methodology was tested using Envisat-ASAR C-band images and validation was carried out using GPS stations resulting in a mean RMS error of 6.9 mm. The estimated deformation time series shows a differential postseismic deformation pattern that can be attributed to an off Boso peninsula motion triggered by the 2011 Tohoku earthquake. (C) 2015 Elsevier Inc. All rights reserved.	[ElGharbawi, Tamer; Tamura, Masayuki] Kyoto Univ, Dept Civil & Earth Resources Engn, Nishikyo Ku, Kyoto 6158540, Japan	ElGharbawi, T (reprint author), Kyoto Univ, Dept Civil & Earth Resources Engn, Nishikyo Ku, Kyoto 6158540, Japan.	elgharbawi.mosaad.64z@st.kyoto-u.ac.jp					Burgmann R, 2000, ANNU REV EARTH PL SC, V28, P169, DOI 10.1146/annurev.earth.28.1.169; GOLDSTEIN RM, 1993, SCIENCE, V262, P1525, DOI 10.1126/science.262.5139.1525; Yasuda S, 2012, SOILS FOUND, V52, P793, DOI 10.1016/j.sandf.2012.11.004; Wei M, 2010, ADV SPACE RES, V46, P236, DOI 10.1016/j.asr.2010.03.013; Tong X, 2013, J GEOPHYS RES-SOL EA, V118, P369, DOI 10.1029/2012JB009442; Wright TJ, 2004, SCIENCE, V305, P236, DOI 10.1126/science.1096388; Tokimatsu K, 2012, SOILS FOUND, V52, P956, DOI 10.1016/j.sandf.2012.11.014; Goldstein RM, 1998, GEOPHYS RES LETT, V25, P4035, DOI 10.1029/1998GL900033; Gourmelen N, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB007064; MASSONNET D, 1994, NATURE, V369, P227, DOI 10.1038/369227a0; Ozawa S, 2014, GEOPHYS RES LETT, V41, P2762, DOI 10.1002/2014GL060072; Berardino P, 2002, IEEE T GEOSCI REMOTE, V40, P2375, DOI 10.1109/TGRS.2002.803792; Biggs J, 2007, GEOPHYS J INT, V170, P1165, DOI 10.1111/j.1365-246X.2007.03415.x; Feng GC, 2012, IEEE GEOSCI REMOTE S, V9, P302, DOI 10.1109/LGRS.2011.2168191; Bhattacharya S, 2011, SOIL DYN EARTHQ ENG, V31, P1618, DOI 10.1016/j.soildyn.2011.06.006; Buckley S.M., 2003, J GEOPHYS RES, V108, P8; Costanthi M., 1999, GEOSC REM SENS S 199, V1, P267; EIGharbawi T., 2014, ISPRS J PHOTOGRAMM, V88, P156; Imakiire T., 2011, B GSI, V59, P21; Ishihara K., 2014, EARTHQUAKE GEOTECHNI, P93; Ishitsuka K., 2012, EARTH PLANETS SPACE, P1267; Martinez N. Y., 2012, IEEE GEOSCI REMOTE L, V9, P539, DOI [10.1109/LGRS.2012.2196020, DOI 10.1109/LGRS.2012.2196020]; Samsonov S, 2007, IEEE T GEOSCI REMOTE, V45, P512, DOI 10.1109/TGRS.2006.887166; Sandwell DT, 1998, J GEOPHYS RES-SOL EA, V103, P30183, DOI 10.1029/1998JB900008; Schmidt D.A., 2003, J GEOPHYS RES SOLID, V1978-2012, P108; Somerville P. G., 2014, GEOSCI LETT, V1, P1, DOI DOI 10.1186/2196-4092-1-10; Tamura M, 2013, CONFERENCE PROCEEDINGS OF 2013 ASIA-PACIFIC CONFERENCE ON SYNTHETIC APERTURE RADAR (APSAR), P548; Toda S, 2008, NAT GEOSCI, V1, P771, DOI 10.1038/ngeo318; Tsukamoto Y, 2012, SOILS FOUND, V52, P987, DOI 10.1016/j.sandf.2012.11.016; Yamagiwa A., 2006, B GEOGRAPHICAL SURVE, P27; Yamaguchi A, 2012, SOILS FOUND, V52, P811, DOI 10.1016/j.sandf.2012.11.005; Zhang S., 2008, INT ARCH PHOTOGRAMME, P161	32	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0034-4257	1879-0704		REMOTE SENS ENVIRON	Remote Sens. Environ.	OCT	2015	168						374	387		10.1016/j.rse.2015.07.016		14	Environmental Sciences; Remote Sensing; Imaging Science & Photographic Technology	Environmental Sciences & Ecology; Remote Sensing; Imaging Science & Photographic Technology	CR5SY	WOS:000361405500029		
J	Kakigano, A; Tomimatsu, T; Mimura, K; Kanayama, T; Fujita, S; Minato, K; Kumasawa, K; Taniguchi, Y; Kanagawa, T; Endo, M; Ishihara, T; Namba, T; Mizushima, T; Kimura, T				Kakigano, Aiko; Tomimatsu, Takuji; Mimura, Kazuya; Kanayama, Tomoko; Fujita, Satoko; Minato, Kenji; Kumasawa, Keiichi; Taniguchi, Yukiko; Kanagawa, Takeshi; Endo, Masayuki; Ishihara, Tomoaki; Namba, Takushi; Mizushima, Tohru; Kimura, Tadashi			Drug Repositioning for Preeclampsia Therapeutics by In Vitro Screening: Phosphodiesterase-5 Inhibitor Vardenafil Restores Endothelial Dysfunction via Induction of Placental Growth Factor	REPRODUCTIVE SCIENCES			English	Article						drug repositioning; preeclampsia; PlGF; angiogenesis; PDE5 inhibitor	UTERINE ARTERY; MOUSE MODEL; SILDENAFIL; ANGIOGENESIS; PREGNANCY; RISK; PRAVASTATIN; EXPRESSION; INSIGHTS; PATHWAY	We screened a library of 528 approved drugs to identify candidate compounds with therapeutic potential as preeclampsia treatments via their proangiogenic properties. Using human umbilical vein endothelial cells (HUVECs), we assessed whether the screened drugs induced placental growth factor (PIGF) and restored damaged endothelial cell function. Enzyme-linked immunosorbent assays (ELISAs) were carried out to measure levels of PlGF in conditioned media treated with each drug (100 mu mol/L) in the drug library. Tube formation assays were performed using HUVECs to evaluate the angiogenic effects of drugs that induced PlGF. We also performed ELISA, quantitative reverse transcription polymerase chain reaction, and tube formation assays after treatment with a range of concentrations of the candidate drug. Of the drugs that induced PlGF, vardenafil was the only compound that significantly facilitated tube formation in comparison with the control cells (P < .01). Treatment with vardenafil at concentrations of 50, 100, and 250 mu mol/L increased expression of PlGF in a dose-dependent manner. Vardenafil (250 mu mol/L) significantly improved tube formation which was inhibited in the presence of soluble fms-like tyrosine kinase 1 (100 ng/mL) and/or soluble endoglin (100 ng/mL). Production of PlGF from HUVECs in the presence of sera derived from patients with preeclampsia was significantly elevated by administration of vardenafil (250 mu mol/L). By assessing drug repositioning through screening a library of approved drugs, we identified vardenafil as a potential protective agent against preeclampsia. The therapeutic mechanism of vardenafil may involve inhibition of the systemic maternal antiangiogenic state that leads to preeclampsia, in addition to its vasodilating effect. As concentrations used are high and unlikely to be useful clinically, further work is needed before testing it in humans.	[Kakigano, Aiko; Tomimatsu, Takuji; Mimura, Kazuya; Kanayama, Tomoko; Fujita, Satoko; Minato, Kenji; Kumasawa, Keiichi; Taniguchi, Yukiko; Kanagawa, Takeshi; Endo, Masayuki; Kimura, Tadashi] Osaka Univ, Dept Obstet & Gynecol, Sch Med, Suita, Osaka 5650871, Japan; [Ishihara, Tomoaki; Mizushima, Tohru] Keio Univ, Fac Pharm, Tokyo, Japan; [Namba, Takushi] Kochi Univ, Ctr Sci Res, Kochi 780, Japan	Tomimatsu, T (reprint author), Osaka Univ, Dept Obstet & Gynecol, Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tomimatsu@gyne.med.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [T23592402, T25462555, T25462556, A00249080]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by Grant-in-Aid for General Scientific Research (T23592402, T25462555, T25462556 and A00249080) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Miller SC, 2010, BIOCHEM PHARMACOL, V79, P1272, DOI 10.1016/j.bcp.2009.12.021; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)17987-2; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Roberts JM, 2005, HYPERTENSION, V46, P1243, DOI 10.1161/01.HYP.0000188408.49896.c5; Ramesar SV, 2011, EUR J OBSTET GYN R B, V157, P136, DOI 10.1016/j.ejogrb.2011.03.005; Lin TH, 2012, ULTRASOUND OBST GYN, V40, P609, DOI 10.1002/uog.11142; Samangaya RA, 2009, HYPERTENS PREGNANCY, V28, P369, DOI 10.3109/10641950802601278; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Rogers JM, 2009, REPROD TOXICOL, V28, P152, DOI 10.1016/j.reprotox.2009.03.012; Goodwin AM, 2007, MICROVASC RES, V74, P172, DOI 10.1016/j.mvr.2007.05.006; Sahara M, 2010, ARTERIOSCL THROM VAS, V30, P1315, DOI 10.1161/ATVBAHA.109.201327; von Dadelszen P, 2011, BJOG-INT J OBSTET GY, V118, P624, DOI 10.1111/j.1471-0528.2010.02879.x; Wareing M, 2004, AM J OBSTET GYNECOL, V190, P1283, DOI 10.1016/j.ajog.2003.12.024; Nelson SH, 2000, CIRC RES, V87, P406; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Stanley JL, 2012, HYPERTENSION, V59, P1021, DOI 10.1161/HYPERTENSIONAHA.111.186270; Shahinas D, 2010, J MED CHEM, V53, P3552, DOI 10.1021/jm901796s; Kumasawa K, 2011, P NATL ACAD SCI USA, V108, P1451, DOI 10.1073/pnas.1011293108; Costantine MM, 2013, OBSTET GYNECOL, V121, P349, DOI [http://10.1097/AOG.0b013e31827d8ad5, 10.1097/AOG.0b013e31827d8ad5]; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Bdolah Y, 2004, SEMIN NEPHROL, V24, P548, DOI 10.1016/S0270-9295(04)00125-1; Fisk NM, 2008, PLOS MED, V5, P22, DOI 10.1371/journal.pmed.0050022; Gerald GB, 2011, DRUGS PREGNANCY LACT, V9th; Jeremy JY, 1997, BRIT J UROL, V79, P958, DOI 10.1046/j.1464-410X.1997.00206.x; Khalil RA, 1998, HYPERTENSION, V31, P1065; Levine RJ, 2005, JAMA-J AM MED ASSOC, V293, P77, DOI 10.1001/jama.293.1.77; Mimura K, 2010, AM J OBSTET GYNECOL, V202; Pyriochou A, 2007, J CELL PHYSIOL, V211, P197, DOI 10.1002/jcp.20929	32	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	OCT	2015	22	10					1272	1280		10.1177/1933719115574340		9	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CR7LD	WOS:000361530300011		
J	Miyazaki, T; Sumii, R; Tanaka, H; Amemiya, K; Hino, S				Miyazaki, T.; Sumii, R.; Tanaka, H.; Amemiya, K.; Hino, S.			Surface electronic structures of lithium nickel oxide solid solutions: selective methane oxidation	RESEARCH ON CHEMICAL INTERMEDIATES			English	Article						Lithium nickel oxides; Ultraviolet photoemission spectroscopy; Valence band structure; Oxidative coupling of methane; Selective oxidation	CATALYSIS	Ultraviolet photoelectron spectra (UPS) of lithium nickel oxide (Li (x) Ni2-x O-2, 0 < x a parts per thousand currency sign 1.0) solid solution were measured using a synchrotron radiation light source. The upper valence UPS are confirmed to consist of five structures for E (b) < 15 eV. The electronic density of two O2p states changed as the compositional ratio of Li and Ni. After a contact reaction of LiNiO2 and methane gas, the peak intensity of one of two O2p states decreased remarkably. It was found that the surface oxygen at the lower binding energy was selectively contributed to dissociate sigma-bond between carbon and hydrogen of methane.	[Miyazaki, T.; Tanaka, H.; Hino, S.] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan; [Sumii, R.] Ultraviolet Synchrotron Orbital Radiat Facil UVSO, Inst Mol Sci, Okazaki, Aichi 4448577, Japan; [Sumii, R.; Amemiya, K.] High Energy Accelerator Res Org KEK PF, Inst Mat Struct Sci, Tsukuba, Ibaraki 3050801, Japan	Miyazaki, T (reprint author), Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan.	miyazaki@eng.ehime-u.ac.jp					Dedov AG, 2003, APPL CATAL A-GEN, V245, P209, DOI 10.1016/S0926-860X(02)00641-5; LUNSFORD JH, 1995, ANGEW CHEM INT EDIT, V34, P970, DOI 10.1002/anie.199509701; Zeng Y, 2001, APPL CATAL A-GEN, V213, P33, DOI 10.1016/S0926-860X(00)00877-2; MLECZKO L, 1995, FUEL PROCESS TECHNOL, V42, P217, DOI 10.1016/0378-3820(94)00121-9; ITO T, 1985, J AM CHEM SOC, V107, P5062, DOI 10.1021/ja00304a008; Gaffney M., 1988, J CATAL, V114, P422; HATANO M, 1988, INORG CHIM ACTA, V146, P243, DOI 10.1016/S0020-1693(00)80615-5; KELLER GE, 1982, J CATAL, V73, P9, DOI 10.1016/0021-9517(82)90075-6; Maksimov NG, 1998, CATAL TODAY, V42, P279, DOI 10.1016/S0920-5861(98)00103-5; Miyazaki T, 1997, APPL SURF SCI, V121, P492, DOI 10.1016/S0169-4332(97)00347-4; Miyazaki T, 1997, STUD SURF SCI CATAL, V110, P245; Miyazaki T., 2008, APPL CATAL A-GEN, V38, P79	12	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0922-6168	1568-5675		RES CHEM INTERMEDIAT	Res. Chem. Intermed.	OCT	2015	41	10					7405	7412		10.1007/s11164-014-1820-5		8	Chemistry, Multidisciplinary	Chemistry	CR6TY	WOS:000361481800034		
J	Nishikiori, H; Sato, Y; Oki, K; Fujii, T				Nishikiori, Hiromasa; Sato, Yohei; Oki, Kyoichi; Fujii, Tsuneo			Photocatalytic degradation of chlorinated propenes using TiO2	RESEARCH ON CHEMICAL INTERMEDIATES			English	Article						Titanium dioxide; Photocatalysis; Chlorinated propene; Chlorinated butene; Degradation	GAS-PHASE; HETEROGENEOUS PHOTOCATALYSIS; DICHLOROACETYL CHLORIDE; REACTION PATHWAYS; ACTIVE-SITES; TRICHLOROETHYLENE; OXIDATION; PHOTOOXIDATION; SURFACE; MECHANISM	The photocatalytic degradation of chlorinated propenes using TiO2 was investigated by FTIR spectroscopy. The chlorinated propenes were degraded to HCl, CO2, CO, H2O, and HCOOH during UV irradiation. During the degradation of 3-chloro-1-propene, the concentrations of CO2, CO, and HCOOH increased just after starting the irradiation. The onset of the HCl formation was delayed. On the other hand, the onset of the HCOOH formation was delayed during the degradation of 1-chloro-1-propene. During the degradation of 2-chloro-1-propene, the rate of the HCOOH production was slower than that during the degradation of 3-chloro-1-propene although the HCl production was not delayed. These results indicated that HCOOH was produced by the degradation of the double-bonded carbon bonding to two H atoms during the initial stage. The chlorinated compounds were preferentially produced from the double-bonded carbon bonding to the Cl atom and rapidly degraded to HCl, CO2, and CO during the initial stage. The residual part was degraded in the latter steps. Furthermore, it is suggested that the Cl atom on one of the double-bonded C atoms of the propenes was transferred to the other C atom before the degradation. Consequently, the double-bonded carbon bonding to two H atoms in 2-chloro-1-propene was chlorinated, then degraded to HCl, CO2, and CO during the initial stage.	[Nishikiori, Hiromasa; Sato, Yohei; Oki, Kyoichi; Fujii, Tsuneo] Shinshu Univ, Fac Engn, Dept Environm Sci & Technol, Nagano 3808553, Japan	Nishikiori, H (reprint author), Shinshu Univ, Fac Engn, Dept Environm Sci & Technol, 4-17-1 Wakasato, Nagano 3808553, Japan.	nishiki@shinshu-u.ac.jp					Amama PB, 2002, APPL CATAL B-ENVIRON, V37, P321, DOI 10.1016/S0926-3373(02)00010-3; Amama PB, 2001, J MOL CATAL A-CHEM, V176, P165, DOI 10.1016/S1381-1169(01)00249-7; Fan JF, 1996, J AM CHEM SOC, V118, P4686, DOI 10.1021/ja952155q; Mohseni M, 2005, CHEMOSPHERE, V59, P335, DOI 10.1016/j.chemosphere.2004.10.054; Wang KH, 1998, APPL CATAL B-ENVIRON, V17, P313, DOI 10.1016/S0926-3373(97)00099-4; Mul G, 2001, J CATAL, V201, P128, DOI 10.1006/jcat.2001.3239; Yamazaki S, 2001, APPL CATAL B-ENVIRON, V33, P109, DOI 10.1016/S0926-3373(01)00167-9; Oki K, 2003, INT J PHOTOENERGY, V5, P11, DOI 10.1155/S1110662X03000059; Hernandez-Alonso MD, 2013, CATAL TODAY, V206, P32, DOI 10.1016/j.cattod.2012.01.029; Driessen MD, 1998, J PHYS CHEM B, V102, P549, DOI 10.1021/jp972351e; Joung SK, 2006, CHEM-EUR J, V12, P5526, DOI 10.1002/chem.200501020; JACOBY WA, 1994, ENVIRON SCI TECHNOL, V28, P1661, DOI 10.1021/es00058a018; Anpo M., 1984, J PHYS CHEM-US, V88, P2527; ANPO M, 1987, CHEM LETT, P1997, DOI 10.1246/cl.1987.1997; Backes MJ, 2005, APPL CATAL B-ENVIRON, V61, P21, DOI 10.1016/j.apeatb.2005.03.012; Fujii T., 2003, PHOTOCHEM, V34, P176; Hwang SJ, 1998, J AM CHEM SOC, V120, P4388, DOI 10.1021/ja974192i; Joung SK, 2005, SURF SCI, V598, P174, DOI 10.1016/j.susc.2005.08.037; Joung SK, 2006, J PHOTOCH PHOTOBIO A, V184, P273, DOI 10.1016/j.jphotochem.2006.04.040; Kim JS, 1998, CHEMOSPHERE, V36, P483, DOI 10.1016/S0045-6535(97)00370-6; Lukaski AC, 2003, CATAL LETT, V89, P129, DOI 10.1023/A:1024740030721; Nimlos Mark R., 1993, Environmental Science and Technology, V27, P732, DOI 10.1021/es00041a018; Nishikiori H, 2010, RES CHEM INTERMEDIAT, V36, P947, DOI 10.1007/s11164-010-0207-5; Oki K, 2003, RES CHEM INTERMEDIAT, V29, P827, DOI 10.1163/156856703322601834; Ozaki S, 2004, APPL CATAL B-ENVIRON, V52, P81, DOI 10.1016/j.apcatb.2003.10.010; Wang JH, 2005, J PHYS CHEM B, V109, P20858, DOI 10.1021/jp050892v; Wang KH, 2002, J HAZARD MATER, V90, P63, DOI 10.1016/S0304-3894(01)00331-4; Wang KH, 1998, CHEMOSPHERE, V36, P2763; Yamazaki S, 2009, RES CHEM INTERMEDIAT, V35, P91, DOI 10.1007/s11164-008-0001-9; YAMAZAKINISHIDA S, 1995, J PHYS CHEM-US, V99, P15814, DOI 10.1021/j100043a020; Zuo GM, 2003, J PHOTOCH PHOTOBIO A, V161, P51, DOI 10.1016/S1010-6030(03)00271-5	31	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0922-6168	1568-5675		RES CHEM INTERMEDIAT	Res. Chem. Intermed.	OCT	2015	41	10					7641	7654		10.1007/s11164-014-1849-5		14	Chemistry, Multidisciplinary	Chemistry	CR6TY	WOS:000361481800051		
J	Takahashi, N; Fujibayashi, T; Kida, D; Hirano, Y; Kato, T; Kato, D; Saito, K; Kaneko, A; Yabe, Y; Takagi, H; Oguchi, T; Miyake, H; Watanabe, T; Hayashi, M; Kanayama, Y; Funahashi, K; Hanabayashi, M; Hirabara, S; Asai, S; Takemoto, T; Terabe, K; Asai, N; Yoshioka, Y; Ishiguro, N; Kojima, T				Takahashi, Nobunori; Fujibayashi, Takayoshi; Kida, Daihei; Hirano, Yuji; Kato, Takefumi; Kato, Daizo; Saito, Kiwamu; Kaneko, Atsushi; Yabe, Yuichiro; Takagi, Hideki; Oguchi, Takeshi; Miyake, Hiroyuki; Watanabe, Tsuyoshi; Hayashi, Masatoshi; Kanayama, Yasuhide; Funahashi, Koji; Hanabayashi, Masahiro; Hirabara, Shinya; Asai, Shuji; Takemoto, Toki; Terabe, Kenya; Asai, Nobuyuki; Yoshioka, Yutaka; Ishiguro, Naoki; Kojima, Toshihisa			Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use	RHEUMATOLOGY INTERNATIONAL			English	Article						Rheumatoid arthritis; Biological DMARDs; Abatacept; Methotrexate; Tacrolimus	HEALTH-ASSESSMENT QUESTIONNAIRE; DOUBLE-BLIND; INADEQUATE RESPONSE; JAPANESE PATIENTS; MULTICENTER REGISTRY; AMERICAN-COLLEGE; DISEASE-ACTIVITY; EFFICACY; SAFETY; TRIAL	This observational retrospective study examined whether abatacept efficacy could be augmented with concomitant methotrexate (MTX) or tacrolimus (TAC) in patients with rheumatoid arthritis (RA) who experienced failure with prior biological disease-modifying antirheumatic drugs (DMARDs) and in whom favorable therapeutic efficacy is difficult to achieve. All patients with a prior biological DMARD history who were treated with abatacept for 52 weeks and registered in a Japanese multicentre registry were included. Clinical efficacy and safety of abatacept according to the concomitant drug used, i.e., none (ABT-mono), MTX (ABT-MTX), and TAC (ABT-TAC), were compared. A greater mean percent change of DAS28-ESR was observed in the ABT-TAC group compared with the ABT-mono group at weeks 12 (-20.5 vs. -5.4 %, p = 0.035) and 24 (-25.0 vs. -11.0 %, p = 0.036). ABT-MTX and ABT-TAC groups had a significantly higher proportion of patients who achieved low disease activity (LDA) within 52 weeks compared with the respective baselines, while no significant change was observed in the ABT-mono group. A higher proportion of patients in the ABT-TAC group achieved EULAR moderate response compared with the ABT-mono group at week 52 (66.7 vs. 35.0 %, p = 0.025). Multivariate logistic regression analysis revealed that concomitant TAC use was independently associated with the achievement of LDA and EULAR response at 52 weeks, while concomitant MTX use was not. Concomitant TAC use may offer a suitable option for RA patients treated with abatacept after prior biological DMARD failure, likely because both abatacept and TAC affect T cell activation.	[Takahashi, Nobunori; Kato, Daizo; Funahashi, Koji; Hanabayashi, Masahiro; Hirabara, Shinya; Asai, Shuji; Takemoto, Toki; Terabe, Kenya; Asai, Nobuyuki; Yoshioka, Yutaka; Ishiguro, Naoki; Kojima, Toshihisa] Nagoya Univ, Grad Sch Med, Dept Orthoped Surg & Rheumatol, Nagoya Univ Hosp,Showa Ku, Nagoya, Aichi 4668550, Japan; [Fujibayashi, Takayoshi] Konan Kosei Hosp, Dept Orthoped Surg, Konan, Aichi, Japan; [Kida, Daihei; Kaneko, Atsushi] Nagoya Med Ctr, Dept Orthoped Surg & Rheumatol, Naka Ku, Nagoya, Aichi, Japan; [Hirano, Yuji] Toyohashi Municipal Hosp, Dept Rheumatol, Toyohashi, Aichi, Japan; [Kato, Takefumi] Kato Orthoped Clin, Okazaki, Aichi, Japan; [Saito, Kiwamu] Saito Clin, Meito Ku, Nagoya, Aichi, Japan; [Yabe, Yuichiro] Tokyo Koseinenkin Hosp, Dept Rheumatol, Shinjuku Ku, Tokyo, Japan; [Takagi, Hideki] Nagoya Cent Hosp, Dept Orthoped Surg, Nakamura Ku, Nagoya, Aichi, Japan; [Oguchi, Takeshi] Anjo Kosei Hosp, Dept Orthoped Surg, Anjo, Japan; [Miyake, Hiroyuki] Ichinomiya Municipal Hosp, Dept Orthoped Surg, Ichinomiya, Japan; [Watanabe, Tsuyoshi] Kariya Toyota Gen Hosp, Dept Orthoped Surg, Kariya, Aichi, Japan; [Hayashi, Masatoshi] Nagano Red Cross Hosp, Dept Rheumatol, Nagano, Japan; [Kanayama, Yasuhide] Toyota Kosei Hosp, Dept Orthoped Surg, Josui, Toyota, Japan	Takahashi, N (reprint author), Nagoya Univ, Grad Sch Med, Dept Orthoped Surg & Rheumatol, Nagoya Univ Hosp,Showa Ku, 65 Tsuruma Cho, Nagoya, Aichi 4668550, Japan.	nobunori@med.nagoya-u.ac.jp			Daiichi Sankyo; Takeda Pharmaceutical; Hisamitsu Pharmaceutical; Otsuka Pharmaceutical; Taisho Toyama Pharmaceutical; Kaken Pharmaceutical; Eisai; Janssen Pharmaceutical; Bristol-Myers Squibb; Abbott Japan; Chugai Pharmaceutical; Mitsubishi Tanabe Pharmaceutical; Astellas Pharma; Pfizer Japan; Mitsubishi Tanabe Pharma; Takeda Pharma; Eisai Pharma; AbbVie; Pfizer; Chugai Pharma; Abbott; UCB; Janssen	N.I. received grants, lecture fees, and fees for serving on speakers' bureaus from Daiichi Sankyo, Takeda Pharmaceutical, Hisamitsu Pharmaceutical, Otsuka Pharmaceutical, Taisho Toyama Pharmaceutical, Kaken Pharmaceutical, Eisai, Janssen Pharmaceutical, Bristol-Myers Squibb, Abbott Japan, Chugai Pharmaceutical, Mitsubishi Tanabe Pharmaceutical, Astellas Pharma, and Pfizer Japan. T.K. received lecture fees (<US$5000) from Mitsubishi Tanabe Pharma, Takeda Pharma, Eisai Pharma, AbbVie, Bristol-Myers Squibb, and Pfizer, and $10 000 from Chugai Pharma. N.T. received speaker's fees from Abbott Japan, Eisai, Mitsubishi Tanabe Pharma, Pfizer, Chugai Pharmaceutical, Takeda Pharma, and Bristol-Myers Squibb (<$5000). Y.H. received speaker's fees from Abbott Japan, Eisai, Mitsubishi Tanabe Pharma, Pfizer, Chugai Pharmaceutical, and Bristol-Myers Squibb (<$5000). A.K. received lecture fees (<$5000) from Mitsubishi Tanabe Pharma, Takeda Pharma, Eisai Pharma, Chugai Pharma, Abbott, Bristol-Myers Squibb, UCB, Janssen, and Pfizer. All other authors have no conflicts of interest to report.	Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Kremer JM, 2006, ANN INTERN MED, V144, P865; Gottenberg JE, 2012, ANN RHEUM DIS, V71, P1815, DOI 10.1136/annrheumdis-2011-201109; Leffers HC, 2011, ANN RHEUM DIS, V70, P1216, DOI 10.1136/ard.2010.140129; Kremer JM, 2011, ANN RHEUM DIS, V70, P1826, DOI 10.1136/ard.2010.139345; Breedveld FC, 2006, ARTHRITIS RHEUM, V54, P26, DOI 10.1002/art.21519; Matsuda Y, 2003, ARTHRIT RHEUM-ARTHR, V49, P784, DOI 10.1002/art.11465; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI 10.1136/ard.2010.138461; Takakubo Y, 2012, RHEUMATOL INT, V32, P3487, DOI 10.1007/s00296-011-2200-8; Schiff M, 2009, ANN RHEUM DIS, V68, P1708, DOI 10.1136/ard.2008.099218; Naniwa T, 2009, RHEUMATOL INT, V29, P1287, DOI 10.1007/s00296-009-0845-3; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Kameda H, 2011, J RHEUMATOL, V38, P1585, DOI 10.3899/jrheum.110014; Kojima T, 2012, MOD RHEUMATOL, V22, P339, DOI 10.1007/s10165-011-0518-4; Balkan W, 2009, GENE, V446, P90, DOI 10.1016/j.gene.2009.06.013; Mori S, 2012, MOD RHEUMATOL, V22, P947, DOI 10.1007/s10165-012-0593-1; Takahashi N, 2013, MOD RHEUMATOL, V23, P904, DOI 10.1007/s10165-012-0760-4; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Fujibayashi T, 2015, MOD RHEUMATOL, V25, P825, DOI 10.3109/14397595.2015.1029238; Furst DE, 2002, ARTHRITIS RHEUM, V46, P2020, DOI 10.1002/art.10427; Hirabara S, 2014, CLIN RHEUMATOL, V33, P1247, DOI 10.1007/s10067-014-2711-2; Kaneko A, 2013, MOD RHEUMATOL, V23, P466, DOI 10.1007/s10165-012-0705-y; Kawai S, 2006, RHEUMATOLOGY, V45, P441, DOI 10.1093/rheumatology/kei172; Kawai S, 2006, J RHEUMATOL, V33, P2153; Kondo H, 2004, J RHEUMATOL, V31, P243; Miwa Y, 2013, MOD RHEUMATOL, V23, P920, DOI 10.1007/s10165-012-0765-z; Miyazaki M, 2007, CLIN RHEUMATOL, V26, P231, DOI 10.1007/s10067-006-0287-1; Nagasawa H, 2010, MOD RHEUMATOL, V20, P337, DOI 10.1007/s10165-010-0284-8; Takahashi N, 2015, J RHEUMATOL, V42, P786, DOI 10.3899/jrheum.141288; Takahashi N, 2014, CLIN RHEUMATOL, V33, P39, DOI 10.1007/s10067-013-2392-2; Takahashi N, 2015, RHEUMATOLOGY, V54, P854, DOI 10.1093/rheumatology/keu418; Takeuchi T, 2014, MOD RHEUMATOL, V24, P8, DOI 10.3109/14397595.2013.854074; Takeuchi T, 2012, MOD RHEUMATOL, V22, P327, DOI 10.1007/s10165-011-0516-6; vanGestel A, 1996, ARTHRITIS RHEUM, V39, P535, DOI 10.1002/art.1780390325; Westhovens R, 2009, ANN RHEUM DIS, V68, P1870, DOI 10.1136/ard.2008.101121; Yocum DE, 2003, ARTHRITIS RHEUM, V48, P3328, DOI 10.1002/art.11363; Yokota K, 2009, RHEUMATOL INT, V29, P459, DOI 10.1007/s00296-008-0694-5	37	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0172-8172	1437-160X		RHEUMATOL INT	Rheumatol. Int.	OCT	2015	35	10					1707	1716		10.1007/s00296-015-3283-4		10	Rheumatology	Rheumatology	CR7UD	WOS:000361556100011		
J	Lee, Y; Motomura, G; Yamamoto, T; Nakashima, Y; Ohishi, M; Hamai, S; Iura, K; Iwamoto, Y				Lee, Yongseung; Motomura, Goro; Yamamoto, Takuaki; Nakashima, Yasuharu; Ohishi, Masanobu; Hamai, Satoshi; Iura, Kunio; Iwamoto, Yukihide			Rapidly destructive arthrosis of the hip joint in a young adult with systemic lupus erythematosus	RHEUMATOLOGY INTERNATIONAL			English	Review						Rapidly destructive arthrosis (RDA); Subchondral insufficiency fracture of the femoral head (SIF); Systemic lupus erythematosus (SLE)	SUBCHONDRAL INSUFFICIENCY FRACTURE; FEMORAL-HEAD; OSTEOARTHRITIS; ARTHROPATHY; BONE; OSTEONECROSIS; CARTILAGE; DISEASE	A 37-year-old female had been treated with corticosteroids for systemic lupus erythematosus clinically diagnosed at age 10. She suddenly had right hip pain without any antecedent trauma. Four months after the onset of pain, she visited her primary care physician. On magnetic resonance imaging, joint space narrowing at the weight-bearing area was already seen with bone marrow edematous lesions in both the femoral head and acetabulum. She was treated non-operatively; however, her pain continued to worsen in severity. Thirteen months after the onset of pain, she was referred to our hospital. A plain radiograph showed subluxation of the collapsed femoral head accompanied by destruction of the acetabular rim. Because of her severe intractable pain, she underwent total hip arthroplasty 1 month after her first visit. Histological examination of the resected femoral head revealed pseudogranulomatous lesions along with prominent callus formation, suggesting rapid destruction of the femoral head.	[Lee, Yongseung; Motomura, Goro; Yamamoto, Takuaki; Nakashima, Yasuharu; Ohishi, Masanobu; Hamai, Satoshi; Iura, Kunio; Iwamoto, Yukihide] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, Fukuoka 8128582, Japan	Motomura, G (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	goromoto@ortho.med.kyushu-u.ac.jp					BOCK GW, 1993, RADIOLOGY, V186, P461; SLOWMANKOVACS SD, 1990, ARTHRITIS RHEUM, V33, P412, DOI 10.1002/art.1780330316; Tang XL, 2013, LUPUS, V22, P1162, DOI 10.1177/0961203313498802; Ishihara K, 2010, CLIN ORTHOP RELAT R, V468, P1331, DOI 10.1007/s11999-009-1213-z; Yamamoto T, 2000, ARTHRITIS RHEUM, V43, P2423, DOI 10.1002/1529-0131(200011)43:11<2423::AID-ANR8>3.0.CO;2-Z; Boutry N, 2002, AM J ROENTGENOL, V179; Gladman DD, 2001, J RHEUMATOL, V28, P2226; Ikemura S, 2010, AM J ROENTGENOL, V195, pW63, DOI 10.2214/AJR.09.3271; Ishiguro N, 2001, HAEMOPHILIA, V7, P127, DOI 10.1046/j.1365-2516.2001.00475.x; Iwasaki K, 2011, CLIN IMAG, V35, P208, DOI 10.1016/j.clinimag.2010.05.005; Iwasaki K, 2012, BRIT J RADIOL, V85, P214, DOI 10.1259/bjr/44936440; Kamimura K, 2012, ARCH NIIGATA SOC ORT, V28, P103; MENKES CJ, 1985, J RHEUMATOL, V12, P130; MITROVIC DR, 1992, RHEUMATOL INT, V12, P17; Song WS, 2004, J BONE JOINT SURG AM, V86A, P1917; Yamaguchi R, 2014, RHEUMATOLOGY, V53, P2191, DOI 10.1093/rheumatology/keu253; Yamamoto T, 2006, ANN RHEUM DIS, V65, P837, DOI 10.1136/ard.2005.041095; Zhao G, 2010, SKELETAL RADIOL, V39, P185, DOI 10.1007/s00256-009-0750-6	18	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0172-8172	1437-160X		RHEUMATOL INT	Rheumatol. Int.	OCT	2015	35	10					1753	1757		10.1007/s00296-015-3304-3		5	Rheumatology	Rheumatology	CR7UD	WOS:000361556100018		
J	Suzuki, S; Noda, K; Ohira, Y; Shikino, K; Ikusaka, M				Suzuki, Shingo; Noda, Kazutaka; Ohira, Yoshiyuki; Shikino, Kiyoshi; Ikusaka, Masatomi			Finger stiffness or edema as presenting symptoms of eosinophilic fasciitis	RHEUMATOLOGY INTERNATIONAL			English	Article						Clinical feature; Eosinophilic fasciitis; Finger; Range of motion	OF-THE-LITERATURE; MRI	To investigate the clinical features and finger symptoms of eosinophilic fasciitis (EF), we reviewed five patients with EF. The chief complaint was pain, edema and/or stiffness of the extremities. The distal extremities were affected in all patients, and there was also proximal involvement in one patient. One patient had asymmetrical symptoms. All four patients with upper limb involvement had limited range of motion of the wrist joints, and three of them complained of finger symptoms. Two of these three patients showed slight non-pitting edema of the hands, and the other one had subcutaneous induration of the forearm. All four patients with lower limb symptoms had limited range of motion of the ankle joints, and two showed edema or induration of the legs. Inflammatory changes in the joints were not detected in any of the patients. Two patients displayed neither objective induration nor edema, and two patients had muscle tenderness. In conclusion, finger symptoms of patients with EF might be caused by fasciitis of the forearms, which leads to dysfunction of the long finger flexors and extensors as well as slight edema of hands. Limited range of motion of wrist and/or ankle joints indicates sensitively distal muscle dysfunction caused by fasciitis.	[Suzuki, Shingo; Noda, Kazutaka; Ohira, Yoshiyuki; Shikino, Kiyoshi; Ikusaka, Masatomi] Chiba Univ Hosp, Dept Gen Med, Chuo Ku, Chiba, Chiba 2608677, Japan	Suzuki, S (reprint author), Chiba Univ Hosp, Dept Gen Med, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608677, Japan.	shngszkthk@yahoo.co.jp					SHULMAN LE, 1984, J RHEUMATOL, V11, P569; Manzini CU, 2012, CLIN RHEUMATOL, V31, P183, DOI 10.1007/s10067-011-1866-3; Bischoff L, 2008, INT J DERMATOL, V47, P29, DOI 10.1111/j.1365-4632.2007.03544.x; Pillen S, 2006, NEUROMUSCULAR DISORD, V16, P144, DOI 10.1016/j.nmd.2005.12.001; Avouac J, 2012, RHEUMATOLOGY, V51, P1347, DOI 10.1093/rheumatology/kes041; Ohno M, 2001, RHEUMATOLOGY, V40, P1428, DOI 10.1093/rheumatology/40.12.1428; Costenbader KH, 2001, AM J MED, V111, P318, DOI 10.1016/S0002-9343(01)00839-7; Desvignes-Engelbert A, 2010, JOINT BONE SPINE, V77, P367, DOI 10.1016/j.jbspin.2010.04.008; Desvignes-Engelbert A, 2010, CLIN RHEUMATOL, V29, P1461, DOI 10.1007/s10067-010-1508-1; Haddad Housam, 2014, Hematol Oncol Stem Cell Ther, V7, P90, DOI 10.1016/j.hemonc.2013.12.003; Huppke P, 2002, EUR J PEDIATR, V161, P528, DOI 10.1007/s00431-002-1038-1; Hur Jin-Wuk, 2005, Korean Journal of Internal Medicine, V20, P180; Liou CH, 2003, SKELETAL RADIOL, V32, P52, DOI 10.1007/s00256-002-0596-7; Okita M, 2009, ULTRASOUND MED BIOL, V35, P237, DOI 10.1016/j.ultrasmedbio.2008.09.001; Philpott H, 2008, AUSTRALAS J DERMATOL, V49, P27, DOI 10.1111/j.1440-0960.2007.00415.x; Servy A, 2010, PATHOL RES INT, DOI [10.4061/2011/716935, DOI 10.4061/2011/716935]; Seshadri R, 2008, ARTHRIT RHEUM-ARTHR, V59, P989, DOI 10.1002/art.23829; Sugimoto T, 2007, RHEUMATOL INT, V27, P791, DOI 10.1007/s00296-006-0302-5; Yang SN, 2012, JCR-J CLIN RHEUMATOL, V18, P249, DOI 10.1097/RHU.0b013e318262e3dd	19	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0172-8172	1437-160X		RHEUMATOL INT	Rheumatol. Int.	OCT	2015	35	10					1769	1772		10.1007/s00296-015-3338-6		4	Rheumatology	Rheumatology	CR7UD	WOS:000361556100020		
J	Taguchi, A; Sakai, C; Soma, T; Kasahara, Y; Stern, DM; Kajimoto, K; Ihara, M; Daimon, T; Yamahara, K; Doi, K; Kohara, N; Nishimura, H; Matsuyama, T; Naritomi, H; Sakai, N; Nagatsuka, K				Taguchi, Akihiko; Sakai, Chiaki; Soma, Toshihiro; Kasahara, Yukiko; Stern, David M.; Kajimoto, Katsufumi; Ihara, Masafumi; Daimon, Takashi; Yamahara, Kenichi; Doi, Kaori; Kohara, Nobuo; Nishimura, Hiroyuki; Matsuyama, Tomohiro; Naritomi, Hiroaki; Sakai, Nobuyuki; Nagatsuka, Kazuyuki			Intravenous Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke: Phase1/2a Clinical Trial in a Homogeneous Group of Stroke Patients	STEM CELLS AND DEVELOPMENT			English	Article							ACUTE MYOCARDIAL-INFARCTION; CIRCULATING CD34-POSITIVE CELLS; CEREBRAL-BLOOD-FLOW; LEFT-VENTRICULAR FUNCTION; MESENCHYMAL STEM-CELLS; ACUTE ISCHEMIC-STROKE; RANDOMIZED-TRIAL; THERAPEUTIC ANGIOGENESIS; INTRACORONARY INJECTION; PROGENITOR CELLS	The goal of this clinical trial was to assess the feasibility and safety of transplanting autologous bone marrow mononuclear cells into patients suffering severe embolic stroke. Major inclusion criteria included patients with cerebral embolism, age 20-75 years, National Institute of Health Stroke Scale (NIHSS) score displaying improvement of <= 5 points during the first 7 days after stroke, and NIHSS score of >= 10 on day 7 after stroke. Bone marrow aspiration (25 or 50 mL; N = 6 patients in each case) was performed 7-10 days poststroke, and bone marrow mononuclear cells were administrated intravenously. Mean total transplanted cell numbers were 2.5 x 10(8) and 3.4 x 10(8) cells in the lower and higher dose groups, respectively. No apparent adverse effects of administering bone marrow cells were observed. Compared with the lower dose, patients receiving the higher dose of bone marrow cells displayed a trend toward improved neurologic outcomes. Compared with 1 month after treatment, patients receiving cell therapy displayed a trend toward improved cerebral blood flow and metabolic rate of oxygen consumption 6 months after treatment. In comparison with historical controls, patients receiving cell therapy had significantly better neurologic outcomes. Our results indicated that intravenous transplantation of autologous bone marrow mononuclear cells is safe and feasible. Positive results and trends favoring neurologic recovery and improvement in cerebral blood flow and metabolism by cell therapy underscore the relevance of larger scale randomized controlled trials using this approach.	[Taguchi, Akihiko; Kasahara, Yukiko; Ihara, Masafumi] Inst Biomed Res & Innovat, Dept Regenerat Med Res, Kobe, Hyogo 6500047, Japan; [Taguchi, Akihiko; Kajimoto, Katsufumi; Ihara, Masafumi; Naritomi, Hiroaki; Nagatsuka, Kazuyuki] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Suita, Osaka, Japan; [Sakai, Chiaki; Sakai, Nobuyuki] Inst Biomed Res & Innovat, Dept Endovasc Therapy, Kobe, Hyogo 6500047, Japan; [Sakai, Chiaki; Sakai, Nobuyuki] Kobe City Med Ctr Gen Hosp, Dept Neurosurg, Kobe, Hyogo, Japan; [Soma, Toshihiro] Hyogo Coll Med, Dept Hematol, Nishinomiya, Hyogo 6638501, Japan; [Stern, David M.] Univ Tennessee, Execut Deans Off, Memphis, TN USA; [Daimon, Takashi] Hyogo Coll Med, Dept Biostat, Nishinomiya, Hyogo 6638501, Japan; [Yamahara, Kenichi] Natl Cerebral & Cardiovasc Ctr, Dept Regenerat Med, Suita, Osaka, Japan; [Doi, Kaori] Natl Cerebral & Cardiovasc Ctr, Dept Nursing, Suita, Osaka, Japan; [Kohara, Nobuo] Kobe City Med Ctr Gen Hosp, Dept Neurol, Kobe, Hyogo, Japan; [Nishimura, Hiroyuki] Nishinomiya Kyoritsu Neurosurg Hosp, Dept Neurol, Nishinomiya, Hyogo, Japan; [Matsuyama, Tomohiro] Hyogo Coll Med, Inst Adv Med Sci, Nishinomiya, Hyogo 6638501, Japan	Taguchi, A (reprint author), Inst Biomed Res & Innovat, Dept Regenerat Med Res, Chuo Ku, 2-2 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	taguchi@fbri.org			Ministry of Health, Labour and Welfare [H24-Iryokiki-007]	This work was supported by Health Labour Sciences Research Grant (H24-Iryokiki-007) from the Ministry of Health, Labour and Welfare.	Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Uemura M, 2012, CURR VASC PHARMACOL, V10, P285; Yoshihara T, 2008, J CEREBR BLOOD F MET, V28, P1086, DOI 10.1038/jcbfm.2008.1; Hess DC, 2014, INT J STROKE, V9, P381, DOI 10.1111/ijs.12065; Liu JL, 2014, PROG NEUROBIOL, V115, P138, DOI 10.1016/j.pneurobio.2013.11.004; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Simari RD, 2014, CIRC RES, V114, P1564, DOI 10.1161/CIRCRESAHA.114.303720; Ringelstein EB, 2013, STROKE, V44, P2681, DOI 10.1161/STROKEAHA.113.001531; Taguchi A, 2009, J CEREBR BLOOD F MET, V29, P34, DOI 10.1038/jcbfm.2008.92; Rosado-de-Castro PH, 2013, REGEN MED, V8, P145, DOI [10.2217/rme.13.2, 10.2217/RME.13.2]; Yamaguchi T, 2000, STROKE, V31, P817; Savitz SI, 2005, CEREBROVASC DIS, V20, P101, DOI 10.1159/000086518; Traverse JH, 2012, JAMA-J AM MED ASSOC, V308, P2380, DOI 10.1001/jama.2012.28726; Yang B, 2013, STROKE, V44, P3463, DOI 10.1161/STROKEAHA.111.000821; Taguchi A, 2004, CIRCULATION, V109, P2972, DOI 10.1161/01.CIR.0000133311.25587.DE; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Kondziolka D, 2000, NEUROLOGY, V55, P565; Surder D, 2013, CIRCULATION, V127, P1968, DOI 10.1161/CIRCULATIONAHA.112.001035; Moniche F, 2012, STROKE, V43, P2242, DOI 10.1161/STROKEAHA.112.659409; Fadini GP, 2010, ATHEROSCLEROSIS, V209, P10, DOI 10.1016/j.atherosclerosis.2009.08.033; Nakano-Doi A, 2010, STEM CELLS, V28, P1292, DOI 10.1002/stem.454; Terai S, 2006, STEM CELLS, V24, P2292, DOI 10.1634/stemcells.2005-0542; Honmou O, 2011, BRAIN, V134, P1790, DOI 10.1093/brain/awr063; Rosland GV, 2009, CANCER RES, V69, P5331, DOI 10.1158/0008-5472.CAN-08-4630; Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388; Fujita Y, 2010, STROKE, V41, P2938, DOI 10.1161/STROKEAHA.110.596379; Taguchi A, 2003, EUR J VASC ENDOVASC, V25, P276, DOI 10.1053/ejvs.2002.1831; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Prasad K, 2012, INDIAN J MED RES, V136, P221; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Savitz SI, 2011, ANN NEUROL, V70, P59, DOI 10.1002/ana.22458; Arboix Adria, 2012, Curr Cardiol Rev, V8, P54; Carrera E, 2014, BRAIN, V137, P2408, DOI 10.1093/brain/awu101; Chen DC, 2014, CELL TRANSPLANT, V23, P1599, DOI 10.3727/096368914X678562; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; DeReuck J, 1997, CLIN NEUROL NEUROSUR, V99, P11, DOI 10.1016/S0303-8467(96)00561-6; Garbuzova-Davis S, 2014, J COMP NEUROL, V522, P3120, DOI 10.1002/cne.23582; Moniche F, 2014, CELL TRANSPLANT, V23, pS57, DOI 10.3727/096368914X684934; Pearson TA, 1999, CARDIOVASC DRUG THER, V13, P95, DOI 10.1023/A:1007727924276; Prasad K, 2014, STROKE, V45, P3618, DOI 10.1161/STROKEAHA.114.007028; Suarez-Monteagudo C, 2009, RESTOR NEUROL NEUROS, V27, P151, DOI 10.3233/RNN-2009-0483; Taguchi A, 2014, STROKE, V45, pE8, DOI 10.1161/STROKEAHA.113.003683; Taguchi A, 2008, J CEREBR BLOOD F MET, V28, P445, DOI 10.1038/sj.jcbfm.9600541; Takasawa M, 2001, NEURORADIOLOGY, V43, P821; Tsutsumi K, 1998, JPN J STROKE, V20, P489; Vasconcelos-dos-Santos A, 2012, STEM CELL RES, V9, P1, DOI 10.1016/j.scr.2012.02.002	47	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1547-3287	1557-8534		STEM CELLS DEV	Stem Cells Dev.	OCT 1	2015	24	19					2207	2218		10.1089/scd.2015.0160		12	Cell & Tissue Engineering; Hematology; Medicine, Research & Experimental; Transplantation	Cell Biology; Hematology; Research & Experimental Medicine; Transplantation	CR5PP	WOS:000361395900001		
J	Fry, DE; Pine, M; Locke, D; Reband, A; Torres, Z; Pine, G				Fry, Donald E.; Pine, Michael; Locke, David; Reband, Agnes; Torres, Zeke; Pine, Gregory			Medicare inpatient and 90-day postdischarge adverse outcomes in carotid artery surgery	SURGERY			English	Article							VASCULAR-SURGERY; PREDICTION MODELS; RISK; READMISSIONS; MORTALITY; ENDARTERECTOMY; PROGRAM; DEATHS; COSTS; CARE	Background. Longitudinal, risk-adjusted measurement of outcomes of carotid artery (CA) surgery is necessary for the evaluation of quality performance and for the assessment of strategies of quality improvement. Methods. Patients from quality coding hospitals who underwent CA surgery and met procedural and diagnostic coding requirements in the Medicare Inpatient Limited Data Set from 2009 to 2011 were used to design logistic prediction models for the Adverse Outcomes (AOs) of inpatient deaths, 3-sigma prolonged length-of-stay outliers (prLOS) among live discharges, 90-day post-discharge deaths without readmission (PD-90), and 90-day post-discharge readmissions (ReAdm-90). Results. A total of 653 quality coding hospitals had 54,183 CA surgery cases. There were 122 inpatient deaths (0.23%) and 3,337 (6.2%) prLOS. After discharge, there were 258 patients that were PD-90 and 9,804 patients (18.1 % of live discharges) were readmitted. Among all readmissions, 1,592 (13.3%) were judged to be totally unrelated to the index operation. A total of 495 patients died during readmission to the hospital. The rate of total adverse outcome was 22.6% with all ReAdm-90 cases counted. Conclusion. In CA surgery, more AOs occur in the 90 days after discharge than during the inpatient period of care. ReAdm-90 remains the major cause for AOs and represents the greatest opportunity for improvement in the care of CA surgery patients.	[Fry, Donald E.; Pine, Michael; Locke, David; Reband, Agnes; Torres, Zeke; Pine, Gregory] Michael Pine & Associates, Chicago, IL USA; [Fry, Donald E.] Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA; [Fry, Donald E.] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA	Fry, DE (reprint author), 1 East Wacker Dr 1210, Kyoto 60601, Japan.	dfry@consultmpa.com					Fry DE, 2012, AM J SURG, V203, P392, DOI 10.1016/j.amjsurg.2011.09.011; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Hackbarth G, 2008, NEW ENGL J MED, V359, P3, DOI 10.1056/NEJMp0803749; Bekelis K, 2013, STROKE, V44, P1085, DOI 10.1161/STROKEAHA.111.674358; Pine M, 2007, JAMA-J AM MED ASSOC, V297, P71, DOI 10.1001/jama.297.1.71; Fry DE, 2009, AM J SURG, V197, P479, DOI 10.1016/j.amjsurg.2008.07.056; Brooke BS, 2012, J VASC SURG, V56, P556, DOI 10.1016/j.jvs.2012.03.260; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Tabak YP, 2014, J AM MED INFORM ASSN, V21, P455, DOI 10.1136/amiajnl-2013-001790; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Escobar GJ, 2008, MED CARE, V46, P232, DOI 10.1097/MLR.0b013e3181589bb6; Centers for Medicare and Medicaid Services, BUNDL PAYM CAR IMPR; Centers for Medicare and Medicaid Services, READM RED PROGR; Chongruksut W, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000190.pub3; Fry DE, 2015, AM J SURG, V209, P509, DOI 10.1016/j.amjsurg.2014.12.005; Fry DE, 2007, ANN SURG, V246, P875, DOI 10.1097/SLA.0b013e3180cc2e7a; Fry DE, 2014, AM J SURG, V207, P326, DOI 10.1016/j.amjsurg.2013.09.007; Fry DE, 2011, AM J SURG, V201, P363, DOI 10.1016/j.amjsurg.2010.08.025; Fry DE, 2014, SURGERY, V156, P931, DOI 10.1016/j.surg.2014.06.023; Gupta PK, 2014, J VASC SURG, V59, P473, DOI 10.1016/j.jvs.2013.09.002; Lawson EH, 2013, ANN SURG, V258, P10, DOI 10.1097/SLA.0b013e31828e3ac3; Naessens JM, 2004, INT J QUAL HEALTH C, V16, pI27, DOI 10.1093/intqhc/mzh012; Pine Michael, 2009, Perspect Health Inf Manag, V6, P2; Pine M, 2010, MED CARE, V48, P862, DOI 10.1097/MLR.0b013e3181eb3176; PURSELL DE, 1970, DEMOGRAPHY, V7, P87, DOI 10.2307/2060025; Rambachan A, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2013.08.020; Rau J., 2014, KAISER HLTH NEWS; Wheeler DJ, 2000, UNDERSTANDING VARIAT, V2nd, P137	28	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	OCT	2015	158	4					1056	1062		10.1016/j.surg.2015.06.005		7	Surgery	Surgery	CR3VF	WOS:000361260500044		
J	Rodman, T				Rodman, Tara			A More Humane Mikado: Re-envisioning the Nation through Occupation-Era Productions of The Mikado in Japan	THEATRE RESEARCH INTERNATIONAL			English	Article								The first authorized productions in Japan of Gilbert and Sullivan's The Mikado took place in the early years of the post-war American occupation. A group of Japanese theatre-makers whose international engagement had been circumscribed by the war were involved in these productions - first a 1946 American-led version for occupation personnel, and then an 'all-Japanese' version in 1947 and 1948. For these artists, The Mikado, a foreign operetta that was simultaneously 'about Japan' and not, offered a way of rebuilding post-war Japanese theatre, and, in doing so, imagining new possibilities for the nation. Through The Mikado they performed a 'cosmopolitanism at home', a mode of engagement with the international from within the borders of one's own nation.	[Rodman, Tara] Northwestern Univ, Interdisciplinary Doctoral Program Theatre & Dram, Evanston, IL 60208 USA; [Rodman, Tara] Fulbright Fdn, Tokyo, Japan; [Rodman, Tara] Nippon Fdn, Tokyo, Japan	Rodman, T (reprint author), Northwestern Univ, Interdisciplinary Doctoral Program Theatre & Dram, Evanston, IL 60208 USA.	tararodman@u.northwestern.edu					[Anonymous], 1948, NY TIMES, P27; [Anonymous], 1946, MASSEZU          DEC, V1; [Anonymous], 1981, YOMIURI SHINBUN; Breckenridge C. A., 2002, COSMOPOLITANISM; CHAMBERSLETSON JT, 2013, RACE SO DIFFERENT PE; Cheah Pheng, 1998, COSMOPOLITICS THINKI; Delanty G., 2009, COSMOPOLITAN IMAGINA; Dower J. W., 1999, EMBRACING DEFEAT JAP; Hiroshi Eguchi, 1946, ENGEKIKAI        OCT, V4, p[40, 40]; Koreya Senda, 1975, MOHITOTSU SHINGEKISH, p[141, 144]; Lee Josephine, 2010, JAPAN PURE INVENTION, P187; Leiter Samuel L., 2009, RISING FLAMES REBIRT, P125; Michio Ito, MIKADO PROGRAMME, P14; Miho Nagato, MIKADO PROGRAMME, P18; Moto Otaguro, 1947, MIKADO PROGRAMME, P12; MS, 1946, NIHON ENGEKI     SEP, V4; Naoki Inose, 1991, MIKADO NO SHOZO, V1991, P581; Sasaki Hideaki, 1996, IBUNKA HE SHISEN ATA, P59; Sumiko Enbutsu, 2003, EAST             MAR, V38, P6; The First Opera at the National Theatre, 1970, YOMIURI SHINBUN; Townsend Sarah L., 2011, J MOD LITERATURE, V34, P45	21	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0307-8833	1474-0672		THEATRE RES INT	Theatre Res. Int.	OCT	2015	40	3					288	302		10.1017/S030788331500036X		15	Theater	Theater	CR2JX	WOS:000361156700005		
J	Ishida, M; Kakizaki, T; Morimitsu, Y; Ohara, T; Hatakeyama, K; Yoshiaki, H; Kohori, J; Nishio, T				Ishida, Masahiko; Kakizaki, Tomohiro; Morimitsu, Yasujiro; Ohara, Takayoshi; Hatakeyama, Katsunori; Yoshiaki, Hitoshi; Kohori, Junna; Nishio, Takeshi			Novel glucosinolate composition lacking 4-methylthio-3-butenyl glucosinolate in Japanese white radish (Raphanus sativus L.)	THEORETICAL AND APPLIED GENETICS			English	Article							BRASSICA-OLERACEA; CRUCIFEROUS VEGETABLES; ARABIDOPSIS-THALIANA; PUNGENT PRINCIPLE; ISOTHIOCYANATE; ROOTS; IDENTIFICATION; PLANTS; BIOSYNTHESIS; BIOCHEMISTRY	Genetic analysis and gene mapping of the 4-methylthio-3-butenyl glucosinolate-less trait of white radish were performed and a white radish cultivar with new glucosinolate composition was developed. A spontaneous mutant having significantly low 4-methylthio-3-butenyl glucosinolate (4MTB-GSL) content was identified from a landrace of Japanese white radish (Raphanus sativus L.) through intensive evaluation of glucosinolate profiles of 632 lines including genetic resources and commercial cultivars using high-performance liquid chromatography (HPLC) analysis. A line lacking 4MTB-GSL was developed using the selected mutant as a gene source. Genetic analyses of F-1, F-2, and BC1F1 populations of this line suggested that the 4MTB-GSL-less trait is controlled by a single recessive allele. Using SNP and SCAR markers, 96 F-2 plants were genotyped, and a linkage map having nine linkage groups with a total map distance of 808.3 cM was constructed. A gene responsible for the 4MTB-GSL-less trait was mapped between CL1753 and CL5895 at the end of linkage group 1. The genetic distance between these markers was 4.2 cM. By selfing and selection of plants lacking 4MTB-GSL, a new cultivar, 'Daikon parental line No. 5', was successfully developed. This cultivar was characterized by glucoerucin, which accounted for more than 90 % of the total glucosinolates (GSLs). The total GSL content in roots was ca. 12 mu mol/g DW, significantly lower than those in common white radish cultivars. Significance of this line in radish breeding is discussed.	[Ishida, Masahiko] NARO Inst Vegetable & Tea Sci, Tsukuba Vegetable Res Stn, Tsukuba, Ibaraki 3058666, Japan; [Kakizaki, Tomohiro; Ohara, Takayoshi; Hatakeyama, Katsunori; Yoshiaki, Hitoshi; Kohori, Junna] NARO Inst Vegetable & Tea Sci, Tsu, Mie 5142392, Japan; [Morimitsu, Yasujiro] Ochanomizu Univ, Grad Sch Humanities & Sci, Dept Food & Nutr Sci, Bunkyo Ku, Tokyo 1128610, Japan; [Nishio, Takeshi] Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan	Nishio, T (reprint author), Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, 1-1 Tsutsumidori Amamiya Machi, Sendai, Miyagi 9818555, Japan.	nishio@bios.tohoku.ac.jp			Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN), Japan	This work was partly supported by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN), Japan.	Millan S, 2009, ANAL BIOANAL CHEM, V394, P1661, DOI 10.1007/s00216-009-2823-8; Li G, 2003, THEOR APPL GENET, V106, P1116, DOI 10.1007/s00122-002-1161-4; FENWICK GR, 1983, CRC CR REV FOOD SCI, V18, P123; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Zasada IA, 2004, SOIL BIOL BIOCHEM, V36, P1017, DOI 10.1016/j.soilbio.2003.12.014; Kroymann J, 2001, PLANT PHYSIOL, V127, P1077, DOI 10.1104/pp.127.3.1077; Moon JK, 2010, J AGR FOOD CHEM, V58, P6672, DOI 10.1021/jf1003573; Clarke DB, 2010, ANAL METHODS-UK, V2, P310, DOI 10.1039/b9ay00280d; Kliebenstein DJ, 2001, PLANT CELL, V13, P681, DOI 10.1105/tpc.13.3.681; MITHEN R, 1995, HEREDITY, V74, P210, DOI 10.1038/hdy.1995.29; Takahashi A, 2015, BIOSCI BIOTECH BIOCH, V79, P1512, DOI 10.1080/09168451.2015.1032881; Giamoustaris A, 1996, THEOR APPL GENET, V93, P1006, DOI 10.1007/BF00224105; Herr I, 2010, CANCER TREAT REV, V36, P377, DOI 10.1016/j.ctrv.2010.01.002; Bidart-Bouzat MG, 2008, J CHEM ECOL, V34, P1026, DOI 10.1007/s10886-008-9498-z; Bones AM, 1996, PHYSIOL PLANTARUM, V97, P194, DOI 10.1034/j.1399-3054.1996.970128.x; Ediage EN, 2011, J CHROMATOGR A, V1218, P4395, DOI 10.1016/j.chroma.2011.05.012; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Pedras MSC, 2003, PHYTOCHEMISTRY, V64, P949, DOI 10.1016/S0031-9422(03)00441-2; Li GY, 2002, GENETICS, V162, P1937; Cohen JH, 2000, J NATL CANCER I, V92, P61, DOI 10.1093/jnci/92.1.61; Montaut S, 2010, PHYTOCHEMISTRY, V71, P6, DOI 10.1016/j.phytochem.2009.09.021; Wang H, 2011, GENE, V487, P135, DOI 10.1016/j.gene.2011.07.021; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Mithen RF, 2000, J SCI FOOD AGR, V80, P967, DOI 10.1002/(SICI)1097-0010(20000515)80:7<967::AID-JSFA597>3.0.CO;2-V; Li G, 2003, THEOR APPL GENET, V107, P168, DOI 10.1007/s00122-003-1236-x; Melchini A, 2010, TOXINS, V2, P593, DOI 10.3390/toxins2040593; Banga O., 1976, Evolution of crop plants., P60; Bjerg B, 1987, GLUCOSINOLATES RAPES, P125; CARLSON DG, 1985, J AM SOC HORTIC SCI, V110, P634; FRIIS P, 1966, ACTA CHEM SCAND, V20, P698, DOI 10.3891/acta.chem.scand.20-0698; Gao MQ, 2005, THEOR APPL GENET, V111, P949, DOI 10.1007/s00122-005-0029-9; Hirani AH, 2012, CROP PLANT, DOI [10.5772/45646, DOI 10.5772/45646]; Ishida M, 2013, J JAPAN ASS ODOR ENV, V44, P307; Ishida M, 2011, BREEDING SCI, V61, P208, DOI 10.1270/jsbbs.61.208; Ishida M, 2003, BREEDING SCI, V53, P291, DOI 10.1270/jsbbs.53.291; Ishida M, 2012, BREEDING SCI, V62, P63, DOI 10.1270/jsbbs.62.63; Kitamura S, 1958, JAPANESE RADISH, P1; Kitashiba H, 2014, DNA RES, V21, P481, DOI 10.1093/dnares/dsu014; Li F, 2011, DNA RES, V18, P401, DOI 10.1093/dnares/dsr027; Liu, 2014, NAT COMMUN, V5, P3930; Nishio T, 1996, THEOR APPL GENET, V92, P388, DOI 10.1007/BF00223684; OZAWA Y, 1990, AGR BIOL CHEM TOKYO, V54, P1849; OZAWA Y, 1990, AGR BIOL CHEM TOKYO, V54, P1241; Rosa E. A. S., 1997, Horticultural Reviews, V19, P99; Shiokai S, 2010, MOL BREEDING, V25, P179, DOI 10.1007/s11032-009-9315-6; Shiokai S, 2010, PLANT CELL REP, V29, P829, DOI 10.1007/s00299-010-0867-z; Shirasawa K, 2006, THEOR APPL GENET, V113, P147, DOI 10.1007/s00122-006-0281-7; UDA Y, 1993, J JPN SOC FOOD SCI, V40, P743; Wang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-836; Zou ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053541	50	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0040-5752	1432-2242		THEOR APPL GENET	Theor. Appl. Genet.	OCT	2015	128	10					2037	2046		10.1007/s00122-015-2564-3		10	Agronomy; Plant Sciences; Genetics & Heredity; Horticulture	Agriculture; Plant Sciences; Genetics & Heredity	CR7QI	WOS:000361545100010		
J	Susukida, T; Sekine, S; Ogimura, E; Aoki, S; Oizumi, K; Horie, T; Ito, K				Susukida, Takeshi; Sekine, Shuichi; Ogimura, Eiichiro; Aoki, Shigeki; Oizumi, Kumiko; Horie, Toshiharu; Ito, Kousei			Basal efflux of bile acids contributes to drug-induced bile acid-dependent hepatocyte toxicity in rat sandwich-cultured hepatocytes	TOXICOLOGY IN VITRO			English	Article						Drug-induced liver injury; Bile acid; Sandwich-cultured hepatocyte; Bile salt export pump; Multidrug resistance-associated protein	SALT EXPORT PUMP; ORGANIC SOLUTE TRANSPORTER; ALPHA-OST-BETA; FAMILIAL INTRAHEPATIC CHOLESTASIS; RESISTANCE-ASSOCIATED PROTEIN-2; HEPATOBILIARY TRANSPORTER; HEPATIC-UPTAKE; LIVER-INJURY; INHIBITION; EXPRESSION	The bile salt export pump (BSEP or Bsep) functions as an apical transporter to eliminate bile acids (BAs) from hepatocytes into the bile. BSEP or Bsep inhibitors engender BA retention, suggested as an underlying mechanism of cholestatic drug-induced liver injury. We previously reported a method to evaluate BSEP-mediated BA-dependent hepatocyte toxicity by using sandwich-cultured hepatocytes (SCHs). However, basal efflux transporters, including multidrug resistance-associated proteins (MRP or Mrp) 3 and 4, also participate in BA efflux. This study examined the contribution of basal efflux transporters to BA-dependent hepatocyte toxicity in rat SCHs. The apical efflux of [H-3]taurocholic acid (TC) was potently inhibited by 10 mu M cyclosporine A (CsA), with later inhibition of basal PHITC efflux, while MK571 simultaneously inhibited both apical and basal [H-3]TC efflux. CsA-induced BA-dependent hepatocyte toxicity was 30% at most at 10 mu M CsA and similar to 60% at 50 mu M, while MK571 exacerbated hepatocyte toxicity at concentrations of >= 50 mu M. Quinidine inhibited only basal [H-3]TC efflux and showed BA-dependent hepatocyte toxicity in rat SCHs. Hence, inhibition of basal efflux transporters as well as Bsep may precipitate BA-dependent hepatocyte toxicity in rat SCHs. (C) 2015 Elsevier Ltd. All rights reserved.	[Susukida, Takeshi; Sekine, Shuichi; Ogimura, Eiichiro; Aoki, Shigeki; Oizumi, Kumiko; Ito, Kousei] Chiba Univ, Grad Sch Pharmaceut Sci, Lab Biopharmaceut, Chiba, Japan; [Horie, Toshiharu] Teikyo Heisei Univ, Fac Pharmaceut Sci, Tokyo, Japan	Ito, K (reprint author), Inohana 1-8-1,Chuo Ku, Chiba 2608675, Japan.	itokousei@chiba-u.jp			JSPS KAKENHI Grant [24390037, 23790172]	This work was supported by JSPS KAKENHI Grant Numbers 24390037, 23790172.	Akita H, 2002, PHARMACEUT RES, V19, P34, DOI 10.1023/A:1013699130991; Stieger B, 2000, GASTROENTEROLOGY, V118, P422, DOI 10.1016/S0016-5085(00)70224-1; Letschert K, 2006, TOXICOL SCI, V91, P140, DOI 10.1093/toxsci/kfj141; Swift B, 2010, DRUG METAB REV, V42, P446, DOI 10.3109/03602530903491881; Dawson S, 2012, DRUG METAB DISPOS, V40, P130, DOI 10.1124/dmd.111.040758; Ballatori N, 2005, HEPATOLOGY, V42, P1270, DOI 10.1002/hep.20961; Fattinger K, 2001, CLIN PHARMACOL THER, V69, P223, DOI 10.1067/mcp.2001.114667; Byrne JA, 2002, GASTROENTEROLOGY, V123, P1649, DOI 10.1053/gast.2002.36591; Morgan RE, 2010, TOXICOL SCI, V118, P485, DOI 10.1093/toxsci/kfq269; Meier PJ, 2002, ANNU REV PHYSIOL, V64, P635, DOI 10.1146/annurev.physiol.64.082201.100300; Dawson PA, 2005, J BIOL CHEM, V280, P6960, DOI 10.1074/jbc.M412752200; Pedersen JM, 2013, TOXICOL SCI, V136, P328, DOI 10.1093/toxsci/kft197; Ogimura E, 2011, BIOCHEM BIOPH RES CO, V416, P313, DOI 10.1016/j.bbrc.2011.11.032; Rius M, 2003, HEPATOLOGY, V38, P374, DOI 10.1053/jhep.2003.50331; Li LQ, 1998, J BIOL CHEM, V273, P16184, DOI 10.1074/jbc.273.26.16184; St-Pierre MV, 2001, J EXP BIOL, V204, P1673; Shitara Y, 2003, J PHARMACOL EXP THER, V304, P610, DOI 10.1124/jpet.102.041921; Kock K, 2014, DRUG METAB DISPOS, V42, P665, DOI 10.1124/dmd.113.054304; Nakanishi T, 2011, DRUG METAB DISPOS, V39, P984, DOI 10.1124/dmd.111.038059; Vanwijngaerden YM, 2011, HEPATOLOGY, V54, P1741, DOI 10.1002/hep.24582; Li LQ, 2000, MOL PHARMACOL, V58, P335; Keitel V, 2005, HEPATOLOGY, V41, P1160, DOI 10.1002/hep.20682; Morgan RE, 2013, TOXICOL SCI, V136, P216, DOI 10.1093/toxsci/kft176; Zollner G, 2007, LIVER INT, V27, P920, DOI 10.1111/j.1478-3231.2007.01506.x; Zelcer N, 2003, BIOCHEM J, V371, P361, DOI 10.1042/BJ20021886; Ninomiya M, 2005, DRUG METAB DISPOS, V33, P225, DOI 10.1124/dmd.104.002196; Seward DJ, 2003, J BIOL CHEM, V278, P27473, DOI 10.1074/jbc.M301106200; Kaplowitz N, 2001, DRUG SAFETY, V24, P483, DOI 10.2165/00002018-200124070-00001; Kostrubsky SE, 2006, TOXICOL SCI, V90, P451, DOI 10.1093/toxsci/kfj095; Schuster D, 2005, CURR PHARM DESIGN, V11, P3545, DOI 10.2174/138161205774414510; Jemnitz K, 2010, TOXICOL SCI, V115, P80, DOI 10.1093/toxsci/kfq044; Strautnieks SS, 1998, NAT GENET, V20, P233; Di Marco A, 2003, EUR J BIOCHEM, V270, P3768, DOI 10.1046/j.1432-1033.2003.03763.x; Kemp DC, 2005, TOXICOL SCI, V83, P207, DOI 10.1093/toxsci/kfi020; LIANG D, 1993, HEPATOLOGY, V18, P1162; Mennone A, 2006, HEPATOLOGY, V43, P1013, DOI 10.1002/hep.21159; Tchaparian EH, 2011, DRUG METAB DISPOS, V39, P2387, DOI 10.1124/dmd.111.039545; Teng S, 2007, BRIT J PHARMACOL, V151, P367, DOI 10.1038/sj.bjb.0707235; Wang RX, 2013, AM J PHYSIOL-GASTR L, V305, pG286, DOI 10.1152/ajpgi.00082.2013; Warner DJ, 2012, DRUG METAB DISPOS, V40, P2332, DOI 10.1124/dmd.112.047068; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879; Yang K, 2014, MOL PHARMACEUT, V11, P766, DOI 10.1021/mp400471e	42	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-2333			TOXICOL IN VITRO	Toxicol. Vitro	OCT	2015	29	7					1454	1463		10.1016/j.tiv.2015.06.004		10	Toxicology	Toxicology	CR3WJ	WOS:000361263500018		
J	Kimura, Y; Fujimura, C; Ito, Y; Takahashi, T; Nakajima, Y; Ohmiya, Y; Aiba, S				Kimura, Yutaka; Fujimura, Chizu; Ito, Yumiko; Takahashi, Toshiya; Nakajima, Yoshihiro; Ohmiya, Yoshihiro; Aiba, Setsuya			Optimization of the IL-8 Luc assay as an in vitro test for skin sensitization	TOXICOLOGY IN VITRO			English	Article						Contact dermatitis; Sensitization test; Luciferase assay; Alternative method; Skin sensitization	TEST H-CLAT; SCREENING CONTACT ALLERGENS; HUMAN CELL-LINES; THP-1 CELLS; DENDRITIC CELLS; PEPTIDE REACTIVITY; GENE-EXPRESSION; P38 MAPK; ACTIVATION; CHEMICALS	We previously reported a dataset of the IL-8 Luc assay covering reference chemicals published by ECVAM, in which the effects of chemicals on IL-8 promoter activity were evaluated by an IL-8 reporter cell line, THP-G8 cells. To clarify its performance, we created another dataset of 88 sensitizers and 34 non-sensitizers. Simultaneously, to improve its performance, we changed the incubation time from 5 h to 16 h, deleted the criterion regarding the effects of N-acetylcysteine, and set an exclusion criterion for detergents. These modifications significantly improved its performance. In addition, we examined the following three criteria to judge chemicals as sensitizers: Criterion 1: Fold induction of SLO luciferase activity (FInSLO-LA) >= 1.4, Criterion 2: the lower limit of the 95% confidence interval of FInSLO-LA >= 1.0, Criterion 3: the intersection of criteria 1 and 2. Among them, Criterion 1 produced the best performance, demonstrating that the accuracy, sensitivity and specificity were 81%, 79%, and 90%, respectively. In addition, we found that the IL-8 Luc assay solubilizing chemicals with X-VIVO substantially improved its performance. Finally, the IL-8 Luc assay combined with DPRA and DEREK could improve substantially its performance. These data suggest that the IL-8 Luc assay is a promising test method to screen skin sensitizers. (C) 2015 Elsevier Ltd. All rights reserved.	[Aiba, Setsuya] Tohoku Univ, Grad Sch Med, Dept Dermatol, Sendai, Miyagi 9808574, Japan; Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Takamatsu, Kagawa 7610395, Japan; Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki 3058566, Japan	Aiba, S (reprint author), Tohoku Univ, Grad Sch Med, Dept Dermatol, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	saiba@med.tohoku.ac.jp			New Energy and Industrial Development Organization (NEDO); JSPS KAKENHI Grant [26670473]; Health Labor Sciences Research in Japan; Ministry Economy, Science and Industry in Japan; Japanese Society for Alternatives to Animal Experiments	This work was supported in part by the New Energy and Industrial Development Organization (NEDO), by Grant-in-Aid for Challenging Exploratory Research of JSPS KAKENHI Grant Number 26670473, by Health Labor Sciences Research in Japan, and by Ministry Economy, Science and Industry in Japan, and Japanese Society for Alternatives to Animal Experiments.	Takenouchi O, 2013, J TOXICOL SCI, V38, P599; Jowsey IR, 2006, J APPL TOXICOL, V26, P341, DOI 10.1002/jat.1146; Sakaguchi H, 2006, TOXICOL IN VITRO, V20, P774, DOI 10.1016/j.tiv.2005.10.014; Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013; Python F, 2007, TOXICOL APPL PHARM, V220, P113, DOI 10.1016/j.taap.2006.12.026; Nukada Y, 2013, TOXICOL IN VITRO, V27, P609, DOI 10.1016/j.tiv.2012.11.006; Piroird C, 2015, TOXICOL IN VITRO, V29, P901, DOI 10.1016/j.tiv.2015.03.009; Saito R, 2011, TOXICOL APPL PHARM, V254, P245, DOI 10.1016/j.taap.2011.04.017; Jaworska J, 2013, J APPL TOXICOL, V33, P1353, DOI 10.1002/jat.2869; Nakajima Y, 2005, BIOTECHNIQUES, V38, P891, DOI 10.2144/05386ST03; Nukada Y, 2012, TOXICOL IN VITRO, V26, P1150, DOI 10.1016/j.tiv.2012.07.001; Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040; Zhang XL, 2005, EUR J IMMUNOL, V35, P3258, DOI 10.1002/eji.200526116; Corazza M, 2010, J EUR ACAD DERMATOL, V24, P1, DOI 10.1111/j.1468-3083.2009.03349.x; Divkovic M, 2005, CONTACT DERMATITIS, V53, P189, DOI 10.1111/j.0105-1873.2005.00683.x; Mitjans M, 2008, TOXICOL IN VITRO, V22, P386, DOI 10.1016/j.tiv.2007.10.005; Holland R, 2010, ANTIOXID REDOX SIGN, V13, P1749, DOI 10.1089/ars.2010.3273; Gerberick GF, 2007, TOXICOL SCI, V97, P417, DOI 10.1093/toxsci/kfm064; Ashikaga T, 2010, ATLA-ALTERN LAB ANIM, V38, P275; Basketter DA, 2014, DERMATITIS, V25, P11, DOI 10.1097/DER.0000000000000003; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; Casati S, 2009, ATLA-ALTERN LAB ANIM, V37, P305; Ashikaga T, 2006, TOXICOL IN VITRO, V20, P767, DOI 10.1016/j.tiv.2005.10.012; Takahashi T, 2011, TOXICOL SCI, V124, P359, DOI 10.1093/toxsci/kfr237; Toebak MJ, 2006, TOXICOL IN VITRO, V20, P117, DOI 10.1016/j.tiv.2005.06.039; Itoh K, 2010, ANTIOXID REDOX SIGN, V13, P1665, DOI 10.1089/ars.2010.3222; Mori R, 2008, PROSTATE, V68, P1555, DOI 10.1002/pros.20815; Jaworska J, 2011, ALTEX-ALTERN ANIM EX, V28, P211; Nukada Y, 2008, J TOXICOL SCI, V33, P175, DOI 10.2131/jts.33.175; Singha B, 2014, J BIOL CHEM, V289, P2687, DOI 10.1074/jbc.M113.502641; Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009; Tsujita-Inoue K, 2014, TOXICOL IN VITRO, V28, P626, DOI 10.1016/j.tiv.2014.01.003; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213; Coquette A, 1999, TOXICOL IN VITRO, V13, P867, DOI 10.1016/S0887-2333(99)00076-4; EDWARDS DR, 1985, EXP CELL RES, V157, P127, DOI 10.1016/0014-4827(85)90157-0; Feijoo E, 2005, INT J CANCER, V116, P275, DOI 10.1002/ijc.21046; Gouwy M, 2014, IMMUNOBIOLOGY, V219, P218, DOI 10.1016/j.imbio.2013.10.004; Hopkins JE, 2005, CHEM RES TOXICOL, V18, P375, DOI 10.1021/tx049688+; ICCVAM, 2011, ICCVAM TEST METH EV; Jimenez F, 2010, J IMMUNOL, V184, P5571, DOI 10.4049/jimmunol.0803494; LEONARD EJ, 1990, J IMMUNOL, V144, P1323; MARCHESE A, 1995, GENOMICS, V29, P335; Mitjans M, 2010, TOXICOL IN VITRO, V24, P1803, DOI 10.1016/j.tiv.2010.06.001; Natsch A, 2009, TOXICOL SCI, V107, P106, DOI 10.1093/toxsci/kfn204; Natsuaki Y, 2014, NAT IMMUNOL, V15, P1064, DOI 10.1038/ni.2992; Noguchi T, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-40; OECD, 2012, OECD SER TEST ASS, V168; Saito K, 2013, TOXICOL IN VITRO, V27, P857, DOI 10.1016/j.tiv.2012.12.025; SEBOK K, 1993, J IMMUNOL, V150, P1524; Trompezinski S, 2008, TOXICOL APPL PHARM, V230, P397, DOI 10.1016/j.taap.2008.03.012; White KJ, 2011, J INVEST DERMATOL, V131, P435, DOI 10.1038/jid.2010.308	52	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-2333			TOXICOL IN VITRO	Toxicol. Vitro	OCT	2015	29	7					1816	1830		10.1016/j.tiv.2015.07.006		15	Toxicology	Toxicology	CR3WJ	WOS:000361263500055		
J	Ibuki, Y; Shikata, M; Toyooka, T				Ibuki, Yuko; Shikata, Mariko; Toyooka, Tatsushi			gamma-H2AX is a sensitive marker of DNA damage induced by metabolically activated 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone	TOXICOLOGY IN VITRO			English	Article						NNK; Histone H2AX; CYP2A6; CYP2A13; DSBs	TOBACCO-SPECIFIC CARCINOGEN; PRIMARY HUMAN HEPATOCYTES; LUNG CARCINOGENESIS; CYTOCHROME-P450 ENZYMES; HISTONE H2AX; HUMAN CYP2A6; EXPRESSION; PHOSPHORYLATION; TUMORIGENESIS; CANCER	4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a nicotine-derived nitrosamine, is a potent pulmonary carcinogen present in tobacco smoke. DNA adducts induced by metabolically activated NNK cause carcinogenesis; however, the DNA adducts are difficult to detect in cultured cells because of low intrinsic metabolic enzyme activity. In this study, we indirectly detected NNK-induced DNA adducts via the phosphorylation of histone H2AX (gamma-H2AX) in A549 human lung adenocarcinoma epithelial cells. NNK treatment dose-dependently induced gamma-H2AX. This gamma-H2AX induction was suppressed by ataxia telangiectasia mutated inhibitors, suggesting that DNA double-strand breaks (DSBs) are formed during replication and repair of DNA adducts; however, DSBs could not be directly detected by biased sinusoidal field gel electrophoresis (BSFGE). CYP2A13-overexpressing cells showed prolonged gamma-H2AX induction compared with control cells, and DSBs could be detected by BSFGE in CYP2A13-overexpressing cells as a clear migration of double-stranded DNA. These findings suggest that gamma-H2AX is a sensitive marker of DNA adducts and provides a possible system for genotoxicity screening of chemicals such as NNK, which need metabolic activation to induce DNA damage. (C) 2015 Elsevier Ltd. All rights reserved.	[Ibuki, Yuko; Shikata, Mariko; Toyooka, Tatsushi] Univ Shizuoka, Grad Div Nutr & Environm Sci, Shizuoka 4228526, Japan; [Toyooka, Tatsushi] Natl Inst Occupat Safety & Hlth, Kawasaki, Kanagawa, Japan	Ibuki, Y (reprint author), Univ Shizuoka, Grad Div Nutr & Environm Sci, Shizuoka 4228526, Japan.	ibuki@u-shizuoka-ken.ac.jp			Ministry of Health, Labour and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [24510084]	This work was supported in part by a Grant-in-Aid from the Ministry of Health, Labour and Welfare, Japan, and a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (24510084).	Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Higashi E, 2007, DRUG METAB DISPOS, V35, P1935, DOI 10.1124/dmd.107.016568; Farmer PB, 2008, MUTAT RES-REV MUTAT, V659, P68, DOI 10.1016/j.mrrev.2008.03.006; Raunio Hannu, 2012, Drug Metabolism and Drug Interactions, V27, P73, DOI 10.1515/dmdi-2012-0001; Hecht SS, 2012, INT J CANCER, V131, P2724, DOI 10.1002/ijc.27816; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Westerink WMA, 2007, TOXICOL IN VITRO, V21, P1581, DOI 10.1016/j.tiv.2007.05.014; Jalas JR, 2003, CHEM RES TOXICOL, V16, P794, DOI 10.1021/tx0340221; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Wilkening S, 2003, DRUG METAB DISPOS, V31, P1035, DOI 10.1124/dmd.31.8.1035; Su T, 2000, CANCER RES, V60, P5074; Jalas JR, 2005, CHEM RES TOXICOL, V18, P95, DOI 10.1021/tx049847p; Balbo S, 2014, CHEM RES TOXICOL, V27, P356, DOI 10.1021/tx4004352; de Feraudy S, 2010, P NATL ACAD SCI USA, V107, P6870, DOI 10.1073/pnas.1002175107; Weng Y, 2007, CANCER RES, V67, P7825, DOI 10.1158/0008-5472.CAN-07-1006; Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002; Janmohamed A, 2001, BIOCHEM PHARMACOL, V62, P777, DOI 10.1016/S0006-2952(01)00718-3; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Koskela S, 1999, BIOCHEM PHARMACOL, V57, P1407, DOI 10.1016/S0006-2952(99)00015-5; Balbo S, 2014, CARCINOGENESIS, V35, P2798, DOI 10.1093/carcin/bgu204; Chiang HC, 2011, TOXICOL APPL PHARM, V253, P145, DOI 10.1016/j.taap.2011.03.022; IARC, 2007, IARC MON EV CARC RIS, V89, P1; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC MONOGR EVAL CAR, V83, P1; Ibuki Y, 2014, CARCINOGENESIS, V35, P1228, DOI 10.1093/carcin/bgt492; Lacoste S, 2007, MUTAT RES-FUND MOL M, V624, P18, DOI 10.1016/j.mrfmmm.2007.02.030; Li L, 2014, CARCINOGENESIS, V35, P2584, DOI 10.1093/carcin/bgu182; Pluchino LA, 2015, FREE RADICAL BIO MED, V80, P12, DOI 10.1016/j.freeradbiomed.2014.12.015; Staretz ME, 1997, CANCER RES, V57, P259; Takeuchi H, 2003, CANCER RES, V63, P7581; Toyooka T, 2009, MUTAT RES-GEN TOX EN, V676, P34, DOI 10.1016/j.mrgentox.2009.03.002; Toyooka T, 2011, J INVEST DERMATOL, V131, P1313, DOI 10.1038/jid.2011.28; Toyooka T, 2006, ENVIRON SCI TECHNOL, V40, P3603, DOI 10.1021/es060182i; Wong HL, 2005, CHEM RES TOXICOL, V18, P913, DOI 10.1021/tx0500777; Zhang X, 2007, J PHARMACOL EXP THER, V323, P570, DOI 10.1124/jpet.107.127068	34	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-2333			TOXICOL IN VITRO	Toxicol. Vitro	OCT	2015	29	7					1831	1838		10.1016/j.tiv.2015.07.023		8	Toxicology	Toxicology	CR3WJ	WOS:000361263500056		
J	Kamata, R; Shiraishi, F; Kageyama, S; Nakajima, D				Kamata, Ryo; Shiraishi, Fujio; Kageyama, Shiho; Nakajima, Daisuke			Detection and measurement of the agonistic activities of PCBs and mono-hydroxylated PCBs to the constitutive androstane receptor using a recombinant yeast assay	TOXICOLOGY IN VITRO			English	Article						Constitutive androstane receptor; Polychlorinated biphenyls; Hydroxylated PCB; Recombinant yeast; 2 ',4 ',6 '-Trichlorobiphenyl-4-ol; (4 '-OH-CB30); 2,2 ',4 ',6 '-Tetrachlorobiphenyl-4-ol; (4 '-OH-CB50)	POLYCHLORINATED-BIPHENYLS PCBS; PREGNANE-X-RECEPTOR; TUMOR PROMOTION; METABOLITES; CAR; INDUCTION; BLOOD; NONYLPHENOL; EXPRESSION; RETENTION	Polychlorinated biphenyls (PCBs) are thought to exert their toxicities mainly by binding to the aryl hydrocarbon receptor and by stimulating transcription of various genes, notably metabolizing enzymes including the cytochrome P450 (CYP) 1 family. However, PCBs and their metabolites could have potential to activate other nuclear receptors and subsequent events. We focused on the constitutive androstane receptor (CAR) inducing CYP2B and measured the agonistic activity of PCBs and mono-hydroxylated PCBs (OH-PCBs) to the CAR using yeast cells transduced with the human CAR and its response pathway. Twenty-nine of 34 tested PCBs and 72 of 91 OH-PCBs exhibited CAR agonistic effects. Of 41 OH-PCBs that had the same chlorination patterns as the tested PCBs, 9 had activities more than twice those of their non-hydroxylated analogs. In particular, 2',4',6'-trichlorobiphenyl-4-ol and 2,2',4',6'-tetrachlorobiphenyl-4-ol were 332- and 22-fold more potent than their analogs and were 15 times and 2.8 times, respectively, as active as a reference substance, 4-tert-octylphenol. The activities of 17 of the OH-PCBs were reduced to less than half those of their non-hydroxylated analogs. Four OH-PCBs derived from 3 active PCBs were inactive. However, a consistent relationship between hydroxyl substituent position and activity could not be discerned. Comprehensive evaluation of the toxic potential of PCBs and their hydroxylated metabolites and their concentrations in the environment are required. (C) 2015 Elsevier Ltd. All rights reserved.	[Kamata, Ryo] Kitasato Univ, Sch Vet Med, Toxicol Lab, Towada, Aomori 0348628, Japan; [Shiraishi, Fujio; Nakajima, Daisuke] Natl Inst Environm Studies, Ctr Environm Risk Res, Tsukuba, Ibaraki 3058506, Japan; [Kageyama, Shiho] Koriyama Womens Univ, Fac Home Econ, Koriyama, Fukushima 9638503, Japan	Kamata, R (reprint author), Kitasato Univ, Sch Vet Med, Toxicol Lab, 35-1 Higashi 23 Bancho, Towada, Aomori 0348628, Japan.	kamata@vmas.kitasato-u.ac.jp					SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.2307/3432519; Graham MJ, 2008, TOXICOLOGY, V254, P184, DOI 10.1016/j.tox.2008.09.002; Nishikawa J, 1999, TOXICOL APPL PHARM, V154, P76, DOI 10.1006/taap.1998.8557; BALLSCHMITER K, 1980, FRESEN Z ANAL CHEM, V302, P20, DOI 10.1007/BF00469758; Maglich JM, 2003, J BIOL CHEM, V278, P17277, DOI 10.1074/jbc.M300138200; JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434; Kamata R, 2008, TOXICOL IN VITRO, V22, P1050, DOI 10.1016/j.tiv.2008.01.002; Carlson DB, 2001, ENVIRON TOXICOL CHEM, V20, P351, DOI 10.1897/1551-5028(2001)020<0351:HTAHTA>2.0.CO;2; Campbell LM, 2003, ENVIRON SCI TECHNOL, V37, P1720, DOI 10.1021/es026225m; Kamata R, 2009, TOXICOL IN VITRO, V23, P736, DOI 10.1016/j.tiv.2009.03.004; Li HX, 2003, ENVIRON SCI TECHNOL, V37, P832, DOI 10.1021/es026215l; Sandala GM, 2004, SCI TOTAL ENVIRON, V331, P125, DOI 10.1016/j.scitotenv.2003.03.001; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Arulmozhiraja S, 2005, TOXICOL SCI, V84, P49, DOI 10.1093/toxsci/kfi063; Laws SC, 2000, TOXICOL SCI, V54, P154, DOI 10.1093/toxsci/54.1.154; Gahrs M, 2013, TOXICOL APPL PHARM, V272, P77, DOI 10.1016/j.taap.2013.05.034; BERGMAN A, 1994, ENVIRON HEALTH PERSP, V102, P464, DOI 10.2307/3432042; Eveillard A, 2009, BIOCHEM PHARMACOL, V77, P1735, DOI 10.1016/j.bcp.2009.02.023; Whysner J, 1996, PHARMACOL THERAPEUT, V71, P153, DOI 10.1016/0163-7258(96)00067-8; Al-Salman F, 2012, TOXICOL APPL PHARM, V263, P7, DOI 10.1016/j.taap.2012.05.016; BRANDT I, 1982, CHEM-BIOL INTERACT, V40, P45, DOI 10.1016/0009-2797(82)90027-8; Fangstrom B, 2005, AMBIO, V34, P184, DOI 10.1639/0044-7447(2005)034[0184:HPMINF]2.0.CO;2; Hernandez JP, 2007, TOXICOL SCI, V98, P416, DOI 10.1093/toxsci/kfm107; IARC (International Agency for Research on Cancer), 2001, IARC MONOGRAPHS EVAL, V79; Martinez JM, 2005, ENVIRON HEALTH PERSP, V113, P1022, DOI 10.1289/ehp.7735; Okumura T., 1975, INVESTIGATION BEHAV; Omiecinski CJ, 2011, TOXICOL SCI, V120, pS49, DOI 10.1093/toxsci/kfq338; Sakiyama T, 2007, ORGANOHALOGEN COMP, V69, P1380; Sapozhnikova Y, 2005, ARCH ENVIRON CON TOX, V49, P439, DOI 10.1007/s00244-005-8011-8; Shiraishi F, 2003, CHEMOSPHERE, V52, P33, DOI 10.1016/S0045-6535(03)00261-3; Tien ES, 2006, XENOBIOTICA, V36, P1152, DOI 10.1080/00498250600861827; WEHLER EK, 1989, DRUG METAB DISPOS, V17, P441; Wyde ME, 2005, TOXICOL SCI, V86, P281, DOI 10.1093/toxsci/kfi204	33	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-2333			TOXICOL IN VITRO	Toxicol. Vitro	OCT	2015	29	7					1859	1867		10.1016/j.tiv.2015.07.021		9	Toxicology	Toxicology	CR3WJ	WOS:000361263500059		
J	Nakajima, H				Nakajima, Haruki			Defoliation by gypsy moths negatively affects the production of acorns by two Japanese oak species	TREES-STRUCTURE AND FUNCTION			English	Article						Insect herbivory; Gypsy moth defoliation; Tree reproduction; Mast seeding; Quercus crispula; Quercus serrata	LYMANTRIA-DISPAR; SEED PRODUCTION; BLACK BEARS; INSECT DEFOLIATION; TEMPERATE FOREST; QUERCUS-CRISPULA; FRUIT PRODUCTION; DECIDUOUS TREES; NORTHERN JAPAN; SUGAR MAPLE	This study showed the negative effects of insect defoliation on the reproduction of canopy trees, where defoliation was not artificially manipulated but rather observed in a natural setting. The gypsy moth (Lymantria diapar) is a serious defoliator with the ability to completely defoliate forest canopies. Although the negative effects of defoliation on tree reproduction have been revealed in studies with artificially manipulated defoliation, few studies have examined the effect of insect defoliation on the reproduction of canopy trees under natural condition. In this study, visual surveys were used to clarify the effect of gypsy moth defoliation on the production of acorns by oaks (Quercus spp.). Surveys were conducted in an outbreak year at 22 sites in central Japan (13 sites with Quercus crispula and nine sites with Q. serrata). Five of the Q. crispula sites were severely defoliated (mean defoliation ranged from 67 to 88 %), while the remainder of the Q. crispula sites and all of the Q. serrata sites were lightly defoliated (0-20 %). A negative effect of gypsy moth defoliation on acorn production was detected for Q. crispula. However, there was a synchronous decrease in acorn production from the previous year and crop levels were low at all sites regardless of the defoliation severity. The consistent low crop levels were likely the result of weather-related factors. Defoliation also negatively affected the production of acorns for Q. serrata; however, severe defoliation was not present at any Q. serrata sites. This study suggests that insect defoliation can affect forest ecosystem processes, such as the regeneration of host trees and the behavior of wildlife that depend on seed production, by reducing the reproductive potential of host trees.	Toyama Prefectural Agr Forestry & Fisheries Res C, Forest Res Inst, Tateyama, Toyama 9301362, Japan	Nakajima, H (reprint author), Toyama Prefectural Agr Forestry & Fisheries Res C, Forest Res Inst, 3 Yoshimine, Tateyama, Toyama 9301362, Japan.	nakajima@fes.pref.toyama.jp			Toyama Prefecture, Japan	I am grateful to my colleagues at Toyama Prefectural Government for their helpful support. This study was funded by Toyama Prefecture, Japan.	Akasofu Y, 1973, FOR PESTS, V22, P214; WILLIAMS DW, 1991, J ECON ENTOMOL, V84, P1508; Piper FI, 2014, J ECOL, V102, P1101, DOI 10.1111/1365-2745.12284; MARQUIS RJ, 1984, SCIENCE, V226, P537, DOI 10.1126/science.226.4674.537; SCHOWALTER TD, 1986, ANNU REV ENTOMOL, V31, P177; Gandhi KJK, 2010, BIOL INVASIONS, V12, P389, DOI 10.1007/s10530-009-9627-9; de Beurs KM, 2008, REMOTE SENS ENVIRON, V112, P3983, DOI 10.1016/j.rse.2008.07.008; KOENIG WD, 1994, CAN J FOREST RES, V24, P2105, DOI 10.1139/x94-270; Lovett GM, 2006, BIOSCIENCE, V56, P395, DOI 10.1641/0006-3568(2006)056[0395:FERTEP]2.0.CO;2; Palacio S, 2012, TREES-STRUCT FUNCT, V26, P1627, DOI 10.1007/s00468-012-0739-y; Hoch G, 2013, OECOLOGIA, V171, P653, DOI 10.1007/s00442-012-2579-2; Liebhold A, 2000, POPUL ECOL, V42, P257, DOI 10.1007/PL00012004; Shibata M, 2002, ECOLOGY, V83, P1727, DOI 10.2307/3071991; Morris WF, 2007, ECOLOGY, V88, P1021, DOI 10.1890/06-0442; Alalouni U, 2013, J APPL ENTOMOL, V137, P721, DOI 10.1111/jen.12072; WARGO PM, 1972, FOREST SCI, V18, P203; Oka T, 2004, J WILDLIFE MANAGE, V68, P979, DOI 10.2193/0022-541X(2004)068[0979:RBCIBP]2.0.CO;2; Eisenbies MH, 2007, FOREST SCI, V53, P683; AOKI J, 1974, Applied Entomology and Zoology, V9, P185; Arimoto M, 2014, APPL ENTOMOL ZOOL, V49, P159, DOI 10.1007/s13355-013-0235-x; BAKER W. L., 1941, JOUR FOREST, V39, P1017; Bell JL, 1997, AUK, V114, P708; Campball R. W., 1977, FOREST SCI MONOGR, V19, P1; COLLINS S, 1961, ECOLOGY, V42, P836, DOI 10.2307/1933521; CRAWLEY MJ, 1985, NATURE, V314, P163, DOI 10.1038/314163a0; Eschtruth AK, 2014, ECOLOGY, V95, P1770, DOI 10.1890/13-1980.1; Fajvan MA, 1996, FOREST ECOL MANAG, V89, P79, DOI 10.1016/S0378-1127(96)03865-0; Fajvan MA, 2008, TREES-STRUCT FUNCT, V22, P257, DOI 10.1007/s00468-007-0183-6; Fukumoto H, 2011, J FOREST RES-JPN, V16, P62, DOI 10.1007/s10310-010-0208-7; FUKUYAMA K, 1990, APPL ENTOMOL ZOOL, V25, P205; FURUNO TOOSHU, 1964, J JAPAN FOREST SOC, V46, P14; FURUTA K, 1982, Z ANGEW ENTOMOL, V93, P513; Gottschalk KW, 1990, P WORKSH SO APP MAST, P42; Gottschalk KW, 1998, EUR J FOREST PATHOL, V28, P121; GRACE JR, 1986, FOREST SCI, V32, P855; Haynes KJ, 2012, POPUL ECOL, V54, P239, DOI 10.1007/s10144-012-0305-x; Higashiura Y, 2011, HEREDITY, V106, P603, DOI 10.1038/hdy.2010.92; HIGASHIURA Y, 1980, RES POPUL ECOL, V22, P147, DOI 10.1007/BF02513542; HIGASHIURA Y, 1987, ECOL ENTOMOL, V12, P25, DOI 10.1111/j.1365-2311.1987.tb00981.x; Hoch G, 2005, PLANT CELL ENVIRON, V28, P651, DOI 10.1111/j.1365-3040.2004.01311.x; Ichie T, 2013, J ECOL, V101, P525, DOI 10.1111/1365-2745.12038; Imada M., 1990, Journal of the Japanese Forestry Society, V72, P426; Ishihama N, 2011, T M HOKKAIDO BR JPN, V59, P59; JANZEN DH, 1976, AM MIDL NAT, V95, P474, DOI 10.2307/2424414; Jedlicka J, 2004, AM MIDL NAT, V152, P231, DOI 10.1674/0003-0031(2004)152[0231:GMDOOT]2.0.CO;2; Jikumaru S, 2007, CAN J BOT, V85, P25, DOI 10.1139/B06-146; Kaitaniemi P, 1999, ECOLOGY, V80, P524, DOI 10.1890/0012-9658(1999)080[0524:EOCDOG]2.0.CO;2; Kamata N, 2002, B ENTOMOL RES, V92, P109, DOI 10.1070/BER2002159; Kasbohm JW, 1998, URSUS-SERIES, V10, P259; Kasbohm JW, 1994, THESIS STATE U BLACK; KASBOHM JW, 1995, CAN J ZOOL, V73, P1771, DOI 10.1139/z95-208; Koenig WD, 2013, ECOLOGY, V94, P83, DOI 10.1890/12-0940.1; Koenig WD, 2014, POPUL ECOL, V56, P63, DOI 10.1007/s10144-013-0408-z; Kosola KR, 2001, OECOLOGIA, V129, P65, DOI 10.1007/s004420100694; Koyama R, 1954, FOR PESTS, V3, P296; Kozakai C, 2011, J WILDLIFE MANAGE, V75, P867, DOI 10.1002/jwmg.122; KULMAN HM, 1971, ANNU REV ENTOMOL, V16, P289, DOI 10.1146/annurev.en.16.010171.001445; Lesnoff M, 2012, AOD ANAL OVERDISPERS; Liebhold AM, 1995, NE221 USDA FOR SERV; Liebhold AM, 2008, AGR FOREST ENTOMOL, V10, P69; Liebhold AM, 1998, ENVIRON ENTOMOL, V27, P858; Maeto K, 2003, OECOLOGIA, V137, P392, DOI 10.1007/s00442-003-1381-6; Massad TJ, 2013, OECOLOGIA, V172, P1, DOI 10.1007/s00442-012-2470-1; MAY JD, 1995, CAN J FOREST RES, V25, P1858, DOI 10.1139/x95-200; Mizui N., 1991, Journal of the Japanese Forestry Society, V73, P258; Mizutani M, 2014, CHUBU FOR RES, V62, P63; Mizutani M., 2013, Journal of the Japanese Forest Society, V95, P76, DOI 10.4005/jjfs.95.76; Muzika RM, 1999, CAN J FOREST RES, V29, P1365, DOI 10.1139/cjfr-29-9-1365; Naidoo R, 2001, FOREST SCI, V47, P338; Nakajima H., 2013, Journal of the Japanese Forest Society, V95, P71, DOI 10.4005/jjfs.95.71; Nakajima H, 2014, FOREST ECOL MANAG, V334, P18, DOI 10.1016/j.foreco.2014.08.021; Nakajima H, 2015, J FOREST RES-JPN, V20, P94, DOI 10.1007/s10310-014-0440-7; Nakajima H, 2011, ANN FOREST SCI, V68, P1333, DOI 10.1007/s13595-011-0132-9; OBESO JR, 1993, FUNCT ECOL, V7, P150, DOI 10.2307/2389881; Obeso JR, 1998, FUNCT ECOL, V12, P486, DOI 10.1046/j.1365-2435.1998.00216.x; Onodera K, 2011, B HOKKAIDO FOR RES I, V48, P47; R Core Team, 2014, R LANG ENV STAT COMP; Rieske LK, 2008, FOREST ECOL MANAG, V256, P121, DOI 10.1016/j.foreco.2008.04.015; ROCKWOOD LL, 1973, ECOLOGY, V54, P1363, DOI 10.2307/1934200; Saitoh T, 2008, POPUL ECOL, V50, P159, DOI 10.1007/s10144-008-0076-6; Salleo S, 2003, TREES-STRUCT FUNCT, V17, P367, DOI 10.1007/s00468-003-0247-1; SCHULTZ JC, 1982, SCIENCE, V217, P149, DOI 10.1126/science.217.4555.149; STEPHENSON AG, 1980, ECOLOGY, V61, P57, DOI 10.2307/1937155; WARGO PM, 1972, PHYTOPATHOLOGY, V62, P1278; Wesolowski T, 2015, EUR J FOREST RES, V134, P99, DOI 10.1007/s10342-014-0836-0; Yasaka M, 2008, J FOREST RES-JPN, V13, P83, DOI 10.1007/s10310-007-0052-6	86	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0931-1890	1432-2285		TREES-STRUCT FUNCT	Trees-Struct. Funct.	OCT	2015	29	5					1559	1566		10.1007/s00468-015-1237-9		8	Forestry	Forestry	CR6BZ	WOS:000361429500022		
J	Kayama, M; Qu, LY; Koike, T				Kayama, Masazumi; Qu, Laiye; Koike, Takayoshi			Elements and ectomycorrhizal symbiosis affecting the growth of Japanese larch seedlings regenerated on slopes of an active volcano in northern Japan	TREES-STRUCTURE AND FUNCTION			English	Article						Larch; Volcanic ash soil; Nutrient; Stoichiometry; Ectomycorrhizal symbiosis	LARIX-KAEMPFERI SEEDLINGS; CENOCOCCUM-GRANIFORME; SOIL PROPERTIES; PLANT-GROWTH; EXCESS IRON; FUNGI; PHOSPHORUS; ALUMINUM; NITROGEN; FOREST	The growth of Japanese larch seedlings is regulated by the presence of nutrients as well as ectomycorrhizal symbiosis. The mountain slope of an active volcano is a severe environment for the regeneration of larch (Larix kaempferi Sarg. hereafter larch) seedlings. To determine parameters affecting the growth of larch seedlings, we analyzed stoichiometry of elements in the soils and plant organs, ectomycorrhizal (ECM) colonization, and photosynthetic abilities. These parameters were compared with two different elevations. From nutrient analysis of plant organs from larch seedlings grown on the slope of a volcano, potassium (K) was insufficient compared with the seedlings grown in other habitats. Symbiosis with ECM fungi enabled the uptake of nutrients, especially phosphorous (P) and nitrogen (N). The main factor affecting the differences in relative height growth rate (RHGr) of larch was attributed to ECM colonization. There was a positive relationship between ECM colonization and concentrations of P or N in needles. Larch seedlings with high rates of ECM colonization showed high concentrations of P and N, and had high photosynthetic rates. At lower elevation sites, concentrations of N and K in needles were low with high density of individuals. Moreover, larch showed a high accumulation of aluminum (Al) and iron (Fe) even though the amount of these elements in the soil was small. These seedlings exhibited a suppressed photosynthetic rate and RHGr. Symbiosis with ECM fungi could suppress the excessive uptake of Al and Fe.	[Kayama, Masazumi; Qu, Laiye] Hokkaido Univ Forests, FSC, Sapporo, Hokkaido 0600809, Japan; [Koike, Takayoshi] Hokkaido Univ, Silviculture & Forest Ecol Studies, Sapporo, Hokkaido 0608589, Japan	Kayama, M (reprint author), Japan Int Res Ctr Agr Sci, 1-1 Ohwashi, Tsukuba, Ibaraki 3058686, Japan.	kayama@affrc.go.jp					Adikari Y, 2007, NEW FOREST, V33, P53, DOI 10.1007/s11056-006-9013-8; Akasaka M, 2009, PLANT ECOL, V202, P235, DOI 10.1007/s11258-008-9464-4; Akasaka M, 2007, J PLANT RES, V120, P329, DOI 10.1007/s10265-006-0052-1; Akasaka M, 2005, J VEG SCI, V16, P647, DOI 10.1658/1100-9233(2005)016[0647:TSPIMA]2.0.CO;2; Kayama M, 2007, TREE PHYSIOL, V27, P1585; Bourioug M, 2014, ARAB J SCI ENG, V39, P5325, DOI 10.1007/s13369-014-1100-0; Douhan GW, 2005, NEW PHYTOL, V166, P263, DOI 10.1111/j.1469-8137.2004.01305.x; Pereira EG, 2013, PLANT SCI, V201, P81, DOI 10.1016/j.plantsci.2012.12.003; Yang LT, 2011, PLANT SCI, V180, P521, DOI 10.1016/j.plantsci.2010.11.011; Chen LS, 2005, TREE PHYSIOL, V25, P317; Imaya A, 2007, SOIL SCI PLANT NUTR, V53, P621, DOI 10.1111/j.1747-0765.2007.00175.x; Nogueira MA, 2007, PLANT SOIL, V298, P273, DOI 10.1007/s11104-007-9379-1; TAM PCF, 1995, MYCORRHIZA, V5, P181, DOI 10.1007/BF00203335; Adamski JM, 2011, J PLANT PHYSIOL, V168, P2056, DOI 10.1016/j.jplph.2011.06.003; Chalot M, 1998, FEMS MICROBIOL REV, V22, P21, DOI 10.1016/S0168-6445(98)00004-7; Jiang HX, 2008, TREE PHYSIOL, V28, P1863; GENETET I, 1984, PLANT PHYSIOL, V76, P395, DOI 10.1104/pp.76.2.395; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Siqueira-Silva AI, 2012, ECOTOX ENVIRON SAFE, V78, P265, DOI 10.1016/j.ecoenv.2011.11.030; Quoreshi AM, 1998, CAN J FOREST RES, V28, P674; Plassard C, 2010, TREE PHYSIOL, V30, P1129, DOI 10.1093/treephys/tpq063; Jentschke G, 2000, PHYSIOL PLANTARUM, V109, P107, DOI 10.1034/j.1399-3054.2000.100201.x; Nara K, 2006, NEW PHYTOL, V171, P187, DOI 10.1111/j.8137.2006.01744.x; Pettigrew WT, 2008, PHYSIOL PLANTARUM, V133, P670, DOI 10.1111/j.1399-3054.2008.01073.x; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; Osaki M, 1997, SOIL SCI PLANT NUTR, V43, P551; BAE KS, 1989, APPL ENVIRON MICROB, V55, P2511; Baillon F, 1988, TREES-STRUCT FUNCT, V2, P173; Barron-Gafford GA, 2003, FOREST SCI, V49, P291; BAUTISTA AT, 1993, SOIL SCI PLANT NUTR, V39, P517; Bown HE, 2007, TREE PHYSIOL, V27, P335; Braatne JH, 1999, ECOLOGY, V80, P891; Donan Agricultural Experiment Station, 2013, ANN REP DON AGR EXP; FINLAY RD, 1989, NEW PHYTOL, V112, P185, DOI 10.1111/j.1469-8137.1989.tb02373.x; Geological survey of Japan, 2013, HOKK KOM VOLC; Hakodate district forest office, 1967, HIST HAK DISTR FOR O; Haruki M, 2001, ECOL RES, V16, P451, DOI 10.1046/j.1440-1703.2001.00407.x; HODGE A, 1995, MYCOL RES, V99, P935; Horikawa Y, 1972, ATLAS JAPANESE FLORA; Igarashi T., 1987, Research Bulletins of the College Experiment Forests, Hokkaido University, V44, P1019; Ishikawa T, 1978, RES B FAC AGR GIFU U, V41, P251; Ishimaru K, 2005, J FOREST RES-JPN, V10, P27, DOI 10.1007/s10310-004-0097-8; Japan Meteorological Agency, 2006, MONTHL REP CLIM; Kayama M, 2014, TREES-STRUCT FUNCT, V28, P569, DOI 10.1007/s00468-013-0973-y; Kayama M, 2009, LANDSC ECOL ENG, V5, P125, DOI 10.1007/s11355-009-0069-4; Kayama M, 2011, PHOTOSYNTHETICA, V49, P239, DOI 10.1007/s11099-011-0030-2; Koike T., 2000, RES NOTE FAC FORESTR, V92, P49; Kondo Toshihiro, 1999, Diversity and Distributions, V5, P223, DOI 10.1046/j.1472-4642.1999.00056.x; Larcher W, 2003, PHYSL PLANT ECOLOGY; Leski T, 2012, SYMBIOSIS, V56, P45, DOI 10.1007/s13199-012-0164-4; LEYTON L., 1957, Plant and Soil, V9, P31, DOI 10.1007/BF01343480; Maeda T, 1978, JPN J FOREST ENV, V19, P1; MARSCHNER H., 1995, MINERAL NUTR HIGHER; Nakamura T., 1961, Journal of the Faculty of Agriculture, Shinshu University, V2, P377; Nguyen NT, 2005, PLANT SOIL, V277, P139, DOI 10.1007/s11104-005-6516-6; Qu LaiYe, 2003, Eurasian Journal of Forest Research, V6, P65; Qu LaiYe, 2004, Eurasian Journal of Forest Research, V7-1, P43; Qu LY, 2004, TREE PHYSIOL, V24, P1369; RAAIMAKERS D, 1995, OECOLOGIA, V102, P120; READ DJ, 1991, EXPERIENTIA, V47, P376, DOI 10.1007/BF01972080; Sasaoka E., 2000, Research Bulletin of the Hokkaido University Forests, V57, P105; Sasaoka E., 1999, Journal of the Japanese Forestry Society, V81, P22; SPARKS D. L., 1996, METHODS SOIL ANAL 3; Sugimoto S, 1966, CONSIDERING LARCH FO; Takada J, 1994, DATA ELEMENTAL CONCE; Tanaka A, 2008, ECOL RES, V23, P71, DOI 10.1007/s11284-007-0340-9; THOMPSON GW, 1984, APPL ENVIRON MICROB, V48, P556; Tsuda K, 1963, B FFPRI, V214, P1; Usami H, 2007, P JPN FOREST SOC C, V118, pC31; van Reeuwijk L. P., 1993, PROCEDURES SOIL ANAL; van Scholl L, 2008, PLANT SOIL, V303, P35, DOI 10.1007/s11104-007-9513-0; Yang GT, 1998, MYCOL RES, V102, P1503, DOI 10.1017/S0953756298006480; Yoshii Y, 1932, BOT MAG, V46, P208; Zhang HH, 2011, AFR J MICROBIOL RES, V5, P365; Zhang L, 2014, PEDOSPHERE, V24, P683, DOI 10.1016/S1002-0160(14)60054-0	75	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0931-1890	1432-2285		TREES-STRUCT FUNCT	Trees-Struct. Funct.	OCT	2015	29	5					1567	1579		10.1007/s00468-015-1238-8		13	Forestry	Forestry	CR6BZ	WOS:000361429500023		
J	Ichiyanagi, O; Nagaoka, A; Izumi, T; Kawamura, Y; Kato, T				Ichiyanagi, Osamu; Nagaoka, Akira; Izumi, Takuji; Kawamura, Yuko; Kato, Tomoyuki			Age-related delay in urinary stone clearance in elderly patients with solitary proximal ureteral calculi treated by extracorporeal shock wave lithotripsy	UROLITHIASIS			English	Article						Aging; Extracorporeal shock wave lithotripsy; Ureteral stone; Stone-free; Elder	MULTIVARIATE-ANALYSIS; PREFERRED TREATMENT; HOUNSFIELD UNITS; TRACT STONES; RENAL STONES; SUCCESS; ESWL; HYDRONEPHROSIS; UROLITHIASIS; OUTCOMES	We investigated the effects of aging on the stone-free rate (SFR) after shock wave lithotripsy (SWL) for the treatment of proximal ureteral calculi. A total of 247 consecutive patients were retrospectively selected, classified into seven groups set at 10 year increments (from 20 to 90 years), and examined for SFR after SWL. According to our final analysis, 185 male and 62 female patients with an average age of 54.1 years had stones with a diameter of 11.5 mm and a density of 893.1 Hounsfield units. On average, SFR was 74.9 % at 3 months after 1.7 SWL sessions. SFR gradually reached >= 90 % for each age-group after 1.5-2 years. Median durations to achieve 50 % SFR were estimated to be 21 and 86 days for those in their 20 and 80 s, respectively. However, the difference between the two estimates was not significant (p = 0.064). The durations to achieve 50 % SFR for the other groups lay between these two estimates. Aging does not affect long-term SFR, but patients aged >= 80 years might experience delayed stone clearance within the first 12 months after SWL.	[Ichiyanagi, Osamu; Nagaoka, Akira; Kato, Tomoyuki] Yamagata Univ, Fac Med, Dept Urol, Yamagata, Yamagata, Japan; [Izumi, Takuji; Kawamura, Yuko] South Miyagi Med Ctr, Dept Urol, Ogawara Town, Miyagi, Japan	Ichiyanagi, O (reprint author), Yamagata Univ, Fac Med, Dept Urol, Iida Nishi 2-2-2, Yamagata, Yamagata, Japan.	o.ichiyanagi@med.id.yamagata-u.ac.jp					Abdel-Khalek M, 2003, SCAND J UROL NEPHROL, V37, P413, DOI 10.1080/00365590310006255; ACKERMANN DK, 1994, EUR UROL, V25, P105; Kanao K, 2006, J UROLOGY, V176, P1453, DOI 10.1016/j.juro.2006.06.089; Ng CF, 2009, CURR OPIN UROL, V19, P211, DOI 10.1097/MOU.0b013e32831e16b7; Albala DM, 2001, J UROLOGY, V166, P2072, DOI 10.1016/S0022-5347(05)65508-5; Pareek G, 2005, UROLOGY, V65, P33, DOI 10.1016/j.urology.2004.08.004; Dhar NB, 2004, J UROLOGY, V172, P2271, DOI 10.1097/01.ju.0000143459.03836.2d; Osman MM, 2005, EUR UROL, V47, P860, DOI 10.1016/j.eururo.2005.01.005; Pareek G, 2003, J UROLOGY, V169, P1679, DOI 10.1097/01.ju.0000055608.92069.3a; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Wiesenthal JD, 2011, J UROLOGY, V186, P556, DOI 10.1016/j.juro.2011.03.109; Abe T, 2005, J ENDOUROL, V19, P768, DOI 10.1089/end.2005.19.768; DRETLER SP, 1988, J UROLOGY, V139, P1124; Abdel-Khalek M, 2004, SCAND J UROL NEPHROL, V38, P161, DOI 10.1080/00365590310022626; Ng CF, 2009, J UROLOGY, V181, P1151, DOI 10.1016/j.juro.2008.10.161; Christian C, 2009, UROLOGY, V74, P259, DOI 10.1016/j.urology.2008.08.522; Yasui T, 2008, UROLOGY, V71, P209, DOI 10.1016/j.urology.2007.09.034; Preminger GM, 2007, EUR UROL, V52, P1610, DOI 10.1016/j.eururo.2007.09.039; KAPLAN C, 1975, AM J PATHOL, V80, P227; DRIPPS RD, 1961, JAMA-J AM MED ASSOC, V178, P261; Ghoneim IA, 2005, EUR UROL, V48, P296, DOI 10.1016/j.eururo.2005.02.017; Halachmi S, 2006, AGING MALE, V9, P171, DOI 10.1080/13685530600907985; Hsiao HL, 2008, KAOHSIUNG J MED SCI, V24, P507, DOI 10.1016/S1607-551X(09)70009-9; Ikegaya H, 2005, BJU INT, V96, P1145, DOI 10.1111/j.1464-410X.2005.05924_2.x; Kimura Motohiko, 2008, Nihon Hinyokika Gakkai Zasshi, V99, P571; Madbouly K, 2005, J UROLOGY, V173, P127, DOI 10.1097/01.ju.0000147820.36996.86; Matsuura H, 1999, Hinyokika Kiyo, V45, P393; Neisius A, 2015, WORLD J UROL, V33, P213, DOI 10.1007/s00345-014-1369-3; Ng CF, 2007, BJU INT, V100, P392, DOI 10.1111/j.1464-410X.2007.06909.x; Sarica K, 2015, UROLITHIASIS, V43, P83, DOI 10.1007/s00240-014-0724-6; Seitz C, 2006, EUR UROL, V49, P378, DOI 10.1016/j.eururo.2005.09.022; Shiroyanagi Y, 2002, INT J UROL, V9, P304, DOI 10.1046/j.1442-2042.2002.00475.x	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	2194-7228	2194-7236		UROLITHIASIS	Urolithiasis	OCT	2015	43	5					419	426		10.1007/s00240-015-0783-3		8	Urology & Nephrology	Urology & Nephrology	CR7UI	WOS:000361556600004		
J	Ito, H; Kuroda, S; Kawahara, T; Makiyama, K; Yao, M; Matsuzaki, J				Ito, Hiroki; Kuroda, Shinnosuke; Kawahara, Takashi; Makiyama, Kazuhide; Yao, Masahiro; Matsuzaki, Junichi			Clinical factors prolonging the operative time of flexible ureteroscopy for renal stones: a single-center analysis	UROLITHIASIS			English	Article						Ureteroscopy; Kidney stone; Lithotripsy; Operative time	HOLMIUM LASER LITHOTRIPSY; SHOCK-WAVE LITHOTRIPSY; PERCUTANEOUS NEPHROLITHOTOMY; CENTER EXPERIENCE; HOUNSFIELD UNITS; SEMIRIGID URETEROSCOPY; INTRARENAL STONES; FREE RATES; 2 CM; COMPLICATIONS	The objective of the study was to evaluate the clinical factors affecting the operative time of flexible ureteroscopy (fURS). We retrospectively evaluated 233 patients with renal stones who had been treated successfully and had stone-free status 3 months after fURS and holmium laser lithotripsy between December 2009 and December 2013 at a single institute. Operative time was divided into three periods (total, before fragmentation, and after starting fragmentation), and associations between possible factors and these periods were analyzed by a multivariate logistic regression model with backward selection. The mean total operative time was 74.0 +/- 32.0 min. There were significant differences in the following clinical factors: sex, body height, stone volume, maximum and mean Hounsfield units (HUs), diameter of the ureteral access sheath, and experience of the surgeon, between patients who underwent procedures with a total operative time of less or more than 90 min. A multivariate assessment revealed four independent factors influencing total operative time (P < 0.05): stone volume (P < 0.001), experience of the surgeon (P < 0.001), maximum HUs (P = 0.014), and lack of preoperative stenting (P = 0.027). Larger stone volume, lower experience level of the surgeon, higher HUs, and the absence of preoperative stenting were identified as parameters prolonging the total operative time of fURS and, in particular, the operative time after starting fragmentation. On the other hand, operative time before starting fragmentation, which represented the time required to identify the stone by ureteroscopy and insert the access sheath, was more difficult to predict preoperatively.	[Ito, Hiroki; Kuroda, Shinnosuke; Kawahara, Takashi; Matsuzaki, Junichi] Ohguchi East Gen Hosp, Dept Urol, Yokohama, Kanagawa, Japan; [Ito, Hiroki; Makiyama, Kazuhide; Yao, Masahiro] Yokohama City Univ, Grad Sch Med, Dept Urol, Kanazawa Ku, Yokohama, Kanagawa 232, Japan	Ito, H (reprint author), Ohguchi East Gen Hosp, Dept Urol, Yokohama, Kanagawa, Japan.	pug_daikichi@yahoo.co.jp					Akman T, 2011, J ENDOUROL, V25, P1269, DOI 10.1089/end.2011.0061; Akman T, 2012, BJU INT, V109, P1384, DOI 10.1111/j.1464-410X.2011.10691.x; Mitropoulos D, 2012, EUR UROL, V61, P341, DOI 10.1016/j.eururo.2011.10.033; Aboumarzouk OM, 2012, J ENDOUROL, V26, P1257, DOI 10.1089/end.2012.0217; Kijvikai K, 2011, NAT REV UROL, V8, P81, DOI 10.1038/nrurol.2010.209; Michel MS, 2007, EUR UROL, V51, P899, DOI 10.1016/j.eururo.2006.10.020; Cohen J, 2013, BJU INT, V111, pE127, DOI 10.1111/j.1464-410X.2012.11352.x; Breda A, 2009, EUR UROL, V55, P1190, DOI 10.1016/j.eururo.2008.06.019; Kawahara T, 2012, INT J UROL, V19, P881, DOI 10.1111/j.1442-2042.2012.03046.x; Geavlete P, 2006, J ENDOUROL, V20, P179, DOI 10.1089/end.2006.20.179; Netsch C, 2012, UROLOGY, V80, P1214, DOI 10.1016/j.urology.2012.06.064; Falahatkar S, 2011, J ENDOUROL, V25, P1831, DOI 10.1089/end.2011.0278; Sugihara T, 2013, INT J UROL, V20, P1193, DOI 10.1111/iju.12157; Fuganti PE, 2008, UROLOGY, V72, P770, DOI 10.1016/j.urology.2008.05.042; Pareek G, 2005, UROLOGY, V65, P33, DOI 10.1016/j.urology.2004.08.004; Breda A, 2008, J UROLOGY, V179, P981, DOI 10.1016/j.juro.2007.10.083; Hyams ES, 2010, J ENDOUROL, V24, P1411, DOI 10.1089/end.2009.0645; Seitz C, 2012, EUR UROL, V61, P146, DOI 10.1016/j.eururo.2011.09.016; Chu L, 2011, J ENDOUROL, V25, P751, DOI 10.1089/end.2010.0400; Hubert KC, 2005, J UROLOGY, V174, P1079, DOI 10.1097/01.ju.0000169130.80049.9c; Pareek G, 2003, J UROLOGY, V169, P1679, DOI 10.1097/01.ju.0000055608.92069.3a; El-Nahas AR, 2012, BJU INT, V110, P898, DOI 10.1111/j.1464-410X.2012.10961.x; Ito H, 2012, UROLOGY, V80, P524, DOI 10.1016/j.urology.2012.04.001; Ito H, 2012, J ENDOUROL, V26, P1125, DOI 10.1089/end.2012.0154; Ito H, 2015, BJU INT, V115, P446, DOI 10.1111/bju.12775; Saw KC, 2000, J ENDOUROL, V14, P471, DOI 10.1089/end.2000.14.471; Sugihara T, 2013, BJU INT, V111, P459, DOI 10.1111/j.1464-410X.2012.11594.x	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	2194-7228	2194-7236		UROLITHIASIS	Urolithiasis	OCT	2015	43	5					467	475		10.1007/s00240-015-0789-x		9	Urology & Nephrology	Urology & Nephrology	CR7UI	WOS:000361556600010		
J	Demirhan, Y; Saglam, H; Turkoglu, F; Alaboz, H; Ozyuzer, L; Miyakawa, N; Kadowaki, K				Demirhan, Y.; Saglam, H.; Turkoglu, F.; Alaboz, H.; Ozyuzer, L.; Miyakawa, N.; Kadowaki, K.			Area dependence and influence of crystal inhomogeneity on superconducting properties of Bi2212 mesa structures	VACUUM			English	Article						Terahertz emitters; Intrinsic Josephson junctions; Bi2212 single crystals; ac-Josephson effect; High-T-c superconductors	INTRINSIC JOSEPHSON-JUNCTIONS; SPIN-POLARIZED CURRENT; TERAHERTZ TECHNOLOGY; THZ RADIATION; BI2SR2CACU2O8+DELTA; INJECTION; EMISSION	The rapid increase in applications of terahertz waves requires new techniques to obtain continuous wave terahertz sources. Mesa structures fabricated from high-T-c superconductor Bi2Sr2CaCu2O8+delta (Bi2212) single crystal have been observed as an intense, coherent, continuous electromagnetic wave source in the terahertz (THz) frequency region. However, in order to produce coherent radiation with high applicable power, we need large mesa structures that enter a collective electromagnetic state in which their oscillations are largely synchronized in phase. On the other hand, large mesa structures cause a heating problem. In this study, we report on the critical current density dependence of mesa area and the crystal inhomogeneity to understand heating problems in large area mesas for terahertz radiation. Since the doping dependence of Bi2212 is an important parameter, the as-grown Bi2212 crystals were heat-treated at various temperatures under vacuum conditions. We have fabricated triple mesa structures from Bi2212 single crystal using e-beam lithography and argon ion beam etching techniques with same area and with different area on the same chip. We investigated and compared characteristics of triple mesas which are on the same chip and next to each other. In this way, we searched the crystal inhomogeneity in triple mesa structures and studied the critical current density dependence of mesa area to obtain high emission power for the THz radiation. Our experimental results clearly show that the Josephson critical current density is decreasing when the area of mesa is increasing. (C) 2015 Elsevier Ltd. All rights reserved.	[Demirhan, Y.; Saglam, H.; Turkoglu, F.; Alaboz, H.; Ozyuzer, L.] Izmir Inst Technol, Dept Phys, TR-35430 Izmir, Turkey; [Miyakawa, N.] Tokyo Univ Sci, Dept Appl Chem, Tokyo 162, Japan; [Kadowaki, K.] Univ Tsukuba, Tsukuba, Ibaraki, Japan	Demirhan, Y (reprint author), Izmir Inst Technol, Dept Phys, TR-35430 Izmir, Turkey.	yasemindemirhan@iyte.edu.tr			TUBITAK (Scientific and Technological Council of Turkey) [110T248]; SANTEZ [1386.STZ.2012-1]	This work has been supported in part by TUBITAK (Scientific and Technological Council of Turkey) under project number 110T248. We would also like to acknowledge SANTEZ project number 1386.STZ.2012-1. The infrastructure of Applied Quantum Research Center (UKAM) was used to perform some parts of the experiments.	Kashiwagi T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.010113; Turkoglu F, 2013, PHYSICA C, V491, P7, DOI 10.1016/j.physc.2013.01.014; Koshelev AE, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.014530; Siegel PH, 2004, IEEE T MICROW THEORY, V52, P2438, DOI [10.1109/TMTT.2004.835916, 10.1109/TMTT.2004.83516]; Guenon S, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.214506; Tachiki M, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.134515; Kurter C, 2009, IEEE T APPL SUPERCON, V19, P428, DOI 10.1109/TASC.2009.2019235; Ferguson B, 2002, NAT MATER, V1, P26, DOI 10.1038/nmat708; Tsujimoto M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.037005; Kadowaki K, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.023703; Kleine-Ostmann T, 2011, J INFRARED MILLIM TE, V32, P143, DOI 10.1007/s10762-010-9758-1; Wang HB, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.057002; Bae MH, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.027002; Chan WL, 2007, REP PROG PHYS, V70, P1325, DOI 10.1088/0034-4885/70/8/R02; Krasnov VM, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.174517; Tonouchi M, 2007, NAT PHOTONICS, V1, P97, DOI 10.1038/nphoton.2007.3; Hu X, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.134510; Hu X, 2010, SUPERCOND SCI TECH, V23, DOI 10.1088/0953-2048/23/5/053001; KLEINER R, 1992, PHYS REV LETT, V68, P2394, DOI 10.1103/PhysRevLett.68.2394; Benseman TM, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.064523; Ozyuzer L, 2007, SCIENCE, V318, P1291, DOI 10.1126/science.1149802; Welp U, 2013, NAT PHOTONICS, V7, P702, DOI [10.1038/nphoton.2013.216, 10.1038/NPHOTON.2013.216]; Klemm RA, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/2/025701; Koval Y, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3327825; Krasnov VM, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.136501; Krasnov VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.077003; Kurter C, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.224518; Li MY, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.060505; Ozyuzer L, 2007, PHYSICA C, V460, P950, DOI 10.1016/j.physc.2007.03.322; Ozyuzer L, 2007, IEEE T APPL SUPERCON, V17, P577, DOI 10.1109/TASC.2007.898651; Ozyuzer L, 2009, SUPERCOND SCI TECH, V22, DOI 10.1088/0953-2048/22/11/114009; Turkoglu F, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/12/125004; Wang HB, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.017006; Watanabe T, 1997, PHYS REV LETT, V79, P2113, DOI 10.1103/PhysRevLett.79.2113; Zhu XB, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.224501	35	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-207X			VACUUM	Vacuum	OCT	2015	120		B		SI		89	94		10.1016/j.vacuum.2015.05.002		6	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CR5SW	WOS:000361405300015		
J	Sassa, Y; Bui, VN; Saitoh, K; Watanabe, Y; Koyama, S; Endoh, D; Horie, M; Tomonaga, K; Furuya, T; Nagai, M; Omatsu, T; Imai, K; Ogawa, H; Mizutani, T				Sassa, Yukiko; Vuong Nghia Bui; Saitoh, Keisuke; Watanabe, Yukiko; Koyama, Satoshi; Endoh, Daiji; Horie, Masayuki; Tomonaga, Keizo; Furuya, Tetsuya; Nagai, Makoto; Omatsu, Tsutomu; Imai, Kunitoshi; Ogawa, Haruko; Mizutani, Tetsuya			Parrot bornavirus-2 and-4 RNA detected in wild bird samples in Japan are phylogenetically adjacent to those found in pet birds in Japan	VIRUS GENES			English	Article						Avian bornavirus; Wild bird; PDD; Neurological disorder	PROVENTRICULAR DILATATION DISEASE; GEESE BRANTA-CANADENSIS; AVIAN BORNAVIRUS; PSITTACINE BIRDS; VERTICAL TRANSMISSION; TRUMPETER SWANS; VIRUS; GENOTYPE; IDENTIFICATION; ANTIBODIES	Bornaviruses (family Bornaviridae) are non-segmented negative-strand RNA viruses. Avian bornaviruses (ABVs), which are causative agents of proventricular dilatation disease, are a genetically diverse group with at least 15 genotypes, including parrot bornaviruses (PaBVs) and aquatic bird bornavirus 1(ABBV-1). Borna disease virus 1(BoDV-1), which infects mammals and causes neurological diseases, has also been reported to infect avian species, although the numbers of the cases have been markedly fewer than those of ABVs. In this study, we conducted genetic surveillance to detect ABVs (PaBV-1 to -5 and ABBV-1) and BoDV-1 in wild birds in Japan. A total of 2078 fecal or cloacal swab samples were collected from wild birds in 2006, 2007, 2008, and 2011, in two regions of Japan. The results demonstrated the presence of PaBV-2 and -4 RNA, while no positive results for other PaBVs, ABBV-1, and BoDV-1 were obtained. PaBV-2 and -4 RNA were detected in 18 samples (0.9 %) of the genera Anas, Grus, Larus, Calidris, Haliaeetus, and Emberiza, in which either PaBV-2 RNA or PaBV-4 RNA, or both PaBV-2 and -4 RNA were detected in 15 (0.7 %), 5 (0.2 %), and 2 (0.1 %) samples, respectively. The nucleotide sequences of PaBV-2 and -4 detected in these samples from wild birds are phylogenetically close to those found in samples from pet birds in Japan, with identities ranging from 99.8 to 100 % and from 98.2 to 99.4 %, respectively. To the best of our knowledge, this is the first report on the detection of PaBV-2 and -4 RNA detected in samples from wild birds.	[Sassa, Yukiko] Tokyo Univ Agr & Technol, Lab Vet Infect Dis, Fuchu, Tokyo 1838509, Japan; [Vuong Nghia Bui; Imai, Kunitoshi; Ogawa, Haruko] Obihiro Univ Agr & Vet Med Japan, Res Ctr Anim Hyg & Food Safety, Obihiro, Hokkaido 0808555, Japan; [Saitoh, Keisuke; Watanabe, Yukiko] Inst Raptor Biomed Japan, Kushiro, Hokkaido 0840922, Japan; [Koyama, Satoshi] TUAT, Ethol Lab, Fuchu, Tokyo 1838509, Japan; [Endoh, Daiji] Rakuno Gakuen Univ, Sch Vet Med, Dept Basic Vet Radiol, Ebetsu, Hokkaido 0698501, Japan; [Horie, Masayuki] Kagoshima Univ, Joint Fac Vet Med, Transboundary Anim Dis Ctr, Kagoshima, Kagoshima 8900065, Japan; [Tomonaga, Keizo] Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Lab Human Tumor Viruses,Sakyo Ku, Kyoto 6068507, Japan; [Furuya, Tetsuya] TUAT, Lab Vet Microbiol, Fuchu, Tokyo 1838509, Japan; [Furuya, Tetsuya; Nagai, Makoto; Omatsu, Tsutomu; Mizutani, Tetsuya] TUAT, Res & Educ Ctr Prevent Global Infect Dis Anim, Fuchu, Tokyo 1838509, Japan	Sassa, Y (reprint author), Tokyo Univ Agr & Technol, Lab Vet Infect Dis, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	sassa_y@cc.tuat.ac.jp			JSPS KAKENHI [24780294, 19659115, 24580430]; MEXT	We thank Dr. Daisuke Hayakawa (Wanpark Kochi Animal Land, 6-9-1 Sanbasidori, Kochi-shi, Kochi 780-8010, Japan) for valuable advice on captive birds. We are grateful to Dr. Kei Fujii, Dr. Satoshi Konno, Dr. Miwa Konno, Dr. Yukiyoshi Ikeda, Dr. Maki Kobayashi, Dr. Mizuho Suzuki, Dr. Emi Yamaguchi, and Dr. Yuichi Osa for valuable advice on wild birds. This work was supported by JSPS KAKENHI Grant Numbers 24780294, 19659115, and 24580430, by grants from the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, and by "Women's Science Career Acceleration Program" under MEXT funds for supporting positive activities for female researchers.	Payne S, 2011, J VIROL, V85, P12053, DOI 10.1128/JVI.05700-11; Delnatte P, 2011, VET REC, V169, P108, DOI 10.1136/vr.d4620; Gray P, 2010, EMERG INFECT DIS, V16, P473, DOI 10.3201/eid1603.091257; Rubbenstroth D, 2013, VET MICROBIOL, V165, P287, DOI 10.1016/j.vetmic.2013.03.024; Payne Susan L, 2012, Anim Health Res Rev, V13, P145, DOI 10.1017/S1466252312000205; Raghav R, 2010, J VET DIAGN INVEST, V22, P495; Lierz M, 2011, EMERG INFECT DIS, V17, P2390, DOI 10.3201/eid1712.111317; Lierz M, 2009, AVIAN PATHOL, V38, P491, DOI 10.1080/03079450903349238; GOSZTONYI G, 1995, CURR TOP MICROBIOL, V190, P39; De Kloet SR, 2009, AVIAN DIS, V53, P568; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; Bourque L, 2015, AVIAN PATHOL, V44, P323, DOI 10.1080/03079457.2015.1050956; Weissenbock H, 2009, EMERG INFECT DIS, V15, P1453, DOI 10.3201/eid1509.090353; Monaco E, 2012, J AVIAN MED SURG, V26, P144, DOI 10.1647/2011-049R1.1; Weissenbock H, 2009, J VIROL, V83, P11367, DOI 10.1128/JVI.01343-09; Horie M, 2012, MICROBIOL IMMUNOL, V56, P346, DOI 10.1111/j.1348-0421.2012.00436.x; Kuhn JH, 2015, ARCH VIROL, V160, P621, DOI 10.1007/s00705-014-2276-z; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Rubbenstroth D, 2014, VET MICROBIOL, V168, P318, DOI 10.1016/j.vetmic.2013.11.032; Kistler AL, 2010, J VIROL, V84, P2176, DOI 10.1128/JVI.02191-09; Honkavuori KS, 2008, EMERG INFECT DIS, V14, P1883, DOI 10.3201/eid1412.080984; Kerski A, 2012, AVIAN DIS, V56, P471, DOI 10.1637/9879-080511-Reg.1; Delnatte P, 2013, AVIAN PATHOL, V42, P114, DOI 10.1080/03079457.2013.769669; Rubbenstroth D, 2012, VET MICROBIOL, V161, P36, DOI 10.1016/j.vetmic.2012.07.004; Berg M, 2001, EPIDEMIOL INFECT, V127, P173, DOI 10.1017/S0950268801005702; Gregory Christopher R., 1994, Journal of the Association of Avian Veterinarians, V8, P69; Guo JH, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0197-9; Guo J., 2013, GENOME ANNOUNC, V24, P5, DOI [10.1128/genomeA.00839-13, DOI 10.1128/GENOMEA.00839-13]; Hagiwara K, 2009, J VET MED SCI, V71, P1009, DOI 10.1292/jvms.71.1009; Ludwig T H, 1973, Med Microbiol Immunol, V158, P275; MALKINSON M, 1993, VET REC, V133, P304; Nedorost N, 2012, AVIAN DIS, V56, P414, DOI 10.1637/10026-112911-ResNote.1; Philadelpho NA, 2014, VET MICROBIOL, V174, P584, DOI 10.1016/j.vetmic.2014.10.020; Sassa Y, 2013, VIRUS GENES, V47, P173, DOI 10.1007/s11262-013-0913-3; Watanabe Y, 2006, J VET MED SCI, V68, P171, DOI 10.1292/jvms.68.171	35	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0920-8569	1572-994X		VIRUS GENES	Virus Genes	OCT	2015	51	2					234	243		10.1007/s11262-015-1240-7		10	Genetics & Heredity; Virology	Genetics & Heredity; Virology	CR6LU	WOS:000361459400008		
J	Matsushima, M; Matsunaga, Y				Matsushima, Midori; Matsunaga, Yoshiho			Social Capital and Subjective Well-Being in Japan (vol 26, pg 1046, 2015)	VOLUNTAS			English	Correction									[Matsushima, Midori; Matsunaga, Yoshiho] Osaka Univ Commerce, Fac Business Adm, Higashiosaka, Osaka 5778505, Japan	Matsushima, M (reprint author), Osaka Univ Commerce, Fac Business Adm, 4-1-10 Mikuriyasakaemachi, Higashiosaka, Osaka 5778505, Japan.	midori@daishodai.ac.jp					Matsushima M, 2015, VOLUNTAS, V26, P1016, DOI 10.1007/s11266-015-9581-3	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0957-8765	1573-7888		VOLUNTAS	Voluntas	OCT	2015	26	5					2146	2146		10.1007/s11266-015-9623-x		1	Social Issues	Social Issues	CR6LW	WOS:000361459600027		
J	Khansur, NH; Kawashima, H; Wada, S; Hudspeth, JM; Daniels, J				Khansur, Neamul H.; Kawashima, Hideto; Wada, Satoshi; Hudspeth, Jessica M.; Daniels, John			Enhanced extrinsic domain switching strain in core-shell structured BaTiO3-KNbO3 ceramics	ACTA MATERIALIA			English	Article						Core-shell microstructure; Piezoelectricity; Domain switching; High-energy X-ray diffraction	LEAD-ZIRCONATE-TITANATE; MORPHOTROPIC PHASE-BOUNDARY; FREE PIEZOELECTRIC CERAMICS; X-RAY-DIFFRACTION; BARIUM-TITANATE; SOLID-SOLUTION; FERROELASTIC CERAMICS; SYSTEM; FERROELECTRICS; TEXTURE	Large electric-field-induced strain in piezoelectric ceramics is a primary requirement for their actuator applications. This macroscopic strain is generated from both intrinsic lattice strain and extrinsic domain switching and/or phase transformations. Among these contributions, non-180 degrees ferroelectric domain switching can generate a large electric-field-induced strain due to the change in orientation of the coupled spontaneous strain. However, the large fraction of non-180 degrees ferroelectric domain switching is a one-time effect during electrical poling. Here, we show that electric-field-induced non-180 degrees ferroelectric domain switching in the microstructurally engineered material BaTiO3-KNbO3 (BT-KN) is largely reversible. In situ high energy X-ray diffraction showed approximately 95% reversibility in the switched fraction of non-180 degrees ferroelectric domains during unipolar cycling. This reversibility is hypothesised to be due to the unique grain boundary structure of this material, where ferroelectric domain walls do not interact strongly with grain boundary defects. The domain switching behaviour of core-shell BT-KN has been contrasted with that of polycrystalline BaTiO3 and commercial lead zirconate titanate Pb(Zr,Ti)O-3. The large and reversible non-180 degrees ferroelectric domain switching of core-shell BT-KN offers a distinctive strain response. The results indicate a unique family of large strain lead-free materials based on enhanced reversible non-180 degrees ferroelectric domain switching can be developed for future actuator applications. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Khansur, Neamul H.; Daniels, John] Univ New S Wales, Sch Mat Sci & Engn, Sydney, NSW 2052, Australia; [Kawashima, Hideto; Wada, Satoshi] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi 4008510, Japan; [Hudspeth, Jessica M.] European Synchrotron Radiat Facil, F-38043 Grenoble, France	Daniels, J (reprint author), Univ New S Wales, Sch Mat Sci & Engn, Sydney, NSW 2052, Australia.	j.daniels@unsw.edu.au	Khansur, Neamul /H-9684-2012; Daniels, John/C-7497-2011	Khansur, Neamul /0000-0001-8769-3329; 	AINSE research fellowship; ARC Discovery Project [DP120103968]	JED acknowledges financial support from an AINSE research fellowship and ARC Discovery Project DP120103968. We acknowledge the European Synchrotron Radiation Facility for provision of X-ray beamtime.	Ahart M, 2008, NATURE, V451, P545, DOI 10.1038/nature06459; Hammersley AP, 1996, HIGH PRESSURE RES, V14, P235, DOI 10.1080/08957959608201408; Leist T, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.120205; Noheda B, 1999, APPL PHYS LETT, V74, P2059, DOI 10.1063/1.123756; Sasaki A, 1999, JPN J APPL PHYS 1, V38, P5564, DOI 10.1143/JJAP.38.5564; Cordero F, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/41/415901; Groh C, 2014, ADV FUNCT MATER, V24, P356, DOI 10.1002/adfm.201302102; Daniels JE, 2014, J APPL PHYS, V115, DOI 10.1063/1.4881835; Hinterstein M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.077602; Makiuchi Y, 2005, JPN J APPL PHYS 1, V44, P4350, DOI 10.1143/JJAP.44.4350; TAKENAKA T, 1991, JPN J APPL PHYS 1, V30, P2236, DOI 10.1143/JJAP.30.2236; Daniels JE, 2010, ACTA MATER, V58, P2103, DOI 10.1016/j.actamat.2009.11.052; Daniels JE, 2009, J SYNCHROTRON RADIAT, V16, P463, DOI 10.1107/S0909049509015519; Nagata H, 2003, JPN J APPL PHYS 1, V42, P7401, DOI 10.1143/JJAP.42.7401; Rodel J, 2009, J AM CERAM SOC, V92, P1153, DOI 10.1111/j.1551-2916.2009.03061.x; Pramanick A, 2011, J AM CERAM SOC, V94, P293, DOI 10.1111/j.1551-2916.2010.04240.x; Hoffmann MJ, 2001, ACTA MATER, V49, P1301, DOI 10.1016/S1359-6454(01)00025-8; Guo R, 2000, PHYS REV LETT, V84, P5423, DOI 10.1103/PhysRevLett.84.5423; Khansur NH, 2014, J APPL PHYS, V115, DOI 10.1063/1.4869786; Lee DS, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3621878; Jones JL, 2005, J APPL PHYS, V98, DOI 10.1063/1.1988978; Hall DA, 2004, J APPL PHYS, V96, P4245, DOI 10.1063/1.1787590; Jones JL, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2338756; Daniels JE, 2009, IEEE T ULTRASON FERR, V56, P1539, DOI 10.1109/TUFFC.2009.1218; Coelho A. A., 2007, TOPAS ACAD V4 1; Daniels JE, 2006, J PHYS D APPL PHYS, V39, P5294, DOI 10.1088/0022-3727/39/24/029; Elkechai O, 1996, PHYS STATUS SOLIDI A, V157, P499, DOI 10.1002/pssa.2211570234; Frantti J, 2008, J PHYS CHEM B, V112, P6521, DOI 10.1021/jp711829t; Fujii I, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3662397; Groh C, 2014, J APPL PHYS, V115, DOI 10.1063/1.4876680; Hall DA, 2005, J MECH PHYS SOLIDS, V53, P249, DOI 10.1016/j.jmps.2004.07.002; Hiruma Y, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3194146; Ishii H, 2001, JPN J APPL PHYS 1, V40, P5660, DOI 10.1143/JJAP.40.5660; Jaffe B, 1971, PIEZOELECTRIC CERAMI; Jones JL, 2005, J APPL PHYS, V97, DOI 10.1063/1.1849821; Kungl H, 2007, ACTA MATER, V55, P1849, DOI 10.1016/j.actamat.2006.10.046; Lee D. S., 2013, JPN J APPL PHYS, V52, P6; Liss K-D, 2003, TEXTURE MICROSTRUCT, V35, P219, DOI DOI 10.1080/07303300310001634952; Moulson A. J., 2003, ELECTROCERAMICS MAT; Noheda B., 2001, Physical Review B (Condensed Matter), V63, DOI 10.1103/PhysRevB.63.014103; Picht G, 2010, FUNCT MATER LETT, V3, P59, DOI 10.1142/S1793604710000889; Tsurekawa S, 2007, SCRIPTA MATER, V56, P577, DOI [10.1016/j.scriptamat.2006.12.029, 10.1016/j.scripamat.2006.12.029]; Wada S, 2013, SENSOR ACTUAT A-PHYS, V200, P26, DOI 10.1016/j.sna.2012.12.025; Wada S., 2012, JPN J APPL PHYS, V51; Wada S, 2008, JPN J APPL PHYS, V47, P7678, DOI 10.1143/JJAP.47.7678; Wads S., 2011, JPN J APPL PHYS, V50; Wel J., 2015, J EUR CERAM SOC, V35, P1659; Zhiwu C., 2009, JPN J APPL PHYS, V48	48	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	OCT 1	2015	98						182	189		10.1016/j.actamat.2015.07.034		8	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CR1GX	WOS:000361074000018		
J	Asai, T; Misu, S; Sawa, R; Doi, T; Yamada, M				Asai, Tsuyoshi; Misu, Shogo; Sawa, Ryuichi; Doi, Takehiko; Yamada, Minoru			Multi-chronic musculoskeletal pain is a useful clinical index to predict the risk of falls in older adults with normal motor function	AGING CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						Chronic musculoskeletal pain; Risk factor of fall; Community-dwelling older adults; Dual-tasking	PHYSICAL PERFORMANCE BATTERY; LOWER-EXTREMITY FUNCTION; ELDERLY PERSONS; DUAL-TASKING; DISABLED WOMEN; COMMUNITY; DISABILITY; WALKING; PEOPLE; GAIT	The number of chronic musculoskeletal pain sites (nCMSP) is reportedly associated with risk of falls. Older participants in community-based research show a wide range of physical functions, but few studies have focused on the risk of falls in older adults with normal motor function (NMF). Clarification of the effects of pain on dual-tasking performance is also important, given the strong link between falls and dual-tasking. The objectives were to investigate the associations between: (1) nCMSP and falls; and (2) nCMSP and dual-task performance in older adults with NMF. A total of 112 older adults with NMF (44 men, 68 women; 73.4 +/- A 4.6 years) were classified as fallers (n = 22) or non-fallers (n = 90) according to their fall history. Musculoskeletal pain in the lower body was assessed using questions ascertaining pain in musculoskeletal sites (back, hip, knee, foot, or toe). Participants were assigned to three pain groups according to nCMSP. Basic physical performances and gait performances (normal gait, fast gait, or dual-task gait) were measured. The nCMSP represented a significant risk factor for falls according to logistic regression modeling after adjusting for the five chair stand test and fear of falls. The nCMSP was not associated with any gait variables. Potential fall risk may be increased by nCMSP, even in older adults with NMF. Pain-related reduction in attention resources may not represent a risk factor for falls among older adults with NMF. The nCMSP represents a potential risk factor for falls in older adults with NMF.	[Asai, Tsuyoshi] Kobe Gakuin Univ, Fac Rehabil, Dept Phys Therapy, Nishi Ku, Kobe, Hyogo 6512180, Japan; [Misu, Shogo] West Hosp, Kobe City Med Ctr, Kobe City Hosp Org, Kobe, Hyogo 6530013, Japan; [Sawa, Ryuichi] Kobe Univ, Grad Sch Hlth Sci, Suma Ku, Kobe, Hyogo 6540142, Japan; [Doi, Takehiko] Natl Ctr Geriatr & Gerontol, Dept Hlth & Med Care, Ctr Dev Adv Med Dementia, Sect Hlth Promot, Obu, Aichi 4748511, Japan; [Yamada, Minoru] Univ Tsukuba, Grad Sch Comprehens Human Sci, Bunkyo Ku, Tokyo 1120012, Japan	Asai, T (reprint author), Kobe Gakuin Univ, Fac Rehabil, Dept Phys Therapy, Nishi Ku, 518 Ikawadanicho, Kobe, Hyogo 6512180, Japan.	asai@reha.kobegakuin.ac.jp			KAKENHI in Japan [22700685]	This study was supported by a Grant-in-Aid for Young Scientists (B) (22700685) from KAKENHI in Japan. We wish to thank all individuals who volunteered for the study. The following contributors to data collection, analysis, and manuscript preparation are gratefully acknowledged: T. Ogaya and Y. Fukumoto.	Springer S, 2006, MOVEMENT DISORD, V21, P950, DOI 10.1002/mds.20848; Graven-Nielsen T, 2002, MUSCLE NERVE, V26, P708, DOI 10.1002/mus.10225; Zhang F, 2013, J AGING HEALTH, V25, P478, DOI 10.1177/0898264313475813; Helme RD, 2001, CLIN GERIATR MED, V17, P417, DOI 10.1016/S0749-0690(05)70078-1; Cheng YY, 2014, GAIT POSTURE, V40, P403, DOI 10.1016/j.gaitpost.2014.05.064; Leveille SG, 2007, PAIN, V128, P69, DOI 10.1016/j.pain.2006.08.031; Beauchet O, 2008, J AM GERIATR SOC, V56, P1265, DOI 10.1111/j.1532-5415.2008.01766.x; Leveille SG, 2009, JAMA-J AM MED ASSOC, V302, P2214, DOI 10.1001/jama.2009.1738; Leveille SG, 2002, J AM GERIATR SOC, V50, P671, DOI 10.1046/j.1532-5415.2002.50161.x; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037//0033-2909.125.3.356; Eggermont LHP, 2009, J GERONTOL A-BIOL, V64, P763, DOI 10.1093/gerona/glp016; Beauchet O, 2009, EUR J NEUROL, V16, P786, DOI 10.1111/j.1468-1331.2009.02612.x; Yogev-Seligmann G, 2010, PHYS THER, V90, P177, DOI 10.2522/ptj.20090043; Asai T, 2014, GAIT POSTURE, V39, P54, DOI 10.1016/j.gaitpost.2013.05.025; Shumway-Cook A, 2007, J AM GERIATR SOC, V55, P58, DOI 10.1111/j.1532-5415.2006.00962.x; Allen NE, 2013, PARKINSONS DIS-US, DOI 10.1155/2013/906274; GURALNIK JM, 1994, J GERONTOL, V49, pM85; Kalbe E, 2003, DEMENT GERIATR COGN, V16, P193, DOI 10.1159/000072802; Kwan MMS, 2011, J AM GERIATR SOC, V59, P536, DOI 10.1111/j.1532-5415.2010.03286.x; Janssen I, 2004, AM J EPIDEMIOL, V159, P413, DOI 10.1093/aje/kwh058; Ensrud KE, 2009, J AM GERIATR SOC, V57, P492, DOI 10.1111/j.1532-5415.2009.02137.x; van Haastregt JCM, 2008, AM J GERIAT PSYCHIAT, V16, P186, DOI 10.1097/JGP.0b013e3181591c1e; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x; SPEECHLEY M, 1991, J AM GERIATR SOC, V39, P46; Baranzini F, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-228; Beauchet Olivier, 2005, J Neuroeng Rehabil, V2, P26, DOI 10.1186/1743-0003-2-26; Chang SF, 2014, J NURS SCHOLARSHIP, V46, P207, DOI 10.1111/jnu.12068; Clarke A, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-78; CUMMINGS SR, 1994, NEW ENGL J MED, V331, P872, DOI 10.1056/NEJM199409293311310; Hausdorff Jeffrey M, 2005, J Neuroeng Rehabil, V2, P19, DOI 10.1186/1743-0003-2-19; Keogh E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083272; Kwan MMS, 2011, ARCH PHYS MED REHAB, V92, P1080, DOI 10.1016/j.apmr.2011.01.018; Lord SR, 2006, AGE AGEING, V35, P55, DOI 10.1093/ageing/afl088; Maki BE, 2006, AGE AGEING, V35, pii12; Onder G, 2006, PAIN, V121, P53, DOI 10.1016/j.pain.2005.12.003; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Yamada M, 2014, GERIATR GERONTOL INT, V14, P8, DOI 10.1111/ggi.12209; Yogev Seligmann G, 2008, MOVEMENT DISORD, V23, P329	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1594-0667	1720-8319		AGING CLIN EXP RES	Aging Clin. Exp. Res.	OCT	2015	27	5					711	716		10.1007/s40520-015-0340-5		6	Geriatrics & Gerontology	Geriatrics & Gerontology	CR0FX	WOS:000360995000019		
J	Murata, A; Mayumi, T; Muramatsu, K; Ohtani, M; Matsuda, S				Murata, Atsuhiko; Mayumi, Toshihiko; Muramatsu, Keiji; Ohtani, Makoto; Matsuda, Shinya			Effect of dementia on outcomes of elderly patients with hemorrhagic peptic ulcer disease based on a national administrative database	AGING CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						Hemorrhagic peptic ulcer; Elderly patient; Outcome; Dementia; National administrative database	LENGTH-OF-STAY; DISSEMINATED INTRAVASCULAR COAGULATION; ENDOSCOPIC SUBMUCOSAL DISSECTION; GASTRIC-CANCER; RISK-FACTORS; ALZHEIMERS-DISEASE; VASCULAR DEMENTIA; PROPENSITY SCORE; HOSPITAL VOLUME; DELIRIUM	Little information is available on the effect of dementia on outcomes of elderly patients with hemorrhagic peptic ulcer disease at the population level. This study aimed to investigate the effect of dementia on outcomes of elderly patients with hemorrhagic peptic ulcer based on a national administrative database. A total of 14,569 elderly patients (a parts per thousand yen80 years) who were treated by endoscopic hemostasis for hemorrhagic peptic ulcer were referred to 1073 hospitals between 2010 and 2012 in Japan. We collected patients' data from the administrative database to compare clinical and medical economic outcomes of elderly patients with hemorrhagic peptic ulcers. Patients were divided into two groups according to the presence of dementia: patients with dementia (n = 695) and those without dementia (n = 13,874). There were no significant differences in in-hospital mortality within 30 days and overall mortality between the groups (odds ratio; OR 1.00, 95 % confidence interval; CI 0.68-1.46, p = 0.986 and OR 1.02, 95 % CI 0.74-1.41, p = 0.877). However, the length of stay (LOS) and medical costs during hospitalization were significantly higher in patients with dementia compared with those without dementia. The unstandardized coefficient for LOS was 3.12 days (95 % CI 1.58-4.67 days, p < 0.001), whereas that for medical costs was 1171.7 US dollars (95 % CI 533.8-1809.5 US dollars, p < 0.001). Length of stay and medical costs during hospitalization are significantly increased in elderly patients with dementia undergoing endoscopic hemostasis for hemorrhagic peptic ulcer disease.	[Murata, Atsuhiko; Muramatsu, Keiji; Ohtani, Makoto; Matsuda, Shinya] Univ Occupat & Environm Hlth, Dept Prevent Med & Community Hlth, Sch Med, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Mayumi, Toshihiko] Univ Occupat & Environm Hlth, Dept Emergency Med, Kitakyushu, Fukuoka 8078555, Japan	Murata, A (reprint author), Univ Occupat & Environm Hlth, Dept Prevent Med & Community Hlth, Sch Med, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	amurata@med.uoeh-u.ac.jp			Ministry of Health, Labour, and Welfare, Japan	This study was funded by Grants-in-Aid for Research on Policy Planning and Evaluation from the Ministry of Health, Labour, and Welfare, Japan.	Prince M, 2012, LANCET, V380, P50, DOI 10.1016/S0140-6736(12)60399-7; Robinson TN, 2009, ANN SURG, V249, P173, DOI 10.1097/SLA.0b013e31818e4776; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Marmo R, 2008, AM J GASTROENTEROL, V103, P1639, DOI 10.1111/j.1572-0241.2008.01865.x; Murata A, 2014, SURG ENDOSC, V28, P1298, DOI 10.1007/s00464-013-3326-4; Murata A, 2014, J THROMB THROMBOLYS, V38, P364, DOI 10.1007/s11239-014-1068-3; Sekita A, 2010, ACTA PSYCHIAT SCAND, V122, P319, DOI 10.1111/j.1600-0447.2010.01587.x; Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8; Murata A, 2014, J SURG RES, V186, P157, DOI 10.1016/j.jss.2013.09.015; Berr C, 2005, EUR NEUROPSYCHOPHARM, V15, P463, DOI 10.1016/j.euroneuro.2005.04.003; Michaud L, 2007, J PSYCHOSOM RES, V62, P371, DOI 10.1016/j.jpsychores.2006.10.004; Yachimski PS, 2008, NAT CLIN PRACT GASTR, V5, P80, DOI 10.1038/ncpgasthep1034; Hirota C, 2010, GERIATR GERONTOL INT, V10, P40, DOI 10.1111/j.1447-0594.2009.00557.x; Westreich D, 2010, J CLIN EPIDEMIOL, V63, P826, DOI 10.1016/j.jclinepi.2009.11.020; Young J, 2007, BRIT MED J, V334, P842, DOI 10.1136/bmj.39169.706574.AD; Saravay SM, 2004, PSYCHOSOMATICS, V45, P235, DOI 10.1176/appi.psy.45.3.235; Theocharis GJ, 2008, J CLIN GASTROENTEROL, V42, P128, DOI 10.1097/01.mcg.0000248004.73075.ad; Murata A, 2012, YONSEI MED J, V53, P701, DOI 10.3349/ymj.2012.53.4.701; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Han JH, 2011, ACAD EMERG MED, V18, P451, DOI 10.1111/j.1553-2712.2011.01065.x; Murata A, 2013, J PUBLIC HEALTH MAN, V19, pE23, DOI 10.1097/PHH.0b013e31828b7150; Feng P, 2012, STAT MED, V31, P681, DOI 10.1002/sim.4168; Bakkevold KE, 2010, CLIN EXP GASTROENTER, V23, P71; Chow LWC, 1998, BRIT J SURG, V85, P121; Christensen Steffen, 2007, BMC Geriatr, V7, P8, DOI 10.1186/1471-2318-7-8; Inagaki A, 2012, SEISHIN SHINKEIGAKU, V14, P1374; Iwamoto Y, 2010, SEISHINIGAKU, V52, P87; Lewis JD, 2000, CRIT CARE MED, V28, P46, DOI 10.1097/00003246-200001000-00007; Mizuno Masafumi, 2012, Seishin Shinkeigaku Zasshi, V114, P1359; Murata A, 2014, TOHOKU J EXP MED, V233, P9, DOI 10.1620/tjem.233.9; Murata A, 2013, GERIATR GERONTOL INT, V13, P731, DOI 10.1111/j.1447-0594.2012.00938.x; Murata A, 2014, J DIGEST DIS, V15, P62, DOI 10.1111/1751-2980.12106; Murata A, 2011, TOHOKU J EXP MED, V223, P1, DOI 10.1620/tjem.223.1; Sugawara N, 2015, PSYCHIAT CLIN NEUROS, V69, P117, DOI 10.1111/pcn.12219; Tagami T, 2014, J THROMB HAEMOST, V12, P1470, DOI 10.1111/jth.12643; Yamaguchi Y, 2003, J GASTROEN HEPATOL, V18, P521, DOI 10.1046/j.1440-1746.2003.02960.x	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1594-0667	1720-8319		AGING CLIN EXP RES	Aging Clin. Exp. Res.	OCT	2015	27	5					717	725		10.1007/s40520-015-0328-1		9	Geriatrics & Gerontology	Geriatrics & Gerontology	CR0FX	WOS:000360995000020		
J	Sugimoto, M				Sugimoto, M.			Letter: sitafloxacin for H.pylori infection in Japan: considerations on resistance rates, generalisability and its place in the therapeutic algorithm - author's reply	ALIMENTARY PHARMACOLOGY & THERAPEUTICS			English	Letter									Shiga Univ, Div Digest Endoscopy, Med Sci Hosp, Shiga, Japan	Sugimoto, M (reprint author), Shiga Univ, Div Digest Endoscopy, Med Sci Hosp, Shiga, Japan.	sugimo@belle.shiga-med.ac.jp					Asaka M, 2010, HELICOBACTER, V15, P1, DOI 10.1111/j.1523-5378.2009.00738.x; Molina-Infante J, 2015, ALIMENT PHARM THER, V42, P942, DOI 10.1111/apt.13350; Murakami K, 2013, J GASTROENTEROL, V48, P1128, DOI 10.1007/s00535-012-0731-8; Rimbara E, 2005, CLIN MICROBIOL INFEC, V11, P307, DOI 10.1111/j.1469-0691.2005.01099.x; Sugimoto M, 2015, ALIMENT PHARM THER, V42, P477, DOI 10.1111/apt.13280	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-2813	1365-2036		ALIMENT PHARM THER	Aliment. Pharmacol. Ther.	OCT	2015	42	7					943	944		10.1111/apt.13359		2	Gastroenterology & Hepatology; Pharmacology & Pharmacy	Gastroenterology & Hepatology; Pharmacology & Pharmacy	CQ8ZO	WOS:000360900300024		
J	Amano, H; Kikuchi, T; Morita, Y; Kondo, O; Suzuki, H; de Leon, MSP; Zollikofer, CPE; Bastir, M; Stringer, C; Ogihara, N				Amano, Hideki; Kikuchi, Takeo; Morita, Yusuke; Kondo, Osamu; Suzuki, Hiromasa; de Leon, Marcia S. Ponce; Zollikofer, Christoph P. E.; Bastir, Markus; Stringer, Chris; Ogihara, Naomichi			Virtual reconstruction of the Neanderthal Amud 1 cranium	AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY			English	Article						computerized reconstruction; geometric morphometrics; thin-plate spline interpolation; endocast; fossil	GEOMETRIC MORPHOMETRICS; MODERN HUMANS; EVOLUTION; PROGRESS; OBJECTS; BRAIN; CAVE; BASE; HOMO	ObjectivesWe describe a new computer reconstruction to obtain complete anatomical information of the ecto- and endocranium from the imperfectly preserved skull of the Neanderthal Amud 1. Materials and MethodsData were obtained from computed tomography scans of the fossil cranium. Adhesive and plaster were then virtually removed from the original specimen, and the fragments comprising the fossil cranium were separated. These fragments were then mathematically reassembled based on the smoothness of the joints. Both sides of the cranium were reassembled separately, and then aligned based on bilateral symmetry and the distance between the mandibular fossae obtained from the associated mandible. The position of the isolated maxilla was determined based on the position of the mandible that was anatomically articulated to the mandibular fossae. To restore missing basicranial and damaged endocranial regions, the cranium of Forbes' Quarry 1 was warped onto that of La Chapelle-aux-Saints 1, and the resulting composite Neanderthal cranium was then warped onto the reconstructed Amud 1 by an iterative thin-plate spline deformation. ResultsComparison of the computer reconstruction with the original indicated that the newly reconstructed Amud 1 cranium was slightly shorter and wider in the anteroposterior and mediolateral directions, respectively, suggesting that it was relatively more brachycephalic. The endocranial volume was estimated to be 1,736 cm(3), which was quite similar to the original estimated value of 1,740 cm(3). DiscussionThis new computer reconstruction enables not only measurement of new cranial metrics, but also inclusion of the Amud 1 specimen in three-dimensional geometric morphometric analyses that were previously difficult due to its incompleteness. Am J Phys Anthropol 158:185-197, 2015. (c) 2015 Wiley Periodicals, Inc.	[Amano, Hideki; Kikuchi, Takeo; Morita, Yusuke; Ogihara, Naomichi] Keio Univ, Fac Sci & Technol, Dept Mech Engn, Yokohama, Kanagawa 2238522, Japan; [Kondo, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; [Suzuki, Hiromasa] Univ Tokyo, Grad Sch Engn, Dept Precis Engn, Tokyo 1138656, Japan; [de Leon, Marcia S. Ponce; Zollikofer, Christoph P. E.] Univ Zurich, Inst Anthropol, CH-8057 Zurich, Switzerland; [Bastir, Markus] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, Paleoanthropol Grp, E-28006 Madrid, Spain; [Stringer, Chris] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England	Ogihara, N (reprint author), Keio Univ, Fac Sci & Technol, Dept Mech Engn, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	ogihara@mech.keio.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [22101006]	Grant sponsor: Japanese Ministry of Education, Culture, Sports, Science and Technology; Grant number: 22101006.	Amano H., 2014, DYNAMICS LEARNING NE, V2, P161; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; Gunz P, 2009, J HUM EVOL, V57, P48, DOI 10.1016/j.jhevol.2009.04.004; Perez SI, 2006, J ANAT, V208, P769, DOI 10.1111/j.1469-7580.2006.00576.x; Holliday TW, 2000, AM ANTHROPOL, V102, P54, DOI 10.1525/aa.2000.102.1.54; Valladas H, 1999, J ARCHAEOL SCI, V26, P259, DOI 10.1006/jasc.1998.0334; De Leon MSP, 1999, ANAT REC, V254, P474; Bruner E, 2003, P NATL ACAD SCI USA, V100, P15335, DOI 10.7073/pnas.2536671100; Huang QX, 2006, ACM T GRAPHIC, V25, P569, DOI 10.1145/1141911.1141925; Adams DC, 2004, ITAL J ZOOL, V71, P5; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Gunz P, 2012, J HUM EVOL, V62, P300, DOI 10.1016/j.jhevol.2011.11.013; Gunz P, 2010, CURR BIOL, V20, pR921, DOI 10.1016/j.cub.2010.10.018; Bastir M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1593; Benazzi S, 2011, J HUM EVOL, V61, P75, DOI 10.1016/j.jhevol.2011.02.005; Benazzi S, 2014, AM J PHYS ANTHROPOL, V153, P154, DOI 10.1002/ajpa.22376; Bookstein F L, 1997, Med Image Anal, V1, P225, DOI 10.1016/S1361-8415(97)85012-8; Boule M, 1913, HOMME FOSSILE CHAPEL; Bruner E, 2008, AM J PHYS ANTHROPOL, V137, P30, DOI 10.1002/ajpa.20837; Bruner E, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00019; Condemi S., 1992, HOMMES FOSSILES SACC; Gunz P, 2005, MODERN MORPHOMETRICS; Heim JL, 1976, HOMMES FOSSILES FERR; Holloway RL, 2004, HUMAN FOSSIL RECORD; Keith A, 1939, STONE AGE MOUNT CARM; Kikuchi T, 2013, ANTHROPOL SCI, V121, P115, DOI 10.1537/ase.130618; Morita Y, 2013, AM J PHYS ANTHROPOL, V151, P658, DOI 10.1002/ajpa.22315; Neeser R, 2009, AM J PHYS ANTHROPOL, V140, P1, DOI 10.1002/ajpa.21023; Ogawa T, 1970, AMUD MAN HIS CAVE SI, P407; Ogihara N, 2006, AM J PHYS ANTHROPOL, V130, P1, DOI 10.1002/ajpa.20332; Ogihara N, 2015, ANTHROPOL SCI, V123, P57, DOI 10.1537/ase.141109; Papaioannou G, 2002, IEEE T PATTERN ANAL, V24, P114, DOI 10.1109/34.982888; Rink WJ, 2001, GEOARCHAEOLOGY, V16, P701, DOI 10.1002/gea.1017; Sergi S., 1974, CRANIO NEANDERTALIAN; Suzuki H, 1970, AMUD MAN HIS CAVE SI; Suzuki H., 1970, AMUD MAN HIS CAVE SI, P123; Trinkaus E., 1983, SHANIDAR NEANDERTALS; Vandermeersch B., 1981, HOMMES FOSSILES QAFZ; Weber GW, 2011, VIRTUAL ANTHROPOLOGY: GUIDE TO A NEW INTERDISCIPLINARY FIELD, P1, DOI 10.1007/978-3-211-49347-2; Weidenreich F., 1943, Palaeontologia Sinica, VD 10, P1; Weinert H, 1925, SCHADEL EISZEITLICHE; Zollikofer C., 2005, VIRTUAL RECONSTRUCTI	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-9483	1096-8644		AM J PHYS ANTHROPOL	Am. J. Phys. Anthropol.	OCT	2015	158	2					185	197		10.1002/ajpa.22777		13	Anthropology; Evolutionary Biology	Anthropology; Evolutionary Biology	CR2VM	WOS:000361188800002		
J	Kusaka, S; Uno, KT; Nakano, T; Nakatsukasa, M; Cerling, TE				Kusaka, Soichiro; Uno, Kevin T.; Nakano, Takanori; Nakatsukasa, Masato; Cerling, Thure E.			Carbon isotope ratios of human tooth enamel record the evidence of terrestrial resource consumption during the Jomon period, Japan	AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY			English	Article						diet; collagen; enamel; human; Holocene	INDIVIDUAL AMINO-ACIDS; BONE-COLLAGEN; SOUTHERN ONTARIO; STABLE NITROGEN; DENTAL-CARIES; HUMAN DIET; FRACTIONATION; BIOAPATITE; APATITE; MARINE	Objective:Archaeological remains strongly suggest that the Holocene Japanese hunter-gatherers, the Jomon people, utilized terrestrial plants as their primary food source. However, carbon and nitrogen isotope analysis of bone collagen indicates that they primarily exploited marine resources. We hypothesize that this inconsistency stems from the route of protein synthesis and the different proportions of protein-derived carbon in tooth enamel versus bone collagen. Carbon isotope ratios from bone collagen reflect that of dietary protein and may provide a biased signal of diet, whereas isotope ratios from tooth enamel reflect the integrated diet from all macronutrients (carbohydrates, lipids, and proteins). Methods:In order to evaluate the differences in inferred diet between the archaeological evidence and bone collagen isotope data, this study investigated carbon isotopes in Jomon tooth enamel from four coastal sites of the Middle to Late-Final Jomon period (5,000-2,300 years BP). Results:Carbon isotope ratios of human teeth are as depleted as coeval terrestrial mammals, suggesting that C-3 plants and terrestrial mammals were major dietary resources for the Jomon people. Dietary dependence on marine resources calculated from enamel was significantly lower than that calculated from bone collagen. The discrepancy in isotopic ratios between enamel and collagen and the nitrogen isotope ratio in collagen shows a negative correlation on individual and population levels, suggesting diets with variable proportions of terrestrial and marine resources. Conclusion:This study highlights the usefulness of coupling tooth enamel and bone collagen in carbon isotopic studies to reconstruct prehistoric human diet. Am J Phys Anthropol 158:300-311, 2015. (c) 2015 Wiley Periodicals, Inc.	[Kusaka, Soichiro] Museum Nat & Environm Hist, Shizuoka, Shizuoka 4228017, Japan; [Uno, Kevin T.] Columbia Univ, Div Biol & Paleo Environm, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Nakano, Takanori] Res Inst Human & Nat, Ctr Res Promot, Kyoto 6038047, Japan; [Nakatsukasa, Masato] Kyoto Univ, Grad Sch Sci, Kyoto 6068502, Japan; [Cerling, Thure E.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84013 USA	Kusaka, S (reprint author), Museum Nat & Environm Hist, Suruga Ku, 5762 Oya, Shizuoka, Shizuoka 4228017, Japan.	soichiro1_kusaka@pref.shizuoka.lg.jp			Research Fellowship from the Japan Society for the Promotion of Science (JSPS) [17651023]	Grant sponsor: Research Fellowship from the Japan Society for the Promotion of Science (JSPS); Grant number: 17651023.	Akazawa T, 1986, PREHISTORIC HUNTER G, P73; Ambrose S. H., 1993, PREHISTORIC HUMAN BO, P1; AYLIFFE LK, 1994, GEOCHIM COSMOCHIM AC, V58, P5291, DOI 10.1016/0016-7037(94)90312-3; WALKER PL, 1986, AM J PHYS ANTHROPOL, V71, P51, DOI 10.1002/ajpa.1330710107; Budd P, 2000, APPL GEOCHEM, V15, P687, DOI 10.1016/S0883-2927(99)00069-4; LAWS EA, 1995, GEOCHIM COSMOCHIM AC, V59, P1131, DOI 10.1016/0016-7037(95)00030-4; Cerling TE, 1999, OECOLOGIA, V120, P347, DOI 10.1007/s004420050868; Passey BH, 2005, J ARCHAEOL SCI, V32, P1459, DOI 10.1016/j.jas.2005.03.015; Pfeiffer S, 2014, J ARCHAEOL SCI, V42, P334, DOI 10.1016/j.jas.2013.11.008; Naito YI, 2013, J ARCHAEOL SCI, V40, P2913, DOI 10.1016/j.jas.2013.03.012; Knudson KJ, 2009, J ANTHROPOL ARCHAEOL, V28, P244, DOI 10.1016/j.jaa.2008.10.006; Howland MR, 2003, INT J OSTEOARCHAEOL, V13, P54, DOI 10.1002/oa.658; Loftus E, 2012, AM J PHYS ANTHROPOL, V147, P499, DOI 10.1002/ajpa.22012; Froehle AW, 2010, J ARCHAEOL SCI, V37, P2662, DOI 10.1016/j.jas.2010.06.003; SCHWARCZ HP, 1991, J ARCHAEOL SCI, V18, P261, DOI 10.1016/0305-4403(91)90065-W; Naito YI, 2010, AM J PHYS ANTHROPOL, V143, P31, DOI 10.1002/ajpa.21287; Jim S, 2004, GEOCHIM COSMOCHIM AC, V68, P61, DOI 10.1016/S0016-7037(03)00216-3; Clementz MT, 2009, GEOL J, V44, P605, DOI 10.1002/gj.1173; Harrison RG, 2003, J ANTHROPOL ARCHAEOL, V22, P227, DOI 10.1016/S0278-4165(03)00037-0; Ambrose SH, 1997, AM J PHYS ANTHROPOL, V104, P343; Yesner DR, 2003, J ANTHROPOL ARCHAEOL, V22, P279, DOI 10.1016/S0278-4165(03)00040-0; Buikstra J. E., 1994, STANDARDS DATA COLLE; CHISHOLM B, 1992, PACIFIC NORTHEAST ASIA IN PREHISTORY, P69; Fagre T., 1993, PREHISTORIC HUMAN BO, P121; Fry B., 2006, STABLE ISOTOPE ECOLO; FUJITA H, 1995, ANTHROPOL SCI, V103, P23; Hillson S., 1996, DENT ANTHR; Inaba A, 1971, HIROSHIMA KEN BUNKAZ; Kiyono K, 1969, STUDY JAPANESE SHELL; Kobayashi T, 2004, JOMON REFLECTIONS FO; KRUEGER HW, 1984, ACS SYM SER, V258, P205; Kusaka S, 2008, ANTHROPOL SCI, V116, P171, DOI 10.1537/asc.070703; Kusaka S, 2010, J ARCHAEOL SCI, V37, P1968, DOI 10.1016/j.jas.2010.03.002; LEETHORP JA, 1989, J ARCHAEOL SCI, V16, P585, DOI 10.1016/0305-4403(89)90024-1; Minagawa M., 2001, B NATL MUSEUM JAPANE, V86, P333; MINAGAWA M, 1992, PACIFIC NORTHEAST ASIA IN PREHISTORY, P59; Mizoguchi K, 2002, ARCHAEOLOGICAL HIST; Murray K, 2009, HARPERS ILLUSTRATED, P28; Nishida M, 1980, ANTHR Q, V11, P3; Omoto K, 1999, INTERDISCIPLINARY PE, P223; SCHOENINGER MJ, 1983, SCIENCE, V220, P1381, DOI 10.1126/science.6344217; Shimada S, 1920, EXCAVATION SHELL MOU, P1; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Stenhouse MJ, 1979, RADIOCARBON DATING, P324; Temple DH, 2007, AM J PHYS ANTHROPOL, V133, P1035, DOI 10.1002/ajpa.20645; Temple DH, 2011, AM J HUM BIOL, V23, P107, DOI 10.1002/ajhb.21113; Toizumi T, 2000, ZOO ARCHAEOL, V14, P23; Toizumi T, 2008, M JAP ARACH ASS JAP, P69; Tomioka N, 2010, JOMON ARCHAEOLOGY, V4; Tsuji S, 1983, QUATERNARY RES, V22, P251; Tsukada M, 1986, WINDOWS JAPANESE PAS, P11; TURNER CG, 1979, AM J PHYS ANTHROPOL, V51, P619, DOI 10.1002/ajpa.1330510413; van der Merwe NJ, 2003, J ANTHROPOL ARCHAEOL, V22, P245, DOI 10.1016/S0278-4165(03)00038-2; Warinner C, 2009, J ARCHAEOL SCI, V36, P1690, DOI 10.1016/j.jas.2009.03.034; Watanabe M, 1975, PLANT BASED DIET JOM; Yamanouchi S, 1964, INTRO JAPANESE PREHI; Yasuda Y, 1990, CLIMATE CIVILIZATION; Yoneda M, 2004, J ARCHAEOL SCI, V31, P97, DOI 10.1016/S0305-4403(03)00103-1	58	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-9483	1096-8644		AM J PHYS ANTHROPOL	Am. J. Phys. Anthropol.	OCT	2015	158	2					300	311		10.1002/ajpa.22775		12	Anthropology; Evolutionary Biology	Anthropology; Evolutionary Biology	CR2VM	WOS:000361188800011		
J	Okamoto, S; Iida, O; Nakamura, M; Yamauchi, Y; Fukunaga, M; Yokoi, Y; Soga, Y; Zen, K; Hirano, K; Suematsu, N; Suzuki, K; Shintani, Y; Miyashita, Y; Urasawa, K; Kitano, I; Yamaoka, T; Ohura, N; Hamasaki, T; Uematsu, M; Nanto, S				Okamoto, Shin; Iida, Osamu; Nakamura, Masato; Yamauchi, Yasutaka; Fukunaga, Masashi; Yokoi, Yoshiaki; Soga, Yoshimitsu; Zen, Kan; Hirano, Keisuke; Suematsu, Nobuhiro; Suzuki, Kenji; Shintani, Yoshiaki; Miyashita, Yusuke; Urasawa, Kazushi; Kitano, Ikuro; Yamaoka, Terutoshi; Ohura, Norihiko; Hamasaki, Toshimitsu; Uematsu, Masaaki; Nanto, Shinsuke		OLIVE Investigators	Postprocedural Skin Perfusion Pressure Correlates With Clinical Outcomes 1 Year After Endovascular Therapy for Patients With Critical Limb Ischemia	ANGIOLOGY			English	Article						skin perfusion pressure; critical limb ischemia; the endovascular treatment for infrainguinal vessel (OLIVE) Registry		Background: Although skin perfusion pressure (SPP) is widely used clinically to predict probability of wound healing, correlation between clinical outcomes and SPP has not been systematically studied. Methods: This subanalysis of the prospective multicenter OLIVE registry of patients who received infrainguinal endovascular therapy (EVT) for critical limb ischemia (CLI) assessed the association between clinical outcomes and postoperative SPP in 211 consecutive patients. Logistic regression analysis was performed, with amputation-free survival (AFS), modified major adverse limb events (MALEs), and complete wound healing as dependent variables and postprocedural SPP as independent variable. Result: Pre- and postprocedural SPP was 28 11 and 46 +/- 18 mm Hg, respectively. In logistic regression analysis, postprocedural SPP correlated with 1-year AFS (P = .018), modified MALEs (P < .001), and wound healing (P = .022). Conclusion: Postprocedural SPP correlates with clinical outcomes after EVT for patients with CLI.	[Okamoto, Shin; Iida, Osamu; Uematsu, Masaaki] Kansai Rosai Hosp, Ctr Cardiovasc, Amagasaki, Hyogo, Japan; [Nakamura, Masato] Toho Univ, Ohashi Med Ctr, Div Cardiovasc Med, Tokyo, Japan; [Yamauchi, Yasutaka] Kikuna Mem Hosp, Ctr Cardiovasc, Yokohama, Kanagawa, Japan; [Fukunaga, Masashi] Hyogo Coll Med, Dept Internal Med, Div Cardiovasc, Nishinomiya, Hyogo, Japan; [Yokoi, Yoshiaki] Kishiwada Tokushukai Hosp, Dept Cardiol, Osaka, Japan; [Soga, Yoshimitsu] Kokura Mem Hosp, Dept Cardiol, Fukuoka, Japan; [Zen, Kan] Omihachiman Community Med Ctr, Dept Cardiovasc Med, Shiga, Japan; [Hirano, Keisuke] Saiseikai Yokohama City Eastern Hosp, Div Cardiol, Yokohama, Kanagawa, Japan; [Suematsu, Nobuhiro] Fukuoka Red Cross Hosp, Dept Cardiol, Fukuoka, Japan; [Suzuki, Kenji] Sendai Kousei Hosp, Dept Cardiol, Sendai, Miyagi, Japan; [Shintani, Yoshiaki] Shin Koga Hosp, Dept Cardiol, Fukuoka, Japan; [Miyashita, Yusuke] Shinshu Univ, Grad Sch Med, Dept Cardiovasc Med, Nagano, Japan; [Urasawa, Kazushi] Tokeidai Mem Hosp, Ctr Cardiovasc, Sapporo, Hokkaido, Japan; [Kitano, Ikuro] Shin Suma Gen Hosp, Wound Treatment Ctr, Kobe, Hyogo, Japan; [Yamaoka, Terutoshi] Matsuyama Red Cross Hosp, Dept Vasc Surg, Matsuyama, Ehime, Japan; [Ohura, Norihiko] Kyorin Univ, Sch Med, Dept Plast & Reconstruct Surg, Tokyo, Japan; [Hamasaki, Toshimitsu] Osaka Univ, Grad Sch Med, Dept Biomed Stat, Osaka, Japan; [Nanto, Shinsuke] Osaka Univ, Grad Sch Med, Dept Adv Cardiovasc Therapeut, Osaka, Japan	Okamoto, S (reprint author), Kansai Rosai Hosp Cardiovasc Ctr, 3-1-69 Inabaso, Amagasaki, Hyogo 6608511, Japan.	shiinn.okmt@gmail.com	Hamasaki, Toshimitsu/N-3851-2015	Hamasaki, Toshimitsu/0000-0002-4928-1160			ADERA HM, 1995, J VASC SURG, V21, P823, DOI 10.1016/S0741-5214(05)80014-X; Iida O, 2013, CIRC-CARDIOVASC INTE, V6, P68, DOI 10.1161/CIRCINTERVENTIONS.112.975318; Castronuovo JJ, 1997, J VASC SURG, V26, P629, DOI 10.1016/S0741-5214(97)70062-4; Conte MS, 2009, J VASC SURG, V50, P1462, DOI 10.1016/j.jvs.2009.09.044; Yamada T, 2008, J VASC SURG, V47, P318, DOI 10.1016/j.jvs.2007.10.045; Iida O, 2013, J VASC SURG, V57, P974, DOI 10.1016/j.jvs.2012.10.096; Iida O, 2012, EUR J VASC ENDOVASC, V44, P425, DOI 10.1016/j.ejvs.2012.07.017; Takkin Lo, 2009, WOUNDS, V21, P310	8	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-3197	1940-1574		ANGIOLOGY	Angiology	OCT	2015	66	9					862	866		10.1177/0003319715569907		5	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR0LY	WOS:000361011400011		
J	Shintani, Y; Soga, Y; Takahara, M; Iida, O; Kawasaki, D; Yamauchi, Y; Suzuki, K; Hirano, K; Kawasaki, T				Shintani, Yoshiaki; Soga, Yoshimitsu; Takahara, Mitsuyoshi; Iida, Osamu; Kawasaki, Daizo; Yamauchi, Yasutaka; Suzuki, Kenji; Hirano, Keisuke; Kawasaki, Tomohiro			Clinical Outcomes of SMART Versus Luminexx Nitinol Stent Implantation for Aortoiliac Artery Disease: A Propensity Score-Matched Multicenter Study	ANGIOLOGY			English	Article						nitinol stent; aortoiliac artery; endovascular therapy	OCCLUSIVE DISEASE; CROSSOVER BYPASS; SOCIETY; COMPLICATIONS; PREVALENCE; DEPLOYMENT; PLACEMENT; FRACTURES; LESIONS; IMPACT	Background: Endovascular therapy for aortoiliac (AI) lesions using stents is widely accepted. However, the long-term outcome of 2 different types of nitinol stents for AI lesions is unknown. The aim of this study was to examine the long-term outcome of the SMART and Luminexx nitinol stents for the treatment of de novo AI lesions. Methods: This study was a multicenter retrospective analysis of a prospectively maintained database. The study enrolled consecutive patients undergoing primary stenting for de novo AI artery stenosis between January 2005 and December 2009. A total of 1503 lesions in 1229 patients treated with SMART or Luminexx primary stenting were enrolled. The primary end point was primary patency, secondary end points were the primary assisted patency, secondary patency, and major adverse limb events (MALEs), which included major amputation and major reintervention. To minimize the differences between the groups, a propensity score matching analysis was performed, and 284 lesions per group were analyzed to identify outcomes. Results: After the propensity score matching analysis, the lesion length was 60 37 and 57 +/- 31 mm (P = .275), and the reference vessel diameter was 8.2 +/- 1.5 and 8.3 +/- 1.5 mm (P = .482) in the SMART and Luminexx groups, respectively. The primary patency at 3 years was not significantly different between the groups (83.5% vs 82.2%, P = .842, respectively). The assisted primary patency and secondary patency rates were also not significantly different (91.7% vs 93.2%, P = .340, 99.2% vs 98.8%, P = .922). In addition, the MALE rate was not significantly different between the groups (98.3% vs 97.3%, P = .821). Conclusion: The current data suggest that the use of nitinol stents for the AI artery provided good long-term patency and freedom from MALE for 3 years of follow-up, regardless of whether SMART or Luminexx stents were used.	[Shintani, Yoshiaki; Kawasaki, Tomohiro] Shin Koga Hosp, Dept Cardiol, Ctr Cardiovasc, Kurume, Fukuoka 8308577, Japan; [Soga, Yoshimitsu] Kokura Mem Hosp, Dept Cardiol, Kitakyushu, Japan; [Takahara, Mitsuyoshi] Osaka Univ, Grad Sch Med, Dept Metab Med, Osaka, Japan; [Iida, Osamu] Kansai Rosai Hosp, Ctr Cardiovasc, Amagasaki, Hyogo, Japan; [Kawasaki, Daizo] Morinomiya Hosp, Dept Cardiol, Osaka, Japan; [Yamauchi, Yasutaka] Kikuna Mem Hosp, Dept Cardiol, Yokohama, Kanagawa, Japan; [Suzuki, Kenji] Sendai Kosei Hosp, Dept Cardiol, Sendai, Miyagi, Japan; [Hirano, Keisuke] Saiseikai Yokohama City Eastern Hosp, Dept Cardiol, Yokohama, Kanagawa, Japan	Shintani, Y (reprint author), Shin Koga Hosp, Dept Cardiol, Ctr Cardiovasc, 120 Tenjin Cho, Kurume, Fukuoka 8308577, Japan.	yoshiaki0407@yahoo.co.jp					Leville CD, 2006, J VASC SURG, V43, P32, DOI 10.1016/j.jvs.2005.09.034; Ichihashi S, 2011, J VASC SURG, V53, P992, DOI 10.1016/j.jvs.2010.10.069; Klein WM, 2006, RADIOLOGY, V238, P734, DOI 10.1148/radiol.2382041053; Ballard JL, 1996, J VASC SURG, V24, P545, DOI 10.1016/S0741-5214(96)70070-8; Soga Y, 2012, CIRC J, V76, P2697, DOI 10.1253/circj.CJ-12-0492; Iida O, 2009, JACC-CARDIOVASC INTE, V2, P665, DOI 10.1016/j.jcin.2009.04.014; Sachwani GR, 2013, J VASC SURG, V57, P1030, DOI 10.1016/j.jvs.2012.09.038; Conte MS, 2009, J VASC SURG, V50, P1462, DOI 10.1016/j.jvs.2009.09.044; Scheinert D, 2005, J AM COLL CARDIOL, V45, P312, DOI 10.1016/j.jacc.2004.11.026; Dake MD, 2013, J AM COLL CARDIOL, V61, P2417, DOI 10.1016/j.jacc.2013.03.034; Tendera M, 2011, EUR HEART J, V32, P2851, DOI 10.1093/eurheartj/ehr211; Johansen K, 1996, J VASC SURG, V24, P553; Higashiura W, 2009, J VASC SURG, V49, P645, DOI 10.1016/j.jvs.2008.10.019; Javed U, 2013, CATHETER CARDIO INTE, V82, P1176, DOI 10.1002/ccd.24975; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Andros G, 2008, J VASC SURG, V47, P53; Ricco JB, 2008, J VASC SURG, V47, P45, DOI 10.1016/j.jvs.2007.08.050; STRUNK HM, 1993, ROFO FORTSCHR RONTG, V159, P251, DOI 10.1055/s-2008-1032759; Suzuki K, 2011, CIRC J, V75, P939, DOI 10.1253/circj.CJ-10-1029	19	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-3197	1940-1574		ANGIOLOGY	Angiology	OCT	2015	66	9					875	881		10.1177/0003319714564207		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR0LY	WOS:000361011400013		
J	Yokokawa, T; Kawakami, K; Mae, Y; Sugita, K; Watanabe, H; Suzuki, K; Suenaga, M; Mizunuma, N; Yamaguchi, T; Hama, T				Yokokawa, Takashi; Kawakami, Kazuyoshi; Mae, Yutaro; Sugita, Kazuo; Watanabe, Hiroshi; Suzuki, Kenichi; Suenaga, Mitsukuni; Mizunuma, Nobuyuki; Yamaguchi, Toshiharu; Hama, Toshihiro			Risk Factors Exacerbating Hand-Foot Skin Reaction Induced by Capecitabine plus Oxaliplatin with or without Bevacizumab Therapy	ANNALS OF PHARMACOTHERAPY			English	Article						hand-foot skin reaction; risk factor; capecitabine; CapeOx; diabetes; bevacizumab	METASTATIC COLORECTAL-CANCER; RANDOMIZED PHASE-III; ORAL CAPECITABINE; 1ST-LINE THERAPY; COLON-CANCER; TRIAL; PHARMACOKINETICS; COMBINATION; DYSFUNCTION; IMPAIRMENT	Background: Capecitabine plus oxaliplatin (CapeOx) +/- bevacizumab therapy is associated with a high incidence of hand-foot skin reaction (HFSR), hindering treatment. However, timing of onset and risk factors remain unclear. Objective: This study examined the development of HFSR and risk factors for its exacerbation to a serious condition in CapeOx +/- bevacizumab therapy. Methods: We retrospectively examined patients with colorectal cancer receiving CapeOx +/- bevacizumab therapy between October 1, 2009, and March 31, 2012. The observation period was defined as lasting until completion of 8 cycles. The relationship between cumulative dose of capecitabine and cumulative proportion of patients developing HFSR was evaluated by Kaplan-Meier methods. Risk factors for exacerbation of HFSR to a serious condition were assessed by multiple logistic regression. Results: Data for 203 patients were analyzed. For patients treated at cumulative capecitabine doses of 100 000 mg/m(2) and 200 000 mg/m(2), Grade 1 HFSR occurred in 80% and 90%, respectively, and moderate-to-severe HFSR (Grade 2+) occurred in 10% and 20%, respectively. Multivariate analysis showed significant associations with diabetes (odds ratio [OR] = 4.79; 95% confidence interval [CI] = 1.86-12.34; P = 0.001), concomitant use of bevacizumab (OR = 6.01; 95% CI = 2.20-16.41; P = 0.001), history of fluorinated pyrimidine administration (OR = 2.42; 95% CI = 1.10-5.33; P = 0.027), and early onset (within 21 days) of Grade 1 HFSR (OR = 3.78; 95% CI = 1.64-8.70; P = 0.001). Conclusions: HFSR in CapeOx therapy is a cumulative toxicity and risk of exacerbation to a serious condition increases with diabetes, concomitant use of bevacizumab, history of fluorinated pyrimidine administration, and onset of Grade 1 HFSR within 21 days.	[Yokokawa, Takashi; Kawakami, Kazuyoshi; Mae, Yutaro; Sugita, Kazuo; Watanabe, Hiroshi; Suzuki, Kenichi; Suenaga, Mitsukuni; Mizunuma, Nobuyuki; Yamaguchi, Toshiharu; Hama, Toshihiro] Canc Inst Hosp, Tokyo, Japan	Yokokawa, T (reprint author), Japanese Fdn Canc Res, Dept Pharm, Canc Inst Hosp, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	takashi.yokokawa@jfcr.or.jp					Scheithauer W, 2003, ANN ONCOL, V14, P1735, DOI 10.1093/annonc/mdg500; Rittie L, 2013, AM J PATHOL, V182, P163, DOI 10.1016/j.ajpath.2012.09.019; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Azad NS, 2009, CLIN CANCER RES, V15, P1411, DOI 10.1158/1078-0432.CCR-08-1141; Sigaudo-Roussel D, 2004, DIABETES, V53, P1564, DOI 10.2337/diabetes.53.6.1564; Wolf SL, 2010, J CLIN ONCOL, V28, P5182, DOI 10.1200/JCO.2010.31.1431; Cassidy J, 2002, ANN ONCOL, V13, P566, DOI 10.1093/annonc/mdf089; Lin E, 2002, ONCOLOGY-NY, V16, P31; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Benson AB, 2013, J NATL COMPR CANC NE, V11, P141; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Yoshimoto N, 2010, BREAST CANCER-TOKYO, V17, P298, DOI 10.1007/s12282-009-0171-3; Kang YK, 2010, J CLIN ONCOL, V28, P3824, DOI 10.1200/JCO.2010.29.1807; Saaristo A, 2006, AM J PATHOL, V169, P1080, DOI 10.2353/ajpath.2006.051251; Zhang RX, 2012, ANN ONCOL, V23, P1348, DOI 10.1093/annonc/mdr400; Benson AB, 2012, J NATL COMPR CANC NE, V10, P1528; Cassidy J, 2008, J CLIN ONCOL, V26, P2006, DOI 10.1200/JCO.2007.14.9898; Diasio RB, 2000, ONCOLOGY-NY, V14, P19; FINLAY AY, 1989, LANCET, V2, P155; Flores RA, 2012, J CLIN ONCOL, V30; Mortimer JE, 2003, J ONCOL PHARM PRACT, V9, P161, DOI 10.1191/1078155203jp116oa; Poole C, 2002, CANCER CHEMOTH PHARM, V49, P225, DOI 10.1007/s00280-001-0408-0; Twelves C, 1999, CLIN CANCER RES, V5, P1696	23	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1060-0280	1542-6270		ANN PHARMACOTHER	Ann. Pharmacother.	OCT	2015	49	10					1120	1124		10.1177/1060028015594451		5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CR2PU	WOS:000361173600005		
J	Joo, MW; Shin, SH; Kang, YK; Kawai, A; Kim, HS; Asavamongkolkul, A; Jeon, DG; Do Kim, J; Niu, XH; Tsuchiya, H; Puri, A; Wang, EHM; Chung, SH; Chung, YG				Joo, Min Wook; Shin, Seung Han; Kang, Yong-Koo; Kawai, Akira; Kim, Han Soo; Asavamongkolkul, Apichat; Jeon, Dae-Geun; Do Kim, Jae; Niu, Xiaohui; Tsuchiya, Hiroyuki; Puri, Ajay; Wang, Edward H. M.; Chung, So Hak; Chung, Yang-Guk			Osteosarcoma in Asian Populations Over the Age of 40 Years: A Multicenter Study	ANNALS OF SURGICAL ONCOLOGY			English	Article							OSTEOGENIC-SARCOMA; PATIENTS OLDER; PROGNOSTIC-FACTORS; PAGETS-DISEASE; ONCOLOGY-GROUP; SOFT-TISSUES; ADULTS; CHEMOTHERAPY; CANCER; BONE	Elderly patients with osteosarcoma (OSA) are no longer uncommon; however, many questions remain regarding this population. We investigated the clinicopathological characteristics and prognostic factors of OSA in an Asian population over the age of 40 years. This was a multi-national, multi-institutional study by the Eastern Asian Musculoskeletal Oncology Group (EAMOG). A total of 232 patients were enrolled (116 males and 116 females), with a median age of 50 years at diagnosis; 25 (10.8 %) patients exhibited initial metastasis. Median follow-up was 52 months for survivors. We observed 102 osteolytic and mixed radiographic findings for 173 lesions. Histological subtypes other than osteoblastic type were frequent. Radiation-associated OSA was seen in seven patients, with a 5-year overall survival (OS) of 16.7 %. No Paget's OSA was observed. High-grade spinopelvic OSA was seen in 29 (12.5 %) patients. The 5-year OS was 59.4 % in patients without initial metastasis and 45.2 % in patients with spinopelvic OSA. While surgery and initial metastasis were common prognostic factors for OS, chemotherapy was not. Histologic response to neoadjuvant chemotherapy was poor in 61 of 83 patients. This study revealed distinct clinicopathological features of OSA patients over 40 years of age compared with younger patients, such as the high incidence of axial tumors, common osteolytic and mixed radiographic findings, the high frequency of unusual histologic subtypes, and poor prognosis. Contrary to Western elderly patients with OSA, there was no Paget's OSA in this study, which may result in a lower incidence of secondary OSA. Prognostic factor analyses demonstrated chemotherapy did not influence OS.	[Joo, Min Wook; Kang, Yong-Koo] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Orthopaed Surg, Suwon, Gyeonggi Do, South Korea; [Shin, Seung Han; Chung, Yang-Guk] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Orthopaed Surg, Seoul, South Korea; [Kawai, Akira] Natl Canc Ctr, Dept Musculoskeletal Oncol, Tokyo, Japan; [Kim, Han Soo] Seoul Natl Univ Hosp, Dept Orthopaed Surg, Seoul 110744, South Korea; [Asavamongkolkul, Apichat] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Orthopaed Surg, Bangkok 10700, Thailand; [Jeon, Dae-Geun] Korea Canc Ctr Hosp, Dept Orthoped Surg, Seoul, South Korea; [Do Kim, Jae; Chung, So Hak] Kosin Univ, Gospel Hosp, Dept Orthopaed Surg, Busan, South Korea; [Niu, Xiaohui] Beijing Ji Shui Tan Hosp, Dept Orthoped Oncol Surg, Beijing, Peoples R China; [Tsuchiya, Hiroyuki] Kanazawa Univ, Sch Med, Dept Orthopaed Surg, Kanazawa, Ishikawa 920, Japan; [Puri, Ajay] Tata Mem Hosp, Dept Orthopaed Oncol, Bombay 400012, Maharashtra, India; [Wang, Edward H. M.] Univ Philippines, Dept Orthoped, Coll Med, Manila, Philippines; [Wang, Edward H. M.] Univ Philippines, Philippine Gen Hosp, Manila, Philippines	Joo, MW (reprint author), Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Orthopaed Surg, Suwon, Gyeonggi Do, South Korea.	ygchung@catholic.ac.kr					Longhi A, 2008, J CLIN ONCOL, V26, P5368, DOI 10.1200/JCO.2007.14.9104; Iwata S, 2014, ANN SURG ONCOL, V21, P263, DOI 10.1245/s10434-013-3210-4; Grimer RJ, 2003, EUR J CANCER, V39, P157, DOI 10.1016/S0959-8049(02)00478-1; Bacci G, 1998, ONCOL REP, V5, P1259; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Weeden S, 2001, EUR J CANCER, V37, P39, DOI 10.1016/S0959-8049(00)00362-2; Grimer RJ, 2002, J BONE JOINT SURG BR, V84B, P395, DOI 10.1302/0301-620X.84B3.12019; HUVOS AG, 1986, CANCER, V57, P1442, DOI 10.1002/1097-0142(19860401)57:7<1442::AID-CNCR2820570734>3.0.CO;2-3; Carsi B, 2002, CLIN ORTHOP RELAT R, P53; STARK A, 1990, J BONE JOINT SURG BR, V72, P89; Song WS, 2010, EJSO-EUR J SURG ONC, V36, P483, DOI 10.1016/j.ejso.2010.03.006; HUVOS AG, 1985, CANCER, V55, P1244, DOI 10.1002/1097-0142(19850315)55:6<1244::AID-CNCR2820550617>3.0.CO;2-1; Antman K, 1998, CANCER, V82, P1288, DOI 10.1002/(SICI)1097-0142(19980401)82:7<1288::AID-CNCR11>3.0.CO;2-2; Bielack SS, 1999, J CLIN ONCOL, V17, P1164; DESANTOS LA, 1978, AM J ROENTGENOL, V131, P481; Dorfman H. D., 1998, BONE TUMORS, P128; Doyle T, 2002, BONE, V31, P616, DOI 10.1016/S8756-3282(02)00876-1; ENNEKING WF, 1980, CLIN ORTHOP RELAT R, P106; HUVOS AG, 1983, CANCER, V52, P1489, DOI 10.1002/1097-0142(19831015)52:8<1489::AID-CNCR2820520826>3.0.CO;2-X; Jeon DG, 2006, J KOREAN MED SCI, V21, P715, DOI 10.3346/jkms.2006.21.4.715; Kimmick GG, 1997, DRUG AGING, V10, P34, DOI 10.2165/00002512-199710010-00004; Manoso MW, 2005, CLIN ORTHOP RELAT R, P110; Nishida Y, 2009, J SURG ONCOL, V100, P48, DOI 10.1002/jso.21287; Okada K, 2004, ANN SURG ONCOL, V11, P998, DOI 10.1245/ASO.2004.03.004; Shaylor P J, 1999, Sarcoma, V3, P191, DOI 10.1080/13577149977631; Unni KK, 1996, DAHLINS BONE TUMORS, V5th, P143; WANG YM, 1979, CANCER TREAT REP, V63, P405	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	OCT	2015	22	11					3557	3564		10.1245/s10434-015-4414-6		8	Oncology; Surgery	Oncology; Surgery	CR1EX	WOS:000361067900020		
J	Nishida, T; Matsushima, T; Tsujimoto, M; Takahashi, T; Kawasaki, Y; Nakayama, S; Omori, T; Yamamura, M; Cho, H; Hirota, S; Ueshima, S; Ishihara, H				Nishida, Toshirou; Matsushima, Tomoko; Tsujimoto, Masahiko; Takahashi, Tsuyoshi; Kawasaki, Yuko; Nakayama, Satoshi; Omori, Takeshi; Yamamura, Masahiro; Cho, Haruhiko; Hirota, Seiichi; Ueshima, Shigeyuki; Ishihara, Hideki			Cyclin-Dependent Kinase Activity Correlates with the Prognosis of Patients Who Have Gastrointestinal Stromal Tumors	ANNALS OF SURGICAL ONCOLOGY			English	Article							OF-FUNCTION MUTATIONS; ADJUVANT IMATINIB; FREE SURVIVAL; CELL-CYCLE; TRIAL; RISK; GIST; CANCER; KIT; STRATIFICATION	The estimation of recurrence risk remains a critical issue in relation to gastrointestinal stromal tumors (GISTs) treated with adjuvant therapy. The accuracy of the commonly used risk stratifications is not always adequate. For this study, data were prospectively collected from 68 patients with GISTs who underwent R0 surgery between 2004 and 2009. The results from this analysis cohort were evaluated using the data obtained from an additional 40 patients in the validation cohort. Cyclin-dependent kinase 1 (CDK1)- and CDK2-specific activities were measured using a non-RI kinase assay system. The specific activities of CDK1 and CDK2, but not their expression, significantly correlated with recurrence. The specific activities of both CDK1 and CDK2 were independently correlated with mitosis and significantly correlated with recurrence-free survival (RFS). In the multivariate analysis, CDK2-specific activity (P = 0.0006), tumor size (P = 0.0347), and KIT deletion mutations (P = 0.0006) were significantly correlated with RFS in the analysis cohort. In the validation cohort, CDK2-specific activity (P = 0.0368) was identified as an independent prognostic factor for tumor recurrences with tumor location (P = 0.0442). The results suggest that the specific activities of CDK1 and CDK2 may reflect the proliferative activity of GISTs and that CDK2-specific activity is a good prognostic factor predicting recurrence after macroscopic complete resection of GISTs.	[Nishida, Toshirou] Natl Canc Ctr, Dept Surg, Hosp East, Kashiwa, Chiba, Japan; [Nishida, Toshirou; Omori, Takeshi; Ueshima, Shigeyuki] Osaka Police Hosp, Dept Surg, Osaka, Japan; [Tsujimoto, Masahiko] Osaka Police Hosp, Dept Pathol, Osaka, Japan; [Nishida, Toshirou; Takahashi, Tsuyoshi] Osaka Univ, Grad Sch Med, Dept Surg, Suita, Osaka, Japan; [Matsushima, Tomoko; Kawasaki, Yuko; Nakayama, Satoshi; Ishihara, Hideki] Sysmex Corp, Kobe, Hyogo, Japan; [Yamamura, Masahiro] Kawasaki Med Univ, Dept Clin Oncol, Kurashiki, Okayama, Japan; [Cho, Haruhiko] Kanagawa Canc Ctr, Dept Surg, Yokohama, Kanagawa 2410815, Japan; [Hirota, Seiichi] Hyogo Coll Med, Dept Surg Pathol, Kobe, Hyogo, Japan	Nishida, T (reprint author), Natl Canc Ctr, Dept Surg, Hosp East, Kashiwa, Chiba, Japan.	tnishida@east.ncc.go.jp					DeMatteo RP, 2009, LANCET, V373, P1097, DOI 10.1016/S0140-6736(09)60500-6; Joensuu H, 2008, HUM PATHOL, V39, P1411, DOI 10.1016/j.humpath.2008.06.025; Fletcher CDM, 2002, HUM PATHOL, V33, P459, DOI 10.1053/hupa.2002.123545; Takahashi T, 2007, INT J CLIN ONCOL, V12, P369, DOI 10.1007/s10147-007-0705-7; Joensuu H, 2012, LANCET ONCOL, V13, P265, DOI 10.1016/S1470-2045(11)70299-6; Ishihara H, 2005, BBA-MOL BASIS DIS, V1741, P226, DOI 10.1016/j.bbadis.2005.06.001; Corless CL, 2014, J CLIN ONCOL, V32, P1563, DOI 10.1200/JCO.2013.51.2046; Nishida T, 2014, EXPERT OPIN PHARMACO, V15, P1979, DOI 10.1517/14656566.2014.937707; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Gold JS, 2009, LANCET ONCOL, V10, P1045, DOI 10.1016/S1470-2045(09)70242-6; Wozniak A, 2012, ANN ONCOL, V23, P353, DOI 10.1093/annonc/mdr127; Rossi S, 2011, AM J SURG PATHOL, V35, P1646, DOI 10.1097/PAS.0b013e31822d63a7; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Lagarde P, 2012, CLIN CANCER RES, V18, P826, DOI 10.1158/1078-0432.CCR-11-1610; Joensuu H, 2012, JAMA-J AM MED ASSOC, V307, P1265, DOI 10.1001/jama.2012.347; Martin-Broto J, 2010, ANN ONCOL, V21, P1552, DOI 10.1093/annonc/mdq047; Joensuu H, 2013, LANCET, V382, P973, DOI 10.1016/S0140-6736(13)60106-3; Hirota S, 2003, GASTROENTEROLOGY, V125, P660, DOI 10.1016/S001-5085(03)01046-1; Schmieder M, 2008, NEOPLASIA, V10, P1154, DOI 10.1593/neo.08646; Nishida T, 2008, INT J CLIN ONCOL, V13, P416, DOI 10.1007/s10147-008-0798-7; Kim SJ, 2008, ANN ONCOL, V19, P68, DOI 10.1093/annonc/mdm358; Miettinen M, 2006, SEMIN DIAGN PATHOL, V23, P70, DOI 10.1053/j.semdp.2006.09.001; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Demetri GD, 2010, J NATL COMPR CANC NE, V8, pS1; ESMO/European Sarcoma Network Working Group, 2014, ANN ONCOL, V25, piii21, DOI 10.1093/annonc/mdu255; Haller F, 2008, J PATHOL, V216, P225, DOI 10.1002/path.2402; Haller F, 2005, CLIN CANCER RES, V11, P6589, DOI 10.1158/1078-0432.CCR-05-0329; Hohenberger P, 2010, BRIT J SURG, V97, P1854, DOI 10.1002/bjs.7222; Reichardt P, 2011, EUR J CANCER, V47, P15; Romeo S, 2009, CLIN CANCER RES, V15, P4191, DOI 10.1158/1078-0432.CCR-08-3297	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	OCT	2015	22	11					3565	3573		10.1245/s10434-015-4438-y		9	Oncology; Surgery	Oncology; Surgery	CR1EX	WOS:000361067900021		
J	Kosuga, T; Hiki, N; Nunobe, S; Ohashi, M; Kubota, T; Kamiya, S; Sano, T; Yamaguchi, T				Kosuga, Toshiyuki; Hiki, Naoki; Nunobe, Souya; Ohashi, Manabu; Kubota, Takeshi; Kamiya, Satoshi; Sano, Takeshi; Yamaguchi, Toshiharu			Does the Single-Stapling Technique for Circular-Stapled Esophagojejunostomy Reduce Anastomotic Complications After Laparoscopic Total Gastrectomy?	ANNALS OF SURGICAL ONCOLOGY			English	Article							ASSISTED DISTAL GASTRECTOMY; GASTRIC-CANCER; FEASIBILITY; OUTCOMES; MULTICENTER; STENOSIS; SAFETY; COHORT	Laparoscopic total gastrectomy (LTG) is used for early gastric cancer (EGC) in the upper stomach. However, the incidences of postoperative anastomotic complications such as leakage and stricture remain high. This study investigated whether using a single-stapling technique (SST) instead of a hemi-double-stapling technique (HDST) for intracorporeal circular-stapled esophagojejunostomy could reduce anastomotic complications after LTG. This retrospective study included 136 patients with EGC treated by LTG with intracorporeal circular-stapled esophagojejunostomy. Originally, HDST was used for esophagojejunostomy in 71 patients (original group). Thereafter, the esophagojejunostomy procedure was modified, and SST was used in a further 65 patients (modified group). The impact of the anastomotic procedure (SST or HDST) on anastomotic complications after LTG was determined by uni- and multivariate analyses. The incidence of anastomotic complications was significantly lower in the modified group (7.7 %) than in the original group (22.5 %; P = 0.017). The frequency of anastomotic leakage was lower in the modified group (3.1 %) than in the original group (9.9 %), although the difference was not statistically significant. Meanwhile, the frequency of anastomotic stricture was significantly less common in the modified group (6.2 %) than in the original group (18.3 %; P = 0.032). Multivariate analysis showed that anastomotic procedure with SST was significantly associated with a lower rate of postoperative anastomotic complications (odds ratio [OR], 0.217; 95 % confidence interval [CI], 0.063-0.631; P = 0.004), as was the operation time (OR, 0.237; 95 % CI 0.082-0.667; P = 0.007). The use of SST for intracorporeal circular-stapled esophagojejunostomy could reduce anastomotic complications after LTG.	[Kosuga, Toshiyuki; Hiki, Naoki; Nunobe, Souya; Ohashi, Manabu; Kubota, Takeshi; Kamiya, Satoshi; Sano, Takeshi; Yamaguchi, Toshiharu] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Gastroenterol Ctr,Koto Ku, Tokyo, Japan; [Kosuga, Toshiyuki] Kyoto Prefectural Univ Med, Dept Surg, Div Digest Surg, Kyoto 602, Japan; [Kubota, Takeshi] Japanese Red Cross Kyoto Daiichi Hosp, Dept Surg Gastroenterol, Kyoto, Japan	Kosuga, T (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Gastroenterol Ctr,Koto Ku, Tokyo, Japan.	naoki.hiki@jfcr.or.jp					Zuiki T, 2013, SURG ENDOSC, V27, P3683, DOI 10.1007/s00464-013-2945-0; Nunobe S, 2011, J GASTROINTEST SURG, V15, P1520, DOI 10.1007/s11605-011-1489-7; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Hiki N, 2013, GASTRIC CANCER, V16, P460, DOI 10.1007/s10120-013-0286-2; [Anonymous], 2011, GASTRIC CANC, V14, P101; Shim JH, 2013, AM J SURG, V206, P346, DOI 10.1016/j.amjsurg.2012.11.011; Lee SE, 2009, J SURG ONCOL, V100, P392, DOI 10.1002/jso.21345; Katai H, 2010, GASTRIC CANCER, V13, P238, DOI 10.1007/s10120-010-0565-0; Hiki N, 2007, GASTRIC CANCER, V10, P181, DOI 10.1007/s10120-007-0433-8; Kosuga T, 2014, ANN SURG ONCOL, V21, P2028, DOI 10.1245/s10434-014-3520-1; Kitano S, 2007, ANN SURG, V245, P68, DOI 10.1097/01.sla.0000225364.03133.f8; Fukagawa T, 2010, WORLD J SURG, V34, P1859, DOI 10.1007/s00268-010-0609-y; Fukunaga T, 2013, ANN SURG ONCOL, V20, P2676, DOI 10.1245/s10434-013-2930-9; Japanese Gastric Cancer Association, 2011, GASTRIC CANCER, V14, P113, DOI [10.1007/s10120-011-0042-4, DOI 10.1007/S10120-011-0042-4]]; Jeong O, 2012, SURG ENDOSC, V26, P3418, DOI 10.1007/s00464-012-2356-7	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	OCT	2015	22	11					3606	3612		10.1245/s10434-015-4417-3		7	Oncology; Surgery	Oncology; Surgery	CR1EX	WOS:000361067900026		
J	Fukuchi, M; Ishiguro, T; Ogata, K; Suzuki, O; Kumagai, Y; Ishibashi, K; Ishida, H; Kuwano, H; Mochiki, E				Fukuchi, Minoru; Ishiguro, Toru; Ogata, Kyoichi; Suzuki, Okihide; Kumagai, Youichi; Ishibashi, Keiichiro; Ishida, Hideyuki; Kuwano, Hiroyuki; Mochiki, Erito			Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer	ANNALS OF SURGICAL ONCOLOGY			English	Article							S-1 PLUS CISPLATIN; PHASE-III TRIAL; ADJUVANT SURGERY; CHEMOTHERAPY; 5-FLUOROURACIL; COMBINATION; MITOMYCIN	The prognosis of unresectable gastric cancer is poor. Chemotherapy occasionally converts an initially unresectable gastric cancer to a resectable cancer. The responses of noncurative factors to initial chemotherapy and the outcomes of additional (conversion) surgery were retrospectively evaluated in 151 patients with unresectable gastric cancer receiving combination chemotherapy with S-1 plus cisplatin or paclitaxel from February 2003 to December 2013. Forty (26 %) of 151 patients underwent conversion surgery. After chemotherapy, R0 resection was accomplished in 32 patients (80 %). The 5-year overall survival (OS) rate among the 40 patients who underwent conversion surgery was 43 % (median survival time, 53 months). The 5-year OS rate in the 111 patients treated with chemotherapy alone was 1 % (median survival time, 14 months). Patients who underwent conversion surgery had significantly longer OS times than patients who underwent chemotherapy alone (P < 0.01). The 5-year OS rate among patients who underwent R0 resection was 49 % (median survival time, 62 months). Patients who underwent R0 resection had significantly longer OS times than those who underwent R1 and R2 resection (P = 0.03). Among patients who underwent conversion surgery, multivariate Cox regression analysis showed that one noncurative factor (odds ratio 0.49; 95 % confidence interval 0.28-0.88; P = 0.02) and R0 resection (odds ratio 0.52; 95 % confidence interval 0.28-0.95; P = 0.03) were significant independent predictors for favorable OS. Patients with unresectable gastric cancer initially exhibiting one noncurative factor may obtain a survival benefit from chemotherapy and subsequent curative surgery.	[Fukuchi, Minoru; Ishiguro, Toru; Suzuki, Okihide; Kumagai, Youichi; Ishibashi, Keiichiro; Ishida, Hideyuki; Mochiki, Erito] Saitama Med Univ, Saitama Med Ctr, Dept Digest Tract & Gen Surg, Kawagoe, Saitama, Japan; [Ogata, Kyoichi; Kuwano, Hiroyuki] Gunma Univ, Dept Gen Surg Sci, Grad Sch Med, Maebashi, Gumma 371, Japan	Fukuchi, M (reprint author), Saitama Med Univ, Saitama Med Ctr, Dept Digest Tract & Gen Surg, Kawagoe, Saitama, Japan.	mfukuchi@saitama-med.ac.jp					Yoshida K, 2011, PATHOBIOLOGY, V78, P343, DOI 10.1159/000328197; Kodera Y, 2012, GASTRIC CANCER, V15, P335, DOI 10.1007/s10120-012-0156-3; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Koizumi W, 2003, BRIT J CANCER, V89, P2207, DOI 10.1038/sj.bjc.6601413; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Ohtsu A, 2003, J CLIN ONCOL, V21, P54, DOI 10.1200/JCO.2003.04.130; Mochiki E, 2012, BRIT J CANCER, V107, P31, DOI 10.1038/bjc.2012.222; Chua YJ, 2007, ANN SURG ONCOL, V14, P2687, DOI 10.1245/s10434-007-9423-7; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354; Iwasaki Y, 2013, J SURG ONCOL, V107, P741, DOI 10.1002/jso.23301; Nakajima T, 1997, ANN SURG ONCOL, V4, P203, DOI 10.1007/BF02306611; Okabe H, 2009, ANN SURG ONCOL, V16, P3227, DOI 10.1245/s10434-009-0706-z; Suzuki T, 2010, ONCOL LETT, V1, P743, DOI 10.3892/ol_00000130; FINDLAY M, 1994, ANN ONCOL, V5, P609; Japanese Gastric Cancer Association, 2011, GASTRIC CANCER, V14, P113, DOI [10.1007/s10120-011-0042-4, DOI 10.1007/S10120-011-0042-4]]; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; MACDONALD JS, 1980, ANN INTERN MED, V93, P533; Sobin LH, 2009, TNM CLASSIFICATION M; Wang Y, 2014, CANCER CHEMOTH PHARM, V73, P1155, DOI 10.1007/s00280-014-2449-1	19	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	OCT	2015	22	11					3618	3624		10.1245/s10434-015-4422-6		7	Oncology; Surgery	Oncology; Surgery	CR1EX	WOS:000361067900028		
J	Miyazaki, T; Ojima, H; Fukuchi, M; Sakai, M; Sohda, M; Tanaka, N; Suzuki, S; Ieta, K; Saito, K; Sano, A; Yokobori, T; Inose, T; Nakajima, M; Kato, H; Kuwano, H				Miyazaki, Tatsuya; Ojima, Hitoshi; Fukuchi, Minoru; Sakai, Makoto; Sohda, Makoto; Tanaka, Naritaka; Suzuki, Shigemasa; Ieta, Keisuke; Saito, Kana; Sano, Akihiko; Yokobori, Takehiko; Inose, Takanori; Nakajima, Masanobu; Kato, Hiroyuki; Kuwano, Hiroyuki			Phase II Study of Docetaxel, Nedaplatin, and 5-Fluorouracil Combined Chemotherapy for Advanced Esophageal Cancer	ANNALS OF SURGICAL ONCOLOGY			English	Article							SQUAMOUS-CELL CARCINOMA; PREOPERATIVE CHEMOTHERAPY; CISPLATIN; FLUOROURACIL; PLATINUM(II); TRIAL	We performed a prospective, multi-institutional, phase-II, clinical trial of a docetaxel, nedaplatin, and 5-fluorouracil (DNF) regimen in patients with unresectable esophageal cancer. Our goal was to determine the efficacy and feasibility of this DNF protocol. Thirty-four patients with unresectable esophageal cancer were enrolled and received DNF therapy. The DNF regimen was repeated every 4 weeks for up to 8 weeks, based on the following recommended doses: docetaxel, 60 mg/m(2) (day 1); nedaplatin, 70 mg/m(2) (day 1); and 5-fluorouracil, 700 mg/m(2) (days 1-5). The primary endpoint was the response rate. The secondary endpoints were overall survival and chemotherapy toxicities. The complete response rate and response rate were 5.9 and 47.1 %, respectively. The 2-year overall survival rate and progression-free survival rate were 44.3 and 27.3 %, respectively. The median survival time was 594 days. The median progression-free time was 277 days. No treatment-related deaths occurred. Thirty patients (30/34) with grade 3, 4 neutropenia improved relatively quickly with administration of granulocyte colony-stimulating factor. DNF combination chemotherapy is a useful regimen with relatively minor adverse events and may serve as an effective protocol in patients with unresectable esophageal cancer.	[Miyazaki, Tatsuya; Ojima, Hitoshi; Fukuchi, Minoru; Sakai, Makoto; Sohda, Makoto; Tanaka, Naritaka; Suzuki, Shigemasa; Ieta, Keisuke; Saito, Kana; Sano, Akihiko; Yokobori, Takehiko; Inose, Takanori; Kuwano, Hiroyuki] Gunma Univ, Grad Sch, Dept Gen Surg Sci Surg 1, Maebashi, Gumma 371, Japan; [Ojima, Hitoshi; Sano, Akihiko] Gunma Prefectural Canc Ctr, Dept Surg Gastroenterol, Ota, Japan; [Fukuchi, Minoru; Saito, Kana] Gunma Chuo Hosp, Dept Surg, Maebashi, Gunma, Japan; [Sakai, Makoto; Ieta, Keisuke; Saito, Kana] Isesaki City Hosp, Dept Surg, Isesaki, Gunma, Japan; [Nakajima, Masanobu; Kato, Hiroyuki] Dokkyo Med Univ, Dept Surg 1, Tsuga, Tochigi, Japan	Miyazaki, T (reprint author), Gunma Univ, Grad Sch, Dept Gen Surg Sci Surg 1, Maebashi, Gumma 371, Japan.	tatsuyamiyazaki@gunma-u.ac.jp					AJANI JA, 1994, SEMIN ONCOL, V21, P474; AJANI JA, 1992, EUR J CANCER, V28A, P880, DOI 10.1016/0959-8049(92)90140-W; AKAZA H, 1992, CANCER CHEMOTH PHARM, V31, P187, DOI 10.1007/BF00685546; IIZUKA T, 1992, JPN J CLIN ONCOL, V22, P172; Yamasaki M, 2011, ONCOLOGY-BASEL, V80, P307, DOI 10.1159/000329806; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Osaka Y, 2011, ANTICANCER RES, V31, P633; SASAKI Y, 1989, CANCER CHEMOTH PHARM, V23, P243, DOI 10.1007/BF00451649; FUKUDA M, 1990, CANCER CHEMOTH PHARM, V26, P393, DOI 10.1007/BF02994087; Guo Jing-Feng, 2010, Chin J Cancer, V29, P321; Hayashi K, 2001, JPN J CLIN ONCOL, V31, P419, DOI 10.1093/jjco/hye090; HILGENBERG AD, 1988, ANN THORAC SURG, V45, P357; Kato H, 2007, DIGEST SURG, V24, P88, DOI 10.1159/000101894; Kuwano Hiroyuki, 2003, Ann Thorac Cardiovasc Surg, V9, P6; Minamide J, 2007, GAN TO KAGAKU RYOHO, V34, P49; Miyazaki T, 2013, CANCER CHEMOTH PHARM, V71, P853, DOI 10.1007/s00280-013-2076-2; SASAKI Y, 1990, JPN J CANCER RES, V81, P196; SUZUMURA Y, 1989, ANTICANCER RES, V9, P1083; Watanabe M, 2014, ANN SURG ONCOL, V21, P2838, DOI 10.1245/s10434-014-3684-8	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	OCT	2015	22	11					3653	3658		10.1245/s10434-015-4440-4		6	Oncology; Surgery	Oncology; Surgery	CR1EX	WOS:000361067900033		
J	Baba, Y; Ishimoto, T; Harada, K; Kosumi, K; Murata, A; Miyake, K; Hiyoshi, Y; Kurashige, J; Iwatsuki, M; Iwagami, S; Miyamoto, Y; Sakamoto, Y; Yoshida, N; Oki, E; Iyama, K; Watanabe, M; Baba, H				Baba, Yoshifumi; Ishimoto, Takatsugu; Harada, Kazuto; Kosumi, Keisuke; Murata, Asuka; Miyake, Keisuke; Hiyoshi, Yukiharu; Kurashige, Junji; Iwatsuki, Masaaki; Iwagami, Shiro; Miyamoto, Yuji; Sakamoto, Yasuo; Yoshida, Naoya; Oki, Eiji; Iyama, Ken-ichi; Watanabe, Masayuki; Baba, Hideo			Molecular Characteristics of Basaloid Squamous Cell Carcinoma of the Esophagus: Analysis of KRAS, BRAF, and PIK3CA Mutations and LINE-1 Methylation	ANNALS OF SURGICAL ONCOLOGY			English	Article							COLORECTAL-CANCER; IMMUNOHISTOCHEMICAL EXPRESSION; HYPOMETHYLATION; PROGNOSIS; AMPLIFICATION; EVOLUTION; MARKERS; TUMORS; BCL-2	Basaloid squamous cell carcinoma (BSCC) of the esophagus is a rare carcinoma with distinct characteristics, and was recently recognized as a variant of squamous cell carcinoma (SCC). We previously revealed genetic and epigenetic alterations associated with esophageal SCCs in relation to clinical outcome, including mutations in KRAS, BRAF, and PIK3CA, p53 expression, and long interspersed nucleotide element-1 (LINE-1) methylation, a surrogate marker for global DNA methylation level. In this study, we explored these features in BSCC. A database of 502 esophageal cancers was used to evaluate the clinical and molecular characteristics of BSCC. KRAS, BRAF, and PIK3CA mutations and LINE-1 methylation were analyzed by pyrosequencing. Of 502 tumors, 22 (4.4 %) were pathologically diagnosed as BSCC, and 440 (87 %) as SCC. No prognostic differences between BSCC and SCC cases were identified (p = 0.41). KRAS or BRAF mutations were not observed in BSCCs. While 23 % of SCC tumors harbored a PIK3CA mutation, all BSCC cases were wild-type for PIK3CA (p = 0.002), and there were no differences in p53 expression between BSCCs and SCCs (p = 0.57), as assessed by immunohistochemistry. Furthermore, BSCC tissues exhibited significantly lower levels of LINE-1 methylation than SCC tissues (p < 0.0001). These findings imply that esophageal BSCC and SCC retain different cellular phenotypes with distinct genetic and epigenetic alterations; thus, tailored therapeutic strategies should be developed against each cancer type.	[Baba, Yoshifumi; Ishimoto, Takatsugu; Harada, Kazuto; Kosumi, Keisuke; Murata, Asuka; Miyake, Keisuke; Hiyoshi, Yukiharu; Kurashige, Junji; Iwatsuki, Masaaki; Iwagami, Shiro; Miyamoto, Yuji; Sakamoto, Yasuo; Yoshida, Naoya; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Kumamoto, Japan; [Oki, Eiji] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan; [Iyama, Ken-ichi] Kumamoto Gen Hosp, Dept Pathol, Kumamoto, Japan; [Watanabe, Masayuki] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Tokyo, Japan	Baba, H (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Kumamoto, Japan.	hdobaba@kumamoto-u.ac.jp					Abe K, 1996, AM J SURG PATHOL, V20, P453, DOI 10.1097/00000478-199604000-00008; Ohashi K, 2003, PATHOL RES PRACT, V199, P713, DOI 10.1078/0344-0338-00487; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Baba Y, 2013, SURGERY, V153, P234, DOI 10.1016/j.surg.2012.08.001; Iwagami S, 2013, ANN SURG, V257, P449, DOI 10.1097/SLA.0b013e31826d8602; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Martini M, 2012, NAT REV CLIN ONCOL, V9, P87, DOI 10.1038/nrclinonc.2011.164; Ogino S, 2008, INT J CANCER, V122, P2767, DOI 10.1002/ijc.23470; Shigaki H, 2013, CLIN CANCER RES, V19, P2451, DOI 10.1158/1078-0432.CCR-12-3559; Sarbia M, 1997, CANCER, V79, P1871, DOI 10.1002/(SICI)1097-0142(19970515)79:10<1871::AID-CNCR5>3.0.CO;2-J; Morice WG, 1998, HUM PATHOL, V29, P609, DOI 10.1016/S0046-8177(98)80011-7; Imamhasan A, 2012, HUM PATHOL, V43, P2012, DOI 10.1016/j.humpath.2012.02.010; Taby R, 2010, CA-CANCER J CLIN, V60, P376, DOI 10.3322/caac.20085; Chen SB, 2012, J CANCER RES CLIN, V138, P1165, DOI 10.1007/s00432-012-1180-8; Lam KY, 2001, J PATHOL, V195, P435, DOI 10.1002/path.984; Baba Y, 2014, CLIN CANCER RES, V20, P1114, DOI 10.1158/1078-0432.CCR-13-1645; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Baba Y, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-125; Bellizzi AM, 2009, AM J SURG PATHOL, V33, P1608, DOI 10.1097/PAS.0b013e3181b46fd4; Cho KJ, 2000, HISTOPATHOLOGY, V36, P331; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Koide N, 1997, SURG TODAY, V27, P685; Li TJ, 2004, ARCH PATHOL LAB MED, V128, P1124; McNamara MJ, 2012, CURR ONCOL REP, V14, P342, DOI 10.1007/s11912-012-0239-7; Murata A, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0728-z; Owonikoko T, 2001, J PATHOL, V193, P155, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH758>3.0.CO;2-D; Sarbia M, 1999, AM J PATHOL, V155, P1027, DOI 10.1016/S0002-9440(10)65203-0; Shigaki H, 2013, ANN SURG ONCOL, V20, pS485, DOI 10.1245/s10434-012-2819-z; WAIN SL, 1986, HUM PATHOL, V17, P1158, DOI 10.1016/S0046-8177(86)80422-1	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	OCT	2015	22	11					3659	3665		10.1245/s10434-015-4445-z		7	Oncology; Surgery	Oncology; Surgery	CR1EX	WOS:000361067900034		
J	Matsushita, D; Uenosono, Y; Arigami, T; Yanagita, S; Nishizono, Y; Hagihara, T; Hirata, M; Haraguchi, N; Arima, H; Kijima, Y; Kurahara, H; Maemura, K; Okumura, H; Ishigami, S; Natsugoe, S				Matsushita, Daisuke; Uenosono, Yoshikazu; Arigami, Takaaki; Yanagita, Shigehiro; Nishizono, Yuka; Hagihara, Takahiko; Hirata, Munetsugu; Haraguchi, Naoto; Arima, Hideo; Kijima, Yuko; Kurahara, Hiroshi; Maemura, Kosei; Okumura, Hiroshi; Ishigami, Sumiya; Natsugoe, Shoji			Clinical Significance of Circulating Tumor Cells in Peripheral Blood of Patients with Esophageal Squamous Cell Carcinoma	ANNALS OF SURGICAL ONCOLOGY			English	Article							METASTATIC BREAST-CANCER; GASTRIC-CANCER; CARCINOEMBRYONIC ANTIGEN; MOLECULAR-DETECTION; EXPRESSION; SURVIVAL	Esophageal squamous cell carcinoma is an aggressive gastrointestinal tract cancer. To date, the presence of circulating tumor cells (CTC) has been reported as a prognostic factor in peripheral blood from patients with gastrointestinal cancers. The CellSearch system was used to isolate and enumerate CTCs. A total of 90 patients with esophageal squamous cell carcinoma who received chemotherapy or chemoradiotherapy were enrolled. Peripheral blood specimens were collected before and after treatments. At baseline analysis, CTCs were detected in 25 patients (27.8 %). Overall survival was significantly shorter in patients with than without CTCs. Follow-up blood specimens were obtained from 71 patients. Partial response, stable disease, and progressive disease after treatment were seen in 32, 12, and 27 patients, respectively. CTC positivity after treatment in the progressive disease group (40.7 %) was significantly higher than that of the partial response group (6.3 %). Patients with a change in CTC status from positive to negative had a good prognosis as well as patients without baseline CTCs. Evaluation of CTCs may be a promising indicator for predicting tumor prognosis and the clinical efficacy of chemotherapy or chemoradiation therapy in patients with esophageal squamous cell carcinoma.	[Matsushita, Daisuke; Uenosono, Yoshikazu; Arigami, Takaaki; Yanagita, Shigehiro; Nishizono, Yuka; Hagihara, Takahiko; Hirata, Munetsugu; Haraguchi, Naoto; Arima, Hideo; Kijima, Yuko; Kurahara, Hiroshi; Maemura, Kosei; Okumura, Hiroshi; Ishigami, Sumiya; Natsugoe, Shoji] Kagoshima Univ, Grad Sch Med, Dept Digest Surg & Breast & Thyroid Surg, Kagoshima 890, Japan	Matsushita, D (reprint author), Kagoshima Univ, Grad Sch Med, Dept Digest Surg & Breast & Thyroid Surg, Kagoshima 890, Japan.	m7762@m2.kufm.kagoshima-u.ac.jp					Ghossein RA, 1999, CLIN CANCER RES, V5, P1950; Ma X, 2014, P NATL ACAD SCI USA, V111, P6389, DOI 10.1073/pnas.1400272111; Smerage JB, 2014, J CLIN ONCOL, V32, P3483, DOI 10.1200/JCO.2014.56.2561; BOYER B, 1989, J CELL BIOL, V109, P1495, DOI 10.1083/jcb.109.4.1495; Kalykaki A, 2014, CANCER CHEMOTH PHARM, V73, P685, DOI 10.1007/s00280-014-2387-y; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Uenosono Y, 2013, CANCER-AM CANCER SOC, V119, P3984, DOI 10.1002/cncr.28309; Vogel I, 2001, VIRCHOWS ARCH, V439, P109, DOI 10.1007/s004280100476; Hiraiwa K, 2008, ANN SURG ONCOL, V15, P3092, DOI 10.1245/s10434-008-0122-9; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Arigami T, 2011, WORLD J SURG, V35, P2051, DOI 10.1007/s00268-011-1186-4; Bertazza L, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-111; Hagihara T, 2013, ANN SURG ONCOL, V20, P3031, DOI 10.1245/s10434-013-2973-y; Leversha MA, 2009, CLIN CANCER RES, V15, P2091, DOI 10.1158/1078-0432.CCR-08-2036; Mimori K, 2008, CLIN CANCER RES, V14, P2609, DOI 10.1158/1078-0432.CCR-07-4354; Mimori K, 2008, ANN SURG ONCOL, V15, P2934, DOI 10.1245/s10434-008-9916-z; Nakashima S, 2003, SURGERY, V133, P162, DOI 10.1067/msy.2003.9; Napier Kyle J, 2014, World J Gastrointest Oncol, V6, P112, DOI 10.4251/wjgo.v6.i5.112; Natsugoe Shoji, 2011, Nihon Geka Gakkai Zasshi, V112, P111; Natsugoe S, 2006, DIS ESOPHAGUS, V19, P468, DOI 10.1111/j.1442-2050.2006.00615.x; Noh YH, 2001, EXP MOL MED, V33, P8; Setoyama T, 2006, CLIN CANCER RES, V12, P5972, DOI 10.1158/1078-0432.CCR-06-0637; Sobin LH, 2010, TNM CLASSIFICATION M; Yeh KH, 1998, ANTICANCER RES, V18, P1283; Yin XD, 2012, DIS ESOPHAGUS, V25, P750, DOI 10.1111/j.1442-2050.2012.01326.x	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	OCT	2015	22	11					3674	3680		10.1245/s10434-015-4392-8		7	Oncology; Surgery	Oncology; Surgery	CR1EX	WOS:000361067900036		
J	Miyajima, A; Yazawa, S; Kosaka, T; Tanaka, N; Shirotake, S; Mizuno, R; Kikuchi, E; Oya, M				Miyajima, Akira; Yazawa, Satoshi; Kosaka, Takeo; Tanaka, Nobuyuki; Shirotake, Suguru; Mizuno, Ryuichi; Kikuchi, Eiji; Oya, Mototsugu			Prognostic Impact of Renin-Angiotensin System Blockade on Renal Cell Carcinoma After Surgery	ANNALS OF SURGICAL ONCOLOGY			English	Article							II TYPE-1 RECEPTOR; PROSTATE-CANCER; TUMOR ANGIOGENESIS; INTERFERON-ALPHA; GROWTH-FACTOR; INHIBITORS; TRIAL; RISK; ASSOCIATION; CANDESARTAN	Angiotensin 2 is a key biologic peptide in the renin-angiotensin system (RAS) that regulates blood pressure and renal hemodynamics. The potential role of the RAS in the promotion of tumor growth, angiogenesis, and metastasis also has been shown in the past few decades. This study investigated the prognostic impact of RAS blockade on patients with renal cell carcinoma (RCC) after surgery. The study identified 557 patients with pathologically diagnosed RCC (pT1-4 N0M0) and evaluated the prognostic factors after surgery for patients administered or not administered angiotensin-converting enzyme inhibitors (ACEs) or angiotensin 2 receptor blockers (ARBs). The median follow-up period was 5.1 years. Radical nephrectomy was performed for 349 patients (62.7 %), whereas the remaining 208 patients (37.3 %) underwent partial nephrectomy. A total of 104 patients (18.7 %) were administered RAS inhibitors: ACEs (n = 22) or ARBs (n = 82). Multivariate analysis showed that administration of RAS inhibitors (P = 0.044; HR 2.69), longer tumor length (P < 0.001; HR 1.02), high-grade tumor (P < 0.001; HR 3.55), and positive microvascular invasion (P < 0.003; HR 3.13) were not independent risk factors for a decrease in subsequent disease-specific survival after surgery for RCC. The 5-year disease-specific survival rate was 96.8 % among the patients administered RAS inhibitors and 89.8 % among their counterparts (P = 0.019). The authors propose renin-angiotensin blockade as a possible potent choice for effective treatment after surgical treatment of RCC.	[Miyajima, Akira; Yazawa, Satoshi; Kosaka, Takeo; Tanaka, Nobuyuki; Shirotake, Suguru; Mizuno, Ryuichi; Kikuchi, Eiji; Oya, Mototsugu] Keio Univ, Sch Med, Dept Urol, Tokyo, Japan	Miyajima, A (reprint author), Keio Univ, Sch Med, Dept Urol, Tokyo, Japan.	akiram@keio.jp					Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; George AJ, 2010, NAT REV CANCER, V10, P745, DOI 10.1038/nrc2945; Sipahi I, 2010, LANCET ONCOL, V11, P627, DOI 10.1016/S1470-2045(10)70106-6; Egami K, 2003, J CLIN INVEST, V112, P67, DOI 10.1172/JCI200316645; Miyajima A, 2002, CANCER RES, V62, P4176; Ronquist G, 2004, PROSTATE, V58, P50, DOI 10.1002/pros.10294; Tatokoro M, 2011, CANCER SCI, V102, P137, DOI 10.1111/j.1349-7006.2010.01756.x; Arrieta O, 2005, BRIT J CANCER, V92, P1247, DOI 10.1038/sj.bjc.6602483; Lever AF, 1998, LANCET, V352, P179, DOI 10.1016/S0140-6736(98)03228-0; Khakoo AY, 2008, CANCER RES, V68, P9112, DOI 10.1158/0008-5472.CAN-08-0851; Uemura H, 2003, MOL CANCER THER, V2, P1139; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Keizman D, 2011, EUR J CANCER, V47, P1955, DOI 10.1016/j.ejca.2011.04.019; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Levey AS, 1999, ANN INTERN MED, V130, P461; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; Figlin RA, 1999, J UROLOGY, V161, P381, DOI 10.1016/S0022-5347(01)61897-4; Yuge K, 2012, ANN SURG ONCOL, V19, P3987, DOI 10.1245/s10434-012-2568-z; Wilop S, 2009, J CANCER RES CLIN, V135, P1429, DOI 10.1007/s00432-009-0587-3; Ager EI, 2008, CARCINOGENESIS, V29, P1675, DOI 10.1093/carcin/bgn171; Christian JB, 2008, J NATL CANCER I, V100, P1223, DOI 10.1093/jnci/djn262; Figlin RA, 1999, J UROLOGY, V161; Grandi Anna M., 2006, Cardiovascular & Hematological Agents in Medicinal Chemistry, V4, P219, DOI 10.2174/187152506777698326; Greco S, 2003, J CELL PHYSIOL, V196, P370, DOI 10.1002/jcp.10313; GUINAN PD, 1995, J UROLOGY, V153, P901, DOI 10.1016/S0022-5347(01)67599-2; Juillerat-Jeanneret L, 2004, BRIT J CANCER, V90, P1059, DOI 10.1038/sj.bjc.6601646; Kosugi M, 2006, CLIN CANCER RES, V12, P2888, DOI 10.1158/1078-0432.CCR-05-2213; Shirotake S, 2011, UROLOGY, V77, P1009; Shirotake S, 2011, UROLOGY, V77, pe1019; Shirotake S, 2012, AM J PATHOL, V180, P1008, DOI 10.1016/j.ajpath.2011.11.027; Tanaka N, 2012, BRIT J CANCER, V106, P290, DOI 10.1038/bjc.2011.565; Teo KK, 2011, J HYPERTENS, V29, P623, DOI 10.1097/HJH.0b013e328344a7de	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	OCT	2015	22	11					3751	3759		10.1245/s10434-015-4436-0		9	Oncology; Surgery	Oncology; Surgery	CR1EX	WOS:000361067900047		
J	Dejaco, C; Singh, YP; Perel, P; Hutchings, A; Camellino, D; Mackie, S; Abril, A; Bachta, A; Balint, P; Barraclough, K; Bianconi, L; Buttgereit, F; Carsons, S; Ching, D; Cid, M; Cimmino, M; Diamantopoulos, A; Docken, W; Duftner, C; Fashanu, B; Gilbert, K; Hildreth, P; Hollywood, J; Jayne, D; Lima, M; Maharaj, A; Mallen, C; Martinez-Taboada, V; Maz, M; Merry, S; Miller, J; Mori, S; Neill, L; Nordborg, E; Nott, J; Padbury, H; Pease, C; Salvarani, C; Schirmer, M; Schmidt, W; Spiera, R; Tronnier, D; Wagner, A; Whitlock, M; Matteson, EL; Dasgupta, B				Dejaco, Christian; Singh, Yogesh P.; Perel, Pablo; Hutchings, Andrew; Camellino, Dario; Mackie, Sarah; Abril, Andy; Bachta, Artur; Balint, Peter; Barraclough, Kevin; Bianconi, Lina; Buttgereit, Frank; Carsons, Steven; Ching, Daniel; Cid, Maria; Cimmino, Marco; Diamantopoulos, Andreas; Docken, William; Duftner, Christina; Fashanu, Billy; Gilbert, Kate; Hildreth, Pamela; Hollywood, Jane; Jayne, David; Lima, Manuella; Maharaj, Ajesh; Mallen, Christian; Martinez-Taboada, Victor; Maz, Mehrdad; Merry, Steven; Miller, Jean; Mori, Shunsuke; Neill, Lorna; Nordborg, Elisabeth; Nott, Jennifer; Padbury, Hannah; Pease, Colin; Salvarani, Carlo; Schirmer, Michael; Schmidt, Wolfgang; Spiera, Robert; Tronnier, David; Wagner, Alexandre; Whitlock, Madeline; Matteson, Eric L.; Dasgupta, Bhaskar			2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative	ANNALS OF THE RHEUMATIC DISEASES			English	Article							GIANT-CELL ARTERITIS; ERYTHROCYTE SEDIMENTATION-RATE; PROVISIONAL CLASSIFICATION CRITERIA; CLINICAL-PRACTICE GUIDELINES; DOSE GLUCOCORTICOID THERAPY; FOLLOW-UP; ADVERSE EVENTS; DOUBLE-BLIND; MUSCULOSKELETAL MANIFESTATIONS; EULAR RECOMMENDATIONS	Therapy for polymyalgia rheumatica (PMR) varies widely in clinical practice as international recommendations for PMR treatment are not currently available. In this paper, we report the 2015 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) recommendations for the management of PMR. We used the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology as a framework for the project. Accordingly, the direction and strength of the recommendations are based on the quality of evidence, the balance between desirable and undesirable effects, patients' and clinicians' values and preferences, and resource use. Eight overarching principles and nine specific recommendations were developed covering several aspects of PMR, including basic and follow-up investigations of patients under treatment, risk factor assessment, medical access for patients and specialist referral, treatment strategies such as initial glucocorticoid (GC) doses and subsequent tapering regimens, use of intramuscular GCs and disease modifying anti-rheumatic drugs (DMARDs), as well as the roles of non-steroidal anti-rheumatic drugs and non-pharmacological interventions. These recommendations will inform primary, secondary and tertiary care physicians about an international consensus on the management of PMR. These recommendations should serve to inform clinicians about best practices in the care of patients with PMR.	[Dejaco, Christian] Med Univ Graz, Dept Rheumatol, Graz, Austria; [Dejaco, Christian; Singh, Yogesh P.; Fashanu, Billy; Hollywood, Jane; Whitlock, Madeline; Dasgupta, Bhaskar] Southend Univ Hosp, Dept Rheumatol, Westcliff On Sea SS0 0RY, Essex, England; [Perel, Pablo] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Hutchings, Andrew] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England; [Camellino, Dario] Univ Genoa, Dept Internal Med, Res Lab, I-16126 Genoa, Italy; [Camellino, Dario] Univ Genoa, Acad Div Clin Rheumatol, Genoa, Italy; [Mackie, Sarah; Pease, Colin] Univ Leeds, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England; [Mackie, Sarah; Pease, Colin] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England; [Abril, Andy] Mayo Clin, Dept Rheumatol, Jacksonville, FL 32224 USA; [Bachta, Artur] Mil Inst Med, Dept Internal Med & Rheumatol, Warsaw, Poland; [Balint, Peter] Natl Inst Rheumatism & Physiotherapy, Dept Rheumatol 3, Budapest, Hungary; [Barraclough, Kevin] Hoyland House Gen Practice, Painswick, Glos, England; [Bianconi, Lina] Gen Practice, Bibbiano, Italy; [Buttgereit, Frank] Charite, Dept Rheumatol, D-13353 Berlin, Germany; [Carsons, Steven] SUNY Stony Brook, Div Rheumatol Allergy & Immunol, Sch Med, Mineola, NY USA; [Ching, Daniel] Timaru Hosp, Dept Rheumatol, Timaru, New Zealand; [Cid, Maria] Univ Barcelona, Dept System Autoimmune Dis, Hosp Clin, Barcelona, Spain; [Diamantopoulos, Andreas] Hosp Southern Norway Trust, Dept Rheumatol, Kristiansand, Norway; [Docken, William] Brigham & Womens Hosp, Div Rheumatol, Boston, MA 02115 USA; [Duftner, Christina; Schirmer, Michael] Med Univ Innsbruck, Dept Internal Med Clin 6, A-6020 Innsbruck, Austria; [Gilbert, Kate; Hildreth, Pamela; Miller, Jean; Neill, Lorna; Nott, Jennifer; Padbury, Hannah] PMRGCAuk, London, England; [Jayne, David] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Lima, Manuella] Hosp Univ Pedro Ernesto, Dept Rheumatol, Rio De Janeiro, Brazil; [Maharaj, Ajesh] Univ KwaZulu Natal, Dept Internal Med, Prince Mshiyeni Mem Hosp, Nelson R Mandela Sch Med, Durban, South Africa; [Mallen, Christian] Keele Univ, Arthritis Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England; [Martinez-Taboada, Victor] Univ Cantabria, Fac Med, Serv Reumatol, Hosp Univ Marques de Valdecilla, E-39005 Santander, Spain; [Maz, Mehrdad] Univ Kansas, Med Ctr, Dept Med, Div Allergy Clin Immunol & Rheumatol, Kansas City, KS 66103 USA; [Merry, Steven] Mayo Clin, Dept Family Med, Rochester, MN USA; [Mori, Shunsuke] NHO Kumamoto Saishunsou Natl Hosp, Clin Res Ctr Rheumat Dis, Dept Rheumatol, Kumamoto, Japan; [Nordborg, Elisabeth] Sahlgrens Univ Hosp, Dept Rheumatol, S-41345 Gothenburg, Sweden; [Salvarani, Carlo] Azienda Ospeda IRCCS Reggio Emilia, Dept Internal Med, Div Rheumatol, Reggio Emilia, Italy; [Schmidt, Wolfgang] Immanuel Krankenhaus Berlin, Med Ctr Rheumatol Berlin Buch Berlin, Berlin, Germany; [Spiera, Robert] Hosp Special Surg, Dept Med, New York, NY 10021 USA; [Wagner, Alexandre] Univ Fed Sao Paulo, Dept Internal Med, Sao Paulo, Brazil; [Matteson, Eric L.] Mayo Clin, Coll Med, Dept Hlth Sci Res, Div Rheumatol, Rochester, MN USA	Dasgupta, B (reprint author), Southend Univ Hosp, Dept Rheumatol, Westcliff On Sea SS0 0RY, Essex, England.	Bhaskar.dasgupta@southend.nhs.uk		Schirmer, Michael/0000-0001-9208-7809	American College of Rheumatology; European League Against Rheumatism	This study was supported by research grants from the American College of Rheumatology and the European League Against Rheumatism.	Al Rashidi A, 2013, JCR-J CLIN RHEUMATOL, V19, P400, DOI 10.1097/RHU.0b013e3182a6aa0e; Angeli A, 1974, Chronobiologia, V1 Suppl 1, P253; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Gossec L, 2012, ANN RHEUM DIS, V71, P4, DOI 10.1136/annrheumdis-2011-200350; CHUANG TY, 1982, ANN INTERN MED, V97, P672; Curtis JR, 2006, ARTHRIT RHEUM-ARTHR, V55, P420, DOI 10.1002/art.21984; Hoes JN, 2007, ANN RHEUM DIS, V66, P1560, DOI 10.1136/ard.2007.072157; Brozek JL, 2011, ALLERGY, V66, P588, DOI 10.1111/j.1398-9995.2010.02530.x; Myklebust G, 2001, SCAND J RHEUMATOL, V30, P260; Duru N, 2013, ANN RHEUM DIS, V72, P1905, DOI 10.1136/annrheumdis-2013-203249; DESILVA M, 1986, ANN RHEUM DIS, V45, P136, DOI 10.1136/ard.45.2.136; McDonough AK, 2008, CURR OPIN RHEUMATOL, V20, P131, DOI 10.1097/BOR.0b013e3282f51031; Grossman JM, 2010, ARTHRIT CARE RES, V62, P1515, DOI 10.1002/acr.20295; Dasgupta B, 2012, ANN RHEUM DIS, V71, P484, DOI 10.1136/annrheumdis-2011-200329; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Brozek JL, 2009, ALLERGY, V64, P1109, DOI 10.1111/j.1398-9995.2009.02083.x; Kremers HM, 2005, J RHEUMATOL, V32, P65; Mackie SL, 2010, RHEUMATOLOGY, V49, P716, DOI 10.1093/rheumatology/kep395; Salvarani C, 2005, ARTHRIT RHEUM-ARTHR, V53, P33, DOI 10.1002/art.20901; Dejaco C, 2011, ANN RHEUM DIS, V70, P447, DOI 10.1136/ard.2010.133850; Caporali R, 2004, ANN INTERN MED, V141, P493; Ferraccioli G, 1996, J RHEUMATOL, V23, P624; Hayden JA, 2006, ANN INTERN MED, V144, P427; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Diamantopoulos AP, 2013, BIOMED RES INT, DOI 10.1155/2013/120638; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Dasgupta B, 2010, RHEUMATOLOGY, V49, P186, DOI 10.1093/rheumatology/kep303a; KYLE V, 1989, ANN RHEUM DIS, V48, P658, DOI 10.1136/ard.48.8.658; Cantini F, 2000, SEMIN ARTHRITIS RHEU, V30, P17, DOI 10.1053/sarh.2000.8366; Gonzalez-Gay MA, 1999, J RHEUMATOL, V26, P1326; Adizie T, 2012, INT J CLIN PRACT, V66, P906, DOI 10.1111/j.1742-1241.2012.02981.x; Barraclough K, 2008, FAM PRACT, V25, P328, DOI 10.1093/fampra/cmn044; Dasgupta B, 2012, ARTHRITIS RHEUM-US, V64, P943, DOI 10.1002/art.34356; vanderVeen MJ, 1996, ANN RHEUM DIS, V55, P218, DOI 10.1136/ard.55.4.218; van der Goes MC, 2010, ANN RHEUM DIS, V69, P1913, DOI 10.1136/ard.2009.124958; BIRD HA, 1979, ANN RHEUM DIS, V38, P434, DOI 10.1136/ard.38.5.434; JONES JG, 1981, ANN RHEUM DIS, V40, P1, DOI 10.1136/ard.40.1.1; Dasgupta B, 1998, BRIT J RHEUMATOL, V37, P189; Macchioni P, 2013, SEMIN ARTHRITIS RHEU, V43, P113, DOI 10.1016/j.semarthrit.2013.01.003; Brozek JL, 2009, ALLERGY, V64, P669, DOI 10.1111/j.1398-9995.2009.01973.x; AYOUB WT, 1985, AM J MED, V79, P309, DOI 10.1016/0002-9343(85)90309-2; Caplanne D, 1996, ANN RHEUM DIS, V55, P403, DOI 10.1136/ard.55.6.403-b; Ceccato F, 2006, JCR-J CLIN RHEUMATOL, V12, P167, DOI 10.1097/01.rhu.0000231381.21179.e6; Cimmino MA, 2006, ANN NY ACAD SCI, V1069, P315, DOI 10.1196/annals.1351.030; CIMMINO MA, 1994, ANN RHEUM DIS, V53, P331, DOI 10.1136/ard.53.5.331; DEANDRADE JR, 1964, J CLIN ENDOCR METAB, V24, P261; Dejaco Christian, 2015, Ann Rheum Dis, V74, P1808, DOI 10.1136/annrheumdis-2015-207578; Dejaco C, 2011, AGING HLTH, V7, P633, DOI DOI 10.2217/AHE.11.50; DIRAIMONDO VC, 1958, METABOLISM, V7, P5; DIRAIMONDO VC, 1956, AM J MED, V21, P321, DOI 10.1016/0002-9343(56)90033-X; Dolan AL, 1997, ARTHRITIS RHEUM, V40, P2022, DOI 10.1002/art.1780401115; Fu Hua-zhou, 2007, Zhongguo Zhong Xi Yi Jie He Za Zhi, V27, P894; GonzalezGay MA, 1997, ARCH INTERN MED, V157, P317, DOI 10.1001/archinte.157.3.317; Grade Working Group, GRADE HOM; GRANT SD, 1965, NEW ENGL J MED, V273, P1115, DOI 10.1056/NEJM196511182732101; Hagihara K, 2010, J RHEUMATOL, V37, P1075, DOI 10.3899/jrheum.091185; Hamrin B, 1972, Acta Med Scand Suppl, V533, P1; Haus Erhard, 2012, Bull NYU Hosp Jt Dis, V70 Suppl 1, P3; HEALEY LA, 1984, SEMIN ARTHRITIS RHEU, V13, P322, DOI 10.1016/0049-0172(84)90012-X; Hernandez-Rodriguez J, 2009, ARCH INTERN MED, V169, P1839, DOI 10.1001/archinternmed.2009.352; Hutchings A, 2007, ARTHRIT RHEUM-ARTHR, V57, P803, DOI 10.1002/art.22777; Kanemaru K, 1986, Nihon Ronen Igakkai Zasshi, V23, P469; Kanik K S, 1997, J Clin Rheumatol, V3, P319, DOI 10.1097/00124743-199712000-00003; Kimura M, 2012, J RHEUMATOL, V39, P148, DOI 10.3899/jrheum.110558; Larrosa M, 2000, J RHEUMATOL, V27, P1815; Lee JH, 2013, RHEUMATOL INT, V33, P1475, DOI 10.1007/s00296-012-2580-4; Nagaoka S, 2000, RINSHOU RYUMACHI, V12, P348; Nazarinia AM, 2012, KOOMESH, V14, P265; NHG, NHG STAND POL RHEUM; NICHOLS T, 1965, J CLIN ENDOCR METAB, V25, P343; Paulsen S, 1971, Ugeskr Laeger, V133, P944; Proven A, 1999, J RHEUMATOL, V26, P1333; Ramiro S., 2013, ANN RHEUM DIS, V73, P529, DOI DOI 10.1136/ANNRHEUMDIS-2013-204575; Salvarani C, 1999, ANN RHEUM DIS, V58, P303, DOI 10.1136/ard.58.5.303; Salvarani C, 1998, ARTHRITIS RHEUM, V41, P1221, DOI 10.1002/1529-0131(199807)41:7<1221::AID-ART12>3.0.CO;2-W; Schmidt WA, 2011, RATIONELLE DIAGNOSTI; Smolen JS, 2013, ANN RHEUM DIS, V73, P492, DOI [DOI 10.1136/ANNRHEUMDIS-2013-204573, 10.1136/annrheumdis-2013-204573]; Wang Bo, 2009, China Journal of Traditional Chinese Medicine and Pharmacy, V24, P596	78	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-4967	1468-2060		ANN RHEUM DIS	Ann. Rheum. Dis.	OCT	2015	74	10					1799	1807		10.1136/annrheumdis-2015-207492		9	Rheumatology	Rheumatology	CR0WC	WOS:000361043200006		
J	Yamada, T; Fedotovskaya, O; Cheng, AJ; Cornachione, AS; Minozzo, FC; Aulin, C; Friden, C; Turesson, C; Andersson, DC; Glenmark, B; Lundberg, IE; Rassier, DE; Westerblad, H; Lanner, JT				Yamada, Takashi; Fedotovskaya, Olga; Cheng, Arthur J.; Cornachione, Anabelle S.; Minozzo, Fabio C.; Aulin, Cecilia; Friden, Cecilia; Turesson, Carl; Andersson, Daniel C.; Glenmark, Birgitta; Lundberg, Ingrid E.; Rassier, Dilson E.; Westerblad, Hakan; Lanner, Johanna T.			Nitrosative modifications of the Ca2+ release complex and actin underlie arthritis-induced muscle weakness	ANNALS OF THE RHEUMATIC DISEASES			English	Article							NITRIC-OXIDE SYNTHASE; COLLAGEN-INDUCED ARTHRITIS; SKELETAL-MUSCLE; INTRACELLULAR CALCIUM; RHEUMATOID-ARTHRITIS; SUDDEN-DEATH; PEROXYNITRITE; MICE; EXERCISE; FORCE	Objective Skeletal muscle weakness is a prominent clinical feature in patients with rheumatoid arthritis (RA), but the underlying mechanism(s) is unknown. Here we investigate the mechanisms behind arthritis-induced skeletal muscle weakness with special focus on the role of nitrosative stress on intracellular Ca2+ handling and specific force production. Methods Nitric oxide synthase (NOS) expression, degree of nitrosative stress and composition of the major intracellular Ca2+ release channel (ryanodine receptor 1, RyR1) complex were measured in muscle. Changes in cytosolic free Ca2+ concentration ([Ca2+](i)) and force production were assessed in single-muscle fibres and isolated myofibrils using atomic force cantilevers. Results The total neuronal NOS (nNOS) levels were increased in muscles both from collagen-induced arthritis (CIA) mice and patients with RA. The nNOS associated with RyR1 was increased and accompanied by increased [Ca2+](i) during contractions of muscles from CIA mice. A marker of peroxynitrite-derived nitrosative stress (3-nitrotyrosine, 3-NT) was increased on the RyR1 complex and on actin of muscles from CIA mice. Despite increased [Ca2+](i), individual CIA muscle fibres were weaker than in healthy controls, that is, force per cross-sectional area was decreased. Furthermore, force and kinetics were impaired in CIA myofibrils, hence actin and myosin showed decreased ability to interact, which could be a result of increased 3-NT content on actin. Conclusions Arthritis-induced muscle weakness is linked to nitrosative modifications of the RyR1 protein complex and actin, which are driven by increased nNOS associated with RyR1 and progressively increasing Ca2+ activation.	[Yamada, Takashi; Fedotovskaya, Olga; Cheng, Arthur J.; Westerblad, Hakan; Lanner, Johanna T.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Yamada, Takashi] Sapporo Med Univ, Sch Hlth Sci, Sapporo, Hokkaido, Japan; [Cornachione, Anabelle S.; Minozzo, Fabio C.; Rassier, Dilson E.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada; [Cornachione, Anabelle S.; Minozzo, Fabio C.; Rassier, Dilson E.] McGill Univ, Dept Phys & Physiol, Montreal, PQ, Canada; [Aulin, Cecilia; Lundberg, Ingrid E.] Karolinska Univ Hosp, Rheumatol Unit, Dept Med, Solna, Sweden; [Aulin, Cecilia; Lundberg, Ingrid E.] Karolinska Inst, Stockholm, Sweden; [Friden, Cecilia] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Turesson, Carl] Lund Univ, Rheumatol Sect, Dept Clin Sci, Malmo, Sweden; [Andersson, Daniel C.] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Cardiol Unit, Stockholm, Sweden; [Glenmark, Birgitta] Karolinska Univ Hosp, Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden	Lanner, JT (reprint author), Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.	johanna.lanner@ki.se		Cheng, Arthur/0000-0003-3862-2967	Swedish Research Council; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01 AR062083]; Canadian Institute for Health Research (CIHR); Karolinska Institutet Foundation; Swedish Foundation for Strategic Research; Magnus Bergvall Foundation; Swedish Heart and Lung Foundation; French Muscular Dystrophy Association (AFM); Ake Wiberg Foundation; Swedish Rheumatism Association; Combine Sweden; Stockholm County Council; Karolinska Institutet	This work was supported by The Swedish Research Council, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) grant #R01 AR062083 (HW), Canadian Institute for Health Research (CIHR), Karolinska Institutet Foundation, Swedish Foundation for Strategic Research, Magnus Bergvall Foundation, Swedish Heart and Lung Foundation, The French Muscular Dystrophy Association (AFM), Ake Wiberg Foundation, Swedish Rheumatism Association, Combine Sweden, Regional Agreement on Medical Training and Clinical Research (ALF) between Stockholm County Council and Karolinska Institutet.	Andrade FH, 1998, J PHYSIOL-LONDON, V509, P565, DOI 10.1111/j.1469-7793.1998.565bn.x; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014; ALLEN DG, 1995, J PHYSIOL-LONDON, V487, P331; FORSTERMANN U, 1994, HYPERTENSION, V23, P1121; Yamada T, 2009, ARTHRITIS RHEUM-US, V60, P3280, DOI 10.1002/art.24907; Lanner JT, 2012, NAT MED, V18, P244, DOI 10.1038/nm.2598; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; HIGUCHI M, 1985, J GERONTOL, V40, P281; Lanner JT, 2012, ADV EXP MED BIOL, V740, P217, DOI 10.1007/978-94-007-2888-2_9; Andrade FH, 2001, FASEB J, V15, P309; Salanova M, 2008, HISTOCHEM CELL BIOL, V130, P105, DOI 10.1007/s00418-008-0399-6; Luo S, 2009, REDOX REP, V14, P159, DOI 10.1179/135100009X392601; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Dutka TL, 2011, J APPL PHYSIOL, V110, P705, DOI 10.1152/japplphysiol.00739.2010; HELLIWELL PS, 1994, ANN RHEUM DIS, V53, P726, DOI 10.1136/ard.53.11.726; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Stuehr D, 2001, J BIOL CHEM, V276, P14533, DOI 10.1074/jbc.R100011200; NORDESJO LO, 1983, SCAND J RHEUMATOL, V12, P152; Williams Richard O., 2007, V136, P191; Sears CE, 2004, PHILOS T R SOC B, V359, P1021, DOI 10.1098/rstb.2004.1477; El-Dwairi Q, 1998, AM J PHYSIOL-CELL PH, V274, pC770; Arnett FC, 1987, ARTHRITIS RHEUM, V31, P315; Dutka TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035226; Labuda A, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3503220; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Mattart L, 2012, CELL SIGNAL, V24, P199, DOI 10.1016/j.cellsig.2011.09.002; McCartney-Francis NL, 2001, J IMMUNOL, V166, P2734; Rassier DE, 2008, P R SOC B, V275, P2577, DOI 10.1098/rspb.2008.0719; Snook JH, 2008, FREE RADICAL BIO MED, V44, P14, DOI 10.1016/j.freeradbiomed.2007.09.004	30	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-4967	1468-2060		ANN RHEUM DIS	Ann. Rheum. Dis.	OCT	2015	74	10					1907	1914		10.1136/annrheumdis-2013-205007		8	Rheumatology	Rheumatology	CR0WC	WOS:000361043200022		
J	Abbas, S; Ahmed, I; Iida, T; Lee, YJ; Busse, HJ; Fujiwara, T; Ohkuma, M				Abbas, Saira; Ahmed, Iftikhar; Iida, Toshiya; Lee, Yong-Jae; Busse, Hans-Juergen; Fujiwara, Toru; Ohkuma, Moriya			A heavy-metal tolerant novel bacterium, Alcaligenes pakistanensis sp nov., isolated from industrial effluent in Pakistan	ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY			English	Article						Heavy metals tolerance; Industrial effluent; Alcaligenes pakistanensis; nirK gene; gyrB gene	DENITRIFICANS RUGER; LIPID-COMPOSITION; WASTE-WATER; TAN 1983; IDENTIFICATION; HUMANS; CHROMATOGRAPHY; FAMILY	Two strains, NCCP-650(T) and NCCP-667, were isolated from industrial effluent and their taxonomic positions were investigated using a polyphasic taxonomic approach. The strains were found to be Gram-stain negative, strictly aerobic, motile short rods, which are tolerant to heavy-metals (Cr+2, As+2, Pb+2 and Cu+2). Cells were observed to grow at a temperature range of 10-37 A degrees C (optimal 25-33 A degrees C), pH range of 5.5-10.0 (optimal 6.5-7.5) and can tolerate 0-7 % NaCl (w/v) (optimum 0-1 %) in tryptic soya agar medium. Sequencing of the 16S rRNA gene and two housekeeping genes, gyrB and nirK, of the isolated strains revealed that both strains belong to the Betaproteobacteria showing highest sequence similarities with members of the genus Alcaligenes. The chemotaxonomic data [major quinones as Q-8; predominant cellular fatty acids as summed features 3 (C-16aEuroS:1 omega 7c/iso-C-15aEuroS:0 2OH) and C-16:0 followed by Summed features 2 (iso-C-16aEuroS:1 I/C-14aEuroS:0 3OH), C-17:0 Cyclo and C-18:1 omega 7c; major polar lipids as diphosphatidylglycerol, phosphatidylglycerol, phosphatidylethanolamine and one unidentified aminolipid] also supported the affiliation of the isolated strains with the genus Alcaligenes. DNA-DNA hybridizations between the two strains and with closely related type strains of species of the genus Alcaligenes confirmed that both isolates belong to a single novel species within the genus Alcaligenes. On the basis of phylogenetic analyses, physiological, biochemical characteristics and DNA-DNA hybridization, the isolated strains can be differentiated from established Alcaligenes species and thus represent a novel species, for which the name Alcaligenes pakistanensis sp. nov. is proposed with the type strain NCCP-650(T) (=LMG 28368(T) = KCTC42083(T) = JCM 30216(T)).	[Abbas, Saira; Ahmed, Iftikhar] Natl Agr Res Ctr, Natl Culture Collect Pakistan, NIGAB, Islamabad 45500, Pakistan; [Abbas, Saira; Ahmed, Iftikhar] Natl Agr Res Ctr, Dept Plant Genom & Biotechnol, PARC Inst Adv Studies Agr, Islamabad 45500, Pakistan; [Abbas, Saira; Ahmed, Iftikhar; Iida, Toshiya; Ohkuma, Moriya] RIKEN BioResource Ctr, Japan Collect Microorganisms, Tsukuba, Ibaraki 3050074, Japan; [Abbas, Saira; Ahmed, Iftikhar; Fujiwara, Toru] Univ Tokyo, Lab Plant Nutr & Fertilizers, Dept Appl Biol Chem, Grad Sch Agr & Life Sci,Bunkyo Ku, Tokyo 1138657, Japan; [Lee, Yong-Jae] KRIBB, Biol Resources Ctr, Korean Collect Type Cultures, Taejon 305806, South Korea; [Busse, Hans-Juergen] Univ Vienna, Inst Mikrobiol, Vet Med, A-1210 Vienna, Austria	Ahmed, I (reprint author), Natl Agr Res Ctr, Natl Culture Collect Pakistan, NIGAB, Pk Rd, Islamabad 45500, Pakistan.	iftikharnarc@hotmail.com			Higher Education Commission of Pakistan under International Research Support Initiative Program (IRSIP); PSDP from Pakistan Agricultural Research Council (PARC), Islamabad, Pakistan [CS-55/RADP/PARC]; Japan Society for Promotion of Science (JSPS)	The financial support from Higher Education Commission of Pakistan to S.A. under International Research Support Initiative Program (IRSIP) is gratefully acknowledged. This work was also supported partly by financial assistance from PSDP funded Project Research for Agricultural Development Project (RADP) under a sub-project (Grant No. CS-55/RADP/PARC) entitled "Establishment of Microbial Bio-Resource Laboratories: National Culture Collection of Pakistan (NCCP)" from Pakistan Agricultural Research Council (PARC), Islamabad, Pakistan and partially from Japan Society for Promotion of Science (JSPS) under fellowship program to I.A.	Affan Q.u.A., 2009, J BASIC APPL SCI, V5, P55; Euzeby JP, 1997, INT J SYST BACTERIOL, V47, P590; Stolz A, 2007, INT J SYST EVOL MICR, V57, P572, DOI 10.1099/ijs.0.64761-0; Abbas S, 2014, PAK J AGR SCI, V51, P595; Altenburger P, 1996, J BIOTECHNOL, V47, P39, DOI 10.1016/0168-1656(96)01376-4; EZAKI T, 1989, INT J SYST BACTERIOL, V39, P224; Van Trappen S, 2005, INT J SYST EVOL MICR, V55, P2571, DOI 10.1099/ijs.0.63849-0; Zahoor A, 2009, J ENVIRON SCI-CHINA, V21, P814, DOI 10.1016/S1001-0742(08)62346-3; STANECK JL, 1974, APPL MICROBIOL, V28, P226; VANDAMME P, 1995, INT J SYST BACTERIOL, V45, P37; Sorokin DY, 2005, INT J SYST EVOL MICR, V55, P1405, DOI 10.1099/ijs.0.63737-0; Brady C, 2008, SYST APPL MICROBIOL, V31, P447, DOI 10.1016/j.syapm.2008.09.004; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Busse HJ, 1997, INT J SYST BACTERIOL, V47, P698; Tripathi M, 2011, INDIAN J MICROBIOL, V51, P61, DOI 10.1007/s12088-011-0089-2; Ahmed I, 2014, INT J AGRIC BIOL, V16, P447; Roohi A, 2014, INT J AGRIC BIOL, V16, P564; Coenye T, 2003, INT J SYST EVOL MICR, V53, P1825, DOI 10.1099/ijs.0.02609-0; Busse H. J., 2005, BERGEYS MANUAL SYS C, V2, P653; BUSSE J, 1988, SYST APPL MICROBIOL, V11, P1; Castellani A., 1919, MANUAL TROPICAL MED, V3rd; DELEY J, 1986, INT J SYST BACTERIOL, V36, P405; MIKAMI H, 1983, BUNSEKI KAGAKU, V32, pE207; Rehfuss M, 2005, SYST APPL MICROBIOL, V28, P421, DOI 10.1016/j.syapm.2005.03.003; Sasser M., 1990, 101 MIDI; Schroll G, 2001, SYST APPL MICROBIOL, V24, P37, DOI 10.1078/0723-2020-00001; TINDALL BJ, 1990, SYST APPL MICROBIOL, V13, P128; TINDALL BJ, 1990, FEMS MICROBIOL LETT, V66, P199; Tripathi M., 2010, Research Journal of Microbiology, V5, P707; Vandamme P, 1996, INT J SYST BACTERIOL, V46, P849; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463; Yokota A., 1992, B JFCC, V8, P136	32	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0003-6072	1572-9699		ANTON LEEUW INT J G	Antonie Van Leeuwenhoek	OCT	2015	108	4					859	870		10.1007/s10482-015-0540-1		12	Microbiology	Microbiology	CQ8NG	WOS:000360864000005		
J	Rahman, MA; Shirai, M; Aziz, MA; Ushirokita, R; Kubota, S; Suzuki, H; Azuma, Y				Rahman, Mohd. Akhlakur; Shirai, Mutsunori; Aziz, Md. Abdul; Ushirokita, Rie; Kubota, Sayuri; Suzuki, Harumi; Azuma, Yoshinao			An epistatic effect of apaf-1 and caspase-9 on chlamydial infection	APOPTOSIS			English	Article						Chlamydia pneumoniae; Apaf-1; Caspase-9; Apoptosis; Infection; Chlamydia trachomatis; Host-parasite interaction	HOST-CELL APOPTOSIS; PNEUMONIAE INHIBITS APOPTOSIS; BCL-2 FAMILY PROTEINS; TRACHOMATIS INFECTION; EPITHELIAL-CELLS; PROAPOPTOTIC PROTEINS; BH3-ONLY PROTEINS; CYTOCHROME-C; DEGRADATION; ACTIVATION	Chlamydia is an obligate intracellular bacterial pathogen that replicates solely within a membrane-bound vacuole termed an inclusion. Chlamydia seems to perturb multiple cellular processes of the host, such as, rearrangement of the membrane trafficking system for its intracellular multiplication, and inhibition of host cell apoptosis for persistent infection. In an attempt to clarify host factor involvement in apoptosis regulation, we found that inhibition of Caspase-9 restricted, while Apaf-1 promoted, Chlamydia pneumoniae infection in HEp-2, HeLa, and mouse epithelial fibroblast (MEF) cells. These opposition contributions to the chlamydial infection were confirmed using caspase-9 (-/-) and apaf-1 (-/-) MEFs. Similar phenomena also appeared in the case of infection with Chlamydia trachomatis. Interestingly, caspase-9 in apaf-1 (-/-) MEFs was activated by chlamydial infection but during the infection caspase-3 was not activated. That is, caspase-9 was activated without support for multiplication and activation by Apaf-1, and the activated caspase-9 may be physically disconnected from the caspase cascade. This may be partially explained by the observation of caspase-9 accumulation within chlamydial inclusions. The sequestration of caspase-9 by chlamydia seems to result in apoptosis repression, which is crucial for the chlamydial development cycle. Because Apaf-1 shares domains with intracellular innate immune receptor NOD1, it may play a key role in the strategy to regulate chlamydial infection.	[Rahman, Mohd. Akhlakur; Shirai, Mutsunori; Suzuki, Harumi; Azuma, Yoshinao] Yamaguchi Univ, Dept Microbiol & Immunol, Sch Med, Ube, Yamaguchi 7558505, Japan; [Aziz, Md. Abdul; Ushirokita, Rie; Kubota, Sayuri; Azuma, Yoshinao] Kindai Univ, Biol Oriented Sci & Technol, Wakayama 6496493, Japan	Azuma, Y (reprint author), Yamaguchi Univ, Dept Microbiol & Immunol, Sch Med, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.	azuma@waka.kindai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [16012245, 16790255]; Ministry of Health, Labor and Welfare [Kou14-4]	We thank Cho-Chou Kuo (Washington Univ.) for critical comments, Yoshihide Tsujimoto and Yutaka Eguchi (Osaka Univ.) for providing Bcl-2 overexpressing HeLa cells, Shin Yonehara (Kyoto Univ.) for providing Caspase-9 knockout MEFs and Xiaodong Wang (Univ. of Texas Southwestern Medical Center) for providing Apaf-1 knockout MEFs. This study was supported by a Grant-in-Aid for Scientific Research and Knowledge Cluster Initiative from the Ministry of Education, Culture, Sports, Science and Technology of Japan (16012245, 16790255), and a research grant for Cardiovascular Diseases from the Ministry of Health, Labor and Welfare (Kou14-4).	MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; Fischer SE, 2004, J EXP MED, V200, P905, DOI 10.1084/jem.20040402; Miyairi I, 2006, CURR OPIN MICROBIOL, V9, P102, DOI 10.1016/j.mib.2005.12.004; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Snavely EA, 2014, PATHOG DIS, V71, P336, DOI 10.1111/2049-632X.12179; Gao LY, 2000, TRENDS MICROBIOL, V8, P306, DOI 10.1016/S0966-842X(00)01784-4; Airenne S, 2002, SCAND J IMMUNOL, V55, P390, DOI 10.1046/j.1365-3083.2002.01075.x; Fischer SF, 2004, INFECT IMMUN, V72, P1107, DOI 10.1128/IAI.72.2.1107-1115.2004; Wahl C, 2003, INT J MED MICROBIOL, V293, P377, DOI 10.1078/1438-4221-00274; Zermati Y, 2007, MOL CELL, V28, P624, DOI 10.1016/j.molcel.2007.09.030; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; Shimizu S, 1999, NATURE, V399, P483; Tsujimoto Y, 1998, GENES CELLS, V3, P697, DOI 10.1046/j.1365-2443.1998.00223.x; Fischer SF, 2001, INFECT IMMUN, V69, P7121, DOI 10.1128/IAI.69.11.7121-7129.2001; Rajalingam K, 2001, INFECT IMMUN, V69, P7880, DOI 10.1128/IAI.69.12.7880-7888.2001; HAHN DL, 1991, JAMA-J AM MED ASSOC, V266, P225, DOI 10.1001/jama.266.2.225; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Pirbhai M, 2006, J BIOL CHEM, V281, P31495, DOI 10.1074/jbc.M602796200; Honarpour N, 2000, DEV BIOL, V218, P248, DOI 10.1006/dbio.1999.9585; Ohgushi M, 2005, MOL CELL BIOL, V25, P10017, DOI 10.1128/MCB.25.22.10017-10028.2005; Campbell LA, 2004, NAT REV MICROBIOL, V2, P23, DOI 10.1038/nrmicro796; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Rahman MA, 2005, J ANTIMICROB CHEMOTH, V56, P861, DOI 10.1093/jac/dki331; Chowdhury I, 2006, CELL MOL BIOL LETT, V11, P506, DOI 10.2478/s11658-006-0041-3; Bitzer M, 2002, J BIOL CHEM, V277, P29817, DOI 10.1074/jbc.M111898200; Chen AL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002842; Dong F, 2005, INFECT IMMUN, V73, P1861, DOI 10.1128/IAI.73.3.1861-1864.2005; Geng YM, 2000, J IMMUNOL, V164, P5522; Gibellini D, 1998, ZBL BAKT-INT J MED M, V288, P35; GRAYSTON JT, 1986, NEW ENGL J MED, V315, P161, DOI 10.1056/NEJM198607173150305; Katoh I, 2008, CELL RES, V18, P1210, DOI 10.1038/cr.2008.87; Kinoshita J, 2004, NEUROBIOL AGING, V25, P639, DOI 10.1016/j.neurobiolaging.2004.02.007; Kun Du, 2013, Apoptosis, V18, P1083, DOI 10.1007/s10495-013-0865-z; Miura K, 2008, DNA RES, V15, P83, DOI 10.1093/dnares/dsm032; Murata M, 2007, MICROBIOL-SGM, V153, P585, DOI 10.1099/mic.0.29213-0; Ojcius DM, 1998, J IMMUNOL, V161, P4220; Perfettini JL, 2002, INFECT IMMUN, V70, P55, DOI 10.1128/IAI.70.1.55-61.2002; Perfettini JL, 2000, INFECT IMMUN, V68, P2237, DOI 10.1128/IAI.68.4.2237-2244.2000; Rajalingam K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003102; Rajalingam K, 2006, PLOS PATHOG, V2, P1013, DOI 10.1371/journal.ppat.0020114; Schoier J, 2006, FEMS IMMUNOL MED MIC, V47, P207, DOI 10.1111/j.1574-695X.2006.00083.x; Schoier J, 2001, MICROB PATHOGENESIS, V31, P173, DOI 10.1006/mpat.2001.0460; Tse SML, 2005, J BIOL CHEM, V280, P25210, DOI 10.1074/jbc.M501980200; Verbeke P, 2006, PLOS PATHOG, V2, P408, DOI 10.1371/journal.ppat.0020045; Werts C, 2006, CELL DEATH DIFFER, V13, P798, DOI 10.1038/sj.cdd.4401890; Ying SM, 2005, INFECT IMMUN, V73, P1399, DOI 10.1128/IAI.73.3.1399-1403.2005	46	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1360-8185	1573-675X		APOPTOSIS	Apoptosis	OCT	2015	20	10					1271	1280		10.1007/s10495-015-1161-x		10	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CQ8EO	WOS:000360839500001		
J	Xue, J; Wang, WX; Zhang, JZ; Wu, SJ; Li, H				Xue, Jia; Wang, Wen-Xue; Zhang, Jia-Zhen; Wu, Su-Jun; Li, Hang			Experimental and Numerical Study on the Tensile Behaviour of UACS/Al Fibre Metal Laminate	APPLIED COMPOSITE MATERIALS			English	Article						Fibre metal laminate; Discontinuous reinforcement; Tensile test; Finite element analysis; Cohesive zone modelling	ARRAYED CHOPPED STRANDS; PROGRESSIVE FAILURE; COHESIVE ELEMENTS; ANGLED SLITS; SIMULATION; GROWTH; STRENGTH; PREPREG; STRESS; MODEL	A new fibre metal laminate fabricated with aluminium sheets and unidirectionally arrayed chopped strand (UACS) plies is proposed. The UACS ply is made by cutting parallel slits into a unidirectional carbon fibre prepreg. The UACS/Al laminate may be viewed as aluminium laminate reinforced by highly aligned, discontinuous carbon fibres. The tensile behaviour of UACS/Al laminate, including thermal residual stress and failure progression, is investigated through experiments and numerical simulation. Finite element analysis was used to simulate the onset and propagation of intra-laminar fractures occurring within slits of the UACS plies and delamination along the interfaces. The finite element models feature intra-laminar cohesive elements inserted into the slits and inter-laminar cohesive elements inserted at the interfaces. Good agreement are obtained between experimental results and finite element analysis, and certain limitations of the finite element models are observed and discussed. The combined experimental and numerical studies provide a detailed understanding of the tensile behaviour of UACS/Al laminates.	[Xue, Jia; Zhang, Jia-Zhen] COMAC, Beijing Aeronaut Sci & Technol Res Inst, Beijing, Peoples R China; [Wang, Wen-Xue] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan; [Xue, Jia; Wu, Su-Jun] Beihang Univ, Mat Sci & Engn Sch, Beijing 100191, Peoples R China; [Li, Hang] Hunan Univ, Coll Civil Engn, Changsha 410082, Hunan, Peoples R China	Xue, J (reprint author), COMAC, Beijing Aeronaut Sci & Technol Res Inst, Future Sic Tech Pk, Beijing, Peoples R China.	xuejia@comac.cc	Kyushu, RIAM/F-4018-2015		 [22360052]	This study was partially supported by Grant-in Aid for Scientific Research (B) (22360052) of Japan.	ABAQUS-Inc, 2010, DEF CONST RESP COH E; Xue J, 2011, COMPOS PART A-APPL S, V42, P986, DOI 10.1016/j.compositesa.2011.04.001; Chen JF, 2014, COMPOS PART A-APPL S, V61, P185, DOI 10.1016/j.compositesa.2014.02.013; Cortes P, 2006, COMPOS PART B-ENG, V37, P163, DOI 10.1016/j.compositesb.2005.06.002; Asundi A, 1997, J MATER PROCESS TECH, V63, P384, DOI 10.1016/S0924-0136(96)02652-0; Turon A, 2010, COMPOS STRUCT, V92, P1857, DOI 10.1016/j.compstruct.2010.01.012; Chen X, 2013, ENG FRACT MECH, V99, P223, DOI 10.1016/j.engfracmech.2012.12.017; Nakatani H, 2011, COMPOS PART A-APPL S, V42, P772, DOI 10.1016/j.compositesa.2011.03.005; Khan SU, 2009, COMPOS SCI TECHNOL, V69, P396, DOI 10.1016/j.compscitech.2008.11.006; LIN CT, 1991, COMPOSITES, V22, P135, DOI 10.1016/0010-4361(91)90672-4; Chen JF, 2014, COMPOS STRUCT, V114, P64, DOI 10.1016/j.compstruct.2014.03.046; Cortes P, 2004, J REINF PLAST COMP, V23, P1615, DOI 10.1177/0731684404039796; Feraboli P, 2009, COMPOS PART A-APPL S, V40, P289, DOI 10.1016/j.compositesa.2008.12.012; Feraboli P, 2010, COMPOS PART A-APPL S, V41, P888, DOI 10.1016/j.compositesa.2010.03.002; Li H, 2014, COMPOS PART A-APPL S, V57, P108, DOI 10.1016/j.compositesa.2013.11.003; Li H, 2013, COMPOS PART A-APPL S, V45, P127, DOI 10.1016/j.compositesa.2012.09.009; Taketa I, 2008, COMPOS PART A-APPL S, V39, P1884, DOI 10.1016/j.compositesa.2008.09.012; Taketa I, 2009, COMPOS PART A-APPL S, V40, P1174, DOI 10.1016/j.compositesa.2009.05.006; Taketa I, 2010, COMPOS PART A-APPL S, V41, P1639, DOI 10.1016/j.compositesa.2010.07.010; Taketa I, 2011, COMPOS PART B-ENG, V42, P1764, DOI 10.1016/j.compositesb.2011.01.021; Thomas J, 2001, AIR SPACE EUROPE, V3, P35, DOI 10.1016/S1290-0958(01)90050-4; Wang W. X., 48 AIAA ASME ASCE AI, P2007; Xue J., 2012, THESIS KYUSHU U JAPA; Yamaguchi T, 2009, COMPOS SCI TECHNOL, V69, P1968, DOI 10.1016/j.compscitech.2009.04.020; Yashiro S, 2009, COMPOS PART A-APPL S, V40, P938, DOI 10.1016/j.compositesa.2009.04.023	25	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0929-189X	1573-4897		APPL COMPOS MATER	Appl. Compos. Mater.	OCT	2015	22	5					489	505		10.1007/s10443-014-9419-y		17	Materials Science, Composites	Materials Science	CQ9MW	WOS:000360940200003		
J	Wu, CF; Wang, QH; Yu, M; Zhang, X; Song, N; Chang, Q; Gao, M; Sonomoto, K				Wu, Chuanfu; Wang, Qunhui; Yu, Miao; Zhang, Xiao; Song, Na; Chang, Qiang; Gao, Ming; Sonomoto, Kenji			Effect of ethanol pre-fermentation and inoculum-to-substrate ratio on methane yield from food waste and distillers' grains	APPLIED ENERGY			English	Article						Food waste; Distillers' grains; Anaerobic digestion; Ethanol pre-fermentation; Co-digestion	2-PHASE ANAEROBIC-DIGESTION; CO-DIGESTION; FERMENTATION; HYDROGEN; SLUDGE; ACID; PRETREATMENT; INHIBITION; HYDROLYSIS; REACTORS	Anaerobic digestion of food waste and distillers' grains with ethanol pre-fermentation (EP) at different inoculum-to-substrate ratios (ISRs) was investigated. With EP, the highest methane yield of 581.2 mL/g-VS was observed at ISR 2.5, with the methane yields of ISR 1.0 and ISR 0.4 being 41.8% and 71.7% lower. At the same ISR, the methane yield without EP (control group) was 143.2 mL/g-VS, 57.7% lower than that with EP. EP effectively alleviated inhibition by acidification, greatly reduced the duration of the lag phase, and markedly stimulated the growth of methanogens, compared with that of the control group. Thermodynamics analysis of various acidogenic fermentation patterns suggested that directing the acidogenic phase towards ethanol, instead of towards volatile fatty acids, allocates more potentially available energy for methanogens. Thus, EP prior to anaerobic digestion is a suitable way to stabilize an anaerobic digestion system even at a low ISR. (C) 2015 Elsevier Ltd. All rights reserved.	[Wu, Chuanfu; Wang, Qunhui; Yu, Miao; Zhang, Xiao; Song, Na; Chang, Qiang] Univ Sci & Technol Beijing, Dept Environm Engn, Sch Civil & Environm Engn, Beijing 10083, Peoples R China; [Wu, Chuanfu; Wang, Qunhui] Univ Sci & Technol Beijing, Beijing Key Lab Resource Oriented Treatment Ind P, Beijing 10083, Peoples R China; [Gao, Ming; Sonomoto, Kenji] Kyushu Univ, Fac Agr Grad Sch, Dept Biosci & Biotechnol, Higashi Ku, Fukuoka 8128581, Japan	Wang, QH (reprint author), Univ Sci & Technol Beijing, Dept Environm Engn, 30 Xueyuan Rd, Beijing 100083, Peoples R China.	wangqh59@sina.com			National Key Technology RD Program [2014BAC24B01]; National Natural Science Foundation of China [51278050]	This study was supported by the National Key Technology R&D Program (2014BAC24B01) and National Natural Science Foundation of China (Grant No. 51278050).	Ariunbaatar J, 2014, APPL ENERG, V123, P143, DOI 10.1016/j.apenergy.2014.02.035; THAUER RK, 1977, BACTERIOL REV, V41, P100; Nathao C, 2013, INT J HYDROGEN ENERG, V38, P15764, DOI 10.1016/j.ijhydene.2013.05.047; Hernandez M, 2013, RENEW ENERG, V53, P187, DOI 10.1016/j.renene.2012.11.024; Kawai M, 2014, BIORESOURCE TECHNOL, V157, P174, DOI 10.1016/j.biortech.2014.01.018; Siegert I, 2005, PROCESS BIOCHEM, V40, P3412, DOI 10.1016/j.procbio.2005.01.025; Demirel B, 2002, J CHEM TECHNOL BIOT, V77, P743, DOI 10.1002/jctb.630; Dogan T, 2005, J ENVIRON SCI HEAL A, V40, P633, DOI 10.1081/ESE-200046616; Liew LN, 2011, BIORESOURCE TECHNOL, V102, P8828, DOI 10.1016/j.biortech.2011.07.005; Zhu JY, 2010, BIORESOURCE TECHNOL, V101, P7523, DOI 10.1016/j.biortech.2010.04.060; Koch K, 2015, APPL ENERG, V137, P250, DOI 10.1016/j.apenergy.2014.10.025; Liu GQ, 2009, BIORESOURCE TECHNOL, V100, P5103, DOI 10.1016/j.biortech.2009.03.081; GUNASEELAN VN, 1995, BIOMASS BIOENERG, V8, P39; Chen XH, 2014, APPL ENERG, V122, P34, DOI 10.1016/j.apenergy.2014.01.076; Kim DH, 2013, BIORESOURCE TECHNOL, V127, P267, DOI 10.1016/j.biortech.2012.09.088; Liu XY, 2013, BIORESOURCE TECHNOL, V146, P317, DOI 10.1016/j.biortech.2013.07.096; Jeihanipour A, 2013, RENEW ENERG, V52, P128, DOI 10.1016/j.renene.2012.10.042; Zhou YL, 2011, BIOMASS BIOENERG, V35, P3251, DOI 10.1016/j.biombioe.2011.04.002; Neves L, 2004, PROCESS BIOCHEM, V39, P2019, DOI 10.1016/j.procbio.2003.10.002; Forster-Carneiro T, 2008, BIORESOURCE TECHNOL, V99, P6994, DOI 10.1016/j.biortech.2008.01.018; Xu SY, 2012, BIORESOURCE TECHNOL, V126, P425, DOI 10.1016/j.biortech.2011.12.059; Chen TH, 1996, BIORESOURCE TECHNOL, V56, P179, DOI 10.1016/0960-8524(96)00016-8; Chen Y, 2008, BIORESOURCE TECHNOL, V99, P4044, DOI 10.1016/j.biortech.2007.01.057; CHO JK, 1995, BIORESOURCE TECHNOL, V52, P245, DOI 10.1016/0960-8524(95)00031-9; Dererie DY, 2011, BIORESOURCE TECHNOL, V102, P4449, DOI 10.1016/j.biortech.2010.12.096; Ebner J, 2014, APPL ENERG, V130, P86, DOI 10.1016/j.apenergy.2014.04.099; Eskicioglu C, 2011, PROCESS BIOCHEM, V46, P1682, DOI 10.1016/j.procbio.2011.04.013; Gallaghan FJ, 2002, BIOMASS BIOENERG, V1, P71; Li J, 1998, J HARBIN U CIVIL ENG, V31, P50; Lu F, 2012, BIORESOURCE TECHNOL, V105, P169, DOI 10.1016/j.biortech.2011.11.104; Ma F, 1995, J HARBIN U ARCHITEC, V28, P63; Ma HZ, 2014, APPL ENERG, V129, P89, DOI 10.1016/j.apenergy.2014.04.098; Ministry of Housing and Urban-Rural Development of the People's Republic of China, 2012, TECHN COD FOOD WAST; Paoli FD, 2011, BIORESOURCE TECHNOLO, V102, P6621; PIPYN P, 1981, BIOTECHNOL BIOENG, V23, P1145, DOI 10.1002/bit.260230521; Ren N, 1995, CHINA BIOGAS, V13, P1; Wang LH, 2012, BIOSYST ENG, V112, P130, DOI 10.1016/j.biosystemseng.2012.03.006; Wang Q, 1997, BIOTECHNOL TECH, V11, P105, DOI 10.1023/A:1018472607261	38	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0306-2619	1872-9118		APPL ENERG	Appl. Energy	OCT 1	2015	155						846	853		10.1016/j.apenergy.2015.04.081		8	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	CQ9QV	WOS:000360950900069		
J	Ueda, H; Tanaka, H; Sakurai, Y				Ueda, H.; Tanaka, H.; Sakurai, Y.			The improvement of the energy resolution in epi-thermal neutron region of Bonner sphere using boric acid water solution moderator	APPLIED RADIATION AND ISOTOPES			English	Article						Boron neutron capture therapy; Bonner sphere; Thermal neutron absorber; Activation detector; Neutron spectrometry; Spectrum unfolding		Bonner sphere is useful to evaluate the neutron spectrum in detail. We are improving the energy resolution in epi-thermal neutron region of Bonner sphere, using boric acid water solution as a moderator. Its response function peak is narrower than that for polyethylene moderator and the improvement of the resolution is expected. The resolutions between polyethylene moderator and boric acid water solution moderator were compared by simulation calculation. Also the influence in the uncertainty of Bonner sphere configuration to spectrum estimation was simulated. (C) 2015 Elsevier Ltd. All rights reserved.	[Ueda, H.] Kyoto Univ, Grad Sch Engn, Nishikyo Ku, Kyoto 6158530, Japan; [Tanaka, H.; Sakurai, Y.] Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 5900494, Japan	Sakurai, Y (reprint author), Kyoto Univ, Inst Res Reactor, Asashiro Nishi 2-1010, Kumatori, Osaka 5900494, Japan.	yosakura@rri.kyoto-u.ac.jp					Sakurai Y, 2000, NUCL INSTRUM METH A, V453, P569, DOI 10.1016/S0168-9002(00)00465-4; Liu YH, 2013, IEEE T NUCL SCI, V60, P783, DOI 10.1109/TNS.2012.2235463; Alevra AV, 2003, RADIAT PROT DOSIM, V107, P37; BLUE TE, 1993, PHYS MED BIOL, V38, P1693, DOI 10.1088/0031-9155/38/12/002; Aroua A, 1997, RADIAT PROT DOSIM, V70, P285; IUCLID Dataset, 2000, 10043353 EUR COMM EU; Reginatto M., 2002, METHODS PHYS RES A, V480, P690; Reginatto Marcel, 2004, TECHNICAL REPORT; X-5 Monte Carlo Team, 2003, LAUR031987 LOS AL NA	9	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0969-8043			APPL RADIAT ISOTOPES	Appl. Radiat. Isot.	OCT	2015	104						25	28		10.1016/j.apradiso.2015.06.020		4	Chemistry, Inorganic & Nuclear; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Chemistry; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	CQ9QA	WOS:000360948600004		
